geneid,gene_symbol,uniprotid,gene_dsi,gene_dpi,gene_pli,protein_class,protein_class_name,diseaseid,disease_name,disease_class,disease_class_name,disease_type,disease_semantic_type,score,ei,el,year_initial,year_final,source
1,A1BG,P04217,0.7,0.538,4.9917e-09,DTO_05007575,Receptor,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
2,A2M,P01023,0.529,0.769,4.5229e-11,DTO_05007584,Enzyme modulator,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.51,1.0,,1998.0,2001.0,ALL
3,A2MP1,,,,,,,C0010200,Coughing,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0,,2017.0,2017.0,ALL
9,NAT1,P18440,0.536,0.846,1.9294e-14,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.75,,1995.0,2018.0,ALL
10,NAT2,P11245,0.451,0.885,3.2744e-06,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.939,,1995.0,2018.0,ALL
12,SERPINA3,P01011,0.486,0.846,8.833e-14,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,1998.0,2017.0,ALL
13,AADAC,P22760,0.631,0.615,0.0029108,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
14,AAMP,Q13685,0.792,0.115,0.76172,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
15,AANAT,Q16613,0.67,0.692,0.002969,,,C0393770,Delayed Sleep Phase Syndrome,C10;F03;C24,   Nervous System Diseases;    Mental Disorders;    Occupational Diseases,disease,Disease or Syndrome,0.31,1.0,,2003.0,2003.0,ALL
16,AARS1,P49588,0.647,0.462,1.8242e-08,DTO_05007557,Nucleic acid binding,C2750090,"Charcot-Marie-Tooth Disease, Axonal, Type 2n",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2010.0,2019.0,ALL
17,AAVS1,,0.595,0.731,,,,C0008533,Hemophilia B,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.09,1.0,,2002.0,2017.0,ALL
18,ABAT,P80404,0.628,0.538,0.0063216,DTO_05007624,Enzyme,C0342708,Gamma aminobutyric acid transaminase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,1998.0,2019.0,ALL
19,ABCA1,O95477,0.467,0.846,1.4525e-13,DTO_05007405,Transporter,C0039292,Tangier Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.991,,1999.0,2019.0,ALL
20,ABCA2,Q9BZC7,0.67,0.615,1.0,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2004.0,2017.0,ALL
21,ABCA3,Q99758,0.592,0.615,6.6226e-08,DTO_05007405,Transporter,C1970456,"Surfactant Metabolism Dysfunction, Pulmonary, 3",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2004.0,2018.0,ALL
22,ABCB7,O75027,0.678,0.385,0.99994,DTO_05007405,Transporter,C1845028,"ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA",C16;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.74,1.0,,1999.0,2018.0,ALL
23,ABCF1,Q8NE71,0.674,0.538,1.2823e-09,DTO_05007624,Enzyme,C0020517,Hypersensitivity,C20,   Immune System Diseases,group,Pathologic Function,0.3,1.0,,2011.0,2011.0,ALL
24,ABCA4,P78363,0.493,0.769,5.3499e-48,DTO_05007405,Transporter,C0271093,Stargardt's disease,,,phenotype,Disease or Syndrome,1.0,0.995,limited,1997.0,2020.0,ALL
25,ABL1,P00519,0.432,0.923,0.99998,DTO_03300101,Kinase,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.8,0.983,,1982.0,2020.0,ALL
26,AOC1,P19801,0.628,0.769,6.7236e-08,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.31,1.0,,1983.0,2018.0,ALL
27,ABL2,P42684,0.619,0.654,3.6365e-07,DTO_03300101,Kinase,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.2,1.0,,1995.0,1995.0,ALL
28,ABO,P16442,0.427,0.885,,DTO_05007624,Enzyme,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.5,0.96,,2009.0,2018.0,ALL
29,ABR,Q12979,0.65,0.5,0.62738,DTO_05007584,Enzyme modulator,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.31,1.0,,2010.0,2014.0,ALL
30,ACAA1,P09110,0.729,0.462,3.5904e-09,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2007.0,2007.0,ALL
31,ACACA,Q13085,0.48,0.846,1.0,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2011.0,2019.0,ALL
32,ACACB,O00763,0.644,0.654,7.6499e-47,,,C0021655,Insulin Resistance,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.5,1.0,,2006.0,2012.0,ALL
33,ACADL,P28330,0.736,0.462,1.743e-12,DTO_05007624,Enzyme,C0220711,Long chain acyl-CoA dehydrogenase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.5,1.0,disputed,1983.0,2014.0,ALL
34,ACADM,P11310,0.638,0.462,2.0548e-12,DTO_05007624,Enzyme,C0220710,Medium-chain acyl-coenzyme A dehydrogenase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.991,definitive,1983.0,2019.0,ALL
35,ACADS,P16219,0.663,0.538,2.8026e-06,,,C0342783,Deficiency of butyryl-CoA dehydrogenase,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1989.0,2018.0,ALL
36,ACADSB,P45954,0.691,0.5,2.6565e-11,,,C1864912,2-Methylbutyryl-CoA Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,definitive,2000.0,2016.0,ALL
37,ACADVL,P49748,0.653,0.654,4.2385e-15,DTO_05007624,Enzyme,C3887523,Very long chain acyl-CoA dehydrogenase deficiency,C16;C18;C05;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.989,definitive,1985.0,2020.0,ALL
38,ACAT1,P24752,0.538,0.692,9.8525e-08,DTO_05007624,Enzyme,C1536500,Deficiency of acetyl-CoA acetyltransferase,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,definitive,1979.0,2019.0,ALL
39,ACAT2,Q9BWD1,0.686,0.462,5.5303e-07,DTO_05007624,Enzyme,C0342735,Cytosolic acetoacetyl-CoA thiolase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
40,ASIC2,Q16515,0.653,0.538,0.99912,DTO_01300327,Ion channel,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
41,ASIC1,P78348,0.653,0.615,0.93017,DTO_01300327,Ion channel,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
43,ACHE,P22303,0.445,0.885,0.99827,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.4,0.985,,1991.0,2020.0,ALL
46,ACLS,,0.931,0.154,,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
47,ACLY,P53396,0.563,0.692,0.083556,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2011.0,2015.0,ALL
48,ACO1,P21399,0.628,0.577,3.8322e-18,DTO_05007624,Enzyme,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0,,2011.0,2011.0,ALL
49,ACR,P10323,0.493,0.846,0.012215,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,1993.0,2020.0,ALL
50,ACO2,Q99798,0.619,0.654,0.20791,DTO_05007624,Enzyme,C3281192,INFANTILE CEREBELLAR-RETINAL DEGENERATION,,,disease,Disease or Syndrome,0.74,1.0,,2012.0,2019.0,ALL
51,ACOX1,Q15067,0.61,0.731,0.062095,DTO_05007624,Enzyme,C1849678,Peroxisomal ACYL-COA oxidase deficiency,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.92,1.0,strong,1994.0,2016.0,ALL
52,ACP1,P24666,0.566,0.731,1.7531e-08,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,1990.0,2017.0,ALL
53,ACP2,P11117,0.78,0.346,6.2383e-05,DTO_05007624,Enzyme,C0268410,Acid Phosphatase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
54,ACP5,P13686,0.561,0.731,0.078651,,,C1842763,SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION,C16;C05;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.72,1.0,,1958.0,2018.0,ALL
55,ACP3,P15309,0.525,0.731,2.5463e-16,DTO_05007624,Enzyme,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
56,ACRV1,P26436,1.0,0.077,1.2111e-06,,,C1175175,Severe Acute Respiratory Syndrome,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
58,ACTA1,P68133,0.54,0.769,1.1385e-06,DTO_05007530,Cellular structure,C3711389,Actin-Accumulation Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.93,1.0,,1988.0,2018.0,ALL
59,ACTA2,P62736,0.508,0.846,0.93017,DTO_05007530,Cellular structure,C3151201,MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME,,,disease,Disease or Syndrome,0.78,1.0,,2007.0,2019.0,ALL
60,ACTB,P60709,0.325,0.923,0.98564,DTO_05007530,Cellular structure,C1855722,"Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation",C23;C16;C11;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.72,1.0,,1989.0,2018.0,ALL
62,ACTBP2,,0.861,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
70,ACTC1,P68032,0.61,0.538,0.73668,DTO_05007530,Cellular structure,C3150681,"CARDIOMYOPATHY, DILATED, 1R",,,disease,Disease or Syndrome,0.8,1.0,strong,1998.0,2019.0,ALL
71,ACTG1,P63261,0.477,0.846,0.0047837,DTO_05007530,Cellular structure,C1858172,"Deafness, Autosomal Dominant 20",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1996.0,2014.0,ALL
72,ACTG2,P63267,0.505,0.808,0.071036,DTO_05007530,Cellular structure,C0042781,Visceral Myopathy,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.75,0.917,,2012.0,2020.0,ALL
81,ACTN4,O43707,0.508,0.808,1.0,,,C4551527,Focal segmental glomerulosclerosis 1,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.8,1.0,strong,2000.0,2015.0,ALL
86,ACTL6A,O96019,0.678,0.346,0.99665,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,strong,2017.0,2017.0,ALL
87,ACTN1,P12814,0.695,0.577,0.99997,,,C3554663,"BLEEDING DISORDER, PLATELET-TYPE, 15",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2015.0,ALL
88,ACTN2,P35609,0.686,0.462,0.99968,,,C2677338,"Cardiomyopathy, Dilated, 1AA",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2004.0,2016.0,ALL
89,ACTN3,Q08043,0.663,0.5,,,,C3888204,ACTN3 DEFICIENCY,,,disease,Disease or Syndrome,0.2,0.909,,2001.0,2019.0,ALL
90,ACVR1,Q04771,0.535,0.731,0.3254,DTO_03300101,Kinase,C0016037,Fibrodysplasia Ossificans Progressiva,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,1.0,1.0,,2006.0,2020.0,ALL
91,ACVR1B,P36896,0.663,0.385,0.99969,DTO_03300101,Kinase,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2004.0,2004.0,ALL
92,ACVR2A,P27037,0.636,0.615,0.99972,DTO_03300101,Kinase,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
93,ACVR2B,Q13705,0.601,0.615,0.83412,DTO_03300101,Kinase,C3151057,"HETEROTAXY, VISCERAL, 4, AUTOSOMAL",,,disease,Disease or Syndrome,0.9,1.0,,1997.0,1999.0,ALL
94,ACVRL1,P37023,0.493,0.769,0.00096719,DTO_03300101,Kinase,C1838163,OSLER-RENDU-WEBER SYNDROME 2,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.76,1.0,definitive,1996.0,2018.0,ALL
95,ACY1,Q03154,0.653,0.577,6.9169e-09,,,C1835922,Aminoacylase 1 deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2005.0,2011.0,ALL
98,ACYP2,P14621,0.659,0.577,6.5331e-05,DTO_05007624,Enzyme,C2750088,"HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO",,,disease,Finding,0.3,1.0,,2015.0,2015.0,ALL
100,ADA,P00813,0.44,0.885,2.8825e-12,DTO_05007624,Enzyme,C0392607,Severe combined immunodeficiency due to adenosine deaminase deficiency,C16;C18;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.977,limited,1980.0,2019.0,ALL
101,ADAM8,P78325,0.59,0.731,2.1983e-14,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
102,ADAM10,O14672,0.489,0.846,1.0,,,C0406811,Reticulate acropigmentation of Kitamura,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2013.0,2019.0,ALL
103,ADAR,P55265,0.501,0.808,0.026282,DTO_05007624,Enzyme,C0393591,AICARDI-GOUTIERES SYNDROME,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2012.0,2020.0,ALL
104,ADARB1,P78563,0.588,0.654,0.80347,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.333,,2004.0,2014.0,ALL
105,ADARB2,Q9NS39,0.716,0.308,0.85603,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
106,ADCP1,,0.89,0.154,,,,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0,,1980.0,1980.0,ALL
107,ADCY1,Q08828,0.659,0.462,0.99747,,,C1857809,"DEAFNESS, AUTOSOMAL RECESSIVE 44",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
108,ADCY2,Q08462,0.695,0.308,0.99898,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.62,1.0,,2014.0,2019.0,ALL
109,ADCY3,O60266,0.678,0.615,1.9545e-11,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.49,1.0,,2008.0,2018.0,ALL
111,ADCY5,O95622,0.617,0.577,0.99928,,,C1847627,"Dyskinesia, Familial, with Facial Myokymia",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,,2001.0,2017.0,ALL
112,ADCY6,O43306,0.729,0.5,0.0058268,,,C4225385,LETHAL CONGENITAL CONTRACTURE SYNDROME 8,,,disease,Disease or Syndrome,0.71,1.0,limited,2014.0,2020.0,ALL
113,ADCY7,P51828,0.656,0.462,9.4815e-07,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.41,1.0,,2015.0,2017.0,ALL
114,ADCY8,P40145,0.705,0.577,1.7766e-06,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.51,1.0,,2009.0,2013.0,ALL
115,ADCY9,O60503,0.682,0.538,0.97943,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
116,ADCYAP1,P18509,0.51,0.846,0.52424,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.75,,2001.0,2019.0,ALL
117,ADCYAP1R1,P41586,0.561,0.769,7.2275e-10,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2007.0,2017.0,ALL
118,ADD1,P35611,0.612,0.615,0.9883,DTO_05007530,Cellular structure,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.6,0.861,,1995.0,2019.0,ALL
119,ADD2,P35612,0.678,0.615,0.9961,DTO_05007530,Cellular structure,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.24,1.0,,1991.0,2007.0,ALL
120,ADD3,Q9UEY8,0.641,0.5,0.9988,DTO_05007530,Cellular structure,C4310767,"CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2013.0,ALL
123,PLIN2,Q99541,0.564,0.692,7.5281e-09,DTO_05007405,Transporter,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.38,1.0,,2006.0,2019.0,ALL
124,ADH1A,P07327,0.647,0.577,1.7118e-11,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,1999.0,2013.0,ALL
125,ADH1B,P00325,0.502,0.846,9.934e-07,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,1.0,,1994.0,2019.0,ALL
126,ADH1C,P00326,0.547,0.731,,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,1.0,,1991.0,2019.0,ALL
127,ADH4,P08319,0.641,0.462,8.0684e-07,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,1994.0,2019.0,ALL
128,ADH5,P11766,0.604,0.731,2.5356e-11,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,1994.0,2006.0,ALL
130,ADH6,P28332,0.78,0.231,1.6373e-06,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
131,ADH7,P40394,0.656,0.462,1.5123e-11,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2004.0,2014.0,ALL
132,ADK,P55263,0.584,0.769,0.00031276,DTO_03300101,Kinase,C3280381,HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2016.0,ALL
133,ADM,P35318,0.436,0.808,0.040831,DTO_05007599,Signaling,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.6,1.0,,2000.0,2020.0,ALL
134,ADORA1,P30542,0.578,0.692,0.015215,DTO_02300001,G-protein coupled receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
135,ADORA2A,P29274,0.526,0.769,0.5971,DTO_02300001,G-protein coupled receptor,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.5,1.0,,2008.0,2016.0,ALL
136,ADORA2B,P29275,0.617,0.692,1.7674e-05,DTO_02300001,G-protein coupled receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
140,ADORA3,P0DMS8,0.682,0.5,0.0001441,DTO_02300001,G-protein coupled receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
141,ADPRH,P54922,0.805,0.231,2.991e-06,DTO_05007624,Enzyme,C1863512,"HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.03,1.0,,2002.0,2019.0,ALL
142,PARP1,P09874,0.389,0.923,0.00033366,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,0.968,,1997.0,2020.0,ALL
143,PARP4,Q9UKK3,0.729,0.269,4.8204e-27,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
146,ADRA1D,P25100,0.636,0.731,4.0117e-05,DTO_02300001,G-protein coupled receptor,C1135196,"Heart Failure, Diastolic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
147,ADRA1B,P35368,0.686,0.5,0.13541,DTO_02300001,G-protein coupled receptor,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.3,1.0,,2001.0,2002.0,ALL
148,ADRA1A,P35348,0.462,0.846,3.3722e-07,DTO_02300001,G-protein coupled receptor,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2007.0,2009.0,ALL
150,ADRA2A,P08913,0.578,0.615,0.00081816,DTO_02300001,G-protein coupled receptor,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.53,0.75,,2001.0,2011.0,ALL
151,ADRA2B,P18089,0.465,0.846,4.4533e-06,DTO_02300001,G-protein coupled receptor,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.4,1.0,,2011.0,2011.0,ALL
152,ADRA2C,P18825,0.682,0.346,0.50159,DTO_02300001,G-protein coupled receptor,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.38,0.889,,2002.0,2012.0,ALL
153,ADRB1,P08588,0.555,0.769,2.8786e-06,DTO_02300001,G-protein coupled receptor,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.6,0.933,,1991.0,2019.0,ALL
154,ADRB2,P07550,0.442,0.923,0.52545,DTO_02300001,G-protein coupled receptor,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.51,1.0,,2002.0,2008.0,ALL
155,ADRB3,P13945,0.533,0.731,2.4637e-07,DTO_02300001,G-protein coupled receptor,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.52,1.0,,2004.0,2017.0,ALL
156,GRK2,P25098,0.532,0.654,0.99998,DTO_03300101,Kinase,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.6,0.98,,1994.0,2020.0,ALL
157,GRK3,P35626,0.621,0.731,0.71059,DTO_03300101,Kinase,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.56,1.0,,2003.0,2010.0,ALL
158,ADSL,P30566,0.631,0.654,8.9207e-12,DTO_05007624,Enzyme,C0268126,Adenylosuccinate lyase deficiency (disorder),C16;C18;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Mental Disorders",disease,Disease or Syndrome,0.79,1.0,strong,1992.0,2017.0,ALL
159,ADSS2,P30520,0.839,0.308,0.32971,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
160,AP2A1,O95782,0.641,0.5,1.0,DTO_05007575,Receptor,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
161,AP2A2,O94973,0.76,0.423,1.0,DTO_05007575,Receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.11,1.0,,2013.0,2018.0,ALL
162,AP1B1,Q10567,0.716,0.385,0.99828,DTO_05007405,Transporter,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.3,1.0,moderate,2019.0,2019.0,ALL
163,AP2B1,P63010,0.711,0.423,0.9983,DTO_05007405,Transporter,C0086132,Depressive Symptoms,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.31,1.0,,2009.0,2009.0,ALL
164,AP1G1,O43747,0.89,0.115,0.99998,DTO_05007575,Receptor,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
165,AEBP1,Q8IUX7,0.631,0.654,7.3471e-11,,,C4693870,"EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2",,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2019.0,ALL
166,TLE5,Q08117,0.695,0.538,0.93594,DTO_05007542,Transcription factor,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
167,CRISP1,P54107,0.78,0.231,1.8344e-06,DTO_05007608,Immune response,C0039128,Syphilis,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,2008.0,2014.0,ALL
170,AFA,,0.792,0.462,,,,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0,,1999.0,2003.0,ALL
172,AFG3L1P,,0.931,0.115,,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2008.0,2018.0,ALL
173,AFM,P43652,0.59,0.731,4.2654e-19,DTO_05007405,Transporter,C0013221,Drug toxicity,C25,   Chemically-Induced Disorders,group,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
174,AFP,P02771,0.429,0.885,1.1383e-11,DTO_05007405,Transporter,C1863081,alpha-Fetoprotein Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,,2004.0,2004.0,ALL
175,AGA,P20933,0.57,0.808,4.2802e-06,DTO_05007624,Enzyme,C0268225,Aspartylglucosaminuria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,1.0,0.96,,1990.0,2019.0,ALL
176,ACAN,P16112,0.528,0.846,1.0,DTO_05007621,Extracellular structure,C2748544,"Spondyloepimetaphyseal Dysplasia, Aggrecan Type",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,,2009.0,2017.0,ALL
177,AGER,Q15109,0.42,0.885,6.3528e-16,DTO_05007575,Receptor,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.6,0.974,,1999.0,2019.0,ALL
178,AGL,P35573,0.644,0.615,2.7564e-27,DTO_05007624,Enzyme,C0017922,Glycogen Storage Disease Type III,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.988,,1987.0,2020.0,ALL
181,AGRP,O00253,0.488,0.769,0.00069912,DTO_05007599,Signaling,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,0.938,,1997.0,2019.0,ALL
182,JAG1,P78504,0.429,0.808,1.0,,,C0085280,Alagille Syndrome,C16;C06;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.9,0.952,strong,1997.0,2019.0,ALL
183,AGT,P01019,0.367,0.923,4.9706e-08,DTO_05007584,Enzyme modulator,C0266313,Allanson Pantzar McLeod syndrome,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.71,1.0,,2005.0,2015.0,ALL
185,AGTR1,P30556,0.423,0.846,0.00053161,DTO_02300001,G-protein coupled receptor,C0266313,Allanson Pantzar McLeod syndrome,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.7,1.0,,2005.0,2015.0,ALL
186,AGTR2,P50052,0.496,0.808,0.0082345,DTO_02300001,G-protein coupled receptor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.6,1.0,,2001.0,2019.0,ALL
187,APLNR,P35414,0.588,0.692,0.78907,DTO_02300001,G-protein coupled receptor,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2003.0,2019.0,ALL
189,AGXT,P21549,0.593,0.731,1.2332e-07,DTO_05007624,Enzyme,C0268164,"Primary hyperoxaluria, type I",C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,1.0,,1973.0,2019.0,ALL
190,NR0B1,P51843,0.494,0.808,0.97025,DTO_00102000,Nuclear receptor,C0342482,X-linked Adrenal Hypoplasia,C19,   Endocrine System Diseases,disease,Disease or Syndrome,1.0,1.0,strong,1994.0,2019.0,ALL
191,AHCY,P23526,0.582,0.692,0.035922,DTO_05007624,Enzyme,C3151058,S-adenosylhomocysteine hydrolase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,moderate,1959.0,2018.0,ALL
192,AIC,,0.729,0.462,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
196,AHR,P35869,0.41,0.923,0.99999,DTO_05007542,Transcription factor,C0700501,Congenital nystagmus,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.5,1.0,,1997.0,2013.0,ALL
197,AHSG,P02765,0.506,0.846,3.209e-10,DTO_05007584,Enzyme modulator,C1859878,Alopecia-Mental Retardation Syndrome 1,C23;C17;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.5,1.0,,2017.0,2017.0,ALL
199,AIF1,P55008,0.521,0.808,1.8793e-06,DTO_05007616,Calcium-binding protein,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.54,1.0,,2007.0,2020.0,ALL
202,CRYBG1,Q9Y4K1,0.743,0.462,3.5143e-33,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.38,1.0,,1996.0,2012.0,ALL
203,AK1,P00568,0.711,0.5,0.027319,DTO_03300101,Kinase,C2675459,"Adenylate Kinase Deficiency, Hemolytic Anemia Due To",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,1.0,,1989.0,2017.0,ALL
204,AK2,P54819,0.678,0.423,6.2706e-05,DTO_03300101,Kinase,C0272167,Reticular dysgenesis,C16;C18;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.75,1.0,,2009.0,2019.0,ALL
205,AK4,P27144,0.705,0.462,0.13353,DTO_03300101,Kinase,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
207,AKT1,P31749,0.311,0.962,0.9759,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.9,0.865,limited,2001.0,2019.0,ALL
208,AKT2,P31751,0.474,0.769,0.64432,DTO_03300101,Kinase,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.96,1.0,,2001.0,2018.0,ALL
210,ALAD,P13716,0.556,0.615,5.6185e-05,DTO_05007624,Enzyme,C0268328,Porphobilinogen synthase deficiency,C16;C06;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.73,1.0,,1991.0,2016.0,ALL
211,ALAS1,P13196,0.705,0.462,0.10979,DTO_05007624,Enzyme,C0032708,Disorders of Porphyrin Metabolism,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.52,1.0,,1995.0,2019.0,ALL
212,ALAS2,P22557,0.606,0.577,0.99586,DTO_05007624,Enzyme,C4551511,X-linked sideroblastic anemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1992.0,2019.0,ALL
213,ALB,P02768,0.317,0.962,0.64329,DTO_05007405,Transporter,C0342185,"Hyperthyroxinemia, Familial Dysalbuminemic",C16;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Endocrine System Diseases",disease,Disease or Syndrome,0.8,0.941,strong,1986.0,2019.0,ALL
214,ALCAM,Q13740,0.502,0.808,0.73267,DTO_05007620,Cell adhesion,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.32,1.0,,2005.0,2011.0,ALL
215,ABCD1,P33897,0.563,0.731,0.99896,DTO_05007405,Transporter,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,1.0,0.977,definitive,1981.0,2020.0,ALL
216,ALDH1A1,P00352,0.46,0.846,0.95448,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.39,1.0,,1983.0,2017.0,ALL
217,ALDH2,P05091,0.457,0.885,3.3959e-10,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,1.0,,1991.0,2019.0,ALL
218,ALDH3A1,P30838,0.641,0.577,3.9013e-17,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2004.0,2004.0,ALL
219,ALDH1B1,P30837,0.691,0.462,2.6981e-06,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
220,ALDH1A3,P47895,0.578,0.654,0.14128,DTO_05007624,Enzyme,C3554524,"MICROPHTHALMIA, ISOLATED 8",,,disease,Disease or Syndrome,0.7,1.0,,2002.0,2015.0,ALL
221,ALDH3B1,P43353,0.821,0.346,6.2437e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2005.0,2009.0,ALL
222,ALDH3B2,P48448,1.0,0.077,3.1881e-13,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
223,ALDH9A1,P49189,0.76,0.269,1.0995e-11,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
224,ALDH3A2,P51648,0.619,0.769,9.4055e-06,,,C0037231,Sjogren-Larsson Syndrome,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1981.0,2019.0,ALL
225,ABCD2,Q9UBJ2,0.711,0.5,4.7079e-06,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
226,ALDOA,P04075,0.631,0.615,0.0013228,,,C0272066,Glycogen Storage Disease XII,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1981.0,2016.0,ALL
229,ALDOB,P05062,0.623,0.538,7.8786e-07,,,C0016751,Hereditary fructose intolerance syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.77,1.0,,1983.0,2017.0,ALL
230,ALDOC,P09972,0.78,0.231,0.092245,,,C0006023,Borna Disease,C01;C22,   Infections;    Animal Diseases,disease,Disease or Syndrome,0.2,1.0,,2007.0,2007.0,ALL
231,AKR1B1,P15121,0.491,0.885,2.0216e-05,DTO_05007624,Enzyme,C0086543,Cataract,C11,   Eye Diseases,disease,Acquired Abnormality,0.4,0.947,,1995.0,2019.0,ALL
236,AKR1B1P2,,1.0,0.154,,,,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.03,1.0,,1998.0,2007.0,ALL
238,ALK,Q9UM73,0.396,0.846,3.2299e-06,DTO_03300101,Kinase,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.7,0.957,,2000.0,2020.0,ALL
239,ALOX12,P18054,0.558,0.692,1.4397e-15,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2014.0,ALL
240,ALOX5,P09917,0.447,0.885,1.2059e-06,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,0.95,,1997.0,2020.0,ALL
241,ALOX5AP,P20292,0.612,0.731,0.070729,DTO_05007624,Enzyme,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.4,1.0,,2004.0,2018.0,ALL
242,ALOX12B,O75342,0.603,0.577,0.00075626,DTO_05007624,Enzyme,C0079154,Congenital Nonbullous Ichthyosiform Erythroderma,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.75,0.889,limited,2003.0,2013.0,ALL
243,ALOX12P1,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
245,ALOX12P2,,1.0,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2014.0,ALL
246,ALOX15,P16050,0.502,0.846,1.1397e-23,DTO_05007624,Enzyme,C0027430,Nasal Polyps,C23;C08;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.41,1.0,,2019.0,2019.0,ALL
247,ALOX15B,O15296,0.663,0.462,1.4819e-18,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2003.0,2014.0,ALL
248,ALPI,P09923,0.563,0.769,2.4527e-18,DTO_05007624,Enzyme,C3658208,Dysbiosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.2,1.0,,2017.0,2017.0,ALL
249,ALPL,P05186,0.546,0.769,0.0003636,DTO_05007624,Enzyme,C0268412,Infantile hypophosphatasia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,1.0,,1987.0,2019.0,ALL
250,ALPP,P05187,0.487,0.808,1.8144e-13,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2004.0,2019.0,ALL
251,ALPG,P10696,0.691,0.269,1.4933e-11,DTO_05007624,Enzyme,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
253,ALS3,,0.839,0.231,,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2012.0,2017.0,ALL
257,ALX3,O95076,0.578,0.692,0.019117,,,C1876203,Frontonasal dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.76,1.0,,1980.0,2018.0,ALL
258,AMBN,Q9NP70,0.716,0.231,1.0497e-09,DTO_05007530,Cellular structure,C4225394,"AMELOGENESIS IMPERFECTA, TYPE IF",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2016.0,ALL
259,AMBP,P02760,0.537,0.731,2.7886e-13,,,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.31,0.667,,1996.0,2017.0,ALL
261,AMCN,,0.682,0.615,,,,C0280324,Laryngeal Squamous Cell Carcinoma,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.08,1.0,,2015.0,2019.0,ALL
262,AMD1,P17707,0.593,0.577,0.98227,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
263,AMD1P2,,0.608,0.538,,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2020.0,ALL
265,AMELX,Q99217,0.599,0.769,0.074507,,,C1845053,"Amelogenesis Imperfecta, Hypomaturation Type, with Snow-Capped Teeth",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.6,1.0,strong,1993.0,2004.0,ALL
266,AMELY,Q99218,0.743,0.269,8.3683e-05,,,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
267,AMFR,Q9UKV5,0.599,0.692,5.8368e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2006.0,2016.0,ALL
268,AMH,P03971,0.476,0.846,3.3974e-12,,,C1849930,Persistent Mullerian duct syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Anatomical Abnormality,0.8,0.958,strong,1991.0,2020.0,ALL
269,AMHR2,Q16671,0.638,0.423,2.7013e-10,DTO_03300101,Kinase,C1849930,Persistent Mullerian duct syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Anatomical Abnormality,0.89,1.0,strong,1996.0,2019.0,ALL
270,AMPD1,P23109,0.573,0.692,1.9099e-21,DTO_05007624,Enzyme,C3714933,MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,limited,2000.0,2016.0,ALL
271,AMPD2,Q01433,0.663,0.577,4.5084e-07,DTO_05007624,Enzyme,C4014354,"PONTOCEREBELLAR HYPOPLASIA, TYPE 9",,,disease,Disease or Syndrome,0.73,1.0,,2013.0,2020.0,ALL
272,AMPD3,Q01432,0.743,0.385,1.1323e-12,DTO_05007624,Enzyme,C2752073,Erythrocyte Amp Deaminase Deficiency,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.6,1.0,,1994.0,2001.0,ALL
273,AMPH,P49418,0.653,0.462,1.7006e-05,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
274,BIN1,O00499,0.55,0.692,0.77822,,,C0410204,"Myopathy, Centronuclear, Autosomal Recessive",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome; Congenital Abnormality,0.73,1.0,,2007.0,2018.0,ALL
275,AMT,P48728,0.674,0.692,0.0027214,,,C0751748,Nonketotic Hyperglycinemia,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,definitive,1983.0,2019.0,ALL
276,AMY1A,P04745,0.644,0.731,0.00032325,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,0.929,,2014.0,2019.0,ALL
277,AMY1B,P04745,0.647,0.731,0.00060271,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,0.923,,2014.0,2019.0,ALL
278,AMY1C,P04745,0.647,0.731,0.0033974,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,0.923,,2014.0,2019.0,ALL
279,AMY2A,P04746,0.716,0.423,8.5411e-12,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,2011.0,2019.0,ALL
280,AMY2B,P19961,0.821,0.269,5.8844e-30,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
282,ANCR,,0.751,0.154,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,0.75,,2017.0,2019.0,ALL
283,ANG,P03950,0.511,0.769,0.28738,,,C2678468,Amyotrophic Lateral Sclerosis 9,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2004.0,2015.0,ALL
284,ANGPT1,Q15389,0.446,0.808,0.95208,DTO_05007599,Signaling,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.4,1.0,,2005.0,2019.0,ALL
285,ANGPT2,O15123,0.41,0.846,0.83208,DTO_05007599,Signaling,C0018923,Hemangiosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
286,ANK1,P16157,0.54,0.885,1.0,,,C2674218,"SPHEROCYTOSIS, TYPE 1 (disorder)",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.91,1.0,strong,1980.0,2011.0,ALL
287,ANK2,Q01484,0.626,0.538,1.0,,,C1970119,"CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.75,1.0,,2003.0,2017.0,ALL
288,ANK3,Q12955,0.578,0.654,1.0,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,1.0,,2008.0,2020.0,ALL
289,ANOP1,,0.89,0.154,,,,C0003119,Anophthalmos,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.02,0.5,,2002.0,2005.0,ALL
290,ANPEP,P15144,0.462,0.769,3.7492e-09,DTO_05007624,Enzyme,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
291,SLC25A4,P12235,0.568,0.692,0.45334,DTO_05007405,Transporter,C1836460,"Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 2",C23;C18;C11;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2000.0,2017.0,ALL
292,SLC25A5,P05141,0.736,0.346,0.93194,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,1996.0,2019.0,ALL
293,SLC25A6,P12236,0.769,0.231,0.13859,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2012.0,2019.0,ALL
301,ANXA1,P04083,0.442,0.885,1.2009e-07,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.6,0.958,,1998.0,2019.0,ALL
302,ANXA2,P07355,0.453,0.808,9.7728e-05,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.36,1.0,,2008.0,2018.0,ALL
304,ANXA2P2,A6NMY6,1.0,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,0.0,,2019.0,2019.0,ALL
305,ANXA2P3,,0.931,0.077,,,,C0005411,Biliary Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
306,ANXA3,P12429,0.61,0.615,6.5152e-12,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,1.0,,2012.0,2012.0,ALL
307,ANXA4,P09525,0.599,0.692,1.1858e-08,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,2004.0,2011.0,ALL
308,ANXA5,P08758,0.458,0.769,3.7978e-15,,,C0019202,Hepatolenticular Degeneration,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,2011.0,2011.0,ALL
309,ANXA6,P08133,0.514,0.846,1.0804e-08,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
310,ANXA7,P20073,0.631,0.615,8.5846e-10,,,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2013.0,2014.0,ALL
311,ANXA11,P50995,0.65,0.692,4.7001e-10,,,C4693381,AMYOTROPHIC LATERAL SCLEROSIS 23,,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2018.0,ALL
312,ANXA13,P27216,0.722,0.538,4.2441e-10,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2017.0,2017.0,ALL
313,AOAH,P28039,0.722,0.462,4.3783e-14,,,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
314,AOC2,O75106,0.674,0.654,3.2599e-15,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.06,1.0,,2003.0,2019.0,ALL
316,AOX1,Q06278,0.716,0.308,1.171e-31,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,2009.0,2018.0,ALL
317,APAF1,O14727,0.525,0.769,9.6242e-06,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,2006.0,2015.0,ALL
318,NUDT2,P50583,0.78,0.154,0.0057495,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
319,APOF,Q13790,0.805,0.231,0.010295,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2015.0,2017.0,ALL
320,APBA1,Q02410,0.743,0.346,0.53701,DTO_05007405,Transporter,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
321,APBA2,Q99767,0.7,0.385,0.74272,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
322,APBB1,O00213,0.722,0.346,0.96811,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,0.944,,1998.0,2019.0,ALL
323,APBB2,Q92870,0.76,0.231,0.065197,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
324,APC,P25054,0.373,0.962,1.0,,,C0032580,Adenomatous Polyposis Coli,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,1.0,0.961,strong,1989.0,2020.0,ALL
325,APCS,P02743,0.531,0.808,0.031714,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.34,0.8,,2003.0,2014.0,ALL
326,AIRE,O43918,0.516,0.808,4.0468e-12,,,C0085859,Polyglandular Type I Autoimmune Syndrome,C20;C19,   Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,1.0,0.985,,1991.0,2020.0,ALL
327,APEH,P13798,0.666,0.577,5.0018e-13,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
328,APEX1,P27695,0.458,0.846,1.9191e-07,,,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,2005.0,2010.0,ALL
329,BIRC2,Q13490,0.535,0.731,0.42708,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2014.0,2015.0,ALL
330,BIRC3,Q13489,0.491,0.769,0.065597,DTO_05007584,Enzyme modulator,C0242647,Mucosa-Associated Lymphoid Tissue Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.6,0.971,,1999.0,2016.0,ALL
331,XIAP,P98170,0.447,0.808,0.91837,DTO_05007584,Enzyme modulator,C1845076,"Lymphoproliferative Syndrome, X-Linked, 2",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.69,1.0,strong,2009.0,2020.0,ALL
332,BIRC5,O15392,0.495,0.731,0.055854,DTO_05007584,Enzyme modulator,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.4,1.0,,2005.0,2008.0,ALL
333,APLP1,P51693,0.76,0.308,0.12235,DTO_05007584,Enzyme modulator,C2076600,Influenza due to Influenza A virus subtype H1N1,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
334,APLP2,Q06481,0.659,0.462,0.37966,DTO_05007584,Enzyme modulator,C0027746,Nerve Degeneration,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2002.0,2002.0,ALL
335,APOA1,P02647,0.429,0.885,0.00054909,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.7,1.0,,2002.0,2019.0,ALL
336,APOA2,P02652,0.582,0.769,0.0448,DTO_05007405,Transporter,C0745103,Hyperlipoproteinemia Type IIa,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.51,1.0,,2002.0,2002.0,ALL
337,APOA4,P06727,0.582,0.577,5.4536e-06,,,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.4,1.0,,1994.0,2019.0,ALL
338,APOB,P04114,0.453,0.808,1.9234e-16,,,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.9,0.985,strong,1987.0,2019.0,ALL
339,APOBEC1,P41238,0.647,0.385,1.6791e-08,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
341,APOC1,P02654,0.581,0.577,0.21685,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.5,1.0,,1999.0,2019.0,ALL
342,APOC1P1,,0.89,0.154,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2018.0,ALL
343,AQP8,O94778,0.638,0.615,0.00036707,DTO_01300327,Ion channel,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
344,APOC2,P02655,0.606,0.577,0.40164,,,C1720779,Apolipoprotein C-II Deficiency (disorder),C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.75,1.0,,1993.0,2017.0,ALL
345,APOC3,P02656,0.531,0.731,0.010024,,,C3151467,Apolipoprotein C-III Deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.61,1.0,,1991.0,2016.0,ALL
346,APOC4,P55056,0.743,0.385,8.893e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
347,APOD,P05090,0.584,0.577,0.00054449,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,0.667,,2002.0,2006.0,ALL
348,APOE,P02649,0.338,0.962,0.0018685,,,C0020479,Hyperlipoproteinemia Type III,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.977,strong,1977.0,2020.0,ALL
350,APOH,P02749,0.563,0.769,1.5614e-15,,,C4277682,Chemical and Drug Induced Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.5,1.0,,2005.0,2013.0,ALL
351,APP,P05067,0.422,0.846,0.046544,DTO_05007584,Enzyme modulator,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.9,0.981,,1987.0,2020.0,ALL
353,APRT,P07741,0.423,0.846,5.4539e-13,,,C0268120,Adenine phosphoribosyltransferase deficiency,C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,1.0,,1986.0,2016.0,ALL
354,KLK3,P07288,0.443,0.885,4.4271e-06,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.5,0.958,,1989.0,2020.0,ALL
355,FAS,P25445,0.372,0.923,0.8117,,,C1328840,Autoimmune Lymphoproliferative Syndrome,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1978.0,2018.0,ALL
356,FASLG,P48023,0.43,0.885,0.18345,DTO_05007599,Signaling,C1328840,Autoimmune Lymphoproliferative Syndrome,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.89,1.0,strong,1984.0,2017.0,ALL
357,SHROOM2,Q13796,0.729,0.385,0.0029403,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
358,AQP1,P29972,0.467,0.885,2.5697e-07,DTO_01300327,Ion channel,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.55,1.0,,2010.0,2019.0,ALL
359,AQP2,P41181,0.581,0.769,2.4855e-06,DTO_01300327,Ion channel,C0162283,Nephrogenic Diabetes Insipidus,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.9,1.0,strong,1988.0,2020.0,ALL
360,AQP3,Q92482,0.546,0.769,0.13398,DTO_01300327,Ion channel,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.33,1.0,,2011.0,2019.0,ALL
361,AQP4,P55087,0.456,0.885,0.0022919,DTO_01300327,Ion channel,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,2010.0,2010.0,ALL
362,AQP5,P55064,0.552,0.769,0.053249,DTO_01300327,Ion channel,C1838359,"Diffuse palmoplantar keratoderma, Bothnian type",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,1.0,moderate,1996.0,2016.0,ALL
363,AQP6,Q13520,0.695,0.577,0.015875,DTO_01300327,Ion channel,C0020757,Ichthyoses,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.02,1.0,,1991.0,2006.0,ALL
364,AQP7,O14520,0.67,0.462,4.0504e-16,DTO_01300327,Ion channel,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,1.0,,2006.0,2019.0,ALL
366,AQP9,O43315,0.565,0.808,0.24027,DTO_01300327,Ion channel,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2002.0,2013.0,ALL
367,AR,P10275,0.351,0.846,0.98837,DTO_00102000,Nuclear receptor,C0039585,Androgen-Insensitivity Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,1.0,0.966,,1970.0,2019.0,ALL
368,ABCC6,O95255,0.54,0.654,5.6167e-35,DTO_05007405,Transporter,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.982,,1978.0,2020.0,ALL
369,ARAF,P10398,0.619,0.654,0.96322,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.41,1.0,,2014.0,2016.0,ALL
372,ARCN1,P48444,0.705,0.462,0.99997,DTO_05007405,Transporter,C4310686,"SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY",,,disease,Disease or Syndrome,0.4,1.0,,2016.0,2016.0,ALL
373,TRIM23,P36406,0.716,0.308,0.0003937,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
374,AREG,P15514,0.487,0.769,0.35407,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1993.0,2020.0,ALL
375,ARF1,P84077,0.626,0.615,0.89967,,,C1868720,Periventricular Nodular Heterotopia,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.41,1.0,,2009.0,2016.0,ALL
377,ARF3,P61204,0.751,0.385,0.35273,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,1998.0,2008.0,ALL
378,ARF4,P18085,0.751,0.308,0.95992,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
379,ARL4D,P49703,0.931,0.077,0.03757,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
381,ARF5,P84085,1.0,0.077,0.94298,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
382,ARF6,P62330,0.631,0.577,0.71536,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2008.0,2019.0,ALL
383,ARG1,P05089,0.476,0.846,0.00035944,DTO_05007624,Enzyme,C0268548,Hyperargininemia,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",phenotype,Disease or Syndrome,1.0,1.0,definitive,1944.0,2020.0,ALL
384,ARG2,P78540,0.569,0.731,0.00018207,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.39,1.0,,2003.0,2017.0,ALL
387,RHOA,P61586,0.502,0.808,0.60405,DTO_05007584,Enzyme modulator,C0020981,Angioimmunoblastic Lymphadenopathy,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,1.0,,2014.0,2019.0,ALL
388,RHOB,P62745,0.653,0.423,0.12253,DTO_05007584,Enzyme modulator,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.33,0.667,,2011.0,2014.0,ALL
389,RHOC,P08134,0.641,0.308,0.76766,DTO_05007584,Enzyme modulator,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2003.0,2019.0,ALL
390,RND3,P61587,0.656,0.385,0.96682,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2017.0,ALL
391,RHOG,P84095,0.89,0.192,0.42952,DTO_05007584,Enzyme modulator,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
392,ARHGAP1,Q07960,0.638,0.577,0.76774,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
393,ARHGAP4,P98171,0.736,0.5,0.97693,DTO_05007584,Enzyme modulator,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
394,ARHGAP5,Q13017,0.769,0.192,0.99862,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2000.0,2017.0,ALL
395,ARHGAP6,O43182,0.769,0.269,0.99845,DTO_05007530,Cellular structure,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
396,ARHGDIA,P52565,0.663,0.577,0.03642,DTO_05007584,Enzyme modulator,C3808953,"NEPHROTIC SYNDROME, TYPE 8",,,disease,Disease or Syndrome,0.6,,strong,,,ALL
397,ARHGDIB,P52566,0.633,0.654,0.0006377,DTO_05007584,Enzyme modulator,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
398,ARHGDIG,Q99819,0.931,0.077,0.92154,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
399,RHOH,Q15669,0.666,0.462,0.14861,DTO_05007584,Enzyme modulator,C0014522,Epidermodysplasia Verruciformis,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,moderate,2012.0,2013.0,ALL
400,ARL1,P40616,1.0,0.038,0.093716,,,C0919659,Oropharyngeal candidiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
401,PHOX2A,O14813,0.7,0.346,0.49018,,,C1865915,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2",C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.73,0.8,strong,2001.0,2012.0,ALL
402,ARL2,P36404,0.743,0.269,0.021417,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
403,ARL3,P36405,0.603,0.615,0.0014071,,,C4748442,JOUBERT SYNDROME 35,,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
405,ARNT,P27540,0.575,0.692,0.99581,DTO_05007542,Transcription factor,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.37,1.0,,2006.0,2019.0,ALL
406,ARNTL,O00327,0.51,0.885,0.99444,DTO_05007542,Transcription factor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,1.0,,2006.0,2019.0,ALL
407,ARR3,P36575,0.46,0.846,0.10401,DTO_05007584,Enzyme modulator,C4538795,"MYOPIA 26, X-LINKED, FEMALE-LIMITED",,,disease,Disease or Syndrome,0.4,1.0,,2016.0,2016.0,ALL
408,ARRB1,P49407,0.588,0.846,0.99394,DTO_05007584,Enzyme modulator,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.32,1.0,,2016.0,2019.0,ALL
409,ARRB2,P32121,0.561,0.769,0.50658,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2007.0,2008.0,ALL
410,ARSA,P15289,0.448,0.923,1.0893e-11,DTO_05007624,Enzyme,C0023522,"Leukodystrophy, Metachromatic",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.978,,1975.0,2019.0,ALL
411,ARSB,P15848,0.595,0.692,7.0009e-09,,,C0026709,Mucopolysaccharidosis VI,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1979.0,2019.0,ALL
412,STS,P08842,0.431,0.846,0.80886,DTO_05007624,Enzyme,C0079588,"Ichthyosis, X-Linked",C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,0.974,,1978.0,2019.0,ALL
413,ARSC2,,1.0,0.192,,,,C0221033,Trisomy X syndrome,C23;C16;C13;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0,,1984.0,1984.0,ALL
414,ARSD,P51689,0.535,0.808,0.0016285,DTO_05007624,Enzyme,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,0.955,,2009.0,2020.0,ALL
415,ARSL,P51690,0.663,0.654,0.58982,DTO_05007624,Enzyme,C1844853,Brachytelephalangic Chondrodysplasia Punctata,,,disease,Disease or Syndrome,0.63,1.0,strong,1995.0,2013.0,ALL
416,ARSF,P54793,0.663,0.615,3.1126e-14,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2007.0,2013.0,ALL
417,ART1,P52961,0.7,0.385,5.1026e-12,,,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,2013.0,2017.0,ALL
419,ART3,Q13508,0.839,0.192,5.1018e-15,,,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
420,ART4,Q93070,0.931,0.154,0.0015662,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
421,ARVCF,O00192,0.54,0.769,5.0422e-11,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.46,1.0,,2005.0,2019.0,ALL
424,ARVD3,,0.792,0.192,,,,C0349788,Arrhythmogenic Right Ventricular Dysplasia,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.05,1.0,,2001.0,2014.0,ALL
425,ARVD4,,1.0,0.077,,,,C0349788,Arrhythmogenic Right Ventricular Dysplasia,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0,,1997.0,1997.0,ALL
427,ASAH1,Q13510,0.526,0.808,1.2588e-12,DTO_05007624,Enzyme,C0268255,Farber Lipogranulomatosis,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1989.0,2019.0,ALL
429,ASCL1,P50553,0.552,0.692,0.67692,DTO_05007542,Transcription factor,C1275808,Congenital central hypoventilation,C23;C08;C10,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.61,1.0,limited,2003.0,2003.0,ALL
430,ASCL2,Q99929,0.691,0.423,0.34557,DTO_05007542,Transcription factor,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,0.833,,2004.0,2019.0,ALL
431,ASD1,,0.861,0.154,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
432,ASGR1,P07306,0.805,0.192,3.8718e-15,DTO_05007575,Receptor,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2015.0,2018.0,ALL
433,ASGR2,P07307,,,9.8145e-10,DTO_05007575,Receptor,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
434,ASIP,P42127,0.584,0.692,0.016298,DTO_05007599,Signaling,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.38,1.0,,2002.0,2013.0,ALL
435,ASL,P04424,0.593,0.731,8.5727e-10,DTO_05007624,Enzyme,C0268547,Argininosuccinic Aciduria,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1976.0,2019.0,ALL
438,ASMT,P46597,0.691,0.346,1.2722e-20,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2008.0,2014.0,ALL
439,GET3,O43681,1.0,0.038,0.94316,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
440,ASNS,P08243,0.595,0.692,9.3611e-06,DTO_05007624,Enzyme,C3809971,ASPARAGINE SYNTHETASE DEFICIENCY,,,disease,Disease or Syndrome,0.73,1.0,definitive,1968.0,2019.0,ALL
443,ASPA,P45381,0.564,0.731,0.00041128,,,C0206307,Canavan Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.967,strong,1990.0,2020.0,ALL
444,ASPH,Q12797,0.61,0.615,6.6268e-15,,,C1832167,"Ectopia Lentis, Spontaneous Filtering Blebs, and Craniofacial Dysmorphism",C16;C11;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.72,1.0,moderate,2014.0,2018.0,ALL
445,ASS1,P00966,0.523,0.731,1.5095e-09,DTO_05007624,Enzyme,C0175683,Citrullinemia,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,definitive,1982.0,2020.0,ALL
460,ASTN1,O14525,0.736,0.308,0.99998,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
462,SERPINC1,P01008,0.507,0.769,0.99892,DTO_05007584,Enzyme modulator,C0272375,Antithrombin III Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.987,strong,1984.0,2019.0,ALL
463,ZFHX3,Q15911;Q6ZP98,0.621,0.654,0.44753,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.5,0.966,,2009.0,2019.0,ALL
465,ATD,,0.656,0.731,,,,C4551856,Asphyxiating Thoracic Dystrophy 1,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.3,,,,,ALL
466,ATF1,P18846,0.588,0.577,0.63426,,,C0206651,Clear Cell Sarcoma of Soft Tissue,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.977,,1993.0,2019.0,ALL
467,ATF3,P18847,0.494,0.885,0.089296,DTO_05007542,Transcription factor,C0848558,Hypospadias,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.37,1.0,,2005.0,2018.0,ALL
468,ATF4,P18848,0.507,0.769,0.015659,,,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.34,1.0,,2016.0,2020.0,ALL
470,ATHS,,0.551,0.769,,,,C0020630,Hypophosphatasia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,1988.0,2018.0,ALL
471,ATIC,P31939,0.576,0.731,3.0109e-19,DTO_05007624,Enzyme,C1837530,AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,strong,2004.0,2004.0,ALL
472,ATM,Q13315,0.374,0.885,5.5884e-47,DTO_03300101,Kinase,C0004135,Ataxia Telangiectasia,C16;C18;C20;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.982,,1953.0,2020.0,ALL
473,RERE,Q9P2R6,0.526,0.846,1.0,,,C4310772,"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART",,,disease,Disease or Syndrome,0.71,1.0,,2015.0,2018.0,ALL
474,ATOH1,Q92858,0.633,0.5,0.017833,DTO_05007624,Enzyme,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2007.0,2019.0,ALL
475,ATOX1,O00244,0.656,0.5,0.58645,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2013.0,2013.0,ALL
476,ATP1A1,P05023,0.601,0.808,1.0,DTO_05007405,Transporter,C4747974,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD",,,disease,Disease or Syndrome,0.7,1.0,strong,2018.0,2018.0,ALL
477,ATP1A2,P50993,0.597,0.615,0.00018093,DTO_05007405,Transporter,C1865322,"MIGRAINE, FAMILIAL HEMIPLEGIC, 2",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.8,1.0,,2003.0,2020.0,ALL
478,ATP1A3,P13637,0.544,0.615,1.0,DTO_05007405,Transporter,C0338488,Alternating hemiplegia of childhood,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.977,,2009.0,2019.0,ALL
479,ATP12A,P54707,0.575,0.769,7.1254e-14,DTO_05007405,Transporter,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.2,1.0,,2013.0,2013.0,ALL
480,ATP1A4,Q13733,0.805,0.269,2.1395e-20,DTO_05007405,Transporter,C0003165,Anthracosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
481,ATP1B1,P05026,0.7,0.462,0.99881,DTO_05007405,Transporter,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,,2009.0,2009.0,ALL
482,ATP1B2,P14415,0.705,0.308,0.073684,DTO_05007405,Transporter,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2014.0,2014.0,ALL
483,ATP1B3,P54709,0.78,0.154,0.10244,DTO_05007405,Transporter,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
486,FXYD2,P54710,0.78,0.346,0.11431,DTO_05007405,Transporter,C1835171,"Hypomagnesemia 2, renal",C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.7,1.0,,2000.0,2016.0,ALL
487,ATP2A1,O14983,0.682,0.423,1.5354e-14,DTO_05007405,Transporter,C1832918,Brody myopathy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,1995.0,2014.0,ALL
488,ATP2A2,P16615,0.529,0.808,0.99945,DTO_05007405,Transporter,C0022595,Keratosis Follicularis,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.974,limited,1999.0,2018.0,ALL
489,ATP2A3,Q93084,0.617,0.577,2.247e-09,DTO_05007405,Transporter,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2005.0,2010.0,ALL
490,ATP2B1,P20020,0.666,0.5,1.0,DTO_05007405,Transporter,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.7,0.966,,1999.0,2019.0,ALL
491,ATP2B2,Q01814,0.659,0.731,1.0,DTO_05007405,Transporter,C1832394,"Deafness, Autosomal Recessive 12",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.5,1.0,moderate,2007.0,2007.0,ALL
492,ATP2B3,Q16720,0.631,0.692,0.99945,DTO_05007405,Transporter,C0796205,"SPINOCEREBELLAR ATAXIA, X-LINKED 1",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2012.0,2012.0,ALL
493,ATP2B4,P23634,0.659,0.577,0.0015112,DTO_05007405,Transporter,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.2,1.0,,2007.0,2007.0,ALL
495,ATP4A,P20648,0.575,0.769,9.4424e-12,DTO_05007405,Transporter,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,0.909,,2003.0,2019.0,ALL
496,ATP4B,P51164,0.76,0.269,4.6372e-05,DTO_05007405,Transporter,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2010.0,2010.0,ALL
498,ATP5F1A,P25705,0.604,0.731,0.99945,DTO_05007405,Transporter,C3808899,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4",,,disease,Disease or Syndrome,0.7,1.0,moderate,2013.0,2013.0,ALL
501,ALDH7A1,P49419,0.551,0.769,1.3923e-22,DTO_05007624,Enzyme,C1849508,"EPILEPSY, PYRIDOXINE-DEPENDENT",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.8,1.0,definitive,2006.0,2020.0,ALL
506,ATP5F1B,P06576,0.626,0.654,0.97679,DTO_05007405,Transporter,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.5,1.0,,2015.0,2015.0,ALL
509,ATP5F1C,P36542,0.89,0.115,0.00079192,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,1.0,,2018.0,2018.0,ALL
513,ATP5F1D,P30049,0.674,0.5,0.073813,DTO_05007405,Transporter,C4748269,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
514,ATP5F1E,P56381,0.686,0.5,0.0088748,DTO_05007405,Transporter,C3279708,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2016.0,ALL
516,ATP5MC1,P05496,0.805,0.308,0.42691,,,C0027877,Neuronal Ceroid-Lipofuscinoses,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0,,1994.0,2013.0,ALL
517,ATP5MC2,Q06055,0.861,0.192,7.4577e-06,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2015.0,ALL
521,ATP5ME,P56385,1.0,0.038,0.085765,DTO_05007405,Transporter,C0949541,Hurthle Cell Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
522,ATP5PF,P18859,0.716,0.538,0.006131,DTO_05007405,Transporter,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
523,ATP6V1A,P38606,0.579,0.615,0.86801,DTO_05007405,Transporter,C4479409,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID",,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
525,ATP6V1B1,P15313,0.695,0.346,2.3997e-09,DTO_05007405,Transporter,C0403554,"Renal Tubular Acidosis, Distal, with Progressive Nerve Deafness",C23;C16;C18;C13;C12;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,definitive,1999.0,2017.0,ALL
526,ATP6V1B2,P21281,0.606,0.577,0.99154,DTO_05007405,Transporter,C2675730,"Deafness, Congenital, and Onychodystrophy, Autosomal Dominant",C23;C16;C10;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.62,1.0,,2014.0,2019.0,ALL
527,ATP6V0C,P27449,0.78,0.154,0.74232,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2005.0,2018.0,ALL
528,ATP6V1C1,P21283,0.821,0.192,0.00015353,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2014.0,2017.0,ALL
529,ATP6V1E1,P36543,0.61,0.769,0.528,DTO_05007405,Transporter,C4479387,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC",,,disease,Disease or Syndrome,0.7,1.0,,2017.0,2017.0,ALL
533,ATP6V0B,Q99437,0.931,0.115,0.96895,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
534,ATP6V1G2,O95670,0.839,0.269,0.0028604,DTO_05007405,Transporter,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2001.0,2011.0,ALL
535,ATP6V0A1,Q93050,0.821,0.192,0.99797,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
537,ATP6AP1,Q15904,0.691,0.577,0.99079,,,C4310819,IMMUNODEFICIENCY 47,,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2018.0,ALL
538,ATP7A,Q04656,0.494,0.769,0.99983,DTO_05007405,Transporter,C0022716,Menkes Kinky Hair Syndrome,C16;C18;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1953.0,2019.0,ALL
539,ATP5PO,P48047,0.861,0.192,0.058145,,,C0016325,Fluoride Poisoning,C25,   Chemically-Induced Disorders,disease,Injury or Poisoning,0.2,1.0,,2011.0,2011.0,ALL
540,ATP7B,P35670,0.529,0.654,4.8001e-30,DTO_05007405,Transporter,C0019202,Hepatolenticular Degeneration,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.98,definitive,1983.0,2020.0,ALL
545,ATR,Q13535,0.456,0.923,3.5177e-09,DTO_03300101,Kinase,C0265202,Seckel syndrome,C23;C16;C05;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2003.0,2018.0,ALL
546,ATRX,P46100,0.452,0.808,1.0,,,C1845055,"ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED",C16;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.982,,1995.0,2019.0,ALL
547,KIF1A,Q12756,0.559,0.692,1.0,DTO_05007530,Cellular structure,C1835896,"SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE (disorder)",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.93,1.0,,2011.0,2020.0,ALL
549,AUH,Q13825,0.686,0.346,8.024e-06,DTO_05007624,Enzyme,C0342727,"3-@METHYLGLUTACONIC ACIDURIA, TYPE I",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.75,1.0,definitive,1982.0,2017.0,ALL
551,AVP,P01185,0.437,0.846,0.074413,DTO_05007599,Signaling,C0687720,Central Diabetes Insipidus,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,1.0,0.988,,1978.0,2020.0,ALL
552,AVPR1A,P37288,0.663,0.5,6.8987e-07,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.52,0.5,,2007.0,2017.0,ALL
553,AVPR1B,P47901,0.705,0.385,0.00037047,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.5,,2012.0,2013.0,ALL
554,AVPR2,P30518,0.568,0.769,0.55589,DTO_02300001,G-protein coupled receptor,C0162283,Nephrogenic Diabetes Insipidus,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.9,1.0,strong,1992.0,2019.0,ALL
558,AXL,P30530,0.489,0.615,0.012951,DTO_03300101,Kinase,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.4,1.0,,2011.0,2019.0,ALL
560,AZF1,,0.711,0.269,,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.1,0.95,,1997.0,2017.0,ALL
563,AZGP1,P25311,0.566,0.769,4.1545e-06,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.39,1.0,,2006.0,2019.0,ALL
566,AZU1,P20160,0.636,0.692,3.9068e-05,DTO_05007624,Enzyme,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.07,1.0,,2017.0,2019.0,ALL
567,B2M,P61769,0.447,0.846,0.56167,DTO_05007608,Immune response,C1855796,"Hypoproteinemia, Hypercatabolic",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,strong,2006.0,2015.0,ALL
570,BAAT,Q14032,0.578,0.654,7.8651e-08,,,C1843139,"Hypercholanemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,,2003.0,2013.0,ALL
571,BACH1,O14867,0.585,0.731,0.57072,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2004.0,2019.0,ALL
572,BAD,Q92934,0.553,0.769,0.0046237,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.35,1.0,,2002.0,2013.0,ALL
573,BAG1,Q99933,0.538,0.769,6.5264e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1999.0,2019.0,ALL
574,BAGE,Q13072,0.711,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,0.889,,1995.0,2006.0,ALL
575,ADGRB1,O14514,0.695,0.231,1.0,DTO_02300001,G-protein coupled receptor,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
576,ADGRB2,O60241,0.89,0.192,0.99982,DTO_02300001,G-protein coupled receptor,C0747251,Progressive spastic paraparesis,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.11,1.0,,2017.0,2017.0,ALL
577,ADGRB3,O60242,0.736,0.192,1.0,DTO_02300001,G-protein coupled receptor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
578,BAK1,Q16611,0.555,0.769,7.4028e-06,DTO_05007599,Signaling,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2008.0,2008.0,ALL
579,NKX3-2,P78367,0.736,0.308,0.63821,DTO_05007542,Transcription factor,C2750066,Spondylo-Megaepiphyseal-Metaphyseal Dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.72,1.0,,1997.0,2019.0,ALL
580,BARD1,Q99728,0.597,0.538,1.3777e-24,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,1.0,0.896,limited,1996.0,2020.0,ALL
581,BAX,Q07812,0.417,0.885,0.31746,DTO_05007599,Signaling,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.52,1.0,,1997.0,2018.0,ALL
582,BBS1,Q8NFJ9,0.593,0.692,3.4063e-12,,,C2936862,Bardet-Biedl syndrome 1 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.94,1.0,,1999.0,2017.0,ALL
583,BBS2,Q9BXC9,0.565,0.654,1.0328e-17,,,C2936863,Bardet-Biedl syndrome 2 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,,2001.0,2019.0,ALL
585,BBS4,Q96RK4,0.647,0.615,1.4549e-16,,,C2936864,Bardet-Biedl syndrome 4 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,,2001.0,2019.0,ALL
586,BCAT1,P54687,0.606,0.538,3.7984e-08,DTO_05007624,Enzyme,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
587,BCAT2,O15382,0.686,0.385,2.826e-12,DTO_05007624,Enzyme,C0024776,Maple Syrup Urine Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.52,1.0,,2004.0,2019.0,ALL
590,BCHE,P06276,0.447,0.923,1.0643e-13,,,C1283400,Butyrylcholinesterase deficiency,C23;C16;C18;C08,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.72,1.0,,1957.0,2016.0,ALL
593,BCKDHA,P12694,0.695,0.423,9.8243e-09,,,C0024776,Maple Syrup Urine Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,1989.0,2019.0,ALL
594,BCKDHB,P21953,0.682,0.5,4.3112e-09,DTO_05007624,Enzyme,C0024776,Maple Syrup Urine Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,1973.0,2019.0,ALL
595,CCND1,P24385,0.344,0.923,0.89057,DTO_05007584,Enzyme modulator,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.7,0.975,,1992.0,2019.0,ALL
596,BCL2,P10415,0.291,0.885,0.55903,DTO_05007599,Signaling,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.67,1.0,,2006.0,2020.0,ALL
597,BCL2A1,Q16548,0.529,0.731,0.20785,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,2003.0,2019.0,ALL
598,BCL2L1,Q07817,0.493,0.885,0.93667,DTO_05007599,Signaling,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2006.0,2007.0,ALL
599,BCL2L2,Q92843,0.599,0.615,0.46908,DTO_05007599,Signaling,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.21,1.0,,2004.0,2010.0,ALL
602,BCL3,P20749,0.541,0.731,0.98871,,,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,,2015.0,2015.0,ALL
603,BCL5,,0.89,0.154,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1994.0,1994.0,ALL
604,BCL6,P41182,0.444,0.808,0.96038,,,C0024305,"Lymphoma, Non-Hodgkin",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.6,0.956,,1993.0,2015.0,ALL
605,BCL7A,Q4VC05,0.736,0.385,0.07823,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2014.0,ALL
606,NBEAP1,P0C6P0,0.861,0.154,,,,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,1997.0,1997.0,ALL
607,BCL9,O00512,0.595,0.615,0.49607,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.43,1.0,,2011.0,2015.0,ALL
608,TNFRSF17,Q02223,0.588,0.692,1.3715e-06,DTO_05007575,Receptor,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.1,0.979,,2004.0,2020.0,ALL
610,HCN2,Q9UL51,0.653,0.385,0.48885,DTO_01300327,Ion channel,C0009952,Febrile Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.22,1.0,,2005.0,2013.0,ALL
611,OPN1SW,P03999,0.519,0.769,0.021134,DTO_02300001,G-protein coupled receptor,C0155017,"Color Blindness, Blue",C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.74,0.667,,1992.0,2018.0,ALL
613,BCR,P11274,0.431,0.885,0.98761,DTO_05007584,Enzyme modulator,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.7,0.969,,1980.0,2020.0,ALL
616,BCRP4,,0.805,0.154,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1991.0,1991.0,ALL
617,BCS1L,Q9Y276,0.534,0.808,4.6972e-13,,,C1864002,GRACILE SYNDROME (disorder),C23;C16;C06;C18;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.77,1.0,,1998.0,2019.0,ALL
618,BCYRN1,,0.666,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1997.0,2019.0,ALL
622,BDH1,Q02338,0.729,0.423,7.5703e-08,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
623,BDKRB1,P46663,0.619,0.731,0.0046897,DTO_02300001,G-protein coupled receptor,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2002.0,2011.0,ALL
624,BDKRB2,P30411,0.585,0.808,0.11863,DTO_02300001,G-protein coupled receptor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.57,1.0,,1996.0,2016.0,ALL
627,BDNF,P23560,0.345,0.923,0.65626,DTO_05007599,Signaling,C1275808,Congenital central hypoventilation,C23;C08;C10,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.62,1.0,limited,2002.0,2018.0,ALL
629,CFB,P00751,0.532,0.769,4.6696e-16,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.7,0.966,limited,2006.0,2019.0,ALL
631,BFSP1,Q12934,0.729,0.231,1.8463e-07,,,C3808107,"CATARACT 33, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.5,1.0,strong,2007.0,2017.0,ALL
632,BGLAP,P02818,0.462,0.846,4.6155e-08,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,1.0,,2000.0,2017.0,ALL
633,BGN,P21810,0.484,0.808,0.45229,,,C1848097,"Spondyloepimetaphyseal Dysplasia, X-Linked",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,,2016.0,2017.0,ALL
634,CEACAM1,P13688,0.525,0.731,0.00078816,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.32,1.0,,2007.0,2011.0,ALL
635,BHMT,Q93088,0.595,0.731,3.739e-14,,,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.34,0.8,,2003.0,2019.0,ALL
636,BICD1,Q96G01,0.821,0.231,1.5724e-05,,,C0034067,Pulmonary Emphysema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.13,1.0,,2011.0,2014.0,ALL
637,BID,P55957,0.555,0.808,1.5646e-11,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2012.0,2019.0,ALL
638,BIK,Q13323,0.653,0.462,5.0334e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2009.0,2009.0,ALL
639,PRDM1,O75626,0.538,0.731,0.9565,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.55,1.0,,2009.0,2017.0,ALL
640,BLK,P51451,0.585,0.769,8.348e-14,DTO_03300101,Kinase,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.976,,2008.0,2020.0,ALL
641,BLM,P54132,0.535,0.808,1.5376e-15,,,C0005859,Bloom Syndrome,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,1.0,0.994,definitive,1994.0,2020.0,ALL
642,BLMH,Q13867,0.716,0.423,0.12878,DTO_05007624,Enzyme,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
643,CXCR5,P32302,0.524,0.769,0.72861,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,0.833,,2008.0,2019.0,ALL
644,BLVRA,P53004,0.663,0.423,0.00034786,DTO_05007624,Enzyme,C3279964,Hyperbiliverdinemia,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.61,1.0,,2009.0,2011.0,ALL
645,BLVRB,P30043,0.695,0.423,4.1869e-06,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
646,BNC1,Q01954,0.736,0.423,0.96479,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2010.0,2019.0,ALL
648,BMI1,P35226,0.448,0.808,0.94286,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
649,BMP1,P13497,0.554,0.769,0.00088564,,,C3553887,"OSTEOGENESIS IMPERFECTA, TYPE XIII",,,disease,Disease or Syndrome,0.71,1.0,strong,2012.0,2019.0,ALL
650,BMP2,P12643,0.432,0.846,0.98799,DTO_05007599,Signaling,C1832702,"BRACHYDACTYLY, TYPE A2",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.75,1.0,strong,2005.0,2018.0,ALL
651,BMP3,P12645,0.678,0.423,0.056398,DTO_05007599,Signaling,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.12,1.0,,2014.0,2016.0,ALL
652,BMP4,P12644,0.422,0.808,0.9564,DTO_05007599,Signaling,C2677434,OROFACIAL CLEFT 11,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.71,1.0,,1986.0,2009.0,ALL
653,BMP5,P22003,0.653,0.577,0.00090084,DTO_05007599,Signaling,C0152423,Congenital small ears,C16;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Otorhinolaryngologic Diseases",disease,Congenital Abnormality,0.31,1.0,limited,2009.0,2009.0,ALL
654,BMP6,P22004,0.531,0.808,0.75947,DTO_05007599,Signaling,C0282193,Iron Overload,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.39,0.889,strong,2009.0,2018.0,ALL
655,BMP7,P18075,0.498,0.769,0.12727,DTO_05007599,Signaling,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.37,1.0,,2003.0,2018.0,ALL
656,BMP8B,P34820,0.792,0.192,0.0001897,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2017.0,ALL
657,BMPR1A,P36894,0.522,0.731,0.90333,DTO_03300101,Kinase,C0345893,Juvenile polyposis syndrome,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,1.0,0.978,definitive,1993.0,2019.0,ALL
658,BMPR1B,O00238,0.573,0.615,0.99863,DTO_03300101,Kinase,C1832702,"BRACHYDACTYLY, TYPE A2",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.76,0.875,,2003.0,2014.0,ALL
659,BMPR2,Q13873,0.538,0.654,0.99998,DTO_03300101,Kinase,C0034091,Pulmonary Veno-Occlusive Disease (disorder),C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.72,1.0,,2003.0,2016.0,ALL
660,BMX,P51813,0.663,0.385,0.006673,DTO_03300101,Kinase,C0345958,Large cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
661,POLR3D,P05423,,,3.8286e-11,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
662,BNIP1,Q12981,0.792,0.346,9.678e-07,,,C0017612,"Glaucoma, Open-Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
663,BNIP2,Q12982,0.861,0.115,6.4641e-05,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
664,BNIP3,Q12983,0.52,0.731,1.9687e-05,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.33,1.0,,2005.0,2009.0,ALL
665,BNIP3L,O60238,0.636,0.654,0.15274,,,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.2,1.0,,2003.0,2003.0,ALL
666,BOK,Q9UMX3,0.722,0.346,0.16279,DTO_05007599,Signaling,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0,,2005.0,2005.0,ALL
667,DST,Q03001,0.552,0.846,1.0,DTO_05007530,Cellular structure,C3539003,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI",,,disease,Disease or Syndrome,0.71,1.0,limited,2010.0,2017.0,ALL
668,FOXL2,P58012,0.542,0.692,0.87762,DTO_05007542,Transcription factor,C0220663,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS (disorder)",C16;C13;C11;C17;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,1.0,,1995.0,2020.0,ALL
669,BPGM,P07738,0.821,0.154,0.021313,,,C1291620,Deficiency of bisphosphoglycerate mutase,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,1989.0,2004.0,ALL
670,BPHL,Q86W56;Q86WA6,0.722,0.231,4.5804e-07,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0,,2013.0,2019.0,ALL
671,BPI,P17213,0.61,0.769,1.6514e-14,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2010.0,2010.0,ALL
672,BRCA1,P38398,0.367,0.923,9.2157e-29,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,1.0,0.956,strong,1992.0,2020.0,ALL
673,BRAF,P15056,0.319,0.846,0.99995,DTO_03300101,Kinase,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,1.0,0.983,,1986.0,2020.0,ALL
675,BRCA2,P51587,0.379,0.846,2.3581e-25,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,1.0,0.951,strong,1994.0,2020.0,ALL
676,BRDT,Q58F21,0.751,0.231,5.7616e-09,DTO_05007378,Epigenetic regulator,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
677,ZFP36L1,Q07352,0.659,0.5,0.67406,DTO_05007557,Nucleic acid binding,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
678,ZFP36L2,P47974,0.686,0.5,0.966,DTO_05007557,Nucleic acid binding,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.31,0.5,,2010.0,2017.0,ALL
680,BRS3,P32247,0.474,0.846,0.94849,DTO_02300001,G-protein coupled receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2001.0,2018.0,ALL
682,BSG,P35613,0.458,0.769,2.5873e-05,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,0.974,,2003.0,2020.0,ALL
683,BST1,Q10588,0.67,0.423,4.2099e-11,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.5,0.92,,2009.0,2019.0,ALL
684,BST2,Q10589,0.57,0.769,0.00042516,,,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.1,1.0,,2009.0,2019.0,ALL
685,BTC,P35070,0.644,0.577,0.062276,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
686,BTD,P43251,0.628,0.654,1.4972e-07,DTO_05007624,Enzyme,C0220754,Biotinidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.988,definitive,1993.0,2019.0,ALL
687,KLF9,Q13886,0.595,0.577,0.88783,DTO_05007557,Nucleic acid binding,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.33,1.0,,2011.0,2019.0,ALL
688,KLF5,Q13887,0.534,0.769,0.8181,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.64,1.0,,2011.0,2019.0,ALL
689,BTF3,P20290,0.674,0.577,0.75624,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2013.0,2019.0,ALL
690,BTF3P11,,0.519,0.731,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,0.941,,2004.0,2019.0,ALL
694,BTG1,P62324,0.564,0.692,0.53641,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2005.0,2005.0,ALL
695,BTK,Q06187,0.464,0.808,0.99996,DTO_03300101,Kinase,C0221026,X-linked agammaglobulinemia,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.964,,1975.0,2020.0,ALL
696,BTN1A1,Q13410,0.839,0.346,1.9496e-08,DTO_05007584,Enzyme modulator,C0751383,Juvenile Neuronal Ceroid Lipofuscinosis,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,0.929,,1997.0,2018.0,ALL
699,BUB1,O43683,0.528,0.731,4.8813e-09,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.7,1.0,,2000.0,2018.0,ALL
700,BVR1,,1.0,0.154,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1994.0,1994.0,ALL
701,BUB1B,O60566,0.502,0.808,6.998e-10,DTO_03300101,Kinase,C1850343,Mosaic variegated aneuploidy syndrome 1,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,1.0,1.0,definitive,2004.0,2019.0,ALL
705,BYSL,Q13895,0.821,0.231,9.9642e-05,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
706,TSPO,P30536,0.444,0.885,0.00027398,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2013.0,2019.0,ALL
708,C1QBP,Q07021,0.569,0.692,2.0164e-07,,,C4540209,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33,,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
710,SERPING1,P05155,0.507,0.769,0.96351,DTO_05007584,Enzyme modulator,C2717906,Hereditary Angioedema Type I,C17;C20;C14,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.73,0.958,strong,1988.0,2018.0,ALL
712,C1QA,P02745,0.623,0.654,0.0038204,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.67,0.7,,1996.0,2012.0,ALL
713,C1QB,P02746,0.711,0.538,0.15392,,,C3150902,C1q DEFICIENCY,,,disease,Disease or Syndrome,0.71,1.0,strong,1997.0,2015.0,ALL
714,C1QC,P02747,0.751,0.423,0.048591,,,C3150902,C1q DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,strong,1996.0,1996.0,ALL
715,C1R,P00736,0.638,0.654,0.77888,DTO_05007624,Enzyme,C4551499,"EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1",C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2017.0,ALL
716,C1S,P09871,0.705,0.462,0.00067654,DTO_05007624,Enzyme,C4310681,"EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2017.0,ALL
717,C2,P06681,0.617,0.692,1.3494e-16,,,C3150275,COMPLEMENT COMPONENT 2 DEFICIENCY,,,disease,Disease or Syndrome,0.77,0.9,strong,1975.0,2010.0,ALL
718,C3,P01024,0.445,0.885,0.90421,DTO_05007584,Enzyme modulator,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.7,1.0,limited,2007.0,2020.0,ALL
719,C3AR1,Q16581,0.601,0.731,3.3053e-09,DTO_02300001,G-protein coupled receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.25,1.0,,2001.0,2016.0,ALL
720,C4A,P0C0L4;P0C0L5,0.563,0.769,1.5416e-11,DTO_05007584,Enzyme modulator,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.957,,1987.0,2018.0,ALL
721,C4B,P0C0L4;P0C0L5,0.603,0.808,0.83464,DTO_05007584,Enzyme modulator,C3280641,Decreased serum complement C4b,,,disease,Disease or Syndrome,0.63,1.0,strong,1992.0,2016.0,ALL
722,C4BPA,P04003,0.556,0.846,0.45739,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2015.0,2015.0,ALL
725,C4BPB,P20851,0.678,0.692,4.3958e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2015.0,2015.0,ALL
726,CAPN5,O15484,0.663,0.615,2.5197e-08,DTO_05007624,Enzyme,C0242852,Proliferative vitreoretinopathy,C11,   Eye Diseases,disease,Disease or Syndrome,0.71,1.0,,2012.0,2019.0,ALL
727,C5,P01031,0.55,0.731,8.079e-24,DTO_05007584,Enzyme modulator,C0343047,Complement component 5 deficiency,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.61,1.0,strong,1977.0,2015.0,ALL
728,C5AR1,P21730,0.513,0.808,0.40249,DTO_02300001,G-protein coupled receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
729,C6,P13671,0.7,0.615,5.8646e-22,,,C2676232,Complement Component 6 Deficiency,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.62,1.0,strong,1987.0,2012.0,ALL
730,C7,P10643,0.751,0.423,1.0747e-14,,,C1864694,Complement Component 7 Deficiency,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.72,1.0,strong,1989.0,2007.0,ALL
731,C8A,P07357,0.821,0.192,6.5536e-16,,,C3151081,"COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I",,,disease,Disease or Syndrome,0.5,1.0,strong,1998.0,1998.0,ALL
732,C8B,P07358,0.76,0.269,2.3057e-19,,,C3151080,"COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II",,,disease,Disease or Syndrome,0.62,1.0,strong,1990.0,2009.0,ALL
733,C8G,P07360,1.0,0.077,2.6521e-17,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
735,C9,P02748,0.619,0.692,1.6323e-24,,,C3151189,C9 Deficiency,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.75,1.0,strong,1998.0,2017.0,ALL
738,VPS51,Q9UID3,0.452,0.846,1.052e-08,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,1997.0,2019.0,ALL
740,MRPL49,Q13405,0.89,0.115,0.00031078,DTO_05007557,Nucleic acid binding,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
741,ZNHIT2,Q9UHR6,0.805,0.115,2.2483e-05,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
744,MPPED2,Q15777,0.78,0.385,0.99349,DTO_05007624,Enzyme,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.12,1.0,,2011.0,2014.0,ALL
745,MYRF,Q9Y2G1,0.584,0.731,1.0,,,C4748946,CARDIAC-UROGENITAL SYNDROME,,,disease,Disease or Syndrome,0.6,1.0,,2018.0,2018.0,ALL
746,TMEM258,P61165,0.644,0.654,0.0018504,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
747,DAGLA,Q9Y4D2,0.821,0.308,0.99999,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
750,GAS8-AS1,O95177,0.751,0.192,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.35,1.0,,2016.0,2019.0,ALL
752,FMNL1,O95466,0.711,0.577,0.99985,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
753,LDLRAD4,O15165,0.769,0.231,0.62011,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
754,PTTG1IP,P53801,0.678,0.346,0.0049827,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
755,CFAP410,O43822,0.633,0.615,3.291e-07,,,C1865695,"Spondylometaphyseal dysplasia, axial",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.63,1.0,strong,2013.0,2017.0,ALL
757,TMEM50B,P56557,1.0,0.077,0.029357,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
758,MPPED1,O15442,1.0,0.038,0.0019823,DTO_05007624,Enzyme,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
759,CA1,P00915,0.623,0.769,4.7481e-11,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
760,CA2,P00918,0.506,0.808,1.6946e-06,,,C0345407,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3",C16;C18;C13;C05;C12;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.99,1.0,strong,1985.0,2020.0,ALL
761,CA3,P07451,0.682,0.5,0.0017251,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.5,1.0,,2014.0,2015.0,ALL
762,CA4,P22748,0.674,0.577,7.1318e-06,,,C1833245,Retinitis Pigmentosa 17,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.74,1.0,,2000.0,2010.0,ALL
763,CA5A,P35218,0.686,0.5,7.9051e-05,,,C3810404,"CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO",,,disease,Disease or Syndrome,0.7,1.0,definitive,1995.0,2016.0,ALL
765,CA6,P23280,0.769,0.385,0.00035958,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
766,CA7,P43166,0.89,0.154,0.10796,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
767,CA8,P35219,0.595,0.654,0.0082516,,,C2750509,"Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 3",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.9,1.0,,2005.0,2016.0,ALL
768,CA9,Q16790,0.483,0.731,1.3027e-09,,,C0003130,Anoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.4,1.0,,2001.0,2008.0,ALL
770,CA11,O75493,0.674,0.385,0.00095695,,,C0200633,Neutrophil count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
771,CA12,O43570,0.592,0.731,1.2849e-11,,,C1840437,Isolated hyperchlorhidrosis,,,phenotype,Finding,0.7,1.0,,2010.0,2016.0,ALL
772,CACD,,0.821,0.077,,,,C1536451,Central areolar choroidal sclerosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0,,2009.0,2019.0,ALL
773,CACNA1A,O00555,0.489,0.769,1.0,DTO_01300327,Ion channel,C0752124,Spinocerebellar Ataxia Type 6 (disorder),C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.986,,1997.0,2019.0,ALL
774,CACNA1B,Q00975,0.65,0.577,0.99998,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2010.0,2017.0,ALL
775,CACNA1C,Q13936,0.51,0.846,1.0,DTO_01300327,Ion channel,C1832916,Timothy syndrome,C23;C16;C05;F03;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Mental Disorders;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.969,strong,2004.0,2019.0,ALL
776,CACNA1D,Q01668,0.582,0.577,1.0,DTO_01300327,Ion channel,C3554018,SINOATRIAL NODE DYSFUNCTION AND DEAFNESS,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.72,1.0,moderate,2004.0,2019.0,ALL
777,CACNA1E,Q15878,0.65,0.577,1.0,DTO_01300327,Ion channel,C4748988,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
778,CACNA1F,O60840,0.595,0.5,1.2337e-05,DTO_01300327,Ion channel,C1848172,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,1.0,1.0,,1998.0,2019.0,ALL
779,CACNA1S,Q13698,0.595,0.692,6.2588e-12,DTO_01300327,Ion channel,C3714580,Hypokalemic periodic paralysis type 1,,,disease,Disease or Syndrome,0.8,0.974,,1994.0,2018.0,ALL
780,DDR1,Q08345,0.497,0.808,4.6331e-06,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.43,1.0,,2007.0,2019.0,ALL
781,CACNA2D1,P54289,0.641,0.5,0.99989,DTO_01300327,Ion channel,C1142166,Brugada Syndrome (disorder),C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.62,1.0,disputed,2005.0,2015.0,ALL
782,CACNB1,Q02641,0.792,0.154,0.78689,DTO_01300327,Ion channel,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
783,CACNB2,Q08289,0.659,0.538,2.6719e-06,DTO_01300327,Ion channel,C2678477,Brugada Syndrome 4,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,,2005.0,2016.0,ALL
784,CACNB3,P54284,0.821,0.346,0.00028915,DTO_01300327,Ion channel,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
785,CACNB4,O00305,0.653,0.231,0.030679,DTO_01300327,Ion channel,C1866039,"EPISODIC ATAXIA, TYPE 5",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2000.0,2008.0,ALL
786,CACNG1,Q06432,1.0,0.077,1.4908e-08,DTO_01300327,Ion channel,C0029458,"Osteoporosis, Postmenopausal",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
788,SLC25A20,O43772,0.563,0.769,1.1972e-07,DTO_05007405,Transporter,C0342791,Carnitine-Acylcarnitine Translocase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.77,1.0,definitive,1997.0,2019.0,ALL
790,CAD,P27708,0.482,0.846,0.99993,DTO_05007624,Enzyme,C4225320,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2019.0,ALL
793,CALB1,P05937,0.606,0.615,0.24308,DTO_05007616,Calcium-binding protein,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.333,,2008.0,2018.0,ALL
794,CALB2,P22676,0.545,0.692,4.5423e-07,DTO_05007616,Calcium-binding protein,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.4,0.933,,2001.0,2019.0,ALL
795,S100G,P29377,0.931,0.038,0.11469,DTO_05007616,Calcium-binding protein,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
796,CALCA,P01258;P06881,0.416,0.923,0.015562,DTO_05007599,Signaling,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.54,1.0,,2003.0,2019.0,ALL
797,CALCB,P10092,0.78,0.385,0.097127,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2010.0,2010.0,ALL
799,CALCR,P30988,0.464,0.846,3.1176e-09,DTO_02300001,G-protein coupled receptor,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.5,1.0,,2000.0,2018.0,ALL
800,CALD1,Q05682,0.578,0.692,0.99879,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
801,CALM1,P0DP23;P0DP24;P0DP25,0.472,0.808,0.94473,DTO_05007616,Calcium-binding protein,C1631597,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.74,1.0,strong,2009.0,2019.0,ALL
805,CALM2,P0DP23;P0DP24;P0DP25,0.472,0.808,0.92086,DTO_05007616,Calcium-binding protein,C4015695,LONG QT SYNDROME 15,,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2016.0,ALL
808,CALM3,P0DP23;P0DP24;P0DP25,0.485,0.846,0.92749,DTO_05007616,Calcium-binding protein,C1631597,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.34,1.0,,2016.0,2019.0,ALL
810,CALML3,P27482,0.621,0.5,0.00090968,DTO_05007616,Calcium-binding protein,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.31,1.0,,2017.0,2019.0,ALL
811,CALR,P27797,0.413,0.923,0.89133,DTO_05007616,Calcium-binding protein,C0001815,Primary Myelofibrosis,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.8,0.929,limited,2013.0,2020.0,ALL
813,CALU,O43852,0.7,0.385,0.014005,DTO_05007616,Calcium-binding protein,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
814,CAMK4,Q16566,0.621,0.654,0.50957,DTO_03300101,Kinase,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.51,1.0,,2008.0,2008.0,ALL
815,CAMK2A,Q9UQM7,0.612,0.538,0.99845,DTO_03300101,Kinase,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.52,1.0,,2011.0,2019.0,ALL
816,CAMK2B,Q13554,0.626,0.538,0.73914,DTO_03300101,Kinase,C4540484,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 54",,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2018.0,ALL
817,CAMK2D,Q13557,0.743,0.308,0.002287,DTO_03300101,Kinase,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
818,CAMK2G,Q13555,0.67,0.462,0.9991,DTO_03300101,Kinase,C4552072,X-linked infantile spasms,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,limited,2017.0,2017.0,ALL
819,CAMLG,P49069,0.769,0.154,0.00061836,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
820,CAMP,P49913,0.466,0.846,0.0043897,,,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.25,1.0,,2006.0,2019.0,ALL
821,CANX,P27824,0.582,0.769,0.86635,DTO_05007613,Chaperone,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
822,CAPG,P40121,0.548,0.731,9.357e-14,DTO_05007530,Cellular structure,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
823,CAPN1,P07384,0.539,0.808,5.8554e-10,DTO_05007624,Enzyme,C4310800,"SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.71,1.0,,2016.0,2019.0,ALL
824,CAPN2,P17655,0.59,0.692,3.519e-22,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
825,CAPN3,P20807,0.564,0.615,3.5865e-19,DTO_05007624,Enzyme,C1869123,Limb-girdle muscular dystrophy type 2A,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.994,strong,1995.0,2019.0,ALL
826,CAPNS1,P04632,0.674,0.538,7.11e-07,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2007.0,2018.0,ALL
827,CAPN6,Q9Y6Q1,0.839,0.077,0.81903,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
828,CAPS,Q13938,0.638,0.731,1.7206e-05,,,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2019.0,ALL
829,CAPZA1,P52907,0.821,0.115,0.93292,DTO_05007530,Cellular structure,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
830,CAPZA2,P47755,,,0.99828,DTO_05007530,Cellular structure,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
831,CAST,P20810,0.541,0.846,4.1218e-12,,,C4225381,"PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS",,,disease,Disease or Syndrome,0.72,1.0,strong,2015.0,2019.0,ALL
832,CAPZB,P47756,0.729,0.308,0.91165,DTO_05007530,Cellular structure,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
833,CARS1,P49589,0.722,0.538,0.00040314,DTO_05007624,Enzyme,C0334121,Inflammatory Myofibroblastic Tumor,C23,"   Pathological Conditions, Signs and Symptoms",disease,Neoplastic Process,0.31,1.0,,2002.0,2003.0,ALL
834,CASP1,P29466,0.413,0.885,3.5183e-05,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.36,1.0,,1999.0,2018.0,ALL
835,CASP2,P42575,0.565,0.731,0.0015026,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2010.0,2010.0,ALL
836,CASP3,P42574,0.351,0.923,0.10017,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.6,0.98,,1999.0,2020.0,ALL
837,CASP4,P49662,0.636,0.654,3.0474e-08,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
838,CASP5,P51878,0.653,0.5,1.752e-16,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,1999.0,2015.0,ALL
839,CASP6,P55212,0.61,0.615,0.00012665,DTO_05007624,Enzyme,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2001.0,2001.0,ALL
840,CASP7,P55210,0.581,0.654,5.3589e-05,DTO_05007624,Enzyme,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.5,1.0,,2004.0,2018.0,ALL
841,CASP8,Q14790,0.404,0.923,3.7236e-06,DTO_05007624,Enzyme,C1846545,Autoimmune Lymphoproliferative Syndrome Type 2B,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.94,1.0,strong,2002.0,2019.0,ALL
842,CASP9,P55211,0.458,0.808,7.3826e-06,DTO_05007624,Enzyme,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.5,1.0,,2001.0,2011.0,ALL
843,CASP10,Q92851,0.528,0.692,4.6392e-12,DTO_05007624,Enzyme,C1858968,"Autoimmune Lymphoproliferative Syndrome, Type IIA",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.73,1.0,strong,1999.0,2011.0,ALL
844,CASQ1,P31415,0.722,0.423,3.857e-18,,,C4015624,"MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES",,,disease,Disease or Syndrome,0.7,1.0,moderate,2014.0,2017.0,ALL
845,CASQ2,O14958,0.691,0.385,1.3885e-12,,,C2677794,Stress-induced polymorphic ventricular tachycardia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.95,1.0,strong,2001.0,2018.0,ALL
846,CASR,P41180,0.41,0.846,0.046698,DTO_02300001,G-protein coupled receptor,C0342637,"Hypocalciuric hypercalcemia, familial, type 1",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,1.0,0.993,,1976.0,2020.0,ALL
847,CAT,P04040,0.359,0.962,1.6263e-10,DTO_05007624,Enzyme,C0268419,Acatalasia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1988.0,2019.0,ALL
856,CATR1,Q13166,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1998.0,1998.0,ALL
857,CAV1,Q03135,0.388,0.885,0.008274,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.8,0.977,,1999.0,2019.0,ALL
858,CAV2,P51636,0.575,0.692,0.026973,DTO_05007584,Enzyme modulator,C0017612,"Glaucoma, Open-Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.4,1.0,,2010.0,2010.0,ALL
859,CAV3,P56539,0.564,0.692,0.0054565,DTO_05007584,Enzyme modulator,C1853698,Rippling muscle disease,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.9,1.0,,2001.0,2018.0,ALL
860,RUNX2,Q13950,0.437,0.846,0.94884,DTO_05007542,Transcription factor,C0008928,Cleidocranial Dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.976,,1997.0,2019.0,ALL
861,RUNX1,Q01196,0.425,0.808,0.65377,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.8,0.985,strong,1991.0,2020.0,ALL
862,RUNX1T1,Q06455,0.53,0.808,0.97768,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.4,0.986,,1993.0,2020.0,ALL
863,CBFA2T3,O75081,0.638,0.462,0.048373,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
864,RUNX3,Q13761,0.459,0.731,0.84295,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,1994.0,2019.0,ALL
865,CBFB,Q13951,0.601,0.538,0.9589,,,C0023479,Acute myelomonocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.55,1.0,,2000.0,2009.0,ALL
866,SERPINA6,P08185,0.606,0.731,8.3448e-07,DTO_05007584,Enzyme modulator,C1852529,Corticosteroid-Binding Globulin Deficiency,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.95,1.0,,1992.0,2019.0,ALL
867,CBL,P22681,0.527,0.769,0.00060921,DTO_05007624,Enzyme,C0349639,Juvenile Myelomonocytic Leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.8,1.0,strong,2009.0,2019.0,ALL
868,CBLB,Q13191,0.691,0.423,0.99825,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.44,0.8,,2010.0,2017.0,ALL
869,CBLN1,P23435,1.0,0.038,0.17628,,,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
871,SERPINH1,P50454,0.545,0.769,0.027553,DTO_05007584,Enzyme modulator,C3151211,"OSTEOGENESIS IMPERFECTA, TYPE X",,,disease,Disease or Syndrome,0.91,1.0,strong,2010.0,2018.0,ALL
873,CBR1,P16152,0.572,0.654,6.2783e-05,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.5,1.0,,2015.0,2015.0,ALL
874,CBR3,O75828,0.736,0.385,3.0158e-06,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
875,CBS,P0DN79;P35520,0.465,0.885,3.0799e-05,DTO_05007624,Enzyme,C0019880,Homocystinuria,C16;C18;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.983,,1988.0,2019.0,ALL
878,CCA1,,0.89,0.192,,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
882,CCAL1,,0.89,0.038,,,,C0553730,Calcium pyrophosphate deposition disease,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0,,2004.0,2018.0,ALL
883,KYAT1,Q16773,0.736,0.308,1.8743e-12,DTO_05007624,Enzyme,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.31,0.5,,2012.0,2018.0,ALL
885,CCK,P06307,0.453,0.846,3.3034e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,1995.0,2016.0,ALL
886,CCKAR,P32238,0.615,0.5,0.0040329,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.53,0.8,,1998.0,2005.0,ALL
887,CCKBR,P32239,0.573,0.615,2.1404e-06,DTO_02300001,G-protein coupled receptor,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.51,1.0,,2002.0,2019.0,ALL
889,KRIT1,O00522,0.5,0.808,0.00069333,,,C2919945,Cavernous Hemangioma of Brain,C16;C04;C10;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Anatomical Abnormality,1.0,0.991,,1992.0,2019.0,ALL
890,CCNA2,P20248,0.578,0.654,0.99962,DTO_05007584,Enzyme modulator,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
891,CCNB1,P14635,0.512,0.731,0.15993,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2008.0,2019.0,ALL
892,CCNC,P24863,0.695,0.462,0.99914,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,1996.0,2019.0,ALL
894,CCND2,P30279,0.477,0.808,0.98658,DTO_05007584,Enzyme modulator,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.61,1.0,,2004.0,2019.0,ALL
896,CCND3,P30281,0.554,0.654,0.98347,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,1996.0,2019.0,ALL
898,CCNE1,P24864,0.538,0.731,0.97187,DTO_05007584,Enzyme modulator,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.6,1.0,,2008.0,2019.0,ALL
899,CCNF,P41002,0.7,0.615,0.12679,DTO_05007584,Enzyme modulator,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.46,1.0,,2016.0,2019.0,ALL
900,CCNG1,P51959,0.628,0.615,0.00073222,DTO_05007584,Enzyme modulator,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2006.0,2018.0,ALL
901,CCNG2,Q16589,0.615,0.577,0.0096861,DTO_05007584,Enzyme modulator,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
902,CCNH,P51946,0.595,0.769,0.00081328,DTO_05007584,Enzyme modulator,C0024668,"Mammary Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.5,1.0,,2003.0,2003.0,ALL
904,CCNT1,O60563,0.716,0.346,0.051092,DTO_05007584,Enzyme modulator,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2011.0,2011.0,ALL
905,CCNT2,O60583,0.931,0.115,0.92681,DTO_05007584,Enzyme modulator,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
907,CCT,,0.588,0.769,,,,C4049005,"Cataract, total congenital with posterior sutural opacities in Heterozygotes",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.05,1.0,,1996.0,2019.0,ALL
908,CCT6A,P40227,0.711,0.423,0.99532,DTO_05007613,Chaperone,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
909,CD1A,P06126,0.543,0.769,4.1954e-24,,,C0019621,"Histiocytosis, Langerhans-Cell",C08;C15,   Respiratory Tract Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,0.957,,2001.0,2020.0,ALL
910,CD1B,P29016,0.722,0.423,5.3558e-11,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.07,1.0,,2004.0,2019.0,ALL
911,CD1C,P29017,0.633,0.692,1.5963e-08,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.04,1.0,,2017.0,2019.0,ALL
912,CD1D,P15813,0.532,0.769,1.8805e-06,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2000.0,2018.0,ALL
913,CD1E,P15812,0.805,0.154,3.2556e-18,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
914,CD2,P06729,0.641,0.577,0.47108,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0,,2012.0,2017.0,ALL
915,CD3D,P04234,0.626,0.577,8.5898e-05,,,C3810147,IMMUNODEFICIENCY 19,,,disease,Disease or Syndrome,0.61,1.0,strong,2003.0,2017.0,ALL
916,CD3E,P07766,0.615,0.615,0.00034464,,,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.62,1.0,definitive,1991.0,2014.0,ALL
917,CD3G,P09693,0.695,0.346,1.712e-05,,,C3810107,IMMUNODEFICIENCY 17,,,disease,Disease or Syndrome,0.7,1.0,strong,2007.0,2014.0,ALL
919,CD247,P20963,0.539,0.731,0.016734,,,C1857798,Immunodeficiency due to Defect in CD3-Zeta,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.6,1.0,moderate,2015.0,2015.0,ALL
920,CD4,P01730,0.604,0.654,0.00078914,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
921,CD5,P06127,0.682,0.308,2.3074e-10,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,1.0,,1986.0,2008.0,ALL
922,CD5L,O43866,0.593,0.846,4.2297e-17,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2017.0,2019.0,ALL
923,CD6,P30203,0.489,0.808,9.2695e-05,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.42,1.0,,2009.0,2016.0,ALL
924,CD7,P09564,0.722,0.385,0.05135,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
925,CD8A,P01732,0.587,0.769,1.6806e-05,,,C1837065,"CD8 Deficiency, Familial",C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.7,1.0,moderate,2001.0,2008.0,ALL
926,CD8B,P10966,0.674,0.462,0.00040103,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
927,CD8B2,A6NJW9,1.0,0.038,,,,C0272178,Drug-induced neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
928,CD9,P21926,0.528,0.769,0.0047221,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.33,1.0,,1995.0,2007.0,ALL
929,CD14,P08571,0.392,0.885,4.8813e-05,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,0.836,,2001.0,2020.0,ALL
930,CD19,P15391,0.43,0.885,0.90496,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.6,1.0,,2002.0,2020.0,ALL
931,MS4A1,P11836,0.411,0.846,5.0781e-05,DTO_05007575,Receptor,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.51,1.0,,2010.0,2011.0,ALL
932,MS4A3,Q96HJ5,0.805,0.192,2.6344e-05,DTO_05007575,Receptor,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
933,CD22,P20273,0.556,0.615,0.8044,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,1999.0,2020.0,ALL
939,CD27,P26842,0.517,0.692,0.010011,,,C3554540,LYMPHOPROLIFERATIVE SYNDROME 2,,,disease,Disease or Syndrome,0.72,0.75,strong,2012.0,2017.0,ALL
940,CD28,P10747,0.436,0.885,0.35779,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,1.0,,1996.0,2018.0,ALL
941,CD80,P33681,0.475,0.769,0.010898,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.33,1.0,,2011.0,2019.0,ALL
942,CD86,P42081,0.483,0.769,0.94879,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.34,1.0,,1999.0,2019.0,ALL
943,TNFRSF8,P28908,0.444,0.808,0.86407,,,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,0.991,,1987.0,2020.0,ALL
944,TNFSF8,P32971,0.61,0.538,0.75809,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
945,CD33,P20138,0.524,0.769,5.6888e-07,DTO_05007575,Receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.4,0.972,,2011.0,2019.0,ALL
946,SIGLEC6,O43699,0.861,0.192,0.0058774,DTO_05007575,Receptor,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0,,2016.0,2019.0,ALL
947,CD34,P28906,0.368,0.808,4.9881e-06,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,0.955,,1995.0,2020.0,ALL
948,CD36,P16671,0.446,0.846,1.0857e-60,DTO_05007575,Receptor,C1842090,Platelet Glycoprotein IV Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.9,0.973,,1993.0,2019.0,ALL
949,SCARB1,Q8WTV0,0.559,0.731,0.066228,DTO_05007575,Receptor,C1853096,HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6,,,phenotype,Finding,0.6,1.0,limited,2016.0,2016.0,ALL
950,SCARB2,Q14108,0.606,0.615,8.9495e-05,DTO_05007575,Receptor,C0751779,Action Myoclonus-Renal Failure Syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.8,1.0,,2008.0,2018.0,ALL
951,CD37,P11049,0.647,0.462,4.3887e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2007.0,2019.0,ALL
952,CD38,P28907,0.407,0.885,2.3129e-06,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.5,1.0,,2005.0,2014.0,ALL
953,ENTPD1,P49961,0.499,0.769,0.0080716,DTO_05007624,Enzyme,C3810289,"SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2018.0,ALL
954,ENTPD2,Q9Y5L3,0.76,0.269,1.4578e-14,DTO_05007624,Enzyme,C0023892,Biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,,2004.0,2004.0,ALL
955,ENTPD6,O75354,0.89,0.154,1.1814e-06,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
956,ENTPD3,O75355,0.89,0.154,2.6387e-21,DTO_05007624,Enzyme,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
957,ENTPD5,O75356,0.674,0.346,4.554e-05,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
958,CD40,P25942,0.396,0.846,0.84603,,,C1720957,"Hyper-IgM Immunodeficiency Syndrome, Type 3",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,,2001.0,2016.0,ALL
959,CD40LG,P29965,0.414,0.846,0.72079,DTO_05007599,Signaling,C0398689,"Hyper-IgM Immunodeficiency Syndrome, Type 1",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.983,,1992.0,2020.0,ALL
960,CD44,P16070,0.363,0.962,2.4476e-07,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,1991.0,2019.0,ALL
961,CD47,Q08722,0.468,0.769,0.91924,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2019.0,2019.0,ALL
962,CD48,P09326,0.592,0.692,1.7302e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2012.0,2012.0,ALL
963,CD53,P19397,0.736,0.423,0.0022961,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
965,CD58,P19256,0.584,0.769,0.25092,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.5,1.0,,2008.0,2019.0,ALL
966,CD59,P13987,0.469,0.808,0.60568,,,C2676767,CD59 Deficiency,C23;C13;C12;C15,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.76,1.0,,1992.0,2019.0,ALL
967,CD63,P08962,0.542,0.731,0.017439,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2001.0,2001.0,ALL
968,CD68,P34810,0.408,0.808,1.4063e-06,DTO_05007405,Transporter,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.35,1.0,,2006.0,2018.0,ALL
969,CD69,Q07108,0.488,0.923,0.029691,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.41,1.0,,2009.0,2019.0,ALL
970,CD70,P32970,0.542,0.692,0.010394,,,C4748863,LYMPHOPROLIFERATIVE SYNDROME 3,,,disease,Disease or Syndrome,0.41,1.0,,2017.0,2017.0,ALL
971,CD72,P21854,0.7,0.269,0.020272,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.05,1.0,,2004.0,2019.0,ALL
972,CD74,P04233,0.512,0.808,0.24889,DTO_05007584,Enzyme modulator,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,0.875,,2004.0,2017.0,ALL
973,CD79A,P11912,0.536,0.731,0.69226,DTO_05007575,Receptor,C0001768,Agammaglobulinemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.62,1.0,strong,2002.0,2018.0,ALL
974,CD79B,P40259,0.576,0.577,0.9163,DTO_05007575,Receptor,C0001768,Agammaglobulinemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.61,1.0,strong,2008.0,2014.0,ALL
975,CD81,P60033,0.555,0.846,0.91844,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.51,1.0,,2011.0,2011.0,ALL
976,ADGRE5,P48960,0.601,0.538,3.0761e-06,DTO_02300001,G-protein coupled receptor,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
977,CD151,P48509,0.564,0.654,1.0841e-05,,,C1836823,Nephropathy with Pretibial Epidermolysis Bullosa and Deafness,C23;C16;C13;C17;C12;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,,2004.0,2018.0,ALL
978,CDA,P32320,0.558,0.731,0.0081038,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2000.0,2015.0,ALL
981,CDAN3,,0.792,0.115,,,,C0002876,Congenital dyserythropoietic anemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0,,1997.0,2013.0,ALL
982,CDB2,,0.78,0.154,,,,C4700127,Thiel-behnke,,,disease,Disease or Syndrome,0.03,1.0,,1995.0,2008.0,ALL
983,CDK1,P06493,0.482,0.808,0.99206,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.6,1.0,,1999.0,2019.0,ALL
984,CDK11B,P21127,0.711,0.462,6.4813e-05,DTO_03300101,Kinase,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
987,LRBA,P50851,0.608,0.692,7.1503e-12,,,C3553512,"IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2017.0,ALL
988,CDC5L,Q99459,0.743,0.385,1.0,,,C0428568,Fasting blood glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
989,SEPTIN7,Q16181,0.7,0.577,0.99924,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2011.0,ALL
990,CDC6,Q99741,0.552,0.731,1.1499e-09,,,C1868684,"EAR, PATELLA, SHORT STATURE SYNDROME",C23;C16;C05;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.54,1.0,,2011.0,2017.0,ALL
991,CDC20,Q12834,0.587,0.577,3.0001e-07,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,0.833,,2002.0,2017.0,ALL
993,CDC25A,P30304,0.564,0.615,0.84041,DTO_05007624,Enzyme,C0085548,Autosomal Recessive Polycystic Kidney Disease,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.21,1.0,,2012.0,2012.0,ALL
994,CDC25B,P30305,0.601,0.654,0.3643,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
995,CDC25C,P30307,0.576,0.769,4.1014e-13,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2011.0,2019.0,ALL
996,CDC27,P30260,0.729,0.308,0.99675,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2013.0,2016.0,ALL
997,CDC34,P49427,0.705,0.308,0.95625,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.02,1.0,,2009.0,2012.0,ALL
998,CDC42,P60953,0.458,0.846,0.78728,DTO_05007584,Enzyme modulator,C4225222,TAKENOUCHI-KOSAKI SYNDROME,,,disease,Disease or Syndrome,0.71,1.0,,2015.0,2018.0,ALL
999,CDH1,P12830,0.401,0.808,0.14631,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.8,1.0,limited,1991.0,2019.0,ALL
1000,CDH2,P19022,0.535,0.731,0.99171,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.38,1.0,,2010.0,2019.0,ALL
1001,CDH3,P22223,0.56,0.615,2.7988e-10,,,C1857041,"Ectodermal dysplasia, ectrodactyly, and macular dystrophy",C16;C11;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.74,1.0,,2002.0,2017.0,ALL
1002,CDH4,P55283,0.695,0.462,0.74348,,,C0023980,Longevity,,,phenotype,Temporal Concept,0.1,1.0,,2010.0,2010.0,ALL
1003,CDH5,P33151,0.561,0.692,0.51314,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,1.0,,2000.0,2018.0,ALL
1004,CDH6,P55285,0.691,0.385,0.91966,,,C0006625,Cachexia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0,,2007.0,2007.0,ALL
1005,CDH7,Q9ULB5,0.769,0.231,0.5975,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
1006,CDH8,P55286,0.743,0.385,0.98806,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2012.0,2012.0,ALL
1007,CDH9,Q9ULB4,0.751,0.308,0.83147,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2019.0,ALL
1008,CDH10,Q9Y6N8,0.76,0.385,0.29379,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2016.0,2017.0,ALL
1009,CDH11,P55287,0.512,0.808,0.9999,,,C0809936,Branchio-skeleto-genital syndrome,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.63,1.0,strong,2017.0,2018.0,ALL
1010,CDH12,P55289,0.821,0.308,0.00036444,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.5,,2011.0,2012.0,ALL
1012,CDH13,P55290,0.501,0.846,0.0007058,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.51,1.0,,2006.0,2008.0,ALL
1013,CDH15,P55291,0.653,0.615,1.7656e-14,,,C2675488,"Mental Retardation, Autosomal Dominant 3",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.6,1.0,,2008.0,2015.0,ALL
1014,CDH16,O75309,0.76,0.154,3.6527e-25,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
1015,CDH17,Q12864,0.636,0.615,3.4172e-14,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2006.0,2008.0,ALL
1016,CDH18,Q13634,0.769,0.269,0.21478,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2012.0,2012.0,ALL
1017,CDK2,P24941,0.456,0.692,0.61054,DTO_03300101,Kinase,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.941,,1994.0,2019.0,ALL
1018,CDK3,Q00526,0.716,0.385,2.1415e-07,DTO_03300101,Kinase,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2008.0,2008.0,ALL
1019,CDK4,P11802,0.412,0.808,0.062909,DTO_03300101,Kinase,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.7,0.961,strong,1994.0,2020.0,ALL
1020,CDK5,Q00535,0.495,0.846,0.13892,DTO_03300101,Kinase,C4225359,LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA,,,disease,Disease or Syndrome,0.6,1.0,limited,2015.0,2015.0,ALL
1021,CDK6,Q00534,0.471,0.731,0.98315,DTO_03300101,Kinase,C4015156,"MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2013.0,ALL
1022,CDK7,P50613,0.566,0.731,4.4725e-07,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1996.0,2020.0,ALL
1024,CDK8,P49336,0.597,0.654,0.40964,DTO_03300101,Kinase,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0,strong,2019.0,2019.0,ALL
1025,CDK9,P50750,0.498,0.769,8.893e-05,DTO_03300101,Kinase,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2011.0,2011.0,ALL
1026,CDKN1A,P38936,0.403,0.769,0.0018575,,,C0038356,Stomach Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.52,1.0,,2004.0,2017.0,ALL
1027,CDKN1B,P46527,0.409,0.769,0.62376,,,C1970712,"Multiple Endocrine Neoplasia, Type IV",C16;C04;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Endocrine System Diseases",disease,Neoplastic Process,0.79,1.0,definitive,1996.0,2019.0,ALL
1028,CDKN1C,P49918,0.456,0.846,0.81963,,,C0004903,Beckwith-Wiedemann Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.8,1.0,,1992.0,2019.0,ALL
1029,CDKN2A,P42771;Q8N726,0.3,0.885,0.39474,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.8,0.957,,1994.0,2019.0,ALL
1030,CDKN2B,P42772,0.417,0.769,0.0073369,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.7,0.882,,1995.0,2019.0,ALL
1031,CDKN2C,P42773,0.527,0.654,0.39526,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,0.818,,1993.0,2018.0,ALL
1032,CDKN2D,P55273,0.547,0.769,0.49473,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
1033,CDKN3,Q16667,0.514,0.769,0.0019455,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.59,0.9,,1997.0,2017.0,ALL
1036,CDO1,Q16878,0.592,0.654,0.0096603,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2012.0,2019.0,ALL
1038,CDR1,P51861,0.576,0.808,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,0.952,,2001.0,2019.0,ALL
1039,CDR2,Q01850,0.647,0.654,4.299e-07,,,C0393534,Paraneoplastic Cerebellar Degeneration,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Disease or Syndrome,0.09,1.0,,1997.0,2019.0,ALL
1040,CDS1,Q92903,0.647,0.462,0.00064056,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
1041,CDSN,Q15517,0.585,0.731,0.46391,,,C1840299,Hypotrichosis Simplex of Scalp,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2003.0,2012.0,ALL
1043,CD52,P31358,0.615,0.5,0.40282,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,1999.0,2020.0,ALL
1044,CDX1,P47902,0.644,0.346,0.14253,DTO_05007542,Transcription factor,C3495676,Anorectal Malformations,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",group,Anatomical Abnormality,0.32,1.0,strong,2013.0,2018.0,ALL
1045,CDX2,Q99626,0.458,0.769,0.52887,DTO_05007542,Transcription factor,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,0.909,,1999.0,2019.0,ALL
1046,CDX4,O14627,0.769,0.154,0.0060181,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.05,0.8,,2006.0,2016.0,ALL
1047,CLGN,O14967,0.839,0.115,1.2813e-11,DTO_05007613,Chaperone,C0337443,Sodium measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
1048,CEACAM5,P06731,0.42,0.846,4.1625e-10,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
1050,CEBPA,P49715,0.496,0.692,0.55365,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,1.0,0.985,definitive,1992.0,2020.0,ALL
1051,CEBPB,P17676,0.508,0.731,0.35809,DTO_05007542,Transcription factor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,1.0,,1993.0,2019.0,ALL
1052,CEBPD,P49716,0.57,0.769,0.61219,DTO_05007542,Transcription factor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2004.0,2019.0,ALL
1053,CEBPE,Q15744,0.674,0.385,0.0070769,DTO_05007542,Transcription factor,C0398593,Specific granule deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.72,1.0,strong,1999.0,2018.0,ALL
1054,CEBPG,P53567,0.861,0.154,0.43688,DTO_05007542,Transcription factor,C0007121,Bronchogenic Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
1055,CECR,,0.599,0.731,,,,C0265493,Cat eye syndrome,C23;C16;C11,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.31,1.0,,1999.0,2001.0,ALL
1056,CEL,P19835,0.514,0.808,1.538e-06,,,C1853297,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.65,1.0,,2006.0,2018.0,ALL
1057,CELP,,0.769,0.423,,,,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.33,1.0,,2015.0,2019.0,ALL
1058,CENPA,P49450,0.678,0.385,0.011536,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2011.0,2019.0,ALL
1059,CENPB,P07199,0.805,0.385,0.99634,,,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.03,1.0,,1994.0,2019.0,ALL
1060,CENPC,Q03188,0.743,0.538,7.3778e-05,DTO_05007557,Nucleic acid binding,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
1061,CENPCP1,,0.931,0.077,,,,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
1062,CENPE,Q02224,0.636,0.692,0.24146,DTO_05007530,Cellular structure,C4015080,"MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
1063,CENPF,P49454,0.601,0.654,1.8822e-36,,,C1855705,Jejunal Atresia with Microcephaly and Ocular Anomalies,C16;C06;C11;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,,2015.0,2020.0,ALL
1066,CES1,P23141,0.59,0.692,3.3228e-15,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.34,1.0,,2010.0,2018.0,ALL
1068,CETN1,Q12798,0.584,0.654,0.21511,DTO_05007616,Calcium-binding protein,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2015.0,ALL
1069,CETN2,P41208,0.729,0.385,0.50331,DTO_05007616,Calcium-binding protein,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
1070,CETN3,O15182,0.792,0.154,0.00010528,DTO_05007616,Calcium-binding protein,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
1071,CETP,P11597,0.512,0.731,1.1892e-23,,,C3149462,HYPERALPHALIPOPROTEINEMIA 1,,,disease,Disease or Syndrome,0.8,0.933,limited,1990.0,2018.0,ALL
1072,CFL1,P23528,0.529,0.769,0.55563,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.39,1.0,,2010.0,2019.0,ALL
1073,CFL2,Q9Y281,0.659,0.5,6.4399e-05,,,C1853154,Nemaline Myopathy 7,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,definitive,2001.0,2018.0,ALL
1075,CTSC,P53634,0.541,0.731,1.1451e-07,DTO_05007624,Enzyme,C0030360,Papillon-Lefevre Disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,0.968,strong,1998.0,2020.0,ALL
1080,CFTR,P13569,0.424,0.885,2.1735e-58,DTO_01300327,Ion channel,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,1.0,0.979,,1989.0,2020.0,ALL
1081,CGA,P01215,0.508,0.808,0.34518,,,C0001621,Adrenal Gland Diseases,C19,   Endocrine System Diseases,group,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
1082,CGB3,P0DN86,0.57,0.654,0.098257,DTO_05007599,Signaling,C0015951,Fetal Resorption,C23;C13,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications",disease,Disease or Syndrome,0.3,1.0,,1986.0,1986.0,ALL
1084,CEACAM3,P40198,0.494,0.731,1.067e-09,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1992.0,2019.0,ALL
1087,CEACAM7,Q14002,0.494,0.769,1.3466e-07,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1992.0,2019.0,ALL
1088,CEACAM8,P31997,0.682,0.538,3.3021e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
1089,CEACAM4,O75871,0.716,0.423,6.1219e-08,,,C0699790,Colon Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.05,1.0,,1988.0,1997.0,ALL
1098,CEACAMP10,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
1101,CHAD,O15335,0.821,0.192,0.0069766,DTO_05007575,Receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
1102,RCBTB2,O95199,0.792,0.231,2.4857e-09,DTO_05007584,Enzyme modulator,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.02,1.0,,2008.0,2010.0,ALL
1103,CHAT,P28329,0.52,0.808,5.6328e-11,DTO_05007624,Enzyme,C0393929,Familial infantile myasthenia,C23;C04;C08;C20;C10,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Respiratory Tract Diseases;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,strong,2001.0,2017.0,ALL
1104,RCC1,P18754,0.686,0.538,0.93109,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
1105,CHD1,O14646,0.628,0.692,1.0,,,C4540131,PILAROWSKI-BJORNSSON SYNDROME,,,disease,Disease or Syndrome,0.7,1.0,,2018.0,2018.0,ALL
1106,CHD2,O14647,0.585,0.577,1.0,,,C3809278,"EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET",,,disease,Disease or Syndrome,0.6,1.0,strong,2013.0,2017.0,ALL
1107,CHD3,Q12873,0.67,0.577,1.0,,,C4748701,SNIJDERS BLOK-CAMPEAU SYNDROME,,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2019.0,ALL
1108,CHD4,Q14839,0.593,0.654,1.0,,,C4310688,SIFRIM-HITZ-WEISS SYNDROME,,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2016.0,ALL
1109,AKR1C4,P17516,0.587,0.846,2.2341e-17,DTO_05007624,Enzyme,C1839840,"MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE",C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.6,1.0,,2011.0,2011.0,ALL
1111,CHEK1,O14757,0.492,0.808,3.14e-08,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2005.0,2019.0,ALL
1112,FOXN3,O00409,0.686,0.538,0.93167,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0,,2017.0,2019.0,ALL
1113,CHGA,P10645,0.49,0.808,0.030369,,,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,1986.0,2020.0,ALL
1114,CHGB,P05060,0.599,0.654,2.3622e-07,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2002.0,2017.0,ALL
1116,CHI3L1,P36222,0.419,0.885,1.1133e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,0.9,,2003.0,2019.0,ALL
1117,CHI3L2,Q15782,0.78,0.308,1.9866e-14,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
1118,CHIT1,Q13231,0.525,0.692,7.1716e-16,,,C0017205,Gaucher Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.4,1.0,,1999.0,2020.0,ALL
1119,CHKA,P35790,0.615,0.615,0.22747,DTO_03300101,Kinase,C0080178,Spina Bifida,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.31,1.0,,2006.0,2006.0,ALL
1120,CHKB,Q9Y259,0.663,0.423,3.7831e-07,DTO_03300101,Kinase,C1865233,"Muscular Dystrophy, Congenital, Megaconial Type",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.93,1.0,,2006.0,2019.0,ALL
1121,CHM,P24386,0.592,0.654,0.99899,DTO_05007624,Enzyme,C0008525,Choroideremia,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,1.0,0.965,,1987.0,2020.0,ALL
1122,CHML,P26374,0.769,0.385,3.9968e-05,DTO_05007624,Enzyme,C0008525,Choroideremia,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.06,1.0,,1994.0,2019.0,ALL
1123,CHN1,P15882,0.573,0.615,0.030508,,,C0013261,Duane Retraction Syndrome,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2007.0,2017.0,ALL
1124,CHN2,P52757,0.711,0.615,0.0023008,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
1128,CHRM1,P11229,0.653,0.577,0.99059,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.5,,2002.0,2019.0,ALL
1129,CHRM2,P08172,0.585,0.615,0.18197,DTO_02300001,G-protein coupled receptor,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.54,1.0,,2002.0,2011.0,ALL
1130,LYST,Q99698,0.621,0.692,0.015026,,,C0007965,Chediak-Higashi Syndrome,C16;C11;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.982,,1968.0,2019.0,ALL
1131,CHRM3,P20309,0.464,0.885,0.99253,DTO_02300001,G-protein coupled receptor,C0033770,Prune Belly Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.65,1.0,,2011.0,2019.0,ALL
1132,CHRM4,P08173,0.821,0.231,0.97439,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2002.0,2019.0,ALL
1133,CHRM5,P08912,0.769,0.346,0.0040271,DTO_02300001,G-protein coupled receptor,C0024809,Marijuana Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
1134,CHRNA1,P02708,0.615,0.577,2.0681e-08,DTO_01300327,Ion channel,C1854678,"MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE",C23;C16;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,1.0,,1982.0,2018.0,ALL
1135,CHRNA2,Q15822,0.705,0.385,6.4532e-10,DTO_01300327,Ion channel,C1835905,"Epilepsy, Nocturnal Frontal Lobe, Type 4",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.7,1.0,,2006.0,2015.0,ALL
1136,CHRNA3,P32297,0.588,0.692,1.4197e-07,DTO_01300327,Ion channel,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.53,1.0,,2009.0,2014.0,ALL
1137,CHRNA4,P43681,0.492,0.808,8.5474e-05,DTO_01300327,Ion channel,C1838049,"Epilepsy, Nocturnal Frontal Lobe, Type 1",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,1995.0,2003.0,ALL
1138,CHRNA5,P30532,0.593,0.577,2.1488e-06,DTO_01300327,Ion channel,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.56,1.0,,2009.0,2019.0,ALL
1139,CHRNA7,P36544;Q494W8,0.532,0.654,0.00041549,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,0.75,,1998.0,2019.0,ALL
1140,CHRNB1,P11230,0.7,0.462,5.0456e-08,DTO_01300327,Ion channel,C4225374,"MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL",,,disease,Disease or Syndrome,0.6,1.0,strong,1977.0,2016.0,ALL
1141,CHRNB2,P17787,0.617,0.308,0.00072964,DTO_01300327,Ion channel,C1854335,"Epilepsy, Nocturnal Frontal Lobe, Type 3",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.9,1.0,,2000.0,2011.0,ALL
1142,CHRNB3,Q05901,0.705,0.308,8.5898e-06,DTO_01300327,Ion channel,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2014.0,2017.0,ALL
1143,CHRNB4,P30926,0.644,0.423,0.1427,DTO_01300327,Ion channel,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.5,1.0,,2008.0,2018.0,ALL
1144,CHRND,Q07001,0.641,0.462,5.4466e-09,DTO_01300327,Ion channel,C4225372,"MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL",,,disease,Disease or Syndrome,0.8,1.0,,1996.0,2006.0,ALL
1145,CHRNE,Q04844,0.636,0.577,4.7293e-09,DTO_01300327,Ion channel,C1837091,"MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1996.0,2011.0,ALL
1146,CHRNG,P07510,0.573,0.692,3.3338e-19,DTO_01300327,Ion channel,C0265261,Multiple pterygium syndrome,C23;C16;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.78,1.0,,2006.0,2019.0,ALL
1147,CHUK,O15111,0.556,0.731,0.99403,DTO_03300101,Kinase,C3150891,COCOON SYNDROME,,,disease,Disease or Syndrome,0.92,1.0,,1999.0,2015.0,ALL
1149,CIDEA,O60543,0.751,0.269,5.5761e-06,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.37,1.0,,2005.0,2019.0,ALL
1152,CKB,P12277,0.608,0.615,0.2189,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2009.0,2012.0,ALL
1153,CIRBP,Q14011,0.592,0.731,0.33636,DTO_05007557,Nucleic acid binding,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,,2005.0,2017.0,ALL
1154,CISH,Q9NSE2,0.5,0.808,0.00053852,DTO_05007584,Enzyme modulator,C0004610,Bacteremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.31,1.0,,2010.0,2010.0,ALL
1155,TBCB,Q99426,0.931,0.115,0.011028,DTO_05007613,Chaperone,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
1158,CKM,P06732,0.743,0.423,0.0078152,DTO_03300101,Kinase,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.31,1.0,,1988.0,2018.0,ALL
1159,CKMT1B,P12532,0.729,0.346,3.2331e-05,DTO_03300101,Kinase,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.2,1.0,,2010.0,2010.0,ALL
1160,CKMT2,P17540,0.792,0.192,1.6195e-17,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
1161,ERCC8,Q13216,0.551,0.885,2.7974e-15,,,C0009207,Cockayne Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.978,strong,1996.0,2020.0,ALL
1163,CKS1B,P61024,0.587,0.654,0.4314,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2004.0,2019.0,ALL
1164,CKS2,P33552,0.644,0.462,0.41878,DTO_05007584,Enzyme modulator,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
1167,CLA3,,1.0,0.038,,,,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
1173,AP2M1,Q96CW1,0.751,0.231,0.99919,DTO_05007621,Extracellular structure,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0,strong,2019.0,2019.0,ALL
1174,AP1S1,P61966,0.743,0.308,0.099959,DTO_05007405,Transporter,C1836330,ERYTHROKERATODERMIA VARIABILIS 3 (disorder),C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.75,1.0,,2005.0,2019.0,ALL
1175,AP2S1,P53680,0.705,0.346,0.78518,DTO_05007405,Transporter,C1833372,"HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.7,1.0,,2013.0,2016.0,ALL
1176,AP3S1,Q92572,0.931,0.154,1.0159e-05,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
1178,CLC,Q05315,0.65,0.731,2.3026e-05,DTO_05007599,Signaling,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2018.0,ALL
1179,CLCA1,A8K7I4,0.659,0.538,3.2791e-09,DTO_01300327,Ion channel,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2001.0,2019.0,ALL
1180,CLCN1,P35523,0.641,0.423,3.2501e-20,DTO_01300327,Ion channel,C0027127,Myotonia Congenita,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.968,,1982.0,2019.0,ALL
1181,CLCN2,P51788,0.626,0.462,5.546e-12,DTO_01300327,Ion channel,C3810242,LEUKOENCEPHALOPATHY WITH ATAXIA,,,disease,Disease or Syndrome,0.7,1.0,,2003.0,2015.0,ALL
1182,CLCN3,P51790,0.621,0.615,0.99973,DTO_01300327,Ion channel,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.4,1.0,,2008.0,2019.0,ALL
1183,CLCN4,P51793,0.587,0.654,0.99893,DTO_01300327,Ion channel,C0796221,"MENTAL RETARDATION, X-LINKED 15",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2016.0,ALL
1184,CLCN5,P51795,0.593,0.577,0.99242,DTO_01300327,Ion channel,C1848336,Dent disease 1,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.98,0.977,,1996.0,2020.0,ALL
1185,CLCN6,P51797,0.769,0.231,6.1077e-08,DTO_01300327,Ion channel,C0027877,Neuronal Ceroid-Lipofuscinoses,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.21,1.0,,2006.0,2006.0,ALL
1186,CLCN7,P51798,0.59,0.731,0.27238,DTO_01300327,Ion channel,C3179239,Osteopetrosis Autosomal Dominant Type 2,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.93,1.0,,2001.0,2019.0,ALL
1187,CLCNKA,P51800,0.711,0.385,4.2296e-17,DTO_01300327,Ion channel,C4310805,"BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS",,,disease,Disease or Syndrome,0.6,1.0,,2004.0,2008.0,ALL
1188,CLCNKB,P51801,0.593,0.692,1.4025e-22,DTO_01300327,Ion channel,C1846343,"Bartter syndrome, type 3",C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.8,1.0,strong,1997.0,2019.0,ALL
1191,CLU,P10909,0.426,0.885,7.8072e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.5,0.94,,1991.0,2020.0,ALL
1192,CLIC1,O00299,0.601,0.5,0.00019265,DTO_01300327,Ion channel,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.37,1.0,,2009.0,2019.0,ALL
1193,CLIC2,O15247,0.7,0.5,0.049547,DTO_01300327,Ion channel,C3550913,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 32",,,disease,Disease or Syndrome,0.7,1.0,limited,2012.0,2015.0,ALL
1195,CLK1,P49759,0.769,0.423,7.5962e-07,DTO_03300101,Kinase,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,2014.0,2017.0,ALL
1196,CLK2,P49760,0.691,0.462,0.99997,DTO_03300101,Kinase,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
1198,CLK3,P49761,0.89,0.231,0.23,DTO_03300101,Kinase,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2017.0,2017.0,ALL
1200,TPP1,O14773,0.551,0.808,6.2564e-07,DTO_05007624,Enzyme,C1876161,"CEROID LIPOFUSCINOSIS, NEURONAL, 2",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1997.0,2019.0,ALL
1201,CLN3,Q13286,0.572,0.692,1.3327e-07,DTO_05007405,Transporter,C0751383,Juvenile Neuronal Ceroid Lipofuscinosis,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.994,,1990.0,2019.0,ALL
1203,CLN5,O75503,0.705,0.269,1.7111e-08,,,C1850442,"CEROID LIPOFUSCINOSIS, NEURONAL, 5",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.97,1.0,,1998.0,2019.0,ALL
1207,CLNS1A,P54105,1.0,0.038,0.081436,DTO_05007405,Transporter,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
1208,CLPS,P04118,0.89,0.077,0.0095685,DTO_05007584,Enzyme modulator,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2009.0,2009.0,ALL
1209,CLPTM1,O96005,0.769,0.346,0.95767,DTO_05007624,Enzyme,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
1211,CLTA,P09496,0.628,0.654,0.96319,DTO_05007405,Transporter,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.1,,,,,ALL
1212,CLTB,P09497,0.821,0.231,0.33443,DTO_05007405,Transporter,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
1213,CLTC,Q00610,0.558,0.769,1.0,DTO_05007405,Transporter,C4693389,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 56",,,disease,Mental or Behavioral Dysfunction,0.6,1.0,strong,2016.0,2017.0,ALL
1215,CMA1,P23946,0.514,0.692,7.5861e-09,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.33,1.0,,2003.0,2018.0,ALL
1218,CMD1B,,0.722,0.5,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2004.0,2019.0,ALL
1230,CCR1,P32246,0.531,0.769,0.38775,DTO_02300001,G-protein coupled receptor,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.54,1.0,,2012.0,2019.0,ALL
1232,CCR3,P51677,0.527,0.808,0.00012636,DTO_02300001,G-protein coupled receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,0.909,,1999.0,2019.0,ALL
1233,CCR4,P51679,0.51,0.731,0.06863,DTO_02300001,G-protein coupled receptor,C0023493,Adult T-Cell Lymphoma/Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,1.0,,2002.0,2020.0,ALL
1234,CCR5,P51681,0.398,0.885,4.3094e-10,DTO_02300001,G-protein coupled receptor,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.4,0.839,,2002.0,2019.0,ALL
1235,CCR6,P51684,0.485,0.808,0.0057867,DTO_02300001,G-protein coupled receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,1.0,,2001.0,2019.0,ALL
1236,CCR7,P32248,0.443,0.769,0.057623,DTO_02300001,G-protein coupled receptor,C0023493,Adult T-Cell Lymphoma/Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
1237,CCR8,P51685,0.597,0.692,0.0077492,DTO_02300001,G-protein coupled receptor,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
1238,ACKR2,O00590,0.641,0.615,0.001388,DTO_02300001,G-protein coupled receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
1240,CMKLR1,Q99788,0.612,0.692,0.010767,DTO_02300001,G-protein coupled receptor,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2018.0,ALL
1241,LTB4R,Q15722,0.576,0.692,0.11994,DTO_02300001,G-protein coupled receptor,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.31,1.0,,2000.0,2005.0,ALL
1243,CMM,,0.67,0.385,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.09,1.0,,1987.0,2017.0,ALL
1244,ABCC2,Q92887,0.483,0.808,5.2025e-47,DTO_05007405,Transporter,C0022350,"Jaundice, Chronic Idiopathic",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1996.0,2020.0,ALL
1253,CMTX2,,1.0,0.077,,,,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,1995.0,1995.0,ALL
1254,CMTX3,,0.821,0.154,,,,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,2006.0,2018.0,ALL
1255,CNA1,,0.931,0.038,,,,C0344529,Cornea plana,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.02,1.0,,1996.0,1996.0,ALL
1257,CNC2,,0.674,0.692,,,,C0406810,Carney Complex,C16;C04;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.06,1.0,,2000.0,2018.0,ALL
1258,CNGB1,Q14028,0.628,0.538,1.8369e-37,DTO_01300327,Ion channel,C3151066,RETINITIS PIGMENTOSA 45,,,disease,Disease or Syndrome,0.7,1.0,,2001.0,2001.0,ALL
1259,CNGA1,P29973,0.695,0.269,2.7618e-11,DTO_01300327,Ion channel,C3151059,RETINITIS PIGMENTOSA 49,,,disease,Disease or Syndrome,0.7,1.0,,1995.0,2014.0,ALL
1260,CNGA2,Q16280,0.931,0.154,0.00098232,DTO_01300327,Ion channel,C0393778,Congenital anosmia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Congenital Abnormality,0.32,1.0,,2015.0,2017.0,ALL
1261,CNGA3,Q16281,0.65,0.154,8.0327e-20,DTO_01300327,Ion channel,C1857618,Achromatopsia 2,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.94,1.0,,1998.0,2019.0,ALL
1263,PLK3,Q9H4B4,0.644,0.538,1.8504e-06,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,1996.0,2019.0,ALL
1264,CNN1,P51911,0.682,0.5,0.13803,DTO_05007530,Cellular structure,C0201534,Antiphospholipid antibodies measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
1265,CNN2,Q99439,0.666,0.538,0.024399,DTO_05007530,Cellular structure,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
1266,CNN3,Q15417,0.705,0.462,0.59852,DTO_05007530,Cellular structure,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2002.0,2002.0,ALL
1267,CNP,P09543,0.604,0.692,0.98405,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.4,,2006.0,2018.0,ALL
1268,CNR1,P21554,0.446,0.808,0.50652,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,0.982,,2005.0,2020.0,ALL
1269,CNR2,P34972,0.509,0.846,6.5369e-06,DTO_02300001,G-protein coupled receptor,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.55,1.0,,2006.0,2019.0,ALL
1270,CNTF,P26441,0.561,0.615,2.3384e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.39,0.25,,1996.0,2008.0,ALL
1271,CNTFR,P26992,0.722,0.385,0.95549,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
1272,CNTN1,Q12860,0.599,0.577,0.15131,,,C2675527,"Myopathy, Congenital, Compton-North",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,2008.0,2011.0,ALL
1275,COD2,,0.931,0.038,,,,C0339530,Progressive cone-rod dystrophy,,,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
1277,COL1A1,P02452,0.43,0.808,1.0,,,C0023931,Lobstein Disease,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.976,,1988.0,2019.0,ALL
1278,COL1A2,P08123,0.486,0.846,1.0,,,C0268362,Osteogenesis imperfecta type III (disorder),C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.95,1.0,strong,1991.0,2018.0,ALL
1280,COL2A1,P02458,0.444,0.846,1.0,,,C0220685,Achondrogenesis type 2,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,1.0,1.0,,1988.0,2012.0,ALL
1281,COL3A1,P02461,0.477,0.808,1.0,,,C0268338,"Ehlers-Danlos Syndrome, Type IV",C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1980.0,2019.0,ALL
1282,COL4A1,P02462,0.484,0.731,1.0,,,C4551998,"Porencephaly, Type 1, Autosomal Dominant",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,1977.0,2018.0,ALL
1284,COL4A2,P08572,0.563,0.654,3.5842e-15,,,C3280970,PORENCEPHALY 2,,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2018.0,ALL
1285,COL4A3,Q01955,0.552,0.692,1.0699e-12,,,C0241908,"Hematuria, Benign Familial",C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,1.0,,1996.0,2019.0,ALL
1286,COL4A4,P53420,0.644,0.5,6.7123e-16,,,C0241908,"Hematuria, Benign Familial",C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1982.0,2018.0,ALL
1287,COL4A5,P29400,0.553,0.654,1.0,,,C4746986,"ALPORT SYNDROME 1, X-LINKED",,,disease,Disease or Syndrome,0.9,1.0,strong,1991.0,2017.0,ALL
1288,COL4A6,Q14031,0.686,0.423,0.89901,,,C3806737,"DEAFNESS, X-LINKED 6",,,disease,Disease or Syndrome,0.7,1.0,limited,1998.0,2015.0,ALL
1289,COL5A1,P20908,0.536,0.769,1.0,,,C0268335,Ehlers-Danlos syndrome type 1,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.73,1.0,strong,1996.0,2010.0,ALL
1290,COL5A2,P05997,0.568,0.731,1.0,,,C4538407,"EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2",,,disease,Disease or Syndrome,0.6,1.0,moderate,1993.0,2016.0,ALL
1291,COL6A1,P12109,0.587,0.731,0.99995,DTO_05007575,Receptor,C1834674,BETHLEM MYOPATHY 1,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1993.0,2019.0,ALL
1292,COL6A2,P12110,0.599,0.692,6.5112e-08,DTO_05007575,Receptor,C0410179,Ullrich congenital muscular dystrophy 1,C23;C16;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2001.0,2017.0,ALL
1293,COL6A3,P12111,0.563,0.769,1.8131e-20,DTO_05007575,Receptor,C0410179,Ullrich congenital muscular dystrophy 1,C23;C16;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,strong,2002.0,2018.0,ALL
1294,COL7A1,Q02388,0.545,0.808,2.4411e-40,DTO_05007575,Receptor,C0079474,Hallopeau-Siemens Disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.983,strong,1993.0,2020.0,ALL
1295,COL8A1,P27658,0.678,0.538,0.4051,DTO_05007621,Extracellular structure,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.3,1.0,,2008.0,2008.0,ALL
1296,COL8A2,P25067,0.67,0.423,0.11765,DTO_05007621,Extracellular structure,C1850959,"Corneal dystrophy, Fuchs' endothelial, 1",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2001.0,2019.0,ALL
1297,COL9A1,P20849,0.566,0.731,3.0742e-19,,,C0026760,Multiple Epiphyseal Dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.7,1.0,limited,2001.0,2019.0,ALL
1298,COL9A2,Q14055,0.572,0.769,1.0453e-08,,,C3280342,"STICKLER SYNDROME, TYPE V",,,disease,Disease or Syndrome,0.6,1.0,,2002.0,2011.0,ALL
1299,COL9A3,Q14050,0.569,0.769,3.278e-12,,,C1832998,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 3",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,,1999.0,2014.0,ALL
1300,COL10A1,Q03692,0.619,0.5,2.9839e-05,DTO_05007621,Extracellular structure,C0265289,Metaphyseal chondrodysplasia Schmid type,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.95,1.0,,1994.0,2019.0,ALL
1301,COL11A1,P12107,0.495,0.846,1.0,,,C1858084,"STICKLER SYNDROME, TYPE II (disorder)",C11;C17,   Eye Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.98,1.0,,1971.0,2020.0,ALL
1302,COL11A2,P13942,0.435,0.846,0.70197,,,C4520892,Otospondylomegaepiphyseal dysplasia,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1964.0,2015.0,ALL
1303,COL12A1,Q99715,0.615,0.692,0.97361,DTO_05007575,Receptor,C1834674,BETHLEM MYOPATHY 1,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.61,1.0,limited,2014.0,2018.0,ALL
1305,COL13A1,Q5TAT6,0.608,0.654,3.7355e-14,,,C4225235,"MYASTHENIC SYNDROME, CONGENITAL, 19",,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2017.0,ALL
1306,COL15A1,P39059,0.682,0.577,2.5406e-08,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2017.0,ALL
1307,COL16A1,Q07092,1.0,0.038,2.9031e-24,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
1308,COL17A1,Q9UMD9,0.545,0.769,2.2869e-27,,,C1852551,Epithelial Recurrent Erosion Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.75,1.0,strong,2003.0,2019.0,ALL
1310,COL19A1,Q14993,0.89,0.154,4.8406e-33,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
1311,COMP,P49747,0.503,0.808,1.3462e-09,,,C0410538,Pseudoachondroplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,1.0,0.974,,1995.0,2019.0,ALL
1312,COMT,P21964,0.4,0.923,1.1377e-06,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,1.0,,1997.0,2019.0,ALL
1314,COPA,P53621,0.7,0.385,1.0,DTO_05007405,Transporter,C4225334,"AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE",,,disease,Disease or Syndrome,0.71,1.0,strong,2015.0,2017.0,ALL
1315,COPB1,P53618,0.89,0.192,0.99994,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
1316,KLF6,Q99612,0.501,0.846,0.97946,DTO_05007557,Nucleic acid binding,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.66,1.0,,2005.0,2019.0,ALL
1317,SLC31A1,O15431,0.612,0.577,0.065398,DTO_05007405,Transporter,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2014.0,2014.0,ALL
1318,SLC31A2,O15432,0.78,0.423,8.5199e-05,DTO_05007405,Transporter,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
1319,CORD1,,0.722,0.423,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.03,1.0,,2004.0,2019.0,ALL
1325,CORT,O00230,0.641,0.654,0.013143,DTO_05007599,Signaling,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.03,1.0,,2017.0,2019.0,ALL
1326,MAP3K8,P41279,0.516,0.846,0.96825,DTO_03300101,Kinase,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.33,1.0,,2004.0,2016.0,ALL
1327,COX4I1,P13073,0.691,0.5,0.39416,,,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.3,,limited,,,ALL
1329,COX5B,P10606,0.711,0.423,0.87383,DTO_05007624,Enzyme,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
1337,COX6A1,P12074,0.78,0.154,0.0023136,DTO_05007624,Enzyme,C4015029,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D",,,disease,Disease or Syndrome,0.9,1.0,,2014.0,2014.0,ALL
1339,COX6A2,Q02221,1.0,0.077,0.18881,DTO_05007624,Enzyme,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.02,1.0,,2009.0,2019.0,ALL
1340,COX6B1,P14854,0.7,0.577,0.12065,,,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.7,1.0,,2008.0,2016.0,ALL
1343,COX6B1P3,,,,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
1345,COX6C,P09669,0.861,0.385,0.048848,,,C0265223,Cohen syndrome,C23;C16;C18;C11;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Congenital Abnormality,0.1,1.0,,2004.0,2016.0,ALL
1346,COX7A1,P24310,0.805,0.192,3.727e-05,DTO_05007624,Enzyme,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,,,,,ALL
1347,COX7A2,P14406,0.839,0.038,0.0045177,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
1349,COX7B,P24311,0.595,0.654,0.67459,,,C3550921,LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2,,,disease,Disease or Syndrome,0.6,1.0,,1998.0,2016.0,ALL
1350,COX7C,P15954,1.0,0.077,0.56366,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
1351,COX8A,P10176,0.4,0.846,0.11606,DTO_05007624,Enzyme,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.75,1.0,,1997.0,2016.0,ALL
1352,COX10,Q12887,0.623,0.654,0.08405,DTO_05007624,Enzyme,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.94,1.0,,1999.0,2016.0,ALL
1353,COX11,Q9Y6N1,0.821,0.115,0.016088,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,2010.0,2017.0,ALL
1355,COX15,Q7KZN9,0.638,0.538,1.1031e-13,,,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,limited,2002.0,2016.0,ALL
1356,CP,P00450,0.466,0.846,4.2013e-10,DTO_05007624,Enzyme,C0878682,Ceruloplasmin deficiency,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.9,1.0,,1987.0,2019.0,ALL
1357,CPA1,P15085,0.65,0.577,2.6567e-11,DTO_05007624,Enzyme,C0149521,"Pancreatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.63,1.0,moderate,2013.0,2017.0,ALL
1358,CPA2,P48052,0.861,0.192,1.4033e-15,DTO_05007624,Enzyme,C0003129,Anoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0,,2009.0,2009.0,ALL
1359,CPA3,P15088,0.729,0.346,2.0416e-16,DTO_05007624,Enzyme,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
1360,CPB1,P15086,0.626,0.654,2.6104e-22,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
1361,CPB2,Q96IY4,0.536,0.846,2.7076e-17,DTO_05007624,Enzyme,C0002453,Amenorrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2005.0,2005.0,ALL
1362,CPD,O75976,0.686,0.654,0.00074113,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
1363,CPE,P16870,0.584,0.692,0.99233,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,0.923,moderate,1991.0,2013.0,ALL
1364,CLDN4,O14493,0.514,0.692,6.9789e-05,DTO_05007527,Cell-cell junction,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
1365,CLDN3,O15551,0.558,0.615,0.52233,DTO_05007527,Cell-cell junction,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,0.75,,2001.0,2019.0,ALL
1366,CLDN7,O95471,0.494,0.808,0.0028828,DTO_05007527,Cell-cell junction,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.34,1.0,,2009.0,2016.0,ALL
1368,CPM,P14384,0.682,0.538,1.6604e-05,,,C0037116,Silicosis,C08;C24,   Respiratory Tract Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.31,1.0,,2014.0,2019.0,ALL
1369,CPN1,P15169,0.729,0.423,8.6973e-08,,,C0398782,Carboxypeptidase N Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.5,1.0,,2003.0,2003.0,ALL
1370,CPN2,P22792,0.839,0.192,0.0026009,DTO_05007575,Receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
1371,CPOX,P36551,0.488,0.846,0.17152,DTO_05007624,Enzyme,C0162531,Hereditary Coproporphyria,C16;C06;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.938,strong,1983.0,2019.0,ALL
1373,CPS1,P31327,0.59,0.615,1.0947e-09,DTO_05007624,Enzyme,C0751753,Carbamoyl-Phosphate Synthase I Deficiency Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.87,1.0,definitive,1986.0,2019.0,ALL
1374,CPT1A,P50416,0.555,0.808,5.114e-09,DTO_05007624,Enzyme,C1829703,Carnitine palmitoyl transferase 1A deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.9,1.0,definitive,1981.0,2016.0,ALL
1375,CPT1B,Q92523,0.653,0.538,1.5291e-11,DTO_05007624,Enzyme,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.36,1.0,,2008.0,2016.0,ALL
1376,CPT2,P23786,0.542,0.769,4.598e-10,DTO_05007624,Enzyme,C1833511,"CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE",C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,,1992.0,2016.0,ALL
1378,CR1,P17927,0.533,0.808,1.6488e-35,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.5,0.971,,2009.0,2019.0,ALL
1379,CR1L,Q2VPA4,0.931,0.115,7.6434e-27,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
1380,CR2,P20023,0.556,0.654,4.7399e-19,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.69,1.0,moderate,2006.0,2020.0,ALL
1381,CRABP1,P29762,0.631,0.615,0.0058779,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2005.0,2005.0,ALL
1382,CRABP2,P29373,0.593,0.615,0.0015096,,,C0268583,Methylmalonic acidemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
1384,CRAT,P43155,0.656,0.577,9.4796e-12,DTO_05007624,Enzyme,C4693587,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8,,,disease,Disease or Syndrome,0.6,1.0,,2018.0,2018.0,ALL
1385,CREB1,P16220,0.463,0.885,0.99673,,,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.51,1.0,,2001.0,2009.0,ALL
1386,ATF2,P15336,0.551,0.808,0.99131,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,1991.0,2018.0,ALL
1387,CREBBP,Q92793,0.428,0.808,1.0,,,C0035934,Rubinstein-Taybi Syndrome,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.988,definitive,1997.0,2019.0,ALL
1388,ATF6B,Q99941,0.839,0.192,3.1036e-07,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
1389,CREBL2,O60519,1.0,0.077,0.72167,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
1390,CREM,Q03060,0.575,0.692,0.50878,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2012.0,2019.0,ALL
1392,CRH,P06850,0.439,0.808,0.71614,DTO_05007599,Signaling,C0010481,Cushing Syndrome,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.6,1.0,,1992.0,2019.0,ALL
1393,CRHBP,P24387,0.659,0.5,0.21476,DTO_05007599,Signaling,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.52,1.0,,1996.0,2010.0,ALL
1394,CRHR1,P34998,0.517,0.769,3.7856e-05,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.6,1.0,,2004.0,2019.0,ALL
1395,CRHR2,Q13324,0.584,0.731,8.5473e-17,DTO_02300001,G-protein coupled receptor,C0003123,Anorexia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.54,1.0,,1999.0,2019.0,ALL
1396,CRIP1,P50238,0.666,0.577,0.00049848,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
1397,CRIP2,P52943,0.743,0.385,0.00018101,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,1999.0,2013.0,ALL
1398,CRK,P46108,0.394,0.923,0.95936,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,,2005.0,2010.0,ALL
1399,CRKL,P46109,0.553,0.769,0.44604,,,C0012236,DiGeorge Syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.52,1.0,,2001.0,2019.0,ALL
1400,CRMP1,Q14194,0.525,0.808,0.99173,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
1401,CRP,P02741,0.299,0.962,0.0036969,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.6,0.955,,1989.0,2020.0,ALL
1404,HAPLN1,P10915,0.663,0.577,0.60242,DTO_05007621,Extracellular structure,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,1.0,,2011.0,2011.0,ALL
1406,CRX,O43186,0.565,0.692,0.51043,DTO_05007542,Transcription factor,C3151192,LEBER CONGENITAL AMAUROSIS 7,,,disease,Disease or Syndrome,0.9,1.0,,1998.0,2014.0,ALL
1407,CRY1,Q16526,0.585,0.769,1.662e-09,DTO_05007624,Enzyme,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2012.0,2017.0,ALL
1408,CRY2,Q49AN0,0.599,0.692,0.00031808,DTO_05007624,Enzyme,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2010.0,2017.0,ALL
1409,CRYAA,A0A140G945;P02489,0.653,0.385,0.17396,,,C1858679,"CATARACT, AUTOSOMAL DOMINANT",C11,   Eye Diseases,disease,Disease or Syndrome,0.9,1.0,,1996.0,2013.0,ALL
1410,CRYAB,P02511,0.515,0.731,0.02247,,,C1837317,Alpha-B Crystallinopathy,C11;C05;C10;C14,   Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.9,1.0,,1998.0,2012.0,ALL
1411,CRYBA1,P05813,0.716,0.269,6.4088e-05,,,C1833229,"Cataract, Congenital Zonular, with Sutural Opacities",C11,   Eye Diseases,disease,Disease or Syndrome,0.8,1.0,,1998.0,2015.0,ALL
1412,CRYBA2,P53672,0.839,0.192,0.00019464,,,C4011454,CATARACT 42,,,disease,Disease or Syndrome,0.5,1.0,,2013.0,2013.0,ALL
1413,CRYBA4,P53673,0.716,0.269,3.4999e-09,,,C3808012,"CATARACT 23, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.7,1.0,,2006.0,2010.0,ALL
1414,CRYBB1,P53674,0.686,0.231,0.00070069,,,C3888124,"CATARACT 17, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.6,1.0,,2002.0,2017.0,ALL
1415,CRYBB2,P43320,0.623,0.462,0.38956,,,C1832175,"Cataract, Congenital, Cerulean Type, 2",C11,   Eye Diseases,disease,Disease or Syndrome,0.8,1.0,,1980.0,2017.0,ALL
1416,CRYBB2P1,,0.89,0.231,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
1417,CRYBB3,P26998,0.769,0.269,3.5766e-11,,,C1857853,"Cataract, Congenital Nuclear, Autosomal Recessive 2",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2005.0,2013.0,ALL
1418,CRYGA,P11844,0.805,0.269,4.3304e-10,,,C0029531,Other cataract,C11,   Eye Diseases,disease,Disease or Syndrome,0.2,1.0,,1983.0,1984.0,ALL
1419,CRYGB,P07316,0.78,0.269,8.1381e-08,,,C3808800,"CATARACT 39, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.8,1.0,limited,1984.0,2012.0,ALL
1420,CRYGC,P07315,0.612,0.577,0.0006061,,,C1852438,"CATARACT, COPPOCK-LIKE",C11,   Eye Diseases,disease,Disease or Syndrome,0.82,1.0,,1999.0,2017.0,ALL
1421,CRYGD,P07320,0.51,0.808,0.00030317,,,C3540850,"CATARACT 4, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.9,1.0,,1999.0,2011.0,ALL
1427,CRYGS,P22914,0.743,0.192,0.023028,,,C3805410,"CATARACT 20, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.9,1.0,strong,1983.0,2005.0,ALL
1428,CRYM,Q14894,0.769,0.346,0.02569,DTO_05007624,Enzyme,C4084708,"DEAFNESS, AUTOSOMAL DOMINANT 40",,,disease,Disease or Syndrome,0.7,1.0,limited,1997.0,2016.0,ALL
1429,CRYZ,Q08257,0.524,0.731,5.6616e-23,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.0,,2003.0,2013.0,ALL
1431,CS,O75390,0.59,0.654,0.98402,DTO_05007624,Enzyme,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.32,1.0,,1996.0,2018.0,ALL
1432,MAPK14,Q16539,0.379,0.923,0.37466,DTO_03300101,Kinase,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.4,1.0,,2007.0,2019.0,ALL
1434,CSE1L,P55060,0.521,0.808,1.0,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2012.0,2018.0,ALL
1435,CSF1,P09603,0.473,0.808,0.99634,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1992.0,2019.0,ALL
1436,CSF1R,P07333,0.448,0.808,0.13278,DTO_03300101,Kinase,C3711381,Hereditary Diffuse Leukoencephalopathy with Spheroids,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.8,1.0,,1989.0,2020.0,ALL
1437,CSF2,P04141,0.33,0.962,0.83468,DTO_05007599,Signaling,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.51,1.0,,1998.0,2007.0,ALL
1438,CSF2RA,P15509,0.67,0.615,2.3956e-10,DTO_05007599,Signaling,C0034050,Pulmonary Alveolar Proteinosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2019.0,ALL
1439,CSF2RB,P32927,0.705,0.423,0.17646,DTO_05007575,Receptor,C0034050,Pulmonary Alveolar Proteinosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.64,1.0,strong,1995.0,2019.0,ALL
1440,CSF3,P09919,0.377,0.885,0.38046,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1993.0,2019.0,ALL
1441,CSF3R,Q99062,0.55,0.692,1.5225e-10,DTO_05007599,Signaling,C0543669,"Neutrophilia, Hereditary",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.83,1.0,,1998.0,2014.0,ALL
1442,CSH1,P0DML2;P0DML3,0.566,0.808,2.1264e-05,DTO_05007599,Signaling,C0175693,Russell-Silver syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.33,1.0,,1998.0,2003.0,ALL
1443,CSH2,P0DML2;P0DML3,0.566,0.808,0.013182,DTO_05007599,Signaling,C0009207,Cockayne Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,0.984,,1996.0,2020.0,ALL
1444,CSHL1,Q14406,0.647,0.577,3.0815e-12,DTO_05007599,Signaling,C0271567,"Isolated Growth Hormone Deficiency, Type II",C05;C10;C19,   Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
1445,CSK,P41240,0.606,0.692,0.99977,DTO_03300101,Kinase,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.32,1.0,,2012.0,2015.0,ALL
1446,CSN1S1,P47710,0.78,0.346,1.4185e-16,DTO_05007612,Storage,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,1999.0,2013.0,ALL
1447,CSN2,P05814,0.641,0.538,7.1828e-06,DTO_05007612,Storage,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,1998.0,2005.0,ALL
1448,CSN3,P07498,0.736,0.346,0.011763,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
1452,CSNK1A1,P48729,0.686,0.385,0.99758,DTO_03300101,Kinase,C0023493,Adult T-Cell Lymphoma/Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
1453,CSNK1D,P48730,0.65,0.615,0.99577,DTO_03300101,Kinase,C3808874,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2",,,disease,Disease or Syndrome,0.6,1.0,,2005.0,2015.0,ALL
1454,CSNK1E,P49674,0.619,0.615,0.99926,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2003.0,2019.0,ALL
1455,CSNK1G2,P78368,0.743,0.346,0.99138,DTO_03300101,Kinase,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
1456,CSNK1G3,Q9Y6M4,0.839,0.269,0.99947,DTO_03300101,Kinase,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2018.0,ALL
1457,CSNK2A1,P68400,0.597,0.731,0.98711,DTO_03300101,Kinase,C4310739,OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME,,,disease,Disease or Syndrome,0.72,1.0,,2016.0,2020.0,ALL
1459,CSNK2A2,P19784,0.644,0.577,0.9994,DTO_03300101,Kinase,C0007114,Malignant neoplasm of skin,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2008.0,2008.0,ALL
1460,CSNK2B,P67870,0.686,0.538,0.91728,DTO_03300101,Kinase,C0007114,Malignant neoplasm of skin,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2008.0,2008.0,ALL
1462,VCAN,P13611,0.497,0.808,1.0,DTO_05007621,Extracellular structure,C1840452,Hyaloideoretinal degeneration of Wagner,C11,   Eye Diseases,disease,Disease or Syndrome,0.7,0.938,,1999.0,2018.0,ALL
1463,NCAN,O14594,0.67,0.5,0.068,DTO_05007621,Extracellular structure,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.68,1.0,,2011.0,2019.0,ALL
1464,CSPG4,Q6UVK1,0.599,0.615,2.6212e-05,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2015.0,2017.0,ALL
1465,CSRP1,P21291,0.686,0.346,0.0003328,DTO_05007530,Cellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2007.0,2008.0,ALL
1466,CSRP2,Q16527,0.78,0.269,4.769e-07,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,1997.0,2018.0,ALL
1468,SLC25A10,Q9UBX3,0.666,0.5,5.8727e-10,DTO_05007405,Transporter,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2002.0,2002.0,ALL
1469,CST1,P01037,0.659,0.577,3.3855e-08,,,C0018621,Hay fever,C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.32,1.0,,2013.0,2017.0,ALL
1470,CST2,P09228,0.743,0.577,8.0628e-08,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
1471,CST3,P01034,0.436,0.808,0.0039011,,,C1527338,"Hereditary Cerebral Amyloid Angiopathy, Icelandic Type",C16;C18;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.77,1.0,,1987.0,2013.0,ALL
1472,CST4,P01036,0.743,0.462,6.6761e-07,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
1473,CST5,P28325,0.821,0.231,6.8894e-06,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
1474,CST6,Q15828,0.612,0.615,0.37188,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1997.0,2014.0,ALL
1475,CSTA,P01040,0.592,0.731,0.00015316,DTO_05007584,Enzyme modulator,C1842797,"Exfoliative Ichthyosis, Autosomal Recessive, Ichthyosis Bullosa of Siemens-like",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.5,,moderate,,,ALL
1476,CSTB,P04080,0.53,0.692,0.0065562,DTO_05007584,Enzyme modulator,C0751785,Unverricht-Lundborg Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.984,,1994.0,2019.0,ALL
1477,CSTF1,Q05048,0.931,0.077,0.95401,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
1478,CSTF2,P33240,0.792,0.231,0.99959,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
1479,CSTF3,Q12996,0.89,0.154,0.98279,DTO_05007557,Nucleic acid binding,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
1480,CSTP1,,0.89,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2013.0,2019.0,ALL
1482,NKX2-5,P52952,0.533,0.692,0.94531,DTO_05007542,Transcription factor,C0039685,Tetralogy of Fallot,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.96,0.909,,1999.0,2018.0,ALL
1483,CTAA1,,0.568,0.731,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2009.0,2019.0,ALL
1485,CTAG1B,P78358,0.507,0.731,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.98,,2000.0,2020.0,ALL
1486,CTBS,Q01459,0.695,0.654,1.0768e-07,,,C0008354,Cholera,C01,   Infections,disease,Disease or Syndrome,0.1,0.9,,2005.0,2018.0,ALL
1487,CTBP1,Q13363,0.559,0.692,0.98442,DTO_05007542,Transcription factor,C4693578,"HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2019.0,ALL
1488,CTBP2,P56545,0.638,0.615,0.0013557,DTO_05007542,Transcription factor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.46,1.0,,2008.0,2018.0,ALL
1489,CTF1,Q16619,0.636,0.423,0.041899,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.33,1.0,,2011.0,2018.0,ALL
1490,CCN2,P29279,0.399,0.846,0.00050202,DTO_05007599,Signaling,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.7,0.963,,2001.0,2019.0,ALL
1491,CTH,P32929,0.578,0.615,7.482e-08,DTO_05007624,Enzyme,C0220993,Cystathioninuria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.94,1.0,definitive,1986.0,2019.0,ALL
1493,CTLA4,P16410,0.369,0.923,0.94085,,,C4015214,CTLA4 Haploinsufficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.75,1.0,strong,2014.0,2019.0,ALL
1495,CTNNA1,P35221,0.584,0.538,0.96962,DTO_05007530,Cellular structure,C1837029,"Macular Dystrophy, Butterfly-Shaped Pigmentary, 2",C11,   Eye Diseases,disease,Disease or Syndrome,0.8,1.0,,2016.0,2016.0,ALL
1496,CTNNA2,P26232,0.663,0.5,0.42501,DTO_05007530,Cellular structure,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2014.0,2019.0,ALL
1497,CTNS,O60931,0.628,0.538,0.00030924,,,C2931187,Nephropathic cystinosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.98,,1998.0,2019.0,ALL
1498,CTNNA1P1,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
1499,CTNNB1,P35222,0.303,0.885,0.99999,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.9,1.0,,1999.0,2019.0,ALL
1500,CTNND1,O60716,0.5,0.808,0.99999,DTO_05007530,Cellular structure,C1861536,Blepharo-cheilo-dontic syndrome,C16;C11;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.31,1.0,,2017.0,2017.0,ALL
1501,CTNND2,Q9UQB3,0.579,0.731,1.0,DTO_05007530,Cellular structure,C0010314,Cri-du-Chat Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.35,1.0,,2000.0,2019.0,ALL
1503,CTPS1,P17812,0.736,0.269,0.99259,DTO_05007624,Enzyme,C4014617,IMMUNODEFICIENCY 24,,,disease,Disease or Syndrome,0.7,1.0,strong,1998.0,2016.0,ALL
1504,CTRB1,P17538,0.76,0.385,2.4233e-06,DTO_05007624,Enzyme,C0003129,Anoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0,,2009.0,2009.0,ALL
1506,CTRL,P40313,0.599,0.846,1.0976e-09,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2019.0,ALL
1508,CTSB,P07858,0.457,0.846,5.8819e-11,DTO_05007624,Enzyme,C0406756,Keratolytic winter erythema,C23;C16;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.52,1.0,,2012.0,2017.0,ALL
1509,CTSD,P07339,0.478,0.846,0.00091747,DTO_05007624,Enzyme,C1864669,NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCY,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.93,1.0,,1995.0,2018.0,ALL
1510,CTSE,P14091,0.631,0.615,1.4371e-14,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
1511,CTSG,P08311,0.563,0.731,9.5595e-06,DTO_05007624,Enzyme,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0,,1996.0,2009.0,ALL
1512,CTSH,P09668,0.626,0.654,1.2518e-08,DTO_05007624,Enzyme,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.43,1.0,,2008.0,2015.0,ALL
1513,CTSK,P43235,0.497,0.808,3.0989e-05,DTO_05007624,Enzyme,C0238402,Pycnodysostosis,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,0.979,,1996.0,2019.0,ALL
1514,CTSL,P07711,0.488,0.846,0.0080454,DTO_05007624,Enzyme,C0025286,Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.32,1.0,,2005.0,2010.0,ALL
1515,CTSV,O60911,0.716,0.462,2.3031e-07,DTO_05007624,Enzyme,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,,,,,ALL
1519,CTSO,P43234,0.931,0.077,5.9474e-09,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.05,1.0,,1994.0,2017.0,ALL
1520,CTSS,P25774,0.539,0.731,0.34178,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.35,1.0,,2005.0,2019.0,ALL
1521,CTSW,P56202,0.89,0.077,6.8595e-12,DTO_05007624,Enzyme,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
1522,CTSZ,Q9UBR2,0.647,0.577,2.2587e-16,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
1523,CUX1,P39880;Q13948,0.465,0.846,1.0,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,0.962,,2004.0,2019.0,ALL
1524,CX3CR1,P49238,0.457,0.885,0.061371,DTO_02300001,G-protein coupled receptor,C3151079,"MACULAR DEGENERATION, AGE-RELATED, 12",,,disease,Disease or Syndrome,0.5,1.0,,2007.0,2007.0,ALL
1525,CXADR,P78310,0.454,0.885,0.36867,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
1527,TEX28,O15482,0.821,0.154,,,,C0155015,"Color Blindness, Red",C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
1528,CYB5A,P00167,0.601,0.654,0.0015821,DTO_05007624,Enzyme,C4285231,METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA,,,disease,Disease or Syndrome,0.6,1.0,,1994.0,2012.0,ALL
1534,CYB561,P49447,0.78,0.192,0.61092,DTO_05007624,Enzyme,C4748569,ORTHOSTATIC HYPOTENSION 2,,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
1535,CYBA,P13498,0.52,0.769,8.8678e-06,,,C1856255,"Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1990.0,2016.0,ALL
1536,CYBB,P04839,0.452,0.885,0.99904,DTO_01300327,Ion channel,C0018203,Chronic granulomatous disease,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.9,0.986,limited,1987.0,2020.0,ALL
1537,CYC1,P08574,0.656,0.462,0.13875,,,C3809553,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2013.0,ALL
1538,CYLC1,P35663,0.89,0.077,0.93145,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1992.0,1992.0,ALL
1539,CYLC2,Q14093,0.821,0.192,4.4812e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
1540,CYLD,Q9NQC7,0.498,0.846,0.99993,DTO_05007624,Enzyme,C1275122,Familial multiple trichoepitheliomata,C16;C04;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Skin and Connective Tissue Diseases",disease,Neoplastic Process,0.8,1.0,,2003.0,2019.0,ALL
1541,CYMD,,0.821,0.231,,,,C0011311,Dengue Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
1543,CYP1A1,P04798,0.436,0.846,1.0635e-17,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2000.0,2012.0,ALL
1544,CYP1A2,P05177,0.494,0.923,2.4795e-10,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,0.895,,1993.0,2014.0,ALL
1545,CYP1B1,Q16678,0.457,0.769,2.2024e-05,DTO_05007624,Enzyme,C1856439,"GLAUCOMA 3, PRIMARY CONGENITAL, A",C11,   Eye Diseases,disease,Disease or Syndrome; Congenital Abnormality,0.7,1.0,,1997.0,2016.0,ALL
1548,CYP2A6,P11509,0.556,0.731,5.401e-09,,,C0028043,Nicotine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.957,,1999.0,2020.0,ALL
1549,CYP2A7,P20853,0.686,0.538,3.7792e-15,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.2,1.0,,2013.0,2013.0,ALL
1551,CYP3A7,P24462,0.67,0.5,6.1237e-14,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2006.0,2006.0,ALL
1553,CYP2A13,Q16696,0.695,0.462,8.6461e-07,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2003.0,2013.0,ALL
1555,CYP2B6,P20813,0.428,0.846,1.9303e-10,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,0.947,,1983.0,2019.0,ALL
1556,CYP2B7P,,0.76,0.385,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0,,2018.0,2019.0,ALL
1557,CYP2C19,P33261,0.467,0.846,6.4882e-20,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.39,1.0,,2010.0,2018.0,ALL
1558,CYP2C8,P10632,0.615,0.615,1.9759e-22,,,C4693948,"DRUG METABOLISM, ALTERED, CYP2C8-RELATED",,,disease,Disease or Syndrome,0.4,1.0,,2015.0,2016.0,ALL
1559,CYP2C9,P11712,0.506,0.885,1.2709e-10,,,C0750384,Coumarin Resistance,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.41,1.0,,2016.0,2016.0,ALL
1562,CYP2C18,P33260,0.666,0.731,3.3436e-10,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
1564,CYP2D7,A0A087X1C5,0.659,0.577,,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.21,1.0,,2010.0,2018.0,ALL
1565,CYP2D6,P10635,0.437,0.885,1.0793e-25,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2004.0,2019.0,ALL
1568,CYP2D8P,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
1571,CYP2E1,P05181,0.459,0.885,8.0688e-09,,,C0085762,Alcohol abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.74,1.0,,1992.0,2013.0,ALL
1572,CYP2F1,P24903,0.805,0.154,3.4078e-09,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.2,1.0,,2001.0,2001.0,ALL
1573,CYP2J2,P51589,0.628,0.615,1.6181e-15,,,C0004626,"Pneumonia, Bacterial",C01;C08,   Infections;    Respiratory Tract Diseases,group,Disease or Syndrome,0.2,1.0,,2004.0,2004.0,ALL
1576,CYP3A4,P08684,0.462,0.885,5.7979e-11,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.958,,2002.0,2019.0,ALL
1577,CYP3A5,P20815,0.511,0.846,6.2948e-17,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.39,0.778,,2003.0,2018.0,ALL
1578,CYP3A51P,,0.89,0.154,,,,C0948089,Acute Coronary Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
1579,CYP4A11,Q02928,0.695,0.462,1.087e-24,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2014.0,2019.0,ALL
1580,CYP4B1,P13584,0.691,0.308,3.2777e-10,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2000.0,2008.0,ALL
1581,CYP7A1,P22680,0.576,0.615,0.00024507,DTO_05007624,Enzyme,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.7,1.0,,1993.0,2020.0,ALL
1582,CYP8B1,Q9UNU6,0.711,0.269,2.0558e-05,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0,,2012.0,2018.0,ALL
1583,CYP11A1,P05108,0.547,0.731,5.4912e-07,,,C3151055,"ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE",,,disease,Disease or Syndrome,0.72,1.0,strong,2001.0,2017.0,ALL
1584,CYP11B1,P15538,0.563,0.615,8.245e-07,,,C0268292,Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency,C16;C18;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1991.0,2019.0,ALL
1585,CYP11B2,P19099,0.553,0.615,7.1321e-19,,,C0268293,Corticosterone Methyl Oxidase Type I Deficiency,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.71,1.0,limited,1997.0,2014.0,ALL
1586,CYP17A1,P05093,0.462,0.769,0.00026255,,,C0268285,"Adrenal hyperplasia, congenital, type 5",C16;C18;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.8,0.978,strong,1988.0,2018.0,ALL
1587,ADAM3A,,0.792,0.231,,,,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
1588,CYP19A1,P11511,0.41,0.885,1.7022e-05,DTO_05007624,Enzyme,C1960539,Aromatase deficiency,C16;C18;C13;C17;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.8,1.0,,1993.0,2019.0,ALL
1589,CYP21A2,P08686,0.525,0.769,0.00025989,,,C2936858,Congenital adrenal hyperplasia due to 21 hydroxylase deficiency,C16;C18;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.8,0.976,,1980.0,2020.0,ALL
1590,CYP21A1P,,0.78,0.5,,,,C0001627,Congenital adrenal hyperplasia,C16;C18;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.1,1.0,,1990.0,2013.0,ALL
1591,CYP24A1,Q07973,0.518,0.692,3.1964e-23,DTO_05007624,Enzyme,C4310232,"Hypercalcemia, Infantile, 1",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2018.0,ALL
1592,CYP26A1,O43174,0.619,0.577,8.4269e-11,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,2008.0,2008.0,ALL
1593,CYP27A1,Q02318,0.538,0.731,5.2916e-19,DTO_05007624,Enzyme,C0238052,"Xanthomatosis, Cerebrotendinous",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.985,,1975.0,2019.0,ALL
1594,CYP27B1,O15528,0.502,0.769,1.9194e-07,DTO_05007624,Enzyme,C0268689,"Vitamin D-dependent rickets, type 1",C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1997.0,2020.0,ALL
1595,CYP51A1,Q16850,0.653,0.615,1.4563e-07,DTO_05007624,Enzyme,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.21,1.0,,2006.0,2019.0,ALL
1600,DAB1,O75553,0.626,0.615,0.99915,DTO_05007599,Signaling,C3889636,SPINOCEREBELLAR ATAXIA 37,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.53,1.0,limited,2017.0,2019.0,ALL
1601,DAB2,P98082,0.565,0.731,0.40701,DTO_05007599,Signaling,C0014072,Experimental Autoimmune Encephalomyelitis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2011.0,2011.0,ALL
1602,DACH1,Q9UI36,0.604,0.538,0.99954,DTO_05007542,Transcription factor,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2019.0,ALL
1603,DAD1,P61803,0.78,0.346,0.085505,DTO_05007624,Enzyme,C0007095,Carcinoid Tumor,C04,   Neoplasms,phenotype,Neoplastic Process,0.02,1.0,,2008.0,2013.0,ALL
1604,CD55,P08174,0.51,0.808,5.6753e-12,,,C0033680,Protein-Losing Enteropathies,C06,   Digestive System Diseases,group,Disease or Syndrome,0.54,1.0,strong,2017.0,2019.0,ALL
1605,DAG1,Q14118,0.498,0.808,0.98117,DTO_05007575,Receptor,C3151184,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9",,,disease,Disease or Syndrome,0.91,1.0,,2003.0,2019.0,ALL
1606,DGKA,P23743,0.7,0.346,0.46072,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2013.0,2019.0,ALL
1607,DGKB,Q9Y6T7,0.716,0.423,0.52991,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
1608,DGKG,P49619,0.76,0.462,6.0186e-13,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
1609,DGKQ,P52824,0.736,0.423,1.7603e-09,DTO_03300101,Kinase,C0086981,Sicca Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
1610,DAO,P14920,0.636,0.615,6.2271e-22,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.67,1.0,moderate,2010.0,2018.0,ALL
1611,DAP,P51397,0.53,0.808,0.0035018,DTO_05007584,Enzyme modulator,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.4,1.0,,2011.0,2016.0,ALL
1612,DAPK1,P53355,0.472,0.808,0.99767,DTO_03300101,Kinase,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,0.917,,2006.0,2019.0,ALL
1613,DAPK3,O43293,0.612,0.654,0.0065541,DTO_03300101,Kinase,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
1615,DARS1,P14868,0.711,0.5,8.536e-06,DTO_05007624,Enzyme,C3809008,HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY,,,disease,Disease or Syndrome,0.73,1.0,,2013.0,2018.0,ALL
1616,DAXX,Q9UER7,0.544,0.692,0.098633,,,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.38,1.0,,2011.0,2019.0,ALL
1617,DAZ1,Q9NQZ3,0.705,0.385,,DTO_05007557,Nucleic acid binding,C1507149,Partial chromosome Y deletion,C23;C16;C13;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2002.0,2010.0,ALL
1618,DAZL,Q92904,0.78,0.154,0.99449,DTO_05007557,Nucleic acid binding,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
1620,BRINP1,O60477,0.615,0.615,0.99251,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2014.0,2018.0,ALL
1621,DBH,P09172,0.511,0.846,3.3352e-10,,,C0342687,dopamine beta hydroxylase deficiency,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.71,1.0,strong,1995.0,2011.0,ALL
1622,DBI,P07108,0.65,0.654,0.0013944,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2004.0,2011.0,ALL
1627,DBN1,Q16643,0.633,0.538,0.99705,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2004.0,2013.0,ALL
1628,DBP,Q10586,0.556,0.731,0.23376,DTO_05007557,Nucleic acid binding,C4707243,Familial thoracic aortic aneurysm and aortic dissection,,,disease,Disease or Syndrome,0.3,,limited,,,ALL
1629,DBT,P11182,0.638,0.462,1.0467e-05,DTO_05007624,Enzyme,C0024776,Maple Syrup Urine Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1991.0,2020.0,ALL
1630,DCC,P43146,0.471,0.808,0.99448,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.7,0.946,,1990.0,2019.0,ALL
1632,ECI1,P42126,0.743,0.308,1.5853e-12,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
1633,DCK,P27707,0.561,0.692,1.545e-05,DTO_03300101,Kinase,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,1994.0,2017.0,ALL
1634,DCN,P07585,0.457,0.808,0.31231,,,C1864738,"Corneal Dystrophy, Congenital Stromal",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.95,1.0,strong,2005.0,2015.0,ALL
1635,DCTD,P32321,0.78,0.192,0.00070935,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2009.0,2017.0,ALL
1636,ACE,P12821,0.328,0.923,1.0344e-37,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.9,0.915,strong,1998.0,2020.0,ALL
1637,DCR,,0.674,0.538,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.36,0.833,,1993.0,2010.0,ALL
1638,DCT,P40126,0.619,0.654,7.3889e-14,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,0.977,,1994.0,2019.0,ALL
1639,DCTN1,Q14203,0.597,0.5,0.084251,DTO_05007613,Chaperone,C1868594,Perry Syndrome,C23;C08;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,1.0,,2003.0,2018.0,ALL
1641,DCX,O43602,0.511,0.769,0.3042,,,C4551968,"Lissencephaly, X-Linked, 1",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.73,1.0,,1998.0,2018.0,ALL
1642,DDB1,Q16531,0.666,0.577,0.99979,DTO_05007557,Nucleic acid binding,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
1643,DDB2,Q92466,0.576,0.654,7.397e-06,DTO_05007557,Nucleic acid binding,C1848411,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E",C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome; Congenital Abnormality,1.0,0.85,definitive,1996.0,2016.0,ALL
1644,DDC,P20711,0.535,0.769,3.7519e-08,,,C1291564,Deficiency of aromatic-L-amino-acid decarboxylase,,,disease,Disease or Syndrome,0.98,1.0,,2004.0,2019.0,ALL
1645,AKR1C1,Q04828,0.593,0.615,3.524e-15,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.33,1.0,,2001.0,2018.0,ALL
1646,AKR1C2,P52895,0.608,0.577,6.8956e-11,DTO_05007624,Enzyme,C1839840,"MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE",C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2011.0,2011.0,ALL
1647,GADD45A,P24522,0.526,0.769,0.044075,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.34,1.0,,2000.0,2015.0,ALL
1649,DDIT3,P35638,0.467,0.846,0.59066,,,C0206634,"Liposarcoma, Myxoid",C04,   Neoplasms,disease,Neoplastic Process,0.6,0.958,,1992.0,2019.0,ALL
1650,DDOST,P39656,0.644,0.692,0.00061409,DTO_05007624,Enzyme,C3281084,Congenital disorder of glycosylation type 1r,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2012.0,2012.0,ALL
1652,DDT,P30046,0.575,0.731,0.32959,DTO_05007624,Enzyme,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2001.0,2019.0,ALL
1653,DDX1,Q92499,0.67,0.577,0.99449,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
1654,DDX3X,O00571,0.537,0.769,0.99986,,,C4085582,"MENTAL RETARDATION, X-LINKED 102",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2015.0,ALL
1655,DDX5,P17844,0.592,0.692,0.99998,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
1656,DDX6,P26196,0.663,0.385,0.99964,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0,,2012.0,2017.0,ALL
1657,DMXL1,Q9Y485,0.805,0.154,1.0,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
1659,DHX8,Q14562,1.0,0.192,9.1546e-07,DTO_05007624,Enzyme,C0677776,Hereditary Breast and Ovarian Cancer Syndrome,C16;C04;C13;C17;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Endocrine System Diseases",disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
1660,DHX9,Q08211,0.623,0.615,1.0,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2014.0,2019.0,ALL
1662,DDX10,Q13206,0.722,0.269,9.4565e-17,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2013.0,2018.0,ALL
1663,DDX11,Q96FC9,0.674,0.577,2.3461e-21,DTO_05007624,Enzyme,C3150658,WARSAW BREAKAGE SYNDROME,,,disease,Disease or Syndrome,0.8,1.0,strong,2010.0,2019.0,ALL
1665,DHX15,O43143,0.7,0.346,1.0,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2016.0,2019.0,ALL
1666,DECR1,Q16698,0.426,0.885,4.4689e-14,DTO_05007624,Enzyme,C1857252,"2,4-Dienoyl-CoA Reductase Deficiency",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.5,1.0,limited,2014.0,2015.0,ALL
1667,DEFA1,P59665,0.636,0.731,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0,,2010.0,2018.0,ALL
1668,DEFA3,P59666,0.716,0.538,0.090546,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
1669,DEFA4,P12838,0.861,0.231,0.49798,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
1670,DEFA5,Q01523,0.695,0.423,5.1896e-06,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.33,1.0,,2008.0,2017.0,ALL
1671,DEFA6,Q01524,0.792,0.115,4.2537e-06,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
1672,DEFB1,P60022,0.509,0.808,0.4059,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,2003.0,2016.0,ALL
1673,DEFB4A,O15263,0.507,0.769,0.0011637,,,C0155862,Streptococcal pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
1674,DES,P17661,0.46,0.846,0.0088282,,,C1832370,"MYOPATHY, MYOFIBRILLAR, DESMIN-RELATED",C16;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1989.0,2019.0,ALL
1675,CFD,P00746,0.587,0.731,6.7045e-06,DTO_05007624,Enzyme,C0398764,Complement Factor D Deficiency,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2018.0,ALL
1676,DFFA,O00273,0.663,0.385,8.6585e-05,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
1677,DFFB,O76075,0.7,0.346,1.1349e-05,DTO_05007624,Enzyme,C0333704,Chromosome Breaks,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2019.0,2019.0,ALL
1678,TIMM8A,O60220,0.51,0.846,0.65195,,,C0796074,MOHR-TRANEBJAERG SYNDROME,C23;C16;C11;C10;F03;C09;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,0.958,definitive,1996.0,2019.0,ALL
1680,DFNX3,,0.861,0.192,,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
1687,GSDME,O60443,0.656,0.423,3.2843e-09,,,C1832932,"DEAFNESS, AUTOSOMAL DOMINANT 5 (disorder)",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.62,1.0,strong,1998.0,2019.0,ALL
1689,DFNA7,,0.861,0.154,,,,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
1690,COCH,O43405,0.659,0.385,1.2365e-07,DTO_05007575,Receptor,C1832425,"Deafness, Autosomal Dominant 9",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.99,1.0,strong,1998.0,2017.0,ALL
1694,DFNA16,,,,,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
1705,DFNB13,,0.931,0.231,,,,C0152268,Nodular Sclerosis Classical Hodgkin Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,0.0,,2003.0,2003.0,ALL
1706,DFNB14,,0.931,0.154,,,,C0271829,Pendred's syndrome,C23;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
1709,DFNB17,,0.931,0.192,,,,C0339789,Congenital deafness,C23;C16;C13;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Congenital Abnormality,0.01,1.0,,2004.0,2004.0,ALL
1713,DFNB20,,1.0,0.115,,,,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
1714,DGCR,,0.678,0.538,,,,C0012236,DiGeorge Syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,1994.0,2019.0,ALL
1716,DGUOK,Q16854,0.593,0.5,3.7122e-07,DTO_03300101,Kinase,C3151513,MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE),,,disease,Disease or Syndrome,0.7,1.0,,1997.0,2016.0,ALL
1717,DHCR7,Q9UBM7,0.5,0.846,3.949e-13,DTO_05007624,Enzyme,C0175694,Smith-Lemli-Opitz Syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.987,definitive,1987.0,2018.0,ALL
1718,DHCR24,Q15392,0.498,0.769,0.031029,DTO_05007624,Enzyme,C1865596,Desmosterolosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.79,1.0,,2000.0,2019.0,ALL
1719,DHFR,P00374,0.513,0.808,0.0343,DTO_05007624,Enzyme,C3151205,Megaloblastic Anemia due to Dihydrofolate Reductase Deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.72,1.0,,2011.0,2019.0,ALL
1723,DHODH,Q02127,0.576,0.769,0.0029884,DTO_05007624,Enzyme,C0265257,Genee-Wiedemann syndrome,C16;C11;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.75,1.0,strong,2010.0,2016.0,ALL
1725,DHPS,P49366,0.67,0.538,0.00016305,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,strong,2012.0,2012.0,ALL
1727,CYB5R3,P00387,0.638,0.654,0.00019204,,,C0268193,NADH cytochrome B5 reductase deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.71,1.0,,1991.0,2018.0,ALL
1728,NQO1,P15559,0.434,0.885,1.1867e-09,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.6,0.947,,1996.0,2017.0,ALL
1729,DIAPH1,O60610,0.623,0.654,0.91507,,,C4225261,"SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME",,,disease,Disease or Syndrome,0.7,1.0,strong,1989.0,2016.0,ALL
1730,DIAPH2,O60879,0.678,0.538,0.99443,,,C1845293,Premature Ovarian Failure 2a,C16;C13;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases",disease,Disease or Syndrome,0.5,1.0,moderate,1998.0,1998.0,ALL
1731,SEPTIN1,Q8WYJ6,0.705,0.462,1.9572e-08,DTO_05007584,Enzyme modulator,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.08,1.0,,2017.0,2019.0,ALL
1732,DIH1,,0.769,0.462,,,,C0018852,Heavy Chain Disease,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.02,1.0,,1980.0,2015.0,ALL
1733,DIO1,P49895,0.638,0.769,0.58399,,,C0020551,Hyperthyroxinemia,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,1988.0,1988.0,ALL
1734,DIO2,Q92813,0.59,0.731,0.6196,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2009.0,ALL
1735,DIO3,P55073,0.593,0.731,0.62331,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.32,1.0,,2012.0,2016.0,ALL
1736,DKC1,O60832,0.547,0.769,0.99916,DTO_05007557,Nucleic acid binding,C0265965,Dyskeratosis Congenita,C16;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.9,0.969,strong,1998.0,2019.0,ALL
1737,DLAT,P10515,0.576,0.731,2.2998e-08,,,C1855565,Pyruvate Dehydrogenase E2 Deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2005.0,2016.0,ALL
1738,DLD,P09622,0.517,0.769,0.0095142,DTO_05007624,Enzyme,C0268193,NADH cytochrome B5 reductase deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.8,1.0,definitive,1981.0,2018.0,ALL
1739,DLG1,Q12959,0.647,0.654,0.99393,DTO_05007575,Receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.39,0.9,,2002.0,2018.0,ALL
1740,DLG2,Q15700,0.67,0.577,0.70796,DTO_05007575,Receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.46,0.75,,2003.0,2019.0,ALL
1741,DLG3,Q92796,0.544,0.615,0.99999,,,C3275443,"MENTAL RETARDATION, X-LINKED 90 (disorder)",,,disease,Disease or Syndrome,0.8,1.0,strong,2016.0,2016.0,ALL
1742,DLG4,P78352,0.595,0.654,0.99954,DTO_05007575,Receptor,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.55,1.0,,2010.0,2019.0,ALL
1743,DLST,P36957,0.653,0.615,0.48474,DTO_05007624,Enzyme,C0349464,Wernicke-Korsakoff Syndrome,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.31,0.0,,2001.0,2001.0,ALL
1745,DLX1,P56177,0.695,0.462,0.96232,DTO_05007542,Transcription factor,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.32,1.0,,2003.0,2010.0,ALL
1746,DLX2,Q07687,0.711,0.423,0.97847,DTO_05007542,Transcription factor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2008.0,2009.0,ALL
1747,DLX3,O60479,0.601,0.692,0.0025519,DTO_05007542,Transcription factor,C0265333,Tricho-dento-osseous syndrome (disorder),C16;C17;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1998.0,2019.0,ALL
1748,DLX4,Q92988,0.585,0.654,0.016921,DTO_05007542,Transcription factor,C4225209,OROFACIAL CLEFT 15,,,disease,Congenital Abnormality,0.6,1.0,moderate,2015.0,2015.0,ALL
1749,DLX5,P56178,0.604,0.692,0.21842,DTO_05007542,Transcription factor,C1857344,Split-Hand-Foot Malformation With Sensorineural Hearing Loss,C23;C16;C05;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.7,1.0,,2012.0,2016.0,ALL
1750,DLX6,P56179,0.659,0.615,0.92126,DTO_05007542,Transcription factor,C2931019,Split hand foot deformity 1,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.55,1.0,limited,2002.0,2017.0,ALL
1755,DMBT1,Q9UGM3,0.533,0.654,4.476e-63,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,1999.0,2004.0,ALL
1756,DMD,P11532,0.423,0.923,1.0,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.98,strong,1981.0,2020.0,ALL
1757,SARDH,Q9UL12,0.523,0.846,5.2689e-16,DTO_05007624,Enzyme,C0268563,Sarcosinemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.73,1.0,limited,1986.0,2016.0,ALL
1758,DMP1,Q13316,0.556,0.615,1.4881e-07,,,C0342643,Autosomal recessive hypophosphatemic vitamin D refractory rickets,C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,1.0,,2006.0,2020.0,ALL
1759,DNM1,Q05193,0.595,0.692,0.99917,DTO_05007584,Enzyme modulator,C4225357,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31",,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2017.0,ALL
1760,DMPK,Q09013,0.603,0.692,0.038339,DTO_03300101,Kinase,C3250443,MYOTONIC DYSTROPHY 1,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,0.981,,1992.0,2019.0,ALL
1761,DMRT1,Q9Y5R6,0.559,0.654,0.7387,,,C0039590,Testicular Neoplasms,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,group,Neoplastic Process,0.4,1.0,,2010.0,2013.0,ALL
1762,DMWD,Q09019,0.89,0.192,0.36917,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
1763,DNA2,P51530,0.626,0.731,1.2748e-18,,,C3554599,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 6",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2013.0,ALL
1767,DNAH5,Q8TE73,0.59,0.692,4.8607e-64,DTO_05007624,Enzyme,C1837618,"CILIARY DYSKINESIA, PRIMARY, 3",C16;C08;C09;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.9,1.0,,2000.0,2016.0,ALL
1768,DNAH6,Q9C0G6,0.769,0.462,1.1201e-36,DTO_05007624,Enzyme,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
1769,DNAH8,Q96JB1,0.556,0.731,1.1489e-60,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2020.0,ALL
1770,DNAH9,Q9NYC9,0.716,0.5,3.0547e-60,DTO_05007624,Enzyme,C4551720,Primary Ciliary Dyskinesia,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.54,1.0,strong,2001.0,2018.0,ALL
1773,DNASE1,P24855,0.505,0.846,6.9801e-21,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.9,0.955,,2000.0,2020.0,ALL
1774,DNASE1L1,P49184,0.821,0.154,0.38833,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
1775,DNASE1L2,Q92874,0.931,0.115,3.3152e-07,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
1776,DNASE1L3,Q13609,0.575,0.769,3.0012e-05,,,C3280742,SYSTEMIC LUPUS ERYTHEMATOSUS 16,,,disease,Disease or Syndrome,0.5,1.0,moderate,2011.0,2011.0,ALL
1777,DNASE2,O00115,0.7,0.462,0.00045225,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.33,1.0,strong,2005.0,2020.0,ALL
1778,DYNC1H1,Q14204,0.547,0.769,1.0,DTO_05007624,Enzyme,C3280220,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O",,,disease,Disease or Syndrome,0.9,1.0,strong,2011.0,2018.0,ALL
1780,DYNC1I1,O14576,0.76,0.192,1.7637e-07,DTO_05007530,Cellular structure,C4721453,Peripheral Nervous System Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.31,1.0,,2011.0,2011.0,ALL
1781,DYNC1I2,Q13409,0.76,0.385,1.0648e-08,DTO_05007530,Cellular structure,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.4,1.0,moderate,2019.0,2019.0,ALL
1783,DYNC1LI2,O43237,1.0,0.077,0.98346,DTO_05007530,Cellular structure,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
1785,DNM2,P50570,0.542,0.769,0.99998,DTO_05007584,Enzyme modulator,C0175709,Centronuclear myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.9,0.982,limited,2005.0,2019.0,ALL
1786,DNMT1,P26358,0.406,0.885,1.0,DTO_05007378,Epigenetic regulator,C3807295,"CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.77,1.0,definitive,1998.0,2016.0,ALL
1787,TRDMT1,O14717,0.743,0.308,3.5589e-10,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
1788,DNMT3A,Q9Y6K1,0.445,0.846,7.3538e-39,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.8,0.955,limited,2009.0,2019.0,ALL
1789,DNMT3B,Q9UBC3,0.453,0.846,0.19964,,,C4551557,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.92,1.0,strong,1999.0,2016.0,ALL
1791,DNTT,P04053,0.606,0.692,2.9548e-10,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,0.875,,1998.0,2011.0,ALL
1793,DOCK1,Q14185,0.641,0.577,0.0068117,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
1794,DOCK2,Q92608,0.674,0.462,0.99969,,,C4225328,IMMUNODEFICIENCY 40,,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2018.0,ALL
1795,DOCK3,Q8IZD9,0.619,0.692,1.0,,,C4749014,"NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA",,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2019.0,ALL
1796,DOK1,Q99704,0.65,0.538,0.029002,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
1797,DXO,O77932,0.821,0.269,3.6417e-10,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
1798,DPAGT1,Q9H3H5,0.621,0.538,1.117e-05,DTO_05007624,Enzyme,C2931004,Congenital disorder of glycosylation type 1J,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,strong,2003.0,2019.0,ALL
1800,DPEP1,P16444,0.57,0.654,3.473e-10,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.42,1.0,,2017.0,2019.0,ALL
1801,DPH1,Q9BZG8,0.653,0.538,8.0168e-17,,,C4310801,"DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2015.0,ALL
1802,DPH2,Q9BQC3,1.0,0.038,9.0918e-06,,,C0012546,Diphtheria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
1803,DPP4,P27487,0.42,0.808,7.2797e-09,DTO_05007624,Enzyme,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2015.0,ALL
1804,DPP6,P42658,0.603,0.692,0.33997,DTO_05007624,Enzyme,C4225375,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 33",,,disease,Mental or Behavioral Dysfunction,0.7,1.0,strong,2013.0,2013.0,ALL
1805,DPT,Q07507,0.641,0.654,4.2743e-06,DTO_05007621,Extracellular structure,C0042345,Varicosity,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
1806,DPYD,Q12882,0.493,0.846,3.3686e-22,DTO_05007624,Enzyme,C1959620,Dihydropyrimidine Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.941,strong,1988.0,2019.0,ALL
1807,DPYS,Q14117,0.621,0.577,2.785e-11,DTO_05007624,Enzyme,C0342803,Dihydropyrimidinase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,,1998.0,2017.0,ALL
1808,DPYSL2,Q16555,0.585,0.692,0.99375,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.4,0.947,,1999.0,2020.0,ALL
1809,DPYSL3,Q14195,0.628,0.462,0.99887,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2010.0,2019.0,ALL
1810,DR1,Q01658,0.839,0.231,0.92117,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
1811,SLC26A3,P40879,0.554,0.692,1.3699e-13,DTO_05007405,Transporter,C0267662,Congenital chloride diarrhea,C23;C16;C18,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.964,strong,1996.0,2019.0,ALL
1812,DRD1,P21728,0.529,0.808,0.9555,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,1.0,,1992.0,2015.0,ALL
1813,DRD2,P14416,0.436,0.846,0.74709,DTO_02300001,G-protein coupled receptor,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.8,1.0,,1993.0,2019.0,ALL
1814,DRD3,P35462,0.529,0.692,0.0023694,DTO_02300001,G-protein coupled receptor,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.52,0.667,,1999.0,2010.0,ALL
1815,DRD4,P21917,0.517,0.577,9.3362e-09,DTO_02300001,G-protein coupled receptor,C0041671,Attention Deficit Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2004.0,2018.0,ALL
1816,DRD5,P21918,0.603,0.423,1.348e-16,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.53,1.0,,1998.0,2014.0,ALL
1819,DRG2,P55039,0.839,0.154,5.2108e-07,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
1820,ARID3A,Q99856,0.678,0.5,0.99065,DTO_05007557,Nucleic acid binding,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
1821,DRP2,Q13474,0.805,0.115,3.7475e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0,,2003.0,2006.0,ALL
1822,ATN1,P54259,0.409,0.885,0.99992,,,C0751781,Dentatorubral-Pallidoluysian Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,limited,1995.0,2020.0,ALL
1823,DSC1,Q08554,0.695,0.385,3.4979e-16,DTO_05007620,Cell adhesion,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
1824,DSC2,Q02487,0.61,0.538,5.1749e-08,DTO_05007620,Cell adhesion,C1864850,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 11",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2018.0,ALL
1825,DSC3,Q14574,0.57,0.808,2.2848e-21,DTO_05007620,Cell adhesion,C2751292,Hypotrichosis And Recurrent Skin Vesicles,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.71,1.0,limited,2009.0,2009.0,ALL
1826,DSCAM,O60469,0.686,0.385,1.0,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
1827,RCAN1,P53805,0.572,0.808,0.016675,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,1.0,,2012.0,2019.0,ALL
1828,DSG1,Q02413,0.606,0.538,0.92688,DTO_05007620,Cell adhesion,C3809719,"Severe dermatitis, multiple allergies, metabolic wasting syndrome",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,1.0,,2013.0,2020.0,ALL
1829,DSG2,Q14126,0.601,0.692,2.7913e-10,DTO_05007620,Cell adhesion,C1857777,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 10",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2018.0,ALL
1830,DSG3,P32926,0.603,0.654,1.4584e-20,DTO_05007620,Cell adhesion,C0030809,Pemphigus Vulgaris,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,1994.0,2020.0,ALL
1831,TSC22D3,Q99576,0.619,0.654,0.4339,,,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
1832,DSP,P15924,0.514,0.808,0.99978,DTO_05007530,Cellular structure,C1854063,Cardiomyopathy dilated with Woolly hair and keratoderma,C16;C17;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.96,0.971,strong,1999.0,2019.0,ALL
1833,EPYC,Q99645,0.861,0.231,5.7495e-07,,,C0271183,Severe myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.04,1.0,,2006.0,2011.0,ALL
1834,DSPP,Q9NZW4,0.556,0.769,1.1191e-07,,,C0399380,"Dentin dyspalsia, Shields type 2",C07,   Stomatognathic Diseases,disease,Congenital Abnormality,0.77,1.0,,1997.0,2017.0,ALL
1836,SLC26A2,P50443,0.553,0.692,7.4963e-07,DTO_05007405,Transporter,C0220726,Diastrophic dysplasia,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.9,1.0,,1992.0,2019.0,ALL
1837,DTNA,Q9Y4J8,0.695,0.385,0.63459,,,C1858725,"NONCOMPACTION OF LEFT VENTRICULAR MYOCARDIUM, FAMILIAL ISOLATED, AUTOSOMAL DOMINANT 1",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,,2001.0,2001.0,ALL
1838,DTNB,O60941,0.805,0.308,2.7969e-10,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
1839,HBEGF,Q99075,0.52,0.769,0.07563,DTO_05007599,Signaling,C2609414,Acute kidney injury,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Injury or Poisoning,0.5,1.0,,1995.0,2001.0,ALL
1840,DTX1,Q86Y01,0.656,0.5,0.00098982,DTO_05007624,Enzyme,C0028945,oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
1841,DTYMK,P23919,0.705,0.231,6.1537e-05,DTO_03300101,Kinase,C0023904,"Liver Neoplasms, Experimental",C06;C04,   Digestive System Diseases;    Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.2,1.0,,1980.0,1980.0,ALL
1842,ECM2,O94769,0.931,0.038,3.333e-09,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
1843,DUSP1,P28562,0.491,0.808,0.010151,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.33,0.75,,2005.0,2019.0,ALL
1844,DUSP2,Q05923,0.558,0.769,4.4697e-05,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
1845,DUSP3,P51452,0.705,0.308,0.46156,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2004.0,2011.0,ALL
1846,DUSP4,Q13115,0.603,0.654,0.88152,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2001.0,2005.0,ALL
1847,DUSP5,Q16690,0.597,0.654,0.0033227,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.32,1.0,,2014.0,2020.0,ALL
1848,DUSP6,Q16828,0.511,0.846,0.97603,,,C3808981,HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.7,1.0,limited,2013.0,2013.0,ALL
1849,DUSP7,Q16829,0.743,0.308,0.69024,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2003.0,2003.0,ALL
1850,DUSP8,Q13202,0.769,0.385,0.69975,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2003.0,2003.0,ALL
1852,DUSP9,Q99956,0.705,0.308,0.81981,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.15,1.0,,2011.0,2019.0,ALL
1854,DUT,P33316,0.678,0.615,0.0012744,DTO_05007624,Enzyme,C0037290,Skin Pigmentation,,,phenotype,Organ or Tissue Function,0.1,1.0,,2007.0,2007.0,ALL
1855,DVL1,O14640,0.531,0.769,3.7313e-06,DTO_05007599,Signaling,C0265205,Robinow Syndrome,C16;C13;C05;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.53,1.0,,2015.0,2018.0,ALL
1856,DVL2,O14641,0.621,0.577,1.3576e-05,DTO_05007599,Signaling,C0040761,Transposition of Great Vessels,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.2,1.0,,2002.0,2002.0,ALL
1857,DVL3,Q92997,0.537,0.731,0.38544,DTO_05007599,Signaling,C0265205,Robinow Syndrome,C16;C13;C05;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.54,1.0,,2016.0,2018.0,ALL
1858,DWS,,0.931,0.077,,,,C0010964,Dandy-Walker Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
1859,DYRK1A,Q13627,0.533,0.769,0.99967,DTO_03300101,Kinase,C3279839,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 7",,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2017.0,ALL
1861,TOR1A,O14656,0.566,0.731,0.00050557,DTO_05007613,Chaperone,C1851945,"DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.943,,1994.0,2018.0,ALL
1866,DYT7,,0.805,0.269,,,,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.03,1.0,,1997.0,2010.0,ALL
1867,DYX1,,0.931,0.115,,,,C0476254,Dyslexia,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.05,1.0,,1999.0,2011.0,ALL
1869,E2F1,Q01094,0.441,0.846,0.9877,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2003.0,2019.0,ALL
1870,E2F2,Q14209,0.599,0.692,0.25505,DTO_05007557,Nucleic acid binding,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.32,1.0,,2018.0,2018.0,ALL
1871,E2F3,O00716,0.57,0.692,0.9458,DTO_05007557,Nucleic acid binding,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.34,0.8,,2016.0,2018.0,ALL
1874,E2F4,Q16254,0.599,0.692,0.45258,DTO_05007557,Nucleic acid binding,C0235874,Disease Exacerbation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2018.0,2018.0,ALL
1875,E2F5,Q15329,0.686,0.308,0.935,DTO_05007557,Nucleic acid binding,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
1876,E2F6,O75461,0.67,0.385,0.10158,DTO_05007557,Nucleic acid binding,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.32,1.0,,2013.0,2019.0,ALL
1877,E4F1,Q66K89,0.931,0.077,0.080072,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
1879,EBF1,Q9UH73,0.584,0.654,0.99697,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
1880,GPR183,P32249,0.7,0.462,0.017257,DTO_02300001,G-protein coupled receptor,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
1881,EBM,,0.78,0.538,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
1889,ECE1,P42892,0.541,0.769,0.95987,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.63,1.0,,2000.0,2014.0,ALL
1890,TYMP,P19971,0.495,0.769,0.00011694,DTO_05007624,Enzyme,C4551995,Mitochondrial DNA Depletion Syndrome 1,,,disease,Disease or Syndrome,0.7,1.0,,1999.0,2015.0,ALL
1891,ECH1,Q13011,0.89,0.077,6.1604e-07,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2017.0,2017.0,ALL
1892,ECHS1,P30084,0.601,0.654,0.00087731,DTO_05007624,Enzyme,C4225391,MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,definitive,1993.0,2017.0,ALL
1893,ECM1,Q16610,0.576,0.731,4.6627e-14,,,C0023795,Lipoid Proteinosis of Urbach and Wiethe,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.8,1.0,,2002.0,2018.0,ALL
1894,ECT2,Q9H8V3,0.603,0.615,8.0837e-10,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2018.0,2019.0,ALL
1896,EDA,Q92838,0.553,0.808,0.97391,,,C0162359,Christ-Siemens-Touraine syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,0.99,,1992.0,2019.0,ALL
1901,S1PR1,P21453,0.546,0.769,0.73269,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
1902,LPAR1,Q92633,0.534,0.808,0.18603,DTO_02300001,G-protein coupled receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.42,1.0,,2004.0,2019.0,ALL
1903,S1PR3,Q99500,0.638,0.654,0.046945,DTO_02300001,G-protein coupled receptor,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.03,1.0,,2012.0,2017.0,ALL
1906,EDN1,P05305,0.38,0.846,0.45504,DTO_05007599,Signaling,C1865295,Auriculo-condylar syndrome,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.62,1.0,moderate,2013.0,2017.0,ALL
1907,EDN2,P20800,0.716,0.462,0.060323,DTO_05007599,Signaling,C0020649,Hypotension,C14,   Cardiovascular Diseases,phenotype,Finding,0.3,1.0,,1992.0,1992.0,ALL
1908,EDN3,P14138,0.608,0.577,0.024568,DTO_05007599,Signaling,C2750457,"Waardenburg Syndrome, Type 4b",C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.9,1.0,moderate,1994.0,2017.0,ALL
1909,EDNRA,P25101,0.426,0.885,0.99158,DTO_02300001,G-protein coupled receptor,C4225349,MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA,,,disease,Disease or Syndrome,0.91,1.0,strong,2010.0,2016.0,ALL
1910,EDNRB,P24530,0.47,0.846,0.0092419,DTO_02300001,G-protein coupled receptor,C1848519,"WAARDENBURG SYNDROME, TYPE 4A",C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,1.0,1.0,moderate,1994.0,2018.0,ALL
1911,PHC1,P78364,0.644,0.692,0.99938,DTO_05007557,Nucleic acid binding,C3809431,"MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,limited,2013.0,2015.0,ALL
1912,PHC2,Q8IXK0,0.89,0.192,0.54641,DTO_05007557,Nucleic acid binding,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2019.0,ALL
1913,EEC1,,0.691,0.538,,,,C0265554,Ectrodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.08,1.0,,2000.0,2013.0,ALL
1914,EEC2,,0.931,0.077,,,,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
1915,EEF1A1,P68104,0.584,0.654,0.97863,DTO_05007624,Enzyme,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.32,1.0,,1995.0,2002.0,ALL
1917,EEF1A2,Q05639,0.554,0.808,0.99558,DTO_05007624,Enzyme,C4225337,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33",,,disease,Disease or Syndrome,0.7,1.0,strong,1988.0,2018.0,ALL
1933,EEF1B2,P24534,0.751,0.346,0.066287,DTO_05007557,Nucleic acid binding,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2020.0,ALL
1934,EEF1B2P2,,0.612,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2018.0,ALL
1936,EEF1D,P29692,0.751,0.192,8.9931e-07,DTO_05007557,Nucleic acid binding,C0001144,Acne Vulgaris,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
1937,EEF1G,P26641,0.736,0.192,0.99967,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
1938,EEF2,P13639,0.599,0.731,0.99995,DTO_05007624,Enzyme,C1836395,SPINOCEREBELLAR ATAXIA 26,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2012.0,2012.0,ALL
1939,EIF2D,P41214,0.839,0.154,2.2302e-09,DTO_05007575,Receptor,C0017605,Angle Closure Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,0.0,,2019.0,2019.0,ALL
1940,EEGV1,,1.0,0.077,,,,C0220669,Familial benign neonatal epilepsy,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
1942,EFNA1,P20827,0.61,0.5,0.46263,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,0.667,,2005.0,2011.0,ALL
1943,EFNA2,O43921,0.686,0.462,0.038008,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2011.0,2017.0,ALL
1944,EFNA3,P52797,0.7,0.346,0.12599,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2019.0,ALL
1945,EFNA4,P52798,0.76,0.346,0.00035006,DTO_05007599,Signaling,C0010278,Craniosynostosis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.02,1.0,,2006.0,2018.0,ALL
1946,EFNA5,P52803,0.615,0.654,0.96051,DTO_05007599,Signaling,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.3,1.0,,2006.0,2006.0,ALL
1947,EFNB1,P98172,0.561,0.769,0.93251,DTO_05007599,Signaling,C0220767,Craniofrontonasal dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.958,,2004.0,2019.0,ALL
1948,EFNB2,P52799,0.561,0.692,0.98845,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2010.0,2016.0,ALL
1949,EFNB3,Q15768,0.736,0.231,0.3205,DTO_05007599,Signaling,C0026650,Movement Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.2,,,,,ALL
1950,EGF,P01133,0.357,0.923,8.5294e-17,,,C2673648,"Hypomagnesemia 4, Renal",C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.6,1.0,,2007.0,2007.0,ALL
1951,CELSR3,Q9NYQ7,0.716,0.423,0.99998,DTO_02300001,G-protein coupled receptor,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,moderate,2016.0,2016.0,ALL
1952,CELSR2,Q9HCU4,0.656,0.577,0.99994,DTO_02300001,G-protein coupled receptor,C0014173,Endometrial Hyperplasia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
1953,MEGF6,O75095,0.89,0.192,3.7965e-34,DTO_05007621,Extracellular structure,C0005689,Bladder Exstrophy,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
1954,MEGF8,Q7Z7M0,0.584,0.538,1.9329e-05,DTO_05007584,Enzyme modulator,C1275078,Acrocephalopolysyndactyly type 2,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.82,1.0,strong,2012.0,2018.0,ALL
1955,MEGF9,Q9H1U4,0.89,0.077,0.9881,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
1956,EGFR,P00533,0.295,0.885,0.36837,DTO_03300101,Kinase,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.7,0.976,,1989.0,2020.0,ALL
1957,EGI,,0.861,0.077,,,,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
1958,EGR1,P18146,0.433,0.923,0.3509,DTO_05007557,Nucleic acid binding,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.5,1.0,,2002.0,2006.0,ALL
1959,EGR2,P11161,0.547,0.769,0.50292,DTO_05007557,Nucleic acid binding,C0011195,Dejerine-Sottas Disease (disorder),C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.94,1.0,limited,1999.0,2019.0,ALL
1960,EGR3,Q06889,0.599,0.731,0.95288,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.5,,2007.0,2018.0,ALL
1961,EGR4,Q05215,0.751,0.538,0.0063486,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2007.0,2012.0,ALL
1962,EHHADH,Q08426,0.67,0.5,5.2377e-10,DTO_05007624,Enzyme,C3810100,FANCONI RENOTUBULAR SYNDROME 3,,,disease,Disease or Syndrome,0.6,1.0,limited,2014.0,2014.0,ALL
1964,EIF1AX,P47813,0.716,0.231,0.91015,DTO_05007557,Nucleic acid binding,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.38,0.889,,2007.0,2019.0,ALL
1965,EIF2S1,P05198,0.587,0.692,0.97031,DTO_05007557,Nucleic acid binding,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.33,1.0,,2002.0,2009.0,ALL
1967,EIF2B1,Q14232,0.663,0.538,7.615e-05,,,C1858991,Childhood Ataxia with Central Nervous System Hypomyelinization,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.8,0.906,strong,2001.0,2020.0,ALL
1968,EIF2S3,P41091,0.604,0.731,0.96388,DTO_05007624,Enzyme,C1846278,"MENTAL RETARDATION, EPILEPTIC SEIZURES, HYPOGONADISM AND HYPOGENITALISM, MICROCEPHALY, AND OBESITY (disorder)",C23;C16;C18;C05;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.75,1.0,strong,1998.0,2020.0,ALL
1969,EPHA2,P29317,0.501,0.731,1.073e-05,DTO_03300101,Kinase,C1861825,"CATARACT, POSTERIOR POLAR, 1",C11,   Eye Diseases,disease,Disease or Syndrome,0.9,1.0,strong,2006.0,2013.0,ALL
1973,EIF4A1,P60842,0.631,0.654,0.99987,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
1974,EIF4A2,Q14240,0.604,0.731,0.99835,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2011.0,2019.0,ALL
1975,EIF4B,P23588,0.705,0.385,0.99999,DTO_05007557,Nucleic acid binding,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
1977,EIF4E,P06730,0.448,0.846,0.94133,DTO_05007557,Nucleic acid binding,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2009.0,2016.0,ALL
1978,EIF4EBP1,Q13541,0.494,0.885,0.20762,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.34,1.0,,2009.0,2015.0,ALL
1979,EIF4EBP2,Q13542,0.716,0.423,0.30552,DTO_05007557,Nucleic acid binding,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
1981,EIF4G1,Q04637,0.553,0.808,1.0,DTO_05007557,Nucleic acid binding,C3280271,PARKINSON DISEASE 18,,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2016.0,ALL
1982,EIF4G2,P78344,0.593,0.692,1.0,DTO_05007557,Nucleic acid binding,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0,,2003.0,2003.0,ALL
1983,EIF5,P55010,0.716,0.308,0.98758,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
1984,EIF5A,P63241,0.612,0.692,0.73709,DTO_05007557,Nucleic acid binding,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
1990,CELA1,Q9UNI1,0.7,0.385,0.00023937,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
1991,ELANE,P08246,0.447,0.846,0.0012274,DTO_05007624,Enzyme,C0221023,Cyclic neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.8,1.0,strong,1999.0,2019.0,ALL
1992,SERPINB1,P30740,0.663,0.731,3.5486e-08,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2014.0,2016.0,ALL
1993,ELAVL2,Q12926,0.486,0.808,0.99514,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.35,1.0,,1996.0,2012.0,ALL
1994,ELAVL1,Q15717,0.56,0.731,0.98849,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
1995,ELAVL3,Q14576,0.705,0.385,0.77072,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
1996,ELAVL4,P26378,0.682,0.269,0.90806,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0,,2003.0,2003.0,ALL
1997,ELF1,P32519,0.691,0.462,0.01065,DTO_05007542,Transcription factor,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.14,1.0,,2002.0,2011.0,ALL
1998,ELF2,Q15723,0.743,0.308,0.99482,DTO_05007542,Transcription factor,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
1999,ELF3,P78545,0.551,0.808,0.98323,DTO_05007542,Transcription factor,C0005426,Biliary Tract Neoplasm,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
2000,ELF4,Q99607,0.644,0.462,0.06139,DTO_05007542,Transcription factor,C0472813,X-linked agammaglobulinemia with growth hormone deficiency,C16;C05;C20;C10;C19;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Immune System Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
2001,ELF5,Q9UKW6,0.691,0.385,0.00086946,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,1.0,,2007.0,2019.0,ALL
2002,ELK1,P19419,0.537,0.692,0.93711,DTO_05007542,Transcription factor,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2007.0,2007.0,ALL
2004,ELK3,P41970,0.49,0.846,0.083508,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2006.0,2020.0,ALL
2005,ELK4,P28324,0.674,0.423,0.0034071,DTO_05007542,Transcription factor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.06,0.833,,2009.0,2017.0,ALL
2006,ELN,P15502,0.415,0.885,2.1429e-14,,,C0003499,Supravalvular aortic stenosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.8,1.0,,1993.0,2019.0,ALL
2009,EML1,O00423,0.705,0.462,0.99608,,,C4284594,BAND HETEROTOPIA,,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2017.0,ALL
2010,EMD,P50402,0.542,0.731,0.93178,,,C0751337,X-Linked Emery-Dreifuss Muscular Dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,1994.0,2019.0,ALL
2011,MARK2,Q7KZI7,0.555,0.692,0.99999,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2007.0,2015.0,ALL
2012,EMP1,P54849,0.56,0.769,0.49706,DTO_05007530,Cellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2007.0,2018.0,ALL
2013,EMP2,P54851,0.65,0.692,2.3873e-07,DTO_05007530,Cellular structure,C4014507,"NEPHROTIC SYNDROME, TYPE 10",,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2014.0,ALL
2014,EMP3,P54852,0.619,0.423,2.6151e-06,DTO_05007530,Cellular structure,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
2015,ADGRE1,Q14246,0.769,0.385,1.4801e-23,DTO_02300001,G-protein coupled receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
2016,EMX1,Q04741,0.861,0.231,0.89532,DTO_05007542,Transcription factor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2019.0,ALL
2017,CTTN,Q14247,0.546,0.769,0.089176,DTO_05007530,Cellular structure,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.944,,1997.0,2019.0,ALL
2018,EMX2,Q04743,0.623,0.577,0.9507,DTO_05007542,Transcription factor,C0266484,Schizencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.46,1.0,,1997.0,2008.0,ALL
2019,EN1,Q05925,0.821,0.269,0.93135,DTO_05007542,Transcription factor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
2020,EN2,P19622,0.674,0.462,0.63448,DTO_05007542,Transcription factor,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.59,1.0,,2004.0,2019.0,ALL
2021,ENDOG,Q14249,0.656,0.5,0.00018287,,,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2008.0,2008.0,ALL
2022,ENG,P17813,0.446,0.846,0.99858,,,C0039445,Hereditary hemorrhagic telangiectasia,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.991,definitive,1994.0,2019.0,ALL
2023,ENO1,P06733,0.481,0.885,1.914e-05,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,0.905,,2008.0,2019.0,ALL
2026,ENO2,P09104,0.475,0.846,0.38396,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.4,1.0,,2006.0,2020.0,ALL
2027,ENO3,P13929,0.769,0.308,1.5718e-19,DTO_05007624,Enzyme,C2752027,Glycogen Storage Disease XIII,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2001.0,2014.0,ALL
2028,ENPEP,Q07075,0.564,0.731,1.3878e-28,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2013.0,2019.0,ALL
2029,ENSA,O43768,0.76,0.308,0.34917,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
2030,SLC29A1,Q99808,0.587,0.731,0.90069,DTO_05007405,Transporter,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.52,1.0,,2004.0,2018.0,ALL
2033,EP300,Q09472,0.459,0.846,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.7,1.0,,2004.0,2020.0,ALL
2034,EPAS1,Q99814,0.454,0.731,0.5961,DTO_05007542,Transcription factor,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.7,0.974,,2001.0,2019.0,ALL
2035,EPB41,P11171,0.691,0.5,3.5942e-05,,,C0013902,"Elliptocytosis, Hereditary",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.83,1.0,strong,1988.0,2016.0,ALL
2036,EPB41L1,Q9H4G0,0.839,0.192,0.87683,,,C3280285,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 11",,,disease,Disease or Syndrome,0.6,1.0,limited,2011.0,2015.0,ALL
2037,EPB41L2,O43491,0.839,0.308,0.99318,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
2038,EPB42,P16452,0.729,0.269,9.9014e-09,DTO_05007624,Enzyme,C2675192,"Spherocytosis, Type 5",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1992.0,1999.0,ALL
2039,DMTN,Q08495,0.691,0.538,0.90082,DTO_05007530,Cellular structure,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
2040,STOM,P27105,0.666,0.538,2.7047e-05,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2010.0,2016.0,ALL
2041,EPHA1,P21709,0.544,0.731,1.4624e-23,DTO_03300101,Kinase,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.5,0.933,,2009.0,2019.0,ALL
2042,EPHA3,P29320,0.497,0.692,1.1953e-05,DTO_03300101,Kinase,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
2043,EPHA4,P54764,0.566,0.846,1.0,DTO_03300101,Kinase,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.5,0.909,,2012.0,2019.0,ALL
2044,EPHA5,P54756,0.626,0.615,7.2877e-05,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2005.0,2005.0,ALL
2045,EPHA7,Q15375,0.619,0.5,1.0,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2005.0,2019.0,ALL
2046,EPHA8,P29322,0.686,0.346,1.834e-10,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2013.0,2013.0,ALL
2047,EPHB1,P54762,0.518,0.846,0.9985,DTO_03300101,Kinase,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
2048,EPHB2,P29323,0.374,0.846,0.99997,DTO_03300101,Kinase,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.5,1.0,,2001.0,2019.0,ALL
2049,EPHB3,P54753,0.682,0.462,0.46242,DTO_03300101,Kinase,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
2050,EPHB4,P54760,0.524,0.692,0.013497,DTO_03300101,Kinase,C4310629,LYMPHATIC MALFORMATION 7,,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2018.0,ALL
2051,EPHB6,O15197,0.619,0.538,1.2013e-07,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2014.0,2017.0,ALL
2052,EPHX1,P07099,0.5,0.846,3.2154e-09,,,C1843139,"Hypercholanemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,limited,2003.0,2015.0,ALL
2053,EPHX2,P34913,0.568,0.654,1.7936e-21,DTO_05007624,Enzyme,C0745103,Hyperlipoproteinemia Type IIa,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.61,1.0,,2004.0,2004.0,ALL
2054,STX2,P32856,0.626,0.577,2.1087e-07,DTO_05007405,Transporter,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
2055,CLN8,Q9UBY8,0.682,0.423,0.0035591,,,C1838570,"CEROID LIPOFUSCINOSIS, NEURONAL, 8",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.94,1.0,,1986.0,2019.0,ALL
2056,EPO,P01588,0.381,0.885,0.01125,,,C4693552,"ERYTHROCYTOSIS, FAMILIAL, 5",,,disease,Disease or Syndrome,0.6,1.0,limited,2016.0,2018.0,ALL
2057,EPOR,P19235,0.526,0.692,0.0101,DTO_05007575,Receptor,C4551637,"Erythrocytosis familial, 1",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.8,0.867,strong,1993.0,2018.0,ALL
2058,EPRS1,P07814,0.644,0.538,1.0353e-09,DTO_05007624,Enzyme,C4693733,"LEUKODYSTROPHY, HYPOMYELINATING, 15",,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
2059,EPS8,Q12929,0.608,0.615,0.97308,DTO_05007575,Receptor,C3892050,"DEAFNESS, AUTOSOMAL RECESSIVE 102",,,disease,Disease or Syndrome,0.6,1.0,strong,1993.0,1993.0,ALL
2060,EPS15,P42566,0.722,0.269,0.0034774,DTO_05007584,Enzyme modulator,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.04,1.0,,2015.0,2019.0,ALL
2063,NR2F6,P10588,0.682,0.346,0.45111,DTO_00102000,Nuclear receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.41,1.0,,2001.0,2016.0,ALL
2064,ERBB2,P04626,0.328,0.923,0.0059892,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.8,0.97,,1987.0,2020.0,ALL
2065,ERBB3,P21860,0.448,0.808,1.7003e-15,DTO_03300101,Kinase,C1843478,Lethal Congenital Contracture Syndrome 2,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.6,1.0,moderate,2003.0,2007.0,ALL
2066,ERBB4,Q15303,0.455,0.846,0.99912,DTO_03300101,Kinase,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.7,0.917,,2009.0,2018.0,ALL
2067,ERCC1,P07992,0.445,0.846,1.5933e-07,DTO_05007624,Enzyme,C1853100,CEREBROOCULOFACIOSKELETAL SYNDROME 4,C23;C16;C11;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,,2007.0,2013.0,ALL
2068,ERCC2,P18074,0.42,0.846,7.0654e-20,DTO_05007624,Enzyme,C0268138,"Xeroderma Pigmentosum, Complementation Group D",C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.935,definitive,1977.0,2017.0,ALL
2069,EREG,O14944,0.554,0.692,1.1659e-05,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2008.0,2017.0,ALL
2070,EYA4,O95677,0.604,0.615,0.04872,,,C1832476,"Deafness, Autosomal Dominant 10",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.73,1.0,,1999.0,2019.0,ALL
2071,ERCC3,P19447,0.504,0.846,3.4312e-11,DTO_05007624,Enzyme,C0268136,"Xeroderma pigmentosum, group B",C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1990.0,2019.0,ALL
2072,ERCC4,Q92889,0.468,0.846,1.3758e-12,DTO_05007624,Enzyme,C0268140,"Xeroderma pigmentosum, group F",C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,1.0,1.0,definitive,1988.0,2019.0,ALL
2073,ERCC5,P28715,0.499,0.731,2.732e-13,,,C0268141,"Xeroderma pigmentosum, group G",C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1975.0,2016.0,ALL
2074,ERCC6,P0DP91;Q03468,0.507,0.808,5.1622e-22,,,C0009207,Cockayne Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.989,strong,1982.0,2020.0,ALL
2077,ERF,P50548,0.572,0.654,0.98968,DTO_05007542,Transcription factor,C4310679,CHITAYAT SYNDROME,,,disease,Disease or Syndrome,0.71,1.0,strong,2015.0,2019.0,ALL
2078,ERG,P11308,0.453,0.808,0.96413,DTO_05007542,Transcription factor,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,1994.0,2019.0,ALL
2079,ERH,P84090,0.839,0.154,0.88774,DTO_05007542,Transcription factor,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
2081,ERN1,O75460,0.513,0.808,0.99027,DTO_03300101,Kinase,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2015.0,2018.0,ALL
2086,ERV3-1,Q14264,0.7,0.423,,,,C0008497,Choriocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.06,1.0,,1988.0,2000.0,ALL
2090,ESA4,,1.0,0.154,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1982.0,1982.0,ALL
2091,FBL,P22087,0.572,0.654,0.99319,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2011.0,2019.0,ALL
2096,ESAT,,0.716,0.308,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.1,0.99,,1996.0,2019.0,ALL
2098,ESD,P10768,0.656,0.615,5.3945e-07,DTO_05007624,Enzyme,C0003129,Anoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0,,2009.0,2009.0,ALL
2099,ESR1,P03372,0.324,0.962,0.9992,DTO_00102000,Nuclear receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,1.0,0.967,,1983.0,2020.0,ALL
2100,ESR2,Q92731,0.4,0.923,4.4516e-08,DTO_00102000,Nuclear receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,0.97,,1996.0,2020.0,ALL
2101,ESRRA,P11474,0.548,0.654,0.59696,DTO_00102000,Nuclear receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.962,,2002.0,2019.0,ALL
2103,ESRRB,O95718,0.565,0.846,0.12609,DTO_00102000,Nuclear receptor,C1837857,"DEAFNESS, AUTOSOMAL RECESSIVE 35",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1997.0,2008.0,ALL
2104,ESRRG,P62508,0.621,0.692,0.071232,DTO_00102000,Nuclear receptor,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.18,1.0,,2002.0,2018.0,ALL
2107,ETF1,P62495,0.78,0.269,0.996,DTO_05007557,Nucleic acid binding,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
2108,ETFA,P13804,0.508,0.731,0.0029217,DTO_05007624,Enzyme,C0268596,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.79,1.0,definitive,1991.0,2019.0,ALL
2109,ETFB,P38117,0.711,0.538,0.016558,DTO_05007624,Enzyme,C0268596,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.65,1.0,moderate,1993.0,2019.0,ALL
2110,ETFDH,Q16134,0.678,0.462,2.778e-13,DTO_05007624,Enzyme,C0268596,Multiple Acyl Coenzyme A Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,definitive,1985.0,2019.0,ALL
2112,ETM2,,0.931,0.038,,,,C0270736,Essential Tremor,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.06,1.0,,2003.0,2008.0,ALL
2113,ETS1,P14921,0.444,0.731,0.7816,DTO_05007542,Transcription factor,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.957,,2000.0,2019.0,ALL
2114,ETS2,P15036,0.548,0.808,0.99888,DTO_05007542,Transcription factor,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1992.0,2013.0,ALL
2115,ETV1,P50549,0.631,0.385,0.93694,DTO_05007542,Transcription factor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.962,,2005.0,2020.0,ALL
2116,ETV2,O00321,0.792,0.154,2.6344e-09,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2018.0,2018.0,ALL
2117,ETV3,P41162,0.67,0.577,0.97596,DTO_05007542,Transcription factor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
2118,ETV4,P43268,0.545,0.5,2.8688e-08,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1996.0,2019.0,ALL
2119,ETV5,P41161,0.565,0.731,0.99999,DTO_05007542,Transcription factor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.39,1.0,,2008.0,2019.0,ALL
2120,ETV6,P41212,0.477,0.731,0.9735,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.8,0.981,strong,1995.0,2019.0,ALL
2121,EVC,P57679,0.587,0.577,3.462e-25,,,C0013903,Ellis-Van Creveld Syndrome,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.96,1.0,definitive,2000.0,2018.0,ALL
2122,MECOM,Q03112,0.513,0.731,1.0,,,C4225221,RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2,,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2018.0,ALL
2123,EVI2A,P22794,0.821,0.231,0.0020438,DTO_05007575,Receptor,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
2124,EVI2B,P34910,0.861,0.154,0.063333,,,C0562350,Hip circumference,,,phenotype,Clinical Attribute,0.1,1.0,,2015.0,2015.0,ALL
2125,EVPL,Q92817,0.599,0.423,5.7048e-25,DTO_05007530,Cellular structure,C0005699,Blast Phase,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.1,0.818,,1987.0,2008.0,ALL
2128,EVX1,P49640,0.861,0.154,6.9817e-07,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
2130,EWSR1,Q01844,0.474,0.692,0.99981,DTO_05007557,Nucleic acid binding,C0553580,Ewings sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.7,0.969,,1993.0,2020.0,ALL
2131,EXT1,Q16394,0.522,0.769,0.99732,DTO_05007624,Enzyme,C0015306,Hereditary Multiple Exostoses,C16;C04;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases",disease,Congenital Abnormality,1.0,0.977,definitive,1989.0,2019.0,ALL
2132,EXT2,Q93063,0.576,0.654,1.3179e-09,DTO_05007624,Enzyme,C0015306,Hereditary Multiple Exostoses,C16;C04;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.7,0.977,,1994.0,2019.0,ALL
2133,EXT3,,0.931,0.115,,,,C0015306,Hereditary Multiple Exostoses,C16;C04;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.05,1.0,,1994.0,2018.0,ALL
2134,EXTL1,Q92935,0.861,0.154,7.3142e-12,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
2135,EXTL2,Q9UBQ6,0.839,0.192,0.00017608,,,C0015306,Hereditary Multiple Exostoses,C16;C04;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.02,0.5,,1998.0,2000.0,ALL
2137,EXTL3,O43909,0.599,0.731,2.5023e-05,,,C4479452,IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES,,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
2138,EYA1,Q99502,0.531,0.731,0.94588,,,C0265234,Branchio-Oto-Renal Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.8,0.979,definitive,1996.0,2018.0,ALL
2139,EYA2,O00167,0.636,0.462,0.097959,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
2140,EYA3,Q99504,0.839,0.154,0.99702,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
2145,EZH1,Q92800,0.663,0.577,0.042501,DTO_05007378,Epigenetic regulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
2146,EZH2,Q15910,0.376,0.885,1.0,DTO_05007378,Epigenetic regulator,C0265210,Weaver syndrome,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.8,1.0,,2011.0,2019.0,ALL
2147,F2,P00734,0.415,0.885,0.0011118,DTO_05007624,Enzyme,C0020640,Inherited Factor II deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.964,strong,1983.0,2019.0,ALL
2149,F2R,P25116,0.444,0.846,0.0084678,DTO_02300001,G-protein coupled receptor,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2006.0,2014.0,ALL
2150,F2RL1,P55085,0.48,0.769,0.00014843,DTO_02300001,G-protein coupled receptor,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.34,1.0,,2003.0,2014.0,ALL
2151,F2RL2,O00254,0.626,0.577,1.7486e-05,DTO_02300001,G-protein coupled receptor,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.07,1.0,,2012.0,2018.0,ALL
2152,F3,P13726,0.415,0.846,0.018872,DTO_05007575,Receptor,C0012739,Disseminated Intravascular Coagulation,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.6,0.963,,1994.0,2019.0,ALL
2153,F5,P12259,0.441,0.846,5.919e-15,DTO_05007624,Enzyme,C0015499,Hereditary Factor V Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.78,1.0,strong,1994.0,2019.0,ALL
2155,F7,P08709,0.623,0.615,1.349e-05,DTO_05007624,Enzyme,C0015503,Factor VII Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.74,1.0,definitive,1988.0,2019.0,ALL
2157,F8,P00451,0.542,0.769,1.0,DTO_05007624,Enzyme,C0019069,Hemophilia A,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.983,definitive,1977.0,2020.0,ALL
2158,F9,P00740,0.465,0.885,0.99776,DTO_05007624,Enzyme,C0008533,Hemophilia B,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.979,definitive,1976.0,2020.0,ALL
2159,F10,P00742,0.493,0.769,2.3473e-06,DTO_05007624,Enzyme,C0015519,Factor X Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,definitive,1981.0,2019.0,ALL
2160,F11,P03951,0.59,0.692,3.6146e-26,DTO_05007624,Enzyme,C0015523,Hereditary Factor XI Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1981.0,2019.0,ALL
2161,F12,P00748,0.612,0.577,8.2526e-08,DTO_05007624,Enzyme,C0015526,Factor XII Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.97,1.0,definitive,1979.0,2019.0,ALL
2162,F13A1,P00488,0.575,0.731,5.2851e-08,DTO_05007624,Enzyme,C0015530,Hereditary Factor XIII Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.98,1.0,strong,1992.0,2019.0,ALL
2165,F13B,P05160,0.686,0.5,8.9128e-10,,,C2750481,"Factor XIII, B Subunit, Deficiency Of",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Finding,0.7,1.0,strong,1993.0,2015.0,ALL
2166,FAAH,O00519,0.545,0.692,4.4449e-11,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,0.905,,2005.0,2020.0,ALL
2167,FABP4,P15090,0.5,0.808,5.1764e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,0.857,,1998.0,2019.0,ALL
2168,FABP1,P07148,0.588,0.692,9.8037e-07,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
2169,FABP2,P12104,0.608,0.654,0.0049806,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,1999.0,1999.0,ALL
2170,FABP3,P05413,0.585,0.692,0.44326,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.0,,2014.0,2016.0,ALL
2171,FABP5,Q01469,0.585,0.731,0.047008,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2010.0,2014.0,ALL
2172,FABP6,P51161,0.743,0.346,1.5516e-06,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
2173,FABP7,O15540,0.584,0.577,0.00078595,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2007.0,2019.0,ALL
2175,FANCA,O15360,0.505,0.731,1.5943e-68,,,C3469521,"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.986,definitive,1996.0,2020.0,ALL
2176,FANCC,Q00597,0.507,0.808,2.7921e-13,,,C3468041,"FANCONI ANEMIA, COMPLEMENTATION GROUP C",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.95,1.0,definitive,1992.0,2018.0,ALL
2177,FANCD2,Q9BXW9,0.479,0.885,1.0974e-30,,,C3160738,"FANCONI ANEMIA, COMPLEMENTATION GROUP D2",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,1.0,,2001.0,2019.0,ALL
2178,FANCE,Q9HB96,0.553,0.808,1.5278e-06,,,C3160739,"FANCONI ANEMIA, COMPLEMENTATION GROUP E",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.71,1.0,,1995.0,2015.0,ALL
2180,ACSL1,P33121,0.617,0.577,0.0015324,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.52,1.0,,1992.0,2015.0,ALL
2181,ACSL3,O95573,0.674,0.538,0.00034758,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2011.0,2011.0,ALL
2182,ACSL4,O60488,0.561,0.769,0.98103,DTO_05007624,Enzyme,C1845672,"Mental Retardation, X-Linked 63",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2002.0,2003.0,ALL
2184,FAH,P16930,0.612,0.538,4.0347e-17,,,C0268490,"Tyrosinemia, Type I",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.99,definitive,1981.0,2019.0,ALL
2185,PTK2B,Q14289,0.448,0.808,0.93536,DTO_03300101,Kinase,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,2006.0,2006.0,ALL
2186,BPTF,Q12830,0.56,0.769,1.0,,,C4540327,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES,,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
2187,FANCB,Q8NB91,0.468,0.769,0.99631,,,C1848599,VACTERL Association With Hydrocephalus,C16;C06;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.62,1.0,strong,2004.0,2016.0,ALL
2188,FANCF,Q9NPI8,0.535,0.731,0.45886,,,C3469526,"FANCONI ANEMIA, COMPLEMENTATION GROUP F",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.62,1.0,,1997.0,2016.0,ALL
2189,FANCG,O15287,0.556,0.769,2.4859e-14,,,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,0.935,strong,1998.0,2017.0,ALL
2191,FAP,Q12884,0.496,0.808,1.9009e-28,DTO_05007624,Enzyme,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
2192,FBLN1,P23142,0.587,0.654,0.91878,,,C1842422,Synpolydactyly 2,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.6,1.0,,2002.0,2014.0,ALL
2193,FARSA,Q9Y285,0.89,0.154,0.014084,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2016.0,ALL
2194,FASN,P49327,0.474,0.846,1.0,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.98,,1997.0,2019.0,ALL
2195,FAT1,Q14517,0.508,0.808,1.1969e-12,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2013.0,2018.0,ALL
2196,FAT2,Q9NYQ8,0.792,0.346,6.023e-18,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
2197,FAU,P35544,0.792,0.269,0.85252,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1992.0,1992.0,ALL
2199,FBLN2,P98095,0.682,0.615,7.0135e-06,DTO_05007621,Extracellular structure,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2007.0,2017.0,ALL
2200,FBN1,P35555,0.417,0.846,1.0,DTO_05007616,Calcium-binding protein,C0024796,Marfan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.986,definitive,1973.0,2020.0,ALL
2201,FBN2,P35556,0.505,0.808,1.0,DTO_05007616,Calcium-binding protein,C0220668,Congenital contractural arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,1.0,0.979,strong,1973.0,2019.0,ALL
2202,EFEMP1,Q12805,0.54,0.769,0.99992,DTO_05007621,Extracellular structure,C1832174,DOYNE HONEYCOMB RETINAL DYSTROPHY,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,1.0,0.947,limited,1999.0,2018.0,ALL
2203,FBP1,P09467,0.575,0.692,0.079124,DTO_05007624,Enzyme,C0016756,"Fructose-1,6-Diphosphatase Deficiency",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,,1995.0,2018.0,ALL
2204,FCAR,P24071,0.666,0.538,6.5959e-08,DTO_05007575,Receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
2205,FCER1A,P12319,0.705,0.385,3.0826e-05,DTO_05007620,Cell adhesion,C0042109,Urticaria,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0,,2006.0,2010.0,ALL
2206,MS4A2,Q01362,0.691,0.5,5.6048e-09,DTO_05007575,Receptor,C0013182,Drug Allergy,C20;C25,   Immune System Diseases;    Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0,,2006.0,2010.0,ALL
2207,FCER1G,P30273,0.674,0.615,0.66327,,,C0013182,Drug Allergy,C20;C25,   Immune System Diseases;    Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0,,2008.0,2009.0,ALL
2208,FCER2,P06734,0.56,0.654,7.6122e-12,DTO_05007575,Receptor,C0014038,Encephalitis,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2001.0,2001.0,ALL
2209,FCGR1A,P12314,0.532,0.731,0.00013116,DTO_05007620,Cell adhesion,C0006663,Calcinosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.3,1.0,,2011.0,2011.0,ALL
2210,FCGR1B,Q92637,0.633,0.692,1.3372e-10,DTO_05007620,Cell adhesion,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,1993.0,2018.0,ALL
2212,FCGR2A,P12318,0.48,0.769,2.0054e-06,DTO_05007620,Cell adhesion,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,0.852,,2002.0,2020.0,ALL
2213,FCGR2B,P31994,0.522,0.846,0.45637,DTO_05007620,Cell adhesion,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.9,0.98,,1995.0,2019.0,ALL
2214,FCGR3A,P08637,0.432,0.962,3.6955e-06,DTO_05007620,Cell adhesion,C3810342,IMMUNODEFICIENCY 20,,,disease,Disease or Syndrome,0.6,1.0,moderate,1996.0,2012.0,ALL
2215,FCGR3B,O75015,0.452,0.962,3.0294e-07,DTO_05007620,Cell adhesion,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,0.925,,1999.0,2019.0,ALL
2217,FCGRT,P55899,0.563,0.654,0.041493,,,C0201899,Aspartate aminotransferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
2218,FKTN,O75072,0.511,0.692,8.6576e-07,,,C0410174,Fukuyama Type Congenital Muscular Dystrophy,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1992.0,2019.0,ALL
2219,FCN1,O00602,0.647,0.577,3.9675e-17,DTO_05007599,Signaling,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
2220,FCN2,Q15485,0.517,0.846,3.5646e-11,DTO_05007599,Signaling,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2016.0,2019.0,ALL
2221,FCP1,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
2222,FDFT1,P37268,0.621,0.615,4.0998e-15,,,C0006868,Cannabis Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2006.0,2006.0,ALL
2224,FDPS,P14324,0.599,0.769,0.0056199,DTO_05007624,Enzyme,C4225262,"POROKERATOSIS 9, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2016.0,ALL
2227,FDPSP3,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
2230,FDX1,P10109,0.751,0.462,0.086575,,,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.2,1.0,,2003.0,2003.0,ALL
2232,FDXR,P22570,0.566,0.808,1.1493e-06,DTO_05007624,Enzyme,C4521678,AUDITORY NEUROPATHY AND OPTIC ATROPHY,,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
2233,FEB1,,0.78,0.346,,,,C0009952,Febrile Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0,,2000.0,2014.0,ALL
2234,FEB2,,0.861,0.154,,,,C0009952,Febrile Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2001.0,2002.0,ALL
2235,FECH,P22830,0.585,0.577,0.0027587,DTO_05007624,Enzyme,C0162568,Erythropoietic Protoporphyria,C16;C06;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,0.992,strong,1977.0,2020.0,ALL
2237,FEN1,P39748,0.55,0.731,4.7743e-05,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.49,0.8,,2003.0,2019.0,ALL
2239,GPC4,O75487,0.547,0.769,0.92613,,,C0796154,"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1",C23;C16;C05;C10;C19;F03;F01;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.57,0.875,,1998.0,2020.0,ALL
2241,FER,P16591,0.628,0.615,0.6633,DTO_03300101,Kinase,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
2242,FES,P07332,0.593,0.769,3.7916e-15,DTO_03300101,Kinase,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
2243,FGA,P02671,0.573,0.769,1.2236e-13,,,C2584774,Congenital hypofibrinogenemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.79,0.933,strong,1992.0,2020.0,ALL
2244,FGB,P02675,0.584,0.692,0.56616,DTO_05007599,Signaling,C2584774,Congenital hypofibrinogenemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.76,1.0,strong,2000.0,2017.0,ALL
2245,FGD1,P98174,0.573,0.731,0.9997,DTO_05007584,Enzyme modulator,C0175701,Aarskog syndrome,C16;C05;C19;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,0.935,definitive,1994.0,2017.0,ALL
2246,FGF1,P05230,0.507,0.846,0.44406,DTO_05007599,Signaling,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.35,1.0,,2007.0,2017.0,ALL
2247,FGF2,P09038,0.383,0.923,0.0184,DTO_05007599,Signaling,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.51,1.0,,2002.0,2010.0,ALL
2248,FGF3,P11487,0.505,0.808,9.3139e-05,DTO_05007599,Signaling,C1853144,"Deafness, Congenital, with Inner Ear Agenesis, Microtia, and Microdontia",C23;C16;C10;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.73,1.0,definitive,1987.0,2018.0,ALL
2249,FGF4,P08620,0.588,0.577,0.1406,DTO_05007599,Signaling,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,1.0,,1989.0,2011.0,ALL
2250,FGF5,P12034,0.641,0.5,2.0811e-10,DTO_05007599,Signaling,C0854699,Trichomegaly,C17,   Skin and Connective Tissue Diseases,phenotype,Finding,0.4,1.0,,2014.0,2014.0,ALL
2251,FGF6,P10767,0.729,0.308,0.00039765,DTO_05007599,Signaling,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2002.0,2002.0,ALL
2252,FGF7,P21781,0.519,0.846,0.77089,DTO_05007599,Signaling,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.34,1.0,,1996.0,2008.0,ALL
2253,FGF8,P55075,0.507,0.769,0.67676,DTO_05007599,Signaling,C3552574,HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.6,1.0,,2008.0,2014.0,ALL
2254,FGF9,P31371,0.528,0.846,0.94704,DTO_05007599,Signaling,C2751826,Multiple Synostoses Syndrome 3,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.92,1.0,,2009.0,2017.0,ALL
2255,FGF10,O15520,0.53,0.692,0.93779,DTO_05007599,Signaling,C0265269,Lacrimoauriculodentodigital syndrome,C23;C16;C11;C05;C10;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.93,1.0,,1999.0,2016.0,ALL
2256,FGF11,Q92914,0.78,0.346,0.00018767,DTO_05007599,Signaling,C0523912,Testosterone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
2257,FGF12,P61328,0.619,0.615,0.62294,DTO_05007599,Signaling,C4310685,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2016.0,ALL
2258,FGF13,Q92913,0.514,0.808,0.89489,DTO_05007599,Signaling,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.38,0.889,,1996.0,2019.0,ALL
2259,FGF14,Q92915,0.619,0.692,0.90887,DTO_05007599,Signaling,C1836383,SPINOCEREBELLAR ATAXIA 27,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.95,1.0,,2002.0,2019.0,ALL
2260,FGFR1,P11362,0.362,0.885,0.99984,DTO_03300101,Kinase,C0220658,Pfeiffer Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.9,1.0,,1994.0,2020.0,ALL
2261,FGFR3,P22607,0.391,0.846,1.6432e-05,DTO_03300101,Kinase,C0001080,Achondroplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,1.0,0.974,definitive,1994.0,2020.0,ALL
2262,GPC5,P78333,0.626,0.654,3.9864e-10,,,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.42,1.0,,2011.0,2019.0,ALL
2263,FGFR2,P21802,0.38,0.808,0.99731,DTO_03300101,Kinase,C0220658,Pfeiffer Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.983,,1994.0,2019.0,ALL
2264,FGFR4,P22455,0.49,0.769,7.1917e-13,DTO_03300101,Kinase,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.6,0.929,,2004.0,2016.0,ALL
2266,FGG,P02679,0.633,0.615,0.04963,DTO_05007599,Signaling,C2584774,Congenital hypofibrinogenemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.74,1.0,strong,2000.0,2018.0,ALL
2267,FGL1,Q08830,0.638,0.692,1.6765e-25,DTO_05007599,Signaling,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
2268,FGR,P09769,0.647,0.615,0.48408,DTO_03300101,Kinase,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
2270,FGS2,,1.0,0.154,,,,C0220769,FG syndrome,C23;C16;C06;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,2000.0,2007.0,ALL
2271,FH,P07954,0.489,0.846,0.08824,DTO_05007624,Enzyme,C1708350,Hereditary Leiomyomatosis and Renal Cell Cancer,C16;C04;C13;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases",disease,Neoplastic Process,0.8,0.972,,1994.0,2020.0,ALL
2272,FHIT,P49789,0.444,0.846,0.0057055,,,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.53,1.0,,1998.0,2017.0,ALL
2273,FHL1,Q13642,0.532,0.731,0.96979,,,C2678055,"MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY (disorder)",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.78,1.0,,2008.0,2018.0,ALL
2274,FHL2,Q14192,0.556,0.731,2.8693e-05,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,1997.0,2015.0,ALL
2275,FHL3,Q13643,0.736,0.269,0.0017791,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
2277,VEGFD,O43915,0.538,0.769,2.498e-05,DTO_05007599,Signaling,C0751674,Lymphangioleiomyomatosis,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.39,1.0,,2006.0,2019.0,ALL
2278,FIM1,,0.931,0.192,,,,C0042029,Urinary tract infection,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
2279,FIM3,,0.89,0.154,,,,C0598766,Leukemogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.02,1.0,,1988.0,1989.0,ALL
2280,FKBP1A,P62942,0.641,0.654,0.81452,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2001.0,2001.0,ALL
2281,FKBP1B,P68106,0.769,0.192,0.39358,DTO_05007624,Enzyme,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.21,1.0,,2006.0,2008.0,ALL
2282,FKBP1AP1,,0.7,0.538,,,,C0016037,Fibrodysplasia Ossificans Progressiva,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0,,2011.0,2019.0,ALL
2283,FKBP1AP2,,0.7,0.538,,,,C0016037,Fibrodysplasia Ossificans Progressiva,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0,,2011.0,2019.0,ALL
2284,FKBP1AP3,,0.7,0.538,,,,C0016037,Fibrodysplasia Ossificans Progressiva,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0,,2011.0,2019.0,ALL
2285,FKBP1AP4,,0.7,0.538,,,,C0016037,Fibrodysplasia Ossificans Progressiva,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0,,2011.0,2019.0,ALL
2286,FKBP2,P26885,0.792,0.308,0.049274,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
2287,FKBP3,Q00688,0.805,0.269,0.00066025,,,C0374997,Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.02,1.0,,2015.0,2018.0,ALL
2288,FKBP4,Q02790,0.532,0.769,0.15539,DTO_05007624,Enzyme,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,0.667,,2009.0,2020.0,ALL
2289,FKBP5,Q13451,0.524,0.769,0.73393,DTO_05007624,Enzyme,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,0.8,,2009.0,2020.0,ALL
2290,FOXG1,P55316,0.522,0.692,0.94355,,,C3150705,FOXG1 syndrome,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.79,1.0,,2008.0,2019.0,ALL
2294,FOXF1,Q12946,0.54,0.692,0.95792,,,C0031190,Persistent Fetal Circulation Syndrome,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.7,1.0,,2009.0,2019.0,ALL
2295,FOXF2,Q12947,0.621,0.5,0.84666,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.31,1.0,,2016.0,2018.0,ALL
2296,FOXC1,Q12948,0.483,0.846,0.95337,DTO_05007542,Transcription factor,C2678503,"AXENFELD-RIEGER SYNDROME, TYPE 3",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,1998.0,2017.0,ALL
2297,FOXD1,Q16676,0.636,0.462,0.68874,DTO_05007542,Transcription factor,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2017.0,2020.0,ALL
2298,FOXD4,Q12950,0.89,0.115,6.6406e-06,DTO_05007542,Transcription factor,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
2299,FOXI1,Q12951,0.686,0.462,0.77268,DTO_05007542,Transcription factor,C0271829,Pendred's syndrome,C23;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.63,1.0,,2003.0,2011.0,ALL
2300,FOXL1,Q12952,0.674,0.462,0.035865,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2011.0,2017.0,ALL
2301,FOXE3,Q13461,0.568,0.654,0.18135,DTO_05007542,Transcription factor,C1853230,"Aphakia, congenital primary",C11,   Eye Diseases,disease,Congenital Abnormality,0.74,1.0,,1986.0,2016.0,ALL
2302,FOXJ1,Q92949,0.619,0.577,0.96901,,,C0022521,Kartagener Syndrome,C16;C08;C09;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.51,1.0,,2000.0,2019.0,ALL
2303,FOXC2,Q99958,0.515,0.731,0.13356,DTO_05007542,Transcription factor,C0265345,Lymphedema distichiasis syndrome,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.8,1.0,,2000.0,2018.0,ALL
2304,FOXE1,O00358,0.573,0.731,0.79203,DTO_05007542,Transcription factor,C1855794,Bamforth syndrome,C16;C17;C05;C19;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Endocrine System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.93,1.0,,1998.0,2014.0,ALL
2305,FOXM1,Q08050,0.441,0.769,0.0007414,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.6,1.0,,1992.0,2019.0,ALL
2306,FOXD2,O60548,0.821,0.192,0.029038,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
2307,FOXS1,O43638,0.769,0.115,0.23329,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
2308,FOXO1,Q12778,0.433,0.846,0.99725,,,C0206655,Alveolar rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.8,0.992,limited,1995.0,2019.0,ALL
2309,FOXO3,O43524,0.431,0.808,0.98806,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.52,1.0,,2006.0,2019.0,ALL
2312,FLG,P20930,0.525,0.846,0.00028793,DTO_05007530,Cellular structure,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.7,0.961,moderate,2005.0,2020.0,ALL
2313,FLI1,Q01543,0.468,0.692,0.9894,DTO_05007542,Transcription factor,C4479515,"BLEEDING DISORDER, PLATELET-TYPE, 21",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2017.0,ALL
2314,FLII,Q13045,0.52,0.808,5.5313e-12,,,C0795864,Smith-Magenis syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,1995.0,2005.0,ALL
2315,MLANA,Q16655,0.579,0.692,1.2584e-09,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.982,,1994.0,2020.0,ALL
2316,FLNA,P21333,0.419,0.846,1.0,,,C1848213,"Periventricular Heterotopia, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.81,1.0,strong,1998.0,2013.0,ALL
2317,FLNB,O75369,0.458,0.923,6.0505e-10,,,C1848934,SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.87,1.0,,2004.0,2018.0,ALL
2318,FLNC,Q14315,0.568,0.615,0.99994,,,C1836050,"Filaminopathy, autosomal dominant",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,definitive,1998.0,2018.0,ALL
2319,FLOT2,Q14254,0.633,0.615,7.1158e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2004.0,2019.0,ALL
2321,FLT1,P17948,0.419,0.846,0.99983,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,1.0,,1999.0,2019.0,ALL
2322,FLT3,P36888,0.462,0.654,0.60777,DTO_03300101,Kinase,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,1.0,0.985,,1992.0,2020.0,ALL
2323,FLT3LG,P49771,0.564,0.577,0.9404,,,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.2,1.0,,2007.0,2007.0,ALL
2324,FLT4,P35916,0.457,0.808,1.0,DTO_03300101,Kinase,C1704423,Milroy Disease,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.8,1.0,,1998.0,2019.0,ALL
2326,FMO1,Q01740,0.805,0.269,9.1198e-11,DTO_05007624,Enzyme,C1862941,"Amyotrophic Lateral Sclerosis, Sporadic",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2006.0,2006.0,ALL
2327,FMO2,Q99518,0.805,0.269,3.143e-07,DTO_05007624,Enzyme,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
2328,FMO3,P31513,0.638,0.5,6.5145e-16,DTO_05007624,Enzyme,C0342739,Trimethylaminuria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.972,strong,1997.0,2020.0,ALL
2329,FMO4,P31512,1.0,0.077,1.0592e-10,DTO_05007624,Enzyme,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
2330,FMO5,P49326,0.805,0.154,3.6951e-15,DTO_05007624,Enzyme,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
2331,FMOD,Q06828,0.623,0.538,0.0023576,,,C0039503,Tendinitis,C05;C26,   Musculoskeletal Diseases;    Wounds and Injuries,disease,Disease or Syndrome,0.2,1.0,,2010.0,2010.0,ALL
2332,FMR1,Q06787,0.473,0.769,0.64718,DTO_05007557,Nucleic acid binding,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.985,definitive,1991.0,2020.0,ALL
2334,AFF2,P51816,0.636,0.538,0.99577,DTO_05007542,Transcription factor,C0751157,FRAXE Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,definitive,1993.0,2013.0,ALL
2335,FN1,P02751,0.365,0.962,0.0014045,DTO_05007599,Signaling,C0432221,"Spondylometaphyseal dysplasia, 'corner fracture' type",C23;C16;C05;C26,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Wounds and Injuries",disease,Disease or Syndrome,0.7,1.0,,2017.0,2019.0,ALL
2339,FNTA,P49354,1.0,0.115,0.94721,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
2342,FNTB,P49356,1.0,0.077,0.078838,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
2346,FOLH1,Q04609,0.453,0.885,6.1977e-09,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.4,1.0,,1997.0,2020.0,ALL
2348,FOLR1,P15328,0.522,0.885,0.12642,,,C2751584,Neurodegeneration Due To Cerebral Folate Transport Deficiency,C10,   Nervous System Diseases,phenotype,Disease or Syndrome,0.79,0.952,definitive,1991.0,2019.0,ALL
2350,FOLR2,P14207,0.559,0.654,5.4816e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,0.6,,2007.0,2019.0,ALL
2352,FOLR3,P41439,0.805,0.269,0.015409,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
2353,FOS,P01100,0.411,0.885,0.26176,DTO_05007542,Transcription factor,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.51,1.0,,2012.0,2018.0,ALL
2354,FOSB,P53539,0.463,0.846,0.97553,DTO_05007542,Transcription factor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.38,0.889,,2007.0,2018.0,ALL
2355,FOSL2,P15408,0.595,0.692,0.98293,DTO_05007542,Transcription factor,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2013.0,ALL
2356,FPGS,Q05932,0.644,0.423,1.1579e-06,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,0.857,,2003.0,2016.0,ALL
2357,FPR1,P21462,0.576,0.769,,DTO_02300001,G-protein coupled receptor,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.31,1.0,moderate,2011.0,2018.0,ALL
2358,FPR2,P25090,0.547,0.769,0.40137,DTO_02300001,G-protein coupled receptor,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0,,2011.0,2011.0,ALL
2359,FPR3,P25089,0.839,0.346,,DTO_02300001,G-protein coupled receptor,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
2360,FRA1A,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
2373,FRA2A,,,,,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0,,2014.0,2014.0,ALL
2375,FRA2C,,0.839,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2011.0,2015.0,ALL
2395,FXN,Q16595,0.51,0.654,0.34491,DTO_05007624,Enzyme,C0016719,Friedreich Ataxia,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.997,definitive,1976.0,2020.0,ALL
2396,FRA5C,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
2398,FRA5E,,1.0,0.077,,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
2403,FRA6C,,,,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
2405,FRA6E,,0.792,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2004.0,2010.0,ALL
2406,FRA6F,,0.89,0.077,,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
2408,FRA7A,,1.0,0.038,,,,C0524528,Pervasive Development Disorder,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,2014.0,2014.0,ALL
2414,FRA7G,,0.695,0.462,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2000.0,2000.0,ALL
2415,FRA7H,,0.89,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
2421,FRA8C,,0.861,0.192,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
2429,FRA9E,,0.89,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
2432,FRA10B,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
2436,FRA10F,,,,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
2438,FRA11A,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
2443,FRA11F,,1.0,0.077,,,,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
2444,FRK,P42685,0.674,0.5,1.8071e-12,DTO_03300101,Kinase,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
2446,FRA11H,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
2448,FRA12A,,1.0,0.192,,,,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.02,1.0,,2007.0,2009.0,ALL
2457,FRA14B,,0.89,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
2460,FRA16A,,1.0,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
2461,FRA16B,,0.89,0.115,,,,C0023480,"Leukemia, Myelomonocytic, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1990.0,1990.0,ALL
2463,FRA16D,,0.656,0.577,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2000.0,2015.0,ALL
2464,FRA16E,,0.931,0.077,,,,C3149276,"CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.3,,,,,ALL
2468,FRA18B,,1.0,0.038,,,,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
2475,MTOR,P42345,0.343,0.885,1.0,DTO_03300101,Kinase,C1846385,FOCAL CORTICAL DYSPLASIA OF TAYLOR,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,strong,2015.0,2018.0,ALL
2477,FRAXA,,0.641,0.462,,,,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,0.983,,1991.0,2015.0,ALL
2478,FRAXB,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2002.0,2004.0,ALL
2479,FRAXC,,1.0,0.077,,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
2481,FRAXE,,0.636,0.462,,,,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,0.97,,1993.0,2011.0,ALL
2483,FRG1,Q14331,0.722,0.423,6.1368e-07,DTO_05007557,Nucleic acid binding,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.4,0.957,,1996.0,2017.0,ALL
2487,FRZB,Q92765,0.573,0.654,0.0010842,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.4,0.923,,1998.0,2019.0,ALL
2488,FSHB,P01225,0.631,0.577,0.34452,DTO_05007599,Signaling,C1856716,"Follicle-stimulating hormone deficiency, isolated",C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.71,1.0,strong,1993.0,2017.0,ALL
2489,FSHMD1A,,0.638,0.808,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,1989.0,2019.0,ALL
2490,FSHMD1B,,1.0,0.115,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,1997.0,1997.0,ALL
2491,CENPI,Q92674,0.792,0.115,0.99974,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
2492,FSHR,P23945,0.539,0.654,1.3689e-11,DTO_02300001,G-protein coupled receptor,C0085083,Ovarian Hyperstimulation Syndrome,C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.8,0.96,,2003.0,2019.0,ALL
2494,NR5A2,O00482,0.563,0.731,0.23807,DTO_00102000,Nuclear receptor,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.5,1.0,,2010.0,2018.0,ALL
2495,FTH1,P02794,0.559,0.731,0.13999,DTO_05007612,Storage,C1851316,"Iron Overload, Autosomal Dominant",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.7,1.0,moderate,2001.0,2001.0,ALL
2498,FTH1P3,,0.751,0.269,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
2512,FTL,P02792,0.559,0.692,1.6617e-09,DTO_05007612,Storage,C1833213,"Hyperferritinemia, hereditary, with congenital cataracts",C18;C11,   Nutritional and Metabolic Diseases;    Eye Diseases,disease,Disease or Syndrome,0.8,1.0,,1990.0,2019.0,ALL
2515,ADAM2,Q99965,0.861,0.154,1.8889e-22,DTO_05007624,Enzyme,C0153594,Malignant neoplasm of testis,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
2516,NR5A1,Q13285,0.479,0.731,0.9896,DTO_00102000,Nuclear receptor,C2751825,PREMATURE OVARIAN FAILURE 7 (disorder),C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,1.0,,2000.0,2016.0,ALL
2517,FUCA1,P04066,0.623,0.577,2.6956e-08,,,C0016788,Fucosidase Deficiency Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1988.0,2019.0,ALL
2519,FUCA2,Q9BTY2,0.821,0.423,4.3892e-07,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
2520,GAST,P01350,0.485,0.808,0.0027394,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,1986.0,2018.0,ALL
2521,FUS,P35637,0.47,0.846,0.9993,DTO_05007557,Nucleic acid binding,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,0.981,,2009.0,2020.0,ALL
2522,FUSE,,0.792,0.231,,,,C0005699,Blast Phase,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
2523,FUT1,P19526,0.541,0.692,0.00054555,DTO_05007624,Enzyme,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
2524,FUT2,Q10981,0.552,0.731,5.3218e-14,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.5,1.0,,2010.0,2020.0,ALL
2525,FUT3,P21217,0.606,0.615,6.2991e-05,DTO_05007624,Enzyme,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
2526,FUT4,P22083,0.505,0.731,7.7294e-06,DTO_05007624,Enzyme,C0040053,Thrombosis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0,,2007.0,2007.0,ALL
2527,FUT5,Q11128,0.76,0.115,,DTO_05007624,Enzyme,C0854723,Retinal Dystrophies,C11,   Eye Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
2528,FUT6,P51993,0.695,0.385,,DTO_05007624,Enzyme,C0200641,Blood basophil count (lab test),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
2529,FUT7,Q11130,0.682,0.462,1.29e-06,DTO_05007624,Enzyme,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
2530,FUT8,Q9BYC5,0.603,0.692,0.0099264,,,C4693905,CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION,,,disease,Disease or Syndrome,0.61,1.0,,2005.0,2019.0,ALL
2531,KDSR,Q06136,0.674,0.538,0.11662,,,C4479620,ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4,,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
2532,ACKR1,Q16570,0.608,0.731,0.00021424,DTO_02300001,G-protein coupled receptor,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.37,1.0,,1998.0,2019.0,ALL
2533,FYB1,O15117,0.711,0.538,0.23803,,,C2678311,Thrombocytopenia 3,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2015.0,ALL
2534,FYN,P06241,0.556,0.731,0.99406,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.45,0.5,,2000.0,2019.0,ALL
2535,FZD2,Q14332,0.558,0.654,0.65266,DTO_02300001,G-protein coupled receptor,C2750355,Omodysplasia 2,C23;C16;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,strong,2015.0,2018.0,ALL
2537,IFI6,P09912,0.711,0.5,0.013731,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
2538,G6PC,P35575,0.56,0.692,1.8404e-05,,,C0017920,Glycogen Storage Disease Type I,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.9,1.0,,1983.0,2020.0,ALL
2539,G6PD,P11413,0.424,0.846,0.97158,DTO_05007624,Enzyme,C2720289,"ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1969.0,2019.0,ALL
2542,SLC37A4,O43826,0.617,0.654,1.6748e-05,DTO_05007405,Transporter,C0268146,Glucose-6-phosphate transport defect,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,,1997.0,2020.0,ALL
2543,GAGE1,Q13065;Q13069,0.716,0.231,0.013113,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
2547,XRCC6,P12956,0.552,0.769,0.99904,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
2548,GAA,P10253,0.631,0.577,2.8174e-18,DTO_05007624,Enzyme,C0017921,Glycogen storage disease type II,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.994,definitive,1965.0,2019.0,ALL
2549,GAB1,Q13480,0.584,0.654,0.18433,DTO_05007575,Receptor,C1854275,"DEAFNESS, AUTOSOMAL RECESSIVE 26",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.6,1.0,,2018.0,2018.0,ALL
2550,GABBR1,Q9UBS5,0.587,0.769,0.99991,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.56,0.5,,1999.0,2018.0,ALL
2551,GABPA,Q06546,0.379,0.885,0.99812,DTO_05007542,Transcription factor,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2013.0,2019.0,ALL
2553,GABPB1,Q06547,0.743,0.346,0.91121,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
2554,GABRA1,P14867,0.563,0.577,0.91489,DTO_01300327,Ion channel,C0270853,Juvenile Myoclonic Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.67,1.0,,2002.0,2019.0,ALL
2555,GABRA2,P47869,0.641,0.346,0.99598,DTO_01300327,Ion channel,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,0.8,,2004.0,2017.0,ALL
2556,GABRA3,P34903,0.636,0.577,0.038786,DTO_01300327,Ion channel,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,1989.0,2004.0,ALL
2557,GABRA4,P48169,0.751,0.308,0.7786,DTO_01300327,Ion channel,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2005.0,2015.0,ALL
2558,GABRA5,P31644,0.621,0.385,0.90535,DTO_01300327,Ion channel,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2001.0,2007.0,ALL
2559,GABRA6,Q16445,0.678,0.423,1.336e-12,DTO_01300327,Ion channel,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,0.667,,1999.0,2019.0,ALL
2560,GABRB1,P18505,0.686,0.5,0.98116,DTO_01300327,Ion channel,C4310691,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45",,,disease,Disease or Syndrome,0.7,1.0,moderate,2013.0,2016.0,ALL
2561,GABRB2,P47870,0.619,0.5,0.84876,DTO_01300327,Ion channel,C4693362,"EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2",,,disease,Disease or Syndrome,0.5,1.0,strong,2014.0,2017.0,ALL
2562,GABRB3,P28472,0.546,0.615,0.95138,DTO_01300327,Ion channel,C2677087,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5",,,phenotype,Finding,0.6,1.0,strong,2008.0,2017.0,ALL
2563,GABRD,O14764,0.558,0.692,0.99345,DTO_01300327,Ion channel,C2751603,"EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10",,,disease,Finding,0.5,1.0,limited,2004.0,2018.0,ALL
2564,GABRE,P78334,0.839,0.231,0.00018436,DTO_01300327,Ion channel,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
2565,GABRG1,Q8N1C3,0.78,0.192,9.7634e-05,DTO_01300327,Ion channel,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2008.0,2014.0,ALL
2566,GABRG2,P18507,0.548,0.654,0.73852,DTO_01300327,Ion channel,C1843244,"EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2",,,disease,Disease or Syndrome,0.6,1.0,strong,2001.0,2018.0,ALL
2567,GABRG3,Q99928,0.711,0.423,0.84683,DTO_01300327,Ion channel,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2004.0,2015.0,ALL
2568,GABRP,O00591,0.736,0.462,1.8174e-13,DTO_01300327,Ion channel,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2005.0,2019.0,ALL
2569,GABRR1,P24046,0.839,0.115,8.6523e-14,DTO_01300327,Ion channel,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
2570,GABRR2,P28476,0.805,0.115,1.4645e-05,DTO_01300327,Ion channel,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
2571,GAD1,Q99259,0.486,0.885,0.046164,DTO_05007624,Enzyme,C2751938,"Cerebral Palsy, Spastic Quadriplegic, 1",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2004.0,2004.0,ALL
2572,GAD2,Q05329,0.529,0.731,0.75083,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.38,0.9,,2004.0,2017.0,ALL
2574,GAGE2C,Q13066,0.89,0.154,0.3546,,,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,1995.0,1995.0,ALL
2576,GAGE4,Q13065;Q13069,0.805,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,1999.0,2000.0,ALL
2577,GAGE5,Q13065;Q13069,0.805,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,1999.0,2000.0,ALL
2578,GAGE6,Q13070,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
2579,GAGE7,A1L429;O76087;P0CL80;P0CL81;P0CL82,0.76,0.269,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
2580,GAK,O14976,0.805,0.231,0.0051818,DTO_03300101,Kinase,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.5,1.0,,2009.0,2020.0,ALL
2581,GALC,P54803,0.604,0.615,5.2142e-15,,,C0023521,Globoid cell leukodystrophy,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1970.0,2020.0,ALL
2582,GALE,Q14376,0.722,0.385,1.4757e-10,,,C0751161,UDPglucose 4-epimerase deficiency disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,strong,1995.0,2015.0,ALL
2583,B4GALNT1,Q00973,0.644,0.615,3.9259e-05,,,C1836632,"SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2013.0,2014.0,ALL
2584,GALK1,P51570,0.682,0.346,1.042e-05,DTO_03300101,Kinase,C0268155,Deficiency of galactokinase,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,1986.0,2018.0,ALL
2585,GALK2,Q01415,0.861,0.154,7.8958e-14,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
2587,GALR1,P47211,0.656,0.5,0.00053174,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2007.0,2007.0,ALL
2588,GALNS,P34059,0.56,0.808,2.9611e-10,DTO_05007624,Enzyme,C0026707,Mucopolysaccharidosis IV,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.9,1.0,,1980.0,2016.0,ALL
2589,GALNT1,Q10472,0.743,0.269,0.0019091,DTO_05007624,Enzyme,C0018824,Heart valve disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,,,,,ALL
2590,GALNT2,Q10471,0.678,0.538,0.0084175,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.12,1.0,,2011.0,2014.0,ALL
2591,GALNT3,Q14435,0.603,0.769,7.4143e-09,DTO_05007624,Enzyme,C1876187,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,1.0,,2004.0,2019.0,ALL
2592,GALT,P07902,0.612,0.654,2.0533e-06,DTO_05007624,Enzyme,C0016952,Galactosemias,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.963,,1970.0,2019.0,ALL
2593,GAMT,Q14353,0.691,0.269,0.0094758,,,C0574080,Guanidinoacetate methyltransferase deficiency,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.94,1.0,definitive,1940.0,2017.0,ALL
2595,GANC,Q8TET4,0.931,0.115,7.5457e-35,DTO_05007624,Enzyme,C0002876,Congenital dyserythropoietic anemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
2596,GAP43,P17677,0.564,0.731,0.021461,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,1.0,,1998.0,2012.0,ALL
2597,GAPDH,P04406,0.447,0.808,0.11388,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,1988.0,2019.0,ALL
2615,LRRC32,Q14392,0.619,0.577,0.001078,DTO_05007575,Receptor,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2019.0,2019.0,ALL
2617,GARS1,P41250,0.623,0.5,0.3065,DTO_05007624,Enzyme,C1832274,"Charcot-Marie-Tooth disease, Type 2D",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,2003.0,2019.0,ALL
2618,GART,P22102,0.631,0.615,0.00027711,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
2619,GAS1,P54826,0.587,0.654,0.81915,,,C0431362,Lobar Holoprosencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.5,1.0,,2007.0,2007.0,ALL
2620,GAS2,O43903,0.792,0.269,0.00080175,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
2621,GAS6,Q14393,0.5,0.769,0.034477,DTO_05007621,Extracellular structure,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.34,1.0,,2003.0,2018.0,ALL
2622,GAS8,O95995,0.636,0.654,1.0876e-12,,,C4225230,"CILIARY DYSKINESIA, PRIMARY, 33",,,disease,Disease or Syndrome,0.9,1.0,limited,2015.0,2016.0,ALL
2623,GATA1,P15976,0.483,0.808,0.94798,,,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.9,0.947,strong,1995.0,2020.0,ALL
2624,GATA2,P23769,0.496,0.654,0.97927,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.8,0.974,,1994.0,2020.0,ALL
2625,GATA3,P23771,0.415,0.846,0.89887,,,C1840333,Barakat syndrome,C23;C13;C12;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,1.0,0.957,definitive,1995.0,2019.0,ALL
2626,GATA4,P43694,0.458,0.846,0.49308,,,C1842778,Atrial septal defect 2,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.9,1.0,,2003.0,2016.0,ALL
2627,GATA6,Q92908,0.478,0.808,0.99709,,,C0039685,Tetralogy of Fallot,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.73,1.0,,2010.0,2014.0,ALL
2628,GATM,P50440,0.666,0.615,0.051418,,,C2675179,Arginine:Glycine Amidinotransferase Deficiency,C23;C16;C18;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.76,1.0,definitive,1940.0,2018.0,ALL
2629,GBA,P04062,0.5,0.808,1.4355e-06,,,C1961835,"Gaucher Disease, Type 1",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.984,,1983.0,2020.0,ALL
2630,GBAP1,,0.623,0.538,,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.11,1.0,,2015.0,2019.0,ALL
2631,NIPSNAP2,O75323,0.89,0.077,1.3407e-08,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
2632,GBE1,Q04446,0.612,0.654,1.1497e-12,DTO_05007624,Enzyme,C0017923,Glycogen Storage Disease Type IV,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,1.0,,1996.0,2017.0,ALL
2633,GBP1,P32455,0.626,0.731,1.2564e-15,DTO_05007584,Enzyme modulator,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
2634,GBP2,P32456,0.751,0.385,4.0322e-10,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
2635,GBP3,Q9H0R5,1.0,0.038,1.0303e-18,DTO_05007584,Enzyme modulator,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
2636,GBX1,Q14549,0.89,0.077,0.40982,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
2637,GBX2,P52951,0.751,0.385,0.71347,DTO_05007542,Transcription factor,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2002.0,2002.0,ALL
2638,GC,P02774,0.489,0.885,2.7301e-11,DTO_05007405,Transporter,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.37,0.75,,1988.0,2018.0,ALL
2639,GCDH,Q92947,0.691,0.385,0.004856,,,C0268595,"Glutaric aciduria, type 1",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1988.0,2020.0,ALL
2641,GCG,P01275,0.431,0.885,0.034814,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,0.99,,1986.0,2020.0,ALL
2642,GCGR,P47871,0.656,0.308,2.2154e-06,DTO_02300001,G-protein coupled receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.5,0.891,,1995.0,2020.0,ALL
2643,GCH1,P30793,0.511,0.846,0.90292,DTO_05007624,Enzyme,C1851920,Dopa-Responsive Dystonia,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.8,0.939,,1989.0,2019.0,ALL
2644,GCHFR,P30047,0.579,0.808,0.048251,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
2645,GCK,P35557,0.523,0.808,0.63464,DTO_03300101,Kinase,C0342277,Diabetes mellitus autosomal dominant type II (disorder),C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,1.0,1.0,strong,1992.0,2019.0,ALL
2646,GCKR,Q14397,0.604,0.615,8.5354e-19,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.5,0.957,,2005.0,2020.0,ALL
2647,BLOC1S1,P78537,1.0,0.038,0.070821,DTO_05007542,Transcription factor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2015.0,2015.0,ALL
2648,KAT2A,Q92830,0.61,0.731,0.57331,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
2649,NR6A1,Q15406,0.716,0.385,0.98169,DTO_00102000,Nuclear receptor,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2016.0,2016.0,ALL
2650,GCNT1,Q02742,0.716,0.346,0.0033333,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.32,1.0,,2005.0,2005.0,ALL
2651,GCNT2,Q8N0V5,0.65,0.538,2.4065e-05,,,C3805373,CATARACT 13 WITH ADULT i PHENOTYPE,,,disease,Disease or Syndrome,0.7,1.0,,2001.0,2001.0,ALL
2652,OPN1MW,P04001;P0DN77;P0DN78,0.572,0.769,0.037781,DTO_02300001,G-protein coupled receptor,C0339537,Cone monochromatism,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.77,1.0,strong,1995.0,2019.0,ALL
2653,GCSH,P23434,0.76,0.385,0.001602,,,C0751748,Nonketotic Hyperglycinemia,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.69,1.0,limited,1990.0,2016.0,ALL
2656,GCY,,0.631,0.615,,,,C0332853,Anastomosis,,,disease,Acquired Abnormality,0.1,1.0,,2017.0,2019.0,ALL
2657,GDF1,P27539,0.529,0.692,0.41237,DTO_05007599,Signaling,C0039685,Tetralogy of Fallot,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.71,1.0,,2007.0,2017.0,ALL
2658,GDF2,Q9UK05,0.529,0.731,0.0024656,DTO_05007599,Signaling,C3809710,"TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5",,,disease,Disease or Syndrome,0.7,1.0,moderate,2013.0,2015.0,ALL
2660,MSTN,O14793,0.528,0.731,0.5052,DTO_05007599,Signaling,C2931112,Myostatin-related muscle hypertrophy,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.6,1.0,,1997.0,2009.0,ALL
2661,GDF9,O60383,0.644,0.385,5.5222e-06,DTO_05007599,Signaling,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2000.0,2019.0,ALL
2662,GDF10,P55107,0.628,0.654,0.0053478,DTO_05007599,Signaling,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2008.0,2008.0,ALL
2664,GDI1,P31150,0.572,0.654,0.99471,DTO_05007624,Enzyme,C3887939,"MENTAL RETARDATION, X-LINKED 41",,,disease,Disease or Syndrome,0.9,1.0,strong,1998.0,2009.0,ALL
2665,GDI2,P50395,0.76,0.308,0.84933,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
2667,GDI2P1,,0.931,0.192,,,,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0,,1998.0,1998.0,ALL
2668,GDNF,P39905,0.434,0.885,0.2035,DTO_05007599,Signaling,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.7,1.0,,1996.0,2013.0,ALL
2669,GEM,P55040,0.467,0.769,1.179e-08,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,0.9,,2006.0,2019.0,ALL
2670,GFAP,P14136,0.421,0.885,1.4601e-06,,,C0270726,Alexander Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.972,,1976.0,2020.0,ALL
2671,GFER,P55789,0.56,0.846,0.00017308,DTO_05007624,Enzyme,C2751320,"Myopathy, Mitochondrial Progressive, With Congenital Cataract, Hearing Loss, And Developmental Delay",C23;C18;C11;C05;C10;F03;C09,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.71,1.0,,2009.0,2017.0,ALL
2672,GFI1,Q99684,0.546,0.769,0.25492,DTO_05007542,Transcription factor,C2751288,"Neutropenia, Severe Congenital, Autosomal Dominant 2",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2003.0,2003.0,ALL
2673,GFPT1,Q06210,0.612,0.654,0.89953,DTO_05007624,Enzyme,C3552335,"MYASTHENIC SYNDROME, CONGENITAL, 12",,,disease,Disease or Syndrome,0.8,1.0,,2011.0,2017.0,ALL
2674,GFRA1,P56159,0.619,0.615,0.1175,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.37,1.0,,1996.0,2019.0,ALL
2675,GFRA2,O00451,0.716,0.423,0.097532,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2010.0,2010.0,ALL
2676,GFRA3,O60609,0.736,0.346,0.027638,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
2677,GGCX,P38435,0.678,0.538,2.0199e-14,,,C1848534,"VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.74,1.0,strong,1998.0,2019.0,ALL
2678,GGT1,P19440,0.496,0.885,7.5307e-05,DTO_05007624,Enzyme,C0268524,gamma-Glutamyltransferase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,limited,2014.0,2018.0,ALL
2681,GGTA1P,Q4G0N0,0.89,0.192,,,,C0234166,Hyperexplexia,C10,   Nervous System Diseases,phenotype,Sign or Symptom,0.08,1.0,,2006.0,2019.0,ALL
2683,B4GALT1,P15291,0.674,0.538,0.037435,DTO_05007624,Enzyme,C2931009,Congenital disorder of glycosylation type 2D,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,,2002.0,2016.0,ALL
2686,GGT7,Q9UJ14,0.89,0.077,0.98393,DTO_05007624,Enzyme,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
2687,GGT5,P36269,1.0,0.077,2.1567e-11,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.2,1.0,,1997.0,1997.0,ALL
2688,GH1,P01241,0.373,0.923,0.030057,DTO_05007599,Signaling,C0271567,"Isolated Growth Hormone Deficiency, Type II",C05;C10;C19,   Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.75,1.0,strong,1996.0,2019.0,ALL
2689,GH2,P01242,0.769,0.5,0.024553,DTO_05007599,Signaling,C0175693,Russell-Silver syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.3,1.0,,2003.0,2003.0,ALL
2690,GHR,P10912,0.49,0.846,8.4385e-05,DTO_05007599,Signaling,C0271568,Laron Syndrome,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,1.0,0.98,,1987.0,2020.0,ALL
2691,GHRH,P01286,0.503,0.769,0.14964,DTO_05007599,Signaling,C0034063,Pulmonary Edema,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
2692,GHRHR,Q02643,0.568,0.692,1.0082e-07,DTO_02300001,G-protein coupled receptor,C4722273,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV",,,disease,Disease or Syndrome,0.61,1.0,strong,1996.0,2003.0,ALL
2693,GHSR,Q92847,0.528,0.769,0.0065825,DTO_02300001,G-protein coupled receptor,C1858656,"Short Stature, Idiopathic, Autosomal",C05;C10;C19,   Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2009.0,ALL
2694,CBLIF,P27352,0.507,0.808,0.00024911,,,C1394891,Intrinsic Factor Deficiency,C18;C15,   Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.72,1.0,,2004.0,2015.0,ALL
2695,GIP,P09681,0.57,0.654,0.27108,,,C0003123,Anorexia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.33,1.0,,2017.0,2018.0,ALL
2696,GIPR,P48546,0.67,0.538,1.9703e-29,DTO_02300001,G-protein coupled receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.39,0.917,,2001.0,2019.0,ALL
2697,GJA1,P17302,0.393,0.885,0.15523,DTO_05007527,Cell-cell junction,C0812437,Oculo-dento-digital syndrome,C16;C11;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,1.0,1.0,,1975.0,2019.0,ALL
2700,GJA3,Q9Y6H8,0.647,0.346,0.0013126,DTO_05007527,Cell-cell junction,C1866078,"Cataract, Zonular Pulverulent 3",C11,   Eye Diseases,disease,Disease or Syndrome,0.9,1.0,,1999.0,2018.0,ALL
2701,GJA4,P35212,0.663,0.5,0.055777,DTO_05007527,Cell-cell junction,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.33,0.75,,1999.0,2019.0,ALL
2702,GJA5,P36382,0.575,0.577,0.017871,DTO_05007527,Cell-cell junction,C0039685,Tetralogy of Fallot,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.62,1.0,,2003.0,2013.0,ALL
2703,GJA8,P48165,0.587,0.577,0.002205,DTO_05007527,Cell-cell junction,C1861828,"Cataract, Zonular Pulverulent 1",C11,   Eye Diseases,disease,Disease or Syndrome,0.93,1.0,,1998.0,2016.0,ALL
2705,GJB1,P08034,0.514,0.731,0.84627,DTO_05007527,Cell-cell junction,C0393808,"Charcot-Marie-Tooth disease, X-linked, 1",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1993.0,2019.0,ALL
2706,GJB2,P29033,0.441,0.846,6.562e-16,DTO_05007527,Cell-cell junction,C0265336,Senter syndrome,C23;C16;C11;C17;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,1.0,1.0,,1991.0,2019.0,ALL
2707,GJB3,O75712,0.621,0.462,0.0021767,DTO_05007527,Cell-cell junction,C0265961,Erythrokeratodermia variabilis,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.9,0.967,strong,1998.0,2019.0,ALL
2709,GJB5,O95377,0.89,0.154,1.3704e-05,DTO_05007527,Cell-cell junction,C0007114,Malignant neoplasm of skin,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,1995.0,1995.0,ALL
2710,GK,P32189,0.656,0.577,0.98937,DTO_03300101,Kinase,C0268418,Deficiency of glycerol kinase,,,disease,Disease or Syndrome,0.8,1.0,,1988.0,2009.0,ALL
2717,GLA,P06280,0.537,0.769,0.99675,,,C0002986,Fabry Disease,C16;C18;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.992,definitive,1967.0,2020.0,ALL
2719,GPC3,P51654,0.466,0.808,0.9982,,,C0796154,"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1",C23;C16;C05;C10;C19;F03;F01;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.956,definitive,1995.0,2019.0,ALL
2720,GLB1,P16278,0.448,0.808,7.9215e-10,DTO_05007624,Enzyme,C0086652,Mucopolysaccharidosis type IVB,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1977.0,2018.0,ALL
2722,GLC1B,,0.839,0.038,,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.05,1.0,,1996.0,2013.0,ALL
2723,GLC1C,,0.861,0.038,,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.05,1.0,,1997.0,2014.0,ALL
2724,GLC1D,,1.0,0.038,,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0,,1998.0,2004.0,ALL
2728,GLC3B,,0.769,0.154,,,,C1533041,Primary congenital glaucoma,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.05,0.8,,1996.0,2011.0,ALL
2729,GCLC,P48506,0.509,0.885,0.42718,DTO_05007624,Enzyme,C1856603,"Gamma-Glutamylcysteine Synthetase Deficiency, Hemolytic Anemia due to",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,1.0,strong,1996.0,2016.0,ALL
2730,GCLM,P48507,0.588,0.846,0.99011,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,0.25,,2006.0,2009.0,ALL
2731,GLDC,P23378,0.628,0.577,6.5777e-28,DTO_05007624,Enzyme,C0751748,Nonketotic Hyperglycinemia,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.982,definitive,1990.0,2020.0,ALL
2733,GLE1,Q53GS7,0.628,0.577,2.0536e-10,DTO_05007405,Transporter,C1854664,LETHAL CONGENITAL CONTRACTURE SYNDROME 1,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.74,0.857,,2006.0,2018.0,ALL
2734,GLG1,Q92896,0.821,0.192,1.0,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
2735,GLI1,P08151,0.431,0.846,7.6639e-14,,,C1395852,Polydactyly preaxial type 1,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.7,1.0,strong,2019.0,2019.0,ALL
2736,GLI2,P10070,0.446,0.846,0.97303,,,C4014479,CULLER-JONES SYNDROME,,,disease,Disease or Syndrome,0.71,1.0,,2003.0,2019.0,ALL
2737,GLI3,P10071,0.436,0.846,0.99999,,,C0265306,Greig cephalopolysyndactyly syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,1.0,0.917,strong,1991.0,2019.0,ALL
2739,GLO1,Q04760,0.537,0.769,9.6718e-07,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.52,1.0,,2005.0,2019.0,ALL
2740,GLP1R,P43220,0.471,0.846,0.29347,DTO_02300001,G-protein coupled receptor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.56,1.0,,2002.0,2020.0,ALL
2741,GLRA1,P23415,0.628,0.5,0.00015816,DTO_01300327,Ion channel,C0234166,Hyperexplexia,C10,   Nervous System Diseases,phenotype,Sign or Symptom,0.7,0.979,moderate,1992.0,2019.0,ALL
2742,GLRA2,P23416,0.751,0.423,0.97334,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2001.0,2001.0,ALL
2743,GLRB,P48167,0.705,0.308,0.0014157,DTO_01300327,Ion channel,C3553291,HYPEREKPLEXIA 2,,,disease,Disease or Syndrome,0.8,1.0,,1970.0,2013.0,ALL
2744,GLS,O94925,0.489,0.808,0.96154,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,0.75,,2007.0,2019.0,ALL
2745,GLRX,P35754,0.619,0.577,5.6744e-07,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.22,1.0,,2013.0,2017.0,ALL
2746,GLUD1,P00367,0.584,0.731,0.0070495,DTO_05007624,Enzyme,C1847555,"Hyperinsulinemic hypoglycemia, familial, 6",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.77,1.0,,1998.0,2018.0,ALL
2747,GLUD2,P49448,0.678,0.423,0.03152,DTO_05007624,Enzyme,C3160718,"PARKINSON DISEASE, LATE-ONSET",,,disease,Disease or Syndrome,0.4,,,,,ALL
2752,GLUL,P15104,0.513,0.731,0.9957,DTO_05007624,Enzyme,C1864910,"Glutamine deficiency, congenital",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.72,1.0,limited,1966.0,2019.0,ALL
2760,GM2A,P17900,0.678,0.692,0.03103,DTO_05007405,Transporter,C0268275,"Tay-Sachs Disease, AB Variant",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.92,1.0,strong,1991.0,2016.0,ALL
2761,GM2AP1,,0.931,0.154,,,,C0028064,Niemann-Pick Diseases,C16;C18;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
2762,GMDS,O60547,0.716,0.385,0.99132,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
2764,GMFB,P60983,0.743,0.308,0.0053339,DTO_05007584,Enzyme modulator,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2011.0,2019.0,ALL
2765,GML,Q99445,0.705,0.423,0.21757,,,C0001627,Congenital adrenal hyperplasia,C16;C18;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
2766,GMPR,P36959,0.792,0.231,1.3075e-05,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
2767,GNA11,P29992,0.563,0.731,0.88941,DTO_05007584,Enzyme modulator,C0220633,Uveal melanoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.8,0.977,,2010.0,2019.0,ALL
2768,GNA12,Q03113,0.547,0.769,0.96994,DTO_05007584,Enzyme modulator,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.41,1.0,,2011.0,2017.0,ALL
2769,GNA15,P30679,0.78,0.269,0.0059721,DTO_05007584,Enzyme modulator,C0035242,Respiratory Tract Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
2770,GNAI1,P63096,0.751,0.538,0.91125,DTO_05007584,Enzyme modulator,C0002622,Amnesia,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2001.0,2001.0,ALL
2771,GNAI2,P04899,0.636,0.577,0.89194,DTO_05007584,Enzyme modulator,C1370419,Ovarian Granulosa Cell Tumor,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.4,,,,,ALL
2773,GNAI3,P08754,0.653,0.615,0.038287,DTO_05007584,Enzyme modulator,C4551996,Auriculocondylar syndrome 1,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.7,1.0,,1994.0,2016.0,ALL
2774,GNAL,P38405,0.674,0.308,0.99829,DTO_05007584,Enzyme modulator,C3554447,DYSTONIA 25,,,disease,Disease or Syndrome,0.73,1.0,,2013.0,2018.0,ALL
2775,GNAO1,P09471,0.523,0.808,0.98963,DTO_05007584,Enzyme modulator,C3809606,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17",,,disease,Disease or Syndrome,0.91,1.0,strong,2013.0,2019.0,ALL
2776,GNAQ,P50148,0.516,0.808,0.98069,DTO_05007584,Enzyme modulator,C0038505,Sturge-Weber Syndrome,C04;C10;C14,   Neoplasms;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.8,1.0,,2013.0,2019.0,ALL
2778,GNAS,O95467;P63092;P84996;Q5JWF2,0.42,0.885,0.68076,DTO_05007584,Enzyme modulator,C0033835,Pseudopseudohypoparathyroidism,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1998.0,2018.0,ALL
2779,GNAT1,P11488,0.666,0.308,9.8532e-13,DTO_05007584,Enzyme modulator,C0339535,"Night blindness, congenital stationary",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.73,1.0,strong,1996.0,2016.0,ALL
2780,GNAT2,P19087,0.674,0.231,6.9544e-06,DTO_05007584,Enzyme modulator,C1841721,ACHROMATOPSIA 4,C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.81,1.0,limited,2002.0,2013.0,ALL
2781,GNAZ,P19086,0.722,0.346,0.96272,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,0.5,,2006.0,2017.0,ALL
2782,GNB1,P62873,0.617,0.731,0.9992,DTO_05007624,Enzyme,C4310774,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 42",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2018.0,ALL
2783,GNB2,P62879,0.743,0.192,0.98876,DTO_05007624,Enzyme,C0018935,Hematocrit procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
2784,GNB3,P16520,0.518,0.808,3.3303e-11,DTO_05007624,Enzyme,C0339535,"Night blindness, congenital stationary",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.51,0.5,,2015.0,2016.0,ALL
2785,GNG3,P63215,,,0.54217,DTO_05007584,Enzyme modulator,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2004.0,2004.0,ALL
2786,GNG4,P50150,0.821,0.231,0.15575,DTO_05007584,Enzyme modulator,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
2787,GNG5,P63218,0.89,0.231,0.18814,DTO_05007584,Enzyme modulator,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
2788,GNG7,O60262,0.76,0.269,0.49663,DTO_05007584,Enzyme modulator,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2008.0,2008.0,ALL
2791,GNG11,P61952,0.76,0.231,0.54709,DTO_05007584,Enzyme modulator,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
2792,GNGT1,P63211,0.861,0.192,0.25287,DTO_05007584,Enzyme modulator,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2013.0,2013.0,ALL
2793,GNGT2,O14610,0.805,0.154,0.19392,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
2794,GNL1,P36915,0.805,0.423,0.99928,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2009.0,ALL
2796,GNRH1,P01148,0.524,0.731,0.15146,,,C1856897,"Eunuchoidism, familial hypogonadotropic",C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.9,1.0,,1977.0,2013.0,ALL
2797,GNRH2,O43555,0.805,0.192,1.3359e-07,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2007.0,2011.0,ALL
2798,GNRHR,P30968,0.54,0.654,0.067566,DTO_02300001,G-protein coupled receptor,C0342384,Idiopathic hypogonadotropic hypogonadism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,1.0,0.981,strong,1997.0,2018.0,ALL
2799,GNS,P15586,0.705,0.538,0.00056441,DTO_05007624,Enzyme,C0086650,MPS III D,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.77,1.0,,1988.0,2016.0,ALL
2800,GOLGA1,Q92805,0.89,0.231,1.4256e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
2801,GOLGA2,Q08379,0.716,0.5,0.98756,DTO_05007405,Transporter,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
2802,GOLGA3,Q08378,0.931,0.115,0.0067951,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2015.0,2015.0,ALL
2803,GOLGA4,Q13439,0.656,0.692,9.481e-16,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
2804,GOLGB1,Q14789,0.695,0.615,9.2969e-12,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
2805,GOT1,P17174,0.601,0.692,0.0011573,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
2806,GOT2,P00505,0.529,0.731,0.014233,,,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.3,1.0,,2019.0,2019.0,ALL
2810,SFN,P31947,0.561,0.769,0.36544,DTO_05007613,Chaperone,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.38,1.0,,2010.0,2019.0,ALL
2811,GP1BA,P07359,0.565,0.692,0.0032325,DTO_05007575,Receptor,C0005129,Bernard-Soulier Syndrome,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,1.0,,1990.0,2020.0,ALL
2812,GP1BB,P13224,0.524,0.769,0.51249,,,C0005129,Bernard-Soulier Syndrome,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1988.0,2019.0,ALL
2813,GP2,P55259,0.67,0.5,1.675e-21,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2019.0,2019.0,ALL
2814,GP5,P40197,0.805,0.231,0.00018766,,,C0005129,Bernard-Soulier Syndrome,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.07,0.714,,1983.0,2005.0,ALL
2815,GP9,P14770,0.695,0.5,0.47575,,,C0005129,Bernard-Soulier Syndrome,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.981,definitive,1983.0,2019.0,ALL
2817,GPC1,P35052,0.587,0.731,0.015547,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2001.0,2018.0,ALL
2819,GPD1,P21695,0.67,0.5,0.0055506,DTO_05007624,Enzyme,C3280953,"HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE",,,disease,Disease or Syndrome,0.72,1.0,strong,2012.0,2018.0,ALL
2820,GPD2,P43304,0.678,0.538,8.1316e-11,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.45,0.833,,1996.0,2005.0,ALL
2821,GPI,P06744,0.491,0.769,2.8385e-06,DTO_05007624,Enzyme,C3150730,"HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY",,,disease,Disease or Syndrome,0.7,1.0,,1977.0,2018.0,ALL
2822,GPLD1,P80108,0.656,0.577,1.5871e-15,,,C0201850,Alkaline phosphatase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2019.0,ALL
2823,GPM6A,P51674,0.729,0.423,0.98962,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2008.0,2019.0,ALL
2824,GPM6B,Q13491,0.78,0.192,0.34626,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
2825,GPR1,P46091,0.792,0.385,4.0135e-06,DTO_02300001,G-protein coupled receptor,C0006111,Brain Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
2826,CCR10,P46092,0.626,0.654,0.00050508,DTO_02300001,G-protein coupled receptor,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
2827,GPR3,P46089,0.743,0.5,0.00026263,DTO_02300001,G-protein coupled receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.05,1.0,,2013.0,2020.0,ALL
2828,GPR4,P46093,0.674,0.462,0.10018,DTO_02300001,G-protein coupled receptor,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
2829,XCR1,P46094,0.678,0.577,0.016001,DTO_02300001,G-protein coupled receptor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2012.0,2019.0,ALL
2830,GPR6,P46095,0.89,0.115,0.068111,DTO_02300001,G-protein coupled receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
2831,NPBWR1,P48145,0.89,0.115,1.4304e-08,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
2832,NPBWR2,P48146,0.931,0.192,9.2479e-05,DTO_02300001,G-protein coupled receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
2833,CXCR3,P49682,0.436,0.808,0.181,DTO_02300001,G-protein coupled receptor,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.39,1.0,,2002.0,2019.0,ALL
2834,PRLHR,P49683,0.792,0.308,7.7094e-05,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.21,1.0,,2003.0,2006.0,ALL
2835,GPR12,P47775,0.931,0.115,0.36177,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.2,1.0,,2006.0,2006.0,ALL
2837,UTS2R,Q9UKP6,0.566,0.692,2.3172e-05,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2014.0,2016.0,ALL
2838,GPR15,P49685,0.743,0.308,1.1106e-06,DTO_02300001,G-protein coupled receptor,C0524957,Corneal Topography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2013.0,ALL
2840,GPR17,Q13304,0.686,0.615,8.4259e-05,DTO_02300001,G-protein coupled receptor,C0393953,Anterior Cerebral Circulation Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
2841,GPR18,Q14330,0.769,0.269,5.3465e-10,DTO_02300001,G-protein coupled receptor,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
2842,GPR19,Q15760,0.792,0.269,0.10405,DTO_02300001,G-protein coupled receptor,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
2843,GPR20,Q99678,1.0,0.077,0.441,DTO_02300001,G-protein coupled receptor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
2844,GPR21,Q99679,1.0,0.077,0.1128,DTO_02300001,G-protein coupled receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
2845,GPR22,Q99680,1.0,0.038,0.060335,DTO_02300001,G-protein coupled receptor,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0,,2010.0,2012.0,ALL
2846,LPAR4,Q99677,0.769,0.346,0.0022346,DTO_02300001,G-protein coupled receptor,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
2847,MCHR1,Q99705,0.65,0.5,4.7359e-05,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2006.0,2020.0,ALL
2848,GPR25,O00155,,,0.0093779,DTO_02300001,G-protein coupled receptor,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
2849,GPR26,Q8NDV2,0.792,0.077,0.52096,DTO_02300001,G-protein coupled receptor,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
2850,GPR27,Q9NS67,1.0,0.077,0.34682,DTO_02300001,G-protein coupled receptor,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
2852,GPER1,Q99527,0.505,0.731,0.57434,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.982,,1997.0,2020.0,ALL
2853,GPR31,O00270,0.839,0.115,0.020514,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
2854,GPR32,O75388,1.0,0.038,,DTO_02300001,G-protein coupled receptor,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
2857,GPR34,Q9UPC5,0.743,0.346,0.26387,DTO_02300001,G-protein coupled receptor,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
2859,GPR35,Q9HC97,0.587,0.654,0.0049273,DTO_02300001,G-protein coupled receptor,C0566602,Primary sclerosing cholangitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0,,2013.0,2013.0,ALL
2861,GPR37,O15354,0.716,0.385,0.00033812,DTO_02300001,G-protein coupled receptor,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
2862,MLNR,O43193,1.0,0.115,0.012661,DTO_02300001,G-protein coupled receptor,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2011.0,2011.0,ALL
2863,GPR39,O43194,0.65,0.615,2.8069e-09,DTO_02300001,G-protein coupled receptor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
2864,FFAR1,O14842,0.619,0.577,0.00075686,DTO_02300001,G-protein coupled receptor,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2020.0,ALL
2865,FFAR3,O14843,0.839,0.308,0.00023758,DTO_02300001,G-protein coupled receptor,C0341106,Eosinophilic esophagitis,C06;C20;C15,   Digestive System Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.02,1.0,,2019.0,2019.0,ALL
2866,GPR42,O15529,0.475,0.846,0.050905,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2002.0,2020.0,ALL
2867,FFAR2,O15552,0.686,0.462,0.0094238,DTO_02300001,G-protein coupled receptor,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2010.0,2018.0,ALL
2868,GRK4,P32298,0.716,0.5,1.6286e-15,DTO_03300101,Kinase,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
2869,GRK5,P34947,0.588,0.769,0.67567,DTO_03300101,Kinase,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.32,1.0,,2015.0,2019.0,ALL
2870,GRK6,P43250,0.67,0.654,0.00048726,DTO_03300101,Kinase,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0,,1999.0,1999.0,ALL
2872,MKNK2,Q9HBH9,0.711,0.423,1.3965e-05,DTO_03300101,Kinase,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2017.0,2017.0,ALL
2873,GPS1,Q13098,0.769,0.346,0.99819,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
2874,GPS2,Q13227,0.691,0.346,0.053179,DTO_05007584,Enzyme modulator,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.04,1.0,,2016.0,2019.0,ALL
2875,GPT,P24298,0.403,0.923,3.5945e-19,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.5,1.0,,2006.0,2012.0,ALL
2876,GPX1,P07203,0.458,0.923,3.8518e-05,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.52,1.0,,2010.0,2017.0,ALL
2877,GPX2,P18283,0.619,0.5,0.00014995,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.35,0.8,,2013.0,2019.0,ALL
2878,GPX3,P22352,0.522,0.769,0.050966,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.52,1.0,,2001.0,2018.0,ALL
2879,GPX4,P36969,0.516,0.808,4.7865e-05,DTO_05007624,Enzyme,C1855229,"Spondylometaphyseal dysplasia, Sedaghatian type",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.72,1.0,moderate,2014.0,2018.0,ALL
2880,GPX5,O75715,0.931,0.077,0.00055229,DTO_05007624,Enzyme,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
2882,GPX7,Q96SL4,0.769,0.269,5.8451e-06,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
2885,GRB2,P62993,0.546,0.769,0.93934,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2008.0,2019.0,ALL
2886,GRB7,Q14451,0.603,0.462,1.3644e-06,DTO_05007575,Receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1994.0,2019.0,ALL
2887,GRB10,Q13322,0.628,0.615,0.93945,DTO_05007575,Receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
2888,GRB14,Q14449,0.743,0.346,0.053089,DTO_05007575,Receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.43,1.0,,2011.0,2019.0,ALL
2889,RAPGEF1,Q13905,0.751,0.308,0.99995,DTO_05007584,Enzyme modulator,C0221238,Mesangial proliferative glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0,,2010.0,2010.0,ALL
2890,GRIA1,P42261,0.57,0.577,0.99869,DTO_01300327,Ion channel,C0036337,Schizoaffective Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2012.0,2012.0,ALL
2891,GRIA2,P42262,0.573,0.692,0.99916,DTO_01300327,Ion channel,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,moderate,2009.0,2019.0,ALL
2892,GRIA3,P42263,0.566,0.692,0.99976,DTO_01300327,Ion channel,C2678051,"MENTAL RETARDATION, X-LINKED 94 (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2007.0,2007.0,ALL
2893,GRIA4,P48058,0.631,0.615,0.01831,DTO_01300327,Ion channel,C4693391,NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES,,,disease,Disease or Syndrome,0.5,1.0,,2008.0,2017.0,ALL
2894,GRID1,Q9ULK0,0.743,0.385,0.99931,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2005.0,2018.0,ALL
2895,GRID2,O43424,0.67,0.5,1.0,DTO_01300327,Ion channel,C4015505,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18",,,disease,Disease or Syndrome,0.9,1.0,,2010.0,2016.0,ALL
2896,GRN,P28799,0.435,0.846,0.069666,,,C1843792,"FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED",,,disease,Disease or Syndrome,0.98,1.0,moderate,2006.0,2018.0,ALL
2897,GRIK1,P39086,0.641,0.462,1.1948e-09,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,0.5,,1994.0,2012.0,ALL
2898,GRIK2,Q13002,0.561,0.769,0.99841,DTO_01300327,Ion channel,C1970198,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.6,1.0,strong,2007.0,2007.0,ALL
2899,GRIK3,Q13003,0.674,0.538,0.99998,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,0.6,,2002.0,2010.0,ALL
2900,GRIK4,Q16099,0.678,0.423,0.11126,DTO_01300327,Ion channel,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,1.0,,2006.0,2019.0,ALL
2901,GRIK5,Q16478,0.792,0.231,0.99425,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2006.0,2008.0,ALL
2902,GRIN1,Q05586,0.561,0.692,0.97629,DTO_01300327,Ion channel,C3280282,"NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2017.0,ALL
2903,GRIN2A,Q12879,0.522,0.808,0.99998,DTO_01300327,Ion channel,C0282512,Landau-Kleffner Syndrome,C10,   Nervous System Diseases,disease,Mental or Behavioral Dysfunction,0.64,1.0,,2013.0,2018.0,ALL
2904,GRIN2B,Q13224,0.51,0.692,1.0,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,0.972,,2000.0,2020.0,ALL
2905,GRIN2C,Q14957,0.792,0.269,2.3053e-07,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,0.75,,2003.0,2014.0,ALL
2906,GRIN2D,O15399,0.65,0.538,0.99996,DTO_01300327,Ion channel,C4310687,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2018.0,ALL
2907,GRINA,Q7Z429,0.76,0.346,0.44203,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2018.0,2018.0,ALL
2908,NR3C1,P04150,0.393,0.885,0.96958,DTO_00102000,Nuclear receptor,C1841972,Glucocorticoid Receptor Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.953,strong,1991.0,2020.0,ALL
2909,ARHGAP35,Q9NRY4,0.751,0.269,1.0,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2018.0,ALL
2911,GRM1,Q13255,0.528,0.808,0.14279,DTO_02300001,G-protein coupled receptor,C3553816,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13",,,disease,Disease or Syndrome,0.9,1.0,,2006.0,2015.0,ALL
2912,GRM2,Q14416,0.582,0.577,0.12019,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.893,,1995.0,2019.0,ALL
2913,GRM3,Q14832,0.606,0.538,0.78458,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,0.885,,2002.0,2019.0,ALL
2914,GRM4,Q14833,0.636,0.5,0.99307,DTO_02300001,G-protein coupled receptor,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.45,1.0,,2013.0,2020.0,ALL
2915,GRM5,P41594,0.525,0.846,0.99872,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,1.0,,2001.0,2020.0,ALL
2916,GRM6,O15303,0.7,0.308,4.4632e-17,DTO_02300001,G-protein coupled receptor,C1850362,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.91,1.0,,2005.0,2017.0,ALL
2917,GRM7,Q14831,0.628,0.538,0.99896,DTO_02300001,G-protein coupled receptor,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.49,0.8,,2010.0,2019.0,ALL
2918,GRM8,O00222,0.636,0.577,4.5334e-07,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,0.333,,2001.0,2018.0,ALL
2919,CXCL1,P09341,0.449,0.923,0.11845,DTO_05007599,Signaling,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.58,1.0,,1996.0,2019.0,ALL
2920,CXCL2,P19875,0.513,0.885,3.6079e-07,DTO_05007599,Signaling,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.5,1.0,,2000.0,2010.0,ALL
2921,CXCL3,P19876,0.65,0.692,0.00030234,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2005.0,2014.0,ALL
2922,GRP,P07492,0.524,0.769,0.0025347,,,C0002622,Amnesia,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2001.0,2001.0,ALL
2923,PDIA3,P30101,0.566,0.769,0.99608,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.37,0.875,,2007.0,2019.0,ALL
2925,GRPR,P30550,0.595,0.538,0.22444,DTO_02300001,G-protein coupled receptor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.973,,2000.0,2020.0,ALL
2926,GRSF1,Q12849,1.0,0.077,1.066e-11,DTO_05007557,Nucleic acid binding,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
2928,GSC2,O15499,0.89,0.269,0.0044347,,,C0220704,Shprintzen syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.04,1.0,,1997.0,1998.0,ALL
2931,GSK3A,P49840,0.644,0.538,0.9997,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2005.0,2014.0,ALL
2932,GSK3B,P49841,0.43,0.846,0.95571,DTO_03300101,Kinase,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.7,0.982,,2000.0,2020.0,ALL
2933,GSM1,,0.743,0.423,,,,C0040136,Thyroid Neoplasm,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,1995.0,1995.0,ALL
2934,GSN,P06396,0.475,0.885,3.8905e-11,DTO_05007530,Cellular structure,C1622345,Meretoja syndrome,C16;C18;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases",disease,Disease or Syndrome,0.71,1.0,strong,1983.0,2013.0,ALL
2935,GSPT1,P15170,0.7,0.462,0.99986,DTO_05007624,Enzyme,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
2936,GSR,P00390,0.494,0.846,1.2922e-06,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2010.0,2014.0,ALL
2937,GSS,P48637,0.626,0.731,1.7584e-06,DTO_05007624,Enzyme,C0398746,Gluthathione synthetase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.74,0.944,definitive,1953.0,2019.0,ALL
2938,GSTA1,P08263,0.561,0.731,1.7305e-06,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,0.667,,2005.0,2015.0,ALL
2939,GSTA2,P09210,0.722,0.308,2.5611e-07,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2006.0,2006.0,ALL
2940,GSTA3,Q16772,0.736,0.231,0.0012851,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
2941,GSTA4,O15217,0.678,0.462,0.010958,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.33,1.0,,2005.0,2018.0,ALL
2942,GSTA6P,,1.0,0.077,,,,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
2944,GSTM1,P09488,0.38,0.923,0.0020641,,,C4277682,Chemical and Drug Induced Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.5,1.0,,2007.0,2011.0,ALL
2946,GSTM2,P28161,0.488,0.808,3.3913e-07,,,C0860207,Drug-Induced Liver Disease,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,phenotype,Disease or Syndrome,0.35,1.0,,2001.0,2014.0,ALL
2947,GSTM3,P21266,0.552,0.808,4.3638e-07,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,2004.0,2017.0,ALL
2948,GSTM4,Q03013,0.736,0.269,1.3834e-08,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
2949,GSTM5,P46439,0.78,0.231,1.1942e-07,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
2950,GSTP1,P09211,0.383,0.923,0.014155,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.6,0.862,,1995.0,2019.0,ALL
2952,GSTT1,P30711,0.393,0.923,0.00014834,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,0.915,,1996.0,2019.0,ALL
2953,GSTT2,P0CG29,0.76,0.423,0.014962,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
2954,GSTZ1,O43708,0.659,0.538,5.5058e-11,,,C1291607,Deficiency of maleylacetoacetate isomerase,,,disease,Disease or Syndrome,0.6,1.0,moderate,1998.0,2017.0,ALL
2956,MSH6,P52701,0.462,0.731,3.6705e-05,DTO_05007557,Nucleic acid binding,C0265325,Turcot syndrome (disorder),C16;C06;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.968,definitive,1997.0,2019.0,ALL
2957,GTF2A1,P52655,0.805,0.192,0.99038,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
2958,GTF2A2,P52657,0.931,0.038,0.026061,DTO_05007542,Transcription factor,C0206659,Embryonal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
2959,GTF2B,Q00403,0.769,0.308,0.00011548,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2017.0,2019.0,ALL
2961,GTF2E2,P29084,0.617,0.692,0.039299,DTO_05007542,Transcription factor,C4310785,"TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE",,,disease,Disease or Syndrome,0.7,1.0,moderate,2016.0,2016.0,ALL
2962,GTF2F1,P35269,0.931,0.115,7.2585e-06,DTO_05007557,Nucleic acid binding,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
2963,GTF2F2,P13984,0.931,0.115,0.00020055,DTO_05007557,Nucleic acid binding,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
2965,GTF2H1,P32780,0.469,0.846,0.98982,DTO_05007542,Transcription factor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,0.909,,2005.0,2019.0,ALL
2966,GTF2H2,Q13888,0.65,0.577,0.015519,DTO_05007542,Transcription factor,C0009207,Cockayne Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,1993.0,2019.0,ALL
2967,GTF2H3,Q13889,0.656,0.615,3.0414e-08,DTO_05007557,Nucleic acid binding,C0009207,Cockayne Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,1993.0,2019.0,ALL
2968,GTF2H4,Q92759,0.573,0.846,4.2353e-07,DTO_05007542,Transcription factor,C0036202,Sarcoidosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
2969,GTF2I,P78347,0.5,0.808,0.99592,,,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,0.975,,1998.0,2019.0,ALL
2970,GTF2IP1,,1.0,0.115,,,,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,1998.0,1998.0,ALL
2971,GTF3A,Q92664,0.736,0.462,1.7789e-11,DTO_05007542,Transcription factor,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
2972,BRF1,Q92994,0.7,0.462,0.00010409,DTO_05007542,Transcription factor,C4015495,CEREBELLOFACIODENTAL SYNDROME,,,disease,Disease or Syndrome,0.71,1.0,,2015.0,2017.0,ALL
2973,GTS,,0.682,0.615,,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.32,1.0,,1995.0,2017.0,ALL
2974,GUCY1B2,O75343,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
2975,GTF3C1,Q12789,1.0,0.077,1.0,,,C4021085,Abnormality of brain morphology,,,phenotype,Anatomical Abnormality,0.1,,,,,ALL
2976,GTF3C2,Q8WUA4,0.931,0.115,0.9944,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
2977,GUCY1A2,P33402,0.792,0.192,0.31409,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,1.0,,2008.0,2011.0,ALL
2978,GUCA1A,P43080,0.647,0.5,0.00041429,,,C1865869,CONE DYSTROPHY 3 (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.72,1.0,,1998.0,2011.0,ALL
2979,GUCA1B,Q9UMX6,0.682,0.423,0.00021337,,,C3151190,RETINITIS PIGMENTOSA 48,,,disease,Disease or Syndrome,0.61,1.0,,2005.0,2011.0,ALL
2980,GUCA2A,Q02747,0.663,0.462,0.28692,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,1998.0,2019.0,ALL
2981,GUCA2B,Q16661,0.695,0.385,0.38097,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.31,1.0,,2005.0,2005.0,ALL
2982,GUCY1A1,Q02108,0.686,0.577,3.1253e-08,,,C3810403,MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2016.0,ALL
2983,GUCY1B1,Q02153,0.805,0.308,2.5834e-05,,,C0428886,Mean blood pressure,,,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
2984,GUCY2C,P25092,0.599,0.577,1.3919e-30,DTO_03300101,Kinase,C2939175,Meconium ileus,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.73,0.75,,2012.0,2019.0,ALL
2986,GUCY2F,P51841,0.821,0.231,1.0552e-13,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
2987,GUK1,Q16774,0.769,0.346,2.3324e-05,DTO_03300101,Kinase,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2007.0,2007.0,ALL
2989,GULOP,,0.805,0.308,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
2990,GUSB,P08236,0.53,0.846,4.0382e-08,,,C0085132,Mucopolysaccharidosis VII,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1973.0,2019.0,ALL
2992,GYG1,P46976,0.722,0.308,4.8291e-12,DTO_05007624,Enzyme,C3150754,GLYCOGEN STORAGE DISEASE XV,,,disease,Disease or Syndrome,0.71,1.0,,2010.0,2020.0,ALL
2993,GYPA,P02724,0.538,0.885,0.0010811,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.37,1.0,,2003.0,2019.0,ALL
2994,GYPB,P06028,0.585,0.808,8.3815e-05,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.33,1.0,,2015.0,2019.0,ALL
2995,GYPC,P04921,0.641,0.654,0.11297,,,C0013902,"Elliptocytosis, Hereditary",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.42,1.0,,1991.0,2001.0,ALL
2996,GYPE,P15421,0.578,0.808,0.0036896,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0,,1988.0,2011.0,ALL
2997,GYS1,P13807,0.722,0.385,0.0002914,,,C1969054,"Glycogen Storage Disease 0, Muscle",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2007.0,2015.0,ALL
2998,GYS2,P54840,0.686,0.462,9.7872e-22,,,C1855861,"Glycogen Storage Disease 0, Liver",C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.72,1.0,strong,1998.0,2018.0,ALL
2999,GZMH,P20718,0.78,0.346,1.2818e-07,DTO_05007624,Enzyme,C0221032,Familial generalized lipodystrophy,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.04,1.0,,2008.0,2019.0,ALL
3000,GUCY2D,Q02846,0.57,0.769,6.4574e-10,DTO_03300101,Kinase,C2931258,"Amaurosis congenita of Leber, type 1",C11,   Eye Diseases,disease,Disease or Syndrome,1.0,0.984,,1995.0,2020.0,ALL
3001,GZMA,P12544,0.597,0.731,2.0457e-06,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3002,GZMB,P10144,0.453,0.808,3.6674e-14,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2009.0,2019.0,ALL
3003,GZMK,P49863,0.821,0.269,0.0081495,DTO_05007624,Enzyme,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.02,1.0,,2007.0,2019.0,ALL
3004,GZMM,P51124,0.686,0.577,0.011275,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2007.0,2017.0,ALL
3005,H1-0,P07305,0.663,0.692,0.6427,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
3006,H1-2,P16403,0.722,0.423,0.0275,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2007.0,2017.0,ALL
3007,H1-3,P16402,1.0,0.115,0.1561,DTO_05007557,Nucleic acid binding,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.01,1.0,,2010.0,2010.0,ALL
3008,H1-4,P10412,0.682,0.385,0.18608,DTO_05007557,Nucleic acid binding,C4479637,RAHMAN SYNDROME,,,disease,Disease or Syndrome,0.4,1.0,strong,2017.0,2017.0,ALL
3009,H1-5,P16401,0.839,0.192,0.57467,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
3010,H1-6,P22492,0.931,0.115,,DTO_05007557,Nucleic acid binding,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2013.0,ALL
3012,H2AC8,P04908,0.839,0.115,0.032343,DTO_05007557,Nucleic acid binding,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
3014,H2AX,P16104,0.484,0.808,0.17652,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2005.0,2019.0,ALL
3015,H2AZ1,P0C0S5,0.674,0.385,0.87861,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2010.0,2019.0,ALL
3017,H2BC5,P58876;P62807,0.861,0.154,4.2079e-06,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
3020,H3-3A,P84243,0.559,0.692,0.1231,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.5,0.955,,2012.0,2018.0,ALL
3021,H3-3B,P84243,0.599,0.385,0.80682,,,C0008441,Chondroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.39,1.0,,2013.0,2019.0,ALL
3024,H1-1,Q02539,0.861,0.077,7.1262e-08,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
3026,HABP2,Q14520,0.593,0.615,1.9637e-15,DTO_05007624,Enzyme,C4225292,"THYROID CANCER, NONMEDULLARY, 5",,,disease,Neoplastic Process,0.6,1.0,limited,2003.0,2017.0,ALL
3028,HSD17B10,Q99714,0.656,0.538,0.93604,DTO_05007624,Enzyme,C3266731,2-methyl-3-hydroxybutyric aciduria,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",phenotype,Disease or Syndrome,0.75,1.0,definitive,1999.0,2019.0,ALL
3029,HAGH,Q16775,0.729,0.462,0.00017657,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2015.0,2015.0,ALL
3030,HADHA,P40939,0.569,0.769,4.4354e-06,DTO_05007624,Enzyme,C1969443,Trifunctional Protein Deficiency With Myopathy And Neuropathy,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,1.0,,1994.0,2019.0,ALL
3032,HADHB,P55084,0.619,0.692,1.5183e-11,DTO_05007624,Enzyme,C1969443,Trifunctional Protein Deficiency With Myopathy And Neuropathy,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.78,1.0,definitive,1996.0,2019.0,ALL
3033,HADH,Q16836,0.65,0.538,6.5638e-05,,,C1291230,3-Hydroxyacyl-CoA Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,definitive,2001.0,2016.0,ALL
3034,HAL,P42357,0.641,0.538,2.4971e-23,,,C0220992,Histidinemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.73,1.0,,1991.0,2005.0,ALL
3035,HARS1,P12081,0.569,0.808,2.3839e-06,DTO_05007624,Enzyme,C3281066,"USHER SYNDROME, TYPE IIIB",,,disease,Disease or Syndrome,0.71,1.0,limited,1995.0,2017.0,ALL
3036,HAS1,Q92839,0.67,0.577,1.3084e-12,,,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.2,1.0,,2008.0,2008.0,ALL
3037,HAS2,Q92819,0.588,0.692,0.99013,,,C0011848,Diabetes Insipidus,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0,,2009.0,2009.0,ALL
3038,HAS3,O00219,0.644,0.692,0.88316,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
3039,HBA1,P69905,0.508,0.808,0.0067313,,,C0002312,alpha-Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.985,strong,1979.0,2019.0,ALL
3040,HBA2,P69905,0.512,0.808,0.003063,,,C0002312,alpha-Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.987,strong,1971.0,2019.0,ALL
3041,HBAP1,,1.0,0.077,,,,C0011175,Dehydration,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
3042,HBM,Q6B0K9,0.805,0.269,0.012271,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
3043,HBB,P68871,0.494,0.808,1.2274e-09,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.994,,1957.0,2020.0,ALL
3044,HBBP1,,0.931,0.154,,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
3045,HBD,P02042,0.659,0.231,,,,C0271985,Delta-Beta Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.35,1.0,,1982.0,1992.0,ALL
3046,HBE1,P02100,0.686,0.269,0.019963,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.12,1.0,,2002.0,2013.0,ALL
3047,HBG1,P69891,0.615,0.538,0.56611,,,C0019025,Hemoglobin F Disease,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.4,0.978,,1982.0,2019.0,ALL
3048,HBG2,P69892,0.565,0.692,0.66982,,,C3151421,"CYANOSIS, TRANSIENT NEONATAL",,,disease,Disease or Syndrome,0.71,1.0,,1989.0,2015.0,ALL
3049,HBQ1,P09105,0.839,0.115,0.00082894,,,C3841459,Hb H disease,,,disease,Disease or Syndrome,0.02,1.0,,1988.0,1992.0,ALL
3050,HBZ,P02008,0.686,0.346,0.020559,,,C3278365,HEMOGLOBIN H HYDROPS FETALIS SYNDROME,,,disease,Disease or Syndrome,0.3,1.0,limited,1997.0,1997.0,ALL
3051,HBZP1,,,,,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
3052,HCCS,P53701,0.559,0.731,0.88624,DTO_05007624,Enzyme,C0796070,"MICROPHTHALMIA, SYNDROMIC 7",C16;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.8,1.0,,1998.0,2016.0,ALL
3053,SERPIND1,P05546,0.619,0.654,2.5137e-10,DTO_05007584,Enzyme modulator,C0398626,Heparin cofactor II deficiency (disorder),C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.7,1.0,strong,1989.0,2004.0,ALL
3054,HCFC1,P51610,0.601,0.692,1.0,,,C0796208,"MENTAL RETARDATION, X-LINKED 3",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2013.0,ALL
3055,HCK,P08631,0.663,0.5,0.01976,DTO_03300101,Kinase,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
3057,HCL2,,0.705,0.308,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0,,2005.0,2017.0,ALL
3059,HCLS1,P14317,0.539,0.846,1.3157e-06,DTO_05007530,Cellular structure,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0,,1992.0,2003.0,ALL
3060,HCRT,O43612,0.5,0.808,0.028774,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.7,0.959,,1999.0,2019.0,ALL
3061,HCRTR1,O43613,0.623,0.654,0.00017378,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2005.0,2007.0,ALL
3062,HCRTR2,O43614,0.7,0.577,0.005035,DTO_02300001,G-protein coupled receptor,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.6,0.941,,1999.0,2018.0,ALL
3064,HTT,P42858,0.548,0.654,1.0,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,1.0,0.987,limited,1993.0,2020.0,ALL
3065,HDAC1,Q13547,0.46,0.846,0.61427,DTO_05007378,Epigenetic regulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2008.0,2017.0,ALL
3066,HDAC2,Q92769,0.476,0.846,0.99997,DTO_05007378,Epigenetic regulator,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.6,1.0,,2004.0,2019.0,ALL
3067,HDC,P19113,0.584,0.692,0.0041094,,,C0040517,Gilles de la Tourette syndrome,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.68,0.9,,2001.0,2020.0,ALL
3068,HDGF,P51858,0.575,0.654,0.27272,DTO_05007599,Signaling,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
3069,HDLBP,Q00341,0.636,0.731,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2011.0,2019.0,ALL
3070,HELLS,Q9NRZ9,0.603,0.731,0.99979,,,C4310798,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4,,,disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2015.0,ALL
3071,NCKAP1L,P55160,0.839,0.269,0.85489,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3073,HEXA,P06865,0.633,0.615,1.3405e-11,DTO_05007624,Enzyme,C0039373,Tay-Sachs Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1982.0,2019.0,ALL
3074,HEXB,P07686,0.644,0.654,3.4915e-10,DTO_05007624,Enzyme,C0036161,Sandhoff Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.987,strong,1989.0,2020.0,ALL
3075,CFH,P08603,0.441,0.885,0.86061,,,C1853147,"MACULAR DEGENERATION, AGE-RELATED, 4 (disorder)",C11,   Eye Diseases,disease,Disease or Syndrome,0.9,1.0,strong,2003.0,2015.0,ALL
3077,HFE,Q30201,0.436,0.846,2.5587e-08,,,C3469186,"HEMOCHROMATOSIS, TYPE 1",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.9,0.979,,1987.0,2019.0,ALL
3078,CFHR1,Q03591,0.588,0.615,2.6297e-08,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.5,1.0,moderate,2006.0,2017.0,ALL
3080,CFHR2,P36980,0.769,0.346,1.5063e-08,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.41,1.0,limited,2008.0,2013.0,ALL
3081,HGD,Q93099,0.631,0.577,2.9631e-08,DTO_05007624,Enzyme,C0002066,Alkaptonuria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.982,definitive,1955.0,2019.0,ALL
3082,HGF,P14210,0.374,0.885,0.99947,DTO_05007624,Enzyme,C1842342,"DEAFNESS, AUTOSOMAL RECESSIVE 39 (disorder)",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.6,1.0,moderate,2016.0,2016.0,ALL
3083,HGFAC,Q04756,0.628,0.462,1.9843e-08,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2001.0,2009.0,ALL
3084,NRG1,Q02297,0.464,0.885,0.99665,DTO_05007599,Signaling,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2003.0,2017.0,ALL
3087,HHEX,Q03014,0.599,0.692,0.54289,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,0.949,,2007.0,2020.0,ALL
3090,HIC1,Q14526,0.522,0.615,0.13002,DTO_05007542,Transcription factor,C0265219,Miller Dieker syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.51,1.0,,1999.0,2000.0,ALL
3091,HIF1A,Q16665,0.327,0.923,0.9777,DTO_05007542,Transcription factor,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.6,1.0,,2005.0,2019.0,ALL
3092,HIP1,O00291,0.653,0.577,0.76173,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3093,UBE2K,P61086,0.631,0.654,0.98621,,,C0162635,Angelman Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,0.938,,1997.0,2019.0,ALL
3094,HINT1,P49773,0.619,0.577,0.0018235,DTO_05007624,Enzyme,C0242287,Isaacs syndrome,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.8,1.0,,2006.0,2020.0,ALL
3096,HIVEP1,P15822,0.711,0.5,1.0,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,,,,,ALL
3097,HIVEP2,P31629,0.711,0.5,1.0,,,C4310771,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 43",,,disease,Disease or Syndrome,0.6,1.0,limited,2015.0,2015.0,ALL
3098,HK1,P19367,0.542,0.731,0.91459,DTO_03300101,Kinase,C1854449,"Neuropathy, hereditary motor and sensory, Russe type",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2000.0,2017.0,ALL
3099,HK2,P52789,0.515,0.769,0.0045893,DTO_03300101,Kinase,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.52,1.0,,1998.0,2011.0,ALL
3101,HK3,P52790,0.805,0.154,5.599e-23,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
3104,ZBTB48,P10074,0.89,0.077,0.00011507,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,1997.0,1997.0,ALL
3105,HLA-A,P04439,0.37,0.846,0.0013299,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.47,0.5,,2002.0,2019.0,ALL
3106,HLA-B,P01889,0.379,0.885,3.8642e-05,,,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,0.939,,1980.0,2019.0,ALL
3107,HLA-C,P10321,0.415,0.846,1.5695e-06,,,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.4,0.907,,1991.0,2019.0,ALL
3108,HLA-DMA,P28067,0.608,0.654,0.002381,DTO_05007608,Immune response,C0011616,Contact Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
3109,HLA-DMB,P28068,0.638,0.615,0.0024627,DTO_05007608,Immune response,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
3110,MNX1,P50219,0.555,0.615,0.78819,DTO_05007542,Transcription factor,C1531773,Currarino triad,C16;C06;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.885,strong,1995.0,2018.0,ALL
3111,HLA-DOA,P06340,0.509,0.808,2.9776e-10,DTO_05007608,Immune response,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
3112,HLA-DOB,P13765,0.705,0.5,1.9197e-06,DTO_05007608,Immune response,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2003.0,2007.0,ALL
3113,HLA-DPA1,P20036,0.552,0.846,2.5e-06,DTO_05007608,Immune response,C0524909,"Hepatitis B, Chronic",C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.44,1.0,,2009.0,2015.0,ALL
3115,HLA-DPB1,P04440,0.453,0.923,5.3254e-10,DTO_05007608,Immune response,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,0.938,,1988.0,2020.0,ALL
3116,HLA-DPB2,,0.743,0.5,,,,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.4,1.0,,2013.0,2013.0,ALL
3117,HLA-DQA1,P01909,0.416,0.846,0.023947,DTO_05007608,Immune response,C0014848,Esophageal Achalasia,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.52,1.0,,2002.0,2014.0,ALL
3118,HLA-DQA2,P01906,0.617,0.769,1.0089e-05,DTO_05007608,Immune response,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,1.0,,2007.0,2011.0,ALL
3119,HLA-DQB1,P01920,0.407,0.885,0.0089259,DTO_05007608,Immune response,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.8,0.956,limited,1996.0,2019.0,ALL
3120,HLA-DQB2,P05538,0.573,0.731,0.042679,DTO_05007608,Immune response,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0,,1990.0,2018.0,ALL
3121,HLA-DQB3,,0.931,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
3122,HLA-DRA,P01903,0.581,0.769,0.51949,DTO_05007608,Immune response,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.48,1.0,,2010.0,2015.0,ALL
3123,HLA-DRB1,P01911,0.333,0.923,0.0010997,DTO_05007608,Immune response,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.7,0.88,,1994.0,2019.0,ALL
3124,HLA-DRB2,,0.861,0.269,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
3125,HLA-DRB3,P79483,0.57,0.885,,DTO_05007608,Immune response,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.11,1.0,,2016.0,2017.0,ALL
3126,HLA-DRB4,P13762,0.565,0.846,,DTO_05007608,Immune response,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2002.0,2002.0,ALL
3127,HLA-DRB5,Q30154,0.608,0.731,3.6359e-07,DTO_05007608,Immune response,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.32,1.0,,2015.0,2017.0,ALL
3128,HLA-DRB6,,0.821,0.308,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
3131,HLF,Q16534,0.628,0.615,0.95215,DTO_05007557,Nucleic acid binding,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,1.0,,1992.0,2020.0,ALL
3132,HLA-DRB9,,0.682,0.654,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2019.0,ALL
3133,HLA-E,P13747,0.545,0.769,0.036773,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
3134,HLA-F,P30511,0.631,0.654,3.276e-05,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
3135,HLA-G,P17693,0.461,0.769,1.365e-11,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,1.0,,2005.0,2018.0,ALL
3136,HLA-H,P01893,0.736,0.5,,,,C0018995,Hemochromatosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,1997.0,1998.0,ALL
3137,HLA-J,,0.861,0.269,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
3138,HLA-K,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
3139,HLA-L,,0.861,0.269,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
3140,MR1,Q95460,0.716,0.346,4.9023e-18,,,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,,limited,,,ALL
3141,HLCS,P50747,0.65,0.654,1.9208e-08,DTO_05007624,Enzyme,C0268581,Holocarboxylase Synthetase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,,1981.0,2016.0,ALL
3142,HLX,Q14774,0.716,0.308,0.88317,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
3145,HMBS,P08397,0.559,0.731,0.94884,DTO_05007624,Enzyme,C0162565,Acute intermittent porphyria,C16;C06;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.983,strong,1974.0,2020.0,ALL
3146,HMGB1,P09429,0.368,0.923,0.82035,DTO_05007557,Nucleic acid binding,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,0.929,,2011.0,2019.0,ALL
3148,HMGB2,P26583,0.615,0.615,0.95087,DTO_05007557,Nucleic acid binding,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2009.0,2018.0,ALL
3149,HMGB3,O15347,0.604,0.615,0.79758,DTO_05007557,Nucleic acid binding,C3806742,"MICROPHTHALMIA, SYNDROMIC 13",,,disease,Disease or Syndrome,0.6,1.0,,1971.0,2014.0,ALL
3150,HMGN1,P05114,0.711,0.538,0.20661,DTO_05007557,Nucleic acid binding,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
3151,HMGN2,P05204,0.695,0.423,0.86341,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,1990.0,2019.0,ALL
3155,HMGCL,P35914,0.691,0.462,2.5638e-06,DTO_05007624,Enzyme,C0268601,HMG CoA lyase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.78,0.967,definitive,1988.0,2020.0,ALL
3156,HMGCR,P04035,0.529,0.692,0.99861,,,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.6,1.0,,1978.0,2019.0,ALL
3157,HMGCS1,Q01581,0.769,0.346,0.99824,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2008.0,2008.0,ALL
3158,HMGCS2,P54868,0.666,0.577,4.3354e-14,,,C2751532,3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,definitive,1994.0,2016.0,ALL
3159,HMGA1,P17096,0.494,0.769,0.83209,DTO_05007557,Nucleic acid binding,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,0.929,,2005.0,2018.0,ALL
3161,HMMR,O75330,0.544,0.615,5.5222e-21,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.49,0.889,,2002.0,2019.0,ALL
3162,HMOX1,P09601,0.381,0.923,0.0096817,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.7,0.9,,2005.0,2020.0,ALL
3163,HMOX2,P30519,0.678,0.577,0.00026198,,,C2937358,Cerebral Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0,,2006.0,2006.0,ALL
3164,NR4A1,P22736,0.49,0.731,0.37074,DTO_00102000,Nuclear receptor,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.35,1.0,,2009.0,2017.0,ALL
3166,HMX1,Q9NP08,0.729,0.346,0.72623,,,C2677500,Oculoauricular Syndrome,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.91,1.0,,1997.0,2018.0,ALL
3167,HMX2,A2RU54,0.931,0.115,4.9891e-05,,,C0025281,Meniere Disease,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
3169,FOXA1,P55317,0.522,0.731,0.22227,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,0.986,,2004.0,2019.0,ALL
3170,FOXA2,Q9Y261,0.528,0.769,0.74225,DTO_05007542,Transcription factor,C3888018,Congenital Hyperinsulinism,C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.34,1.0,strong,2001.0,2018.0,ALL
3171,FOXA3,P55318,0.711,0.346,0.73257,DTO_05007542,Transcription factor,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
3172,HNF4A,P41235,0.461,0.808,0.15285,DTO_00102000,Nuclear receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,1.0,0.942,,1992.0,2019.0,ALL
3174,HNF4G,Q14541,0.729,0.423,0.070708,DTO_00102000,Nuclear receptor,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.12,0.5,,2016.0,2018.0,ALL
3175,ONECUT1,Q9UBC0,0.686,0.346,0.52333,DTO_05007542,Transcription factor,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
3176,HNMT,P50135,0.579,0.808,0.019734,,,C4225220,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2019.0,ALL
3177,SLC29A2,Q14542,0.653,0.577,3.2307e-14,DTO_05007405,Transporter,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2005.0,2008.0,ALL
3178,HNRNPA1,P09651,0.529,0.885,0.99911,,,C3715156,AMYOTROPHIC LATERAL SCLEROSIS 20,,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2016.0,ALL
3181,HNRNPA2B1,P22626,0.566,0.808,0.99732,,,C1833662,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA,C16;C18;C05;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.5,1.0,,2013.0,2013.0,ALL
3182,HNRNPAB,Q99729,0.839,0.231,0.76526,,,C0024668,"Mammary Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2004.0,2004.0,ALL
3183,HNRNPC,P07910,0.606,0.538,0.97772,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,0.889,,2001.0,2017.0,ALL
3184,HNRNPD,Q14103,0.621,0.654,0.99621,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.26,1.0,,2010.0,2019.0,ALL
3185,HNRNPF,P52597,0.736,0.346,0.96415,DTO_05007557,Nucleic acid binding,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
3186,RBMXP1,,0.861,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2006.0,2011.0,ALL
3187,HNRNPH1,P31943,0.711,0.538,0.99993,DTO_05007557,Nucleic acid binding,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.31,1.0,,2007.0,2016.0,ALL
3188,HNRNPH2,P55795,0.691,0.462,0.95448,DTO_05007557,Nucleic acid binding,C4310814,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
3189,HNRNPH3,P31942,0.839,0.192,0.99221,DTO_05007557,Nucleic acid binding,C0022548,Keloid,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Acquired Abnormality,0.01,1.0,,2013.0,2013.0,ALL
3190,HNRNPK,P61978,0.539,0.846,0.99998,DTO_05007624,Enzyme,C4225274,AU-KLINE SYNDROME,,,disease,Disease or Syndrome,0.72,1.0,,2009.0,2020.0,ALL
3191,HNRNPL,P14866,0.663,0.5,0.99685,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2011.0,2019.0,ALL
3192,HNRNPU,Q00839,0.575,0.654,1.0,,,C4479319,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54",,,disease,Disease or Syndrome,0.6,1.0,strong,2013.0,2016.0,ALL
3195,TLX1,P31314,0.644,0.308,0.74161,,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.6,0.938,,1989.0,2019.0,ALL
3196,TLX2,O43763,0.659,0.538,0.2548,,,C1832589,"Neuronal Intestinal Dysplasia, Type B",C06;C10,   Digestive System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0,,1997.0,1997.0,ALL
3197,HOXA@,,0.599,0.654,,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,1992.0,2019.0,ALL
3198,HOXA1,P49639,0.575,0.769,0.28514,,,C1832215,Athabaskan brainstem dysgenesis,C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.92,1.0,,1999.0,2014.0,ALL
3199,HOXA2,O43364,0.7,0.385,0.19917,,,C2676772,"Microtia, Hearing Impairment, And Cleft Palate",C23;C16;C05;C10;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,,1997.0,2017.0,ALL
3200,HOXA3,O43365,0.695,0.538,0.9445,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
3201,HOXA4,Q00056,0.663,0.5,8.5959e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
3202,HOXA5,P20719,0.595,0.577,0.0029693,DTO_05007542,Transcription factor,C0019284,Diaphragmatic Hernia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
3203,HOXA6,P31267,0.736,0.5,2.9887e-06,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
3204,HOXA7,P31268,0.65,0.5,0.0013606,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2007.0,2019.0,ALL
3205,HOXA9,P31269,0.521,0.692,4.3591e-05,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.4,0.987,,1996.0,2020.0,ALL
3206,HOXA10,P31260,0.538,0.692,0.88453,,,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.35,1.0,,2006.0,2018.0,ALL
3207,HOXA11,P31270,0.568,0.692,0.94342,,,C1854273,Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia,C16;C05;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.61,1.0,limited,2000.0,2015.0,ALL
3208,HPCA,P84074,0.76,0.385,0.6783,,,C1857093,"DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2015.0,2018.0,ALL
3209,HOXA13,P31271,0.552,0.654,0.9551,,,C1841679,Hand foot uterus syndrome,C16;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,1.0,,1971.0,2019.0,ALL
3210,HOXB@,,0.631,0.538,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,1993.0,2015.0,ALL
3211,HOXB1,P14653,0.633,0.538,0.081766,,,C3553625,"FACIAL PARESIS, HEREDITARY CONGENITAL, 3",,,disease,Disease or Syndrome,0.6,1.0,moderate,2012.0,2012.0,ALL
3212,HOXB2,P14652,0.612,0.577,0.00014636,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,1993.0,2015.0,ALL
3213,HOXB3,P14651,0.631,0.615,0.8917,,,C0019284,Diaphragmatic Hernia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
3214,HOXB4,P17483,0.647,0.423,0.059777,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,0.667,,2002.0,2017.0,ALL
3215,HOXB5,P09067,0.644,0.577,0.69589,DTO_05007542,Transcription factor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.41,1.0,,2012.0,2014.0,ALL
3216,HOXB6,P17509,0.666,0.385,0.00073817,DTO_05007542,Transcription factor,C0027831,Neurofibromatosis 1,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.03,0.667,,1987.0,1989.0,ALL
3217,HOXB7,P09629,0.57,0.615,0.00028382,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2015.0,2019.0,ALL
3218,HOXB8,P17481,0.636,0.538,0.84752,,,C0040953,Trichotillomania,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.52,1.0,,2002.0,2018.0,ALL
3219,HOXB9,P17482,0.572,0.654,0.31202,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,2010.0,2016.0,ALL
3220,HOXC@,,0.695,0.462,,,,C0009081,Congenital clubfoot,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.02,1.0,,2016.0,2018.0,ALL
3221,HOXC4,P09017,0.76,0.192,0.16846,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
3222,HOXC5,Q00444,0.682,0.269,5.7754e-05,DTO_05007542,Transcription factor,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
3223,HOXC6,P09630,0.595,0.692,0.51165,DTO_05007542,Transcription factor,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
3224,HOXC8,P31273,0.659,0.538,0.1695,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2002.0,2018.0,ALL
3225,HOXC9,P31274,0.691,0.346,0.012993,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
3226,HOXC10,Q9NYD6,0.641,0.5,0.17368,,,C0345392,Congenital kyphoscoliosis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.2,1.0,,2008.0,2008.0,ALL
3227,HOXC11,O43248,0.729,0.308,0.004059,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2010.0,2015.0,ALL
3228,HOXC12,P31275,0.89,0.154,2.4299e-09,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2017.0,2017.0,ALL
3229,HOXC13,P31276,0.695,0.346,0.42048,,,C3554127,"ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2017.0,ALL
3230,HOXD@,,0.631,0.538,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2016.0,2019.0,ALL
3231,HOXD1,Q9GZZ0,0.78,0.231,0.0031828,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2010.0,2017.0,ALL
3232,HOXD3,P31249,0.67,0.462,0.44051,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.38,1.0,,2009.0,2018.0,ALL
3233,HOXD4,P09016,0.76,0.346,0.0054479,,,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.31,1.0,,2005.0,2005.0,ALL
3234,HOXD8,P13378,0.736,0.423,0.10544,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
3235,HOXD9,P28356,0.67,0.462,0.017004,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2015.0,2017.0,ALL
3236,HOXD10,P28358,0.59,0.538,0.062918,,,C0240912,Vertical Talus,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.74,1.0,limited,2004.0,2016.0,ALL
3237,HOXD11,P31277,0.67,0.462,0.0011418,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
3238,HOXD12,P35452,0.861,0.154,0.00027657,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
3239,HOXD13,P35453,0.483,0.808,0.0086055,,,C2699746,"Syndactyly, type 2",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,1.0,0.978,,1993.0,2019.0,ALL
3240,HP,P00738,0.412,0.885,1.736e-05,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.6,1.0,,1990.0,2017.0,ALL
3241,HPCAL1,P37235,0.743,0.308,0.89103,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3242,HPD,P32754,0.573,0.769,0.00052764,DTO_05007624,Enzyme,C0268623,"Tyrosinemia, Type III",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.94,1.0,moderate,1972.0,2012.0,ALL
3244,HPE1,,0.89,0.115,,,,C0079541,Holoprosencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.31,1.0,,1995.0,1995.0,ALL
3247,HPFH2,,0.821,0.115,,,,C0271994,Hereditary persistence of fetal hemoglobin thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.06,1.0,,1985.0,2019.0,ALL
3248,HPGD,P15428,0.516,0.731,1.4357e-05,,,C2678439,CRANIOOSTEOARTHROPATHY,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,limited,2008.0,2015.0,ALL
3249,HPN,P05981,0.641,0.577,0.99911,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.96,,2001.0,2019.0,ALL
3250,HPR,P00739,0.578,0.615,5.4618e-10,DTO_05007624,Enzyme,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
3251,HPRT1,P00492,0.5,0.808,0.93728,DTO_05007624,Enzyme,C0023374,Lesch-Nyhan Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.985,definitive,1971.0,2020.0,ALL
3257,HPS1,Q92902,0.636,0.692,1.3245e-07,,,C2931875,Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,C16;C18;C11;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.94,1.0,definitive,1978.0,2018.0,ALL
3258,HPT,,0.593,0.692,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1991.0,2018.0,ALL
3259,HPV6AI1,,1.0,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
3260,HPV18I1,,,,,,,C3887947,HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1,,,phenotype,Finding,0.3,,,,,ALL
3261,HPV18I2,,0.931,0.038,,,,C3887948,HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2,,,phenotype,Finding,0.3,,,,,ALL
3263,HPX,P02790,0.599,0.731,1.3005e-11,DTO_05007624,Enzyme,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
3265,HRAS,P01112,0.378,0.885,0.079774,DTO_05007584,Enzyme modulator,C0587248,Costello syndrome (disorder),C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.974,definitive,1982.0,2020.0,ALL
3266,ERAS,Q7Z444,0.705,0.423,0.22267,DTO_05007584,Enzyme modulator,C0563625,Agnosia for Pain,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.04,1.0,,2018.0,2019.0,ALL
3267,AGFG1,P52594,0.569,0.769,0.99276,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3268,AGFG2,O95081,0.7,0.423,0.00025383,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
3269,HRH1,P35367,0.647,0.654,1.858e-06,DTO_02300001,G-protein coupled receptor,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.36,1.0,,1996.0,2019.0,ALL
3270,HRC,P23327,0.663,0.577,9.9367e-09,,,C0005910,Body Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.3,1.0,,2006.0,2006.0,ALL
3272,HRES1,P13985,0.636,0.615,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,0.923,,2001.0,2019.0,ALL
3273,HRG,P04196,0.603,0.577,5.8888e-14,DTO_05007584,Enzyme modulator,C2751090,Thrombophilia Due To Histidine-Rich Glycoprotein Deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,1.0,strong,1998.0,2018.0,ALL
3274,HRH2,P25021,0.647,0.462,0.1217,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,1996.0,2000.0,ALL
3275,PRMT2,P55345,0.722,0.385,0.0016132,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.2,1.0,,2010.0,2010.0,ALL
3276,PRMT1,Q99873,0.552,0.808,0.99907,DTO_05007378,Epigenetic regulator,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.24,1.0,,2010.0,2019.0,ALL
3280,HES1,Q14469,0.468,0.885,0.7072,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.38,1.0,,2009.0,2019.0,ALL
3281,HSBP1,O75506,1.0,0.038,0.23354,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
3283,HSD3B1,P14060,0.619,0.462,2.3984e-07,DTO_05007624,Enzyme,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.52,1.0,,2004.0,2019.0,ALL
3284,HSD3B2,P26439,0.582,0.5,7.176e-08,DTO_05007624,Enzyme,C0342471,3 beta-Hydroxysteroid dehydrogenase deficiency,C16;C18;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.78,1.0,,1993.0,2015.0,ALL
3290,HSD11B1,P28845,0.52,0.731,0.41696,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,0.97,,2002.0,2019.0,ALL
3291,HSD11B2,P80365,0.532,0.808,0.11777,DTO_05007624,Enzyme,C3887949,Apparent mineralocorticoid excess,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.981,strong,1995.0,2019.0,ALL
3292,HSD17B1,P14061,0.61,0.615,0.00013421,DTO_05007624,Enzyme,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.4,0.786,,2001.0,2018.0,ALL
3293,HSD17B3,P37058,0.641,0.346,8.4911e-07,,,C0268296,17-Hydroxysteroid Dehydrogenase Deficiency,C16;C18;C13;C17;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.79,1.0,strong,1994.0,2018.0,ALL
3294,HSD17B2,P37059,0.656,0.385,1.8462e-10,DTO_05007624,Enzyme,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.37,1.0,,2002.0,2020.0,ALL
3295,HSD17B4,P51659,0.546,0.654,2.4175e-10,,,C0342870,Bifunctional peroxisomal enzyme deficiency,C23;C16;C13;C12;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",phenotype,Pathologic Function,0.9,1.0,,1989.0,2017.0,ALL
3297,HSF1,Q00613,0.507,0.769,0.74762,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,0.968,,1988.0,2020.0,ALL
3298,HSF2,Q03933,0.711,0.423,0.97536,DTO_05007542,Transcription factor,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.31,1.0,,2018.0,2019.0,ALL
3299,HSF4,Q9ULV5,0.663,0.423,1.0632e-09,DTO_05007542,Transcription factor,C3888417,"CATARACT 5, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.8,1.0,,2002.0,2013.0,ALL
3300,DNAJB2,P25686,0.743,0.192,5.444e-05,,,C3553989,"SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5",,,disease,Disease or Syndrome,0.7,1.0,limited,2012.0,2016.0,ALL
3301,DNAJA1,P31689,0.805,0.308,0.090813,,,C0026636,Mouth Diseases,C07,   Stomatognathic Diseases,group,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
3303,HSPA1A,P0DMV8;P0DMV9,0.486,0.769,0.030228,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.38,0.8,,2005.0,2018.0,ALL
3304,HSPA1B,P0DMV8;P0DMV9,0.474,0.808,0.0053464,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,0.667,,2005.0,2020.0,ALL
3305,HSPA1L,P34931,0.603,0.654,1.057e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,0.5,,2005.0,2018.0,ALL
3306,HSPA2,P54652,0.55,0.808,0.048648,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
3308,HSPA4,P34932,0.394,0.923,0.99954,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,0.75,,1996.0,2018.0,ALL
3309,HSPA5,P11021,0.434,0.885,0.77341,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,0.974,,2001.0,2020.0,ALL
3310,HSPA6,P17066,0.743,0.423,6.8282e-06,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
3311,HSPA7,P48741,0.931,0.077,,,,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0,,2000.0,2003.0,ALL
3312,HSPA8,P11142,0.553,0.808,0.99863,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2004.0,2019.0,ALL
3313,HSPA9,P38646,0.502,0.885,0.96852,,,C4225180,EVEN-PLUS SYNDROME,,,disease,Disease or Syndrome,0.72,1.0,,1999.0,2019.0,ALL
3315,HSPB1,P04792,0.436,0.808,2.7797e-07,,,C1847823,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.76,1.0,strong,2004.0,2018.0,ALL
3316,HSPB2,Q16082,0.457,0.769,0.00032989,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,1993.0,2019.0,ALL
3320,HSP90AA1,P07900,0.411,0.923,0.86025,DTO_05007613,Chaperone,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1992.0,2020.0,ALL
3321,IGSF3,O75054,0.736,0.423,0.26474,,,C1835612,LACRIMAL DUCT DEFECT,,,phenotype,Finding,0.4,1.0,,2014.0,2014.0,ALL
3324,HSP90AA2P,Q14568,0.76,0.269,,DTO_05007613,Chaperone,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2010.0,2010.0,ALL
3326,HSP90AB1,P08238,0.608,0.654,0.99923,DTO_05007613,Chaperone,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
3329,HSPD1,P10809,0.432,0.808,0.99257,,,C1854467,"Spastic paraplegia 13, autosomal dominant",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.92,1.0,,1975.0,2016.0,ALL
3336,HSPE1,P61604,0.617,0.769,0.80379,DTO_05007613,Chaperone,C0033141,"Cardiomyopathies, Primary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2003.0,2003.0,ALL
3337,DNAJB1,P25685,0.597,0.692,0.039437,,,C0334287,Fibrolamellar Hepatocellular Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2014.0,2020.0,ALL
3338,DNAJC4,Q9NNZ3,1.0,0.038,1.8113e-10,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
3339,HSPG2,P98160,0.438,0.885,1.0376e-19,DTO_05007584,Enzyme modulator,C4551479,"Schwartz-Jampel Syndrome, Type 1",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.93,1.0,,1999.0,2018.0,ALL
3340,NDST1,P52848,0.608,0.692,0.99995,,,C4015283,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46",,,disease,Disease or Syndrome,0.7,1.0,limited,2011.0,2014.0,ALL
3342,HTC2,,0.392,0.808,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2011.0,2013.0,ALL
3344,FOXN2,P32314,0.805,0.231,0.49701,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
3346,HTN1,P15515,0.736,0.5,0.04232,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
3347,HTN3,P15516,0.686,0.5,4.1066e-05,,,C0745130,Resistant hypertensive disorder,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.07,0.571,,2017.0,2019.0,ALL
3349,HTOR,,1.0,0.077,,,,C0003615,Appendicitis,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
3350,HTR1A,P08908,0.522,0.846,0.19956,DTO_02300001,G-protein coupled receptor,C3553418,"PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT",,,disease,Disease or Syndrome,0.6,,limited,,,ALL
3351,HTR1B,P28222,0.551,0.769,0.18947,DTO_02300001,G-protein coupled receptor,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,1998.0,2012.0,ALL
3352,HTR1D,P28221,0.716,0.308,0.00064061,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,1993.0,2005.0,ALL
3354,HTR1E,P28566,0.805,0.192,0.29344,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2015.0,2015.0,ALL
3355,HTR1F,P30939,0.716,0.192,0.0046656,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,0.5,,1996.0,2004.0,ALL
3356,HTR2A,P28223,0.473,0.846,0.51124,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.8,0.6,,1997.0,2018.0,ALL
3357,HTR2B,P41595,0.647,0.538,2.6913e-10,DTO_02300001,G-protein coupled receptor,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.5,1.0,,2007.0,2009.0,ALL
3358,HTR2C,P28335,0.555,0.692,0.037023,DTO_02300001,G-protein coupled receptor,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2004.0,2018.0,ALL
3359,HTR3A,P46098,0.608,0.538,1.7499e-10,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.38,0.5,,2001.0,2013.0,ALL
3360,HTR4,Q13639,0.61,0.615,0.024701,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,0.25,,2002.0,2013.0,ALL
3361,HTR5A,P47898,0.716,0.231,0.0062906,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2000.0,2016.0,ALL
3362,HTR6,P50406,0.626,0.5,0.00018524,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.824,,1999.0,2018.0,ALL
3363,HTR7,P34969,0.592,0.5,0.045409,DTO_02300001,G-protein coupled receptor,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.53,1.0,,2004.0,2018.0,ALL
3364,HUS1,O60921,0.805,0.192,3.0073e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
3371,TNC,P24821,0.433,0.846,1.2592e-07,,,C3810170,"DEAFNESS, AUTOSOMAL DOMINANT 56",,,disease,Disease or Syndrome,0.7,1.0,moderate,2013.0,2013.0,ALL
3373,HYAL1,Q12794,0.633,0.577,0.00019112,DTO_05007624,Enzyme,C1291490,Hyaluronidase Deficiency,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.9,1.0,,1996.0,2016.0,ALL
3375,IAPP,P10997,0.507,0.808,0.0031814,DTO_05007599,Signaling,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,0.958,,1989.0,2020.0,ALL
3376,IARS1,P41252,0.606,0.692,1.7339e-21,DTO_05007624,Enzyme,C4310720,"GROWTH RETARDATION, INTELLECTUAL DEVELOPMENTAL DISORDER, HYPOTONIA, AND HEPATOPATHY",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2018.0,ALL
3378,IBD2,,0.805,0.154,,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,1998.0,2012.0,ALL
3381,IBSP,P21815,0.653,0.538,1.3519e-11,DTO_05007621,Extracellular structure,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.35,1.0,,2004.0,2019.0,ALL
3382,ICA1,Q05084,0.686,0.5,0.00099069,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,1993.0,2017.0,ALL
3383,ICAM1,P05362,0.364,0.962,0.035295,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.6,1.0,,1995.0,2019.0,ALL
3384,ICAM2,P13598,0.659,0.462,0.00075003,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2004.0,2006.0,ALL
3385,ICAM3,P32942,0.619,0.654,2.7302e-25,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
3386,ICAM4,Q14773,0.792,0.269,1.2077e-06,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
3394,IRF8,Q02556,0.539,0.808,0.94807,DTO_05007542,Transcription factor,C3808589,IMMUNODEFICIENCY 32A,,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2011.0,ALL
3396,MRPL58,Q14197,0.691,0.308,5.6196e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
3397,ID1,P41134,0.544,0.692,0.00031026,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,0.933,,2005.0,2019.0,ALL
3398,ID2,Q02363,0.572,0.731,0.66939,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2007.0,2017.0,ALL
3399,ID3,Q02535,0.615,0.692,0.72177,DTO_05007542,Transcription factor,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.33,1.0,,2012.0,2013.0,ALL
3400,ID4,P47928,0.59,0.615,0.031243,DTO_05007542,Transcription factor,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2003.0,2003.0,ALL
3402,IDDM3,,0.861,0.154,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,1994.0,2005.0,ALL
3403,IDDM4,,0.839,0.192,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.06,0.833,,1994.0,2004.0,ALL
3405,IDDM6,,0.931,0.115,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,1997.0,2005.0,ALL
3406,IDDM7,,0.861,0.192,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.05,1.0,,1995.0,2003.0,ALL
3407,IDDM8,,0.821,0.192,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.07,0.857,,1996.0,2010.0,ALL
3410,IDDM11,,0.931,0.115,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,0.667,,1996.0,2004.0,ALL
3412,IDDM13,,0.89,0.192,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.05,1.0,,1998.0,2002.0,ALL
3414,IDDM15,,1.0,0.115,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,0.667,,2000.0,2008.0,ALL
3416,IDE,P14735,0.604,0.577,0.0066309,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.6,0.955,,2000.0,2019.0,ALL
3417,IDH1,O75874,0.424,0.808,2.6244e-12,,,C0014084,Enchondromatosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.79,1.0,,2011.0,2019.0,ALL
3418,IDH2,P48735,0.434,0.808,0.88271,,,C0014084,Enchondromatosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.77,1.0,,2011.0,2019.0,ALL
3419,IDH3A,P50213,0.705,0.385,0.15704,DTO_05007624,Enzyme,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.51,1.0,strong,2017.0,2018.0,ALL
3420,IDH3B,O43837,0.7,0.462,2.9929e-11,DTO_05007624,Enzyme,C2675496,Retinitis Pigmentosa 46,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2008.0,2008.0,ALL
3422,IDI1,Q13907,1.0,0.077,3.9769e-05,DTO_05007624,Enzyme,C1862941,"Amyotrophic Lateral Sclerosis, Sporadic",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
3423,IDS,P22304,0.559,0.769,0.94725,,,C0026705,Mucopolysaccharidosis II,C16;C18;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.994,definitive,1991.0,2019.0,ALL
3424,IDSP1,,0.931,0.192,,,,C0026705,Mucopolysaccharidosis II,C16;C18;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
3425,IDUA,P35475,0.499,0.846,3.7599e-13,DTO_05007624,Enzyme,C0023786,Mucopolysaccharidosis I,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1992.0,2020.0,ALL
3426,CFI,P05156,0.569,0.731,3.5432e-08,,,C3463916,Complement Factor I (C3 inactivator) deficiency,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.72,1.0,strong,1996.0,2017.0,ALL
3428,IFI16,Q16666,0.603,0.769,1.7803e-11,DTO_05007542,Transcription factor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
3429,IFI27,P40305,0.437,0.769,0.010698,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
3430,IFI35,P80217,0.76,0.462,4.2821e-07,DTO_05007542,Transcription factor,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
3431,SP110,Q9HB58,0.656,0.5,1.4595e-14,,,C1856128,Hepatic venoocclusive disease with immunodeficiency,C06;C20;C14,   Digestive System Diseases;    Immune System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.72,0.75,,2006.0,2017.0,ALL
3433,IFIT2,P09913,0.656,0.5,0.25099,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
3434,IFIT1,P09914,0.666,0.5,0.00027793,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
3437,IFIT3,O14879,0.628,0.731,0.11732,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
3438,IFN1@,,0.565,0.731,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2005.0,2019.0,ALL
3439,IFNA1,P01562,0.371,0.923,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.4,0.943,,1995.0,2019.0,ALL
3440,IFNA2,P01563,0.442,0.885,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.4,1.0,,1988.0,2019.0,ALL
3441,IFNA4,P05014,0.861,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2012.0,2018.0,ALL
3442,IFNA5,P01569,0.792,0.269,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
3443,IFNA6,P05013,0.839,0.231,,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,1.0,,1995.0,1999.0,ALL
3444,IFNA7,P01567,,,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
3445,IFNA8,P32881,0.839,0.115,,,,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
3446,IFNA10,P01566,0.89,0.115,,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
3447,IFNA13,P01562,0.374,0.923,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,0.857,,2003.0,2019.0,ALL
3448,IFNA14,P01570,0.89,0.038,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
3449,IFNA16,P05015,1.0,,,,,C0853112,Chronic infection with HIV,,,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
3451,IFNA17,P01571,0.636,0.615,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1992.0,2005.0,ALL
3454,IFNAR1,P17181,0.532,0.769,3.2501e-12,DTO_05007575,Receptor,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.34,1.0,,2008.0,2019.0,ALL
3455,IFNAR2,P48551,0.585,0.731,8.5332e-06,DTO_05007575,Receptor,C4225252,IMMUNODEFICIENCY 45,,,disease,Disease or Syndrome,0.7,1.0,limited,2015.0,2015.0,ALL
3456,IFNB1,P01574,0.421,0.846,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.56,1.0,,2008.0,2019.0,ALL
3458,IFNG,P01579,0.288,0.962,0.47156,,,C0002874,Aplastic Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.9,1.0,limited,1992.0,2020.0,ALL
3459,IFNGR1,P15260,0.529,0.692,0.015503,DTO_05007575,Receptor,C4014863,IMMUNODEFICIENCY 27B,,,disease,Disease or Syndrome,0.7,1.0,strong,1998.0,1998.0,ALL
3460,IFNGR2,P38484,0.597,0.577,0.95281,DTO_05007575,Receptor,C4013947,IMMUNODEFICIENCY 28,,,disease,Disease or Syndrome,0.7,1.0,strong,2000.0,2019.0,ALL
3466,IFNR,,0.792,0.192,,,,C0014070,Encephalomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
3467,IFNW1,P05000,0.743,0.346,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
3475,IFRD1,O00458,0.666,0.462,0.0012141,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3476,IGBP1,P78318,0.641,0.692,0.98274,DTO_05007608,Immune response,C1845446,"Corpus Callosum, Agenesis of, with Mental Retardation, Ocular Coloboma, and Micrognathia",C23;C16;C11;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.6,1.0,,2003.0,2003.0,ALL
3478,IGES,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2002.0,2003.0,ALL
3479,IGF1,P05019,0.318,0.885,0.2716,,,C1837475,Insulin-Like Growth Factor I Deficiency,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1993.0,2020.0,ALL
3480,IGF1R,P08069,0.399,0.885,0.96799,DTO_03300101,Kinase,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.7,1.0,,1991.0,2019.0,ALL
3481,IGF2,P01344,0.39,0.885,0.044127,,,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.9,1.0,,1992.0,2019.0,ALL
3482,IGF2R,P11717,0.518,0.731,1.0,DTO_05007575,Receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.7,1.0,,1995.0,2019.0,ALL
3483,IGFALS,P35858,0.511,0.846,5.4379e-11,DTO_05007575,Receptor,C3900122,Acid-Labile Subunit Deficiency,,,disease,Laboratory or Test Result,0.7,1.0,,2004.0,2016.0,ALL
3484,IGFBP1,P08833,0.502,0.808,0.00094677,DTO_05007584,Enzyme modulator,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.36,1.0,,2003.0,2012.0,ALL
3485,IGFBP2,P18065,0.478,0.769,0.11898,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,0.667,,2005.0,2018.0,ALL
3486,IGFBP3,P17936,0.439,0.808,0.91029,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.6,0.815,,2004.0,2019.0,ALL
3487,IGFBP4,P22692,0.572,0.731,0.023057,DTO_05007584,Enzyme modulator,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
3488,IGFBP5,P24593,0.544,0.692,0.96283,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.941,,1996.0,2018.0,ALL
3489,IGFBP6,P24592,0.601,0.692,0.02915,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2005.0,2005.0,ALL
3490,IGFBP7,Q16270,0.476,0.769,0.0012873,,,C3280205,RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS,,,disease,Disease or Syndrome,0.51,1.0,moderate,2002.0,2020.0,ALL
3491,CCN1,O00622,0.473,0.731,0.71388,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,0.929,,2006.0,2019.0,ALL
3492,IGH,,0.473,0.654,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,1.0,,1991.0,2020.0,ALL
3493,IGHA1,P01876,0.617,0.692,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2005.0,2015.0,ALL
3494,IGHA2,P01877,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
3495,IGHD,P01880,0.722,0.346,,,,C0013338,Pituitary dwarfism,C05;C10;C19,   Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,2002.0,2016.0,ALL
3496,IGHDOR15@,,0.931,0.154,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
3497,IGHE,P01854,0.626,0.538,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,0.966,,1996.0,2018.0,ALL
3498,IGHEP1,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
3500,IGHG1,P01857,0.7,0.5,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,,,,,ALL
3501,IGHG2,P01859,0.76,0.192,,,,C0027121,Myositis,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
3502,IGHG3,P01860,0.513,0.769,,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,1999.0,2019.0,ALL
3503,IGHG4,P01861,0.931,0.038,,,,C0206655,Alveolar rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
3505,IGHGP,,1.0,0.038,,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
3507,IGHM,P01871,0.644,0.654,,,,C0001768,Agammaglobulinemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.6,1.0,strong,2002.0,2002.0,ALL
3508,IGHMBP2,P38935,0.636,0.615,3.0212e-16,,,C1858517,SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS 1,C16;C08;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.957,,1975.0,2020.0,ALL
3512,JCHAIN,P01591,0.691,0.462,0.033839,,,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,1994.0,1996.0,ALL
3514,IGKC,P01834,0.7,0.423,,,,C3279824,Kappa-Chain Deficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.6,1.0,moderate,1969.0,1985.0,ALL
3516,RBPJ,Q06330,0.518,0.808,0.99853,DTO_05007557,Nucleic acid binding,C3553748,ADAMS-OLIVER SYNDROME 3,,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2018.0,ALL
3519,IGKV@,,0.743,0.231,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,2005.0,2019.0,ALL
3535,IGL,,0.659,0.346,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0,,1991.0,2013.0,ALL
3537,IGLC1,P0CG04,0.821,0.385,,,,C0005699,Blast Phase,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
3538,IGLC2,P0DOY2,0.805,0.462,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1984.0,1984.0,ALL
3539,IGLC3,P0DOY3,0.821,0.423,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1984.0,1984.0,ALL
3540,IGLC4,,0.839,0.385,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1984.0,1984.0,ALL
3541,IGLC5,,0.839,0.385,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1984.0,1984.0,ALL
3542,IGLC6,P0CF74,0.839,0.385,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1984.0,1984.0,ALL
3543,IGLL1,P15814,0.678,0.538,0.013899,,,C0001768,Agammaglobulinemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2016.0,ALL
3544,IGLL2P,,1.0,0.038,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
3546,IGLV@,,0.78,0.423,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,2005.0,2009.0,ALL
3547,IGSF1,Q8N6C5,0.608,0.5,0.99993,DTO_05007575,Receptor,C3550963,"HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT",C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.9,1.0,strong,2012.0,2015.0,ALL
3548,IHG1,,0.89,0.192,,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,2008.0,2017.0,ALL
3549,IHH,Q14623,0.573,0.538,0.31397,,,C1862151,"BRACHYDACTYLY, TYPE A1 (disorder)",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.96,0.9,,2001.0,2019.0,ALL
3550,IK,Q13123,0.729,0.5,2.4864e-06,DTO_05007599,Signaling,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2014.0,2014.0,ALL
3551,IKBKB,O14920,0.506,0.846,0.99192,DTO_03300101,Kinase,C4747743,IMMUNODEFICIENCY 15B,,,disease,Disease or Syndrome,0.6,1.0,strong,2013.0,2014.0,ALL
3552,IL1A,P01583,0.333,0.962,0.0001602,,,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.4,0.955,,1986.0,2019.0,ALL
3553,IL1B,P01584,0.276,0.962,0.13005,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.6,0.966,,1989.0,2020.0,ALL
3554,IL1R1,P14778,0.509,0.769,0.15126,DTO_05007575,Receptor,C1527304,Allergic Reaction,C20,   Immune System Diseases,phenotype,Pathologic Function,0.4,1.0,,2011.0,2013.0,ALL
3556,IL1RAP,Q9NPH3,0.647,0.654,0.25846,DTO_05007575,Receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2004.0,2017.0,ALL
3557,IL1RN,P18510,0.373,0.923,0.030914,,,C2748507,INTERLEUKIN 1 RECEPTOR ANTAGONIST DEFICIENCY,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.74,1.0,strong,2009.0,2017.0,ALL
3558,IL2,P60568,0.336,0.885,0.47968,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,0.992,,1983.0,2020.0,ALL
3559,IL2RA,P01589,0.389,0.885,0.054709,DTO_05007575,Receptor,C1853392,"Interleukin 2 Receptor, Alpha, Deficiency of",C20,   Immune System Diseases,disease,Disease or Syndrome,0.71,0.8,,1997.0,2014.0,ALL
3560,IL2RB,P14784,0.491,0.846,0.29095,DTO_05007575,Receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.47,0.909,,1992.0,2019.0,ALL
3561,IL2RG,P31785,0.535,0.769,0.99152,DTO_05007599,Signaling,C1279481,X-Linked Combined Immunodeficiency Diseases,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",group,Disease or Syndrome,0.8,0.965,strong,1989.0,2019.0,ALL
3562,IL3,P08700,0.489,0.731,2.5874e-09,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.38,1.0,,2007.0,2018.0,ALL
3563,IL3RA,P26951,0.56,0.769,2.9891e-27,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2007.0,2009.0,ALL
3565,IL4,P05112,0.332,0.962,0.0047372,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.6,0.964,,1992.0,2020.0,ALL
3566,IL4R,P24394,0.474,0.846,0.00023013,DTO_05007575,Receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,0.954,,1999.0,2020.0,ALL
3567,IL5,P05113,0.437,0.846,0.0056529,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.973,,1991.0,2020.0,ALL
3568,IL5RA,Q01344,0.647,0.654,2.6791e-08,DTO_05007599,Signaling,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
3569,IL6,P05231,0.248,0.962,0.31536,,,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.7,0.966,,1995.0,2020.0,ALL
3570,IL6R,P08887,0.471,0.846,3.1681e-05,DTO_05007599,Signaling,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.51,1.0,,2011.0,2018.0,ALL
3572,IL6ST,P40189,0.475,0.808,0.99978,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.59,0.909,,2000.0,2020.0,ALL
3574,IL7,P13232,0.464,0.808,0.92574,,,C0024312,Lymphopenia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.4,1.0,,2003.0,2019.0,ALL
3575,IL7R,P16871,0.487,0.769,3.763e-07,DTO_05007575,Receptor,C1837028,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive",C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.7,1.0,,1998.0,2016.0,ALL
3576,CXCL8,P10145,0.31,0.962,0.00027377,DTO_05007599,Signaling,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,2000.0,2017.0,ALL
3577,CXCR1,P25024,0.508,0.769,3.0337e-07,DTO_02300001,G-protein coupled receptor,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.32,1.0,,2011.0,2014.0,ALL
3578,IL9,P15248,0.461,0.846,8.1087e-07,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
3579,CXCR2,P25025,0.445,0.923,0.013736,DTO_02300001,G-protein coupled receptor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.34,1.0,,2011.0,2019.0,ALL
3581,IL9R,Q01113,0.659,0.654,2.6805e-22,DTO_05007575,Receptor,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0,,1999.0,1999.0,ALL
3586,IL10,P22301,0.281,0.923,0.0058874,,,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,0.857,,2007.0,2019.0,ALL
3587,IL10RA,Q13651,0.579,0.692,0.017808,DTO_05007575,Receptor,C2751053,"INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.6,1.0,strong,2009.0,2017.0,ALL
3588,IL10RB,Q08334,0.636,0.577,2.5103e-06,DTO_05007575,Receptor,C2675508,"INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.6,1.0,strong,2009.0,2017.0,ALL
3589,IL11,P20809,0.481,0.808,0.00031772,,,C0029410,Osteoarthritis of hip,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.41,1.0,,2018.0,2019.0,ALL
3590,IL11RA,Q14626,0.663,0.654,6.2882e-21,DTO_05007599,Signaling,C3280073,CRANIOSYNOSTOSIS AND DENTAL ANOMALIES,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2013.0,ALL
3592,IL12A,P29459,0.491,0.808,0.04746,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.64,0.857,,2009.0,2018.0,ALL
3593,IL12B,P29460,0.48,0.885,0.00011439,DTO_05007599,Signaling,C4013948,IMMUNODEFICIENCY 29,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2014.0,ALL
3594,IL12RB1,P42701,0.555,0.731,9.3569e-15,DTO_05007599,Signaling,C4013949,IMMUNODEFICIENCY 30,,,disease,Disease or Syndrome,0.75,1.0,strong,1998.0,2019.0,ALL
3595,IL12RB2,Q99665,0.608,0.692,1.6212e-09,DTO_05007599,Signaling,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.14,0.889,,2009.0,2018.0,ALL
3596,IL13,P35225,0.386,0.846,0.014426,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.982,,1995.0,2020.0,ALL
3597,IL13RA1,P78552,0.659,0.577,0.96333,DTO_05007599,Signaling,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2019.0,2019.0,ALL
3598,IL13RA2,Q14627,0.556,0.654,4.021e-07,DTO_05007599,Signaling,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.21,1.0,,2008.0,2008.0,ALL
3600,IL15,P40933,0.422,0.846,0.70859,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.4,0.966,,2000.0,2020.0,ALL
3601,IL15RA,Q13261,0.603,0.769,2.332e-06,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
3603,IL16,Q14005,0.501,0.846,1.2449e-10,DTO_05007599,Signaling,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,0.75,,2008.0,2018.0,ALL
3604,TNFRSF9,Q07011,0.502,0.769,0.32153,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2014.0,2019.0,ALL
3605,IL17A,Q16552,0.324,0.923,0.043049,,,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.6,0.979,,2007.0,2020.0,ALL
3606,IL18,Q14116,0.365,0.923,0.030717,,,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.6,1.0,,2006.0,2018.0,ALL
3607,FOXK2,Q01167,0.722,0.385,0.025464,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.14,1.0,,2015.0,2018.0,ALL
3608,ILF2,Q12905,0.67,0.654,0.9965,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.31,1.0,,2004.0,2016.0,ALL
3609,ILF3,Q12906,0.621,0.654,1.0,DTO_05007557,Nucleic acid binding,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.14,1.0,,2011.0,2011.0,ALL
3611,ILK,Q13418,0.503,0.769,3.7887e-05,DTO_03300101,Kinase,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
3612,IMPA1,P29218,0.623,0.731,0.00047793,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,1997.0,2016.0,ALL
3613,IMPA2,O14732,0.695,0.385,0.0010588,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.39,0.8,,2000.0,2018.0,ALL
3614,IMPDH1,P20839,0.623,0.462,5.7762e-06,DTO_05007624,Enzyme,C1867299,Retinitis Pigmentosa 10,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.72,1.0,,2002.0,2008.0,ALL
3615,IMPDH2,P12268,0.659,0.5,4.3635e-06,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
3617,IMPG1,Q17R60,0.722,0.154,1.3662e-29,DTO_05007621,Extracellular structure,C4015342,"MACULAR DYSTROPHY, VITELLIFORM, 4",,,disease,Disease or Syndrome,0.6,1.0,strong,2013.0,2013.0,ALL
3619,INCENP,Q9NQS7,0.7,0.346,0.88595,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
3620,IDO1,P14902,0.454,0.846,3.3013e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2006.0,2019.0,ALL
3621,ING1,Q9UK53,0.573,0.692,0.0096662,DTO_05007557,Nucleic acid binding,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.71,1.0,,2000.0,2000.0,ALL
3622,ING2,Q9H160,0.599,0.654,0.72928,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.962,,1998.0,2019.0,ALL
3623,INHA,P05111,0.578,0.615,0.0064728,DTO_05007599,Signaling,C4552766,Miscarriage,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,1.0,,2004.0,2008.0,ALL
3624,INHBA,P08476,0.601,0.615,0.97979,DTO_05007599,Signaling,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.31,1.0,,2003.0,2007.0,ALL
3625,INHBB,P09529,0.711,0.423,0.97287,DTO_05007599,Signaling,C0342549,Familial Testotoxicosis,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
3626,INHBC,P55103,0.792,0.423,5.6341e-05,DTO_05007599,Signaling,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3627,CXCL10,P02778,0.378,0.885,0.36865,DTO_05007599,Signaling,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.51,1.0,,2005.0,2018.0,ALL
3628,INPP1,P49441,0.821,0.192,7.898e-07,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,1998.0,2006.0,ALL
3630,INS,P01308,0.445,0.923,0.30091,,,C1833104,"DIABETES MELLITUS, PERMANENT NEONATAL",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,1.0,0.955,strong,1998.0,2019.0,ALL
3631,INPP4A,Q96PE3,0.736,0.538,0.99952,,,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
3632,INPP5A,Q14642,0.743,0.385,0.98121,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2010.0,2015.0,ALL
3633,INPP5B,P32019,0.729,0.385,5.0487e-16,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
3635,INPP5D,Q92835,0.558,0.731,0.97198,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.45,1.0,,2013.0,2020.0,ALL
3636,INPPL1,O15357,0.59,0.769,0.0023313,,,C0432219,Opsismodysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.76,1.0,,2013.0,2017.0,ALL
3638,INSIG1,O15503,0.695,0.5,0.0012827,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2002.0,2002.0,ALL
3640,INSL3,P51460,0.604,0.538,0.015764,,,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.9,0.857,,1999.0,2019.0,ALL
3641,INSL4,Q14641,0.76,0.269,0.00011355,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
3642,INSM1,Q01101,0.584,0.654,0.26893,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.4,1.0,,2006.0,2019.0,ALL
3643,INSR,P06213,0.432,0.846,3.6145e-05,DTO_03300101,Kinase,C0265344,Donohue Syndrome,C16;C18;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.8,0.97,,1985.0,2018.0,ALL
3645,INSRR,P14616,0.508,0.808,5.3976e-24,DTO_03300101,Kinase,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
3646,EIF3E,P60228,0.633,0.423,0.05196,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
3651,PDX1,P52945,0.53,0.654,0.017775,,,C0342276,Maturity onset diabetes mellitus in young,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.9,0.97,strong,1998.0,2019.0,ALL
3652,IPP,Q9Y573,0.76,0.308,2.0966e-05,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
3653,IPW,,0.682,0.423,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.35,1.0,,1997.0,2014.0,ALL
3654,IRAK1,P51617,0.506,0.808,0.98774,DTO_03300101,Kinase,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,1.0,,2007.0,2019.0,ALL
3655,ITGA6,P23229,0.539,0.769,1.9014e-07,,,C1856934,Epidermolysis bullosa with pyloric atresia,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.68,1.0,,1997.0,2017.0,ALL
3656,IRAK2,O43187,0.722,0.385,2.6055e-19,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
3658,IREB2,P48200,0.619,0.577,0.99991,DTO_05007624,Enzyme,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0,,2011.0,2011.0,ALL
3659,IRF1,P10914,0.468,0.769,0.9909,DTO_05007542,Transcription factor,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.66,1.0,,1998.0,2019.0,ALL
3660,IRF2,P14316,0.575,0.769,0.79793,DTO_05007542,Transcription factor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,0.75,,2012.0,2018.0,ALL
3661,IRF3,Q14653,0.517,0.808,0.00011576,DTO_05007542,Transcription factor,C4225294,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7",,,phenotype,Finding,0.6,1.0,moderate,2015.0,2015.0,ALL
3662,IRF4,Q15306,0.491,0.769,0.85677,DTO_05007542,Transcription factor,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.5,0.933,,2008.0,2019.0,ALL
3663,IRF5,Q13568,0.489,0.731,0.0090365,DTO_05007542,Transcription factor,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.949,,2005.0,2020.0,ALL
3664,IRF6,O14896,0.486,0.769,0.99961,DTO_05007542,Transcription factor,C0265259,Popliteal pterygium syndrome,C16;C13;C11;C05;C12;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,1.0,0.969,,2002.0,2018.0,ALL
3665,IRF7,Q92985,0.547,0.846,4.4508e-15,DTO_05007542,Transcription factor,C4225358,IMMUNODEFICIENCY 39,,,disease,Disease or Syndrome,0.7,1.0,moderate,1997.0,2015.0,ALL
3667,IRS1,P35568,0.488,0.769,0.023645,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.9,0.939,,1993.0,2019.0,ALL
3669,ISG20,Q96AZ6,0.414,0.846,0.002899,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3670,ISL1,P61371,0.579,0.654,0.86857,DTO_05007542,Transcription factor,C0005689,Bladder Exstrophy,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.43,1.0,,2015.0,2018.0,ALL
3671,ISLR,O14498,0.931,0.192,0.018643,DTO_05007575,Receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
3672,ITGA1,P56199,0.644,0.654,2.6124e-16,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.42,1.0,,2012.0,2019.0,ALL
3673,ITGA2,P17301,0.522,0.731,6.2805e-11,,,C3280114,Glycoprotein IA Deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.5,1.0,limited,1999.0,1999.0,ALL
3674,ITGA2B,P08514,0.493,0.692,1.5205e-16,,,C1861195,"Glanzmann Thrombasthenia, Autosomal Dominant",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1998.0,2013.0,ALL
3675,ITGA3,P26006,0.573,0.731,3.5545e-07,,,C3553636,"INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL",,,disease,Disease or Syndrome,0.72,1.0,,2012.0,2018.0,ALL
3676,ITGA4,P13612,0.558,0.769,0.00010067,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,0.952,,2002.0,2019.0,ALL
3678,ITGA5,P08648,0.524,0.769,0.42455,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.35,1.0,,2002.0,2019.0,ALL
3679,ITGA7,Q13683,0.588,0.654,4.2657e-17,,,C2750786,"Muscular Dystrophy, Congenital, Due To Integrin Alpha-7 Deficiency",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,1997.0,2015.0,ALL
3680,ITGA9,Q13797,0.621,0.692,0.0081584,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
3681,ITGAD,Q13349,0.839,0.192,2.0034e-21,,,C0017979,Glycosuria,C18;C13;C12,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
3682,ITGAE,P38570,0.579,0.692,3.9199e-20,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.917,,2014.0,2020.0,ALL
3683,ITGAL,P20701,0.511,0.885,0.0043213,,,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.33,1.0,,1996.0,2017.0,ALL
3684,ITGAM,P11215,0.443,0.808,3.3148e-11,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,1.0,,2008.0,2019.0,ALL
3685,ITGAV,P06756,0.526,0.769,0.00022844,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,1998.0,1998.0,ALL
3687,ITGAX,P20702,0.504,0.769,1.3665e-15,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
3688,ITGB1,P05556,0.496,0.808,0.98208,DTO_05007575,Receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2003.0,2019.0,ALL
3689,ITGB2,P05107,0.444,0.923,5.0817e-15,DTO_05007575,Receptor,C0398738,Leukocyte adhesion deficiency type 1,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1990.0,2019.0,ALL
3690,ITGB3,P05106,0.485,0.846,0.0017189,DTO_05007575,Receptor,C0040015,Thrombasthenia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1982.0,2020.0,ALL
3691,ITGB4,P16144,0.525,0.731,9.5287e-19,DTO_05007575,Receptor,C1856934,Epidermolysis bullosa with pyloric atresia,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,1.0,,1995.0,2017.0,ALL
3692,EIF6,P56537,0.584,0.538,0.2378,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
3693,ITGB5,P18084,0.656,0.577,9.8905e-08,DTO_05007575,Receptor,C0040128,Thyroid Diseases,C19,   Endocrine System Diseases,group,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
3694,ITGB6,P18564,0.597,0.692,1.6277e-22,DTO_05007575,Receptor,C4015557,"AMELOGENESIS IMPERFECTA, TYPE IH",,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2016.0,ALL
3695,ITGB7,P26010,0.729,0.462,2.3661e-06,DTO_05007575,Receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
3696,ITGB8,P26012,0.65,0.462,0.99767,DTO_05007575,Receptor,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
3697,ITIH1,P19827,0.691,0.462,2.0755e-31,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,1.0,,2009.0,2019.0,ALL
3698,ITIH2,P19823,0.839,0.308,3.8025e-23,DTO_05007584,Enzyme modulator,C0271093,Stargardt's disease,,,phenotype,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
3699,ITIH3,Q06033,0.769,0.231,1.4628e-13,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.44,1.0,,2011.0,2019.0,ALL
3700,ITIH4,Q14624,0.559,0.769,6.4352e-13,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2014.0,ALL
3702,ITK,Q08881,0.555,0.769,3.1402e-08,DTO_03300101,Kinase,C3552634,LYMPHOPROLIFERATIVE SYNDROME 1,,,disease,Disease or Syndrome,0.7,1.0,definitive,1997.0,2015.0,ALL
3703,STT3A,P46977,0.67,0.577,0.002045,DTO_05007624,Enzyme,C3810062,Congenital disorder of glycosylation type 1w,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,,2013.0,2019.0,ALL
3704,ITPA,Q9BY32,0.604,0.5,1.0144e-07,DTO_05007624,Enzyme,C4225256,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35",,,disease,Disease or Syndrome,0.71,1.0,strong,2009.0,2019.0,ALL
3705,ITPK1,Q13572,0.76,0.346,0.99389,DTO_03300101,Kinase,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0,,2015.0,2015.0,ALL
3706,ITPKA,P23677,0.769,0.154,0.64926,DTO_03300101,Kinase,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
3707,ITPKB,P27987,0.805,0.192,0.99994,DTO_03300101,Kinase,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2017.0,2020.0,ALL
3708,ITPR1,Q14643,0.534,0.846,1.0,DTO_01300327,Ion channel,C0431401,Gillespie syndrome,C23;C16;C11;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.78,1.0,,2012.0,2020.0,ALL
3709,ITPR2,Q14571,0.631,0.654,5.7127e-29,DTO_01300327,Ion channel,C1862871,"ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.9,1.0,,2014.0,2014.0,ALL
3710,ITPR3,Q14573,0.555,0.808,2.5541e-22,DTO_01300327,Ion channel,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.33,0.667,,2006.0,2010.0,ALL
3712,IVD,P26440,0.705,0.462,1.5329e-14,DTO_05007624,Enzyme,C0268575,Isovaleryl-CoA dehydrogenase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,definitive,1983.0,2020.0,ALL
3713,IVL,P07476,0.626,0.5,,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,1991.0,2009.0,ALL
3714,JAG2,Q9Y219,0.576,0.846,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2010.0,2011.0,ALL
3716,JAK1,P23458,0.474,0.769,0.99998,DTO_03300101,Kinase,C0032463,Polycythemia Vera,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.49,1.0,,2005.0,2020.0,ALL
3717,JAK2,O60674,0.385,0.885,0.65372,DTO_03300101,Kinase,C0001815,Primary Myelofibrosis,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,1.0,0.968,,2005.0,2020.0,ALL
3718,JAK3,P52333,0.505,0.731,5.9311e-06,DTO_03300101,Kinase,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1995.0,2019.0,ALL
3719,JBS,,0.792,0.385,,,,C0004903,Beckwith-Wiedemann Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
3720,JARID2,Q92833,0.615,0.577,0.99999,DTO_05007542,Transcription factor,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2018.0,ALL
3725,JUN,P05412,0.442,0.885,0.05962,DTO_05007542,Transcription factor,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.51,1.0,,2001.0,2013.0,ALL
3726,JUNB,P17275,0.467,0.769,0.86299,DTO_05007542,Transcription factor,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.32,1.0,,1998.0,2017.0,ALL
3727,JUND,P17535,0.475,0.808,0.70054,DTO_05007542,Transcription factor,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.32,1.0,,1998.0,2017.0,ALL
3728,JUP,P14923,0.628,0.5,0.00080103,,,C1969081,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 12",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2007.0,2017.0,ALL
3730,ANOS1,P23352,0.537,0.769,0.99793,,,C1563719,Kallmann Syndrome 1,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.72,1.0,,1993.0,2019.0,ALL
3732,CD82,P27701,0.507,0.731,1.2726e-08,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.6,0.973,,1995.0,2019.0,ALL
3734,ANOS2P,,1.0,0.154,,,,C0162809,Kallmann Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0,,1992.0,1992.0,ALL
3735,KARS1,Q15046,0.636,0.577,4.211e-09,DTO_05007624,Enzyme,C3150897,"CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B",,,disease,Disease or Syndrome,0.7,1.0,,1996.0,2017.0,ALL
3736,KCNA1,Q09470,0.573,0.577,0.076028,DTO_01300327,Ion channel,C1719788,Episodic ataxia type 1,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.974,,1994.0,2018.0,ALL
3737,KCNA2,P16389,0.612,0.577,0.91067,DTO_01300327,Ion channel,C4225350,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2015.0,2017.0,ALL
3738,KCNA3,P22001,0.76,0.385,0.89392,DTO_01300327,Ion channel,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.02,1.0,,2007.0,2011.0,ALL
3739,KCNA4,P22459,0.716,0.423,0.98327,DTO_01300327,Ion channel,C4748984,"MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM",,,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
3741,KCNA5,P22460,0.606,0.5,0.0010938,DTO_01300327,Ion channel,C0020542,Pulmonary Hypertension,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.5,1.0,,2010.0,2017.0,ALL
3742,KCNA6,P17658,0.792,0.154,0.49728,DTO_01300327,Ion channel,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2001.0,2001.0,ALL
3743,KCNA7,Q96RP8,1.0,0.077,0.14232,DTO_01300327,Ion channel,C1879286,Hereditary bundle branch system defect,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
3744,KCNA10,Q16322,0.931,0.077,0.00083822,DTO_01300327,Ion channel,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
3745,KCNB1,Q14721,0.65,0.462,0.99977,DTO_01300327,Ion channel,C4015119,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2017.0,ALL
3746,KCNC1,P48547,0.711,0.154,0.98957,DTO_01300327,Ion channel,C4015420,"EPILEPSY, PROGRESSIVE MYOCLONIC 7",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2015.0,2017.0,ALL
3747,KCNC2,Q96PR1,0.861,0.154,0.18911,DTO_01300327,Ion channel,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
3748,KCNC3,Q14003,0.705,0.462,0.20575,DTO_01300327,Ion channel,C1854488,Spinocerebellar ataxia 13,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.77,1.0,,2006.0,2018.0,ALL
3749,KCNC4,Q03721,0.722,0.423,0.0044543,DTO_01300327,Ion channel,C0014556,"Epilepsy, Temporal Lobe",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
3750,KCND1,Q9NSA2,,,0.25536,DTO_01300327,Ion channel,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
3751,KCND2,Q9NZV8,0.751,0.308,0.012477,DTO_01300327,Ion channel,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,limited,2014.0,2018.0,ALL
3752,KCND3,Q9UK17,0.619,0.615,0.98972,DTO_01300327,Ion channel,C1846367,Spinocerebellar ataxia 19,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.74,0.857,,2005.0,2018.0,ALL
3753,KCNE1,P15382,0.588,0.615,0.003396,DTO_01300327,Ion channel,C1867904,LONG QT SYNDROME 5,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.71,1.0,,1997.0,2015.0,ALL
3755,KCNG1,Q9UIX4,0.89,0.077,0.026243,DTO_01300327,Ion channel,C0236773,Depressed bipolar I disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
3756,KCNH1,O95259,0.542,0.731,0.54625,DTO_01300327,Ion channel,C2678486,Temple-Baraitser Syndrome,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome; Congenital Abnormality,0.75,1.0,,2015.0,2016.0,ALL
3757,KCNH2,Q12809,0.522,0.731,0.99593,DTO_01300327,Ion channel,C1865020,Short QT Syndrome 1,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.92,1.0,,1995.0,2018.0,ALL
3758,KCNJ1,P48048,0.619,0.577,4.6255e-05,DTO_01300327,Ion channel,C1855849,"Bartter syndrome, antenatal , type 2",C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.91,1.0,strong,1996.0,2012.0,ALL
3759,KCNJ2,P63252,0.572,0.731,0.30653,DTO_01300327,Ion channel,C1563715,Andersen Syndrome,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,0.987,,2001.0,2019.0,ALL
3760,KCNJ3,P48549,0.653,0.5,0.99108,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
3761,KCNJ4,P48050,0.805,0.385,0.9649,DTO_01300327,Ion channel,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
3762,KCNJ5,P48544,0.56,0.577,0.00033577,DTO_01300327,Ion channel,C3150733,LONG QT SYNDROME 13,,,disease,Disease or Syndrome,0.7,1.0,limited,2005.0,2010.0,ALL
3763,KCNJ6,P48051,0.615,0.692,0.54063,DTO_01300327,Ion channel,C3279800,KEPPEN-LUBINSKY SYNDROME,,,disease,Disease or Syndrome,0.72,1.0,,2015.0,2018.0,ALL
3764,KCNJ8,Q15842,0.619,0.538,0.37965,DTO_01300327,Ion channel,C0795905,Cantu syndrome,C23;C16;C17;C05;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.67,0.875,moderate,2013.0,2020.0,ALL
3765,KCNJ9,Q92806,0.821,0.231,0.30133,DTO_01300327,Ion channel,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0,,2000.0,2002.0,ALL
3766,KCNJ10,P78508,0.599,0.654,0.1502,DTO_01300327,Ion channel,C2748572,SeSAME syndrome,C23;C10;F03;C09;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,1.0,1.0,strong,1997.0,2019.0,ALL
3767,KCNJ11,Q14654,0.529,0.615,0.010894,DTO_01300327,Ion channel,C1833104,"DIABETES MELLITUS, PERMANENT NEONATAL",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,1.0,0.984,strong,2001.0,2018.0,ALL
3768,KCNJ12,Q14500,0.839,0.192,0.054242,DTO_01300327,Ion channel,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
3769,KCNJ13,O60928,0.659,0.308,0.013685,DTO_01300327,Ion channel,C1860405,Snowflake vitreoretinal degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.78,1.0,,2008.0,2019.0,ALL
3772,KCNJ15,Q99712,0.769,0.308,0.11313,DTO_01300327,Ion channel,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
3773,KCNJ16,Q9NPI9,0.861,0.385,8.8743e-12,DTO_01300327,Ion channel,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
3775,KCNK1,O00180,0.76,0.462,0.031161,DTO_01300327,Ion channel,C0020507,Hyperplasia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0,,2013.0,2013.0,ALL
3776,KCNK2,O95069,0.626,0.654,0.019089,DTO_01300327,Ion channel,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,1.0,,2007.0,2019.0,ALL
3777,KCNK3,O14649,0.584,0.654,0.90018,DTO_01300327,Ion channel,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.7,0.952,strong,2012.0,2020.0,ALL
3778,KCNMA1,Q12791,0.518,0.846,0.99731,DTO_01300327,Ion channel,C1836173,Generalized Epilepsy and Paroxysmal Dyskinesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.73,1.0,,2005.0,2019.0,ALL
3779,KCNMB1,Q16558,0.716,0.423,2.0696e-06,DTO_01300327,Ion channel,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.55,1.0,,2003.0,2010.0,ALL
3780,KCNN1,Q92952,0.89,0.077,0.85412,DTO_01300327,Ion channel,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
3781,KCNN2,Q9H2S1,0.769,0.385,0.99099,DTO_01300327,Ion channel,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2017.0,2018.0,ALL
3782,KCNN3,Q9UGI6,0.621,0.615,0.97227,DTO_01300327,Ion channel,C0796013,Zimmerman Laband syndrome,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.51,1.0,moderate,2019.0,2019.0,ALL
3783,KCNN4,O15554,0.653,0.577,5.0256e-07,DTO_01300327,Ion channel,C0272051,Xerocytosis,C23;C16;C13;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.65,0.833,strong,2015.0,2019.0,ALL
3784,KCNQ1,P51787,0.485,0.769,4.5453e-08,DTO_01300327,Ion channel,C0022387,Jervell-Lange Nielsen Syndrome,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1997.0,2019.0,ALL
3785,KCNQ2,O43526,0.537,0.654,0.99998,DTO_01300327,Ion channel,C3149074,"SEIZURES, BENIGN FAMILIAL NEONATAL, 1",,,disease,Disease or Syndrome,0.7,1.0,,1998.0,2016.0,ALL
3786,KCNQ3,O43525,0.604,0.462,0.80089,DTO_01300327,Ion channel,C1852581,"EPILEPSY, BENIGN NEONATAL, 2",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.941,,1998.0,2018.0,ALL
3787,KCNS1,Q96KK3,0.89,0.115,0.11183,DTO_01300327,Ion channel,C0086132,Depressive Symptoms,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.31,1.0,,2014.0,2014.0,ALL
3788,KCNS2,Q9ULS6,1.0,0.038,0.059023,DTO_01300327,Ion channel,C0270736,Essential Tremor,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
3790,KCNS3,Q9BQ31,0.89,0.115,0.0011942,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2012.0,2014.0,ALL
3791,KDR,P35968,0.378,0.885,0.99982,DTO_03300101,Kinase,C1865871,"HEMANGIOMA, CAPILLARY INFANTILE",C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",disease,Disease or Syndrome,0.7,1.0,limited,2002.0,2008.0,ALL
3792,KEL,P23276,0.839,0.346,3.1154e-21,DTO_05007624,Enzyme,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
3795,KHK,P50053,0.7,0.346,2.0668e-09,DTO_03300101,Kinase,C0268160,Deficiency of fructokinase,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.74,1.0,,1994.0,2018.0,ALL
3796,KIF2A,O00139,0.59,0.731,0.99998,DTO_05007530,Cellular structure,C3809414,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2016.0,ALL
3797,KIF3C,O14782,0.76,0.231,0.99153,DTO_05007530,Cellular structure,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
3798,KIF5A,Q12840,0.593,0.731,0.99995,DTO_05007530,Cellular structure,C1858712,"Spastic paraplegia 10, autosomal dominant",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.76,1.0,strong,2002.0,2018.0,ALL
3799,KIF5B,P33176,0.604,0.538,0.99427,DTO_05007530,Cellular structure,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.36,1.0,,2011.0,2019.0,ALL
3800,KIF5C,O60282,0.686,0.346,1.0,DTO_05007530,Cellular structure,C3809013,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2017.0,ALL
3801,KIFC3,Q9BVG8,0.861,0.231,0.0056474,DTO_05007530,Cellular structure,C0268318,Cholestasis of pregnancy,C06;C13,   Digestive System Diseases;    Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
3802,KIR2DL1,P43626,0.631,0.615,3.5684e-15,DTO_05007575,Receptor,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
3803,KIR2DL2,P43627,0.612,0.654,,DTO_05007575,Receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
3804,KIR2DL3,P43628,0.612,0.654,2.6789e-09,DTO_05007575,Receptor,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,0.9,,2004.0,2018.0,ALL
3805,KIR2DL4,Q99706,0.7,0.5,0.042308,DTO_05007575,Receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
3806,KIR2DS1,Q14954,0.537,0.769,,DTO_05007575,Receptor,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
3808,KIR2DS3,Q14952,0.716,0.423,,DTO_05007575,Receptor,C0018133,Graft-vs-Host Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.02,0.5,,2007.0,2009.0,ALL
3809,KIR2DS4,P43632,0.674,0.5,,DTO_05007575,Receptor,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
3810,KIR2DS5,Q14953,0.678,0.5,,DTO_05007575,Receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2010.0,2015.0,ALL
3811,KIR3DL1,P43629,0.475,0.769,8.3578e-14,DTO_05007575,Receptor,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.4,0.923,,2007.0,2019.0,ALL
3812,KIR3DL2,P43630,0.543,0.769,6.0804e-12,DTO_05007575,Receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
3813,KIR3DS1,Q14943,0.617,0.692,,DTO_05007575,Receptor,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,0.9,,2006.0,2015.0,ALL
3814,KISS1,Q15726,0.507,0.808,0.49039,,,C3541462,HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.9,1.0,limited,2007.0,2012.0,ALL
3815,KIT,P10721,0.366,0.808,0.98087,DTO_03300101,Kinase,C0024899,Mastocytosis,C04;C17;C20,   Neoplasms;    Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,1.0,0.989,strong,1992.0,2020.0,ALL
3816,KLK1,P06870,0.533,0.769,0.00015311,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.6,1.0,,1995.0,2018.0,ALL
3817,KLK2,P20151,0.653,0.423,0.00012775,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.97,,1998.0,2019.0,ALL
3818,KLKB1,P03952,0.604,0.692,6.2893e-13,DTO_05007624,Enzyme,C0272339,Prekallikrein deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.74,0.9,strong,1974.0,2019.0,ALL
3820,KLRB1,Q12918,0.601,0.615,2.4129e-07,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
3821,KLRC1,P26715,0.604,0.731,4.139e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2019.0,ALL
3822,KLRC2,P26717,0.636,0.731,4.8735e-10,,,C0022336,Creutzfeldt-Jakob disease,C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
3823,KLRC3,Q07444,0.792,0.269,2.1937e-10,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2016.0,ALL
3824,KLRD1,Q13241,0.636,0.692,0.0008747,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
3827,KNG1,P01042,0.481,0.885,3.2071e-10,DTO_05007584,Enzyme modulator,C0272340,High molecular weight kininogen deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.77,0.889,strong,1976.0,2019.0,ALL
3831,KLC1,Q07866,0.695,0.385,0.37095,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2014.0,2019.0,ALL
3832,KIF11,P52732,0.56,0.769,1.0,DTO_05007530,Cellular structure,C1835265,"Lymphedema, microcephaly and chorioretinopathy syndrome",C23;C16;C11;C05;C10;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.74,1.0,,2012.0,2016.0,ALL
3833,KIFC1,Q9BW19,0.656,0.538,0.00065654,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2017.0,2019.0,ALL
3834,KIF25,Q9UIL4,1.0,0.038,9.6357e-07,DTO_05007530,Cellular structure,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
3835,KIF22,Q14807,0.552,0.654,9.1697e-10,DTO_05007530,Cellular structure,C1863732,Spondyloepimetaphyseal dysplasia with multiple dislocations,C16;C05;C26,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Wounds and Injuries",disease,Disease or Syndrome,0.73,1.0,,2011.0,2015.0,ALL
3836,KPNA1,P52294,0.736,0.577,0.99818,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
3837,KPNB1,Q14974,0.691,0.385,1.0,DTO_05007405,Transporter,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
3838,KPNA2,P52292,0.588,0.654,0.54133,DTO_05007405,Transporter,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2015.0,2016.0,ALL
3839,KPNA3,O00505,0.736,0.5,0.95357,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2005.0,2012.0,ALL
3840,KPNA4,O00629,0.716,0.5,0.99989,DTO_05007405,Transporter,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
3841,KPNA5,O15131,0.931,0.115,0.00013525,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
3842,TNPO1,Q92973,0.691,0.538,1.0,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
3843,IPO5,O00410,0.805,0.231,1.0,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2004.0,2011.0,ALL
3845,KRAS,P01116,0.32,0.923,0.00078803,DTO_05007584,Enzyme modulator,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.985,definitive,1993.0,2019.0,ALL
3846,KRTAP5-9,P26371,0.931,0.115,0.014981,,,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0,,2011.0,2013.0,ALL
3848,KRT1,P04264,0.575,0.654,0.73629,,,C0079153,"Hyperkeratosis, Epidermolytic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,1.0,0.951,,1992.0,2019.0,ALL
3849,KRT2,P35908,0.76,0.154,0.0012882,,,C0432306,Ichthyosis Bullosa of Siemens,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.8,1.0,limited,1994.0,2005.0,ALL
3850,KRT3,P12035,0.751,0.385,8.9951e-10,,,C0339277,"Corneal Dystrophy, Juvenile Epithelial of Meesmann",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.67,1.0,strong,1997.0,2016.0,ALL
3851,KRT4,P19013,0.736,0.423,5.4962e-10,,,C1721005,"Leukokeratosis, Hereditary Mucosal",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.78,1.0,,1998.0,2019.0,ALL
3852,KRT5,P13647,0.512,0.731,0.64172,,,C0079295,Epidermolysis Bullosa Herpetiformis Dowling-Meara,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.95,1.0,strong,1992.0,2019.0,ALL
3853,KRT6A,P02538,0.61,0.692,7.0326e-05,,,C1706595,"Pachyonychia Congenita, Jadassohn Lewandowsky Type",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.53,1.0,strong,1999.0,2013.0,ALL
3854,KRT6B,P04259,0.663,0.577,5.5245e-10,,,C3714949,PACHYONYCHIA CONGENITA 4,,,disease,Disease or Syndrome,0.6,1.0,strong,1998.0,2011.0,ALL
3855,KRT7,P08729,0.463,0.808,3.0861e-12,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.923,,2004.0,2019.0,ALL
3856,KRT8,P05787,0.517,0.654,2.36e-08,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.5,0.917,,1995.0,2019.0,ALL
3857,KRT9,P35527,0.678,0.346,1.1272e-06,,,C1721006,"Keratoderma, Palmoplantar, Epidermolytic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1992.0,2019.0,ALL
3858,KRT10,P13645,0.579,0.692,0.0025253,,,C0079153,"Hyperkeratosis, Epidermolytic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.8,0.98,,1992.0,2020.0,ALL
3859,KRT12,Q99456,0.751,0.192,2.5279e-14,,,C0339277,"Corneal Dystrophy, Juvenile Epithelial of Meesmann",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.7,1.0,strong,1996.0,2019.0,ALL
3860,KRT13,P13646,0.631,0.692,0.00064096,,,C1721005,"Leukokeratosis, Hereditary Mucosal",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.54,1.0,,1995.0,2018.0,ALL
3861,KRT14,P02533,0.53,0.731,0.00020311,,,C0079295,Epidermolysis Bullosa Herpetiformis Dowling-Meara,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.98,1.0,strong,1991.0,2019.0,ALL
3866,KRT15,P19012,0.659,0.538,2.3926e-16,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
3868,KRT16,P08779,0.565,0.769,1.5006e-14,,,C1706595,"Pachyonychia Congenita, Jadassohn Lewandowsky Type",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.95,1.0,strong,1995.0,2013.0,ALL
3872,KRT17,Q04695,0.531,0.654,1.098e-11,,,C1721007,"Pachyonychia Congenita, Type 2 (disorder)",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.78,1.0,,1994.0,2013.0,ALL
3875,KRT18,P05783,0.53,0.692,0.73477,,,C1861556,"Cirrhosis, Familial",C23;C16;C06,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.5,1.0,,1997.0,2003.0,ALL
3880,KRT19,P08727,0.46,0.731,0.0043426,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,0.75,,2010.0,2019.0,ALL
3881,KRT31,Q15323,0.729,0.462,0.0075531,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
3882,KRT32,Q14532,0.805,0.192,1.3564e-18,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
3885,KRT34,O76011,0.931,0.077,5.9309e-08,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
3886,KRT35,Q92764,1.0,0.077,2.4391e-06,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
3887,KRT81,Q14533,0.659,0.462,1.2108e-18,,,C0546966,Monilethrix,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.72,1.0,,1997.0,2015.0,ALL
3889,KRT83,P78385,0.716,0.269,3.3665e-14,,,C0546966,Monilethrix,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.72,1.0,,2005.0,2015.0,ALL
3891,KRT85,P78386,0.751,0.115,3.1183e-06,,,C1865951,"Ectodermal Dysplasia, Pure Hair-Nail Type",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2010.0,ALL
3892,KRT86,O43790,0.736,0.308,3.6139e-07,,,C0546966,Monilethrix,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.65,1.0,,1997.0,2015.0,ALL
3895,KTN1,Q86UP2,0.736,0.5,0.0064543,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
3897,L1CAM,P32004,0.475,0.769,1.0,,,C0265216,X-linked hydrocephalus syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.984,,1986.0,2020.0,ALL
3898,LAD1,O00515,0.584,0.731,1.7834e-14,DTO_05007530,Cellular structure,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
3899,AFF3,P51826,0.623,0.692,0.99996,DTO_05007542,Transcription factor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.46,1.0,,2009.0,2016.0,ALL
3902,LAG3,P18627,0.517,0.692,0.27623,DTO_05007575,Receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2006.0,2019.0,ALL
3903,LAIR1,Q6GTX8,0.569,0.692,3.2563e-07,DTO_05007575,Receptor,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
3904,LAIR2,Q6ISS4,0.78,0.269,2.5967e-07,DTO_05007575,Receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
3906,LALBA,P00709,0.729,0.423,0.4603,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,1981.0,2018.0,ALL
3908,LAMA2,P24043,0.553,0.692,2.4118e-47,DTO_05007584,Enzyme modulator,C1263858,"Muscular dystrophy congenital, merosin negative",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1955.0,2018.0,ALL
3909,LAMA3,Q16787,0.576,0.731,8.8349e-46,DTO_05007584,Enzyme modulator,C0079301,Junctional Epidermolysis Bullosa,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1992.0,2018.0,ALL
3910,LAMA4,Q16363,0.682,0.577,1.3909e-24,,,C3808935,"CARDIOMYOPATHY, DILATED, 1JJ",,,disease,Disease or Syndrome,0.6,1.0,,2007.0,2007.0,ALL
3911,LAMA5,O15230,0.636,0.577,0.0064742,DTO_05007584,Enzyme modulator,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.31,1.0,moderate,2019.0,2019.0,ALL
3912,LAMB1,P07942,0.615,0.654,5.0687e-22,DTO_05007584,Enzyme modulator,C3554657,LISSENCEPHALY 5,,,disease,Disease or Syndrome,0.7,1.0,moderate,2007.0,2015.0,ALL
3913,LAMB2,P55268,0.601,0.654,2.5006e-19,DTO_05007584,Enzyme modulator,C1836876,Pierson syndrome,C23;C16;C13;C11;C12;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1995.0,2018.0,ALL
3914,LAMB3,Q13751,0.558,0.692,2.3136e-15,DTO_05007584,Enzyme modulator,C0079683,Herlitz Disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.92,1.0,,1994.0,2018.0,ALL
3915,LAMC1,P11047,0.628,0.654,1.0,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.41,1.0,,2013.0,2019.0,ALL
3916,LAMP1,P11279,0.542,0.769,0.8747,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.13,1.0,,2006.0,2017.0,ALL
3918,LAMC2,Q13753,0.389,0.923,2.8791e-12,DTO_05007584,Enzyme modulator,C0079683,Herlitz Disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.81,1.0,,1992.0,2017.0,ALL
3920,LAMP2,P13473,0.552,0.731,0.26698,DTO_05007405,Transporter,C0878677,Glycogen Storage Disease Type IIb,C16;C18;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1995.0,2020.0,ALL
3921,RPSA,P08865,0.485,0.769,0.93037,DTO_05007557,Nucleic acid binding,C0685889,Splenic Hypoplasia,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Congenital Abnormality,0.74,1.0,,2013.0,2019.0,ALL
3923,RPSAP13,,,,,,,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
3925,STMN1,P16949,0.458,0.885,0.075244,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1998.0,2019.0,ALL
3927,LASP1,Q14847,0.572,0.615,0.9827,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2013.0,2019.0,ALL
3929,LBP,P18428,0.525,0.808,4.1897e-15,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,,2010.0,2019.0,ALL
3930,LBR,Q14739,0.473,0.808,0.18143,DTO_05007624,Enzyme,C0030779,Pelger-Huet Anomaly,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.944,strong,2002.0,2019.0,ALL
3931,LCAT,P04180,0.588,0.654,0.08102,DTO_05007624,Enzyme,C0023195,Lecithin Acyltransferase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.974,,1967.0,2019.0,ALL
3932,LCK,P06239,0.564,0.769,0.99926,DTO_03300101,Kinase,C4014233,IMMUNODEFICIENCY 22,,,disease,Disease or Syndrome,0.7,1.0,strong,2001.0,2012.0,ALL
3933,LCN1,P31025,0.633,0.731,1.3298e-08,DTO_05007624,Enzyme,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0,,2018.0,2019.0,ALL
3934,LCN2,P80188,0.405,0.885,1.1404e-09,DTO_05007624,Enzyme,C2609414,Acute kidney injury,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Injury or Poisoning,0.5,1.0,,2011.0,2017.0,ALL
3936,LCP1,P13796,0.663,0.654,0.55261,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3937,LCP2,Q13094,0.716,0.308,0.92466,DTO_05007599,Signaling,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3938,LCT,P09848,0.581,0.808,0.059849,DTO_05007624,Enzyme,C0268179,"Lactase Deficiency, Congenital",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Pathologic Function,0.7,1.0,,2006.0,2016.0,ALL
3939,LDHA,P00338,0.507,0.808,0.069173,DTO_05007624,Enzyme,C2931743,Lactate dehydrogenase deficiency type A,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,strong,1984.0,2016.0,ALL
3940,LDHAP1,,1.0,0.038,,,,C0036631,Seminoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
3945,LDHB,P07195,0.604,0.615,4.9734e-06,DTO_05007624,Enzyme,C3279904,Lactate Dehydrogenase B Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,1990.0,2001.0,ALL
3948,LDHC,P07864,0.711,0.5,5.2747e-07,DTO_05007624,Enzyme,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.3,1.0,,2011.0,2013.0,ALL
3949,LDLR,P01130,0.449,0.885,9.841e-24,,,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.9,0.977,strong,1982.0,2020.0,ALL
3950,LECT2,O14960,0.653,0.5,0.0014806,DTO_05007599,Signaling,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
3952,LEP,P41159,0.349,0.846,0.46491,,,C3554224,LEPTIN DEFICIENCY OR DYSFUNCTION,,,disease,Disease or Syndrome,0.8,0.957,strong,1996.0,2020.0,ALL
3953,LEPR,P48357,0.433,0.808,0.99475,DTO_05007599,Signaling,C3554225,LEPTIN RECEPTOR DEFICIENCY,,,disease,Disease or Syndrome,0.72,1.0,strong,1998.0,2019.0,ALL
3954,LETM1,O95202,0.545,0.692,1.2141e-06,DTO_05007405,Transporter,C1956097,Wolf-Hirschhorn Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.6,0.944,,1999.0,2019.0,ALL
3955,LFNG,Q8NES3,0.659,0.5,0.097612,DTO_05007624,Enzyme,C1853296,"SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 3",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.7,1.0,,2006.0,2016.0,ALL
3956,LGALS1,P09382,0.435,0.846,0.004488,DTO_05007599,Signaling,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.34,0.8,,2006.0,2019.0,ALL
3957,LGALS2,P05162,0.7,0.385,0.020219,DTO_05007599,Signaling,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,0.8,,2004.0,2012.0,ALL
3958,LGALS3,P17931,0.392,0.846,2.3207e-05,DTO_05007599,Signaling,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.5,1.0,,2003.0,2014.0,ALL
3959,LGALS3BP,Q08380,0.546,0.769,2.679e-07,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.4,1.0,,2016.0,2020.0,ALL
3960,LGALS4,P56470,0.599,0.731,2.7538e-07,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1997.0,2019.0,ALL
3963,LGALS7,P47929,0.599,0.769,0.14567,DTO_05007599,Signaling,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.33,1.0,,2005.0,2017.0,ALL
3964,LGALS8,O00214,0.628,0.615,3.8769e-06,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2001.0,2015.0,ALL
3965,LGALS9,O00182,0.496,0.769,6.548e-06,DTO_05007599,Signaling,C0027697,Nephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.31,1.0,,2000.0,2018.0,ALL
3972,LHB,P01229,0.638,0.462,0.0022475,DTO_05007599,Signaling,C0271582,Isolated lutropin deficiency (disorder),C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.7,1.0,strong,1992.0,1992.0,ALL
3973,LHCGR,P22888,0.528,0.692,5.2988e-08,DTO_02300001,G-protein coupled receptor,C0266432,Leydig cell agenesis,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.8,1.0,,1995.0,2018.0,ALL
3975,LHX1,P48742,0.691,0.385,0.029231,DTO_05007557,Nucleic acid binding,C1720887,Female Urogenital Diseases,C13,   Female Urogenital Diseases and Pregnancy Complications,group,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
3976,LIF,P15018,0.483,0.769,0.5242,DTO_05007599,Signaling,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.34,1.0,,2009.0,2019.0,ALL
3977,LIFR,P42702,0.523,0.808,1.4888e-13,DTO_05007599,Signaling,C0796176,STUVE-WIEDEMANN SYNDROME,C16;C04;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.78,1.0,strong,2004.0,2019.0,ALL
3978,LIG1,P18858,0.678,0.5,0.0042142,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,1996.0,2007.0,ALL
3980,LIG3,P49916,0.641,0.654,1.439e-10,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
3981,LIG4,P49917,0.478,0.846,4.1635e-06,,,C1847827,LIG4 Syndrome,C23;C16;C05;C20,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.99,1.0,,2001.0,2016.0,ALL
3982,LIM2,P55344,0.716,0.423,0.00067834,DTO_05007530,Cellular structure,C3809004,"CATARACT 19, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.9,1.0,strong,1996.0,2002.0,ALL
3983,ABLIM1,O14639,0.839,0.154,0.9301,DTO_05007530,Cellular structure,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
3984,LIMK1,P53667,0.488,0.731,0.99937,DTO_03300101,Kinase,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,0.867,limited,1998.0,2019.0,ALL
3985,LIMK2,P53671,0.65,0.654,0.01561,DTO_03300101,Kinase,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
3987,LIMS1,P48059,0.691,0.5,0.0031502,DTO_05007530,Cellular structure,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
3988,LIPA,P38571,0.564,0.654,5.532e-07,DTO_05007624,Enzyme,C0043208,Wolman Disease,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.989,strong,1976.0,2020.0,ALL
3989,LIPB,,,,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
3990,LIPC,P11150,0.585,0.654,3.2764e-07,DTO_05007624,Enzyme,C3151466,HEPATIC LIPASE DEFICIENCY (disorder),C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.71,1.0,,1991.0,2013.0,ALL
3991,LIPE,Q05469,0.599,0.5,9.7458e-12,,,C4014869,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6",,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2014.0,ALL
3992,FADS1,O60427,0.582,0.769,0.37384,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2014.0,2014.0,ALL
3993,LLGL2,Q6P1M3,0.769,0.192,2.8797e-12,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2008.0,2019.0,ALL
3995,FADS3,Q9Y5Q0,0.821,0.308,0.0025334,,,C0202177,Phospholipid measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
3996,LLGL1,Q15334,0.636,0.423,2.4685e-05,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
3998,LMAN1,P49257,0.716,0.423,0.0042632,DTO_05007405,Transporter,C4551981,Familial Multiple Coagulation Factor Deficiency I,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,definitive,1998.0,2011.0,ALL
4000,LMNA,P02545,0.384,0.885,0.9994,,,C0033300,Progeria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.967,,2003.0,2020.0,ALL
4001,LMNB1,P20700,0.564,0.731,0.55481,,,C3164344,Adult onset autosomal dominant leukodystrophy,,,disease,Disease or Syndrome,0.55,1.0,,2008.0,2019.0,ALL
4004,LMO1,P25800,0.623,0.538,0.63546,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.7,1.0,,2011.0,2020.0,ALL
4005,LMO2,P25791,0.585,0.654,0.15884,,,C0023492,"Leukemia, T-Cell",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,1.0,,1991.0,2016.0,ALL
4007,PRICKLE3,O43900,1.0,0.077,0.63198,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
4008,LMO7,Q8WWI1,0.722,0.5,0.00024661,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
4009,LMX1A,Q8TE12,0.67,0.423,0.99114,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2015.0,ALL
4010,LMX1B,O60663,0.565,0.731,0.74637,DTO_05007557,Nucleic acid binding,C0027341,Nail-Patella Syndrome,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.937,,1991.0,2020.0,ALL
4012,LNPEP,Q9UIQ6,0.514,0.731,0.99957,DTO_05007624,Enzyme,C0024668,"Mammary Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.5,1.0,,2006.0,2006.0,ALL
4013,VWA5A,O00534,0.792,0.231,2.5953e-29,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
4014,LORICRIN,P23490,0.674,0.423,0.33454,,,C1858805,"Vohwinkel Syndrome, Variant Form",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.55,1.0,,1998.0,2010.0,ALL
4015,LOX,P28300,0.447,0.846,0.98769,,,C4284414,"AORTIC ANEURYSM, FAMILIAL THORACIC 10",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
4016,LOXL1,Q08397,0.59,0.615,0.88677,,,C0206368,Exfoliation Syndrome,C11,   Eye Diseases,disease,Disease or Syndrome,0.5,0.947,,2007.0,2020.0,ALL
4017,LOXL2,Q9Y4K0,0.527,0.731,3.3844e-07,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
4018,LPA,P08519,0.444,0.769,6.5917e-89,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.5,0.964,,1995.0,2020.0,ALL
4023,LPL,P06858,0.474,0.808,1.2712e-09,DTO_05007624,Enzyme,C0023817,Hyperlipoproteinemia Type I,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.993,strong,1977.0,2019.0,ALL
4025,LPO,P22079,0.678,0.577,7.4989e-17,DTO_05007624,Enzyme,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
4026,LPP,Q93052,0.543,0.769,0.0071908,DTO_05007584,Enzyme modulator,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.41,1.0,,2001.0,2001.0,ALL
4033,LRMP,Q12912,0.805,0.154,5.4252e-10,DTO_05007405,Transporter,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,1999.0,1999.0,ALL
4034,LRCH4,O75427,,,1.3453e-06,,,C1290884,Inflammatory disorder,C23,"   Pathological Conditions, Signs and Symptoms",group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
4035,LRP1,Q07954,0.482,0.769,1.0,,,C0263428,Burnett Schwartz Berberian syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.52,1.0,,2015.0,2018.0,ALL
4036,LRP2,P98164,0.491,0.846,0.99999,,,C1857277,Donnai-Barrow syndrome,C23;C16;C18;C13;C11;C12;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.96,1.0,strong,2003.0,2018.0,ALL
4037,LRP3,O75074,,,6.4582e-06,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
4038,LRP4,O75096,0.568,0.692,1.4386e-06,,,C3280402,SCLEROSTEOSIS 2,,,disease,Disease or Syndrome,0.82,0.667,,2011.0,2018.0,ALL
4040,LRP6,O75581,0.536,0.808,0.69664,,,C1970440,"CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2 (disorder)",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,,2007.0,2013.0,ALL
4041,LRP5,O75197,0.485,0.846,0.50992,,,C0432252,Osteoporosis with pseudoglioma,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,1.0,,2001.0,2017.0,ALL
4043,LRPAP1,P30533,0.579,0.731,4.4951e-07,,,C3809482,"MYOPIA 23, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,moderate,1992.0,2016.0,ALL
4045,LSAMP,Q13449,0.558,0.654,0.98742,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2014.0,2018.0,ALL
4046,LSP1,P33241,0.7,0.462,1.472e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.5,1.0,,2007.0,2017.0,ALL
4047,LSS,P48449,0.606,0.654,1.813e-07,,,C4225300,CATARACT 44,,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2017.0,ALL
4048,LTA4H,P09960,0.617,0.654,2.9568e-08,,,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.33,1.0,,2006.0,2018.0,ALL
4049,LTA,P01374,0.434,0.885,0.19685,DTO_05007599,Signaling,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.5,0.926,,2001.0,2018.0,ALL
4050,LTB,Q06643,0.555,0.769,9.6063e-11,DTO_05007599,Signaling,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
4051,CYP4F3,Q08477,0.551,0.808,3.5413e-16,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
4052,LTBP1,Q14766,0.67,0.5,3.7191e-09,DTO_05007616,Calcium-binding protein,C0409959,"Osteoarthritis, Knee",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.4,1.0,,2018.0,2019.0,ALL
4053,LTBP2,Q14767,0.572,0.692,0.00074122,DTO_05007616,Calcium-binding protein,C2751316,"Glaucoma 3, Primary Congenital, D",C11,   Eye Diseases,disease,Disease or Syndrome,0.6,1.0,,2009.0,2010.0,ALL
4054,LTBP3,Q9NS15,0.564,0.846,0.68647,DTO_05007616,Calcium-binding protein,C1832594,Verloes Bourguignon syndrome,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.81,1.0,strong,2002.0,2019.0,ALL
4055,LTBR,P36941,0.592,0.692,0.3058,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
4056,LTC4S,Q16873,0.647,0.731,0.00084628,DTO_05007624,Enzyme,C1319853,"Asthma, Aspirin-Induced",C08;C20;C25,   Respiratory Tract Diseases;    Immune System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.34,0.875,,1997.0,2011.0,ALL
4057,LTF,P02788,0.543,0.846,1.2665e-21,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.39,0.9,,1999.0,2019.0,ALL
4058,LTK,P29376,0.743,0.308,9.286e-26,DTO_03300101,Kinase,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
4059,BCAM,P50895,0.666,0.462,1.1032e-08,DTO_05007620,Cell adhesion,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2011.0,2019.0,ALL
4060,LUM,P51884,0.543,0.731,0.07696,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.32,1.0,,2016.0,2018.0,ALL
4061,LY6E,Q16553,0.563,0.808,0.3211,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
4062,LY6H,O94772,,,0.16827,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
4063,LY9,Q9HBG7,0.736,0.462,2.6039e-13,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
4064,CD180,Q99467,0.682,0.538,6.842e-05,DTO_05007575,Receptor,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.04,1.0,,1999.0,2018.0,ALL
4065,LY75,O60449,0.67,0.538,7.4472e-46,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
4066,LYL1,P12980,0.67,0.192,0.77265,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2005.0,2019.0,ALL
4067,LYN,P07948,0.603,0.615,0.99886,DTO_03300101,Kinase,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.32,1.0,,2001.0,2010.0,ALL
4068,SH2D1A,O60880,0.525,0.731,0.38935,,,C0549463,X-Linked Lymphoproliferative Disorder,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,1.0,0.972,strong,1998.0,2020.0,ALL
4069,LYZ,P61626,0.526,0.846,3.4114e-06,,,C0268389,"Amyloidosis, familial visceral",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,1991.0,2012.0,ALL
4070,TACSTD2,P09758,0.537,0.731,0.0046571,,,C0339273,"Corneal dystrophy, Lattice type 3",C16;C18;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1999.0,2016.0,ALL
4071,TM4SF1,P30408,0.644,0.462,0.0015619,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2008.0,2019.0,ALL
4072,EPCAM,P16422,0.451,0.885,1.2844e-07,,,C2750737,"DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL",C23;C06;C18,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.99,1.0,,2008.0,2019.0,ALL
4074,M6PR,P20645,0.716,0.269,0.0092215,DTO_05007575,Receptor,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2004.0,2004.0,ALL
4076,CAPRIN1,Q14444,0.691,0.5,0.97247,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2013.0,2019.0,ALL
4077,NBR1,Q14596,0.736,0.462,6.6564e-09,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
4080,MAA,,0.666,0.577,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,1990.0,2008.0,ALL
4081,MAB21L1,Q13394,0.736,0.192,0.28626,,,C0266470,Cerebellar Hypoplasia,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Congenital Abnormality,0.4,1.0,strong,2019.0,2019.0,ALL
4082,MARCKS,P29966,0.559,0.769,0.32648,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.34,1.0,,2014.0,2018.0,ALL
4083,MARCKSP1,,,,,,,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
4084,MXD1,Q05195,0.564,0.692,0.23163,DTO_05007542,Transcription factor,C0162820,"Dermatitis, Allergic Contact",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
4085,MAD2L1,Q13257,0.575,0.615,0.0092952,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.37,1.0,,2001.0,2017.0,ALL
4086,SMAD1,Q15797,0.533,0.731,0.98803,DTO_05007542,Transcription factor,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.35,1.0,,2010.0,2019.0,ALL
4087,SMAD2,Q15796,0.456,0.808,0.99661,DTO_05007542,Transcription factor,C4707243,Familial thoracic aortic aneurysm and aortic dissection,,,disease,Disease or Syndrome,0.5,1.0,moderate,1996.0,2015.0,ALL
4088,SMAD3,P84022,0.415,0.923,0.79796,DTO_05007542,Transcription factor,C3151087,LOEYS-DIETZ SYNDROME 3,,,disease,Disease or Syndrome,0.76,1.0,definitive,2001.0,2018.0,ALL
4089,SMAD4,Q13485,0.401,0.808,0.99881,DTO_05007542,Transcription factor,C0345893,Juvenile polyposis syndrome,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,1.0,0.98,definitive,1997.0,2020.0,ALL
4090,SMAD5,Q99717,0.633,0.615,0.99838,DTO_05007542,Transcription factor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2008.0,2016.0,ALL
4091,SMAD6,O43541,0.579,0.731,3.6282e-20,DTO_05007542,Transcription factor,C3542024,AORTIC VALVE DISEASE 2,,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2019.0,ALL
4092,SMAD7,O15105,0.47,0.769,0.54854,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,0.984,,2001.0,2019.0,ALL
4093,SMAD9,O15198,0.666,0.308,6.4444e-05,DTO_05007542,Transcription factor,C3203102,Idiopathic pulmonary arterial hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.66,0.857,,2009.0,2018.0,ALL
4094,MAF,O75444,0.623,0.769,0.74382,DTO_05007542,Transcription factor,C3888097,"CATARACT 21, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.8,1.0,strong,2002.0,2014.0,ALL
4095,MAFD1,,0.743,0.269,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,1995.0,2019.0,ALL
4096,MAFD2,,0.641,0.731,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.05,1.0,,2017.0,2020.0,ALL
4097,MAFG,O15525,0.729,0.192,0.73176,DTO_05007542,Transcription factor,C0008372,Intrahepatic Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
4099,MAG,P20916,0.579,0.692,0.49228,DTO_05007575,Receptor,C4225250,"SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2016.0,ALL
4100,MAGEA1,P43355,0.601,0.462,,DTO_05007620,Cell adhesion,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.903,,1991.0,2017.0,ALL
4101,MAGEA2,P43356,0.663,0.385,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,1994.0,2018.0,ALL
4102,MAGEA3,P43357,0.588,0.5,,DTO_05007620,Cell adhesion,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,1.0,,1999.0,2020.0,ALL
4103,MAGEA4,P43358,0.653,0.346,,DTO_05007620,Cell adhesion,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2019.0,2019.0,ALL
4104,MAGEA5,P43359,0.89,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
4105,MAGEA6,P43360,0.736,0.231,,DTO_05007620,Cell adhesion,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2019.0,ALL
4108,MAGEA9,P43362,0.861,0.115,,DTO_05007620,Cell adhesion,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
4109,MAGEA10,P43363,0.821,0.154,,DTO_05007620,Cell adhesion,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,1999.0,2018.0,ALL
4110,MAGEA11,P43364,0.805,0.154,0.68445,DTO_05007620,Cell adhesion,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2009.0,2013.0,ALL
4111,MAGEA12,P43365,0.821,0.115,,DTO_05007620,Cell adhesion,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,0.75,,2000.0,2019.0,ALL
4112,MAGEB1,P43366,0.89,0.115,,DTO_05007620,Cell adhesion,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.01,1.0,,1995.0,1995.0,ALL
4113,MAGEB2,O15479,0.78,0.269,,DTO_05007620,Cell adhesion,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2002.0,2016.0,ALL
4115,MAGEB4,O15481,0.89,0.115,,DTO_05007620,Cell adhesion,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
4116,MAGOH,P61326,1.0,0.077,0.7974,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
4117,MAK,P20794,0.695,0.346,8.6266e-19,DTO_03300101,Kinase,C3280042,RETINITIS PIGMENTOSA 62,,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2011.0,ALL
4118,MAL,P21145,0.57,0.577,0.83197,DTO_05007405,Transporter,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.34,1.0,,2004.0,2018.0,ALL
4121,MAN1A1,P33908,0.78,0.308,0.11123,DTO_05007613,Chaperone,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
4122,MAN2A2,P49641,1.0,0.038,1.4995e-10,,,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2008.0,2008.0,ALL
4123,MAN2C1,Q9NTJ4,0.751,0.269,2.7689e-29,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
4124,MAN2A1,Q16706,0.705,0.538,1.6205e-10,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.21,1.0,,1997.0,2001.0,ALL
4125,MAN2B1,O00754,0.674,0.462,4.7921e-22,,,C0024748,alpha-Mannosidosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1977.0,2019.0,ALL
4126,MANBA,O00462,0.736,0.462,1.3066e-18,DTO_05007624,Enzyme,C4048196,beta-Mannosidosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,1.0,,1988.0,2019.0,ALL
4128,MAOA,P21397,0.465,0.769,0.99928,,,C0796275,Brunner Syndrome,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.91,1.0,,1993.0,2016.0,ALL
4129,MAOB,P27338,0.533,0.808,0.99903,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.6,0.991,,1993.0,2020.0,ALL
4130,MAP1A,P78559,0.792,0.269,1.0,DTO_05007530,Cellular structure,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0,,1988.0,1988.0,ALL
4131,MAP1B,P46821,0.628,0.5,1.0,DTO_05007530,Cellular structure,C1868720,Periventricular Nodular Heterotopia,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.42,1.0,,2018.0,2019.0,ALL
4133,MAP2,P11137,0.537,0.692,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,0.857,,2001.0,2019.0,ALL
4134,MAP4,P27816,0.682,0.5,0.84782,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
4135,MAP6,Q96JE9,0.578,0.769,0.39507,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.57,1.0,,2002.0,2018.0,ALL
4137,MAPT,P10636,0.446,0.923,0.0060258,,,C0236642,Pick Disease of the Brain,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.8,0.975,,1998.0,2020.0,ALL
4139,MARK1,Q9P0L2,0.663,0.577,0.60045,DTO_03300101,Kinase,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2008.0,2010.0,ALL
4140,MARK3,P27448,0.729,0.423,1.4273e-06,DTO_03300101,Kinase,C4748978,VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI,,,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
4141,MARS1,P56192,0.638,0.654,2.0536e-15,,,C4225400,INTERSTITIAL LUNG AND LIVER DISEASE,,,disease,Disease or Syndrome,0.73,1.0,,2013.0,2018.0,ALL
4142,MAS1,P04201,0.533,0.769,8.2518e-05,DTO_02300001,G-protein coupled receptor,C0040053,Thrombosis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0,,2015.0,2015.0,ALL
4143,MAT1A,Q00266,0.582,0.577,0.00080978,DTO_05007624,Enzyme,C0268621,Hepatic methionine adenosyltransferase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.78,1.0,definitive,1951.0,2019.0,ALL
4144,MAT2A,P31153,0.615,0.654,0.99846,DTO_05007624,Enzyme,C4707243,Familial thoracic aortic aneurysm and aortic dissection,,,disease,Disease or Syndrome,0.6,1.0,limited,2015.0,2015.0,ALL
4145,MATK,P42679,0.656,0.423,2.3097e-06,DTO_03300101,Kinase,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
4146,MATN1,P21941,0.644,0.615,0.0025559,DTO_05007575,Receptor,C0039585,Androgen-Insensitivity Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.06,1.0,,2009.0,2014.0,ALL
4147,MATN2,O00339,0.76,0.423,6.249e-14,DTO_05007575,Receptor,C0242350,Erectile dysfunction,C12;F03,   Male Urogenital Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
4148,MATN3,O15232,0.644,0.385,1.35e-08,DTO_05007575,Receptor,C1846843,"EPIPHYSEAL DYSPLASIA, MULTIPLE, 5",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.91,1.0,,2001.0,2019.0,ALL
4149,MAX,P61244,0.553,0.769,0.8335,DTO_05007542,Transcription factor,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.8,1.0,strong,2011.0,2019.0,ALL
4150,MAZ,P56270,0.617,0.654,0.94363,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
4151,MB,P02144,0.556,0.731,0.030636,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.21,1.0,,2002.0,2017.0,ALL
4152,MBD1,Q9UIS9,0.631,0.577,0.99717,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2003.0,2018.0,ALL
4153,MBL2,P11226,0.39,0.846,0.0026836,DTO_05007575,Receptor,C3280586,Mannose-Binding Protein Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,0.935,moderate,1994.0,2019.0,ALL
4154,MBNL1,Q9NR56,0.65,0.615,0.70579,DTO_05007557,Nucleic acid binding,C3250443,MYOTONIC DYSTROPHY 1,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.4,1.0,,2000.0,2018.0,ALL
4155,MBP,P02686,0.51,0.885,0.28446,,,C0011303,Demyelinating Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.58,1.0,,1985.0,2017.0,ALL
4156,MBS1,,0.805,0.308,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2010.0,2017.0,ALL
4157,MC1R,Q01726,0.524,0.808,8.1075e-11,DTO_02300001,G-protein coupled receptor,C0268495,Oculocutaneous albinism type 2,C16;C18;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.63,1.0,,2003.0,2015.0,ALL
4158,MC2R,Q01718,0.582,0.654,0.00030712,DTO_02300001,G-protein coupled receptor,C4049650,Familial Glucocorticoid Deficiency Type 1,C16;C18;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,0.944,,1993.0,2019.0,ALL
4159,MC3R,P41968,0.695,0.462,9.9877e-08,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,0.786,,2000.0,2019.0,ALL
4160,MC4R,P32245,0.535,0.692,0.00091697,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.961,,1997.0,2020.0,ALL
4161,MC5R,P33032,0.743,0.423,6.513e-05,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2005.0,2005.0,ALL
4162,MCAM,P43121,0.514,0.731,0.00015954,DTO_05007620,Cell adhesion,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.5,1.0,,2013.0,2013.0,ALL
4163,MCC,P23508,0.568,0.731,4.6577e-16,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,0.929,,1991.0,2018.0,ALL
4166,CHST6,Q9GZX3,0.76,0.269,2.4495e-09,,,C1636149,"Macular dystrophy, corneal type 1",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.8,0.917,strong,2000.0,2019.0,ALL
4167,MCDR1,,0.861,0.077,,,,C0730294,North Carolina macular dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.08,1.0,,1998.0,2019.0,ALL
4168,MCF2,P10911,0.76,0.385,0.9718,DTO_05007599,Signaling,C0006012,Borderline Personality Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2013.0,2018.0,ALL
4170,MCL1,Q07820,0.43,0.808,0.96349,DTO_05007599,Signaling,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.4,0.984,,2000.0,2020.0,ALL
4171,MCM2,P49736,0.527,0.731,2.6301e-05,DTO_05007624,Enzyme,C4310775,"DEAFNESS, AUTOSOMAL DOMINANT 70",,,disease,Disease or Syndrome,0.7,1.0,limited,2015.0,2015.0,ALL
4172,MCM3,P25205,0.656,0.462,6.9522e-11,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,0.857,,2004.0,2018.0,ALL
4173,MCM4,P33991,0.666,0.654,0.00014571,DTO_05007624,Enzyme,C1864947,"Natural Killer Cell Deficiency, Familial Isolated",C20,   Immune System Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2012.0,ALL
4174,MCM5,P33992,0.617,0.615,0.00059281,DTO_05007557,Nucleic acid binding,C4479655,MEIER-GORLIN SYNDROME 8,,,disease,Disease or Syndrome,0.5,1.0,,2017.0,2017.0,ALL
4175,MCM6,Q14566,0.666,0.615,0.97833,DTO_05007624,Enzyme,C0268181,"Lactose Intolerance, Adult Type",C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
4176,MCM7,P33993,0.572,0.654,1.9396e-24,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.23,1.0,,2014.0,2019.0,ALL
4179,CD46,P15529,0.477,0.808,4.7013e-07,,,C2931788,Atypical Hemolytic Uremic Syndrome,C13;C12;C15,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,1.0,limited,2003.0,2019.0,ALL
4184,SMCP,P49901,0.621,0.692,,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2020.0,ALL
4185,ADAM11,O75078,0.67,0.538,1.0387e-05,DTO_05007624,Enzyme,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,,,,,ALL
4188,MDFI,Q99750,0.861,0.154,0.33402,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
4189,DNAJB9,Q9UBS3,0.7,0.385,0.36507,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
4190,MDH1,P40925,0.682,0.538,0.92765,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2004.0,2009.0,ALL
4191,MDH2,P40926,0.595,0.731,0.0066821,DTO_05007624,Enzyme,C4479208,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51",,,disease,Disease or Syndrome,0.7,1.0,,2017.0,2017.0,ALL
4192,MDK,P21741,0.494,0.808,0.23005,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.62,1.0,,2004.0,2019.0,ALL
4193,MDM2,Q00987,0.362,0.846,0.99981,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,0.904,,1994.0,2019.0,ALL
4194,MDM4,O15151,0.461,0.808,0.99992,DTO_05007557,Nucleic acid binding,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.6,1.0,,2002.0,2018.0,ALL
4195,MDRV,,1.0,0.115,,,,C1834014,Oculopharyngodistal Myopathy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
4199,ME1,P48163,0.628,0.615,8.2005e-14,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2011.0,2019.0,ALL
4200,ME2,P23368,0.705,0.346,3.0296e-15,DTO_05007624,Enzyme,C0024713,Manic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
4201,MEA1,Q16626,0.839,0.231,1.0536e-05,,,C0024776,Maple Syrup Urine Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
4204,MECP2,P51608,0.414,0.846,0.89382,DTO_05007378,Epigenetic regulator,C0035372,Rett Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.977,definitive,1975.0,2020.0,ALL
4205,MEF2A,Q02078,0.585,0.692,0.98706,DTO_05007542,Transcription factor,C1842247,"CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.43,0.667,,2005.0,2010.0,ALL
4207,BORCS8-MEF2B,Q02080,0.78,0.154,0.0039873,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
4208,MEF2C,Q06413,0.517,0.769,0.017256,DTO_05007542,Transcription factor,C3150700,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 20",,,disease,Disease or Syndrome,0.6,1.0,,2009.0,2016.0,ALL
4209,MEF2D,Q14814,0.608,0.5,0.99705,DTO_05007542,Transcription factor,C0338480,Common Migraine,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.33,0.75,,2012.0,2017.0,ALL
4210,MEFV,O15553,0.44,0.885,1.0177e-14,,,C0031069,Familial Mediterranean Fever,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,1.0,0.993,,1993.0,2020.0,ALL
4211,MEIS1,O00470,0.579,0.615,0.99951,DTO_05007624,Enzyme,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.5,0.875,,2007.0,2019.0,ALL
4212,MEIS2,O14770,0.601,0.808,0.99938,DTO_05007624,Enzyme,C1832950,"Cardiac Malformation, Cleft Lip-Palate, Microcephaly and Digital Anomalies",C16;C05;C10;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
4214,MAP3K1,Q13233,0.538,0.731,0.99998,DTO_03300101,Kinase,C3151064,"46,XY SEX REVERSAL 6",,,disease,Disease or Syndrome,0.7,1.0,,2003.0,2010.0,ALL
4215,MAP3K3,Q99759,0.626,0.692,0.98535,DTO_03300101,Kinase,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
4216,MAP3K4,Q9Y6R4,0.729,0.462,1.0,DTO_03300101,Kinase,C0014170,Endometrial Neoplasms,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,group,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
4217,MAP3K5,Q99683,0.513,0.808,0.51964,DTO_03300101,Kinase,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.36,0.833,,2006.0,2020.0,ALL
4218,RAB8A,P61006,0.61,0.577,0.97543,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2003.0,2003.0,ALL
4221,MEN1,O00255,0.444,0.808,0.99971,,,C0025267,Multiple Endocrine Neoplasia Type 1,C16;C04;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Endocrine System Diseases",disease,Neoplastic Process,0.9,0.959,strong,1989.0,2020.0,ALL
4222,MEOX1,P50221,0.623,0.615,0.00019076,DTO_05007542,Transcription factor,C0022738,Klippel-Feil Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.63,1.0,,2013.0,2018.0,ALL
4223,MEOX2,P50222,0.686,0.5,0.91495,DTO_05007542,Transcription factor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
4224,MEP1A,Q16819,0.78,0.231,9.1509e-13,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
4225,MEP1B,Q16820,0.931,0.115,1.9369e-24,DTO_05007624,Enzyme,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2017.0,2017.0,ALL
4232,MEST,Q5EB52,0.631,0.538,0.39908,DTO_05007624,Enzyme,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
4233,MET,P08581,0.38,0.846,0.96998,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,1.0,0.969,,1994.0,2020.0,ALL
4234,METTL1,Q9UBP6,0.931,0.154,0.001962,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2009.0,2019.0,ALL
4236,MFAP1,P55081,0.431,0.846,0.79602,DTO_05007621,Extracellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,1988.0,2018.0,ALL
4237,MFAP2,P55001,0.769,0.423,4.2671e-06,,,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
4238,MFAP3,P55082,1.0,0.077,0.0011201,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2013.0,ALL
4239,MFAP4,P55083,0.691,0.462,0.11416,DTO_05007599,Signaling,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
4240,MFGE8,Q08431,0.548,0.808,4.3953e-05,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,1.0,,2000.0,2019.0,ALL
4241,MELTF,P08582,0.663,0.5,1.1795e-16,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.929,,1986.0,2009.0,ALL
4245,MGAT1,P26572,0.674,0.538,0.98879,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
4246,SCGB2A1,O75556,0.686,0.462,0.23239,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.05,1.0,,1999.0,2017.0,ALL
4247,MGAT2,Q10469,0.65,0.577,0.034151,DTO_05007624,Enzyme,C2931008,Congenital disorder of glycosylation type 2A,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.92,1.0,,1996.0,2016.0,ALL
4248,MGAT3,Q09327,0.743,0.538,0.14725,DTO_05007624,Enzyme,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
4249,MGAT5,Q09328,0.638,0.5,0.99998,DTO_05007624,Enzyme,C0014378,Enterovirus Infections,C01,   Infections,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
4250,SCGB2A2,Q13296,0.722,0.308,0.00017485,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.967,,1996.0,2019.0,ALL
4253,MIA2,Q96PC5,0.7,0.577,1.0326e-06,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
4254,KITLG,P21583,0.473,0.885,0.85024,,,C1840392,"HYPERPIGMENTATION, FAMILIAL PROGRESSIVE",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.73,1.0,strong,2009.0,2018.0,ALL
4255,MGMT,P16455,0.412,0.885,1.1756e-07,,,C0334588,Giant Cell Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.51,1.0,,2010.0,2016.0,ALL
4256,MGP,P08493,0.539,0.846,3.6072e-05,,,C1855607,Keutel syndrome,C16;C18;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.73,1.0,strong,1999.0,2014.0,ALL
4257,MGST1,P10620,0.691,0.462,0.0026577,,,C0270715,"Degenerative Diseases, Central Nervous System",C10,   Nervous System Diseases,group,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
4258,MGST2,Q99735,0.89,0.115,0.078275,DTO_05007624,Enzyme,C0263361,Psoriasis vulgaris,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0,,2006.0,2006.0,ALL
4259,MGST3,O14880,0.931,0.192,0.00020347,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
4261,CIITA,P33076,0.536,0.808,1.3618e-07,,,C2931418,Bare lymphocyte syndrome 2,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.72,1.0,,1993.0,2005.0,ALL
4264,MHS2,,0.89,0.115,,,,C0024591,Malignant hyperpyrexia due to anesthesia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.02,1.0,,1992.0,1993.0,ALL
4265,MHS4,,0.89,0.154,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
4266,MHS6,,0.931,0.154,,,,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
4267,CD99,P14209,0.491,0.731,0.0026127,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.5,,1994.0,2003.0,ALL
4277,MICB,Q29980,0.576,0.731,4.0609e-05,,,C0019100,Severe Dengue,C01,   Infections,disease,Disease or Syndrome,0.43,1.0,,2011.0,2017.0,ALL
4279,MICD,,0.861,0.231,,,,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
4280,MICE,,0.769,0.192,,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
4281,MID1,O15344,0.621,0.654,0.97967,,,C2936904,"Opitz GBBB Syndrome, X-Linked",C16;C13;C05;C12;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.9,1.0,definitive,1997.0,2017.0,ALL
4282,MIF,P14174,0.412,0.885,0.012262,,,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.56,1.0,,2003.0,2010.0,ALL
4283,CXCL9,Q07325,0.462,0.808,0.0029304,DTO_05007599,Signaling,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2009.0,2020.0,ALL
4284,MIP,P30301,0.507,0.846,0.030956,DTO_01300327,Ion channel,C3809001,"CATARACT 15, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.9,1.0,strong,1968.0,2015.0,ALL
4285,MIPEP,Q99797,0.666,0.615,1.5876e-15,DTO_05007624,Enzyme,C4310661,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31,,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2016.0,ALL
4286,MITF,O75030,0.499,0.808,0.98119,,,C1860339,"WAARDENBURG SYNDROME, TYPE IIA",C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,1.0,1.0,,1967.0,2019.0,ALL
4287,ATXN3,P54252,0.521,0.808,0.10575,DTO_05007624,Enzyme,C0024408,Machado-Joseph Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,0.981,,1994.0,2020.0,ALL
4288,MKI67,P46013,0.431,0.808,1.2598e-28,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1996.0,2019.0,ALL
4289,MKLN1,Q9UL63,0.769,0.269,0.99998,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2017.0,2017.0,ALL
4291,MLF1,P58340,0.666,0.385,4.3955e-09,DTO_05007599,Signaling,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.5,1.0,,1996.0,2019.0,ALL
4292,MLH1,P40692,0.399,0.808,3.41e-05,DTO_05007557,Nucleic acid binding,C1333990,Hereditary Nonpolyposis Colorectal Cancer,C16;C06;C04;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nutritional and Metabolic Diseases",disease,Neoplastic Process,0.9,0.977,,1975.0,2020.0,ALL
4293,MAP3K9,P80192,0.711,0.269,0.11764,DTO_03300101,Kinase,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
4294,MAP3K10,Q02779,0.628,0.615,0.58758,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
4295,MLN,P12872,0.656,0.577,0.0041058,,,C0013182,Drug Allergy,C20;C25,   Immune System Diseases;    Chemically-Induced Disorders,group,Pathologic Function,0.3,1.0,,2006.0,2006.0,ALL
4296,MAP3K11,Q16584,0.597,0.615,0.010875,DTO_03300101,Kinase,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
4297,KMT2A,Q03164,0.41,0.885,1.0,,,C1854630,Growth Deficiency and Mental Retardation with Facial Dysmorphism,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,1.0,strong,2012.0,2019.0,ALL
4298,MLLT1,Q03111,0.663,0.346,0.98669,DTO_05007557,Nucleic acid binding,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.31,1.0,,2015.0,2017.0,ALL
4299,AFF1,P51825,0.659,0.423,0.71038,DTO_05007542,Transcription factor,C1292769,Precursor B-cell lymphoblastic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.32,1.0,,1994.0,2018.0,ALL
4300,MLLT3,P42568,0.674,0.5,0.99964,DTO_05007557,Nucleic acid binding,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
4301,AFDN,P55196,0.65,0.462,1.0,DTO_05007530,Cellular structure,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.2,1.0,,1993.0,2018.0,ALL
4302,MLLT6,P55198,0.769,0.192,0.99997,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,1999.0,2005.0,ALL
4303,FOXO4,P98177,0.588,0.769,0.81332,,,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,1.0,limited,2012.0,2012.0,ALL
4306,NR3C2,P08235,0.469,0.846,0.83739,DTO_00102000,Nuclear receptor,C1449842,"Pseudohypoaldosteronism, Type I, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.67,1.0,strong,2000.0,2010.0,ALL
4308,TRPM1,Q7Z4N2,0.626,0.462,1.6009e-42,DTO_01300327,Ion channel,C0339535,"Night blindness, congenital stationary",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.8,1.0,strong,2009.0,2019.0,ALL
4311,MME,P08473,0.407,0.808,1.465e-18,DTO_05007624,Enzyme,C4015635,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
4312,MMP1,P03956,0.385,0.885,7.7197e-18,DTO_05007624,Enzyme,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.9,0.875,limited,2002.0,2019.0,ALL
4313,MMP2,P08253,0.333,0.923,0.83878,DTO_05007624,Enzyme,C1850155,TORG-WINCHESTER SYNDROME,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.79,1.0,strong,2001.0,2019.0,ALL
4314,MMP3,P08254,0.408,0.885,5.7362e-15,DTO_05007624,Enzyme,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.5,1.0,,2008.0,2012.0,ALL
4316,MMP7,P09237,0.446,0.885,1.0404e-09,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,1994.0,2019.0,ALL
4317,MMP8,P22894,0.488,0.808,1.0661e-24,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.36,1.0,,2001.0,2018.0,ALL
4318,MMP9,P14780,0.305,0.923,1.8869e-17,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.6,0.861,,2001.0,2019.0,ALL
4319,MMP10,P09238,0.553,0.808,5.907e-15,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.38,0.75,,2006.0,2019.0,ALL
4320,MMP11,P24347,0.542,0.692,2.4125e-05,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,1995.0,2019.0,ALL
4321,MMP12,P39900,0.484,0.885,,DTO_05007624,Enzyme,C0034067,Pulmonary Emphysema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.4,1.0,,1997.0,2019.0,ALL
4322,MMP13,P45452,0.452,0.923,7.8767e-18,DTO_05007624,Enzyme,C0432225,Metaphyseal chondrodysplasia Spahr type,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,strong,2014.0,2015.0,ALL
4323,MMP14,P50281,0.447,0.769,0.99522,DTO_05007624,Enzyme,C0432289,Winchester syndrome (disorder),C23;C16;C18;C11;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,limited,2012.0,2018.0,ALL
4324,MMP15,P51511,0.644,0.5,0.073354,DTO_05007624,Enzyme,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
4325,MMP16,P51512,0.626,0.577,0.91797,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.12,1.0,,2011.0,2019.0,ALL
4326,MMP17,Q9ULZ9,0.705,0.308,2.1964e-08,DTO_05007624,Enzyme,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
4327,MMP19,Q99542,0.623,0.615,1.9975e-20,DTO_05007624,Enzyme,C1969063,Cavitary Optic Disc Anomalies,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.5,1.0,,2015.0,2015.0,ALL
4329,ALDH6A1,Q02252,0.716,0.462,7.5619e-10,DTO_05007624,Enzyme,C3279840,Methylmalonate Semialdehyde Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2000.0,2016.0,ALL
4330,MN1,Q10571,0.682,0.385,0.99999,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.35,1.0,,2004.0,2017.0,ALL
4331,MNAT1,P51948,0.539,0.846,1.3117e-12,DTO_05007584,Enzyme modulator,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2004.0,2019.0,ALL
4332,MNDA,P41218,0.695,0.308,3.0917e-17,DTO_05007542,Transcription factor,C0024301,"Lymphoma, Follicular",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2009.0,2017.0,ALL
4335,MNT,Q99583,0.663,0.615,0.99739,DTO_05007542,Transcription factor,C0265219,Miller Dieker syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,2004.0,2004.0,ALL
4336,MOBP,Q13875,0.7,0.423,0.54623,DTO_05007530,Cellular structure,C0038868,Progressive supranuclear palsy,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.42,1.0,,2011.0,2018.0,ALL
4337,MOCS1,Q9NZB8,0.743,0.231,9.1165e-07,,,C1854988,"Molybdenum Cofactor Deficiency, Complementation Group A",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1998.0,2005.0,ALL
4338,MOCS2,O96007;O96033,0.729,0.308,0.00046138,,,C1854989,"Molybdenum Cofactor Deficiency, Complementation Group B",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1999.0,2006.0,ALL
4340,MOG,Q16653,0.546,0.731,0.13748,DTO_05007584,Enzyme modulator,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.63,1.0,,2007.0,2014.0,ALL
4342,MOS,P00540,0.617,0.5,0.58928,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
4343,MOV10,Q9HCE1,0.76,0.308,0.80908,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.11,1.0,,2011.0,2018.0,ALL
4345,CD200,P41217,0.529,0.769,0.41359,,,C0003089,Ankylosing spondylitis and other inflammatory spondylopathies,C01;C05,   Infections;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.2,1.0,,2000.0,2005.0,ALL
4350,MPG,P29372,0.597,0.731,1.9454e-12,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,1995.0,2018.0,ALL
4351,MPI,P34949,0.585,0.654,1.1715e-07,DTO_05007624,Enzyme,C1865145,Congenital disorder of glycosylation type 1B,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.79,0.947,strong,1998.0,2017.0,ALL
4352,MPL,P40238,0.51,0.692,4.0719e-09,DTO_05007575,Receptor,C0001815,Primary Myelofibrosis,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,1.0,0.978,,1995.0,2020.0,ALL
4353,MPO,P05164,0.377,0.923,7.105e-15,DTO_05007624,Enzyme,C0398595,Myeloperoxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.824,limited,1979.0,2019.0,ALL
4354,MPP1,Q00013,0.617,0.5,0.9877,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
4355,MPP2,Q14168,0.78,0.308,2.876e-07,DTO_05007624,Enzyme,C0030354,Papilloma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,1999.0,2018.0,ALL
4356,MPP3,Q13368,0.861,0.115,3.4521e-06,DTO_05007624,Enzyme,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
4357,MPST,P25325,0.588,0.654,3.4664e-05,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
4358,MPV17,P39210,0.595,0.577,9.6582e-11,DTO_05007575,Receptor,C1850406,NAVAJO NEUROHEPATOPATHY,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.76,1.0,,2006.0,2019.0,ALL
4359,MPZ,P25189,0.503,0.846,0.27158,,,C0011195,Dejerine-Sottas Disease (disorder),C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1992.0,2019.0,ALL
4360,MRC1,P22897,0.413,0.846,0.94335,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.31,1.0,,2018.0,2018.0,ALL
4361,MRE11,P49959,0.527,0.808,1.264e-12,,,C1858391,ATAXIA-TELANGIECTASIA-LIKE DISORDER,C16;C18;C20;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,0.963,,1999.0,2019.0,ALL
4363,ABCC1,P33527,0.445,0.808,0.0011727,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.5,0.972,,1995.0,2019.0,ALL
4397,MS,,0.599,0.692,,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2009.0,2019.0,ALL
4412,MRX49,,0.821,0.385,,,,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.03,1.0,,1999.0,2008.0,ALL
4430,MYO1B,O43795,0.691,0.538,7.2357e-05,DTO_05007530,Cellular structure,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
4434,MSD,,0.674,0.654,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2015.0,2019.0,ALL
4435,CITED1,Q99966,0.691,0.346,0.024446,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2007.0,2019.0,ALL
4436,MSH2,P43246,0.406,0.808,0.89539,DTO_05007557,Nucleic acid binding,C1333990,Hereditary Nonpolyposis Colorectal Cancer,C16;C06;C04;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nutritional and Metabolic Diseases",disease,Neoplastic Process,1.0,0.983,definitive,1993.0,2020.0,ALL
4437,MSH3,P20585,0.474,0.769,7.4413e-31,DTO_05007557,Nucleic acid binding,C4310719,FAMILIAL ADENOMATOUS POLYPOSIS 4,,,disease,Disease or Syndrome,0.6,1.0,moderate,2000.0,2016.0,ALL
4438,MSH4,O15457,0.805,0.154,2.1195e-18,DTO_05007557,Nucleic acid binding,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.02,1.0,,2008.0,2017.0,ALL
4439,MSH5,O43196,0.641,0.692,3.2035e-11,DTO_05007557,Nucleic acid binding,C4479510,PREMATURE OVARIAN FAILURE 13,,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
4440,MSI1,O43347,0.55,0.615,0.99357,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2010.0,2016.0,ALL
4477,MSMB,P08118,0.498,0.846,0.016199,DTO_05007599,Signaling,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.7,0.984,,1993.0,2020.0,ALL
4478,MSN,P26038,0.534,0.769,0.99967,DTO_05007530,Cellular structure,C4310812,IMMUNODEFICIENCY 50,,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2018.0,ALL
4479,MSNP1,,0.931,0.038,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2009.0,2009.0,ALL
4481,MSR1,P21757,0.553,0.654,2.1571e-20,DTO_05007624,Enzyme,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.58,1.0,,2002.0,2016.0,ALL
4482,MSRA,Q9UJ68,0.608,0.615,1.5332e-15,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.43,1.0,,2009.0,2019.0,ALL
4485,MST1,P26927,0.465,0.885,4.7831e-19,DTO_05007624,Enzyme,C0566602,Primary sclerosing cholangitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.63,1.0,,2011.0,2013.0,ALL
4486,MST1R,Q04912,0.542,0.808,7.8684e-37,DTO_03300101,Kinase,C4310729,"NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3",,,phenotype,Finding,0.4,1.0,,2016.0,2016.0,ALL
4487,MSX1,P28360,0.525,0.731,0.16517,DTO_05007542,Transcription factor,C3489529,"Tooth Agenesis, Familial",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.72,1.0,,1996.0,2017.0,ALL
4488,MSX2,P35548,0.539,0.769,0.26173,DTO_05007542,Transcription factor,C1868598,PARIETAL FORAMINA,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.85,1.0,,2000.0,2006.0,ALL
4489,MT1A,P04731,0.537,0.808,0.0044674,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2007.0,2019.0,ALL
4490,MT1B,P07438,0.585,0.731,0.0053775,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.08,1.0,,1998.0,2019.0,ALL
4493,MT1E,P04732,0.569,0.769,0.031344,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2011.0,2019.0,ALL
4494,MT1F,P04733,0.628,0.654,0.046878,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,1990.0,2018.0,ALL
4495,MT1G,P13640,0.604,0.731,0.032173,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
4496,MT1H,P80294,0.638,0.654,0.0063432,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.08,1.0,,1998.0,2019.0,ALL
4498,MT1JP,,0.588,0.731,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.923,,2009.0,2019.0,ALL
4499,MT1M,Q8N339,0.617,0.692,0.0043473,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.9,,2009.0,2019.0,ALL
4500,MT1L,Q93083,0.633,0.692,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.09,0.889,,1998.0,2019.0,ALL
4501,MT1X,P80297,0.619,0.692,0.00093353,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,1.0,,1998.0,2019.0,ALL
4502,MT2A,P02795,0.553,0.808,1.2279e-05,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2003.0,2019.0,ALL
4503,MT2P1,,1.0,0.115,,,,C0025268,Multiple Endocrine Neoplasia Type 2a,C16;C04;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Endocrine System Diseases",disease,Neoplastic Process,0.01,1.0,,1986.0,1986.0,ALL
4504,MT3,P25713,0.582,0.615,0.064484,,,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,2013.0,2013.0,ALL
4507,MTAP,Q13126,0.514,0.731,7.5973e-08,DTO_05007624,Enzyme,C1862177,Diaphyseal medullary stenosis with malignant fibrous histiocytoma,C16;C04;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.6,1.0,,2012.0,2012.0,ALL
4508,ATP6,P00846,0.541,0.731,,DTO_05007405,Transporter,C1328349,Neuropathy ataxia and retinis pigmentosa,C16;C18;C11;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,0.95,,1990.0,2019.0,ALL
4509,ATP8,P03928,0.666,0.615,,DTO_05007405,Transporter,C2748884,"CARDIOMYOPATHY, INFANTILE HYPERTROPHIC",,,disease,Disease or Syndrome,0.4,1.0,,2009.0,2009.0,ALL
4511,TRNC,,0.751,0.346,,,,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,,,,,ALL
4512,COX1,P00395,0.441,0.885,,DTO_05007624,Enzyme,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.62,1.0,,1999.0,2011.0,ALL
4513,COX2,P00403,0.352,0.962,,DTO_05007624,Enzyme,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.64,1.0,,1999.0,2015.0,ALL
4514,COX3,P00414,0.546,0.808,,DTO_05007624,Enzyme,C0917796,"Optic Atrophy, Hereditary, Leber",C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.61,1.0,,1993.0,1994.0,ALL
4515,MTCP1,P56278,0.821,0.308,0.45211,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
4519,CYTB,P00156,0.529,0.808,,,,C0917796,"Optic Atrophy, Hereditary, Leber",C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.64,1.0,,1991.0,2007.0,ALL
4520,MTF1,Q14872,0.751,0.5,0.96897,DTO_05007542,Transcription factor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2004.0,2004.0,ALL
4521,NUDT1,P36639,0.597,0.769,7.4464e-12,DTO_05007624,Enzyme,C0006635,Cadmium poisoning,C25,   Chemically-Induced Disorders,disease,Injury or Poisoning,0.2,1.0,,2001.0,2001.0,ALL
4522,MTHFD1,P11586,0.554,0.769,0.0044614,DTO_05007624,Enzyme,C1866558,"Neural tube defect, folate-sensitive",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,limited,1998.0,2006.0,ALL
4524,MTHFR,P42898,0.337,0.885,3.2068e-10,,,C1856058,"HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY",,,disease,Disease or Syndrome,0.8,1.0,definitive,1991.0,2019.0,ALL
4528,MTIF2,P46199,1.0,,3.7464e-10,DTO_05007624,Enzyme,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,,,,,ALL
4534,MTM1,Q13496,0.573,0.731,0.99961,DTO_05007624,Enzyme,C0410203,X-linked centronuclear myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Congenital Abnormality,0.8,1.0,definitive,1995.0,2019.0,ALL
4535,ND1,P03886,0.522,0.769,,DTO_05007624,Enzyme,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.74,1.0,,1996.0,2014.0,ALL
4536,ND2,P03891,0.601,0.615,,,,C0917796,"Optic Atrophy, Hereditary, Leber",C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,,1991.0,1992.0,ALL
4537,ND3,P03897,0.604,0.654,,,,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.49,1.0,,2001.0,2019.0,ALL
4538,ND4,P03905,0.546,0.769,,DTO_05007624,Enzyme,C0917796,"Optic Atrophy, Hereditary, Leber",C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,1988.0,2019.0,ALL
4539,ND4L,P03901,0.805,0.308,,DTO_05007624,Enzyme,C0917796,"Optic Atrophy, Hereditary, Leber",C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.65,0.6,,1995.0,2018.0,ALL
4540,ND5,P03915,0.531,0.769,,DTO_05007624,Enzyme,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.78,1.0,,1997.0,2020.0,ALL
4541,ND6,P03923,0.544,0.808,,,,C0917796,"Optic Atrophy, Hereditary, Leber",C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,1992.0,2019.0,ALL
4542,MYO1F,O00160,0.722,0.385,2.3663e-07,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
4543,MTNR1A,P48039,0.59,0.808,7.2327e-07,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2011.0,ALL
4544,MTNR1B,P49286,0.588,0.731,0.00064771,DTO_02300001,G-protein coupled receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.5,0.987,,2008.0,2020.0,ALL
4547,MTTP,P55157,0.505,0.846,1.04e-05,DTO_05007405,Transporter,C0000744,Abetalipoproteinemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.982,,1985.0,2019.0,ALL
4548,MTR,Q99707,0.482,0.808,2.4301e-12,,,C1855128,"Methylcobalamin Deficiency, CblG Type",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,1996.0,2017.0,ALL
4549,RNR1,A0A0C5B5G6,0.626,0.769,,,,C1857332,"Deafness, Sensorineural, Autosomal-Mitochondrial Type",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.5,1.0,,2013.0,2013.0,ALL
4550,RNR2,Q8IVG9,0.603,0.692,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2014.0,2014.0,ALL
4552,MTRR,Q9UBK8,0.502,0.808,2.1794e-14,,,C1856057,"Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type",C16;C18;C17;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,,1998.0,2016.0,ALL
4553,TRNA,,0.931,0.192,,,,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.11,1.0,,2006.0,2009.0,ALL
4555,TRND,,1.0,,,,,C4016606,"MITOCHONDRIAL MYOPATHY, ISOLATED",,,disease,Finding,0.1,,,,,ALL
4556,TRNE,,0.647,0.692,,,,C0342289,Diabetes-deafness syndrome maternally transmitted (disorder),C23;C18;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.4,1.0,,1997.0,1997.0,ALL
4558,TRNF,,0.582,0.731,,,,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,,1998.0,2010.0,ALL
4563,TRNG,,1.0,0.077,,,,C0424551,Impaired exercise tolerance,,,phenotype,Finding,0.1,,,,,ALL
4564,TRNH,,0.597,0.731,,,,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2004.0,2004.0,ALL
4565,TRNI,,0.743,0.385,,,,C0162672,MERRF Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.4,,,,,ALL
4566,TRNK,,0.608,0.577,,,,C0162672,MERRF Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.43,1.0,,2003.0,2016.0,ALL
4567,TRNL1,,0.534,0.731,,,,C0162672,MERRF Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.62,1.0,,1993.0,2011.0,ALL
4568,TRNL2,,0.76,0.385,,,,C0162674,Chronic progressive external ophthalmoplegia,C23;C18;C11;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.4,1.0,,2013.0,2013.0,ALL
4569,TRNM,,0.931,0.231,,,,C0162670,Mitochondrial Myopathies,C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.12,1.0,,2014.0,2018.0,ALL
4570,TRNN,,0.682,0.577,,,,C0162674,Chronic progressive external ophthalmoplegia,C23;C18;C11;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.4,1.0,,2013.0,2013.0,ALL
4571,TRNP,,0.792,0.423,,,,C0162672,MERRF Syndrome,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,,2009.0,2016.0,ALL
4572,TRNQ,,0.59,0.731,,,,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,,,,,ALL
4573,TRNR,,1.0,0.115,,,,C0162666,Mitochondrial Encephalomyopathies,C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
4574,TRNS1,,0.555,0.808,,,,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.61,1.0,,1995.0,2010.0,ALL
4575,TRNS2,,0.579,0.731,,,,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.5,1.0,,2006.0,2006.0,ALL
4576,TRNT,,0.729,0.538,,,,C1838876,"MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE",C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.6,1.0,,1991.0,1991.0,ALL
4577,TRNV,,0.67,0.423,,,,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,1998.0,2015.0,ALL
4578,TRNW,,0.563,0.731,,,,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.61,1.0,,1998.0,2015.0,ALL
4579,TRNY,,0.931,0.231,,,,C0022541,Kearns-Sayre syndrome,C23;C18;C11;C05;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
4580,MTX1,Q13505,0.546,0.731,0.013271,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.13,1.0,,1999.0,2016.0,ALL
4582,MUC1,P15941,0.384,0.885,0.018774,,,C1868139,Medullary cystic kidney disease 1,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.64,1.0,,2000.0,2017.0,ALL
4583,MUC2,Q02817,0.486,0.808,9.433e-10,DTO_05007584,Enzyme modulator,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,1994.0,2019.0,ALL
4584,MUC3A,Q02505,0.636,0.5,1.4752e-10,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,0.778,,1994.0,2007.0,ALL
4585,MUC4,Q99102,0.506,0.769,2.7904e-54,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.32,1.0,,2005.0,2007.0,ALL
4586,MUC5AC,P98088,0.483,0.808,9.9887e-09,DTO_05007584,Enzyme modulator,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2001.0,2020.0,ALL
4588,MUC6,Q6W4X9,0.559,0.615,2.2123e-39,DTO_05007584,Enzyme modulator,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,1997.0,2014.0,ALL
4589,MUC7,Q8TAX7,0.674,0.731,0.014582,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.43,0.333,,2001.0,2009.0,ALL
4591,TRIM37,O94972,0.61,0.654,9.7042e-12,,,C0524582,Mulibrey Nanism,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,1.0,,1999.0,2020.0,ALL
4593,MUSK,O15146,0.57,0.769,4.2474e-08,DTO_03300101,Kinase,C4225368,"MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY",,,disease,Disease or Syndrome,0.81,1.0,strong,2004.0,2019.0,ALL
4594,MMUT,P22033,0.534,0.731,1.7087e-22,DTO_05007624,Enzyme,C1855114,Methylmalonic Aciduria due to Methylmalonyl-CoA Mutase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.9,1.0,definitive,1972.0,2017.0,ALL
4595,MUTYH,Q9UIF7,0.521,0.769,1.2619e-18,DTO_05007624,Enzyme,C1837991,"Colorectal Adenomatous Polyposis, Autosomal Recessive",C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Disease or Syndrome,0.71,1.0,definitive,1987.0,2018.0,ALL
4597,MVD,P53602,0.568,0.769,2.7438e-17,,,C3553549,"POROKERATOSIS 7, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2017.0,ALL
4598,MVK,Q03426,0.576,0.731,0.16679,DTO_03300101,Kinase,C0398691,Hyperimmunoglobulinemia D,C16;C18;C20;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,,1997.0,2019.0,ALL
4599,MX1,P20591,0.599,0.731,3.4206e-18,DTO_05007584,Enzyme modulator,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.4,1.0,,1995.0,2019.0,ALL
4600,MX2,P20592,0.751,0.231,6.4792e-09,DTO_05007584,Enzyme modulator,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.41,1.0,,2011.0,2019.0,ALL
4601,MXI1,P50539,0.547,0.615,0.0011217,DTO_05007542,Transcription factor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.66,1.0,,1995.0,2001.0,ALL
4602,MYB,P10242,0.49,0.692,0.81924,,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.59,1.0,,2007.0,2019.0,ALL
4603,MYBL1,P10243,0.705,0.308,1.0,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2013.0,2019.0,ALL
4604,MYBPC1,Q00872,0.666,0.462,4.835e-05,,,C3280526,"ARTHROGRYPOSIS, DISTAL, TYPE 1B",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2016.0,ALL
4605,MYBL2,P10244,0.59,0.538,0.12226,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2011.0,2019.0,ALL
4606,MYBPC2,Q14324,0.861,0.115,3.8252e-23,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2002.0,2005.0,ALL
4607,MYBPC3,Q14896,0.593,0.385,8.0087e-11,,,C1861862,Familial Hypertrophic Cardiomyopathy Type 4,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.9,1.0,definitive,1990.0,2019.0,ALL
4608,MYBPH,Q13203,0.678,0.577,2.2535e-13,,,C0038522,Subacute Sclerosing Panencephalitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,1994.0,2020.0,ALL
4609,MYC,P01106,0.344,0.923,0.99801,DTO_05007542,Transcription factor,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,1.0,0.977,,1982.0,2020.0,ALL
4610,MYCL,P12524,0.599,0.731,0.11551,DTO_05007542,Transcription factor,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.4,1.0,,1987.0,2017.0,ALL
4611,MYCLP1,P12525,0.89,0.077,,DTO_05007542,Transcription factor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
4613,MYCN,P04198,0.454,0.808,0.88897,DTO_05007542,Transcription factor,C4551774,FEINGOLD SYNDROME 1,C23;C16;C06;C05;C08;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.71,0.75,,2005.0,2018.0,ALL
4615,MYD88,Q99836,0.414,0.923,0.12443,DTO_05007584,Enzyme modulator,C2677092,MYD88 Deficiency,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.76,0.909,,2008.0,2019.0,ALL
4616,GADD45B,O75293,0.585,0.769,0.21058,,,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
4617,MYF5,P13349,0.686,0.423,0.00022918,DTO_05007542,Transcription factor,C4748418,"OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES",,,disease,Disease or Syndrome,0.6,1.0,moderate,2018.0,2018.0,ALL
4618,MYF6,P23409,0.691,0.423,0.0041218,DTO_05007542,Transcription factor,C1834558,"Myopathy, Centronuclear, Autosomal Dominant",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,,,,,ALL
4619,MYH1,P12882,0.805,0.5,1.3645e-56,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
4620,MYH2,Q9UKX2,0.619,0.731,3.6703e-23,,,C1854106,"INCLUSION BODY MYOPATHY 3, AUTOSOMAL DOMINANT",C23;C11;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2000.0,2014.0,ALL
4621,MYH3,P11055,0.563,0.654,6.7197e-21,,,C0265224,Freeman-Sheldon syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1997.0,2019.0,ALL
4622,MYH4,Q9Y623,0.839,0.231,1.0355e-55,,,C0149940,Sciatic Neuropathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0,,2004.0,2004.0,ALL
4624,MYH6,P13533,0.581,0.615,1.5952e-32,,,C2750466,"Cardiomyopathy, Dilated, 1EE",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.9,1.0,,2005.0,2017.0,ALL
4625,MYH7,P12883,0.516,0.692,4.2385e-16,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.8,0.988,definitive,1990.0,2019.0,ALL
4626,MYH8,P13535,0.682,0.385,2.0456e-51,,,C0265226,Hecht syndrome (disorder),C23;C16;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.73,1.0,,1996.0,2017.0,ALL
4627,MYH9,P35579,0.505,0.808,1.0,,,C0340978,May-Hegglin anomaly,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",phenotype,Disease or Syndrome,1.0,1.0,definitive,1998.0,2020.0,ALL
4628,MYH10,P35580,0.705,0.423,1.0,,,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0,,1998.0,1998.0,ALL
4629,MYH11,P35749,0.528,0.731,0.77299,,,C1851504,"Aortic aneurysm, familial thoracic 4",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2016.0,ALL
4632,MYL1,P05976,0.839,0.346,0.00013017,DTO_05007616,Calcium-binding protein,C0270960,Congenital myopathy (disorder),C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Congenital Abnormality,0.31,1.0,strong,2018.0,2018.0,ALL
4633,MYL2,P10916,0.601,0.615,2.7303e-08,DTO_05007616,Calcium-binding protein,C1834460,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,definitive,1980.0,2019.0,ALL
4634,MYL3,P08590,0.695,0.308,0.087906,DTO_05007616,Calcium-binding protein,C1837471,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1996.0,2019.0,ALL
4635,MYL4,P12829,0.729,0.423,0.00012029,DTO_05007616,Calcium-binding protein,C4310636,"ATRIAL FIBRILLATION, FAMILIAL, 18",,,disease,Disease or Syndrome,0.5,1.0,,2016.0,2016.0,ALL
4636,MYL5,Q02045,0.89,0.077,8.4023e-14,DTO_05007616,Calcium-binding protein,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
4638,MYLK,Q15746,0.51,0.846,9.1706e-12,DTO_03300101,Kinase,C3151077,"AORTIC ANEURYSM, FAMILIAL THORACIC 7",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2017.0,ALL
4640,MYO1A,Q9UBC5,0.769,0.269,8.897e-46,DTO_05007530,Cellular structure,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.3,,limited,,,ALL
4641,MYO1C,O00159,0.7,0.423,1.639e-14,DTO_05007530,Cellular structure,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
4642,MYO1D,O94832,0.78,0.269,1.2784e-12,DTO_05007530,Cellular structure,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
4643,MYO1E,Q12965,0.711,0.385,6.769e-05,DTO_05007530,Cellular structure,C3279905,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6,,,disease,Disease or Syndrome,0.6,1.0,strong,2011.0,2013.0,ALL
4644,MYO5A,Q9Y4I1,0.628,0.615,0.944,DTO_05007530,Cellular structure,C1859194,"GRISCELLI SYNDROME, TYPE 1",C23;C16;C18;C17;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.9,1.0,,1997.0,2011.0,ALL
4645,MYO5B,Q9ULV0,0.641,0.731,3.3805e-23,DTO_05007530,Cellular structure,C0341306,Microvillus inclusion disease,C16;C06;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.958,,2008.0,2019.0,ALL
4646,MYO6,Q9UM54,0.631,0.731,2.4287e-05,DTO_05007530,Cellular structure,C1843028,"Deafness, Autosomal Recessive 37",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1995.0,2005.0,ALL
4647,MYO7A,Q13402,0.585,0.423,1.6097e-38,DTO_05007530,Cellular structure,C1568247,"Usher Syndrome, Type I",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,1.0,0.99,definitive,1956.0,2020.0,ALL
4648,MYO7B,Q6PIF6,1.0,0.115,8.9527e-31,DTO_05007530,Cellular structure,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
4649,MYO9A,B2RTY4,0.647,0.5,0.48923,,,C0003886,Arthrogryposis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.6,1.0,limited,1998.0,2016.0,ALL
4650,MYO9B,Q13459,0.644,0.615,1.0,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.6,0.792,limited,2005.0,2017.0,ALL
4651,MYO10,Q9HD67,0.678,0.462,3.1562e-05,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
4653,MYOC,Q99972,0.595,0.5,7.633e-12,DTO_05007530,Cellular structure,C1842028,"GLAUCOMA 1, OPEN ANGLE, A",C11,   Eye Diseases,disease,Disease or Syndrome,0.72,1.0,strong,1996.0,2015.0,ALL
4654,MYOD1,P15172,0.569,0.654,0.15239,DTO_05007542,Transcription factor,C0035412,Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.917,,1989.0,2020.0,ALL
4656,MYOG,P15173,0.623,0.615,0.89602,DTO_05007542,Transcription factor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.2,1.0,,2008.0,2008.0,ALL
4657,MYP1,,0.821,0.154,,,,C0271183,Severe myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.08,1.0,,2004.0,2015.0,ALL
4658,MYP2,,0.659,0.308,,,,C0271183,Severe myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2001.0,2019.0,ALL
4659,PPP1R12A,O14974,0.626,0.615,1.0,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,,1993.0,2020.0,ALL
4660,PPP1R12B,O60237,0.769,0.269,0.00012038,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
4661,MYT1,Q01538,0.722,0.423,0.97791,DTO_05007542,Transcription factor,C0265240,Goldenhar Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
4664,NAB1,Q13506,0.805,0.269,0.021949,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2015.0,ALL
4665,NAB2,Q15742,0.641,0.577,0.56734,,,C1266119,Solitary fibrous tumor,C04,   Neoplasms,disease,Neoplastic Process,0.6,0.974,,2013.0,2020.0,ALL
4666,NACA,Q13765,0.78,0.269,4.7299e-05,DTO_05007542,Transcription factor,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
4668,NAGA,P17050,0.647,0.538,1.7703e-11,,,C1836544,"Schindler Disease, Type I",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.77,1.0,strong,1975.0,2020.0,ALL
4669,NAGLU,P54802,0.546,0.769,1.3655e-08,,,C0026706,Mucopolysaccharidosis III,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.85,1.0,,1999.0,2019.0,ALL
4670,HNRNPM,P52272,0.729,0.346,0.99999,DTO_05007557,Nucleic acid binding,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
4671,NAIP,Q13075,0.636,0.654,0.00016166,,,C0043116,HMN (Hereditary Motor Neuropathy) Proximal Type I,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.33,1.0,,1997.0,2002.0,ALL
4673,NAP1L1,P55209,0.647,0.692,0.99941,DTO_05007584,Enzyme modulator,C0242184,Hypoxia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.2,1.0,,2014.0,2014.0,ALL
4674,NAP1L2,Q9ULW6,0.839,0.192,0.78108,DTO_05007584,Enzyme modulator,C0001144,Acne Vulgaris,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
4676,NAP1L4,Q99733,0.861,0.231,0.77147,DTO_05007584,Enzyme modulator,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
4677,NARS1,O43776,0.722,0.423,2.9489e-09,DTO_05007624,Enzyme,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,0.903,,2015.0,2020.0,ALL
4678,NASP,P49321,0.805,0.077,0.99553,,,C0518015,Hemoglobin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
4680,CEACAM6,P40199,0.561,0.731,1.1884e-06,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
4681,NBL1,P41271,0.67,0.5,0.059018,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
4682,NUBP1,P53384,0.743,0.231,8.7342e-14,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.04,1.0,,2010.0,2018.0,ALL
4683,NBN,O60934,0.467,0.808,2.1838e-16,DTO_05007557,Nucleic acid binding,C0398791,Nijmegen Breakage Syndrome,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,1.0,0.981,definitive,1985.0,2019.0,ALL
4684,NCAM1,P13591,0.415,0.885,0.99999,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,1997.0,2019.0,ALL
4685,NCAM2,O15394,0.736,0.5,0.2306,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
4686,NCBP1,Q09161,0.839,0.077,1.0,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1987.0,1987.0,ALL
4688,NCF2,P19878,0.601,0.692,4.0054e-07,DTO_05007624,Enzyme,C1856245,"Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type II",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,,1994.0,2014.0,ALL
4689,NCF4,Q15080,0.644,0.615,9.0248e-08,,,C3151409,"GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III",,,disease,Disease or Syndrome,0.6,1.0,,2007.0,2018.0,ALL
4690,NCK1,P16333,0.638,0.5,0.0020702,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.3,1.0,,2009.0,2009.0,ALL
4691,NCL,P19338,0.509,0.808,0.99992,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2012.0,2016.0,ALL
4692,NDN,Q99608,0.578,0.654,0.67495,DTO_05007557,Nucleic acid binding,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.6,0.972,,1997.0,2017.0,ALL
4693,NDP,Q00604,0.566,0.692,0.65042,,,C0266526,Norrie disease,C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Congenital Abnormality,1.0,1.0,definitive,1992.0,2019.0,ALL
4694,NDUFA1,O15239,0.636,0.423,0.55315,,,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.7,1.0,,2007.0,2018.0,ALL
4695,NDUFA2,O43678,0.617,0.577,0.77351,DTO_05007624,Enzyme,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.52,1.0,moderate,1998.0,2018.0,ALL
4696,NDUFA3,O95167,1.0,0.077,0.071883,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
4697,NDUFA4,O00483,0.695,0.462,0.023901,DTO_05007624,Enzyme,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.3,1.0,strong,2018.0,2018.0,ALL
4698,NDUFA5,Q16718,0.839,0.231,0.0018728,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
4700,NDUFA6,P56556,0.711,0.346,0.00013244,DTO_05007624,Enzyme,C4748840,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33",,,disease,Disease or Syndrome,0.6,1.0,,2018.0,2018.0,ALL
4701,NDUFA7,O95182,0.931,0.115,6.6032e-05,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
4702,NDUFA8,P51970,1.0,0.077,0.34407,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
4703,NEB,P20929,0.608,0.692,4.5589e-41,,,C1850569,Nemaline Myopathy 2,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.92,1.0,definitive,1998.0,2018.0,ALL
4704,NDUFA9,Q16795,0.653,0.385,0.0047988,DTO_05007624,Enzyme,C4748809,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26",,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2018.0,ALL
4705,NDUFA10,O95299,0.678,0.385,6.2418e-08,DTO_05007624,Enzyme,C4748796,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22",,,disease,Disease or Syndrome,0.6,1.0,strong,2011.0,2016.0,ALL
4706,NDUFAB1,O14561,0.656,0.692,0.52661,DTO_05007405,Transporter,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.05,1.0,,2001.0,2017.0,ALL
4708,NDUFB2,O95178,0.743,0.538,1.0531e-05,,,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
4709,NDUFB3,O43676,0.705,0.538,1.6105e-05,,,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.6,1.0,strong,2012.0,2016.0,ALL
4711,NDUFB5,O43674,1.0,0.038,0.00073075,DTO_05007624,Enzyme,C0520863,Diastolic dysfunction,,,phenotype,Pathologic Function,0.2,1.0,,2015.0,2015.0,ALL
4712,NDUFB6,O95139,0.821,0.231,0.00016201,,,C0020557,Hypertriglyceridemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
4713,NDUFB7,P17568,0.89,0.192,0.0031709,DTO_05007624,Enzyme,C0019202,Hepatolenticular Degeneration,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
4714,NDUFB8,O95169,0.638,0.654,0.0074738,DTO_05007624,Enzyme,C4748839,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32",,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2018.0,ALL
4715,NDUFB9,Q9Y6M9,0.7,0.385,0.00016312,DTO_05007624,Enzyme,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.5,1.0,moderate,2012.0,2012.0,ALL
4716,NDUFB10,O96000,0.729,0.308,0.0047516,,,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
4718,NDUFC2,O95298,0.805,0.308,0.68071,DTO_05007624,Enzyme,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.21,1.0,,2016.0,2016.0,ALL
4719,NDUFS1,P28331,0.595,0.692,6.626e-11,DTO_05007624,Enzyme,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.62,1.0,,2001.0,2016.0,ALL
4720,NDUFS2,O75306,0.601,0.654,0.0014212,DTO_05007624,Enzyme,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.61,1.0,,2004.0,2016.0,ALL
4722,NDUFS3,O75489,0.581,0.769,0.00058312,,,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.64,1.0,moderate,1998.0,2018.0,ALL
4723,NDUFV1,P49821,0.617,0.538,6.3562e-11,,,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.64,1.0,,1999.0,2018.0,ALL
4724,NDUFS4,O43181,0.587,0.808,0.00031196,,,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.968,definitive,2001.0,2019.0,ALL
4725,NDUFS5,O43920,,,0.026413,,,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.3,,limited,,,ALL
4726,NDUFS6,O75380,0.686,0.423,0.096359,DTO_05007624,Enzyme,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.71,1.0,,2004.0,2016.0,ALL
4728,NDUFS8,O00217,0.636,0.538,0.16592,DTO_05007624,Enzyme,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.63,1.0,moderate,1998.0,2018.0,ALL
4729,NDUFV2,P19404,0.61,0.5,0.005576,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.59,1.0,,2003.0,2015.0,ALL
4730,NDUFV2P1,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
4731,NDUFV3,P56181,0.89,0.154,2.8018e-18,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2000.0,2000.0,ALL
4733,DRG1,Q9Y295,0.682,0.346,0.32895,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.15,1.0,,2000.0,2017.0,ALL
4734,NEDD4,P46934,0.569,0.846,8.7208e-13,DTO_05007624,Enzyme,C0022548,Keloid,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Acquired Abnormality,0.44,1.0,,2010.0,2019.0,ALL
4735,SEPTIN2,Q15019,0.653,0.462,0.28815,DTO_05007584,Enzyme modulator,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0,,2005.0,2005.0,ALL
4736,RPL10A,P62906,0.861,0.192,0.85357,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
4738,NEDD8,Q15843,0.576,0.692,0.84938,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.917,,2002.0,2019.0,ALL
4739,NEDD9,Q14511,0.548,0.769,0.12634,,,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.12,1.0,,2014.0,2018.0,ALL
4741,NEFM,P07197,0.674,0.577,0.017983,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2009.0,2009.0,ALL
4744,NEFH,P12036,0.588,0.769,2.6684e-12,,,C4310790,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC",,,disease,Disease or Syndrome,0.6,,,,,ALL
4745,NELL1,Q92832,0.539,0.731,8.6694e-12,DTO_05007616,Calcium-binding protein,C0010278,Craniosynostosis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.56,1.0,,2002.0,2020.0,ALL
4747,NEFL,P07196,0.488,0.769,,,,C1843225,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.95,1.0,,2000.0,2019.0,ALL
4750,NEK1,Q96PY6,0.575,0.769,1.9084e-25,DTO_03300101,Kinase,C0024507,Majewski Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.72,1.0,,2011.0,2012.0,ALL
4751,NEK2,P51955,0.572,0.692,1.1514e-06,DTO_03300101,Kinase,C3809954,RETINITIS PIGMENTOSA 67,,,disease,Disease or Syndrome,0.6,,limited,,,ALL
4752,NEK3,P51956,0.821,0.154,5.3204e-18,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.05,1.0,,2005.0,2019.0,ALL
4753,NELL2,Q99435,0.641,0.462,0.99952,DTO_05007616,Calcium-binding protein,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
4756,NEO1,Q92859,0.623,0.692,0.24398,,,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
4758,NEU1,Q99519,0.513,0.769,7.3441e-05,DTO_05007624,Enzyme,C4282398,Sialidase deficiency,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,strong,1996.0,2014.0,ALL
4759,NEU2,Q9Y3R4,0.743,0.346,4.5314e-14,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2007.0,2009.0,ALL
4760,NEUROD1,Q13562,0.543,0.808,0.77109,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.8,0.92,strong,1999.0,2018.0,ALL
4761,NEUROD2,Q15784,0.619,0.538,0.94202,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2011.0,2011.0,ALL
4762,NEUROG1,Q92886,0.656,0.538,0.00021722,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2007.0,2008.0,ALL
4763,NF1,P21359,0.44,0.885,0.90175,DTO_05007584,Enzyme modulator,C0027831,Neurofibromatosis 1,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,1.0,0.976,,1977.0,2020.0,ALL
4771,NF2,P35240,0.468,0.885,1.0,,,C0027832,Neurofibromatosis 2,C16;C04;C10;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Neoplastic Process,1.0,0.987,definitive,1991.0,2020.0,ALL
4772,NFATC1,O95644,0.517,0.731,0.15652,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
4773,NFATC2,Q13469,0.525,0.731,0.99995,DTO_05007542,Transcription factor,C0020542,Pulmonary Hypertension,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.5,1.0,,2007.0,2017.0,ALL
4774,NFIA,Q12857,0.599,0.808,0.99959,DTO_05007557,Nucleic acid binding,C4478940,BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS,,,disease,Congenital Abnormality,0.6,1.0,limited,2007.0,2007.0,ALL
4775,NFATC3,Q12968,0.636,0.538,0.99813,DTO_05007542,Transcription factor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2014.0,2019.0,ALL
4776,NFATC4,Q14934,0.691,0.538,0.8679,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
4778,NFE2,Q16621,0.628,0.577,0.66693,DTO_05007624,Enzyme,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2014.0,ALL
4779,NFE2L1,Q14494,0.678,0.538,0.99759,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.21,1.0,,2017.0,2017.0,ALL
4780,NFE2L2,Q16236,0.357,0.885,0.0035719,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.6,0.962,,2006.0,2020.0,ALL
4781,NFIB,O00712,0.573,0.654,0.99861,DTO_05007557,Nucleic acid binding,C4748993,"MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT",,,disease,Disease or Syndrome,0.6,1.0,,2018.0,2018.0,ALL
4782,NFIC,P08651,0.626,0.654,0.090534,DTO_05007557,Nucleic acid binding,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
4783,NFIL3,Q16649,0.633,0.615,0.81979,DTO_05007542,Transcription factor,C0393770,Delayed Sleep Phase Syndrome,C10;F03;C24,   Nervous System Diseases;    Mental Disorders;    Occupational Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
4784,NFIX,Q14938,0.547,0.769,0.99903,DTO_05007557,Nucleic acid binding,C3553660,Malan overgrowth syndrome,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.79,1.0,,2010.0,2019.0,ALL
4790,NFKB1,P19838,0.396,0.923,1.0,DTO_05007542,Transcription factor,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.56,1.0,,2015.0,2018.0,ALL
4791,NFKB2,Q00653,0.509,0.808,1.0,DTO_05007542,Transcription factor,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.78,1.0,,1998.0,2019.0,ALL
4792,NFKBIA,P25963,0.487,0.885,0.99452,,,C2677481,"Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2003.0,2012.0,ALL
4793,NFKBIB,Q15653,0.743,0.462,0.42245,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
4794,NFKBIE,O00221,0.7,0.385,0.77098,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.42,1.0,,2012.0,2016.0,ALL
4795,NFKBIL1,Q9UBC1,0.653,0.615,0.025515,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.47,1.0,,2001.0,2011.0,ALL
4796,TONSL,Q96HA7,0.653,0.615,2.5965e-13,,,C1300260,"Spondyloepimetaphyseal dysplasia, sponastrime type",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.32,1.0,,2019.0,2019.0,ALL
4798,NFRKB,Q6P4R8,1.0,0.077,0.13431,DTO_05007557,Nucleic acid binding,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
4799,NFX1,Q12986,1.0,0.077,0.00011474,DTO_05007542,Transcription factor,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
4800,NFYA,P23511,0.65,0.654,0.14619,DTO_05007557,Nucleic acid binding,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.32,1.0,,2005.0,2019.0,ALL
4801,NFYB,P25208,0.729,0.385,0.00024967,,,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0,,2007.0,2013.0,ALL
4802,NFYC,Q13952,0.792,0.423,0.10847,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
4803,NGF,P01138,0.391,0.885,0.82026,DTO_05007599,Signaling,C0020075,"Hereditary Sensory Autonomic Neuropathy, Type 5",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.95,,1992.0,2019.0,ALL
4804,NGFR,P08138,0.477,0.846,0.097889,DTO_05007575,Receptor,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,1999.0,2003.0,ALL
4807,NHLH1,Q02575,0.686,0.538,0.25683,DTO_05007542,Transcription factor,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,0.981,,2009.0,2019.0,ALL
4808,NHLH2,Q02577,0.821,0.231,0.57964,DTO_05007542,Transcription factor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.34,1.0,,2006.0,2017.0,ALL
4809,SNU13,P55769,0.78,0.346,0.74848,DTO_05007557,Nucleic acid binding,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
4810,NHS,Q6T4R5,0.466,0.846,0.99999,,,C0796085,Nance-Horan syndrome,C16;C11;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1991.0,2019.0,ALL
4811,NID1,P14543,0.631,0.577,7.2197e-12,,,C0010964,Dandy-Walker Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.42,1.0,,2013.0,2019.0,ALL
4812,NIDDM1,,0.89,0.115,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.08,1.0,,1998.0,2008.0,ALL
4813,NIDDM2,,0.931,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.08,1.0,,1996.0,2011.0,ALL
4814,NINJ1,Q92982,0.67,0.577,0.11745,DTO_05007620,Cell adhesion,C0162820,"Dermatitis, Allergic Contact",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
4815,NINJ2,Q9NZG7,0.751,0.269,0.0010696,DTO_05007620,Cell adhesion,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
4817,NIT1,Q86X76,0.792,0.192,8.9425e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2006.0,2018.0,ALL
4818,NKG7,Q16617,0.839,0.154,0.00014538,DTO_05007530,Cellular structure,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,1999.0,1999.0,ALL
4820,NKTR,P30414,0.76,0.346,0.94032,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.03,1.0,,2017.0,2019.0,ALL
4821,NKX2-2,O95096,0.678,0.269,0.41392,DTO_05007542,Transcription factor,C0158981,Neonatal diabetes mellitus,C16;C18;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.31,1.0,strong,2014.0,2014.0,ALL
4824,NKX3-1,Q99801,0.722,0.269,0.00047049,DTO_05007542,Transcription factor,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.6,1.0,,1999.0,2013.0,ALL
4825,NKX6-1,P78426,0.76,0.231,0.062705,DTO_05007542,Transcription factor,C0002152,Alloxan Diabetes,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.3,1.0,,2005.0,2005.0,ALL
4826,NNAT,Q16517,0.633,0.538,0.40136,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2007.0,2007.0,ALL
4827,NM,,0.473,0.808,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,0.917,,2000.0,2020.0,ALL
4828,NMB,P08949,0.729,0.423,0.019529,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.24,1.0,,1991.0,2016.0,ALL
4829,NMBR,P28336,0.711,0.423,1.9761e-08,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2013.0,2013.0,ALL
4830,NME1,P15531,0.443,0.808,0.0031764,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,0.885,,1991.0,2018.0,ALL
4831,NME2,P22392,0.573,0.731,8.8471e-09,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,1995.0,2018.0,ALL
4832,NME3,Q13232,0.711,0.346,5.7291e-08,DTO_03300101,Kinase,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,1997.0,2013.0,ALL
4833,NME4,O00746,0.76,0.308,0.0010351,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,0.667,,2001.0,2019.0,ALL
4835,NQO2,P16083,0.628,0.5,8.7572e-07,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.43,1.0,,2009.0,2011.0,ALL
4836,NMT1,P30419,0.78,0.423,0.9955,DTO_05007624,Enzyme,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
4837,NNMT,P40261,0.559,0.654,5.2791e-08,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2012.0,2014.0,ALL
4838,NODAL,Q96S42,0.588,0.731,0.97028,DTO_05007599,Signaling,C3495537,"Heterotaxy, Visceral, 5, Autosomal",C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.7,1.0,,1997.0,2009.0,ALL
4839,NOP2,P46087,0.656,0.5,0.99996,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,1993.0,2019.0,ALL
4841,NONO,Q15233,0.554,0.731,0.9935,DTO_05007557,Nucleic acid binding,C4225417,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 34",,,disease,Mental or Behavioral Dysfunction,0.7,1.0,strong,2015.0,2017.0,ALL
4842,NOS1,P29475,0.408,0.885,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,0.964,,1995.0,2019.0,ALL
4843,NOS2,P35228,0.364,0.923,4.0277e-15,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.6,0.9,,1997.0,2020.0,ALL
4846,NOS3,P29474,0.378,0.885,6.7246e-07,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.7,0.942,,1996.0,2019.0,ALL
4848,CNOT2,Q9NZN8,0.805,0.269,0.99981,DTO_05007542,Transcription factor,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
4849,CNOT3,O75175,0.686,0.615,1.0,DTO_05007542,Transcription factor,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.64,0.75,,2013.0,2019.0,ALL
4850,CNOT4,O95628,0.839,0.192,0.99996,DTO_05007557,Nucleic acid binding,C0489786,Height,,,phenotype,Organism Attribute,0.1,1.0,,2011.0,2011.0,ALL
4851,NOTCH1,P46531,0.369,0.885,1.0,,,C0149630,Bicuspid aortic valve,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.7,0.955,,2005.0,2019.0,ALL
4852,NPY,P01303,0.447,0.846,0.14294,DTO_05007599,Signaling,C0085762,Alcohol abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.72,1.0,,2003.0,2017.0,ALL
4853,NOTCH2,Q04721,0.441,0.808,1.0,,,C0917715,Hajdu-Cheney Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.968,,1996.0,2019.0,ALL
4854,NOTCH3,Q9UM47,0.435,0.808,0.40757,,,C4551768,"CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1",,,disease,Disease or Syndrome,0.8,1.0,,1997.0,2016.0,ALL
4855,NOTCH4,Q99466,0.534,0.731,2.0544e-23,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,0.75,,2000.0,2019.0,ALL
4856,CCN3,P48745,0.554,0.615,0.0066442,DTO_05007599,Signaling,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
4857,NOVA1,P51513,0.67,0.5,0.99621,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
4858,NOVA2,Q9UNW9,0.769,0.192,0.98259,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
4860,PNP,P00491,0.527,0.885,6.9987e-06,DTO_05007624,Enzyme,C0268125,Purine-nucleoside phosphorylase deficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.96,1.0,,1979.0,2018.0,ALL
4861,NPAS1,Q99742,0.861,0.154,0.97067,DTO_05007542,Transcription factor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2004.0,2017.0,ALL
4862,NPAS2,Q99743,0.595,0.654,1.0,,,C0085159,Seasonal Affective Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2003.0,2015.0,ALL
4863,NPAT,Q14207,0.751,0.308,0.28233,,,C3547187,response to metformin,,,phenotype,Cell Function,0.1,1.0,,2011.0,2011.0,ALL
4864,NPC1,O15118,0.518,0.692,6.5418e-06,DTO_05007405,Transporter,C3179455,"Niemann-Pick Disease, Type C1",C16;C18;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.994,strong,1988.0,2020.0,ALL
4867,NPHP1,O15259,0.572,0.731,1.241e-17,,,C4551979,Nephronophthisis 1,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.8,0.952,,1977.0,2016.0,ALL
4868,NPHS1,O60500,0.597,0.615,2.5376e-14,,,C0403399,Finnish congenital nephrotic syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.8,1.0,,1998.0,2019.0,ALL
4869,NPM1,P06748,0.464,0.846,0.99816,DTO_05007613,Chaperone,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.7,0.983,,1996.0,2020.0,ALL
4871,NPM1P2,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
4878,NPPA,P01160,0.505,0.769,0.00054522,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.6,1.0,,1989.0,2019.0,ALL
4879,NPPB,P16860,0.513,0.808,9.8786e-06,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.6,0.985,,1991.0,2020.0,ALL
4880,NPPC,P23582,0.568,0.769,0.060647,DTO_05007599,Signaling,C0041956,Ureteral obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Disease or Syndrome,0.31,1.0,,2014.0,2015.0,ALL
4881,NPR1,P16066,0.608,0.654,0.00029303,DTO_03300101,Kinase,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.6,0.917,,1997.0,2017.0,ALL
4882,NPR2,P20594,0.573,0.615,4.2042e-05,DTO_03300101,Kinase,C1864356,"ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.95,1.0,,2004.0,2019.0,ALL
4883,NPR3,P17342,0.633,0.615,1.006e-05,,,C0003706,Arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.3,1.0,,1999.0,1999.0,ALL
4884,NPTX1,Q15818,0.691,0.385,0.62501,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,2017.0,2018.0,ALL
4885,NPTX2,P47972,0.617,0.615,0.030511,,,C0038587,Substance Withdrawal Syndrome,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2009.0,2009.0,ALL
4886,NPY1R,P25929,0.628,0.423,0.042605,DTO_02300001,G-protein coupled receptor,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.51,1.0,,2001.0,2015.0,ALL
4887,NPY2R,P49146,0.612,0.577,0.035526,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.53,1.0,,2008.0,2017.0,ALL
4889,NPY5R,Q15761,0.691,0.462,0.0063686,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.52,0.75,,1996.0,2007.0,ALL
4891,SLC11A2,P49281,0.566,0.769,0.0066528,DTO_05007405,Transporter,C2673913,"Anemia, Hypochromic Microcytic, With Iron Overload",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.63,1.0,,2006.0,2011.0,ALL
4892,NRAP,Q86VF7,0.861,0.115,3.2577e-50,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
4893,NRAS,P01111,0.39,0.808,0.49009,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.8,0.966,strong,1993.0,2020.0,ALL
4897,NRCAM,Q92823,0.666,0.423,0.015254,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.51,1.0,,2008.0,2011.0,ALL
4898,NRDC,O43847,0.647,0.5,0.044066,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2015.0,ALL
4899,NRF1,Q16656,0.603,0.808,0.99922,,,C0006079,Bowen's Disease,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
4900,NRGN,Q92686,0.608,0.615,0.4819,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,0.967,,2008.0,2019.0,ALL
4901,NRL,P54845,0.647,0.462,0.047637,DTO_05007542,Transcription factor,C1834329,RETINITIS PIGMENTOSA 27,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,1999.0,2012.0,ALL
4902,NRTN,Q99748,0.686,0.538,0.030223,DTO_05007599,Signaling,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.15,1.0,,1998.0,2011.0,ALL
4904,YBX1,P67809,0.519,0.769,0.94646,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.967,,2002.0,2019.0,ALL
4905,NSF,P46459,0.659,0.577,0.018338,DTO_05007624,Enzyme,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2012.0,2016.0,ALL
4907,NT5E,P21589,0.436,0.885,2.2881e-11,DTO_05007624,Enzyme,C1859372,Calcification of Joints and Arteries,C18;C05;C14,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.73,1.0,,2011.0,2016.0,ALL
4908,NTF3,P20783,0.519,0.808,0.93201,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.778,,1994.0,2019.0,ALL
4909,NTF4,P34130,0.644,0.692,0.012031,DTO_05007599,Signaling,C2751294,"GLAUCOMA 1, OPEN ANGLE, O",C11,   Eye Diseases,disease,Disease or Syndrome,0.7,1.0,limited,2009.0,2010.0,ALL
4911,NTF6B,,0.89,0.077,,,,C0005283,beta Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,1991.0,1991.0,ALL
4913,NTHL1,P78549,0.623,0.615,5.6607e-10,DTO_05007624,Enzyme,C4225157,FAMILIAL ADENOMATOUS POLYPOSIS 3,,,disease,Disease or Syndrome,0.7,1.0,moderate,2015.0,2017.0,ALL
4914,NTRK1,P04629,0.422,0.808,1.9568e-06,DTO_03300101,Kinase,C0020074,HSAN Type IV,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,1996.0,2020.0,ALL
4915,NTRK2,Q16620,0.479,0.808,1.0,DTO_03300101,Kinase,C3151303,"Obesity, Hyperphagia, and Developmental Delay",C23;C18;F03,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Mental Disorders",disease,Disease or Syndrome,0.7,1.0,,2004.0,2017.0,ALL
4916,NTRK3,Q16288,0.522,0.692,0.9983,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.44,1.0,,1998.0,2015.0,ALL
4917,NTN3,O00634,1.0,0.115,3.2291e-07,DTO_05007584,Enzyme modulator,C0085413,"Polycystic Kidney, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0,,1997.0,1997.0,ALL
4919,ROR1,Q01973,0.552,0.731,0.99645,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,1.0,,2012.0,2020.0,ALL
4920,ROR2,Q01974,0.498,0.731,0.00012401,DTO_03300101,Kinase,C1849334,"Robinow syndrome, autosomal recessive",C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,1.0,1.0,strong,2000.0,2020.0,ALL
4921,DDR2,Q16832,0.541,0.769,0.5503,DTO_03300101,Kinase,C1849011,"SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE",C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.73,1.0,strong,1993.0,2018.0,ALL
4922,NTS,P30990,0.517,0.769,3.8527e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,1.0,,1999.0,2019.0,ALL
4923,NTSR1,P30989,0.563,0.692,1.928e-08,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2013.0,2015.0,ALL
4924,NUCB1,Q02818,0.729,0.5,8.1576e-08,DTO_05007616,Calcium-binding protein,C0014518,Toxic Epidermal Necrolysis,C17;C20;C25;C07,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Chemically-Induced Disorders;    Stomatognathic Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
4925,NUCB2,P80303,0.54,0.731,2.0028e-10,DTO_05007616,Calcium-binding protein,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,2007.0,2017.0,ALL
4926,NUMA1,Q14980,0.644,0.577,1.0,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.62,1.0,,1997.0,2017.0,ALL
4927,NUP88,Q99567,0.659,0.577,1.9577e-08,DTO_05007405,Transporter,C1276035,Pena-Shokeir syndrome type I,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.41,1.0,,2018.0,2018.0,ALL
4928,NUP98,P52948,0.532,0.577,1.0,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.4,0.96,,1996.0,2019.0,ALL
4929,NR4A2,P43354,0.529,0.846,0.99959,DTO_00102000,Nuclear receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,0.8,,1999.0,2020.0,ALL
4931,NVL,O15381,0.821,0.308,4.2587e-19,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
4933,NYS2,,1.0,0.115,,,,C0585539,X-Linked Infantile Nystagmus,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2011.0,2011.0,ALL
4935,GPR143,P51810,0.659,0.385,0.92526,DTO_02300001,G-protein coupled receptor,C0342684,"Ocular albinism, type I",C16;C18;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,0.974,,1995.0,2020.0,ALL
4936,OA3,,0.89,0.154,,,,C0040580,Tracheal Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
4937,OAP,,0.792,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
4938,OAS1,P00973,0.626,0.654,3.4489e-05,DTO_05007624,Enzyme,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.32,1.0,,2005.0,2017.0,ALL
4939,OAS2,P29728,0.67,0.538,2.605e-21,DTO_05007624,Enzyme,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
4940,OAS3,Q9Y6K5,0.608,0.615,1.9653e-33,DTO_05007624,Enzyme,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
4942,OAT,P04181,0.593,0.731,7.7182e-07,DTO_05007624,Enzyme,C0018425,Gyrate Atrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,1.0,0.962,definitive,1981.0,2019.0,ALL
4943,TBC1D25,Q3MII6,0.805,0.269,0.52262,DTO_05007624,Enzyme,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
4945,OATP1,,0.89,0.154,,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
4946,OAZ1,P54368,0.722,0.423,0.17847,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2003.0,2017.0,ALL
4947,OAZ2,O95190,0.805,0.115,0.31316,DTO_05007584,Enzyme modulator,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
4948,OCA2,Q04671,0.539,0.808,2.9064e-13,,,C0268495,Oculocutaneous albinism type 2,C16;C18;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,1.0,,1994.0,2017.0,ALL
4952,OCRL,Q01968,0.553,0.731,0.99999,DTO_05007624,Enzyme,C0028860,Oculocerebrorenal Syndrome,C16;C18;C13;C12;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,1993.0,2020.0,ALL
4953,ODC1,P11926,0.51,0.731,0.16966,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,1990.0,2019.0,ALL
4956,ODF1,Q14990,0.769,0.385,0.9721,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
4957,ODF2,Q5BJF6,0.931,0.038,0.0012405,,,C0403823,Asthenozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
4958,OMD,Q99983,0.769,0.269,1.243e-05,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
4963,OFC1,,1.0,0.115,,,,C1861537,OROFACIAL CLEFT 1,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,0.0,,2011.0,2011.0,ALL
4964,OFC2,,0.931,0.115,,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,1998.0,1998.0,ALL
4965,OFC3,,0.89,0.115,,,,C1861537,OROFACIAL CLEFT 1,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
4967,OGDH,Q02218,0.653,0.538,0.99728,,,C2752074,ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,limited,2016.0,2016.0,ALL
4968,OGG1,O15527,0.453,0.808,3.9314e-12,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.64,1.0,,2003.0,2011.0,ALL
4969,OGN,P20774,0.631,0.577,0.00074118,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.31,1.0,,2007.0,2014.0,ALL
4973,OLR1,P78380,0.544,0.769,0.007199,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.54,1.0,,1998.0,2019.0,ALL
4974,OMG,P23515,0.716,0.462,0.97114,,,C0027831,Neurofibromatosis 1,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.04,1.0,,1994.0,2000.0,ALL
4975,OMP,P47874,0.686,0.654,0.00040499,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
4976,OPA1,O60313,0.51,0.846,0.98636,DTO_05007584,Enzyme modulator,C0338508,Optic Atrophy 1,C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.989,,1997.0,2019.0,ALL
4977,OPA2,,0.931,0.115,,,,C1839576,OPTIC ATROPHY 2 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,,2006.0,2006.0,ALL
4978,OPCML,Q14982,0.606,0.654,0.22804,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.63,1.0,,2003.0,2014.0,ALL
4982,TNFRSF11B,O00300,0.422,0.808,0.16171,,,C0268414,Hyperphosphatasemia with bone disease,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.8,1.0,,2002.0,2020.0,ALL
4983,OPHN1,O60890,0.633,0.538,0.99985,DTO_05007584,Enzyme modulator,C1845366,"Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,1998.0,2018.0,ALL
4985,OPRD1,P41143,0.604,0.731,0.0033233,DTO_02300001,G-protein coupled receptor,C1510472,Drug Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.34,1.0,,2008.0,2018.0,ALL
4986,OPRK1,P41145,0.555,0.615,4.0625e-05,DTO_02300001,G-protein coupled receptor,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.55,1.0,,1996.0,2019.0,ALL
4987,OPRL1,P41146,0.628,0.462,0.48172,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2005.0,2018.0,ALL
4988,OPRM1,P35372,0.457,0.808,7.8882e-11,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,0.8,,1998.0,2019.0,ALL
4990,SIX6,O95475,0.588,0.654,0.51776,DTO_05007542,Transcription factor,C4225424,OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY,,,disease,Disease or Syndrome,0.6,1.0,,2004.0,2015.0,ALL
4995,OR3A2,P47893,1.0,0.077,0.00022954,DTO_02300001,G-protein coupled receptor,C0349141,"Mental and behavioral disorders due to use of cocaine, unspecified mental and behavioral disorder",,,group,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2014.0,ALL
4998,ORC1,Q13415,0.595,0.654,1.7297e-14,DTO_05007557,Nucleic acid binding,C1868684,"EAR, PATELLA, SHORT STATURE SYNDROME",C23;C16;C05;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.65,1.0,,2011.0,2017.0,ALL
4999,ORC2,Q13416,0.861,0.115,0.84443,DTO_05007557,Nucleic acid binding,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
5000,ORC4,O43929,0.612,0.654,7.5667e-13,DTO_05007557,Nucleic acid binding,C3151097,MEIER-GORLIN SYNDROME 2,,,disease,Disease or Syndrome,0.6,1.0,,1998.0,2015.0,ALL
5001,ORC5,O43913,0.861,0.115,2.115e-06,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,1998.0,2001.0,ALL
5002,SLC22A18,Q96BI1,0.595,0.692,6.458e-06,DTO_05007405,Transporter,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.6,1.0,,1998.0,1998.0,ALL
5003,SLC22A18AS,Q8N1D0,0.931,0.115,0.0025627,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
5004,ORM1,P02763,0.608,0.731,1.1456e-05,,,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.31,0.5,,1988.0,2003.0,ALL
5005,ORM2,P19652,0.722,0.462,2.0003e-06,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2015.0,2019.0,ALL
5007,OSBP,P22059,0.705,0.346,0.99855,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5008,OSM,P13725,0.505,0.769,0.58916,DTO_05007599,Signaling,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,1993.0,2019.0,ALL
5009,OTC,P00480,0.565,0.846,0.87295,,,C0268542,Ornithine carbamoyltransferase deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1976.0,2018.0,ALL
5010,CLDN11,O75508,0.623,0.731,0.91076,DTO_05007527,Cell-cell junction,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.34,1.0,,2008.0,2019.0,ALL
5012,OTSC1,,0.821,0.269,,,,C0029899,Otosclerosis,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.04,1.0,,2002.0,2014.0,ALL
5013,OTX1,P32242,0.686,0.385,0.85508,DTO_05007542,Transcription factor,C0201544,Prostate specific antigen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
5015,OTX2,P32243,0.514,0.808,0.92344,DTO_05007542,Transcription factor,C1864690,"Microphthalmia, Syndromic 5",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1997.0,2014.0,ALL
5016,OVGP1,Q12889,0.729,0.538,0.00067299,,,C0004681,Bagassosis,C08;C24,   Respiratory Tract Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
5017,OVOL1,O14753,0.716,0.423,0.87808,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.45,1.0,,2012.0,2019.0,ALL
5018,OXA1L,Q15070,0.59,0.731,1.8749e-10,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.909,,2003.0,2019.0,ALL
5019,OXCT1,P55809,0.686,0.423,0.0047279,DTO_05007624,Enzyme,C0342792,Succinyl-CoA:3-oxoacid CoA transferase deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.7,1.0,,1998.0,2019.0,ALL
5020,OXT,P01178,0.615,0.423,0.71197,DTO_05007599,Signaling,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.5,1.0,,1997.0,2008.0,ALL
5021,OXTR,P30559,0.541,0.769,0.00071066,DTO_02300001,G-protein coupled receptor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.971,,2004.0,2020.0,ALL
5023,P2RX1,P51575,0.584,0.808,6.7632e-11,DTO_01300327,Ion channel,C0149504,"Encephalopathy, Toxic",C10;C25,   Nervous System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2010.0,2010.0,ALL
5024,P2RX3,P56373,0.565,0.769,1.0318e-06,DTO_01300327,Ion channel,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.36,1.0,,2009.0,2019.0,ALL
5025,P2RX4,Q99571,0.547,0.808,4.9835e-12,DTO_01300327,Ion channel,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2003.0,2003.0,ALL
5026,P2RX5,Q93086,0.548,0.769,2.8546e-13,DTO_01300327,Ion channel,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.917,,2008.0,2019.0,ALL
5027,P2RX7,Q99572,0.45,0.808,3.3344e-11,DTO_01300327,Ion channel,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.59,0.7,,2000.0,2016.0,ALL
5028,P2RY1,P47900,0.551,0.769,0.51522,DTO_02300001,G-protein coupled receptor,C0040053,Thrombosis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0,,2007.0,2007.0,ALL
5029,P2RY2,P41231,0.543,0.808,0.084245,DTO_02300001,G-protein coupled receptor,C0011175,Dehydration,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.2,1.0,,2005.0,2005.0,ALL
5030,P2RY4,P51582,0.743,0.385,0.1687,DTO_02300001,G-protein coupled receptor,C0162830,"Dermatitis, Phototoxic",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
5031,P2RY6,Q15077,0.647,0.654,1.5307e-06,DTO_02300001,G-protein coupled receptor,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
5032,P2RY11,Q96G91,0.705,0.538,0.0077062,DTO_02300001,G-protein coupled receptor,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.58,1.0,,2011.0,2019.0,ALL
5033,P4HA1,P13674,0.736,0.385,0.93166,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.04,1.0,,2014.0,2020.0,ALL
5034,P4HB,P07237,0.488,0.808,0.99662,,,C1862178,Cole Carpenter syndrome,C16;C11;C17;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.63,1.0,,2015.0,2018.0,ALL
5036,PA2G4,Q9UQ80,0.617,0.5,0.99876,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
5037,PEBP1,P30086,0.5,0.808,0.09167,DTO_05007584,Enzyme modulator,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.33,1.0,,2015.0,2019.0,ALL
5042,PABPC3,Q9H361,0.861,0.077,8.4423e-15,,,C0028960,Oligospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
5043,PABX,,0.89,0.077,,,,C0008445,Chondrodysplasia Punctata,C05,   Musculoskeletal Diseases,disease,Congenital Abnormality,0.03,0.667,,1993.0,1995.0,ALL
5044,PABY,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1999.0,1999.0,ALL
5045,FURIN,P09958,0.612,0.769,0.99994,DTO_05007624,Enzyme,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,1987.0,2005.0,ALL
5046,PCSK6,P29122,0.626,0.538,5.3148e-13,DTO_05007624,Enzyme,C0476254,Dyslexia,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.12,1.0,,2011.0,2016.0,ALL
5047,PAEP,P09466,0.43,0.846,3.1109e-08,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.939,,1997.0,2019.0,ALL
5048,PAFAH1B1,P43034,0.504,0.769,0.99995,,,C0431375,Classical Lissencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1993.0,2018.0,ALL
5049,PAFAH1B2,P68402,0.839,0.308,0.93401,,,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
5050,PAFAH1B3,Q15102,0.89,0.231,0.0024816,,,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0,,2001.0,2001.0,ALL
5051,PAFAH2,Q99487,1.0,0.038,3.8282e-09,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
5052,PRDX1,Q06830,0.485,0.846,7.6959e-10,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.37,1.0,,2006.0,2019.0,ALL
5053,PAH,P00439,0.516,0.769,6.4046e-23,,,C0031485,Phenylketonurias,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",group,Disease or Syndrome,0.8,0.985,,1977.0,2020.0,ALL
5054,SERPINE1,P05121,0.359,0.885,0.043609,DTO_05007584,Enzyme modulator,C2750067,Plasminogen Activator Inhibitor-1 Deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,1.0,strong,1992.0,2011.0,ALL
5055,SERPINB2,P05120,0.502,0.808,6.3773e-12,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.909,,1995.0,2019.0,ALL
5058,PAK1,Q13153,0.494,0.808,0.0013306,DTO_03300101,Kinase,C4748428,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2019.0,ALL
5062,PAK2,Q13177,0.653,0.538,0.97169,DTO_03300101,Kinase,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
5063,PAK3,O75914,0.569,0.731,0.98716,DTO_03300101,Kinase,C0796237,"Mental Retardation, X-Linked 30",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1998.0,2003.0,ALL
5064,PALM,O75781,0.861,0.154,0.51902,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
5066,PAM,P19021,0.542,0.692,6.934e-06,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.42,1.0,,2014.0,2019.0,ALL
5067,CNTN3,Q9P232,0.612,0.654,1.9893e-05,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
5068,REG3A,Q06141,0.522,0.769,0.00062895,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.26,1.0,,2004.0,2019.0,ALL
5069,PAPPA,Q13219,0.558,0.692,0.1613,,,C0948089,Acute Coronary Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.39,1.0,,2001.0,2019.0,ALL
5071,PRKN,O60260,0.431,0.846,6.9346e-07,DTO_05007624,Enzyme,C1868675,"PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE",C10,   Nervous System Diseases,disease,Disease or Syndrome,1.0,0.994,,1998.0,2019.0,ALL
5072,PARK3,,0.821,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,0.917,,1999.0,2013.0,ALL
5073,PARN,O95453,0.575,0.769,0.00037303,DTO_05007557,Nucleic acid binding,C4225347,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2015.0,ALL
5074,PAWR,Q96IZ0,0.542,0.846,0.089515,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,1.0,,1999.0,2017.0,ALL
5075,PAX1,P15863,0.593,0.654,0.70019,,,C1833691,Otofaciocervical Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.53,1.0,,2013.0,2018.0,ALL
5076,PAX2,Q02962,0.495,0.731,0.66999,,,C1852759,Papillorenal syndrome,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1995.0,2019.0,ALL
5077,PAX3,P23760,0.481,0.769,0.24063,,,C0206655,Alveolar rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,1.0,0.983,,1993.0,2019.0,ALL
5078,PAX4,O43316,0.644,0.423,0.00042273,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,1.0,0.857,limited,1999.0,2019.0,ALL
5079,PAX5,Q02548,0.487,0.654,0.99798,,,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.7,0.96,,2001.0,2019.0,ALL
5080,PAX6,P26367,0.45,0.769,0.99975,,,C0003076,Aniridia,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,1.0,0.984,,1978.0,2020.0,ALL
5081,PAX7,P23759,0.597,0.538,0.14469,,,C0206655,Alveolar rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.8,0.976,limited,1995.0,2019.0,ALL
5082,PDCL,Q13371,0.89,0.077,0.30486,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
5083,PAX9,P55771,0.636,0.538,0.30866,,,C1970291,"Tooth Agenesis, Selective, 3",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.7,1.0,,2003.0,2017.0,ALL
5087,PBX1,P40424,0.534,0.846,0.99527,DTO_05007542,Transcription factor,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.5,1.0,,1990.0,2007.0,ALL
5089,PBX2,P40425,0.686,0.462,0.99532,DTO_05007542,Transcription factor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2011.0,2016.0,ALL
5090,PBX3,P40426,0.619,0.5,0.36301,DTO_05007542,Transcription factor,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
5091,PC,P11498,0.515,0.808,0.013834,DTO_05007624,Enzyme,C0034341,Pyruvate Carboxylase Deficiency Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,0.971,,1983.0,2019.0,ALL
5092,PCBD1,P61457,0.623,0.769,0.00033216,DTO_05007624,Enzyme,C1849700,Hyperphenylalaninemia with primapterinuria,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,1993.0,2017.0,ALL
5093,PCBP1,Q15365,0.65,0.538,0.90945,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2012.0,2019.0,ALL
5094,PCBP2,Q15366,0.647,0.577,0.99617,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2014.0,2020.0,ALL
5095,PCCA,P05165,0.682,0.538,3.1345e-15,DTO_05007624,Enzyme,C0268579,Propionic acidemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,,1993.0,2019.0,ALL
5096,PCCB,P05166,0.695,0.577,1.53e-08,DTO_05007624,Enzyme,C0268579,Propionic acidemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,,1990.0,2019.0,ALL
5097,PCDH1,Q08174,0.769,0.308,0.99838,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.08,0.875,,2012.0,2018.0,ALL
5098,PCDHGC3,Q9UN70,0.89,0.154,0.12536,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
5099,PCDH7,O60245,0.663,0.462,0.39505,,,C0014548,"Epilepsy, Generalized",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2018.0,ALL
5100,PCDH8,O95206,0.659,0.577,3.424e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2008.0,2012.0,ALL
5101,PCDH9,Q9HC56,0.682,0.5,0.80865,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
5104,SERPINA5,P05154,0.507,0.808,6.2368e-09,DTO_05007584,Enzyme modulator,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
5105,PCK1,P35558,0.608,0.538,8.7476e-15,DTO_03300101,Kinase,C0268194,Phosphoenolpyruvate carboxykinase deficiency,C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.61,1.0,strong,2014.0,2017.0,ALL
5106,PCK2,Q16822,0.653,0.423,1.7471e-23,DTO_03300101,Kinase,C0003129,Anoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0,,2008.0,2008.0,ALL
5108,PCM1,Q15154,0.644,0.615,3.7067e-16,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.38,0.75,,2006.0,2019.0,ALL
5110,PCMT1,P22061,0.691,0.423,0.78453,DTO_05007624,Enzyme,C0080178,Spina Bifida,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.32,1.0,,2006.0,2012.0,ALL
5111,PCNA,P12004,0.382,0.846,0.97606,DTO_05007557,Nucleic acid binding,C4014676,ATAXIA-TELANGIECTASIA-LIKE DISORDER 2,,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
5116,PCNT,O95613,0.564,0.808,4.0172e-58,,,C0432246,"Microcephalic Osteodysplastic Primordial Dwarfism, Type II",C23;C16;C13;C05;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.8,1.0,,2004.0,2019.0,ALL
5118,PCOLCE,Q15113,0.76,0.269,5.8392e-05,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.32,1.0,,2016.0,2019.0,ALL
5119,CHMP1A,Q9HD42,0.695,0.5,0.00028502,,,C3554209,Congenital pontocerebellar hypoplasia type 8,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2012.0,2012.0,ALL
5120,PCOS1,,0.722,0.423,,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,1994.0,2019.0,ALL
5121,PCP4,P48539,0.682,0.423,0.0021696,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
5122,PCSK1,P29120,0.548,0.615,2.745e-09,DTO_05007624,Enzyme,C1833053,Proprotein Convertase 1 3 Deficiency,C23;C18;C19,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.71,1.0,strong,1997.0,2019.0,ALL
5125,PCSK5,Q92824,0.659,0.538,2.5352e-12,DTO_05007624,Enzyme,C0220708,VATER Association,C16;C06;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.5,1.0,,2008.0,2008.0,ALL
5126,PCSK2,P16519,0.663,0.462,0.99853,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2001.0,2005.0,ALL
5127,CDK16,Q00536,0.636,0.577,0.9948,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2007.0,2011.0,ALL
5128,CDK17,Q00537,,,0.99947,DTO_03300101,Kinase,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
5129,CDK18,Q07002,0.769,0.192,6.9526e-11,DTO_03300101,Kinase,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
5130,PCYT1A,P49585,0.485,0.885,2.024e-05,,,C1837073,Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy,C16;C11;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,,2014.0,2014.0,ALL
5131,PDB1,,0.705,0.538,,,,C0029401,Osteitis Deformans,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.07,0.857,,2001.0,2017.0,ALL
5132,PDC,P20941,0.581,0.731,0.00010134,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,1997.0,2016.0,ALL
5133,PDCD1,Q15116,0.402,0.846,0.41706,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.8,0.949,,1998.0,2020.0,ALL
5134,PDCD2,Q16342,0.7,0.423,3.8955e-07,,,C0011573,Endogenous depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
5136,PDE1A,P54750,0.743,0.385,0.013549,,,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,2003.0,2003.0,ALL
5137,PDE1C,Q14123,0.7,0.423,5.3913e-09,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
5138,PDE2A,O00408,0.666,0.577,0.631,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2003.0,2003.0,ALL
5139,PDE3A,Q14432,0.67,0.577,0.00019291,,,C1862170,Brachydactyly with hypertension,C16;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.77,1.0,strong,1998.0,2020.0,ALL
5140,PDE3B,Q13370,0.659,0.577,5.7226e-05,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
5141,PDE4A,P27815,0.523,0.846,0.98167,,,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,1.0,,2007.0,2019.0,ALL
5142,PDE4B,Q07343,0.566,0.731,0.4746,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.53,1.0,,2007.0,2010.0,ALL
5143,PDE4C,Q08493,0.805,0.154,1.4755e-07,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
5144,PDE4D,Q08499,0.519,0.846,0.9998,,,C3553250,ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.71,1.0,,2012.0,2017.0,ALL
5145,PDE6A,P16499,0.691,0.269,6.5775e-25,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1995.0,2019.0,ALL
5146,PDE6C,P51160,0.7,0.269,2.323e-16,,,C0152200,Achromatopsia,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.87,1.0,strong,2009.0,2019.0,ALL
5147,PDE6D,O43924,0.623,0.577,0.006423,DTO_05007624,Enzyme,C3810278,JOUBERT SYNDROME 22,,,disease,Disease or Syndrome,0.4,1.0,,2014.0,2019.0,ALL
5148,PDE6G,P18545,0.695,0.308,0.013418,DTO_05007624,Enzyme,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.72,1.0,strong,1997.0,2010.0,ALL
5149,PDE6H,Q13956,0.7,0.269,0.0082921,DTO_05007624,Enzyme,C0152200,Achromatopsia,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,moderate,2012.0,2015.0,ALL
5150,PDE7A,Q13946,0.659,0.577,0.0045645,,,C0025229,Melioidosis,C01,   Infections,disease,Disease or Syndrome,0.04,1.0,,2015.0,2019.0,ALL
5151,PDE8A,O60658,0.76,0.5,0.00011503,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
5152,PDE9A,O76083,0.736,0.192,0.0045595,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2000.0,2000.0,ALL
5153,PDE1B,Q01064,0.769,0.423,0.33646,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2007.0,2017.0,ALL
5154,PDGFA,P04085,0.533,0.731,0.80842,DTO_05007599,Signaling,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.32,0.667,,1989.0,2005.0,ALL
5155,PDGFB,P01127,0.488,0.846,0.77006,DTO_05007599,Signaling,C3809645,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2016.0,ALL
5156,PDGFRA,P16234,0.415,0.808,1.0,DTO_03300101,Kinase,C0238198,Gastrointestinal Stromal Tumors,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.8,0.954,definitive,2003.0,2020.0,ALL
5157,PDGFRL,Q15198,0.769,0.385,1.1787e-14,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.41,1.0,,1995.0,2010.0,ALL
5158,PDE6B,P35913,0.626,0.346,2.6155e-27,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1992.0,2019.0,ALL
5159,PDGFRB,P09619,0.416,0.846,0.9041,DTO_03300101,Kinase,C0432284,Infantile myofibromatosis,C04,   Neoplasms,disease,Disease or Syndrome,1.0,1.0,strong,2013.0,2019.0,ALL
5160,PDHA1,P08559,0.581,0.538,0.98842,,,C0034345,Pyruvate Dehydrogenase Complex Deficiency Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,1990.0,2015.0,ALL
5161,PDHA2,P29803,0.89,0.154,3.9282e-09,,,C0403810,Oligosynaptic Infertility,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
5162,PDHB,P11177,0.711,0.385,0.15201,,,C3279841,Pyruvate Dehydrogenase E1-Beta Deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2004.0,2016.0,ALL
5163,PDK1,Q15118,0.51,0.808,1.0963e-05,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2005.0,2019.0,ALL
5164,PDK2,Q15119,0.751,0.269,3.7102e-06,DTO_03300101,Kinase,C0033141,"Cardiomyopathies, Primary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
5165,PDK3,Q15120,0.678,0.5,0.44547,DTO_03300101,Kinase,C3806702,"CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6",,,disease,Disease or Syndrome,0.73,1.0,,2013.0,2016.0,ALL
5166,PDK4,Q16654,0.578,0.577,9.142e-12,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2015.0,2019.0,ALL
5167,ENPP1,P22413,0.498,0.808,4.9944e-08,DTO_05007624,Enzyme,C3809781,Cole disease,,,disease,Disease or Syndrome,0.72,1.0,,2009.0,2018.0,ALL
5168,ENPP2,Q13822,0.582,0.769,0.0027913,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.5,1.0,,2006.0,2012.0,ALL
5169,ENPP3,O14638,0.663,0.538,3.468e-23,DTO_05007624,Enzyme,C0202178,Phosphorus measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
5170,PDPK1,O15530,0.588,0.808,0.98013,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.55,1.0,,2005.0,2019.0,ALL
5171,PDR,,0.592,0.692,,,,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2020.0,ALL
5172,SLC26A4,O43511,0.507,0.885,8.9898e-22,DTO_05007405,Transporter,C0271829,Pendred's syndrome,C23;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1996.0,2019.0,ALL
5173,PDYN,P01213,0.535,0.577,0.00017033,DTO_05007599,Signaling,C1853250,SPINOCEREBELLAR ATAXIA 23,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,,2010.0,2013.0,ALL
5174,PDZK1,Q5T2W1,0.65,0.654,1.1586e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2000.0,2015.0,ALL
5175,PECAM1,P16284,0.426,0.846,,DTO_05007620,Cell adhesion,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.49,1.0,,2003.0,2018.0,ALL
5176,SERPINF1,P36955,0.46,0.846,7.8044e-08,DTO_05007584,Enzyme modulator,C3279564,"Osteogenesis Imperfecta, Type VI",C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2011.0,2019.0,ALL
5177,PEE1,,,,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
5178,PEG3,Q9GZU2,0.61,0.654,2.6257e-05,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5179,PENK,P01210,0.56,0.808,0.0002077,DTO_05007599,Signaling,C0013386,"Dyskinesia, Drug-Induced",C23;C10;C25,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.5,1.0,,1998.0,2010.0,ALL
5182,PEPB,,1.0,0.038,,,,C0003125,Anorexia Nervosa,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
5183,PEPC,,,,,,,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2017.0,2017.0,ALL
5184,PEPD,P12955,0.621,0.769,1.4633e-14,DTO_05007624,Enzyme,C0268532,Deficiency of prolidase,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.76,1.0,strong,1990.0,2017.0,ALL
5187,PER1,O15534,0.556,0.731,0.00029308,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,1.0,,2005.0,2018.0,ALL
5188,GATB,O75879,1.0,,3.9989e-10,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
5189,PEX1,O43933,0.538,0.769,1.0572e-14,,,C0043459,Zellweger Syndrome,C16;C06;C18;C13;C12;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1997.0,2020.0,ALL
5190,PEX6,Q13608,0.547,0.731,6.253e-06,,,C3553936,PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER),C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,1996.0,2016.0,ALL
5191,PEX7,O00628,0.603,0.615,8.1798e-13,,,C1859133,"RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.98,0.964,,1995.0,2017.0,ALL
5192,PEX10,O60683,0.584,0.654,0.00054204,,,C3553948,PEROXISOME BIOGENESIS DISORDER 6B,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,1995.0,2016.0,ALL
5193,PEX12,O00623,0.601,0.615,9.4838e-16,DTO_05007405,Transporter,C3553929,PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER),C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,1997.0,2017.0,ALL
5194,PEX13,Q92968,0.597,0.654,5.8959e-05,,,C3554001,PEROXISOME BIOGENESIS DISORDER 11B,,,disease,Disease or Syndrome,0.7,1.0,strong,1999.0,2015.0,ALL
5195,PEX14,O75381,0.592,0.692,0.22566,DTO_05007575,Receptor,C3554004,PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER),,,disease,Disease or Syndrome,0.6,1.0,,2004.0,2016.0,ALL
5196,PF4,P02776,0.522,0.846,0.043062,DTO_05007599,Signaling,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.4,0.955,,1994.0,2020.0,ALL
5197,PF4V1,P10720,0.76,0.462,0.00081618,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
5198,PFAS,O15067,0.78,0.308,9.8526e-18,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,1988.0,1988.0,ALL
5199,CFP,P27918,0.573,0.692,0.68778,,,C1839454,"PROPERDIN DEFICIENCY, X-LINKED",C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.7,1.0,limited,1995.0,2019.0,ALL
5201,PFDN1,O60925,0.821,0.192,0.84732,DTO_05007542,Transcription factor,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
5202,PFDN2,Q9UHV9,1.0,0.077,0.34971,DTO_05007613,Chaperone,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
5203,PFDN4,Q9NQP4,0.792,0.231,0.47588,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
5204,PFDN5,Q99471,0.716,0.5,0.00056773,DTO_05007613,Chaperone,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2003.0,2015.0,ALL
5205,ATP8B1,O43520,0.61,0.5,2.7666e-10,DTO_05007405,Transporter,C4551898,"Cholestasis, progressive familial intrahepatic 1",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.8,0.978,,1996.0,2018.0,ALL
5207,PFKFB1,P16118,1.0,0.038,4.878e-07,DTO_03300101,Kinase,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.2,1.0,,1998.0,1998.0,ALL
5208,PFKFB2,O60825,0.76,0.231,2.3914e-07,DTO_03300101,Kinase,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
5209,PFKFB3,Q16875,0.561,0.808,0.24579,DTO_03300101,Kinase,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
5210,PFKFB4,Q16877,0.666,0.346,2.1422e-09,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,2014.0,2019.0,ALL
5211,PFKL,P17858,0.722,0.269,2.702e-17,DTO_03300101,Kinase,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,1995.0,2001.0,ALL
5212,VIT,Q6UXI7,0.821,0.154,5.435e-32,DTO_05007575,Receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
5213,PFKM,P08237,0.666,0.5,3.7625e-18,DTO_03300101,Kinase,C0017926,Glycogen Storage Disease Type VII,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.94,1.0,,1990.0,2016.0,ALL
5214,PFKP,Q01813,0.76,0.346,8.8342e-25,DTO_03300101,Kinase,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
5216,PFN1,P07737,0.565,0.769,0.73258,,,C3553719,AMYOTROPHIC LATERAL SCLEROSIS 18,,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2012.0,ALL
5217,PFN2,P35080,0.686,0.462,0.4212,,,C0035227,Respiratory Function Tests,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
5218,CDK14,O94921,0.659,0.423,2.5012e-08,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.47,1.0,,2007.0,2019.0,ALL
5222,PGA5,P0DJD9,0.78,0.308,4.6125e-10,DTO_05007624,Enzyme,C0014868,Esophagitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2003.0,2003.0,ALL
5223,PGAM1,P18669,0.621,0.615,2.5841e-07,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.32,1.0,,2006.0,2019.0,ALL
5224,PGAM2,P15259,0.792,0.308,1.3574e-07,,,C0268149,Glycogen storage disease type X,C13;C05;C12;C10,   Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.73,1.0,,1993.0,2017.0,ALL
5225,PGC,P20142,0.603,0.692,6.752e-11,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
5226,PGD,P52209,0.576,0.769,0.98788,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
5228,PGF,P49763,0.46,0.846,0.1288,DTO_05007599,Signaling,C4552766,Miscarriage,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.33,1.0,,2008.0,2019.0,ALL
5229,PGGT1B,P53609,0.769,0.346,0.040841,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
5230,PGK1,P00558,0.542,0.769,0.76537,DTO_03300101,Kinase,C1970848,Phosphoglycerate Kinase 1 Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.77,1.0,,1980.0,2019.0,ALL
5231,PGK1P1,,0.821,0.269,,,,C0162359,Christ-Siemens-Touraine syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0,,1992.0,1992.0,ALL
5232,PGK2,P07205,0.89,0.115,9.6757e-06,DTO_03300101,Kinase,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
5236,PGM1,P36871,0.628,0.577,5.0551e-15,,,C2752015,Glycogen Storage Disease XIV,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2009.0,2016.0,ALL
5238,PGM3,O95394,0.61,0.769,1.4641e-05,,,C4014371,IMMUNODEFICIENCY 23,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2015.0,ALL
5239,PGM5,Q15124,0.751,0.269,0.00059096,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
5241,PGR,P06401,0.426,0.885,0.051042,DTO_00102000,Nuclear receptor,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.6,0.966,,1995.0,2020.0,ALL
5243,ABCB1,P08183,0.344,0.885,1.2564e-05,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.6,0.96,,1990.0,2020.0,ALL
5244,ABCB4,P21439,0.529,0.615,2.2138e-07,DTO_05007405,Transporter,C2609268,Low phospholipid-associated cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.8,0.947,strong,2001.0,2020.0,ALL
5245,PHB,P35232,0.511,0.846,0.7588,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,0.944,,1994.0,2018.0,ALL
5246,PHBP1,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
5250,SLC25A3,Q00325,0.566,0.692,0.074834,DTO_05007405,Transporter,C1835845,Mitochondrial Phosphate Carrier Deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.7,1.0,,2007.0,2016.0,ALL
5251,PHEX,P78562,0.548,0.808,0.99996,DTO_05007624,Enzyme,C0733682,"Hypophosphatemic Rickets, X-Linked Dominant",C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,0.976,strong,1987.0,2020.0,ALL
5252,PHF1,O43189,0.691,0.346,0.99956,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.9,,2006.0,2020.0,ALL
5253,PHF2,O75151,0.711,0.423,1.0,,,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2017.0,2017.0,ALL
5255,PHKA1,P46020,0.839,0.115,2.0904e-07,DTO_03300101,Kinase,C1845151,"Glycogen Storage Disease, Type IXD",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1970.0,2016.0,ALL
5256,PHKA2,P46019,0.678,0.462,0.3839,DTO_03300101,Kinase,C3694531,GLYCOGEN STORAGE DISEASE IXa1,,,disease,Disease or Syndrome,0.7,1.0,strong,1994.0,2017.0,ALL
5257,PHKB,Q93100,0.769,0.269,1.581e-21,DTO_05007584,Enzyme modulator,C0543514,Glycogen Storage Disease IXB,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1997.0,2016.0,ALL
5260,PHKG1,Q16816,0.931,0.154,3.572e-15,DTO_03300101,Kinase,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5261,PHKG2,P15735,0.674,0.538,0.0038581,DTO_03300101,Kinase,C2751643,Glycogen Storage Disease IXC,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,strong,1996.0,2018.0,ALL
5264,PHYH,O14832,0.659,0.577,2.3792e-06,,,C0034960,Refsum Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1984.0,2017.0,ALL
5265,SERPINA1,P01009,0.41,0.923,6.8497e-08,DTO_05007584,Enzyme modulator,C0221757,alpha 1-Antitrypsin Deficiency,C23;C16;C06;C08,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.7,0.978,,1978.0,2020.0,ALL
5266,PI3,P19957,0.57,0.692,0.16965,DTO_05007584,Enzyme modulator,C0011616,Contact Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
5267,SERPINA4,P29622,0.641,0.654,9.7276e-09,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
5268,SERPINB5,P36952,0.582,0.577,0.0036486,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2000.0,2019.0,ALL
5269,SERPINB6,P35237,0.547,0.769,0.00011009,DTO_05007584,Enzyme modulator,C3150704,"DEAFNESS, AUTOSOMAL RECESSIVE 91",,,disease,Disease or Syndrome,0.6,1.0,strong,1995.0,1995.0,ALL
5270,SERPINE2,P07093,0.592,0.692,0.7299,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2009.0,2019.0,ALL
5271,SERPINB8,P50452,0.792,0.154,2.7764e-09,DTO_05007584,Enzyme modulator,C1838440,ICHTHYOSIS EXFOLIATIVA,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.51,1.0,limited,2002.0,2016.0,ALL
5272,SERPINB9,P50453,0.695,0.5,0.012327,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
5273,SERPINB10,P48595,0.89,0.192,3.3122e-10,DTO_05007584,Enzyme modulator,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
5274,SERPINI1,Q99574,0.631,0.462,0.026631,DTO_05007584,Enzyme modulator,C1858680,Familial encephalopathy with neuroserpin inclusion bodies,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.95,1.0,,1999.0,2018.0,ALL
5275,SERPINB13,Q9UIV8,0.89,0.077,7.0156e-06,DTO_05007584,Enzyme modulator,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
5276,SERPINI2,O75830,0.931,0.038,6.9523e-15,DTO_05007584,Enzyme modulator,C0272170,Shwachman syndrome,,,disease,Disease or Syndrome,0.2,1.0,,2005.0,2005.0,ALL
5277,PIGA,P37287,0.575,0.654,0.96072,,,C3275508,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2,,,disease,Disease or Syndrome,0.71,1.0,,2012.0,2018.0,ALL
5279,PIGC,Q92535,0.691,0.346,0.0055065,DTO_05007624,Enzyme,C4540521,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16,,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
5281,PIGF,Q07326,0.716,0.385,0.00071995,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2011.0,2011.0,ALL
5283,PIGH,Q14442,0.76,0.231,0.2307,,,C4747891,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17,,,disease,Disease or Syndrome,0.6,1.0,,2018.0,2018.0,ALL
5284,PIGR,P01833,0.615,0.808,0.81331,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
5286,PIK3C2A,O00443,0.633,0.692,0.010126,DTO_03300101,Kinase,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.11,1.0,,2019.0,2019.0,ALL
5287,PIK3C2B,O00750,0.691,0.462,0.99651,DTO_03300101,Kinase,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.32,1.0,,2011.0,2016.0,ALL
5288,PIK3C2G,O75747,0.839,0.269,9.5013e-40,DTO_03300101,Kinase,C0038868,Progressive supranuclear palsy,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
5289,PIK3C3,Q8NEB9,0.647,0.615,8.4165e-11,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,1.0,,2004.0,2009.0,ALL
5290,PIK3CA,P42336,0.292,0.923,1.0,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,1.0,0.985,,2001.0,2020.0,ALL
5291,PIK3CB,P42338,0.322,0.885,0.99964,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.99,,2001.0,2020.0,ALL
5292,PIM1,P11309,0.482,0.769,0.84846,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,1.0,,2005.0,2020.0,ALL
5293,PIK3CD,O00329,0.319,0.885,0.99999,DTO_03300101,Kinase,C3714976,ACTIVATED PI3K-DELTA SYNDROME,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2006.0,2020.0,ALL
5294,PIK3CG,P48736,0.32,0.885,1.4076e-06,DTO_03300101,Kinase,C0016059,Fibrosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.5,1.0,,2003.0,2011.0,ALL
5295,PIK3R1,P27986,0.477,0.885,0.99978,DTO_03300101,Kinase,C0878684,SHORT syndrome,C23;C18;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,0.955,definitive,2000.0,2019.0,ALL
5296,PIK3R2,O00459,0.551,0.808,0.016273,DTO_05007584,Enzyme modulator,C4012727,MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,,2006.0,2017.0,ALL
5297,PI4KA,P42356,0.695,0.577,3.1234e-12,DTO_03300101,Kinase,C4225295,"POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS",,,disease,Disease or Syndrome,0.6,1.0,limited,2015.0,2015.0,ALL
5298,PI4KB,Q9UBF8,0.839,0.308,0.86607,DTO_03300101,Kinase,C0014378,Enterovirus Infections,C01,   Infections,group,Disease or Syndrome,0.08,1.0,,2012.0,2020.0,ALL
5300,PIN1,Q13526,0.488,0.769,0.74031,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.944,,2001.0,2019.0,ALL
5303,PIN4,Q9Y237,0.861,0.231,0.71293,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
5304,PIP,P12273,0.556,0.808,0.00068286,,,C0037199,Sinusitis,C01;C08;C09,   Infections;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
5305,PIP4K2A,P48426,0.647,0.423,0.14155,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.75,,2005.0,2014.0,ALL
5306,PITPNA,Q00169,0.89,0.231,0.96513,DTO_05007405,Transporter,C0795956,Chylomicron retention disease,C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.2,1.0,,2003.0,2003.0,ALL
5307,PITX1,P78337,0.561,0.654,0.88244,,,C0009081,Congenital clubfoot,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.97,0.889,,2008.0,2019.0,ALL
5308,PITX2,Q99697,0.489,0.808,0.97618,,,C3714873,"Axenfeld-Rieger Syndrome, Type 1",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.91,1.0,,1996.0,2006.0,ALL
5309,PITX3,O75364,0.585,0.692,0.81276,,,C1862839,Anterior segment mesenchymal dysgenesis,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.75,1.0,strong,1998.0,2012.0,ALL
5310,PKD1,P98161,0.493,0.769,1.0,,,C3149841,POLYCYSTIC KIDNEY DISEASE 1,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,0.986,definitive,1992.0,2018.0,ALL
5311,PKD2,Q13563,0.552,0.731,0.00017271,DTO_01300327,Ion channel,C0085413,"Polycystic Kidney, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,0.984,definitive,1994.0,2020.0,ALL
5312,PKD3,,0.76,0.308,,,,C0085413,"Polycystic Kidney, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.06,0.833,,1996.0,2014.0,ALL
5313,PKLR,P30613,0.603,0.615,3.4869e-07,DTO_03300101,Kinase,C0340968,Deficiency of pyruvate kinase,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1991.0,2019.0,ALL
5314,PKHD1,P08F94,0.576,0.654,1.1657e-47,,,C0085548,Autosomal Recessive Polycystic Kidney Disease,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,1.0,,1975.0,2019.0,ALL
5315,PKM,P14618,0.482,0.808,0.8549,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,1998.0,2020.0,ALL
5316,PKNOX1,P55347,0.674,0.538,0.99401,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5317,PKP1,Q13835,0.659,0.462,0.00058339,DTO_05007530,Cellular structure,C1858302,Ectodermal dysplasia/ skin fragility syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.78,1.0,strong,1997.0,2013.0,ALL
5318,PKP2,Q99959,0.606,0.538,3.1147e-18,DTO_05007530,Cellular structure,C1836906,"Arrhythmogenic Right Ventricular Dysplasia, Familial, 9",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,definitive,1996.0,2017.0,ALL
5319,PLA2G1B,P04054,0.468,0.846,1.0057e-10,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,1997.0,2019.0,ALL
5320,PLA2G2A,P14555,0.488,0.808,0.097278,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.4,1.0,,1999.0,2018.0,ALL
5321,PLA2G4A,P47712,0.496,0.846,5.9817e-05,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.55,1.0,,2010.0,2019.0,ALL
5322,PLA2G5,P39877,0.751,0.385,5.3834e-05,DTO_05007624,Enzyme,C1856718,"Fleck Retina, Familial Benign",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2011.0,2011.0,ALL
5324,PLAG1,Q6DJT9,0.493,0.808,0.99532,DTO_05007542,Transcription factor,C1519176,Salivary Gland Pleomorphic Adenoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.6,0.941,,1996.0,2019.0,ALL
5325,PLAGL1,Q9UM63,0.566,0.769,0.9764,,,C1832386,"Diabetes Mellitus, Transient Neonatal, 1",C16;C18;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.36,1.0,,2000.0,2012.0,ALL
5326,PLAGL2,Q9UPG8,0.691,0.385,0.98253,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.08,1.0,,2017.0,2020.0,ALL
5327,PLAT,P00750,0.445,0.885,5.6593e-05,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.5,1.0,,2010.0,2014.0,ALL
5328,PLAU,P00749,0.425,0.923,2.3058e-06,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.68,1.0,,2002.0,2013.0,ALL
5329,PLAUR,Q03405,0.536,0.731,0.0053378,,,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.5,1.0,,2002.0,2012.0,ALL
5330,PLCB2,Q00722,0.78,0.231,3.0661e-20,DTO_05007624,Enzyme,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
5331,PLCB3,Q01970,0.729,0.385,0.93999,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2004.0,2004.0,ALL
5332,PLCB4,Q15147,0.61,0.731,3.0437e-06,DTO_05007624,Enzyme,C1865295,Auriculo-condylar syndrome,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.63,1.0,moderate,2012.0,2017.0,ALL
5333,PLCD1,P51178,0.636,0.577,1.737e-19,DTO_05007624,Enzyme,C0544855,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3",,,phenotype,Congenital Abnormality,0.7,1.0,,2011.0,2011.0,ALL
5334,PLCL1,Q15111,0.608,0.654,0.012059,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.13,1.0,,2012.0,2019.0,ALL
5335,PLCG1,P19174,0.564,0.692,7.9288e-05,DTO_05007624,Enzyme,C0018923,Hemangiosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.55,1.0,,2014.0,2017.0,ALL
5336,PLCG2,P16885,0.588,0.808,0.99562,DTO_05007624,Enzyme,C3553961,"AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED",C20,   Immune System Diseases,disease,Disease or Syndrome,0.71,1.0,,2012.0,2018.0,ALL
5337,PLD1,Q13393,0.576,0.731,4.7758e-21,,,C1859330,"Cardiac Valvular Defect, Developmental",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,moderate,2017.0,2017.0,ALL
5338,PLD2,O14939,0.617,0.654,4.1429e-27,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2013.0,2017.0,ALL
5339,PLEC,Q15149,0.523,0.808,8.3469e-12,DTO_05007530,Cellular structure,C2931072,Epidermolysa bullosa simplex and limb girdle muscular dystrophy,C16;C17;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1996.0,2017.0,ALL
5340,PLG,P00747,0.389,0.923,0.010345,DTO_05007624,Enzyme,C1968804,"Plasminogen Deficiency, Type I",C16;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,1.0,definitive,1982.0,2019.0,ALL
5341,PLEK,P08567,0.588,0.731,0.001067,DTO_05007530,Cellular structure,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
5345,SERPINF2,P08697,0.575,0.808,0.013624,DTO_05007584,Enzyme modulator,C2752081,ALPHA-2-PLASMIN INHIBITOR DEFICIENCY,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.92,1.0,strong,1989.0,2008.0,ALL
5346,PLIN1,O60240,0.59,0.654,3.1486e-11,,,C3151268,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4",,,disease,Disease or Syndrome,0.6,1.0,,2011.0,2018.0,ALL
5347,PLK1,P53350,0.467,0.808,0.97851,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
5348,FXYD1,O00168,0.682,0.385,0.24395,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2002.0,2002.0,ALL
5349,FXYD3,Q14802,0.682,0.423,1.0105e-05,DTO_01300327,Ion channel,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2006.0,2006.0,ALL
5350,PLN,P26678,0.595,0.577,0.44947,,,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.7,1.0,definitive,1993.0,2019.0,ALL
5351,PLOD1,Q02809,0.579,0.731,1.4837e-15,DTO_05007624,Enzyme,C0268342,Ehlers-Danlos syndrome type 6,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.77,1.0,strong,1993.0,2015.0,ALL
5352,PLOD2,O00469,0.559,0.654,6.6965e-08,DTO_05007624,Enzyme,C1836602,Bruck syndrome 2,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,,2003.0,2012.0,ALL
5354,PLP1,P60201,0.543,0.769,0.92845,DTO_05007530,Cellular structure,C0205711,Pelizaeus-Merzbacher Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.979,definitive,1962.0,2019.0,ALL
5355,PLP2,Q04941,0.711,0.385,0.0043931,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2018.0,2020.0,ALL
5356,PLRG1,O43660,0.769,0.192,0.99911,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.07,1.0,,2007.0,2015.0,ALL
5357,PLS1,Q14651,0.821,0.346,1.1321e-05,DTO_05007530,Cellular structure,C0011053,Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Finding,0.3,1.0,,2019.0,2019.0,ALL
5358,PLS3,P13797,0.656,0.5,0.98844,DTO_05007530,Cellular structure,C3806712,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18,,,phenotype,Finding,0.6,,strong,,,ALL
5359,PLSCR1,O15162,0.674,0.5,0.011923,DTO_05007405,Transporter,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.31,1.0,,2013.0,2018.0,ALL
5360,PLTP,P55058,0.633,0.654,8.9961e-09,,,C0020557,Hypertriglyceridemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.31,1.0,,2003.0,2003.0,ALL
5361,PLXNA1,Q9UIW2,0.621,0.615,0.99951,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1994.0,2019.0,ALL
5362,PLXNA2,O75051,0.447,0.808,1.0768e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,1.0,,2006.0,2018.0,ALL
5364,PLXNB1,O43157,0.621,0.692,0.00038291,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,1.0,,2007.0,2019.0,ALL
5365,PLXNB3,Q9ULL4,0.861,0.154,0.23163,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2009.0,2012.0,ALL
5366,PMAIP1,Q13794,0.559,0.808,0.11182,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.34,1.0,,2007.0,2017.0,ALL
5367,PMCH,P20382,0.615,0.808,0.11486,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.54,1.0,,2001.0,2019.0,ALL
5368,PNOC,Q13519,0.603,0.577,0.015028,DTO_05007599,Signaling,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.4,1.0,,1998.0,2019.0,ALL
5371,PML,P29590,0.477,0.846,0.21291,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.6,0.978,,1990.0,2020.0,ALL
5372,PMM1,Q92871,0.861,0.231,1.6587e-06,DTO_05007624,Enzyme,C0349653,Congenital disorder of glycosylation type 1A,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.03,1.0,,1997.0,2006.0,ALL
5373,PMM2,O15305,0.535,0.769,1.4072e-17,DTO_05007624,Enzyme,C0349653,Congenital disorder of glycosylation type 1A,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,,1995.0,2019.0,ALL
5375,PMP2,P02689,0.769,0.231,0.0084728,,,C4748940,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2018.0,ALL
5376,PMP22,Q01453,0.471,0.885,0.90958,DTO_05007530,Cellular structure,C0011195,Dejerine-Sottas Disease (disorder),C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1993.0,2017.0,ALL
5378,PMS1,P54277,0.569,0.654,1.3178e-17,DTO_05007557,Nucleic acid binding,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.4,,,,,ALL
5379,PMS2P1,A4D2B8,1.0,0.077,,DTO_05007557,Nucleic acid binding,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
5380,PMS2P2,O95744,0.861,0.115,,DTO_05007557,Nucleic acid binding,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
5387,PMS2P3,Q13401,0.931,0.115,,DTO_05007557,Nucleic acid binding,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
5393,EXOSC9,Q06265,0.705,0.423,1.7871e-11,DTO_05007624,Enzyme,C4748058,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1D",,,disease,Disease or Syndrome,0.61,1.0,strong,2018.0,2020.0,ALL
5394,EXOSC10,Q01780,0.839,0.154,1.9676e-14,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
5395,PMS2,P54278,0.484,0.808,4.5176e-27,DTO_05007557,Nucleic acid binding,C0265325,Turcot syndrome (disorder),C16;C06;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.978,definitive,1995.0,2020.0,ALL
5396,PRRX1,P54821,0.543,0.769,0.24291,,,C0265242,Otocephaly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.62,1.0,,2011.0,2013.0,ALL
5406,PNLIP,P16233,0.743,0.308,1.604e-08,DTO_05007624,Enzyme,C3280527,PANCREATIC LIPASE DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,limited,2014.0,2016.0,ALL
5407,PNLIPRP1,P54315,1.0,0.077,1.0944e-13,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
5408,PNLIPRP2,P54317,0.89,0.038,3.9766e-10,DTO_05007624,Enzyme,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
5409,PNMT,P11086,0.653,0.538,0.0050065,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.26,0.857,,1992.0,2018.0,ALL
5411,PNN,Q9H307,0.638,0.577,0.11262,,,C0011206,Delirium,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,1.0,,2009.0,2019.0,ALL
5412,UBL3,O95164,0.89,0.154,0.73544,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
5413,SEPTIN5,Q99719,0.691,0.462,0.92671,DTO_05007584,Enzyme modulator,C0270715,"Degenerative Diseases, Central Nervous System",C10,   Nervous System Diseases,group,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
5414,SEPTIN4,O43236;Q8NEP4,0.644,0.692,2.7268e-05,DTO_05007584,Enzyme modulator,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
5420,PODXL,O00592,0.551,0.731,0.0010333,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,2006.0,2018.0,ALL
5422,POLA1,P09884,0.653,0.731,1.0,,,C1845050,"PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS",C23;C16;C18;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,1.0,,2009.0,2019.0,ALL
5423,POLB,P06746,0.606,0.654,3.4002e-05,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,1996.0,2009.0,ALL
5424,POLD1,P28340,0.507,0.769,2.4179e-06,,,C3715192,"ANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME",,,disease,Disease or Syndrome,0.74,1.0,,2013.0,2018.0,ALL
5425,POLD2,P49005,0.861,0.231,0.00097201,DTO_05007624,Enzyme,C0428568,Fasting blood glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
5426,POLE,Q07864,0.526,0.731,8.0488e-27,,,C3554576,"FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE",,,disease,Disease or Syndrome,0.71,1.0,moderate,2012.0,2012.0,ALL
5427,POLE2,P56282,1.0,0.038,2.8528e-07,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
5428,POLG,P54098,0.457,0.846,2.0756e-09,DTO_05007624,Enzyme,C0205710,Alpers Syndrome (disorder),C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,1.0,0.992,,2001.0,2019.0,ALL
5429,POLH,Q9Y253,0.663,0.462,3.5414e-09,,,C1848410,"Xeroderma pigmentosum, variant type",C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.94,1.0,definitive,1999.0,2018.0,ALL
5430,POLR2A,P24928,0.65,0.423,1.0,DTO_05007624,Enzyme,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.31,0.0,strong,2019.0,2019.0,ALL
5431,POLR2B,P30876,0.839,0.231,0.52372,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2015.0,2015.0,ALL
5432,POLR2C,P19387,0.839,0.115,0.0014592,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
5433,POLR2D,O15514,0.839,0.346,0.21392,DTO_05007542,Transcription factor,C0206708,Cervical Intraepithelial Neoplasia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
5434,POLR2E,P19388,0.736,0.192,7.2128e-09,DTO_05007624,Enzyme,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
5435,POLR2F,P61218,0.722,0.308,0.012528,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
5436,POLR2G,P62487,0.78,0.269,1.257e-06,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
5439,POLR2J,P52435,1.0,0.077,0.0071512,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
5440,POLR2K,P53803,1.0,0.077,0.0011708,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
5441,POLR2L,P62875,1.0,0.077,0.00045417,DTO_05007624,Enzyme,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
5442,POLRMT,O00411,0.839,0.346,1.739e-20,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
5443,POMC,P01189,0.356,0.846,0.00011658,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.9,0.959,strong,1996.0,2020.0,ALL
5444,PON1,P27169,0.409,0.885,9.8142e-11,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,0.929,,2007.0,2019.0,ALL
5445,PON2,Q15165,0.566,0.808,5.4352e-05,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.4,1.0,,2010.0,2013.0,ALL
5446,PON3,Q15166,0.663,0.692,2.1034e-07,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.4,1.0,,2010.0,2013.0,ALL
5447,POR,P16435,0.502,0.769,3.4212e-10,,,C1860042,Antley-Bixler Syndrome with Disordered Steroidogenesis,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.74,1.0,strong,2004.0,2018.0,ALL
5449,POU1F1,P28069,0.548,0.654,0.045046,,,C2751608,"Pituitary Hormone Deficiency, Combined, 1",C23;C16;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1992.0,2016.0,ALL
5450,POU2AF1,Q16633,0.608,0.615,0.56553,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.42,1.0,,2012.0,2017.0,ALL
5451,POU2F1,P14859,0.558,0.769,0.90229,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2008.0,2008.0,ALL
5452,POU2F2,P09086,0.599,0.692,0.99884,,,C2930967,Gastro-enteropancreatic neuroendocrine tumor,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
5453,POU3F1,Q03052,0.711,0.462,0.56469,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2005.0,2005.0,ALL
5454,POU3F2,P20265,0.7,0.423,0.92007,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.52,1.0,,2011.0,2019.0,ALL
5455,POU3F3,P20264,0.682,0.615,0.88278,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
5456,POU3F4,P49335,0.633,0.654,0.5746,,,C1844678,Progressive hearing loss stapes fixation,C23;C16;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.75,1.0,strong,1995.0,2014.0,ALL
5457,POU4F1,Q01851,0.628,0.5,0.88762,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2008.0,2010.0,ALL
5458,POU4F2,Q12837,0.729,0.269,0.074814,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,1.0,,2001.0,2011.0,ALL
5459,POU4F3,Q15319,0.7,0.538,0.91964,,,C1865366,"Deafness, Autosomal Dominant 15",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.71,1.0,strong,1998.0,2017.0,ALL
5460,POU5F1,Q01860,0.441,0.846,0.95371,,,C0205851,Germ cell tumor,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2003.0,2017.0,ALL
5462,POU5F1B,Q06416,0.67,0.346,0.00029118,,,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.15,1.0,,2007.0,2019.0,ALL
5463,POU6F1,Q14863,0.839,0.231,0.88028,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
5464,PPA1,Q15181,0.656,0.615,1.917e-05,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
5465,PPARA,Q07869,0.432,0.885,0.030182,DTO_00102000,Nuclear receptor,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.6,1.0,,2005.0,2020.0,ALL
5467,PPARD,Q03181,0.513,0.846,0.99497,DTO_00102000,Nuclear receptor,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.5,1.0,,2005.0,2010.0,ALL
5468,PPARG,P37231,0.358,0.885,0.029194,DTO_00102000,Nuclear receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.96,,1997.0,2020.0,ALL
5469,MED1,Q15648,0.573,0.692,1.0,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2010.0,2019.0,ALL
5471,PPAT,Q06203,0.705,0.385,0.98606,DTO_05007624,Enzyme,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,1979.0,1979.0,ALL
5473,PPBP,P02775,0.544,0.808,0.057739,DTO_05007599,Signaling,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
5475,PPEF1,O14829,0.89,0.115,0.9873,,,C0271091,"Retinoschisis, Juvenile, X-Linked",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,1997.0,1997.0,ALL
5476,CTSA,P10619,0.619,0.731,5.8984e-09,DTO_05007624,Enzyme,C0268233,GALACTOSIALIDOSIS,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1991.0,2019.0,ALL
5478,PPIA,P62937,0.51,0.769,0.55734,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.36,1.0,,2003.0,2018.0,ALL
5479,PPIB,P23284,0.641,0.577,4.7242e-05,,,C1850169,"OSTEOGENESIS IMPERFECTA, TYPE IX (disorder)",C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.93,1.0,strong,2009.0,2017.0,ALL
5480,PPIC,P45877,0.805,0.231,0.00030514,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
5481,PPID,Q08752,0.603,0.692,1.9309e-09,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
5491,PPIAP9,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
5493,PPL,O60437,0.666,0.538,1.5145e-42,DTO_05007530,Cellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2019.0,ALL
5494,PPM1A,P35813,0.691,0.5,0.99834,DTO_05007624,Enzyme,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
5495,PPM1B,O75688,0.711,0.5,0.0090829,DTO_05007624,Enzyme,C1848030,Hypotonia-Cystinuria Syndrome,C23;C16;C18;C13;C05;C12;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.32,1.0,,2008.0,2018.0,ALL
5496,PPM1G,O15355,0.839,0.269,0.9604,DTO_05007624,Enzyme,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2015.0,2015.0,ALL
5498,PPOX,P50336,0.678,0.5,0.02829,,,C0162532,Variegate Porphyria,C16;C06;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.9,1.0,,1981.0,2019.0,ALL
5499,PPP1CA,P62136,0.674,0.5,0.98588,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
5500,PPP1CB,P62140,0.601,0.577,0.99912,DTO_05007624,Enzyme,C4479577,NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2,,,disease,Disease or Syndrome,0.61,1.0,,2016.0,2019.0,ALL
5501,PPP1CC,P36873,0.861,0.154,0.95777,DTO_05007624,Enzyme,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
5502,PPP1R1A,Q13522,0.559,0.692,0.021894,DTO_05007584,Enzyme modulator,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.39,1.0,,2004.0,2018.0,ALL
5504,PPP1R2,P41236,0.839,0.192,0.06928,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
5506,PPP1R3A,Q16821,0.711,0.577,9.3122e-16,DTO_05007584,Enzyme modulator,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,1.0,0.929,limited,1994.0,2018.0,ALL
5507,PPP1R3C,Q9UQK1,0.711,0.5,0.0026397,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
5510,PPP1R7,Q15435,0.821,0.231,0.99458,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2010.0,2019.0,ALL
5511,PPP1R8,Q12972,0.722,0.385,0.98791,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,1.0,,2010.0,2018.0,ALL
5514,PPP1R10,Q96QC0,0.751,0.423,1.0,,,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
5515,PPP2CA,P67775,0.608,0.769,0.9893,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.41,1.0,strong,2019.0,2019.0,ALL
5516,PPP2CB,P62714,0.861,0.192,0.34419,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2013.0,2017.0,ALL
5518,PPP2R1A,P30153,0.588,0.577,0.98389,DTO_05007624,Enzyme,C4225352,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 36",,,disease,Mental or Behavioral Dysfunction,0.7,1.0,,2015.0,2015.0,ALL
5519,PPP2R1B,P30154,0.678,0.423,3.0047e-15,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.52,1.0,,1999.0,1999.0,ALL
5520,PPP2R2A,P63151,0.67,0.462,0.99495,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.32,1.0,,2008.0,2019.0,ALL
5521,PPP2R2B,Q00005,0.601,0.577,0.98467,DTO_05007624,Enzyme,C1858501,Spinocerebellar Ataxia 12,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2001.0,2018.0,ALL
5522,PPP2R2C,Q9Y2T4,0.7,0.5,0.89954,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2014.0,ALL
5523,PPP2R3A,Q06190,0.805,0.231,0.62349,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
5524,PTPA,Q15257,0.48,0.846,0.99057,DTO_05007584,Enzyme modulator,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2011.0,2019.0,ALL
5525,PPP2R5A,Q15172,0.931,0.115,0.81558,DTO_05007624,Enzyme,C0013990,Pathological accumulation of air in tissues,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
5526,PPP2R5B,Q15173,0.931,0.154,0.98416,DTO_05007624,Enzyme,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
5527,PPP2R5C,Q13362,0.751,0.308,0.97071,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
5528,PPP2R5D,Q14738,0.722,0.462,0.99993,DTO_05007624,Enzyme,C4225354,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 35",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2015.0,ALL
5529,PPP2R5E,Q16537,0.691,0.423,0.99997,DTO_05007624,Enzyme,C1257806,Chromosomal Instability,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2015.0,2015.0,ALL
5530,PPP3CA,Q08209,0.568,0.769,0.99988,,,C4540199,"EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1",,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2018.0,ALL
5531,PPP4C,P60510,0.7,0.462,0.4554,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2018.0,2018.0,ALL
5532,PPP3CB,P16298,0.76,0.308,0.99998,,,C0019202,Hepatolenticular Degeneration,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
5533,PPP3CC,P48454,0.769,0.192,0.26374,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2003.0,2018.0,ALL
5534,PPP3R1,P63098,0.682,0.538,0.41481,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.63,1.0,,2003.0,2018.0,ALL
5535,PPP3R2,Q96LZ3,0.931,0.077,0.0010651,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
5536,PPP5C,P53041,0.644,0.692,0.99938,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
5537,PPP6C,O00743,0.729,0.231,0.85535,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.54,1.0,,2012.0,2015.0,ALL
5538,PPT1,P50897,0.593,0.808,4.862e-05,DTO_05007624,Enzyme,C1850451,"CEROID LIPOFUSCINOSIS, NEURONAL, 1",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.98,1.0,,1989.0,2019.0,ALL
5539,PPY,P01298,0.663,0.308,0.01181,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,1981.0,2002.0,ALL
5540,NPY4R,P0DQD5;P50391,0.792,0.269,8.2144e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2001.0,2016.0,ALL
5542,PRB1,P04280,0.621,0.692,8.3839e-11,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2012.0,2017.0,ALL
5544,PRB3,Q04118,0.839,0.269,6.2362e-07,,,C4016308,PRB3S(CYS),,,phenotype,Finding,0.1,,,,,ALL
5545,PRB4,P10163,0.861,0.231,1.2854e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
5546,PRCC,Q92733,0.716,0.231,0.96281,,,C1306837,Papillary Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.43,1.0,,1996.0,2017.0,ALL
5547,PRCP,P42785,0.633,0.692,8.7577e-12,DTO_05007624,Enzyme,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
5548,PRD,,0.821,0.231,,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
5549,PRELP,P51888,0.695,0.5,4.7067e-05,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
5550,PREP,P48147,0.576,0.731,0.08025,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2007.0,2007.0,ALL
5551,PRF1,P14222,0.54,0.692,5.4875e-06,,,C1863727,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.92,1.0,strong,1989.0,2017.0,ALL
5552,SRGN,P10124,0.588,0.731,0.69656,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
5553,PRG2,P13727,0.678,0.538,0.00019062,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5554,PRH1,P02810,0.659,0.5,0.0072243,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2000.0,2018.0,ALL
5555,PRH2,P02810,0.663,0.5,0.012493,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2000.0,2018.0,ALL
5557,PRIM1,P49642,0.861,0.154,0.0009938,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
5558,PRIM2,P49643,0.861,0.231,1.1605e-07,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
5562,PRKAA1,Q13131,0.453,0.846,0.13725,DTO_03300101,Kinase,C0021655,Insulin Resistance,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.5,1.0,,2010.0,2012.0,ALL
5563,PRKAA2,P54646,0.456,0.846,3.5282e-08,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2016.0,2020.0,ALL
5564,PRKAB1,Q9Y478,0.46,0.846,0.0052573,DTO_03300101,Kinase,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.37,1.0,,2011.0,2019.0,ALL
5565,PRKAB2,O43741,0.931,0.115,0.72559,DTO_05007584,Enzyme modulator,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2002.0,2006.0,ALL
5566,PRKACA,P17612,0.606,0.692,0.97142,DTO_03300101,Kinase,C4014425,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
5567,PRKACB,P22694,0.67,0.577,0.35122,DTO_03300101,Kinase,C0206698,Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2015.0,2018.0,ALL
5568,PRKACG,P22612,0.644,0.654,,DTO_03300101,Kinase,C4015405,"BLEEDING DISORDER, PLATELET-TYPE, 19",,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2014.0,ALL
5570,PKIB,Q9C010,0.792,0.308,0.046118,DTO_05007584,Enzyme modulator,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
5571,PRKAG1,P54619,,,3.6224e-05,DTO_03300101,Kinase,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
5573,PRKAR1A,P10644,0.401,0.846,0.99985,,,C0406810,Carney Complex,C16;C04;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.961,definitive,2000.0,2020.0,ALL
5575,PRKAR1B,P31321,0.716,0.385,0.17935,,,C4751505,PRKAR1B-related neurodegenerative dementia with intermediate filaments,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
5576,PRKAR2A,P13861,0.805,0.269,0.11865,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
5577,PRKAR2B,P31323,0.722,0.538,0.99713,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.31,1.0,,2010.0,2014.0,ALL
5578,PRKCA,P17252,0.44,0.846,0.3677,DTO_03300101,Kinase,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.5,1.0,,2005.0,2011.0,ALL
5579,PRKCB,P05771,0.453,0.885,1.0,DTO_03300101,Kinase,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.54,1.0,,1999.0,2019.0,ALL
5580,PRKCD,Q05655,0.48,0.846,0.99995,DTO_03300101,Kinase,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2001.0,2002.0,ALL
5581,PRKCE,Q02156,0.597,0.692,0.99988,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,1.0,,1995.0,1995.0,ALL
5582,PRKCG,P05129,0.617,0.5,0.99985,DTO_03300101,Kinase,C1854369,Spinocerebellar ataxia 14,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.96,,2002.0,2019.0,ALL
5583,PRKCH,P24723,0.653,0.577,0.42878,DTO_03300101,Kinase,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,1.0,,2013.0,2013.0,ALL
5584,PRKCI,P41743,0.584,0.5,0.067986,DTO_03300101,Kinase,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2009.0,2016.0,ALL
5585,PKN1,Q16512,0.647,0.692,0.20442,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5586,PKN2,Q16513,0.711,0.423,1.0,DTO_03300101,Kinase,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2019.0,2019.0,ALL
5587,PRKD1,Q15139,0.531,0.846,6.6485e-07,DTO_03300101,Kinase,C4479250,CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA,,,disease,Disease or Syndrome,0.7,1.0,moderate,2015.0,2016.0,ALL
5588,PRKCQ,Q04759,0.636,0.654,0.2972,DTO_03300101,Kinase,C0035305,Retinal Detachment,C11,   Eye Diseases,disease,Disease or Syndrome,0.5,1.0,,2016.0,2016.0,ALL
5589,PRKCSH,P14314,0.674,0.538,1.0122e-07,DTO_05007624,Enzyme,C0158683,Polycystic liver disease,C23;C06;C04,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Neoplasms",disease,Disease or Syndrome,0.7,1.0,,2003.0,2017.0,ALL
5590,PRKCZ,Q05513,0.604,0.654,0.541,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2017.0,2019.0,ALL
5591,PRKDC,P78527,0.54,0.808,1.0,DTO_03300101,Kinase,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1995.0,2018.0,ALL
5592,PRKG1,Q13976,0.603,0.769,0.99938,DTO_03300101,Kinase,C3809513,"AORTIC ANEURYSM, FAMILIAL THORACIC 8",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2016.0,ALL
5593,PRKG2,Q13237,0.705,0.308,0.64685,DTO_03300101,Kinase,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5594,MAPK1,P28482,0.33,0.923,0.99698,DTO_03300101,Kinase,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.962,,2001.0,2020.0,ALL
5595,MAPK3,P27361,0.379,0.885,0.036884,DTO_03300101,Kinase,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2002.0,2019.0,ALL
5596,MAPK4,P31152,0.821,0.231,0.21895,DTO_03300101,Kinase,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
5597,MAPK6,Q16659,0.678,0.346,0.69646,DTO_03300101,Kinase,C0020507,Hyperplasia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
5598,MAPK7,Q13164,0.553,0.654,0.0031023,DTO_03300101,Kinase,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.31,1.0,,2007.0,2017.0,ALL
5599,MAPK8,P45983,0.397,0.885,0.99823,DTO_03300101,Kinase,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.5,1.0,,2006.0,2010.0,ALL
5600,MAPK11,Q15759,0.695,0.462,0.00033565,DTO_03300101,Kinase,C0033141,"Cardiomyopathies, Primary",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,1999.0,1999.0,ALL
5601,MAPK9,P45984,0.561,0.731,0.069738,DTO_03300101,Kinase,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.31,1.0,,2011.0,2017.0,ALL
5602,MAPK10,P53779,0.606,0.692,0.27553,DTO_03300101,Kinase,C0238111,Lennox-Gastaut syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,limited,2006.0,2013.0,ALL
5603,MAPK13,O15264,0.705,0.577,6.7197e-11,DTO_03300101,Kinase,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
5604,MAP2K1,Q02750,0.439,0.846,0.89669,DTO_03300101,Kinase,C1275081,Cardio-facio-cutaneous syndrome,C23;C16;C17;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,1.0,1.0,definitive,2006.0,2019.0,ALL
5605,MAP2K2,P36507,0.534,0.731,0.96673,DTO_03300101,Kinase,C1275081,Cardio-facio-cutaneous syndrome,C23;C16;C17;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.8,0.966,definitive,2006.0,2019.0,ALL
5606,MAP2K3,P46734,0.619,0.615,0.022009,DTO_03300101,Kinase,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5607,MAP2K5,Q13163,0.628,0.654,0.004765,DTO_03300101,Kinase,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
5608,MAP2K6,P52564,0.631,0.615,0.91334,DTO_03300101,Kinase,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2004.0,2014.0,ALL
5609,MAP2K7,O14733,0.419,0.808,0.99552,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.54,1.0,,2012.0,2020.0,ALL
5610,EIF2AK2,P19525,0.538,0.769,0.017643,DTO_03300101,Kinase,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.33,0.75,,2000.0,2019.0,ALL
5611,DNAJC3,Q13217,0.67,0.577,0.017493,,,C4015436,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
5612,THAP12,O43422,,,0.96834,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
5613,PRKX,P51817,0.821,0.231,0.032585,DTO_03300101,Kinase,C0202230,Thyroid stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
5616,PRKY,O43930,0.839,0.192,,DTO_03300101,Kinase,C0432470,"46, XY female",C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.02,1.0,,1997.0,2001.0,ALL
5617,PRL,P01236,0.406,0.885,2.9015e-07,DTO_05007599,Signaling,C0020514,Hyperprolactinemia,C10;C19,   Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.6,0.967,,1982.0,2020.0,ALL
5618,PRLR,P16471,0.572,0.692,0.98732,DTO_05007599,Signaling,C0020514,Hyperprolactinemia,C10;C19,   Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.76,1.0,,2013.0,2019.0,ALL
5619,PRM1,P04553,0.722,0.269,0.02677,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2003.0,2019.0,ALL
5620,PRM2,P04554,0.792,0.154,0.024644,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.08,1.0,,2003.0,2019.0,ALL
5621,PRNP,F7VJQ1;P04156,0.445,0.923,0.00063182,,,C0017495,Gerstmann-Straussler-Scheinker Disease,C16;C01;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Infections;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.993,,1989.0,2019.0,ALL
5623,PSPN,O60542,0.608,0.769,0.00011172,DTO_05007599,Signaling,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.5,,2008.0,2017.0,ALL
5624,PROC,P04070,0.504,0.808,1.9118e-05,DTO_05007624,Enzyme,C0398625,Protein C Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1984.0,2020.0,ALL
5625,PRODH,O43272,0.612,0.692,5.3577e-12,DTO_05007624,Enzyme,C0268529,Proline dehydrogenase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.77,1.0,,1996.0,2014.0,ALL
5626,PROP1,O75360,0.576,0.615,0.087746,,,C0878683,Pituitary Dwarfism Type 3,C05;C10;C19,   Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,1.0,,1998.0,2017.0,ALL
5627,PROS1,P07225,0.467,0.846,0.00047089,,,C3278211,"THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.6,1.0,strong,1994.0,2016.0,ALL
5628,PROS2P,,0.78,0.192,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
5629,PROX1,Q92786,0.565,0.538,0.99884,DTO_05007542,Transcription factor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.46,1.0,,2010.0,2019.0,ALL
5630,PRPH,P41219,0.623,0.462,4.7898e-14,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.5,1.0,,2000.0,2016.0,ALL
5631,PRPS1,P60891,0.584,0.731,0.91542,DTO_03300101,Kinase,C0796028,"ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.77,1.0,,1993.0,2019.0,ALL
5634,PRPS2,P11908,0.89,0.115,0.93544,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2016.0,ALL
5635,PRPSAP1,Q14558,0.931,0.077,1.7124e-07,DTO_05007624,Enzyme,C1335177,Ovarian Serous Adenocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
5636,PRPSAP2,O60256,1.0,0.038,0.0031244,DTO_05007624,Enzyme,C0740394,Hyperuricemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
5638,PRRG1,O14668,1.0,0.077,0.13149,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
5639,PRRG2,O14669,1.0,0.038,9.0627e-07,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
5640,PRS,,0.663,0.615,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.04,1.0,,2018.0,2019.0,ALL
5641,LGMN,Q99538,0.579,0.731,0.00040535,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
5644,PRSS1,P07477,0.563,0.692,4.1384e-11,DTO_05007624,Enzyme,C0238339,Hereditary pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.8,0.975,strong,1996.0,2020.0,ALL
5645,PRSS2,P07478,0.628,0.769,,DTO_05007624,Enzyme,C0238339,Hereditary pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.63,1.0,,2006.0,2016.0,ALL
5646,PRSS3,P35030,0.617,0.615,3.5636e-12,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2006.0,2006.0,ALL
5648,MASP1,P48740,0.565,0.885,1.2276e-11,DTO_05007624,Enzyme,C0796059,Oculopalatoskeletal syndrome,C16;C11;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.62,1.0,strong,1996.0,2015.0,ALL
5649,RELN,P78509,0.515,0.731,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,0.909,,1998.0,2020.0,ALL
5650,KLK7,P49862,0.61,0.615,0.0006467,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.9,,2008.0,2019.0,ALL
5651,TMPRSS15,P98073,0.751,0.385,4.5847e-32,,,C0268416,Enterokinase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.62,1.0,,2002.0,2012.0,ALL
5652,PRSS8,Q16651,0.641,0.5,0.10007,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2004.0,2006.0,ALL
5653,KLK6,Q92876,0.575,0.654,0.0060052,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2002.0,2019.0,ALL
5654,HTRA1,Q92743,0.532,0.692,0.00049201,DTO_05007624,Enzyme,C1838577,Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy,C23;C17;C05;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,0.962,,2002.0,2019.0,ALL
5655,KLK10,O43240,0.608,0.538,4.3662e-07,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2000.0,2016.0,ALL
5657,PRTN3,P24158,0.503,0.808,3.8044e-05,DTO_05007624,Enzyme,C3495801,Granulomatosis with polyangiitis,C08;C20;C14,   Respiratory Tract Diseases;    Immune System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.6,0.988,,1992.0,2019.0,ALL
5660,PSAP,P07602,0.532,0.846,0.99051,,,C0268262,Metachromatic Leukodystrophy due to Saposin B Deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,strong,1990.0,2019.0,ALL
5662,PSD,A5PKW4,0.626,0.654,0.90358,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2005.0,2019.0,ALL
5663,PSEN1,P49768,0.469,0.846,0.97322,DTO_05007624,Enzyme,C1843013,"Alzheimer disease, familial, type 3",C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.9,0.993,,1995.0,2020.0,ALL
5664,PSEN2,P49810,0.55,0.654,0.00053736,DTO_05007624,Enzyme,C3150958,"Cardiomyopathy, Dilated, 1V",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.7,1.0,,2006.0,2006.0,ALL
5669,PSG1,P11464,0.769,0.385,1.6242e-29,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2015.0,ALL
5670,PSG2,P11465,0.492,0.731,1.382e-30,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1992.0,2019.0,ALL
5671,PSG3,Q16557,1.0,0.077,2.9137e-25,,,C0037317,Sleep disturbances,C10;F03;F01,   Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.01,1.0,,2017.0,2017.0,ALL
5672,PSG4,Q00888,1.0,0.077,5.9115e-29,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
5673,PSG5,Q15238,0.631,0.615,8.8239e-22,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
5675,PSG6,Q00889,0.89,0.077,4.8204e-22,,,C0020217,Hydatidiform Mole,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,1990.0,1990.0,ALL
5676,PSG7,Q13046,0.821,0.346,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
5678,PSG9,Q00887,0.89,0.192,3.8689e-22,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
5680,PSG11,Q9UQ72,1.0,0.038,4.8498e-17,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
5681,PSKH1,P11801,0.931,0.077,0.26016,DTO_03300101,Kinase,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2019.0,ALL
5682,PSMA1,P25786,0.711,0.308,0.98251,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
5683,PSMA2,P25787,0.792,0.231,0.98234,,,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
5684,PSMA3,P25788,0.805,0.423,0.98462,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2016.0,ALL
5685,PSMA4,P25789,0.716,0.385,0.59959,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
5686,PSMA5,P28066,0.674,0.538,0.99376,,,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
5687,PSMA6,P60900,0.653,0.654,0.98619,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.5,1.0,,2006.0,2016.0,ALL
5688,PSMA7,O14818,0.659,0.462,0.98768,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2015.0,2020.0,ALL
5689,PSMB1,P20618,0.78,0.269,0.96996,,,C4721453,Peripheral Nervous System Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.31,1.0,,2011.0,2011.0,ALL
5690,PSMB2,P49721,0.821,0.269,0.91397,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
5691,PSMB3,P49720,1.0,0.038,0.95656,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
5692,PSMB4,P28070,0.659,0.615,0.0026437,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
5693,PSMB5,P28074,0.711,0.385,0.95893,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
5694,PSMB6,P28072,0.561,0.731,0.015779,,,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,1988.0,2002.0,ALL
5695,PSMB7,Q99436,0.839,0.269,0.89419,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
5696,PSMB8,P28062,0.533,0.808,0.021795,,,C4746851,PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1,,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2016.0,ALL
5697,PYY,P10082,0.588,0.615,0.011784,DTO_05007599,Signaling,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,0.926,,2004.0,2019.0,ALL
5698,PSMB9,P28065,0.514,0.808,0.0027499,,,C0001197,Acrodermatitis,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
5699,PSMB10,P40306,0.736,0.462,1.7692e-06,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
5700,PSMC1,P62191,0.78,0.462,0.99945,DTO_05007624,Enzyme,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
5701,PSMC2,P35998,0.792,0.077,0.99985,DTO_05007624,Enzyme,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
5702,PSMC3,P17980,0.792,0.423,0.9547,DTO_05007624,Enzyme,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
5704,PSMC4,P43686,0.931,0.077,0.30101,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
5705,PSMC5,P62195,0.686,0.538,0.93308,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5706,PSMC6,P62333,0.705,0.577,0.99662,DTO_05007624,Enzyme,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.03,0.667,,2013.0,2018.0,ALL
5707,PSMD1,Q99460,0.78,0.231,1.0,DTO_05007584,Enzyme modulator,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
5708,PSMD2,Q13200,0.612,0.692,1.0,DTO_05007584,Enzyme modulator,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
5709,PSMD3,O43242,0.751,0.462,0.99997,DTO_05007584,Enzyme modulator,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
5710,PSMD4,P55036,0.617,0.654,0.99726,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.909,,2004.0,2019.0,ALL
5711,PSMD5,Q16401,0.89,,3.2398e-08,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
5713,PSMD7,P51665,0.551,0.692,0.26367,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.8,,2012.0,2020.0,ALL
5714,PSMD8,P48556,0.716,0.385,0.068806,DTO_05007584,Enzyme modulator,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
5715,PSMD9,O00233,0.435,0.846,4.8603e-06,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.926,,1996.0,2019.0,ALL
5716,PSMD10,O75832,0.552,0.808,0.50136,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2006.0,2019.0,ALL
5717,PSMD11,O00231,0.839,0.269,0.99987,,,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
5718,PSMD12,O00232,0.578,0.808,0.99984,DTO_05007584,Enzyme modulator,C4479599,STANKIEWICZ-ISIDOR SYNDROME,,,disease,Disease or Syndrome,0.4,1.0,strong,2017.0,2017.0,ALL
5719,PSMD13,Q9UNM6,0.861,0.154,0.99901,DTO_05007584,Enzyme modulator,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
5720,PSME1,Q06323,0.736,0.462,0.13197,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
5721,PSME2,Q9UL46,0.839,0.269,0.015838,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2011.0,2017.0,ALL
5723,PSPH,P78330,0.57,0.808,0.00096703,DTO_05007624,Enzyme,C1291463,Deficiency of phosphoserine phosphatase,,,disease,Disease or Syndrome,0.7,1.0,,2004.0,2014.0,ALL
5724,PTAFR,P25105,0.575,0.731,0.24232,DTO_02300001,G-protein coupled receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
5725,PTBP1,P26599,0.517,0.769,0.99961,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,2002.0,2003.0,ALL
5726,TAS2R38,P59533,0.531,0.808,0.1303,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.54,0.75,,1992.0,2010.0,ALL
5727,PTCH1,Q13635,0.398,0.885,1.0,,,C0004779,Basal Cell Nevus Syndrome,C16;C04;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Neoplastic Process,1.0,0.994,definitive,1960.0,2020.0,ALL
5728,PTEN,P60484,0.305,0.923,0.25651,DTO_05007624,Enzyme,C0018553,"Hamartoma Syndrome, Multiple",C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",disease,Neoplastic Process,1.0,0.961,,1972.0,2019.0,ALL
5729,PTGDR,Q13258,0.65,0.615,3.58e-06,DTO_02300001,G-protein coupled receptor,C1846534,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1",,,disease,Disease or Syndrome,0.3,,,,,ALL
5730,PTGDS,P41222,0.503,0.846,0.0050922,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2014.0,ALL
5731,PTGER1,P34995,0.674,0.538,0.00097345,DTO_02300001,G-protein coupled receptor,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.33,1.0,,2001.0,2011.0,ALL
5732,PTGER2,P43116,0.597,0.731,0.0074901,DTO_02300001,G-protein coupled receptor,C1319853,"Asthma, Aspirin-Induced",C08;C20;C25,   Respiratory Tract Diseases;    Immune System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.4,1.0,,2006.0,2006.0,ALL
5733,PTGER3,P43115,0.601,0.731,0.37217,DTO_02300001,G-protein coupled receptor,C0014518,Toxic Epidermal Necrolysis,C17;C20;C25;C07,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Chemically-Induced Disorders;    Stomatognathic Diseases,disease,Disease or Syndrome,0.32,1.0,,2011.0,2019.0,ALL
5734,PTGER4,P35408,0.558,0.731,0.9755,DTO_02300001,G-protein coupled receptor,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.5,1.0,,2008.0,2008.0,ALL
5737,PTGFR,P43088,0.705,0.423,0.066085,DTO_02300001,G-protein coupled receptor,C0001883,Airway Obstruction,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.3,1.0,,1975.0,1975.0,ALL
5738,PTGFRN,Q9P2B2,0.76,0.269,0.00047574,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
5739,PTGIR,P43119,0.711,0.423,0.00088819,DTO_02300001,G-protein coupled receptor,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
5740,PTGIS,Q16647,0.617,0.654,1.197e-09,,,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.63,0.0,limited,2001.0,2003.0,ALL
5741,PTH,P01270,0.397,0.846,0.012093,,,C1832648,Hypoparathyroidism familial isolated,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.78,1.0,,1986.0,2017.0,ALL
5742,PTGS1,P23219,0.46,0.885,6.2425e-07,DTO_05007624,Enzyme,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.52,1.0,,2007.0,2020.0,ALL
5743,PTGS2,P35354,0.314,0.962,0.99597,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.6,0.965,,1996.0,2019.0,ALL
5744,PTHLH,P12272,0.453,0.846,0.81146,,,C3150644,"BRACHYDACTYLY, TYPE E2",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2010.0,ALL
5745,PTH1R,Q03431,0.544,0.731,0.57253,DTO_02300001,G-protein coupled receptor,C0265295,Jansen type metaphyseal chondrodysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,,1995.0,2017.0,ALL
5746,PTH2R,P49190,0.78,0.308,1.4112e-20,DTO_02300001,G-protein coupled receptor,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.1,,,,,ALL
5747,PTK2,Q05397,0.497,0.808,0.99987,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.6,1.0,,2003.0,2020.0,ALL
5753,PTK6,Q13882,0.65,0.269,4.3468e-13,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2009.0,2019.0,ALL
5754,PTK7,Q13308,0.568,0.615,0.99721,DTO_03300101,Kinase,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.33,1.0,,2011.0,2019.0,ALL
5756,TWF1,Q12792,0.78,0.308,2.087e-05,DTO_05007530,Cellular structure,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
5757,PTMA,P06454,0.604,0.731,0.034451,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.32,0.667,,2000.0,2019.0,ALL
5761,PTMAP4,,0.638,0.731,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2006.0,2019.0,ALL
5763,PTMS,P20962,0.76,0.154,0.19751,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
5764,PTN,P21246,0.515,0.808,0.0075073,DTO_05007599,Signaling,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
5765,PTOS1,,1.0,0.077,,,,C0266573,Congenital ptosis,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0,,2008.0,2008.0,ALL
5768,QSOX1,O00391,0.67,0.577,2.5936e-05,DTO_05007624,Enzyme,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
5770,PTPN1,P18031,0.523,0.731,0.81293,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.5,0.961,,1999.0,2019.0,ALL
5771,PTPN2,P17706,0.538,0.692,0.99953,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.68,1.0,,2008.0,2016.0,ALL
5774,PTPN3,P26045,0.647,0.462,6.706e-09,,,C0206698,Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2014.0,2014.0,ALL
5775,PTPN4,P29074,0.633,0.538,0.99663,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.07,0.857,,2017.0,2018.0,ALL
5777,PTPN6,P29350,0.485,0.769,0.99999,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
5778,PTPN7,P35236,0.736,0.385,9.4147e-14,DTO_05007624,Enzyme,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
5780,PTPN9,P43378,0.705,0.346,0.10956,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.13,1.0,,2012.0,2017.0,ALL
5781,PTPN11,Q06124,0.385,0.923,0.99998,,,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.987,definitive,2001.0,2020.0,ALL
5782,PTPN12,Q05209,0.641,0.769,0.99996,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.51,1.0,,1994.0,2018.0,ALL
5783,PTPN13,Q12923,0.592,0.654,1.4172e-25,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2005.0,2019.0,ALL
5784,PTPN14,Q15678,0.638,0.615,0.22055,,,C3150875,CHOANAL ATRESIA AND LYMPHEDEMA,,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2013.0,ALL
5786,PTPRA,P18433,0.573,0.654,0.99998,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2011.0,2019.0,ALL
5787,PTPRB,P23467,0.743,0.308,0.50207,,,C0018923,Hemangiosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.54,1.0,,2014.0,2019.0,ALL
5788,PTPRC,P08575,0.435,0.808,1.0,DTO_05007624,Enzyme,C1837028,"Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive",C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.6,1.0,,2000.0,2001.0,ALL
5789,PTPRD,P23468,0.584,0.731,1.0,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,1.0,,2008.0,2011.0,ALL
5790,PTPRCAP,Q14761,0.89,0.154,0.54001,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
5791,PTPRE,P23469,0.861,0.192,0.00081616,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2008.0,2011.0,ALL
5792,PTPRF,P10586,0.578,0.615,1.0,DTO_05007624,Enzyme,C0175755,Congenital absent nipple,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.41,1.0,limited,2014.0,2014.0,ALL
5793,PTPRG,P23470,0.619,0.731,5.0736e-06,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
5794,PTPRH,Q9HD43,0.691,0.423,1.0298e-36,DTO_05007624,Enzyme,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
5795,PTPRJ,Q12913,0.606,0.615,1.2879e-11,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2002.0,2010.0,ALL
5796,PTPRK,Q15262,0.686,0.385,0.90291,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2007.0,2013.0,ALL
5797,PTPRM,P28827,0.821,0.192,0.99998,DTO_05007624,Enzyme,C1266708,Polybrominated biphenyl measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
5798,PTPRN,Q16849,0.736,0.346,7.9561e-07,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,0.926,,1994.0,2019.0,ALL
5799,PTPRN2,Q92932,0.678,0.577,5.392e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5800,PTPRO,Q16827,0.656,0.423,1.1875e-05,,,C3280100,"NEPHROTIC SYNDROME, TYPE 6",,,disease,Disease or Syndrome,0.5,1.0,limited,2018.0,2018.0,ALL
5801,PTPRR,Q15256,0.743,0.346,8.7415e-07,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2012.0,2017.0,ALL
5802,PTPRS,Q13332,0.769,0.308,0.99983,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2018.0,2019.0,ALL
5803,PTPRZ1,P23471,0.623,0.615,0.98997,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,0.667,,2008.0,2017.0,ALL
5804,PTPRZ2,,0.792,0.269,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2014.0,2017.0,ALL
5805,PTS,Q03393,0.636,0.654,6.4613e-06,,,C0878676,6-pyruvoyl-tetrahydropterin synthase deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,definitive,1987.0,2017.0,ALL
5806,PTX3,P26022,0.457,0.808,6.9827e-05,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2004.0,2004.0,ALL
5810,RAD1,O60671,0.76,0.346,0.00012252,DTO_05007624,Enzyme,C4721414,Mantle cell lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0,,2009.0,2019.0,ALL
5813,PURA,Q00577,0.644,0.5,0.94029,DTO_05007557,Nucleic acid binding,C4015357,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 31",,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2018.0,ALL
5814,PURB,Q96QR8,0.839,0.115,0.62543,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2001.0,2018.0,ALL
5816,PVALB,P20472,0.547,0.692,0.086602,DTO_05007616,Calcium-binding protein,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.985,,2003.0,2020.0,ALL
5817,PVR,P15151,0.51,0.769,3.922e-10,,,C0032371,Poliomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.38,1.0,,1986.0,2017.0,ALL
5818,NECTIN1,Q15223,0.523,0.808,0.061154,,,C2931488,Zlotogora-Ogur syndrome,C23;C16;C17;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.73,1.0,,2000.0,2015.0,ALL
5819,NECTIN2,Q92692,0.575,0.769,0.96926,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.44,1.0,,2008.0,2019.0,ALL
5820,PVT1,,0.495,0.731,,,,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,1.0,,2010.0,2017.0,ALL
5822,PWP2,Q15269,0.861,0.115,0.00069944,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
5824,PEX19,P40855,0.585,0.731,0.0003188,DTO_05007612,Storage,C1832200,Peroxisome biogenesis disorders,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.51,1.0,strong,1999.0,2016.0,ALL
5825,ABCD3,P28288,0.751,0.423,0.0078364,DTO_05007405,Transporter,C4225390,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5",,,disease,Congenital Abnormality,0.7,1.0,limited,2015.0,2015.0,ALL
5826,ABCD4,O14678,0.769,0.308,1.3364e-12,DTO_05007405,Transporter,C3553915,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2015.0,ALL
5827,PXMP2,Q9NR77,0.743,0.192,0.009178,DTO_05007575,Receptor,C0270911,"Charcot-Marie-Tooth Disease, Type Ia (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.08,1.0,,1992.0,1997.0,ALL
5828,PEX2,P28328,0.582,0.654,0.00025931,,,C3542026,PEROXISOME BIOGENESIS DISORDER 5B,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,1992.0,2016.0,ALL
5829,PXN,P49023,0.547,0.654,0.082342,DTO_05007530,Cellular structure,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,1996.0,2019.0,ALL
5830,PEX5,P50542,0.561,0.731,5.5557e-05,DTO_05007405,Transporter,C3550234,PEROXISOME BIOGENESIS DISORDER 2B,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,1995.0,2016.0,ALL
5831,PYCR1,P32322,0.57,0.654,0.00019947,,,C2751987,"Cutis Laxa, Autosomal Recessive, Type IIB",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.75,1.0,,2001.0,2017.0,ALL
5832,ALDH18A1,P54886,0.551,0.769,0.00081212,DTO_05007624,Enzyme,C4225272,"SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.71,1.0,strong,2015.0,2019.0,ALL
5833,PCYT2,Q99447,0.821,0.192,0.0008643,DTO_05007624,Enzyme,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.31,1.0,strong,2012.0,2019.0,ALL
5834,PYGB,P11216,0.792,0.308,1.4144e-14,DTO_05007624,Enzyme,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
5836,PYGL,P06737,0.705,0.423,1.71e-17,DTO_05007624,Enzyme,C0017925,Glycogen Storage Disease Type VI,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.72,1.0,,1998.0,2017.0,ALL
5837,PYGM,P11217,0.65,0.577,2.033e-13,DTO_05007624,Enzyme,C0017924,Glycogen Storage Disease Type V,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.989,,1983.0,2020.0,ALL
5858,PZP,P20742,0.705,0.423,6.8173e-36,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5859,QARS1,P47897,0.716,0.231,2.6952e-13,DTO_05007624,Enzyme,C4014239,"MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2016.0,ALL
5860,QDPR,P09417,0.691,0.5,0.00015254,DTO_05007624,Enzyme,C0268465,Phenylketonuria II,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.76,1.0,,1987.0,2019.0,ALL
5861,RAB1A,P62820,0.623,0.615,0.82305,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,,,,,ALL
5862,RAB2A,P61019,0.722,0.385,0.98913,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
5863,RGL2,O15211,0.89,0.231,0.026981,DTO_05007584,Enzyme modulator,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
5864,RAB3A,P20336,0.691,0.462,0.9463,,,C0014474,Ependymoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
5865,RAB3B,P20337,0.861,0.115,0.31473,,,C1519383,Smoking Behaviors,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2010.0,2010.0,ALL
5866,RAB3IL1,Q8TBN0,0.931,0.115,0.00036755,DTO_05007584,Enzyme modulator,C0202177,Phospholipid measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
5867,RAB4A,P20338,0.705,0.577,0.2026,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,1995.0,2020.0,ALL
5868,RAB5A,P20339,0.601,0.731,0.62452,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
5869,RAB5B,P61020,0.722,0.346,0.026434,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
5870,RAB6A,P20340,0.716,0.462,0.95237,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2009.0,2017.0,ALL
5871,MAP4K2,Q12851,0.89,0.154,1.5422e-11,DTO_03300101,Kinase,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
5872,RAB13,P51153,0.821,0.077,0.02472,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
5873,RAB27A,P51159,0.585,0.692,3.0027e-07,,,C1868679,"GRISCELLI SYNDROME, TYPE 2",C16;C18;C17;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,,2000.0,2019.0,ALL
5874,RAB27B,O00194,0.608,0.692,0.038714,,,C0032197,Platelet Storage Pool Deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.21,1.0,,1997.0,2007.0,ALL
5875,RABGGTA,Q92696,0.89,0.269,1.7504e-10,DTO_05007624,Enzyme,C0079504,Hermanski-Pudlak Syndrome,C16;C18;C11;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.2,,,,,ALL
5876,RABGGTB,P53611,1.0,0.077,0.007867,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
5877,RABIF,P47224,0.931,0.115,0.014371,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
5878,RAB5C,P51148,0.736,0.308,0.93717,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5879,RAC1,P63000,0.429,0.962,0.76228,DTO_05007584,Enzyme modulator,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.6,1.0,,2004.0,2019.0,ALL
5880,RAC2,P15153,0.556,0.731,0.96627,DTO_05007584,Enzyme modulator,C1842398,Neutrophil Immunodeficiency Syndrome,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.71,1.0,,2000.0,2015.0,ALL
5881,RAC3,P60763,0.682,0.423,0.0026125,DTO_05007584,Enzyme modulator,C4021085,Abnormality of brain morphology,,,phenotype,Anatomical Abnormality,0.4,1.0,strong,2019.0,2019.0,ALL
5883,RAD9A,Q99638,0.7,0.462,4.0279e-06,DTO_05007584,Enzyme modulator,C0085183,"Neoplasms, Second Primary",C04,   Neoplasms,phenotype,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
5884,RAD17,O75943,0.7,0.269,0.0569,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
5885,RAD21,O60216,0.528,0.846,0.99701,,,C0270972,Cornelia De Lange Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,definitive,2007.0,2020.0,ALL
5886,RAD23A,P54725,0.769,0.346,0.18355,DTO_05007557,Nucleic acid binding,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
5887,RAD23B,P54727,0.638,0.731,0.9963,DTO_05007557,Nucleic acid binding,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2009.0,2020.0,ALL
5888,RAD51,Q06609,0.447,0.846,0.026578,,,C4284093,"FANCONI ANEMIA, COMPLEMENTATION GROUP R",,,disease,Disease or Syndrome,0.61,1.0,,2015.0,2016.0,ALL
5889,RAD51C,O43502,0.533,0.692,6.1906e-14,,,C3150653,"FANCONI ANEMIA, COMPLEMENTATION GROUP O",,,disease,Disease or Syndrome,0.71,1.0,moderate,2003.0,2018.0,ALL
5890,RAD51B,O15315,0.556,0.769,2.079e-15,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.5,0.895,,2009.0,2019.0,ALL
5891,MOK,Q9UQ07,0.476,0.769,8.8397e-22,DTO_03300101,Kinase,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2001.0,2019.0,ALL
5892,RAD51D,O75771,0.674,0.385,1.0631e-09,,,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.6,0.824,strong,2011.0,2019.0,ALL
5893,RAD52,P43351,0.61,0.654,7.1128e-11,DTO_05007557,Nucleic acid binding,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.45,1.0,,2008.0,2018.0,ALL
5894,RAF1,P04049,0.418,0.885,0.85295,DTO_03300101,Kinase,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1992.0,2019.0,ALL
5896,RAG1,P15918,0.509,0.769,2.7659e-05,DTO_05007624,Enzyme,C2700553,Omenn Syndrome,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.8,0.978,strong,1998.0,2018.0,ALL
5897,RAG2,P55895,0.507,0.769,0.020287,,,C2700553,Omenn Syndrome,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1998.0,2019.0,ALL
5898,RALA,P11233,0.656,0.577,0.97289,DTO_05007584,Enzyme modulator,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.31,1.0,strong,2018.0,2018.0,ALL
5899,RALB,P11234,0.861,0.231,0.020067,DTO_05007584,Enzyme modulator,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
5900,RALGDS,Q12967,0.722,0.462,0.88814,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
5901,RAN,P62826,0.576,0.808,0.97576,DTO_05007584,Enzyme modulator,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2002.0,2005.0,ALL
5902,RANBP1,P43487,0.736,0.615,0.82235,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2011.0,2011.0,ALL
5903,RANBP2,P49792,0.578,0.615,1.0,DTO_05007584,Enzyme modulator,C2675556,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3",,,phenotype,Finding,0.7,1.0,,1989.0,2016.0,ALL
5905,RANGAP1,P46060,0.617,0.538,0.025531,DTO_05007584,Enzyme modulator,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.31,1.0,,2013.0,2016.0,ALL
5906,RAP1A,P62834,0.502,0.808,0.62227,DTO_05007584,Enzyme modulator,C0796004,Kabuki make-up syndrome,C16;C09;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Otorhinolaryngologic Diseases;    Hemic and Lymphatic Diseases",disease,Congenital Abnormality,0.31,1.0,,2015.0,2015.0,ALL
5908,RAP1B,P61224,0.565,0.769,0.90995,DTO_05007584,Enzyme modulator,C0796004,Kabuki make-up syndrome,C16;C09;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Otorhinolaryngologic Diseases;    Hemic and Lymphatic Diseases",disease,Congenital Abnormality,0.31,1.0,,2015.0,2015.0,ALL
5909,RAP1GAP,P47736,0.626,0.5,0.84376,DTO_05007584,Enzyme modulator,C0040136,Thyroid Neoplasm,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.35,1.0,,2007.0,2012.0,ALL
5910,RAP1GDS1,P52306,0.7,0.308,0.93288,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,1999.0,2017.0,ALL
5911,RAP2A,P10114,0.751,0.538,0.85068,DTO_05007584,Enzyme modulator,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2003.0,2003.0,ALL
5912,RAP2B,P61225,0.644,0.462,0.48658,DTO_05007584,Enzyme modulator,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0,,1998.0,2019.0,ALL
5913,RAPSN,Q13702,0.593,0.731,0.0015148,,,C1276035,Pena-Shokeir syndrome type I,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.65,1.0,,2002.0,2020.0,ALL
5914,RARA,P10276,0.47,0.846,0.96305,DTO_00102000,Nuclear receptor,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.7,0.981,,1990.0,2020.0,ALL
5915,RARB,P10826,0.478,0.846,0.99983,DTO_00102000,Nuclear receptor,C3809803,"MICROPHTHALMIA, SYNDROMIC 12",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2016.0,ALL
5916,RARG,P13631,0.608,0.731,0.99478,DTO_00102000,Nuclear receptor,C0876994,Cardiotoxicity,C23;C25;C14;C26,"   Pathological Conditions, Signs and Symptoms;    Chemically-Induced Disorders;    Cardiovascular Diseases;    Wounds and Injuries",disease,Injury or Poisoning,0.4,1.0,,2015.0,2015.0,ALL
5917,RARS1,P54136,0.604,0.538,3.2689e-08,,,C4015323,"LEUKODYSTROPHY, HYPOMYELINATING, 9",,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2017.0,ALL
5918,RARRES1,P49788,0.628,0.385,2.6799e-09,DTO_05007584,Enzyme modulator,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2005.0,2009.0,ALL
5919,RARRES2,Q99969,0.519,0.731,2.716e-05,,,C0018206,granulosa cell tumor,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
5920,PLAAT4,Q9UL19,0.5,0.808,1.2234e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2000.0,2020.0,ALL
5921,RASA1,P20936,0.481,0.885,1.0,DTO_05007584,Enzyme modulator,C1842180,CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION (disorder),C16;C17;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2003.0,2020.0,ALL
5922,RASA2,Q15283,0.579,0.769,7.391e-31,DTO_05007584,Enzyme modulator,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.51,1.0,limited,2014.0,2014.0,ALL
5923,RASGRF1,Q13972,0.537,0.769,0.99999,DTO_05007584,Enzyme modulator,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.43,1.0,,2013.0,2018.0,ALL
5924,RASGRF2,O14827,0.644,0.615,0.15243,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
5925,RB1,P06400,0.444,0.885,1.0,DTO_05007557,Nucleic acid binding,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.8,0.986,,1984.0,2020.0,ALL
5926,ARID4A,P29374,0.769,0.192,1.0,DTO_05007542,Transcription factor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
5927,KDM5A,P29375,0.597,0.731,1.0,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2019.0,ALL
5928,RBBP4,Q09028,0.644,0.654,0.99565,,,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.05,1.0,,2007.0,2017.0,ALL
5929,RBBP5,Q15291,0.821,0.231,0.99981,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
5930,RBBP6,Q7Z6E9,0.638,0.538,1.0,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
5931,RBBP7,Q16576,0.736,0.346,0.98393,,,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.08,1.0,,1998.0,2008.0,ALL
5932,RBBP8,Q99708,0.584,0.808,3.0764e-12,DTO_05007542,Transcription factor,C0796063,microcephaly-digital anomalies syndrome,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.71,1.0,strong,2001.0,2011.0,ALL
5933,RBL1,P28749,0.666,0.385,2.9339e-12,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2015.0,2015.0,ALL
5934,RBL2,Q08999,0.579,0.769,0.99835,DTO_05007557,Nucleic acid binding,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.32,1.0,,2002.0,2013.0,ALL
5935,RBM3,P98179,0.595,0.654,0.82616,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,1.0,,2006.0,2019.0,ALL
5936,RBM4,Q9BWF3,0.736,0.269,0.99005,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,0.8,,2014.0,2019.0,ALL
5937,RBMS1,P29558,0.861,0.231,0.11929,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.12,1.0,,2010.0,2018.0,ALL
5939,RBMS2,Q15434,0.89,0.154,1.3611e-06,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
5940,RBMY1A1,P0C7P1;P0DJD3,0.736,0.423,0.29035,DTO_05007557,Nucleic acid binding,C1507149,Partial chromosome Y deletion,C23;C16;C13;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2003.0,2010.0,ALL
5944,RBMY1HP,,0.839,0.192,,,,C0022735,Klinefelter Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
5947,RBP1,P09455,0.565,0.731,5.9233e-06,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.35,1.0,,1995.0,2014.0,ALL
5948,RBP2,P50120,0.615,0.615,0.22089,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2003.0,2019.0,ALL
5949,RBP3,P10745,0.621,0.5,0.00010889,,,C3715216,RETINITIS PIGMENTOSA 66,,,disease,Disease or Syndrome,0.7,1.0,,2009.0,2013.0,ALL
5950,RBP4,P02753,0.493,0.808,0.51951,DTO_05007405,Transporter,C3554593,"RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME",,,disease,Disease or Syndrome,0.7,1.0,strong,1999.0,2017.0,ALL
5953,RCD1,,1.0,0.115,,,,C0011175,Dehydration,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
5954,RCN1,Q15293,0.711,0.5,2.8821e-05,DTO_05007616,Calcium-binding protein,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
5955,RCN2,Q14257,0.78,0.269,0.029405,DTO_05007616,Calcium-binding protein,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
5956,OPN1LW,P04000,0.497,0.808,0.97535,DTO_02300001,G-protein coupled receptor,C0339537,Cone monochromatism,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.97,1.0,strong,1993.0,2019.0,ALL
5957,RCVRN,P35243,0.729,0.423,1.7064e-09,,,C0730307,Cancer-Associated Retinopathy,C04;C11,   Neoplasms;    Eye Diseases,disease,Disease or Syndrome,0.05,1.0,,1995.0,2010.0,ALL
5959,RDH5,Q92781,0.656,0.462,8.872e-11,DTO_05007624,Enzyme,C0311338,Fundus Albipunctatus,C11,   Eye Diseases,disease,Congenital Abnormality,0.8,1.0,,1999.0,2017.0,ALL
5961,PRPH2,P23942,0.551,0.5,0.11554,,,C1842475,Retinitis Pigmentosa 7,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.91,1.0,limited,1985.0,2016.0,ALL
5962,RDX,P35241,0.593,0.615,0.85245,DTO_05007530,Cellular structure,C1970239,"DEAFNESS, AUTOSOMAL RECESSIVE, 24",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1993.0,2007.0,ALL
5964,RDXP2,,1.0,0.077,,,,C1136249,"Mental Retardation, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
5965,RECQL,P46063,0.615,0.615,1.5345e-20,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.933,,2014.0,2019.0,ALL
5966,REL,Q04864,0.579,0.692,0.99836,DTO_05007542,Transcription factor,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.55,1.0,,2001.0,2010.0,ALL
5967,REG1A,P05451,0.467,0.846,1.3499e-05,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.24,1.0,,2005.0,2019.0,ALL
5968,REG1B,P48304,0.716,0.308,1.9522e-06,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2015.0,2019.0,ALL
5969,REG1CP,,1.0,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
5970,RELA,Q04206,0.406,0.885,0.99948,DTO_05007542,Transcription factor,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.55,0.857,,1996.0,2019.0,ALL
5971,RELB,Q01201,0.597,0.731,0.994,DTO_05007542,Transcription factor,C0239998,Recurrent infections,C23;C01;C05,"   Pathological Conditions, Signs and Symptoms;    Infections;    Musculoskeletal Diseases",phenotype,Finding,0.3,1.0,limited,2015.0,2015.0,ALL
5972,REN,P00797,0.37,0.923,2.4297e-07,DTO_05007624,Enzyme,C0266313,Allanson Pantzar McLeod syndrome,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.79,0.9,,2005.0,2019.0,ALL
5973,RENBP,P51606,0.528,0.769,0.44916,DTO_05007624,Enzyme,C1449563,"Cardiomyopathy, Familial Idiopathic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.32,1.0,,1999.0,2018.0,ALL
5976,UPF1,Q92900,0.663,0.615,1.0,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,0.875,,2008.0,2019.0,ALL
5977,DPF2,Q92785,0.604,0.731,0.99985,DTO_05007624,Enzyme,C4747954,COFFIN-SIRIS SYNDROME 7,,,disease,Disease or Syndrome,0.61,1.0,strong,2018.0,2020.0,ALL
5978,REST,Q13127,0.535,0.808,0.99186,DTO_05007542,Transcription factor,C3891301,"WILMS TUMOR, SUSCEPTIBILITY TO",C04,   Neoplasms,phenotype,Finding,0.7,1.0,,2015.0,2015.0,ALL
5979,RET,P07949,0.392,0.885,1.0,DTO_03300101,Kinase,C0025269,Multiple Endocrine Neoplasia Type 2b,C16;C04;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Endocrine System Diseases",disease,Neoplastic Process,1.0,1.0,,1992.0,2019.0,ALL
5980,REV3L,O60673,0.588,0.654,1.0,,,C0221060,Mobius Syndrome,C16;C10;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.33,1.0,,2015.0,2019.0,ALL
5981,RFC1,P35251,0.541,0.808,0.97305,,,C4255193,Bilateral Vestibulopathy,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.41,1.0,,2019.0,2019.0,ALL
5982,RFC2,P35250,0.52,0.769,2.2054e-06,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.12,1.0,,2003.0,2004.0,ALL
5983,RFC3,P40938,0.705,0.269,9.576e-06,DTO_05007624,Enzyme,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
5984,RFC4,P35249,0.743,0.192,4.4992e-07,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2018.0,ALL
5985,RFC5,P40937,0.861,0.115,0.00050356,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
5986,RFNG,Q9Y644,,,3.7851e-09,DTO_05007624,Enzyme,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
5987,TRIM27,P14373,0.572,0.808,0.99685,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2003.0,2006.0,ALL
5988,RFPL1,O75677,0.931,0.231,0.012421,,,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
5989,RFX1,P22670,0.636,0.538,0.99724,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2011.0,2018.0,ALL
5990,RFX2,P48378,0.89,0.154,0.9997,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
5991,RFX3,P48380,0.686,0.462,1.0,DTO_05007542,Transcription factor,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
5992,RFX4,Q33E94,0.821,0.231,0.99999,DTO_05007542,Transcription factor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2005.0,2007.0,ALL
5993,RFX5,P48382,0.65,0.577,1.9605e-11,DTO_05007624,Enzyme,C2931418,Bare lymphocyte syndrome 2,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.61,1.0,,1997.0,2000.0,ALL
5994,RFXAP,O00287,0.663,0.577,0.023275,,,C2931418,Bare lymphocyte syndrome 2,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.64,0.5,,2000.0,2012.0,ALL
5995,RGR,P47804,0.691,0.385,2.4228e-10,DTO_02300001,G-protein coupled receptor,C3151068,RETINITIS PIGMENTOSA 44,,,disease,Disease or Syndrome,0.6,1.0,,1999.0,1999.0,ALL
5996,RGS1,Q08116,0.653,0.731,0.78178,DTO_05007584,Enzyme modulator,C0011581,Depressive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
5997,RGS2,P41220,0.561,0.769,5.6973e-06,DTO_05007584,Enzyme modulator,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.6,0.957,,1992.0,2018.0,ALL
5998,RGS3,P49796,0.722,0.385,2.2646e-11,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
5999,RGS4,P49798,0.621,0.577,5.1409e-08,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,0.8,,2005.0,2010.0,ALL
6000,RGS7,P49802,0.722,0.462,0.77696,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.31,1.0,,2017.0,2018.0,ALL
6001,RGS10,O43665,0.76,0.423,0.75933,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2004.0,2019.0,ALL
6002,RGS12,O14924,0.769,0.462,4.0922e-09,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
6003,RGS13,O14921,0.769,0.423,0.0004479,DTO_05007584,Enzyme modulator,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
6004,RGS16,O15492,0.769,0.308,1.0062e-05,DTO_05007584,Enzyme modulator,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2017.0,ALL
6005,RHAG,Q02094,0.716,0.346,0.010404,DTO_05007405,Transporter,C1861455,STOMATOCYTOSIS I,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.71,1.0,strong,1998.0,2013.0,ALL
6006,RHCE,P18577,0.666,0.5,0.0011629,,,C0002881,"Anemia, Hemolytic, Congenital",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.3,1.0,,1998.0,1998.0,ALL
6007,RHD,Q02161,0.612,0.654,2.8534e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2002.0,2008.0,ALL
6008,RHEBP1,,0.792,0.192,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
6009,RHEB,Q15382,0.631,0.577,0.98119,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2020.0,2020.0,ALL
6010,RHO,P08100,0.525,0.769,0.00013108,DTO_02300001,G-protein coupled receptor,C3151001,Retinitis Pigmentosa 4,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.91,1.0,,1990.0,2018.0,ALL
6011,GRK1,Q15835,0.695,0.423,3.0677e-05,DTO_03300101,Kinase,C3150678,OGUCHI DISEASE 2,,,disease,Disease or Syndrome,0.8,1.0,strong,1997.0,2007.0,ALL
6012,RIEG2,,0.674,0.462,,,,C0025221,Meleda Disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.05,0.8,,2002.0,2006.0,ALL
6013,RLN1,P04808,0.769,0.346,0.0065226,DTO_05007599,Signaling,C0020564,Hypertrophy,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
6014,RIT2,Q99578,0.647,0.538,0.00063244,DTO_05007584,Enzyme modulator,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,0.938,,2011.0,2020.0,ALL
6015,RING1,Q06587,0.653,0.423,0.64854,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
6016,RIT1,Q92963,0.527,0.808,0.13281,DTO_05007584,Enzyme modulator,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.9,1.0,definitive,2013.0,2019.0,ALL
6017,RLBP1,P12271,0.644,0.5,1.1303e-05,DTO_05007405,Transporter,C1843816,Bothnia Retinal Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.9,1.0,limited,1999.0,2001.0,ALL
6018,RLF,Q13129,0.931,0.115,1.0,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
6019,RLN2,P04090,0.626,0.615,0.00090025,DTO_05007599,Signaling,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.33,1.0,,2005.0,2016.0,ALL
6022,RMD1,,1.0,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,1998.0,1998.0,ALL
6023,RMRP,,0.519,0.731,,,,C0220748,Cartilage-hair hypoplasia,C16;C06;C05;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Musculoskeletal Diseases;    Immune System Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.7,1.0,,1982.0,2020.0,ALL
6029,RN7SL1,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
6035,RNASE1,P07998,0.604,0.692,0.025608,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1999.0,2019.0,ALL
6036,RNASE2,P10153,0.621,0.692,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.06,1.0,,2004.0,2019.0,ALL
6037,RNASE3,P12724,0.49,0.808,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,1.0,,1996.0,2019.0,ALL
6038,RNASE4,P34096,0.736,0.385,0.00017566,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2006.0,2006.0,ALL
6039,RNASE6,Q93091,0.931,0.077,0.082292,,,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
6041,RNASEL,Q05823,0.579,0.692,1.9513e-10,DTO_03300101,Kinase,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.7,0.958,,2002.0,2017.0,ALL
6045,RNF2,Q99496,0.608,0.615,0.99743,,,C0080178,Spina Bifida,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.2,1.0,,2010.0,2010.0,ALL
6046,BRD2,P25440,0.45,0.808,0.99957,DTO_05007378,Epigenetic regulator,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.53,1.0,,1999.0,2018.0,ALL
6047,RNF4,P78317,0.705,0.462,0.79973,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.11,1.0,,2012.0,2018.0,ALL
6048,RNF5,Q99942,0.716,0.538,3.6989e-05,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
6049,RNF6,Q9Y252,0.656,0.615,0.01389,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.5,,,,,ALL
6050,RNH1,P13489,0.569,0.731,2.5541e-10,DTO_05007542,Transcription factor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,0.818,,2006.0,2019.0,ALL
6051,RNPEP,Q9H4A4,0.705,0.385,2.6051e-17,,,C0024668,"Mammary Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.5,1.0,,2006.0,2006.0,ALL
6052,RNR1,,0.931,0.038,,,,C0038362,Stomatitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
6059,ABCE1,P61221,0.674,0.462,0.9738,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
6060,RNU1-4,,0.626,0.577,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,0.867,,1997.0,2014.0,ALL
6066,RNU2-1,,0.76,0.385,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2016.0,ALL
6079,SNORD15A,,0.653,0.577,,,,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2014.0,2014.0,ALL
6080,SNORA73A,,0.769,0.385,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2002.0,2012.0,ALL
6084,RNY1,,0.821,0.192,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
6085,RNY3,,0.89,0.115,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
6086,RNY4,,0.821,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
6090,RNY5,,0.861,0.231,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
6091,ROBO1,Q9Y6N7,0.535,0.731,7.2696e-16,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.37,1.0,,2002.0,2019.0,ALL
6092,ROBO2,Q9HCK4,0.633,0.462,1.0,,,C1970483,Vesicoureteral Reflux 2,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.7,1.0,limited,2007.0,2007.0,ALL
6093,ROCK1,Q13464,0.513,0.731,1.0,DTO_03300101,Kinase,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,2007.0,2007.0,ALL
6094,ROM1,Q03395,0.579,0.654,0.00041221,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,limited,1992.0,2017.0,ALL
6095,RORA,P35398,0.533,0.808,0.40096,DTO_00102000,Nuclear receptor,C4748041,INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA,,,disease,Disease or Syndrome,0.5,1.0,strong,2018.0,2018.0,ALL
6096,RORB,Q92753,0.644,0.5,0.99991,DTO_00102000,Nuclear receptor,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
6097,RORC,P51449,0.576,0.769,0.99985,DTO_00102000,Nuclear receptor,C4225266,IMMUNODEFICIENCY 42,,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2015.0,ALL
6098,ROS1,P08922,0.439,0.885,1.6184e-72,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.7,1.0,,2012.0,2020.0,ALL
6100,RP9,Q8TA86,0.67,0.5,0.018956,,,C1867300,RETINITIS PIGMENTOSA 9,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.72,1.0,,2002.0,2008.0,ALL
6101,RP1,P56715,0.663,0.462,4.415e-13,,,C0220701,RETINITIS PIGMENTOSA 1,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.9,1.0,,1999.0,2014.0,ALL
6102,RP2,O75695,0.67,0.346,0.95597,DTO_05007624,Enzyme,C2681923,RETINITIS PIGMENTOSA 2 (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.95,0.955,,1998.0,2018.0,ALL
6103,RPGR,Q92834,0.536,0.692,0.99804,,,C1845667,RETINITIS PIGMENTOSA 3,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.97,1.0,,1996.0,2014.0,ALL
6114,RP22,,0.89,0.154,,,,C0036323,Schistosomiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
6116,RP24,,0.931,0.077,,,,C0339525,Autosomal dominant retinitis pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0,,2013.0,2013.0,ALL
6117,RPA1,P27694,0.619,0.692,0.08777,DTO_05007557,Nucleic acid binding,C0263454,Chloracne,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
6118,RPA2,P15927,0.769,0.231,0.50461,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
6119,RPA3,P35244,0.769,0.154,8.5529e-09,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
6120,RPE,Q96AT9,0.575,0.538,0.00025152,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
6121,RPE65,Q16518,0.417,0.808,6.4889e-14,DTO_05007624,Enzyme,C1859844,"LEBER CONGENITAL AMAUROSIS, TYPE II (disorder)",C11,   Eye Diseases,disease,Disease or Syndrome,0.96,0.981,,1997.0,2018.0,ALL
6122,RPL3,P39023,0.736,0.462,0.99441,DTO_05007557,Nucleic acid binding,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
6123,RPL3L,Q92901,0.89,0.192,4.947e-16,DTO_05007557,Nucleic acid binding,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
6124,RPL4,P36578,0.792,0.269,0.99984,,,C0374997,Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.02,1.0,,2006.0,2012.0,ALL
6125,RPL5,P46777,0.617,0.615,0.99776,DTO_05007557,Nucleic acid binding,C2931850,Aase Smith syndrome 2,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2009.0,ALL
6128,RPL6,Q02878,0.7,0.385,0.99326,DTO_05007557,Nucleic acid binding,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2002.0,2002.0,ALL
6129,RPL7,P18124,1.0,0.038,0.99626,DTO_05007557,Nucleic acid binding,C0006309,Brucellosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
6130,RPL7A,P62424,0.769,0.154,0.99485,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
6132,RPL8,P62917,0.839,0.115,0.95531,DTO_05007557,Nucleic acid binding,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
6133,RPL9,P32969,0.805,0.308,0.96197,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.31,1.0,,2010.0,2020.0,ALL
6134,RPL10,P27635,0.568,0.731,0.90915,DTO_05007557,Nucleic acid binding,C4478383,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2015.0,ALL
6135,RPL11,P62913,0.65,0.577,0.96088,DTO_05007557,Nucleic acid binding,C2675512,Diamond-Blackfan Anemia 7,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2013.0,ALL
6136,RPL12,P30050,0.931,0.115,0.053094,DTO_05007557,Nucleic acid binding,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
6137,RPL13,P26373,0.751,0.385,0.95062,DTO_05007557,Nucleic acid binding,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
6138,RPL15,P61313,0.686,0.615,0.97146,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.51,1.0,strong,2013.0,2017.0,ALL
6139,RPL17,P18621,0.559,0.731,0.92412,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
6141,RPL18,Q07020,0.743,0.385,0.96644,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.5,1.0,moderate,2017.0,2017.0,ALL
6142,RPL18A,Q02543,0.89,0.192,0.98228,,,C0085762,Alcohol abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,1.0,,2001.0,2001.0,ALL
6143,RPL19,P84098,0.751,0.308,0.98197,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.3,1.0,limited,2013.0,2013.0,ALL
6144,RPL21,P46778,0.839,0.115,0.83747,DTO_05007557,Nucleic acid binding,C4014563,HYPOTRICHOSIS 12,,,disease,Disease or Syndrome,0.6,1.0,limited,2011.0,2011.0,ALL
6146,RPL22,P35268,0.666,0.346,0.15619,DTO_05007557,Nucleic acid binding,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
6147,RPL23A,P62750,0.78,0.308,0.90573,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
6150,MRPL23,Q16540,0.89,0.115,1.6288e-08,DTO_05007557,Nucleic acid binding,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
6152,RPL24,P83731,0.861,0.192,0.64137,DTO_05007557,Nucleic acid binding,C0238198,Gastrointestinal Stromal Tumors,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
6154,RPL26,P61254,0.695,0.423,0.9163,DTO_05007557,Nucleic acid binding,C3554042,DIAMOND-BLACKFAN ANEMIA 11,,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2012.0,ALL
6155,RPL27,P61353,0.769,0.385,0.85027,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.51,1.0,,2015.0,2017.0,ALL
6156,RPL30,P62888,0.821,0.077,0.84674,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
6157,RPL27A,P46776,0.89,0.115,0.91072,DTO_05007557,Nucleic acid binding,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
6158,RPL28,P46779,0.839,0.192,0.76854,DTO_05007557,Nucleic acid binding,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
6159,RPL29,P47914,0.644,0.462,0.19534,DTO_05007557,Nucleic acid binding,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,2004.0,2019.0,ALL
6160,RPL31,P62899,0.78,0.308,0.84958,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.31,1.0,strong,2014.0,2017.0,ALL
6161,RPL32,P62910,0.839,0.192,0.79962,DTO_05007557,Nucleic acid binding,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
6163,RPL32P1,,1.0,0.077,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
6164,RPL34,P49207,0.7,0.308,0.70885,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
6165,RPL35A,P18077,0.736,0.385,0.89535,DTO_05007557,Nucleic acid binding,C2675859,Diamond-Blackfan Anemia 5,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,,2008.0,2015.0,ALL
6167,RPL37,P61927,0.861,0.154,0.18273,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
6168,RPL37A,P61513,0.839,0.346,0.0051255,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
6169,RPL38,P63173,0.89,0.038,0.8255,DTO_05007557,Nucleic acid binding,C0029882,Otitis Media,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.21,1.0,,1979.0,2011.0,ALL
6170,RPL39,P62891,0.76,0.192,0.57637,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2017.0,ALL
6171,RPL41,P62945,0.78,0.269,0.18377,,,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.03,1.0,,2002.0,2009.0,ALL
6173,RPL36A,P83881,0.656,0.385,0.42737,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.33,1.0,,2015.0,2018.0,ALL
6175,RPLP0,P05388,0.736,0.5,0.76762,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.2,1.0,,2014.0,2014.0,ALL
6176,RPLP1,P05386,0.821,0.115,0.37039,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2009.0,2018.0,ALL
6181,RPLP2,P05387,0.805,0.192,0.66744,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
6182,MRPL12,P52815,0.931,0.115,0.0032204,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
6184,RPN1,P04843,0.792,0.269,0.239,DTO_05007624,Enzyme,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
6185,RPN2,P04844,0.686,0.462,0.11487,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
6187,RPS2,P15880,0.76,0.462,0.8469,DTO_05007557,Nucleic acid binding,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
6188,RPS3,P23396,0.7,0.346,0.92,DTO_05007557,Nucleic acid binding,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2015.0,ALL
6189,RPS3A,P61247,0.839,0.192,0.97002,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
6191,RPS4X,P62701,0.711,0.5,0.93222,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2011.0,2017.0,ALL
6192,RPS4Y1,P22090,0.861,0.269,0.62651,DTO_05007557,Nucleic acid binding,C0041408,Turner Syndrome,C16;C13;C12;C19;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,1990.0,1996.0,ALL
6193,RPS5,P46782,0.89,0.154,0.94764,DTO_05007557,Nucleic acid binding,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
6194,RPS6,P62753,0.547,0.692,0.9759,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2008.0,2019.0,ALL
6195,RPS6KA1,Q15418,0.619,0.654,0.0019056,DTO_03300101,Kinase,C0015923,Fetal Alcohol Syndrome,C16;C13;C25,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
6196,RPS6KA2,Q15349,0.636,0.538,0.0094073,DTO_03300101,Kinase,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2019.0,2019.0,ALL
6197,RPS6KA3,P51812,0.491,0.846,0.99999,DTO_03300101,Kinase,C0265252,Coffin-Lowry syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.983,definitive,1996.0,2020.0,ALL
6198,RPS6KB1,P23443,0.511,0.731,0.97285,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2017.0,2020.0,ALL
6199,RPS6KB2,Q9UBS0,0.678,0.538,5.9588e-21,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,2011.0,2018.0,ALL
6201,RPS7,P62081,0.682,0.462,0.95439,DTO_05007557,Nucleic acid binding,C2675511,Diamond-Blackfan Anemia 8,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.6,1.0,strong,2008.0,2017.0,ALL
6202,RPS8,P62241,0.805,0.192,0.99003,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
6203,RPS9,P46781,0.78,0.154,0.87956,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2008.0,2008.0,ALL
6204,RPS10,P46783,0.729,0.462,0.97108,DTO_05007557,Nucleic acid binding,C2750081,Diamond-Blackfan Anemia 9,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,definitive,2010.0,2015.0,ALL
6205,RPS11,P62280,0.931,0.038,0.94396,DTO_05007557,Nucleic acid binding,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
6206,RPS12,P25398,0.76,0.231,0.88531,DTO_05007557,Nucleic acid binding,C0020557,Hypertriglyceridemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.2,1.0,,2015.0,2015.0,ALL
6207,RPS13,P62277,0.931,0.077,0.87646,DTO_05007557,Nucleic acid binding,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
6208,RPS14,P62263,0.631,0.5,0.90388,DTO_05007557,Nucleic acid binding,C0740302,5q-syndrome,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2007.0,2019.0,ALL
6209,RPS15,P62841,0.695,0.231,0.83284,DTO_05007557,Nucleic acid binding,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.36,1.0,,2015.0,2019.0,ALL
6210,RPS15A,P62244,0.638,0.538,0.802,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
6217,RPS16,P62249,0.89,0.154,0.68713,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
6218,RPS17,P08708,0.751,0.462,0.32566,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.68,1.0,strong,2007.0,2017.0,ALL
6222,RPS18,P62269,0.861,0.192,0.9759,DTO_05007557,Nucleic acid binding,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
6223,RPS19,P39019,0.48,0.846,0.92111,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,0.975,strong,1992.0,2020.0,ALL
6224,RPS20,P60866,0.61,0.692,0.020686,DTO_05007557,Nucleic acid binding,C3896578,Familial Colorectal Cancer Type X,C16;C06;C04;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nutritional and Metabolic Diseases",disease,Neoplastic Process,0.32,1.0,,2014.0,2018.0,ALL
6227,RPS21,P63220,0.805,0.269,0.1406,DTO_05007557,Nucleic acid binding,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
6228,RPS23,P62266,0.7,0.5,0.85944,DTO_05007557,Nucleic acid binding,C4479431,"BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY",,,disease,Disease or Syndrome,0.7,1.0,moderate,2017.0,2017.0,ALL
6229,RPS24,P62847,0.695,0.423,0.68141,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.69,1.0,definitive,2006.0,2017.0,ALL
6230,RPS25,P62851,0.89,0.115,0.86346,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
6231,RPS26,P62854,0.716,0.538,0.84833,DTO_05007557,Nucleic acid binding,C2750080,Diamond-Blackfan Anemia 10,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.71,1.0,strong,2010.0,2019.0,ALL
6232,RPS27,P42677,0.578,0.769,0.75663,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.51,1.0,,2015.0,2017.0,ALL
6233,RPS27A,P62979,0.621,0.808,0.91944,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.3,1.0,strong,2016.0,2016.0,ALL
6234,RPS28,P62857,0.716,0.423,0.68259,DTO_05007557,Nucleic acid binding,C4225411,DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS,,,disease,Disease or Syndrome,0.6,1.0,moderate,2014.0,2014.0,ALL
6235,RPS29,P62273,0.729,0.423,0.29053,,,C4014641,DIAMOND-BLACKFAN ANEMIA 13,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
6236,RRAD,P55042,0.638,0.538,0.43879,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,1999.0,2014.0,ALL
6237,RRAS,P10301,0.543,0.808,0.004663,DTO_05007584,Enzyme modulator,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.51,1.0,limited,2013.0,2014.0,ALL
6238,RRBP1,Q9P2E9,0.615,0.577,2.2851e-11,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
6239,RREB1,Q92766,0.5,0.808,1.0,,,C0012236,DiGeorge Syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
6240,RRM1,P23921,0.552,0.692,1.0,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.4,0.966,,2004.0,2019.0,ALL
6241,RRM2,P31350,0.555,0.769,0.2964,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.37,1.0,,2005.0,2019.0,ALL
6242,RTKN,Q9BST9,0.711,0.269,2.696e-06,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0,,2015.0,2019.0,ALL
6247,RS1,O15537,0.686,0.5,0.95743,DTO_05007624,Enzyme,C3714753,"RETINOSCHISIS 1, X-LINKED, JUVENILE",,,disease,Disease or Syndrome,0.81,1.0,limited,1997.0,2017.0,ALL
6248,RSC1A1,Q92681,0.751,0.308,2.3498e-13,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.2,1.0,,2005.0,2005.0,ALL
6249,CLIP1,P30622,0.617,0.654,0.68088,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2014.0,2015.0,ALL
6251,RSU1,Q15404,0.716,0.308,0.00089071,,,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
6252,RTN1,Q16799,0.666,0.615,0.98593,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
6253,RTN2,O75298,0.711,0.385,0.41643,,,C1858106,"SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2012.0,2017.0,ALL
6256,RXRA,P19793,0.543,0.769,0.99852,DTO_00102000,Nuclear receptor,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.51,1.0,,2004.0,2008.0,ALL
6257,RXRB,P28702,0.686,0.654,0.99719,DTO_00102000,Nuclear receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2003.0,2012.0,ALL
6258,RXRG,P48443,0.674,0.615,0.42421,DTO_00102000,Nuclear receptor,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
6259,RYK,P34925,0.705,0.423,0.98922,DTO_03300101,Kinase,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.31,1.0,,2000.0,2006.0,ALL
6261,RYR1,P21817,0.489,0.808,1.5944e-29,DTO_01300327,Ion channel,C0751951,Central Core Myopathy (disorder),C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,1.0,1.0,,1993.0,2019.0,ALL
6262,RYR2,Q92736,0.539,0.615,0.99999,DTO_01300327,Ion channel,C1631597,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.995,,2001.0,2020.0,ALL
6263,RYR3,Q15413,0.666,0.462,0.70566,DTO_01300327,Ion channel,C0543888,Epileptic encephalopathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,limited,2014.0,2018.0,ALL
6271,S100A1,P23297,0.421,0.846,0.0060044,DTO_05007616,Calcium-binding protein,C0265110,Cerebral Vasospasm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2002.0,2002.0,ALL
6272,SORT1,Q99523,0.573,0.615,0.99987,DTO_05007405,Transporter,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.4,1.0,,2008.0,2019.0,ALL
6273,S100A2,P29034,0.603,0.577,5.8403e-05,DTO_05007616,Calcium-binding protein,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.9,,2001.0,2017.0,ALL
6274,S100A3,P33764,0.792,0.115,0.0079273,DTO_05007616,Calcium-binding protein,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2008.0,2017.0,ALL
6275,S100A4,P26447,0.448,0.769,0.0061838,DTO_05007616,Calcium-binding protein,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.929,,1995.0,2018.0,ALL
6276,S100A5,P33763,0.805,0.308,5.5111e-05,DTO_05007616,Calcium-binding protein,C0238281,Middle Cerebral Artery Syndrome,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
6277,S100A6,P06703,0.51,0.808,0.17565,DTO_05007616,Calcium-binding protein,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
6278,S100A7,P31151,0.546,0.769,0.45274,DTO_05007616,Calcium-binding protein,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.4,0.957,,1995.0,2020.0,ALL
6279,S100A8,P05109,0.43,0.962,0.13761,DTO_05007616,Calcium-binding protein,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.34,1.0,,2001.0,2017.0,ALL
6280,S100A9,P06702,0.433,0.885,0.4777,DTO_05007616,Calcium-binding protein,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2004.0,2019.0,ALL
6281,S100A10,P60903,0.528,0.769,0.16843,DTO_05007616,Calcium-binding protein,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.6,1.0,,2006.0,2019.0,ALL
6282,S100A11,P31949,0.556,0.731,0.0084662,DTO_05007616,Calcium-binding protein,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
6283,S100A12,P80511,0.488,0.846,0.48234,DTO_05007616,Calcium-binding protein,C0026636,Mouth Diseases,C07,   Stomatognathic Diseases,group,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
6284,S100A13,Q99584,0.751,0.154,0.049652,DTO_05007616,Calcium-binding protein,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2010.0,2018.0,ALL
6285,S100B,P04271,0.383,0.923,0.04387,DTO_05007616,Calcium-binding protein,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.74,1.0,,2004.0,2017.0,ALL
6286,S100P,P25815,0.78,0.346,0.033257,DTO_05007616,Calcium-binding protein,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
6288,SAA1,P0DJI8,0.513,0.808,0.01493,DTO_05007405,Transporter,C0221014,Reactive systemic amyloidosis,C18;C17,   Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.4,0.935,,1986.0,2018.0,ALL
6289,SAA2,P0DJI9,0.568,0.731,2.7019e-06,DTO_05007405,Transporter,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,0.933,,1986.0,2018.0,ALL
6290,SAA3P,,0.722,0.5,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2001.0,2011.0,ALL
6291,SAA4,P35542,0.78,0.269,0.012346,DTO_05007405,Transporter,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
6293,VPS52,Q8N1B4,0.78,0.231,0.00038938,DTO_05007405,Transporter,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,2002.0,2014.0,ALL
6294,SAFB,Q15424,0.592,0.654,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.08,1.0,,1997.0,2015.0,ALL
6295,SAG,P10523,0.57,0.731,1.4921e-16,DTO_05007584,Enzyme modulator,C0339535,"Night blindness, congenital stationary",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.71,1.0,strong,1995.0,2009.0,ALL
6296,ACSM3,Q53FZ2,0.623,0.615,1.441e-14,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
6297,SALL2,Q9Y467,0.674,0.423,0.00013767,DTO_05007542,Transcription factor,C0009363,Congenital ocular coloboma (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.42,1.0,,2014.0,2017.0,ALL
6298,SAI1,,0.56,0.615,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,0.933,,1992.0,2020.0,ALL
6299,SALL1,Q9NSC2,0.539,0.808,0.99971,DTO_05007542,Transcription factor,C0265246,Townes syndrome,C23;C16;C06;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.9,0.929,strong,1998.0,2018.0,ALL
6300,MAPK12,P53778,0.695,0.346,5.8734e-07,DTO_03300101,Kinase,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
6301,SARS1,P49591,0.558,0.769,0.99925,DTO_05007624,Enzyme,C4540188,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES",,,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
6302,TSPAN31,Q12999,0.556,0.654,0.21925,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2011.0,ALL
6303,SAT1,P21673,0.539,0.808,0.8706,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.36,1.0,,2008.0,2020.0,ALL
6304,SATB1,Q01826,0.525,0.769,0.99051,DTO_05007542,Transcription factor,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
6305,SBF1,O95248,0.7,0.5,0.99933,DTO_05007624,Enzyme,C3695063,Charcot-Marie-Tooth disease type 4B3,,,disease,Disease or Syndrome,0.72,1.0,strong,2013.0,2017.0,ALL
6307,MSMO1,Q15800,0.729,0.385,0.089971,DTO_05007624,Enzyme,C4225189,"MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2016.0,ALL
6309,SC5D,O75845,0.641,0.577,0.0025941,DTO_05007624,Enzyme,C1846421,Lathosterolosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2002.0,2019.0,ALL
6310,ATXN1,P54253,0.534,0.769,0.97498,,,C0752120,Spinocerebellar Ataxia Type 1,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.983,,1980.0,2020.0,ALL
6311,ATXN2,Q99700,0.482,0.808,0.85289,DTO_05007557,Nucleic acid binding,C0752121,Spinocerebellar Ataxia Type 2,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,1997.0,2019.0,ALL
6314,ATXN7,O15265,0.581,0.654,0.9595,,,C0752125,Spinocerebellar Ataxia Type 7,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.985,,1997.0,2019.0,ALL
6315,ATXN8OS,P0DMR3,0.65,0.423,,,,C1837454,SPINOCEREBELLAR ATAXIA 8,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,,2000.0,2019.0,ALL
6317,SERPINB3,P29508,0.565,0.615,8.2146e-16,DTO_05007584,Enzyme modulator,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2001.0,2018.0,ALL
6318,SERPINB4,P48594,0.623,0.423,8.7622e-17,DTO_05007584,Enzyme modulator,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
6319,SCD,O00767,0.49,0.808,0.96968,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.5,1.0,,2002.0,2005.0,ALL
6320,CLEC11A,Q9Y240,0.633,0.577,0.00038003,DTO_05007621,Extracellular structure,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.32,1.0,,2009.0,2010.0,ALL
6322,SCML1,Q9UN30,0.89,0.077,0.96276,DTO_05007557,Nucleic acid binding,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
6323,SCN1A,P35498,0.477,0.808,1.0,DTO_01300327,Ion channel,C0751122,Infantile Severe Myoclonic Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.9,0.974,definitive,2001.0,2020.0,ALL
6324,SCN1B,Q07699,0.575,0.538,0.10186,DTO_01300327,Ion channel,C1858672,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,1998.0,2019.0,ALL
6326,SCN2A,Q99250,0.518,0.731,1.0,DTO_01300327,Ion channel,C3150987,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11",,,disease,Disease or Syndrome,0.7,1.0,,2004.0,2019.0,ALL
6327,SCN2B,O60939,0.678,0.192,0.0017119,DTO_01300327,Ion channel,C3809312,"ATRIAL FIBRILLATION, FAMILIAL, 14",,,disease,Disease or Syndrome,0.6,1.0,,2009.0,2009.0,ALL
6328,SCN3A,Q9NY46,0.617,0.538,1.0,DTO_01300327,Ion channel,C4693694,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4",,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2017.0,ALL
6329,SCN4A,P35499,0.554,0.731,0.01294,DTO_01300327,Ion channel,C0238357,Hyperkalemic periodic paralysis,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1989.0,2019.0,ALL
6330,SCN4B,Q8IWT1,0.705,0.346,6.4529e-07,DTO_01300327,Ion channel,C2678484,Long Qt Syndrome 10,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2007.0,2013.0,ALL
6331,SCN5A,Q14524,0.513,0.654,0.91291,DTO_01300327,Ion channel,C1142166,Brugada Syndrome (disorder),C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.984,definitive,1995.0,2020.0,ALL
6332,SCN7A,Q01118,0.585,0.692,2.1568e-17,DTO_01300327,Ion channel,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
6334,SCN8A,Q9UQD0,0.51,0.731,1.0,DTO_01300327,Ion channel,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.9,0.971,,2007.0,2020.0,ALL
6335,SCN9A,Q15858,0.543,0.615,4.7524e-19,DTO_01300327,Ion channel,C0014805,Primary Erythermalgia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.8,1.0,,2004.0,2017.0,ALL
6336,SCN10A,Q9Y5Y9,0.566,0.692,9.9457e-38,DTO_01300327,Ion channel,C1142166,Brugada Syndrome (disorder),C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,0.929,disputed,1998.0,2019.0,ALL
6337,SCNN1A,P37088,0.601,0.577,1.0835e-11,DTO_01300327,Ion channel,C1449843,"Pseudohypoaldosteronism, Type I, Autosomal Recessive",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.61,1.0,strong,1999.0,2013.0,ALL
6338,SCNN1B,P51168,0.628,0.577,5.7545e-08,DTO_01300327,Ion channel,C0221043,Liddle Syndrome,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1995.0,2018.0,ALL
6339,SCNN1D,P51172,0.821,0.192,1.6507e-33,DTO_01300327,Ion channel,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.02,1.0,,2015.0,2017.0,ALL
6340,SCNN1G,P51170,0.633,0.577,0.48199,DTO_01300327,Ion channel,C1449843,"Pseudohypoaldosteronism, Type I, Autosomal Recessive",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1996.0,2015.0,ALL
6341,SCO1,O75880,0.638,0.769,0.00022337,DTO_05007624,Enzyme,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.94,1.0,,2000.0,2013.0,ALL
6342,SCP2,P22307,0.644,0.5,8.7451e-07,,,C3150990,LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY,,,disease,Disease or Syndrome,0.7,1.0,,2006.0,2015.0,ALL
6343,SCT,P09683,0.484,0.846,1.4425e-07,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.857,,1999.0,2006.0,ALL
6344,SCTR,P47872,0.678,0.423,2.4257e-12,DTO_02300001,G-protein coupled receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2019.0,2019.0,ALL
6345,SRL,Q86TD4,0.597,0.731,8.0004e-08,DTO_05007584,Enzyme modulator,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2014.0,2014.0,ALL
6346,CCL1,P22362,0.587,0.692,0.0079669,DTO_05007599,Signaling,C0017658,Glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.5,1.0,,1999.0,2001.0,ALL
6347,CCL2,P13500,0.321,0.962,0.60786,DTO_05007599,Signaling,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.6,0.875,,2001.0,2019.0,ALL
6348,CCL3,P10147,0.46,0.885,0.34981,DTO_05007599,Signaling,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,2009.0,2012.0,ALL
6349,CCL3L1,P16619,0.65,0.654,0.12057,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.36,0.833,,2007.0,2014.0,ALL
6351,CCL4,P13236;Q8NHW4,0.466,0.923,0.24134,DTO_05007599,Signaling,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.33,1.0,,2009.0,2020.0,ALL
6352,CCL5,P13501,0.403,0.885,0.0017516,DTO_05007599,Signaling,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.6,0.886,,1996.0,2019.0,ALL
6354,CCL7,P80098,0.548,0.846,0.00089294,DTO_05007599,Signaling,C0017658,Glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.5,1.0,,1999.0,2001.0,ALL
6355,CCL8,P80075,0.546,0.692,0.041412,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.34,1.0,,2007.0,2019.0,ALL
6356,CCL11,P51671,0.473,0.885,0.010211,DTO_05007599,Signaling,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.953,,1995.0,2019.0,ALL
6357,CCL13,Q99616,0.628,0.692,0.040987,DTO_05007599,Signaling,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
6358,CCL14,Q16627,0.695,0.423,0.00010929,DTO_05007599,Signaling,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2001.0,2019.0,ALL
6359,CCL15,Q16663,0.67,0.615,0.3333,DTO_05007599,Signaling,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
6360,CCL16,O15467,0.686,0.5,0.22498,DTO_05007599,Signaling,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
6361,CCL17,Q92583,0.518,0.808,0.00013932,DTO_05007599,Signaling,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.5,1.0,,2005.0,2011.0,ALL
6362,CCL18,P55774,0.489,0.846,0.0091743,DTO_05007599,Signaling,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2013.0,2019.0,ALL
6363,CCL19,Q99731,0.542,0.692,0.31691,DTO_05007599,Signaling,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.31,1.0,,2011.0,2018.0,ALL
6364,CCL20,P78556,0.474,0.846,0.00024242,DTO_05007599,Signaling,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.64,1.0,,2004.0,2017.0,ALL
6366,CCL21,O00585,0.502,0.769,0.036239,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,0.857,,2003.0,2019.0,ALL
6367,CCL22,O00626,0.5,0.846,0.0084014,DTO_05007599,Signaling,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.4,1.0,,2002.0,2019.0,ALL
6368,CCL23,P55773,0.76,0.346,0.00059735,DTO_05007599,Signaling,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
6369,CCL24,O00175,0.608,0.731,0.0070888,DTO_05007599,Signaling,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.34,1.0,,2005.0,2019.0,ALL
6370,CCL25,O15444,0.61,0.692,0.015241,DTO_05007599,Signaling,C0022346,Icterus,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.2,1.0,,2008.0,2008.0,ALL
6372,CXCL6,P80162,0.582,0.692,2.7101e-09,DTO_05007599,Signaling,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.32,1.0,,2004.0,2007.0,ALL
6373,CXCL11,O14625,0.519,0.808,0.31408,DTO_05007599,Signaling,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.31,1.0,,2018.0,2019.0,ALL
6374,CXCL5,P42830,0.519,0.769,5.0431e-06,DTO_05007599,Signaling,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.35,1.0,,1996.0,2019.0,ALL
6375,XCL1,P47992,0.601,0.692,0.0012982,DTO_05007599,Signaling,C1332309,Anti-Basement Membrane Glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0,,1998.0,1998.0,ALL
6376,CX3CL1,P78423,0.478,0.808,0.60837,DTO_05007599,Signaling,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2004.0,2010.0,ALL
6377,SCZD1,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,1991.0,1991.0,ALL
6378,SCZD2,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,1993.0,2018.0,ALL
6382,SDC1,P18827,0.445,0.769,0.0084118,DTO_05007621,Extracellular structure,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
6383,SDC2,P34741,0.536,0.808,0.4049,DTO_05007621,Extracellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2000.0,2019.0,ALL
6385,SDC4,P31431,0.603,0.615,0.0041475,DTO_05007621,Extracellular structure,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2012.0,2018.0,ALL
6386,SDCBP,O00560,0.653,0.385,0.00058136,DTO_05007405,Transporter,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
6387,CXCL12,P48061,0.379,0.846,0.11851,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.988,,2003.0,2020.0,ALL
6388,SDF2,Q99470,0.89,0.154,0.026377,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
6389,SDHA,P31040,0.517,0.731,2.6088e-10,DTO_05007624,Enzyme,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.73,0.917,moderate,1992.0,2017.0,ALL
6390,SDHB,P21912,0.474,0.846,0.00024397,DTO_05007624,Enzyme,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.8,0.989,,1982.0,2020.0,ALL
6391,SDHC,Q99643,0.517,0.846,0.00020065,,,C0238198,Gastrointestinal Stromal Tumors,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.8,0.973,strong,2000.0,2019.0,ALL
6392,SDHD,O14521,0.472,0.885,0.33697,DTO_05007405,Transporter,C0030421,Paraganglioma,C04,   Neoplasms,disease,Neoplastic Process,0.8,0.994,strong,1996.0,2020.0,ALL
6395,SEA,,0.606,0.615,,,,C0002312,alpha-Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,0.938,,1989.0,2017.0,ALL
6396,SEC13,P55735,1.0,0.115,0.017926,DTO_05007405,Transporter,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
6397,SEC14L1,Q92503,0.78,0.346,0.63264,,,C0027902,Neuropsychological Tests,,,phenotype,Diagnostic Procedure,0.1,1.0,,2009.0,2009.0,ALL
6398,SECTM1,Q8WVN6,0.931,0.077,0.057603,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
6399,TRAPPC2,P0DI81;P0DI82,0.722,0.308,0.002414,DTO_05007542,Transcription factor,C3541456,"Spondyloepiphyseal Dysplasia Tarda, X-Linked",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.8,1.0,,1999.0,2019.0,ALL
6400,SEL1L,Q9UBV2,0.628,0.654,0.98233,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
6401,SELE,P16581,0.447,0.808,7.9058e-10,,,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.5,1.0,,2006.0,2013.0,ALL
6402,SELL,P14151,0.505,0.846,4.9624e-07,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.31,1.0,,1998.0,2016.0,ALL
6403,SELP,P16109,0.46,0.769,5.0448e-32,,,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.5,1.0,,2002.0,2011.0,ALL
6404,SELPLG,Q14242,0.564,0.692,0.1768,,,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2002.0,2002.0,ALL
6405,SEMA3F,Q13275,0.653,0.615,0.99989,DTO_05007599,Signaling,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.32,1.0,,2011.0,2019.0,ALL
6406,SEMG1,P04279,0.628,0.615,0.35697,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
6407,SEMG2,Q02383,,,0.058203,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
6414,SELENOP,P49908,0.545,0.769,8.2884e-07,DTO_05007621,Extracellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.38,1.0,,2002.0,2019.0,ALL
6415,SELENOW,P63302,0.736,0.462,0.00026801,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
6416,MAP2K4,P45985,0.559,0.692,0.99709,DTO_03300101,Kinase,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,,,,,ALL
6418,SET,Q01105,0.507,0.808,0.99597,DTO_05007584,Enzyme modulator,C4748195,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 58",,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2018.0,ALL
6419,SETMAR,Q53H47,0.617,0.692,0.00010188,DTO_05007378,Epigenetic regulator,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.03,1.0,,2013.0,2019.0,ALL
6421,SFPQ,P23246,0.593,0.654,0.99992,DTO_05007557,Nucleic acid binding,C4518356,MiT family translocation renal cell carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,1997.0,2017.0,ALL
6422,SFRP1,Q8N474,0.479,0.846,0.96457,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1999.0,2019.0,ALL
6423,SFRP2,Q96HF1,0.544,0.731,0.0016693,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,0.963,,2004.0,2019.0,ALL
6424,SFRP4,Q6FHJ7,0.524,0.654,9.2586e-05,,,C0265294,Pyle metaphyseal dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.73,1.0,strong,2012.0,2019.0,ALL
6425,SFRP5,Q5T4F7,0.559,0.692,5.1843e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2008.0,2008.0,ALL
6426,SRSF1,Q07955,0.563,0.692,0.98268,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2013.0,2015.0,ALL
6427,SRSF2,Q01130,0.561,0.731,0.47898,DTO_05007557,Nucleic acid binding,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.5,1.0,,2012.0,2020.0,ALL
6428,SRSF3,P84103,0.619,0.615,0.96323,DTO_05007557,Nucleic acid binding,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
6429,SRSF4,Q08170,0.821,0.308,0.86723,DTO_05007557,Nucleic acid binding,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,1.0,,2011.0,2011.0,ALL
6430,SRSF5,Q13243,0.604,0.808,0.69255,DTO_05007557,Nucleic acid binding,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.31,1.0,,2010.0,2017.0,ALL
6431,SRSF6,Q13247,0.67,0.462,0.91099,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2016.0,2019.0,ALL
6432,SRSF7,Q16629,0.792,0.231,0.98203,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
6433,SFSWAP,Q12872,0.78,0.269,0.99999,DTO_05007557,Nucleic acid binding,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2014.0,2014.0,ALL
6434,TRA2B,P62995,0.7,0.5,0.99312,DTO_05007557,Nucleic acid binding,C0038868,Progressive supranuclear palsy,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
6439,SFTPB,P07988,0.575,0.654,0.00025934,,,C1968602,"Surfactant Metabolism Dysfunction, Pulmonary, 1",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.7,1.0,strong,1994.0,2015.0,ALL
6440,SFTPC,P11686,0.556,0.692,0.00075276,,,C1970470,"SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2 (disorder)",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2001.0,2009.0,ALL
6441,SFTPD,P35247,0.5,0.846,7.4927e-05,DTO_05007697,Surfactant,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.7,0.917,,2001.0,2019.0,ALL
6442,SGCA,Q16586,0.592,0.654,0.0027124,DTO_05007616,Calcium-binding protein,C2936332,Alpha-Sarcoglycanopathies,C16;C05;C08;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,1.0,,1994.0,2019.0,ALL
6443,SGCB,Q16585,0.656,0.346,9.5805e-07,,,C1858593,"Limb-girdle muscular dystrophy, type 2E",C16;C05;C08;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.96,1.0,strong,1995.0,2018.0,ALL
6444,SGCD,Q92629,0.641,0.615,0.0020725,DTO_05007530,Cellular structure,C1832525,Limb-girdle muscular dystrophy type 2F,C16;C05;C08;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.94,1.0,,1996.0,2017.0,ALL
6445,SGCG,Q13326,0.621,0.615,4.821e-05,DTO_05007530,Cellular structure,C0410173,Severe autosomal recessive muscular dystrophy of childhood - North African type (disorder),C16;C05;C08;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1995.0,2018.0,ALL
6446,SGK1,O00141,0.506,0.769,0.0023046,DTO_03300101,Kinase,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2012.0,2015.0,ALL
6447,SCG5,P05408,0.663,0.462,6.2865e-05,DTO_05007599,Signaling,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2008.0,2014.0,ALL
6448,SGSH,P51688,0.638,0.692,0.00010158,DTO_05007624,Enzyme,C0026706,Mucopolysaccharidosis III,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.89,1.0,,1997.0,2019.0,ALL
6449,SGTA,O43765,0.65,0.5,0.94632,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2013.0,2019.0,ALL
6450,SH3BGR,P55822,0.89,0.154,0.0021831,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
6451,SH3BGRL,O75368,0.792,0.231,0.30081,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
6452,SH3BP2,P78314,0.623,0.654,1.156e-11,,,C0008029,Cherubism,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,1.0,0.971,,2001.0,2019.0,ALL
6453,ITSN1,Q15811,0.656,0.577,1.0,DTO_05007584,Enzyme modulator,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
6455,SH3GL1,Q99961,0.686,0.346,0.011714,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.4,,,,,ALL
6456,SH3GL2,Q99962,0.659,0.5,0.00011862,,,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.2,1.0,,2004.0,2004.0,ALL
6457,SH3GL3,Q99963,0.76,0.308,0.00010242,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2008.0,2019.0,ALL
6461,SHB,Q15464,0.821,0.115,0.96874,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
6462,SHBG,P04278,0.438,0.808,1.2538e-06,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.51,1.0,,1994.0,2019.0,ALL
6463,SHFM2,,0.861,0.115,,,,C1839258,SPLIT-HAND/FOOT MALFORMATION 2,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.03,1.0,,2006.0,2011.0,ALL
6464,SHC1,P29353,0.597,0.538,0.0017351,DTO_05007599,Signaling,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.3,1.0,,2009.0,2009.0,ALL
6468,FBXW4,P57775,0.633,0.577,0.00067616,,,C1838652,SPLIT-HAND/FOOT MALFORMATION 3,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.31,1.0,,2007.0,2013.0,ALL
6469,SHH,Q15465,0.461,0.846,0.98258,,,C1840529,HOLOPROSENCEPHALY 3,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,1995.0,2013.0,ALL
6470,SHMT1,P34896,0.566,0.654,1.275e-14,DTO_05007624,Enzyme,C0024305,"Lymphoma, Non-Hodgkin",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.35,1.0,,2004.0,2015.0,ALL
6472,SHMT2,P34897,0.621,0.5,7.8195e-08,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
6473,SHOX,O15266,0.561,0.654,0.66566,,,C0265309,Leri-Weill dyschondrosteosis,C23;C16;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,0.962,,1999.0,2019.0,ALL
6474,SHOX2,O60902,0.674,0.5,0.016059,,,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,0.0,,2003.0,2003.0,ALL
6476,SI,P14410,0.569,0.692,3.9353e-60,DTO_05007624,Enzyme,C1283620,"Sucrase-isomaltase deficiency, congenital",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.79,1.0,strong,1996.0,2018.0,ALL
6477,SIAH1,Q8IUQ4,0.631,0.538,0.69866,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
6478,SIAH2,O43255,0.633,0.538,0.68669,,,C0023308,Lens Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
6480,ST6GAL1,P15907,0.569,0.731,0.2341,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2011.0,2019.0,ALL
6482,ST3GAL1,Q11201,0.666,0.423,0.58269,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
6483,ST3GAL2,Q16842,0.769,0.385,0.9417,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2018.0,2019.0,ALL
6484,ST3GAL4,Q11206,0.588,0.692,0.039802,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
6487,ST3GAL3,Q11203,0.606,0.654,0.0025598,,,C1970200,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,,2007.0,2011.0,ALL
6489,ST8SIA1,Q92185,0.678,0.5,0.493,,,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
6490,PMEL,P40967,0.531,0.769,3.0571e-18,DTO_05007599,Signaling,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.986,,1994.0,2019.0,ALL
6491,STIL,Q15468,0.584,0.731,0.20105,,,C2675187,"MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 7 (disorder)",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2009.0,2015.0,ALL
6492,SIM1,P81133,0.626,0.654,0.99828,DTO_05007542,Transcription factor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,0.955,strong,1998.0,2019.0,ALL
6493,SIM2,Q14190,0.619,0.731,0.19959,DTO_05007542,Transcription factor,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.3,1.0,,2002.0,2002.0,ALL
6494,SIPA1,Q96FS4,0.638,0.538,0.0045822,DTO_05007584,Enzyme modulator,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2012.0,ALL
6495,SIX1,Q15475,0.496,0.692,0.65297,DTO_05007542,Transcription factor,C0265234,Branchio-Oto-Renal Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.9,1.0,definitive,1998.0,2018.0,ALL
6496,SIX3,O95343,0.56,0.692,0.94714,DTO_05007542,Transcription factor,C1834877,HOLOPROSENCEPHALY 2 (disorder),C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.92,1.0,,1999.0,2011.0,ALL
6497,SKI,P12755,0.503,0.808,0.99901,,,C1321551,Shprintzen-Goldberg syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.74,1.0,definitive,2002.0,2015.0,ALL
6498,SKIL,P12757,0.621,0.538,0.98512,,,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
6499,SKIV2L,Q15477,0.615,0.654,1.2931e-22,,,C1857276,Trichohepatoenteric Syndrome,C23;C16;C13;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.67,0.889,strong,2012.0,2018.0,ALL
6500,SKP1,P63208,0.666,0.615,0.37294,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2013.0,2019.0,ALL
6502,SKP2,Q13309,0.492,0.808,0.96042,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.6,1.0,,1998.0,2019.0,ALL
6503,SLA,Q13239,0.736,0.5,0.34325,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
6504,SLAMF1,Q13291,0.612,0.615,0.0070368,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
6505,SLC1A1,P43005,0.561,0.654,8.6876e-06,DTO_05007405,Transporter,C1857253,Dicarboxylicaminoaciduria,C23;C16;C13;C12;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.91,1.0,limited,1992.0,2011.0,ALL
6506,SLC1A2,P43004,0.511,0.731,0.71036,DTO_05007405,Transporter,C4310717,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41",,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2018.0,ALL
6507,SLC1A3,P43003,0.573,0.577,0.98914,DTO_05007405,Transporter,C2675211,"EPISODIC ATAXIA, TYPE 6 (disorder)",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,,2005.0,2017.0,ALL
6508,SLC4A3,P48751,0.751,0.154,1.227e-05,DTO_05007405,Transporter,C0018790,Cardiac Arrest,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,moderate,2018.0,2018.0,ALL
6509,SLC1A4,P43007,0.7,0.385,0.06559,DTO_05007405,Transporter,C4225254,"SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2018.0,ALL
6510,SLC1A5,Q15758,0.587,0.577,0.16869,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.333,,1997.0,2018.0,ALL
6511,SLC1A6,P48664,0.78,0.154,0.76237,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2002.0,2007.0,ALL
6512,SLC1A7,O00341,0.769,0.346,7.5281e-11,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
6513,SLC2A1,P11166,0.388,0.808,0.9941,DTO_05007405,Transporter,C1847501,Glut1 Deficiency Syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.983,definitive,1989.0,2019.0,ALL
6514,SLC2A2,P11168,0.572,0.692,3.4337e-08,DTO_05007405,Transporter,C3495427,Fanconi-Bickel Syndrome,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,0.974,,1997.0,2019.0,ALL
6515,SLC2A3,P11169,0.534,0.769,0.010333,DTO_05007405,Transporter,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.33,1.0,,2014.0,2018.0,ALL
6517,SLC2A4,P14672,0.528,0.769,4.7123e-05,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.8,0.951,,1990.0,2020.0,ALL
6518,SLC2A5,P22732,0.647,0.5,3.5691e-10,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.39,1.0,,2004.0,2019.0,ALL
6519,SLC3A1,Q07837,0.593,0.731,7.2168e-27,DTO_05007405,Transporter,C0010691,Cystinuria,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,0.987,definitive,1993.0,2019.0,ALL
6520,SLC3A2,P08195,0.565,0.731,4.2163e-08,DTO_05007405,Transporter,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.32,1.0,,2014.0,2018.0,ALL
6521,SLC4A1,P02730,0.522,0.731,0.84602,DTO_05007405,Transporter,C2675212,"Spherocytosis, Type 4",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.9,1.0,,1991.0,2005.0,ALL
6522,SLC4A2,P04920,0.682,0.346,0.98521,DTO_05007405,Transporter,C0085548,Autosomal Recessive Polycystic Kidney Disease,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.5,1.0,,2008.0,2008.0,ALL
6523,SLC5A1,P13866,0.584,0.654,8.747e-08,DTO_05007405,Transporter,C0268186,Congenital glucose-galactose malabsorption,C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.8,1.0,strong,1991.0,2019.0,ALL
6524,SLC5A2,P31639,0.499,0.769,4.9184e-14,DTO_05007405,Transporter,C0017980,"Glycosuria, Renal",C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2002.0,2020.0,ALL
6525,SMTN,P53814,0.736,0.346,1.5966e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
6526,SLC5A3,P53794,0.7,0.423,0.96739,DTO_05007405,Transporter,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2007.0,2007.0,ALL
6527,SLC5A4,Q9NY91,0.839,0.192,1.148e-16,DTO_05007405,Transporter,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
6528,SLC5A5,Q92911,0.499,0.769,0.0029492,DTO_05007405,Transporter,C1848805,Thyroid Dyshormonogenesis 1,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,1.0,,1997.0,2016.0,ALL
6529,SLC6A1,P30531,0.592,0.538,0.99993,DTO_05007405,Transporter,C4085238,MYOCLONIC-ATONIC EPILEPSY,,,disease,Disease or Syndrome,0.74,1.0,strong,2012.0,2019.0,ALL
6530,SLC6A2,P23975,0.49,0.846,0.081524,DTO_05007405,Transporter,C1535893,Orthostatic intolerance,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.61,1.0,,2000.0,2003.0,ALL
6531,SLC6A3,Q01959,0.453,0.885,0.99758,DTO_05007405,Transporter,C2751067,"Parkinsonism-Dystonia, Infantile",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.8,1.0,,2009.0,2019.0,ALL
6532,SLC6A4,P31645,0.429,0.808,0.24602,DTO_05007405,Transporter,C0038644,Sudden infant death syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.8,0.933,,2001.0,2014.0,ALL
6533,SLC6A6,P31641,0.682,0.538,0.98987,DTO_05007405,Transporter,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
6534,SLC6A7,Q99884,0.89,0.231,5.5547e-10,DTO_05007405,Transporter,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
6535,SLC6A8,P48029,0.476,0.846,0.99778,DTO_05007405,Transporter,C1845862,"Creatine deficiency, X-linked",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,2001.0,2019.0,ALL
6536,SLC6A9,P48067,0.641,0.5,2.1702e-05,DTO_05007405,Transporter,C4310943,GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE,,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2016.0,ALL
6538,SLC6A11,P48066,0.716,0.462,4.83e-05,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
6539,SLC6A12,P48065,0.716,0.5,1.2837e-08,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2011.0,2014.0,ALL
6540,SLC6A13,Q9NSD5,0.736,0.346,1.2157e-11,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2010.0,2011.0,ALL
6541,SLC7A1,P30825,0.678,0.5,0.99291,DTO_05007405,Transporter,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,2001.0,2003.0,ALL
6542,SLC7A2,P52569,0.7,0.5,2.3434e-11,DTO_05007405,Transporter,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
6543,SLC8A2,Q9UPR5,0.78,0.154,0.99633,DTO_05007405,Transporter,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.21,1.0,,2006.0,2013.0,ALL
6545,SLC7A4,O43246,0.666,0.423,2.8317e-07,DTO_05007405,Transporter,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.07,1.0,,1994.0,2008.0,ALL
6546,SLC8A1,P32418,0.544,0.769,0.9957,DTO_05007405,Transporter,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.5,1.0,,2004.0,2007.0,ALL
6547,SLC8A3,P57103,0.666,0.346,0.00073391,DTO_05007405,Transporter,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,2004.0,2010.0,ALL
6548,SLC9A1,P19634,0.55,0.731,0.79049,DTO_05007405,Transporter,C4225383,LICHTENSTEIN-KNORR SYNDROME,,,disease,Disease or Syndrome,0.72,0.667,strong,2015.0,2019.0,ALL
6549,SLC9A2,Q9UBY0,0.839,0.308,0.0024247,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
6550,SLC9A3,P48764,0.612,0.615,0.97845,DTO_05007405,Transporter,C0267663,"Congenital secretory diarrhea, sodium type (disorder)",C23;C16;C18,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Congenital Abnormality,0.72,1.0,strong,2015.0,2019.0,ALL
6553,SLC9A5,Q14940,0.78,0.346,1.7991e-08,DTO_05007405,Transporter,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
6554,SLC10A1,Q14973,0.626,0.462,4.7887e-16,DTO_05007405,Transporter,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.4,0.946,,2013.0,2020.0,ALL
6555,SLC10A2,Q12908,0.621,0.538,9.5802e-17,DTO_05007405,Transporter,C2750087,"Bile Acid Malabsorption, Primary",C23;C06;C18,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,limited,1997.0,1997.0,ALL
6556,SLC11A1,P49279,0.525,0.846,1.5485e-19,DTO_05007405,Transporter,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.6,0.971,,1994.0,2019.0,ALL
6557,SLC12A1,Q13621,0.631,0.538,6.6809e-17,DTO_05007405,Transporter,C1866495,"Bartter syndrome, antenatal type 1",C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.92,1.0,strong,1996.0,2017.0,ALL
6558,SLC12A2,P55011,0.552,0.808,0.96153,DTO_05007405,Transporter,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.55,1.0,,2004.0,2019.0,ALL
6559,SLC12A3,P55017,0.493,0.808,3.0324e-32,DTO_05007405,Transporter,C0268450,Gitelman Syndrome,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1996.0,2020.0,ALL
6560,SLC12A4,Q9UP95,0.76,0.385,2.0528e-11,DTO_05007405,Transporter,C0342895,Fish-Eye Disease,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
6561,SLC13A1,Q9BZW2,0.861,0.269,1.2291e-17,DTO_05007405,Transporter,C0005940,Bone Diseases,C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
6563,SLC14A1,Q13336,0.678,0.538,5.7661e-14,DTO_05007405,Transporter,C0002880,Autoimmune hemolytic anemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.3,1.0,,1984.0,1984.0,ALL
6564,SLC15A1,P46059,0.7,0.615,4.9948e-13,DTO_05007405,Transporter,C2699541,Cytokine Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
6565,SLC15A2,Q16348,0.805,0.308,5.4803e-20,DTO_05007405,Transporter,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
6566,SLC16A1,P53985,0.499,0.846,0.00073565,DTO_05007405,Transporter,C1855577,Erythrocyte Lactate Transporter Defect,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2000.0,2003.0,ALL
6567,SLC16A2,P36021,0.592,0.577,0.98828,DTO_05007405,Transporter,C0795889,Allan-Herndon-Dudley syndrome (AHDS),C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,2004.0,2020.0,ALL
6568,SLC17A1,Q14916,0.76,0.462,4.1179e-16,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2006.0,2014.0,ALL
6569,SLC34A1,Q06495,0.619,0.423,8.9128e-27,DTO_05007405,Transporter,C2676786,"Nephrolithiasis-Osteoporosis, Hypophosphatemic, 1",C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.7,1.0,,2002.0,2014.0,ALL
6570,SLC18A1,P54219,0.647,0.462,2.8012e-21,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,1.0,,2006.0,2019.0,ALL
6571,SLC18A2,Q05940,0.554,0.769,0.075523,DTO_05007405,Transporter,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.6,0.966,,1996.0,2020.0,ALL
6572,SLC18A3,Q16572,0.608,0.654,0.45355,DTO_05007405,Transporter,C4310654,"MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC",,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2019.0,ALL
6573,SLC19A1,P41440,0.523,0.692,6.4655e-06,DTO_05007405,Transporter,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.4,0.786,,2003.0,2013.0,ALL
6574,SLC20A1,Q8WUM9,0.582,0.577,0.067227,DTO_05007405,Transporter,C0005944,Metabolic Bone Disorder,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,group,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
6575,SLC20A2,Q08357,0.638,0.577,0.96545,DTO_05007405,Transporter,C4551624,Idiopathic basal ganglia calcification 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.76,1.0,,2005.0,2017.0,ALL
6576,SLC25A1,P53007,0.553,0.731,0.058829,DTO_05007405,Transporter,C2746066,Combined D-2- and L-2-hydroxyglutaric aciduria,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2013.0,2018.0,ALL
6578,SLCO2A1,Q92959,0.578,0.654,2.2804e-13,DTO_05007405,Transporter,C3280800,"HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2",,,disease,Disease or Syndrome,0.63,1.0,strong,2012.0,2019.0,ALL
6579,SLCO1A2,P46721,0.656,0.577,1.0581e-16,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
6580,SLC22A1,O15245,0.556,0.731,1.4614e-22,DTO_05007405,Transporter,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.38,1.0,,2011.0,2020.0,ALL
6581,SLC22A3,O75751,0.531,0.846,7.7723e-10,DTO_05007405,Transporter,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.47,1.0,,2007.0,2020.0,ALL
6582,SLC22A2,O15244,0.572,0.769,2.0202e-12,DTO_05007405,Transporter,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
6583,SLC22A4,Q9H015,0.603,0.769,1.8253e-08,DTO_05007405,Transporter,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.857,,2003.0,2019.0,ALL
6584,SLC22A5,O76082,0.608,0.731,5.2651e-16,DTO_05007405,Transporter,C0342788,Renal carnitine transport defect,C23;C05;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.979,definitive,1985.0,2019.0,ALL
6585,SLIT1,O75093,0.89,0.115,0.99999,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2013.0,2013.0,ALL
6586,SLIT3,O75094,0.623,0.615,0.75233,,,C0019284,Diaphragmatic Hernia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.5,1.0,,2003.0,2014.0,ALL
6588,SLN,O00631,0.612,0.5,0.28701,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2006.0,2020.0,ALL
6590,SLPI,P03973,0.449,0.846,0.00089665,DTO_05007584,Enzyme modulator,C0860207,Drug-Induced Liver Disease,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,phenotype,Disease or Syndrome,0.31,1.0,,2007.0,2017.0,ALL
6591,SNAI2,O43623,0.505,0.692,0.79531,,,C0080024,Piebaldism,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.73,1.0,,1998.0,2014.0,ALL
6594,SMARCA1,P28370,0.504,0.808,1.0,DTO_05007624,Enzyme,C0265338,Coffin-Siris syndrome,C23;C16;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.57,1.0,moderate,2012.0,2019.0,ALL
6595,SMARCA2,P51531,0.527,0.769,1.0,DTO_05007378,Epigenetic regulator,C1303073,Nicolaides Baraitser syndrome,C23;C16;C17;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,0.929,strong,2012.0,2020.0,ALL
6596,HLTF,Q14527,0.606,0.5,1.8724e-28,,,C0022665,Kidney Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2006.0,2008.0,ALL
6597,SMARCA4,P51532,0.45,0.885,1.0,DTO_05007378,Epigenetic regulator,C2750074,Rhabdoid Tumor Predisposition Syndrome 2,C04,   Neoplasms,disease,Disease or Syndrome,0.7,1.0,definitive,2000.0,2014.0,ALL
6598,SMARCB1,Q12824,0.434,0.846,0.9971,DTO_05007557,Nucleic acid binding,C1266184,Atypical Teratoid Rhabdoid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.8,0.938,definitive,1999.0,2019.0,ALL
6599,SMARCC1,Q92922,0.674,0.423,1.0,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
6601,SMARCC2,Q8TAQ2,0.644,0.615,1.0,DTO_05007624,Enzyme,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.41,1.0,strong,2019.0,2019.0,ALL
6602,SMARCD1,Q96GM5,0.695,0.385,0.99947,DTO_05007557,Nucleic acid binding,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.31,1.0,strong,2019.0,2019.0,ALL
6603,SMARCD2,Q92925,0.7,0.385,6.4893e-05,DTO_05007557,Nucleic acid binding,C0398593,Specific granule deficiency,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
6604,SMARCD3,Q6STE5,0.821,0.269,0.40464,DTO_05007557,Nucleic acid binding,C0149721,Left Ventricular Hypertrophy,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,2013.0,2013.0,ALL
6605,SMARCE1,Q969G3,0.572,0.769,0.99915,,,C0265338,Coffin-Siris syndrome,C23;C16;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.67,1.0,,2012.0,2020.0,ALL
6606,SMN1,Q16637,0.454,0.769,0.015829,DTO_05007378,Epigenetic regulator,C0043116,HMN (Hereditary Motor Neuropathy) Proximal Type I,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.978,strong,1978.0,2019.0,ALL
6607,SMN2,Q16637,0.459,0.769,0.10337,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,0.985,strong,1993.0,2020.0,ALL
6608,SMO,Q99835,0.489,0.731,4.2771e-07,DTO_02300001,G-protein coupled receptor,C0795915,Winter Shortland Temple syndrome,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,,2014.0,2020.0,ALL
6609,SMPD1,P17405,0.499,0.885,3.8932e-10,DTO_05007624,Enzyme,C0268242,"Niemann-Pick Disease, Type A",C16;C18;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1991.0,2020.0,ALL
6610,SMPD2,O60906,0.686,0.423,3.5507e-18,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2005.0,2010.0,ALL
6611,SMS,P52788,0.491,0.846,0.97297,,,C0796160,"MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,definitive,1969.0,2019.0,ALL
6612,SUMO3,P55854,0.686,0.538,0.32841,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2013.0,2019.0,ALL
6613,SUMO2,P61956,0.666,0.615,0.86943,,,C1278049,Serum gamma-glutamyl transferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
6614,SIGLEC1,Q9BZZ2,0.597,0.654,5.3298e-46,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
6615,SNAI1,O95863,0.474,0.808,0.21754,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2001.0,2019.0,ALL
6616,SNAP25,P60880,0.489,0.808,0.98653,DTO_05007405,Transporter,C4225364,"MYASTHENIC SYNDROME, CONGENITAL, 18",,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2019.0,ALL
6617,SNAPC1,Q16533,1.0,0.077,2.3628e-16,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
6618,SNAPC2,Q13487,0.839,0.077,0.10137,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,2016.0,2016.0,ALL
6620,SNCB,Q16143,0.619,0.577,0.068062,DTO_05007405,Transporter,C0752347,Lewy Body Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.7,0.929,moderate,2002.0,2018.0,ALL
6621,SNAPC4,Q5SXM2,1.0,0.038,2.6507e-29,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
6622,SNCA,P37840,0.427,0.885,0.8829,DTO_05007405,Transporter,C1868595,"PARKINSON DISEASE 1, AUTOSOMAL DOMINANT (disorder)",,,disease,Disease or Syndrome,0.9,1.0,,1997.0,2015.0,ALL
6623,SNCG,O76070,0.55,0.615,0.0008475,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.97,,1997.0,2019.0,ALL
6624,FSCN1,Q16658,0.504,0.731,0.86852,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2000.0,2019.0,ALL
6625,SNRNP70,P08621,0.595,0.692,0.99926,DTO_05007557,Nucleic acid binding,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2013.0,ALL
6626,SNRPA,P09012,0.769,0.308,2.8099e-05,DTO_05007557,Nucleic acid binding,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
6627,SNRPA1,P09661,1.0,0.077,0.98984,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
6628,SNRPB,P14678,0.595,0.731,0.70858,DTO_05007557,Nucleic acid binding,C0265342,Cerebrocostomandibular Syndrome,C23;C16;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.74,1.0,strong,2014.0,2016.0,ALL
6629,SNRPB2,P08579,0.931,0.115,0.050625,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
6631,SNRPC,P09234,0.931,0.154,0.72303,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,1998.0,2002.0,ALL
6632,SNRPD1,P62314,0.729,0.615,0.79903,DTO_05007557,Nucleic acid binding,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.24,1.0,,1997.0,2018.0,ALL
6634,SNRPD3,P62318,0.78,0.192,0.85838,DTO_05007557,Nucleic acid binding,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
6635,SNRPE,P62304,0.78,0.346,0.90614,DTO_05007557,Nucleic acid binding,C3554409,HYPOTRICHOSIS 11,,,disease,Disease or Syndrome,0.6,1.0,moderate,1998.0,2013.0,ALL
6636,SNRPF,P62306,0.805,0.154,0.79498,DTO_05007557,Nucleic acid binding,C0034067,Pulmonary Emphysema,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.11,1.0,,2014.0,2014.0,ALL
6637,SNRPG,P62308,0.89,0.115,0.80443,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
6638,SNRPN,P63162;Q9Y675,0.538,0.731,0.043181,DTO_05007557,Nucleic acid binding,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.972,limited,1992.0,2019.0,ALL
6640,SNTA1,Q13424,0.678,0.308,0.0056417,,,C2751830,Long Qt Syndrome 12,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2005.0,2008.0,ALL
6641,SNTB1,Q13884,0.792,0.269,0.0010263,,,C0220641,Lip and Oral Cavity Carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.11,1.0,,2017.0,2017.0,ALL
6642,SNX1,Q13596,0.751,0.192,0.93179,DTO_05007405,Transporter,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.04,1.0,,2012.0,2019.0,ALL
6643,SNX2,O60749,0.792,0.231,0.98462,DTO_05007405,Transporter,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2011.0,2014.0,ALL
6645,SNTB2,Q13425,0.931,0.038,0.00042801,,,C1285654,Memory performance,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
6646,SOAT1,P35610,0.424,0.846,7.3621e-10,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
6647,SOD1,P00441,0.379,0.962,0.1773,DTO_05007624,Enzyme,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,1.0,0.98,strong,1976.0,2019.0,ALL
6648,SOD2,P04179,0.379,0.923,0.15499,DTO_05007624,Enzyme,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.57,0.917,,2005.0,2020.0,ALL
6649,SOD3,P08294,0.531,0.808,0.00072272,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.55,1.0,,2003.0,2019.0,ALL
6650,CAPN15,O75808,0.89,0.077,0.96857,DTO_05007624,Enzyme,C0038663,Suicide attempt,F01,   Behavior and Behavior Mechanisms,phenotype,Injury or Poisoning,0.1,1.0,,2019.0,2019.0,ALL
6651,SON,P18583,0.565,0.769,1.0,,,C4310696,Zhu-Tokita-Takenouchi-Kim syndrome,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",phenotype,Disease or Syndrome,0.71,1.0,,2015.0,2019.0,ALL
6652,SORD,Q00796,0.552,0.769,4.4938e-08,DTO_05007624,Enzyme,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.5,1.0,,2003.0,2008.0,ALL
6653,SORL1,Q92673,0.582,0.692,7.6609e-11,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.5,0.973,,2004.0,2020.0,ALL
6654,SOS1,Q07889,0.485,0.808,1.0,DTO_05007584,Enzyme modulator,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.969,definitive,1991.0,2019.0,ALL
6655,SOS2,Q07890,0.608,0.692,0.99955,DTO_05007584,Enzyme modulator,C4225282,NOONAN SYNDROME 9,,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2015.0,ALL
6656,SOX1,O00570,0.617,0.692,0.62322,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2012.0,2019.0,ALL
6657,SOX2,P48431,0.405,0.808,0.70662,DTO_05007542,Transcription factor,C1859773,"Microphthalmia, Syndromic 3",C16;C06;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.75,1.0,,1996.0,2018.0,ALL
6658,SOX3,P41225,0.535,0.731,0.44948,DTO_05007542,Transcription factor,C2678223,"Mental Retardation, X-Linked, With Panhypopituitarism",C23;C16;C10;C19;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.6,1.0,,1981.0,2005.0,ALL
6659,SOX4,Q06945,0.489,0.808,0.92656,DTO_05007542,Transcription factor,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.41,1.0,strong,2019.0,2019.0,ALL
6660,SOX5,P35711,0.545,0.769,0.99995,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.42,1.0,,2010.0,2018.0,ALL
6662,SOX9,P48436,0.419,0.846,0.99772,,,C1861922,CAMPOMELIC DYSPLASIA,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.972,strong,1994.0,2019.0,ALL
6663,SOX10,P56693,0.461,0.808,0.99166,,,C1836727,"Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease",C16;C06;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.93,1.0,,1998.0,2018.0,ALL
6664,SOX11,P35716,0.494,0.808,0.85844,DTO_05007542,Transcription factor,C0265338,Coffin-Siris syndrome,C23;C16;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.66,0.833,,2014.0,2019.0,ALL
6665,SOX15,O60248,0.7,0.346,0.21474,DTO_05007542,Transcription factor,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
6666,SOX12,O15370,0.682,0.385,0.85589,DTO_05007542,Transcription factor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0,,2017.0,2019.0,ALL
6667,SP1,P08047,0.493,0.769,0.99997,DTO_05007557,Nucleic acid binding,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,0.818,,2003.0,2017.0,ALL
6668,SP2,Q02086,0.931,0.115,0.99721,DTO_05007557,Nucleic acid binding,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
6670,SP3,Q02447,0.711,0.5,0.99995,DTO_05007557,Nucleic acid binding,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,0.0,,2013.0,2013.0,ALL
6671,SP4,Q02446,0.711,0.423,0.99288,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.66,1.0,,2005.0,2019.0,ALL
6672,SP100,P23497,0.729,0.385,2.7583e-12,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,0.917,,1995.0,2020.0,ALL
6674,SPAG1,Q07617,0.663,0.577,1.445e-09,,,C3809706,"CILIARY DYSKINESIA, PRIMARY, 28",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2016.0,ALL
6675,UAP1,Q16222,0.89,0.154,0.023389,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
6676,SPAG4,Q9NPE6,0.76,0.154,2.7163e-07,DTO_05007530,Cellular structure,C0919677,Protein C measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
6677,SPAM1,P38567,0.691,0.5,1.8621e-10,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2002.0,2019.0,ALL
6678,SPARC,P09486,0.445,0.846,0.89148,DTO_05007599,Signaling,C4225301,"OSTEOGENESIS IMPERFECTA, TYPE XVII",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2015.0,ALL
6683,SPAST,Q9UBP0,0.579,0.577,0.99939,DTO_05007530,Cellular structure,C1866855,"Spastic paraplegia 4, autosomal dominant",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1991.0,2019.0,ALL
6687,SPG7,Q9UQ90,0.436,0.885,1.9683e-36,DTO_05007624,Enzyme,C1846564,"SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.93,1.0,,1998.0,2018.0,ALL
6688,SPI1,P17947,0.631,0.654,0.98206,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.6,1.0,,1999.0,2019.0,ALL
6689,SPIB,Q01892,0.628,0.538,0.91231,DTO_05007542,Transcription factor,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.62,1.0,,2010.0,2015.0,ALL
6690,SPINK1,P00995,0.492,0.808,0.31476,,,C0238339,Hereditary pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.8,1.0,strong,2000.0,2018.0,ALL
6691,SPINK2,P20155,0.89,0.077,0.069796,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.11,1.0,,2017.0,2017.0,ALL
6692,SPINT1,O43278,0.57,0.577,1.0175e-05,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.22,1.0,,2001.0,2007.0,ALL
6693,SPN,P16150,0.563,0.692,0.014408,,,C0006663,Calcinosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.3,1.0,,2011.0,2011.0,ALL
6694,SPP2,Q13103,0.751,0.269,1.693e-14,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
6695,SPOCK1,Q08629,0.61,0.577,0.82592,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,0.8,,2007.0,2019.0,ALL
6696,SPP1,P10451,0.353,0.885,2.146e-06,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.6,1.0,,1995.0,2019.0,ALL
6697,SPR,P35270,0.631,0.654,0.0434,,,C0268468,"Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency",C23;C16;C18;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.71,0.889,,2001.0,2017.0,ALL
6698,SPRR1A,P35321,0.729,0.269,0.0060385,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,1996.0,1996.0,ALL
6699,SPRR1B,P22528,0.821,0.269,0.00063211,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2003.0,2006.0,ALL
6700,SPRR2A,P35326,0.612,0.731,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
6701,SPRR2B,P35325,0.839,0.154,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0,,2011.0,2012.0,ALL
6702,SPRR2C,,0.931,0.115,,,,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
6704,SPRR2E,P22531,1.0,0.038,0.060135,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
6705,SPRR2F,Q96RM1,1.0,0.038,0.08518,,,C0014173,Endometrial Hyperplasia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
6707,SPRR3,Q9UBC9,0.736,0.269,,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.03,1.0,,2011.0,2017.0,ALL
6708,SPTA1,P02549,0.638,0.538,2.6001e-18,,,C2678338,"SPHEROCYTOSIS, TYPE 3 (disorder)",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1962.0,2016.0,ALL
6709,SPTAN1,Q13813,0.601,0.615,1.0,,,C3150731,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5",,,disease,Disease or Syndrome,0.61,1.0,,2010.0,2018.0,ALL
6710,SPTB,P11277,0.65,0.462,1.0,,,C0013902,"Elliptocytosis, Hereditary",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.75,1.0,strong,1990.0,2016.0,ALL
6711,SPTBN1,Q01082,0.619,0.538,1.0,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
6712,SPTBN2,O15020,0.619,0.731,9.9268e-05,,,C0752123,Spinocerebellar Ataxia Type 5,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.938,,2006.0,2019.0,ALL
6713,SQLE,Q14534,0.674,0.577,0.97594,DTO_05007624,Enzyme,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2001.0,2001.0,ALL
6714,SRC,P12931,0.467,0.885,0.99691,DTO_03300101,Kinase,C4310789,THROMBOCYTOPENIA 6,,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
6715,SRD5A1,P18405,0.631,0.538,1.1557e-05,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.55,1.0,,2006.0,2017.0,ALL
6716,SRD5A2,P31213,0.564,0.615,,DTO_05007624,Enzyme,C0268297,Pseudovaginal Perineoscrotal Hypospadias,C16;C18;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1977.0,2019.0,ALL
6717,SRI,P30626,0.587,0.769,3.4837e-10,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
6718,AKR1D1,P51857,0.711,0.385,1.7175e-07,DTO_05007624,Enzyme,C1856127,"Bile acid synthesis defect, congenital, 2",C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2003.0,2015.0,ALL
6720,SREBF1,P36956,0.518,0.808,0.014708,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2000.0,2013.0,ALL
6721,SREBF2,Q12772,0.566,0.577,0.20734,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.53,1.0,,2003.0,2019.0,ALL
6722,SRF,P11831,0.534,0.808,0.97545,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,2007.0,2020.0,ALL
6723,SRM,P19623,0.666,0.577,0.23479,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
6725,SRMS,Q9H3Y6,0.805,0.154,1.2721e-12,DTO_03300101,Kinase,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
6726,SRP9,P49458,0.89,0.192,0.41934,DTO_05007557,Nucleic acid binding,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
6728,SRP19,P09132,0.931,0.192,0.0069014,DTO_05007557,Nucleic acid binding,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
6729,SRP54,P61011,0.612,0.769,0.99895,DTO_05007557,Nucleic acid binding,C0272170,Shwachman syndrome,,,disease,Disease or Syndrome,0.51,1.0,,2017.0,2019.0,ALL
6730,SRP68,Q9UHB9,0.839,0.077,0.045673,DTO_05007557,Nucleic acid binding,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
6731,SRP72,O76094,0.711,0.269,0.0017104,,,C3808553,Bone marrow failure syndrome 1,,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2018.0,ALL
6732,SRPK1,Q96SB4,0.628,0.538,1.91e-05,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.933,,2006.0,2019.0,ALL
6733,SRPK2,P78362,0.653,0.423,0.99697,DTO_03300101,Kinase,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2019.0,2019.0,ALL
6734,SRPRA,P08240,0.931,0.077,0.77836,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
6736,SRY,Q05066,0.456,0.808,,DTO_05007542,Transcription factor,C2748895,Ovotesticular Disorders of Sex Development,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.8,1.0,strong,1992.0,2019.0,ALL
6737,TRIM21,P19474,0.485,0.808,3.3549e-09,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2006.0,2018.0,ALL
6738,RO60,P10155,0.61,0.692,0.58278,DTO_05007557,Nucleic acid binding,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,0.929,,1987.0,2019.0,ALL
6739,SSAV1,,0.695,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2007.0,2017.0,ALL
6741,SSB,P05455,0.612,0.692,0.089615,DTO_05007557,Nucleic acid binding,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,0.957,,1984.0,2019.0,ALL
6742,SSBP1,Q04837,0.678,0.385,0.0036396,DTO_05007557,Nucleic acid binding,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
6744,ITPRID2,P28290,0.711,0.385,5.3472e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2011.0,2018.0,ALL
6745,SSR1,P43307,0.711,0.269,0.2706,DTO_05007616,Calcium-binding protein,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2014.0,2019.0,ALL
6746,SSR2,P43308,0.76,0.269,0.21478,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
6747,SSR3,Q9UNL2,1.0,0.077,0.74736,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
6748,SSR4,P51571,0.705,0.423,0.87499,,,C4012395,Congenital disorder of glycosylation type 1y,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2015.0,ALL
6749,SSRP1,Q08945,0.575,0.731,0.99585,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2009.0,2019.0,ALL
6750,SST,P61278,0.399,0.885,0.34128,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,0.933,,1993.0,2019.0,ALL
6751,SSTR1,P30872,0.606,0.615,0.7473,DTO_02300001,G-protein coupled receptor,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.32,1.0,,2005.0,2008.0,ALL
6752,SSTR2,P30874,0.539,0.731,0.44416,DTO_02300001,G-protein coupled receptor,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,2005.0,2020.0,ALL
6753,SSTR3,P32745,0.659,0.423,9.9007e-05,DTO_02300001,G-protein coupled receptor,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,2007.0,2010.0,ALL
6754,SSTR4,P31391,0.469,0.846,3.6978e-13,DTO_02300001,G-protein coupled receptor,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,2009.0,2009.0,ALL
6755,SSTR5,P35346,0.59,0.615,0.00095544,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2002.0,2010.0,ALL
6756,SSX1,Q16384,0.674,0.308,3.6857e-45,DTO_05007557,Nucleic acid binding,C0039101,synovial sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.7,0.918,,1998.0,2018.0,ALL
6757,SSX2,Q16385,0.581,0.615,,DTO_05007557,Nucleic acid binding,C0039101,synovial sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.7,0.973,,1994.0,2020.0,ALL
6758,SSX5,O60225,0.89,0.154,1.0514e-08,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
6759,SSX4,O60224,0.751,0.308,0.5203,,,C0039101,synovial sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0,,2000.0,2019.0,ALL
6760,SS18,Q15532,0.641,0.462,0.74566,DTO_05007557,Nucleic acid binding,C0039101,synovial sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.6,0.959,,1994.0,2020.0,ALL
6761,ST2,,0.576,0.692,,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,0.952,,2017.0,2020.0,ALL
6762,ST3,,,,,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1993.0,1993.0,ALL
6764,DENND2B,P78524,0.931,0.154,0.99996,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
6765,ST8,,0.78,0.269,,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0,,1997.0,2017.0,ALL
6767,ST13,P50502,0.584,0.692,0.66074,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2000.0,2017.0,ALL
6768,ST14,Q9Y5Y6,0.514,0.769,0.56042,DTO_05007624,Enzyme,C1835851,"Ichthyosis with hypotrichosis, autosomal recessive",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.75,1.0,,2007.0,2018.0,ALL
6769,STAC,Q99469,0.931,0.154,1.435e-07,,,C0162820,"Dermatitis, Allergic Contact",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
6770,STAR,P49675,0.513,0.808,8.7679e-11,,,C0342474,Lipoid congenital adrenal hyperplasia,C16;C18;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.8,1.0,,1995.0,2018.0,ALL
6772,STAT1,P42224,0.399,0.885,0.99999,DTO_05007557,Nucleic acid binding,C3151088,IMMUNODEFICIENCY 31B,,,disease,Disease or Syndrome,0.7,1.0,,2003.0,2019.0,ALL
6773,STAT2,P52630,0.569,0.615,0.93065,DTO_05007557,Nucleic acid binding,C4225260,IMMUNODEFICIENCY 44,,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2017.0,ALL
6774,STAT3,P40763,0.32,0.923,1.0,DTO_05007557,Nucleic acid binding,C2936739,"Hyper-Immunoglobulin E Syndrome, Autosomal Dominant",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.981,,2007.0,2020.0,ALL
6775,STAT4,Q14765,0.471,0.769,0.7662,DTO_05007557,Nucleic acid binding,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.961,,2002.0,2020.0,ALL
6776,STAT5A,P42229,0.445,0.808,0.99994,DTO_05007557,Nucleic acid binding,C0024668,"Mammary Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.5,1.0,,2002.0,2007.0,ALL
6777,STAT5B,P51692,0.442,0.808,0.99988,DTO_05007557,Nucleic acid binding,C1855548,Laron syndrome type 2,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,1.0,,2003.0,2016.0,ALL
6778,STAT6,P42226,0.475,0.808,0.98849,DTO_05007557,Nucleic acid binding,C1266119,Solitary fibrous tumor,C04,   Neoplasms,disease,Neoplastic Process,0.6,0.961,,2013.0,2020.0,ALL
6779,STATH,P02808,0.608,0.769,7.9792e-05,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
6780,STAU1,O95793,0.729,0.423,0.99976,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2014.0,ALL
6781,STC1,P52823,0.532,0.731,0.20364,DTO_05007599,Signaling,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.2,1.0,,2004.0,2004.0,ALL
6782,HSPA13,P48723,0.821,0.192,0.016897,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2005.0,2008.0,ALL
6783,SULT1E1,P49888,0.508,0.808,1.9701e-07,,,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.5,1.0,,2006.0,2015.0,ALL
6785,ELOVL4,Q9GZR5,0.601,0.577,0.83227,DTO_05007624,Enzyme,C1838644,Stargardt disease 3,C11,   Eye Diseases,disease,Disease or Syndrome,0.9,0.929,,1998.0,2019.0,ALL
6786,STIM1,Q13586,0.501,0.808,0.77534,,,C1861451,Stormorken Syndrome,C23;C16;C11;C17;C10;F03;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Mental Disorders;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,,2013.0,2020.0,ALL
6787,NEK4,P51957,0.751,0.192,8.6883e-27,DTO_03300101,Kinase,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2011.0,2014.0,ALL
6788,STK3,Q13188,0.666,0.5,6.2043e-07,DTO_03300101,Kinase,C3544205,Ovarian clear cell carcinoma,,,disease,Neoplastic Process,0.3,,,,,ALL
6789,STK4,Q13043,0.638,0.462,0.014598,DTO_03300101,Kinase,C3553943,"T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS",,,disease,Disease or Syndrome,0.73,1.0,limited,2012.0,2018.0,ALL
6790,AURKA,O14965,0.475,0.731,0.8676,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.88,,1997.0,2019.0,ALL
6792,CDKL5,O76039,0.522,0.692,0.99932,DTO_03300101,Kinase,C1839333,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,0.972,definitive,2003.0,2019.0,ALL
6793,STK10,O94804,0.792,0.346,1.2774e-14,DTO_03300101,Kinase,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
6794,STK11,Q15831,0.435,0.808,0.9934,DTO_03300101,Kinase,C0031269,Peutz-Jeghers Syndrome,C16;C06;C04;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.992,definitive,1997.0,2019.0,ALL
6795,AURKC,Q9UQB9,0.736,0.308,0.077907,DTO_03300101,Kinase,C0403812,"Male Infertility with Large-Headed, Multiflagellar, Polyploid Spermatozoa",C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.6,1.0,,2007.0,2011.0,ALL
6799,SULT1A2,P50226,0.89,0.115,3.6786e-12,,,C0004403,Autosome Abnormalities,C23,"   Pathological Conditions, Signs and Symptoms",group,Cell or Molecular Dysfunction,0.3,1.0,,2006.0,2006.0,ALL
6801,STRN,O43815,0.705,0.385,0.66061,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
6804,STX1A,Q16623,0.621,0.654,0.9785,DTO_05007405,Transporter,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2008.0,2011.0,ALL
6809,STX3,Q13277,0.769,0.423,0.041297,DTO_05007405,Transporter,C0341306,Microvillus inclusion disease,C16;C06;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.53,1.0,strong,2014.0,2020.0,ALL
6810,STX4,Q12846,0.839,0.346,1.3021e-07,DTO_05007405,Transporter,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.2,1.0,,2007.0,2007.0,ALL
6811,STX5,Q13190,0.821,0.308,0.84297,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
6812,STXBP1,P61764,0.532,0.692,1.0,DTO_05007405,Transporter,C2677326,"Epileptic Encephalopathy, Early Infantile, 4",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.71,1.0,,2008.0,2018.0,ALL
6813,STXBP2,Q15833,0.686,0.5,3.0444e-08,DTO_05007405,Transporter,C2751293,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.71,1.0,,2009.0,2017.0,ALL
6814,STXBP3,O00186,0.61,0.769,5.1597e-05,DTO_05007405,Transporter,C0038868,Progressive supranuclear palsy,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,2003.0,2019.0,ALL
6815,STYX,Q8WUJ0,0.839,0.154,0.37747,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
6817,SULT1A1,P50225,0.554,0.769,3.039e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.806,,2000.0,2018.0,ALL
6818,SULT1A3,P0DMM9;P0DMN0,0.722,0.5,0.36251,,,C0751383,Juvenile Neuronal Ceroid Lipofuscinosis,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,1994.0,1995.0,ALL
6819,SULT1C2,O00338,0.821,0.154,2.646e-10,,,C0002793,Anaplasia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
6820,SULT2B1,O00204,0.641,0.538,0.43553,,,C4539754,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14",,,disease,Congenital Abnormality,0.6,1.0,strong,2017.0,2017.0,ALL
6821,SUOX,P51687,0.638,0.615,9.399e-07,,,C2931746,Sulfocysteinuria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.75,1.0,,1997.0,2020.0,ALL
6822,SULT2A1,Q06520,0.545,0.769,1.2523e-15,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.35,1.0,,1998.0,2019.0,ALL
6824,ETF1P1,,1.0,0.115,,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.1,1.0,,2010.0,2010.0,ALL
6825,ETF1P2,,1.0,0.077,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
6827,SUPT4H1,P63272,0.839,0.231,0.0008774,DTO_05007557,Nucleic acid binding,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
6829,SUPT5H,O00267,,,1.0,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
6832,SUPV3L1,Q8IYB8,0.821,0.115,0.032006,,,C0872084,Sarcopenia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.31,1.0,,2009.0,2009.0,ALL
6833,ABCC8,Q09428,0.474,0.846,7.9571e-24,DTO_05007405,Transporter,C1835887,"DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)",C16;C18;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.9,1.0,,2000.0,2006.0,ALL
6834,SURF1,Q15526,0.578,0.654,1.5883e-13,DTO_05007624,Enzyme,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.987,definitive,1998.0,2018.0,ALL
6836,SURF4,O15260,0.931,0.154,0.60564,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
6837,MED22,Q15528,,,8.0393e-05,,,C2825857,Factor VIII measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
6838,SURF6,O75683,0.931,0.115,6.449e-07,DTO_05007557,Nucleic acid binding,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
6839,SUV39H1,O43463,0.595,0.577,0.98957,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
6840,SVIL,O95425,0.805,0.231,0.00086302,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2007.0,2017.0,ALL
6843,VAMP1,P23763,0.628,0.538,0.0039396,,,C1970107,"ATAXIA, SPASTIC, 1, AUTOSOMAL DOMINANT",C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2012.0,2017.0,ALL
6844,VAMP2,P63027,0.65,0.462,0.88736,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2008.0,2008.0,ALL
6845,VAMP7,P51809,0.612,0.577,0.013777,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2003.0,2003.0,ALL
6846,XCL2,Q9UBD3,0.821,0.192,0.0090664,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
6847,SYCP1,Q15431,0.67,0.577,0.99997,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
6850,SYK,P43405,0.475,0.808,0.99986,DTO_03300101,Kinase,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,0.929,,2009.0,2019.0,ALL
6853,SYN1,P17600,0.597,0.462,0.99216,DTO_05007530,Cellular structure,C1845343,"Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders",C23;C16;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.7,1.0,,2004.0,2011.0,ALL
6854,SYN2,Q92777,0.653,0.577,,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.49,0.889,,2000.0,2019.0,ALL
6855,SYP,P08247,0.481,0.808,0.91549,DTO_05007405,Transporter,C3275408,"MENTAL RETARDATION, X-LINKED 96",,,disease,Disease or Syndrome,0.7,1.0,strong,2009.0,2009.0,ALL
6856,SYPL1,Q16563,0.931,0.115,0.046723,DTO_05007405,Transporter,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
6857,SYT1,P21579,0.412,0.846,0.60038,DTO_05007405,Transporter,C4748715,BAKER-GORDON SYNDROME,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2018.0,ALL
6860,SYT4,Q9H2B2,0.861,0.192,0.43924,DTO_05007405,Transporter,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2011.0,2019.0,ALL
6861,SYT5,O00445,1.0,0.038,0.001902,DTO_05007405,Transporter,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
6862,TBXT,O15178,0.674,0.462,0.024262,DTO_05007542,Transcription factor,C3810343,SACRAL AGENESIS WITH VERTEBRAL ANOMALIES,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
6863,TAC1,P20366,0.424,0.923,0.74608,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.6,0.96,,1993.0,2020.0,ALL
6865,TACR2,P21452,0.7,0.5,8.8349e-05,DTO_02300001,G-protein coupled receptor,C0006261,Bronchial Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
6866,TAC3,Q9UHF0,0.604,0.731,0.01165,,,C3553843,HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.7,1.0,strong,2009.0,2013.0,ALL
6867,TACC1,O75410,0.769,0.192,5.4901e-05,,,C0206726,gliosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
6868,ADAM17,P78536,0.453,0.808,0.99528,,,C3280501,"INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1",,,disease,Disease or Syndrome,0.6,1.0,moderate,2010.0,2012.0,ALL
6869,TACR1,P25103,0.502,0.885,0.00038437,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.55,1.0,,2008.0,2014.0,ALL
6870,TACR3,P29371,0.553,0.769,1.8068e-17,DTO_02300001,G-protein coupled receptor,C3553844,HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.9,1.0,strong,2007.0,2014.0,ALL
6871,TADA2A,O75478,0.729,0.538,9.2222e-09,DTO_05007557,Nucleic acid binding,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
6872,TAF1,P21675,0.581,0.808,1.0,DTO_03300101,Kinase,C1839130,"Dystonia 3, Torsion, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.962,,1992.0,2019.0,ALL
6873,TAF2,Q6P1X5,0.743,0.308,0.0025958,DTO_05007624,Enzyme,C3810080,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40",,,disease,Disease or Syndrome,0.7,1.0,limited,2011.0,2015.0,ALL
6874,TAF4,O00268,0.839,0.231,1.0,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
6875,TAF4B,Q92750,0.792,0.192,0.23446,,,C4014449,SPERMATOGENIC FAILURE 13,,,disease,Disease or Syndrome,0.6,1.0,limited,2014.0,2014.0,ALL
6876,TAGLN,Q01995,0.54,0.692,0.08527,DTO_05007530,Cellular structure,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2002.0,2004.0,ALL
6877,TAF5,Q15542,,,0.99973,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
6878,TAF6,P49848,0.769,0.308,8.2703e-09,DTO_05007542,Transcription factor,C4310702,ALAZAMI-YUAN SYNDROME,,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2015.0,ALL
6879,TAF7,Q15545,0.931,0.077,0.89371,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
6880,TAF9,Q16594,0.89,0.231,4.2231e-07,DTO_05007557,Nucleic acid binding,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
6882,TAF11,Q15544,,,0.11202,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
6883,TAF12,Q16514,0.769,0.154,0.95008,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
6884,TAF13,Q15543,0.716,0.385,0.015944,DTO_05007557,Nucleic acid binding,C4479476,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60",,,disease,Mental or Behavioral Dysfunction,0.7,1.0,moderate,2017.0,2017.0,ALL
6885,MAP3K7,O43318,0.477,0.808,0.99971,DTO_03300101,Kinase,C2931461,Forney Robinson Pascoe syndrome,C23;C16;C05;C10;C09;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.71,1.0,moderate,2016.0,2018.0,ALL
6886,TAL1,P17542,0.505,0.731,0.5659,DTO_05007542,Transcription factor,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.6,0.982,,1990.0,2019.0,ALL
6887,TAL2,Q16559,0.839,0.115,0.47392,DTO_05007542,Transcription factor,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,,,,,ALL
6888,TALDO1,P37837,0.608,0.654,2.5234e-06,,,C1291329,Transaldolase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.74,1.0,strong,2001.0,2015.0,ALL
6889,TALDO1P1,,1.0,0.077,,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
6890,TAP1,Q03518,0.5,0.808,5.3431e-06,DTO_05007405,Transporter,C1858266,"Bare Lymphocyte Syndrome, Type I",C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.6,1.0,strong,1999.0,1999.0,ALL
6891,TAP2,Q03519,0.517,0.808,6.8911e-11,DTO_05007405,Transporter,C1858266,"Bare Lymphocyte Syndrome, Type I",C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.71,1.0,strong,1994.0,2014.0,ALL
6892,TAPBP,O15533,0.576,0.769,6.6044e-09,DTO_05007575,Receptor,C1858266,"Bare Lymphocyte Syndrome, Type I",C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.61,1.0,moderate,2002.0,2002.0,ALL
6894,TARBP1,Q13395,0.821,0.308,1.3937e-23,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
6895,TARBP2,Q15633,0.65,0.5,0.46644,,,C0920269,Microsatellite Instability,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2015.0,2015.0,ALL
6896,TARBP2P1,,0.839,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2009.0,2015.0,ALL
6897,TARS1,P26639,0.716,0.423,9.9483e-13,DTO_05007624,Enzyme,C0751356,Idiopathic Inflammatory Myopathies,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2006.0,2013.0,ALL
6898,TAT,P17735,0.492,0.846,0.0068998,,,C0268487,Tyrosine Transaminase Deficiency Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,definitive,1969.0,2019.0,ALL
6899,TBX1,O43435,0.433,0.808,0.83661,DTO_05007542,Transcription factor,C0012236,DiGeorge Syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.988,,1995.0,2019.0,ALL
6900,CNTN2,Q02246,0.581,0.692,0.0021095,DTO_05007575,Receptor,C3809374,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5",,,disease,Disease or Syndrome,0.6,,,,,ALL
6901,TAZ,Q16635,0.477,0.808,0.72591,DTO_05007624,Enzyme,C0574083,3-Methylglutaconic aciduria type 2,C16;C18;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,0.979,strong,1991.0,2020.0,ALL
6902,TBCA,O75347,0.682,0.538,0.16004,DTO_05007613,Chaperone,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,1998.0,1998.0,ALL
6903,TBCC,Q15814,0.792,0.269,3.7118e-06,DTO_05007613,Chaperone,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2006.0,2006.0,ALL
6904,TBCD,Q9BTW9,0.599,0.615,1.0032e-07,DTO_05007530,Cellular structure,C4310671,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2017.0,ALL
6905,TBCE,Q15813,0.575,0.692,1.7455e-08,DTO_05007613,Chaperone,C1855840,HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME,C23;C16;C05;C10;C19;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.75,1.0,strong,2002.0,2018.0,ALL
6906,SERPINA7,P05543,0.641,0.615,0.0026137,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
6907,TBL1X,O60907,0.674,0.538,0.97946,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
6908,TBP,P20226,0.552,0.846,0.015031,DTO_05007542,Transcription factor,C1846707,SPINOCEREBELLAR ATAXIA 17,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,2003.0,2019.0,ALL
6909,TBX2,Q13207,0.544,0.769,0.99329,DTO_05007542,Transcription factor,C4748741,VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION,,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
6910,TBX5,Q99593,0.528,0.769,0.99954,DTO_05007542,Transcription factor,C0265264,Holt-Oram syndrome,C16;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.95,,1996.0,2019.0,ALL
6911,TBX6,O95947,0.659,0.385,0.0068128,DTO_05007542,Transcription factor,C4083048,SPONDYLOCOSTAL DYSOSTOSIS 5,,,disease,Disease or Syndrome,0.9,1.0,strong,1985.0,2015.0,ALL
6913,TBX15,Q96SF7,0.603,0.5,0.65773,DTO_05007542,Transcription factor,C1850040,Pelviscapular dysplasia,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.62,1.0,,2008.0,2013.0,ALL
6915,TBXA2R,P21731,0.597,0.654,0.00012823,DTO_02300001,G-protein coupled receptor,C3279614,"BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO",,,disease,Finding,0.7,1.0,strong,1993.0,1996.0,ALL
6916,TBXAS1,P24557,0.619,0.615,1.4088e-20,,,C1856465,Ghosal Hematodiaphyseal Dysplasia,C16;C05;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Hemic and Lymphatic Diseases",disease,Congenital Abnormality,0.72,1.0,,2008.0,2019.0,ALL
6917,TCEA1,P23193,0.695,0.615,0.89541,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2013.0,2020.0,ALL
6919,TCEA2,Q15560,0.805,0.154,0.00056849,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
6920,TCEA3,O75764,0.861,0.154,0.0045078,DTO_05007557,Nucleic acid binding,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
6921,ELOC,Q15369,0.656,0.5,0.74421,DTO_05007584,Enzyme modulator,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.46,1.0,,2013.0,2019.0,ALL
6922,SKP1P1,,,,,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
6923,ELOB,Q15370,0.736,0.462,0.091842,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
6924,ELOA,Q14241,0.769,0.423,1.0,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
6925,TCF4,P15884,0.464,0.846,0.99981,DTO_05007542,Transcription factor,C1970431,PITT-HOPKINS SYNDROME,C23;C08;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,1.0,1.0,definitive,2007.0,2019.0,ALL
6926,TBX3,O15119,0.525,0.769,0.98907,DTO_05007542,Transcription factor,C1866994,Ulnar-mammary syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,1.0,,1997.0,2020.0,ALL
6927,HNF1A,P20823,0.478,0.846,0.96115,DTO_05007557,Nucleic acid binding,C1838100,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3 (disorder)",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,1.0,0.985,strong,1996.0,2020.0,ALL
6928,HNF1B,P35680,0.473,0.808,0.99976,DTO_05007557,Nucleic acid binding,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.8,0.978,,1998.0,2019.0,ALL
6929,TCF3,P15923,0.476,0.846,0.025824,DTO_05007542,Transcription factor,C0001768,Agammaglobulinemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
6932,TCF7,P36402,0.556,0.654,0.0053732,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0,,2014.0,2014.0,ALL
6934,TCF7L2,Q9NQB0,0.485,0.846,0.99537,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.7,0.925,,1999.0,2019.0,ALL
6935,ZEB1,P37275,0.442,0.808,0.96665,DTO_05007542,Transcription factor,C2750448,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2005.0,2014.0,ALL
6936,GCFC2,P16383,0.722,0.462,2.5566e-24,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
6938,TCF12,Q99081,0.565,0.654,0.67602,DTO_05007542,Transcription factor,C0221356,Brachycephaly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.6,1.0,,2013.0,2013.0,ALL
6939,TCF15,Q12870,0.839,0.154,0.51981,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
6940,ZNF354A,O60765,0.792,0.192,5.6407e-06,,,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.2,1.0,,1993.0,1993.0,ALL
6941,TCF19,Q9Y242,0.674,0.692,0.00093832,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2017.0,2020.0,ALL
6942,TCF20,Q9UGU0,0.644,0.423,1.0,DTO_05007542,Transcription factor,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.41,1.0,strong,2016.0,2019.0,ALL
6943,TCF21,O43680,0.537,0.692,0.82553,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.5,0.933,,2011.0,2020.0,ALL
6944,VPS72,Q15906,0.931,0.077,0.00020208,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
6945,MLX,Q9UH92,0.722,0.346,0.11032,,,C0039263,Takayasu Arteritis,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.34,1.0,,2013.0,2018.0,ALL
6946,TCL4,,1.0,0.115,,,,C0023492,"Leukemia, T-Cell",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1988.0,1988.0,ALL
6947,TCN1,P20061,0.641,0.577,2.3229e-17,,,C0002888,"Anemia, Megaloblastic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.3,1.0,,1972.0,1972.0,ALL
6948,TCN2,P20062,0.578,0.615,1.0478e-06,,,C0342701,Transcobalamin II deficiency,,,disease,Disease or Syndrome,0.72,1.0,,1984.0,2014.0,ALL
6949,TCOF1,Q13428,0.55,0.808,0.9541,,,C0242387,Mandibulofacial Dysostosis,C16;C11;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.966,,1996.0,2019.0,ALL
6950,TCP1,P17987,0.619,0.654,0.99527,DTO_05007613,Chaperone,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2015.0,2016.0,ALL
6954,TCP11,Q8WWU5,1.0,0.077,1.0587e-07,DTO_05007575,Receptor,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
6955,TRA,P0DSE1,0.628,0.577,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.33,1.0,,2009.0,2012.0,ALL
6956,TRAV6,A0A075B6T7,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,1998.0,1998.0,ALL
6957,TRB,P0DSE2,0.636,0.538,,,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.33,1.0,,2005.0,2013.0,ALL
6962,TRBV20OR9-2,,0.403,0.923,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,0.88,,1989.0,2019.0,ALL
6964,TRD,,0.65,0.692,,,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.36,1.0,,1999.0,2008.0,ALL
6965,TRG,,0.631,0.538,,,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.37,1.0,,1987.0,2014.0,ALL
6966,TRGC1,P0CF51,0.663,0.385,,,,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,1994.0,2014.0,ALL
6973,TRGV1,,1.0,0.115,,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
6974,TRGV2,A0A075B6R0,1.0,0.115,,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
6978,TRGV5,A0A0B4J1U4,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
6980,TRGV6,,1.0,0.038,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
6981,TRGV7,,1.0,0.038,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
6983,TRGV9,Q99603,1.0,0.038,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
6985,TRGV11,,1.0,0.038,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
6986,TRGVA,,1.0,0.038,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
6987,TRGVB,,0.931,0.077,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
6988,TCTA,P57738,0.861,0.231,0.00046337,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2008.0,ALL
6990,DYNLT3,P51808,0.769,0.269,0.71894,DTO_05007530,Cellular structure,C0339528,X-linked retinitis pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.02,1.0,,1995.0,1996.0,ALL
6991,TCTE3,Q8IZS6,0.861,0.231,2.278e-09,DTO_05007530,Cellular structure,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
6992,PPP1R11,O60927,0.604,0.731,0.35781,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2007.0,2018.0,ALL
6993,DYNLT1,P63172,0.931,0.077,7.3232e-05,DTO_05007530,Cellular structure,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
6996,TDG,Q13569,0.674,0.385,0.00056268,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2006.0,2019.0,ALL
6997,TDGF1,P13385,0.584,0.731,9.1591e-11,DTO_05007616,Calcium-binding protein,C0431362,Lobar Holoprosencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.5,1.0,,2002.0,2002.0,ALL
6998,TDGF1P3,P51864,0.631,0.5,,DTO_05007616,Calcium-binding protein,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,1997.0,2018.0,ALL
6999,TDO2,P48775,0.599,0.654,2.0378e-10,DTO_05007624,Enzyme,C2931837,Familial hypertryptophanemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.51,1.0,,2017.0,2017.0,ALL
7001,PRDX2,P32119,0.474,0.885,0.086513,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.37,1.0,,2003.0,2019.0,ALL
7003,TEAD1,P28347,0.555,0.731,0.9998,DTO_05007542,Transcription factor,C1862382,SVEINSSON CHORIORETINAL ATROPHY,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.73,1.0,,2004.0,2019.0,ALL
7004,TEAD4,Q15561,0.636,0.5,3.233e-05,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2014.0,2019.0,ALL
7006,TEC,P42680,1.0,0.115,,DTO_03300101,Kinase,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
7007,TECTA,O75443,0.7,0.385,2.9863e-16,,,C1832187,"Deafness, Autosomal Dominant 12",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1999.0,2014.0,ALL
7008,TEF,Q10587,0.686,0.538,0.63291,DTO_05007557,Nucleic acid binding,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2014.0,2017.0,ALL
7009,TMBIM6,P55061,0.653,0.577,0.015024,,,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.2,1.0,,2008.0,2008.0,ALL
7010,TEK,Q02763,0.462,0.692,1.0,DTO_03300101,Kinase,C1838437,"VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.73,1.0,,1996.0,2017.0,ALL
7011,TEP1,Q99973,0.621,0.654,4.383e-49,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.31,1.0,,1998.0,2001.0,ALL
7012,TERC,,0.471,0.846,,,,C0265965,Dyskeratosis Congenita,C16;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,,2001.0,2019.0,ALL
7013,TERF1,P54274,0.563,0.692,0.90655,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.882,,2001.0,2019.0,ALL
7014,TERF2,Q15554,0.541,0.731,0.99237,,,C0023493,Adult T-Cell Lymphoma/Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.32,1.0,,2006.0,2007.0,ALL
7015,TERT,O14746,0.374,0.846,0.99046,DTO_05007624,Enzyme,C0002874,Aplastic Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.79,1.0,strong,2005.0,2013.0,ALL
7016,TESK1,Q15569,0.89,0.154,0.99255,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7018,TF,P02787,0.527,0.846,4.1001e-08,DTO_05007624,Enzyme,C0521802,Congenital atransferrinemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.91,1.0,strong,1987.0,2007.0,ALL
7019,TFAM,Q00059,0.529,0.731,0.17259,,,C4310690,MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE),,,disease,Disease or Syndrome,0.6,1.0,moderate,2016.0,2016.0,ALL
7020,TFAP2A,P05549,0.488,0.769,0.98964,DTO_05007542,Transcription factor,C0376524,Branchio-Oculo-Facial Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.8,1.0,,1996.0,2019.0,ALL
7021,TFAP2B,Q92481,0.57,0.769,0.99023,DTO_05007542,Transcription factor,C1868570,CHAR SYNDROME,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.99,1.0,,1995.0,2019.0,ALL
7022,TFAP2C,Q92754,0.633,0.538,0.92204,DTO_05007542,Transcription factor,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
7023,TFAP4,Q01664,0.751,0.231,0.99731,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,2013.0,2018.0,ALL
7024,TFCP2,Q12800,0.65,0.385,3.5836e-06,DTO_05007542,Transcription factor,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2006.0,2006.0,ALL
7025,NR2F1,P10589,0.656,0.654,0.99482,DTO_00102000,Nuclear receptor,C3810363,"Optic atrophy, intellectual disability syndrome",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.75,1.0,,2014.0,2020.0,ALL
7026,NR2F2,P24468,0.575,0.692,0.98972,DTO_00102000,Nuclear receptor,C4014310,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
7027,TFDP1,Q14186,0.623,0.692,0.97174,DTO_05007557,Nucleic acid binding,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
7029,TFDP2,Q14188,0.769,0.308,0.9995,DTO_05007557,Nucleic acid binding,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
7030,TFE3,P19532,0.542,0.654,0.97985,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.5,0.983,,1996.0,2020.0,ALL
7031,TFF1,P04155,0.529,0.769,0.00088929,DTO_05007599,Signaling,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2000.0,2019.0,ALL
7032,TFF2,Q03403,0.61,0.538,2.2197e-07,DTO_05007599,Signaling,C0242488,Acute Lung Injury,C08,   Respiratory Tract Diseases,disease,Injury or Poisoning,0.3,1.0,,2010.0,2010.0,ALL
7033,TFF3,Q07654,0.518,0.885,0.01591,DTO_05007599,Signaling,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.32,1.0,,2013.0,2019.0,ALL
7035,TFPI,P10646,0.486,0.808,0.2477,DTO_05007584,Enzyme modulator,C0149871,Deep Vein Thrombosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.37,0.875,,2001.0,2018.0,ALL
7036,TFR2,Q9UP52,0.585,0.615,1.2918e-09,DTO_05007624,Enzyme,C1858664,"HEMOCHROMATOSIS, TYPE 3",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,1.0,,2001.0,2019.0,ALL
7037,TFRC,P02786,0.437,0.885,6.9902e-05,DTO_05007624,Enzyme,C4225219,IMMUNODEFICIENCY 46,,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2016.0,ALL
7038,TG,P01266,0.48,0.808,2.8802e-59,DTO_05007584,Enzyme modulator,C0342194,Thyroid Dyshormonogenesis 3,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.7,1.0,,1999.0,2017.0,ALL
7039,TGFA,P01135,0.432,0.885,0.71981,DTO_05007599,Signaling,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.6,1.0,,1992.0,2016.0,ALL
7040,TGFB1,P01137,0.287,0.962,0.03685,DTO_05007599,Signaling,C0011989,Camurati-Engelmann Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,1.0,,2000.0,2019.0,ALL
7041,TGFB1I1,O43294,0.638,0.423,0.027032,DTO_05007530,Cellular structure,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.09,0.889,,1999.0,2016.0,ALL
7042,TGFB2,P61812,0.433,0.885,0.99905,DTO_05007599,Signaling,C2697932,Loeys-Dietz Syndrome,C16;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.89,1.0,strong,2012.0,2018.0,ALL
7043,TGFB3,P10600,0.498,0.808,0.98727,DTO_05007599,Signaling,C4707243,Familial thoracic aortic aneurysm and aortic dissection,,,disease,Disease or Syndrome,0.7,1.0,limited,2006.0,2015.0,ALL
7044,LEFTY2,O00292,0.736,0.231,0.00029307,DTO_05007599,Signaling,C0266642,Situs ambiguus,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.5,1.0,,1999.0,1999.0,ALL
7045,TGFBI,Q15582,0.484,0.769,5.9686e-08,DTO_05007599,Signaling,C0339278,Reis-Bucklers' corneal dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.8,0.95,strong,1998.0,2019.0,ALL
7046,TGFBR1,P36897,0.451,0.885,0.85379,DTO_03300101,Kinase,C2697932,Loeys-Dietz Syndrome,C16;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1993.0,2019.0,ALL
7047,TGM4,P49221,0.769,0.231,3.796e-20,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
7048,TGFBR2,P37173,0.413,0.846,0.12535,DTO_03300101,Kinase,C2697932,Loeys-Dietz Syndrome,C16;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,1.0,strong,2003.0,2019.0,ALL
7049,TGFBR3,Q03167,0.55,0.808,0.0030577,,,C1862932,"ANEURYSM, INTRACRANIAL BERRY, 1 (disorder)",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
7050,TGIF1,Q15583,0.588,0.769,0.010454,DTO_05007624,Enzyme,C0079541,Holoprosencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.7,1.0,strong,1995.0,2018.0,ALL
7051,TGM1,P22735,0.565,0.769,2.2509e-13,DTO_05007624,Enzyme,C0079154,Congenital Nonbullous Ichthyosiform Erythroderma,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,1.0,limited,1994.0,2019.0,ALL
7052,TGM2,P21980,0.445,0.808,6.8118e-18,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2001.0,2018.0,ALL
7053,TGM3,Q08188,0.653,0.385,2.9739e-06,DTO_05007624,Enzyme,C0432347,Uncombable hair syndrome,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.52,1.0,,2016.0,2018.0,ALL
7054,TH,P07101,0.462,0.885,1.6878e-06,,,C2673535,"DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE (disorder)",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.72,1.0,definitive,1964.0,2018.0,ALL
7055,THAS,,0.56,0.808,,,,C0002902,Anencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0,,1985.0,1985.0,ALL
7056,THBD,P07204,0.457,0.769,0.053769,,,C0398623,Thrombophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,0.909,,1991.0,2019.0,ALL
7057,THBS1,P07996,0.407,0.885,0.99985,,,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.5,1.0,,2006.0,2006.0,ALL
7058,THBS2,P35442,0.526,0.769,0.55641,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.31,1.0,,2013.0,2019.0,ALL
7059,THBS3,P49746,0.792,0.269,2.5795e-21,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7060,THBS4,P35443,0.644,0.654,1.5117e-18,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
7062,TCHH,Q07283,0.736,0.269,4.7135e-24,,,C0432347,Uncombable hair syndrome,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.31,1.0,,2016.0,2016.0,ALL
7063,THM,,0.686,0.5,,,,C0026896,Myasthenia Gravis,C04;C20;C10,   Neoplasms;    Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.06,1.0,,2010.0,2020.0,ALL
7064,THOP1,P52888,0.573,0.846,0.0001213,DTO_05007624,Enzyme,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
7066,THPO,P40225,0.513,0.692,0.19714,,,C0836924,Thrombocytosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.5,0.969,,1995.0,2020.0,ALL
7067,THRA,P10827,0.566,0.769,0.32748,DTO_00102000,Nuclear receptor,C3280817,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6",,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2016.0,ALL
7068,THRB,P10828,0.554,0.769,0.99676,DTO_00102000,Nuclear receptor,C2940786,Thyroid Hormone Resistance Syndrome,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.9,0.973,strong,1990.0,2019.0,ALL
7069,THRSP,Q92748,0.695,0.462,0.0029238,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
7070,THY1,P04216,0.496,0.808,0.049895,,,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.5,1.0,,2008.0,2013.0,ALL
7071,KLF10,Q13118,0.631,0.615,0.0045769,DTO_05007557,Nucleic acid binding,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.51,1.0,limited,1995.0,2017.0,ALL
7072,TIA1,P31483,0.595,0.577,0.27493,,,C0221054,Welander Distal Myopathy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,,1999.0,2019.0,ALL
7073,TIAL1,Q01085,0.769,0.346,0.99992,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
7074,TIAM1,Q13009,0.579,0.731,0.95662,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,1.0,,2005.0,2019.0,ALL
7075,TIE1,P35590,0.61,0.654,1.2446e-19,DTO_03300101,Kinase,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
7076,TIMP1,P01033,0.38,0.885,0.4993,DTO_05007584,Enzyme modulator,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.56,1.0,,2011.0,2019.0,ALL
7077,TIMP2,P16035,0.425,0.846,0.78893,DTO_05007584,Enzyme modulator,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.35,1.0,,2002.0,2019.0,ALL
7078,TIMP3,P35625,0.445,0.923,0.63037,DTO_05007584,Enzyme modulator,C1850938,"FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY",C11,   Eye Diseases,disease,Disease or Syndrome,1.0,1.0,limited,1994.0,2019.0,ALL
7079,TIMP4,Q99727,0.559,0.769,0.00038342,DTO_05007584,Enzyme modulator,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.32,1.0,,2006.0,2019.0,ALL
7080,NKX2-1,P43699,0.457,0.808,0.35874,DTO_05007542,Transcription factor,C0393584,Benign Hereditary Chorea,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.96,,2002.0,2018.0,ALL
7082,TJP1,Q07157,0.576,0.692,1.0,DTO_05007527,Cell-cell junction,C0038525,Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.21,1.0,,2009.0,2019.0,ALL
7083,TK1,P04183,0.592,0.538,0.13731,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,0.833,,2003.0,2019.0,ALL
7084,TK2,O00142,0.585,0.615,3.9054e-07,DTO_03300101,Kinase,C3149750,MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE),,,disease,Disease or Syndrome,0.7,1.0,,2001.0,2016.0,ALL
7086,TKT,P29401,0.595,0.769,0.006748,DTO_05007624,Enzyme,C4310751,"SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS",,,disease,Disease or Syndrome,0.71,1.0,moderate,2016.0,2019.0,ALL
7087,ICAM5,Q9UMF0,0.716,0.346,0.002139,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.53,1.0,,2005.0,2013.0,ALL
7088,TLE1,Q04724,0.56,0.654,0.99922,DTO_05007542,Transcription factor,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
7089,TLE2,Q04725,0.805,0.192,1.643e-07,DTO_05007542,Transcription factor,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
7090,TLE3,Q04726,0.674,0.462,1.0,DTO_05007542,Transcription factor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
7091,TLE4,Q04727,0.674,0.462,0.99999,DTO_05007542,Transcription factor,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2002.0,2002.0,ALL
7092,TLL1,O43897,0.716,0.5,0.17306,,,C2751315,Atrial Septal Defect 6,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.71,1.0,limited,2009.0,2019.0,ALL
7093,TLL2,Q9Y6L7,0.89,0.077,2.1374e-31,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
7094,TLN1,Q9Y490,0.641,0.615,1.0,,,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
7095,SEC62,Q99442,0.653,0.308,0.98295,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,1998.0,2019.0,ALL
7096,TLR1,Q15399,0.496,0.808,5.8704e-23,,,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.37,1.0,,2007.0,2018.0,ALL
7097,TLR2,O60603,0.361,0.923,1.0152e-06,,,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.56,1.0,,2005.0,2012.0,ALL
7098,TLR3,O15455,0.427,0.885,1.6349e-07,DTO_05007575,Receptor,C0276226,Herpes encephalitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.7,0.947,,2007.0,2019.0,ALL
7099,TLR4,O00206,0.321,0.962,4.6131e-09,,,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.6,0.968,,2001.0,2020.0,ALL
7100,TLR5,O60602,0.518,0.885,2.4773e-13,,,C0025229,Melioidosis,C01,   Infections,disease,Disease or Syndrome,0.56,0.857,,2007.0,2019.0,ALL
7101,NR2E1,Q9Y466,0.628,0.538,0.99864,DTO_00102000,Nuclear receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2008.0,2016.0,ALL
7102,TSPAN7,P41732,0.604,0.731,0.74577,,,C1846174,"Mental Retardation, X-Linked 58",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2000.0,2012.0,ALL
7103,TSPAN8,P19075,0.617,0.577,0.0055131,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2008.0,2017.0,ALL
7104,TM4SF4,P48230,0.769,0.192,7.2513e-08,,,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
7105,TSPAN6,O43657,0.931,0.192,0.066079,,,C0276496,Familial Alzheimer Disease (FAD),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
7106,TSPAN4,O14817,0.743,0.269,6.4243e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7107,GPR137B,O60478,,,1.4197e-11,,,C0025265,"Memory, Short-Term",,,phenotype,Mental Process,0.1,1.0,,2011.0,2011.0,ALL
7108,TM7SF2,O76062,0.486,0.808,1.366e-07,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2003.0,2020.0,ALL
7109,TRAPPC10,P48553,0.769,0.385,0.99999,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
7110,TMF1,P82094,0.861,0.154,1.4543e-05,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.31,1.0,,2001.0,2009.0,ALL
7111,TMOD1,P28289,0.695,0.462,0.47845,DTO_05007530,Cellular structure,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
7112,TMPO,P42166;P42167,0.631,0.577,1.5453e-07,DTO_05007599,Signaling,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.61,1.0,limited,2005.0,2005.0,ALL
7113,TMPRSS2,O15393,0.615,0.5,2.4044e-10,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.4,0.97,,2001.0,2019.0,ALL
7114,TMSB4X,P62328,0.541,0.692,0.41205,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2008.0,2008.0,ALL
7117,TMSB4XP8,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
7122,CLDN5,O00501,0.559,0.769,0.89512,DTO_05007527,Cell-cell junction,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.39,1.0,,2004.0,2019.0,ALL
7123,CLEC3B,P05452,0.729,0.308,0.0020953,DTO_05007621,Extracellular structure,C0036310,Scheuermann's Disease,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.2,1.0,,2001.0,2001.0,ALL
7124,TNF,P01375,0.231,0.962,0.8033,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.975,,1989.0,2020.0,ALL
7125,TNNC2,P02585,0.931,0.077,0.01624,DTO_05007616,Calcium-binding protein,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,,no reported evidence,,,ALL
7126,TNFAIP1,Q13829,0.722,0.5,0.13509,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
7127,TNFAIP2,Q03169,0.711,0.423,8.2527e-05,DTO_05007405,Transporter,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
7128,TNFAIP3,P21580,0.481,0.808,0.99972,DTO_05007624,Enzyme,C4225218,"AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE",,,disease,Disease or Syndrome,0.71,1.0,,2016.0,2019.0,ALL
7130,TNFAIP6,P98066,0.582,0.731,1.0939e-06,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
7132,TNFRSF1A,P19438,0.409,0.923,0.9949,,,C1275126,TNF receptor-associated periodic fever syndrome (TRAPS),C23;C16;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,1.0,strong,1998.0,2019.0,ALL
7133,TNFRSF1B,P20333,0.425,0.885,0.50201,,,C0026948,Mycosis Fungoides,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.51,1.0,,2015.0,2016.0,ALL
7134,TNNC1,P63316,0.647,0.462,0.67833,DTO_05007616,Calcium-binding protein,C2750472,"Cardiomyopathy, Familial Hypertrophic, 13",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2001.0,2019.0,ALL
7135,TNNI1,P19237,0.861,0.154,7.0162e-05,DTO_05007530,Cellular structure,C0006663,Calcinosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.01,1.0,,2005.0,2005.0,ALL
7136,TNNI2,P48788,0.631,0.423,0.14351,DTO_05007530,Cellular structure,C1834523,"ARTHROGRYPOSIS, DISTAL, TYPE 2B",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.96,1.0,strong,2003.0,2018.0,ALL
7137,TNNI3,P19429,0.52,0.769,0.096284,DTO_05007530,Cellular structure,C1860752,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7",,,disease,Disease or Syndrome,0.9,1.0,strong,1997.0,2019.0,ALL
7138,TNNT1,P13805,0.633,0.577,7.0202e-14,DTO_05007530,Cellular structure,C1854380,NEMALINE MYOPATHY 5,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.95,1.0,strong,2000.0,2019.0,ALL
7139,TNNT2,P45379,0.601,0.423,0.0020041,DTO_05007530,Cellular structure,C1832243,"CARDIOMYOPATHY, DILATED, 1D (disorder)",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.9,1.0,strong,1991.0,2019.0,ALL
7140,TNNT3,P45378,0.653,0.308,2.0758e-07,DTO_05007530,Cellular structure,C0220662,"ARTHROGRYPOSIS, DISTAL, TYPE 1",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.52,1.0,strong,2009.0,2013.0,ALL
7141,TNP1,P09430,0.805,0.192,0.037552,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,2011.0,2020.0,ALL
7142,TNP2,Q05952,1.0,0.038,0.0091467,DTO_05007557,Nucleic acid binding,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,0.0,,2011.0,2011.0,ALL
7143,TNR,Q92752,0.686,0.346,0.52437,DTO_05007599,Signaling,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
7145,TNS1,Q9HBL0,0.691,0.538,0.059861,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7146,TNXA,Q16473,0.821,0.269,,,,C0001627,Congenital adrenal hyperplasia,C16;C18;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.02,1.0,,2005.0,2015.0,ALL
7148,TNXB,P22105,0.572,0.731,0.018547,,,C1848029,Ehlers-Danlos syndrome caused by tenascin-X deficiency,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.61,1.0,,1997.0,2017.0,ALL
7150,TOP1,P11387,0.542,0.692,1.0,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,1993.0,2019.0,ALL
7152,TOP1P2,,,,,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0,,1997.0,1997.0,ALL
7153,TOP2A,P11388,0.497,0.731,0.99086,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.974,,1999.0,2019.0,ALL
7155,TOP2B,Q02880,0.612,0.615,0.99989,,,C0023466,"Leukemia, Monocytic, Chronic",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
7156,TOP3A,Q13472,0.656,0.615,5.0983e-11,DTO_05007624,Enzyme,C4748176,"MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
7157,TP53,P04637,0.236,0.962,0.53235,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,1.0,0.973,,1982.0,2020.0,ALL
7158,TP53BP1,Q12888,0.52,0.731,0.99985,DTO_05007378,Epigenetic regulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2000.0,2019.0,ALL
7159,TP53BP2,Q13625,0.604,0.577,0.0025482,DTO_05007584,Enzyme modulator,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2003.0,2018.0,ALL
7161,TP73,O15350,0.449,0.808,0.99696,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.875,,1999.0,2019.0,ALL
7162,TPBG,Q13641,0.722,0.385,0.012627,DTO_05007575,Receptor,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
7163,TPD52,P55327,0.597,0.692,8.4929e-05,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,1.0,,2004.0,2019.0,ALL
7164,TPD52L1,Q16890,0.861,0.192,1.4908e-05,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
7165,TPD52L2,O43399,0.736,0.192,0.00020188,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2013.0,2018.0,ALL
7166,TPH1,P17752,0.553,0.731,3.1872e-07,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.6,1.0,,2004.0,2019.0,ALL
7167,TPI1,P60174,0.517,0.846,0.030193,DTO_05007624,Enzyme,C1860808,Triosephosphate Isomerase Deficiency,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1986.0,2018.0,ALL
7168,TPM1,P09493,0.56,0.615,0.0010165,DTO_05007530,Cellular structure,C1861863,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3 (disorder)",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1994.0,2019.0,ALL
7169,TPM2,P07951,0.53,0.654,0.00023947,DTO_05007530,Cellular structure,C0220662,"ARTHROGRYPOSIS, DISTAL, TYPE 1",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.73,1.0,,1997.0,2018.0,ALL
7170,TPM3,P06753,0.49,0.808,0.0066522,DTO_05007530,Cellular structure,C0546264,Congenital Fiber Type Disproportion,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Congenital Abnormality,0.74,1.0,strong,2002.0,2017.0,ALL
7171,TPM4,P67936,0.656,0.577,0.38852,DTO_05007530,Cellular structure,C0334121,Inflammatory Myofibroblastic Tumor,C23,"   Pathological Conditions, Signs and Symptoms",disease,Neoplastic Process,0.33,1.0,,2000.0,2017.0,ALL
7172,TPMT,P51580,0.593,0.692,7.1064e-06,,,C0342801,Thiopurine S methyltranferase deficiency,C16;C18;C20;C25,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.8,1.0,limited,2000.0,2019.0,ALL
7173,TPO,P07202,0.455,0.846,1.8182e-21,DTO_05007624,Enzyme,C0010308,Congenital Hypothyroidism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1979.0,2018.0,ALL
7174,TPP2,P29144,0.729,0.462,0.99912,DTO_05007624,Enzyme,C0272126,Evans syndrome,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.31,1.0,strong,2014.0,2015.0,ALL
7175,TPR,P12270,0.647,0.654,1.0,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.32,1.0,,1992.0,2016.0,ALL
7177,TPSAB1,P20231;Q15661,0.722,0.5,1.2733e-13,DTO_05007624,Enzyme,C0013363,Dysautonomia,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2016.0,2016.0,ALL
7178,TPT1,P13693,0.528,0.731,0.80548,DTO_05007530,Cellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.35,1.0,,2002.0,2015.0,ALL
7179,TPTE,P56180,0.821,0.308,5.551e-24,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7180,CRISP2,P16562,0.512,0.769,1.4437e-12,DTO_05007608,Immune response,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1999.0,2019.0,ALL
7181,NR2C1,P13056,0.839,0.154,0.68284,DTO_00102000,Nuclear receptor,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
7182,NR2C2,P49116,0.534,0.808,0.99892,DTO_00102000,Nuclear receptor,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
7183,TRC-GCA24-1,,0.729,0.346,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,2009.0,2011.0,ALL
7184,HSP90B1,P14625,0.522,0.808,0.9972,DTO_05007613,Chaperone,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2007.0,2009.0,ALL
7185,TRAF1,Q13077,0.554,0.731,0.0035639,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,0.85,,2007.0,2019.0,ALL
7186,TRAF2,Q12933,0.546,0.769,0.99979,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.923,,2008.0,2019.0,ALL
7187,TRAF3,Q13114,0.541,0.769,0.99869,DTO_05007599,Signaling,C0276226,Herpes encephalitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.53,1.0,,2010.0,2011.0,ALL
7188,TRAF5,O00463,0.659,0.654,1.6736e-12,DTO_05007599,Signaling,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7189,TRAF6,Q9Y4K3,0.472,0.808,0.99739,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,1.0,,2008.0,2019.0,ALL
7190,HSP90B2P,Q58FF3,0.558,0.846,,DTO_05007613,Chaperone,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.917,,2005.0,2020.0,ALL
7193,TRE-TTC3-1,,0.751,0.269,,,,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2014.0,2017.0,ALL
7195,TRNAG1,,0.931,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.947,,2012.0,2020.0,ALL
7196,TRG-GCC2-6,,0.861,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2011.0,2019.0,ALL
7197,TRG-TCC1-1,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2019.0,ALL
7198,TRG-GCC3-1,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2019.0,ALL
7200,TRH,P20396,0.519,0.846,0.00089084,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.55,1.0,,1983.0,2018.0,ALL
7201,TRHR,P34981,0.695,0.308,0.2711,DTO_02300001,G-protein coupled receptor,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.41,1.0,,1997.0,2018.0,ALL
7202,TRI-AAT9-1,,0.821,0.192,,,,C0011168,Deglutition Disorders,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
7203,CCT3,P49368,0.65,0.577,0.99998,DTO_05007613,Chaperone,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
7204,TRIO,O75962,0.556,0.731,1.0,DTO_03300101,Kinase,C4310740,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 44",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2016.0,ALL
7205,TRIP6,Q15654,0.736,0.192,0.0032632,DTO_05007584,Enzyme modulator,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0,,2010.0,2019.0,ALL
7208,TRL-TAG1-1,,0.861,0.115,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
7214,TRN-GTT2-1,,0.839,0.115,,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
7216,TRO,Q12816,0.682,0.308,3.8486e-05,DTO_05007620,Cell adhesion,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2004.0,2013.0,ALL
7217,TRP-AGG2-5,,0.722,0.423,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.08,1.0,,1991.0,2018.0,ALL
7218,TRP-AGG2-6,,0.666,0.462,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,0.96,,1998.0,2019.0,ALL
7219,TRP-TGG3-1,,0.78,0.269,,,,C0158266,Intervertebral Disc Degeneration,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.04,0.75,,2002.0,2018.0,ALL
7220,TRPC1,P48995,0.566,0.769,0.012904,DTO_01300327,Ion channel,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.3,1.0,,2007.0,2007.0,ALL
7222,TRPC3,Q13507,0.57,0.731,1.0806e-07,DTO_01300327,Ion channel,C4225158,SPINOCEREBELLAR ATAXIA 41,,,disease,Disease or Syndrome,0.5,1.0,,2015.0,2015.0,ALL
7223,TRPC4,Q9UBN4,0.695,0.5,0.48205,DTO_01300327,Ion channel,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7224,TRPC5,Q9UL62,0.653,0.615,0.99973,DTO_01300327,Ion channel,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.31,1.0,,2007.0,2011.0,ALL
7225,TRPC6,Q9Y210,0.514,0.692,3.0274e-07,DTO_01300327,Ion channel,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.9,1.0,strong,2005.0,2019.0,ALL
7226,TRPM2,O94759,0.546,0.731,8.9633e-44,DTO_01300327,Ion channel,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,1.0,,2006.0,2015.0,ALL
7227,TRPS1,Q9UHF7,0.537,0.769,1.0,,,C0432233,Trichorhinophalangeal dysplasia type I,C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.94,1.0,,1999.0,2017.0,ALL
7230,TRR-TCT2-1,,1.0,0.154,,,,C0019269,Hermaphroditism,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
7238,TRT-AGT7-1,,1.0,0.077,,,,C0342185,"Hyperthyroxinemia, Familial Dysalbuminemic",C16;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0,,1995.0,1995.0,ALL
7239,TRV-AAC1-4,,0.821,0.154,,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.03,0.667,,2012.0,2019.0,ALL
7240,TRV-CAC1-2,,1.0,0.077,,,,C0235833,Congenital diaphragmatic hernia,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
7247,TSN,Q15631,0.76,0.192,0.78659,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,0.667,,1995.0,2019.0,ALL
7248,TSC1,Q92574,0.44,0.808,1.0,,,C0041341,Tuberous Sclerosis,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.9,0.981,definitive,1990.0,2020.0,ALL
7249,TSC2,P49815,0.439,0.808,1.0,DTO_05007584,Enzyme modulator,C0041341,Tuberous Sclerosis,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,1.0,0.98,definitive,1994.0,2020.0,ALL
7251,TSG101,Q99816,0.588,0.615,0.34407,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,1997.0,2016.0,ALL
7252,TSHB,P01222,0.67,0.538,0.0083588,DTO_05007599,Signaling,C0271789,"Hypothyroidism, Congenital, Nongoitrous, 4",C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1989.0,2017.0,ALL
7253,TSHR,P16473,0.486,0.808,3.0447e-15,DTO_02300001,G-protein coupled receptor,C0010308,Congenital Hypothyroidism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.9,0.95,strong,1996.0,2019.0,ALL
7257,TSNAX,Q99598,0.76,0.192,0.48922,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.38,0.875,,2000.0,2018.0,ALL
7258,TSPY1,P0CV98;P0CW01;Q01534,0.631,0.423,0.30999,DTO_05007584,Enzyme modulator,C1507149,Partial chromosome Y deletion,C23;C16;C13;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2013.0,2013.0,ALL
7259,TSPYL1,Q9H0U9,0.705,0.5,5.621e-07,DTO_05007584,Enzyme modulator,C1837371,Sudden Infant Death with Dysgenesis of the Testes Syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.63,1.0,moderate,2004.0,2015.0,ALL
7260,EIPR1,Q53HC9,0.821,0.231,0.063628,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
7262,PHLDA2,Q53GA4,0.636,0.615,0.15046,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.38,1.0,,2012.0,2019.0,ALL
7263,TST,Q16762,0.588,0.654,7.8734e-05,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2018.0,ALL
7264,TSTA3,Q13630,0.792,0.231,1.6808e-07,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
7265,TTC1,Q99614,,,2.5494e-06,,,C4021085,Abnormality of brain morphology,,,phenotype,Anatomical Abnormality,0.1,,,,,ALL
7266,DNAJC7,Q99615,0.931,0.154,0.99007,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
7267,TTC3,P53804,0.78,0.385,1.628e-40,DTO_05007613,Chaperone,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7268,TTC4,O95801,0.691,0.385,4.5355e-06,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
7270,TTF1,Q15361,0.537,0.5,6.2102e-13,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2009.0,2020.0,ALL
7272,TTK,P33981,0.555,0.731,0.0012734,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2014.0,2018.0,ALL
7273,TTN,Q8WZ42,0.47,0.885,2.5582e-96,DTO_03300101,Kinase,C1838244,"TIBIAL MUSCULAR DYSTROPHY, TARDIVE",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,strong,2001.0,2017.0,ALL
7274,TTPA,P49638,0.612,0.577,0.0014409,DTO_05007405,Transporter,C1848533,Ataxia with vitamin E deficiency,C23;C18;C10,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1985.0,2015.0,ALL
7275,TUB,P50607,0.659,0.385,0.0031466,,,C4015424,RETINAL DYSTROPHY AND OBESITY,,,disease,Disease or Syndrome,0.61,1.0,moderate,1996.0,2014.0,ALL
7276,TTR,P02766,0.423,0.885,0.51566,DTO_05007405,Transporter,C2751492,"AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.992,,1983.0,2020.0,ALL
7277,TUBA4A,P68366,0.751,0.269,0.15983,DTO_05007530,Cellular structure,C4015512,AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA,,,disease,Disease or Syndrome,0.7,1.0,moderate,2014.0,2015.0,ALL
7278,TUBA3C,P0DPH7;P0DPH8,0.821,0.308,0.004574,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,1998.0,1998.0,ALL
7280,TUBB2A,Q13885,0.678,0.538,0.93478,DTO_05007530,Cellular structure,C3810407,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5",,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2014.0,ALL
7283,TUBG1,P23258,0.729,0.231,0.12882,DTO_05007530,Cellular structure,C3809420,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2018.0,ALL
7284,TUFM,P49411,0.678,0.615,0.004184,DTO_05007624,Enzyme,C1857682,Combined Oxidative Phosphorylation Deficiency 4,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,,2007.0,2019.0,ALL
7286,TUFT1,Q9NNX1,0.682,0.385,0.00010612,,,C0002452,Amelogenesis Imperfecta,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.33,1.0,,1994.0,1998.0,ALL
7287,TULP1,O00294,0.623,0.462,0.00056824,,,C1838603,Retinitis Pigmentosa 14,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.91,1.0,,1997.0,2010.0,ALL
7288,TULP2,O00295,0.861,0.077,2.4676e-16,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
7289,TULP3,O75386,0.716,0.385,1.7488e-06,,,C0238198,Gastrointestinal Stromal Tumors,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
7290,HIRA,P54198,0.537,0.808,1.0,DTO_05007557,Nucleic acid binding,C0012236,DiGeorge Syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,1993.0,2010.0,ALL
7291,TWIST1,Q15672,0.397,0.846,0.34491,DTO_05007542,Transcription factor,C0175699,Saethre-Chotzen Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.986,strong,1995.0,2019.0,ALL
7292,TNFSF4,P23510,0.54,0.808,0.049378,DTO_05007599,Signaling,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.6,0.967,,2008.0,2019.0,ALL
7293,TNFRSF4,P43489,0.547,0.692,0.00015133,,,C3810053,IMMUNODEFICIENCY 16,,,disease,Disease or Syndrome,0.61,0.0,,2013.0,2013.0,ALL
7294,TXK,P42681,0.931,0.192,8.5733e-09,DTO_03300101,Kinase,C3828530,Platelet Component Distribution Width Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
7295,TXN,P10599,0.447,0.885,0.20119,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2000.0,2018.0,ALL
7296,TXNRD1,Q16881,0.529,0.692,1.6062e-06,DTO_05007624,Enzyme,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,2008.0,2008.0,ALL
7297,TYK2,P29597,0.505,0.769,4.4963e-08,DTO_03300101,Kinase,C1969086,Tyrosine Kinase 2 Deficiency,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2006.0,2016.0,ALL
7298,TYMS,P04818,0.425,0.846,0.72247,DTO_05007624,Enzyme,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.6,1.0,,1998.0,2015.0,ALL
7299,TYR,P14679,0.473,0.808,4.9861e-32,DTO_05007624,Enzyme,C0078918,"Albinism, Oculocutaneous",C16;C18;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.9,0.982,strong,1981.0,2019.0,ALL
7301,TYRO3,Q06418,0.559,0.769,8.3343e-10,DTO_03300101,Kinase,C0040053,Thrombosis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0,,2005.0,2005.0,ALL
7303,TYS,,0.821,0.154,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.03,1.0,,1991.0,2013.0,ALL
7305,TYROBP,O43914,0.573,0.769,0.20238,,,C1857316,POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY,C16;C18;C01;C17;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Infections;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,1990.0,2019.0,ALL
7306,TYRP1,P17643,0.507,0.846,6.557e-25,DTO_05007624,Enzyme,C0342683,"ALBINISM, OCULOCUTANEOUS, TYPE III",C16;C18;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.74,1.0,,1997.0,2013.0,ALL
7307,U2AF1,P0DN76;Q01081,0.604,0.577,0.9899,DTO_05007557,Nucleic acid binding,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.8,0.963,,2011.0,2020.0,ALL
7310,ZRSR2P1,Q15695,1.0,0.115,0.00016735,DTO_05007557,Nucleic acid binding,C0032580,Adenomatous Polyposis Coli,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,1998.0,1998.0,ALL
7311,UBA52,P62987,0.769,0.423,0.59849,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,1995.0,2019.0,ALL
7314,UBB,P0CG47,0.599,0.615,0.016904,DTO_05007557,Nucleic acid binding,C0432098,Cleft Soft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.4,1.0,,2007.0,2007.0,ALL
7316,UBC,P0CG48,0.597,0.692,0.14161,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
7317,UBA1,P22314,0.666,0.615,1.0,DTO_05007624,Enzyme,C1844934,"Arthrogryposis multiplex congenita, distal, X-linked",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2008.0,2015.0,ALL
7318,UBA7,P41226,0.729,0.269,3.8164e-17,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2008.0,2008.0,ALL
7319,UBE2A,P49459,0.623,0.692,0.815,,,C3275464,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE",,,disease,Disease or Syndrome,0.7,1.0,definitive,2006.0,2018.0,ALL
7320,UBE2B,P63146,0.644,0.615,0.19663,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,1996.0,2019.0,ALL
7321,UBE2D1,P51668,0.7,0.385,0.11989,DTO_05007624,Enzyme,C1266119,Solitary fibrous tumor,C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0,,2016.0,2020.0,ALL
7322,UBE2D2,P62837,0.861,0.192,0.96547,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
7323,UBE2D3,P61077,0.805,0.154,0.41278,DTO_05007624,Enzyme,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
7324,UBE2E1,P51965,0.743,0.269,0.70538,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
7325,UBE2E2,Q96LR5,0.695,0.423,0.96378,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.45,0.929,,2010.0,2019.0,ALL
7326,UBE2G1,P62253,0.931,0.231,0.84382,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
7327,UBE2G2,P60604,1.0,0.077,0.099496,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
7328,UBE2H,P62256,0.805,0.269,0.94063,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2003.0,2003.0,ALL
7329,UBE2I,P63279,0.544,0.769,0.96496,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
7332,UBE2L3,P68036,0.644,0.615,0.83844,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.49,0.941,,2008.0,2020.0,ALL
7334,UBE2N,P61088,0.593,0.654,0.88156,,,C0012684,Blastocyst Disintegration,C23;C13,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Pathologic Function,0.3,1.0,,2006.0,2006.0,ALL
7335,UBE2V1,A5PLL7;Q13404,0.641,0.654,0.00012406,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2017.0,2019.0,ALL
7336,UBE2V2,Q15819,0.931,0.077,0.03351,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
7337,UBE3A,Q05086,0.561,0.692,0.9998,,,C0162635,Angelman Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.967,definitive,1997.0,2020.0,ALL
7341,SUMO1,P63165,0.533,0.731,0.86128,,,C1866070,OROFACIAL CLEFT 10,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.5,1.0,limited,2012.0,2012.0,ALL
7342,UBP1,Q9NZI7,1.0,0.077,0.99999,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
7343,UBTF,P17480,0.705,0.462,1.0,,,C4540086,"NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY",,,disease,Disease or Syndrome,0.7,1.0,limited,2017.0,2017.0,ALL
7345,UCHL1,P09936,0.482,0.885,0.99095,DTO_05007624,Enzyme,C3809665,"SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.71,1.0,,1998.0,2018.0,ALL
7347,UCHL3,P15374,0.705,0.385,3.3417e-08,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
7348,UPK1B,O75841,0.729,0.346,2.1842e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
7349,UCN,P55089,0.539,0.769,0.44958,DTO_05007599,Signaling,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.32,1.0,,1996.0,2008.0,ALL
7350,UCP1,P25874,0.545,0.769,1.6903e-11,DTO_05007405,Transporter,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,0.952,,1997.0,2020.0,ALL
7351,UCP2,P55851,0.493,0.808,1.5497e-10,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.6,0.857,,1998.0,2019.0,ALL
7352,UCP3,P55916,0.619,0.577,9.5517e-10,DTO_05007405,Transporter,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,0.907,,1998.0,2018.0,ALL
7353,UFD1,Q92890,0.537,0.769,0.99638,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.43,1.0,,2001.0,2013.0,ALL
7355,SLC35A2,P78381,0.525,0.808,0.71792,DTO_05007405,Transporter,C3806688,Solute carrier family 35 member A2 congenital disorder of glycosylation,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.73,1.0,,2013.0,2019.0,ALL
7356,SCGB1A1,P11684,0.546,0.808,0.00079919,DTO_05007599,Signaling,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.35,1.0,,2005.0,2018.0,ALL
7357,UGCG,Q16739,0.56,0.808,0.94147,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
7358,UGDH,O60701,0.678,0.615,0.00068341,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
7360,UGP2,Q16851,0.711,0.308,1.3543e-08,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0,,2020.0,2020.0,ALL
7361,UGT1A,,0.54,0.654,,,,C0017551,Gilbert Disease (disorder),C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,0.962,,1997.0,2019.0,ALL
7363,UGT2B4,P06133,0.751,0.231,4.3777e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2011.0,2016.0,ALL
7364,UGT2B7,P16662,0.647,0.5,1.191e-13,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,2005.0,2013.0,ALL
7365,UGT2B10,P36537,0.89,0.077,1.0278e-17,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
7366,UGT2B15,P54855,0.7,0.423,2.2864e-21,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.867,,1998.0,2018.0,ALL
7367,UGT2B17,O75795,0.641,0.577,9.6905e-08,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.81,,1998.0,2017.0,ALL
7368,UGT8,Q16880,0.636,0.615,0.027986,,,C0518015,Hemoglobin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
7369,UMOD,P07911,0.52,0.846,3.0798e-17,,,C4551496,"Hyperuricemic Nephropathy, Familial Juvenile 1",C23;C16;C18;C13;C05;C12,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,1.0,,2001.0,2018.0,ALL
7371,UCK2,Q9BZX2,0.663,0.462,0.72131,DTO_03300101,Kinase,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
7372,UMPS,P11172,0.584,0.615,0.0001051,,,C0268130,"Hereditary orotic aciduria, type 1",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.63,0.833,strong,1974.0,2017.0,ALL
7373,COL14A1,Q05707,0.674,0.615,1.4327e-14,DTO_05007575,Receptor,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
7374,UNG,P13051,0.617,0.654,0.0017247,,,C1720958,"Hyper-IgM Immunodeficiency Syndrome, Type 5",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2003.0,2005.0,ALL
7375,USP4,Q13107,0.686,0.308,1.6119e-09,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
7376,NR1H2,P55055,0.533,0.769,0.37506,DTO_00102000,Nuclear receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2005.0,2017.0,ALL
7378,UPP1,Q16831,0.682,0.462,0.00037588,DTO_05007624,Enzyme,C0035228,Respiratory Hypersensitivity,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,phenotype,Pathologic Function,0.3,1.0,,2014.0,2014.0,ALL
7379,UPK2,O00526,0.691,0.346,2.9877e-08,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2004.0,2019.0,ALL
7380,UPK3A,O75631,0.711,0.231,1.0773e-10,,,C1619700,RENAL ADYSPLASIA,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.31,1.0,limited,2006.0,2006.0,ALL
7381,UQCRB,P14927,0.736,0.308,0.016423,DTO_05007624,Enzyme,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.3,1.0,strong,2013.0,2013.0,ALL
7384,UQCRC1,P31930,0.751,0.385,0.020028,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2009.0,2009.0,ALL
7385,UQCRC2,P22695,0.722,0.346,2.8623e-06,DTO_05007624,Enzyme,C3554608,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5",,,disease,Disease or Syndrome,0.6,1.0,moderate,2013.0,2013.0,ALL
7386,UQCRFS1,P47985,0.558,0.654,0.18923,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
7388,UQCRH,P07919,0.821,0.154,0.0020194,DTO_05007624,Enzyme,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
7389,UROD,P06132,0.521,0.769,1.2563e-08,,,C0162566,Porphyria Cutanea Tarda,C16;C06;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.9,0.988,,1976.0,2019.0,ALL
7390,UROS,P10746,0.678,0.462,0.031627,DTO_05007624,Enzyme,C0162530,"Porphyria, Erythropoietic",C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.982,,1990.0,2019.0,ALL
7391,USF1,P22415,0.592,0.692,0.023545,,,C0020474,"Hyperlipidemia, Familial Combined",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,0.963,,2001.0,2020.0,ALL
7392,USF2,Q15853,0.626,0.654,0.99253,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
7396,USH1E,,0.861,0.231,,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0,,1997.0,1997.0,ALL
7398,USP1,O94782,0.641,0.538,0.99691,DTO_05007624,Enzyme,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.26,1.0,,2005.0,2017.0,ALL
7399,USH2A,O75445,0.579,0.692,1.5692e-94,DTO_05007584,Enzyme modulator,C1848634,"USHER SYNDROME, TYPE IIA",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,1.0,1.0,,1998.0,2017.0,ALL
7401,CLRN1,P58418,0.633,0.423,1.7074e-08,,,C1568248,"Usher Syndrome, Type III",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1996.0,2020.0,ALL
7402,UTRN,P46939,0.525,0.692,1.0021e-19,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2020.0,ALL
7403,KDM6A,O15550,0.498,0.769,1.0,DTO_05007378,Epigenetic regulator,C0796004,Kabuki make-up syndrome,C16;C09;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Otorhinolaryngologic Diseases;    Hemic and Lymphatic Diseases",disease,Congenital Abnormality,0.8,0.97,strong,2012.0,2020.0,ALL
7404,UTY,O14607,0.78,0.385,0.96681,DTO_05007542,Transcription factor,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
7405,UVRAG,Q9P2Y5,0.436,0.769,0.98942,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.95,,2001.0,2019.0,ALL
7407,VARS1,P26640,0.711,0.5,1.8014e-08,,,C4540493,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY",,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2018.0,ALL
7408,VASP,P50552,0.626,0.577,0.94665,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
7409,VAV1,P15498,0.556,0.769,0.99993,,,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2009.0,2015.0,ALL
7410,VAV2,P52735,0.663,0.577,3.1086e-06,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2010.0,2010.0,ALL
7411,VBP1,P61758,0.805,0.346,0.88445,DTO_05007613,Chaperone,C0019562,Von Hippel-Lindau Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,1996.0,2008.0,ALL
7412,VCAM1,P19320,0.422,0.808,0.79791,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.54,1.0,,2002.0,2018.0,ALL
7414,VCL,P18206,0.575,0.654,0.046788,,,C2750459,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2018.0,ALL
7415,VCP,P55072,0.469,0.923,0.99999,,,C1833662,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA,C16;C18;C05;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.9,1.0,limited,2004.0,2019.0,ALL
7416,VDAC1,P21796,0.556,0.654,0.97266,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
7417,VDAC2,P45880,0.674,0.462,0.63412,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
7419,VDAC3,Q9Y277,0.839,0.231,0.99454,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2006.0,2018.0,ALL
7420,VDI,,0.861,0.269,,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
7421,VDR,P11473,0.352,0.885,1.6787e-05,DTO_00102000,Nuclear receptor,C0342646,"Vitamin D-Dependent Rickets, Type 2A",C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.73,1.0,strong,1988.0,2020.0,ALL
7422,VEGFA,P15692,0.266,0.923,2.4085e-05,DTO_05007599,Signaling,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.6,0.964,,1995.0,2019.0,ALL
7423,VEGFB,P49765,0.592,0.615,1.3114e-09,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2001.0,2012.0,ALL
7424,VEGFC,P49767,0.459,0.769,0.49565,DTO_05007599,Signaling,C4747769,LYMPHATIC MALFORMATION 4,,,disease,Disease or Syndrome,0.5,1.0,strong,2018.0,2018.0,ALL
7425,VGF,O15240,0.626,0.538,0.56825,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,0.833,,2008.0,2019.0,ALL
7428,VHL,P40337,0.443,0.846,0.079515,DTO_05007624,Enzyme,C0019562,Von Hippel-Lindau Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,0.974,,1976.0,2020.0,ALL
7429,VIL1,P09327,0.691,0.423,2.6433e-14,DTO_05007530,Cellular structure,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
7430,EZR,P15311,0.476,0.808,0.17989,DTO_05007530,Cellular structure,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,0.975,,1999.0,2020.0,ALL
7431,VIM,P08670,0.372,0.846,0.71255,,,C3805411,CATARACT 30,,,disease,Disease or Syndrome,0.8,1.0,strong,2009.0,2017.0,ALL
7432,VIP,P01282,0.437,0.846,0.00041995,DTO_05007599,Signaling,C0242488,Acute Lung Injury,C08,   Respiratory Tract Diseases,disease,Injury or Poisoning,0.5,1.0,,1996.0,2010.0,ALL
7433,VIPR1,P32241,0.573,0.654,7.4401e-27,DTO_02300001,G-protein coupled receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.38,1.0,,1996.0,2019.0,ALL
7434,VIPR2,P41587,0.619,0.692,4.718e-11,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.39,0.889,,2011.0,2018.0,ALL
7435,VIS1,,0.743,0.308,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
7436,VLDLR,P98155,0.558,0.692,1.9617e-11,,,C4551552,"Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 1",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.68,1.0,,2005.0,2018.0,ALL
7439,BEST1,O76090,0.465,0.885,1.8214e-12,DTO_01300327,Ion channel,C0339510,Vitelliform Macular Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,1.0,0.972,,1993.0,2019.0,ALL
7441,VPREB1,P12018,0.695,0.5,0.096491,DTO_05007608,Immune response,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2017.0,ALL
7442,TRPV1,Q8NER1,0.446,0.885,1.0103e-16,DTO_01300327,Ion channel,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.6,1.0,,2002.0,2019.0,ALL
7443,VRK1,Q99986,0.621,0.615,0.0021149,DTO_03300101,Kinase,C1843504,Pontocerebellar Hypoplasia Type 1,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.72,1.0,,2009.0,2016.0,ALL
7444,VRK2,Q86Y07,0.722,0.269,1.5681e-11,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.48,1.0,,2009.0,2019.0,ALL
7446,AVSD1,,0.751,0.192,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0,,2013.0,2017.0,ALL
7447,VSNL1,P62760,0.631,0.423,0.45742,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.49,1.0,,2001.0,2019.0,ALL
7448,VTN,P04004,0.509,0.769,1.5014e-10,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.33,1.0,,2016.0,2019.0,ALL
7450,VWF,P04275,0.408,0.885,3.2187e-25,DTO_05007584,Enzyme modulator,C1264040,"von Willebrand Disease, Type 2",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.974,,1987.0,2020.0,ALL
7451,VWFP1,,1.0,0.077,,,,C1292771,"Chronic myelogenous leukemia, BCR/ABL positive",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1992.0,1992.0,ALL
7453,WARS1,P23381,0.65,0.654,0.30288,DTO_05007624,Enzyme,C4540265,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX",,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
7454,WAS,P42768,0.529,0.808,0.99901,DTO_05007530,Cellular structure,C0043194,Wiskott-Aldrich Syndrome,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.987,definitive,1994.0,2020.0,ALL
7455,ZAN,Q9Y493,0.931,0.192,1.6432e-62,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
7456,WIPF1,O43516,0.584,0.731,0.90296,,,C0043194,Wiskott-Aldrich Syndrome,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.6,1.0,,1999.0,2018.0,ALL
7458,EIF4H,Q15056,0.839,0.231,0.43982,DTO_05007557,Nucleic acid binding,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.22,1.0,,1996.0,2012.0,ALL
7461,CLIP2,Q9UDT6,0.529,0.808,0.99997,DTO_05007530,Cellular structure,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.27,1.0,,1998.0,2012.0,ALL
7462,LAT2,Q9GZY6,0.656,0.577,0.00022295,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2009.0,2019.0,ALL
7464,CORO2A,Q92828,0.931,0.077,3.4457e-10,DTO_05007530,Cellular structure,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
7465,WEE1,P30291,0.545,0.769,0.99973,DTO_03300101,Kinase,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.36,1.0,,2014.0,2019.0,ALL
7466,WFS1,O76024,0.528,0.846,1.6231e-38,,,C4551693,Wolfram Syndrome 1,C16;C18;C13;C11;C12;C10;C19;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.98,1.0,,1998.0,2018.0,ALL
7467,WHCR,,0.638,0.577,,,,C0796117,Pitt-Rogers-Danks Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.3,,,,,ALL
7468,NSD2,O96028,0.507,0.769,1.0,DTO_05007378,Epigenetic regulator,C1956097,Wolf-Hirschhorn Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.9,0.963,,1998.0,2019.0,ALL
7469,NELFA,Q9H3P2,0.619,0.615,0.13469,,,C1956097,Wolf-Hirschhorn Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.33,0.667,,2009.0,2012.0,ALL
7471,WNT1,P04628,0.495,0.769,0.3263,DTO_05007599,Signaling,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.7,1.0,,2013.0,2019.0,ALL
7472,WNT2,P09544,0.569,0.615,0.017811,DTO_05007599,Signaling,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,0.571,,2001.0,2012.0,ALL
7473,WNT3,P56703,0.536,0.808,0.87515,DTO_05007599,Signaling,C2931216,Tetra-amelia autosomal recessive,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.62,1.0,moderate,2004.0,2011.0,ALL
7474,WNT5A,P41221,0.443,0.808,0.98732,DTO_05007599,Signaling,C0265205,Robinow Syndrome,C16;C13;C05;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.85,1.0,,2010.0,2018.0,ALL
7475,WNT6,Q9Y6F9,0.67,0.269,0.016431,DTO_05007599,Signaling,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
7476,WNT7A,O00755,0.531,0.692,0.035773,DTO_05007599,Signaling,C1856728,Fuhrmann syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.94,1.0,,2006.0,2017.0,ALL
7477,WNT7B,P56706,0.633,0.346,0.00074076,DTO_05007599,Signaling,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
7478,WNT8A,Q9H1J5,0.839,0.192,0.010244,DTO_05007599,Signaling,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.41,1.0,,2012.0,2018.0,ALL
7479,WNT8B,Q93098,0.839,0.154,0.010991,DTO_05007599,Signaling,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
7480,WNT10B,O00744,0.576,0.654,0.0003616,DTO_05007599,Signaling,C2749665,SPLIT-HAND/FOOT MALFORMATION 6 (disorder),C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,,2002.0,2015.0,ALL
7481,WNT11,O96014,0.608,0.654,0.0064383,DTO_05007599,Signaling,C0000771,"Abnormalities, Drug-Induced",C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.3,1.0,,2015.0,2015.0,ALL
7482,WNT2B,Q93097,0.644,0.615,0.038333,DTO_05007599,Signaling,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
7483,WNT9A,O14904,0.792,0.423,0.91225,DTO_05007599,Signaling,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
7484,WNT9B,O14905,0.78,0.308,0.54137,DTO_05007599,Signaling,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
7485,GET1,O00258,0.805,0.192,0.00086766,,,C0014877,Esotropia,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
7486,WRN,Q14191,0.524,0.808,2.6432e-34,DTO_05007624,Enzyme,C0043119,Werner Syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.952,definitive,1993.0,2019.0,ALL
7490,WT1,P19544,0.422,0.808,0.99648,DTO_05007557,Nucleic acid binding,C0950121,Denys-Drash Syndrome,C16;C04;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,1.0,0.982,,1991.0,2018.0,ALL
7491,WT2,,0.821,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,1997.0,2000.0,ALL
7494,XBP1,P17861,0.477,0.846,0.032014,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2003.0,2018.0,ALL
7495,XBP1P1,,0.653,0.692,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.09,1.0,,2003.0,2017.0,ALL
7497,XCE,,1.0,0.077,,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0,,2008.0,2008.0,ALL
7498,XDH,P47989,0.529,0.846,2.589e-22,DTO_05007624,Enzyme,C0268118,"Xanthinuria, Type I",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.76,1.0,strong,1997.0,2013.0,ALL
7502,XIC,,0.821,0.462,,,,C0041408,Turner Syndrome,C16;C13;C12;C19;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.05,1.0,,1991.0,2010.0,ALL
7503,XIST,,0.522,0.808,,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
7504,XK,P51811,0.575,0.654,0.95373,,,C0398568,Blood group deletion syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,,1998.0,2019.0,ALL
7507,XPA,P23025,0.52,0.846,7.8652e-05,DTO_05007557,Nucleic acid binding,C0268135,"Xeroderma pigmentosum, group A",C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.968,definitive,1978.0,2019.0,ALL
7508,XPC,Q01831,0.504,0.808,3.6866e-11,DTO_05007557,Nucleic acid binding,C2752147,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C",C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome; Congenital Abnormality,1.0,0.987,definitive,1989.0,2019.0,ALL
7511,XPNPEP1,Q9NQW7,0.729,0.346,0.33296,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.04,1.0,,1999.0,2006.0,ALL
7512,XPNPEP2,O43895,0.716,0.346,2.867e-13,,,C0002994,Angioedema,C17;C20;C14,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Cardiovascular Diseases,phenotype,Pathologic Function,0.4,1.0,,2005.0,2005.0,ALL
7514,XPO1,O14980,0.504,0.692,1.0,DTO_05007575,Receptor,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.44,1.0,,2012.0,2019.0,ALL
7515,XRCC1,P18887,0.421,0.923,6.3386e-09,,,C4539948,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26",,,disease,Disease or Syndrome,0.5,1.0,moderate,2017.0,2017.0,ALL
7516,XRCC2,O43543,0.512,0.731,3.955e-07,,,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.54,1.0,strong,2012.0,2019.0,ALL
7517,XRCC3,O43542,0.505,0.769,1.9134e-10,,,C3151417,"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6",,,phenotype,Finding,0.6,1.0,,2000.0,2000.0,ALL
7518,XRCC4,Q13426,0.528,0.769,8.2774e-07,,,C4225288,"SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION",,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2018.0,ALL
7520,XRCC5,P13010,0.554,0.808,0.99999,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.36,1.0,,2007.0,2017.0,ALL
7525,YES1,P07947,0.638,0.577,4.0091e-05,DTO_03300101,Kinase,C0013069,Double Outlet Right Ventricle,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.3,1.0,,2014.0,2014.0,ALL
7526,YES1P1,,0.931,0.077,,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
7528,YY1,P25490,0.481,0.808,0.9938,DTO_05007542,Transcription factor,C4479652,GABRIELE-DE VRIES SYNDROME,,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2017.0,ALL
7529,YWHAB,P31946,0.769,0.385,0.98314,DTO_05007613,Chaperone,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2005.0,2005.0,ALL
7531,YWHAE,P62258,0.53,0.692,0.98479,DTO_05007613,Chaperone,C0265219,Miller Dieker syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,,2000.0,2017.0,ALL
7532,YWHAG,P61981,0.621,0.5,0.964,DTO_05007613,Chaperone,C4540034,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56",,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2017.0,ALL
7533,YWHAH,Q04917,0.743,0.269,0.78366,DTO_05007613,Chaperone,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.54,0.8,,1999.0,2009.0,ALL
7534,YWHAZ,P63104,0.475,0.846,0.93965,DTO_05007613,Chaperone,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.8,,1995.0,2012.0,ALL
7535,ZAP70,P43403,0.497,0.769,0.87696,DTO_03300101,Kinase,C2931299,ZAP70 deficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.73,1.0,strong,1994.0,2019.0,ALL
7536,SF1,Q15637,0.751,0.423,0.99943,DTO_05007557,Nucleic acid binding,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
7538,ZFP36,P26651,0.523,0.692,0.75244,DTO_05007557,Nucleic acid binding,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.36,1.0,,2004.0,2017.0,ALL
7539,ZFP37,Q9Y6Q3,0.89,0.192,6.1213e-13,DTO_05007542,Transcription factor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
7541,ZBTB14,O43829,,,0.26111,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
7542,ZFPL1,O95159,0.89,0.115,0.0087619,DTO_05007542,Transcription factor,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
7543,ZFX,P17010,0.599,0.538,0.99831,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.846,,2012.0,2018.0,ALL
7544,ZFY,P08048,0.716,0.308,0.69359,DTO_05007542,Transcription factor,C0041408,Turner Syndrome,C16;C13;C12;C19;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.04,0.75,,1990.0,2008.0,ALL
7545,ZIC1,Q15915,0.545,0.731,0.93378,DTO_05007542,Transcription factor,C0030044,Acrocephaly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.6,1.0,,2015.0,2015.0,ALL
7546,ZIC2,O95409,0.556,0.769,0.97362,DTO_05007542,Transcription factor,C1864827,HOLOPROSENCEPHALY 5,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,1998.0,2016.0,ALL
7547,ZIC3,O60481,0.587,0.423,0.92495,DTO_05007542,Transcription factor,C1844020,"HETEROTAXY, VISCERAL, 1, X-LINKED",C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.91,1.0,,1952.0,2014.0,ALL
7549,ZNF2,Q9BSG1,1.0,0.231,0.027216,,,C1840333,Barakat syndrome,C23;C13;C12;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
7551,ZNF3,P17036,0.89,0.077,1.9833e-05,DTO_05007542,Transcription factor,C0017154,"Gastritis, Atrophic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
7552,ZNF711,Q9Y462,0.691,0.423,0.97887,,,C2749020,"Mental Retardation, X-Linked, Znf711-Related",C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.6,1.0,strong,2009.0,2017.0,ALL
7553,ZNF7,P17097,0.861,0.192,2.1025e-07,,,C1285654,Memory performance,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
7555,CNBP,P62633,0.556,0.692,0.95994,,,C2931689,Dystrophia myotonica 2,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.6,0.978,,2002.0,2018.0,ALL
7556,ZNF10,P21506,,,0.0016011,DTO_05007542,Transcription factor,C0376544,Hematopoietic Neoplasms,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
7559,ZNF12,P17014,,,0.039662,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
7561,ZNF14,P17017,1.0,0.038,0.10354,,,C0018133,Graft-vs-Host Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,0.0,,2014.0,2014.0,ALL
7567,ZNF19,P17023,,,4.3113e-06,DTO_05007542,Transcription factor,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
7568,ZNF20,P17024,0.89,0.077,0.096582,DTO_05007542,Transcription factor,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,1997.0,1997.0,ALL
7569,ZNF182,P17025,1.0,0.115,0.98405,,,C0043194,Wiskott-Aldrich Syndrome,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,1995.0,1995.0,ALL
7570,ZNF22,P17026,0.78,0.192,0.0020997,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7571,ZNF23,P17027,0.821,0.115,1.0831e-07,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
7572,ZNF24,P17028,0.821,0.269,0.98114,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
7576,ZNF28,P17035,0.931,0.038,0.0074328,,,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
7579,ZSCAN20,P17040,1.0,0.077,0.00048141,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
7580,ZNF32,P17041,0.861,0.154,0.032574,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
7584,ZNF35,P13682,0.67,0.462,0.042004,DTO_05007542,Transcription factor,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.1,1.0,,2004.0,2019.0,ALL
7586,ZKSCAN1,P17029,0.78,0.231,0.96937,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
7587,ZNF37A,P17032,1.0,0.077,1.3004e-09,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
7589,ZSCAN21,Q9Y5A6,1.0,0.038,3.4774e-12,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
7592,ZNF41,P51814,0.711,0.385,0.035083,,,C1136249,"Mental Retardation, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.52,1.0,limited,2003.0,2013.0,ALL
7593,MZF1,P28698,0.617,0.577,1.0667e-10,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.12,1.0,,2015.0,2019.0,ALL
7594,ZNF43,P17038,1.0,0.077,0.00050468,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
7596,ZNF45,Q02386,0.931,0.115,5.6996e-07,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
7597,ZBTB25,P24278,1.0,0.077,2.1949e-06,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
7618,ZNF726P1,Q15940,1.0,0.115,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
7620,ZNF69,Q9UC07,,,5.1561e-08,DTO_05007542,Transcription factor,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
7621,ZNF70,Q9UC06,0.89,0.192,0.0023729,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
7625,ZNF74,Q16587,0.839,0.423,1.5586e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2001.0,2002.0,ALL
7627,ZNF75A,Q96N20,1.0,0.077,0.0021966,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7629,ZNF76,P36508,1.0,0.077,4.764e-19,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2019.0,ALL
7634,ZNF80,P51504,0.89,0.115,,DTO_05007542,Transcription factor,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
7637,ZNF84,P51523,0.89,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
7639,ZNF85,Q03923,,,4.73e-05,,,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
7643,ZNF90,Q03938,1.0,,0.0029038,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
7644,ZNF91,Q05481,0.89,0.077,0.43919,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
7652,ZNF99,A8MXY4,0.931,0.115,0.02495,,,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
7675,ZNF121,P58317,0.89,0.077,0.39211,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
7678,ZNF124,Q15973,0.931,0.154,0.010911,DTO_05007542,Transcription factor,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
7681,MKRN3,Q13064,0.619,0.615,0.27756,DTO_05007624,Enzyme,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.4,1.0,,1989.0,2015.0,ALL
7686,MKRN7P,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
7690,ZNF131,P52739,0.805,0.231,0.99983,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
7691,ZNF132,P52740,0.89,0.192,1.0294e-12,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2012.0,2018.0,ALL
7692,ZNF133,P52736,0.931,0.154,0.0026035,DTO_05007542,Transcription factor,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2018.0,ALL
7693,ZNF134,P52741,1.0,0.115,1.2592e-07,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
7694,ZNF135,P52742,,,1.5569e-12,,,C0235031,Neurologic Symptoms,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",group,Sign or Symptom,0.01,1.0,,2017.0,2017.0,ALL
7695,ZNF136,P52737,0.931,0.038,0.00047939,,,C0001342,Acute periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
7699,ZNF140,P52738,,,1.1679e-06,,,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
7700,ZNF141,Q15928,0.792,0.154,0.10393,,,C3808889,"POLYDACTYLY, POSTAXIAL, TYPE A6",,,disease,Disease or Syndrome,0.6,1.0,limited,2013.0,2013.0,ALL
7701,ZNF142,P52746,0.861,0.192,4.8098e-16,DTO_05007542,Transcription factor,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.41,1.0,strong,2019.0,2019.0,ALL
7702,ZNF143,P52747,0.67,0.577,0.00024403,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
7703,PCGF2,P35227,0.579,0.615,0.86397,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.4,1.0,strong,2018.0,2018.0,ALL
7704,ZBTB16,Q05516,0.545,0.808,0.99907,DTO_05007542,Transcription factor,C2676231,"Skeletal Defects, Genital Hypoplasia, And Mental Retardation",C23;C16;C05;C12;C10;C19;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,limited,2008.0,2008.0,ALL
7705,ZNF146,Q15072,,,0.93205,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,1999.0,1999.0,ALL
7706,TRIM25,Q14258,0.633,0.462,0.0041202,,,C0002879,"Anemia, Hemolytic, Acquired",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
7707,ZNF148,Q9UQR1,0.615,0.654,0.99997,DTO_05007542,Transcription factor,C4310644,"GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES",,,disease,Disease or Syndrome,0.6,1.0,moderate,2016.0,2016.0,ALL
7709,ZBTB17,Q13105,0.674,0.385,0.97933,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
7710,ZNF154,Q13106,0.711,0.5,2.8224e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2011.0,2017.0,ALL
7711,ZNF155,Q12901,1.0,0.077,6.6195e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
7712,ZNF157,P51786,,,9.6717e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
7716,VEZF1,Q14119,0.821,0.115,0.99423,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,0.0,,2010.0,2010.0,ALL
7718,ZNF165,P49910,0.78,0.269,9.111e-09,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
7726,TRIM26,Q12899,0.705,0.577,0.17836,,,C0001807,Aggressive behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2014.0,2014.0,ALL
7727,ZNF174,Q15697,0.931,0.077,0.014823,,,C0085612,Ventricular arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
7728,ZNF175,Q9Y473,0.821,0.231,1.2701e-07,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
7730,ZNF177,Q13360,0.861,0.115,2.4711e-06,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
7732,RNF112,Q9ULX5,0.716,0.5,0.021835,DTO_05007584,Enzyme modulator,C0795864,Smith-Magenis syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0,,1997.0,1998.0,ALL
7737,RNF113A,O15541,0.597,0.769,0.88873,DTO_05007624,Enzyme,C4225420,"TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE",,,disease,Disease or Syndrome,0.6,1.0,limited,2013.0,2017.0,ALL
7738,ZNF184,Q99676,0.839,0.154,0.0036775,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
7739,ZNF185,O15231,0.711,0.5,6.3026e-13,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2003.0,2017.0,ALL
7741,ZSCAN26,Q16670,0.931,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
7743,ZNF189,O75820,0.805,0.115,0.0010884,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,1998.0,1999.0,ALL
7745,ZKSCAN8,Q15776,0.89,0.077,1.7574e-07,,,C0018995,Hemochromatosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,1995.0,1995.0,ALL
7746,ZSCAN9,O15535,1.0,0.038,1.7236e-11,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
7748,ZNF195,O14628,0.931,0.115,0.0038677,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
7750,ZMYM2,Q9UBW7,0.599,0.654,0.66648,DTO_05007584,Enzyme modulator,C0027022,Myeloproliferative disease,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.4,1.0,,1998.0,2016.0,ALL
7753,ZNF202,O95125,0.839,0.115,0.5263,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2006.0,2008.0,ALL
7755,ZNF205,O95201,0.89,0.115,0.032326,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
7756,ZNF207,O43670,1.0,0.038,0.1046,DTO_05007557,Nucleic acid binding,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
7757,ZNF208,O43345,0.769,0.231,5.6261e-05,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
7761,ZNF214,Q9UL59,0.839,0.231,1.1138e-17,,,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.02,0.5,,2003.0,2010.0,ALL
7762,ZNF215,Q9UL58,0.861,0.154,6.1857e-16,,,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.02,0.5,,2003.0,2010.0,ALL
7763,ZFAND5,O76080,0.861,0.192,0.84575,DTO_05007557,Nucleic acid binding,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
7764,ZNF217,O75362,0.617,0.538,0.99995,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2000.0,2015.0,ALL
7766,ZNF223,Q9UK11,,,9.9106e-06,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
7767,ZNF224,Q9NZL3,0.711,0.385,0.0031252,DTO_05007542,Transcription factor,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,2015.0,2018.0,ALL
7773,ZNF230,Q9UIE0,0.931,0.192,0.083152,,,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
7775,ZNF232,Q9UNY5,0.931,0.154,3.3651e-05,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
7776,ZNF236,Q9UL36,0.722,0.5,1.0,DTO_05007542,Transcription factor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
7779,SLC30A1,Q9Y6M5,0.659,0.5,0.98532,DTO_05007405,Transporter,C0022333,Jacksonian Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
7780,SLC30A2,Q9BRI3,0.821,0.192,0.080883,DTO_05007405,Transporter,C1842486,"Zinc Deficiency, Neonatal, due to Low Breast Milk Zinc",C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.65,0.833,,2006.0,2019.0,ALL
7781,SLC30A3,Q99726,0.691,0.423,0.5421,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2014.0,2016.0,ALL
7782,SLC30A4,O14863,0.705,0.385,0.11544,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.31,1.0,,2006.0,2006.0,ALL
7783,ZP2,Q05996,0.931,,6.2157e-08,,,C4014291,OOCYTE MATURATION DEFECT 1,,,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
7784,ZP3,P21754,0.805,0.115,0.00028508,,,C4540205,OOCYTE MATURATION DEFECT 3,,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
7786,MAP3K12,Q12852,0.7,0.346,1.0,DTO_03300101,Kinase,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
7791,ZYX,Q15942,0.674,0.346,2.0307e-10,DTO_05007584,Enzyme modulator,C0200641,Blood basophil count (lab test),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
7792,CCV,,0.931,0.192,,,,C0008149,Chlamydia Infections,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
7795,MEMO1,,0.792,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
7798,LUZP1,Q86V48,1.0,0.077,0.52955,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
7799,PRDM2,Q13029,0.545,0.769,0.99996,,,C0040136,Thyroid Neoplasm,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2006.0,2006.0,ALL
7802,DNALI1,O14645,0.674,0.615,4.1201e-11,DTO_05007530,Cellular structure,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
7803,PTP4A1,Q93096,0.711,0.385,0.28236,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2015.0,ALL
7804,LRP8,Q14114,0.644,0.346,0.99983,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.37,1.0,,2007.0,2018.0,ALL
7805,LAPTM5,Q13571,0.751,0.462,0.90044,DTO_05007405,Transporter,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
7808,AIR,,0.792,0.269,,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,1999.0,2005.0,ALL
7809,BSND,Q8WZ55,0.603,0.692,1.0949e-10,,,C1865270,"BARTTER SYNDROME, TYPE 4A",C23;C13;C12;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.91,1.0,definitive,1998.0,2017.0,ALL
7812,CSDE1,O75534,0.769,0.308,1.0,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,strong,2014.0,2019.0,ALL
7813,EVI5,O60447,0.743,0.346,1.9654e-11,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.16,1.0,,2008.0,2017.0,ALL
7818,DAP3,P51398,0.686,0.385,1.1143e-09,DTO_05007557,Nucleic acid binding,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.42,1.0,,2011.0,2017.0,ALL
7824,D1S111,,0.931,0.115,,,,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,1992.0,1992.0,ALL
7827,NPHS2,Q9NP85,0.576,0.538,7.2218e-09,DTO_05007584,Enzyme modulator,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.7,1.0,,1995.0,2019.0,ALL
7830,PHA2A,,0.931,0.192,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0,,2005.0,2013.0,ALL
7832,BTG2,P78543,0.587,0.538,0.019033,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.38,1.0,,2008.0,2019.0,ALL
7834,PCAP,,0.76,0.231,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.913,,2000.0,2019.0,ALL
7837,PXDN,Q92626,0.647,0.5,2.5126e-07,DTO_05007624,Enzyme,C3151617,ANTERIOR SEGMENT DYSGENESIS 7,,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2015.0,ALL
7839,LEPQTL1,,0.638,0.385,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2011.0,2020.0,ALL
7840,ALMS1,Q8TCU4,0.559,0.808,4.4999e-60,,,C0268425,Alstrom Syndrome,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1998.0,2020.0,ALL
7841,MOGS,Q13724,0.626,0.731,5.8071e-11,,,C1853736,"Congenital Disorder Of Glycosylation, Type IIB",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,strong,1973.0,2019.0,ALL
7844,RNF103,O00237,0.821,0.154,0.89697,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
7846,TUBA1A,Q71U36,0.597,0.769,0.96654,DTO_05007530,Cellular structure,C1969029,Lissencephaly 3,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,,2007.0,2018.0,ALL
7849,PAX8,Q06710,0.477,0.731,0.99869,,,C1869118,"HYPOTHYROIDISM, CONGENITAL, DUE TO THYROID DYSGENESIS",C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.71,1.0,strong,1998.0,2019.0,ALL
7850,IL1R2,P27930,0.593,0.846,6.5372e-15,DTO_05007575,Receptor,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2011.0,2018.0,ALL
7851,MALL,Q13021,0.821,0.154,0.23241,DTO_05007405,Transporter,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
7852,CXCR4,P61073,0.362,0.923,0.017804,DTO_02300001,G-protein coupled receptor,C0472817,WHIM syndrome,C16;C01;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Infections;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,1.0,1.0,strong,2000.0,2019.0,ALL
7855,FZD5,Q13467,0.587,0.615,0.98255,DTO_02300001,G-protein coupled receptor,C0155299,Coloboma of optic disc,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
7857,SCG2,P13521,0.628,0.615,2.1176e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,1997.0,2019.0,ALL
7862,BRPF1,P55201,0.686,0.385,1.0,,,C4310617,INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS,,,disease,Disease or Syndrome,0.71,1.0,moderate,2017.0,2019.0,ALL
7864,SCLC1,,0.612,0.577,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2002.0,2019.0,ALL
7866,IFRD2,Q12894,1.0,0.038,1.098e-09,,,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
7867,MAPKAPK3,Q16644,0.743,0.308,3.7216e-09,DTO_03300101,Kinase,C4310713,"MACULAR DYSTROPHY, PATTERNED, 3",,,disease,Disease or Syndrome,0.51,1.0,,2016.0,2016.0,ALL
7869,SEMA3B,Q13214,0.633,0.615,,DTO_05007599,Signaling,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
7871,SLMAP,Q14BN4,0.686,0.462,0.99976,DTO_05007613,Chaperone,C1142166,Brugada Syndrome (disorder),C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.51,1.0,disputed,1997.0,2012.0,ALL
7873,MANF,P55145,0.621,0.654,0.0013911,,,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.2,1.0,,2010.0,2010.0,ALL
7874,USP7,Q93009,0.538,0.808,1.0,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,2008.0,2018.0,ALL
7879,RAB7A,P51149,0.597,0.692,0.96933,,,C1833219,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,2003.0,2019.0,ALL
7880,MBS2,,0.931,0.115,,,,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
7881,KCNAB1,Q14722,0.821,0.115,0.042256,DTO_01300327,Ion channel,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0,,2001.0,2001.0,ALL
7884,SLBP,Q14493,0.653,0.654,0.068148,DTO_05007557,Nucleic acid binding,C0009363,Congenital ocular coloboma (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.3,1.0,,2019.0,2019.0,ALL
7885,CRSA,,0.89,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
7889,PSORS3,,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
7895,LAG5,,,,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
7903,ST8SIA4,Q92187,0.546,0.846,0.00040145,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2006.0,2013.0,ALL
7905,REEP5,Q00765,0.633,0.615,0.00069737,DTO_05007405,Transporter,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
7908,EOS,,0.666,0.538,,,,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.04,0.75,,2018.0,2020.0,ALL
7909,HEMC,,0.89,0.115,,,,C0008479,Chondrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
7910,PFBI,,1.0,0.038,,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,1998.0,1998.0,ALL
7913,DEK,P35659,0.542,0.769,0.13065,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,2007.0,2019.0,ALL
7915,ALDH5A1,P51649,0.619,0.462,3.0504e-07,DTO_05007624,Enzyme,C0268631,succinic semialdehyde dehydrogenase deficiency,C16;C18;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Mental Disorders",disease,Disease or Syndrome,0.8,1.0,strong,2000.0,2019.0,ALL
7916,PRRC2A,P48634,0.656,0.654,1.0,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7917,BAG6,P46379,0.674,0.615,1.0,DTO_05007584,Enzyme modulator,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
7918,GPANK1,O95872,0.769,0.385,3.2444e-07,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
7919,DDX39B,Q13838,0.641,0.808,0.99725,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.13,1.0,,2001.0,2011.0,ALL
7920,ABHD16A,O95870,0.861,0.269,0.47336,DTO_05007624,Enzyme,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
7921,D6S207E,,1.0,0.038,,,,C0018133,Graft-vs-Host Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
7922,SLC39A7,Q92504,0.743,0.385,0.082078,DTO_05007405,Transporter,C0001768,Agammaglobulinemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.3,1.0,,2019.0,2019.0,ALL
7923,HSD17B8,Q92506,0.805,0.346,3.6923e-05,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
7932,OR2H2,O95918,1.0,0.115,1.9104e-05,DTO_02300001,G-protein coupled receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
7933,OPLL,,0.861,0.154,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
7936,NELFE,P18615,0.686,0.5,0.006895,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.12,0.667,,1997.0,2011.0,ALL
7937,RWS,,0.805,0.192,,,,C0022387,Jervell-Lange Nielsen Syndrome,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,1.0,,2006.0,2017.0,ALL
7938,CP20,,0.821,0.269,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,1996.0,1998.0,ALL
7939,LAP,,0.619,0.731,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
7940,LST1,O00453,0.792,0.308,0.0011303,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.13,1.0,,2006.0,2016.0,ALL
7941,PLA2G7,Q13093,0.537,0.769,5.3314e-22,DTO_05007624,Enzyme,C3280315,Platelet-Activating Factor Acetylhydrolase Deficiency,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,1.0,,1996.0,1998.0,ALL
7942,TFEB,P19484,0.527,0.731,0.89931,,,C4518356,MiT family translocation renal cell carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.37,1.0,,2003.0,2019.0,ALL
7945,PUJO,,0.821,0.154,,,,C0020295,Hydronephrosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.05,1.0,,1998.0,2018.0,ALL
7948,PBCRA1,,0.931,0.077,,,,C1833321,"CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
7952,TNDM,,0.89,0.077,,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2008.0,2014.0,ALL
7954,HBFQTL2,,0.7,0.192,,,,C0005283,beta Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,0.9,,1979.0,2018.0,ALL
7955,RNF217-AS1,,0.839,0.192,,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
7956,NTT,,0.743,0.462,,,,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
7957,EPM2A,O95278,0.608,0.577,8.7182e-06,,,C0751783,Lafora Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.965,,1998.0,2020.0,ALL
7962,PBCA,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
7965,AIMP2,Q13155,0.393,0.923,0.008024,,,C4693912,"LEUKODYSTROPHY, HYPOMYELINATING, 17",,,disease,Disease or Syndrome,0.4,1.0,moderate,2016.0,2018.0,ALL
7971,GHS,,0.659,0.615,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2018.0,ALL
7974,HRX,,0.695,0.192,,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,1993.0,2005.0,ALL
7975,MAFK,O60675,0.592,0.654,0.71128,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
7976,FZD3,Q9NPG1,0.659,0.577,0.00043561,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.4,,2003.0,2016.0,ALL
7977,MHS3,,0.931,0.038,,,,C0024591,Malignant hyperpyrexia due to anesthesia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
7978,MTERF1,Q99551,0.839,0.346,8.6123e-07,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
7979,SEM1,P60896,0.633,0.538,0.018168,,,C2931019,Split hand foot deformity 1,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.35,1.0,limited,1994.0,2009.0,ALL
7980,TFPI2,P48307,0.521,0.769,0.00084274,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
7982,ST7,Q9NRC1,0.743,0.192,0.99703,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
7984,ARHGEF5,Q12774,0.526,0.808,7.5872e-14,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2007.0,2018.0,ALL
7986,GPDS1,,1.0,0.038,,,,C1271398,Pigment dispersion syndrome (disorder),C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
7991,TUSC3,Q13454,0.576,0.615,3.4606e-06,DTO_05007405,Transporter,C1970197,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.6,1.0,strong,2011.0,2016.0,ALL
7994,KAT6A,Q92794,0.56,0.769,1.0,DTO_05007624,Enzyme,C4225396,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 32",,,disease,Mental or Behavioral Dysfunction,0.7,1.0,strong,2015.0,2019.0,ALL
8000,PSCA,O43653,0.555,0.615,0.16856,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.5,1.0,,2001.0,2019.0,ALL
8001,GLRA3,O75311,0.711,0.462,1.7764e-05,DTO_01300327,Ion channel,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
8011,MROS,,0.861,0.077,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
8013,NR4A3,Q92570,0.502,0.808,0.9126,DTO_00102000,Nuclear receptor,C1275278,Extraskeletal Myxoid Chondrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.6,1.0,,1998.0,2019.0,ALL
8019,BRD3,Q15059,0.7,0.5,0.97468,DTO_05007378,Epigenetic regulator,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
8021,NUP214,P35658,0.638,0.385,0.054748,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.5,1.0,,1999.0,2019.0,ALL
8022,LHX3,Q9UBR4,0.644,0.462,0.010863,DTO_05007557,Nucleic acid binding,C3489787,"Pituitary Hormone Deficiency, Combined, 3",C23;C05;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.71,1.0,,2000.0,2017.0,ALL
8026,DGS2,,0.839,0.423,,,,C0012236,DiGeorge Syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,1.0,,1998.0,2011.0,ALL
8027,STAM,Q92783,0.736,0.269,0.85048,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
8028,MLLT10,P55197,0.551,0.462,1.0,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.5,0.958,,1995.0,2019.0,ALL
8029,CUBN,O60494,0.587,0.769,4.6292e-42,,,C4551825,Megaloblastic Anemia 1,C23;C06;C18;C13;C12;C15,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.95,strong,1998.0,2020.0,ALL
8030,CCDC6,Q16204,0.517,0.808,0.57714,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.6,0.988,,1989.0,2020.0,ALL
8031,NCOA4,Q13772,0.619,0.577,2.2037e-06,DTO_05007542,Transcription factor,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.4,1.0,,1994.0,2019.0,ALL
8034,SLC25A16,P16260,0.682,0.269,1.2089e-06,DTO_05007405,Transporter,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
8036,SHOC2,Q9UQ13,0.593,0.769,0.99946,,,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,0.957,disputed,2009.0,2019.0,ALL
8038,ADAM12,O43184,0.565,0.731,5.7284e-07,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2008.0,2018.0,ALL
8039,PROA,,1.0,0.115,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
8045,RASSF7,Q02833,0.621,0.538,2.252e-11,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1993.0,2018.0,ALL
8048,CSRP3,P50461,0.572,0.731,0.00015859,DTO_05007530,Cellular structure,C1843808,"CARDIOMYOPATHY, DILATED, 1M",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.9,1.0,,1997.0,2019.0,ALL
8050,PDHX,O00330,0.595,0.692,9.7242e-05,DTO_05007624,Enzyme,C1855553,Pyruvate Dehydrogenase E3-Binding Protein Deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,1997.0,2015.0,ALL
8056,ECB2,,0.805,0.308,,,,C0002878,"Anemia, Hemolytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
8061,FOSL1,P15407,0.519,0.846,0.15849,DTO_05007542,Transcription factor,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2005.0,2005.0,ALL
8065,CUL5,Q93034,0.691,0.577,1.0,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2003.0,2019.0,ALL
8066,ANC,,0.736,0.385,,,,C0023530,Leukopenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.05,1.0,,2017.0,2019.0,ALL
8068,BRCATA,,,,,,,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
8073,PTP4A2,Q12974,0.695,0.423,0.96626,,,C1135196,"Heart Failure, Diastolic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
8074,FGF23,Q9GZV9,0.46,0.731,0.031014,DTO_05007599,Signaling,C0342642,Autosomal dominant hypophosphatemic rickets,C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,1.0,strong,2000.0,2020.0,ALL
8076,MFAP5,Q13361,0.59,0.615,0.0050619,,,C4015368,"AORTIC ANEURYSM, FAMILIAL THORACIC 9",,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2016.0,ALL
8078,USP5,P45974,0.67,0.577,0.96396,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
8079,MLF2,Q15773,0.792,0.231,0.86042,DTO_05007599,Signaling,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
8081,AD5,,0.769,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2002.0,2005.0,ALL
8082,SSPN,Q14714,0.716,0.462,0.039646,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
8085,KMT2D,O14686,0.465,0.808,1.0,,,C0796004,Kabuki make-up syndrome,C16;C09;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Otorhinolaryngologic Diseases;    Hemic and Lymphatic Diseases",disease,Congenital Abnormality,1.0,0.989,,1997.0,2020.0,ALL
8086,AAAS,Q9NRG9,0.601,0.654,2.4356e-13,,,C0271742,Glucocorticoid deficiency with achalasia,C06;C19,   Digestive System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.8,0.98,,2000.0,2019.0,ALL
8087,FXR1,P51114,0.656,0.615,1.0,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
8089,YEATS4,O95619,0.666,0.231,7.464e-05,DTO_05007557,Nucleic acid binding,C0023827,liposarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2008.0,2010.0,ALL
8090,SPPM,,1.0,0.038,,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
8091,HMGA2,P52926,0.429,0.808,0.87015,DTO_05007557,Nucleic acid binding,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.5,0.978,,1996.0,2020.0,ALL
8092,ALX1,Q15699,0.636,0.462,0.17618,,,C3150706,FRONTONASAL DYSPLASIA 3,,,disease,Disease or Syndrome,0.6,1.0,,2010.0,2016.0,ALL
8093,MGCT,,1.0,0.038,,,,C0206660,Germinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
8094,SMAL,,,,,,,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2014.0,2014.0,ALL
8099,CDK2AP1,O14519,0.656,0.538,0.44839,DTO_05007584,Enzyme modulator,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
8100,IFT88,Q13099,0.621,0.654,7.1224e-11,,,C0085548,Autosomal Recessive Polycystic Kidney Disease,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.53,1.0,,1994.0,2009.0,ALL
8101,CLLS2,,0.678,0.346,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,1993.0,2012.0,ALL
8102,XRS,,0.716,0.5,,,,C0004135,Ataxia Telangiectasia,C16;C18;C20;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.04,0.75,,1989.0,2014.0,ALL
8106,PABPN1,Q86U42,0.674,0.423,0.39216,,,C0270952,"Muscular Dystrophy, Oculopharyngeal",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.979,limited,1998.0,2020.0,ALL
8110,DPF3,Q92784,0.751,0.462,0.020501,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
8111,GPR68,Q15743,0.65,0.462,0.00049976,DTO_02300001,G-protein coupled receptor,C4310665,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA6",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
8113,MCOP1,,1.0,0.077,,,,C0026010,Microphthalmos,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0,,2009.0,2009.0,ALL
8114,IV,,1.0,0.077,,,,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
8115,TCL1A,P56279,0.558,0.5,5.7357e-10,,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.31,1.0,,2014.0,2014.0,ALL
8120,AP3B2,Q13367,0.691,0.346,0.77198,DTO_05007405,Transporter,C4310637,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2016.0,ALL
8123,PWAR5,,0.89,0.192,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.03,0.667,,1996.0,1996.0,ALL
8125,ANP32A,P39687,0.674,0.577,0.98961,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2015.0,2017.0,ALL
8128,ST8SIA2,Q92186,0.674,0.538,0.058099,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.8,,2006.0,2020.0,ALL
8129,HBHR,,0.711,0.577,,,,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2009.0,2015.0,ALL
8130,MCOPCT1,,0.931,0.077,,,,C0026010,Microphthalmos,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0,,2000.0,2000.0,ALL
8131,NPRL3,Q12980,0.678,0.385,0.19021,,,C4310708,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2016.0,ALL
8136,WT3,,0.861,0.192,,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,1991.0,1991.0,ALL
8139,GAN,Q9H2C0,0.674,0.5,0.024842,,,C1850386,GIANT AXONAL NEUROPATHY 1,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.968,,2000.0,2020.0,ALL
8140,SLC7A5,Q01650,0.513,0.808,0.23505,DTO_05007405,Transporter,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.33,1.0,,2010.0,2019.0,ALL
8144,CMS1A1,,0.931,0.154,,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
8148,TAF15,Q92804,0.626,0.5,0.16517,DTO_05007557,Nucleic acid binding,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,0.929,limited,2011.0,2019.0,ALL
8151,WT4,,0.821,0.154,,,,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.07,1.0,,1997.0,2005.0,ALL
8153,RND2,P52198,1.0,0.038,0.00038579,DTO_05007584,Enzyme modulator,C1096063,Drug Resistant Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
8161,COIL,P38432,0.617,0.654,0.009434,DTO_05007557,Nucleic acid binding,C0206180,Ki-1+ Anaplastic Large Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,0.833,,1996.0,2002.0,ALL
8163,CDR3,,0.472,0.808,,,,C1865782,CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3,,,phenotype,Finding,0.3,,,,,ALL
8165,AKAP1,Q92667,0.678,0.577,0.74238,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
8170,SLC14A2,Q15849,0.606,0.692,1.0646e-17,DTO_05007405,Transporter,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.12,1.0,,2014.0,2017.0,ALL
8173,CNSN,,1.0,0.077,,,,C0497327,Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2007.0,2007.0,ALL
8174,MADCAM1,Q13477,0.67,0.5,0.53462,,,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2006.0,2018.0,ALL
8175,SF3A2,Q15428,1.0,0.077,0.88315,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
8178,ELL,P55199,0.7,0.308,0.98542,DTO_05007527,Cell-cell junction,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2013.0,2019.0,ALL
8181,BFIS1,,0.805,0.115,,,,C0220669,Familial benign neonatal epilepsy,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.08,1.0,,1997.0,2014.0,ALL
8184,HBN1,,1.0,0.115,,,,C0027859,Acoustic Neuroma,C04;C10;C09,   Neoplasms;    Nervous System Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
8187,ZNF239,Q16600,1.0,0.077,2.0543e-07,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
8189,SYMPK,Q92797,0.7,0.231,1.0,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
8190,MIA,Q16674,0.537,0.769,1.7345e-05,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2005.0,2006.0,ALL
8192,CLPP,Q16740,0.722,0.423,0.57106,,,C3808414,PERRAULT SYNDROME 3,,,disease,Disease or Syndrome,0.91,1.0,definitive,1995.0,2018.0,ALL
8193,DPF1,Q92782,0.839,0.038,0.99049,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
8195,MKKS,Q9NPJ1,0.566,0.692,2.1265e-09,,,C1858054,BARDET-BIEDL SYNDROME 6,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,,2000.0,2017.0,ALL
8200,GDF5,P43026,0.511,0.692,0.67002,DTO_05007599,Signaling,C1862103,Brachydactyly type C,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,1.0,0.923,,1989.0,2016.0,ALL
8201,MLRL,,0.564,0.769,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
8202,NCOA3,Q9Y6Q9,0.522,0.654,0.54065,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,0.909,,1996.0,2020.0,ALL
8204,NRIP1,P48552,0.592,0.654,0.99394,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.46,1.0,,1999.0,2018.0,ALL
8205,TAM,,0.528,0.731,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.957,,2003.0,2019.0,ALL
8208,CHAF1B,Q13112,0.663,0.538,0.42768,DTO_05007557,Nucleic acid binding,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
8209,GATD3A,A0A0B4J2D5;P0DPI2,0.619,0.654,2.9727e-05,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.13,1.0,,2010.0,2018.0,ALL
8213,BAS,,0.711,0.346,,,,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.05,1.0,,2012.0,2019.0,ALL
8214,DGCR6,Q14129,0.695,0.5,9.8176e-12,,,C0012236,DiGeorge Syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.35,1.0,,1996.0,2010.0,ALL
8215,DVL1P1,P54792,0.716,0.423,,DTO_05007599,Signaling,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0,,2003.0,2010.0,ALL
8216,LZTR1,Q8N653,0.547,0.808,1.0211e-92,,,C4225280,NOONAN SYNDROME 10,,,disease,Disease or Syndrome,0.91,1.0,,2006.0,2019.0,ALL
8218,CLTCL1,P53675,0.821,0.192,2.5101e-37,DTO_05007405,Transporter,C0002768,Congenital Pain Insensitivity,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,limited,2015.0,2015.0,ALL
8220,ESS2,Q96DF8,0.67,0.615,2.4382e-07,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2002.0,2006.0,ALL
8224,SYN3,O14994,0.686,0.462,0.0018871,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.5,,2000.0,2009.0,ALL
8225,GTPBP6,O43824,1.0,0.038,1.1591e-07,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
8226,PUDP,Q08623,0.78,0.231,0.12667,DTO_05007624,Enzyme,C0201983,Dehydroepiandrosterone sulfate measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
8227,AKAP17A,Q02040,0.861,0.192,0.50167,,,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
8228,PNPLA4,P41247,0.89,0.038,0.0025724,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,0.0,,2019.0,2019.0,ALL
8231,CND,,0.821,0.308,,,,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.01,1.0,,1981.0,1981.0,ALL
8233,ZRSR2,Q15696,0.751,0.231,0.99963,DTO_05007557,Nucleic acid binding,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.58,1.0,,2012.0,2020.0,ALL
8237,USP11,P51784,0.691,0.654,0.99996,DTO_05007624,Enzyme,C0006267,Bronchiectasis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
8239,USP9X,Q93008,0.502,0.846,1.0,,,C3806746,"MENTAL RETARDATION, X-LINKED 99",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2016.0,ALL
8241,RBM10,P98175,0.599,0.615,1.0,,,C1839463,TARP syndrome,C16;C05;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.77,1.0,,1970.0,2018.0,ALL
8242,KDM5C,P41229,0.581,0.538,1.0,,,C1845243,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,,2000.0,2018.0,ALL
8243,SMC1A,Q14683,0.509,0.808,1.0,,,C1802395,Congenital muscular hypertrophy-cerebral syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.73,1.0,,2006.0,2019.0,ALL
8260,NAA10,P41227,0.535,0.692,0.76179,DTO_05007624,Enzyme,C3275447,Ogden syndrome,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.78,1.0,strong,2011.0,2019.0,ALL
8263,F8A1,P23610,0.89,0.269,,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.04,1.0,,2001.0,2019.0,ALL
8266,UBL4A,P11441,0.656,0.577,0.29855,,,C2939465,Deficiency of glucose-6-phosphate dehydrogenase,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,1.0,,1971.0,2017.0,ALL
8269,TMEM187,Q14656,0.839,0.231,0.015717,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2012.0,2017.0,ALL
8270,LAGE3,Q14657,0.67,0.462,0.12721,,,C4538784,"GALLOWAY-MOWAT SYNDROME 2, X-LINKED",,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
8277,TKTL1,P51854,0.608,0.654,0.99933,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2006.0,2019.0,ALL
8284,KDM5D,Q9BY66,0.7,0.423,0.92793,DTO_05007542,Transcription factor,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",C16;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
8287,USP9Y,O00507,0.743,0.269,5.7399e-05,,,C1507149,Partial chromosome Y deletion,C23;C16;C13;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,1999.0,2012.0,ALL
8288,EPX,P11678,0.653,0.538,2.2664e-20,DTO_05007624,Enzyme,C1850000,Presentey Anomaly,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.6,1.0,,1994.0,1994.0,ALL
8289,ARID1A,O14497,0.455,0.846,1.0,,,C0265338,Coffin-Siris syndrome,C23;C16;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.73,1.0,strong,2012.0,2019.0,ALL
8290,H3-4,Q16695,0.711,0.538,1.6542e-05,,,C0032273,Pneumoconiosis,C08;C24,   Respiratory Tract Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.31,1.0,,2015.0,2015.0,ALL
8291,DYSF,O75923,0.582,0.692,3.6528e-33,DTO_05007405,Transporter,C1850889,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.992,,1989.0,2019.0,ALL
8292,COLQ,Q9Y215,0.628,0.654,7.9356e-14,,,C1864233,ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY (disorder),C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,,1998.0,2018.0,ALL
8293,SERF1A,O75920,0.89,0.115,,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.06,1.0,,1998.0,2016.0,ALL
8294,H4C9,P62805,0.541,0.692,0.015809,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2005.0,2019.0,ALL
8295,TRRAP,Q9Y4A5,0.572,0.692,1.0,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.5,1.0,,2011.0,2011.0,ALL
8301,PICALM,Q13492,0.592,0.538,0.99896,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.5,0.947,,2009.0,2019.0,ALL
8302,KLRC4,O43908,0.666,0.654,0.0056771,,,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.63,1.0,,2013.0,2017.0,ALL
8309,ACOX2,Q99424,0.769,0.423,2.1841e-10,DTO_05007624,Enzyme,C4310624,"BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6",,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2017.0,ALL
8310,ACOX3,O15254,0.805,0.154,7.6016e-16,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
8312,AXIN1,O15169,0.559,0.577,0.40765,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.8,0.944,,2000.0,2019.0,ALL
8313,AXIN2,Q9Y2T1,0.507,0.692,0.57015,,,C1837750,Oligodontia-Colorectal Cancer Syndrome,C16;C06;C04;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Stomatognathic Diseases",disease,Neoplastic Process,0.71,1.0,moderate,2004.0,2017.0,ALL
8314,BAP1,Q92560,0.454,0.731,0.99443,DTO_05007624,Enzyme,C0151779,Cutaneous Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.8,0.955,strong,2012.0,2019.0,ALL
8315,BRAP,Q7Z569,0.612,0.769,3.7512e-06,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.45,0.857,,2009.0,2015.0,ALL
8317,CDC7,O00311,0.641,0.462,4.4296e-06,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2008.0,2019.0,ALL
8318,CDC45,O75419,0.588,0.692,4.6237e-05,DTO_05007557,Nucleic acid binding,C4310738,MEIER-GORLIN SYNDROME 7,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2016.0,ALL
8320,EOMES,O95936,0.619,0.692,0.98443,DTO_05007542,Transcription factor,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2012.0,2015.0,ALL
8321,FZD1,Q9UP38,0.587,0.615,0.042428,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2007.0,2019.0,ALL
8322,FZD4,Q9ULV1,0.49,0.923,0.96962,DTO_02300001,G-protein coupled receptor,C1851402,Exudative vitreoretinopathy 1,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.74,1.0,moderate,2002.0,2017.0,ALL
8323,FZD6,O60353,0.623,0.615,2.0034e-12,DTO_02300001,G-protein coupled receptor,C3279974,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2011.0,ALL
8324,FZD7,O75084,0.601,0.538,0.08835,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2001.0,2019.0,ALL
8325,FZD8,Q9H461,0.674,0.385,0.78983,DTO_02300001,G-protein coupled receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
8326,FZD9,O00144,0.743,0.308,0.0019309,DTO_02300001,G-protein coupled receptor,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.24,1.0,,1999.0,2011.0,ALL
8328,GFI1B,Q5VTD9,0.623,0.5,0.00052334,,,C1861194,"Thrombasthenia-Thrombocytopenia, Hereditary",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.71,1.0,definitive,2002.0,2019.0,ALL
8329,H2AC13,P0C0S8,0.839,0.192,0.029517,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
8330,H2AC15,P0C0S8,0.839,0.192,0.00010432,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
8331,H2AC14,Q99878,0.931,0.077,0.0237,DTO_05007557,Nucleic acid binding,C0677607,Hashimoto Disease,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2001.0,2008.0,ALL
8332,H2AC16,P0C0S8,0.821,0.192,0.00079028,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
8333,H2AC10P,,1.0,0.038,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
8334,H2AC6,Q93077,0.821,0.269,0.5964,DTO_05007557,Nucleic acid binding,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
8335,H2AC4,P04908,0.89,0.154,0.00057284,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2013.0,ALL
8336,H2AC17,P0C0S8,0.839,0.192,5.4464e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
8337,H2AC18,Q6FI13,0.89,0.115,,,,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
8338,H2AC20,Q16777,0.839,0.154,0.18727,DTO_05007557,Nucleic acid binding,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
8339,H2BC8,P58876;P62807,0.769,0.231,,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
8341,H2BC15,Q99877,0.861,0.192,0.00049469,DTO_05007557,Nucleic acid binding,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
8342,H2BC14,Q99879,0.931,0.077,5.0487e-06,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
8343,H2BC7,P58876;P62807,0.861,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
8344,H2BC6,P58876;P62807,0.839,0.192,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2015.0,2017.0,ALL
8345,H2BC9,Q93079,1.0,0.038,3.8304e-06,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
8346,H2BC10,P58876;P62807,0.861,0.154,,,,C0003504,Aortic Valve Insufficiency,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
8347,H2BC4,P58876;P62807,0.76,0.269,0.0038196,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2008.0,2015.0,ALL
8348,H2BC17,P23527,1.0,0.077,0.00045605,DTO_05007557,Nucleic acid binding,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
8349,H2BC21,Q16778,0.792,0.154,0.54518,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
8350,H3C1,P68431,0.67,0.308,6.293e-07,,,C2750850,GLIOMA SUSCEPTIBILITY 1,,,phenotype,Finding,0.3,1.0,,2012.0,2012.0,ALL
8351,H3C4,P68431,0.67,0.308,0.00113,,,C2986658,Diffuse Intrinsic Pontine Glioma,,,disease,Neoplastic Process,0.05,1.0,,2014.0,2020.0,ALL
8352,H3C3,P68431,0.67,0.308,0.26064,,,C2986658,Diffuse Intrinsic Pontine Glioma,,,disease,Neoplastic Process,0.05,1.0,,2014.0,2020.0,ALL
8353,H3C6,P68431,0.666,0.346,1.4382e-06,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
8354,H3C11,P68431,0.663,0.308,0.0084746,,,C0677865,Brain Stem Glioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
8355,H3C8,P68431,0.67,0.308,1.1617e-06,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
8356,H3C12,P68431,0.666,0.385,0.60556,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
8357,H3C10,P68431,0.67,0.308,0.0057387,,,C2986658,Diffuse Intrinsic Pontine Glioma,,,disease,Neoplastic Process,0.05,1.0,,2014.0,2020.0,ALL
8358,H3C2,P68431,0.653,0.423,1.4796e-05,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.33,1.0,,2012.0,2018.0,ALL
8359,H4C1,P62805,0.541,0.692,0.00020556,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2018.0,2019.0,ALL
8360,H4C4,P62805,0.537,0.692,0.0019851,,,C0022336,Creutzfeldt-Jakob disease,C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
8361,H4C6,P62805,0.541,0.692,0.13072,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2005.0,2019.0,ALL
8362,H4C12,P62805,0.541,0.692,0.0015737,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2005.0,2019.0,ALL
8363,H4C11,P62805,0.541,0.692,0.38683,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2005.0,2019.0,ALL
8364,H4C3,P62805,0.534,0.731,0.00035964,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.32,1.0,,2017.0,2019.0,ALL
8365,H4C8,P62805,0.541,0.692,7.1537e-06,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,0.75,,2009.0,2014.0,ALL
8366,H4C2,P62805,0.537,0.731,0.0029154,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2019.0,ALL
8367,H4C5,P62805,0.541,0.692,0.013453,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2005.0,2019.0,ALL
8368,H4C13,P62805,0.541,0.692,0.00034971,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2005.0,2019.0,ALL
8370,H4C14,P62805,0.541,0.692,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2005.0,2019.0,ALL
8372,HYAL3,O43820,0.769,0.192,3.8292e-07,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2005.0,2019.0,ALL
8378,LOH19CR1,,0.569,0.808,,,,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,1998.0,2020.0,ALL
8379,MAD1L1,Q9Y6D9,0.57,0.731,6.8444e-16,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.44,1.0,,2011.0,2020.0,ALL
8382,NME5,P56597,0.805,0.385,0.00067197,DTO_03300101,Kinase,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.21,1.0,,2012.0,2019.0,ALL
8388,OR1E2,P47887,1.0,0.077,0.0015619,DTO_02300001,G-protein coupled receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
8394,PIP5K1A,Q99755,0.76,0.269,0.0020938,DTO_03300101,Kinase,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2020.0,ALL
8395,PIP5K1B,O14986,0.769,0.462,1.368e-07,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.11,1.0,,2017.0,2017.0,ALL
8396,PIP4K2B,P78356,0.89,0.115,0.99837,DTO_03300101,Kinase,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
8398,PLA2G6,O60733,0.476,0.846,2.4837e-10,DTO_05007584,Enzyme modulator,C0270724,Infantile Neuroaxonal Dystrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,1.0,1.0,,2004.0,2020.0,ALL
8399,PLA2G10,O15496,0.581,0.692,0.069507,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,1999.0,2018.0,ALL
8402,SLC25A11,Q02978,0.666,0.615,0.53487,DTO_05007405,Transporter,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
8403,SOX14,O95416,0.805,0.231,0.85558,DTO_05007542,Transcription factor,C0221060,Mobius Syndrome,C16;C10;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.02,1.0,,1998.0,2000.0,ALL
8404,SPARCL1,Q14515,0.604,0.615,5.6374e-10,DTO_05007599,Signaling,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
8405,SPOP,O43791,0.597,0.5,0.99922,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.7,0.957,,2012.0,2020.0,ALL
8406,SRPX,P78539,0.653,0.577,0.0030756,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
8407,TAGLN2,P37802,0.604,0.577,0.0093548,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2005.0,2016.0,ALL
8408,ULK1,O75385,0.564,0.769,0.99318,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
8409,UXT,Q9UBK9,0.792,0.308,0.86302,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.36,1.0,,2004.0,2019.0,ALL
8410,RPS9P1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
8411,EEA1,Q15075,0.89,0.077,0.92875,DTO_05007405,Transporter,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
8412,BCAR3,O75815,0.695,0.654,0.58213,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.923,,2003.0,2018.0,ALL
8416,ANXA9,O76027,0.839,0.115,2.9752e-17,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2017.0,ALL
8417,STX7,O15400,0.821,0.231,5.0273e-06,DTO_05007405,Transporter,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,1.0,,2016.0,2016.0,ALL
8418,CMAHP,Q9Y471,0.805,0.346,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
8419,BFSP2,Q13515,0.686,0.385,3.2152e-08,,,C3808115,"CATARACT 12, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.6,1.0,,2000.0,2004.0,ALL
8420,SNHG3,,0.682,0.385,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2016.0,2020.0,ALL
8422,MEHMO,,0.89,0.269,,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.04,1.0,,1998.0,2018.0,ALL
8424,BBOX1,O75936,0.839,0.462,2.094e-12,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
8425,LTBP4,Q8N2S1,0.604,0.654,0.49911,DTO_05007616,Calcium-binding protein,C2750804,"Cutis Laxa With Severe Pulmonary, Gastrointestinal, And Urinary Abnormalities",C16;C06;C13;C17;C05;C12;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2009.0,2015.0,ALL
8427,ZNF282,Q9UDV7,0.931,0.115,0.16317,DTO_05007542,Transcription factor,C0023492,"Leukemia, T-Cell",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1999.0,1999.0,ALL
8428,STK24,Q9Y6E0,0.659,0.654,0.011293,DTO_03300101,Kinase,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
8431,NR0B2,Q15466,0.474,0.808,8.3377e-06,DTO_00102000,Nuclear receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.69,1.0,limited,2001.0,2020.0,ALL
8433,UTF1,Q5T230,0.743,0.192,0.50847,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2009.0,2013.0,ALL
8434,RECK,O95980,0.547,0.731,1.9319e-10,DTO_05007584,Enzyme modulator,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,1998.0,2019.0,ALL
8435,SOAT2,O75908,0.716,0.308,5.583e-28,DTO_05007624,Enzyme,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
8436,CAVIN2,O95810,0.617,0.615,7.2412e-09,DTO_05007542,Transcription factor,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.32,1.0,,2015.0,2019.0,ALL
8437,RASAL1,O95294,0.647,0.423,1.2135e-14,DTO_05007584,Enzyme modulator,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
8438,RAD54L,Q92698,0.633,0.423,2.3634e-15,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.62,0.5,,2017.0,2017.0,ALL
8439,NSMAF,Q92636,0.89,0.115,7.6425e-12,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
8440,NCK2,O43639,0.743,0.5,0.45789,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.3,1.0,,2009.0,2009.0,ALL
8443,GNPAT,O15228,0.663,0.462,0.30403,,,C1857242,"Rhizomelic chondrodysplasia punctata, type 2",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.92,1.0,strong,1992.0,2017.0,ALL
8444,DYRK3,O43781,0.743,0.5,3.5842e-06,DTO_03300101,Kinase,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
8445,DYRK2,Q92630,0.67,0.346,0.99751,DTO_03300101,Kinase,C0238198,Gastrointestinal Stromal Tumors,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
8446,DUSP11,O75319,1.0,0.077,8.4923e-07,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
8447,DOC2B,Q14184,0.861,0.154,0.017055,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
8448,DOC2A,Q14183,0.7,0.385,0.0067028,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
8449,DHX16,O60231,0.716,0.5,1.5996e-12,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2009.0,ALL
8450,CUL4B,Q13620,0.556,0.769,1.0,DTO_05007624,Enzyme,C1845861,"MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,definitive,1991.0,2020.0,ALL
8451,CUL4A,Q13619,0.597,0.654,0.99999,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
8452,CUL3,Q13618,0.592,0.654,0.9996,,,C3469606,"PSEUDOHYPOALDOSTERONISM, TYPE IIE",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.71,1.0,strong,2012.0,2015.0,ALL
8453,CUL2,Q13617,0.7,0.5,1.0,DTO_05007624,Enzyme,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
8454,CUL1,Q13616,0.617,0.615,1.0,DTO_05007624,Enzyme,C0014518,Toxic Epidermal Necrolysis,C17;C20;C25;C07,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Chemically-Induced Disorders;    Stomatognathic Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
8455,ATRN,O75882,0.751,0.462,1.0,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
8456,FOXN1,O15353,0.615,0.654,0.94214,,,C1866426,"T-cell immunodeficiency, congenital alopecia and nail dystrophy",C23;C16;C18;C17;C20,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.91,1.0,,1966.0,2014.0,ALL
8458,TTF2,Q9UNY4,0.716,0.308,1.0026e-22,,,C0010308,Congenital Hypothyroidism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.03,1.0,,2002.0,2005.0,ALL
8459,TPST2,O60704,1.0,0.038,0.27109,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
8460,TPST1,O60507,0.78,0.269,0.29239,DTO_05007624,Enzyme,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
8462,KLF11,O14901,0.626,0.654,8.3215e-09,DTO_05007557,Nucleic acid binding,C1864839,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7 (disorder)",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,1.0,limited,2005.0,2005.0,ALL
8463,TEAD2,Q15562,0.792,0.308,1.5226e-06,DTO_05007542,Transcription factor,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
8464,SUPT3H,O75486,0.839,0.154,3.2442e-11,DTO_05007557,Nucleic acid binding,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.11,1.0,,2012.0,2018.0,ALL
8466,ST11,,0.722,0.346,,,,C3873491,Invasive meningococcal disease,C01,   Infections,disease,Disease or Syndrome,0.08,1.0,,2009.0,2019.0,ALL
8467,SMARCA5,O60264,0.67,0.5,1.0,DTO_05007624,Enzyme,C0279980,Extra-osseous Ewing's sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
8468,FKBP6,O75344,0.821,0.231,1.3955e-06,,,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.32,1.0,limited,1998.0,2007.0,ALL
8470,SORBS2,O94875,0.736,0.423,0.035916,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
8471,IRS4,O14654,0.67,0.577,0.36317,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2018.0,2018.0,ALL
8473,OGT,O15294,0.626,0.731,1.0,,,C4478379,"MENTAL RETARDATION, X-LINKED 106",,,disease,Mental or Behavioral Dysfunction,0.6,1.0,strong,2015.0,2017.0,ALL
8476,CDC42BPA,Q5VT25,0.722,0.423,0.99309,DTO_03300101,Kinase,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
8477,GPR65,Q8IYL9,0.653,0.5,0.1114,DTO_02300001,G-protein coupled receptor,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.4,1.0,,2015.0,2019.0,ALL
8480,RAE1,P78406,0.736,0.308,0.99902,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
8481,OFD1,O75665,0.51,0.808,0.95968,,,C1510460,Orofaciodigital Syndrome I,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.88,1.0,,2001.0,2019.0,ALL
8482,SEMA7A,O75326,0.636,0.615,0.17976,DTO_05007599,Signaling,C3899503,Congenital hypogonadotropic hypogonadism,C16;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Endocrine System Diseases",disease,Disease or Syndrome,0.31,1.0,limited,2014.0,2014.0,ALL
8483,CILP,O75339,0.736,0.423,5.3654e-26,,,C0221775,Lumbar disc disease,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.34,0.75,,2005.0,2018.0,ALL
8484,GALR3,O60755,0.76,0.192,0.00013455,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
8487,GEMIN2,O14893,0.597,0.654,1.4999e-06,DTO_05007557,Nucleic acid binding,C0523979,Vitamin D3 measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
8490,RGS5,O15539,0.647,0.423,0.00053488,DTO_05007584,Enzyme modulator,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.55,1.0,,1992.0,2018.0,ALL
8491,MAP4K3,Q8IVH8,0.711,0.423,0.10987,DTO_03300101,Kinase,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
8492,PRSS12,P56730,0.682,0.308,8.382e-29,DTO_05007624,Enzyme,C1855304,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.61,1.0,strong,2002.0,2017.0,ALL
8493,PPM1D,O15297,0.513,0.808,2.2321e-11,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,0.964,,2002.0,2020.0,ALL
8495,PPFIBP2,Q8ND30,0.78,0.269,6.004e-34,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2015.0,2018.0,ALL
8496,PPFIBP1,Q86W92,0.89,0.154,5.1485e-16,,,C0085269,"Plasma Cell Granuloma, Pulmonary",C08,   Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
8497,PPFIA4,O75335,0.821,0.308,1.9863e-05,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2017.0,2018.0,ALL
8498,RANBP3,Q9H6Z4,0.792,0.192,0.99997,DTO_05007584,Enzyme modulator,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
8499,PPFIA2,O75334,0.861,0.154,1.0,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
8500,PPFIA1,Q13136,0.76,0.269,1.0,,,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2008.0,2019.0,ALL
8501,SLC43A1,O75387,0.839,0.115,8.0343e-06,DTO_05007405,Transporter,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
8502,PKP4,Q99569,0.839,0.192,5.269e-13,DTO_05007530,Cellular structure,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
8503,PIK3R3,Q92569,0.556,0.692,3.3583e-10,DTO_05007584,Enzyme modulator,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
8504,PEX3,P56589,0.595,0.731,0.016335,,,C3553999,PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER),,,disease,Disease or Syndrome,0.7,1.0,,2000.0,2017.0,ALL
8505,PARG,Q86W56;Q86WA6,0.656,0.5,0.39209,DTO_05007624,Enzyme,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2015.0,2016.0,ALL
8506,CNTNAP1,P78357,0.554,0.577,3.445e-05,,,C4225386,LETHAL CONGENITAL CONTRACTURE SYNDROME 7,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2017.0,ALL
8507,ENC1,O14682,0.695,0.5,0.46008,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
8508,NIPSNAP1,Q9BPW8,0.931,0.077,0.10005,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
8509,NDST2,P52849,1.0,0.077,0.12803,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
8510,MMP23B,O75900,0.695,0.346,0.11732,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2002.0,2018.0,ALL
8511,MMP23A,,0.722,0.308,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2002.0,2003.0,ALL
8512,MBL1P,,,,,,,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.2,1.0,,2001.0,2009.0,ALL
8513,LIPF,P07098,0.861,0.192,0.00072091,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
8514,KCNAB2,Q13303,0.593,0.692,0.79978,DTO_01300327,Ion channel,C1842870,Chromosome 1p36 Deletion Syndrome,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.52,1.0,,2001.0,2012.0,ALL
8515,ITGA10,O75578,0.821,0.038,2.4464e-19,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
8516,ITGA8,P53708,0.641,0.577,6.0785e-13,,,C1609433,Congenital absence of kidneys syndrome,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.61,1.0,,2014.0,2014.0,ALL
8517,IKBKG,Q9Y6K9,0.493,0.769,0.084853,DTO_03300101,Kinase,C0021171,Bloch Sulzberger syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.987,,1976.0,2019.0,ALL
8518,ELP1,O95163,0.579,0.769,2.1199e-21,DTO_05007584,Enzyme modulator,C0013364,"Dysautonomia, Familial",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome; Congenital Abnormality,1.0,1.0,,1993.0,2019.0,ALL
8519,IFITM1,P13164,0.626,0.5,0.13569,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
8520,HAT1,O14929,0.656,0.5,0.83507,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
8521,GCM1,Q9NP62,0.839,0.077,0.999,,,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.02,1.0,,2004.0,2006.0,ALL
8522,GAS7,O60861,0.7,0.423,0.8523,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
8525,DGKZ,Q13574,0.656,0.538,0.039507,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
8526,DGKE,P52429,0.674,0.538,5.4906e-06,DTO_05007624,Enzyme,C2931788,Atypical Hemolytic Uremic Syndrome,C13;C12;C15,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2019.0,ALL
8527,DGKD,Q16760,0.78,0.346,0.072171,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.42,1.0,,2008.0,2019.0,ALL
8528,DDO,Q99489,0.805,0.231,8.3982e-10,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2015.0,2018.0,ALL
8529,CYP4F2,P78329,0.674,0.308,7.5803e-17,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,0.917,,2008.0,2019.0,ALL
8530,CST7,O76096,0.695,0.423,1.2199e-07,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
8531,YBX3,P16989,0.729,0.385,8.0641e-06,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2009.0,2016.0,ALL
8532,CPZ,Q66K79,0.839,0.154,8.8063e-36,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.12,1.0,,2017.0,2018.0,ALL
8533,COPS3,Q9UNS2,0.729,0.346,0.99949,DTO_05007584,Enzyme modulator,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
8534,CHST1,O43916,0.89,0.077,0.76863,,,C0029422,Osteochondrodysplasias,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
8535,CBX4,O00257,0.67,0.385,0.98196,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.895,,2000.0,2013.0,ALL
8536,CAMK1,Q14012,0.736,0.269,3.0134e-05,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
8537,BCAS1,O75363,0.805,0.192,6.9521e-07,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
8538,BARX2,Q9UMQ3,0.716,0.5,0.21157,DTO_05007542,Transcription factor,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
8539,API5,Q9BZZ5,0.7,0.5,0.99996,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2001.0,2017.0,ALL
8540,AGPS,O00116,0.67,0.538,1.0,,,C1838612,"Rhizomelic chondrodysplasia punctata, type 3",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1998.0,2016.0,ALL
8541,PPFIA3,O75145,0.89,0.192,1.0,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
8542,APOL1,O14791,0.547,0.615,5.1357e-06,DTO_05007405,Transporter,C2675525,"FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO",,,disease,Finding,0.6,1.0,limited,2010.0,2010.0,ALL
8543,LMO4,P61968,0.638,0.5,0.67667,,,C0002902,Anencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.2,1.0,,2005.0,2006.0,ALL
8544,PIR,O00625,0.716,0.385,5.3402e-10,DTO_05007542,Transcription factor,C0011616,Contact Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
8545,CGGBP1,Q9UFW8,1.0,0.038,0.81819,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
8546,AP3B1,O00203,0.619,0.808,0.61532,DTO_05007405,Transporter,C1842362,HERMANSKY-PUDLAK SYNDROME 2,C16;C18;C11;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.94,1.0,,1981.0,2017.0,ALL
8547,FCN3,O75636,0.678,0.5,0.0038008,DTO_05007599,Signaling,C3151226,FICOLIN 3 DEFICIENCY,,,disease,Disease or Syndrome,0.72,1.0,limited,2009.0,2019.0,ALL
8548,BLZF1,Q9H2G9,0.78,0.269,5.0879e-07,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2011.0,2012.0,ALL
8549,LGR5,O75473,0.542,0.654,2.5019e-08,DTO_02300001,G-protein coupled receptor,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
8550,MAPKAPK5,Q8IW41,0.78,0.346,0.35435,DTO_03300101,Kinase,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
8553,BHLHE40,O14503,0.544,0.731,0.99444,DTO_05007542,Transcription factor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.51,1.0,,2008.0,2014.0,ALL
8554,PIAS1,O75925,0.633,0.731,0.99999,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
8555,CDC14B,O60729,0.792,0.192,0.94308,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
8556,CDC14A,Q9UNH5,0.736,0.385,9.6376e-08,,,C1837608,"DEAFNESS, AUTOSOMAL RECESSIVE 32",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,,2016.0,2018.0,ALL
8557,TCAP,O15273,0.682,0.538,0.18939,,,C1866008,"Muscular Dystrophy, Limb-Girdle, Type 2G",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,2010.0,2017.0,ALL
8558,CDK10,Q15131,0.65,0.577,1.193e-16,DTO_03300101,Kinase,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.4,1.0,strong,2017.0,2017.0,ALL
8559,PRPF18,Q99633,1.0,0.077,0.00026823,DTO_05007624,Enzyme,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
8560,DEGS1,O15121,0.621,0.731,0.13877,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,strong,2019.0,2019.0,ALL
8562,DENR,O43583,0.543,0.692,0.87514,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2020.0,ALL
8563,THOC5,Q13769,0.769,0.308,0.045294,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
8564,KMO,O15229,0.674,0.615,4.7825e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,0.8,,2006.0,2018.0,ALL
8565,YARS1,P54577,0.705,0.5,0.0010047,DTO_05007624,Enzyme,C1842237,"Charcot-Marie-Tooth Disease, Dominant Intermediate C",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2003.0,2016.0,ALL
8566,PDXK,O00764,0.705,0.385,0.74906,DTO_03300101,Kinase,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
8567,MADD,Q8WXG6,0.644,0.538,1.5363e-14,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.23,0.667,,2010.0,2019.0,ALL
8568,RRP1,P56182,0.861,0.115,7.4869e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
8569,MKNK1,Q9BUB5,0.606,0.808,8.0483e-10,DTO_03300101,Kinase,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
8570,KHSRP,Q92945,0.526,0.846,1.0,DTO_05007624,Enzyme,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2012.0,2016.0,ALL
8572,PDLIM4,P50479,0.659,0.462,0.98283,DTO_05007530,Cellular structure,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.41,1.0,,2003.0,2003.0,ALL
8573,CASK,O14936,0.538,0.808,1.0,DTO_03300101,Kinase,C1845546,FG SYNDROME 4 (disorder),C23;C16;C06;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2008.0,2017.0,ALL
8574,AKR7A2,O43488,0.743,0.269,1.9938e-10,DTO_05007624,Enzyme,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
8575,PRKRA,O75569,0.579,0.615,0.41653,DTO_03300101,Kinase,C2677567,DYSTONIA 16 (disorder),C10,   Nervous System Diseases,disease,Disease or Syndrome,0.72,1.0,,2008.0,2019.0,ALL
8576,STK16,O75716,0.805,0.231,0.0001182,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,1995.0,1997.0,ALL
8577,TMEFF1,Q8IYR6,0.821,0.269,0.53799,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
8578,SCARF1,Q14162,0.89,0.192,5.2898e-07,DTO_05007575,Receptor,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
8581,LY6D,Q14210,0.792,0.154,0.026045,,,C0013295,Duodenal Ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
8600,TNFSF11,O14788,0.453,0.846,0.0049159,DTO_05007599,Signaling,C1850126,"Osteopetrosis, mild autosomal recessive form",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.8,1.0,strong,2000.0,2016.0,ALL
8601,RGS20,O76081,0.76,0.269,6.4013e-05,DTO_05007584,Enzyme modulator,C0024809,Marijuana Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2012.0,2012.0,ALL
8602,NOP14,P78316,0.76,0.346,2.1363e-06,DTO_05007557,Nucleic acid binding,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
8603,FAM193A,P78312,0.792,0.192,0.99993,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
8604,SLC25A12,O75746,0.711,0.462,0.21604,DTO_05007405,Transporter,C2751855,"Hypomyelination, Global Cerebral",C23;C16;C18;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.94,1.0,strong,2005.0,2019.0,ALL
8605,PLA2G4C,Q9UP65,0.705,0.385,1.6781e-13,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2005.0,2017.0,ALL
8607,RUVBL1,Q9Y265,0.647,0.5,0.99902,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
8608,RDH16,O75452,0.931,0.077,4.3901e-07,DTO_05007624,Enzyme,C0014170,Endometrial Neoplasms,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
8609,KLF7,O75840,0.743,0.385,0.98178,DTO_05007557,Nucleic acid binding,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,,2018.0,2018.0,ALL
8611,PLPP1,O14494,0.729,0.346,0.096417,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
8612,PLPP2,O43688,0.931,0.115,0.00083068,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
8613,PLPP3,O14495,0.722,0.192,0.917,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.49,1.0,,2011.0,2019.0,ALL
8614,STC2,O76061,0.573,0.692,0.26588,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,2002.0,2019.0,ALL
8615,USO1,O60763,0.522,0.885,0.33417,DTO_05007405,Transporter,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.31,0.5,,2007.0,2018.0,ALL
8618,CADPS,Q9ULU8,0.805,0.154,1.4707e-05,DTO_05007616,Calcium-binding protein,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
8620,NPFF,O15130,0.821,0.154,3.646e-05,,,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.2,1.0,,1999.0,1999.0,ALL
8621,CDK13,Q14004,0.606,0.692,0.90753,DTO_03300101,Kinase,C4479246,"CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER",,,disease,Disease or Syndrome,0.71,1.0,strong,2015.0,2019.0,ALL
8622,PDE8B,O95263,0.638,0.5,0.99905,,,C3280094,"PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3",,,disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2008.0,ALL
8623,ASMTL,O95671,0.861,0.115,1.2704e-09,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
8624,PSMG1,O95456,0.579,0.731,0.00034234,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0,,2010.0,2011.0,ALL
8625,RFXANK,O14593,0.644,0.577,8.6716e-06,DTO_05007542,Transcription factor,C2931418,Bare lymphocyte syndrome 2,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.73,0.833,,1998.0,2012.0,ALL
8626,TP63,Q9H3D4,0.362,0.769,0.99728,DTO_05007542,Transcription factor,C1785148,RAPP-HODGKIN SYNDROME,C16;C17;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,1.0,1.0,,2001.0,2019.0,ALL
8629,JRK,O75564,0.612,0.5,,,,C0270853,Juvenile Myoclonic Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.51,1.0,,2001.0,2001.0,ALL
8630,HSD17B6,O14756,0.592,0.692,0.34807,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2006.0,2006.0,ALL
8631,SKAP1,Q86WV1,0.743,0.231,1.8196e-07,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.4,1.0,,2010.0,2017.0,ALL
8632,DNAH17,Q9UFH2,0.839,0.154,1.9559e-63,DTO_05007624,Enzyme,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
8633,UNC5C,O95185,0.65,0.462,0.0008813,DTO_05007575,Receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.36,1.0,,2014.0,2016.0,ALL
8634,RTCA,O00442,0.736,0.385,3.0927e-09,DTO_05007624,Enzyme,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,0.5,,2018.0,2019.0,ALL
8635,RNASET2,O00584,0.682,0.615,0.00026891,,,C2751843,"Leukoencephalopathy, Cystic, Without Megalencephaly",C23;C04;C10,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,strong,2009.0,2016.0,ALL
8636,SSNA1,O43805,0.861,0.192,0.00033383,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
8637,EIF4EBP3,O60516,0.792,0.192,0.00034389,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
8638,OASL,Q15646,0.729,0.385,2.7573e-11,DTO_05007624,Enzyme,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
8639,AOC3,Q16853,0.561,0.769,6.267e-11,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,1990.0,2009.0,ALL
8642,DCHS1,Q96JQ0,0.592,0.731,0.99997,,,C1843003,"MITRAL VALVE PROLAPSE, MYXOMATOUS 2",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.6,1.0,,2015.0,2015.0,ALL
8643,PTCH2,Q9Y6C5,0.563,0.692,3.4086e-16,,,C0004779,Basal Cell Nevus Syndrome,C16;C04;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Neoplastic Process,0.77,1.0,limited,1985.0,2017.0,ALL
8644,AKR1C3,P42330,0.529,0.769,7.5812e-24,DTO_05007624,Enzyme,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.57,0.909,,1993.0,2019.0,ALL
8645,KCNK5,O95279,0.695,0.462,0.32518,DTO_01300327,Ion channel,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
8646,CHRD,Q9H2X0,0.76,0.346,3.7942e-05,,,C0012236,DiGeorge Syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,2003.0,2003.0,ALL
8647,ABCB11,O95342,0.566,0.654,1.5612e-12,DTO_05007405,Transporter,C3489789,"Cholestasis, Progressive Familial Intrahepatic, 2",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.8,1.0,,1998.0,2016.0,ALL
8648,NCOA1,Q15788,0.563,0.731,0.99981,DTO_03300101,Kinase,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.5,1.0,,2004.0,2019.0,ALL
8649,LAMTOR3,Q9UHA4,0.805,0.154,0.7313,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
8650,NUMB,P49757,0.619,0.731,0.0039959,DTO_05007599,Signaling,C4085590,Cone-Rod Dystrophies,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
8651,SOCS1,O15524,0.445,0.808,0.58544,DTO_05007584,Enzyme modulator,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.36,1.0,,2005.0,2019.0,ALL
8653,DDX3Y,O15523,0.722,0.269,0.96494,,,C1507149,Partial chromosome Y deletion,C23;C16;C13;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2000.0,2012.0,ALL
8654,PDE5A,O76074,0.513,0.731,0.00010643,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.32,1.0,,2003.0,2018.0,ALL
8655,DYNLL1,P63167,0.568,0.769,0.6983,DTO_05007530,Cellular structure,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,1998.0,1998.0,ALL
8658,TNKS,O95271,0.576,0.692,0.011406,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
8659,ALDH4A1,P30038,0.792,0.231,1.3725e-05,,,C2931835,Hyperprolinemia type 2,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,moderate,1960.0,2016.0,ALL
8660,IRS2,Q9Y4H2,0.535,0.654,0.99032,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,0.975,,1997.0,2017.0,ALL
8661,EIF3A,Q14152,0.592,0.769,1.0,DTO_05007557,Nucleic acid binding,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,1999.0,2017.0,ALL
8662,EIF3B,P55884,0.666,0.346,1.0,DTO_05007557,Nucleic acid binding,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
8663,EIF3C,Q99613,0.722,0.385,2.2907e-05,DTO_05007557,Nucleic acid binding,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2006.0,2019.0,ALL
8664,EIF3D,O15371,0.653,0.346,0.99983,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
8665,EIF3F,O00303,0.736,0.385,0.97044,DTO_05007624,Enzyme,C4749019,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67",,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
8666,EIF3G,O75821,0.792,0.192,0.98546,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.32,1.0,limited,2015.0,2017.0,ALL
8667,EIF3H,O15372,0.7,0.308,0.047483,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.35,0.8,,2000.0,2006.0,ALL
8668,EIF3I,Q13347,0.743,0.269,0.9493,DTO_05007557,Nucleic acid binding,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
8669,EIF3J,O75822,0.805,0.154,0.85657,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
8671,SLC4A4,Q9Y6R1,0.644,0.692,0.99722,DTO_05007405,Transporter,C1970309,"Renal Tubular Acidosis, Proximal, With Ocular Abnormalities And Mental Retardation",C23;C16;C18;C13;C11;C12;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,strong,1999.0,2008.0,ALL
8672,EIF4G3,O43432,0.78,0.308,1.0,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
8673,VAMP8,Q9BV40,0.61,0.731,0.10726,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
8674,VAMP4,O75379,0.89,0.154,0.14407,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
8675,STX16,O14662,0.656,0.538,0.48261,DTO_05007405,Transporter,C1864100,"PSEUDOHYPOPARATHYROIDISM, TYPE IB",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.4,0.933,,2004.0,2017.0,ALL
8676,STX11,O75558,0.729,0.346,0.00047412,DTO_05007405,Transporter,C1863728,"Hemophagocytic lymphohistiocytosis, familial, 4",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.83,1.0,,2007.0,2015.0,ALL
8677,STX10,O60499,,,1.3079e-09,DTO_05007405,Transporter,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
8678,BECN1,Q14457,0.432,0.846,0.93717,DTO_05007584,Enzyme modulator,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.52,1.0,,2009.0,2017.0,ALL
8681,JMJD7-PLA2G4B,P0C869,1.0,0.038,1.0582e-40,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
8682,PEA15,Q15121,0.553,0.692,0.79212,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
8683,SRSF9,Q13242,0.751,0.346,0.63924,DTO_05007557,Nucleic acid binding,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
8685,MARCO,Q9UEW3,0.659,0.5,7.7683e-21,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,0.667,,2017.0,2019.0,ALL
8689,KRT36,O76013,,,2.0568e-13,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
8691,IDDM17,,0.931,0.115,,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.02,1.0,,2004.0,2004.0,ALL
8692,HYAL2,Q12891,0.644,0.577,0.18682,DTO_05007624,Enzyme,C0020542,Pulmonary Hypertension,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.2,1.0,,2010.0,2010.0,ALL
8693,GALNT4,Q8N4A0,0.736,0.346,0.26691,,,C0036346,"Schizophrenia, Childhood",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
8694,DGAT1,O75907,0.621,0.615,1.4082e-17,DTO_05007624,Enzyme,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.44,1.0,,2012.0,2018.0,ALL
8697,CDC23,Q9UJX2,0.821,0.231,0.99175,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,1998.0,2011.0,ALL
8698,S1PR4,O95977,0.722,0.346,0.0023778,DTO_02300001,G-protein coupled receptor,C0002152,Alloxan Diabetes,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.3,1.0,,2012.0,2012.0,ALL
8701,DNAH11,Q96DT5,0.587,0.692,2.5389e-58,DTO_05007624,Enzyme,C2678473,"CILIARY DYSKINESIA, PRIMARY, 7 (disorder)",C16;C08;C09;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.9,1.0,,1999.0,2014.0,ALL
8702,B4GALT4,O60513,1.0,0.077,5.8287e-07,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
8703,B4GALT3,O60512,0.751,0.269,0.011393,DTO_05007624,Enzyme,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2013.0,2018.0,ALL
8704,B4GALT2,O60909,0.861,0.269,0.19829,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
8705,B3GALT4,O96024,0.792,0.308,0.029753,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2018.0,2019.0,ALL
8706,B3GALNT1,O75752,0.839,0.269,0.002209,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
8708,B3GALT1,Q9Y5Z6,1.0,0.154,0.01019,DTO_05007624,Enzyme,C0796012,Krause-Kivlin syndrome,C23;C16;C05;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
8710,SERPINB7,O75635,0.76,0.346,7.3773e-09,DTO_05007584,Enzyme modulator,C3810072,Palmoplantar keratoderma Nagashima type,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2017.0,ALL
8711,TNK1,Q13470,0.769,0.269,2.6405e-08,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
8712,PAGE1,O75459,0.792,0.231,0.82048,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,1998.0,2000.0,ALL
8714,ABCC3,O15438,0.517,0.769,1.2092e-26,DTO_05007405,Transporter,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.52,1.0,,2008.0,2018.0,ALL
8715,NOL4,O94818,0.792,0.154,0.99949,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2016.0,ALL
8717,TRADD,Q15628,0.7,0.269,0.099502,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2001.0,2015.0,ALL
8718,TNFRSF25,Q93038,0.573,0.769,0.0086475,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.97,,2001.0,2019.0,ALL
8720,MBTPS1,Q14703,0.532,0.692,7.5901e-09,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2007.0,2011.0,ALL
8721,EDF1,O60869,0.931,0.038,0.77742,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
8722,CTSF,Q9UBX1,0.716,0.462,1.9431e-13,DTO_05007624,Enzyme,C3715049,"CEROID LIPOFUSCINOSIS, NEURONAL, 13",,,disease,Disease or Syndrome,0.7,1.0,,2006.0,2014.0,ALL
8724,SNX3,O60493,0.743,0.423,0.24928,,,C1832440,"MICROPHTHALMIA, SYNDROMIC 8",C16;C11;C05;C10;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.31,0.0,limited,2002.0,2002.0,ALL
8725,URI1,O94763,0.633,0.654,1.1089e-05,DTO_05007542,Transcription factor,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2011.0,2019.0,ALL
8726,EED,O75530,0.588,0.615,0.99929,,,C4479654,COHEN-GIBSON SYNDROME,,,disease,Disease or Syndrome,0.61,1.0,strong,2015.0,2019.0,ALL
8727,CTNNAL1,Q9UBT7,0.78,0.269,1.737e-10,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2011.0,2012.0,ALL
8728,ADAM19,Q9H013,0.659,0.538,6.8e-05,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
8729,GBF1,Q92538,0.839,0.269,4.7521e-15,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
8731,RNMT,O43148,0.647,0.5,5.6565e-05,,,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,1988.0,2018.0,ALL
8732,RNGTT,O60942,0.682,0.385,0.37382,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2015.0,2015.0,ALL
8733,GPAA1,O43292,0.647,0.538,5.4966e-09,,,C4540520,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2017.0,ALL
8735,MYH13,Q9UKX3,0.931,0.038,8.0493e-40,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
8736,MYOM1,P52179,0.839,0.269,1.7267e-40,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,limited,2011.0,2011.0,ALL
8737,RIPK1,Q13546,0.479,0.769,0.0079441,DTO_03300101,Kinase,C4748212,IMMUNODEFICIENCY 57,,,disease,Disease or Syndrome,0.4,1.0,strong,2018.0,2018.0,ALL
8738,CRADD,P78560,0.619,0.5,0.87862,,,C3281044,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2016.0,ALL
8739,HRK,O00198,0.769,0.269,0.36033,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2006.0,2013.0,ALL
8740,TNFSF14,O43557,0.529,0.769,0.051663,DTO_05007599,Signaling,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.42,1.0,,2011.0,2013.0,ALL
8741,TNFSF13,O75888,0.499,0.769,0.81724,,,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,1.0,,2011.0,2020.0,ALL
8742,TNFSF12,O43508,0.556,0.769,0.76997,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.41,1.0,,2018.0,2018.0,ALL
8743,TNFSF10,P50591,0.413,0.885,0.13495,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2002.0,2019.0,ALL
8744,TNFSF9,P41273,0.579,0.692,0.31823,,,C0011616,Contact Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
8745,ADAM23,O75077,0.65,0.5,0.99709,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
8747,ADAM21,Q9UKJ8,0.89,0.154,3.5771e-12,DTO_05007624,Enzyme,C0023492,"Leukemia, T-Cell",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
8748,ADAM20,O43506,1.0,0.077,,DTO_05007624,Enzyme,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
8749,ADAM18,Q9Y3Q7,1.0,0.077,6.8847e-35,DTO_05007624,Enzyme,C1321872,Stage IV Skin Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
8751,ADAM15,Q13444,0.626,0.577,2.4409e-16,DTO_05007624,Enzyme,C1527348,Brain Hypoxia,C10,   Nervous System Diseases,phenotype,Pathologic Function,0.2,1.0,,2012.0,2012.0,ALL
8754,ADAM9,Q13443,0.56,0.654,0.029431,DTO_05007624,Enzyme,C1423873,CONE-ROD DYSTROPHY 9,,,disease,Disease or Syndrome,0.81,1.0,,2002.0,2014.0,ALL
8755,ADAM6,,0.931,0.115,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
8756,ADAM7,Q9H2U9,0.839,0.192,1.1927e-19,DTO_05007624,Enzyme,C1321872,Stage IV Skin Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
8760,CDS2,O95674,0.931,0.038,6.8645e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
8761,PABPC4,Q13310,0.729,0.346,0.99905,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
8763,CD164,Q04900,0.674,0.462,0.48906,,,C4283893,"DEAFNESS, AUTOSOMAL DOMINANT 66",,,disease,Disease or Syndrome,0.6,1.0,limited,2015.0,2015.0,ALL
8764,TNFRSF14,Q92956,0.568,0.731,0.80752,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.38,0.889,,2003.0,2017.0,ALL
8766,RAB11A,P62491,0.601,0.692,0.99151,,,C0263454,Chloracne,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
8767,RIPK2,O43353,0.587,0.769,0.39282,DTO_03300101,Kinase,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2010.0,2020.0,ALL
8771,TNFRSF6B,O95407,0.528,0.731,3.874e-06,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.15,1.0,,2009.0,2017.0,ALL
8772,FADD,Q13158,0.537,0.846,0.52595,,,C3151062,"INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS",,,disease,Disease or Syndrome,0.6,1.0,strong,2010.0,2015.0,ALL
8773,SNAP23,O00161,0.686,0.423,0.92412,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
8774,NAPG,Q99747,0.861,0.192,0.081162,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2006.0,2009.0,ALL
8775,NAPA,P54920,0.931,0.038,0.23987,DTO_05007405,Transporter,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,2009.0,2019.0,ALL
8776,MTMR1,Q13613,0.839,0.115,0.9976,DTO_05007624,Enzyme,C0410203,X-linked centronuclear myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Congenital Abnormality,0.02,1.0,,1998.0,2018.0,ALL
8777,MPDZ,O75970,0.638,0.5,5.8009e-38,,,C3554691,"HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2017.0,ALL
8778,SIGLEC5,O15389,0.743,0.423,2.0969e-06,DTO_05007575,Receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
8780,RIOK3,O14730,0.839,0.192,4.7708e-07,DTO_03300101,Kinase,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
8781,PSPHP1,O15172,,,,,,C0201874,Amino acids measurement,,,group,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
8782,MYP3,,0.931,0.038,,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.04,1.0,,2004.0,2012.0,ALL
8784,TNFRSF18,Q9Y5U5,0.631,0.538,1.4516e-06,,,C0023281,Leishmaniasis,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
8785,MATN4,O95460,0.769,0.308,1.1311e-08,DTO_05007575,Receptor,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
8786,RGS11,O94810,0.805,0.154,7.3266e-14,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
8787,RGS9,O75916,0.722,0.308,1.1251e-14,,,C1842073,Prolonged Electroretinal Response Suppression,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",phenotype,Finding,0.7,1.0,limited,2004.0,2004.0,ALL
8788,DLK1,P80370,0.527,0.692,0.034576,DTO_05007599,Signaling,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.37,1.0,,2001.0,2018.0,ALL
8789,FBP2,O00757,0.839,0.231,0.00022129,DTO_05007624,Enzyme,C0017919,Glycogen Storage Disease,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.3,,limited,,,ALL
8790,FPGT,O14772,0.821,0.115,1.0949e-10,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
8792,TNFRSF11A,Q9Y6Q6,0.48,0.846,0.0087667,,,C0432292,Familial expansile osteolysis,C05,   Musculoskeletal Diseases,disease,Congenital Abnormality,0.8,1.0,strong,2000.0,2018.0,ALL
8793,TNFRSF10D,Q9UBN6,0.626,0.615,3e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.818,,1999.0,2019.0,ALL
8794,TNFRSF10C,O14798,0.578,0.731,3.1588e-06,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
8795,TNFRSF10B,O14763,0.505,0.769,0.00019928,,,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.32,1.0,,2007.0,2019.0,ALL
8796,SCEL,O95171,0.792,0.231,4.5807e-21,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
8797,TNFRSF10A,O00220,0.521,0.731,5.0697e-15,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.52,1.0,,2006.0,2019.0,ALL
8798,DYRK4,Q9NR20,1.0,0.115,1.7785e-18,DTO_03300101,Kinase,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
8799,PEX11B,O96011,0.612,0.654,0.00013346,,,C3554055,PEROXISOME BIOGENESIS DISORDER 14B,,,disease,Disease or Syndrome,0.62,1.0,,2012.0,2020.0,ALL
8800,PEX11A,O75192,0.792,0.346,8.4537e-07,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
8801,SUCLG2,Q96I99,0.78,0.308,5.7163e-14,DTO_05007624,Enzyme,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
8802,SUCLG1,P53597,0.666,0.423,0.00048193,,,C3151476,MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA),,,disease,Disease or Syndrome,0.7,1.0,,2007.0,2018.0,ALL
8803,SUCLA2,Q9P2R7,0.566,0.654,0.0023488,DTO_05007624,Enzyme,C2749864,MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA),,,disease,Disease or Syndrome,0.7,1.0,,2005.0,2016.0,ALL
8804,CREG1,O75629,0.663,0.423,0.0012232,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
8805,TRIM24,O15164,0.581,0.615,1.0,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2007.0,2018.0,ALL
8807,IL18RAP,O95256,0.674,0.577,0.0021796,DTO_05007575,Receptor,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.41,1.0,,2008.0,2015.0,ALL
8808,IL1RL2,Q9HB29,0.682,0.5,3.537e-11,DTO_05007575,Receptor,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
8809,IL18R1,Q13478,0.473,0.808,8.625e-06,DTO_05007575,Receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2007.0,2016.0,ALL
8811,GALR2,O43603,0.653,0.615,6.3829e-06,DTO_02300001,G-protein coupled receptor,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2011.0,2016.0,ALL
8812,CCNK,O75909,0.792,0.231,0.9998,DTO_05007584,Enzyme modulator,C4748381,INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES,,,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
8813,DPM1,O60762,0.695,0.385,0.00016237,DTO_05007624,Enzyme,C1837396,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,,2000.0,2016.0,ALL
8814,CDKL1,Q00532,0.682,0.385,2.5004e-07,DTO_03300101,Kinase,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
8815,BANF1,O75531,0.599,0.692,0.6518,,,C3151446,Nestor Guillermo progeria syndrome,C23;C18;C05,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.73,1.0,,2011.0,2019.0,ALL
8816,DCAF5,Q96JK2,,,1.0,DTO_05007584,Enzyme modulator,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
8817,FGF18,O76093,0.647,0.577,0.38517,DTO_05007599,Signaling,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.37,1.0,,2016.0,2019.0,ALL
8818,DPM2,O94777,0.666,0.5,0.31786,,,C3554385,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu",,,disease,Disease or Syndrome,0.7,1.0,,2009.0,2016.0,ALL
8820,HESX1,Q9UBX0,0.561,0.654,0.00079734,,,C0338503,Septo-Optic Dysplasia,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1998.0,2016.0,ALL
8821,INPP4B,O15327,0.573,0.577,0.55218,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.48,1.0,,2015.0,2019.0,ALL
8822,FGF17,O60258,0.593,0.692,0.95609,DTO_05007599,Signaling,C3808983,HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.7,1.0,limited,2013.0,2013.0,ALL
8823,FGF16,O43320,0.751,0.423,0.75107,DTO_05007599,Signaling,C1839728,METACARPAL 4-5 FUSION,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2014.0,ALL
8824,CES2,O00748,0.584,0.731,3.5781e-16,DTO_05007624,Enzyme,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2009.0,2009.0,ALL
8825,LIN7A,O14910,0.736,0.385,1.1286e-07,DTO_05007527,Cell-cell junction,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2002.0,2002.0,ALL
8826,IQGAP1,P46940,0.56,0.692,0.99754,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2010.0,2016.0,ALL
8828,NRP2,O60462,0.539,0.615,0.00080686,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2007.0,2019.0,ALL
8829,NRP1,O14786,0.476,0.808,0.98584,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.38,1.0,,2004.0,2018.0,ALL
8830,PTLAH,,0.931,0.115,,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,1999.0,1999.0,ALL
8831,SYNGAP1,Q96PV0,0.584,0.577,1.0,DTO_05007584,Enzyme modulator,C2675473,"Mental Retardation, Autosomal Dominant 5",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,strong,2009.0,2017.0,ALL
8832,CD84,Q9UIB8,0.76,0.308,6.9102e-09,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
8833,GMPS,P49915,0.769,0.269,0.99825,DTO_05007624,Enzyme,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.21,1.0,,1983.0,2017.0,ALL
8834,TMEM11,P17152,0.729,0.385,0.87922,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2003.0,2010.0,ALL
8835,SOCS2,O14508,0.56,0.731,0.62999,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2013.0,2019.0,ALL
8836,GGH,Q92820,0.608,0.5,0.58132,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,0.857,,2003.0,2016.0,ALL
8837,CFLAR,O15519,0.485,0.846,0.99967,DTO_05007624,Enzyme,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.36,1.0,,2003.0,2008.0,ALL
8838,CCN6,O95389,0.568,0.731,0.00061942,DTO_05007599,Signaling,C0432215,Progressive pseudorheumatoid dysplasia,C05,   Musculoskeletal Diseases,disease,Congenital Abnormality,1.0,0.968,strong,1999.0,2019.0,ALL
8839,CCN5,O76076,0.621,0.462,1.9682e-05,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.846,,1998.0,2019.0,ALL
8840,CCN4,O95388,0.554,0.692,6.3885e-07,DTO_05007599,Signaling,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.37,1.0,,2007.0,2019.0,ALL
8841,HDAC3,O15379,0.511,0.731,0.56737,DTO_05007378,Epigenetic regulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2008.0,2018.0,ALL
8842,PROM1,O43490,0.41,0.846,1.9485e-22,DTO_05007405,Transporter,C2677516,RETINITIS PIGMENTOSA 41 (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.8,1.0,,2009.0,2009.0,ALL
8843,HCAR3,P49019,0.678,0.577,7.8636e-08,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2008.0,2009.0,ALL
8844,KSR1,Q8IVT5,0.666,0.346,0.069796,DTO_03300101,Kinase,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
8846,ALKBH1,Q13686,0.644,0.538,4.8961e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,1997.0,2019.0,ALL
8847,DLEU2,,0.65,0.5,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2011.0,2018.0,ALL
8848,TSC22D1,Q15714,0.619,0.615,0.9599,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
8850,KAT2B,Q92831,0.563,0.692,0.98975,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
8851,CDK5R1,Q15078,0.529,0.808,0.9149,DTO_05007584,Enzyme modulator,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.32,1.0,,2007.0,2011.0,ALL
8852,AKAP4,Q5JQC9,0.7,0.269,0.99323,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2011.0,2017.0,ALL
8853,ASAP2,O43150,0.585,0.731,0.99996,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
8854,ALDH1A2,O94788,0.578,0.692,0.36331,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.42,1.0,,2014.0,2018.0,ALL
8856,NR1I2,O75469,0.418,0.846,7.2668e-09,DTO_00102000,Nuclear receptor,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.4,1.0,,2010.0,2020.0,ALL
8857,FCGBP,Q9Y6R7,0.722,0.231,1.6706e-51,DTO_05007584,Enzyme modulator,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
8858,PROZ,P22891,0.792,0.385,1.1759e-16,DTO_05007624,Enzyme,C3151465,PROTEIN Z DEFICIENCY,,,disease,Disease or Syndrome,0.3,1.0,moderate,2005.0,2005.0,ALL
8859,STK19,P49842,0.691,0.5,6.7428e-09,,,C1368275,Pigmented Basal Cell Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
8861,LDB1,Q86U70,0.736,0.385,0.98529,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
8862,APLN,Q9ULZ1,0.497,0.769,0.45897,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2014.0,2019.0,ALL
8863,PER3,P56645,0.559,0.731,1.3661e-17,DTO_05007542,Transcription factor,C1858496,"Advanced Sleep-Phase Syndrome, Familial",C10;F03;C24,   Nervous System Diseases;    Mental Disorders;    Occupational Diseases,disease,Disease or Syndrome,0.5,1.0,,2016.0,2016.0,ALL
8864,PER2,O15055,0.488,0.846,0.7148,DTO_05007542,Transcription factor,C3807327,"ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1",,,disease,Disease or Syndrome,0.8,1.0,limited,2001.0,2001.0,ALL
8867,SYNJ1,O43426,0.576,0.577,0.42709,DTO_05007624,Enzyme,C3809824,"PARKINSON DISEASE 20, EARLY-ONSET",,,disease,Disease or Syndrome,0.73,1.0,strong,2013.0,2019.0,ALL
8869,ST3GAL5,Q9UNP4,0.65,0.654,0.0013115,,,C1836824,Amish Infantile Epilepsy Syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.72,1.0,,2004.0,2018.0,ALL
8870,IER3,P46695,0.593,0.769,0.63122,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.31,1.0,,2010.0,2011.0,ALL
8871,SYNJ2,O15056,0.691,0.577,8.5042e-14,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2005.0,2015.0,ALL
8872,CDC123,O75794,0.78,0.231,1.1066e-05,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.16,1.0,,2008.0,2019.0,ALL
8874,ARHGEF7,Q14155,0.486,0.846,0.99995,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2020.0,ALL
8875,VNN2,O95498,0.691,0.346,4.448e-15,DTO_05007624,Enzyme,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.31,1.0,,2009.0,2009.0,ALL
8876,VNN1,O95497,0.67,0.5,4.3868e-06,DTO_05007624,Enzyme,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.31,1.0,,2006.0,2013.0,ALL
8877,SPHK1,Q9NYA1,0.48,0.808,3.0327e-07,DTO_03300101,Kinase,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2013.0,2020.0,ALL
8878,SQSTM1,Q13501,0.428,0.885,0.00086035,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,0.974,,2009.0,2020.0,ALL
8879,SGPL1,O95470,0.597,0.731,0.0036264,,,C4540559,"NEPHROTIC SYNDROME, TYPE 14",,,disease,Disease or Syndrome,0.71,1.0,strong,2014.0,2018.0,ALL
8880,FUBP1,Q96AE4,0.61,0.615,1.0,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2012.0,2014.0,ALL
8881,CDC16,Q13042,0.861,0.115,0.61402,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
8882,ZPR1,O75312,0.674,0.462,8.9466e-09,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.14,1.0,,2011.0,2019.0,ALL
8883,NAE1,Q13564,0.736,0.462,1.8043e-13,DTO_05007624,Enzyme,C0740392,"Infarction, Middle Cerebral Artery",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
8884,SLC5A6,Q9Y289,0.674,0.577,0.0060821,DTO_05007405,Transporter,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
8886,DDX18,Q9NVP1,0.805,0.192,0.13804,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
8887,TAX1BP1,Q86VP1,0.792,0.423,1.2061e-07,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
8888,MCM3AP,O60318,0.647,0.654,5.24e-09,,,C4748283,"PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",,,disease,Disease or Syndrome,0.6,1.0,strong,2013.0,2018.0,ALL
8890,EIF2B4,Q9UI10,0.659,0.538,0.96117,,,C1858991,Childhood Ataxia with Central Nervous System Hypomyelinization,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.9,0.909,,2001.0,2020.0,ALL
8891,EIF2B3,Q9NR50,0.729,0.346,0.56695,,,C1858991,Childhood Ataxia with Central Nervous System Hypomyelinization,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2002.0,2017.0,ALL
8892,EIF2B2,P49770,0.647,0.538,2.083e-10,,,C1858991,Childhood Ataxia with Central Nervous System Hypomyelinization,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.8,0.952,,2001.0,2020.0,ALL
8893,EIF2B5,Q13144,0.615,0.769,0.064171,,,C1858991,Childhood Ataxia with Central Nervous System Hypomyelinization,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.99,1.0,strong,2001.0,2019.0,ALL
8894,EIF2S2,P20042,0.621,0.577,0.95327,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2008.0,2019.0,ALL
8895,CPNE3,O75131,0.711,0.5,1.7777e-25,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.31,1.0,,2008.0,2008.0,ALL
8896,BUD31,P41223,0.711,0.5,0.23109,DTO_05007542,Transcription factor,C0029827,Other specified schistosomiasis,C01,   Infections,disease,Disease or Syndrome,0.2,1.0,,2012.0,2012.0,ALL
8897,MTMR3,Q13615,0.682,0.462,0.99937,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2015.0,2019.0,ALL
8898,MTMR2,Q13614,0.659,0.538,3.0351e-07,DTO_05007624,Enzyme,C1832399,"Charcot-Marie-Tooth disease, Type 4B1",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1999.0,2018.0,ALL
8899,PRPF4B,Q13523,0.76,0.269,1.0,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
8900,CCNA1,P78396,0.588,0.654,0.00043117,DTO_05007584,Enzyme modulator,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.33,1.0,,2004.0,2018.0,ALL
8904,CPNE1,Q99829,0.743,0.192,1.7292e-14,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
8905,AP1S2,P56377,0.631,0.615,0.86702,DTO_05007405,Transporter,C0796254,"DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, BASAL GANGLIA DISEASE, AND SEIZURES",C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.93,1.0,,1991.0,2019.0,ALL
8906,AP1G2,O75843,,,5.0978e-28,DTO_05007575,Receptor,C0085298,Sudden Cardiac Death,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.1,1.0,,2011.0,2011.0,ALL
8907,AP1M1,Q9BXS5,0.839,0.154,0.71251,DTO_05007621,Extracellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
8908,GYG2,O15488,1.0,0.115,7.0587e-10,DTO_05007624,Enzyme,C0017919,Glycogen Storage Disease,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.3,1.0,limited,2015.0,2015.0,ALL
8909,ENDOU,P21128,0.682,0.423,3.2354e-14,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2006.0,2019.0,ALL
8910,SGCE,O43556,0.626,0.538,0.023761,DTO_05007616,Calcium-binding protein,C1834570,Myoclonic dystonia,C10,   Nervous System Diseases,disease,Disease or Syndrome,1.0,0.956,,2000.0,2019.0,ALL
8911,CACNA1I,Q9P0X4,0.792,0.231,1.0,DTO_01300327,Ion channel,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.2,1.0,,2006.0,2006.0,ALL
8912,CACNA1H,O95180,0.628,0.423,4.7778e-10,DTO_01300327,Ion channel,C4310756,"HYPERALDOSTERONISM, FAMILIAL, TYPE IV",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2016.0,ALL
8913,CACNA1G,O43497,0.59,0.577,1.0,DTO_01300327,Ion channel,C4225205,SPINOCEREBELLAR ATAXIA 42,,,disease,Disease or Syndrome,0.73,1.0,strong,2015.0,2020.0,ALL
8914,TIMELESS,Q9UNS1,0.533,0.808,9.8476e-35,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,1.0,,2004.0,2017.0,ALL
8915,BCL10,O95999,0.491,0.769,0.33709,,,C0242647,Mucosa-Associated Lymphoid Tissue Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.8,0.968,,1999.0,2018.0,ALL
8916,HERC3,Q15034,0.931,0.115,0.070143,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
8924,HERC2,O95714,0.568,0.692,1.0,,,C3809753,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2013.0,ALL
8925,HERC1,Q15751,0.674,0.5,1.0,DTO_05007584,Enzyme modulator,C4310766,"MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2016.0,ALL
8926,SNURF,P63162;Q9Y675,0.623,0.538,0.4619,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,1996.0,2018.0,ALL
8927,BSN,Q9UPA5,0.769,0.308,1.0,,,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
8928,FOXH1,O75593,0.615,0.654,0.041555,,,C0079541,Holoprosencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.42,1.0,limited,2008.0,2016.0,ALL
8929,PHOX2B,Q99453,0.565,0.731,0.93755,,,C1275808,Congenital central hypoventilation,C23;C08;C10,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.958,strong,2002.0,2020.0,ALL
8930,MBD4,O95243,0.61,0.615,1.9706e-14,DTO_05007624,Enzyme,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
8932,MBD2,Q9UBB5,0.466,0.846,0.34957,DTO_05007378,Epigenetic regulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,1.0,,2002.0,2019.0,ALL
8933,RTL8C,A6ZKI3,0.931,0.192,0.45663,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
8934,RAB29,O14966,0.769,0.231,0.18152,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,0.929,,2010.0,2020.0,ALL
8935,SKAP2,O75563,0.653,0.577,0.0012836,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
8936,WASF1,Q92558,0.547,0.808,0.99757,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.34,1.0,strong,2007.0,2019.0,ALL
8938,BAIAP3,O94812,0.931,0.077,4.3826e-32,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2013.0,2013.0,ALL
8939,FUBP3,Q96I24,1.0,0.077,0.79825,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2008.0,2019.0,ALL
8940,TOP3B,O95985,0.769,0.269,0.00021389,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2013.0,2018.0,ALL
8941,CDK5R2,Q13319,0.769,0.346,0.67068,DTO_05007584,Enzyme modulator,C0024198,Lyme Disease,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,1990.0,1999.0,ALL
8942,KYNU,Q16719,0.617,0.692,4.1806e-18,DTO_05007624,Enzyme,C0268474,Hydroxykynureninuria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.71,1.0,strong,2007.0,2017.0,ALL
8943,AP3D1,O14617,0.678,0.385,0.98648,DTO_05007405,Transporter,C0079504,Hermanski-Pudlak Syndrome,C16;C18;C11;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.53,1.0,limited,2009.0,2019.0,ALL
8945,BTRC,Q9Y297,0.601,0.731,0.011942,,,C0265554,Ectrodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.3,1.0,,2006.0,2013.0,ALL
8968,H3C7,P68431,0.67,0.308,0.0065896,,,C2986658,Diffuse Intrinsic Pontine Glioma,,,disease,Neoplastic Process,0.05,1.0,,2014.0,2020.0,ALL
8969,H2AC11,P0C0S8,0.839,0.192,0.00055075,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
8970,H2BC11,P06899,0.89,0.154,0.031259,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2012.0,2012.0,ALL
8971,H1-10,Q92522,1.0,0.038,0.08771,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.2,1.0,,2016.0,2016.0,ALL
8972,MGAM,O43451,0.592,0.615,1.0382e-35,DTO_05007624,Enzyme,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2020.0,ALL
8973,CHRNA6,Q15825,0.711,0.346,3.5719e-08,DTO_01300327,Ion channel,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2009.0,2011.0,ALL
8974,P4HA2,O15460,0.653,0.577,1.9699e-06,,,C4310655,"MYOPIA 25, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2015.0,ALL
8975,USP13,Q92995,0.659,0.423,3.0651e-12,DTO_05007624,Enzyme,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
8976,WASL,O00401,0.678,0.5,0.87654,DTO_05007530,Cellular structure,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
8985,PLOD3,O60568,0.659,0.385,6.1305e-13,DTO_05007624,Enzyme,C2676285,"Bone Fragility with Contractures, Arterial Rupture, and Deafness",C23;C17;C05,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2008.0,2019.0,ALL
8986,RPS6KA4,O75676,0.743,0.269,0.99715,DTO_03300101,Kinase,C3165106,Infiltrating duct carcinoma of female breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
8987,STBD1,O95210,0.89,0.115,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,0.5,,2011.0,2015.0,ALL
8988,HSPB3,Q12988,0.448,0.769,6.0944e-05,,,C3150619,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC",,,disease,Disease or Syndrome,0.6,1.0,limited,2010.0,2010.0,ALL
8989,TRPA1,O75762,0.546,0.846,7.2309e-35,DTO_01300327,Ion channel,C3808667,"EPISODIC PAIN SYNDROME, FAMILIAL, 1",,,disease,Disease or Syndrome,0.6,1.0,,2010.0,2018.0,ALL
8991,SELENBP1,Q13228,0.493,0.846,3.2268e-16,DTO_05007608,Immune response,C0018520,Halitosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.41,1.0,,2018.0,2018.0,ALL
8992,ATP6V0E1,O15342,1.0,0.077,0.39774,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
8993,PGLYRP1,O75594,0.78,0.346,1.7919e-05,,,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.03,1.0,,2018.0,2019.0,ALL
8994,LIMD1,Q9UGP4,0.691,0.346,0.41673,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
8995,TNFSF18,Q9UNG2,0.78,0.231,0.00019152,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
8996,NOL3,O60936,0.575,0.808,0.0001992,,,C3539916,"MYOCLONUS, FAMILIAL CORTICAL",,,disease,Disease or Syndrome,0.61,1.0,,2012.0,2014.0,ALL
8997,KALRN,O60229,0.644,0.654,1.0,DTO_03300101,Kinase,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
8999,CDKL2,Q92772,0.751,0.346,3.0975e-17,DTO_03300101,Kinase,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
9001,HAP1,P54257,0.604,0.769,3.3512e-26,DTO_05007405,Transporter,C0011573,Endogenous depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,,,,,ALL
9002,F2RL3,Q96RI0,0.539,0.769,4.1298e-05,DTO_02300001,G-protein coupled receptor,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
9013,TAF1C,Q15572,0.861,0.192,1.4604e-24,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2010.0,2012.0,ALL
9014,TAF1B,Q53T94,1.0,0.077,7.9823e-15,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
9015,TAF1A,Q15573,0.805,0.308,1.235e-09,,,C0340427,Familial dilated cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
9016,SLC25A14,O95258,0.839,0.231,0.98821,DTO_05007405,Transporter,C0014070,Encephalomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
9019,MPZL1,O95297,0.736,0.462,0.15905,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2006.0,2006.0,ALL
9020,MAP3K14,Q99558,0.608,0.769,,DTO_03300101,Kinase,C1335167,Ovarian Mucinous Adenocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
9021,SOCS3,O14543,0.434,0.808,0.74613,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2005.0,2019.0,ALL
9022,CLIC3,O95833,0.729,0.423,6.2316e-09,DTO_01300327,Ion channel,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2015.0,ALL
9023,CH25H,O95992,0.663,0.577,0.2272,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.06,1.0,,2004.0,2019.0,ALL
9024,BRSK2,Q8IWQ3,0.7,0.5,0.95141,DTO_03300101,Kinase,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,strong,2017.0,2019.0,ALL
9025,RNF8,O76064,0.695,0.462,0.99943,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
9026,HIP1R,O75146,0.7,0.423,1.4566e-15,DTO_05007530,Cellular structure,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
9027,NAT8,Q9UHE5,0.89,0.231,,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9028,RHBDL1,O75783,0.805,0.269,0.32394,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2017.0,ALL
9030,ERDA1,,0.736,0.154,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,0.4,,1999.0,2004.0,ALL
9031,BAZ1B,Q9UIG0,0.53,0.731,1.0,,,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,,1998.0,2017.0,ALL
9032,TM4SF5,O14894,0.722,0.385,0.0079243,,,C1611184,Calcification of coronary artery,C18;C14,   Nutritional and Metabolic Diseases;    Cardiovascular Diseases,phenotype,Pathologic Function,0.1,1.0,,2012.0,2012.0,ALL
9033,PKD2L1,Q9P0L9,0.565,0.731,1.5748e-27,DTO_01300327,Ion channel,C0003431,Antisocial Personality Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,0.933,,2007.0,2020.0,ALL
9034,CCRL2,O00421,0.621,0.654,0.36861,DTO_02300001,G-protein coupled receptor,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.31,1.0,,2003.0,2006.0,ALL
9037,SEMA5A,Q13591,0.61,0.731,1.5403e-05,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2006.0,2016.0,ALL
9038,TAAR5,O14804,0.78,0.346,6.2057e-11,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
9039,UBA3,Q8TBC4,0.805,0.192,0.50413,DTO_05007624,Enzyme,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
9040,UBE2M,P61081,0.76,0.231,0.79769,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
9043,SPAG9,O60271,0.566,0.769,1.0,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2008.0,2020.0,ALL
9044,BTAF1,O14981,0.89,0.077,1.0,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
9045,RPL14,P50914,0.722,0.308,0.89508,DTO_05007557,Nucleic acid binding,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
9046,DOK2,O60496,0.67,0.5,1.2082e-05,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.31,1.0,,2010.0,2010.0,ALL
9047,SH2D2A,Q9NP31,0.78,0.192,8.2695e-07,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.12,1.0,,2005.0,2019.0,ALL
9048,ARTN,Q5T4W7,0.48,0.846,0.35793,DTO_05007599,Signaling,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2008.0,2019.0,ALL
9049,AIP,O00170,0.517,0.769,0.36163,DTO_05007613,Chaperone,C0033375,Prolactinoma,C04;C10;C19,   Neoplasms;    Nervous System Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.7,1.0,strong,2009.0,2018.0,ALL
9050,PSTPIP2,Q9H939,0.76,0.385,0.0028024,DTO_05007530,Cellular structure,C0263859,"Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.31,1.0,,2010.0,2016.0,ALL
9051,PSTPIP1,O43586,0.65,0.577,2.4606e-06,DTO_05007530,Cellular structure,C1858361,"Pyogenic Arthritis, Pyoderma Gangrenosum and Acne",C01;C17;C05,   Infections;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.8,1.0,,2002.0,2019.0,ALL
9052,GPRC5A,Q8NFJ5,0.579,0.692,6.786e-08,DTO_02300001,G-protein coupled receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0,,2007.0,2007.0,ALL
9053,MAP7,Q14244,0.792,0.308,0.42439,DTO_05007530,Cellular structure,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
9054,NFS1,Q9Y697,0.861,0.308,0.055351,DTO_05007624,Enzyme,C4750855,Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency,C23;C18;C11;C05;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
9055,PRC1,O43663,0.599,0.692,2.6753e-07,DTO_05007530,Cellular structure,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.47,1.0,,2007.0,2018.0,ALL
9056,SLC7A7,Q9UM01,0.603,0.654,7.9543e-07,DTO_05007405,Transporter,C0268647,Lysinuric Protein Intolerance,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1980.0,2020.0,ALL
9057,SLC7A6,Q92536,0.805,0.346,0.0097291,DTO_05007405,Transporter,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2019.0,ALL
9058,SLC13A2,Q13183,0.736,0.346,1.2919e-13,DTO_05007405,Transporter,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.05,1.0,,2014.0,2019.0,ALL
9060,PAPSS2,O95340,0.682,0.462,1.9748e-10,DTO_05007624,Enzyme,C2748515,"Spondyloepimetaphyseal Dysplasia, Pakistani Type",C23;C16;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.92,1.0,,1969.0,2015.0,ALL
9061,PAPSS1,O43252,0.839,0.154,6.3322e-08,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
9063,PIAS2,O75928,0.682,0.385,0.99718,,,C0233849,Personality Traits,F01,   Behavior and Behavior Mechanisms,group,Finding,0.1,1.0,,2012.0,2012.0,ALL
9064,MAP3K6,O95382,0.861,0.192,1.0532e-16,DTO_03300101,Kinase,C1708349,Hereditary Diffuse Gastric Cancer,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2014.0,2014.0,ALL
9066,SYT7,O43581,0.686,0.231,0.96342,DTO_05007405,Transporter,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
9068,ANGPTL1,O95841,0.691,0.5,1.2103e-10,DTO_05007599,Signaling,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
9069,CLDN12,P56749,0.736,0.308,0.048525,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2007.0,2019.0,ALL
9070,ASH2L,Q9UBL3,0.743,0.308,0.99968,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,1.0,,2014.0,2014.0,ALL
9071,CLDN10,P78369,0.626,0.577,0.00083876,DTO_05007527,Cell-cell junction,C4522164,HELIX SYNDROME,,,disease,Disease or Syndrome,0.61,1.0,moderate,2009.0,2018.0,ALL
9073,CLDN8,P56748,0.674,0.5,0.016193,DTO_05007527,Cell-cell junction,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0,,2006.0,2011.0,ALL
9074,CLDN6,P56747,0.656,0.5,0.0040357,DTO_05007527,Cell-cell junction,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.917,,2003.0,2019.0,ALL
9075,CLDN2,P57739,0.575,0.692,0.70328,DTO_05007527,Cell-cell junction,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.42,1.0,,2012.0,2020.0,ALL
9076,CLDN1,O95832,0.481,0.808,0.0010103,DTO_05007527,Cell-cell junction,C1843355,"ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS",C23;C16;C06;C17;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.75,1.0,,2004.0,2018.0,ALL
9077,DIRAS3,O95661,0.631,0.385,,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2009.0,2017.0,ALL
9079,LDB2,O43679,0.76,0.115,0.9546,DTO_05007542,Transcription factor,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
9080,CLDN9,O95484,0.861,0.231,6.3138e-06,DTO_05007527,Cell-cell junction,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
9081,PRY,O14603,0.861,0.115,,,,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",C16;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
9082,XKRY,A2RUG3;O14609,0.931,0.077,,,,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",C16;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
9083,BPY2,O14599,0.76,0.231,,,,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",C16;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
9084,VCY,O14598,0.89,0.231,,,,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",C16;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
9085,CDY1,Q9Y6F8,0.805,0.231,,,,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",C16;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
9086,EIF1AY,O14602,1.0,0.038,0.55208,DTO_05007557,Nucleic acid binding,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
9087,TMSB4Y,O14604,0.931,0.115,0.31923,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
9088,PKMYT1,Q99640,0.7,0.385,0.21858,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2017.0,2019.0,ALL
9091,PIGQ,Q9BRB3,0.61,0.577,1.3575e-06,DTO_05007624,Enzyme,C0029124,Optic Atrophy,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.4,1.0,strong,2019.0,2019.0,ALL
9092,SART1,O43290,0.682,0.308,0.88163,DTO_05007621,Extracellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9093,DNAJA3,Q96EY1,0.722,0.346,0.0098017,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9094,UNC119,Q13432,0.691,0.462,0.00014831,DTO_05007575,Receptor,C3809768,IMMUNODEFICIENCY 13,,,disease,Disease or Syndrome,0.62,1.0,limited,2012.0,2012.0,ALL
9095,TBX19,O60806,0.695,0.462,7.1102e-06,DTO_05007542,Transcription factor,C0271583,"ACTH Deficiency, Isolated",C16;C18;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.76,1.0,strong,2001.0,2019.0,ALL
9096,TBX18,O95935,0.695,0.231,0.99905,DTO_05007542,Transcription factor,C0521619,Obstruction of pelviureteric junction,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Pathologic Function,0.7,1.0,,2015.0,2015.0,ALL
9097,USP14,P54578,0.595,0.654,0.90546,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9098,USP6,P35125,0.633,0.692,2.9469e-35,DTO_05007624,Enzyme,C0410005,Nodular fasciitis,C04;C05;C10,   Neoplasms;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.4,1.0,,2011.0,2019.0,ALL
9099,USP2,O75604,0.682,0.462,0.0006905,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
9100,USP10,Q14694,0.663,0.462,0.99411,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9101,USP8,P40818,0.587,0.654,1.0,DTO_05007624,Enzyme,C0221406,Pituitary-dependent Cushing's disease,C10;C19,   Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.8,1.0,,2015.0,2020.0,ALL
9103,FCGR2C,P31995,0.61,0.654,,DTO_05007620,Cell adhesion,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.54,0.75,,2008.0,2019.0,ALL
9104,RGN,Q15493,0.566,0.692,0.022123,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,,2014.0,2018.0,ALL
9107,MTMR6,Q9Y217,,,3.8619e-08,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9108,MTMR7,Q9Y216,0.839,0.308,2.21e-14,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9110,MTMR4,Q9NYA4,0.931,0.077,0.99959,DTO_05007624,Enzyme,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
9111,NMI,Q13287,0.656,0.346,8.699e-06,DTO_05007542,Transcription factor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9112,MTA1,Q13330,0.547,0.692,1.0,DTO_05007557,Nucleic acid binding,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,1.0,,2012.0,2018.0,ALL
9113,LATS1,O95835,0.563,0.731,0.99987,DTO_03300101,Kinase,C4721806,"Carcinoma, Basal Cell",C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2015.0,2016.0,ALL
9114,ATP6V0D1,P61421,0.76,0.385,0.98763,DTO_05007405,Transporter,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
9118,INA,Q16352,0.633,0.5,1.4818e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
9119,KRT75,O95678,0.78,0.192,4.041e-08,,,C0549150,Pseudofolliculitis barbae (disorder),C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.31,1.0,,2004.0,2004.0,ALL
9120,SLC16A6,O15403,0.861,0.115,0.0019063,DTO_05007405,Transporter,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
9121,SLC16A5,O15375,0.89,0.115,1.9979e-10,DTO_05007405,Transporter,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
9122,SLC16A4,O15374,0.55,0.731,9.6707e-08,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.941,,2013.0,2019.0,ALL
9123,SLC16A3,O15427,0.542,0.731,0.00029385,DTO_05007405,Transporter,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,1.0,,2011.0,2020.0,ALL
9124,PDLIM1,O00151,0.729,0.423,0.0014717,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2016.0,ALL
9125,CNOT9,Q92600,0.769,0.192,0.98565,,,C0151779,Cutaneous Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2015.0,2016.0,ALL
9126,SMC3,Q9UQE7,0.535,0.846,1.0,,,C1853099,Cornelia de Lange Syndrome 3,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,,2014.0,2019.0,ALL
9127,P2RX6,O15547,0.599,0.769,4.468e-09,DTO_01300327,Ion channel,C0341106,Eosinophilic esophagitis,C06;C20;C15,   Digestive System Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
9128,PRPF4,O43172,0.67,0.462,0.9993,DTO_05007557,Nucleic acid binding,C4014681,RETINITIS PIGMENTOSA 70,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2014.0,ALL
9129,PRPF3,O43395,0.695,0.385,1.0,DTO_05007557,Nucleic acid binding,C1832378,Retinitis Pigmentosa 18,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.93,1.0,,2002.0,2011.0,ALL
9130,FAM50A,Q14320,,,0.97913,,,C0028259,Nodule,,,phenotype,Acquired Abnormality,0.01,1.0,,2018.0,2018.0,ALL
9131,AIFM1,O95831,0.527,0.769,0.99795,DTO_05007624,Enzyme,C0795910,COWCHOCK SYNDROME,C23;C16;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.75,1.0,,1985.0,2019.0,ALL
9132,KCNQ4,P56696,0.674,0.462,0.46799,DTO_01300327,Ion channel,C2677637,"Deafness, Autosomal Dominant 2A",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1997.0,2015.0,ALL
9133,CCNB2,O95067,0.686,0.5,5.7407e-12,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2017.0,2019.0,ALL
9134,CCNE2,O96020,0.608,0.538,0.86983,DTO_05007584,Enzyme modulator,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
9135,RABEP1,Q15276,0.792,0.423,0.99851,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
9136,RRP9,O43818,0.89,0.115,0.28533,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
9138,ARHGEF1,Q92888,0.623,0.538,0.76754,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
9139,CBFA2T2,O43439,0.615,0.654,0.99585,DTO_05007542,Transcription factor,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9140,ATG12,O94817,0.626,0.615,4.6926e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2012.0,2019.0,ALL
9141,PDCD5,O14737,0.61,0.538,0.0036424,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2006.0,2018.0,ALL
9143,SYNGR3,O43761,0.89,0.192,0.52946,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
9144,SYNGR2,O43760,0.89,0.115,5.1893e-05,DTO_05007405,Transporter,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
9145,SYNGR1,O43759,0.736,0.346,0.45121,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,1.0,,2004.0,2009.0,ALL
9146,HGS,O14964,0.597,0.808,0.0063571,,,C0036346,"Schizophrenia, Childhood",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
9147,NEMF,O60524,0.805,0.154,0.00035788,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2017.0,2017.0,ALL
9148,NEURL1,O76050,0.556,0.538,0.011091,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.44,1.0,,2016.0,2019.0,ALL
9149,DYRK1B,Q9Y463,0.647,0.462,0.96905,DTO_03300101,Kinase,C4014361,ABDOMINAL OBESITY-METABOLIC SYNDROME 3,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2014.0,ALL
9150,CTDP1,Q9Y5B0,0.641,0.577,0.00059966,DTO_05007624,Enzyme,C1858726,"Congenital Cataracts, Facial Dysmorphism, And Neuropathy",C16;C11;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.6,1.0,,2003.0,2003.0,ALL
9152,SLC6A5,Q9Y345,0.67,0.5,8.977e-15,DTO_05007405,Transporter,C3553288,HYPEREKPLEXIA 3,,,disease,Disease or Syndrome,0.8,1.0,,2003.0,2019.0,ALL
9153,SLC28A2,O43868,0.78,0.385,1.1277e-27,DTO_05007405,Transporter,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2005.0,2005.0,ALL
9154,SLC28A1,O00337,0.686,0.538,5.737e-20,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2006.0,2008.0,ALL
9156,EXO1,Q9UQ84,0.578,0.692,8.12e-13,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.43,1.0,,2009.0,2019.0,ALL
9158,FIBP,O43427,0.674,0.538,4.3854e-06,,,C4310715,THAUVIN-ROBINET-FAIVRE SYNDROME,,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2016.0,ALL
9159,PCSK7,Q16549,0.631,0.615,0.0041859,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9162,DGKI,O75912,0.769,0.269,0.93134,DTO_05007624,Enzyme,C0001175,Acquired Immunodeficiency Syndrome,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
9166,EBAG9,O00559,0.615,0.462,0.077101,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2001.0,2019.0,ALL
9167,COX7A2L,O14548,0.736,0.385,1.1516e-06,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9168,TMSB10,P63313,0.641,0.577,0.018038,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
9169,SCAF11,Q99590,0.584,0.731,1.0,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
9170,LPAR2,Q9HBW0,0.463,0.846,0.036658,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,1997.0,2019.0,ALL
9172,MYOM2,P54296,0.57,0.692,7.0086e-85,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.1,1.0,,1990.0,2020.0,ALL
9173,IL1RL1,Q01638,0.547,0.731,1.4407e-12,DTO_05007575,Receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,0.951,,2008.0,2020.0,ALL
9175,MAP3K13,O43283,0.743,0.192,0.80051,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2016.0,2017.0,ALL
9177,HTR3B,O95264,0.678,0.423,2.4797e-07,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,1.0,,2004.0,2017.0,ALL
9179,AP4M1,O00189,0.638,0.5,4.4873e-17,DTO_05007621,Extracellular structure,C2752008,"Spastic Paraplegia-50, Autosomal Recessive",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.61,1.0,,2009.0,2019.0,ALL
9180,OSMR,Q99650,0.599,0.577,9.2144e-18,DTO_05007599,Signaling,C4551501,"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1",C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2010.0,ALL
9181,ARHGEF2,Q92974,0.502,0.769,1.0,,,C4479613,NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS,,,disease,Disease or Syndrome,0.5,1.0,limited,2014.0,2017.0,ALL
9182,RASSF9,O75901,0.861,0.115,1.4029e-08,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
9183,ZW10,O43264,0.792,0.192,0.0014855,DTO_05007530,Cellular structure,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2004.0,2018.0,ALL
9184,BUB3,O43684,0.588,0.615,0.80927,DTO_05007557,Nucleic acid binding,C1850343,Mosaic variegated aneuploidy syndrome 1,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.31,1.0,,2013.0,2018.0,ALL
9185,REPS2,Q8NFH8,0.751,0.192,0.20309,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2009.0,2013.0,ALL
9187,SLC24A1,O60721,0.716,0.154,9.2153e-05,DTO_05007405,Transporter,C0339535,"Night blindness, congenital stationary",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.72,1.0,strong,2010.0,2016.0,ALL
9188,DDX21,Q9NR30,0.805,0.308,0.99997,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2014.0,2018.0,ALL
9189,ZBED1,O96006,0.716,0.423,0.00036187,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.4,1.0,,2003.0,2019.0,ALL
9191,DEDD,O75618,0.711,0.346,0.95912,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
9194,SLC16A7,O60669,0.682,0.538,0.0058162,DTO_05007405,Transporter,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
9197,SLC33A1,O00400,0.529,0.769,9.8902e-05,DTO_05007405,Transporter,C2675528,"Spastic Paraplegia 42, Autosomal Dominant",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2008.0,2018.0,ALL
9200,HACD1,B0YJ81,0.539,0.846,1.2914e-09,,,C0270960,Congenital myopathy (disorder),C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Congenital Abnormality,0.32,1.0,moderate,2013.0,2017.0,ALL
9201,DCLK1,O15075,0.545,0.615,0.99964,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
9202,ZMYM4,Q5VZL5,0.931,0.077,1.0,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
9203,ZMYM3,Q14202,0.76,0.308,1.0,DTO_05007584,Enzyme modulator,C1136249,"Mental Retardation, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.33,1.0,limited,1996.0,1999.0,ALL
9204,ZMYM6,O95789,0.931,0.115,6.2703e-13,DTO_05007584,Enzyme modulator,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,1.0,limited,2015.0,2015.0,ALL
9205,ZMYM5,Q9UJ78,0.931,0.115,0.00016664,DTO_05007584,Enzyme modulator,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
9208,LRRFIP1,Q32MZ4,0.678,0.5,0.019511,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
9209,LRRFIP2,Q9Y608,0.931,0.154,2.5833e-25,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9210,BMP15,O95972,0.659,0.385,0.0001832,DTO_05007599,Signaling,C1845294,Ovarian Dysgenesis 2,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,1.0,,2004.0,2015.0,ALL
9211,LGI1,O95970,0.568,0.731,0.99914,,,C4551957,"Epilepsy, Familial Temporal Lobe 1",C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,1.0,1.0,,2002.0,2020.0,ALL
9212,AURKB,Q96GD4,0.51,0.769,0.0044521,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.38,1.0,,2008.0,2018.0,ALL
9213,XPR1,Q9UBH6,0.488,0.731,0.99999,DTO_05007405,Transporter,C4225335,"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2016.0,ALL
9214,FCMR,O60667,0.751,0.346,1.6032e-05,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
9215,LARGE1,O95461,0.526,0.654,0.98934,DTO_05007624,Enzyme,C1837229,"Muscular Dystrophy, Congenital, Type 1D",C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.9,1.0,,2003.0,2016.0,ALL
9217,VAPB,O95292,0.666,0.423,0.58111,DTO_05007405,Transporter,C1837728,AMYOTROPHIC LATERAL SCLEROSIS 8 (disorder),C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.73,0.941,,2004.0,2019.0,ALL
9218,VAPA,Q9P0L0,0.76,0.423,0.35325,DTO_05007405,Transporter,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
9219,MTA2,O94776,0.579,0.808,0.74479,DTO_05007557,Nucleic acid binding,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,1.0,,2012.0,2017.0,ALL
9220,TIAF1,O95411,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2012.0,2019.0,ALL
9221,NOLC1,Q14978,0.641,0.615,0.00010396,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1997.0,2017.0,ALL
9223,MAGI1,Q96QZ7,0.628,0.615,0.5597,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2014.0,ALL
9227,LRAT,O95237,0.608,0.654,0.028354,,,C2750063,Leber Congenital Amaurosis 14,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.9,1.0,,2001.0,2011.0,ALL
9228,DLGAP2,Q9P1A6,0.736,0.385,0.99989,DTO_05007575,Receptor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2020.0,ALL
9229,DLGAP1,O14490,0.691,0.385,0.99875,DTO_05007575,Receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,0.333,,2003.0,2018.0,ALL
9230,RAB11B,Q15907,0.691,0.538,0.4442,,,C4540498,"NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER",,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
9231,DLG5,Q8TDM6,0.686,0.5,0.99948,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9232,PTTG1,O95997,0.526,0.654,0.00042161,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.37,1.0,,2006.0,2019.0,ALL
9235,IL32,P24001,0.495,0.731,3.7471e-09,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,1.0,,2007.0,2019.0,ALL
9236,CCPG1,Q9ULG6,,,0.00056126,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9238,TBRG4,Q969Z0,,,1.225e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
9240,PNMA1,Q8ND90,0.931,0.154,0.042869,,,C0007682,CNS disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
9241,NOG,Q13253,0.518,0.731,0.89026,,,C1861385,"SYMPHALANGISM, PROXIMAL",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.8,1.0,,1995.0,2019.0,ALL
9242,MSC,O60682,0.475,0.846,0.024651,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2013.0,2019.0,ALL
9244,CRLF1,O75462,0.597,0.654,3.9958e-05,DTO_05007599,Signaling,C1848947,COLD-INDUCED SWEATING SYNDROME 1,C23;C16;C17;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2003.0,2014.0,ALL
9245,GCNT3,O95395,0.736,0.231,1.1214e-08,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2006.0,2018.0,ALL
9246,UBE2L6,O14933,0.716,0.423,0.0077047,DTO_05007624,Enzyme,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
9247,GCM2,O75603,0.647,0.538,0.00091142,,,C1832648,Hypoparathyroidism familial isolated,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.72,0.857,,2005.0,2017.0,ALL
9248,GPR50,Q13585,0.686,0.462,0.64639,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2005.0,2010.0,ALL
9249,DHRS3,O75911,0.751,0.423,0.22581,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9252,RPS6KA5,O75582,0.722,0.577,0.99909,DTO_03300101,Kinase,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2005.0,2005.0,ALL
9253,NUMBL,Q9Y6R0,0.78,0.231,0.99902,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2006.0,2006.0,ALL
9254,CACNA2D2,Q9NY47,0.626,0.615,0.99997,DTO_01300327,Ion channel,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.51,1.0,strong,2004.0,2019.0,ALL
9255,AIMP1,Q12904,0.566,0.769,3.0411e-07,DTO_05007624,Enzyme,C1850053,"Pelizaeus-Merzbacher-like disease, autosomal recessive, 2",C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2010.0,2019.0,ALL
9256,TSPOAP1,O95153,0.931,0.115,0.00844,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9258,MFHAS1,Q9Y4C4,0.729,0.538,4.2417e-09,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2017.0,2018.0,ALL
9260,PDLIM7,Q9NR12,0.474,0.808,0.70838,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2002.0,2018.0,ALL
9261,MAPKAPK2,P49137,0.587,0.769,0.99957,DTO_03300101,Kinase,C0149745,Oral Ulcer,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
9262,STK17B,O94768,0.769,0.308,0.013619,DTO_03300101,Kinase,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
9263,STK17A,Q9UEE5,0.743,0.192,0.040434,DTO_03300101,Kinase,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9265,CYTH3,O43739,0.931,0.115,0.72252,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
9266,CYTH2,Q99418,0.792,0.154,0.25494,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2013.0,2013.0,ALL
9267,CYTH1,Q15438,0.805,0.231,0.99981,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
9270,ITGB1BP1,O14713,0.861,0.308,9.6972e-05,,,C0005941,"Bone Diseases, Developmental",C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
9271,PIWIL1,Q96J94,0.57,0.731,7.2798e-14,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
9274,BCL7C,Q8WUZ0,0.821,0.115,0.079509,,,C0014474,Ependymoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
9275,BCL7B,Q9BQE9,0.821,0.308,0.18519,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
9276,COPB2,P35606,0.644,0.615,1.0,DTO_05007405,Transporter,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.31,1.0,,2017.0,2017.0,ALL
9277,WDR46,O15213,0.89,0.077,5.4327e-13,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
9278,ZBTB22,O15209,,,0.21918,DTO_05007624,Enzyme,C0740432,Stomach fullness,,,phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
9282,MED14,O60244,0.861,0.154,1.0,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
9283,GPR37L1,O60883,0.751,0.192,1.0195e-09,DTO_02300001,G-protein coupled receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
9284,NPIPA1,E9PIF3;Q9UND3,0.89,0.231,0.32248,,,C0019270,Hernia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.01,1.0,,2019.0,2019.0,ALL
9287,TAAR2,Q9P1P5,0.931,,7.64e-11,DTO_02300001,G-protein coupled receptor,C0375021,"Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site",,,disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
9289,ADGRG1,Q9Y653,0.59,0.654,5.3483e-10,DTO_02300001,G-protein coupled receptor,C1847352,"POLYMICROGYRIA, BILATERAL FRONTOPARIETAL",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.958,strong,2004.0,2019.0,ALL
9290,GPR55,Q9Y2T6,0.619,0.615,2.8503e-05,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,2011.0,2019.0,ALL
9293,GPR52,Q9Y2T5,0.89,0.115,0.0095377,DTO_02300001,G-protein coupled receptor,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2018.0,ALL
9294,S1PR2,O95136,0.585,0.731,0.018286,DTO_02300001,G-protein coupled receptor,C1835854,"DEAFNESS, AUTOSOMAL RECESSIVE 68",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2006.0,2018.0,ALL
9295,SRSF11,Q05519,0.821,0.269,0.99806,DTO_05007557,Nucleic acid binding,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
9296,ATP6V1F,Q16864,0.931,0.115,0.014736,DTO_05007405,Transporter,C0153252,Systemic candidiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
9300,SNORD28,,,,,,,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
9301,SNORD27,,1.0,0.077,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
9304,SNORD22,,0.89,0.115,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
9306,SOCS6,O14544,0.631,0.615,0.98865,DTO_05007584,Enzyme modulator,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
9308,CD83,Q01151,0.566,0.731,0.0052136,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.33,0.75,,2003.0,2017.0,ALL
9310,ZNF235,Q14590,,,3.3787e-10,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9311,ASIC3,Q9UHC3,0.663,0.538,3.4071e-07,DTO_01300327,Ion channel,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0,,2001.0,2001.0,ALL
9312,KCNB2,Q92953,0.89,0.154,0.99613,DTO_01300327,Ion channel,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
9313,MMP20,O60882,0.663,0.538,6.0776e-14,DTO_05007624,Enzyme,C2675858,"Amelogenesis Imperfecta, Hypomaturation Type, Iia2",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2002.0,2017.0,ALL
9314,KLF4,O43474,0.449,0.769,0.99714,DTO_05007557,Nucleic acid binding,C0025286,Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.37,1.0,,2016.0,2019.0,ALL
9315,NREP,Q16612,0.682,0.577,0.0056013,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
9317,PTER,Q96BW5,0.769,0.346,3.2773e-13,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9318,COPS2,P61201,0.792,0.231,0.99997,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
9319,TRIP13,Q15645,0.559,0.654,0.99606,,,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.62,1.0,,2017.0,2020.0,ALL
9320,TRIP12,Q14669,0.678,0.462,1.0,,,C4540324,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 49",,,disease,Mental or Behavioral Dysfunction,0.6,1.0,strong,2017.0,2017.0,ALL
9321,TRIP11,Q15643,0.595,0.654,1.714e-12,,,C0265273,Achondrogenesis type 1A,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.91,1.0,,2010.0,2018.0,ALL
9322,TRIP10,Q15642,0.65,0.654,1.6667e-05,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.21,1.0,,2015.0,2017.0,ALL
9324,HMGN3,Q15651,0.931,0.077,0.057786,DTO_05007557,Nucleic acid binding,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
9325,TRIP4,Q15650,0.641,0.654,5.9901e-07,DTO_05007542,Transcription factor,C4225177,SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1,,,disease,Disease or Syndrome; Congenital Abnormality,0.6,1.0,,2016.0,2016.0,ALL
9326,ZNHIT3,Q15649,0.666,0.462,5.5408e-07,,,C1850055,PEHO syndrome,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.73,1.0,limited,2017.0,2020.0,ALL
9328,GTF3C5,Q9Y5Q8,,,1.6233e-08,DTO_05007557,Nucleic acid binding,C2239219,von Willebrand's factor (lab test),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9330,GTF3C3,Q9Y5Q9,1.0,,6.9686e-07,DTO_05007542,Transcription factor,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0,moderate,2019.0,2019.0,ALL
9331,B4GALT6,Q9UBX8,0.89,0.154,0.90783,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
9332,CD163,Q86VB7,0.427,0.846,0.0008338,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.35,0.833,,2009.0,2018.0,ALL
9333,TGM5,O43548,0.656,0.615,2.4183e-25,DTO_05007624,Enzyme,C1853354,"Peeling skin syndrome, acral type",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.75,1.0,strong,1998.0,2018.0,ALL
9334,B4GALT5,O43286,0.76,0.308,0.99889,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9337,CNOT8,Q9UFF9,0.695,0.462,0.21741,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2010.0,2012.0,ALL
9338,TCEAL1,Q15170,0.7,0.346,0.58578,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2001.0,2017.0,ALL
9340,GLP2R,O95838,0.705,0.269,2.635e-11,DTO_02300001,G-protein coupled receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2017.0,2017.0,ALL
9341,VAMP3,Q15836,0.695,0.385,0.0025882,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2008.0,2008.0,ALL
9342,SNAP29,O95721,0.633,0.654,0.013567,DTO_05007405,Transporter,C1836033,"Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome",C16;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.95,1.0,,2005.0,2019.0,ALL
9343,EFTUD2,Q15029,0.647,0.462,1.0,DTO_05007624,Enzyme,C1864652,"Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate",C23;C16;C11;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,0.938,,1997.0,2019.0,ALL
9344,TAOK2,Q9UL54,0.736,0.231,0.99976,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2017.0,2019.0,ALL
9348,NDST3,O95803,0.805,0.192,1.0699e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2013.0,2018.0,ALL
9349,RPL23,P62829,0.729,0.5,0.33031,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.3,1.0,strong,2017.0,2017.0,ALL
9350,CER1,O95813,0.792,0.269,1.6674e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,1999.0,2008.0,ALL
9351,SLC9A3R2,Q15599,0.588,0.654,0.038353,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.5,1.0,,2004.0,2012.0,ALL
9352,TXNL1,O43396,0.861,0.115,0.88904,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
9353,SLIT2,O94813,0.511,0.769,1.0,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2009.0,2017.0,ALL
9354,UBE4A,Q14139,0.729,0.308,0.10902,DTO_05007584,Enzyme modulator,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
9355,LHX2,P50458,0.678,0.615,0.98812,DTO_05007557,Nucleic acid binding,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0,,2007.0,2007.0,ALL
9356,SLC22A6,Q4U2R8,0.743,0.462,5.3222e-08,DTO_05007405,Transporter,C0006663,Calcinosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.3,1.0,,2003.0,2003.0,ALL
9358,ITGBL1,O95965,0.705,0.423,1.7671e-09,DTO_05007575,Receptor,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2013.0,ALL
9360,PPIG,Q13427,0.497,0.846,0.96292,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2004.0,2019.0,ALL
9361,LONP1,P36776,0.517,0.808,0.9993,DTO_05007624,Enzyme,C1838180,CODAS syndrome,C23;C16;C11;C05;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.78,0.8,,1991.0,2019.0,ALL
9363,RAB33A,Q14088,0.931,0.077,0.82154,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,2005.0,2013.0,ALL
9364,RAB28,P51157,0.792,0.077,0.02487,,,C3809299,CONE-ROD DYSTROPHY 18,,,disease,Disease or Syndrome,0.9,1.0,limited,2013.0,2018.0,ALL
9365,KL,Q9UEF7,0.448,0.769,0.00022444,DTO_05007624,Enzyme,C4692564,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1",,,disease,Disease or Syndrome,0.6,1.0,,2007.0,2015.0,ALL
9366,RAB9BP1,,1.0,0.038,,,,C0595921,Intraocular pressure disorder,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
9367,RAB9A,P51151,0.729,0.423,0.83175,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
9368,SLC9A3R1,O14745,0.547,0.577,8.8416e-05,,,C2676782,"Nephrolithiasis-Osteoporosis, Hypophosphatemic, 2",C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.7,1.0,,2008.0,2012.0,ALL
9369,NRXN3,Q9HDB5;Q9Y4C0,0.656,0.615,1.0,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,limited,2012.0,2019.0,ALL
9370,ADIPOQ,Q15848,0.376,0.885,4.6434e-09,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.6,0.95,,1999.0,2020.0,ALL
9371,KIF3B,O15066,0.76,0.269,0.084213,DTO_05007530,Cellular structure,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9372,ZFYVE9,O95405,0.647,0.615,0.90244,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9373,PLAA,Q9Y263,0.597,0.692,0.46873,DTO_05007584,Enzyme modulator,C4479631,"NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES",,,disease,Disease or Syndrome,0.7,1.0,,2017.0,2017.0,ALL
9374,PPT2,Q9UMR5,0.751,0.5,0.0045415,DTO_05007624,Enzyme,C0027877,Neuronal Ceroid-Lipofuscinoses,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.22,1.0,,2003.0,2005.0,ALL
9375,TM9SF2,Q99805,0.839,0.154,1.0,DTO_05007405,Transporter,C0008055,Chikungunya Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
9376,SLC22A8,Q8TCC7,0.656,0.615,2.6004e-09,DTO_05007405,Transporter,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
9377,COX5A,P20674,0.515,0.846,0.49407,DTO_05007624,Enzyme,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.35,1.0,,1997.0,2017.0,ALL
9378,NRXN1,P58400;Q9ULB1,0.581,0.692,0.99964,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,0.962,,2007.0,2019.0,ALL
9379,NRXN2,P58401;Q9P2S2,0.769,0.308,0.99934,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.74,1.0,moderate,2011.0,2018.0,ALL
9380,GRHPR,Q9UBQ7,0.722,0.308,4.6393e-07,DTO_05007624,Enzyme,C0268165,Primary hyperoxaluria type 2,C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,1.0,,1999.0,2019.0,ALL
9381,OTOF,Q9HC10,0.691,0.385,5.3804e-39,DTO_05007405,Transporter,C1832828,"Deafness, Autosomal Recessive 9",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.96,1.0,definitive,1998.0,2019.0,ALL
9382,COG1,Q8WTW3,0.628,0.692,4.9379e-08,,,C2931011,"Congenital disorder of glycosylation, type 2G",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,strong,2009.0,2016.0,ALL
9383,TSIX,,0.743,0.269,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
9388,LIPG,Q9Y5X9,0.633,0.615,1.0165e-10,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.21,1.0,,2005.0,2005.0,ALL
9390,SLC22A13,Q9Y226,1.0,0.115,5.3133e-14,DTO_05007405,Transporter,C0022665,Kidney Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2009.0,2015.0,ALL
9391,CIAO1,O76071,0.931,0.154,0.0012454,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,1998.0,1998.0,ALL
9392,TGFBRAP1,Q8WUH2,0.751,0.346,0.1651,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
9394,HS6ST1,O60243,0.617,0.731,0.92349,DTO_05007624,Enzyme,C3553977,HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.6,1.0,limited,2011.0,2014.0,ALL
9397,NMT2,O60551,0.89,0.115,0.23627,DTO_05007624,Enzyme,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
9398,CD101,Q93033,0.76,0.423,3.2831e-13,,,C0877445,Candidemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.04,1.0,,2017.0,2018.0,ALL
9399,STOML1,Q9UBI4,0.78,0.308,2.4189e-11,DTO_05007584,Enzyme modulator,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
9400,RECQL5,O94762,0.682,0.5,3.1723e-18,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,0.5,,2007.0,2016.0,ALL
9401,RECQL4,O94761,0.496,0.808,3.3132e-35,DTO_05007624,Enzyme,C0032339,Rothmund-Thomson syndrome,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.986,definitive,1999.0,2019.0,ALL
9402,GRAP2,O75791,0.394,0.923,0.00015256,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2000.0,2020.0,ALL
9403,SELENOF,O60613,0.705,0.308,0.058745,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
9404,LPXN,O60711,0.678,0.423,1.9089e-06,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9406,ZRANB2,O95218,0.89,0.077,0.99949,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9407,TMPRSS11D,O60235,0.636,0.538,1.1964e-05,DTO_05007624,Enzyme,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
9409,PEX16,Q9Y5Y5,0.597,0.615,8.2934e-05,,,C3553960,PEROXISOME BIOGENESIS DISORDER 8B,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2010.0,2016.0,ALL
9410,SNRNP40,Q96DI7,,,0.85265,,,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
9411,ARHGAP29,Q52LW3,0.7,0.5,0.99964,,,C0334634,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
9412,MED21,Q13503,,,0.014255,DTO_05007542,Transcription factor,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
9413,FAM189A2,Q15884,0.861,0.192,1.0131e-09,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
9414,TJP2,Q9UDY2,0.663,0.5,3.236e-11,DTO_05007527,Cell-cell junction,C1843139,"Hypercholanemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,limited,2003.0,2014.0,ALL
9415,FADS2,O95864,0.575,0.692,0.99815,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.61,1.0,,2011.0,2019.0,ALL
9416,DDX23,Q9BUQ8,0.821,0.308,0.54199,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
9419,CRIPT,Q9P021,0.716,0.308,0.00097752,,,C4014339,SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES,,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2016.0,ALL
9420,CYP7B1,O75881,0.563,0.692,3.2954e-06,DTO_05007624,Enzyme,C1849115,"SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2008.0,2020.0,ALL
9421,HAND1,O96004,0.686,0.308,0.10914,,,C0678807,prenatal alcohol exposure,,,phenotype,Finding,0.3,1.0,,2014.0,2014.0,ALL
9422,ZNF264,O43296,0.931,0.077,5.8267e-07,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
9423,NTN1,O95631,0.509,0.846,0.99687,DTO_05007584,Enzyme modulator,C4748869,MIRROR MOVEMENTS 4,,,disease,Disease or Syndrome,0.4,1.0,,2017.0,2017.0,ALL
9424,KCNK6,Q9Y257,0.89,0.115,0.0020738,DTO_01300327,Ion channel,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
9425,CDYL,Q9Y232,0.76,0.308,0.99504,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2012.0,2019.0,ALL
9426,CDY2A,Q9Y6F7,0.805,0.115,,,,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",C16;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
9427,ECEL1,O95672,0.638,0.308,4.7923e-13,DTO_05007624,Enzyme,C3554415,Distal arthrogryposis type 5D,,,disease,Disease or Syndrome,0.95,1.0,,2013.0,2018.0,ALL
9429,ABCG2,Q9UNQ0,0.419,0.885,2.0957e-32,DTO_05007405,Transporter,C1841837,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1",,,disease,Finding,0.6,1.0,limited,2016.0,2016.0,ALL
9430,MYLKP1,,0.805,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
9435,CHST2,Q9Y4C5,0.76,0.269,0.018039,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,1.0,,2007.0,2009.0,ALL
9436,NCR2,O95944,0.656,0.538,2.4749e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2017.0,2019.0,ALL
9437,NCR1,O76036,0.572,0.654,7.3311e-11,DTO_05007575,Receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
9439,MED23,Q9ULK4,0.612,0.654,3.1015e-08,,,C3280265,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2015.0,ALL
9440,MED17,Q9NVC6,0.769,0.269,3.0751e-09,,,C3150921,"MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2010.0,ALL
9441,MED26,O95402,1.0,0.038,0.88242,DTO_05007542,Transcription factor,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
9442,MED27,Q6P2C8,0.769,0.231,1.7718e-05,DTO_05007542,Transcription factor,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2017.0,ALL
9443,MED7,O43513,0.821,0.269,0.016917,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
9444,QKI,Q96PU8,0.617,0.5,0.75121,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,0.8,,2006.0,2014.0,ALL
9445,ITM2B,Q9Y287,0.617,0.654,0.62589,,,C1861735,"Dementia, familial Danish",C23;C11;C10;F03;C09,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.8,0.944,limited,2000.0,2019.0,ALL
9446,GSTO1,P78417,0.541,0.769,5.0916e-09,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.39,0.8,,2005.0,2019.0,ALL
9447,AIM2,O14862,0.521,0.769,2.1942e-09,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.11,1.0,,2015.0,2020.0,ALL
9448,MAP4K4,O95819,0.588,0.692,1.0,DTO_03300101,Kinase,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
9450,LY86,O95711,0.805,0.231,2.2513e-05,,,C0006663,Calcinosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.3,1.0,,2011.0,2011.0,ALL
9451,EIF2AK3,Q9NZJ5,0.501,0.808,0.0027603,DTO_03300101,Kinase,C0432217,Wolcott-Rallison syndrome,C16;C18;C05;C20;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,1.0,0.964,,1995.0,2019.0,ALL
9452,ITM2A,O43736,0.751,0.462,0.19657,,,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2013.0,2017.0,ALL
9453,GGPS1,O95749,0.647,0.577,0.26866,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9454,HOMER3,Q9NSC5,0.861,0.077,0.95363,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
9455,HOMER2,Q9NSB8,0.691,0.5,0.0093921,,,C4225240,"DEAFNESS, AUTOSOMAL DOMINANT 68",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2015.0,ALL
9456,HOMER1,Q86YM7,0.636,0.538,0.9992,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2003.0,2018.0,ALL
9457,FHL5,Q5TD97,0.53,0.769,4.8464e-10,DTO_05007542,Transcription factor,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.41,0.75,,2013.0,2016.0,ALL
9459,ARHGEF6,Q15052,0.678,0.462,0.99998,,,C1136249,"Mental Retardation, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,moderate,2000.0,2001.0,ALL
9462,RASAL2,Q9UJF2,0.67,0.346,0.79641,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,1.0,,2013.0,2019.0,ALL
9463,PICK1,Q9NRD5,0.682,0.538,0.0081806,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,0.75,,2004.0,2017.0,ALL
9464,HAND2,P61296,0.612,0.5,0.39908,,,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.5,1.0,,2002.0,2018.0,ALL
9465,AKAP7,O43687;Q9P0M2,0.821,0.231,2.8942e-07,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
9466,IL27RA,Q6UWB1,0.659,0.731,3.901e-12,DTO_05007599,Signaling,C0004681,Bagassosis,C08;C24,   Respiratory Tract Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
9467,SH3BP5,O60239,0.78,0.423,0.04833,,,C0008029,Cherubism,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
9468,PCYT1B,Q9Y5K3,0.641,0.731,0.89723,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
9469,CHST3,Q7LGC8,0.517,0.846,0.0072431,,,C1837657,"Spondyloepiphyseal dysplasia, Omani type",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.75,1.0,,2004.0,2017.0,ALL
9470,EIF4E2,O60573,0.821,0.115,0.58161,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2014.0,ALL
9472,AKAP6,Q13023,0.695,0.538,0.99983,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
9473,THEMIS2,Q5TEJ8,0.743,0.192,0.0020207,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2008.0,2012.0,ALL
9474,ATG5,Q9H1Y0,0.462,0.885,0.97758,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,1.0,,2012.0,2019.0,ALL
9475,ROCK2,O75116,0.529,0.808,1.0,DTO_03300101,Kinase,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,,2018.0,2018.0,ALL
9476,NAPSA,O96009,0.576,0.654,7.1709e-14,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.85,,2003.0,2020.0,ALL
9477,MED20,Q9H944,0.861,0.077,0.30394,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
9478,CABP1,Q9NZU7,0.805,0.231,0.88789,,,C0014556,"Epilepsy, Temporal Lobe",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0,,2003.0,2003.0,ALL
9479,MAPK8IP1,Q9UQF2,0.716,0.462,0.99983,DTO_05007599,Signaling,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.62,1.0,,2000.0,2018.0,ALL
9480,ONECUT2,O95948,0.792,0.192,0.90701,DTO_05007542,Transcription factor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,2015.0,2019.0,ALL
9481,SLC25A27,O95847,0.711,0.423,0.00026907,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2007.0,2011.0,ALL
9482,STX8,Q9UNK0,0.861,0.231,1.3184e-08,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2015.0,2018.0,ALL
9486,CHST10,O43529,0.89,0.115,9.1356e-05,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
9487,PIGL,Q9Y2B2,0.581,0.731,6.178e-09,,,C1848392,Zunich neuroectodermal syndrome,C23;C16;C11;C17;C10;F03;C09;F01;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases;    Behavior and Behavior Mechanisms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.73,1.0,,2012.0,2019.0,ALL
9488,PIGB,Q92521,0.839,0.038,3.8535e-11,DTO_05007624,Enzyme,C0016506,Foot Deformities,C05,   Musculoskeletal Diseases,group,Anatomical Abnormality,0.3,1.0,strong,2019.0,2019.0,ALL
9489,PGS1,Q32NB8,1.0,0.038,1.2572e-11,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
9491,PSMF1,Q92530,0.931,0.115,3.3092e-08,DTO_05007584,Enzyme modulator,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
9493,KIF23,Q02241,0.682,0.385,1.0,DTO_05007530,Cellular structure,C0271934,"Congenital dyserythropoietic anemia, type III",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.5,1.0,strong,1981.0,2013.0,ALL
9495,AKAP5,P24588,0.821,0.231,0.65191,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2007.0,2007.0,ALL
9496,TBX4,P57082,0.576,0.731,0.5048,DTO_05007542,Transcription factor,C1840061,SMALL PATELLA SYNDROME,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.75,1.0,,2004.0,2019.0,ALL
9497,SLC4A7,Q9Y6M7,0.716,0.423,0.73616,DTO_05007405,Transporter,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
9498,SLC4A8,Q2Y0W8,0.861,0.269,0.99849,DTO_05007405,Transporter,C0362046,Prediabetes syndrome,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0,,2013.0,2013.0,ALL
9499,MYOT,Q9UBF9,0.695,0.385,3.3663e-08,,,C3714934,"MYOPATHY, MYOFIBRILLAR, 3",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.75,1.0,,1988.0,2016.0,ALL
9500,MAGED1,Q9Y5V3,0.682,0.462,0.99831,DTO_05007620,Cell adhesion,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2008.0,2008.0,ALL
9501,RPH3AL,Q9UNE2,0.736,0.308,4.4376e-12,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2006.0,2006.0,ALL
9506,PAGE4,O60829,0.751,0.192,0.6939,,,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0,,2015.0,2015.0,ALL
9507,ADAMTS4,O75173,0.582,0.692,1.9501e-06,DTO_05007624,Enzyme,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2006.0,2006.0,ALL
9508,ADAMTS3,O15072,0.581,0.808,1.0278e-10,DTO_05007624,Enzyme,C4748408,HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3,,,disease,Disease or Syndrome,0.61,1.0,strong,2017.0,2018.0,ALL
9509,ADAMTS2,O95450,0.579,0.808,0.9661,DTO_05007624,Enzyme,C2700425,"EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE",C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.76,0.923,strong,1992.0,2019.0,ALL
9510,ADAMTS1,Q9UHI8,0.555,0.654,0.71601,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,1.0,,2006.0,2019.0,ALL
9512,PMPCB,O75439,0.769,0.192,4.5335e-08,DTO_05007624,Enzyme,C4693741,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6,,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
9513,FXR2,P51116,0.805,0.231,0.99996,DTO_05007557,Nucleic acid binding,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,1995.0,2019.0,ALL
9514,GAL3ST1,Q99999,0.621,0.731,0.66559,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.04,1.0,,2016.0,2019.0,ALL
9515,STXBP5L,Q9Y2K9,0.89,0.192,0.99926,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
9516,LITAF,Q99732,0.65,0.462,0.030752,DTO_05007542,Transcription factor,C0270913,"Charcot-Marie-Tooth disease, Type 1C",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.79,1.0,,2003.0,2017.0,ALL
9517,SPTLC2,O15270,0.736,0.346,0.78035,DTO_05007624,Enzyme,C3150896,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2017.0,ALL
9518,GDF15,Q99988,0.429,0.808,3.0133e-07,DTO_05007599,Signaling,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.4,1.0,,2010.0,2019.0,ALL
9519,TBPL1,P62380,0.506,0.846,0.37902,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2000.0,2020.0,ALL
9520,NPEPPS,P55786,0.519,0.808,1.0,DTO_05007624,Enzyme,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.11,1.0,,2016.0,2019.0,ALL
9521,EEF1E1,O43324,0.59,0.731,0.082607,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.947,,1990.0,2018.0,ALL
9522,SCAMP1,O15126,0.7,0.385,0.977,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9524,TECR,Q9NZ01,0.674,0.423,0.10845,DTO_05007624,Enzyme,C3151462,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14",,,disease,Disease or Syndrome,0.6,1.0,,2011.0,2013.0,ALL
9525,VPS4B,O75351,0.76,0.538,0.23026,DTO_05007530,Cellular structure,C0399379,"Dentin dysplasia, type 1",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.31,1.0,,2016.0,2019.0,ALL
9526,MPDU1,O75352,0.682,0.5,1.0051e-05,,,C1836669,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,strong,2001.0,2016.0,ALL
9527,GOSR1,O95249,0.674,0.615,0.062823,DTO_05007405,Transporter,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
9528,TMEM59,Q9BXS4,0.736,0.192,2.4058e-12,,,C3809250,ESTROGEN RESISTANCE,,,disease,Disease or Syndrome,0.1,,,,,ALL
9529,BAG5,Q9UL15,0.769,0.346,1.81e-06,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2017.0,2017.0,ALL
9530,BAG4,O95429,0.743,0.308,0.00018708,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
9531,BAG3,O95817,0.498,0.846,0.61738,,,C3151293,"CARDIOMYOPATHY, DILATED, 1HH",,,disease,Disease or Syndrome,0.9,1.0,,1990.0,2018.0,ALL
9532,BAG2,O95816,0.78,0.231,0.042,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2015.0,2017.0,ALL
9533,POLR1C,O15160,0.595,0.615,6.3221e-10,DTO_05007624,Enzyme,C1855433,"Mandibulofacial dysostosis, Treacher Collins type, autosomal recessive",C16;C11;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.72,1.0,,1998.0,2018.0,ALL
9535,GMFG,O60234,0.792,0.231,1.1758e-08,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9536,PTGES,O14684,0.54,0.769,0.71317,,,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.51,1.0,,2003.0,2015.0,ALL
9537,TP53I11,O14683,0.861,0.154,0.30718,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2003.0,2018.0,ALL
9538,EI24,O14681,0.67,0.385,0.73348,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
9540,TP53I3,Q53FA7,0.636,0.423,5.9516e-11,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
9541,CIR1,Q86X95,0.716,0.423,5.3057e-08,,,C4049938,Physical Activity Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
9542,NRG2,O14511,0.78,0.308,0.99925,DTO_05007599,Signaling,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0,,2018.0,2019.0,ALL
9543,IGDCC3,Q8IVU1,0.89,0.115,2.7305e-07,,,C0233849,Personality Traits,F01,   Behavior and Behavior Mechanisms,group,Finding,0.1,1.0,,2013.0,2013.0,ALL
9545,RAB3D,O95716,0.682,0.577,1.3302e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
9546,APBA3,O96018,0.839,0.192,2.0716e-12,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,1999.0,2008.0,ALL
9547,CXCL14,O95715,0.554,0.731,0.037302,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.34,1.0,,2010.0,2014.0,ALL
9550,ATP6V1G1,O75348,0.931,0.154,0.10407,DTO_05007405,Transporter,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
9551,ATP5MF,P56134,1.0,0.115,0.01917,DTO_05007405,Transporter,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
9552,SPAG7,O75391,0.821,0.346,0.0006849,DTO_05007557,Nucleic acid binding,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
9553,MRPL33,O75394,0.792,0.269,0.3655,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
9554,SEC22B,O75396,1.0,0.077,,,,C0026936,Mycoplasma Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
9555,MACROH2A1,O75367,0.656,0.5,0.73705,DTO_05007557,Nucleic acid binding,C1861313,"Synostosis, Carpal, with Dysplastic Elbow Joints and Brachydactyly",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.3,1.0,,2019.0,2019.0,ALL
9556,ATP5MPL,P56378,,,0.8054,,,C0201874,Amino acids measurement,,,group,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9557,CHD1L,Q86WJ1,0.631,0.577,1.0034e-36,,,C1968949,Cakut,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.51,1.0,limited,2012.0,2014.0,ALL
9559,VPS26A,O75436,0.821,0.269,0.61411,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2011.0,2013.0,ALL
9560,CCL4L2,P13236;Q8NHW4,0.535,0.885,0.088586,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,0.958,,1999.0,2019.0,ALL
9562,MINPP1,Q9UNW1,0.705,0.462,0.00045482,,,C4225426,"THYROID CANCER, NONMEDULLARY, 2",,,disease,Neoplastic Process,0.6,1.0,,2001.0,2001.0,ALL
9563,H6PD,O95479,0.619,0.654,8.5874e-09,DTO_05007624,Enzyme,C1291245,Cortisone reductase deficiency,C23;C16;C18;C13;C17;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.55,1.0,,2005.0,2011.0,ALL
9564,BCAR1,P56945,0.518,0.846,0.99808,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.971,,1993.0,2019.0,ALL
9566,HPCX,,0.805,0.154,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.909,,1999.0,2010.0,ALL
9567,GTPBP1,O00178,0.792,0.308,0.93001,DTO_05007624,Enzyme,C4317009,Diverticular Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
9568,GABBR2,O75899,0.65,0.538,0.99999,DTO_02300001,G-protein coupled receptor,C4693546,NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS,,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2018.0,ALL
9569,GTF2IRD1,Q9UHL9,0.522,0.769,0.90039,,,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,0.963,,1999.0,2019.0,ALL
9570,GOSR2,O14653,0.653,0.423,4.6633e-07,DTO_05007405,Transporter,C3279627,"EPILEPSY, PROGRESSIVE MYOCLONIC, 6",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2014.0,ALL
9572,NR1D1,P20393,0.608,0.692,0.81796,DTO_00102000,Nuclear receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2009.0,2015.0,ALL
9573,GDF3,Q9NR23,0.595,0.5,4.0734e-05,DTO_05007599,Signaling,C3150968,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2010.0,ALL
9575,CLOCK,O15516,0.463,0.885,0.99957,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,1.0,,2000.0,2019.0,ALL
9576,SPAG6,O75602,0.769,0.308,1.298e-13,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
9577,BABAM2,Q9NXR7,0.682,0.538,0.16651,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
9578,CDC42BPB,Q9Y5S2,0.76,0.385,1.0,DTO_03300101,Kinase,C0345958,Large cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
9580,SOX13,Q9UN79,0.743,0.385,0.94185,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
9581,PREPL,Q4J6C6,0.644,0.538,2.1551e-13,,,C1848030,Hypotonia-Cystinuria Syndrome,C23;C16;C18;C13;C05;C12;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.68,0.917,,2006.0,2019.0,ALL
9582,APOBEC3B,Q9UH17,0.547,0.731,5.2144e-16,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.967,,2010.0,2019.0,ALL
9583,ENTPD4,Q9Y227,1.0,0.038,1.8146e-16,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2011.0,2011.0,ALL
9584,RBM39,Q14498,0.686,0.462,0.99981,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9585,KIF20B,Q96Q89,0.67,0.462,3.7396e-23,DTO_05007530,Cellular structure,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.21,1.0,,2017.0,2017.0,ALL
9586,CREB5,Q02930,0.682,0.538,0.22337,DTO_05007542,Transcription factor,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
9587,MAD2L1BP,Q15013,0.623,0.577,1.4439e-08,,,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,1986.0,2018.0,ALL
9588,PRDX6,P30041,0.572,0.731,4.8237e-05,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.34,1.0,,2009.0,2015.0,ALL
9589,WTAP,Q15007,0.659,0.577,0.99966,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2012.0,2019.0,ALL
9590,AKAP12,Q02952,0.566,0.615,0.035666,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2008.0,2018.0,ALL
9592,IER2,Q9BTL4,0.931,0.154,0.76773,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
9595,CYTIP,O60759,0.711,0.423,0.0021191,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9597,SMAD5-AS1,Q9Y6J3,0.861,0.269,,,,C0032580,Adenomatous Polyposis Coli,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
9600,PITPNM1,O00562,0.805,0.269,0.0013838,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
9601,PDIA4,P13667,0.839,0.154,0.077979,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2020.0,ALL
9603,NFE2L3,Q9Y4A8,0.716,0.308,7.1842e-11,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2020.0,ALL
9604,RNF14,Q9UBS8,0.805,0.115,0.0011129,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2002.0,2007.0,ALL
9605,VPS9D1,Q9Y2B5,0.931,0.115,7.2069e-20,DTO_05007584,Enzyme modulator,C0406208,Suntan,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
9607,CARTPT,Q16568,0.576,0.692,0.093729,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.51,1.0,,1999.0,2010.0,ALL
9609,RAB36,O95755,0.821,0.115,1.6531e-10,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
9610,RIN1,Q13671,0.7,0.385,3.5054e-07,DTO_05007584,Enzyme modulator,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2012.0,ALL
9611,NCOR1,O75376,0.597,0.731,1.0,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.55,1.0,,2006.0,2016.0,ALL
9612,NCOR2,Q9Y618,0.601,0.692,1.0,DTO_05007542,Transcription factor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2005.0,2005.0,ALL
9615,GDA,Q9Y2T3,0.769,0.231,0.99867,DTO_05007624,Enzyme,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2002.0,2002.0,ALL
9616,RNF7,Q9UBF6,0.716,0.308,0.032867,DTO_05007624,Enzyme,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.11,1.0,,2012.0,2017.0,ALL
9617,MTRF1,O75570,0.89,0.077,1.6199e-10,DTO_05007557,Nucleic acid binding,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,1999.0,2002.0,ALL
9618,TRAF4,Q9BUZ4,0.626,0.615,0.93602,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,1996.0,2018.0,ALL
9619,ABCG1,P45844,0.56,0.692,0.11182,DTO_05007405,Transporter,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,0.0,,2000.0,2000.0,ALL
9620,CELSR1,Q9NYQ6,0.7,0.5,0.99994,DTO_02300001,G-protein coupled receptor,C1704423,Milroy Disease,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.4,1.0,strong,2019.0,2019.0,ALL
9622,KLK4,Q9Y5K2,0.559,0.692,4.5377e-06,DTO_05007624,Enzyme,C2673922,"Amelogenesis Imperfecta, Hypomaturation Type, Iia1",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.4,1.0,strong,2017.0,2017.0,ALL
9623,TCL1B,O95988,0.561,0.5,0.010127,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2010.0,2017.0,ALL
9625,AATK,Q6ZMQ8,0.792,0.154,0.20634,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
9626,GUCA1C,O95843,1.0,0.038,2.5694e-07,,,C0877015,Pelvic Organ Prolapse,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
9627,SNCAIP,Q9Y6H5,0.691,0.423,0.00032848,,,C3160718,"PARKINSON DISEASE, LATE-ONSET",,,disease,Disease or Syndrome,0.3,,,,,ALL
9628,RGS6,P49758,0.564,0.769,0.44191,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2014.0,2014.0,ALL
9629,CLCA3P,Q9Y6N3,0.89,0.154,,DTO_01300327,Ion channel,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
9630,GNA14,O95837,0.674,0.5,2.4256e-17,DTO_05007584,Enzyme modulator,C0346073,Tufted angioma of skin,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.51,1.0,strong,2016.0,2019.0,ALL
9631,NUP155,O75694,0.78,0.231,0.65349,,,C4014269,"ATRIAL FIBRILLATION, FAMILIAL, 15",,,disease,Disease or Syndrome,0.6,1.0,,2008.0,2008.0,ALL
9632,SEC24C,P53992,0.543,0.808,1.0,DTO_05007405,Transporter,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2011.0,2011.0,ALL
9633,TESMIN,Q9Y4I5,0.839,0.154,2.2276e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
9635,CLCA2,Q9UQC9,0.686,0.423,1.4744e-28,DTO_01300327,Ion channel,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,1999.0,2018.0,ALL
9636,ISG15,P05161,0.531,0.808,0.40527,DTO_05007557,Nucleic acid binding,C4015293,IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION,,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2015.0,ALL
9637,FEZ2,Q9UHY8,1.0,0.038,1.1496e-11,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
9638,FEZ1,Q99689,0.666,0.5,0.75002,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,0.667,,2004.0,2017.0,ALL
9639,ARHGEF10,O15013,0.729,0.577,6.7739e-30,DTO_05007624,Enzyme,C1842357,"Slowed Nerve Conduction Velocity, Autosomal Dominant",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,moderate,2003.0,2003.0,ALL
9640,ZNF592,Q92610,0.7,0.462,0.99998,,,C1847114,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.61,1.0,limited,2010.0,2015.0,ALL
9641,IKBKE,Q14164,0.597,0.731,0.0090053,DTO_03300101,Kinase,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2015.0,ALL
9643,MORF4L2,Q15014,1.0,0.038,0.81082,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
9644,SH3PXD2A,Q5TCZ1,0.729,0.385,0.98897,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2017.0,2018.0,ALL
9645,MICAL2,O94851,0.716,0.308,2.1766e-12,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
9646,CTR9,Q6PD62,0.7,0.692,1.0,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2004.0,2018.0,ALL
9647,PPM1F,P49593,0.78,0.269,0.0038754,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
9648,GCC2,Q8IWJ2,0.931,0.077,1.9864e-05,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
9649,RALGPS1,Q5JS13,0.861,0.231,0.99999,DTO_05007584,Enzyme modulator,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
9651,PLCH2,O75038,0.861,0.231,1.8065e-18,DTO_05007624,Enzyme,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
9652,TTC37,Q6PGP7,0.626,0.654,1.725e-29,,,C1857276,Trichohepatoenteric Syndrome,C23;C16;C13;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,0.917,strong,2010.0,2018.0,ALL
9653,HS2ST1,Q7LGA3,0.839,0.115,0.54475,,,C0014457,Eosinophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
9654,TTLL4,Q14679,0.861,0.231,5.6814e-13,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2015.0,2019.0,ALL
9655,SOCS5,O75159,0.67,0.654,0.54156,DTO_05007584,Enzyme modulator,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
9656,MDC1,Q14676,0.628,0.692,2.2689e-08,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
9657,IQCB1,Q15051,0.641,0.654,1.3581e-12,,,C0403553,Renal dysplasia and retinal aplasia (disorder),C16;C13;C11;C12;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.69,1.0,strong,2005.0,2018.0,ALL
9658,ZNF516,Q92618,0.821,0.269,0.99992,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9659,PDE4DIP,Q5VU43,0.769,0.308,2.6099e-37,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9662,CEP135,Q66GS9,0.695,0.615,3.5892e-22,DTO_05007584,Enzyme modulator,C3553414,"MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2012.0,ALL
9663,LPIN2,Q92539,0.628,0.615,5.026e-05,,,C1864997,Majeed syndrome,C16;C01;C05;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Infections;    Musculoskeletal Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.77,1.0,strong,2005.0,2019.0,ALL
9665,MARF1,Q9Y4F3,0.931,0.154,1.0,DTO_05007557,Nucleic acid binding,C0201836,Alanine aminotransferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9666,DZIP3,Q86Y13,,,1.6537e-13,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
9667,SAFB2,Q14151,0.89,0.077,0.99979,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9668,ZNF432,O94892,0.805,0.192,3.0049e-14,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.5,1.0,,2008.0,2008.0,ALL
9669,EIF5B,O60841,0.78,0.269,0.99981,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
9670,IPO13,O94829,0.716,0.346,0.99998,DTO_05007405,Transporter,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
9671,WSCD2,Q2TBF2,0.805,0.269,0.78262,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
9672,SDC3,O75056,0.711,0.654,0.41455,DTO_05007621,Extracellular structure,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.44,0.75,,2006.0,2018.0,ALL
9673,SLC25A44,Q96H78,0.931,0.115,0.00092458,DTO_05007405,Transporter,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
9674,KIAA0040,Q15053,0.931,0.154,0.20102,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2011.0,2015.0,ALL
9675,TTI1,O43156,0.931,0.192,4.8982e-10,,,C4021085,Abnormality of brain morphology,,,phenotype,Anatomical Abnormality,0.1,,,,,ALL
9677,PPIP5K1,Q6PFW1,0.7,0.308,0.0026969,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
9678,PHF14,O94880,0.695,0.462,0.26533,DTO_05007542,Transcription factor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
9679,FAM53B,Q14153,0.716,0.423,0.85523,,,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2014.0,2018.0,ALL
9681,DEPDC5,O75140,0.631,0.538,0.1165,DTO_05007557,Nucleic acid binding,C1858477,"Epilepsy, Partial, with Variable Foci",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.77,1.0,definitive,2013.0,2019.0,ALL
9682,KDM4A,O75164,0.606,0.769,1.0,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
9683,N4BP1,O75113,0.78,0.308,0.62056,DTO_05007557,Nucleic acid binding,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
9684,LRRC14,Q15048,,,0.00017297,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
9685,CLINT1,Q14677,0.931,0.038,0.53538,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.06,0.833,,2005.0,2008.0,ALL
9686,VGLL4,Q14135,0.716,0.231,0.072826,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
9687,GREB1,Q4ZG55,0.663,0.385,6.6023e-09,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.46,0.857,,2012.0,2019.0,ALL
9688,NUP93,Q8N1F7,0.729,0.385,1.7535e-06,DTO_05007405,Transporter,C4225166,"NEPHROTIC SYNDROME, TYPE 12",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
9689,BZW1,Q7L1Q6,0.792,0.115,0.94418,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
9690,UBE3C,Q15386,0.722,0.577,1.0,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
9692,PRORP,O15091,0.769,0.269,1.3271e-13,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
9693,RAPGEF2,Q9Y4G8,0.716,0.269,1.0,DTO_05007584,Enzyme modulator,C0014550,Myoclonic Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
9694,EMC2,Q15006,0.839,0.077,0.003297,DTO_05007557,Nucleic acid binding,C0029489,Other alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",phenotype,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
9695,EDEM1,Q92611,0.76,0.269,1.0594e-13,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
9696,CROCC,Q5TZA2,0.751,0.269,1.2656e-24,DTO_05007584,Enzyme modulator,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
9697,TRAM2,Q15035,0.89,0.115,0.94418,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9698,PUM1,Q14671,0.653,0.654,1.0,DTO_05007557,Nucleic acid binding,C4693672,SPINOCEREBELLAR ATAXIA 47,,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
9699,RIMS2,Q9UQ26,0.769,0.423,1.0,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2009.0,ALL
9700,ESPL1,Q14674,0.647,0.462,1.0,DTO_05007624,Enzyme,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
9701,PPP6R2,O75170,0.722,0.462,0.16399,DTO_05007584,Enzyme modulator,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9702,CEP57,Q86XR8,0.615,0.615,0.072685,,,C1850343,Mosaic variegated aneuploidy syndrome 1,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.64,1.0,,2011.0,2019.0,ALL
9703,KIAA0100,Q14667,0.78,0.115,5.4421e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2006.0,2014.0,ALL
9704,DHX34,Q14147,1.0,,6.5588e-13,DTO_05007624,Enzyme,C4225275,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 40",,,disease,Disease or Syndrome,0.3,1.0,limited,2019.0,2019.0,ALL
9705,ST18,O60284,0.711,0.462,0.99459,DTO_05007542,Transcription factor,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
9706,ULK2,Q8IYT8,0.76,0.231,1.877e-08,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
9709,HERPUD1,Q15011,0.606,0.692,0.99582,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2006.0,2006.0,ALL
9710,KIAA0355,O15063,0.805,0.077,0.97288,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
9711,RUBCN,Q92622,0.716,0.423,1.387e-13,,,C3810326,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15",,,disease,Disease or Syndrome,0.6,1.0,limited,2010.0,2013.0,ALL
9712,USP6NL,Q92738,0.861,0.115,0.12097,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
9715,FAM131B,Q86XD5,0.861,0.038,0.99092,,,C0280781,Adult Pilocytic Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2011.0,2015.0,ALL
9716,AQR,O60306,1.0,0.077,1.0,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
9717,SEC14L5,O43304,,,5.0927e-22,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
9718,ECE2,P0DPD6;P0DPD8,0.751,0.423,1.1756e-21,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9719,ADAMTSL2,Q86TH1,0.666,0.346,0.0016001,DTO_05007624,Enzyme,C3278147,GELEOPHYSIC DYSPLASIA 1,,,disease,Disease or Syndrome,0.6,1.0,strong,2008.0,2011.0,ALL
9720,CCDC144A,A2RUR9,1.0,0.038,4.7554e-14,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
9721,GPRIN2,O60269,0.931,0.038,3.8557e-06,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.5,,2013.0,2016.0,ALL
9722,NOS1AP,O75052,0.608,0.423,0.61424,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2005.0,2018.0,ALL
9723,SEMA3E,O15041,0.515,0.769,8.7148e-09,DTO_05007599,Signaling,C0265354,CHARGE Syndrome,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.73,1.0,limited,2002.0,2020.0,ALL
9724,UTP14C,Q5TAP6,0.861,0.192,0.0053453,DTO_05007624,Enzyme,C3150913,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
9725,TMEM63A,O94886,0.89,0.192,1.3865e-12,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
9726,ZNF646,O15015,0.89,0.154,6.7754e-06,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
9727,RAB11FIP3,O75154,0.769,0.269,0.9982,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
9728,SECISBP2L,Q93073,0.931,0.077,0.285,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
9729,KIAA0408,Q6ZU52,,,4.8741e-07,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
9730,DCAF1,Q9Y4B6,0.601,0.731,1.0,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9731,CEP104,O60308,0.67,0.423,1.2281e-12,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.53,1.0,,2015.0,2019.0,ALL
9732,DOCK4,Q8N1I0,0.666,0.423,0.82562,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2012.0,2015.0,ALL
9733,SART3,Q15020,0.584,0.769,0.99661,DTO_05007557,Nucleic acid binding,C0265970,"Porokeratosis, Disseminated Superficial Actinic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.32,1.0,moderate,2005.0,2008.0,ALL
9734,HDAC9,Q9UKV0,0.439,0.846,0.99973,DTO_05007378,Epigenetic regulator,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.5,1.0,,2012.0,2019.0,ALL
9735,KNTC1,P50748,0.67,0.5,5.3346e-43,,,C0424621,Body Fat Distribution,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
9736,USP34,Q70CQ2,0.76,0.462,1.0,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
9737,GPRASP1,Q5JY77,0.931,0.192,0.31099,,,C0018081,Gonorrhea,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,2019.0,2019.0,ALL
9738,CCP110,O43303,0.821,0.115,0.006676,,,C2827362,Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement,,,disease,Neoplastic Process,0.04,1.0,,2001.0,2015.0,ALL
9739,SETD1A,O15047,0.619,0.615,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.65,1.0,moderate,2014.0,2019.0,ALL
9741,LAPTM4A,Q15012,,,0.0042449,DTO_05007405,Transporter,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9742,IFT140,Q96RY7,0.572,0.692,9.914e-24,DTO_05007530,Cellular structure,C1849437,Mainzer-Saldino Disease,C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.93,1.0,,2012.0,2017.0,ALL
9743,ARHGAP32,A7KAX9,0.839,0.115,0.99978,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
9744,ACAP1,Q15027,0.839,0.269,0.067617,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
9745,ZNF536,O15090,0.743,0.346,0.99958,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
9746,CLSTN3,Q9BQT9,0.792,0.423,0.97016,DTO_05007616,Calcium-binding protein,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
9747,TCAF1,Q9Y4C2,0.931,0.077,0.61756,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
9748,SLK,Q9H2G2,0.729,0.385,0.37441,DTO_03300101,Kinase,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
9749,PHACTR2,O75167,0.839,0.269,1.0378e-06,DTO_05007584,Enzyme modulator,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2012.0,2015.0,ALL
9750,RIPOR2,Q9Y4F9,0.792,0.269,0.92284,,,C4225298,"DEAFNESS, AUTOSOMAL RECESSIVE 104",,,disease,Disease or Syndrome,0.6,1.0,moderate,2016.0,2016.0,ALL
9751,SNPH,O15079,0.839,0.192,0.97082,DTO_05007405,Transporter,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
9752,PCDHA9,Q9Y5H5,0.861,0.115,1.8891e-24,,,C0018824,Heart valve disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
9753,ZSCAN12,O43309,0.821,0.231,2.1145e-07,,,C0036202,Sarcoidosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
9754,STARD8,Q92502,0.743,0.346,0.024522,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.51,1.0,,2007.0,2008.0,ALL
9755,TBKBP1,A7MCY6,0.821,0.154,0.27032,,,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.34,1.0,,2011.0,2019.0,ALL
9757,KMT2B,Q9UMN6,0.529,0.808,1.0,,,C4310633,"DYSTONIA 28, CHILDHOOD-ONSET",,,disease,Disease or Syndrome,0.61,1.0,,2016.0,2019.0,ALL
9758,FRMPD4,Q14CM0,0.674,0.423,1.0,,,C4310817,"MENTAL RETARDATION, X-LINKED 104",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2018.0,ALL
9759,HDAC4,P56524,0.484,0.885,1.0,DTO_05007378,Epigenetic regulator,C2931817,Chromosome 2q37 deletion syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.68,1.0,,2009.0,2019.0,ALL
9760,TOX,O94900,0.636,0.538,0.99869,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9761,MLEC,Q14165,0.89,0.077,0.60716,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9762,LZTS3,O60299,0.89,0.231,0.99616,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
9764,KIAA0513,O60268,0.839,0.192,0.23471,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
9765,ZFYVE16,Q7Z3T8,0.931,0.115,2.5587e-13,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9766,SUSD6,Q92537,0.89,0.154,0.63265,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
9767,JADE3,Q92613,0.931,0.077,0.99978,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
9768,PCLAF,Q15004,0.538,0.769,0.16276,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.38,1.0,,2006.0,2019.0,ALL
9770,RASSF2,P50749,0.615,0.5,5.0648e-07,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2005.0,2013.0,ALL
9771,RAPGEF5,Q92565,0.524,0.769,0.98099,DTO_05007584,Enzyme modulator,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2010.0,2019.0,ALL
9772,TMEM94,Q12767,0.628,0.654,2.7548e-14,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.4,1.0,strong,2018.0,2018.0,ALL
9774,BCLAF1,Q9NYF8,0.743,0.462,2.0629e-14,DTO_05007542,Transcription factor,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
9775,EIF4A3,P38919,0.608,0.5,0.99985,,,C1849348,Richieri Costa Pereira syndrome,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.72,1.0,,1998.0,2018.0,ALL
9776,ATG13,O75143,0.769,0.308,0.96359,,,C0018681,Headache,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,1.0,,2018.0,2018.0,ALL
9777,TM9SF4,Q92544,0.821,0.154,0.999,DTO_05007405,Transporter,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
9778,KIAA0232,Q92628,,,0.99999,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2014.0,2018.0,ALL
9779,TBC1D5,Q92609,0.839,0.154,4.6359e-18,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9780,PIEZO1,Q92508,0.552,0.769,3.9379e-21,DTO_01300327,Ion channel,C4225184,LYMPHATIC MALFORMATION 6,,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2019.0,ALL
9781,RNF144A,P50876,0.861,0.192,0.94776,DTO_05007624,Enzyme,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
9782,MATR3,P43243,0.631,0.538,1.0,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,limited,2009.0,2019.0,ALL
9783,RIMS3,Q9UJD0,0.931,0.038,0.00014932,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2009.0,ALL
9784,SNX17,Q15036,0.861,0.192,0.0022034,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
9785,DHX38,Q92620,0.711,0.346,2.1124e-12,DTO_05007624,Enzyme,C4748725,RETINITIS PIGMENTOSA 84,,,disease,Disease or Syndrome,0.6,1.0,moderate,2014.0,2018.0,ALL
9786,KIAA0586,Q9BVV6,0.565,0.731,5.1344e-16,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.67,1.0,,2015.0,2019.0,ALL
9787,DLGAP5,Q15398,0.678,0.423,1.1806e-14,DTO_05007575,Receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2004.0,2019.0,ALL
9788,MTSS1,O43312,0.581,0.654,0.9997,DTO_05007530,Cellular structure,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2006.0,2019.0,ALL
9790,BMS1,Q14692,0.499,0.846,0.0001753,,,C0282160,Aplasia Cutis Congenita,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.8,1.0,,1995.0,2019.0,ALL
9791,PTDSS1,P48651,0.61,0.615,0.15093,DTO_05007624,Enzyme,C0432269,Lenz Majewski hyperostotic dwarfism,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Congenital Abnormality,0.74,1.0,,2014.0,2019.0,ALL
9792,SERTAD2,Q14140,1.0,0.077,0.8808,DTO_05007542,Transcription factor,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9793,CKAP5,Q14008,0.89,0.192,1.0,DTO_05007530,Cellular structure,C0002938,Aneuploidy,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2014.0,2014.0,ALL
9794,MAML1,Q92585,0.67,0.423,0.99995,DTO_05007542,Transcription factor,C0200633,Neutrophil count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
9796,PHYHIP,Q92561,0.861,0.231,0.85981,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
9798,IST1,P53990,0.736,0.231,0.0046461,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2014.0,2017.0,ALL
9801,MRPL19,P49406,0.792,0.231,0.029168,DTO_05007557,Nucleic acid binding,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.31,1.0,,2004.0,2011.0,ALL
9802,DAZAP2,Q15038,0.89,0.231,0.36369,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9804,TOMM20,Q15388,0.743,0.462,0.026672,DTO_05007405,Transporter,C0026846,Muscular Atrophy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.2,1.0,,2011.0,2011.0,ALL
9805,SCRN1,Q12765,0.695,0.538,0.002489,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2006.0,2014.0,ALL
9806,SPOCK2,Q92563,0.751,0.346,0.24144,DTO_05007584,Enzyme modulator,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.12,1.0,,2011.0,2017.0,ALL
9807,IP6K1,Q92551,0.792,0.269,0.92674,DTO_03300101,Kinase,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
9810,RNF40,O75150,0.751,0.269,0.99987,,,C0162283,Nephrogenic Diabetes Insipidus,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
9811,CTIF,O43310,0.821,0.231,0.99994,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
9812,DELE1,Q14154,1.0,0.115,1.2229e-17,,,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
9813,EFCAB14,O75071,1.0,0.077,7.7776e-08,,,C0524910,"Hepatitis C, Chronic",C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
9814,SFI1,A8K8P3,0.792,0.423,5.9369e-44,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2011.0,2011.0,ALL
9815,GIT2,Q14161,0.716,0.385,0.99793,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
9816,URB2,Q14146,,,1.2188e-17,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9817,KEAP1,Q14145,0.475,0.808,0.00038766,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.42,1.0,,2013.0,2019.0,ALL
9818,NUP58,Q9BVL2,0.861,0.077,0.92697,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
9819,TSC22D2,O75157,0.861,0.154,0.96853,,,C0026654,Moyamoya Disease,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
9820,CUL7,Q14999,0.633,0.5,2.5916e-21,,,C2678312,Three M Syndrome 1,C23;C16;C05;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,1.0,,2005.0,2012.0,ALL
9821,RB1CC1,Q8TDY2,0.653,0.538,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.58,1.0,,2002.0,2018.0,ALL
9823,ARMCX2,Q7L311,1.0,0.115,0.69249,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
9824,ARHGAP11A,Q6P4F7,0.821,0.308,2.1115e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
9825,SPATA2,Q9UM82,0.556,0.615,0.97889,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.11,1.0,,2008.0,2015.0,ALL
9826,ARHGEF11,O15085,0.722,0.385,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2003.0,2014.0,ALL
9827,RGP1,Q92546,,,3.2975e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9828,ARHGEF17,Q96PE2,0.805,0.115,0.98445,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2012.0,2019.0,ALL
9829,DNAJC6,O75061,0.641,0.385,0.99986,,,C3809811,"PARKINSON DISEASE 19A, JUVENILE-ONSET",,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2016.0,ALL
9830,TRIM14,Q14142,0.663,0.538,0.004522,,,C1864872,"Spondyloepimetaphyseal dysplasia, Genevieve type",C23;C16;C17;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.1,,,,,ALL
9831,ZNF623,O75123,1.0,0.077,6.9313e-06,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
9832,JAKMIP2,Q96AA8,0.805,0.308,1.0,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
9833,MELK,Q14680,0.566,0.577,4.5055e-22,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2013.0,2018.0,ALL
9834,FAM30A,Q9NZY2,0.76,0.077,0.00087279,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
9836,LCMT2,O60294,0.89,0.077,2.6276e-15,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
9837,GINS1,Q14691,0.691,0.346,7.7028e-07,DTO_05007557,Nucleic acid binding,C4693356,IMMUNODEFICIENCY 55,,,disease,Disease or Syndrome,0.7,1.0,,2017.0,2017.0,ALL
9839,ZEB2,O60315,0.471,0.808,1.0,DTO_05007542,Transcription factor,C1856113,Mowat-Wilson syndrome,C23;C16;C06;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,1.0,1.0,definitive,1991.0,2019.0,ALL
9840,TESPA1,A2RU30,0.839,0.154,4.6856e-06,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
9841,ZBTB24,O43167,0.659,0.654,0.00020919,DTO_05007542,Transcription factor,C3279748,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 2,,,disease,Disease or Syndrome,0.74,1.0,,2011.0,2019.0,ALL
9842,PLEKHM1,Q9Y4G2,0.691,0.577,0.0081382,,,C1969093,"Osteopetrosis, Autosomal Recessive 6",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.8,1.0,limited,2007.0,2016.0,ALL
9843,HEPH,Q9BQS7,0.686,0.462,4.6122e-05,DTO_05007624,Enzyme,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
9844,ELMO1,Q92556,0.608,0.615,0.89997,DTO_05007599,Signaling,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,0.933,,2005.0,2019.0,ALL
9846,GAB2,Q9UQC2,0.563,0.692,0.98325,DTO_05007575,Receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.38,1.0,,2009.0,2018.0,ALL
9847,C2CD5,Q86YS7,0.821,0.154,9.7333e-12,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
9848,MFAP3L,O75121,0.89,0.077,0.8803,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2014.0,ALL
9851,KIAA0753,Q2KHM9,0.631,0.577,1.5545e-28,,,C4310701,OROFACIODIGITAL SYNDROME XV,,,disease,Disease or Syndrome,0.5,1.0,strong,2016.0,2017.0,ALL
9852,EPM2AIP1,Q7L775,1.0,0.077,0.59998,,,C0751783,Lafora Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2003.0,2004.0,ALL
9853,RUSC2,Q8N2Y8,0.729,0.269,0.99949,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.11,1.0,,2016.0,2016.0,ALL
9855,FARP2,O94887,0.678,0.615,4.6425e-36,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.41,1.0,,2010.0,2013.0,ALL
9856,KIAA0319,Q5VV43,0.729,0.385,3.3234e-20,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
9857,CEP350,Q5VT06,0.805,0.154,1.0,,,C0392707,Atopy,C20,   Immune System Diseases,phenotype,Pathologic Function,0.1,1.0,,2009.0,2009.0,ALL
9858,PPP1R26,Q5T8A7,0.861,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
9859,CEP170,Q5SW79,0.89,0.192,1.0,DTO_05007613,Chaperone,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
9860,LRIG2,O94898,0.666,0.423,7.9705e-18,DTO_05007575,Receptor,C0403555,Ochoa syndrome,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.64,1.0,,2013.0,2019.0,ALL
9861,PSMD6,Q15008,0.839,0.269,0.99518,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.42,1.0,,2011.0,2019.0,ALL
9862,MED24,O75448,0.931,0.192,3.3214e-11,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.12,1.0,,2010.0,2016.0,ALL
9863,MAGI2,Q86UL8,0.579,0.654,0.99943,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.85,1.0,,2008.0,2018.0,ALL
9866,TRIM66,O15016,0.736,0.308,6.9399e-12,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
9867,PJA2,O43164,0.78,0.154,0.02374,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
9868,TOMM70,O94826,0.805,0.308,0.99841,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.21,1.0,,1999.0,1999.0,ALL
9869,SETDB1,Q15047,0.631,0.654,1.0,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.35,1.0,,2011.0,2019.0,ALL
9870,AREL1,O15033,0.839,0.154,4.9149e-07,DTO_05007624,Enzyme,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
9871,SEC24D,O94855,0.663,0.577,1.3348e-07,DTO_05007405,Transporter,C1862178,Cole Carpenter syndrome,C16;C11;C17;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.61,1.0,strong,2015.0,2018.0,ALL
9873,FCHSD2,O94868,0.743,0.346,0.56618,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
9874,TLK1,Q9UKI8,0.641,0.577,0.99999,DTO_03300101,Kinase,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
9877,ZC3H11A,O75152,0.821,0.154,0.99996,DTO_05007557,Nucleic acid binding,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.41,1.0,,2014.0,2017.0,ALL
9878,TOX4,O94842,0.751,0.192,0.95637,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2008.0,2016.0,ALL
9879,DDX46,Q7L014,0.736,0.385,1.0,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9880,ZBTB39,O15060,1.0,0.077,0.00018848,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
9881,TRANK1,O15050,0.805,0.077,2.0096e-25,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2013.0,2019.0,ALL
9882,TBC1D4,O60343,0.76,0.385,8.473e-24,DTO_05007624,Enzyme,C4015183,"DIABETES MELLITUS, NONINSULIN-DEPENDENT, 5",,,disease,Disease or Syndrome,0.4,,,,,ALL
9883,POM121,Q96HA1,0.792,0.231,0.057971,DTO_05007557,Nucleic acid binding,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
9884,LRRC37A,A6NMS7,0.805,0.192,0.00054349,DTO_05007575,Receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
9885,OSBPL2,Q9H1P3,0.861,0.154,0.13102,,,C4084712,"DEAFNESS, AUTOSOMAL DOMINANT 67",,,disease,Disease or Syndrome,0.6,1.0,strong,1998.0,1998.0,ALL
9886,RHOBTB1,O94844,0.722,0.308,0.00024175,DTO_05007584,Enzyme modulator,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
9887,SMG7,Q92540,0.805,0.346,0.99998,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2009.0,2019.0,ALL
9889,ZBED4,O75132,0.89,0.115,0.50688,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2015.0,2018.0,ALL
9890,PLPPR4,Q7Z2D5,0.839,0.154,0.86104,DTO_05007624,Enzyme,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
9891,NUAK1,O60285,0.621,0.577,0.098693,DTO_03300101,Kinase,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.31,1.0,,2005.0,2016.0,ALL
9892,SNAP91,O60641,0.638,0.538,0.99993,DTO_05007405,Transporter,C0740392,"Infarction, Middle Cerebral Artery",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,2009.0,2009.0,ALL
9894,TELO2,Q9Y4R8,0.695,0.5,7.2029e-14,,,C4310778,YOU-HOOVER-FONG SYNDROME,,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2017.0,ALL
9895,TECPR2,O15040,0.663,0.423,0.58003,,,C3542549,"SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2016.0,ALL
9896,FIG4,Q92562,0.551,0.731,2.3423e-34,,,C1970011,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,2007.0,2019.0,ALL
9897,WASHC5,Q12768,0.572,0.615,8.2703e-18,DTO_05007405,Transporter,C1863704,"Spastic paraplegia 8, autosomal dominant",C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,,2007.0,2020.0,ALL
9898,UBAP2L,Q14157,0.736,0.308,1.0,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,0.75,,2017.0,2018.0,ALL
9899,SV2B,Q7L1I2,0.792,0.231,5.7007e-05,,,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.31,1.0,,2006.0,2006.0,ALL
9900,SV2A,Q7L0J3,0.722,0.269,0.22782,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
9901,SRGAP3,O43295,0.711,0.346,0.9997,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2012.0,2012.0,ALL
9902,MRC2,Q9UBG0,0.705,0.385,0.67472,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
9903,KLHL21,Q9UJP4,0.89,0.154,6.3071e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
9904,RBM19,Q9Y4C8,0.711,0.577,1.7215e-12,DTO_05007557,Nucleic acid binding,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
9905,SGSM2,O43147,0.89,0.115,4.2902e-09,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9907,AP5Z1,O43299,0.7,0.346,7.2894e-31,,,C3150901,"SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2016.0,ALL
9908,G3BP2,Q9UN86,0.805,0.192,0.99954,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
9909,DENND4B,O75064,0.931,0.077,0.99098,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
9910,RABGAP1L,B7ZAP0;Q5R372,0.743,0.462,0.00010938,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9911,TMCC2,O75069,,,0.29466,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9912,ARHGAP44,Q17R89,0.861,0.192,0.99988,,,C3548510,response to antineoplastic agent,,,phenotype,Organism Function,0.1,1.0,,2013.0,2013.0,ALL
9913,SUPT7L,O94864,0.89,0.115,0.048542,,,C0023493,Adult T-Cell Lymphoma/Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
9914,ATP2C2,O75185,0.769,0.308,5.0246e-60,DTO_05007405,Transporter,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
9915,ARNT2,Q9HBZ2,0.599,0.731,0.99142,DTO_05007542,Transcription factor,C4014708,WEBB-DATTANI SYNDROME,,,disease,Disease or Syndrome,0.5,1.0,limited,2013.0,2013.0,ALL
9917,FAM20B,O75063,0.861,0.308,3.8916e-06,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9918,NCAPD2,Q15021,0.76,0.346,1.0776e-12,DTO_05007557,Nucleic acid binding,C4693831,"MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.3,1.0,,2016.0,2017.0,ALL
9919,SEC16A,O15027,0.792,0.269,0.36049,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
9920,KBTBD11,O94819,0.821,0.192,0.062354,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
9921,RNF10,Q8N5U6,0.821,0.115,0.16406,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2017.0,ALL
9922,IQSEC1,Q6DN90,0.736,0.346,0.99969,,,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.31,1.0,moderate,2019.0,2019.0,ALL
9923,ZBTB40,Q9NUA8,0.89,0.231,1.0543e-10,DTO_05007542,Transcription factor,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
9924,PAN2,Q504Q3,0.76,0.231,0.93596,DTO_05007624,Enzyme,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
9925,ZBTB5,O15062,0.821,0.192,0.61772,DTO_05007542,Transcription factor,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
9926,LPGAT1,Q92604,0.89,0.115,0.98041,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
9927,MFN2,O95140,0.471,0.846,0.99415,DTO_05007624,Enzyme,C4721887,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.81,1.0,,2004.0,2019.0,ALL
9928,KIF14,Q15058,0.578,0.654,4.1141e-05,DTO_05007530,Cellular structure,C4015701,MECKEL SYNDROME 12,,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2019.0,ALL
9929,JOSD1,Q15040,,,0.044609,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
9931,HELZ,P42694,1.0,0.077,1.0,DTO_05007624,Enzyme,C4021085,Abnormality of brain morphology,,,phenotype,Anatomical Abnormality,0.1,,,,,ALL
9933,PUM3,Q15397,0.78,0.346,3.2052e-26,,,C0201899,Aspartate aminotransferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
9934,P2RY14,Q15391,0.78,0.154,0.00054873,DTO_02300001,G-protein coupled receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
9935,MAFB,Q9Y5Q3,0.565,0.731,0.90304,DTO_05007542,Transcription factor,C2674705,"Osteolysis, Hereditary, Of Carpal Bones With Or Without Nephropathy",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.74,1.0,,2012.0,2018.0,ALL
9936,CD302,Q8IX05,0.89,0.154,3.7405e-06,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2011.0,2014.0,ALL
9937,DCLRE1A,Q6PJP8,0.821,0.269,1.9357e-09,,,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.04,1.0,,1991.0,2012.0,ALL
9938,ARHGAP25,P42331,0.792,0.231,0.94635,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
9939,RBM8A,Q9Y5S9,0.604,0.692,0.57268,,,C0175703,Thrombocytopenia-Absent Radius Syndrome,C16;C05;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.77,1.0,,2007.0,2019.0,ALL
9940,DLEC1,Q9Y238,0.572,0.615,2.1303e-35,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,0.833,,2003.0,2012.0,ALL
9941,EXOG,Q9Y2C4,1.0,0.077,1.3331e-11,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
9942,XYLB,O75191,0.821,0.154,1.3597e-22,DTO_03300101,Kinase,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
9943,OXSR1,O95747,0.839,0.269,0.77444,DTO_03300101,Kinase,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.34,1.0,,2012.0,2020.0,ALL
9945,GFPT2,O94808,0.769,0.308,6.3867e-09,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2010.0,ALL
9946,CRYZL1,O95825,,,2.0125e-09,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0,,1999.0,1999.0,ALL
9947,MAGEC1,O60732,0.792,0.308,0.079896,DTO_05007620,Cell adhesion,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2002.0,2012.0,ALL
9948,WDR1,O75083,0.623,0.654,0.99892,DTO_05007530,Cellular structure,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.31,1.0,,2007.0,2017.0,ALL
9949,AMMECR1,Q9Y4X0,0.659,0.692,0.82117,,,C4310810,"MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS",,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
9950,GOLGA5,Q8TBA6,0.861,0.115,5.9628e-05,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,1998.0,2006.0,ALL
9951,HS3ST4,Q9Y661,0.839,0.231,0.79575,,,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
9953,HS3ST3B1,Q9Y662,0.751,0.308,0.29349,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
9955,HS3ST3A1,Q9Y663,0.931,0.077,0.013565,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
9956,HS3ST2,Q9Y278,0.686,0.346,0.10028,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2014.0,2018.0,ALL
9957,HS3ST1,O14792,0.839,0.154,0.0044305,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0,,2004.0,2017.0,ALL
9958,USP15,Q9Y4E8,0.711,0.423,0.99997,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2014.0,2019.0,ALL
9960,USP3,Q9Y6I4,0.729,0.346,0.99989,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
9961,MVP,Q14764,0.512,0.769,6.7564e-08,DTO_05007557,Nucleic acid binding,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
9962,SLC23A2,Q9UGH3,0.65,0.615,0.0062629,DTO_05007405,Transporter,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0,,2008.0,2014.0,ALL
9963,SLC23A1,Q9UHI7,0.743,0.346,0.023504,DTO_05007405,Transporter,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
9965,FGF19,O95750,0.548,0.615,0.57022,DTO_05007599,Signaling,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2002.0,2019.0,ALL
9966,TNFSF15,O95150,0.531,0.692,0.0028159,DTO_05007599,Signaling,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.5,0.96,,2004.0,2019.0,ALL
9967,THRAP3,Q9Y2W1,0.821,0.192,0.99998,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
9968,MED12,Q93074,0.476,0.769,1.0,DTO_05007542,Transcription factor,C0220769,FG syndrome,C23;C16;C06;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,1984.0,2016.0,ALL
9969,MED13,Q9UHV7,0.711,0.538,1.0,,,C0454644,Delayed speech and language development,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.4,1.0,moderate,2018.0,2018.0,ALL
9970,NR1I3,Q14994,0.448,0.846,3.5259e-08,DTO_00102000,Nuclear receptor,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.4,1.0,,2007.0,2020.0,ALL
9971,NR1H4,Q96RI1,0.513,0.808,0.00093892,DTO_00102000,Nuclear receptor,C4310747,"CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
9972,NUP153,P49790,0.729,0.346,1.0,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2008.0,2008.0,ALL
9973,CCS,O14618,0.628,0.423,8.6291e-08,DTO_05007624,Enzyme,C0019189,"Hepatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
9975,NR1D2,Q14995,0.682,0.5,0.0061743,DTO_00102000,Nuclear receptor,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
9976,CLEC2B,Q92478,1.0,0.077,0.011614,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
9978,RBX1,P62877,0.601,0.615,0.94689,DTO_05007624,Enzyme,C0014518,Toxic Epidermal Necrolysis,C17;C20;C25;C07,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Chemically-Induced Disorders;    Stomatognathic Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
9980,DOP1B,Q9Y3R5,0.861,0.192,7.5465e-21,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
9982,FGFBP1,Q14512,0.736,0.385,0.58794,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2001.0,2009.0,ALL
9984,THOC1,Q96FV9,0.691,0.5,0.99955,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
9985,REC8,O95072,0.729,0.231,5.5411e-06,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
9986,RCE1,Q9Y256,0.743,0.269,0.15955,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
9987,HNRNPDL,O14979,0.597,0.654,0.077954,,,C1836765,"LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G (disorder)",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2018.0,ALL
9988,DMTF1,Q9Y222,0.729,0.462,0.96706,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
9989,PPP4R1,Q8TF05,,,0.99958,DTO_05007624,Enzyme,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
9990,SLC12A6,Q9UHW9,0.603,0.5,0.011377,DTO_05007405,Transporter,C0795950,Corpus callosum agenesis neuronopathy,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,2002.0,2019.0,ALL
9991,PTBP3,O95758,0.751,0.154,0.86295,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2018.0,2019.0,ALL
9992,KCNE2,Q9Y6J6,0.628,0.423,0.00010145,DTO_01300327,Ion channel,C3150953,Long Qt Syndrome 6,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.71,1.0,strong,1999.0,2009.0,ALL
9993,DGCR2,P98153,0.623,0.731,5.1573e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,0.8,,2006.0,2019.0,ALL
9994,CASP8AP2,Q9UKL3,0.659,0.5,,DTO_05007542,Transcription factor,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
9997,SCO2,O43819,0.479,0.846,7.5473e-07,DTO_05007624,Enzyme,C1837148,MYOPIA 6 (disorder),C11,   Eye Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2016.0,ALL
10000,AKT3,Q9Y243,0.512,0.808,0.99958,DTO_03300101,Kinase,C4014738,MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2,,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2014.0,ALL
10002,NR2E3,Q9Y5X4,0.603,0.5,,DTO_00102000,Nuclear receptor,C1849394,Enhanced S-Cone Syndrome,C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.974,,2000.0,2019.0,ALL
10003,NAALAD2,Q9Y3Q0,1.0,0.038,1.4282e-20,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
10004,NAALADL1,Q9UQQ1,0.839,0.192,1.8164e-21,DTO_05007624,Enzyme,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
10005,ACOT8,O14734,0.769,0.5,5.9662e-06,DTO_05007624,Enzyme,C0343386,Clostridium difficile infection,C01,   Infections,disease,Disease or Syndrome,0.1,0.917,,2008.0,2018.0,ALL
10006,ABI1,Q8IZP0,0.641,0.538,0.63911,DTO_05007584,Enzyme modulator,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
10007,GNPDA1,P46926,1.0,0.077,1.6024e-07,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10008,KCNE3,Q9Y6H6,0.666,0.423,0.4682,DTO_01300327,Ion channel,C2751089,Brugada Syndrome 6,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,limited,2005.0,2016.0,ALL
10009,ZBTB33,Q86T24,0.821,0.269,0.9127,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
10010,TANK,Q92844,0.678,0.5,0.83828,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
10011,SRA1,Q9HD15,0.568,0.615,5.19e-06,,,C0342384,Idiopathic hypogonadotropic hypogonadism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.31,1.0,,2016.0,2016.0,ALL
10013,HDAC6,Q9UBN7,0.465,0.846,1.0,DTO_05007378,Epigenetic regulator,C3275476,"CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA",,,disease,Disease or Syndrome,0.7,1.0,limited,2010.0,2016.0,ALL
10014,HDAC5,Q9UQL6,0.552,0.769,1.0,DTO_05007378,Epigenetic regulator,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.5,0.5,,2006.0,2014.0,ALL
10015,PDCD6IP,Q8WUM4,0.663,0.5,0.70554,DTO_05007575,Receptor,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
10016,PDCD6,O75340,0.653,0.5,0.0088799,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2017.0,2018.0,ALL
10017,BCL2L10,Q9HD36,0.65,0.654,0.01076,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2008.0,2018.0,ALL
10018,BCL2L11,O43521,0.51,0.731,0.88857,,,C0566602,Primary sclerosing cholangitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0,,2011.0,2017.0,ALL
10019,SH2B3,Q9UQQ2,0.527,0.692,0.00010289,,,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.53,1.0,moderate,2013.0,2018.0,ALL
10020,GNE,Q9Y223,0.61,0.692,2.4844e-16,DTO_05007624,Enzyme,C1853926,NONAKA MYOPATHY,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,2001.0,2019.0,ALL
10021,HCN4,Q9Y3Q4,0.617,0.269,0.99867,DTO_01300327,Ion channel,C1834144,"Sick Sinus Syndrome 2, Autosomal Dominant",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,,2004.0,2016.0,ALL
10022,INSL5,Q9Y5Q6,0.792,0.231,0.13604,,,C0003123,Anorexia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
10023,FRAT1,Q92837,0.653,0.462,0.32349,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,1.0,,2001.0,2015.0,ALL
10024,TROAP,Q12815,0.722,0.192,3.5061e-11,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2017.0,2019.0,ALL
10025,MED16,Q9Y2X0,0.89,0.192,2.5908e-14,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
10026,PIGK,Q92643,0.839,0.154,0.0001381,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
10036,CHAF1A,Q13111,0.581,0.808,1.0,DTO_05007557,Nucleic acid binding,C0026636,Mouth Diseases,C07,   Stomatognathic Diseases,group,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
10038,PARP2,Q9UGN5,0.663,0.538,2.3289e-13,,,C0023787,Lipodystrophy,C18;C17,   Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
10039,PARP3,Q9Y6F1,0.729,0.385,1.9738e-14,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
10040,TOM1L1,O75674,0.89,0.115,4.5993e-10,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
10042,HMGXB4,Q9UGU5,0.78,0.115,0.49435,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
10043,TOM1,O60784,0.711,0.385,1.4544e-11,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
10044,SH2D3C,Q8N5H7,0.729,0.346,0.00035085,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
10045,SH2D3A,Q9BRG2,0.76,0.423,3.6368e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
10046,MAMLD1,Q13495,0.65,0.5,0.62647,,,C2677879,"Hypospadias 2, X-Linked",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.6,1.0,,2006.0,2015.0,ALL
10047,CST8,O60676,0.89,0.192,0.0033735,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
10048,RANBP9,Q96S59,0.716,0.385,0.99999,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2015.0,2017.0,ALL
10049,DNAJB6,O75190,0.659,0.462,0.85436,,,C4721885,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1",,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2012.0,ALL
10050,SLC17A4,Q9Y2C5,0.78,0.385,1.5714e-09,DTO_05007405,Transporter,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0,,2011.0,2014.0,ALL
10051,SMC4,Q9NTJ3,0.678,0.346,1.68e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2006.0,2014.0,ALL
10052,GJC1,P36383,0.722,0.385,0.98795,DTO_05007527,Cell-cell junction,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
10053,AP1M2,Q9Y6Q5,0.931,0.115,2.1436e-08,DTO_05007621,Extracellular structure,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
10054,UBA2,Q9UBT2,0.705,0.346,0.99851,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2012.0,2019.0,ALL
10055,SAE1,Q9UBE0,0.821,0.269,0.9876,DTO_05007624,Enzyme,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
10056,FARSB,Q9NSD9,0.682,0.5,0.0032955,DTO_05007624,Enzyme,C3150910,Brain calcification Rajab type,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2018.0,2018.0,ALL
10057,ABCC5,O15440,0.606,0.654,0.0041518,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2012.0,2019.0,ALL
10058,ABCB6,Q9NP58,0.431,0.885,8.5999e-19,DTO_05007405,Transporter,C1836705,"Pseudohyperkalemia, Familial, 2, due to Red Cell Leak",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.7,1.0,,2013.0,2018.0,ALL
10059,DNM1L,O00429,0.475,0.808,0.00056753,DTO_05007584,Enzyme modulator,C1853139,OPTIC ATROPHY 5 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2007.0,2017.0,ALL
10060,ABCC9,O60706,0.552,0.692,9.3524e-09,DTO_05007405,Transporter,C0795905,Cantu syndrome,C23;C16;C17;C05;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,0.95,definitive,1996.0,2020.0,ALL
10061,ABCF2,Q9UG63,0.78,0.154,0.011301,DTO_05007624,Enzyme,C0235874,Disease Exacerbation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2012.0,2012.0,ALL
10062,NR1H3,Q13133,0.566,0.692,0.90374,DTO_00102000,Nuclear receptor,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.36,1.0,,2010.0,2018.0,ALL
10063,COX17,Q14061,0.78,0.231,0.19879,DTO_05007405,Transporter,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2003.0,2013.0,ALL
10066,SCAMP2,O15127,0.931,0.192,0.16007,DTO_05007624,Enzyme,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
10067,SCAMP3,O14828,0.89,0.077,0.0021904,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2017.0,ALL
10068,IL18BP,O95998,0.603,0.731,1.484e-08,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10071,MUC12,Q9UKN1,0.792,0.192,1.2792e-68,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,1999.0,2019.0,ALL
10072,DPP3,Q9NY33,0.769,0.192,6.7954e-11,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2013.0,2017.0,ALL
10073,SNUPN,O95149,,,1.1094e-14,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2018.0,2018.0,ALL
10075,HUWE1,Q7Z6Z7,0.534,0.769,1.0,DTO_05007624,Enzyme,C2678046,"Mental Retardation, X-Linked, Syndromic, Turner Type",C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2016.0,ALL
10076,PTPRU,Q92729,0.581,0.654,0.39251,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2010.0,2019.0,ALL
10077,TSPAN32,Q96QS1,0.821,0.154,2.1686e-05,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
10079,ATP9A,O75110,,,0.99999,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10081,PDCD7,Q8N8D1,0.821,0.115,8.5544e-06,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2014.0,2019.0,ALL
10082,GPC6,Q9Y625,0.626,0.654,0.14181,,,C1850318,Omodysplasia type 1,C23;C16;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,,2009.0,2014.0,ALL
10083,USH1C,Q9Y6N9,0.628,0.538,3.9714e-18,DTO_05007530,Cellular structure,C1865870,"Deafness, Autosomal Recessive 18",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.8,1.0,,1998.0,2017.0,ALL
10084,PQBP1,O60828,0.57,0.654,0.78935,DTO_05007542,Transcription factor,C0796135,Renpenning syndrome 1,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,definitive,1994.0,2019.0,ALL
10085,EDIL3,O43854,0.564,0.769,0.00014584,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.32,1.0,,2009.0,2018.0,ALL
10086,HHLA1,C9JL84,1.0,0.038,2.9066e-14,,,C0206664,Teratocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,1998.0,1999.0,ALL
10087,CERT1,Q9Y5P4,0.674,0.5,0.66702,DTO_05007405,Transporter,C4225156,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 34",,,disease,Mental or Behavioral Dysfunction,0.6,1.0,,2014.0,2015.0,ALL
10089,KCNK7,Q9Y2U2,1.0,0.077,3.478e-05,DTO_01300327,Ion channel,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
10090,UST,Q9Y2C2,0.792,0.192,0.43933,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
10092,ARPC5,O15511,0.792,0.308,0.8215,DTO_05007530,Cellular structure,C0010308,Congenital Hypothyroidism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.2,1.0,,2013.0,2013.0,ALL
10093,ARPC4,P59998,0.78,0.269,0.97453,DTO_05007530,Cellular structure,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
10094,ARPC3,O15145,0.839,0.154,0.21578,DTO_05007530,Cellular structure,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0,,2010.0,2010.0,ALL
10095,ARPC1B,O15143,0.736,0.346,0.010999,DTO_05007530,Cellular structure,C4540232,PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE,,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
10096,ACTR3,P61158,0.686,0.385,0.99986,DTO_05007530,Cellular structure,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
10097,ACTR2,P61160,0.659,0.654,0.99896,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2014.0,2017.0,ALL
10098,TSPAN5,P62079,0.78,0.308,0.90951,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
10099,TSPAN3,O60637,0.769,0.192,0.059759,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
10100,TSPAN2,O60636,0.769,0.231,2.3496e-05,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.31,1.0,,2016.0,2018.0,ALL
10101,NUBP2,Q9Y5Y2,0.89,0.077,0.00092127,,,C2931196,Craniofacial dysostosis type 1,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.02,1.0,,1994.0,2018.0,ALL
10102,TSFM,P43897,0.736,0.423,1.9197e-09,DTO_05007557,Nucleic acid binding,C1864840,Combined Oxidative Phosphorylation Deficiency 3,C23;C18;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2016.0,ALL
10103,TSPAN1,O60635,0.631,0.462,7.3518e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,0.889,,2006.0,2019.0,ALL
10105,PPIF,P30405,0.593,0.692,0.0019919,,,C0021831,Intestinal Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
10106,CTDSP2,O14595,0.839,0.192,0.11425,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
10107,TRIM10,Q9UDY6,0.821,0.269,3.7432e-09,,,C0162823,"Dermatitis, Irritant",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
10108,MKRN3-AS1,,0.682,0.423,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.32,1.0,,1999.0,1999.0,ALL
10109,ARPC2,O15144,0.769,0.308,0.99769,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2008.0,2010.0,ALL
10110,SGK2,Q9HBY8,0.78,0.192,2.1934e-12,DTO_03300101,Kinase,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10111,RAD50,Q92878,0.556,0.808,3.4392e-27,,,C2751318,Nijmegen Breakage Syndrome-Like Disorder,C23;C16;C18;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2003.0,2017.0,ALL
10112,KIF20A,O95235,0.615,0.615,4.5339e-13,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
10113,PREB,Q9HCU5,0.805,0.192,0.00059272,DTO_05007557,Nucleic acid binding,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
10114,HIPK3,Q9H422,0.678,0.462,0.27733,DTO_03300101,Kinase,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0,,2018.0,2020.0,ALL
10116,FEM1B,Q9UK73,0.821,0.385,0.34865,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0,,2005.0,2005.0,ALL
10117,ENAM,Q9NRM1,0.674,0.346,1.2999e-12,,,C0399368,"Amelogenesis Imperfecta, Type IB",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.91,1.0,strong,2001.0,2017.0,ALL
10120,ACTR1B,P42025,0.729,0.231,0.0010746,DTO_05007530,Cellular structure,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
10121,ACTR1A,P61163,0.792,0.423,0.96621,DTO_05007530,Cellular structure,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
10123,ARL4C,P56559,0.656,0.308,0.76081,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,0.8,,2015.0,2019.0,ALL
10124,ARL4A,P40617,1.0,0.038,0.80528,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
10125,RASGRP1,O95267,0.572,0.731,0.96554,DTO_05007584,Enzyme modulator,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.62,1.0,,2003.0,2018.0,ALL
10126,DNAL4,O96015,0.78,0.231,0.0028273,DTO_05007530,Cellular structure,C4015124,MIRROR MOVEMENTS 3,,,disease,Disease or Syndrome,0.4,,,,,ALL
10127,ZNF263,O14978,0.89,0.038,5.4582e-10,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
10128,LRPPRC,P42704,0.493,0.769,2.3019e-10,,,C1857355,"Leigh syndrome , French Canadian type",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.79,1.0,,2003.0,2019.0,ALL
10129,FRY,Q5TBA9,0.666,0.5,1.0,,,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
10130,PDIA6,Q15084,0.7,0.462,0.24911,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
10131,TRAP1,Q12931,0.59,0.615,1.5965e-29,DTO_05007613,Chaperone,C1968949,Cakut,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.31,1.0,strong,2014.0,2014.0,ALL
10133,OPTN,Q96CV9,0.548,0.808,5.91e-18,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.8,0.914,,1998.0,2019.0,ALL
10134,BCAP31,P51572,0.579,0.808,0.43366,DTO_05007405,Transporter,C3806634,"DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2013.0,ALL
10135,NAMPT,P43490,0.502,0.808,0.97914,DTO_05007599,Signaling,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.57,1.0,,2013.0,2019.0,ALL
10136,CELA3A,P09093,0.78,0.231,8.0514e-09,DTO_05007624,Enzyme,C0267963,Exocrine pancreatic insufficiency,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0,,2011.0,2018.0,ALL
10137,RBM12,Q9NTZ6,0.769,0.269,0.0021086,DTO_05007557,Nucleic acid binding,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,0.0,,2017.0,2017.0,ALL
10138,YAF2,Q8IY57,1.0,0.077,0.79482,DTO_05007542,Transcription factor,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
10139,ARFRP1,Q13795,0.729,0.5,0.13743,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
10140,TOB1,P50616,0.674,0.462,0.95365,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
10141,LINC01587,Q99440,1.0,0.154,7.4562e-09,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
10142,AKAP9,Q99996,0.638,0.385,4.5249e-17,,,C2678483,Long Qt Syndrome 11,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2002.0,2014.0,ALL
10143,CLEC3A,O75596,0.769,0.154,1.9968e-11,DTO_05007621,Extracellular structure,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2015.0,2015.0,ALL
10144,FAM13A,O94988,0.653,0.462,1.8976e-18,,,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.51,1.0,,2013.0,2017.0,ALL
10146,G3BP1,Q13283,0.597,0.654,0.033122,DTO_05007557,Nucleic acid binding,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
10147,SUGP2,Q8IX01,,,0.99995,DTO_05007557,Nucleic acid binding,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
10148,EBI3,Q14213,0.474,0.808,0.10797,DTO_05007599,Signaling,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2006.0,2019.0,ALL
10149,ADGRG2,Q8IZP9,0.736,0.231,0.92694,DTO_02300001,G-protein coupled receptor,C0403814,Congenital bilateral aplasia of vas deferens,C12,   Male Urogenital Diseases,disease,Congenital Abnormality,0.63,0.667,,2016.0,2019.0,ALL
10150,MBNL2,Q5VZF2,0.716,0.577,0.25602,DTO_05007557,Nucleic acid binding,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
10151,HNRNPA3P1,,0.805,0.231,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2005.0,2005.0,ALL
10152,ABI2,Q9NYB9,0.7,0.423,0.43122,DTO_05007584,Enzyme modulator,C1168443,Pseudocholinesterase Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
10153,CEBPZ,Q03701,0.595,0.692,6.5282e-06,DTO_05007542,Transcription factor,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,1996.0,2018.0,ALL
10154,PLXNC1,O60486,0.722,0.269,0.99811,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
10155,TRIM28,Q13263,0.592,0.731,1.0,,,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.62,1.0,strong,2018.0,2019.0,ALL
10156,RASA4,O43374,0.821,0.192,0.115,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2019.0,ALL
10157,AASS,Q9UDR5,0.695,0.577,2.3101e-12,,,C0268553,Hyperlysinemias,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,moderate,1968.0,2016.0,ALL
10158,PDZK1IP1,Q13113,0.666,0.5,0.00091769,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
10159,ATP6AP2,O75787,0.525,0.769,0.87089,DTO_05007575,Receptor,C3806722,"PARKINSONISM WITH SPASTICITY, X-LINKED",,,disease,Disease or Syndrome,0.71,1.0,,2013.0,2013.0,ALL
10160,FARP1,Q9Y4F1,0.769,0.231,5.0676e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
10161,LPAR6,P43657,0.678,0.385,0.0007129,DTO_02300001,G-protein coupled receptor,C3279470,HYPOTRICHOSIS 8,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.61,1.0,strong,2008.0,2014.0,ALL
10162,LPCAT3,Q6P1A2,0.736,0.346,0.99508,DTO_05007624,Enzyme,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
10163,WASF2,Q9Y6W5,0.585,0.769,0.97567,DTO_05007530,Cellular structure,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
10164,CHST4,Q8NCG5,0.792,0.269,2.0001e-09,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2002.0,2006.0,ALL
10165,SLC25A13,Q9UJS0,0.617,0.5,1.2833e-24,DTO_05007405,Transporter,C1853942,"CITRULLINEMIA, TYPE II, NEONATAL-ONSET",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,2002.0,2020.0,ALL
10166,SLC25A15,Q9Y619,0.711,0.346,3.7038e-07,DTO_05007405,Transporter,C0268540,HHH syndrome,C23;C16;C18;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.952,,1999.0,2016.0,ALL
10167,CFM1,,0.931,0.038,,,,C1859047,CYSTIC FIBROSIS MODIFIER 1,,,disease,Disease or Syndrome,0.3,,,,,ALL
10168,ZNF197,O14709,0.606,0.615,5.2329e-13,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.938,,1990.0,2018.0,ALL
10169,SERF2,P84101,0.89,0.077,0.023172,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
10170,DHRS9,Q9BPW9,0.695,0.538,7.2309e-08,DTO_05007624,Enzyme,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2018.0,2019.0,ALL
10171,RCL1,Q9Y2P8,0.792,0.192,0.059378,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
10174,SORBS3,O60504,0.792,0.269,8.2277e-12,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
10178,TENM1,Q9UKZ4,0.653,0.692,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2012.0,2018.0,ALL
10179,RBM7,Q9Y580,0.821,0.115,0.64753,DTO_05007557,Nucleic acid binding,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
10180,RBM6,P78332,0.722,0.385,1.0,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
10181,RBM5,P52756,0.674,0.346,1.0,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
10184,LHFPL2,Q6ZUX7,0.931,0.154,0.056209,,,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
10186,LHFPL6,Q9Y693,0.705,0.462,0.67057,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10188,TNK2,Q07912,0.623,0.538,8.22e-12,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2014.0,2017.0,ALL
10189,ALYREF,Q86V81,0.716,0.538,0.92567,DTO_05007557,Nucleic acid binding,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
10190,TXNDC9,O14530,0.821,0.154,0.37701,DTO_05007584,Enzyme modulator,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
10193,RNF41,Q9H4P4,0.674,0.538,0.96847,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2009.0,ALL
10194,TSHZ1,Q6ZSZ6,0.569,0.731,0.9973,DTO_05007542,Transcription factor,C1842937,"AURAL ATRESIA, CONGENITAL",C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.66,1.0,limited,1989.0,2014.0,ALL
10195,ALG3,Q92685,0.644,0.5,3.6777e-10,DTO_05007624,Enzyme,C1832736,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.75,1.0,,1999.0,2016.0,ALL
10196,PRMT3,O60678,0.743,0.423,4.9032e-25,DTO_05007378,Epigenetic regulator,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.2,1.0,,2010.0,2010.0,ALL
10197,PSME3,P61289,0.587,0.654,0.99714,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
10198,MPHOSPH9,Q99550,0.805,0.269,1.6616e-10,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2014.0,2016.0,ALL
10199,MPHOSPH10,O00566,0.861,0.192,0.84847,DTO_05007557,Nucleic acid binding,C0003578,Apnea,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",phenotype,Sign or Symptom,0.01,1.0,,2019.0,2019.0,ALL
10200,MPHOSPH6,Q99547,0.729,0.308,0.0004107,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10201,NME6,O75414,0.861,0.077,4.2713e-07,DTO_03300101,Kinase,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
10202,DHRS2,Q13268,0.736,0.385,8.7228e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
10203,CALCRL,Q16602,0.653,0.692,0.9853,DTO_02300001,G-protein coupled receptor,C0162820,"Dermatitis, Allergic Contact",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
10204,NUTF2,P61970,0.839,0.231,0.93864,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
10205,MPZL2,O60487,0.653,0.5,1.0755e-12,,,C4748374,"DEAFNESS, AUTOSOMAL RECESSIVE 111",,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
10206,TRIM13,O60858,0.462,0.846,0.6366,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.981,,2003.0,2020.0,ALL
10207,PATJ,Q8NI35,0.751,0.538,1.1917e-50,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
10208,USPL1,Q5W0Q7,0.931,0.077,0.021819,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
10209,EIF1,P41567,0.653,0.577,0.8307,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2006.0,2020.0,ALL
10210,TOPORS,Q9NS56,0.659,0.538,0.99904,DTO_05007624,Enzyme,C1835923,Retinitis Pigmentosa 31,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.6,,,,,ALL
10211,FLOT1,O75955,0.623,0.692,1.0422e-08,,,C0034362,Q Fever,C01,   Infections,disease,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
10212,DDX39A,O00148,0.674,0.692,0.60151,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
10213,PSMD14,O00487,0.716,0.308,0.97662,DTO_05007624,Enzyme,C0023896,Alcoholic Liver Diseases,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,group,Disease or Syndrome,0.2,1.0,,2009.0,2009.0,ALL
10214,SSX3,Q99909,1.0,0.038,0.009026,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
10215,OLIG2,Q13516,0.56,0.577,0.094592,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.6,,2006.0,2020.0,ALL
10216,PRG4,Q92954,0.601,0.615,1.7017e-08,,,C1859690,CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME,C23;C16;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1999.0,2017.0,ALL
10217,CTDSPL,O15194,0.678,0.5,0.0026698,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10218,ANGPTL7,O43827,0.76,0.269,9.168e-17,DTO_05007599,Signaling,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
10219,KLRG1,Q96E93,0.653,0.615,0.0034459,,,C1527336,Sjogren's Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
10220,GDF11,O95390,0.584,0.692,0.97645,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2007.0,2019.0,ALL
10221,TRIB1,Q96RU8,0.617,0.577,0.83343,DTO_03300101,Kinase,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.36,1.0,,2013.0,2019.0,ALL
10223,GPA33,Q99795,0.769,0.154,3.5516e-06,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.06,0.833,,2007.0,2018.0,ALL
10224,ZNF443,Q9Y2A4,1.0,0.077,0.00048827,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
10225,CD96,P40200,0.592,0.692,1.392e-11,,,C0796095,Opitz trigonocephaly syndrome,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.71,1.0,,2007.0,2016.0,ALL
10226,PLIN3,O60664,0.736,0.423,1.179e-07,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10228,STX6,O43752,0.751,0.385,0.010265,DTO_05007405,Transporter,C0038868,Progressive supranuclear palsy,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.43,1.0,,2011.0,2018.0,ALL
10229,COQ7,Q99807,0.736,0.462,3.808e-06,,,C4225226,"COENZYME Q10 DEFICIENCY, PRIMARY, 8",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2018.0,ALL
10230,NBR2,,0.751,0.231,,,,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
10231,RCAN2,Q14206,0.821,0.231,0.83475,DTO_05007599,Signaling,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
10232,MSLN,Q13421,0.525,0.692,5.8751e-25,DTO_05007621,Extracellular structure,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.6,0.981,,1997.0,2019.0,ALL
10233,LRRC23,Q53EV4,1.0,0.038,1.8429e-08,,,C0339682,Regular astigmatism - corneal,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
10234,LRRC17,Q8N6Y2,0.805,0.154,1.1461e-07,DTO_05007575,Receptor,C0026499,Monosomy,C23,"   Pathological Conditions, Signs and Symptoms",group,Congenital Abnormality,0.01,1.0,,2005.0,2005.0,ALL
10235,RASGRP2,Q7LDG7,0.769,0.231,0.2436,DTO_05007584,Enzyme modulator,C4014584,"BLEEDING DISORDER, PLATELET-TYPE, 18",,,disease,Disease or Syndrome,0.7,1.0,definitive,1998.0,2018.0,ALL
10236,HNRNPR,O43390,0.722,0.308,0.99935,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
10238,DCAF7,P61962,0.821,0.231,0.93284,,,C0376634,Craniofacial Abnormalities,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Congenital Abnormality,0.3,1.0,,2006.0,2006.0,ALL
10239,AP3S2,P59780,0.931,0.115,2.3273e-05,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.44,1.0,,2011.0,2019.0,ALL
10240,MRPS31,Q92665,1.0,0.038,5.38e-05,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
10241,CALCOCO2,Q13137,0.722,0.423,0.0001027,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
10242,KCNMB2,Q9Y691,0.722,0.385,0.5544,DTO_01300327,Ion channel,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2012.0,ALL
10243,GPHN,Q9NQX3,0.608,0.538,0.99998,,,C1854990,"Molybdenum Cofactor Deficiency, Complementation Group C",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2001.0,2016.0,ALL
10244,RABEPK,Q7Z6M1,0.553,0.692,2.8422e-11,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.8,,2012.0,2020.0,ALL
10246,SLC17A2,O00624,0.805,0.269,1.4228e-06,DTO_05007405,Transporter,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
10247,RIDA,P52758,0.606,0.769,0.067892,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2012.0,2012.0,ALL
10248,POP7,O75817,0.839,0.269,0.037473,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
10249,GLYAT,Q6IB77,0.729,0.462,3.6418e-08,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2012.0,2012.0,ALL
10250,SRRM1,Q8IYB3,1.0,0.077,1.0,DTO_05007557,Nucleic acid binding,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
10251,SPRY3,O43610,0.89,0.077,0.0038066,DTO_05007599,Signaling,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2015.0,2015.0,ALL
10252,SPRY1,O43609,0.603,0.577,0.0030398,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2010.0,2017.0,ALL
10253,SPRY2,O43597,0.554,0.654,0.97126,DTO_05007599,Signaling,C4225194,"IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3",,,disease,Finding,0.4,1.0,,2015.0,2015.0,ALL
10254,STAM2,O75886,0.7,0.5,1.0416e-05,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.05,1.0,,2017.0,2019.0,ALL
10255,HCG9,,0.7,0.5,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2016.0,ALL
10256,CNKSR1,Q969H4,0.769,0.462,4.289e-30,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2018.0,ALL
10257,ABCC4,O15439,0.536,0.769,1.0674e-07,DTO_05007405,Transporter,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,2007.0,2020.0,ALL
10260,DENND4A,Q7Z401,0.821,0.192,0.99627,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10261,IGSF6,O95976,0.839,0.269,0.0014791,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10262,SF3B4,Q15427,0.576,0.615,0.99176,,,C0265245,Nager syndrome,C16;C11;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2012.0,2019.0,ALL
10263,CDK2AP2,O75956,0.544,0.808,0.78801,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,0.75,,2007.0,2018.0,ALL
10265,IRX5,P78411,0.623,0.846,0.9747,DTO_05007542,Transcription factor,C1970027,"Hypertelorism, Severe, With Midface Prominence, Myopia, Mental Retardation, And Bone Fragility",C23;C16;C11;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,,2012.0,2012.0,ALL
10266,RAMP2,O60895,0.626,0.654,0.051127,DTO_05007575,Receptor,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.5,1.0,,2006.0,2014.0,ALL
10267,RAMP1,O60894,0.663,0.5,0.13181,DTO_05007575,Receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10268,RAMP3,O60896,0.722,0.269,0.016373,DTO_05007575,Receptor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2004.0,2015.0,ALL
10269,ZMPSTE24,O75844,0.517,0.731,8.8702e-16,DTO_05007624,Enzyme,C0033300,Progeria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,0.967,,2002.0,2019.0,ALL
10270,AKAP8,O43823,0.751,0.308,0.66425,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
10272,FSTL3,O95633,0.695,0.423,0.68658,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2007.0,2019.0,ALL
10273,STUB1,Q9UNE7,0.544,0.692,0.018667,,,C4014261,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.94,1.0,,2003.0,2019.0,ALL
10274,STAG1,Q8WVM7,0.656,0.577,1.0,DTO_05007557,Nucleic acid binding,C4539951,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 47",,,disease,Mental or Behavioral Dysfunction,0.7,1.0,strong,2015.0,2019.0,ALL
10276,NET1,Q7Z628,0.663,0.538,2.1017e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,1.0,,2009.0,2018.0,ALL
10277,UBE4B,O95155,0.76,0.346,1.0,DTO_05007584,Enzyme modulator,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
10278,EFS,O43281,0.597,0.615,1.8222e-08,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
10279,PRSS16,Q9NQE7,0.792,0.346,4.0615e-07,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2012.0,2012.0,ALL
10280,SIGMAR1,Q99720,0.544,0.808,0.1678,,,C3280587,"AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE",,,disease,Disease or Syndrome,0.71,1.0,,2011.0,2016.0,ALL
10281,DSCR4,P56555,0.89,0.115,0.0007784,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
10282,BET1,O15155,0.78,0.385,0.0038328,DTO_05007405,Transporter,C0948089,Acute Coronary Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2017.0,ALL
10283,CWC27,Q6UX04,0.722,0.346,4.5628e-07,DTO_05007624,Enzyme,C1855188,Metaphyseal Chondrodysplasia with Retinitis Pigmentosa,C16;C11;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
10285,SMNDC1,O75940,0.89,0.115,0.63777,,,C0023321,Lentigo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
10286,BCAS2,O75934,0.769,0.269,2.7764e-08,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
10287,RGS19,P49795,0.861,0.115,0.96134,DTO_05007584,Enzyme modulator,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
10288,LILRB2,,0.623,0.615,1.2812e-14,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2008.0,2019.0,ALL
10290,SPEG,Q15772,0.686,0.385,0.92315,DTO_03300101,Kinase,C4014814,"MYOPATHY, CENTRONUCLEAR, 5",,,disease,Disease or Syndrome,0.7,1.0,definitive,2009.0,2019.0,ALL
10291,SF3A1,Q15459,0.839,0.115,0.98752,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,0.0,,2015.0,2015.0,ALL
10293,TRAIP,Q9BWF2,0.644,0.654,1.5879e-05,,,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.61,1.0,moderate,2016.0,2016.0,ALL
10294,DNAJA2,O60884,0.839,0.308,0.99796,,,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.2,1.0,,2004.0,2004.0,ALL
10295,BCKDK,O14874,0.769,0.154,5.6598e-05,DTO_03300101,Kinase,C3554078,BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY,,,disease,Disease or Syndrome,0.9,1.0,definitive,1994.0,2016.0,ALL
10296,MAEA,Q7L5Y9,0.736,0.385,0.22741,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.44,0.857,,2011.0,2019.0,ALL
10297,APC2,O95996,0.582,0.654,0.99994,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.52,1.0,,2008.0,2019.0,ALL
10298,PAK4,O96013,0.584,0.731,4.3602e-05,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.9,,2010.0,2019.0,ALL
10299,MARCHF6,O60337,0.722,0.385,1.0,DTO_05007624,Enzyme,C3150860,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,,,,,ALL
10300,KATNB1,Q9BVA0,0.674,0.346,1.4478e-05,,,C4015525,LISSENCEPHALY 6 WITH MICROCEPHALY,,,disease,Congenital Abnormality,0.7,1.0,,2014.0,2016.0,ALL
10301,DLEU1,O43261,0.569,0.692,0.47033,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.2,1.0,,1986.0,2019.0,ALL
10302,SNAPC5,O75971,1.0,0.038,0.00020115,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
10305,MMDK,,0.861,0.154,,,,C1835009,"MESOMELIC DYSPLASIA, KANTAPUTRA TYPE",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0,,1998.0,2010.0,ALL
10306,CTPP,,0.736,0.385,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,1995.0,2000.0,ALL
10307,APBB3,O95704,0.716,0.538,5.0783e-10,,,C0041228,African Trypanosomiasis,C01,   Infections,disease,Disease or Syndrome,0.05,0.8,,2001.0,2008.0,ALL
10308,ZNF267,Q14586,0.769,0.192,0.017108,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
10309,CCNO,P22674,0.621,0.538,0.003548,DTO_05007584,Enzyme modulator,C4014534,"CILIARY DYSKINESIA, PRIMARY, 29",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2019.0,ALL
10311,VPS26C,O14972,0.931,0.115,0.00014872,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
10312,TCIRG1,Q13488,0.565,0.692,2.3981e-13,DTO_05007405,Transporter,C1850127,"Osteopetrosis, Autosomal Recessive 1",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.9,1.0,strong,1985.0,2015.0,ALL
10313,RTN3,O95197,0.647,0.615,6.6163e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2006.0,2019.0,ALL
10314,LANCL1,O43813,0.552,0.692,1.0827e-11,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.8,,2012.0,2020.0,ALL
10316,NMUR1,Q9HB89,0.861,0.077,5.0352e-05,DTO_02300001,G-protein coupled receptor,C0018889,Helminthiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
10317,B3GALT5,Q9Y2C3,0.821,0.115,2.1595e-05,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
10318,TNIP1,Q15025,0.564,0.769,0.47559,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.926,,2009.0,2019.0,ALL
10319,LAMC3,Q9Y6N6,0.722,0.308,1.3704e-23,DTO_05007584,Enzyme modulator,C3279875,"CORTICAL MALFORMATIONS, OCCIPITAL",,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2011.0,ALL
10320,IKZF1,Q13422,0.533,0.769,0.9986,DTO_05007542,Transcription factor,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.7,1.0,,2002.0,2019.0,ALL
10321,CRISP3,P54108,0.716,0.577,2.565e-06,DTO_05007608,Immune response,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
10322,SMYD5,Q6GMV2,0.751,0.192,0.013063,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2005.0,2014.0,ALL
10324,KLHL41,O60662,0.682,0.538,0.00011107,,,C3810384,NEMALINE MYOPATHY 9,,,disease,Disease or Syndrome,0.7,1.0,moderate,2013.0,2017.0,ALL
10326,SIRPB1,O00241;Q5TFQ8,0.839,0.231,2.3107e-12,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2009.0,2014.0,ALL
10327,AKR1A1,P14550,0.51,0.846,6.6621e-07,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,1977.0,2019.0,ALL
10328,EMC8,O43402,1.0,0.077,0.85233,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
10329,RXYLT1,Q9Y2B1,0.633,0.462,1.072e-06,,,C0265221,Walker-Warburg congenital muscular dystrophy,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,,2012.0,2013.0,ALL
10330,CNPY2,Q9Y2B0,0.691,0.385,0.0029232,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
10331,B3GNT3,Q9Y2A9,0.736,0.308,0.73888,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2013.0,2015.0,ALL
10332,CLEC4M,Q9H2X3,0.716,0.231,6.5585e-07,DTO_05007575,Receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
10333,TLR6,Q9Y2C9,0.556,0.769,2.2508e-05,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.35,0.6,,2005.0,2010.0,ALL
10335,MRVI1,Q9Y6F6,0.792,0.269,2.2619e-07,DTO_05007405,Transporter,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
10336,PCGF3,Q3KNV8,1.0,0.077,0.95326,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
10341,H2AC5P,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2013.0,ALL
10342,TFG,Q92734,0.595,0.615,0.14061,,,C1858338,"Neuropathy, hereditary motor and sensory, Okinawa type",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2012.0,2017.0,ALL
10343,PKDREJ,Q9NTG1,0.931,0.115,2.0073e-09,DTO_01300327,Ion channel,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
10344,CCL26,Q9Y258,0.617,0.654,0.010114,DTO_05007599,Signaling,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2001.0,2019.0,ALL
10345,TRDN,Q13061,0.691,0.462,8.357e-22,,,C1631597,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.74,1.0,strong,2012.0,2020.0,ALL
10346,TRIM22,Q8IYM9,0.691,0.5,2.1312e-05,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
10347,ABCA7,Q8IZY2,0.644,0.577,2.1111e-55,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.5,0.985,,2011.0,2019.0,ALL
10349,ABCA10,Q8WWZ4,1.0,0.077,7.6593e-34,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
10350,ABCA9,Q8IUA7,0.839,0.154,9.4911e-48,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
10351,ABCA8,O94911,0.821,0.231,1.609e-52,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
10352,WARS2,Q9UGM6,0.617,0.577,0.050885,,,C4540192,"NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES",,,disease,Disease or Syndrome,0.61,1.0,strong,2017.0,2019.0,ALL
10354,HMGB1P5,,0.821,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,1998.0,2000.0,ALL
10360,NPM3,O75607,0.861,0.192,0.069498,DTO_05007613,Chaperone,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
10361,NPM2,Q86SE8,1.0,0.038,0.00090602,DTO_05007613,Chaperone,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
10362,HMG20B,Q9P0W2,0.861,0.077,0.69112,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10363,HMG20A,Q9NP66,0.89,0.154,0.67769,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.48,1.0,,2011.0,2018.0,ALL
10365,KLF2,Q9Y5W3,0.542,0.692,0.56044,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2017.0,2019.0,ALL
10367,MICU1,Q9BPX6,0.638,0.654,1.9344e-13,DTO_05007616,Calcium-binding protein,C3810285,MYOPATHY WITH EXTRAPYRAMIDAL SIGNS,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2019.0,ALL
10368,CACNG3,O60359,0.861,0.115,0.99417,DTO_01300327,Ion channel,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
10369,CACNG2,Q9Y698,0.729,0.385,0.92315,DTO_01300327,Ion channel,C3280284,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 10",,,disease,Disease or Syndrome,0.6,1.0,limited,2011.0,2011.0,ALL
10370,CITED2,Q99967,0.576,0.654,0.76271,DTO_05007542,Transcription factor,C0039685,Tetralogy of Fallot,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.61,1.0,,2002.0,2018.0,ALL
10371,SEMA3A,Q14563,0.5,0.808,0.9779,DTO_05007599,Signaling,C3554021,HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.6,1.0,limited,2012.0,2014.0,ALL
10376,TUBA1B,P68363,0.568,0.692,0.96767,DTO_05007530,Cellular structure,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
10379,IRF9,Q00978,0.61,0.577,0.60773,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2000.0,2018.0,ALL
10380,BPNT1,O95861,0.805,0.192,2.2279e-05,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
10381,TUBB3,Q13509,0.486,0.808,2.5676e-10,DTO_05007530,Cellular structure,C2748801,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT",C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,2010.0,2017.0,ALL
10382,TUBB4A,P04350,0.608,0.615,0.1091,DTO_05007530,Cellular structure,C1851943,"DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,,2013.0,2017.0,ALL
10383,TUBB4B,P68371,0.65,0.654,0.80877,DTO_05007530,Cellular structure,C4693498,LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS,,,disease,Disease or Syndrome,0.6,1.0,moderate,2017.0,2017.0,ALL
10384,BTN3A3,O00478,0.792,0.308,1.1892e-18,DTO_05007584,Enzyme modulator,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
10385,BTN2A2,Q8WVV5,0.839,0.346,1.3821e-11,DTO_05007584,Enzyme modulator,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
10388,SYCP2,Q9BX26,0.751,0.346,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
10389,SCML2,Q9UQR0,0.805,0.115,0.99961,DTO_05007557,Nucleic acid binding,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
10390,CEPT1,Q9Y6K0,0.861,0.192,0.99351,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
10391,CORO2B,Q9UQ03,0.89,0.192,0.056849,DTO_05007530,Cellular structure,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
10392,NOD1,Q9Y239,0.541,0.769,2.4602e-18,DTO_05007624,Enzyme,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.3,1.0,,2001.0,2001.0,ALL
10393,ANAPC10,Q9UM13,0.78,0.308,0.0055077,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2019.0,ALL
10394,PRG3,Q9Y2Y8,,,0.00033439,DTO_05007584,Enzyme modulator,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
10395,DLC1,Q96QB1,0.529,0.731,0.99948,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.45,1.0,,2013.0,2019.0,ALL
10396,ATP8A1,Q9Y2Q0,0.821,0.308,0.1999,DTO_05007405,Transporter,C0524957,Corneal Topography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2011.0,2011.0,ALL
10397,NDRG1,Q92597,0.488,0.731,0.011324,DTO_05007624,Enzyme,C1832334,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.97,1.0,,2000.0,2018.0,ALL
10398,MYL9,P24844,0.653,0.423,0.019797,DTO_05007616,Calcium-binding protein,C0006114,Cerebral Edema,C10,   Nervous System Diseases,phenotype,Pathologic Function,0.3,1.0,,2007.0,2007.0,ALL
10399,RACK1,P63244,0.545,0.808,0.99836,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2004.0,2004.0,ALL
10400,PEMT,Q9UBM1,0.653,0.538,0.23456,,,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.34,1.0,,2005.0,2019.0,ALL
10401,PIAS3,Q9Y6X2,0.608,0.5,0.98499,,,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.31,1.0,,2014.0,2015.0,ALL
10402,ST3GAL6,Q9Y274,0.821,0.231,2.3272e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10403,NDC80,O14777,0.599,0.538,1.1423e-07,DTO_05007542,Transcription factor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2016.0,2018.0,ALL
10404,CPQ,Q9Y646,0.579,0.769,1.3154e-14,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
10406,WFDC2,Q14508,0.729,0.308,0.79406,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10407,SPAG11B,Q08648;Q6PDA7,0.65,0.731,0.027751,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2018.0,ALL
10408,MYCNOS,P40205,0.7,0.462,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
10409,BASP1,P80723,0.666,0.5,0.69168,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2002.0,2002.0,ALL
10410,IFITM3,Q01628,0.626,0.385,0.030466,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.4,1.0,,2010.0,2019.0,ALL
10411,RAPGEF3,O95398,0.593,0.692,7.0737e-23,DTO_05007584,Enzyme modulator,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.32,1.0,,2012.0,2019.0,ALL
10412,NSA2,O95478,0.78,0.346,0.010263,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
10413,YAP1,P46937,0.432,0.808,0.99918,DTO_05007584,Enzyme modulator,C3805432,"COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2017.0,ALL
10417,SPON2,Q9BUD6,0.705,0.577,2.6609e-15,DTO_05007621,Extracellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2009.0,2017.0,ALL
10418,SPON1,Q9HCB6,0.705,0.385,,DTO_05007621,Extracellular structure,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.12,0.5,,2014.0,2018.0,ALL
10419,PRMT5,O14744,0.539,0.769,0.99999,DTO_05007378,Epigenetic regulator,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.2,1.0,,2010.0,2010.0,ALL
10420,TESK2,Q96S53,0.89,0.192,4.4552e-07,DTO_03300101,Kinase,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
10421,CD2BP2,O95400,,,1.5195e-05,DTO_05007557,Nucleic acid binding,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
10422,UBAC1,Q9BSL1,0.769,0.154,0.0014517,,,C0004610,Bacteremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.04,1.0,,2015.0,2018.0,ALL
10423,CDIPT,O14735,0.89,0.269,0.13014,,,C0019269,Hermaphroditism,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
10424,PGRMC2,O15173,0.78,0.192,0.6801,DTO_05007599,Signaling,C0729353,Subfertility,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2020.0,ALL
10425,ARIH2,O95376,0.792,0.269,0.99374,DTO_05007624,Enzyme,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
10426,TUBGCP3,Q96CW5,0.78,0.231,0.4552,DTO_05007530,Cellular structure,C0431350,Primary microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.3,,,,,ALL
10427,SEC24B,O95487,0.89,0.192,1.0,DTO_05007405,Transporter,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.01,1.0,,2013.0,2013.0,ALL
10428,CFDP1,Q9UEE9,0.619,0.615,0.0036535,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.13,1.0,,2012.0,2019.0,ALL
10430,TMEM147,Q9BVK8,0.861,0.192,0.00014005,DTO_05007575,Receptor,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
10432,RBM14,Q96PK6,0.628,0.615,0.99843,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,1.0,,2007.0,2014.0,ALL
10434,LYPLA1,O75608,0.743,0.462,3.6468e-05,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2018.0,2020.0,ALL
10435,CDC42EP2,O14613,,,0.039267,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
10436,EMG1,Q92979,0.686,0.615,1.4661e-05,DTO_05007557,Nucleic acid binding,C1859405,Bowen-Conradi syndrome,C23;C16;C13;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.96,1.0,moderate,2009.0,2019.0,ALL
10437,IFI30,P13284,0.7,0.423,2.9645e-08,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
10438,C1D,Q13901,0.67,0.462,0.03411,DTO_05007542,Transcription factor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
10439,OLFM1,Q99784,0.695,0.423,0.99679,DTO_05007530,Cellular structure,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
10440,TIMM17A,Q99595,0.861,0.154,0.21724,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,2010.0,2019.0,ALL
10443,N4BP2L2,Q92802,0.78,0.231,1.3341e-09,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
10444,ZER1,Q7Z7L7,,,0.99992,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
10445,MCRS1,Q96EZ8,0.666,0.385,0.16561,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2009.0,2012.0,ALL
10446,LRRN2,O75325,0.769,0.192,0.7805,DTO_05007575,Receptor,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
10447,FAM3C,Q92520,0.691,0.538,0.096904,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2009.0,2018.0,ALL
10449,ACAA2,P42765,0.792,0.308,3.7065e-10,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
10450,PPIE,Q9UNP9,0.861,0.269,0.72832,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
10451,VAV3,Q9UKW4,0.603,0.615,8.4532e-14,,,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.41,1.0,,2014.0,2017.0,ALL
10452,TOMM40,O96008,0.59,0.538,0.99218,DTO_05007405,Transporter,C0276496,Familial Alzheimer Disease (FAD),C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.51,1.0,,2013.0,2018.0,ALL
10454,TAB1,Q15750,0.722,0.423,3.2186e-07,DTO_03300101,Kinase,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
10455,ECI2,O75521,0.821,0.231,6.5525e-08,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
10456,HAX1,O00165,0.631,0.577,8.4813e-08,,,C1853118,Severe congenital neutropenia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",phenotype,Disease or Syndrome,0.8,1.0,,2007.0,2019.0,ALL
10457,GPNMB,Q14956,0.566,0.692,2.8803e-27,DTO_05007599,Signaling,C4554421,"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
10458,BAIAP2,Q9UQB8,0.769,0.192,0.46155,DTO_05007575,Receptor,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
10459,MAD2L2,Q9UI95,0.547,0.731,0.082082,,,C4310652,"FANCONI ANEMIA, COMPLEMENTATION GROUP V",,,disease,Disease or Syndrome,0.7,1.0,moderate,2016.0,2016.0,ALL
10460,TACC3,Q9Y6A5,0.615,0.615,2.7082e-07,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.47,1.0,,2010.0,2018.0,ALL
10461,MERTK,Q12866,0.531,0.692,2.6593e-11,DTO_03300101,Kinase,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2000.0,2019.0,ALL
10462,CLEC10A,Q8IUN9,0.606,0.692,7.7599e-06,DTO_05007575,Receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
10463,SLC30A9,Q6PML9,0.736,0.385,4.6685e-07,DTO_05007405,Transporter,C4539828,BIRK-LANDAU-PEREZ SYNDROME,,,disease,Disease or Syndrome,0.5,1.0,,2017.0,2017.0,ALL
10464,PIBF1,Q8WXW3,0.67,0.462,1.9044e-11,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.62,0.667,limited,2015.0,2019.0,ALL
10465,PPIH,O43447,1.0,0.077,7.4626e-05,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
10466,COG5,Q9UP83,0.656,0.538,9.7667e-20,,,C3150876,COG5 congenital disorder of glycosylation,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.6,1.0,,2009.0,2017.0,ALL
10467,ZNHIT1,O43257,0.89,0.115,2.3592e-06,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
10468,FST,P19883,0.513,0.731,0.98014,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,1.0,,2005.0,2018.0,ALL
10469,TIMM44,O43615,0.76,0.385,0.0015924,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2013.0,2013.0,ALL
10471,PFDN6,O15212,1.0,0.115,0.93592,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
10472,ZBTB18,Q99592,0.666,0.5,0.99658,DTO_05007542,Transcription factor,C3808184,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 22",,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2016.0,ALL
10473,HMGN4,O00479,0.839,0.192,0.31986,DTO_05007557,Nucleic acid binding,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
10474,TADA3,O75528,0.805,0.115,5.6509e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2007.0,2016.0,ALL
10475,TRIM38,O00635,0.792,0.346,1.3947e-08,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
10476,ATP5PD,O75947,0.78,0.346,0.00045999,DTO_05007405,Transporter,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
10477,UBE2E3,Q969T4,0.861,0.192,0.42649,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
10478,SLC25A17,O43808,0.931,0.038,2.7533e-05,DTO_05007405,Transporter,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
10479,SLC9A6,Q92581,0.516,0.846,0.99833,DTO_05007405,Transporter,C2678194,"Mental Retardation, X-Linked, Syndromic, Christianson Type",C23;C16;C11;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,1.0,definitive,2008.0,2020.0,ALL
10480,EIF3M,Q7L2H7,0.78,0.269,0.01748,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
10481,HOXB13,Q92826,0.573,0.462,3.6879e-08,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.6,0.982,,2004.0,2019.0,ALL
10482,NXF1,Q9UBU9,0.531,0.885,0.9763,DTO_05007557,Nucleic acid binding,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,1993.0,2018.0,ALL
10483,SEC23B,Q15437,0.579,0.692,6.0973e-20,DTO_05007584,Enzyme modulator,C1306589,"Congenital dyserythropoietic anemia, type II",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.96,,1989.0,2019.0,ALL
10484,SEC23A,Q15436,0.659,0.423,1.0698e-11,DTO_05007584,Enzyme modulator,C1843042,Craniolenticulosutural Dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2006.0,ALL
10485,C1orf61,Q13536,0.931,0.115,1.0714e-05,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
10486,CAP2,P40123,0.716,0.423,0.69899,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,0.75,,2013.0,2018.0,ALL
10487,CAP1,Q01518,0.529,0.808,0.019817,DTO_05007530,Cellular structure,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
10488,CREB3,O43889,0.663,0.654,1.8489e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,0.75,,2012.0,2019.0,ALL
10489,LRRC41,Q15345,0.931,0.115,0.99986,,,C1527349,Ductal Breast Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,,,,,ALL
10490,VTI1B,Q9UEU0,,,0.10836,DTO_05007405,Transporter,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
10491,CRTAP,O75718,0.636,0.654,0.00055361,DTO_05007621,Extracellular structure,C1853162,Osteogenesis Imperfecta Type VII,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.92,1.0,strong,2006.0,2012.0,ALL
10492,SYNCRIP,O60506,0.722,0.269,0.99939,DTO_05007557,Nucleic acid binding,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
10493,VAT1,Q99536,0.729,0.346,0.0054627,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
10494,STK25,O00506,0.7,0.346,0.051875,DTO_03300101,Kinase,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
10495,ENOX2,Q16206,0.716,0.231,1.5327e-06,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.34,1.0,,2008.0,2018.0,ALL
10497,UNC13B,O14795,0.769,0.385,3.153e-17,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
10498,CARM1,Q86X55,0.601,0.692,0.99998,DTO_05007378,Epigenetic regulator,C0030246,Pustulosis of Palms and Soles,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
10499,NCOA2,Q15596,0.575,0.615,1.0,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.38,0.875,,2002.0,2019.0,ALL
10500,SEMA6C,Q9H3T2,0.861,0.154,1.238e-06,DTO_05007599,Signaling,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2015.0,2018.0,ALL
10501,SEMA6B,Q9H3T3,0.78,0.231,0.06227,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
10505,SEMA4F,O95754,0.805,0.269,9.1544e-13,DTO_05007599,Signaling,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
10507,SEMA4D,Q92854,0.564,0.769,0.97472,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.933,,2006.0,2019.0,ALL
10509,SEMA4B,Q9NPR2,0.743,0.269,0.00054103,DTO_05007599,Signaling,C0001144,Acne Vulgaris,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
10512,SEMA3C,Q99985,0.619,0.731,0.00087445,DTO_05007599,Signaling,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.42,1.0,,2012.0,2016.0,ALL
10513,APPBP2,Q92624,0.722,0.385,0.99567,,,C0022650,Kidney Calculi,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.02,1.0,,2018.0,2019.0,ALL
10514,MYBBP1A,Q9BQG0,0.695,0.615,5.2346e-42,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2005.0,2018.0,ALL
10516,FBLN5,Q9UBX5,0.546,0.692,0.9997,DTO_05007616,Calcium-binding protein,C0010495,Cutis Laxa,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2002.0,2018.0,ALL
10517,FBXW10,Q5XX13,0.931,0.115,1.818e-27,,,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2013.0,2013.0,ALL
10518,CIB2,O75838,0.545,0.808,0.0014456,,,C1836199,"DEAFNESS, AUTOSOMAL RECESSIVE 48",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.92,1.0,,1999.0,2017.0,ALL
10519,CIB1,Q99828,0.458,0.769,0.00032612,,,C4748876,"EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3",,,phenotype,Finding,0.4,1.0,strong,2018.0,2019.0,ALL
10521,DDX17,Q92841,0.769,0.192,0.99999,,,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2015.0,2019.0,ALL
10522,DEAF1,O75398,0.575,0.615,0.00034113,,,C4014414,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 24",,,disease,Disease or Syndrome,0.7,1.0,,2001.0,2017.0,ALL
10523,CHERP,Q8IWX8,0.821,0.154,1.0,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
10524,KAT5,Q92993,0.534,0.769,0.088234,,,C0029810,Other specified iron deficiency anemias,C18;C15,   Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.2,1.0,,2008.0,2008.0,ALL
10525,HYOU1,Q9Y4L1,0.633,0.731,0.86105,,,C1846707,SPINOCEREBELLAR ATAXIA 17,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
10526,IPO8,O15397,0.722,0.346,0.2344,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
10527,IPO7,O95373,0.729,0.269,1.0,DTO_05007584,Enzyme modulator,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.31,1.0,,2004.0,2007.0,ALL
10528,NOP56,O00567,0.663,0.538,0.62098,DTO_05007557,Nucleic acid binding,C3472711,Spinocerebellar ataxia 36,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.69,1.0,,2011.0,2019.0,ALL
10529,NEBL,O76041,0.65,0.692,1.7679e-36,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.41,1.0,,2017.0,2017.0,ALL
10531,PITRM1,Q5JRX3,0.821,0.308,5.9266e-21,DTO_05007624,Enzyme,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,strong,2016.0,2018.0,ALL
10533,ATG7,O95352,0.505,0.769,7.3758e-12,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,1.0,,2012.0,2019.0,ALL
10534,ZNRD2,O60232,0.443,0.769,1.8426e-07,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.925,,1996.0,2019.0,ALL
10535,RNASEH2A,O75792,0.592,0.692,0.0041807,DTO_05007624,Enzyme,C1835912,AICARDI-GOUTIERES SYNDROME 4,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2005.0,2015.0,ALL
10536,P3H3,Q8IVL6,0.729,0.423,7.1076e-12,DTO_05007621,Extracellular structure,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
10537,UBD,O15205,0.597,0.692,0.0070467,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2008.0,2018.0,ALL
10538,BATF,Q16520,0.674,0.5,0.85462,DTO_05007542,Transcription factor,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
10539,GLRX3,O76003,0.686,0.538,0.35753,DTO_05007624,Enzyme,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.3,1.0,,2006.0,2006.0,ALL
10540,DCTN2,Q13561,0.805,0.154,0.99653,DTO_05007530,Cellular structure,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
10541,ANP32B,Q92688,0.541,0.731,0.95827,DTO_05007584,Enzyme modulator,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
10542,LAMTOR5,O43504,0.67,0.5,3.8329e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,1.0,,2013.0,2020.0,ALL
10544,PROCR,Q9UNN8,0.56,0.692,0.0056256,DTO_05007584,Enzyme modulator,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.4,1.0,,2013.0,2018.0,ALL
10547,PSORS4,,0.861,0.077,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2001.0,2014.0,ALL
10549,PRDX4,Q13162,0.619,0.692,0.026755,DTO_05007624,Enzyme,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
10550,ARL6IP5,O75915,0.674,0.462,0.10381,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2007.0,2018.0,ALL
10551,AGR2,O95994,0.556,0.692,9.2381e-08,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,1998.0,2019.0,ALL
10552,ARPC1A,Q92747,0.78,0.308,0.73997,DTO_05007530,Cellular structure,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
10553,HTATIP2,Q9BUP3,0.608,0.577,5.3767e-13,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.6,1.0,,2003.0,2018.0,ALL
10554,AGPAT1,Q99943,0.743,0.423,0.97215,,,C0206368,Exfoliation Syndrome,C11,   Eye Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
10555,AGPAT2,O15120,0.585,0.654,1.236e-07,,,C1720862,Congenital Generalized Lipodystrophy Type 1,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.93,0.857,,2002.0,2019.0,ALL
10557,RPP38,P78345,0.931,0.077,0.00020088,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
10558,SPTLC1,O15269,0.65,0.538,4.1945e-11,DTO_05007624,Enzyme,C0020071,"Hereditary Sensory Autonomic Neuropathy, Type 1",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,1996.0,2019.0,ALL
10559,SLC35A1,P78382,0.601,0.654,0.68262,DTO_05007405,Transporter,C1970344,"Congenital Disorder Of Glycosylation, Type IIF",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.61,1.0,,2015.0,2018.0,ALL
10560,SLC19A2,O60779,0.636,0.692,0.00043398,DTO_05007405,Transporter,C0342287,Thiamine responsive megaloblastic anemia syndrome,C23;C18;C10;C19;C09;C15,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases;    Hemic and Lymphatic Diseases",disease,Congenital Abnormality,1.0,1.0,,1997.0,2019.0,ALL
10561,IFI44,Q8TCB0,0.678,0.538,1.9433e-15,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
10562,OLFM4,Q6UX06,0.576,0.615,2.7754e-06,DTO_05007530,Cellular structure,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,1.0,,2010.0,2010.0,ALL
10563,CXCL13,O43927,0.472,0.731,0.82566,DTO_05007599,Signaling,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,1.0,,2015.0,2019.0,ALL
10564,ARFGEF2,Q9Y6D5,0.659,0.462,0.99993,,,C1842563,"Heterotopia, Periventricular, Autosomal Recessive",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2004.0,2014.0,ALL
10565,ARFGEF1,Q9Y6D6,0.674,0.423,1.0,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
10566,AKAP3,O75969,0.736,0.269,0.056438,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
10567,RABAC1,Q9UI14,0.931,0.077,0.005291,DTO_05007405,Transporter,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2012.0,2019.0,ALL
10568,SLC34A2,O95436,0.656,0.423,9.3992e-11,DTO_05007405,Transporter,C0155912,Pulmonary Alveolar Microlithiasis,C16;C18;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.78,0.9,strong,2004.0,2020.0,ALL
10569,SLU7,O95391,0.729,0.346,1.6328e-09,DTO_05007557,Nucleic acid binding,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
10570,DPYSL4,O14531,0.792,0.346,1.634e-08,DTO_05007624,Enzyme,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
10572,SIVA1,O15304,0.736,0.269,0.025729,,,C0010246,Coxsackievirus Infections,C01,   Infections,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
10573,MRPL28,Q13084,0.505,0.731,1.9955e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1995.0,2015.0,ALL
10574,CCT7,Q99832,0.78,0.192,0.98362,DTO_05007613,Chaperone,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
10575,CCT4,P50991,0.65,0.5,0.99903,DTO_05007613,Chaperone,C0699739,"Sensory Neuropathy, Hereditary",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.22,1.0,,2003.0,2014.0,ALL
10576,CCT2,P78371,0.656,0.577,0.99853,DTO_05007613,Chaperone,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
10577,NPC2,P61916,0.612,0.769,0.0017755,,,C1843366,"NIEMANN-PICK DISEASE, TYPE C2",C16;C18;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.78,1.0,,2000.0,2018.0,ALL
10578,GNLY,P22749,0.584,0.692,9.6899e-09,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
10579,TACC2,O95359,0.751,0.231,4.819e-24,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2003.0,2016.0,ALL
10580,SORBS1,Q9BX66,0.554,0.769,1.534e-12,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2009.0,2020.0,ALL
10581,IFITM2,Q01629,0.792,0.231,0.0051529,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
10584,COLEC10,Q9Y6Z7,0.621,0.692,0.0026167,DTO_05007697,Surfactant,C0796032,Malpuech facial clefting syndrome,C16;C05;F03;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Mental Disorders;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2017.0,ALL
10585,POMT1,Q9Y6A1,0.525,0.615,4.2265e-17,,,C3150415,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1",,,disease,Disease or Syndrome,0.9,1.0,strong,2002.0,2016.0,ALL
10586,MAB21L2,Q9Y586,0.743,0.308,0.43769,,,C4014540,MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2015.0,ALL
10587,TXNRD2,Q9NNW7,0.548,0.731,3.4688e-11,DTO_05007624,Enzyme,C0017612,"Glaucoma, Open-Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.4,1.0,,2012.0,2016.0,ALL
10588,MTHFS,P49914,0.678,0.5,0.00025842,DTO_05007624,Enzyme,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.3,1.0,,2011.0,2011.0,ALL
10589,DRAP1,Q14919,0.861,0.038,0.1299,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
10590,SCGN,O76038,0.695,0.5,2.3395e-11,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.13,1.0,,2017.0,2019.0,ALL
10591,DNPH1,O43598,,,0.032074,,,C0236075,Menopausal symptom,,,phenotype,Sign or Symptom,0.01,1.0,,2019.0,2019.0,ALL
10592,SMC2,O95347,0.653,0.462,0.9999,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10594,PRPF8,Q6P2Q9,0.631,0.615,1.0,DTO_05007557,Nucleic acid binding,C1838702,Retinitis Pigmentosa 13,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.92,1.0,,2001.0,2014.0,ALL
10595,ERN2,Q76MJ5,0.821,0.192,7.1766e-24,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
10597,TRAPPC2B,P0DI81;P0DI82,0.861,0.192,0.029497,DTO_05007542,Transcription factor,C0038015,Spondyloepiphyseal Dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2000.0,2014.0,ALL
10598,AHSA1,O95433,0.396,0.923,0.99896,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2000.0,2020.0,ALL
10599,SLCO1B1,Q9Y6L6,0.538,0.731,1.1086e-21,DTO_05007405,Transporter,C0220991,Rotor Syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,limited,2007.0,2015.0,ALL
10600,USP16,Q9Y5T5,0.805,0.346,1.8493e-09,DTO_05007624,Enzyme,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2013.0,2018.0,ALL
10602,CDC42EP3,Q9UKI2,0.722,0.423,0.18562,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
10603,SH2B2,O14492,0.623,0.731,1.4932e-05,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.08,1.0,,2003.0,2019.0,ALL
10605,PAIP1,Q9H074,0.861,0.115,0.99884,DTO_05007557,Nucleic acid binding,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
10606,PAICS,P22234,0.711,0.346,2.7905e-05,DTO_05007624,Enzyme,C0039585,Androgen-Insensitivity Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.05,1.0,,1996.0,2013.0,ALL
10608,MXD4,Q14582,0.722,0.115,0.77635,DTO_05007542,Transcription factor,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
10609,P3H4,Q92791,0.751,0.385,1.5029e-10,DTO_05007621,Extracellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2000.0,2018.0,ALL
10610,ST6GALNAC2,Q9UJ37,0.78,0.308,7.472e-15,,,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.33,1.0,,2007.0,2009.0,ALL
10611,PDLIM5,Q96HC4,0.525,0.808,0.0016769,DTO_05007530,Cellular structure,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.39,0.8,,2004.0,2014.0,ALL
10612,TRIM3,O75382,0.682,0.423,0.9893,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
10613,ERLIN1,O75477,0.736,0.308,0.17751,,,C4284588,"SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
10614,HEXIM1,O94992,0.65,0.577,0.98396,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10615,SPAG5,Q96R06,0.674,0.385,1.3955e-15,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
10616,RBCK1,Q9BYM8,0.736,0.462,0.13497,DTO_05007624,Enzyme,C4014605,POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY,,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2018.0,ALL
10617,STAMBP,O95630,0.653,0.423,5.4496e-05,DTO_05007624,Enzyme,C3280296,Microcephaly-capillary malformation syndrome,C16;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.75,0.833,,2013.0,2019.0,ALL
10618,TGOLN2,O43493,,,0.0028483,DTO_05007405,Transporter,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,0.0,,2010.0,2010.0,ALL
10620,ARID3B,Q8IVW6,0.659,0.577,0.38022,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10622,POLR3G,O15318,0.89,0.154,1.7611e-10,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
10623,POLR3C,Q9BUI4,0.89,0.115,5.0277e-12,DTO_05007624,Enzyme,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
10625,IVNS1ABP,Q9Y6Y0,0.608,0.769,0.99442,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
10626,TRIM16,O95361,0.67,0.462,3.1558e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,1998.0,2019.0,ALL
10627,MYL12A,O14950;P19105,0.682,0.462,0.00051197,DTO_05007616,Calcium-binding protein,C0949658,"Cardiomyopathy, Hypertrophic, Familial",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,1.0,,2005.0,2019.0,ALL
10628,TXNIP,Q9H3M7,0.49,0.731,0.15918,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2003.0,2019.0,ALL
10630,PDPN,Q86YL7,0.47,0.769,0.00032048,,,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2013.0,2019.0,ALL
10631,POSTN,Q15063,0.428,0.885,1.0666e-09,DTO_05007599,Signaling,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2005.0,2018.0,ALL
10632,ATP5MG,O75964,1.0,0.038,0.0044259,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
10633,RASL10A,Q92737,0.792,0.077,0.18418,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
10634,GAS2L1,Q99501,0.861,0.077,0.83227,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2011.0,2011.0,ALL
10635,RAD51AP1,Q96B01,0.705,0.308,0.011096,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
10636,RGS14,O43566,0.751,0.346,0.0023174,,,C0022650,Kidney Calculi,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.14,1.0,,2012.0,2019.0,ALL
10637,LEFTY1,O75610,0.805,0.385,9.6756e-13,DTO_05007599,Signaling,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
10640,EXOC5,O00471,0.805,0.269,0.99991,DTO_05007405,Transporter,C0149939,Obstructive nephropathy,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.2,,,,,ALL
10641,NPRL2,Q8WTW4,0.644,0.462,0.38813,DTO_05007624,Enzyme,C4310709,"EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2019.0,ALL
10642,IGF2BP1,Q9NZI8,0.56,0.692,0.99933,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.38,1.0,,2014.0,2019.0,ALL
10643,IGF2BP3,O00425,0.57,0.577,0.99999,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2008.0,2018.0,ALL
10644,IGF2BP2,Q9Y6M1,0.588,0.615,0.23861,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.5,0.972,,2007.0,2019.0,ALL
10645,CAMKK2,Q96RR4,0.617,0.654,0.091625,DTO_03300101,Kinase,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.39,1.0,,2011.0,2018.0,ALL
10647,SCGB1D2,O95969,0.769,0.192,0.2703,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.05,1.0,,2002.0,2008.0,ALL
10648,SCGB1D1,O95968,,,1.294e-07,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
10651,MTX2,O75431,1.0,0.077,0.019208,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
10652,YKT6,O15498,0.792,0.231,0.36157,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2016.0,2019.0,ALL
10653,SPINT2,O43291,0.556,0.808,0.00075147,,,C0267663,"Congenital secretory diarrhea, sodium type (disorder)",C23;C16;C18,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Congenital Abnormality,0.75,1.0,,2007.0,2018.0,ALL
10654,PMVK,Q15126,0.769,0.308,2.7113e-05,,,C0949506,Porokeratosis of Mibelli,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.71,1.0,limited,2015.0,2017.0,ALL
10655,DMRT2,Q9Y5R5,0.78,0.462,0.0096606,,,C0432470,"46, XY female",C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.02,0.5,,1999.0,2000.0,ALL
10656,KHDRBS3,O75525,0.736,0.231,0.44237,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
10657,KHDRBS1,Q07666,0.457,0.846,0.99423,DTO_05007557,Nucleic acid binding,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,0.909,,2005.0,2019.0,ALL
10658,CELF1,Q92879,0.631,0.577,0.99971,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.16,1.0,,2013.0,2018.0,ALL
10659,CELF2,O95319,0.628,0.692,0.99965,,,C0014518,Toxic Epidermal Necrolysis,C17;C20;C25;C07,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Chemically-Induced Disorders;    Stomatognathic Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
10660,LBX1,P52954,0.736,0.462,0.67886,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2009.0,2009.0,ALL
10661,KLF1,Q13351,0.621,0.462,0.000358,DTO_05007557,Nucleic acid binding,C3150926,Congenital dyserythropoietic anemia type IV,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.78,1.0,,2010.0,2020.0,ALL
10663,CXCR6,O00574,0.448,0.885,5.7212e-05,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,1997.0,2019.0,ALL
10664,CTCF,P49711,0.504,0.769,0.99994,DTO_05007542,Transcription factor,C3809686,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 21",,,disease,Disease or Syndrome,0.7,1.0,moderate,2011.0,2017.0,ALL
10665,TSBP1,Q5SRN2,0.638,0.692,1.4756e-16,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.13,0.889,,2007.0,2019.0,ALL
10666,CD226,Q15762,0.548,0.769,0.03921,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.36,1.0,,2005.0,2016.0,ALL
10667,FARS2,O95363,0.615,0.731,9.2964e-09,DTO_05007624,Enzyme,C3554168,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14,,,disease,Disease or Syndrome,0.73,1.0,strong,2012.0,2019.0,ALL
10668,CGRRF1,Q99675,0.821,0.231,0.0073203,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
10669,CGREF1,Q99674,1.0,0.077,4.7425e-08,DTO_05007405,Transporter,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
10670,RRAGA,Q7L523,0.792,0.269,0.3557,DTO_05007584,Enzyme modulator,C0206141,Idiopathic Hypereosinophilic Syndrome,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.03,1.0,,2006.0,2008.0,ALL
10671,DCTN6,O00399,0.442,0.769,0.055741,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.925,,1996.0,2019.0,ALL
10672,GNA13,Q14344,0.656,0.538,0.86735,DTO_05007584,Enzyme modulator,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.33,1.0,,2013.0,2019.0,ALL
10673,TNFSF13B,Q9Y275,0.46,0.731,0.98193,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
10674,DURS1,,0.839,0.154,,,,C0007789,Cerebral Palsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
10675,CSPG5,O95196,0.861,0.115,0.056186,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2013.0,ALL
10677,AVIL,O75366,0.89,0.154,1.6972e-13,DTO_05007530,Cellular structure,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
10678,B3GNT2,Q9NY97,0.705,0.5,0.88722,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.33,1.0,,1988.0,2013.0,ALL
10681,GNB5,O14775,0.736,0.308,6.3614e-08,DTO_05007624,Enzyme,C4310682,INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA,,,disease,Disease or Syndrome,0.71,1.0,strong,2016.0,2018.0,ALL
10682,EBP,Q15125,0.494,0.846,0.93645,DTO_05007624,Enzyme,C0282102,"Chondrodysplasia punctata, X-linked dominant type",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,1.0,1.0,strong,1983.0,2019.0,ALL
10683,DLL3,Q9NYJ7,0.552,0.654,5.3576e-05,,,C0265343,Jarcho-Levin syndrome,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.87,1.0,,2000.0,2019.0,ALL
10686,CLDN16,Q9Y5I7,0.647,0.538,0.025466,DTO_05007527,Cell-cell junction,C0268448,Primary hypomagnesemia (disorder),C23;C16;C18;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.9,1.0,,1999.0,2016.0,ALL
10687,PNMA2,Q9UL42,0.89,0.115,0.0015661,,,C0014848,Esophageal Achalasia,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
10690,FUT9,Q9Y231,0.76,0.154,0.08318,DTO_05007624,Enzyme,C0374997,Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.04,1.0,,2017.0,2019.0,ALL
10691,GMEB1,Q9Y692,0.861,0.115,0.98549,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
10692,RRH,O14718,0.89,0.192,2.0709e-09,DTO_02300001,G-protein coupled receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10693,CCT6B,Q92526,0.89,0.154,5.6679e-11,DTO_05007613,Chaperone,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
10694,CCT8,P50990,0.805,0.115,0.96252,DTO_05007613,Chaperone,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2015.0,2019.0,ALL
10695,CNPY3,Q9BT09,0.805,0.269,0.39757,,,C4693663,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
10699,CORIN,Q9Y5Q5,0.695,0.538,6.5072e-35,,,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.6,1.0,,2012.0,2012.0,ALL
10712,FAM189B,P81408,0.89,0.154,8.0554e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
10713,USP39,Q53GS9,0.656,0.385,0.01038,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2016.0,2019.0,ALL
10714,POLD3,Q15054,0.631,0.462,0.99776,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.42,1.0,,2012.0,2019.0,ALL
10715,CERS1,P27544,0.638,0.385,0.096618,,,C4015619,"EPILEPSY, PROGRESSIVE MYOCLONIC, 8",,,disease,Disease or Syndrome,0.7,1.0,moderate,2009.0,2014.0,ALL
10716,TBR1,Q16650,0.666,0.385,0.99901,DTO_05007542,Transcription factor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.65,1.0,,2012.0,2017.0,ALL
10717,AP4B1,Q9Y6B7,0.631,0.654,1.335e-09,DTO_05007405,Transporter,C3279738,"SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.6,1.0,,2011.0,2015.0,ALL
10718,NRG3,P56975,0.67,0.615,0.10947,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,0.786,,2008.0,2020.0,ALL
10720,UGT2B11,O75310,0.861,0.192,5.98e-16,,,C0221391,Melanosis coli,C23;C06;C17,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
10721,POLQ,O75417,0.695,0.462,1.3079e-82,DTO_05007624,Enzyme,C0043346,Xeroderma Pigmentosum,C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.1,1.0,,1999.0,2018.0,ALL
10723,SLC12A7,Q9Y666,0.769,0.385,1.3921e-17,DTO_05007405,Transporter,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
10724,OGA,O60502,0.534,0.731,0.96569,,,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.2,1.0,,2007.0,2007.0,ALL
10725,NFAT5,O94916,0.601,0.692,1.0,DTO_05007542,Transcription factor,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2019.0,ALL
10726,NUDC,Q9Y266,0.76,0.154,0.88682,DTO_05007530,Cellular structure,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
10728,PTGES3,Q15185,0.641,0.731,0.98536,DTO_05007613,Chaperone,C0149504,"Encephalopathy, Toxic",C10;C25,   Nervous System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2018.0,2018.0,ALL
10730,YME1L1,Q96TA2,0.633,0.654,0.028988,DTO_05007624,Enzyme,C4310628,OPTIC ATROPHY 11,,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2018.0,ALL
10732,TCFL5,Q9UL49,0.682,0.423,0.99128,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.04,1.0,,2017.0,2020.0,ALL
10733,PLK4,O00444,0.551,0.731,7.0844e-06,DTO_03300101,Kinase,C0265202,Seckel syndrome,C23;C16;C05;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.51,1.0,,2014.0,2017.0,ALL
10734,STAG3,Q9UJ98,0.722,0.385,8.7188e-13,DTO_05007557,Nucleic acid binding,C3810367,PREMATURE OVARIAN FAILURE 8,,,disease,Disease or Syndrome,0.4,,,,,ALL
10735,STAG2,Q8N3U4,0.568,0.731,1.0,DTO_05007557,Nucleic acid binding,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.57,1.0,,2013.0,2018.0,ALL
10736,SIX2,Q9NPC8,0.604,0.654,0.93869,DTO_05007542,Transcription factor,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.34,1.0,,2008.0,2017.0,ALL
10738,RFPL3,O75679,1.0,0.077,1.6582e-05,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
10740,RFPL1S,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
10741,RBBP9,O75884,0.89,0.231,0.048641,,,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.04,1.0,,1998.0,2012.0,ALL
10742,RAI2,Q9Y5P3,0.751,0.346,0.61158,,,C0201544,Prostate specific antigen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
10743,RAI1,Q7Z5J4,0.545,0.731,1.0,DTO_05007542,Transcription factor,C0795864,Smith-Magenis syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.981,definitive,2001.0,2019.0,ALL
10744,PTTG2,Q9NZH5,0.89,0.154,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
10745,PHTF1,Q9UMS5,0.931,0.192,9.6863e-26,DTO_05007542,Transcription factor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
10746,MAP3K2,Q9Y2U5,0.686,0.231,0.99999,DTO_03300101,Kinase,C0345958,Large cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
10747,MASP2,O00187,0.582,0.692,3.0428e-14,DTO_05007624,Enzyme,C3151085,MASP2 Deficiency,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.71,0.875,limited,2003.0,2020.0,ALL
10748,KLRA1P,,1.0,0.077,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,0.0,,2019.0,2019.0,ALL
10749,KIF1C,O43896,0.7,0.5,0.71767,DTO_05007530,Cellular structure,C1969796,"ATAXIA, SPASTIC, 2, AUTOSOMAL RECESSIVE (disorder)",C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2014.0,2018.0,ALL
10750,GRAP,Q13588,0.821,0.462,0.11064,,,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.11,1.0,,2019.0,2019.0,ALL
10752,CHL1,O00533,0.603,0.654,8.889e-12,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2002.0,2017.0,ALL
10753,CAPN9,O14815,0.861,0.231,1.3256e-22,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
10755,GIPC1,O14908,0.628,0.577,0.0083114,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2002.0,2019.0,ALL
10758,TRAF3IP2,O43734,0.585,0.692,1.615e-09,,,C3714992,"CANDIDIASIS, FAMILIAL, 8",,,disease,Disease or Syndrome,0.7,1.0,limited,2013.0,2013.0,ALL
10761,PLAC1,Q9HBJ0,0.716,0.308,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2016.0,2019.0,ALL
10762,NUP50,Q9UKX7,1.0,0.038,0.28337,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
10763,NES,P48681,0.45,0.808,1.6236e-06,,,C0027720,Nephrosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.5,1.0,,2006.0,2007.0,ALL
10765,KDM5B,Q9UGL1,0.532,0.731,7.9102e-15,DTO_05007378,Epigenetic regulator,C4748219,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65",,,disease,Disease or Syndrome,0.4,1.0,strong,2018.0,2018.0,ALL
10766,TOB2,Q14106,0.839,0.231,0.88658,,,C0042900,Vitiligo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
10767,HBS1L,Q9Y450,0.705,0.462,1.8606e-07,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2019.0,ALL
10768,AHCYL1,O43865,0.861,0.269,0.99429,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
10769,PLK2,Q9NYY3,0.575,0.808,0.9999,DTO_03300101,Kinase,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,2002.0,2010.0,ALL
10771,ZMYND11,Q15326,0.647,0.5,1.0,,,C4015167,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 30",,,disease,Disease or Syndrome,0.4,1.0,,2014.0,2014.0,ALL
10772,SRSF10,O75494,0.736,0.308,0.42275,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2015.0,2015.0,ALL
10774,DHS,,0.769,0.423,,,,C0272051,Xerocytosis,C23;C16;C13;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.08,1.0,,1998.0,2020.0,ALL
10775,POP4,O95707,0.861,0.154,1.8179e-05,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
10776,ARPP19,P56211,0.839,0.231,0.77371,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
10777,ARPP21,Q9UBL0,0.663,0.654,0.012016,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
10778,ZNF271P,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
10780,ZNF234,Q14588,,,1.6875e-12,,,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
10781,ZNF266,Q14584,0.839,0.269,0.022887,DTO_05007542,Transcription factor,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.03,1.0,,2007.0,2010.0,ALL
10782,ZNF274,Q96GC6,1.0,0.115,0.14989,,,C0027746,Nerve Degeneration,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.2,1.0,,2008.0,2008.0,ALL
10783,NEK6,Q9HC98,0.743,0.385,0.038901,DTO_03300101,Kinase,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10785,WDR4,P57081,0.653,0.538,1.3806e-08,DTO_05007557,Nucleic acid binding,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.42,1.0,moderate,2015.0,2018.0,ALL
10786,SLC17A3,O00476,0.769,0.385,4.9259e-22,DTO_05007405,Transporter,C2675207,"URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4",,,phenotype,Finding,0.4,,,,,ALL
10787,NCKAP1,Q9Y2A7,0.722,0.538,1.0,,,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2017.0,2017.0,ALL
10788,IQGAP2,Q13576,0.674,0.269,8.4988e-27,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.54,1.0,,2010.0,2014.0,ALL
10791,VAMP5,O95183,0.821,0.154,0.011061,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10793,ZNF273,Q14593,1.0,0.115,0.027091,,,C2931689,Dystrophia myotonica 2,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,2007.0,2010.0,ALL
10794,ZNF460,Q14592,,,0.68181,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10795,ZNF268,Q14587,0.821,0.077,6.3323e-14,DTO_05007542,Transcription factor,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
10797,MTHFD2,P13995,0.666,0.423,0.0023975,DTO_05007624,Enzyme,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
10800,CYSLTR1,Q9Y271,0.593,0.769,0.01203,DTO_02300001,G-protein coupled receptor,C1319853,"Asthma, Aspirin-Induced",C08;C20;C25,   Respiratory Tract Diseases;    Immune System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.31,1.0,,2006.0,2010.0,ALL
10801,SEPTIN9,Q9UHD8,0.548,0.769,0.99579,DTO_05007584,Enzyme modulator,C1834304,"AMYOTROPHY, HEREDITARY NEURALGIC",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.8,0.938,,2005.0,2019.0,ALL
10803,CCR9,P51686,0.573,0.692,0.0041986,DTO_02300001,G-protein coupled receptor,C0020517,Hypersensitivity,C20,   Immune System Diseases,group,Pathologic Function,0.3,1.0,,2011.0,2011.0,ALL
10804,GJB6,O95452,0.528,0.808,1.658e-07,DTO_05007527,Cell-cell junction,C0162361,Hidrotic Ectodermal Dysplasia,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1998.0,2019.0,ALL
10806,SDCCAG8,Q86SQ7,0.619,0.577,1.1809e-11,,,C0752166,Bardet-Biedl Syndrome,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.64,1.0,strong,2010.0,2019.0,ALL
10807,ENTR1,Q96C92,1.0,0.077,3.6526e-13,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
10808,HSPH1,Q92598,0.65,0.538,0.99822,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
10809,STARD10,Q9Y365,0.839,0.192,8.1718e-05,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
10810,WASF3,Q9UPY6,0.595,0.769,0.54018,DTO_05007530,Cellular structure,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2010.0,2018.0,ALL
10811,NOXA1,Q86UR1,0.861,0.038,2.8065e-09,DTO_05007624,Enzyme,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2010.0,2019.0,ALL
10813,UTP14A,Q9BVJ6,0.805,0.308,0.99983,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
10814,CPLX2,Q6PUV4,0.736,0.231,0.52601,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.58,1.0,,1998.0,2015.0,ALL
10815,CPLX1,O14810,0.576,0.654,0.82499,,,C4693810,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63",,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2017.0,ALL
10817,FRS3,O43559,0.89,0.115,0.55047,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
10818,FRS2,Q8WU20,0.623,0.577,0.99721,,,C0023827,liposarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.33,1.0,,2011.0,2019.0,ALL
10819,OR7E14P,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
10824,DIAPH2-AS1,Q14236,1.0,0.038,,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
10825,NEU3,Q9UQ49,0.666,0.654,2.4425e-08,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2007.0,2019.0,ALL
10826,FAXDC2,Q96IV6,0.839,0.115,1.7164e-08,DTO_05007624,Enzyme,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
10827,FAM114A2,Q9NRY5,1.0,0.077,7.2335e-10,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2019.0,ALL
10840,ALDH1L1,O75891,0.663,0.615,1.4114e-11,DTO_05007624,Enzyme,C0003129,Anoxemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0,,2009.0,2009.0,ALL
10841,FTCD,O95954,0.722,0.423,5.523e-15,DTO_05007624,Enzyme,C0268609,Glutamate formiminotransferase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,,2003.0,2019.0,ALL
10842,PPP1R17,O96001,0.805,0.192,0.0010488,,,C0745103,Hyperlipoproteinemia Type IIa,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
10844,TUBGCP2,Q9BSJ2,0.705,0.462,2.2003e-08,DTO_05007530,Cellular structure,C2076600,Influenza due to Influenza A virus subtype H1N1,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
10845,CLPX,O76031,0.931,0.154,0.92377,DTO_05007613,Chaperone,C4693947,"PROTOPORPHYRIA, ERYTHROPOIETIC, 2",,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2017.0,ALL
10846,PDE10A,Q9Y233,0.619,0.615,0.99986,,,C4310791,"STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
10847,SRCAP,Q6ZRS2,0.61,0.731,1.0,,,C0729582,Floating-harbor syndrome,C23;C16;C05;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2012.0,2020.0,ALL
10848,PPP1R13L,Q8WUF5,0.539,0.692,0.03206,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
10849,CD3EAP,O15446,0.729,0.423,0.031626,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2007.0,2018.0,ALL
10850,CCL27,Q9Y4X3,0.502,0.846,0.013511,DTO_05007599,Signaling,C0011616,Contact Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
10855,HPSE,Q9Y251,0.425,0.808,2.266e-14,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2003.0,2019.0,ALL
10856,RUVBL2,Q9Y230,0.743,0.385,0.99992,,,C0202022,Follicle stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
10857,PGRMC1,O00264,0.588,0.654,0.6711,DTO_05007599,Signaling,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.33,1.0,,2014.0,2019.0,ALL
10858,CYP46A1,Q9Y6A2,0.659,0.5,0.98552,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.4,0.953,,2000.0,2019.0,ALL
10859,LILRB1,Q8NHL6,0.51,0.769,5.6502e-14,DTO_05007575,Receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2015.0,2015.0,ALL
10861,SLC26A1,Q9H2B4,0.686,0.577,1.0564e-11,DTO_01300327,Ion channel,C1833683,"NEPHROLITHIASIS, CALCIUM OXALATE",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.7,1.0,,2010.0,2016.0,ALL
10863,ADAM28,Q9UKQ2,0.666,0.5,2.9634e-24,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.31,1.0,,2016.0,2018.0,ALL
10864,SLC22A7,Q9Y694,0.78,0.308,4.5139e-11,DTO_05007405,Transporter,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
10865,ARID5A,Q03989,0.821,0.269,0.94518,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
10866,HCP5,Q6MZN7,0.595,0.808,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.13,1.0,,2008.0,2019.0,ALL
10867,TSPAN9,O75954,0.839,0.192,0.65913,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10868,USP20,Q9Y2K6,0.931,0.038,7.2852e-05,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
10869,USP19,O94966,0.751,0.346,0.99999,DTO_05007624,Enzyme,C0543888,Epileptic encephalopathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
10870,HCST,Q9UBK5,0.711,0.423,0.0020464,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,1999.0,2017.0,ALL
10871,CD300C,Q08708,0.861,0.192,1.164e-05,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
10873,ME3,Q16798,0.792,0.192,1.5112e-13,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
10874,NMU,P48645,0.61,0.808,0.00041549,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.25,1.0,,2004.0,2017.0,ALL
10875,FGL2,Q14314,0.621,0.615,6.1472e-05,DTO_05007599,Signaling,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10876,EDDM3A,Q14507,1.0,0.115,,DTO_05007599,Signaling,C0266667,Cyclocephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2017.0,2017.0,ALL
10877,CFHR4,Q92496,0.839,0.346,2.384e-18,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.42,1.0,moderate,2008.0,2018.0,ALL
10878,CFHR3,Q02985,0.663,0.462,1.72e-11,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.5,1.0,moderate,2006.0,2019.0,ALL
10879,SMR3B,P02814,0.601,0.654,0.38712,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.929,,2003.0,2019.0,ALL
10880,ACTL7B,Q9Y614,1.0,0.077,2.4547e-06,DTO_05007530,Cellular structure,C0013364,"Dysautonomia, Familial",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0,,1999.0,1999.0,ALL
10881,ACTL7A,Q9Y615,0.861,0.115,5.1316e-07,DTO_05007530,Cellular structure,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
10882,C1QL1,O75973,0.612,0.654,5.6243e-06,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.06,1.0,,2010.0,2019.0,ALL
10884,MRPS30,Q9NP92,0.59,0.731,1.5937e-08,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
10885,WDR3,Q9UNX4,0.78,0.154,2.0951e-13,,,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2010.0,2012.0,ALL
10886,NPFFR2,Q9Y5X5,0.792,0.231,1.6686e-07,DTO_02300001,G-protein coupled receptor,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
10887,PROKR1,Q8TCW9,0.861,0.192,1.1631e-07,DTO_02300001,G-protein coupled receptor,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.3,1.0,,2006.0,2006.0,ALL
10888,GPR83,Q9NYM4,0.861,0.192,1.0181e-06,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0,,1999.0,2013.0,ALL
10890,RAB10,P61026,0.736,0.192,0.97213,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
10891,PPARGC1A,Q9UBK2,0.453,0.885,0.9973,DTO_05007542,Transcription factor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.6,0.925,,2001.0,2020.0,ALL
10892,MALT1,Q9UDY8,0.532,0.769,0.98651,DTO_05007624,Enzyme,C3809583,IMMUNODEFICIENCY 12,,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2015.0,ALL
10893,MMP24,Q9Y5R2,0.743,0.423,0.67752,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
10894,LYVE1,Q9Y5Y7,0.587,0.731,4.7185e-07,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2003.0,2017.0,ALL
10897,YIF1A,O95070,0.89,0.192,6.1818e-10,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
10898,CPSF4,O95639,0.678,0.577,0.26766,DTO_05007624,Enzyme,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
10899,JTB,O76095,0.615,0.769,0.42432,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2001.0,2019.0,ALL
10900,RUNDC3A,Q59EK9,0.931,0.077,0.63623,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
10901,DHRS4,Q9BTZ2,0.931,0.115,1.0222e-05,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
10902,BRD8,Q9H0E9,0.638,0.5,1.5564e-07,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
10903,MTMR11,A4FU01,0.691,0.538,4.7707e-23,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2019.0,ALL
10904,BLCAP,P62952,0.705,0.385,0.50953,,,C0699885,Carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.09,1.0,,2000.0,2018.0,ALL
10905,MAN1A2,O60476,1.0,0.077,0.99892,DTO_05007613,Chaperone,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
10906,TRAFD1,O14545,0.89,0.154,1.9412e-08,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10907,TXNL4A,P83876,0.711,0.385,7.2309e-05,,,C1837822,Burn-Mckeown syndrome,C23;C16;C08;C10;C09;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.73,1.0,,2014.0,2017.0,ALL
10908,PNPLA6,Q8IY17,0.533,0.769,1.94e-13,DTO_05007624,Enzyme,C1859093,"Chorioretinal Dystrophy, Spinocerebellar Ataxia, and Hypogonadotropic Hypogonadism",C16;C11;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.75,0.875,,2013.0,2018.0,ALL
10910,SUGT1,Q9Y2Z0,0.78,0.308,0.45272,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
10911,UTS2,O95399,0.564,0.808,0.031612,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.58,1.0,,2003.0,2017.0,ALL
10912,GADD45G,O95257,0.601,0.769,0.55259,,,C0221238,Mesangial proliferative glomerulonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0,,2006.0,2006.0,ALL
10913,EDAR,Q9UNE0,0.623,0.423,1.3242e-06,,,C3887494,"ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,0.952,,1999.0,2019.0,ALL
10914,PAPOLA,P51003,0.593,0.731,0.99998,DTO_05007557,Nucleic acid binding,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
10915,TCERG1,O14776,0.821,0.192,0.99996,DTO_05007542,Transcription factor,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
10916,MAGED2,Q9UNF1,0.691,0.462,0.99538,DTO_05007620,Cell adhesion,C4310820,"BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
10917,BTNL3,Q6UXE8,1.0,0.077,0.00059654,DTO_05007584,Enzyme modulator,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
10919,EHMT2,Q96KQ7,0.59,0.808,0.00010292,DTO_05007378,Epigenetic regulator,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.34,1.0,,2010.0,2019.0,ALL
10920,COPS8,Q99627,0.805,0.231,0.72485,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
10921,RNPS1,Q15287,0.722,0.5,0.9798,DTO_05007557,Nucleic acid binding,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
10922,FASTK,Q14296,0.617,0.615,0.0047199,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
10923,SUB1,P53999,0.465,0.846,0.89245,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.19,1.0,,1997.0,2019.0,ALL
10924,SMPDL3A,Q92484,0.89,0.115,6.2788e-21,DTO_05007624,Enzyme,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
10926,DBF4,Q9UBU7,0.839,0.154,0.99296,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2018.0,ALL
10927,SPIN1,Q9Y657,0.666,0.385,0.97049,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10928,RALBP1,Q15311,0.536,0.654,0.14667,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2007.0,2010.0,ALL
10929,SRSF8,Q9BRL6,1.0,0.038,,DTO_05007557,Nucleic acid binding,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
10930,APOBEC2,Q9Y235,0.751,0.423,0.01707,DTO_05007624,Enzyme,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.04,1.0,,1998.0,2019.0,ALL
10933,MORF4L1,Q9UBU8,0.736,0.423,0.99339,DTO_05007557,Nucleic acid binding,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
10934,MORF4,,0.705,0.423,,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0,,2018.0,2019.0,ALL
10935,PRDX3,P30048,0.568,0.769,0.0042426,DTO_05007624,Enzyme,C0085084,Motor Neuron Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2006.0,2006.0,ALL
10936,GPR75,O95800,1.0,0.038,1.5813e-05,DTO_02300001,G-protein coupled receptor,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
10938,EHD1,Q9H4M9,0.711,0.462,0.98342,DTO_05007584,Enzyme modulator,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
10939,AFG3L2,Q9Y4W6,0.588,0.462,5.2511e-09,DTO_05007624,Enzyme,C1853249,SPINOCEREBELLAR ATAXIA 28,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.958,,2009.0,2019.0,ALL
10940,POP1,Q99575,0.743,0.346,2.8105e-13,,,C4479357,ANAUXETIC DYSPLASIA 2,,,disease,Disease or Syndrome,0.61,1.0,strong,2011.0,2019.0,ALL
10941,UGT2A1,Q9Y4X1,0.89,0.154,3.8806e-17,,,C0040580,Tracheal Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.02,1.0,,2011.0,2012.0,ALL
10942,PRSS21,Q9Y6M0,0.682,0.654,1.3247e-07,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
10943,MSL3,Q8N5Y2,0.861,0.115,0.99665,DTO_05007557,Nucleic acid binding,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.4,1.0,strong,2005.0,2018.0,ALL
10944,C11orf58,O00193,0.861,0.154,0.1654,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
10945,KDELR1,P24390,0.821,0.269,0.88109,DTO_05007405,Transporter,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
10946,SF3A3,Q12874,0.931,0.154,1.0,DTO_05007557,Nucleic acid binding,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
10947,AP3M2,P53677,0.931,0.077,1.972e-07,DTO_05007621,Extracellular structure,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
10948,STARD3,Q14849,0.729,0.346,7.8915e-05,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2007.0,2019.0,ALL
10949,HNRNPA0,Q13151,0.861,0.115,0.91616,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
10950,BTG3,Q14201,0.528,0.808,0.91582,,,C3495559,Juvenile arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.32,1.0,,2006.0,2018.0,ALL
10951,CBX1,P83916,0.722,0.346,0.97622,DTO_05007378,Epigenetic regulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2007.0,2013.0,ALL
10952,SEC61B,P60468,0.839,0.154,0.02003,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
10953,TOMM34,Q15785,0.711,0.308,0.014459,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2008.0,2018.0,ALL
10954,PDIA5,Q14554,0.805,0.346,1.1464e-09,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2016.0,ALL
10955,SERINC3,Q13530,0.821,0.231,0.7788,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
10956,OS9,Q13438,0.931,0.154,2.8559e-09,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2019.0,ALL
10957,PNRC1,Q12796,0.769,0.269,0.90825,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
10959,TMED2,Q15363,0.61,0.692,0.89231,DTO_05007405,Transporter,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
10960,LMAN2,Q12907,0.839,0.115,0.00010742,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
10961,ERP29,P30040,0.716,0.308,0.75108,DTO_05007405,Transporter,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.32,1.0,,2007.0,2019.0,ALL
10962,MLLT11,Q13015,0.633,0.5,0.52915,,,C0023479,Acute myelomonocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.21,1.0,,1995.0,1995.0,ALL
10963,STIP1,P31948,0.578,0.692,0.99987,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2019.0,ALL
10964,IFI44L,Q53G44,0.729,0.462,1.3464e-12,,,C0011574,Involutional Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2018.0,2018.0,ALL
10965,ACOT2,P49753,0.89,0.115,9.3287e-06,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
10966,RAB40B,Q12829,0.563,0.731,8.6559e-06,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10969,EBNA1BP2,Q99848,0.55,0.692,1.3668e-09,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.8,,2012.0,2020.0,ALL
10970,CKAP4,Q07065,0.436,0.731,0.50863,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.952,,2001.0,2019.0,ALL
10971,YWHAQ,P27348,0.769,0.423,0.69755,DTO_05007613,Chaperone,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
10972,TMED10,P49755,0.659,0.615,0.86011,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2009.0,2019.0,ALL
10973,ASCC3,Q8N3C0,0.861,0.231,1.1501e-20,,,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
10974,ADIRF,Q15847,0.861,0.154,0.036481,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
10975,UQCR11,O14957,1.0,0.038,0.00010553,,,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
10978,CLP1,Q92989,0.7,0.385,0.20272,DTO_05007557,Nucleic acid binding,C4014347,"PONTOCEREBELLAR HYPOPLASIA, TYPE 10",,,disease,Disease or Syndrome,0.91,1.0,,2013.0,2018.0,ALL
10979,FERMT2,Q96AC1,0.588,0.577,0.99999,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2011.0,2018.0,ALL
10980,COPS6,Q7L5N1,0.678,0.423,0.98666,DTO_05007624,Enzyme,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
10981,RAB32,Q13637,0.711,0.462,0.00065061,,,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.32,1.0,,2011.0,2014.0,ALL
10982,MAPRE2,Q15555,0.636,0.692,0.8341,DTO_05007530,Cellular structure,C4225225,"SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2",,,disease,Congenital Abnormality,0.6,1.0,strong,2015.0,2015.0,ALL
10983,CCNI,Q14094,0.821,0.154,0.82718,DTO_05007584,Enzyme modulator,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
10984,KCNQ1OT1,,0.534,0.731,,,,C0004903,Beckwith-Wiedemann Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.6,0.981,,1999.0,2018.0,ALL
10985,GCN1,Q92616,0.821,0.192,1.0,DTO_05007584,Enzyme modulator,C0023524,"Leukoencephalopathy, Progressive Multifocal",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2006.0,2012.0,ALL
10986,IGAD1,,0.861,0.077,,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.03,1.0,,1999.0,2003.0,ALL
10987,COPS5,Q92905,0.566,0.769,0.99925,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2003.0,2018.0,ALL
10988,METAP2,P50579,0.593,0.769,0.0039908,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
10989,IMMT,Q16891,0.576,0.846,0.0133,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
10990,LILRB5,O75023,1.0,0.077,4.4944e-23,DTO_05007575,Receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
10991,SLC38A3,Q99624,0.711,0.5,,DTO_05007405,Transporter,C0220981,Metabolic acidosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.2,1.0,,2007.0,2007.0,ALL
10992,SF3B2,Q13435,0.78,0.308,0.99992,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
10993,SDS,P20132,0.534,0.769,0.00013923,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
10994,ILVBL,A1L0T0,0.89,0.231,1.2177e-08,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
10998,SLC27A5,Q9Y2P5,0.563,0.769,8.3678e-15,DTO_05007405,Transporter,C4274079,Bile acid CoA ligase deficiency and defective amidation,,,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
10999,SLC27A4,Q6P1M0,0.608,0.769,4.4885e-05,DTO_05007405,Transporter,C1837610,ICHTHYOSIS PREMATURITY SYNDROME,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.79,1.0,,2009.0,2020.0,ALL
11000,SLC27A3,Q5K4L6,0.769,0.115,5.2696e-22,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11001,SLC27A2,O14975,0.7,0.462,6.3647e-09,DTO_05007405,Transporter,C0016059,Fibrosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0,,2018.0,2018.0,ALL
11004,KIF2C,Q99661,0.666,0.308,2.5765e-05,DTO_05007530,Cellular structure,C0011616,Contact Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
11005,SPINK5,Q9NQ38,0.604,0.654,4.846e-28,DTO_05007584,Enzyme modulator,C0265962,Ichthyosis linearis circumflexa,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome; Congenital Abnormality,1.0,0.982,strong,2000.0,2019.0,ALL
11006,LILRB4,Q8NHJ6,0.659,0.423,4.7133e-13,DTO_05007575,Receptor,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
11007,CCDC85B,Q15834,0.839,0.115,0.31331,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
11009,IL24,Q13007,0.498,0.769,5.8826e-07,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2005.0,2018.0,ALL
11010,GLIPR1,P48060,0.636,0.5,2.072e-14,DTO_05007608,Immune response,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
11011,TLK2,Q86UE8,0.631,0.538,1.0,DTO_03300101,Kinase,C4748003,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 57",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2018.0,ALL
11012,KLK11,Q9UBX7,0.641,0.5,0.00075409,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
11013,TMSB15A,P0CG34;P0CG35,0.76,0.231,0.39053,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2007.0,2007.0,ALL
11014,KDELR2,P33947,0.839,0.192,0.16699,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11015,KDELR3,O43731,,,5.376e-11,DTO_05007405,Transporter,C0242216,Biliary calculi,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Body Substance,0.1,1.0,,2018.0,2018.0,ALL
11016,ATF7,P17544,0.751,0.192,0.9984,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11017,SNRNP27,Q8WVK2,0.89,0.077,0.00019763,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
11018,TMED1,Q13445,1.0,0.077,1.1564e-06,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
11019,LIAS,O43766,0.695,0.538,2.3146e-05,,,C3280887,"HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2019.0,ALL
11020,IFT27,Q9BW83,0.67,0.462,5.8825e-06,,,C3889475,BARDET-BIEDL SYNDROME 19,,,disease,Disease or Syndrome,0.7,1.0,moderate,2014.0,2019.0,ALL
11021,RAB35,Q15286,0.78,0.308,0.97845,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
11022,TDRKH,Q9Y2W6,0.839,0.192,0.032356,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
11023,VAX1,Q5SQQ9,0.7,0.423,0.7705,DTO_05007542,Transcription factor,C3553077,"MICROPHTHALMIA, SYNDROMIC 11",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2012.0,ALL
11024,LILRA1,O75019,0.805,0.308,7.3933e-20,DTO_05007575,Receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
11025,LILRB3,O75022,0.805,0.269,3.1087e-06,,,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
11026,LILRA3,Q8N6C8,0.722,0.5,1.4548e-06,DTO_05007575,Receptor,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.07,0.714,,2005.0,2016.0,ALL
11027,LILRA2,Q8N149,0.861,0.231,6.9073e-20,DTO_05007575,Receptor,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
11030,RBPMS,Q93062,0.78,0.423,0.97173,DTO_05007557,Nucleic acid binding,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
11031,RAB31,Q13636,0.674,0.577,0.0012566,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
11033,ADAP1,O75689,0.839,0.154,0.5333,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,2002.0,2011.0,ALL
11034,DSTN,P60981,0.644,0.692,0.55116,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
11035,RIPK3,Q9Y572,0.497,0.885,1.1874e-14,DTO_03300101,Kinase,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2016.0,2019.0,ALL
11036,GTF2A1L,Q9UNN4,0.678,0.385,2.7752e-11,DTO_05007542,Transcription factor,C0033804,Pseudohermaphroditism,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,,,,,ALL
11037,STON1,Q9Y6Q2,0.729,0.308,1.4867e-11,DTO_05007621,Extracellular structure,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2013.0,ALL
11039,GUSBP14,,0.839,0.077,,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2001.0,2016.0,ALL
11040,PIM2,Q9P1W9,0.606,0.538,0.94801,DTO_03300101,Kinase,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.37,1.0,,2009.0,2019.0,ALL
11041,B4GAT1,O43505,0.59,0.538,0.0069375,,,C0265221,Walker-Warburg congenital muscular dystrophy,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.62,1.0,,2013.0,2016.0,ALL
11042,GUSBP15,,1.0,0.038,,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,1993.0,1993.0,ALL
11043,MID2,Q9UJV3,0.695,0.5,0.1755,,,C3890168,"MENTAL RETARDATION, X-LINKED 101",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
11044,TENT4A,Q5XG87,0.716,0.269,0.99934,DTO_05007624,Enzyme,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
11045,UPK1A,O00322,0.751,0.192,7.2141e-11,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2014.0,2018.0,ALL
11046,SLC35D2,Q76EJ3,,,5.8967e-13,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
11047,ADRM1,Q16186,0.633,0.538,0.99704,,,C0149678,Epstein-Barr Virus Infections,C01,   Infections,group,Disease or Syndrome,0.04,1.0,,1989.0,2004.0,ALL
11049,NUS1P3,,0.736,0.269,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,2014.0,2018.0,ALL
11051,NUDT21,O43809,0.682,0.231,0.98576,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
11052,CPSF6,Q16630,0.805,0.269,0.99982,DTO_05007557,Nucleic acid binding,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
11054,OGFR,Q9NZT2,0.678,0.308,0.033874,DTO_05007575,Receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11055,ZPBP,Q9BS86,1.0,,0.00031153,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
11056,DDX52,Q9Y2R4,0.931,0.077,1.5121e-15,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
11057,ABHD2,P08910,0.729,0.346,0.68151,DTO_05007624,Enzyme,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
11059,WWP1,Q9H0M0,0.659,0.577,0.99966,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2007.0,2019.0,ALL
11060,WWP2,O00308,0.65,0.615,0.16477,DTO_05007624,Enzyme,C0409959,"Osteoarthritis, Knee",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
11061,CNMD,O75829,0.638,0.5,1.0396e-06,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11062,DUS4L,O95620,0.931,0.038,3.1791e-05,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.11,1.0,,2011.0,2012.0,ALL
11063,SOX30,O94993,0.722,0.192,0.99825,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.32,1.0,,2015.0,2018.0,ALL
11064,CNTRL,Q7Z7A1,0.711,0.423,1.8908e-54,,,C0687120,Nephronophthisis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
11065,UBE2C,O00762,0.558,0.615,0.10513,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2006.0,2020.0,ALL
11066,SNRNP35,Q16560,1.0,0.038,7.1094e-09,DTO_05007557,Nucleic acid binding,C0008354,Cholera,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,1989.0,1989.0,ALL
11067,DEPP1,Q9NTK1,0.695,0.308,0.33608,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2005.0,2014.0,ALL
11068,CYB561D2,O14569,0.861,0.077,0.00013776,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
11069,RAPGEF4,Q8WZA2,0.647,0.538,0.99218,DTO_05007584,Enzyme modulator,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
11070,TMEM115,Q12893,,,0.79454,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
11072,DUSP14,O95147,0.78,0.308,0.12114,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
11073,TOPBP1,Q92547,0.644,0.692,1.0,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2008.0,2008.0,ALL
11074,TRIM31,Q9BZY9,0.626,0.577,4.3248e-06,,,C0162823,"Dermatitis, Irritant",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
11075,STMN2,Q93045,0.674,0.5,0.97687,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
11076,TPPP,O94811,0.57,0.692,0.20334,DTO_05007530,Cellular structure,C3826462,Depression in children,,,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
11077,HSF2BP,O75031,0.931,0.154,2.5257e-16,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2019.0,2019.0,ALL
11078,TRIOBP,Q9H2D6,0.743,0.269,2.0161e-28,DTO_05007584,Enzyme modulator,C1853276,"Deafness, Autosomal Recessive 28",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2010.0,ALL
11079,RER1,O15258,0.821,0.231,0.37879,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2018.0,2018.0,ALL
11080,DNAJB4,Q9UDY4,0.705,0.346,0.016227,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.13,1.0,,2006.0,2017.0,ALL
11081,KERA,O60938,0.678,0.231,1.7098e-07,,,C1857574,CORNEA PLANA 2,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.95,0.875,,2000.0,2016.0,ALL
11082,ESM1,Q9NQ30,0.595,0.654,0.21202,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2009.0,2019.0,ALL
11083,DIDO1,Q9BTC0,0.751,0.308,1.0,DTO_05007557,Nucleic acid binding,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
11085,ADAM30,Q9UKF2,0.89,0.192,,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
11086,ADAM29,Q9UKF5,0.76,0.269,,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
11091,WDR5,P61964,0.619,0.692,0.99978,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11092,SPACA9,Q96E40,0.769,0.423,4.387e-05,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
11093,ADAMTS13,Q76LX8,0.496,0.769,5.1409e-15,DTO_05007624,Enzyme,C1268935,Congenital Thrombotic Thrombocytopenic Purpura,C23;C15,"   Pathological Conditions, Signs and Symptoms;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,0.992,,2001.0,2020.0,ALL
11094,CACFD1,Q9UGQ2,0.931,0.077,0.00080583,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
11095,ADAMTS8,Q9UP79,0.674,0.346,1.1981e-10,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
11096,ADAMTS5,Q9UNA0,0.597,0.654,8.0325e-07,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
11097,NUP42,O15504,0.805,0.346,9.5131e-09,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
11098,PRSS23,O95084,0.722,0.346,1.9421e-05,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
11099,PTPN21,Q16825,0.89,0.192,2.2052e-12,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
11100,HNRNPUL1,Q9BUJ2,0.821,0.269,0.99999,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
11101,ATE1,O95260,0.821,0.154,0.040639,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
11102,RPP14,O95059,0.544,0.808,0.0019269,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.12,1.0,,1990.0,2019.0,ALL
11103,KRR1,Q13601,0.729,0.231,0.00069317,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
11104,KATNA1,O75449,0.861,0.154,1.6782e-05,DTO_05007530,Cellular structure,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
11105,PRDM7,Q9NQW5,,,7.3656e-18,,,C0406208,Suntan,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
11107,PRDM5,Q9NQX1,0.621,0.654,3.6003e-10,,,C3280011,BRITTLE CORNEA SYNDROME 2,,,disease,Disease or Syndrome,0.71,1.0,strong,2011.0,2015.0,ALL
11108,PRDM4,Q9UKN5,0.861,0.231,0.0013238,,,C0018081,Gonorrhea,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
11112,HIBADH,P31937,1.0,0.077,0.0056303,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11113,CIT,O14578,0.555,0.692,0.9997,DTO_03300101,Kinase,C4310723,"MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
11116,FGFR1OP,O95684,0.656,0.577,0.00062816,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
11117,EMILIN1,Q9Y6C2,0.743,0.269,0.0043908,,,C4707243,Familial thoracic aortic aneurysm and aortic dissection,,,disease,Disease or Syndrome,0.3,,limited,,,ALL
11118,BTN3A2,P78410,0.716,0.462,1.1002e-10,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2020.0,ALL
11119,BTN3A1,O00481,0.78,0.269,5.8712e-09,DTO_05007584,Enzyme modulator,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
11120,BTN2A1,Q7KYR7,0.722,0.423,3.3959e-21,DTO_05007584,Enzyme modulator,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.18,1.0,,2011.0,2014.0,ALL
11122,PTPRT,O14522,0.636,0.538,1.0,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2017.0,2017.0,ALL
11123,RCAN3,Q9UKA8,0.821,0.154,0.00015715,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2015.0,ALL
11124,FAF1,Q9UNN5,0.666,0.731,0.99895,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.12,1.0,,2003.0,2018.0,ALL
11126,CD160,O95971,0.59,0.615,6.8425e-05,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2014.0,2017.0,ALL
11127,KIF3A,Q9Y496,0.612,0.615,0.89775,DTO_05007530,Cellular structure,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.44,1.0,,2011.0,2019.0,ALL
11128,POLR3A,O14802,0.538,0.769,1.2821e-23,DTO_05007624,Enzyme,C2676243,"Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism",C23;C16;C10;C19;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Endocrine System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.75,1.0,,1977.0,2018.0,ALL
11129,CLASRP,Q8N2M8,0.931,0.154,0.43077,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
11130,ZWINT,O95229,0.711,0.346,7.2736e-11,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
11131,CAPN11,Q9UMQ6,,,4.4077e-24,DTO_05007624,Enzyme,C2239222,Vascular Endothelial Growth Factor Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
11132,CAPN10,Q9HC96,0.621,0.577,6.9206e-13,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,0.926,,2000.0,2019.0,ALL
11133,KPTN,Q9Y664,0.769,0.192,1.1348e-05,,,C3810225,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
11135,CDC42EP1,Q00587,0.751,0.346,2.5355e-05,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
11136,SLC7A9,P82251,0.666,0.692,9.0644e-10,DTO_05007405,Transporter,C0010691,Cystinuria,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1999.0,2018.0,ALL
11137,PWP1,Q13610,0.931,0.077,1.9862e-12,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11138,TBC1D8,O95759,0.76,0.346,5.5998e-13,DTO_05007624,Enzyme,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
11140,CDC37,Q16543,0.695,0.5,0.90925,DTO_05007584,Enzyme modulator,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2017.0,ALL
11141,IL1RAPL1,Q9NZN1,0.617,0.692,0.99886,DTO_05007575,Receptor,C0796206,Atkin syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,definitive,1999.0,2017.0,ALL
11142,PKIG,Q9Y2B9,0.78,0.269,0.51408,DTO_05007584,Enzyme modulator,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
11143,KAT7,O95251,0.682,0.538,0.99999,DTO_05007624,Enzyme,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2018.0,ALL
11144,DMC1,Q14565,0.821,0.269,5.0628e-05,,,C1384583,Congenital absence of germinal epithelium of testes,C12,   Male Urogenital Diseases,disease,Congenital Abnormality,0.2,,,,,ALL
11145,PLAAT3,P53816,0.722,0.462,1.8145e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2000.0,2017.0,ALL
11146,GLMN,Q92990,0.743,0.385,1.1537e-12,,,C1841984,GLOMUVENOUS MALFORMATIONS,C04,   Neoplasms,disease,Disease or Syndrome,0.8,0.917,,2002.0,2019.0,ALL
11148,HHLA2,Q9UM44,0.653,0.423,1.7284e-06,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2015.0,2019.0,ALL
11149,BVES,Q8NE79,0.722,0.308,9.343e-06,,,C4225199,CARDIAC ARRHYTHMIA WITH INCREASED SERUM CREATINE KINASE,,,disease,Disease or Syndrome,0.7,1.0,limited,2016.0,2016.0,ALL
11151,CORO1A,P31146,0.564,0.692,0.97024,DTO_05007530,Cellular structure,C3809383,IMMUNODEFICIENCY 8,,,disease,Disease or Syndrome,0.7,1.0,strong,2009.0,2014.0,ALL
11152,WDR45,Q9Y484,0.647,0.423,0.99145,,,C3550973,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2012.0,2020.0,ALL
11154,AP4S1,Q9Y587,0.674,0.385,1.7275e-06,DTO_05007405,Transporter,C3279743,"SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.61,1.0,,2011.0,2019.0,ALL
11155,LDB3,O75112,0.659,0.385,9.5733e-06,DTO_05007530,Cellular structure,C1832244,"CARDIOMYOPATHY, DILATED, 1C (disorder)",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.9,1.0,,2003.0,2004.0,ALL
11156,PTP4A3,O75365,0.566,0.654,0.045489,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.38,1.0,,2006.0,2019.0,ALL
11158,RABL2B,Q9UNT1,1.0,0.038,7.7226e-07,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,0.0,,2017.0,2017.0,ALL
11159,RABL2A,Q9UBK7,,,7.2529e-08,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,0.0,,2014.0,2014.0,ALL
11160,ERLIN2,O94905,0.647,0.5,0.00066662,,,C2749936,"SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE (disorder)",C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,,2011.0,2018.0,ALL
11162,NUDT6,P53370,0.705,0.462,2.9113e-05,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11164,NUDT5,Q9UKK9,0.821,0.231,0.001405,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11165,NUDT3,O95989,0.861,0.269,0.42531,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11166,SOX21,Q9Y651,0.751,0.231,0.71344,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
11167,FSTL1,Q12841,0.541,0.808,0.89403,DTO_05007584,Enzyme modulator,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.31,1.0,,2010.0,2010.0,ALL
11168,PSIP1,O75475,0.49,0.846,0.99668,DTO_05007599,Signaling,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.36,0.857,,1993.0,2012.0,ALL
11169,WDHD1,O75717,0.529,0.846,4.3694e-18,DTO_05007557,Nucleic acid binding,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
11170,FAM107A,O95990,0.674,0.462,8.2783e-07,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
11171,STRAP,Q9Y3F4,0.716,0.269,0.90143,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2005.0,2019.0,ALL
11172,INSL6,Q9Y581,0.78,0.308,3.734e-09,DTO_05007599,Signaling,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
11173,ADAMTS7,Q9UKP4,0.666,0.577,2.2517e-14,DTO_05007624,Enzyme,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.4,1.0,,2011.0,2019.0,ALL
11174,ADAMTS6,Q9UKP5,0.769,0.231,0.99998,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11176,BAZ2A,Q9UIF9,0.821,0.154,1.0,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,2015.0,2018.0,ALL
11177,BAZ1A,Q9NRL2,0.792,0.269,1.0,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
11178,LZTS1,Q9Y250,0.633,0.385,0.95491,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.51,1.0,,2002.0,2002.0,ALL
11179,ZNF277,Q9NRM2,0.792,0.308,8.3182e-22,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
11180,WDR6,Q9NNW5,,,2.1434e-09,,,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
11181,TREH,O43280,0.67,0.654,8.9579e-15,,,C0268187,"alpha, alpha-Trehalase deficiency",C23;C16;C18,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,,,,,ALL
11182,SLC2A6,Q9UGQ3,0.674,0.538,6.7106e-06,DTO_05007405,Transporter,C0740394,Hyperuricemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,0.9,,2014.0,2020.0,ALL
11183,MAP4K5,Q9Y4K4,0.769,0.423,0.99469,DTO_03300101,Kinase,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
11184,MAP4K1,Q92918,0.678,0.5,0.98919,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
11185,INMT,O95050,0.89,0.154,0.0033238,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
11186,RASSF1,Q9NS23,0.42,0.808,4.9255e-06,DTO_05007584,Enzyme modulator,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.4,0.962,,2001.0,2018.0,ALL
11187,PKP3,Q9Y446,0.695,0.462,6.283e-05,DTO_05007530,Cellular structure,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
11188,NISCH,Q9Y2I1,0.656,0.577,0.99443,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2011.0,2020.0,ALL
11189,CELF3,Q5SZQ8,0.89,0.231,0.76757,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
11190,CEP250,Q9BV73,0.792,0.192,9.449e-33,DTO_05007584,Enzyme modulator,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.22,1.0,,2018.0,2019.0,ALL
11191,PTENP1,,0.65,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.933,,2000.0,2019.0,ALL
11192,DYX3,,0.931,0.115,,,,C0476254,Dyslexia,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.07,1.0,,1999.0,2014.0,ALL
11193,WBP4,O75554,1.0,0.077,3.9769e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
11194,ABCB8,Q9NUT2,0.931,0.077,1.9164e-15,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
11196,SEC23IP,Q9Y6Y8,0.931,0.115,1.9318e-05,DTO_05007624,Enzyme,C0206750,Coronavirus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
11197,WIF1,Q9Y5W5,0.507,0.731,1.3249e-09,DTO_05007616,Calcium-binding protein,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2004.0,2019.0,ALL
11198,SUPT16H,Q9Y5B9,0.861,0.192,1.0,DTO_05007542,Transcription factor,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.31,1.0,,1979.0,2016.0,ALL
11199,ANXA10,Q9UJ72,0.621,0.462,9.5506e-14,,,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
11200,CHEK2,O96017,0.46,0.808,1.2103e-24,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.8,0.963,,2001.0,2019.0,ALL
11201,POLI,Q9UNA4,0.691,0.423,3.1764e-08,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
11202,KLK8,O60259,0.636,0.615,8.8493e-05,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
11211,FZD10,Q9ULW2,0.705,0.308,0.00052847,DTO_02300001,G-protein coupled receptor,C0039101,synovial sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0,,2005.0,2018.0,ALL
11212,PLPBP,O94903,0.736,0.231,0.03972,,,C4310632,"EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2016.0,ALL
11213,IRAK3,Q9Y616,0.615,0.615,5.3092e-21,DTO_03300101,Kinase,C1970224,"ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5",,,disease,Finding,0.4,,,,,ALL
11214,AKAP13,Q12802,0.626,0.615,0.92909,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2006.0,2017.0,ALL
11215,AKAP11,Q9UKA4,1.0,0.077,0.97878,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
11216,AKAP10,O43572,0.76,0.308,0.10782,,,C0264886,Conduction disorder of the heart,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.5,,,,,ALL
11218,DDX20,Q9UHI6,0.711,0.423,7.7601e-14,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
11219,TREX2,Q9BQ50,0.769,0.346,0.45433,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2011.0,2011.0,ALL
11221,DUSP10,Q9Y6W6,0.686,0.577,0.8335,,,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0,,2007.0,2007.0,ALL
11222,MRPL3,P09001,0.792,0.192,1.3045e-12,,,C3281234,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9,,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2017.0,ALL
11224,RPL35,P42766,0.805,0.346,0.54892,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.5,1.0,,2017.0,2017.0,ALL
11226,GALNT6,Q8NCL4,0.691,0.269,1.4162e-09,DTO_05007624,Enzyme,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
11227,GALNT5,Q7Z7M9,0.78,0.192,7.9311e-14,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
11228,RASSF8,Q8NHQ8,0.705,0.308,0.94158,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
11230,PRAF2,O60831,0.78,0.269,0.74236,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
11231,SEC63,Q9UGP8,0.736,0.308,2.0818e-07,DTO_05007613,Chaperone,C0158683,Polycystic liver disease,C23;C06;C04,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Neoplasms",disease,Disease or Syndrome,0.7,1.0,,2004.0,2016.0,ALL
11232,POLG2,Q9UHN1,0.558,0.769,1.528e-10,DTO_05007624,Enzyme,C1864668,"Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 4",C23;C18;C11;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2019.0,ALL
11234,HPS5,Q9UPZ3,0.674,0.423,1.8969e-13,,,C3888004,HERMANSKY-PUDLAK SYNDROME 5,,,disease,Disease or Syndrome,0.82,1.0,,1980.0,2019.0,ALL
11235,PDCD10,Q9BUL8,0.631,0.692,0.96197,,,C1864040,Cerebral Cavernous Malformations 3,C23;C16;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.9,1.0,strong,2005.0,2019.0,ALL
11236,RNF139,Q8WU17,0.67,0.423,0.53807,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.41,1.0,,2005.0,2005.0,ALL
11237,RNF24,Q9Y225,1.0,0.077,0.030685,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
11240,PADI2,Q9Y2J8,0.61,0.615,4.9471e-11,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2009.0,2009.0,ALL
11243,PMF1,Q6P1K2,0.839,0.192,1.073e-08,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
11244,ZHX1,Q9UKY1,0.711,0.346,0.80424,DTO_05007542,Transcription factor,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2013.0,2019.0,ALL
11245,GPR176,Q14439,,,0.0080793,DTO_02300001,G-protein coupled receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11247,NXPH4,O95158,0.89,0.154,0.22997,DTO_05007599,Signaling,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
11248,NXPH3,O95157,0.861,0.346,0.28443,DTO_05007599,Signaling,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
11249,NXPH2,O95156,0.821,0.154,0.92646,DTO_05007599,Signaling,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
11250,GPR45,Q9Y5Y3,1.0,0.077,0.10453,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
11251,PTGDR2,Q9Y5Y4,0.612,0.692,0.0027025,DTO_02300001,G-protein coupled receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,0.926,,2004.0,2019.0,ALL
11252,PACSIN2,Q9UNF0,0.751,0.385,0.21345,DTO_05007530,Cellular structure,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
11253,MAN1B1,Q9UKM7,0.606,0.577,1.1812e-08,DTO_05007613,Chaperone,C3280127,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15",,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2016.0,ALL
11254,SLC6A14,Q9UN76,0.711,0.385,0.56419,DTO_05007405,Transporter,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
11255,HRH3,Q9Y5N1,0.647,0.462,0.04081,DTO_02300001,G-protein coupled receptor,C0002622,Amnesia,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.51,1.0,,1999.0,2019.0,ALL
11257,TP53TG1,,0.792,0.269,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
11258,DCTN3,O75935,0.641,0.654,1.2577e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,1984.0,2007.0,ALL
11259,FILIP1L,Q4L180,0.705,0.5,1.0757e-09,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2012.0,2017.0,ALL
11260,XPOT,O43592,0.861,0.154,0.99711,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
11261,CHP1,Q99653,0.546,0.769,0.62667,,,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.11,1.0,,2019.0,2019.0,ALL
11262,SP140,Q13342,0.691,0.577,4.9994e-08,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.43,1.0,,2008.0,2017.0,ALL
11264,PXMP4,Q9Y6I8,0.931,0.077,0.00075854,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2019.0,ALL
11266,DUSP12,Q9UNI6,0.78,0.269,0.00013856,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2006.0,2011.0,ALL
11267,SNF8,Q96H20,0.805,0.192,0.00045727,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
11269,DDX19B,Q9UMR2,0.89,0.115,1.5562e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
11270,NRM,Q8IXM6,0.76,0.231,0.021828,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
11272,PRR4,Q16378,0.931,0.077,0.044222,,,C0033845,Pseudotumor Cerebri,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
11273,ATXN2L,Q8WWM7,0.695,0.423,1.0,DTO_05007557,Nucleic acid binding,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
11274,USP18,Q9UMW8,0.601,0.615,0.0014952,,,C3489725,Pseudo-TORCH syndrome,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.51,1.0,strong,2016.0,2016.0,ALL
11275,KLHL2,O95198,0.751,0.462,0.99985,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
11276,SYNRG,Q9UMZ2,1.0,0.077,0.93079,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
11277,TREX1,Q9NSU2,0.517,0.808,0.57528,,,C0393591,AICARDI-GOUTIERES SYNDROME,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.977,strong,2000.0,2020.0,ALL
11278,KLF12,Q9Y4X4,0.647,0.654,0.98067,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2011.0,2015.0,ALL
11279,KLF8,O95600,0.628,0.462,0.0022471,DTO_05007557,Nucleic acid binding,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,limited,2002.0,2002.0,ALL
11280,SCN11A,Q9UI33,0.666,0.462,6.9339e-26,DTO_01300327,Ion channel,C3809882,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2017.0,ALL
11281,POU6F2,P78424,0.769,0.385,0.0015216,,,C1832099,Wilms tumor and radial bilateral aplasia,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.6,1.0,,2001.0,2001.0,ALL
11282,MGAT4B,Q9UQ53,0.89,0.192,0.69145,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
11283,CYP4F8,P98187,0.931,0.077,,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
11284,PNKP,Q96T60,0.553,0.692,3.662e-14,,,C3150667,"MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY",,,disease,Disease or Syndrome,0.75,1.0,,2010.0,2019.0,ALL
11285,B4GALT7,Q9UBV7,0.628,0.654,0.00011304,,,C4552003,"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1",C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.73,1.0,,1987.0,2017.0,ALL
11309,SLCO2B1,O94956,0.653,0.5,1.1159e-05,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2007.0,2011.0,ALL
11311,VPS45,Q9NRW7,0.716,0.308,5.094e-06,DTO_05007405,Transporter,C3809031,"NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2013.0,ALL
11313,LYPLA2,O95372,0.931,0.115,0.94955,,,C0020474,"Hyperlipidemia, Familial Combined",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
11314,CD300A,Q9UGN4,0.769,0.269,1.1537e-06,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
11315,PARK7,Q99497,0.535,0.808,0.75335,DTO_05007624,Enzyme,C1853445,"PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.97,1.0,,2003.0,2017.0,ALL
11316,COPE,O14579,0.686,0.385,0.69249,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2017.0,2018.0,ALL
11317,RBPJL,Q9UBG7,0.931,0.077,2.9189e-11,DTO_05007557,Nucleic acid binding,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2018.0,2018.0,ALL
11318,GPR182,O15218,0.691,0.462,0.00013704,DTO_02300001,G-protein coupled receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
11319,ECD,O95905,0.656,0.538,2.3368e-12,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2001.0,2014.0,ALL
11320,MGAT4A,Q9UM21,0.805,0.308,4.4513e-05,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
11321,GPN1,Q9HCN4,0.769,0.308,5.5764e-05,DTO_05007557,Nucleic acid binding,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.41,1.0,,2016.0,2016.0,ALL
11322,TMC6,Q7Z403,0.705,0.308,5.8557e-10,DTO_01300327,Ion channel,C0014522,Epidermodysplasia Verruciformis,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.8,1.0,,2002.0,2018.0,ALL
11325,DDX42,Q86XP3,0.861,0.115,1.0,,,C0006625,Cachexia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.2,1.0,,2004.0,2004.0,ALL
11326,VSIG4,Q9Y279,0.628,0.615,1.4953e-09,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,0.5,,2017.0,2018.0,ALL
11328,FKBP9,O95302,0.805,0.231,1.0584e-05,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
11329,STK38,Q15208,0.682,0.731,0.00076687,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
11330,CTRC,Q99895,0.653,0.5,1.2851e-12,,,C0238339,Hereditary pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.75,1.0,moderate,2008.0,2017.0,ALL
11331,PHB2,Q99623,0.558,0.769,0.0039339,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,1999.0,2019.0,ALL
11332,ACOT7,O00154,0.531,0.769,0.75926,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,1996.0,2019.0,ALL
11333,PDAP1,Q13442,0.576,0.769,0.049626,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,,limited,,,ALL
11334,TUSC2,O75896,0.556,0.846,0.7671,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2004.0,2017.0,ALL
11335,CBX3,Q13185,0.633,0.346,0.40951,DTO_05007378,Epigenetic regulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2011.0,2019.0,ALL
11336,EXOC3,O60645,0.931,0.192,0.92216,DTO_05007405,Transporter,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
11337,GABARAP,O95166,0.695,0.5,0.26129,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
11338,U2AF2,P26368,0.78,0.154,0.9996,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
11339,OIP5,O43482,0.682,0.385,1.4649e-07,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,1.0,,2010.0,2019.0,ALL
11340,EXOSC8,Q96B26,0.736,0.269,6.9378e-15,DTO_05007624,Enzyme,C4015160,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1C",,,disease,Disease or Syndrome,0.71,1.0,,2014.0,2018.0,ALL
11341,SCRG1,O75711,1.0,0.077,0.044451,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
11342,RNF13,O43567,0.722,0.346,0.00040292,,,C0015544,Failure to Thrive,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.4,1.0,moderate,2019.0,2019.0,ALL
11343,MGLL,Q99685,0.564,0.731,0.020016,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2007.0,2007.0,ALL
11344,TWF2,Q6IBS0,0.931,0.077,0.98055,DTO_05007530,Cellular structure,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
11345,GABARAPL2,P60520,0.821,0.231,0.00022815,DTO_05007530,Cellular structure,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
11346,SYNPO,Q8N3V7,0.663,0.577,0.98573,DTO_05007530,Cellular structure,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.37,1.0,,2006.0,2019.0,ALL
22794,CASC3,O15234,0.792,0.231,0.61338,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2002.0,2008.0,ALL
22795,NID2,Q14112,0.674,0.5,4.1103e-09,DTO_05007616,Calcium-binding protein,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
22796,COG2,Q14746,0.729,0.423,9.3658e-06,,,C4479353,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq",,,disease,Disease or Syndrome,0.7,1.0,limited,2015.0,2015.0,ALL
22797,TFEC,O14948,0.861,0.231,4.2824e-08,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
22798,LAMB4,A4D0S4,0.861,0.115,1.614e-42,DTO_05007584,Enzyme modulator,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
22800,RRAS2,P62070,0.656,0.5,0.97463,DTO_05007584,Enzyme modulator,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.62,1.0,strong,2014.0,2019.0,ALL
22801,ITGA11,Q9UKX5,0.678,0.5,8.661e-08,,,C0013312,Dupuytren Contracture,C04;C17;C05,   Neoplasms;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
22802,CLCA4,Q14CN2,0.729,0.385,6.9601e-15,DTO_01300327,Ion channel,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.34,1.0,,2004.0,2015.0,ALL
22803,XRN2,Q9H0D6,0.821,0.269,0.34851,,,C0038220,Status Epilepticus,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.2,1.0,,2016.0,2016.0,ALL
22806,IKZF3,Q9UKT9,0.608,0.692,0.98416,DTO_05007542,Transcription factor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.46,1.0,,2010.0,2019.0,ALL
22807,IKZF2,Q9UKS7,0.656,0.5,0.98731,DTO_05007542,Transcription factor,C0023493,Adult T-Cell Lymphoma/Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.31,1.0,,2012.0,2015.0,ALL
22808,MRAS,O14807,0.59,0.731,0.92111,DTO_05007584,Enzyme modulator,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.56,1.0,limited,2013.0,2019.0,ALL
22809,ATF5,Q9Y2D1,0.674,0.385,0.29163,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
22813,TDGF1P6,,0.659,0.577,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2009.0,2020.0,ALL
22817,NR1I4,,0.89,0.385,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
22818,COPZ1,P61923,0.861,0.115,0.94896,DTO_05007405,Transporter,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
22820,COPG1,Q9Y678,0.931,0.077,0.17472,DTO_05007405,Transporter,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
22821,RASA3,Q14644,0.769,0.308,1.9114e-10,DTO_05007584,Enzyme modulator,C0002874,Aplastic Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.2,1.0,,2018.0,2018.0,ALL
22822,PHLDA1,Q8WV24,0.647,0.462,0.79833,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
22823,MTF2,Q9Y483,0.861,0.231,0.99987,DTO_05007557,Nucleic acid binding,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
22824,HSPA4L,O95757,0.805,0.192,6.9455e-07,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.02,1.0,,2019.0,2019.0,ALL
22826,DNAJC8,O75937,0.89,0.077,0.050961,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
22827,PUF60,Q9UHX1,0.536,0.769,0.99677,,,C3810023,VERHEIJ SYNDROME,,,disease,Disease or Syndrome,0.74,1.0,,2009.0,2019.0,ALL
22828,SCAF8,Q9UPN6,0.78,0.269,1.0,DTO_05007557,Nucleic acid binding,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2015.0,2015.0,ALL
22829,NLGN4Y,Q8NFZ3,0.769,0.308,0.099388,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.04,1.0,,2005.0,2019.0,ALL
22834,ZNF652,Q9Y2D9,0.76,0.346,0.82299,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.12,1.0,,2006.0,2017.0,ALL
22835,ZFP30,Q9Y2G7,1.0,0.077,3.8484e-07,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
22836,RHOBTB3,O94955,0.931,0.038,4.2416e-06,DTO_05007584,Enzyme modulator,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
22837,COBLL1,Q53SF7,0.792,0.346,0.046671,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.12,1.0,,2012.0,2019.0,ALL
22838,RNF44,Q7L0R7,1.0,0.038,0.27044,,,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2015.0,2015.0,ALL
22839,DLGAP4,Q9Y2H0,0.769,0.269,0.99248,DTO_05007575,Receptor,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.21,1.0,,2019.0,2019.0,ALL
22841,RAB11FIP2,Q7L804,0.821,0.192,0.94451,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
22843,PPM1E,Q8WY54,0.805,0.192,0.98758,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2009.0,2016.0,ALL
22844,FRMPD1,Q5SYB0,0.805,0.154,2.1898e-12,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
22845,DOLK,Q9UPQ8,0.736,0.385,0.0012393,,,C1835849,"Congenital Disorder Of Glycosylation, Type Im",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.72,1.0,,2007.0,2017.0,ALL
22846,VASH1,Q7L8A9,0.601,0.423,0.32566,,,C0020541,Portal Hypertension,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.21,1.0,,2014.0,2014.0,ALL
22847,ZNF507,Q8TCN5,1.0,,0.057483,DTO_05007542,Transcription factor,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
22848,AAK1,Q2M2I8,0.792,0.346,1.0,DTO_03300101,Kinase,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
22849,CPEB3,Q8NE35,0.805,0.192,0.99846,DTO_05007557,Nucleic acid binding,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2017.0,2018.0,ALL
22850,ADNP2,Q6IQ32,1.0,0.038,0.69573,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2015.0,ALL
22852,ANKRD26,Q9UPS8,0.711,0.308,3.5745e-24,,,C1861185,THROMBOCYTOPENIA 2 (disorder),C23;C16;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.79,1.0,definitive,1999.0,2019.0,ALL
22853,LMTK2,Q8IWU2,0.729,0.462,0.99978,DTO_03300101,Kinase,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.44,1.0,,2008.0,2016.0,ALL
22854,NTNG1,Q9Y2I2,0.65,0.423,0.9167,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,1.0,,2004.0,2014.0,ALL
22856,CHSY1,Q86X52,0.612,0.615,0.70781,DTO_05007624,Enzyme,C1854466,Temtamy preaxial brachydactyly syndrome,C23;C16;C05;C10;F03;C07;C09;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.72,1.0,,2004.0,2016.0,ALL
22858,CILK1,Q9UPZ9,0.545,0.808,1.3376e-05,DTO_03300101,Kinase,C2675227,Endocrine-Cerebroosteodysplasia,C10;C19,   Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.9,1.0,,2009.0,2018.0,ALL
22859,ADGRL1,O94910,0.839,0.231,1.0,DTO_02300001,G-protein coupled receptor,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.2,1.0,,2002.0,2002.0,ALL
22861,NLRP1,Q9C000,0.502,0.769,4.9693e-19,,,C4479278,AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS,,,disease,Disease or Syndrome,0.72,1.0,moderate,2017.0,2018.0,ALL
22862,FNDC3A,Q9Y2H6,0.674,0.577,0.99998,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.11,1.0,,1998.0,2016.0,ALL
22863,ATG14,Q6ZNE5,0.76,0.423,0.17435,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
22864,R3HDM2,Q9Y2K5,0.76,0.346,1.0,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
22865,SLITRK3,O94933,,,0.93906,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
22866,CNKSR2,Q8WXI2,0.628,0.538,0.99996,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2019.0,2019.0,ALL
22868,FASTKD2,Q9NYY8,0.659,0.731,2.8891e-06,,,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.61,1.0,,2008.0,2017.0,ALL
22870,PPP6R1,Q9UPN7,,,0.98287,DTO_05007584,Enzyme modulator,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
22871,NLGN1,Q8N2Q7,0.705,0.385,0.85276,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2011.0,2015.0,ALL
22872,SEC31A,O94979,0.76,0.269,7.8773e-05,DTO_05007405,Transporter,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
22873,DZIP1,Q86YF9,0.931,0.077,3.1283e-20,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
22874,PLEKHA6,Q9Y2H5,0.861,0.115,0.013746,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
22875,ENPP4,Q9Y6X5,,,0.11941,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
22876,INPP5F,Q9Y2H2,0.805,0.231,2.3623e-07,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2014.0,2018.0,ALL
22877,MLXIP,Q9HAP2,0.597,0.692,0.98932,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
22878,TRAPPC8,Q9Y2L5,0.89,0.231,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
22879,MON1B,Q7L1V2,0.89,0.077,0.018676,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
22880,MORC2,Q9Y6X9,0.626,0.462,0.99999,,,C4225243,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2018.0,ALL
22881,ANKRD6,Q9Y2G4,0.839,0.154,1.1728e-11,,,C0409959,"Osteoarthritis, Knee",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
22882,ZHX2,Q9Y6X8,0.51,0.654,0.03372,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
22883,CLSTN1,O94985,0.729,0.462,0.97757,DTO_05007616,Calcium-binding protein,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
22884,WDR37,Q9Y2I8,0.751,0.231,0.56642,,,C0009363,Congenital ocular coloboma (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.4,1.0,limited,2019.0,2019.0,ALL
22885,ABLIM3,O94929,1.0,0.077,1.0625e-07,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
22887,FOXJ3,Q9UPW0,0.89,0.192,0.99598,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
22888,UBOX5,O94941,,,0.00072138,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
22889,KHDC4,Q7Z7F0,0.931,0.077,0.96921,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
22890,ZBTB1,Q9Y2K1,,,0.99407,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
22891,ZNF365,Q70YC4;Q70YC5,0.641,0.654,0.00046761,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.5,1.0,,2010.0,2017.0,ALL
22893,BAHD1,Q8TBE0,0.89,0.192,0.98547,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
22894,DIS3,Q9Y2L1,0.839,0.385,1.2694e-21,DTO_05007624,Enzyme,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.06,1.0,,2014.0,2020.0,ALL
22895,RPH3A,Q9Y2J0,0.76,0.385,0.0016609,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
22897,CEP164,Q9UPV0,0.711,0.462,4.8293e-27,,,C3541853,NEPHRONOPHTHISIS 15,,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2012.0,ALL
22898,DENND3,A2RUS2,0.931,0.077,1.3007e-11,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
22899,ARHGEF15,O94989,0.76,0.308,1.66e-06,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
22900,CARD8,Q9Y2G2,0.59,0.731,1.7672e-06,,,C0018099,Gout,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
22901,ARSG,Q96EG1,0.666,0.423,6.3682e-10,DTO_05007624,Enzyme,C4748364,"USHER SYNDROME, TYPE IV",,,disease,Disease or Syndrome,0.6,1.0,moderate,2012.0,2018.0,ALL
22902,RUFY3,Q7L099,0.736,0.231,0.020593,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
22903,BTBD3,Q9Y2F9,1.0,0.077,0.12831,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
22904,SBNO2,Q9Y2G9,0.663,0.538,0.0070655,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
22905,EPN2,O95208,1.0,0.038,0.74755,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
22906,TRAK1,Q9UPV9,0.674,0.423,0.00037311,DTO_05007405,Transporter,C4748688,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68",,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2018.0,ALL
22907,DHX30,Q7L2E3,0.722,0.5,1.0,DTO_05007624,Enzyme,C4540496,NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE,,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
22908,SACM1L,Q9NTJ5,0.682,0.5,0.69536,,,C0007282,Carotid Stenosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,1992.0,1993.0,ALL
22909,FAN1,Q9Y2M0,0.61,0.577,1.6512e-25,,,C3553774,"INTERSTITIAL NEPHRITIS, KARYOMEGALIC",,,disease,Disease or Syndrome,0.93,1.0,strong,2006.0,2020.0,ALL
22911,WDR47,O94967,0.931,0.115,0.29213,,,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2017.0,2017.0,ALL
22913,RALY,Q9UKM9,0.656,0.385,0.13796,,,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
22914,KLRK1,P26718,0.467,0.769,6.9812e-14,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.39,1.0,,2007.0,2019.0,ALL
22915,MMRN1,Q13201,0.465,0.846,2.0714e-25,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2012.0,2012.0,ALL
22916,NCBP2,P52298,0.805,0.115,0.39994,DTO_05007557,Nucleic acid binding,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
22917,ZP1,P60852,0.89,,1.8672e-21,,,C4014291,OOCYTE MATURATION DEFECT 1,,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
22918,CD93,Q9NPY3,0.663,0.5,1.9782e-10,DTO_05007616,Calcium-binding protein,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
22919,MAPRE1,Q15691,0.674,0.462,0.99129,DTO_05007530,Cellular structure,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
22920,KIFAP3,Q92845,0.76,0.346,1.5803e-05,DTO_05007530,Cellular structure,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.15,0.833,,2009.0,2017.0,ALL
22921,MSRB2,Q9Y3D2,0.861,0.154,5.5352e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
22924,MAPRE3,Q9UPY8,0.78,0.231,0.71561,DTO_05007530,Cellular structure,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
22925,PLA2R1,Q13018,0.633,0.577,3.2312e-30,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
22926,ATF6,P18850,0.516,0.846,3.2333e-07,,,C0152200,Achromatopsia,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.76,1.0,strong,2015.0,2019.0,ALL
22927,HABP4,Q5JVS0,0.89,0.115,0.0062064,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
22928,SEPHS2,Q99611,0.839,0.077,0.0022195,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
22929,SEPHS1,P49903,0.695,0.385,0.97637,DTO_05007624,Enzyme,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.03,1.0,,2018.0,2019.0,ALL
22930,RAB3GAP1,Q15042,0.566,0.692,1.4523e-07,,,C1838625,Warburg Sjo Fledelius syndrome,C23;C16;C11;C05;C10;C19;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,0.929,,2005.0,2017.0,ALL
22931,RAB18,Q9NP72,0.582,0.692,0.91006,,,C3280203,WARBURG MICRO SYNDROME 3,,,disease,Disease or Syndrome,0.8,1.0,strong,2011.0,2015.0,ALL
22932,POMZP3,Q6PJE2,1.0,0.038,0.00052926,,,C0730290,Cone Dystrophy,C11,   Eye Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
22933,SIRT2,Q8IXJ6,0.51,0.769,2.3295e-08,DTO_05007378,Epigenetic regulator,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.33,1.0,,2013.0,2019.0,ALL
22934,RPIA,P49247,0.691,0.462,0.00014309,,,C1291609,Ribose 5-Phosphate Isomerase Deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2004.0,2018.0,ALL
22936,ELL2,O00472,0.722,0.269,0.99824,DTO_05007527,Cell-cell junction,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.13,1.0,,2015.0,2018.0,ALL
22937,SCAP,Q12770,0.682,0.462,2.9094e-06,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2004.0,2019.0,ALL
22938,SNW1,Q13573,0.682,0.423,0.99961,DTO_05007542,Transcription factor,C0149940,Sciatic Neuropathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0,,2013.0,2013.0,ALL
22941,SHANK2,Q9UPX8,0.663,0.385,8.4299e-07,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2019.0,2019.0,ALL
22943,DKK1,O94907,0.439,0.885,0.17423,,,C0750929,"Arnold-Chiari Malformation, Type I",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.41,1.0,,2017.0,2017.0,ALL
22944,KIN,O60870,0.769,0.192,1.0187e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2011.0,2018.0,ALL
22947,DUX4L1,,1.0,0.115,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.35,1.0,,2007.0,2018.0,ALL
22948,CCT5,P48643,0.663,0.462,0.99928,DTO_05007613,Chaperone,C1850395,"Neuropathy, Hereditary Sensory, with Spastic Paraplegia, Autosomal Recessive",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2003.0,2014.0,ALL
22949,PTGR1,Q14914,0.729,0.231,3.5375e-08,DTO_05007624,Enzyme,C0023904,"Liver Neoplasms, Experimental",C06;C04,   Digestive System Diseases;    Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
22950,SLC4A1AP,Q9BWU0,0.931,0.115,8.6733e-10,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
22952,CYP2G1P,Q6ZSU1,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
22953,P2RX2,Q9UBL9,0.585,0.769,9.6508e-13,DTO_01300327,Ion channel,C1842371,"DEAFNESS, AUTOSOMAL DOMINANT 41 (disorder)",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.6,1.0,strong,1995.0,2014.0,ALL
22954,TRIM32,Q13049,0.587,0.769,0.0016684,,,C0270968,Limb-girdle muscular dystrophy type 2H,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome; Congenital Abnormality,1.0,0.941,,2002.0,2019.0,ALL
22955,SCMH1,Q96GD3,0.931,0.077,8.6107e-06,DTO_05007557,Nucleic acid binding,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
22974,TPX2,Q9ULW0,0.541,0.692,0.99981,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2002.0,2019.0,ALL
22976,PAXIP1,Q6ZW49,0.769,0.269,1.0,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,2005.0,2019.0,ALL
22977,AKR7A3,O95154,0.931,0.115,1.0209e-19,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
22978,NT5C2,P49902,0.537,0.846,2.1385e-06,DTO_05007624,Enzyme,C3888209,"SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.71,1.0,,2009.0,2017.0,ALL
22979,EFR3B,Q9Y2G0,0.89,0.231,0.024122,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2008.0,2019.0,ALL
22980,TCF25,Q9BQ70,1.0,0.077,0.41572,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
22981,NINL,Q9Y2I6,0.682,0.538,2.6545e-39,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
22982,DIP2C,Q9Y2E4,0.805,0.192,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2017.0,2017.0,ALL
22983,MAST1,Q9Y2H9,0.711,0.385,1.0,DTO_03300101,Kinase,C4748927,MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS,,,disease,Disease or Syndrome,0.61,1.0,strong,2016.0,2018.0,ALL
22984,PDCD11,Q14690,0.839,0.269,3.2929e-16,DTO_05007557,Nucleic acid binding,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
22985,ACIN1,Q9UKV3,0.751,0.308,1.0,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
22986,SORCS3,Q9UPU3,0.76,0.231,3.7354e-05,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.11,1.0,,2013.0,2016.0,ALL
22987,SV2C,Q496J9,0.821,0.192,2.4354e-05,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
22989,MYH15,Q9Y2K3,0.821,0.308,4.5499e-59,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
22990,PCNX1,Q96RV3,0.792,0.115,1.0,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
22992,KDM2A,Q9Y2K7,0.636,0.423,1.0,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
22993,HMGXB3,Q12766,0.821,0.115,0.999,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2009.0,2013.0,ALL
22994,CEP131,Q9UPN4,0.76,0.385,7.3631e-16,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
22995,CEP152,O94986,0.653,0.5,2.6574e-27,DTO_05007599,Signaling,C3553886,"MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,strong,2010.0,2010.0,ALL
22996,TTC39A,Q5SRH9,0.931,0.115,0.0006305,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
22997,IGSF9B,Q9UPX0,0.821,0.192,0.86551,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
22998,LIMCH1,Q9UPQ0,0.792,0.154,0.94734,DTO_05007530,Cellular structure,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
22999,RIMS1,Q86UR5,0.7,0.231,0.9902,DTO_05007584,Enzyme modulator,C1863634,Cone-Rod Dystrophy 7,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.74,1.0,limited,2000.0,2017.0,ALL
23001,WDFY3,Q8IZQ1,0.711,0.423,1.0,,,C4479608,"MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.5,1.0,,2016.0,2017.0,ALL
23002,DAAM1,Q9Y4D1,0.682,0.423,0.99918,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23005,MAPKBP1,O60336,0.805,0.231,0.00021011,,,C4310640,NEPHRONOPHTHISIS 20,,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
23007,PLCH1,Q4KWH8,0.736,0.154,0.39649,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
23008,KLHDC10,Q6PID8,0.861,0.077,0.92564,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
23011,RAB21,Q9UL25,0.792,0.269,0.1111,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
23012,STK38L,Q9Y2H1,0.821,0.154,0.93427,DTO_03300101,Kinase,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0,,2019.0,2019.0,ALL
23013,SPEN,Q96T58,0.644,0.654,1.0,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2020.0,ALL
23014,FBXO21,O94952,1.0,0.038,0.97537,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
23015,GOLGA8A,A7E2F4,0.931,0.038,0.00039454,DTO_05007405,Transporter,C0028768,Obsessive-Compulsive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
23016,EXOSC7,Q15024,1.0,0.115,1.0442e-05,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
23017,FAIM2,Q9BWQ8,0.663,0.5,8.7012e-05,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.2,1.0,,2018.0,2018.0,ALL
23019,CNOT1,A5YKK6,0.674,0.577,1.0,DTO_05007542,Transcription factor,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.4,1.0,strong,2019.0,2019.0,ALL
23020,SNRNP200,O75643,0.695,0.5,1.0,,,C1835895,RETINITIS PIGMENTOSA 33 (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2013.0,ALL
23022,PALLD,Q8WX93,0.628,0.615,5.2547e-06,,,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.37,1.0,,2006.0,2009.0,ALL
23023,TMCC1,O94876,1.0,0.077,0.84526,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
23024,PDZRN3,Q9UPQ7,0.792,0.269,0.98471,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
23025,UNC13A,Q9UPW8,0.705,0.423,1.0,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2009.0,2019.0,ALL
23026,MYO16,Q9Y6X6,0.722,0.308,0.99851,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
23028,KDM1A,O60341,0.512,0.808,0.99667,DTO_05007378,Epigenetic regulator,C4225229,"CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2016.0,ALL
23030,KDM4B,O94953,0.606,0.462,1.0,DTO_05007378,Epigenetic regulator,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
23031,MAST3,O60307,0.931,0.154,0.99991,DTO_03300101,Kinase,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
23032,USP33,Q8TEY7,0.729,0.308,0.86249,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2014.0,2018.0,ALL
23033,DOP1A,Q5JWR5,0.861,0.115,0.99993,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
23034,SAMD4A,Q9UPU9,0.78,0.308,0.99958,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
23035,PHLPP2,Q6ZVD8,0.641,0.346,1.2128e-06,,,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.13,1.0,,2014.0,2019.0,ALL
23036,ZNF292,O60281,0.695,0.423,1.0,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,moderate,2018.0,2018.0,ALL
23037,PDZD2,O15018,0.666,0.538,0.99694,DTO_05007599,Signaling,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.11,1.0,,2018.0,2018.0,ALL
23038,WDTC1,Q8N5D0,0.691,0.5,0.99915,DTO_05007584,Enzyme modulator,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
23039,XPO7,Q9UIA9,0.931,0.077,1.0,DTO_05007405,Transporter,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
23040,MYT1L,Q9UL68,0.659,0.462,1.0,DTO_05007542,Transcription factor,C4225296,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 39",,,disease,Disease or Syndrome,0.61,1.0,strong,2011.0,2019.0,ALL
23041,MON2,Q7Z3U7,0.751,0.308,0.59388,,,C1536220,ST segment elevation myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
23042,PDXDC1,Q6P996,0.78,0.154,3.4641e-12,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
23043,TNIK,Q9UKE5,0.612,0.615,1.0,DTO_03300101,Kinase,C4310755,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54",,,disease,Disease or Syndrome,0.6,1.0,moderate,2016.0,2016.0,ALL
23046,KIF21B,O75037,0.805,0.192,1.7695e-06,DTO_05007530,Cellular structure,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0,,2010.0,2015.0,ALL
23047,PDS5B,Q9NTI5,0.716,0.462,1.0,DTO_05007557,Nucleic acid binding,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2012.0,2017.0,ALL
23048,FNBP1,Q96RU3,0.736,0.269,0.82844,,,C3495676,Anorectal Malformations,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",group,Anatomical Abnormality,0.3,1.0,,2013.0,2013.0,ALL
23049,SMG1,Q96Q15,0.575,0.808,1.0,DTO_03300101,Kinase,C3165106,Infiltrating duct carcinoma of female breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
23051,ZHX3,Q9H4I2,0.792,0.346,0.050815,DTO_05007542,Transcription factor,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
23052,ENDOD1,O94919,0.839,0.192,6.5757e-11,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
23054,NCOA6,Q14686,0.647,0.731,0.99913,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,1996.0,2019.0,ALL
23057,NMNAT2,Q9BZQ4,0.67,0.5,0.98853,DTO_05007624,Enzyme,C0014804,Erythromelalgia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,limited,2019.0,2019.0,ALL
23059,CLUAP1,Q96AJ1,0.805,0.231,0.0004184,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
23060,ZNF609,O15014,0.751,0.346,1.0,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
23061,TBC1D9B,Q66K14,1.0,0.077,5.0231e-12,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
23062,GGA2,Q9UJY4,0.861,0.154,1.2573e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
23063,WAPL,Q7Z5K2,0.931,0.115,1.0,,,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
23064,SETX,Q7Z333,0.57,0.731,0.95483,DTO_05007624,Enzyme,C1853761,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,2004.0,2019.0,ALL
23065,EMC1,Q8N766,0.7,0.462,6.7281e-26,,,C4225172,"CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2019.0,ALL
23066,CAND2,O75155,0.792,0.423,4.326e-16,DTO_05007542,Transcription factor,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.42,1.0,,2016.0,2018.0,ALL
23067,SETD1B,Q9UPS6,0.722,0.423,1.0,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
23070,CMTR1,Q8N1G2,0.861,0.115,0.99252,,,C0004903,Beckwith-Wiedemann Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
23071,ERP44,Q9BS26,0.736,0.346,0.99106,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
23072,HECW1,Q76N89,0.792,0.346,0.99982,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
23074,UHRF1BP1L,A0JNW5,0.821,0.154,0.0042502,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
23075,SWAP70,Q9UH65,0.736,0.385,0.049628,DTO_05007557,Nucleic acid binding,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
23076,RRP1B,Q14684,0.792,0.231,3.0653e-09,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2016.0,2016.0,ALL
23077,MYCBP2,O75592,0.716,0.308,1.0,,,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,1.0,,2013.0,2013.0,ALL
23078,VWA8,A3KMH1,0.769,0.231,8.4114e-70,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2018.0,ALL
23080,AVL9,Q8NBF6,0.792,0.231,0.0026324,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
23081,KDM4C,Q9H3R0,0.601,0.615,6.5189e-07,,,C0236663,Alcohol withdrawal syndrome,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Disease or Syndrome,0.31,1.0,,2012.0,2012.0,ALL
23082,PPRC1,Q5VV67,0.656,0.538,1.0,DTO_05007542,Transcription factor,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2016.0,2016.0,ALL
23085,ERC1,Q8IUD2,0.78,0.385,1.0574e-07,DTO_05007584,Enzyme modulator,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.33,1.0,,1999.0,2005.0,ALL
23086,EXPH5,Q8NEV8,0.792,0.154,4.1598e-26,,,C3554367,"EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.5,1.0,,2012.0,2016.0,ALL
23087,TRIM35,Q9UPQ4,0.89,0.115,0.00087781,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2004.0,2015.0,ALL
23089,PEG10,Q86TG7,0.597,0.615,0.87274,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
23090,ZNF423,Q2M1K9,0.592,0.808,0.99996,,,C3539071,NEPHRONOPHTHISIS 14,,,disease,Disease or Syndrome,0.71,1.0,,2012.0,2016.0,ALL
23091,ZC3H13,Q5T200,0.839,0.115,1.0,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23092,ARHGAP26,Q9UNA1,0.656,0.5,0.99661,DTO_05007584,Enzyme modulator,C0349639,Juvenile Myelomonocytic Leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.6,,limited,,,ALL
23093,TTLL5,Q6EMB2,0.686,0.5,2.9217e-22,DTO_05007624,Enzyme,C4014501,CONE-ROD DYSTROPHY 19,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2016.0,ALL
23094,SIPA1L3,O60292,0.76,0.269,1.0,DTO_05007584,Enzyme modulator,C4225182,CATARACT 45,,,disease,Disease or Syndrome,0.4,,,,,ALL
23095,KIF1B,O60333,0.516,0.808,1.0,DTO_05007530,Cellular structure,C1861678,"Charcot-Marie-Tooth Disease, Axonal, Type 2a1",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,limited,2001.0,2015.0,ALL
23096,IQSEC2,Q5JU85,0.573,0.577,0.99998,,,C2931498,"Mental Retardation, X-Linked 1",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,strong,1992.0,2017.0,ALL
23097,CDK19,Q9BWU1,0.691,0.462,0.99982,DTO_03300101,Kinase,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
23098,SARM1,Q6SZW1,0.682,0.346,1.7007e-10,,,C0035235,Respiratory Syncytial Virus Infections,C01,   Infections,group,Disease or Syndrome,0.31,1.0,,2014.0,2014.0,ALL
23101,MCF2L2,Q86YR7,0.628,0.577,1.1565e-24,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
23102,TBC1D2B,Q9UPU7,0.931,0.115,1.438e-08,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
23105,FSTL4,Q6MZW2,0.89,0.154,0.017889,DTO_05007584,Enzyme modulator,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
23107,MRPS27,Q92552,1.0,0.038,1.9215e-06,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
23108,RAP1GAP2,Q684P5,1.0,0.038,0.96928,DTO_05007584,Enzyme modulator,C1456784,Paranoia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2011.0,2011.0,ALL
23109,DDN,O94850,0.805,0.231,0.359,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
23111,SPART,Q8N0X7,0.588,0.654,2.967e-07,,,C0393559,Troyer syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,2002.0,2020.0,ALL
23112,TNRC6B,Q9UPQ9,0.751,0.462,1.0,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
23113,CUL9,Q8IWT3,0.659,0.654,0.99191,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
23114,NFASC,O94856,0.682,0.423,0.99999,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
23116,TOGARAM1,Q9Y4F4,0.931,0.115,1.333e-08,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23117,NPIPB3,Q92617,0.89,0.269,0.0023295,,,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
23118,TAB2,Q9NYJ8,0.617,0.654,0.99998,,,C3554279,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2",,,disease,Disease or Syndrome; Congenital Abnormality,0.7,1.0,,2010.0,2017.0,ALL
23119,HIC2,Q96JB3,0.861,0.308,0.99668,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
23122,CLASP2,O75122,0.792,0.269,1.0,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23125,CAMTA2,O94983,0.89,0.154,0.99918,DTO_05007542,Transcription factor,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
23126,POGZ,Q7Z3K3,0.599,0.577,1.0,DTO_05007542,Transcription factor,C4225351,White Sutton syndrome,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.63,1.0,,2015.0,2020.0,ALL
23127,COLGALT2,Q8IYK4,0.805,0.269,1.0935e-10,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
23129,PLXND1,Q9Y4D7,0.647,0.577,1.0,,,C0221060,Mobius Syndrome,C16;C10;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.54,1.0,limited,2004.0,2019.0,ALL
23130,ATG2A,Q2TAZ0,1.0,0.077,0.053526,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
23131,GPATCH8,Q9UKJ3,0.931,0.154,1.0,,,C0029434,Osteogenesis Imperfecta,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0,,2011.0,2011.0,ALL
23132,RAD54L2,Q9Y4B4,,,1.0,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
23133,PHF8,Q9UPP1,0.631,0.577,0.99785,,,C1846055,Siderius X-linked mental retardation syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,definitive,2005.0,2018.0,ALL
23135,KDM6B,O15054,0.514,0.808,1.0,DTO_05007378,Epigenetic regulator,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
23136,EPB41L3,Q9Y2J2,0.619,0.615,4.3188e-05,,,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.34,1.0,,2002.0,2007.0,ALL
23137,SMC5,Q8IY18,0.792,0.231,3.1326e-06,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
23139,MAST2,Q6P0Q8,0.76,0.192,1.7079e-19,DTO_03300101,Kinase,C1334807,Mucinous carcinoma of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
23140,ZZEF1,O43149,1.0,0.077,0.83468,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23141,ANKLE2,Q86XL3,0.691,0.5,1.0099e-10,,,C4225249,"MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,limited,2014.0,2014.0,ALL
23142,DCUN1D4,Q92564,1.0,0.077,0.047486,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
23143,LRCH1,Q9Y2L9,0.769,0.269,0.99552,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
23144,ZC3H3,Q8IXZ2,1.0,0.077,0.46998,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
23145,SSPO,A2VEC9,0.805,0.154,,DTO_05007584,Enzyme modulator,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2016.0,2016.0,ALL
23149,FCHO1,O14526,,,0.99845,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
23150,FRMD4B,Q9Y2L6,0.805,0.308,0.4539,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
23151,GRAMD4,Q6IC98,0.861,0.154,0.99998,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
23152,CIC,Q96RK0,0.523,0.692,0.99999,,,C4539848,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 45",,,disease,Mental or Behavioral Dysfunction,0.6,1.0,strong,2010.0,2017.0,ALL
23154,NCDN,Q9UBB6,0.89,0.231,0.99964,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
23155,CLCC1,Q96S66,1.0,0.077,0.0062025,DTO_01300327,Ion channel,C0339526,Autosomal recessive retinitis pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0,,2018.0,2018.0,ALL
23157,SEPTIN6,Q14141,0.644,0.385,0.93177,DTO_05007584,Enzyme modulator,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.08,1.0,,2002.0,2019.0,ALL
23158,TBC1D9,Q6ZT07,0.399,0.846,2.8039e-05,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
23160,WDR43,Q15061,0.89,0.192,0.99997,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
23161,SNX13,Q9Y5W8,,,0.40328,DTO_05007584,Enzyme modulator,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
23162,MAPK8IP3,Q9UPT6,0.682,0.462,1.0,DTO_05007584,Enzyme modulator,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.4,1.0,strong,2017.0,2017.0,ALL
23163,GGA3,Q9NZ52,0.821,0.346,1.6701e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
23164,MPRIP,Q6WCQ1,0.556,0.885,0.98078,DTO_05007584,Enzyme modulator,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
23165,NUP205,Q92621,0.736,0.308,1.0,,,C4225165,"NEPHROTIC SYNDROME, TYPE 13",,,disease,Disease or Syndrome,0.7,1.0,limited,2016.0,2016.0,ALL
23166,STAB1,Q9NY15,0.619,0.692,8.6792e-50,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
23168,RTF1,Q92541,0.931,0.154,1.0,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
23169,SLC35D1,Q9NTN3,0.736,0.385,0.00035546,DTO_05007405,Transporter,C0432194,Schneckenbecken dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.93,1.0,,2007.0,2019.0,ALL
23170,TTLL12,Q14166,0.805,0.231,2.2425e-15,,,C0868848,"Hereditary disturbances in tooth structure, NEC in ICD9CM_2014",,,disease,Congenital Abnormality,0.1,1.0,,2014.0,2014.0,ALL
23171,GPD1L,Q8N335,0.674,0.308,0.038201,DTO_05007624,Enzyme,C2673193,Brugada Syndrome 2,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2005.0,2009.0,ALL
23172,ABRAXAS2,Q15018,0.76,0.308,0.020167,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
23173,METAP1,P53582,0.861,0.154,0.10521,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,0.0,,2017.0,2017.0,ALL
23174,ZCCHC14,Q8WYQ9,0.769,0.462,0.97852,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
23175,LPIN1,Q14693,0.601,0.692,6.4522e-13,,,C1849386,"Myoglobinuria, Acute Recurrent, Autosomal Recessive",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.7,1.0,definitive,2008.0,2019.0,ALL
23176,SEPTIN8,Q92599,0.861,0.192,0.084191,DTO_05007584,Enzyme modulator,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
23177,CEP68,Q76N32,0.839,0.269,0.51822,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2017.0,2018.0,ALL
23178,PASK,Q96RG2,0.792,0.308,1.952e-21,DTO_03300101,Kinase,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2009.0,ALL
23179,RGL1,Q9NZL6,0.839,0.115,0.95608,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
23180,RFTN1,Q14699,0.861,0.077,2.4248e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
23181,DIP2A,Q14689,0.76,0.231,0.11301,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2017.0,2019.0,ALL
23184,MESD,Q14696,0.805,0.192,0.62773,,,C0029434,Osteogenesis Imperfecta,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.31,1.0,moderate,2019.0,2019.0,ALL
23185,LARP4B,Q92615,0.76,0.154,0.99998,DTO_05007557,Nucleic acid binding,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
23186,RCOR1,Q9UKL0,0.678,0.577,0.99992,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2014.0,2018.0,ALL
23187,PHLDB1,Q86UU1,0.722,0.423,0.10667,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.5,1.0,,2009.0,2020.0,ALL
23189,KANK1,Q14678,0.641,0.538,7.9821e-18,,,C2752061,"Cerebral Palsy, Spastic Quadriplegic, 2",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.5,1.0,limited,2005.0,2005.0,ALL
23190,UBXN4,Q92575,0.931,0.115,0.14569,,,C0022578,Keratoconus,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
23191,CYFIP1,Q7L576,0.674,0.538,0.96816,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.38,1.0,,2013.0,2019.0,ALL
23192,ATG4B,Q9Y4P1,0.644,0.538,0.95648,DTO_05007624,Enzyme,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
23193,GANAB,Q14697,0.716,0.423,0.99873,DTO_05007624,Enzyme,C0085413,"Polycystic Kidney, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.64,1.0,,2016.0,2019.0,ALL
23194,FBXL7,Q9UJT9,0.769,0.346,0.31497,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2014.0,2019.0,ALL
23195,MDN1,Q9NU22,0.931,0.115,2.1582e-08,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
23196,FAM120A,Q9NZB2,0.931,0.077,1.0,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
23197,FAF2,Q96CS3,0.861,0.231,0.99911,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
23198,PSME4,Q14997,0.931,0.115,1.0,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
23199,GSE1,Q14687,0.78,0.231,1.0,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2012.0,ALL
23200,ATP11B,Q9Y2G3,0.89,0.115,0.0020092,DTO_05007405,Transporter,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
23201,FAM168A,Q92567,0.729,0.269,0.98674,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
23203,PMPCA,Q10713,0.633,0.577,3.437e-11,DTO_05007624,Enzyme,C1859298,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,1999.0,2019.0,ALL
23204,ARL6IP1,Q15041,0.653,0.577,0.022339,,,C3810294,"SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,moderate,2014.0,2018.0,ALL
23205,ACSBG1,Q96GR2,0.603,0.654,3.959e-05,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
23207,PLEKHM2,Q8IWE5,0.7,0.462,1.7077e-05,,,C1960469,Left ventricular noncompaction,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,,2015.0,2015.0,ALL
23208,SYT11,Q9BT88,0.861,0.192,0.92676,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2007.0,2019.0,ALL
23209,MLC1,Q15049,0.585,0.769,3.2425e-08,DTO_01300327,Ion channel,C1858854,MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS,C23;C16;C04;C18;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Congenital Abnormality,1.0,0.963,strong,2001.0,2019.0,ALL
23210,JMJD6,Q6NYC1,0.615,0.654,0.93353,DTO_05007575,Receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,2012.0,2019.0,ALL
23211,ZC3H4,Q9UPT8,1.0,0.077,1.0,,,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2017.0,2017.0,ALL
23212,RRS1,Q15050,0.656,0.5,0.17712,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
23213,SULF1,Q8IWU6,0.585,0.538,0.0013751,DTO_05007624,Enzyme,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.37,1.0,,2007.0,2017.0,ALL
23214,XPO6,Q96QU8,0.861,0.154,1.0,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
23215,PRRC2C,Q9Y520,0.839,0.192,1.0,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
23216,TBC1D1,Q86TI0,0.716,0.423,1.8584e-13,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.39,0.9,,2006.0,2020.0,ALL
23217,ZFR2,Q9UPR6,1.0,0.077,9.7623e-26,DTO_05007557,Nucleic acid binding,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
23218,NBEAL2,Q6ZNJ1,0.617,0.769,0.059764,,,C0272302,Gray Platelet Syndrome,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,0.917,definitive,2010.0,2019.0,ALL
23219,FBXO28,Q9NVF7,0.78,0.231,0.98681,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2017.0,ALL
23220,DTX4,Q9Y2E6,0.861,0.269,0.21699,DTO_05007624,Enzyme,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
23221,RHOBTB2,Q9BYZ6,0.631,0.615,0.013306,DTO_05007584,Enzyme modulator,C4693899,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2018.0,ALL
23223,RRP12,Q5JTH9,0.89,0.038,5.7892e-11,,,C0200637,Monocyte count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
23224,SYNE2,Q8WXH0,0.623,0.692,1.6503e-25,,,C2751805,"EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.6,1.0,,2007.0,2009.0,ALL
23225,NUP210,Q8TEM1,0.76,0.308,1.0967e-22,DTO_05007405,Transporter,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
23228,PLCL2,Q9UPR0,0.743,0.308,0.99999,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2011.0,2019.0,ALL
23229,ARHGEF9,O43307,0.691,0.385,0.9989,DTO_05007584,Enzyme modulator,C1845102,Hyperekplexia and Epilepsy,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2004.0,2018.0,ALL
23230,VPS13A,Q96RL7,0.65,0.577,9.3125e-22,,,C0393576,Chorea Acanthocytosis Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,2001.0,2019.0,ALL
23232,TBC1D12,O60347,,,1.715e-05,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
23233,EXOC6B,Q9Y2D4,0.682,0.577,0.11692,DTO_05007405,Transporter,C0432243,Spondyloepimetaphyseal Dysplasia With Joint Laxity,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.3,1.0,,2016.0,2018.0,ALL
23234,DNAJC9,Q8WXX5,1.0,0.077,0.0045264,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
23235,SIK2,Q9H0K1,0.674,0.577,0.99651,DTO_03300101,Kinase,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
23236,PLCB1,Q9NQ66,0.595,0.654,0.98337,DTO_05007624,Enzyme,C3150988,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12",,,disease,Disease or Syndrome,0.6,1.0,,2010.0,2010.0,ALL
23237,ARC,Q7LC44,0.573,0.769,0.59433,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,1.0,,2012.0,2019.0,ALL
23239,PHLPP1,O60346,0.597,0.654,0.99927,DTO_05007378,Epigenetic regulator,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
23240,TMEM131L,A2VDJ0,0.839,0.192,0.95975,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23241,PACS2,Q86VP3,0.7,0.423,0.99583,,,C4748070,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66",,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2018.0,ALL
23242,COBL,O75128,0.78,0.269,0.0039121,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
23243,ANKRD28,O15084,0.861,0.115,1.0,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23244,PDS5A,Q29RF7,0.792,0.346,1.0,DTO_05007557,Nucleic acid binding,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
23245,ASTN2,O75129,0.666,0.462,0.99971,,,C0338480,Common Migraine,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.41,1.0,,2012.0,2017.0,ALL
23246,BOP1,Q14137,0.821,0.192,0.092793,DTO_05007557,Nucleic acid binding,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
23247,KIAA0556,O60303,0.644,0.538,1.1859e-29,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.43,1.0,,2015.0,2019.0,ALL
23248,RPRD2,Q5VT52,0.861,0.154,1.0,DTO_05007584,Enzyme modulator,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
23250,ATP11A,P98196,0.682,0.462,4.0487e-06,DTO_05007405,Transporter,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.5,1.0,,2013.0,2013.0,ALL
23251,MINAR1,Q9UPX6,0.89,0.077,1.9551e-05,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
23252,OTUD3,Q5T2D3,0.76,0.231,3.5645e-05,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
23253,ANKRD12,Q6UB98,0.792,0.154,1.0,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
23254,KAZN,Q674X7,0.792,0.192,0.59671,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
23255,MTCL1,Q9Y4B5,0.839,0.192,8.834e-05,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.4,1.0,,2017.0,2019.0,ALL
23256,SCFD1,Q8WVM8,0.839,0.192,0.99962,DTO_05007405,Transporter,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.42,1.0,,2016.0,2019.0,ALL
23258,DENND5A,Q6IQ26,0.821,0.115,0.057546,,,C4310635,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2017.0,ALL
23259,DDHD2,O94830,0.695,0.577,1.4321e-10,DTO_05007624,Enzyme,C3539495,"SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.93,1.0,,2012.0,2018.0,ALL
23261,CAMTA1,Q9Y6Y1,0.599,0.615,1.0,DTO_05007542,Transcription factor,C3553661,"CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2015.0,ALL
23262,PPIP5K2,O43314,0.89,0.154,8.5759e-21,,,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.2,,,,,ALL
23263,MCF2L,O15068,0.559,0.769,2.7178e-07,DTO_05007599,Signaling,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.13,1.0,,2011.0,2015.0,ALL
23264,ZC3H7B,Q9UGR2,0.805,0.192,0.92932,DTO_05007557,Nucleic acid binding,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
23265,EXOC7,Q9UPT5,0.839,0.154,3.2288e-07,DTO_05007405,Transporter,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2013.0,2017.0,ALL
23266,ADGRL2,O95490,0.682,0.385,1.0,DTO_02300001,G-protein coupled receptor,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
23268,DNMBP,Q6XZF7,0.743,0.423,5.7164e-17,,,C0266539,Congenital total cataract,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.3,1.0,,2018.0,2018.0,ALL
23269,MGA,Q8IWI9,0.711,0.423,1.0,DTO_05007542,Transcription factor,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
23270,TSPYL4,Q9UJ04,0.861,0.115,1.2306e-05,DTO_05007584,Enzyme modulator,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
23271,CAMSAP2,Q08AD1,0.792,0.231,0.99999,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
23272,TASOR,Q9UK61,1.0,0.038,0.99954,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
23274,CLEC16A,Q2KHT3,0.612,0.654,0.27595,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.5,1.0,,2007.0,2020.0,ALL
23275,POFUT2,Q9Y2G5,0.839,0.346,0.00021557,DTO_05007624,Enzyme,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
23277,CLUH,O75153,0.861,0.115,0.99474,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23279,NUP160,Q12769,0.751,0.346,6.7751e-06,DTO_05007405,Transporter,C4748552,"NEPHROTIC SYNDROME, TYPE 19",,,disease,Disease or Syndrome,0.5,1.0,limited,2018.0,2019.0,ALL
23281,MTUS2,Q5JR59,0.839,0.154,0.79549,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
23283,CSTF2T,Q9H0L4,,,0.086385,DTO_05007557,Nucleic acid binding,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.02,1.0,,2002.0,2018.0,ALL
23284,ADGRL3,Q9HAR2,0.729,0.385,1.0,DTO_02300001,G-protein coupled receptor,C0041671,Attention Deficit Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.51,1.0,,2012.0,2016.0,ALL
23286,WWC1,Q8IX03,0.61,0.692,0.00039438,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2016.0,ALL
23287,AGTPBP1,Q9UPW5,0.65,0.538,0.42151,DTO_05007624,Enzyme,C4748934,"NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY",,,disease,Disease or Syndrome,0.61,1.0,,2018.0,2019.0,ALL
23288,IQCE,Q6IPM2,0.805,0.115,1.3752e-39,,,C3887487,Postaxial polydactyly type A,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.3,1.0,,2015.0,2017.0,ALL
23291,FBXW11,Q9UKB1,0.626,0.462,0.97611,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.3,1.0,strong,2019.0,2019.0,ALL
23293,SMG6,Q86US8,0.751,0.308,0.98164,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23294,ANKS1A,Q92625,0.805,0.192,0.80916,DTO_05007575,Receptor,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,,2011.0,2018.0,ALL
23295,MGRN1,O60291,0.839,0.192,0.10393,DTO_05007624,Enzyme,C0162534,Prion Diseases,C01;C10,   Infections;    Nervous System Diseases,group,Disease or Syndrome,0.02,0.5,,2013.0,2017.0,ALL
23299,BICD2,Q8TD16,0.615,0.731,0.98272,,,C4747715,"SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2A, CHILDHOOD ONSET, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2018.0,ALL
23300,ATMIN,O43313,0.751,0.346,5.031e-05,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2016.0,ALL
23301,EHBP1,Q8NDI1,0.839,0.231,0.30745,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.42,1.0,,2008.0,2016.0,ALL
23302,WSCD1,Q658N2,0.931,0.077,6.3576e-05,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
23303,KIF13B,Q9NQT8,1.0,0.154,2.1366e-12,DTO_05007530,Cellular structure,C0429087,Electrocardiogram: P-R interval,,,phenotype,Finding,0.1,1.0,,2013.0,2013.0,ALL
23304,UBR2,Q8IWV8,0.821,0.154,1.0,,,C0003175,Anthrax disease,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
23305,ACSL6,Q9UKU0,0.686,0.5,0.0032201,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,0.667,,2006.0,2011.0,ALL
23306,NEMP1,O14524,0.821,0.115,0.91617,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
23307,FKBP15,Q5T1M5,0.821,0.115,5.551e-12,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
23308,ICOSLG,O75144,0.601,0.654,0.00035482,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.4,1.0,,2010.0,2010.0,ALL
23309,SIN3B,O75182,0.743,0.308,0.99999,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2016.0,ALL
23310,NCAPD3,P42695,0.722,0.423,5.821e-09,DTO_05007557,Nucleic acid binding,C4693834,"MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.4,1.0,,2016.0,2016.0,ALL
23312,DMXL2,Q8TDJ6,0.695,0.538,1.0,,,C4015261,POLYENDOCRINE-POLYNEUROPATHY SYNDROME,,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2019.0,ALL
23313,KIAA0930,Q6ICG6,1.0,0.038,6.9792e-05,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
23314,SATB2,Q9UPW6,0.503,0.769,0.99999,DTO_05007542,Transcription factor,C1837218,"Cleft palate, isolated",C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.9,1.0,strong,2003.0,2019.0,ALL
23315,SLC9A8,Q9Y2E8,0.736,0.5,2.9146e-10,DTO_05007405,Transporter,C0338630,Senile Paranoid Dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2009.0,2009.0,ALL
23316,CUX2,O14529,0.644,0.5,1.0,DTO_05007542,Transcription factor,C4748341,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67",,,disease,Disease or Syndrome,0.6,1.0,strong,2012.0,2018.0,ALL
23317,DNAJC13,O75165,0.682,0.577,1.0,,,C3160718,"PARKINSON DISEASE, LATE-ONSET",,,disease,Disease or Syndrome,0.4,1.0,,2014.0,2015.0,ALL
23318,TUT4,Q5TAX3,0.861,0.269,1.0,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
23321,TRIM2,Q9C040,0.686,0.538,0.99603,DTO_05007624,Enzyme,C3809655,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R",,,disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2015.0,ALL
23322,RPGRIP1L,Q68CZ1,0.534,0.769,4.083e-31,DTO_05007584,Enzyme modulator,C1969053,JOUBERT SYNDROME 7,C23;C13;C11;C12;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.9,1.0,,2007.0,2015.0,ALL
23324,MAN2B2,Q9Y2E5,,,6.557e-23,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
23325,WASHC4,Q2M389,0.686,0.346,2.7872e-06,,,C4014386,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43",,,disease,Disease or Syndrome,0.6,1.0,,2011.0,2011.0,ALL
23326,USP22,Q9UPT9,0.61,0.538,0.55212,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2006.0,2019.0,ALL
23327,NEDD4L,Q96PU5,0.573,0.731,1.0,DTO_05007624,Enzyme,C1868720,Periventricular Nodular Heterotopia,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.64,1.0,,2016.0,2019.0,ALL
23328,SASH1,O94885,0.599,0.538,0.001802,,,C2675711,Dyschromatosis Universalis Hereditaria 1,C23;C16;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2020.0,ALL
23329,TBC1D30,Q9Y2I9,,,0.88919,DTO_05007624,Enzyme,C0202098,Insulin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
23331,TTC28,Q96AY4,0.76,0.308,1.0,DTO_05007575,Receptor,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
23332,CLASP1,Q7Z460,0.751,0.5,1.0,DTO_05007530,Cellular structure,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
23333,DPY19L1,Q2PZI1,,,0.00013176,,,C4049938,Physical Activity Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
23334,SZT2,Q5T011,0.67,0.423,2.3263e-14,,,C3809624,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18",,,disease,Disease or Syndrome,0.7,1.0,limited,2013.0,2013.0,ALL
23335,WDR7,Q9Y4E6,0.821,0.077,1.0,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2019.0,ALL
23336,SYNM,O15061,0.575,0.731,3.0339e-24,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2000.0,2019.0,ALL
23338,JADE2,Q9NQC1,0.89,0.192,0.99994,DTO_05007542,Transcription factor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2017.0,2017.0,ALL
23339,VPS39,Q96JC1,0.736,0.577,1.7834e-11,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2019.0,ALL
23341,DNAJC16,Q9Y2G8,,,3.6232e-11,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2016.0,2019.0,ALL
23344,ESYT1,Q9BSJ8,0.805,0.154,1.6707e-13,,,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
23345,SYNE1,Q8NF91,0.511,0.846,3.1899e-52,,,C0410189,"Muscular Dystrophy, Emery-Dreifuss",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.77,1.0,limited,2007.0,2019.0,ALL
23347,SMCHD1,A6NHR9,0.631,0.615,1.0,,,C1834671,FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1B,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.76,1.0,,2012.0,2019.0,ALL
23348,DOCK9,Q9BZ29,0.769,0.192,1.0,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
23349,PHF24,Q9UPV7,1.0,0.077,0.070044,,,C0494475,Tonic - clonic seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
23350,U2SURP,O15042,1.0,0.077,1.0,DTO_05007557,Nucleic acid binding,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
23351,KHNYN,O15037,1.0,0.038,1.6074e-08,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
23352,UBR4,Q5T4S7,0.76,0.269,1.0,,,C1720189,Episodic Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.32,1.0,limited,2014.0,2017.0,ALL
23353,SUN1,O94901,0.729,0.423,9.1868e-06,DTO_05007530,Cellular structure,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
23354,HAUS5,O94927,0.861,0.038,3.2819e-10,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
23355,VPS8,Q8N3P4,1.0,0.077,5.1131e-08,,,C0003886,Arthrogryposis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.5,1.0,limited,1996.0,2016.0,ALL
23358,USP24,Q9UPU5,0.76,0.231,1.0,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
23359,FAM189A1,O60320,1.0,,0.039333,,,C4310653,"LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME",,,disease,Disease or Syndrome,0.1,,,,,ALL
23360,FNBP4,Q8N3X1,1.0,0.038,1.0,,,C0599973,Waardenburg Anophthalmia Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.31,1.0,,2013.0,2013.0,ALL
23361,ZNF629,Q9UEG4,0.691,0.5,0.99978,DTO_05007542,Transcription factor,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,0.8,,2007.0,2019.0,ALL
23362,PSD3,Q9NYI0,0.691,0.423,0.0094778,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2011.0,2019.0,ALL
23363,OBSL1,O75147,0.686,0.308,9.9902e-26,,,C2752041,Three M Syndrome 2,C23;C16;C05;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.61,0.75,,2009.0,2015.0,ALL
23365,ARHGEF12,Q9NZN5,0.686,0.385,1.0,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
23367,LARP1,Q6PKG0,0.722,0.423,1.0,DTO_05007557,Nucleic acid binding,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0,,2015.0,2018.0,ALL
23368,PPP1R13B,Q96KQ4,0.599,0.692,0.99811,DTO_05007584,Enzyme modulator,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
23369,PUM2,Q8TB72,0.743,0.154,0.99492,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
23370,ARHGEF18,Q6ZSZ5,0.7,0.308,0.0017747,,,C4479481,RETINITIS PIGMENTOSA 78,,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
23371,TNS2,Q63HR2,0.769,0.423,3.7043e-07,,,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.31,1.0,strong,2013.0,2018.0,ALL
23373,CRTC1,Q6UUV9,0.565,0.692,0.531,DTO_05007542,Transcription factor,C0279628,Adenocarcinoma Of Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.41,1.0,,2013.0,2016.0,ALL
23376,UFL1,O94874,0.78,0.269,1.1708e-12,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2010.0,2013.0,ALL
23378,RRP8,O43159,0.89,0.269,1.2303e-10,,,C0001849,AIDS Dementia Complex,C01;C20;C10;F03,   Infections;    Immune System Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,1997.0,1997.0,ALL
23379,ICE1,Q9Y2F5,0.931,0.115,1.0,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
23380,SRGAP2,O75044,0.729,0.462,0.97679,DTO_05007584,Enzyme modulator,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
23381,SMG5,Q9UPR3,,,0.012768,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
23382,AHCYL2,Q96HN2,0.931,0.077,0.99127,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
23383,MAU2,Q9Y6X3,0.686,0.462,1.0,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2014.0,ALL
23384,SPECC1L,Q69YQ0,0.593,0.654,0.85887,,,C1801950,"Opitz-G syndrome, type 2",C16;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.72,1.0,,2015.0,2019.0,ALL
23385,NCSTN,Q92542,0.666,0.462,0.99942,,,C4551962,"ACNE INVERSA, FAMILIAL, 1",C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.6,1.0,,2010.0,2012.0,ALL
23386,NUDCD3,Q8IVD9,1.0,0.077,0.44788,DTO_05007530,Cellular structure,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
23387,SIK3,Q9Y2K2,0.631,0.654,1.0,DTO_03300101,Kinase,C4748455,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE",,,disease,Disease or Syndrome,0.5,1.0,strong,2012.0,2018.0,ALL
23389,MED13L,Q71F56,0.617,0.538,1.0,,,C1837341,"Transposition of the Great Arteries, Dextro-Looped 1",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.7,1.0,limited,2003.0,2016.0,ALL
23390,ZDHHC17,Q8IUH5,0.89,0.269,0.99989,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.27,0.875,,2002.0,2017.0,ALL
23392,ECPAS,Q5VYK3,0.931,0.077,1.0,DTO_05007584,Enzyme modulator,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
23394,ADNP,Q9H2P0,0.561,0.808,1.0,,,C4014538,"ADNP-related multiple congenital anomalies, intellectual disability, autism spectrum disorder",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.77,1.0,strong,2014.0,2018.0,ALL
23395,LARS2,Q15031,0.695,0.654,8.9333e-17,DTO_05007624,Enzyme,C0685838,Gonadal dysgenesis XX type deafness,C23;C16;C13;C12;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.76,1.0,strong,2013.0,2019.0,ALL
23396,PIP5K1C,O60331,0.792,0.346,0.97704,DTO_03300101,Kinase,C1969655,LETHAL CONGENITAL CONTRACTURAL SYNDROME 3,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2007.0,2007.0,ALL
23397,NCAPH,Q15003,0.76,0.385,8.0147e-05,,,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.4,1.0,limited,2016.0,2016.0,ALL
23398,PPWD1,Q96BP3,1.0,0.077,3.9819e-05,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2011.0,2014.0,ALL
23399,CTDNEP1,O95476,1.0,0.115,0.97468,,,C0221355,Macrocephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2014.0,2014.0,ALL
23400,ATP13A2,Q9NQ11,0.566,0.577,8.9582e-09,,,C1847640,KUFOR-RAKEB SYNDROME,C10,   Nervous System Diseases,disease,Disease or Syndrome,1.0,0.981,,1991.0,2019.0,ALL
23401,FRAT2,O75474,0.861,0.077,0.047967,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2001.0,2002.0,ALL
23403,FBXO46,Q6PJ61,,,0.69428,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
23404,EXOSC2,Q13868,0.711,0.462,2.8854e-06,DTO_05007624,Enzyme,C4540367,"SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES",,,disease,Disease or Syndrome,0.61,1.0,,2016.0,2020.0,ALL
23405,DICER1,Q9UPY3,0.446,0.846,1.0,DTO_05007624,Enzyme,C1266144,Pleuropulmonary blastoma,C04,   Neoplasms,disease,Neoplastic Process,0.8,0.982,definitive,2006.0,2019.0,ALL
23406,COTL1,Q14019,0.615,0.538,0.039077,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2010.0,2018.0,ALL
23408,SIRT5,Q9NXA8,0.61,0.615,8.6584e-10,DTO_05007378,Epigenetic regulator,C0036337,Schizoaffective Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2007.0,2007.0,ALL
23409,SIRT4,Q9Y6E7,0.603,0.654,6.8625e-10,DTO_05007378,Epigenetic regulator,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
23410,SIRT3,Q9NTG7,0.488,0.731,0.00016261,DTO_05007378,Epigenetic regulator,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,,2011.0,2020.0,ALL
23411,SIRT1,Q96EB6,0.378,0.885,0.087326,DTO_05007378,Epigenetic regulator,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.6,0.964,,2008.0,2020.0,ALL
23412,COMMD3,Q9UBI1,0.769,0.269,2.776e-05,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.03,1.0,,2016.0,2018.0,ALL
23413,NCS1,P62166,0.656,0.615,0.66434,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2003.0,2019.0,ALL
23414,ZFPM2,Q8WW38,0.565,0.731,1.0,DTO_05007542,Transcription factor,C0039685,Tetralogy of Fallot,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,1.0,0.929,limited,2000.0,2018.0,ALL
23415,KCNH4,Q9UQ05,0.603,0.615,0.99984,DTO_01300327,Ion channel,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
23416,KCNH3,Q9ULD8,0.89,0.269,0.99919,DTO_01300327,Ion channel,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
23417,MLYCD,O95822,0.617,0.769,0.00064816,,,C0342793,Malonic aciduria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.76,1.0,definitive,1999.0,2016.0,ALL
23418,CRB1,P82279,0.57,0.654,5.6266e-16,,,C1838647,RETINITIS PIGMENTOSA 12 (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.93,1.0,,1999.0,2017.0,ALL
23420,NOMO1,Q15155,0.792,0.308,1.702e-19,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2013.0,2013.0,ALL
23421,ITGB3BP,Q13352,0.792,0.269,2.9577e-07,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
23423,TMED3,Q9Y3Q3,0.736,0.462,0.022622,DTO_05007405,Transporter,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
23424,TDRD7,Q8NHU6,0.751,0.346,0.00061106,DTO_05007624,Enzyme,C3151304,CATARACT 36,,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
23426,GRIP1,Q9Y3R0,0.581,0.769,0.50828,,,C0265233,Cryptophthalmos syndrome,C16;C13;C11;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2004.0,2013.0,ALL
23428,SLC7A8,Q9UHI5,0.743,0.423,5.1068e-08,DTO_05007405,Transporter,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
23429,RYBP,Q8N488,0.686,0.269,0.17721,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2014.0,ALL
23430,TPSD1,Q9BZJ3,0.711,0.462,8.0398e-12,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
23431,AP4E1,Q9UPM8,0.656,0.385,0.0027529,DTO_05007575,Receptor,C3151056,"SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.61,1.0,,2011.0,2019.0,ALL
23432,GPR161,Q8N6U8,0.686,0.462,0.00034935,DTO_02300001,G-protein coupled receptor,C4053775,Pituitary stalk interruption syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.61,1.0,,2015.0,2015.0,ALL
23433,RHOQ,P17081,0.821,0.192,0.85702,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
23434,LINC01565,O15544,,,,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
23435,TARDBP,Q13148,0.493,0.808,0.98542,,,C2677565,AMYOTROPHIC LATERAL SCLEROSIS 10 (disorder),,,disease,Disease or Syndrome,0.8,1.0,,2008.0,2018.0,ALL
23436,CELA3B,P08861,0.686,0.346,2.4372e-12,DTO_05007624,Enzyme,C0267963,Exocrine pancreatic insufficiency,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.4,1.0,,2003.0,2019.0,ALL
23437,TRS-AGA2-3,,0.743,0.385,,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.05,0.8,,2017.0,2019.0,ALL
23438,HARS2,P49590,0.705,0.462,2.7868e-05,DTO_05007624,Enzyme,C3554105,PERRAULT SYNDROME 2,,,disease,Disease or Syndrome,0.7,1.0,limited,2011.0,2020.0,ALL
23439,ATP1B4,Q9UN42,0.931,0.154,0.00035587,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,0.0,,2014.0,2014.0,ALL
23440,OTP,Q5XKR4,0.743,0.423,0.74039,,,C0007095,Carcinoid Tumor,C04,   Neoplasms,phenotype,Neoplastic Process,0.05,1.0,,2013.0,2019.0,ALL
23443,SLC35A3,Q9Y2D2,0.716,0.308,0.0026044,DTO_05007405,Transporter,C3809910,"ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES",,,disease,Disease or Syndrome,0.7,1.0,,2006.0,2013.0,ALL
23446,SLC44A1,Q8WWI5,0.695,0.346,0.99676,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2013.0,2016.0,ALL
23450,SF3B3,Q15393,0.792,0.231,1.0,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
23451,SF3B1,O75533,0.511,0.731,1.0,DTO_05007557,Nucleic acid binding,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.8,0.971,limited,2011.0,2020.0,ALL
23452,ANGPTL2,Q9UKU9,0.545,0.731,0.0014712,DTO_05007599,Signaling,C0011633,Dermatomyositis,C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.21,1.0,,2012.0,2012.0,ALL
23456,ABCB10,Q9NRK6,0.716,0.423,2.9084e-08,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2017.0,2020.0,ALL
23457,ABCB9,Q9NP78,0.805,0.231,0.00025164,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2017.0,ALL
23460,ABCA6,Q8N139,0.861,0.231,5.1099e-27,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
23461,ABCA5,Q8WWZ7,0.736,0.423,4.7803e-27,DTO_05007405,Transporter,C1851120,"Hypertrichosis Terminalis, Generalized, with or without Gingival Hyperplasia",C23;C16;C17;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
23462,HEY1,Q9Y5J3,0.551,0.692,0.050181,DTO_05007542,Transcription factor,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.33,1.0,,2009.0,2018.0,ALL
23463,ICMT,O60725,0.682,0.423,0.79377,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,0.857,,2004.0,2019.0,ALL
23464,GCAT,O75600,0.861,0.154,1.5281e-08,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
23466,CBX6,O95503,0.861,0.115,0.97568,DTO_05007378,Epigenetic regulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
23467,NPTXR,O95502,0.751,0.423,0.71597,,,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2002.0,2002.0,ALL
23468,CBX5,P45973,0.621,0.731,0.93174,DTO_05007378,Epigenetic regulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
23469,PHF3,Q92576,0.76,0.192,0.99256,DTO_05007557,Nucleic acid binding,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2015.0,ALL
23471,TRAM1,Q15629,0.608,0.654,0.92506,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.969,,2001.0,2019.0,ALL
23473,CAPN7,Q9Y6W3,1.0,0.038,1.2865e-13,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.02,1.0,,2013.0,2018.0,ALL
23474,ETHE1,O95571,0.686,0.346,4.6037e-06,DTO_05007624,Enzyme,C1865349,Ethylmalonic encephalopathy,C23;C16;C18;C10;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,1.0,1.0,,2004.0,2019.0,ALL
23475,QPRT,Q15274,0.736,0.346,0.0046997,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.2,1.0,,1989.0,1989.0,ALL
23476,BRD4,O60885,0.446,0.885,1.0,DTO_05007378,Epigenetic regulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,1.0,,2014.0,2019.0,ALL
23478,SEC11A,P67812,0.769,0.192,0.0022542,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
23479,ISCU,Q9H1K1,0.695,0.423,0.041463,,,C1850718,"MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE",C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.64,1.0,,2008.0,2018.0,ALL
23480,SEC61G,P60059,0.805,0.154,0.63104,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
23481,PES1,O00541,0.656,0.538,0.71904,DTO_05007557,Nucleic acid binding,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,2010.0,2010.0,ALL
23483,TGDS,O95455,0.644,0.538,2.4826e-09,,,C1844887,Catel Manzke syndrome,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.73,1.0,,2014.0,2020.0,ALL
23484,LEPROTL1,O95214,1.0,0.038,0.72072,DTO_05007575,Receptor,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
23491,CES3,Q6UWW8,0.821,0.269,2.3374e-12,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2006.0,2006.0,ALL
23492,CBX7,O95931,0.595,0.615,0.68534,DTO_05007378,Epigenetic regulator,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.42,1.0,,2013.0,2017.0,ALL
23493,HEY2,Q9UBP5,0.572,0.731,0.89343,DTO_05007542,Transcription factor,C1142166,Brugada Syndrome (disorder),C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.35,0.8,,2013.0,2019.0,ALL
23495,TNFRSF13B,O14836,0.558,0.769,2.0908e-15,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.7,1.0,limited,1986.0,2019.0,ALL
23498,HAAO,P46952,0.644,0.538,1.0561e-08,,,C4540004,"VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1",,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
23499,MACF1,Q9UPN3,0.659,0.538,1.0,DTO_05007530,Cellular structure,C0266463,Lissencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.41,1.0,strong,2006.0,2018.0,ALL
23500,DAAM2,Q86T65,0.711,0.538,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2009.0,ALL
23503,ZFYVE26,Q68DK2,0.636,0.615,4.6948e-23,,,C1849128,"Spastic paraplegia 15, autosomal recessive",C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.95,1.0,,2007.0,2016.0,ALL
23504,RIMBP2,O15034,0.89,0.154,0.67813,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
23505,TMEM131,Q92545,0.769,0.269,0.99995,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
23508,TTC9,Q92623,0.839,0.077,0.06817,DTO_05007624,Enzyme,C0027412,Opioid-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
23509,POFUT1,Q9H488,0.65,0.538,0.96303,,,C3714534,dowling-degos disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.66,1.0,strong,2013.0,2019.0,ALL
23510,KCTD2,Q14681,0.931,0.115,0.20119,,,C3548479,response to bronchodilator,,,phenotype,Organism Function,0.1,1.0,,2015.0,2015.0,ALL
23511,NUP188,Q5SRE5,0.931,0.115,0.95428,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
23512,SUZ12,Q15022,0.529,0.577,0.99998,DTO_05007557,Nucleic acid binding,C0206630,Endometrial Stromal Sarcoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.4,0.952,,2001.0,2019.0,ALL
23513,SCRIB,Q14160,0.691,0.423,0.92926,,,C3891448,"NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO",,,disease,Finding,0.3,1.0,,2012.0,2012.0,ALL
23514,SPIDR,Q14159,0.7,0.538,2.3847e-17,,,C0685837,"Pure Gonadal Dysgenesis, 46, XX",C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.3,1.0,,2017.0,2017.0,ALL
23515,MORC3,Q14149,0.743,0.423,0.99985,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23516,SLC39A14,Q15043,0.653,0.615,0.15001,DTO_05007405,Transporter,C4310765,Hypermanganesemia with dystonia 2,,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2018.0,ALL
23517,MTREX,P42285,0.839,0.192,0.86106,,,C0007868,Cervical dysplasia,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
23518,R3HDM1,Q15032,,,0.86068,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23519,ANP32D,O95626,0.861,0.154,,,,C0274294,Chronic mountain sickness,C23;C08,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.02,0.5,,2013.0,2014.0,ALL
23520,ANP32C,O43423,0.931,0.077,,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2001.0,2004.0,ALL
23521,RPL13A,P40429,0.769,0.231,0.83336,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
23522,KAT6B,Q8WYB5,0.525,0.731,1.0,DTO_05007624,Enzyme,C1853566,Genitopatellar Syndrome,C23;C16;C13;C05;C12;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,1.0,,2011.0,2019.0,ALL
23523,CABIN1,Q9Y6J0,0.536,0.846,3.2844e-17,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2010.0,2010.0,ALL
23524,SRRM2,Q9UQ35,0.564,0.692,1.0,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2019.0,ALL
23526,ARHGAP45,Q92619,0.805,0.308,0.22298,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,2009.0,2009.0,ALL
23527,ACAP2,Q15057,0.89,0.077,0.92325,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
23528,ZNF281,Q9Y2X9,0.674,0.346,0.99624,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
23529,CLCF1,Q9UBD9,0.67,0.462,0.94791,,,C1832409,Crisponi syndrome,C23;C16;C17;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.61,1.0,,1991.0,2010.0,ALL
23530,NNT,Q13423,0.601,0.577,0.97271,DTO_05007624,Enzyme,C3553587,GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2017.0,ALL
23531,MMD,Q15546,0.647,0.577,0.0001344,DTO_05007575,Receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,0.8,,2011.0,2019.0,ALL
23532,PRAME,P78395,0.531,0.577,2.394e-07,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,1998.0,2018.0,ALL
23533,PIK3R5,Q8WYR1,0.7,0.5,0.30013,,,C3554690,ATAXIA-OCULOMOTOR APRAXIA 3,,,disease,Disease or Syndrome,0.7,1.0,limited,2012.0,2012.0,ALL
23534,TNPO3,Q9Y5L0,0.663,0.577,1.7546e-06,DTO_05007405,Transporter,C1842062,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2019.0,ALL
23539,SLC16A8,O95907,0.76,0.231,0.0089726,DTO_05007405,Transporter,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.42,1.0,,2013.0,2018.0,ALL
23541,SEC14L2,O76054,0.494,0.885,2.9195e-08,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1984.0,2009.0,ALL
23542,MAPK8IP2,Q13387,0.628,0.654,0.99997,DTO_05007599,Signaling,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
23543,RBFOX2,O43251,0.59,0.846,0.99902,DTO_05007557,Nucleic acid binding,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
23544,SEZ6L,Q9BYH1,0.769,0.346,0.50741,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
23545,ATP6V0A2,Q9Y487,0.57,0.692,2.6314e-11,DTO_05007405,Transporter,C0406587,Wrinkly skin syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.73,1.0,,2008.0,2016.0,ALL
23547,LILRA4,P59901,0.931,0.192,6.8978e-16,DTO_05007575,Receptor,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2008.0,2008.0,ALL
23548,TTC33,Q6PID6,0.931,0.115,0.00056941,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2019.0,ALL
23549,DNPEP,Q9ULA0,0.821,0.154,3.1627e-08,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
23550,PSD4,Q8NDX1,0.691,0.462,0.42272,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
23551,RASD2,Q96D21,0.76,0.308,0.53733,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2008.0,2016.0,ALL
23552,CDK20,Q8IZL9,0.682,0.462,5.9487e-14,DTO_03300101,Kinase,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
23553,HYAL4,Q2M3T9,0.861,0.115,3.0998e-17,DTO_05007624,Enzyme,C0949541,Hurthle Cell Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
23554,TSPAN12,O95859,0.656,0.5,0.69473,,,C2750079,Exudative Vitreoretinopathy 5,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2010.0,2012.0,ALL
23555,TSPAN15,O95858,0.78,0.346,0.0079572,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.12,0.833,,2015.0,2020.0,ALL
23556,PIGN,O95427,0.558,0.615,2.29e-21,DTO_05007621,Extracellular structure,C3279775,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1,,,disease,Disease or Syndrome,0.74,1.0,,2011.0,2018.0,ALL
23557,SNAPIN,O95295,0.931,0.192,0.0015332,,,C4021085,Abnormality of brain morphology,,,phenotype,Anatomical Abnormality,0.1,,,,,ALL
23558,WBP2,Q969T9,0.722,0.269,0.34916,,,C4539964,"DEAFNESS, AUTOSOMAL RECESSIVE 107",,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2016.0,ALL
23560,GTPBP4,Q9BZE4,0.769,0.346,1.0,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0,,2001.0,2016.0,ALL
23562,CLDN14,O95500,0.705,0.462,0.00011061,DTO_05007527,Cell-cell junction,C3279660,"DEAFNESS, AUTOSOMAL RECESSIVE 29",,,disease,Disease or Syndrome,0.9,1.0,strong,2001.0,2017.0,ALL
23563,CHST5,Q9GZS9,,,0.00022148,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
23564,DDAH2,O95865,0.67,0.538,0.013773,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.33,1.0,,2007.0,2019.0,ALL
23566,LPAR3,Q9UBY5,0.509,0.923,0.67935,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
23567,ZNF346,Q9UL40,0.861,0.077,0.11649,,,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2018.0,2019.0,ALL
23568,ARL2BP,Q9Y2Y0,0.647,0.654,3.3482e-05,,,C4747737,RETINITIS PIGMENTOSA 82 WITH OR WITHOUT SITUS INVERSUS,,,disease,Disease or Syndrome,0.9,1.0,limited,2013.0,2018.0,ALL
23569,PADI4,Q9UM07,0.494,0.808,4.6001e-16,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,0.912,,2003.0,2020.0,ALL
23574,PRG1,,0.839,0.231,,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0,,2016.0,2018.0,ALL
23576,DDAH1,O94760,0.604,0.615,0.0027974,DTO_05007624,Enzyme,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
23580,CDC42EP4,Q9H3Q1,0.861,0.192,0.21207,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
23581,CASP14,P31944,0.663,0.462,2.8684e-06,DTO_05007624,Enzyme,C4310621,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12",,,disease,Disease or Syndrome,0.5,,strong,,,ALL
23582,CCNDBP1,O95273,0.729,0.385,0.00030213,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2006.0,2006.0,ALL
23583,SMUG1,Q53HV7,0.322,0.923,0.00045154,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2020.0,ALL
23584,VSIG2,Q96IQ7,1.0,0.038,0.00012031,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
23585,TMEM50A,O95807,,,0.16293,,,C0005833,Blood Sedimentation,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
23586,DDX58,O95786,0.526,0.808,1.7558e-23,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.42,1.0,,2012.0,2016.0,ALL
23587,ELP5,Q8TE02,0.78,0.115,2.078e-13,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
23588,KLHDC2,Q9Y2U9,0.76,0.231,0.026499,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2012.0,2019.0,ALL
23589,CARHSP1,Q9Y2V2,0.89,0.077,5.0284e-05,DTO_05007557,Nucleic acid binding,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
23590,PDSS1,Q5T2R2,0.628,0.615,3.2449e-08,,,C3553354,"COENZYME Q10 DEFICIENCY, PRIMARY, 2",,,disease,Disease or Syndrome,0.7,1.0,,2007.0,2016.0,ALL
23591,FAM215A,Q9Y5M1,0.65,0.5,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2016.0,2018.0,ALL
23592,LEMD3,Q9Y2U8,0.582,0.731,0.99877,,,C0265514,Dermatofibrosis lenticularis disseminata,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,0.917,,1997.0,2019.0,ALL
23593,HEBP2,Q9Y5Z4,0.861,0.115,6.0829e-05,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
23594,ORC6,Q9Y5N6,0.628,0.577,3.3618e-07,DTO_05007557,Nucleic acid binding,C3151113,MEIER-GORLIN SYNDROME 3,,,disease,Disease or Syndrome,0.6,1.0,,1994.0,2015.0,ALL
23595,ORC3,Q9UBD5,0.931,0.231,1.617e-09,DTO_05007557,Nucleic acid binding,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.01,1.0,,2013.0,2013.0,ALL
23596,OPN3,Q9H1Y3,0.769,0.231,0.0012801,DTO_02300001,G-protein coupled receptor,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
23597,ACOT9,Q9Y305,0.931,0.154,6.8017e-09,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
23598,PATZ1,Q9HBE1,0.647,0.423,0.99598,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23600,AMACR,Q9UHK6,0.51,0.769,0.027363,,,C3280428,Alpha-Methylacyl-CoA Racemase Deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,strong,2000.0,2016.0,ALL
23601,CLEC5A,Q9NY25,0.663,0.346,0.12568,,,C0019100,Severe Dengue,C01,   Infections,disease,Disease or Syndrome,0.33,1.0,,2008.0,2017.0,ALL
23603,CORO1C,Q9ULV4,0.663,0.423,0.99813,DTO_05007530,Cellular structure,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
23604,DAPK2,Q9UIK4,0.536,0.692,5.0088e-10,DTO_03300101,Kinase,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2014.0,2017.0,ALL
23607,CD2AP,Q9Y5K6,0.558,0.731,0.22989,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.5,1.0,,2011.0,2019.0,ALL
23608,MKRN1,Q9UHC7,0.805,0.269,0.99421,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23609,MKRN2,Q9H000,0.89,0.077,0.0088248,DTO_05007624,Enzyme,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
23612,PHLDA3,Q9Y5J5,0.805,0.192,0.25036,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
23613,ZMYND8,Q9ULU4,0.78,0.308,1.0,,,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
23616,SH3BP1,Q9Y3L3,0.839,0.154,0.010463,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
23617,TSSK2,Q96PF2,0.839,0.115,0.003861,DTO_03300101,Kinase,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0,,2005.0,2016.0,ALL
23619,ZIM2,Q9NZV7,0.89,0.077,0.001811,DTO_05007542,Transcription factor,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
23620,NTSR2,O95665,0.821,0.269,0.0048692,DTO_02300001,G-protein coupled receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,0.0,,2010.0,2010.0,ALL
23621,BACE1,P56817,0.559,0.769,0.87888,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.6,0.985,,1999.0,2020.0,ALL
23623,RUSC1,Q9BVN2,0.89,0.115,0.9413,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
23624,CBLC,Q9ULV8,0.821,0.192,4.2394e-11,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
23626,SPO11,Q9Y5K1,0.821,0.192,1.4473e-08,DTO_05007557,Nucleic acid binding,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.03,1.0,,2011.0,2017.0,ALL
23627,PRND,Q9UKY0,0.751,0.192,0.012539,,,C0022107,Irritable Mood,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.3,1.0,,2012.0,2012.0,ALL
23629,BRD7P3,,,,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
23630,KCNE5,Q9UJ90,0.666,0.5,0.11854,,,C1142166,Brugada Syndrome (disorder),C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.62,1.0,disputed,1999.0,2019.0,ALL
23632,CA14,Q9ULX7,0.805,0.308,5.9231e-16,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2016.0,ALL
23633,KPNA6,O60684,0.821,0.154,0.9994,DTO_05007405,Transporter,C2062441,Influenza A,,,disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
23635,SSBP2,P81877,0.659,0.269,0.99777,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2019.0,2019.0,ALL
23636,NUP62,P37198,0.47,0.885,0.95006,DTO_05007405,Transporter,C0795996,"STRIATONIGRAL DEGENERATION, INFANTILE (disorder)",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.71,1.0,,2002.0,2016.0,ALL
23637,RABGAP1,Q9Y3P9,,,1.0,DTO_05007624,Enzyme,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2016.0,2016.0,ALL
23639,LRRC6,Q86X45,0.659,0.538,1.0409e-10,,,C3543826,"CILIARY DYSKINESIA, PRIMARY, 19",,,disease,Disease or Syndrome,0.9,1.0,,2012.0,2016.0,ALL
23640,HSPBP1,Q9NZL4,0.861,0.269,0.057208,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2007.0,2009.0,ALL
23641,LDOC1,O95751,0.678,0.385,0.52431,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2013.0,2017.0,ALL
23642,SNHG1,,0.576,0.692,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2019.0,ALL
23643,LY96,Q9Y6Y9,0.636,0.615,7.4167e-05,DTO_05007575,Receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
23644,EDC4,Q6P2E9,0.89,0.115,0.1061,DTO_05007608,Immune response,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
23645,PPP1R15A,O75807,0.608,0.692,2.206e-12,,,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2005.0,2005.0,ALL
23646,PLD3,Q8IV08,0.7,0.462,1.754e-05,,,C4540404,SPINOCEREBELLAR ATAXIA 46,,,disease,Disease or Syndrome,0.3,1.0,,2017.0,2018.0,ALL
23647,ARFIP2,P53365,0.861,0.231,0.77422,DTO_05007584,Enzyme modulator,C0020615,Hypoglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0,,2014.0,2018.0,ALL
23648,SSBP3,Q9BWW4,,,0.99968,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2019.0,ALL
23649,POLA2,Q14181,0.861,0.077,8.7346e-07,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
23650,TRIM29,Q14134,0.606,0.654,8.1158e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2006.0,2016.0,ALL
23654,PLXNB2,O15031,0.78,0.385,0.99234,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
23657,SLC7A11,Q9UPY5,0.603,0.692,5.6817e-05,DTO_05007405,Transporter,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.31,1.0,,2009.0,2018.0,ALL
23658,LSM5,Q9Y4Y9,0.861,0.154,0.026283,DTO_05007557,Nucleic acid binding,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
23659,PLA2G15,Q8NCC3,0.52,0.769,0.37838,DTO_05007624,Enzyme,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.1,0.9,,2008.0,2019.0,ALL
23660,ZKSCAN5,Q9Y2L8,1.0,0.077,0.087589,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
23666,UBBP4,,1.0,0.038,3.623e-06,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2015.0,ALL
23670,CEMIP2,Q9UHN6,0.861,0.231,4.6831e-13,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
23671,TMEFF2,Q9UIK5,0.619,0.5,7.3885e-05,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.39,1.0,,2001.0,2019.0,ALL
23673,STX12,Q86Y82,0.839,0.115,0.95624,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
23676,SMPX,Q9UHP9,0.682,0.5,0.62317,,,C1848204,"DEAFNESS, X-LINKED 4 (disorder)",C23;C16;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.61,1.0,strong,1996.0,2011.0,ALL
23677,SH3BP4,Q9P0V3,0.593,0.692,0.0025338,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2000.0,2019.0,ALL
23678,SGK3,Q96BR1,0.674,0.654,8.5621e-07,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,1.0,,2011.0,2019.0,ALL
23682,RAB38,P57729,0.691,0.5,0.0019671,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
23683,PRKD3,O94806,0.76,0.154,0.0052882,DTO_03300101,Kinase,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
23691,NNO1,,1.0,0.077,,,,C0026010,Microphthalmos,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.02,1.0,,2009.0,2019.0,ALL
23694,MRX73,,1.0,0.077,,,,C1136249,"Mental Retardation, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
23704,KCNE4,Q8WWG9,0.89,0.231,0.24409,DTO_01300327,Ion channel,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
23705,CADM1,Q9BY67,0.491,0.769,0.66216,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.38,0.75,,2002.0,2019.0,ALL
23706,IBGC1,,0.861,0.154,,,,C0393590,Fahr's syndrome (disorder),C18;C10;C14,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0,,2002.0,2015.0,ALL
23708,GSPT2,Q8IYD1,0.821,0.154,0.98321,DTO_05007624,Enzyme,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,,,,,ALL
23710,GABARAPL1,Q9H0R8,0.691,0.5,0.83532,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.05,1.0,,2010.0,2017.0,ALL
23713,DFNB27,,0.931,0.115,,,,C1852271,Auditory neuropathy,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,0.0,,2007.0,2007.0,ALL
23719,DFNA30,,1.0,0.115,,,,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
23723,DFNA24,,0.931,0.115,,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,0.0,,2000.0,2000.0,ALL
23729,SHPK,Q9UHJ6,0.743,0.346,1.0103e-16,DTO_03300101,Kinase,C1291373,Deficiency of sedoheptulokinase,,,disease,Disease or Syndrome,0.6,1.0,limited,2015.0,2016.0,ALL
23731,TMEM245,Q9H330,0.839,0.192,3.6257e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2013.0,2013.0,ALL
23732,FRRS1L,Q9P0K9,0.666,0.231,0.0014611,,,C4310770,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37",,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2019.0,ALL
23739,C3CER1,,0.839,0.231,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2001.0,2002.0,ALL
23741,EID1,Q9Y6B2,0.792,0.346,0.42748,,,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
23742,NPAP1,Q9NZP6,0.67,0.5,,DTO_05007557,Nucleic acid binding,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.35,0.8,,2000.0,2014.0,ALL
23743,BHMT2,Q9H2M3,0.792,0.231,1.9621e-15,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.3,1.0,,2011.0,2011.0,ALL
23746,AIPL1,Q9NZN9,0.644,0.346,1.222e-05,DTO_05007613,Chaperone,C1858386,Leber Congenital Amaurosis 4,C11,   Eye Diseases,disease,Disease or Syndrome,0.93,1.0,,2000.0,2017.0,ALL
23751,TOP3BP1,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
23752,TSSK1A,,,,,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
23753,SDF2L1,Q9HCN8,0.805,0.385,0.18957,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
23759,PPIL2,Q13356,0.792,0.308,0.00082347,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,0.5,,2008.0,2009.0,ALL
23760,PITPNB,P48739,0.931,0.077,0.981,DTO_05007405,Transporter,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
23761,PISD,Q9UG56,0.821,0.308,0.2217,,,C0011053,Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Finding,0.3,1.0,,2019.0,2019.0,ALL
23762,OSBP2,Q969R2,0.78,0.346,0.00043434,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
23764,MAFF,Q9ULX9,0.751,0.346,0.015514,DTO_05007542,Transcription factor,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
23765,IL17RA,Q96F46,0.529,0.808,0.00035636,,,C4310803,IMMUNODEFICIENCY 51,,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2016.0,ALL
23767,FLRT3,Q9NZU0,0.659,0.615,0.22014,,,C3808986,HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.7,1.0,limited,2011.0,2013.0,ALL
23768,FLRT2,O43155,0.821,0.231,0.81715,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
23769,FLRT1,Q9NZU1,0.78,0.231,0.35651,,,C1836010,"Spastic Paraplegia, Optic Atrophy, and Neuropathy",C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
23770,FKBP8,Q14318,0.839,0.231,0.99825,,,C0009081,Congenital clubfoot,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.2,1.0,,2008.0,2008.0,ALL
23771,DIANPH,,0.678,0.5,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,1997.0,2020.0,ALL
23774,BRD1,O95696,0.644,0.654,0.99949,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,0.8,,2006.0,2019.0,ALL
23779,ARHGAP8,P85298,0.839,0.192,8.5171e-28,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2018.0,ALL
23780,APOL2,Q9BQE5,0.722,0.308,0.0073139,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2013.0,2013.0,ALL
23784,POTEH,Q6S545,1.0,0.038,5.1283e-11,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
23786,BCL2L13,Q9BXK5,0.78,0.308,0.0024411,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
23788,MTCH2,Q9Y6C9,0.821,0.269,0.031932,DTO_05007405,Transporter,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.37,0.875,,2009.0,2017.0,ALL
24137,KIF4A,O95239,0.647,0.462,0.99998,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.41,1.0,limited,2014.0,2014.0,ALL
24138,IFIT5,Q13325,0.751,0.385,0.00011794,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.31,1.0,,2013.0,2018.0,ALL
24139,EML2,O95834,0.821,0.192,5.7633e-19,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
24140,FTSJ1,Q9UET6,0.659,0.577,0.99254,,,C0796215,"Mental Retardation, X-Linked 9",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,strong,2004.0,2004.0,ALL
24141,LAMP5,Q9UJQ1,0.861,0.077,2.6473e-09,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
24142,NAA80,Q93015,0.89,0.115,0.16865,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
24144,TFIP11,Q9UBB9,0.644,0.538,1.6636e-12,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,0.667,,2000.0,2019.0,ALL
24145,PANX1,Q96RD7,0.575,0.846,2.4684e-06,DTO_01300327,Ion channel,C0001364,Massive Hepatic Necrosis,C06,   Digestive System Diseases,phenotype,Pathologic Function,0.3,1.0,,2018.0,2018.0,ALL
24146,CLDN15,P56746,0.769,0.269,0.023349,DTO_05007527,Cell-cell junction,C0812413,Malignant Pleural Mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2017.0,ALL
24147,FJX1,Q86VR8,0.705,0.462,0.94412,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
24148,PRPF6,O94906,0.621,0.538,0.0032101,DTO_05007557,Nucleic acid binding,C3151434,RETINITIS PIGMENTOSA 60,,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2011.0,ALL
24149,ZNF318,Q5VUA4,0.792,0.269,0.37383,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
24150,TP53TG3,Q9ULZ0,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1999.0,1999.0,ALL
25758,KIAA1549L,Q6ZVL6,0.861,0.115,1.2946e-07,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
25759,SHC2,P98077,0.729,0.385,2.1349e-14,DTO_05007599,Signaling,C0454651,Specific language impairment,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.05,1.0,,2003.0,2017.0,ALL
25763,H2AP,O75409,,,,DTO_05007557,Nucleic acid binding,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
25764,HYPK,Q9NX55,1.0,0.115,0.036644,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.03,1.0,,2008.0,2017.0,ALL
25766,PRPF40B,Q6NWY9,0.821,0.269,0.99963,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
25769,SLC24A2,Q9UI40,0.821,0.269,0.0057133,DTO_05007405,Transporter,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
25770,C22orf31,O95567,,,1.7066e-07,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
25771,TBC1D22A,Q8WUA7,0.89,0.115,0.41937,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
25776,CBY1,Q9Y3M2,0.769,0.192,0.0012587,,,C0008780,Ciliary Motility Disorders,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",group,Disease or Syndrome,0.2,,,,,ALL
25777,SUN2,Q9UH99,0.691,0.423,1.9389e-08,DTO_05007530,Cellular structure,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.12,1.0,,2017.0,2019.0,ALL
25778,DSTYK,Q6XUX3,0.7,0.462,0.51262,DTO_03300101,Kinase,C1835826,"Renal Hypodysplasia, Nonsyndromic, 1",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Congenital Abnormality,0.7,1.0,,2013.0,2017.0,ALL
25780,RASGRP3,Q8IV61,0.686,0.5,0.0091132,DTO_05007584,Enzyme modulator,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.41,1.0,,2009.0,2017.0,ALL
25782,RAB3GAP2,Q9H2M9,0.584,0.769,0.98674,DTO_05007584,Enzyme modulator,C0796037,Martsolf syndrome,C23;C11;C10;C19;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.74,1.0,strong,2006.0,2018.0,ALL
25787,DGCR9,,,,,,,C0201874,Amino acids measurement,,,group,Laboratory Procedure,0.1,1.0,,2015.0,2015.0,ALL
25788,RAD54B,O95073;Q9Y620,0.659,0.462,8.1173e-13,,,C0024305,"Lymphoma, Non-Hodgkin",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.6,,,,,ALL
25789,TMEM59L,Q9UK28,0.861,0.192,0.0006,,,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
25790,CFAP45,Q9UL16,0.821,0.269,5.5417e-14,,,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
25791,NGEF,Q8N5V2,0.861,0.192,0.66039,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
25792,CIZ1,Q9ULV3,0.617,0.5,0.063172,,,C3538999,DYSTONIA 23,,,disease,Disease or Syndrome,0.5,1.0,moderate,2012.0,2012.0,ALL
25793,FBXO7,Q9Y3I1,0.65,0.769,5.7858e-07,,,C1850100,"PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE (disorder)",C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.77,1.0,,2008.0,2019.0,ALL
25794,FSCN2,O14926,0.682,0.346,3.8311e-13,DTO_05007530,Cellular structure,C1842816,RETINITIS PIGMENTOSA 30,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2005.0,2005.0,ALL
25796,PGLS,O95336,0.769,0.269,0.00075276,DTO_05007624,Enzyme,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
25797,QPCT,Q16769,0.568,0.731,1.1987e-15,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,1.0,,2013.0,2016.0,ALL
25798,BRI3,O95415,0.792,0.192,0.033766,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
25800,SLC39A6,Q13433,0.656,0.462,4.9368e-07,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2003.0,2018.0,ALL
25801,GCA,P28676,0.59,0.731,0.00013787,,,C0039483,Giant Cell Arteritis,C17;C20;C10;C14,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.08,0.75,,2013.0,2019.0,ALL
25802,LMOD1,P29536,0.644,0.654,0.87057,DTO_05007530,Cellular structure,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.41,1.0,,2017.0,2018.0,ALL
25803,SPDEF,O95238,0.623,0.615,0.97178,DTO_05007542,Transcription factor,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.32,1.0,,2007.0,2008.0,ALL
25804,LSM4,Q9Y4Z0,0.931,0.038,0.022117,DTO_05007557,Nucleic acid binding,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
25805,BAMBI,Q13145,0.619,0.692,0.00021381,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.33,1.0,,2011.0,2018.0,ALL
25806,VAX2,Q9UIW0,0.769,0.308,0.15981,DTO_05007542,Transcription factor,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0,,1995.0,2017.0,ALL
25807,RHBDD3,Q9Y3P4,0.861,0.192,4.9464e-05,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
25809,TTLL1,O95922,0.805,0.154,5.9095e-06,DTO_05007624,Enzyme,C0008780,Ciliary Motility Disorders,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",group,Disease or Syndrome,0.2,,,,,ALL
25813,SAMM50,Q9Y512,0.78,0.269,4.8795e-09,,,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.13,1.0,,2012.0,2018.0,ALL
25814,ATXN10,Q9UBB4,0.65,0.385,0.00034514,,,C1963674,Spinocerebellar Ataxia 10,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2000.0,2019.0,ALL
25816,TNFAIP8,O95379,0.601,0.5,0.38452,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.36,0.833,,1997.0,2018.0,ALL
25817,TAFA5,Q7Z5A7,0.792,0.308,0.44685,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
25818,KLK5,Q9Y337,0.623,0.462,0.0070149,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.35,1.0,,2002.0,2010.0,ALL
25819,NOCT,Q9UK39,0.691,0.462,0.042105,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
25820,ARIH1,Q9Y4X5,0.644,0.692,0.99997,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
25821,MTO1,Q9Y2Z2,0.67,0.462,7.38e-06,,,C3553529,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10,,,disease,Disease or Syndrome,0.71,1.0,strong,2012.0,2018.0,ALL
25822,DNAJB5,O75953,0.931,0.115,0.20629,,,C0031117,Peripheral Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
25823,TPSG1,Q9NRR2,0.638,0.5,7.5883e-15,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
25824,PRDX5,P30044,0.522,0.808,0.00017921,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2012.0,2017.0,ALL
25825,BACE2,Q9Y5Z0,0.628,0.615,0.0067632,DTO_05007624,Enzyme,C3888239,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1",,,disease,Finding,0.3,,limited,,,ALL
25827,FBXL2,Q9UKC9,0.751,0.269,0.0075282,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
25828,TXN2,Q99757,0.628,0.615,2.5584e-05,DTO_05007624,Enzyme,C4225200,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29,,,disease,Disease or Syndrome,0.5,1.0,,2016.0,2016.0,ALL
25829,TMEM184B,Q9Y519,1.0,0.077,0.37295,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
25830,SULT4A1,Q9BR01,0.7,0.346,0.96563,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,0.75,,2005.0,2014.0,ALL
25831,HECTD1,Q9ULT8,0.751,0.385,1.0,,,C0037116,Silicosis,C08;C24,   Respiratory Tract Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.03,1.0,,2018.0,2019.0,ALL
25832,NBPF14,Q5TI25,0.89,0.077,3.0119e-36,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0,,2005.0,2017.0,ALL
25833,POU2F3,Q9UKI9,0.626,0.731,1.0299e-06,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,0.7,,1997.0,2014.0,ALL
25834,MGAT4C,Q9UBM8,0.839,0.192,0.00066172,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
25836,NIPBL,Q6KC79,0.521,0.808,1.0,DTO_05007557,Nucleic acid binding,C0270972,Cornelia De Lange Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.988,definitive,1999.0,2019.0,ALL
25837,RAB26,Q9ULW5,0.861,0.077,1.6979e-08,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
25839,COG4,Q9H9E3,0.631,0.615,3.9748e-09,,,C1300285,SAUL-WILSON SYNDROME,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,strong,2018.0,2018.0,ALL
25840,METTL7A,Q9H8H3,0.839,0.115,0.0004753,DTO_05007624,Enzyme,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
25841,ABTB2,Q8N961,0.931,0.038,0.0046627,DTO_05007599,Signaling,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
25842,ASF1A,Q9Y294,0.67,0.615,0.80542,DTO_05007557,Nucleic acid binding,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2018.0,ALL
25843,MOB4,Q9Y3A3,0.751,0.346,0.93103,DTO_05007584,Enzyme modulator,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
25844,YIPF3,Q9GZM5,0.821,0.115,0.14123,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
25847,ANAPC13,Q9BS18,1.0,0.038,0.0013703,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2017.0,2017.0,ALL
25849,PARM1,Q6UWI2,0.769,0.269,0.000869,,,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
25851,TECPR1,Q7Z6L1,,,2.7083e-07,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
25852,ARMC8,Q8IUR7,0.716,0.346,0.99999,,,C0152427,Polydactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.3,,limited,,,ALL
25853,DCAF12,Q5T6F0,0.78,0.192,2.187e-06,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
25854,FAM149A,A5PLN7,0.931,0.154,1.361e-05,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
25855,BRMS1,Q9HCU9,0.597,0.615,1.579e-07,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2000.0,2019.0,ALL
25858,CATSPERZ,Q9NTU4,0.861,0.115,0.020057,,,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2011.0,2014.0,ALL
25859,PART1,,0.483,0.885,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
25861,WHRN,Q9P202,0.67,0.385,7.6538e-05,DTO_05007530,Cellular structure,C1568249,"Usher Syndrome, Type II",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.94,1.0,definitive,2003.0,2017.0,ALL
25862,USP49,Q70CQ1,0.861,0.192,0.93828,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
25865,PRKD2,Q9BZL6,0.666,0.538,0.99995,DTO_03300101,Kinase,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.41,1.0,,2008.0,2008.0,ALL
25870,SUMF2,Q8NBJ7,0.623,0.769,9.9738e-09,,,C0201874,Amino acids measurement,,,group,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
25871,NEPRO,Q6NW34,1.0,0.038,2.0063e-08,,,C0029422,Osteochondrodysplasias,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Disease or Syndrome,0.01,0.0,,2018.0,2018.0,ALL
25873,RPL36,Q9Y3U8,0.839,0.231,0.67802,DTO_05007557,Nucleic acid binding,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.3,1.0,strong,2017.0,2017.0,ALL
25874,MPC2,O95563,0.743,0.308,0.63515,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.44,0.8,,2011.0,2018.0,ALL
25875,LETMD1,Q6P1Q0,0.682,0.308,0.048505,DTO_05007405,Transporter,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.07,1.0,,2003.0,2014.0,ALL
25878,MXRA5,Q9NR99,0.839,0.192,0.043013,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.32,1.0,,2012.0,2015.0,ALL
25879,DCAF13,Q9NV06,0.821,0.192,8.943e-10,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
25880,TMEM186,Q96B77,1.0,0.077,5.1994e-05,,,C0151889,Hyperreflexia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,1.0,,2010.0,2010.0,ALL
25884,CHRDL2,Q6WN34,0.729,0.308,1.595e-06,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.11,1.0,,2017.0,2019.0,ALL
25885,POLR1A,O95602,0.682,0.538,0.9998,DTO_05007624,Enzyme,C4225317,"ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE",,,disease,Disease or Syndrome,0.71,1.0,,2014.0,2018.0,ALL
25886,POC1A,Q8NBT0,0.65,0.5,3.2977e-06,,,C3542022,"SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME",C16;C17;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.76,1.0,,2012.0,2020.0,ALL
25890,ABI3BP,Q7Z7G0,0.686,0.385,1.0074e-08,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
25891,PAMR1,Q6UXH9,0.76,0.538,6.2624e-32,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
25893,TRIM58,Q8NG06,0.769,0.115,1.345e-10,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2019.0,ALL
25894,PLEKHG4,Q58EX7,0.769,0.154,1.0982e-16,,,C0752122,Spinocerebellar Ataxia Type 4,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2008.0,2011.0,ALL
25895,EEF1AKMT3,Q96AZ1,1.0,0.077,0.00031059,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
25896,INTS7,Q9NVH2,0.89,0.115,1.2557e-05,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2012.0,ALL
25897,RNF19A,Q9NV58,0.397,0.923,0.025305,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2000.0,2020.0,ALL
25898,RCHY1,Q96PM5,0.716,0.462,0.066203,DTO_05007624,Enzyme,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
25900,IFFO1,Q0D2I5,0.89,0.115,0.00013393,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
25901,CCDC28A,Q8IWP9,0.78,0.154,3.6463e-10,DTO_05007575,Receptor,C0023462,Acute Megakaryocytic Leukemias,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
25902,MTHFD1L,Q6UB35,0.674,0.538,1.9355e-12,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2004.0,2019.0,ALL
25903,OLFML2B,Q68BL8,0.861,0.115,3.6491e-15,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
25906,ANAPC15,P60006,1.0,0.115,0.29581,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.1,,,,,ALL
25907,TMEM158,Q8WZ71,0.736,0.385,0.14862,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2006.0,2020.0,ALL
25911,DPCD,Q9BVM2,0.89,0.192,0.00028791,,,C0008780,Ciliary Motility Disorders,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",group,Disease or Syndrome,0.2,,,,,ALL
25912,C1orf43,Q9BWL3,1.0,0.077,0.0018462,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
25913,POT1,Q9NUX5,0.56,0.731,0.85343,DTO_05007557,Nucleic acid binding,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.64,1.0,,2013.0,2018.0,ALL
25914,RTTN,Q86VV8,0.619,0.654,8.9747e-34,,,C3553831,"MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2018.0,ALL
25915,NDUFAF3,Q9BU61,0.65,0.577,0.0052693,,,C4748790,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18",,,disease,Disease or Syndrome,0.6,1.0,strong,2009.0,2017.0,ALL
25917,THUMPD3,Q9BV44,,,8.1727e-14,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
25920,NELFB,Q8WX92,0.821,0.154,0.0033903,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2004.0,2018.0,ALL
25921,ZDHHC5,Q9C0B5,0.805,0.192,0.99999,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
25923,ATL3,Q6DD88,0.736,0.462,1.3349e-09,DTO_05007584,Enzyme modulator,C3810194,"NEUROPATHY, HEREDITARY SENSORY, TYPE IF",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
25924,MYRIP,Q8NFW9,0.805,0.154,7.2179e-06,DTO_05007530,Cellular structure,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
25925,ZNF521,Q96K83,0.7,0.385,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,1.0,,2014.0,2014.0,ALL
25926,NOL11,Q9H8H0,0.78,0.231,7.9154e-07,,,C0020608,Hypodontia,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2018.0,2018.0,ALL
25927,CNRIP1,Q96F85,0.861,0.192,0.15874,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2017.0,ALL
25928,SOSTDC1,Q6X4U4,0.588,0.808,0.16334,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2009.0,2019.0,ALL
25929,GEMIN5,Q8TEQ6,0.931,0.077,1.244e-21,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
25930,PTPN23,Q9H3S7,0.743,0.308,0.031312,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,1.0,strong,2015.0,2015.0,ALL
25932,CLIC4,Q9Y696,0.628,0.423,0.0010866,DTO_01300327,Ion channel,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
25934,NIPSNAP3A,Q9UFN0,0.931,0.077,2.2722e-12,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
25936,NSL1,Q96IY1,,,0.0039309,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
25937,WWTR1,Q9GZV5,0.529,0.615,0.93914,DTO_05007584,Enzyme modulator,C0206732,Epithelioid hemangioendothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2011.0,2019.0,ALL
25938,HEATR5A,Q86XA9,,,0.054671,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
25939,SAMHD1,Q9Y3Z3,0.547,0.769,6.4524e-13,,,C0393591,AICARDI-GOUTIERES SYNDROME,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.978,strong,2009.0,2019.0,ALL
25940,FAM98A,Q8NCA5,0.805,0.231,0.54728,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
25941,TPGS2,Q68CL5,0.931,0.115,0.00014656,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0,,1999.0,2004.0,ALL
25942,SIN3A,Q96ST3,0.551,0.692,1.0,DTO_05007624,Enzyme,C4310804,WITTEVEEN-KOLK SYNDROME,,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2019.0,ALL
25943,C20orf194,Q5TEA3,0.861,0.192,1.1351e-12,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
25945,NECTIN3,Q9NQS3,0.729,0.5,0.91574,,,C0403824,Teratozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
25946,ZNF385A,Q96PM9,,,0.2798,,,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
25948,KBTBD2,Q8IY47,,,0.99795,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
25949,SYF2,O95926,0.7,0.5,0.0056136,,,C0014038,Encephalitis,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0,,2014.0,2014.0,ALL
25950,RWDD3,Q9Y3V2,0.751,0.269,0.0014761,,,C3828530,Platelet Component Distribution Width Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
25953,PNKD,Q8N490,0.615,0.615,4.1392e-08,,,C4551506,Paroxysmal Nonkinesigenic Dyskinesia 1,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.923,,1997.0,2018.0,ALL
25957,PNISR,Q8TF01,1.0,0.038,0.99998,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
25959,KANK2,Q63ZY3,0.638,0.615,0.044954,,,C4015202,PALMOPLANTAR KERATODERMA AND WOOLLY HAIR,,,disease,Disease or Syndrome,0.7,1.0,limited,2014.0,2014.0,ALL
25960,ADGRA2,Q96PE1,0.743,0.308,5.4955e-08,DTO_02300001,G-protein coupled receptor,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2009.0,2009.0,ALL
25961,NUDT13,Q86X67,0.931,0.077,6.6163e-12,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
25962,VIRMA,Q69YN4,0.821,0.231,0.99438,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2017.0,2017.0,ALL
25963,TMEM87A,Q8NBN3,,,0.081488,,,C0337428,Fibrinogen assay,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
25966,C2CD2,Q9Y426,1.0,0.038,9.0642e-06,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
25970,SH2B1,Q9NRF2,0.566,0.731,0.96861,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,0.906,moderate,2009.0,2020.0,ALL
25972,UNC50,Q53HI1,0.861,0.231,0.00019753,,,C4317009,Diverticular Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
25973,PARS2,Q7L3T8,0.644,0.423,0.0041217,DTO_05007624,Enzyme,C0205710,Alpers Syndrome (disorder),C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.32,1.0,strong,2017.0,2018.0,ALL
25974,MMACHC,Q9Y4U1,0.644,0.615,1.1402e-13,,,C1848561,Methylmalonic acidemia with homocystinuria,C16;C18;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.95,1.0,definitive,2001.0,2019.0,ALL
25975,EGFL6,Q8IUX8,0.729,0.385,9.9818e-13,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
25976,TIPARP,Q7Z3E1,0.711,0.346,0.99991,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.4,1.0,,2010.0,2013.0,ALL
25977,NECAP1,Q8NC96,0.691,0.346,0.12559,,,C4014430,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21",,,disease,Disease or Syndrome,0.6,1.0,moderate,2019.0,2019.0,ALL
25978,CHMP2B,Q9UQN3,0.543,0.731,4.6203e-06,,,C1833296,"FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED",C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.77,0.9,,1999.0,2017.0,ALL
25979,DHRS7B,Q6IAN0,,,6.7664e-09,,,C0428568,Fasting blood glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
25980,AAR2,Q9Y312,0.839,0.192,8.3057e-06,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
25981,DNAH1,Q9P2D7,0.656,0.615,1.4983e-26,DTO_05007624,Enzyme,C4539783,SPERMATOGENIC FAILURE 18,,,disease,Disease or Syndrome,0.6,1.0,limited,2001.0,2018.0,ALL
25983,NGDN,Q8NEJ9,0.736,0.385,2.0427e-08,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
25984,KRT23,Q9C075,0.716,0.154,4.6553e-13,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2007.0,2013.0,ALL
25987,TSKU,Q8WUA8,0.76,0.269,0.85418,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
25988,HINFP,Q9BQA5,1.0,0.192,0.03685,DTO_05007542,Transcription factor,C0004135,Ataxia Telangiectasia,C16;C18;C20;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
25989,ULK3,Q6PHR2,0.839,0.115,0.0020258,DTO_03300101,Kinase,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0,,2010.0,2016.0,ALL
25992,SNED1,Q8TER0,0.686,0.462,0.66246,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
25996,REXO2,Q9Y3B8,1.0,0.038,0.023229,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
25998,IBTK,Q9P2D0,0.678,0.538,0.0022144,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2014.0,2020.0,ALL
26001,RNF167,Q9H6Y7,,,0.032145,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
26002,MOXD1,Q6UVY6,0.821,0.231,1.5505e-22,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
26003,GORASP2,Q9H8Y8,0.78,0.308,0.88389,,,C0027902,Neuropsychological Tests,,,phenotype,Diagnostic Procedure,0.1,1.0,,2009.0,2009.0,ALL
26005,C2CD3,Q4AC94,0.636,0.538,4.4437e-19,,,C4014780,OROFACIODIGITAL SYNDROME XIV,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2016.0,ALL
26007,TKFC,Q3LXA3,0.839,0.192,3.1694e-12,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
26009,ZZZ3,Q8IYH5,0.931,0.154,0.99998,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
26010,SPATS2L,Q9NUQ6,0.76,0.346,0.55833,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
26011,TENM4,Q6N022,0.65,0.462,1.0,,,C4225223,"TREMOR, HEREDITARY ESSENTIAL, 5",,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2015.0,ALL
26012,NSMF,Q6X4W1,0.606,0.692,0.26482,,,C3553842,HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.7,1.0,,2004.0,2013.0,ALL
26013,L3MBTL1,Q9Y468,0.729,0.269,1.5474e-12,DTO_05007378,Epigenetic regulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1999.0,2018.0,ALL
26015,RPAP1,Q9BWH6,0.89,0.115,1.3781e-17,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
26017,FAM32A,Q9Y421,0.931,0.115,0.030275,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
26018,LRIG1,Q96JA1,0.601,0.538,0.035031,DTO_05007575,Receptor,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
26019,UPF2,Q9HAU5,1.0,0.038,1.0,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
26020,LRP10,Q7Z4F1,0.751,0.231,4.9806e-08,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,2018.0,2019.0,ALL
26022,TMEM98,Q9Y2Y6,0.736,0.308,0.01189,,,C4014848,NANOPHTHALMOS 4,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2015.0,ALL
26024,PTCD1,O75127,0.89,0.231,2.9087e-14,DTO_05007624,Enzyme,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
26025,PCDHGA12,O60330,0.861,0.115,1.423e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2007.0,2011.0,ALL
26027,ACOT11,Q8WXI4,0.76,0.462,1.0844e-16,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
26030,PLEKHG3,A1L390,1.0,0.038,4.6804e-08,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2011.0,2011.0,ALL
26031,OSBPL3,Q9H4L5,0.839,0.192,1.585e-06,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
26033,ATRNL1,Q5VV63,0.546,0.769,0.99915,DTO_05007584,Enzyme modulator,C0020630,Hypophosphatasia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,1988.0,2018.0,ALL
26034,IPCEF1,Q8WWN9,0.821,0.269,0.0015595,,,C0023448,Lymphoid leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
26035,GLCE,O94923,0.729,0.269,0.65444,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
26036,ZNF451,Q9Y4E5,0.861,0.154,1.5111e-12,DTO_05007542,Transcription factor,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
26037,SIPA1L1,O43166,0.805,0.192,1.0,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
26038,CHD5,Q8TDI0,0.604,0.5,1.0,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2003.0,2016.0,ALL
26039,SS18L1,O75177,0.67,0.538,0.98229,DTO_05007557,Nucleic acid binding,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,moderate,2014.0,2014.0,ALL
26040,SETBP1,Q9Y6X0,0.503,0.808,1.0,,,C0265227,Schinzel-Giedion syndrome,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.77,0.909,strong,2010.0,2018.0,ALL
26043,UBXN7,O94888,,,0.99988,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
26045,LRRTM2,O43300,1.0,0.038,0.80903,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
26046,LTN1,O94822,0.89,0.038,0.0084038,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
26047,CNTNAP2,Q9UHC6,0.53,0.846,2.8673e-09,,,C2750246,Pitt-Hopkins-Like Syndrome 1,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2001.0,2011.0,ALL
26050,SLITRK5,O94991,0.839,0.346,0.87019,,,C0028768,Obsessive-Compulsive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2019.0,ALL
26051,PPP1R16B,Q96T49,0.821,0.308,0.99974,DTO_05007584,Enzyme modulator,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
26052,DNM3,Q9UQ16,0.716,0.462,0.0024197,DTO_05007584,Enzyme modulator,C0022665,Kidney Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
26053,AUTS2,Q8WXX7,0.569,0.846,0.99934,,,C4014435,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 26",,,disease,Disease or Syndrome,0.8,1.0,,2013.0,2015.0,ALL
26054,SENP6,Q9GZR1,0.76,0.269,0.99998,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
26056,RAB11FIP5,Q9BXF6,0.805,0.231,0.0014636,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
26057,ANKRD17,O75179,0.931,0.077,1.0,,,C0220641,Lip and Oral Cavity Carcinoma,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.11,1.0,,2017.0,2017.0,ALL
26058,GIGYF2,Q6Y7W6,0.711,0.269,1.0,,,C4083045,"PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO",,,phenotype,Finding,0.7,1.0,,2008.0,2015.0,ALL
26059,ERC2,O15083,0.89,0.269,0.98931,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
26060,APPL1,Q9UKG1,0.626,0.5,0.7952,,,C4225299,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2015.0,ALL
26061,HACL1,Q9UJ83,0.821,0.077,7.4827e-12,DTO_05007624,Enzyme,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
26064,RAI14,Q9P0K7,0.751,0.269,0.99122,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
26065,LSM14A,Q8ND56,,,0.03987,DTO_05007557,Nucleic acid binding,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
26070,MYRF-AS1,,1.0,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
26073,POLDIP2,Q9Y2S7,0.396,0.923,0.41407,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2000.0,2020.0,ALL
26074,CFAP61,Q8NHU2,1.0,0.077,3.1129e-15,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
26083,TBC1D29P,Q9UFV1,1.0,0.077,0.0006788,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
26084,ARHGEF26,Q96DR7,0.78,0.115,1.8567e-14,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0,,2017.0,2018.0,ALL
26085,KLK13,Q9UKR3,0.666,0.346,0.0045435,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.9,,2006.0,2018.0,ALL
26086,GPSM1,Q86YR5,0.736,0.577,2.2075e-05,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2004.0,2004.0,ALL
26088,GGA1,Q9UJY5,0.931,0.154,0.99992,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
26090,ABHD12,Q8N2K0,0.666,0.385,1.9476e-05,DTO_05007624,Enzyme,C2675204,"Polyneuropathy, Hearing Loss, Ataxia, Retinitis Pigmentosa, And Cataract",C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.97,0.833,definitive,2010.0,2019.0,ALL
26091,HERC4,Q5GLZ8,0.792,0.231,0.99961,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
26092,TOR1AIP1,Q5JTV8,0.729,0.346,1.2719e-09,,,C4310731,"MYOPATHY, AUTOSOMAL RECESSIVE, WITH RIGID SPINE AND DISTAL JOINT CONTRACTURES",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
26093,CCDC9,Q9Y3X0,1.0,0.038,2.9036e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
26094,DCAF4,Q8WV16,0.839,0.077,9.2807e-06,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
26095,PTPN20,Q4JDL3,1.0,0.038,0.015945,,,C0019100,Severe Dengue,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
26097,CHTOP,Q9Y3Y2,0.722,0.346,0.76399,DTO_05007557,Nucleic acid binding,C0016037,Fibrodysplasia Ossificans Progressiva,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.05,1.0,,2007.0,2018.0,ALL
26098,EDRF1,Q3B7T1,1.0,0.077,0.0043677,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
26099,SZRD1,Q7Z422,0.861,0.077,0.59651,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
26100,WIPI2,Q9Y4P8,0.736,0.308,0.0063887,,,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.1,,,,,ALL
26103,LRIT1,Q9P2V4,0.641,0.615,4.5907e-15,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2017.0,2019.0,ALL
26112,CCDC69,A6NI79,1.0,0.038,4.9125e-12,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
26115,TANC2,Q9HCD6,0.861,0.154,1.0,,,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.51,1.0,moderate,2017.0,2019.0,ALL
26118,WSB1,Q9Y6I7,0.76,0.269,0.42292,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2008.0,2019.0,ALL
26119,LDLRAP1,Q5SW96,0.641,0.538,6.5037e-06,DTO_05007599,Signaling,C1863512,"HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,1.0,1.0,strong,2001.0,2020.0,ALL
26121,PRPF31,Q8WWY3,0.531,0.731,0.98313,DTO_05007557,Nucleic acid binding,C1838601,Retinitis Pigmentosa 11,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.95,1.0,,1996.0,2011.0,ALL
26122,EPC2,Q52LR7,0.743,0.5,0.99998,DTO_05007557,Nucleic acid binding,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2019.0,2019.0,ALL
26123,TCTN3,Q6NUS6,0.566,0.615,4.1528e-12,,,C0406727,Orofaciodigital syndrome 4,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.72,1.0,,2012.0,2015.0,ALL
26127,FGFR1OP2,Q9NVK5,0.89,0.154,0.00049643,,,C0027022,Myeloproliferative disease,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.31,1.0,,2011.0,2013.0,ALL
26128,KIFBP,Q96EK5,0.615,0.731,0.075682,,,C1836123,Goldberg-Shprintzen megacolon syndrome,C16;C06;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.96,0.9,,1981.0,2019.0,ALL
26130,GAPVD1,Q14C86,1.0,0.077,1.0,DTO_05007584,Enzyme modulator,C1868672,"NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
26133,TRPC4AP,Q8TEL6,0.76,0.231,0.55209,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
26135,SERBP1,Q8NC51,0.716,0.385,0.9995,DTO_05007557,Nucleic acid binding,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
26136,TES,Q9UGI8,0.604,0.692,1.0234e-15,DTO_05007530,Cellular structure,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.33,1.0,,2007.0,2013.0,ALL
26137,ZBTB20,Q9HC78,0.566,0.731,0.97382,,,C0796121,Primrose syndrome,C23;C16;C18;C10;F03;C09;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.77,1.0,,2010.0,2020.0,ALL
26138,LINC00588,Q9Y4M8,1.0,0.077,,,,C0454651,Specific language impairment,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
26140,TTLL3,Q9Y4R7,1.0,0.077,1.0765e-19,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2014.0,2014.0,ALL
26146,TRAF3IP1,Q8TDR0,0.695,0.423,1.9085e-08,,,C4225263,SENIOR-LOKEN SYNDROME 9,,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2015.0,ALL
26147,PHF19,Q5T6S3,0.716,0.385,0.99946,DTO_05007557,Nucleic acid binding,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.12,0.857,,2007.0,2019.0,ALL
26149,ZNF658,Q5TYW1,,,9.0413e-14,DTO_05007542,Transcription factor,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
26150,RIBC2,Q9H4K1,0.839,0.115,2.1427e-12,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
26151,NAT9,Q9BTE0,0.695,0.346,0.00022044,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
26152,ZNF337,Q9Y3M9,,,0.0036778,DTO_05007542,Transcription factor,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
26153,KIF26A,Q9ULI4,,,0.00051939,DTO_05007530,Cellular structure,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
26154,ABCA12,Q86UK0,0.61,0.654,2.922e-15,DTO_05007405,Transporter,C0239849,Harlequin Fetus,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2005.0,2019.0,ALL
26155,NOC2L,Q9Y3T9,0.593,0.731,2.8933e-29,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.12,1.0,,2018.0,2019.0,ALL
26156,RSL1D1,O76021,0.805,0.192,5.1679e-07,DTO_05007557,Nucleic acid binding,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
26160,IFT172,Q9UG01,0.582,0.654,3.2682e-33,DTO_05007530,Cellular structure,C4225342,RETINITIS PIGMENTOSA 71,,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2015.0,ALL
26164,MTG2,Q9H4K7,0.931,0.154,0.00033086,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
26165,SPATA31A7,Q8IWB4,,,0.0025685,,,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
26166,RGS22,Q8NE09,0.78,0.154,1.6387e-30,,,C4721806,"Carcinoma, Basal Cell",C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0,,2014.0,2014.0,ALL
26168,SENP3,Q9H4L4,0.751,0.269,0.84821,DTO_05007624,Enzyme,C0202022,Follicle stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
26173,INTS1,Q8N201,0.666,0.5,7.1069e-11,,,C0086543,Cataract,C11,   Eye Diseases,disease,Acquired Abnormality,0.31,1.0,strong,2007.0,2019.0,ALL
26190,FBXW2,Q9UKT8,0.861,0.115,0.99877,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
26191,PTPN22,Q9Y2R2,0.438,0.846,3.4921e-21,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.9,0.945,,2004.0,2020.0,ALL
26206,SPAG8,Q99932,0.722,0.346,1.6843e-12,,,C1864356,"ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2004.0,2004.0,ALL
26207,PITPNC1,Q9UKF7,0.839,0.231,0.99252,DTO_05007405,Transporter,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
26220,DGCR5,,0.65,0.577,,,,C0201874,Amino acids measurement,,,group,Laboratory Procedure,0.1,1.0,,2015.0,2015.0,ALL
26223,FBXL21P,Q9UKT6,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
26224,FBXL3,Q9UKT7,0.736,0.462,0.9807,,,C1853507,"Mental Retardation, Short Stature, Facial Anomalies, and Joint Dislocations",C23;C16;C05;C10;C19;F03;F01;C26,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms;    Wounds and Injuries",phenotype,Disease or Syndrome,0.6,1.0,strong,2019.0,2019.0,ALL
26225,ARL5A,Q9Y689,0.89,0.154,0.1281,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
26227,PHGDH,O43175,0.484,0.885,0.00013308,DTO_05007624,Enzyme,C1866174,Phosphoglycerate Dehydrogenase Deficiency,C23;C16;C18;C05;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,,2000.0,2014.0,ALL
26228,STAP1,Q9ULZ2,0.792,0.231,1.6993e-05,DTO_05007575,Receptor,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.31,1.0,limited,2014.0,2018.0,ALL
26229,B3GAT3,O94766,0.621,0.538,2.7099e-08,DTO_05007624,Enzyme,C3278404,"MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2019.0,ALL
26230,TIAM2,Q8IVF5,0.76,0.192,3.2439e-05,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
26231,LRRC29,Q8WV35,,,0.00022334,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
26232,FBXO2,Q9UK22,0.805,0.346,0.00021527,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
26233,FBXL6,Q8N531,1.0,,4.2187e-09,,,C3553538,BROWN-VIALETTO-VAN LAERE SYNDROME 2,,,disease,Disease or Syndrome,0.1,,,,,ALL
26234,FBXL5,Q9UKA1,0.711,0.308,0.99854,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
26235,FBXL4,Q9UKA2,0.695,0.423,1.1384e-08,,,C3809592,FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome,,,disease,Disease or Syndrome,0.73,1.0,strong,2013.0,2019.0,ALL
26239,LCE2B,O14633,0.931,0.192,0.097851,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
26240,FAM50B,Q9Y247,0.89,0.077,0.15388,,,C0036631,Seminoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
26242,OR4C1P,,,,,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
26245,OR2M4,Q96R27,,,0.0031458,DTO_02300001,G-protein coupled receptor,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
26249,KLHL3,Q9UH77,0.736,0.346,0.94479,,,C3469605,"PSEUDOHYPOALDOSTERONISM, TYPE IID",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.74,1.0,,2012.0,2019.0,ALL
26253,CLEC4E,Q9ULY5,0.695,0.5,1.1378e-05,DTO_05007575,Receptor,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
26254,OPTC,Q9UBM4,0.743,0.154,4.8162e-10,DTO_05007575,Receptor,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.03,1.0,,2002.0,2007.0,ALL
26255,PTTG3P,Q9NZH4,0.751,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
26256,CABYR,O75952,0.792,0.192,2.258e-06,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
26257,NKX2-8,O15522,0.769,0.269,0.004855,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2011.0,2019.0,ALL
26258,BLOC1S6,Q9UL45,0.769,0.308,8.0385e-09,,,C3280026,HERMANSKY-PUDLAK SYNDROME 9,,,disease,Disease or Syndrome,0.81,1.0,,1971.0,2018.0,ALL
26259,FBXW8,Q8N3Y1,0.743,0.385,5.2356e-16,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
26260,FBXO25,Q8TCJ0,0.839,0.269,0.00019921,,,C0026654,Moyamoya Disease,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
26261,FBXO24,O75426,0.931,0.077,0.00038251,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
26262,TSPAN17,Q96FV3,1.0,0.038,1.511e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
26263,FBXO22,Q8NEZ5,0.743,0.346,0.97746,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
26266,SLC13A4,Q9UKG4,0.805,0.115,0.81559,DTO_05007405,Transporter,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
26267,FBXO10,Q9UK96,0.861,0.154,2.3763e-06,,,C0024668,"Mammary Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.2,1.0,,2007.0,2007.0,ALL
26268,FBXO9,Q9UK97,0.821,0.269,0.00012166,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
26269,FBXO8,Q9NRD0,0.647,0.692,0.48562,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2016.0,2016.0,ALL
26270,FBXO6,Q9NRD1,0.76,0.231,0.015153,,,C0014518,Toxic Epidermal Necrolysis,C17;C20;C25;C07,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Chemically-Induced Disorders;    Stomatognathic Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
26271,FBXO5,Q9UKT4,0.769,0.269,0.96995,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2009.0,2018.0,ALL
26272,FBXO4,Q9UKT5,0.792,0.115,4.0093e-06,,,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
26273,FBXO3,Q9UK99,0.743,0.462,0.98916,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
26275,HIBCH,Q6NVY1,0.7,0.5,2.5766e-13,DTO_05007624,Enzyme,C0342738,Beta-Hydroxyisobutyryl CoA Deacylase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,definitive,1982.0,2019.0,ALL
26276,VPS33B,Q9H267,0.644,0.654,2.4065e-16,DTO_05007405,Transporter,C1859722,"Arthrogryposis, renal dysfunction, and cholestasis 1",C16;C06;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,1.0,,2004.0,2019.0,ALL
26277,TINF2,Q9BSI4,0.575,0.731,0.0012666,,,C0265965,Dyskeratosis Congenita,C16;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.9,0.917,,2008.0,2018.0,ALL
26278,SACS,Q9NZJ4,0.606,0.654,1.0852e-23,,,C1849140,"SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE",C23;C16;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,1999.0,2019.0,ALL
26279,PLA2G2D,Q9UNK4,0.716,0.423,1.8079e-05,DTO_05007624,Enzyme,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2013.0,2015.0,ALL
26280,IL1RAPL2,Q9NP60,0.78,0.385,0.98424,DTO_05007575,Receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
26281,FGF20,Q9NP95,0.663,0.577,0.81379,DTO_05007599,Signaling,C1609433,Congenital absence of kidneys syndrome,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.4,1.0,,2012.0,2012.0,ALL
26284,ERAL1,O75616,0.638,0.577,3.1095e-09,DTO_05007584,Enzyme modulator,C4479656,PERRAULT SYNDROME 6,,,disease,Disease or Syndrome,0.6,1.0,moderate,2017.0,2017.0,ALL
26285,CLDN17,P56750,0.931,0.154,0.00033411,DTO_05007527,Cell-cell junction,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
26286,ARFGAP3,Q9NP61,0.89,0.115,7.0246e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
26287,ANKRD2,Q9GZV1,0.805,0.308,1.4714e-08,,,C0410190,Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder),C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
26289,AK5,Q9Y6K8,0.792,0.269,0.0033057,DTO_03300101,Kinase,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
26290,GALNT8,Q9NY28,0.861,0.269,8.0674e-20,DTO_05007624,Enzyme,C4049938,Physical Activity Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
26291,FGF21,Q9NSA1,0.485,0.769,0.029439,DTO_05007599,Signaling,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.5,1.0,,2013.0,2013.0,ALL
26292,MYCBP,Q99417,0.663,0.5,0.84451,DTO_05007542,Transcription factor,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
26297,SERGEF,Q9UGK8,1.0,0.115,5.2893e-14,,,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
26298,EHF,Q9NZC4,0.65,0.577,0.70543,DTO_05007542,Transcription factor,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.34,1.0,,2007.0,2016.0,ALL
26301,GBGT1,Q8N5D6,0.861,0.192,1.0776e-10,DTO_05007624,Enzyme,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
26330,GAPDHS,O14556,0.78,0.154,3.3372e-05,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
26353,HSPB8,Q9UJY1,0.57,0.577,0.043128,,,C1834692,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2004.0,2017.0,ALL
26354,GNL3,Q9BVP2,0.579,0.577,1.9878e-19,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.13,1.0,,2012.0,2016.0,ALL
26355,FAM162A,Q96A26,1.0,0.077,3.2417e-06,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
26468,LHX6,Q9UPM6,0.736,0.346,0.96572,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2012.0,2015.0,ALL
26469,PTPN18,Q99952,0.821,0.269,1.5e-09,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
26470,SEZ6L2,Q6UXD5,0.769,0.231,0.11743,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2009.0,ALL
26471,NUPR1,O60356,0.606,0.615,0.0041502,,,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.34,1.0,,2006.0,2019.0,ALL
26472,PPP1R14B,Q96C90,0.861,0.231,0.0043794,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
26476,OR10J1,P30954,,,6.3754e-07,DTO_02300001,G-protein coupled receptor,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
26499,PLEK2,Q9NYT0,0.729,0.231,5.2858e-09,DTO_05007530,Cellular structure,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
26503,SLC17A5,Q9NRA2,0.491,0.808,6.8514e-10,DTO_05007405,Transporter,C1096903,"Sialic Acid Storage Disease, Finnish Type (disorder)",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1999.0,2019.0,ALL
26504,CNNM4,Q6P4Q7,0.695,0.346,2.9325e-07,,,C3495589,Jalili syndrome,C16;C11;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.8,1.0,,2009.0,2019.0,ALL
26505,CNNM3,Q8NE01,0.839,0.115,2.1173e-07,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
26507,CNNM1,Q9NRU3,0.78,0.308,0.017607,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
26508,HEYL,Q9NQ87,0.736,0.423,3.2662e-07,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2010.0,2019.0,ALL
26509,MYOF,Q9NZM1,0.691,0.538,1.475e-54,DTO_05007405,Transporter,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
26511,CHIC2,Q9UKJ5,0.769,0.231,0.54245,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.41,1.0,,1999.0,1999.0,ALL
26512,INTS6,Q9UL03,0.711,0.423,1.0,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1996.0,2018.0,ALL
26517,TIMM13,Q9Y5L4,,,0.062511,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
26519,TIMM10,P62072,0.89,0.077,0.0014821,,,C0035412,Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2006.0,2006.0,ALL
26520,TIMM9,Q9Y5J7,0.89,0.115,0.020827,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
26521,TIMM8B,Q9Y5J9,1.0,0.269,0.0086544,,,C0796074,MOHR-TRANEBJAERG SYNDROME,C23;C16;C11;C10;F03;C09;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
26523,AGO1,Q9UL18,0.656,0.577,1.0,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.32,1.0,moderate,2015.0,2018.0,ALL
26524,LATS2,Q9NRM7,0.554,0.654,0.98807,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.33,1.0,,2014.0,2019.0,ALL
26525,IL36RN,Q9UBH0,0.638,0.538,3.3941e-08,,,C0343055,Generalized pustular psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.8,1.0,strong,2011.0,2020.0,ALL
26526,TSPAN16,Q9UKR8,0.839,0.231,4.0908e-06,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
26528,DAZAP1,Q96EP5,0.821,0.231,0.99985,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2013.0,2013.0,ALL
26548,ITGB1BP2,Q9UKP3,0.821,0.038,2.5951e-08,DTO_05007599,Signaling,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
26574,AATF,Q9NY61,0.641,0.731,2.5958e-12,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2009.0,2018.0,ALL
26575,RGS17,Q9UGC6,0.716,0.346,0.26684,DTO_05007584,Enzyme modulator,C0024809,Marijuana Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
26576,SRPK3,Q9UPE1,1.0,0.077,0.29235,DTO_03300101,Kinase,C0206157,"Myopathies, Nemaline",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
26577,PCOLCE2,Q9UKZ9,0.821,0.231,5.4571e-11,,,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
26578,OSTF1,Q92882,0.839,0.192,0.001656,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
26579,MYEOV,Q96EZ4,0.7,0.346,0.0033849,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
26580,BSCL2,Q96G97,0.545,0.692,1.0981e-09,,,C1720863,Congenital Generalized Lipodystrophy Type 2,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,1.0,1.0,,2001.0,2019.0,ALL
26584,DUX1,O43812;Q96PT3,0.89,0.038,,,,C0035412,Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,1998.0,1998.0,ALL
26585,GREM1,O60565,0.508,0.808,0.47436,,,C1832587,"POLYPOSIS SYNDROME, HEREDITARY MIXED, 1",C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Disease or Syndrome,0.61,1.0,strong,2003.0,2016.0,ALL
26586,CKAP2,Q8WWK9,0.7,0.423,8.1751e-13,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2009.0,2018.0,ALL
26608,TBL2,Q9Y4P3,0.538,0.731,0.00018452,,,C0000737,Abdominal Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,,,,,ALL
26609,VCX,Q9H320,0.716,0.538,0.34444,,,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.02,1.0,,2005.0,2013.0,ALL
26610,ELP4,Q96EB1,0.666,0.462,1.2277e-07,,,C0003076,Aniridia,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.43,1.0,,1990.0,2017.0,ALL
26614,OR7E66P,,1.0,0.115,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
26628,OR7E47P,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
26664,OR7C1,O76099,0.89,0.077,,DTO_02300001,G-protein coupled receptor,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
26681,OR4G1P,,0.931,0.115,,,,C0085315,"Toxoplasmosis, Cerebral",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
26689,OR4D1,Q15615,,,0.00017181,DTO_02300001,G-protein coupled receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
26740,OR1J2,Q8NGS2,0.792,0.154,0.093349,DTO_02300001,G-protein coupled receptor,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
26747,NUFIP1,Q9UHK0,0.931,0.115,6.2929e-08,DTO_05007557,Nucleic acid binding,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2011.0,2011.0,ALL
26748,GAGE12I,A1L429;O76087;P0CL80;P0CL81;P0CL82,0.821,0.192,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
26750,RPS6KC1,Q96S38,0.821,0.231,0.001257,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
26751,SH3YL1,Q96HL8,0.931,0.154,5.3675e-08,DTO_05007530,Cellular structure,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
26762,HAVCR1,Q96D42,0.489,0.885,8.5105e-07,,,C0033687,Proteinuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.5,1.0,,2006.0,2009.0,ALL
26768,SNORA73B,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
26777,SNORA71A,,0.931,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
26783,SNORA65,,0.931,0.077,,,,C0002448,Ameloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
26787,SNORD61,,1.0,0.115,,,,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
26793,SNORD56,,1.0,0.038,,,,C0023267,Fibroid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
26799,SNORD50A,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
26801,SNORD48,,0.792,0.154,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
26802,SNORD47,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
26806,SNORD44,,0.821,0.192,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2011.0,2017.0,ALL
26807,SNORD43,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2011.0,2012.0,ALL
26818,SNORD33,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
26820,SNORD24,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
26821,SNORA74A,,0.931,0.115,,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
26824,RNU11,,1.0,0.038,,,,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
26826,RNU6-6P,,0.839,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
26827,RNU6-1,,0.89,0.077,,,,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
26871,RNU1-1,,0.608,0.731,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2001.0,2019.0,ALL
26872,STEAP1,Q9UHE8,0.686,0.462,5.27e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2006.0,2019.0,ALL
26873,OPLAH,O14841,0.792,0.308,6.9736e-17,DTO_05007624,Enzyme,C0268525,5-oxoprolinase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.72,1.0,moderate,2012.0,2016.0,ALL
26952,SMR3A,Q99954,0.751,0.538,0.39147,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0,,2017.0,2019.0,ALL
26953,RANBP6,O60518,0.89,0.038,0.00011385,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
26958,COPG2,Q9UBF2,0.931,0.115,0.0063266,DTO_05007405,Transporter,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
26959,HBP1,O60381,0.674,0.385,0.0042407,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2014.0,2019.0,ALL
26960,NBEA,Q8NFP9,0.76,0.538,1.0,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,strong,2013.0,2018.0,ALL
26973,CHORDC1,Q9UHD1,0.792,0.192,0.90164,DTO_05007599,Signaling,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.21,1.0,,2015.0,2015.0,ALL
26974,ZNF285,Q96NJ3,1.0,0.038,0.0001669,,,C0154778,"Myopia, Degenerative",C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
26980,PABPC1P1,,0.839,0.192,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
26984,SEC22A,Q96IW7,1.0,0.038,1.3936e-06,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
26985,AP3M1,Q9Y2T2,1.0,0.038,0.026524,DTO_05007621,Extracellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2009.0,2009.0,ALL
26986,PABPC1,P11940,0.621,0.654,0.99601,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,1992.0,2011.0,ALL
26993,AKAP8L,Q9ULX6,0.931,0.115,0.028839,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2015.0,2015.0,ALL
26994,RNF11,Q9Y3C5,0.805,0.154,0.57873,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2003.0,2008.0,ALL
26996,GPR160,Q9UJ42,0.805,0.269,0.00072275,DTO_02300001,G-protein coupled receptor,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
26998,FETUB,Q9UGM5,0.686,0.308,8.8804e-08,DTO_05007584,Enzyme modulator,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
26999,CYFIP2,Q96F07,0.633,0.731,1.0,DTO_05007584,Enzyme modulator,C4693925,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2019.0,ALL
27000,DNAJC2,Q99543,0.743,0.154,0.99102,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,2003.0,2018.0,ALL
27004,TCL6,,0.821,0.462,,,,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2009.0,2009.0,ALL
27005,USP21,Q9UK80,0.76,0.346,0.0026379,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
27006,FGF22,Q9HCT0,0.821,0.269,6.6707e-07,DTO_05007599,Signaling,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
27010,TPK1,Q9H3S4,0.792,0.269,0.09146,DTO_03300101,Kinase,C3280866,THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE),,,disease,Disease or Syndrome,0.71,1.0,,2011.0,2019.0,ALL
27013,CNPPD1,Q9BV87,0.931,0.115,7.6384e-09,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
27018,BEX3,Q00994,0.78,0.346,0.62141,,,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2000.0,2000.0,ALL
27019,DNAI1,Q9UI46,0.597,0.692,2.4183e-08,DTO_05007530,Cellular structure,C4551906,"Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus",C16;C08;C09;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.9,1.0,,1999.0,2014.0,ALL
27020,NPTN,Q9Y639,0.67,0.5,0.99304,DTO_05007575,Receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2007.0,2017.0,ALL
27022,FOXD3,Q9UJU5,0.587,0.692,0.58216,DTO_05007542,Transcription factor,C0266525,Irido-corneal dysgenesis,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.31,1.0,strong,2012.0,2012.0,ALL
27023,FOXB1,Q99853,1.0,0.077,0.90634,DTO_05007542,Transcription factor,C0264408,Childhood asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
27030,MLH3,Q9UHC1,0.582,0.538,4.9023e-08,DTO_05007557,Nucleic acid binding,C1333990,Hereditary Nonpolyposis Colorectal Cancer,C16;C06;C04;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nutritional and Metabolic Diseases",disease,Neoplastic Process,0.7,0.933,moderate,2001.0,2019.0,ALL
27031,NPHP3,Q7Z494,0.597,0.654,9.836e-16,,,C1858392,NEPHRONOPHTHISIS 3,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.96,1.0,,2001.0,2019.0,ALL
27032,ATP2C1,P98194,0.663,0.423,1.0,DTO_05007405,Transporter,C0085106,Familial benign pemphigus,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,0.958,,1995.0,2019.0,ALL
27033,ZBTB32,Q9Y2Y4,0.76,0.269,0.00025845,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2016.0,2018.0,ALL
27034,ACAD8,Q9UKU7,0.506,0.885,5.6389e-14,DTO_05007624,Enzyme,C1969809,Isobutyryl-CoA dehydrogenase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,definitive,2003.0,2018.0,ALL
27035,NOX1,Q9Y5S8,0.536,0.808,8.6564e-08,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,1.0,,2008.0,2019.0,ALL
27036,SIGLEC7,Q9Y286,0.535,0.846,2.388e-07,DTO_05007575,Receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
27037,TRMT2A,Q8IZ69,0.931,0.115,1.0841e-08,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
27039,PKD2L2,Q9NZM6,1.0,0.077,6.6526e-14,DTO_01300327,Ion channel,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
27040,LAT,O43561,0.548,0.731,0.0092377,,,C4479588,IMMUNODEFICIENCY 52,,,disease,Disease or Syndrome,0.5,1.0,,2016.0,2017.0,ALL
27042,UTP25,Q68CQ4,0.805,0.269,1.2381e-06,DTO_05007557,Nucleic acid binding,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
27043,PELP1,Q8IZL8,0.612,0.577,0.99998,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.968,,2000.0,2019.0,ALL
27044,SND1,Q7KZF4,0.576,0.769,0.98213,DTO_05007542,Transcription factor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2019.0,ALL
27063,ANKRD1,Q15327,0.628,0.692,2.6259e-10,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.32,1.0,limited,2009.0,2015.0,ALL
27065,NSG1,P42857,0.691,0.538,0.0088286,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
27067,STAU2,Q9NUL3,0.89,0.154,0.97269,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
27068,PPA2,Q9H2U2,0.805,0.115,1.1789e-10,DTO_05007624,Enzyme,C4310663,"SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
27071,DAPP1,Q9UN19,0.931,0.038,0.17169,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
27072,VPS41,P49754,0.821,0.192,4.4224e-18,DTO_05007405,Transporter,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
27074,LAMP3,Q9UQV4,0.56,0.692,0.00026747,DTO_05007405,Transporter,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.36,1.0,,2007.0,2018.0,ALL
27075,TSPAN13,O95857,0.736,0.154,0.00011554,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
27076,LYPD3,O95274,0.931,0.077,1.8345e-11,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2001.0,2019.0,ALL
27077,B9D1,Q9UPM9,0.572,0.692,0.0028034,DTO_05007621,Extracellular structure,C4310706,JOUBERT SYNDROME 27,,,disease,Disease or Syndrome,0.6,1.0,,2011.0,2016.0,ALL
27079,RPUSD2,Q8IZ73,,,8.8012e-07,,,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
27085,MTBP,Q96DY7,0.729,0.269,3.5074e-19,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2015.0,2018.0,ALL
27086,FOXP1,Q9H334,0.46,0.808,0.99998,,,C4013764,MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES,,,disease,Disease or Syndrome,0.7,1.0,strong,2010.0,2017.0,ALL
27087,B3GAT1,Q9P2W7,0.494,0.769,0.13521,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2003.0,2011.0,ALL
27089,UQCRQ,O14949,0.722,0.308,0.04825,,,C3554607,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4",,,disease,Disease or Syndrome,0.6,1.0,,2008.0,2016.0,ALL
27090,ST6GALNAC4,Q9H4F1,0.931,0.115,3.5202e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
27091,CACNG5,Q9UF02,0.839,0.115,0.0061164,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2016.0,ALL
27092,CACNG4,Q9UBN1,0.839,0.346,0.016603,DTO_01300327,Ion channel,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2016.0,2016.0,ALL
27094,KCNMB3,Q9NPA1,0.839,0.231,8.2989e-09,DTO_01300327,Ion channel,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
27095,TRAPPC3,O43617,0.792,0.385,0.25083,,,C0022595,Keratosis Follicularis,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
27097,TAF5L,O75529,0.931,0.115,0.99904,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,0.5,,2005.0,2007.0,ALL
27098,CLUL1,Q15846,0.821,0.192,1.6121e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
27099,SND1-IT1,Q9HBX3,0.89,0.038,,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
27101,CACYBP,Q9HB71,0.617,0.692,0.91984,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,2006.0,2006.0,ALL
27102,EIF2AK1,Q9BQI3,0.633,0.577,7.0148e-07,DTO_03300101,Kinase,C0002878,"Anemia, Hemolytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
27106,ARRDC2,Q8TBH0,,,2.1977e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
27107,ZBTB11,O95625,0.805,0.192,3.2012e-06,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,moderate,2017.0,2018.0,ALL
27109,DMAC2L,Q99766,1.0,0.115,6.451e-06,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
27111,SDCBP2,Q9H190,0.839,0.308,3.6357e-07,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
27112,FAM155B,O75949,0.861,0.231,0.81284,,,C0339143,Thyroid associated opthalmopathies,C16;C11;C20;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Immune System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
27113,BBC3,Q96PG8;Q9BXH1,0.517,0.769,0.0039762,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.33,1.0,,2008.0,2018.0,ALL
27115,PDE7B,Q9NP56,0.691,0.423,0.54578,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2010.0,2016.0,ALL
27120,DKKL1,Q9UK85,0.839,0.269,0.00039771,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2013.0,ALL
27121,DKK4,Q9UBT3,0.647,0.5,0.00076744,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
27122,DKK3,Q9UBP4,0.5,0.731,4.1049e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2005.0,2005.0,ALL
27123,DKK2,Q9UBU2,0.599,0.692,0.75318,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2014.0,ALL
27124,INPP5J,Q15735,0.931,0.077,1.8139e-16,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
27125,AFF4,Q9UHB7,0.644,0.769,1.0,DTO_05007542,Transcription factor,C4085597,CHOPS SYNDROME,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.71,1.0,,2015.0,2015.0,ALL
27127,SMC1B,Q8NDV3,0.931,0.115,0.1041,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
27128,CYTH4,Q9UIA0,0.89,0.077,0.00077316,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
27129,HSPB7,Q9UBY9,0.76,0.346,0.016292,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.11,1.0,,2010.0,2016.0,ALL
27130,INVS,Q9Y283,0.619,0.538,5.5501e-18,,,C1865872,NEPHRONOPHTHISIS 2,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.96,1.0,,1993.0,2020.0,ALL
27131,SNX5,Q9Y5X3,0.751,0.269,0.001446,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
27132,CPNE7,Q9UBL6,0.89,0.115,4.2743e-24,,,C0406208,Suntan,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
27133,KCNH5,Q8NCM2,0.821,0.077,0.019692,DTO_01300327,Ion channel,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,limited,2013.0,2013.0,ALL
27134,TJP3,O95049,0.931,0.115,6.7101e-23,DTO_05007527,Cell-cell junction,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
27136,MORC1,Q86VD1,0.805,0.192,5.8802e-06,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.51,1.0,,2014.0,2018.0,ALL
27141,CIDEB,Q9UHD4,0.861,0.154,8.2186e-15,,,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.2,1.0,,2014.0,2014.0,ALL
27143,PALD1,Q9ULE6,0.686,0.423,3.065e-15,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
27145,FILIP1,Q7Z7B0,0.861,0.154,2.5711e-10,,,C0029410,Osteoarthritis of hip,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.4,1.0,,2018.0,2019.0,ALL
27146,FAM184B,Q9ULE4,0.89,0.077,1.3466e-16,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
27147,DENND2A,Q9ULE3,,,0.067255,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
27148,STK36,Q9NRP7,0.678,0.577,7.1492e-22,DTO_03300101,Kinase,C0022521,Kartagener Syndrome,C16;C08;C09;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.31,1.0,,2017.0,2017.0,ALL
27151,CPAMD8,Q8IZJ3,0.722,0.231,6.9237e-23,DTO_05007584,Enzyme modulator,C4310622,ANTERIOR SEGMENT DYSGENESIS 8,,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2019.0,ALL
27152,INTU,Q9ULD6,0.555,0.769,7.6977e-10,,,C4693616,SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY,,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2018.0,ALL
27156,RSPH14,Q9UHP6,1.0,0.038,0.00036018,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
27158,NDOR1,Q9UHB4,1.0,0.038,4.8084e-13,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
27159,CHIA,Q9BZP6,0.682,0.538,1.0115e-13,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
27161,AGO2,Q9UKV8,0.501,0.885,1.0,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2015.0,2015.0,ALL
27163,NAAA,Q02083,0.579,0.692,2.0742e-10,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2019.0,ALL
27164,SALL3,Q9BXA9,0.729,0.385,0.40326,DTO_05007542,Transcription factor,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
27165,GLS2,Q9UI32,0.597,0.538,1.3239e-10,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2007.0,2007.0,ALL
27166,PRELID1,Q9Y255,,,0.11518,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
27173,SLC39A1,Q9NY26,0.722,0.423,0.12586,DTO_05007405,Transporter,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.37,1.0,,2003.0,2018.0,ALL
27175,TUBG2,Q9NRH3,,,1.2102e-05,DTO_05007530,Cellular structure,C0027583,Nematode infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
27177,IL36B,Q9NZH7,0.861,0.154,0.0032983,,,C3815172,Interleukin 1 Beta Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
27178,IL37,Q9NZH6,0.459,0.846,0.00012343,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2019.0,ALL
27179,IL36A,Q9UHA7,0.78,0.5,0.029783,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
27180,SIGLEC9,Q9Y336,0.666,0.423,2.5343e-05,DTO_05007575,Receptor,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
27181,SIGLEC8,Q9NYZ4,0.711,0.462,3.2193e-07,DTO_05007575,Receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0,,2010.0,2014.0,ALL
27183,VPS4A,Q9UN37,0.76,0.385,0.94474,DTO_05007530,Cellular structure,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
27184,DISC2,,0.716,0.192,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2001.0,2010.0,ALL
27185,DISC1,Q9NRI5,0.548,0.769,1.6756e-06,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.8,1.0,,2006.0,2018.0,ALL
27189,IL17C,Q9P0M4,0.619,0.692,0.0001243,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.5,,2000.0,2011.0,ALL
27190,IL17B,Q9UHF5,0.553,0.769,0.033631,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,0.923,,2006.0,2019.0,ALL
27198,HCAR1,Q9BXC0,0.722,0.385,0.00075927,DTO_02300001,G-protein coupled receptor,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.07,1.0,,2017.0,2019.0,ALL
27199,OXGR1,Q96P68,0.89,0.115,4.9619e-05,DTO_02300001,G-protein coupled receptor,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
27201,GPR78,Q96P69,0.722,0.192,2.6834e-06,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2006.0,2006.0,ALL
27202,C5AR2,Q9P296,0.659,0.654,0.24585,DTO_02300001,G-protein coupled receptor,C0243026,Sepsis,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.04,1.0,,2016.0,2019.0,ALL
27229,TUBGCP4,Q9UGJ1,0.716,0.346,3.6984e-09,DTO_05007530,Cellular structure,C3502492,"Microcephaly with Chorioretinopathy, Autosomal Recessive",C16;C11;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,,2015.0,2015.0,ALL
27230,SERP1,Q9Y6X1,0.729,0.423,0.26523,DTO_05007557,Nucleic acid binding,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
27231,NMRK2,Q9NPI5,,,1.9248e-12,DTO_03300101,Kinase,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
27232,GNMT,Q14749,0.626,0.462,0.0028153,,,C1847720,Hypermethioninemia due to deficiency of glycine N-methyltransferase,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.9,1.0,limited,2000.0,2017.0,ALL
27235,COQ2,Q96H96,0.59,0.731,0.0013386,DTO_05007624,Enzyme,C3551954,"COENZYME Q10 DEFICIENCY, PRIMARY, 1",,,disease,Disease or Syndrome,0.7,1.0,,2006.0,2018.0,ALL
27236,ARFIP1,P53367,0.931,0.077,3.079e-05,DTO_05007584,Enzyme modulator,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
27237,ARHGEF16,Q5VV41,0.931,0.038,4.7056e-13,,,C0028945,oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
27238,GPKOW,Q92917,0.722,0.462,0.99553,DTO_05007557,Nucleic acid binding,C1844016,Holoprosencephaly with Fetal Akinesia-Hypokinesia Sequence,C23;C16;C13;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
27239,GPR162,Q16538,0.631,0.654,0.0093905,DTO_02300001,G-protein coupled receptor,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.09,1.0,,1994.0,2015.0,ALL
27240,SIT1,Q9Y3P8,0.682,0.615,0.00096493,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.03,1.0,,2009.0,2016.0,ALL
27241,BBS9,Q3SYG4,0.615,0.577,4.2117e-17,,,C1859567,BARDET-BIEDL SYNDROME 9,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2005.0,2015.0,ALL
27242,TNFRSF21,O75509,0.729,0.462,0.040615,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2013.0,2013.0,ALL
27243,CHMP2A,O43633,1.0,0.115,0.12719,,,C0338451,Frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
27244,SESN1,Q9Y6P5,0.792,0.385,0.00059629,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
27245,AHDC1,Q5TGY3,0.7,0.5,1.0,,,C4014419,"AHDC1-related intellectual disability, obstructive sleep apnea, mild dysmorphism syndrome",C23;C08;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.75,1.0,strong,2014.0,2020.0,ALL
27246,RNF115,Q9Y4L5,0.792,0.269,0.002366,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.48,1.0,,2005.0,2019.0,ALL
27247,NFU1,Q9UMS0,0.769,0.231,4.1487e-06,,,C3276432,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1,,,disease,Disease or Syndrome,0.74,1.0,,2001.0,2018.0,ALL
27248,ERLEC1,Q96DZ1,0.736,0.269,3.25e-06,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
27249,MMADHC,Q9H3L0,0.751,0.385,2.071e-05,,,C1848552,"Methylmalonic Aciduria and Homocystinuria, CblD Type",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2008.0,2016.0,ALL
27250,PDCD4,Q53EL6,0.494,0.769,3.3572e-07,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2004.0,2019.0,ALL
27252,KLHL20,Q9Y2M5,1.0,0.077,0.0094141,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
27253,PCDH17,O14917,0.633,0.577,0.64056,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2007.0,2019.0,ALL
27254,CSDC2,Q9Y534,0.931,0.154,0.003122,DTO_05007557,Nucleic acid binding,C0038868,Progressive supranuclear palsy,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
27255,CNTN6,Q9UQ52,0.678,0.462,9.0232e-31,DTO_05007575,Receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
27257,LSM1,O15116,0.751,0.269,0.011027,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2017.0,ALL
27258,LSM3,P62310,0.931,0.115,3.9529e-06,DTO_05007557,Nucleic acid binding,C0024232,Lymphatic Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
27259,HPLH1,,0.695,0.538,,,,C4551514,"Hemophagocytic Lymphohistiocytosis, Familial, 1",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.3,,,,,ALL
27283,TINAG,Q9UJW2,0.76,0.231,3.43e-25,DTO_05007624,Enzyme,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
27284,SULT1B1,O43704,0.89,0.154,3.2594e-08,,,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2018.0,2019.0,ALL
27285,TEKT2,Q9UIF3,1.0,0.038,7.4313e-12,DTO_05007530,Cellular structure,C0403823,Asthenozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,2008.0,2016.0,ALL
27286,SRPX2,O60687,0.621,0.462,0.04812,,,C1845070,"Rolandic Epilepsy, Mental Retardation, and Speech Dyspraxia, X-Linked",C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.71,1.0,,2006.0,2015.0,ALL
27287,VENTX,O95231,0.839,0.154,2.7462e-05,DTO_05007542,Transcription factor,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
27288,RBMXL2,O75526,,,0.074817,DTO_05007557,Nucleic acid binding,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
27289,RND1,Q92730,0.769,0.192,0.73701,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
27290,SPINK4,O60575,0.705,0.5,0.29634,DTO_05007584,Enzyme modulator,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
27291,R3HCC1L,Q7Z5L2,0.89,0.077,1.2632e-09,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
27292,DIMT1,Q9UNQ2,0.76,0.385,3.9098e-07,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
27293,SMPDL3B,Q92485,0.861,0.192,2.4146e-09,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
27294,DHDH,Q9UQ10,0.716,0.5,9.1294e-10,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
27295,PDLIM3,Q53GG5,0.547,0.769,3.032e-07,DTO_05007530,Cellular structure,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,limited,1997.0,2010.0,ALL
27297,CRCP,O75575,0.821,0.154,8.9725e-07,,,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.2,1.0,,2003.0,2003.0,ALL
27299,ADAMDEC1,O15204,0.76,0.423,3.6295e-16,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
27300,ZNF544,Q6NX49,1.0,0.038,0.00099546,DTO_05007542,Transcription factor,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
27301,APEX2,Q9UBZ4,0.76,0.385,0.97302,,,C0011311,Dengue Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
27302,BMP10,O95393,0.674,0.5,0.90838,DTO_05007599,Signaling,C0039685,Tetralogy of Fallot,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.2,,,,,ALL
27303,RBMS3,Q6XE24,0.553,0.692,0.2128,,,C0206368,Exfoliation Syndrome,C11,   Eye Diseases,disease,Disease or Syndrome,0.31,1.0,,2017.0,2018.0,ALL
27306,HPGDS,O60760,0.388,0.923,1.8063e-06,,,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.42,1.0,,2009.0,2017.0,ALL
27314,RAB30,Q15771,1.0,0.077,0.92132,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
27315,PGAP2,Q9UHJ9,0.633,0.615,0.93451,DTO_05007584,Enzyme modulator,C3280153,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 17",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2016.0,ALL
27316,RBMX,P38159,0.711,0.538,0.82878,DTO_05007557,Nucleic acid binding,C1846145,"MENTAL RETARDATION, X-LINKED, SYNDROMIC 11",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.4,,,,,ALL
27319,BHLHE22,Q8NFJ8,0.595,0.692,0.79994,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2018.0,ALL
27324,TOX3,O15405,0.636,0.538,0.9995,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.5,0.942,,2007.0,2019.0,ALL
27327,TNRC6A,Q8NDV7,0.674,0.346,1.0,,,C0014550,Myoclonic Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
27328,PCDH11X,Q9BZA7,0.729,0.308,0.015836,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.42,1.0,,2009.0,2011.0,ALL
27329,ANGPTL3,Q9Y5C1,0.584,0.577,1.6455e-13,DTO_05007599,Signaling,C1857970,"Hypobetalipoproteinemia, Familial, 2",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,,,,,ALL
27330,RPS6KA6,Q9UK32,0.686,0.385,0.9865,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
27332,ZNF638,Q14966,0.931,0.154,1.0,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2019.0,ALL
27333,GOLIM4,O00461,0.839,0.231,3.9661e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
27334,P2RY10,O00398,,,0.15542,DTO_02300001,G-protein coupled receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
27335,EIF3K,Q9UBQ5,0.65,0.577,0.0021017,,,C0026896,Myasthenia Gravis,C04;C20;C10,   Neoplasms;    Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.08,0.875,,2016.0,2019.0,ALL
27338,UBE2S,Q16763,0.653,0.5,0.63172,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2007.0,2019.0,ALL
27339,PRPF19,Q9UMS4,0.792,0.346,0.99995,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
27340,UTP20,O75691,0.931,0.154,3.0008e-15,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
27342,RABGEF1,Q9UJ41,0.55,0.731,0.00063083,DTO_05007584,Enzyme modulator,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0,,2012.0,2017.0,ALL
27343,POLL,Q9UGP5,0.711,0.346,1.5836e-10,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2013.0,2016.0,ALL
27344,PCSK1N,Q9UHG2,0.729,0.5,0.53242,DTO_05007584,Enzyme modulator,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
27345,KCNMB4,Q86W47,0.861,0.077,0.93853,DTO_01300327,Ion channel,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
27346,TMEM97,Q5BJF2,0.604,0.615,0.00031267,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2004.0,2020.0,ALL
27347,STK39,Q9UEW8,0.67,0.5,0.99916,DTO_03300101,Kinase,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.4,0.92,,2008.0,2019.0,ALL
27348,TOR1B,O14657,0.861,0.115,0.064206,DTO_05007613,Chaperone,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
27349,MCAT,Q8IVS2,0.524,0.808,0.00030611,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2003.0,2019.0,ALL
27350,APOBEC3C,Q9NRW3,0.722,0.538,0.026691,DTO_05007624,Enzyme,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
27351,DESI1,Q6ICB0,0.606,0.654,0.0057118,DTO_05007624,Enzyme,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0,,1985.0,2017.0,ALL
27352,SGSM3,Q96HU1,0.469,0.808,3.4061e-15,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,1998.0,2017.0,ALL
27429,HTRA2,O43464,0.542,0.692,0.0035755,,,C1853202,"PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO",,,disease,Finding,0.7,1.0,limited,2005.0,2013.0,ALL
27430,MAT2B,Q9NZL9,0.644,0.5,0.046226,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.07,1.0,,1994.0,2020.0,ALL
27433,TOR2A,Q5JU69;Q8N2E6,0.691,0.308,0.13617,DTO_05007613,Chaperone,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,1.0,,2008.0,2019.0,ALL
27434,POLM,Q9NP87,0.729,0.308,7.6227e-11,DTO_05007624,Enzyme,C0005699,Blast Phase,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.02,1.0,,1976.0,1979.0,ALL
27436,EML4,Q9HC35,0.569,0.577,0.00048242,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.4,0.994,,2007.0,2020.0,ALL
27439,TMEM121B,Q9BXQ6,,,0.69941,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
27440,HDHD5,Q9BXW7,,,1.2564e-09,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
27443,CECR2,Q9BXF3,0.743,0.385,1.0,DTO_05007378,Epigenetic regulator,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.34,1.0,,2005.0,2017.0,ALL
27445,PCLO,Q9Y6V0,0.656,0.577,1.0,,,C1842687,PONTOCEREBELLAR HYPOPLASIA TYPE 3 (disorder),C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.7,1.0,limited,2015.0,2015.0,ALL
28227,PPP2R3B,Q9Y5P8,0.931,0.115,4.9344e-08,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.04,0.75,,2010.0,2013.0,ALL
28231,SLCO4A1,Q96BD0,0.769,0.269,1.0328e-10,DTO_05007405,Transporter,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2015.0,2019.0,ALL
28232,SLCO3A1,Q9UIG8,0.736,0.385,0.38961,DTO_05007405,Transporter,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
28234,SLCO1B3,Q9NPD5,0.592,0.769,5.321e-24,DTO_05007405,Transporter,C0220991,Rotor Syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.64,1.0,limited,2012.0,2015.0,ALL
28299,IGKV1-5,P01602,0.805,0.192,,DTO_05007608,Immune response,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2005.0,2008.0,ALL
28309,IGHV3OR16-7,,0.566,0.654,,,,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0,,2005.0,2019.0,ALL
28316,CDH20,Q9HBT6,0.931,0.115,0.45869,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
28337,IGHVIV-44-1,,0.89,0.077,,,,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
28387,IGHV5-78,,0.839,0.231,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,0.667,,1989.0,1993.0,ALL
28388,IGHV5-51,A0A0C4DH38,0.931,0.192,,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
28389,IGHV4-38-2,P0DP08,1.0,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
28391,IGHV4-61,A0A0C4DH41,1.0,0.077,,,,C0035439,Rheumatic Heart Disease,C01;C14,   Infections;    Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0,,2017.0,2017.0,ALL
28392,IGHV4-59,P01825,0.861,0.231,,,,C0002880,Autoimmune hemolytic anemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
28394,IGHV4-39,P01824,0.839,0.154,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,1.0,,2005.0,2019.0,ALL
28395,IGHV4-34,P06331,0.716,0.308,,,,C0349633,Hairy cell leukemia variant,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2009.0,2011.0,ALL
28400,IGHV4-28,A0A0C4DH34,1.0,0.115,,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
28402,IGHV3-69-1,,0.561,0.654,,,,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0,,2004.0,2019.0,ALL
28407,IGHV3-75,,0.769,0.231,,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.05,1.0,,1994.0,2004.0,ALL
28409,IGHV3-73,A0A0B4J1V6,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
28421,IGHV3-52,,0.674,0.423,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,1987.0,2013.0,ALL
28424,IGHV3-48,P01763,0.931,0.115,,,,C0024301,"Lymphoma, Follicular",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
28428,IGHV3-41,,0.89,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
28434,IGHV3-33,P01772,1.0,0.115,,,,C0023443,Hairy Cell Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
28439,IGHV3-30,P01768,0.931,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
28442,IGHV3-23,P01764,0.769,0.269,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2010.0,2019.0,ALL
28444,IGHV3-21,A0A0B4J1V1,0.78,0.192,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.6,0.947,,2005.0,2018.0,ALL
28450,IGHV3-11,P01762,0.931,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2012.0,2014.0,ALL
28452,IGHV3-7,P01780,1.0,0.077,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
28461,IGHV1-69,P01742,0.729,0.462,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,0.8,,2008.0,2019.0,ALL
28462,IGHV1-68,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,0.0,,2018.0,2018.0,ALL
28469,IGHV1-17,,,,,,,C0242621,Isochromosomes,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Acquired Abnormality,0.01,1.0,,1983.0,1983.0,ALL
28471,IGHV1-12,,0.569,0.654,,,,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,0.875,,1984.0,2019.0,ALL
28472,IGHV1-8,P0DP01,1.0,0.115,,,,C4721414,Mantle cell lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
28473,IGHV1-3,A0A0C4DH29,0.89,0.077,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
28474,IGHV1-2,P23083,0.839,0.192,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,2009.0,2016.0,ALL
28475,IGHJ6,,0.931,0.154,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
28476,IGHJ5,,0.89,0.115,,,,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
28477,IGHJ4,,0.89,0.115,,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0,,2012.0,2019.0,ALL
28479,IGHJ3,,1.0,0.231,,,,C0472813,X-linked agammaglobulinemia with growth hormone deficiency,C16;C05;C20;C10;C19;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Immune System Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,0.0,,2012.0,2012.0,ALL
28481,IGHJ2,,0.931,0.115,,,,C0027022,Myeloproliferative disease,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
28484,IGHD7-27,,1.0,0.115,,,,C0085110,Severe Combined Immunodeficiency,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0,,1991.0,1991.0,ALL
28487,IGHD6-13,,1.0,0.115,,,,C0349631,Richter's syndrome,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
28495,IGHD4-11,,1.0,0.038,,,,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,2006.0,2006.0,ALL
28498,IGHD3-16,,1.0,0.231,,,,C0472813,X-linked agammaglobulinemia with growth hormone deficiency,C16;C05;C20;C10;C19;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Immune System Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,0.0,,2012.0,2012.0,ALL
28499,IGHD3-10,,0.931,0.154,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
28500,IGHD3-9,,0.931,0.154,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
28501,IGHD3-3,,1.0,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,1996.0,2001.0,ALL
28508,IGHD1-14,,0.805,0.346,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
28509,IGHD1-7,,0.931,0.154,,,,C0027126,Myotonic Dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2005.0,2013.0,ALL
28511,NKIRAS2,Q9NYR9,0.931,0.115,0.0067229,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
28512,NKIRAS1,Q9NYS0,,,0.00050065,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
28513,CDH19,Q9H159,0.821,0.038,1.2935e-14,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
28514,DLL1,O00548,0.492,0.808,0.99999,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.41,1.0,,2018.0,2019.0,ALL
28516,TRDV3,A0JD37,1.0,0.115,,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
28517,TRDV2,A0JD36,0.931,0.154,,,,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
28518,TRDV1,A0A1B0GX56,0.89,0.154,,,,C0018133,Graft-vs-Host Disease,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
28522,TRDJ1,A0A075B706,0.736,0.269,,,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0,,1999.0,2007.0,ALL
28523,TRDD3,,0.736,0.269,,,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0,,1999.0,2007.0,ALL
28526,TRDC,B7Z8K6,0.729,0.269,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
28556,TRBVA,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
28557,TRBV30,A0A0K0K1B3,1.0,0.077,,,,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
28559,TRBV28,A0A5B6,0.89,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
28560,TRBV27,A0A0K0K1C4,0.861,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
28567,TRBV20-1,A0A075B6N2,0.821,0.346,,,,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
28571,TRBV16,A0A087WV62,0.695,0.5,,,,C0026948,Mycosis Fungoides,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.05,1.0,,1998.0,2020.0,ALL
28573,TRBV14,A0A5B0,0.89,0.154,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,1998.0,1998.0,ALL
28574,TRBV13,A0A0A6YYD4,1.0,0.077,,,,C0014070,Encephalomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
28577,TRBV12-3,P01733,1.0,0.077,,,,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
28585,TRBV10-1,A0A0K0K1A3,0.931,0.077,,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
28586,TRBV9,A0A0B4J1U6,0.931,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
28589,TRBV7-9,P04435,0.695,0.5,,,,C0026948,Mycosis Fungoides,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.05,1.0,,1998.0,2020.0,ALL
28590,TRBV7-8,A0A1B0GX51,0.931,0.077,,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
28596,TRBV7-2,A0A1B0GXF2,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
28600,TRBV6-7,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
28602,TRBV6-5,A0A0K0K1A5,1.0,0.115,,,,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
28605,TRBV6-2,A0A0J9YXY3,1.0,0.192,,,,C1527336,Sjogren's Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,1995.0,1995.0,ALL
28608,TRBV5-7,,1.0,0.077,,,,C0026948,Mycosis Fungoides,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
28609,TRBV5-6,A0A599,1.0,0.192,,,,C1527336,Sjogren's Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
28613,TRBV5-2,,1.0,0.077,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
28619,TRBV3-1,A0A576,0.89,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
28620,TRBV2,A0A1B0GX68,0.861,0.269,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,1993.0,1993.0,ALL
28622,TRBJ2-7,A0A0A0MT78,0.931,0.077,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
28629,TRBJ2-1,A0A0A0MTA7,1.0,0.077,,,,C0026948,Mycosis Fungoides,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
28634,TRBJ1-2,A0A0J9YX06,1.0,0.077,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
28635,TRBJ1-1,A0A0J9YXA8,1.0,0.077,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
28638,TRBC2,A0A5B9,0.931,0.192,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
28639,TRBC1,P01850,0.695,0.5,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,1999.0,2020.0,ALL
28652,TRAV30,A0A087WSZ9,0.861,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
28653,TRAV29DV5,P04437,0.751,0.346,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,0.5,,1997.0,1997.0,ALL
28657,TRAV26-1,A0A087WT03,1.0,0.077,,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
28673,TRAV12-2,A0A075B6T6,1.0,0.038,,,,C0043395,Yellow Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
28676,TRAV10,A0A0B4J240,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
28688,TRAV5,A0A0B4J249,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,1998.0,1998.0,ALL
28689,TRAV4,A0A0B4J268,0.931,0.077,,,,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
28690,TRAV3,A0A0B4J244,1.0,0.077,,,,C4543926,Narcolepsy type 1,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
28694,TRAJ61,,0.89,0.115,,,,C1292758,Precursor T-cell lymphoblastic lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
28695,TRAJ60,,0.751,0.346,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,0.5,,1997.0,1997.0,ALL
28732,TRAJ23,,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
28755,TRAC,P01848,0.691,0.615,,DTO_05007575,Receptor,C3809332,T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,strong,1986.0,2011.0,ALL
28772,IGLV10-54,A0A075B6I4,0.89,0.115,,DTO_05007608,Immune response,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
28778,IGLV6-57,P01721,,,,DTO_05007608,Immune response,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
28780,IGLV5-48,A0A075B6I7,1.0,0.038,,,,C0022104,Irritable Bowel Syndrome,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
28793,IGLV3-25,P01717,1.0,0.038,,DTO_05007608,Immune response,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
28796,IGLV3-21,P80748,1.0,0.115,,DTO_05007608,Immune response,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.07,1.0,,2005.0,2019.0,ALL
28814,IGLV2-18,A0A075B6J9,0.931,0.038,,DTO_05007608,Immune response,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0,,2015.0,2015.0,ALL
28821,IGLV1-50,A0A075B6I6,0.931,0.077,,,,C3890941,Acute Motor Axonal Neuropathy,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
28822,IGLV1-47,P01700,,,,DTO_05007608,Immune response,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
28823,IGLV1-44,P01699,0.89,0.231,,DTO_05007608,Immune response,C0085404,POEMS Syndrome,C16;C20;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0,,2012.0,2018.0,ALL
28825,IGLV1-40,P01703,1.0,0.154,,DTO_05007608,Immune response,C0085404,POEMS Syndrome,C16;C20;C10;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
28831,IGLJ3,,0.931,0.115,,,,C0023443,Hairy Cell Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
28832,IGLJ2,,1.0,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
28875,IGKV3D-15,A0A087WSY6,0.861,0.192,,DTO_05007608,Immune response,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,1998.0,1998.0,ALL
28882,IGKV2D-29,A0A075B6S2,0.931,0.038,,DTO_05007608,Immune response,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
28883,IGKV2D-28,P01615,1.0,0.038,,DTO_05007608,Immune response,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
28890,IGKV2D-10,,,,,,,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
28891,IGKV1D-43,A0A0B4J1Z2,1.0,0.077,,DTO_05007608,Immune response,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
28904,IGKV1D-8,A0A087WSZ0,0.861,0.192,,DTO_05007608,Immune response,C0002726,Amyloidosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,1998.0,1998.0,ALL
28908,IGKV4-1,P06312,1.0,0.077,,DTO_05007608,Immune response,C0238239,Light chain disease,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
28912,IGKV3-20,P01619,0.736,0.308,,DTO_05007608,Immune response,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,2009.0,2019.0,ALL
28913,IGKV3-15,P01624,0.931,0.115,,DTO_05007608,Immune response,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
28915,IGKV3-7,A0A075B6H7,0.89,0.154,,,,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
28919,IGKV2-30,P06310,1.0,0.115,,DTO_05007608,Immune response,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2005.0,2016.0,ALL
28920,IGKV2-29,A2NJV5,0.769,0.231,,DTO_05007608,Immune response,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2005.0,2008.0,ALL
28930,IGKV1-39,P01597,1.0,0.115,,DTO_05007608,Immune response,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2009.0,2014.0,ALL
28942,IGKV1-8,A0A0C4DH67,0.931,0.154,,DTO_05007608,Immune response,C0238239,Light chain disease,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
28949,IGKJ2,,1.0,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
28950,IGKJ1,A0A0A0MT89,1.0,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
28951,TRIB2,Q92519,0.628,0.462,0.98349,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2013.0,2020.0,ALL
28952,CCDC22,O60826,0.595,0.692,0.99979,,,C0796137,3C syndrome,C16;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.51,1.0,,2015.0,2015.0,ALL
28954,REM1,O75628,0.531,0.885,5.3363e-08,,,C0004930,Behavior Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,1998.0,2020.0,ALL
28955,DEXI,O95424,0.792,0.308,0.4145,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.05,0.8,,2012.0,2020.0,ALL
28956,LAMTOR2,Q9Y2Q5,0.538,0.808,0.19816,,,C1835829,Immunodeficiency due to Defect in MAPBP-Interacting Protein,C20,   Immune System Diseases,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
28957,MRPS28,Q9Y2Q9,0.839,0.077,4.6621e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
28958,COA3,Q9Y2R0,0.89,0.231,0.064758,,,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.41,1.0,,2015.0,2015.0,ALL
28959,TMEM176B,Q3YBM2,0.769,0.346,1.4172e-10,DTO_05007575,Receptor,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
28960,DCPS,Q96C86,0.612,0.538,2.4654e-07,DTO_05007624,Enzyme,C4085595,AL-RAQAD SYNDROME,,,disease,Disease or Syndrome,0.71,1.0,strong,2015.0,2018.0,ALL
28962,OSTM1,Q86WC4,0.644,0.577,0.011293,,,C1968603,"Osteopetrosis, Autosomal Recessive 5",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.8,1.0,strong,1975.0,2014.0,ALL
28964,GIT1,Q9Y2X7,0.647,0.538,0.99978,,,C0041671,Attention Deficit Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2011.0,2011.0,ALL
28965,SLC27A6,Q9Y2P4,0.722,0.346,2.4339e-18,DTO_05007405,Transporter,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
28966,SNX24,Q9Y343,,,9.5459e-06,,,C4317009,Diverticular Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
28968,SLC6A16,Q9GZN6,1.0,0.038,4.2922e-13,DTO_05007405,Transporter,C0008354,Cholera,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
28969,BZW2,Q9Y6E2,0.78,0.231,0.1048,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
28970,C11orf54,Q9H0W9,1.0,0.077,2.8718e-08,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
28971,AAMDC,Q9H7C9,0.931,0.269,2.2702e-06,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
28972,SPCS1,Q9Y6A9,0.821,0.154,0.013927,DTO_05007599,Signaling,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
28973,MRPS18B,Q9Y676,0.805,0.231,5.6012e-05,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
28974,C19orf53,Q9UNZ5,1.0,0.038,0.056204,,,C0276289,Zika Virus Infection,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
28976,ACAD9,Q9H845,0.722,0.269,4.5256e-08,DTO_05007624,Enzyme,C1970173,"Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of",C23;C16;C18;C05;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.61,1.0,definitive,2002.0,2016.0,ALL
28977,MRPL42,Q9Y6G3,1.0,0.038,0.039597,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
28978,TMEM14A,Q9Y6G1,0.805,0.154,0.023377,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
28981,IFT81,Q8WYA0,0.7,0.385,9.0878e-12,,,C4693524,SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2018.0,ALL
28982,FLVCR1,Q9Y5Y0,0.529,0.885,0.0013127,DTO_05007405,Transporter,C1836916,POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA,C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.76,1.0,,2010.0,2018.0,ALL
28983,TMPRSS11E,Q9UL52,0.89,0.077,3.9622e-07,DTO_05007624,Enzyme,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
28984,RGCC,Q9H4X1,0.595,0.769,0.0048149,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
28985,MCTS1,Q9ULC4,0.552,0.692,0.87474,DTO_05007575,Receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
28986,MAGEH1,Q9H213,0.743,0.308,0.2292,DTO_05007620,Cell adhesion,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.04,1.0,,1992.0,2002.0,ALL
28987,NOB1,Q9ULX3,0.633,0.423,1.1349e-09,,,C0018781,Noise-induced hearing loss,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Injury or Poisoning,0.2,1.0,,2011.0,2011.0,ALL
28988,DBNL,Q9UJU6,0.695,0.654,0.017939,DTO_05007530,Cellular structure,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
28989,NTMT1,Q9BV86,0.805,0.154,0.050783,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
28990,ASTE1,Q2TB18,1.0,0.038,7.2103e-10,,,C0016048,Fibromatosis,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
28991,COMMD5,Q9GZQ3,0.821,0.154,1.497e-05,DTO_05007616,Calcium-binding protein,C1285654,Memory performance,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
28992,MACROD1,Q9BQ69,0.716,0.462,0.56909,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
28996,HIPK2,Q9H2X6,0.566,0.731,1.0,DTO_03300101,Kinase,C0027719,Nephrosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
28998,MRPL13,Q9BYD1,0.792,0.154,1.4307e-07,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
28999,KLF15,Q9UIH9,0.592,0.654,0.48843,DTO_05007557,Nucleic acid binding,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
29015,SLC43A3,Q8NBI5,0.861,0.154,2.232e-06,DTO_05007405,Transporter,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
29028,ATAD2,Q6PL18,0.636,0.423,0.9982,DTO_05007378,Epigenetic regulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
29034,CPS1-IT1,,0.722,0.308,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0,,2016.0,2019.0,ALL
29035,C16orf72,Q14CZ0,1.0,0.077,0.98049,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2013.0,2013.0,ALL
29058,TMEM230,Q96A57,0.769,0.115,0.00018056,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.4,0.923,,2016.0,2018.0,ALL
29063,ZCCHC4,Q9H5U6,0.931,0.115,2.1595e-10,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
29065,ASAP1-IT1,,0.839,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
29066,ZC3H7A,Q8IWR0,0.89,0.077,1.0,DTO_05007557,Nucleic acid binding,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
29068,ZBTB44,Q8NCP5,,,0.99929,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
29070,CCDC113,Q9H0I3,0.931,0.115,9.3239e-16,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
29071,C1GALT1C1,Q96EU7,0.736,0.423,0.85158,,,C0272137,Tn Syndrome,C20,   Immune System Diseases,disease,Disease or Syndrome,0.7,1.0,limited,2005.0,2016.0,ALL
29072,SETD2,Q9BYW2,0.424,0.846,1.0,DTO_05007378,Epigenetic regulator,C4085873,LUSCAN-LUMISH SYNDROME,,,disease,Disease or Syndrome,0.71,1.0,strong,2012.0,2018.0,ALL
29074,MRPL18,Q9H0U6,,,0.00016217,DTO_05007557,Nucleic acid binding,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
29078,NDUFAF4,Q9P032,0.686,0.385,0.55344,,,C4748778,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15",,,disease,Disease or Syndrome,0.6,1.0,,2008.0,2017.0,ALL
29079,MED4,Q9NPJ6,0.89,0.115,0.0076107,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
29080,CCDC59,Q9P031,1.0,0.115,4.0319e-11,,,C0848558,Hypospadias,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.1,1.0,,2014.0,2014.0,ALL
29081,METTL5,Q9NRN9,1.0,0.115,5.1688e-05,,,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.31,1.0,moderate,2019.0,2019.0,ALL
29082,CHMP4A,Q9BY43,0.89,0.115,3.3901e-09,DTO_05007405,Transporter,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
29085,PHPT1,Q9NRX4,0.674,0.577,6.427e-05,,,C0033806,Pseudohypoparathyroidism,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.07,1.0,,1978.0,2014.0,ALL
29086,BABAM1,Q9NWV8,0.678,0.385,0.96269,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.41,1.0,,2010.0,2017.0,ALL
29087,THYN1,Q9P016,0.89,0.231,1.9691e-16,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
29089,UBE2T,Q9NPD8,0.55,0.731,1.0599e-05,,,C4084840,"FANCONI ANEMIA, COMPLEMENTATION GROUP T",,,disease,Disease or Syndrome,0.71,1.0,,2015.0,2019.0,ALL
29091,STXBP6,Q8NFX7,0.805,0.269,7.8743e-05,DTO_05007405,Transporter,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
29092,LINC00339,,0.695,0.346,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
29094,LGALSL,Q3ZCW2,0.839,0.231,0.018392,DTO_05007599,Signaling,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
29095,ORMDL2,Q53FV1,1.0,0.077,0.19417,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
29097,CNIH4,Q9P003,0.931,0.077,0.021712,DTO_05007405,Transporter,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
29098,RANGRF,Q9HD47,0.751,0.231,2.4357e-05,,,C1142166,Brugada Syndrome (disorder),C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.55,0.889,disputed,2008.0,2019.0,ALL
29099,COMMD9,Q9P000,1.0,0.077,0.39357,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
29100,TMEM208,Q9BTX3,0.861,0.077,0.0015059,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
29101,SSU72,Q9NP77,1.0,,0.77861,DTO_05007624,Enzyme,C3160909,Autoimmune arthritis,,,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
29102,DROSHA,Q9NRR4,0.599,0.692,0.093176,DTO_05007624,Enzyme,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.33,1.0,,2014.0,2019.0,ALL
29103,DNAJC15,Q9Y5T4,0.736,0.192,1.682e-10,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
29104,N6AMT1,Q9Y5N5,1.0,0.077,6.8181e-06,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
29105,CFAP20,Q9Y6A4,0.792,0.154,0.00211,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
29106,SCG3,Q8WXD2,0.705,0.423,0.0014883,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
29107,NXT1,Q9UKK6,0.505,0.731,0.64574,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1995.0,2015.0,ALL
29108,PYCARD,Q9ULZ3,0.457,0.808,0.00019768,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.35,1.0,,2002.0,2014.0,ALL
29109,FHOD1,Q9Y613,0.805,0.154,1.8119e-16,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
29110,TBK1,Q9UHD2,0.513,0.846,0.075174,DTO_03300101,Kinase,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2019.0,ALL
29113,C6orf15,Q6UXA7,0.931,0.038,0.010531,,,C0036202,Sarcoidosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
29114,TAGLN3,Q9UI15,0.931,0.077,0.18493,DTO_05007530,Cellular structure,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2005.0,2005.0,ALL
29115,SAP30BP,Q9UHR5,0.89,0.115,0.00011365,DTO_05007542,Transcription factor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
29116,MYLIP,Q8WY64,0.582,0.692,0.18431,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
29117,BRD7,Q9NPI1,0.638,0.5,0.99774,DTO_05007378,Epigenetic regulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
29118,DDX25,Q9UHL0,0.805,0.269,1.8125e-18,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
29119,CTNNA3,Q9UI47,0.612,0.692,1.0225e-12,DTO_05007530,Cellular structure,C3810138,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2013.0,ALL
29121,CLEC2D,Q9UHP7,0.736,0.308,0.23009,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
29122,PRSS50,Q9UI38,0.729,0.346,0.0002253,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.09,1.0,,1999.0,2018.0,ALL
29123,ANKRD11,Q6UB99,0.556,0.808,1.0,,,C0220687,KBG syndrome,C23;C16;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,1.0,definitive,2008.0,2019.0,ALL
29124,LGALS13,Q9UHV8,0.716,0.462,0.0011274,DTO_05007599,Signaling,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.04,1.0,,2004.0,2017.0,ALL
29125,C11orf21,Q9P2W6,0.821,0.192,0.016355,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,1.0,,2013.0,2017.0,ALL
29126,CD274,Q9NZQ7,0.324,0.923,0.01916,DTO_05007575,Receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,0.979,,2003.0,2020.0,ALL
29127,RACGAP1,Q9H0H5,0.636,0.462,0.0017041,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2011.0,2019.0,ALL
29128,UHRF1,Q96T88,0.54,0.692,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.38,1.0,,2014.0,2019.0,ALL
29760,BLNK,Q8WV28,0.603,0.731,0.61083,DTO_05007599,Signaling,C0001768,Agammaglobulinemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.61,1.0,strong,2015.0,2015.0,ALL
29761,USP25,Q9UHP3,0.743,0.308,0.7522,DTO_05007624,Enzyme,C0429097,QRS complex feature,,,phenotype,Finding,0.1,1.0,,2016.0,2016.0,ALL
29763,PACSIN3,Q9UKS6,,,0.0018909,DTO_05007530,Cellular structure,C0428568,Fasting blood glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
29764,DDU,,1.0,0.077,,,,C1852146,DERMODISTORTIVE URTICARIA,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,1981.0,1981.0,ALL
29765,TMOD4,Q9NZQ9,0.751,0.385,1.8344e-08,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2008.0,2019.0,ALL
29766,TMOD3,Q9NYL9,0.78,0.154,0.06636,DTO_05007530,Cellular structure,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
29767,TMOD2,Q9NZR1,1.0,0.038,0.019553,DTO_05007530,Cellular structure,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
29774,POM121L9P,,0.931,0.077,,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
29775,CARD10,Q9BWT7,0.656,0.423,0.0022648,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.11,1.0,,2012.0,2016.0,ALL
29777,ABT1,Q9ULW3,0.89,0.115,0.020296,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
29780,PARVB,Q9HBI1,0.736,0.385,2.3813e-13,DTO_05007530,Cellular structure,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.14,1.0,,2013.0,2016.0,ALL
29781,NCAPH2,Q6IBW4,0.805,0.385,0.00028787,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
29785,CYP2S1,Q96SQ9,0.743,0.385,4.8125e-05,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.31,1.0,,2003.0,2003.0,ALL
29789,OLA1,Q9NTK5,0.78,0.269,0.058062,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.42,0.667,,2009.0,2014.0,ALL
29796,UQCR10,Q9UDW1,0.839,0.115,0.14162,DTO_05007624,Enzyme,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
29798,C2orf27A,P0DPF5,0.931,0.038,0.3491,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
29799,YPEL1,O60688,0.89,0.115,0.60986,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
29800,ZDHHC1,Q8WTX9,1.0,0.077,4.8355e-10,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
29801,ZDHHC8,Q9ULC8,0.769,0.346,0.85288,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,0.2,,2004.0,2017.0,ALL
29802,VPREB3,Q9UKI3,0.821,0.192,0.094588,DTO_05007608,Immune response,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2010.0,2014.0,ALL
29803,REPIN1,Q9BWE0,0.792,0.231,0.09473,DTO_05007542,Transcription factor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
29841,GRHL1,Q9NZI5,0.7,0.423,0.2395,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.12,1.0,,1996.0,2017.0,ALL
29842,TFCP2L1,Q9NZI6,0.751,0.346,0.99996,DTO_05007542,Transcription factor,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.11,1.0,,2017.0,2018.0,ALL
29843,SENP1,Q9P0U3,0.593,0.654,0.99358,DTO_05007624,Enzyme,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
29844,TFPT,P0C1Z6,0.839,0.154,0.00010562,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
29850,TRPM5,Q9NZQ8,0.736,0.308,4.4415e-22,DTO_01300327,Ion channel,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2014.0,2014.0,ALL
29851,ICOS,Q9Y6W8,0.502,0.731,0.031284,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.8,1.0,,2001.0,2017.0,ALL
29855,UBN1,Q9NPG3,0.839,0.385,0.99995,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
29880,ALG5,Q9Y673,,,0.46347,,,C2697758,Interleukin 10 Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
29881,NPC1L1,Q9UHC9,0.656,0.423,2.3098e-20,DTO_05007405,Transporter,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2007.0,2007.0,ALL
29882,ANAPC2,Q9UJX6,0.931,0.115,0.99993,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
29883,CNOT7,Q9UIV1,0.691,0.5,0.99686,DTO_05007542,Transcription factor,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.2,1.0,,2012.0,2012.0,ALL
29886,SNX8,Q9Y5X2,0.792,0.231,0.062391,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
29887,SNX10,Q9Y5X0,0.633,0.577,3.3891e-10,,,C3554478,"OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8",,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2013.0,ALL
29888,STRN4,Q9NRL3,0.792,0.346,0.99376,,,C0003706,Arachnodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,,,,,ALL
29889,GNL2,Q13823,0.931,0.038,6.52e-05,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
29890,RBM15B,Q8NDT2,0.861,0.154,0.99557,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
29893,PSMC3IP,Q9P2W1,0.659,0.5,3.7819e-05,DTO_05007557,Nucleic acid binding,C3280471,OVARIAN DYSGENESIS 3,,,disease,Disease or Syndrome,0.5,1.0,moderate,2014.0,2014.0,ALL
29894,CPSF1,Q10570,0.821,0.154,3.1043e-10,DTO_05007557,Nucleic acid binding,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
29895,MYLPF,Q96A32,0.89,0.231,0.76035,DTO_05007616,Calcium-binding protein,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
29896,TRA2A,Q13595,0.751,0.269,0.0095214,DTO_05007557,Nucleic acid binding,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
29899,GPSM2,P81274,0.682,0.538,7.6958e-11,,,C1858695,Chudley-Mccullough syndrome,C23;C16;C04;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.76,1.0,definitive,1996.0,2018.0,ALL
29901,SAC3D1,A6NKF1,0.861,0.077,0.0005748,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
29903,CCDC106,Q9BWC9,0.792,0.192,0.027151,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
29904,EEF2K,O00418,0.641,0.385,8.3628e-20,DTO_03300101,Kinase,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
29906,ST8SIA5,O15466,0.931,0.038,0.00056385,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
29909,GPR171,O14626,0.931,0.192,0.00016964,DTO_02300001,G-protein coupled receptor,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
29911,HOOK2,Q96ED9,0.659,0.654,4.6471e-18,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
29914,UBIAD1,Q9Y5Z9,0.7,0.462,0.019529,DTO_05007624,Enzyme,C0271287,Schnyder crystalline corneal dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,1.0,0.957,strong,2007.0,2019.0,ALL
29915,HCFC2,Q9Y5Z7,1.0,0.077,0.99989,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
29916,SNX11,Q9Y5W9,1.0,0.038,7.3043e-07,,,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
29919,RMC1,Q96DM3,0.555,0.731,0.98823,,,C0005910,Body Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
29920,PYCR2,Q96C36,0.682,0.462,2.0652e-06,,,C4225332,"LEUKODYSTROPHY, HYPOMYELINATING, 10",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2017.0,ALL
29922,NME7,Q9Y5B8,0.729,0.423,4.0454e-06,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
29923,HILPDA,Q9Y5L2,0.656,0.538,0.31634,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
29924,EPN1,Q9Y6I3,1.0,0.115,0.78579,,,C0740392,"Infarction, Middle Cerebral Artery",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,2009.0,2009.0,ALL
29925,GMPPB,Q9Y5P6,0.578,0.538,8.437e-07,,,C3714932,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2017.0,ALL
29926,GMPPA,Q96IJ6,0.711,0.385,8.3635e-09,,,C3809738,"ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2013.0,ALL
29927,SEC61A1,P61619,0.722,0.5,0.98675,DTO_05007405,Transporter,C4310741,"HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2019.0,ALL
29928,TIMM22,Q9Y584,1.0,0.077,3.9658e-05,DTO_05007405,Transporter,C0162670,Mitochondrial Myopathies,C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
29929,ALG6,Q9Y672,0.805,0.231,0.00030541,DTO_05007624,Enzyme,C2930997,Congenital disorder of glycosylation type 1C,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.77,1.0,strong,1999.0,2016.0,ALL
29930,PCDHB1,Q9Y5F3,0.861,0.115,7.528e-11,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
29931,LINC00312,Q9Y6C7,0.711,0.385,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.06,1.0,,2009.0,2018.0,ALL
29933,GPR132,Q9UNW8,0.722,0.462,0.016959,DTO_02300001,G-protein coupled receptor,C0003089,Ankylosing spondylitis and other inflammatory spondylopathies,C01;C05,   Infections;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.2,1.0,,2001.0,2001.0,ALL
29934,SNX12,Q9UMY4,0.931,0.115,0.78413,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
29937,NENF,Q9UMX5,0.861,0.308,0.021641,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
29940,DSE,Q9UL01,0.7,0.462,0.6331,,,C3809845,"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2015.0,ALL
29941,PKN3,Q6P5Z2,0.821,0.269,6.1081e-19,DTO_03300101,Kinase,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
29942,PURG,Q9UJV8,0.931,0.154,0.961,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
29943,PADI1,Q9ULC6,0.644,0.692,2.0388e-15,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.03,1.0,,2017.0,2020.0,ALL
29945,ANAPC4,Q9UJX5,0.861,0.154,0.00069453,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
29946,SERTAD3,Q9UJW9,,,0.018142,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
29947,DNMT3L,Q9UJW3,0.638,0.423,8.415e-13,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
29948,OSGIN1,Q9UJX0,0.729,0.423,1.5746e-11,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
29949,IL19,Q9UHD0,0.558,0.769,4.325e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
29950,SERTAD1,Q9UHV2,0.729,0.231,0.32037,DTO_05007542,Transcription factor,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2008.0,2011.0,ALL
29951,PDZRN4,Q6ZMN7,0.805,0.269,9.1425e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
29952,DPP7,Q9UHL4,0.839,0.269,3.9946e-22,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
29953,TRHDE,Q9UKU6,,,1.0218e-06,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
29954,POMT2,Q9UKY4,0.544,0.615,9.4315e-12,,,C3150418,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2",,,disease,Disease or Syndrome,0.71,1.0,strong,2005.0,2018.0,ALL
29956,CERS2,Q96G23,0.691,0.5,0.47978,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2017.0,2019.0,ALL
29957,SLC25A24,Q6NUK1,0.575,0.731,3.3527e-12,DTO_05007405,Transporter,C2676780,"Progeroid Syndrome, Congenital, Petty Type",C23;C16;C18,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.62,1.0,,2017.0,2019.0,ALL
29958,DMGDH,Q9UI17,0.89,0.154,2.0503e-24,DTO_05007624,Enzyme,C1853892,Dimethylglycine Dehydrogenase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,limited,1997.0,2016.0,ALL
29959,NRBP1,Q9UHY1,0.729,0.346,0.99998,DTO_03300101,Kinase,C1335167,Ovarian Mucinous Adenocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
29960,MRM2,Q9UI43,0.821,0.269,0.00023612,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2014.0,2017.0,ALL
29964,PRICKLE4,Q2TBC4,0.839,0.154,4.0289e-05,DTO_05007530,Cellular structure,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
29965,CDIP1,Q9H305,0.931,0.115,0.87001,DTO_05007542,Transcription factor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
29966,STRN3,Q13033,0.839,0.154,0.82925,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
29967,LRP12,Q9Y561,0.743,0.462,0.99799,DTO_05007624,Enzyme,C0270952,"Muscular Dystrophy, Oculopharyngeal",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2019.0,2019.0,ALL
29968,PSAT1,Q9Y617,0.478,0.846,1.0621e-08,,,C1970253,Phosphoserine Aminotransferase Deficiency,C23;C16;C05;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.71,1.0,,2007.0,2020.0,ALL
29969,MDFIC,Q9P1T7,0.76,0.308,0.037611,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
29970,SCHIP1,P0DPB3,0.839,0.308,0.98715,,,C0149745,Oral Ulcer,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
29974,A1CF,Q9NQ94,0.604,0.692,5.9218e-10,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
29978,UBQLN2,Q9UHD9,0.656,0.462,0.84968,,,C3275459,"AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA",,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2015.0,ALL
29979,UBQLN1,Q9UMX0,0.65,0.423,0.99884,,,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0,,2015.0,2015.0,ALL
29980,DONSON,Q9NYP3,0.636,0.538,1.319e-07,,,C4539873,"MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES",,,disease,Disease or Syndrome,0.62,1.0,,2017.0,2019.0,ALL
29982,NRBF2,Q96F24,0.839,0.231,0.00050432,DTO_05007542,Transcription factor,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
29984,RHOD,O00212,0.736,0.385,0.015921,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2014.0,ALL
29985,SLC39A3,Q9BRY0,0.805,0.192,0.1197,DTO_05007405,Transporter,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
29986,SLC39A2,Q9NP94,0.751,0.5,7.204e-05,DTO_05007405,Transporter,C0235950,Zinc deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.03,1.0,,2014.0,2018.0,ALL
29988,SLC2A8,Q9NY64,0.821,0.346,8.0241e-07,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
29990,PILRB,Q9UKJ0,,,0.00012455,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
29991,OBP2A,Q9NY56,0.61,0.462,1.5163e-06,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2004.0,2017.0,ALL
29992,PILRA,Q9UKJ1,0.769,0.308,1.726e-11,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.13,1.0,,2018.0,2019.0,ALL
29993,PACSIN1,Q9BY11,0.931,0.154,0.99887,DTO_05007530,Cellular structure,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
29994,BAZ2B,Q9UIF8,0.839,0.192,0.98162,,,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
29995,LMCD1,Q9NZU5,0.839,0.192,0.0011817,DTO_05007530,Cellular structure,C0026267,Mitral Valve Prolapse Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.4,1.0,,2015.0,2015.0,ALL
29997,NOP53,Q9NZM5,0.597,0.577,0.18147,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
29998,BICRA,Q9NZM4,0.695,0.269,0.98349,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
29999,FSCN3,Q9NQT6,1.0,0.077,1.3467e-10,DTO_05007530,Cellular structure,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
30000,TNPO2,O14787,0.861,0.231,1.0,DTO_05007405,Transporter,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
30001,ERO1A,Q96HE7,0.678,0.538,0.80854,DTO_05007624,Enzyme,C0752308,"Hypoxia-Ischemia, Brain",C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2003.0,2003.0,ALL
30008,EFEMP2,O95967,0.559,0.692,0.0081938,DTO_05007616,Calcium-binding protein,C3280798,"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB",,,disease,Disease or Syndrome,0.7,1.0,strong,1991.0,2016.0,ALL
30009,TBX21,Q9UL17,0.541,0.808,0.99636,DTO_05007542,Transcription factor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.944,,2002.0,2019.0,ALL
30010,NXPH1,P58417,0.711,0.385,0.4837,DTO_05007599,Signaling,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
30011,SH3KBP1,Q96B97,0.705,0.615,0.99899,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2004.0,2004.0,ALL
30012,TLX3,O43711,0.674,0.462,0.25993,,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.4,0.889,,2001.0,2019.0,ALL
30014,SPANXA1,Q9NS26,0.682,0.346,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2004.0,2015.0,ALL
30061,SLC40A1,Q9NP59,0.57,0.731,0.98835,DTO_05007405,Transporter,C1853733,"HEMOCHROMATOSIS, TYPE 4",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,1.0,,1999.0,2019.0,ALL
30062,RAX,Q9Y2V3,0.729,0.346,0.10092,,,C1970237,"Microphthalmia, Isolated 3",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2004.0,2014.0,ALL
30811,HUNK,P57058,0.821,0.115,0.99589,DTO_03300101,Kinase,C0684328,Reasoning,,,phenotype,Mental Process,0.1,1.0,,2011.0,2011.0,ALL
30812,SOX8,P57073,0.674,0.692,0.67167,,,C4721453,Peripheral Nervous System Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.31,1.0,,2010.0,2010.0,ALL
30813,VSX1,Q9NZR4,0.579,0.692,0.035854,,,C1835677,Keratoconus 1,C11,   Eye Diseases,disease,Disease or Syndrome,0.7,1.0,,2002.0,2011.0,ALL
30814,PLA2G2E,Q9NZK7,0.805,0.308,2.4363e-05,DTO_05007624,Enzyme,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
30815,ST6GALNAC6,Q969X2,1.0,0.115,0.0022236,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
30816,ERVW-1,Q9UQF0,0.505,0.692,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,1.0,,2008.0,2019.0,ALL
30817,ADGRE2,Q9UHX3,0.581,0.615,2.7615e-28,DTO_02300001,G-protein coupled receptor,C0157743,Vibratory urticaria,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.62,1.0,,2016.0,2018.0,ALL
30818,KCNIP3,Q9Y2W7,0.626,0.654,0.037604,DTO_01300327,Ion channel,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.39,1.0,,2013.0,2019.0,ALL
30819,KCNIP2,Q9NS61,0.821,0.077,0.015425,DTO_01300327,Ion channel,C0085612,Ventricular arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
30820,KCNIP1,Q9NZI2,0.716,0.5,0.0042091,DTO_01300327,Ion channel,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
30827,CXXC1,Q9P0U4,0.792,0.385,0.89506,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
30829,IBD3,,0.861,0.038,,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.09,0.889,,2000.0,2018.0,ALL
30832,ZNF354C,Q86Y25,0.861,0.154,4.108e-10,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2016.0,2016.0,ALL
30833,NT5C,Q8TCD5,0.729,0.231,0.0027292,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
30834,ZNRD1,Q9P1U0,0.653,0.654,0.2067,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2004.0,2016.0,ALL
30835,CD209,Q9NNX6,0.626,0.769,2.7418e-13,DTO_05007575,Receptor,C0011311,Dengue Fever,C01,   Infections,disease,Disease or Syndrome,0.4,1.0,,2005.0,2018.0,ALL
30836,DNTTIP2,Q5QJE6,1.0,0.077,1.3493e-08,,,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
30837,SOCS7,O14512,0.736,0.423,0.99807,DTO_05007584,Enzyme modulator,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
30844,EHD4,Q9H223,0.931,0.115,4.1903e-05,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
30845,EHD3,Q9NZN3,0.729,0.308,0.042234,DTO_05007584,Enzyme modulator,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2012.0,2014.0,ALL
30846,EHD2,Q9NZN4,0.76,0.385,0.30763,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2009.0,2019.0,ALL
30848,CTAG2,O75638,0.729,0.346,0.10495,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,1998.0,2018.0,ALL
30849,PIK3R4,Q99570,0.663,0.692,0.024537,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
30850,CDR2L,Q86X02,0.861,0.192,0.0019629,,,C1859308,PREMATURE CENTROMERE DIVISION,,,disease,Disease or Syndrome,0.04,1.0,,2013.0,2019.0,ALL
30851,TAX1BP3,O14907,0.716,0.615,0.0052431,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
30968,STOML2,Q9UJZ1,0.601,0.462,0.0024144,DTO_05007584,Enzyme modulator,C0011616,Contact Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
43847,KLK14,Q9P0G3,0.711,0.385,1.9965e-08,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
43849,KLK12,Q9UKR0,0.729,0.308,3.1679e-05,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
49854,ZBTB21,Q9ULJ3,0.89,0.154,0.99778,DTO_05007542,Transcription factor,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
49855,SCAPER,Q9BY12,0.653,0.5,0.0087953,,,C4748658,INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA,,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
49860,CRNN,Q9UBG3,0.736,0.308,0.00012577,DTO_05007616,Calcium-binding protein,C0152018,Esophageal carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2000.0,2014.0,ALL
50484,RRM2B,Q7LG56,0.527,0.769,0.002357,DTO_05007624,Enzyme,C2749861,MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY),,,disease,Disease or Syndrome,0.7,1.0,,2007.0,2016.0,ALL
50485,SMARCAL1,Q9NZC9,0.599,0.654,2.2554e-06,,,C0877024,Schimke immunoosseous dysplasia,C16;C13;C05;C12;C08;C20;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Respiratory Tract Diseases;    Immune System Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,1.0,1.0,,1998.0,2019.0,ALL
50486,G0S2,P27469,0.656,0.423,0.37788,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
50487,PLA2G3,Q9NZ20,0.805,0.231,3.5604e-11,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
50488,MINK1,Q8N4C8,0.743,0.346,1.0,DTO_03300101,Kinase,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
50489,CD207,Q9UJ71,0.631,0.692,2.8182e-06,DTO_05007575,Receptor,C3150657,BIRBECK GRANULE DEFICIENCY,,,disease,Disease or Syndrome,0.3,1.0,,2005.0,2006.0,ALL
50506,DUOX2,Q9NRD8,0.533,0.769,4.5032e-56,DTO_05007624,Enzyme,C0010308,Congenital Hypothyroidism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.9,0.976,strong,2002.0,2019.0,ALL
50507,NOX4,Q9NPH5,0.471,0.885,5.7555e-20,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.6,1.0,,2007.0,2019.0,ALL
50508,NOX3,Q9HBY0,0.729,0.538,1.632e-14,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
50509,COL5A3,P25940,0.89,0.231,3.3468e-20,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
50511,SYCP3,Q8IZU3,0.663,0.385,9.1772e-05,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.63,1.0,,2003.0,2005.0,ALL
50514,DELEC1,Q9P2X7,0.573,0.692,2.6727e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
50515,CHST11,Q9NPF2,0.682,0.5,0.40602,DTO_05007624,Enzyme,C0018536,Hallux Valgus,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,,,,,ALL
50604,IL20,Q9NYY1,0.556,0.769,1.3447e-06,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.31,0.5,,2009.0,2017.0,ALL
50608,IBD4,,0.89,0.077,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0,,2003.0,2018.0,ALL
50614,GALNT9,Q9HCQ5,0.821,0.115,0.0052407,DTO_05007624,Enzyme,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2015.0,2015.0,ALL
50615,IL21R,Q9HBE5,0.55,0.731,0.99835,DTO_05007575,Receptor,C3554687,IMMUNODEFICIENCY 56,,,disease,Disease or Syndrome,0.7,1.0,strong,2003.0,2013.0,ALL
50616,IL22,Q9GZX6,0.393,0.885,0.00018843,,,C0241910,Autoimmune Chronic Hepatitis,C06;C20,   Digestive System Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.31,1.0,,2011.0,2018.0,ALL
50617,ATP6V0A4,Q9HBG4,0.722,0.385,2.1504e-20,DTO_05007405,Transporter,C1864498,"RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE",C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.77,1.0,,1999.0,2018.0,ALL
50618,ITSN2,Q9NZM3,0.711,0.423,9.7511e-13,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
50619,DEF6,Q9H4E7,0.751,0.346,0.99768,DTO_05007557,Nucleic acid binding,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.52,1.0,,2006.0,2018.0,ALL
50624,CUZD1,Q86UP6,0.769,0.308,2.2917e-11,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0,,2015.0,2017.0,ALL
50626,CYHR1,Q6ZMK1,0.805,0.192,0.49115,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
50628,GEMIN4,P57678,0.565,0.808,5.8966e-13,,,C4693567,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES",,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2019.0,ALL
50632,CALY,Q9NYX4,0.821,0.192,0.038696,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.5,,2004.0,2004.0,ALL
50636,ANO7,Q6IWH7,0.839,0.115,3.4578e-42,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.05,1.0,,2005.0,2018.0,ALL
50639,MBL3P,,0.518,0.769,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,0.8,,1999.0,2014.0,ALL
50640,PNPLA8,Q9NP80,0.792,0.308,0.011024,,,C1855033,Mitochondrial myopathy with lactic acidosis,C23;C18;C05;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2018.0,ALL
50649,ARHGEF4,Q9NR80,0.839,0.269,0.0007357,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
50650,ARHGEF3,Q9NR81,0.751,0.346,0.0040454,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
50651,SLC45A1,Q9Y2W3,0.674,0.269,2.4761e-05,DTO_05007405,Transporter,C4479636,INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES,,,disease,Disease or Syndrome,0.6,1.0,moderate,2017.0,2017.0,ALL
50652,PCA3,,0.663,0.615,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.909,,2003.0,2019.0,ALL
50674,NEUROG3,Q9Y4Z2,0.647,0.5,5.9611e-06,DTO_05007624,Enzyme,C1835888,"Diarrhea 4, Malabsorptive, Congenital",C23;C06;C18,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2006.0,ALL
50700,RDH8,Q9NYR8,0.861,0.038,0.0011708,DTO_05007624,Enzyme,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
50715,EJM2,,0.751,0.192,,,,C0270853,Juvenile Myoclonic Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.05,1.0,,1994.0,2018.0,ALL
50717,DCAF8,Q5TAQ9,0.821,0.115,0.99521,DTO_05007584,Enzyme modulator,C4013360,"GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.7,1.0,limited,2014.0,2014.0,ALL
50801,KCNK4,Q9NYG8,0.743,0.385,0.005677,DTO_01300327,Ion channel,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,,2018.0,2018.0,ALL
50802,IGK,,0.647,0.462,,,,C0242596,"Neoplasm, Residual",C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,0.833,,1998.0,2017.0,ALL
50804,MYEF2,Q9P2K5,0.89,0.192,0.63452,DTO_05007557,Nucleic acid binding,C0037290,Skin Pigmentation,,,phenotype,Organ or Tissue Function,0.1,1.0,,2017.0,2017.0,ALL
50805,IRX4,P78413,0.821,0.154,0.011525,DTO_05007542,Transcription factor,C0018818,Ventricular Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.31,1.0,limited,2011.0,2011.0,ALL
50807,ASAP1,Q9ULH1,0.556,0.808,1.0,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
50808,AK3,Q9UIJ7,0.691,0.462,0.0001135,DTO_03300101,Kinase,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
50809,HP1BP3,Q5SSJ5,0.805,0.154,0.98422,,,C0221074,"Depression, Postpartum",C13;F03,   Female Urogenital Diseases and Pregnancy Complications;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2014.0,2020.0,ALL
50810,HDGFL3,Q9Y3E1,0.805,0.192,0.9738,DTO_05007599,Signaling,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
50813,COPS7A,Q9UBW8,0.861,0.115,0.043607,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2011.0,2019.0,ALL
50814,NSDHL,Q15738,0.621,0.538,0.96393,DTO_05007624,Enzyme,C0265267,Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.78,0.909,,2000.0,2019.0,ALL
50823,HMU,,1.0,,,,,C0730362,Disorder of macula of retina,C11,   Eye Diseases,group,Disease or Syndrome,0.01,1.0,,1992.0,1992.0,ALL
50830,TGCT1,,0.861,0.154,,,,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.02,1.0,,2003.0,2004.0,ALL
50831,TAS2R3,Q9NYW6,0.931,0.115,0.00046636,DTO_02300001,G-protein coupled receptor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2001.0,2001.0,ALL
50832,TAS2R4,Q9NYW5,1.0,0.038,5.089e-06,DTO_02300001,G-protein coupled receptor,C0007133,"Carcinoma, Papillary",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
50833,TAS2R16,Q9NYV7,0.736,0.192,,DTO_02300001,G-protein coupled receptor,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2006.0,2019.0,ALL
50834,TAS2R1,Q9NYW7,1.0,0.038,,DTO_02300001,G-protein coupled receptor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0,,2009.0,2009.0,ALL
50835,TAS2R9,Q9NYW1,,,,DTO_02300001,G-protein coupled receptor,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
50838,TAS2R13,Q9NYV9,0.653,0.615,,DTO_02300001,G-protein coupled receptor,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
50839,TAS2R10,Q9NYW0,0.78,0.308,,DTO_02300001,G-protein coupled receptor,C0236734,Caffeine related disorders,,,group,Mental or Behavioral Dysfunction,0.02,1.0,,2017.0,2018.0,ALL
50840,TAS2R14,Q9NYV8,0.769,0.346,,DTO_02300001,G-protein coupled receptor,C0033845,Pseudotumor Cerebri,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
50846,DHH,O43323,0.65,0.423,0.22445,,,C1856273,"46,XY Gonadal Dysgenesis, Complete or Partial, DHH-Related",C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.7,1.0,strong,2004.0,2018.0,ALL
50848,F11R,Q9Y624,0.542,0.731,1.8487e-05,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.24,1.0,,2007.0,2012.0,ALL
50852,TRAT1,Q6PIZ9,0.615,0.692,0.056441,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.95,,1992.0,2019.0,ALL
50853,VILL,O15195,,,3.9093e-23,DTO_05007530,Cellular structure,C0025568,Metaplasia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.01,1.0,,2007.0,2007.0,ALL
50854,SNHG32,,0.805,0.308,0.023621,,,C0001175,Acquired Immunodeficiency Syndrome,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
50855,PARD6A,Q9NPB6,0.861,0.231,0.0064719,DTO_05007527,Cell-cell junction,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2009.0,2017.0,ALL
50856,CLEC4A,Q9UMR7,0.792,0.269,4.1872e-05,DTO_05007575,Receptor,C0020517,Hypersensitivity,C20,   Immune System Diseases,group,Pathologic Function,0.3,1.0,,2013.0,2013.0,ALL
50858,TTTY1,,1.0,0.192,,,,C0206661,Gonadoblastoma,C16;C04;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
50859,SPOCK3,Q9BQ16,0.89,0.154,0.013583,DTO_05007584,Enzyme modulator,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
50861,STMN3,Q9NZ72,0.805,0.077,0.083885,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
50862,RNF141,Q8WVD5,0.931,0.154,9.0192e-05,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
50863,NTM,Q9P121,0.644,0.577,0.057798,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
50865,HEBP1,Q9NRV9,0.695,0.538,4.1767e-06,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
50937,CDON,Q4KMG0,0.601,0.731,2.0608e-15,,,C3280215,HOLOPROSENCEPHALY 11,,,disease,Disease or Syndrome,0.9,1.0,,2003.0,2011.0,ALL
50939,IMPG2,Q9BZV3,0.659,0.308,2.7548e-13,DTO_05007621,Extracellular structure,C3150819,RETINITIS PIGMENTOSA 56,,,disease,Disease or Syndrome,0.6,,,,,ALL
50940,PDE11A,Q9HCR9,0.612,0.654,8.6896e-37,,,C1864851,"Pigmented Nodular Adrenocortical Disease, Primary, 2",C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.6,1.0,strong,2006.0,2006.0,ALL
50941,IBD5,,0.705,0.538,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,0.917,,2003.0,2014.0,ALL
50942,IBD6,,0.861,0.077,,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.05,1.0,,2005.0,2016.0,ALL
50943,FOXP3,Q9BZS1,0.368,0.846,0.99424,,,C0342288,Insulin-dependent diabetes mellitus secretory diarrhea syndrome,C23;C16;C18;C20;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,1.0,0.971,,1991.0,2019.0,ALL
50944,SHANK1,Q9Y566,0.678,0.385,1.0,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.53,1.0,,2008.0,2018.0,ALL
50945,TBX22,Q9Y458,0.603,0.577,0.97704,DTO_05007542,Transcription factor,C1844830,"CLEFT PALATE, X-LINKED",C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.9,0.929,,2001.0,2018.0,ALL
50947,BHD,,0.678,0.385,,,,C0346010,Multiple fibrofolliculomas,C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",disease,Disease or Syndrome,0.09,1.0,,2003.0,2010.0,ALL
50951,MMVP1,,1.0,0.077,,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
50952,HMN7A,,1.0,0.077,,,,C1853710,"HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
50960,MYMY1,,1.0,0.077,,,,C0026654,Moyamoya Disease,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,,,,,ALL
50964,SOST,Q9BQB4,0.474,0.808,0.86731,,,C0432272,Van Buchem disease,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1986.0,2019.0,ALL
50966,ECA1,,0.805,0.231,,,,C0014553,Absence Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,1999.0,2002.0,ALL
50968,FCMTE1,,0.769,0.231,,,,C4273988,Benign adult familial myoclonic epilepsy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0,,2003.0,2009.0,ALL
50971,ENFL2,,0.839,0.346,,,,C3696898,Autosomal Dominant Nocturnal Frontal Lobe Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2000.0,2004.0,ALL
50975,TCO,,0.839,0.115,,,,C3501843,Nonmedullary Thyroid Carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,1998.0,1999.0,ALL
50976,GRD2,,1.0,0.115,,,,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,0.0,,2008.0,2008.0,ALL
50989,HMSNO,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
50999,TMED5,Q9Y3A6,0.682,0.577,5.2721e-09,DTO_05007405,Transporter,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
51000,SLC35B3,Q9H1N7,1.0,0.077,1.3646e-10,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
51002,TPRKB,Q9Y3C4,0.691,0.385,0.00821,,,C4540274,GALLOWAY-MOWAT SYNDROME 5,,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2018.0,ALL
51003,MED31,Q9Y3C7,0.89,0.038,0.00068836,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51004,COQ6,Q9Y2Z9,0.76,0.385,4.3324e-15,DTO_05007624,Enzyme,C3553349,"COENZYME Q10 DEFICIENCY, PRIMARY, 6",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2017.0,ALL
51005,AMDHD2,Q9Y303,1.0,0.077,0.002313,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
51008,ASCC1,Q8N9N2,0.495,0.846,2.6051e-14,,,C4225176,SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2,,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
51009,DERL2,Q9GZP9,0.617,0.615,0.9574,DTO_05007575,Receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,1.0,,2009.0,2018.0,ALL
51010,EXOSC3,Q9NQT5,0.61,0.692,0.00024296,DTO_05007624,Enzyme,C3553449,"PONTOCEREBELLAR HYPOPLASIA, TYPE 1B",,,disease,Disease or Syndrome,0.75,1.0,,2012.0,2020.0,ALL
51012,PRELID3B,Q9Y3B1,,,0.136,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
51013,EXOSC1,Q9Y3B2,0.931,0.154,7.3521e-09,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
51014,TMED7,Q86XR7;Q9Y3B3,0.436,0.808,0.47966,DTO_05007405,Transporter,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
51015,ISOC1,Q96CN7,0.821,0.192,6.0952e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
51018,RRP15,Q9Y3B9,,,0.00029428,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
51019,WASHC3,Q9Y3C0,,,0.0045705,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51020,HDDC2,Q7Z4H3,1.0,0.077,2.0302e-05,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
51021,MRPS16,Q9Y3D3,0.821,0.231,0.058297,DTO_05007557,Nucleic acid binding,C1864843,Combined Oxidative Phosphorylation Deficiency 2,C23;C16;C18;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,moderate,2004.0,2015.0,ALL
51022,GLRX2,Q9NS18,0.839,0.192,0.0008599,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
51023,MRPS18C,Q9Y3D5,0.89,0.154,8.7553e-05,DTO_05007557,Nucleic acid binding,C0027672,"Neoplastic Syndromes, Hereditary",C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",group,Neoplastic Process,0.1,,,,,ALL
51024,FIS1,Q9Y3D6,0.663,0.769,1.302e-05,,,C0600519,Ventricular Remodeling,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organ or Tissue Function,0.3,1.0,,2011.0,2011.0,ALL
51025,PAM16,Q9Y3D7,0.729,0.462,0.23509,DTO_05007405,Transporter,C2750075,"Chondrodysplasia, Megarbane-Dagher-Melki Type",C23;C16;C05;C19;F03,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.7,1.0,moderate,2014.0,2016.0,ALL
51026,GOLT1B,Q9Y3E0,0.89,0.154,0.85264,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
51028,VPS36,Q86VN1,0.89,0.115,0.046442,,,C0011119,Decompression Sickness,C26,   Wounds and Injuries,disease,Disease or Syndrome,0.01,0.0,,2017.0,2017.0,ALL
51029,DESI2,Q9BSY9,0.691,0.385,0.8483,DTO_05007624,Enzyme,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.32,1.0,,2009.0,2011.0,ALL
51030,TVP23B,Q9NYZ1,0.89,0.192,0.00051742,,,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
51031,GLOD4,Q9HC38,1.0,0.077,6.0698e-13,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2001.0,2002.0,ALL
51032,CELA2B,P08218,,,2.5651e-06,DTO_05007624,Enzyme,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2019.0,ALL
51035,UBXN1,Q04323,0.861,0.077,0.72752,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
51042,ZNF593,O00488,0.931,0.077,0.00066476,DTO_05007557,Nucleic acid binding,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
51043,ZBTB7B,O15156,0.805,0.269,0.34362,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
51046,ST8SIA3,O43173,0.89,0.115,0.85912,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
51050,PI15,O43692,0.736,0.308,0.020554,DTO_05007608,Immune response,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
51052,PRLH,P81277,0.736,0.423,0.10769,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.23,1.0,,2006.0,2019.0,ALL
51053,GMNN,O75496,0.554,0.808,0.1149,,,C1868684,"EAR, PATELLA, SHORT STATURE SYNDROME",C23;C16;C05;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.61,1.0,,2015.0,2015.0,ALL
51054,PLEKHA8P1,O95397,0.861,0.231,,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2009.0,2019.0,ALL
51056,LAP3,P28838,0.743,0.231,1.4677e-07,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
51057,WDPCP,O95876,0.576,0.769,1.0908e-10,,,C1857587,Orstavik Lindemann Solberg syndrome,C16;C04;C05;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,,2010.0,2016.0,ALL
51059,FAM135B,Q49AJ0,0.861,0.192,0.99996,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
51060,TXNDC12,O95881,0.839,0.154,3.7354e-05,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
51061,TXNDC11,Q6PKC3,,,1.6814e-10,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
51062,ATL1,Q8WXF7,0.593,0.654,0.98109,DTO_05007584,Enzyme modulator,C2931355,"Spastic paraplegia 3, autosomal dominant",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.75,1.0,,2001.0,2018.0,ALL
51065,RPS27L,Q71UM5,0.839,0.154,0.10011,DTO_05007557,Nucleic acid binding,C0337438,Glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
51066,SSUH2,Q9Y2M2,0.821,0.231,3.9939e-10,,,C0399379,"Dentin dysplasia, type 1",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.31,1.0,,2017.0,2017.0,ALL
51067,YARS2,Q9Y2Z4,0.663,0.462,3.0025e-11,DTO_05007624,Enzyme,C3150802,"MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2",,,disease,Disease or Syndrome,0.62,1.0,,2010.0,2018.0,ALL
51068,NMD3,Q96D46,0.89,0.192,4.1006e-08,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
51070,NOSIP,Q9Y314,0.839,0.231,1.2622e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2014.0,2019.0,ALL
51071,DERA,Q9Y315,0.861,0.115,0.00037318,DTO_05007624,Enzyme,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
51072,MEMO1,Q9Y316,0.705,0.346,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
51073,MRPL4,Q9BYD3,1.0,0.115,4.2719e-10,,,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.02,1.0,,2011.0,2013.0,ALL
51074,APIP,Q96GX9,0.705,0.346,2.6927e-11,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
51075,TMX2,Q9Y320,0.821,0.231,0.64745,,,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.3,1.0,strong,2019.0,2019.0,ALL
51076,CUTC,Q9NTM9,0.861,0.192,0.0006107,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51077,FCF1,Q9Y324,1.0,0.077,0.024364,,,C0029443,Osteomyelitis,C01;C05,   Infections;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
51079,NDUFA13,Q9P0J0,0.556,0.692,3.8049e-06,DTO_05007624,Enzyme,C0749424,Thyroid Hurthle Cell Carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.6,1.0,limited,2005.0,2015.0,ALL
51081,MRPS7,Q9Y2R9,0.722,0.5,0.0012591,DTO_05007557,Nucleic acid binding,C4693450,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34,,,disease,Disease or Syndrome,0.7,1.0,moderate,2015.0,2015.0,ALL
51082,POLR1D,P0DPB5;P0DPB6,0.603,0.692,0.36357,DTO_05007624,Enzyme,C3150983,TREACHER COLLINS SYNDROME 2,,,disease,Disease or Syndrome,0.7,1.0,,1996.0,2011.0,ALL
51083,GAL,P22466,0.493,0.846,4.3885e-06,,,C4225318,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8",,,disease,Disease or Syndrome,0.6,1.0,limited,2015.0,2015.0,ALL
51084,CRYL1,Q9Y2S2,0.663,0.577,3.7186e-06,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
51085,MLXIPL,Q9NP71,0.554,0.731,0.047771,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2009.0,2019.0,ALL
51086,TNNI3K,Q59H18,0.691,0.346,3.0654e-48,,,C4015285,CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2018.0,ALL
51087,YBX2,Q9Y2T7,0.89,0.077,0.99896,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,2009.0,2016.0,ALL
51088,KLHL5,Q96PQ7,0.89,0.154,5.2757e-06,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
51090,PLLP,Q9Y342,0.805,0.269,0.0091916,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2004.0,2004.0,ALL
51091,SEPSECS,Q9HD40,0.656,0.423,1.6143e-08,,,C3151140,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2D",,,disease,Disease or Syndrome,0.75,1.0,,2003.0,2018.0,ALL
51092,SIDT2,Q8NBJ9,0.821,0.269,2.2006e-10,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
51093,RRNAD1,Q96FB5,,,1.403e-11,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2017.0,ALL
51094,ADIPOR1,Q96A54,0.529,0.808,0.6584,DTO_05007575,Receptor,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.53,1.0,,2007.0,2014.0,ALL
51095,TRNT1,Q96Q11,0.7,0.192,0.00015886,,,C4015172,"SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY",,,disease,Disease or Syndrome,0.73,1.0,,2014.0,2016.0,ALL
51096,UTP18,Q9Y5J1,,,0.0023345,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
51098,IFT52,Q9Y366,0.653,0.538,2.0125e-06,,,C4310718,SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY,,,disease,Disease or Syndrome,0.5,1.0,,2016.0,2019.0,ALL
51099,ABHD5,Q8WTS1,0.641,0.538,6.4201e-07,,,C0268238,Triglyceride storage disease with ichthyosis,C16;C18;C17;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1982.0,2019.0,ALL
51100,SH3GLB1,Q9Y371,0.716,0.462,0.99407,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2005.0,2017.0,ALL
51102,MECR,Q9BV79,0.736,0.385,2.2332e-05,,,C4310634,"DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2016.0,ALL
51103,NDUFAF1,Q9Y375,0.7,0.308,0.0036226,,,C4748769,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11",,,disease,Disease or Syndrome,0.6,1.0,strong,2007.0,2011.0,ALL
51105,PHF20L1,A8MW92,0.839,0.154,1.0,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
51106,TFB1M,Q8WVM0,0.839,0.154,6.3927e-10,,,C1857332,"Deafness, Sensorineural, Autosomal-Mitochondrial Type",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
51107,APH1A,Q96BI3,0.656,0.538,0.79479,DTO_05007584,Enzyme modulator,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2003.0,2019.0,ALL
51108,METTL9,Q9H1A3,0.736,0.5,0.80352,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2019.0,ALL
51109,RDH11,Q8TC12,0.769,0.346,1.0807e-07,DTO_05007624,Enzyme,C4015242,"RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
51110,LACTB2,Q53H82,0.931,0.077,3.6864e-05,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
51111,KMT5B,Q4FZB7,0.736,0.423,1.0,DTO_05007378,Epigenetic regulator,C4540474,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 51",,,disease,Mental or Behavioral Dysfunction,0.6,1.0,strong,2014.0,2018.0,ALL
51112,TRAPPC12,Q8WVT3,0.751,0.385,5.3624e-16,DTO_05007624,Enzyme,C4540059,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY",,,disease,Disease or Syndrome,0.7,1.0,,2017.0,2017.0,ALL
51114,ZDHHC9,Q9Y397,0.67,0.577,0.73749,,,C3275406,"MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE",,,disease,Disease or Syndrome,0.9,1.0,strong,2007.0,2018.0,ALL
51115,RMDN1,Q96DB5,0.546,0.769,5.8995e-10,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,1999.0,2019.0,ALL
51116,MRPS2,Q9Y399,0.839,0.154,3.1326e-07,DTO_05007557,Nucleic acid binding,C4693722,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36,,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
51117,COQ4,Q9Y3A0,0.78,0.269,3.3961e-09,,,C4225392,"COENZYME Q10 DEFICIENCY, PRIMARY, 7",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2016.0,ALL
51118,UTP11,Q9Y3A2,1.0,0.077,1.0932e-07,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
51119,SBDS,Q9Y3A5,0.601,0.692,6.2076e-05,DTO_05007624,Enzyme,C0272170,Shwachman syndrome,,,disease,Disease or Syndrome,1.0,0.972,definitive,2003.0,2019.0,ALL
51124,IER3IP1,Q9Y5U9,0.711,0.423,0.023402,,,C3280240,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME",,,disease,Disease or Syndrome,0.71,1.0,,2011.0,2014.0,ALL
51125,GOLGA7,Q7Z5G4,0.931,0.115,0.45619,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
51127,TRIM17,Q9Y577,0.861,0.308,8.3141e-08,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2008.0,2011.0,ALL
51128,SAR1B,Q9Y6B6,0.686,0.462,0.002315,,,C0795956,Chylomicron retention disease,C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.8,1.0,,2003.0,2019.0,ALL
51129,ANGPTL4,Q9BY76,0.498,0.731,2.3089e-11,DTO_05007599,Signaling,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.5,0.941,,2008.0,2019.0,ALL
51130,ASB3,Q9Y575,0.861,0.192,1.4399e-07,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
51131,PHF11,Q9UIL8,0.76,0.385,4.3505e-08,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51132,RLIM,Q9NVW2,0.686,0.5,0.99301,,,C4283894,"MENTAL RETARDATION, X-LINKED 61",,,disease,Disease or Syndrome,0.7,1.0,limited,2009.0,2016.0,ALL
51133,KCTD3,Q9Y597,0.931,0.115,0.1013,,,C0543888,Epileptic encephalopathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,strong,2015.0,2018.0,ALL
51134,CEP83,Q9Y592,0.839,0.077,4.2942e-14,,,C3890591,NEPHRONOPHTHISIS 18,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2014.0,ALL
51135,IRAK4,Q9NWZ3,0.578,0.769,7.8001e-09,DTO_03300101,Kinase,C1843256,IRAK4 Deficiency,C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.61,1.0,,2003.0,2014.0,ALL
51138,COPS4,Q9BT78,0.839,0.154,0.99886,,,C0003504,Aortic Valve Insufficiency,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
51141,INSIG2,Q9Y5U4,0.653,0.5,0.059986,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51142,CHCHD2,Q9Y6H1,0.638,0.538,1.7328e-07,,,C4225238,"PARKINSON DISEASE 22, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2015.0,ALL
51143,DYNC1LI1,Q9Y6G9,0.931,0.115,0.96348,DTO_05007530,Cellular structure,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
51144,HSD17B12,Q53GQ0,0.722,0.308,0.00040288,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
51146,A4GNT,Q9UNA3,0.78,0.115,0.16537,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
51147,ING4,Q9UNL4,0.573,0.577,0.029013,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2012.0,2019.0,ALL
51149,MRNIP,Q6NTE8,0.931,,1.3396e-05,,,C4085252,PAGET DISEASE OF BONE 3,,,disease,Disease or Syndrome,0.1,1.0,,2002.0,2016.0,ALL
51150,SDF4,Q9BRK5,0.595,0.654,0.0091042,DTO_05007616,Calcium-binding protein,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
51151,SLC45A2,Q9UMX9,0.626,0.538,1.6634e-06,DTO_05007405,Transporter,C1847836,"Oculocutaneous Albinism, Type IV",C16;C18;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.78,1.0,,2001.0,2017.0,ALL
51152,LINC00328,,0.608,0.692,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.95,,1994.0,2019.0,ALL
51155,JPT1,Q9UK76,0.695,0.538,0.002505,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
51156,SERPINA10,Q9UK55,0.805,0.192,4.1522e-11,DTO_05007584,Enzyme modulator,C0398623,Thrombophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.51,1.0,,2000.0,2004.0,ALL
51157,ZNF580,Q9UK33,0.931,0.077,0.53362,,,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
51160,VPS28,Q9UK41,1.0,0.077,0.069338,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
51162,EGFL7,Q9UHF1,0.612,0.577,5.5498e-18,DTO_05007616,Calcium-binding protein,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2011.0,2019.0,ALL
51163,DBR1,Q9UK59,0.769,0.385,1.1785e-08,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2012.0,2012.0,ALL
51164,DCTN4,Q9UJW0,0.472,0.846,0.73221,,,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.54,1.0,,2012.0,2019.0,ALL
51166,AADAT,Q8N5Z0,0.76,0.269,0.14641,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51167,CYB5R4,Q7L1T6,0.861,0.154,2.6203e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51168,MYO15A,Q9UKN7,0.722,0.346,1.2504e-56,DTO_05007530,Cellular structure,C1838263,"Deafness, Autosomal Recessive 3",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.92,1.0,strong,1998.0,2019.0,ALL
51170,HSD17B11,Q8NBQ5,0.931,0.077,2.0771e-07,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
51171,HSD17B14,Q9BPX1,,,3.4303e-11,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
51172,NAGPA,Q9UK23,0.792,0.269,3.0095e-12,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
51174,TUBD1,Q9UJT1,0.931,0.154,1.1505e-06,DTO_05007530,Cellular structure,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2017.0,ALL
51175,TUBE1,Q9UJT0,0.821,0.154,0.026894,DTO_05007530,Cellular structure,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,1993.0,1993.0,ALL
51176,LEF1,Q9UJU2,0.486,0.769,0.99789,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.5,1.0,,2005.0,2019.0,ALL
51177,PLEKHO1,Q53GL0,0.638,0.615,0.48341,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2019.0,2019.0,ALL
51179,HAO2,Q9NYQ3,0.736,0.308,5.9977e-10,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2017.0,ALL
51181,DCXR,Q7Z4W1,0.751,0.308,8.351e-07,,,C0268162,Pentosuria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2017.0,ALL
51182,HSPA14,Q0VDF9,0.502,0.769,0.67359,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51184,GPN3,Q9UHW5,0.839,0.154,2.9029e-07,DTO_05007557,Nucleic acid binding,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
51185,CRBN,Q96SW2,0.551,0.654,0.00028911,DTO_05007624,Enzyme,C1843942,"Mental Retardation, Autosomal Recessive 2",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.91,0.857,,2004.0,2019.0,ALL
51186,TCEAL9,Q9UHQ7,0.931,0.115,0.12214,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
51188,SS18L2,Q9UHA2,0.89,0.038,0.01548,DTO_05007557,Nucleic acid binding,C0039101,synovial sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
51191,HERC5,Q9UII4,0.674,0.462,7.6848e-11,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2015.0,2017.0,ALL
51192,CKLF,Q9UBR5,0.682,0.538,0.0049483,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51193,ZNF639,Q9UID6,0.861,0.154,0.00054196,DTO_05007542,Transcription factor,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
51194,IPO11,Q9UI26,0.76,0.385,0.0016626,DTO_05007584,Enzyme modulator,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
51195,RAPGEFL1,Q9UHV5,,,0.29662,DTO_05007584,Enzyme modulator,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
51196,PLCE1,Q9P212,0.572,0.654,5.6754e-11,DTO_05007624,Enzyme,C1853124,"NEPHROTIC SYNDROME, TYPE 3",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.71,1.0,,2006.0,2010.0,ALL
51198,CDKN2A-DT,Q9UH64,0.931,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
51199,NIN,Q8N4C6,0.659,0.731,9.6335e-09,,,C3553870,SECKEL SYNDROME 7,,,disease,Disease or Syndrome,0.7,1.0,limited,2012.0,2014.0,ALL
51200,CPA4,Q9UI42,0.633,0.5,9.3852e-18,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
51201,ZDHHC2,Q9UIJ5,0.729,0.462,0.0010008,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2000.0,2014.0,ALL
51203,NUSAP1,Q9BXS6,0.623,0.346,0.045674,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2017.0,2019.0,ALL
51204,TACO1,Q9BSH4,0.647,0.577,0.0014606,,,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.61,1.0,moderate,2009.0,2016.0,ALL
51205,ACP6,Q9NPH0,0.821,0.192,2.3344e-13,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
51206,GP6,Q9HCN6,0.597,0.615,1.6361e-11,DTO_05007575,Receptor,C3280120,Glycoprotein VI deficiency,,,disease,Disease or Syndrome,0.6,1.0,definitive,2000.0,2013.0,ALL
51207,DUSP13,Q6B8I1;Q9UII6,0.89,0.077,1.132e-05,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
51208,CLDN18,P56856,0.628,0.346,0.0001865,DTO_05007527,Cell-cell junction,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2006.0,2019.0,ALL
51213,LUZP4,Q9P127,1.0,0.115,0.0013873,,,C0153594,Malignant neoplasm of testis,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
51214,IGF2-AS,Q6U949,0.612,0.615,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
51218,GLRX5,Q86SX6,0.659,0.538,0.7456,DTO_05007624,Enzyme,C4225155,"ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY",,,disease,Disease or Syndrome,0.6,1.0,strong,2007.0,2016.0,ALL
51222,ZNF219,Q9P2Y4,1.0,0.077,0.99977,,,C0026010,Microphthalmos,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,0.0,,2018.0,2018.0,ALL
51224,ELOA2,Q8IYF1,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
51225,ABI3,Q9P2A4,0.716,0.231,5.0089e-05,DTO_05007584,Enzyme modulator,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.35,1.0,,2017.0,2019.0,ALL
51226,COPZ2,Q9P299,0.931,0.077,7.4565e-08,DTO_05007405,Transporter,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
51227,PIGP,P57054,0.633,0.462,0.0018935,,,C4539843,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55",,,disease,Disease or Syndrome,0.6,1.0,moderate,2017.0,2019.0,ALL
51228,GLTP,Q9NZD2,0.861,0.115,0.11475,DTO_05007405,Transporter,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
51230,PHF20,Q9BVI0,0.65,0.615,0.99875,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2019.0,ALL
51231,VRK3,Q8IV63,0.821,0.154,3.2374e-11,DTO_03300101,Kinase,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,,,,,ALL
51232,CRIM1,Q9NZV1,0.76,0.308,0.99971,,,C1865286,"MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.51,1.0,moderate,2015.0,2016.0,ALL
51236,HGH1,Q9BTY7,0.821,0.269,0.012417,,,C3714796,Isolated somatotropin deficiency,,,disease,Disease or Syndrome,0.02,1.0,,1992.0,1992.0,ALL
51237,MZB1,Q8WU39,0.565,0.769,0.00031626,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0,,2004.0,2018.0,ALL
51241,COX16,Q9P0S2,0.931,0.154,1.8748e-05,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2014.0,2014.0,ALL
51244,CCDC174,Q6PII3,0.769,0.269,7.142e-08,,,C4225196,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION",,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2015.0,ALL
51246,SHISA5,Q8N114,,,1.1126e-06,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
51247,PAIP2,Q9BPZ3,0.89,0.077,0.55414,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
51249,TMEM69,Q5SWH9,0.931,0.077,0.0001867,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
51251,NT5C3A,Q9H0P0,0.593,0.692,0.015053,DTO_05007624,Enzyme,C1849507,"Uridine 5-Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia due to",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,,2001.0,2016.0,ALL
51252,FAM178B,Q8IXR5,0.931,0.038,8.2105e-13,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
51253,MRPL37,Q9BZE1,1.0,0.077,1.3929e-08,,,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
51255,RNF181,Q9P0P0,1.0,0.077,3.239e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
51256,TBC1D7,Q9P0N9,0.729,0.385,2.9441e-12,,,C0221355,Macrocephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.62,1.0,moderate,2013.0,2014.0,ALL
51257,MARCHF2,Q9P0N8,0.751,0.231,0.032958,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51259,TMEM216,Q9P0N5,0.544,0.615,0.0018855,,,C1842577,JOUBERT SYNDROME 2,C16;C13;C11;C12;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,,2010.0,2017.0,ALL
51263,MRPL30,Q8TCC3,,,0.027748,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
51265,CDKL3,Q8IVW4,0.89,0.231,2.2569e-12,DTO_03300101,Kinase,C0026106,Mild Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0,,2008.0,2008.0,ALL
51266,CLEC1B,Q9P126,0.65,0.615,4.9365e-08,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2015.0,2018.0,ALL
51267,CLEC1A,Q8NC01,0.931,0.038,2.6288e-17,,,C0004030,Aspergillosis,C01,   Infections,disease,Disease or Syndrome,0.3,,,,,ALL
51268,PIPOX,Q9P0Z9,0.722,0.346,6.6433e-12,DTO_05007624,Enzyme,C0282528,Peroxisomal Disorders,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.31,1.0,,1989.0,2000.0,ALL
51270,TFDP3,Q5H9I0,0.751,0.385,,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
51271,UBAP1,Q9NZ09,0.716,0.5,0.91168,,,C0037773,"Spastic Paraplegia, Hereditary",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.34,1.0,strong,2019.0,2020.0,ALL
51272,BET1L,Q9NYM9,0.89,0.077,0.0044178,DTO_05007405,Transporter,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.13,1.0,,2011.0,2019.0,ALL
51274,KLF3,P57682,0.805,0.154,0.8296,DTO_05007557,Nucleic acid binding,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
51275,MAPKAPK5-AS1,Q8N8E1,0.89,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
51277,DNAJC27,Q9NZQ0,0.805,0.308,0.0012809,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
51278,IER5,Q5VY09,0.805,0.115,0.86869,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
51279,C1RL,Q9NZP8,0.839,0.231,3.4642e-08,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
51280,GOLM1,Q8NBJ4,0.56,0.692,9.6171e-09,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2018.0,ALL
51281,ANKMY1,Q9P2S6,,,2.6293e-24,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
51282,SCAND1,P57086,0.931,0.077,0.2222,,,C0919677,Protein C measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
51283,BFAR,Q9NZS9,0.663,0.654,1.5442e-08,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
51284,TLR7,Q9NYK1,0.464,0.885,0.97912,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
51285,RASL12,Q9NYN1,0.751,0.385,0.00087102,DTO_05007584,Enzyme modulator,C0002893,Refractory anemias,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
51286,CEND1,Q8N111,0.821,0.231,0.59751,,,C0004903,Beckwith-Wiedemann Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
51289,RXFP3,Q9NSD7,0.769,0.192,1.6003e-13,DTO_02300001,G-protein coupled receptor,C0152459,Linear atrophy,C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.02,1.0,,2017.0,2019.0,ALL
51290,ERGIC2,Q96RQ1,0.821,0.308,0.013458,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51291,GMIP,Q9P107,0.89,0.038,1.8778e-10,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2005.0,2005.0,ALL
51292,GMPR2,Q9P2T1,0.769,0.115,1.0324e-08,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
51293,CD320,Q9NPF0,0.729,0.462,0.003525,,,C3150900,"METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT",,,disease,Disease or Syndrome,0.9,1.0,limited,2010.0,2013.0,ALL
51294,PCDH12,Q9NPG4,0.722,0.346,2.8508e-13,,,C4538630,"MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS",,,disease,Disease or Syndrome,0.6,1.0,,2008.0,2017.0,ALL
51295,ECSIT,Q9BQ95,0.931,0.192,6.764e-06,,,C3495676,Anorectal Malformations,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",group,Anatomical Abnormality,0.3,1.0,,2013.0,2013.0,ALL
51296,SLC15A3,Q8IY34,0.792,0.154,7.7754e-12,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51297,BPIFA1,Q9NP55,0.617,0.577,1.1971e-08,,,C0015923,Fetal Alcohol Syndrome,C16;C13;C25,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
51298,THEG,Q9P2T0,0.78,0.269,5.0204e-09,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.03,1.0,,2004.0,2006.0,ALL
51299,NRN1,Q9NPD7,0.736,0.385,0.8602,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2010.0,2017.0,ALL
51300,TIMMDC1,Q9NPL8,0.653,0.538,1.1142e-08,,,C4748838,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31",,,disease,Disease or Syndrome,0.4,1.0,moderate,2017.0,2017.0,ALL
51301,GCNT4,Q9P109,,,0.0011474,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
51302,CYP39A1,Q9NYL5,0.736,0.231,3.8748e-16,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
51303,FKBP11,Q9NYL4,0.805,0.231,6.4642e-07,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
51304,ZDHHC3,Q9NYG2,0.89,0.115,0.027681,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
51305,KCNK9,Q9NPC2,0.615,0.577,0.95519,DTO_01300327,Ion channel,C2676770,Birk-Barel Mental Retardation Dysmorphism Syndrome,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.73,1.0,,2008.0,2020.0,ALL
51307,FAM53C,Q9NYF3,1.0,0.038,0.067598,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2019.0,ALL
51308,REEP2,Q9BRK0,0.792,0.269,0.43941,DTO_05007405,Transporter,C3810160,"SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
51309,ARMCX1,Q9P291,0.792,0.269,0.072672,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51310,SLC22A17,Q8WUG5,0.736,0.462,0.010603,DTO_05007405,Transporter,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
51311,TLR8,Q9NR97,0.543,0.769,0.32401,,,C0011616,Contact Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
51312,SLC25A37,Q9NYZ2,0.597,0.731,0.27886,DTO_05007405,Transporter,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
51313,GASK1B,Q6UWH4,0.821,0.154,5.6948e-09,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51314,NME8,Q8N427,0.644,0.692,5.5821e-28,,,C1970506,"CILIARY DYSKINESIA, PRIMARY, 6",C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.5,,limited,,,ALL
51316,PLAC8,Q9NZF1,0.641,0.654,0.11953,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51317,PHF21A,Q96BD5,0.682,0.5,1.0,,,C1832588,Chromosome 11p11.2 Deletion Syndrome,C23;C16;C04;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.55,1.0,,2012.0,2019.0,ALL
51318,MRPL35,Q9NZE8,,,0.0023926,DTO_05007557,Nucleic acid binding,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
51319,RSRC1,Q96IZ7,0.65,0.462,7.4539e-05,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0,,2017.0,2018.0,ALL
51320,MEX3C,Q5U5Q3,0.751,0.346,0.86192,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
51322,WAC,Q9BTA9,0.686,0.615,1.0,,,C4225239,DESANTO-SHINAWI SYNDROME,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2016.0,ALL
51324,SPG21,Q9NZD8,0.695,0.5,0.00066076,,,C1855346,MAST SYNDROME,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.74,1.0,,2003.0,2017.0,ALL
51326,ARL17A,Q8IVW1,,,,,,C0023114,Handedness,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51327,AHSP,Q9NZD4,0.7,0.385,0.0003287,DTO_05007613,Chaperone,C0005283,beta Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,0.8,,2004.0,2019.0,ALL
51330,TNFRSF12A,Q9NP84,0.509,0.692,0.017995,,,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.34,1.0,,2011.0,2019.0,ALL
51332,SPTBN5,Q9NRC6,0.861,0.192,8.2224e-118,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
51333,ZNF771,Q7L3S4,1.0,0.077,0.05992,DTO_05007542,Transcription factor,C0337443,Sodium measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
51334,PRR16,Q569H4,1.0,0.038,0.078558,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51335,NGRN,Q9NPE2,0.89,0.077,0.00077946,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
51337,THEM6,Q8WUY1,0.861,0.115,0.04608,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
51338,MS4A4A,Q96JQ5,0.722,0.308,8.0964e-06,DTO_05007575,Receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.43,1.0,,2011.0,2019.0,ALL
51339,DACT1,Q9NYF0,0.547,0.692,0.40017,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.51,1.0,,2008.0,2019.0,ALL
51340,CRNKL1,Q9BZJ0,0.711,0.385,2.7151e-06,DTO_05007557,Nucleic acid binding,C0151779,Cutaneous Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
51341,ZBTB7A,O95365,0.564,0.769,0.95915,DTO_05007542,Transcription factor,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,2011.0,2019.0,ALL
51343,FZR1,Q9UM11,0.67,0.538,0.99969,DTO_05007584,Enzyme modulator,C0032578,Polyploidy,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2014.0,2014.0,ALL
51347,TAOK3,Q9H2K8,0.792,0.269,0.99975,DTO_03300101,Kinase,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51348,KLRF1,Q9NZS2,0.839,0.231,1.8025e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2010.0,2019.0,ALL
51350,KRT76,Q01546,1.0,0.077,2.7442e-14,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51351,ZNF117,Q03924,,,0.39531,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
51352,WT1-AS,Q06250,0.597,0.615,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
51359,ERVH-4,,0.861,0.077,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,1997.0,1997.0,ALL
51360,MBTPS2,O43462,0.513,0.769,0.99752,DTO_05007624,Enzyme,C1839988,Ichthyosis follicularis atrichia photophobia syndrome,C23;C16;C11;C17;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,,1997.0,2015.0,ALL
51361,HOOK1,Q9UJC3,0.716,0.462,3.8686e-08,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51362,CDC40,O60508,1.0,0.077,0.97944,DTO_05007557,Nucleic acid binding,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
51363,CHST15,Q7LFX5,0.647,0.346,3.5249e-05,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
51364,ZMYND10,O75800,0.553,0.731,2.3034e-07,,,C3809543,"CILIARY DYSKINESIA, PRIMARY, 22",,,disease,Disease or Syndrome,0.9,1.0,,2013.0,2018.0,ALL
51365,PLA1A,Q53H76,0.678,0.5,4.3709e-11,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2010.0,2019.0,ALL
51366,UBR5,O95071,0.597,0.654,1.0,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2006.0,2016.0,ALL
51367,POP5,Q969H6,0.839,0.269,4.142e-07,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
51371,POMP,Q9Y244,0.674,0.346,0.90942,,,C1866029,Keratosis Linearis with Ichthyosis Congenita and Sclerosing Keratoderma,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.62,1.0,,2010.0,2017.0,ALL
51373,MRPS17,Q9Y2R5,,,1.1728e-08,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
51374,ATRAID,Q6UW56,0.601,0.654,0.00010516,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.941,,1990.0,2018.0,ALL
51375,SNX7,Q9UNH6,0.839,0.192,3.7323e-05,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51377,UCHL5,Q9Y5K5,0.695,0.346,0.0012557,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2013.0,2013.0,ALL
51378,ANGPT4,Q9Y264,0.711,0.423,4.5492e-15,DTO_05007599,Signaling,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2010.0,2017.0,ALL
51379,CRLF3,Q8IUI8,0.729,0.346,0.00047973,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
51380,CSAD,Q9Y600,0.678,0.538,6.0781e-12,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2006.0,2006.0,ALL
51382,ATP6V1D,Q9Y5K8,0.805,0.154,4.5061e-05,DTO_05007405,Transporter,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
51384,WNT16,Q9UBV4,0.686,0.654,1.6523e-06,DTO_05007599,Signaling,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
51385,ZNF589,Q86UQ0,,,0.0049175,DTO_05007542,Transcription factor,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2016.0,2016.0,ALL
51386,EIF3L,Q9Y262,0.89,0.077,0.83781,DTO_05007557,Nucleic acid binding,C0280280,"stage, prostate cancer",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
51388,NIP7,Q9Y221,1.0,0.077,0.36417,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51389,RWDD1,Q9H446,,,0.91032,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
51390,AIG1,Q9NVV5,,,3.6161e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
51393,TRPV2,Q9Y5S1,0.581,0.615,7.9184e-13,DTO_01300327,Ion channel,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,0.857,,2010.0,2020.0,ALL
51397,COMMD10,Q9Y6G5,0.78,0.269,6.4803e-12,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
51398,WDR83OS,Q9Y284,1.0,0.077,0.0033142,,,C0155877,Allergic asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
51399,TRAPPC4,Q9Y296,0.805,0.308,4.1207e-06,DTO_05007405,Transporter,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,,2020.0,2020.0,ALL
51400,PPME1,Q9Y570,0.736,0.308,0.99904,DTO_05007624,Enzyme,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0,,2014.0,2016.0,ALL
51406,NOL7,Q9UMY1,0.861,0.115,3.5312e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2006.0,2013.0,ALL
51409,HEMK1,Q9Y5R4,1.0,0.077,3.3864e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
51411,BIN2,Q9UBW5,0.931,0.192,4.5252e-11,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2011.0,2017.0,ALL
51412,ACTL6B,O94805,0.656,0.462,0.00028347,DTO_05007530,Cellular structure,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.41,1.0,strong,2019.0,2019.0,ALL
51421,AMOTL2,Q9Y2J4,0.792,0.077,0.15515,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51422,PRKAG2,Q9UGJ0,0.582,0.654,0.99692,DTO_05007584,Enzyme modulator,C0043202,Wolff-Parkinson-White Syndrome,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,1.0,,1977.0,2016.0,ALL
51426,POLK,Q9UBT6,0.691,0.423,7.4692e-13,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.41,1.0,,2015.0,2015.0,ALL
51427,ZNF107,Q9UII5,1.0,0.115,0.021156,,,C0280324,Laryngeal Squamous Cell Carcinoma,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
51428,DDX41,Q9UJV9,0.636,0.538,5.5908e-08,,,C4225174,"MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO",,,disease,Finding,0.7,1.0,,2015.0,2016.0,ALL
51429,SNX9,Q9Y5X1,0.729,0.385,0.7061,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
51430,SUCO,Q9UBS9,0.722,0.423,0.97455,DTO_05007530,Cellular structure,C0029434,Osteogenesis Imperfecta,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.2,1.0,,2010.0,2010.0,ALL
51433,ANAPC5,Q9UJX4,0.931,0.154,1.6499e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51434,ANAPC7,Q9UJX3,0.839,0.077,0.8485,,,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
51435,SCARA3,Q6AZY7,0.674,0.462,2.9816e-08,DTO_05007575,Receptor,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
51438,MAGEC2,Q9UBF1,0.656,0.5,,DTO_05007620,Cell adhesion,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,1.0,,2003.0,2019.0,ALL
51439,FAM8A1,Q9UBU6,1.0,0.038,0.017471,,,C0033845,Pseudotumor Cerebri,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
51440,HPCAL4,Q9UM19,,,3.2705e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2013.0,2013.0,ALL
51441,YTHDF2,Q9Y5A9,0.736,0.269,0.99943,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2017.0,2019.0,ALL
51442,VGLL1,Q99990,0.805,0.192,0.81365,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
51444,RNF138,Q8WVD3,0.76,0.192,0.67535,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2012.0,2018.0,ALL
51447,IP6K2,Q9UHH9,0.821,0.231,0.973,DTO_03300101,Kinase,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
51449,PCYOX1,Q9UHG3,,,2.2481e-15,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
51450,PRRX2,Q99811,0.638,0.577,0.13959,,,C0004106,Astigmatism,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
51451,LCMT1,Q9UIC8,0.78,0.192,1.789e-05,,,C0012684,Blastocyst Disintegration,C23;C13,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Pathologic Function,0.3,1.0,,2007.0,2007.0,ALL
51454,GULP1,Q9UBP9,0.76,0.423,0.68714,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51455,REV1,Q9UBZ9,0.691,0.385,0.99989,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
51458,RHCG,Q9UBD6,0.743,0.269,0.00010016,DTO_05007405,Transporter,C0020595,Hypoaldosteronism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
51460,SFMBT1,Q9UHJ3,0.736,0.385,0.93588,DTO_05007378,Epigenetic regulator,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2019.0,ALL
51465,UBE2J1,Q9Y385,0.839,0.115,0.43658,,,C0011311,Dengue Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
51466,EVL,Q9UI08,0.729,0.308,0.99761,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.52,1.0,,2008.0,2015.0,ALL
51471,NAT8B,Q9UHF3,0.805,0.192,,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
51473,DCDC2,Q9UHG0,0.546,0.769,5.6611e-10,,,C4479344,"SCLEROSING CHOLANGITIS, NEONATAL",,,disease,Disease or Syndrome,0.74,1.0,,2015.0,2018.0,ALL
51474,LIMA1,Q9UHB6,0.711,0.231,2.7465e-10,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2014.0,2014.0,ALL
51475,CABP2,Q9NPB3,0.861,0.115,0.0025355,,,C3888355,"DEAFNESS, AUTOSOMAL RECESSIVE 93",,,disease,Disease or Syndrome,0.8,1.0,strong,2012.0,2017.0,ALL
51477,ISYNA1,Q9NPH2,0.51,0.769,2.4934e-05,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
51478,HSD17B7,P56937,0.582,0.5,6.6475e-06,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.27,0.875,,1999.0,2015.0,ALL
51479,ANKFY1,Q9P2R3,0.839,0.346,0.95629,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
51480,VCX2,Q9H322,1.0,0.192,0.058136,,,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0,,2005.0,2005.0,ALL
51481,VCX3A,Q9NNX9,0.736,0.308,0.30958,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.09,1.0,,2000.0,2013.0,ALL
51490,SPOUT1,Q5T280,,,4.1284e-09,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
51491,NOP16,Q9Y3C1,0.805,0.154,0.011953,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
51493,RTCB,Q9Y3I0,0.861,0.115,0.0052059,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
51495,HACD3,Q9P035,0.861,0.154,0.0092999,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
51496,CTDSPL2,Q05D32,,,0.99966,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
51497,NELFCD,Q8IXH7,0.705,0.538,0.17607,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.02,1.0,,2018.0,2018.0,ALL
51499,TRIAP1,O43715,0.711,0.5,0.056508,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.03,1.0,,2009.0,2017.0,ALL
51501,HIKESHI,Q53FT3,0.751,0.385,0.52459,,,C4225170,"LEUKODYSTROPHY, HYPOMYELINATING, 13",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2017.0,ALL
51503,CWC15,Q9P013,0.89,0.192,0.97769,,,C0024286,Lymphogranuloma Venereum,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
51504,TRMT112,Q9UI30,,,0.13916,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
51506,UFC1,Q9Y3C8,0.716,0.462,0.0036155,,,C4748081,NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH,,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2019.0,ALL
51510,CHMP5,Q9NZZ3,0.751,0.192,0.0066514,DTO_05007405,Transporter,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.41,1.0,,2007.0,2017.0,ALL
51512,GTSE1,Q9NYZ3,0.705,0.269,2.7012e-05,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2016.0,2017.0,ALL
51513,ETV7,Q9Y603,0.736,0.308,3.9605e-14,DTO_05007542,Transcription factor,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
51514,DTL,Q9NZJ0,0.65,0.577,0.0033019,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2006.0,2018.0,ALL
51517,NCKIPSD,Q9NZQ3,0.612,0.577,0.00022309,,,C0003125,Anorexia Nervosa,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
51520,LARS1,Q9P2J5,0.678,0.577,8.2142e-09,,,C3809522,INFANTILE LIVER FAILURE SYNDROME 1,,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2012.0,ALL
51522,TMEM14C,Q9P0S9,0.931,0.077,0.0061054,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
51523,CXXC5,Q7LFL8,0.678,0.423,0.88856,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51524,TMEM138,Q9NPI0,0.656,0.385,0.047034,,,C3280906,JOUBERT SYNDROME 16,,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2015.0,ALL
51526,OSER1,Q9NX31,,,0.0028566,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
51527,GSKIP,Q9P0R6,0.861,0.154,0.3822,,,C0023466,"Leukemia, Monocytic, Chronic",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
51529,ANAPC11,Q9NYG5,0.751,0.154,0.33285,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
51530,ZC3HC1,Q86WB0,0.76,0.308,0.00025557,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.46,1.0,,2011.0,2019.0,ALL
51531,TRMO,Q9BU70,0.78,0.462,6.4724e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51533,PHF7,Q9BWX1,0.931,0.115,0.0010828,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51534,VTA1,Q9NP79,0.641,0.423,0.00039935,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
51535,PPHLN1,Q8NEY8,0.89,0.077,3.3043e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51537,MTFP1,Q9UDX5,0.89,0.154,0.0079484,,,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,2018.0,2018.0,ALL
51538,ZCCHC17,Q9NP64,0.931,0.154,0.0052857,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
51540,SCLY,Q96I15,0.53,0.731,2.3341e-09,DTO_05007624,Enzyme,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,0.968,,1991.0,2019.0,ALL
51542,VPS54,Q9P1Q0,0.769,0.231,0.99929,DTO_05007405,Transporter,C0027746,Nerve Degeneration,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
51547,SIRT7,Q9NRC8,0.582,0.577,0.0005562,DTO_05007378,Epigenetic regulator,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0,,2013.0,2017.0,ALL
51548,SIRT6,Q8N6T7,0.496,0.846,0.039119,DTO_05007378,Epigenetic regulator,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.5,1.0,,2013.0,2013.0,ALL
51550,CINP,Q9BW66,0.821,0.231,0.057122,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
51552,RAB14,P61106,0.674,0.615,0.99047,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
51554,ACKR4,Q9NPB9,0.751,0.346,2.9962e-09,DTO_02300001,G-protein coupled receptor,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
51555,PEX5L,Q8IYB4,0.805,0.385,0.0079927,DTO_05007405,Transporter,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2019.0,ALL
51557,LGSN,Q5TDP6,0.743,0.346,1.594e-13,DTO_05007624,Enzyme,C0023003,Langer-Giedion Syndrome,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0,,1995.0,2018.0,ALL
51559,NT5DC3,Q86UY8,0.821,0.192,1.4702e-07,DTO_05007624,Enzyme,C1720164,Central corneal thickness,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
51560,RAB6B,Q9NRW1,0.736,0.385,0.95879,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2011.0,2011.0,ALL
51561,IL23A,Q9NPF7,0.415,0.846,0.35806,DTO_05007599,Signaling,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,1.0,,1989.0,2020.0,ALL
51562,MBIP,Q9NS73,0.861,0.269,1.3838e-05,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
51564,HDAC7,Q8WUI4,0.597,0.654,0.99969,DTO_05007378,Epigenetic regulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2014.0,2019.0,ALL
51566,ARMCX3,Q9UH62,0.839,0.115,0.45882,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
51567,TDP2,O95551,0.628,0.462,1.134e-08,,,C4310780,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23",,,disease,Disease or Syndrome,0.61,1.0,strong,2014.0,2019.0,ALL
51569,UFM1,P61960,0.722,0.385,0.15655,,,C4693535,"LEUKODYSTROPHY, HYPOMYELINATING, 14",,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2019.0,ALL
51571,CYRIB,Q9NUQ9,0.76,0.538,0.97612,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51573,GDE1,Q9NZC3,0.481,0.808,6.1163e-06,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2015.0,2018.0,ALL
51574,LARP7,Q4G0J3,0.674,0.615,9.3352e-08,DTO_05007557,Nucleic acid binding,C3554439,Microcephalic primordial dwarfism Alazami type,C23;C16;C05;C10;C19;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.75,1.0,strong,2012.0,2020.0,ALL
51582,AZIN1,O14977,0.716,0.462,0.99485,DTO_05007624,Enzyme,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,1.0,,2016.0,2016.0,ALL
51585,PCF11,O94913,0.89,0.077,1.0,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
51586,MED15,Q96RN5,0.623,0.654,0.99974,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2003.0,2004.0,ALL
51588,PIAS4,Q8N2W9,0.678,0.538,0.99986,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51592,TRIM33,Q9UPN9,0.626,0.577,1.0,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,1999.0,2019.0,ALL
51593,SRRT,Q9BXP5,0.736,0.231,0.59362,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2018.0,2018.0,ALL
51594,NBAS,A2RRP1,0.566,0.692,5.0234e-43,,,C3541319,"SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY",,,disease,Disease or Syndrome,0.76,1.0,,2010.0,2019.0,ALL
51599,LSR,Q86X29,0.666,0.538,6.5186e-08,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2002.0,2005.0,ALL
51601,LIPT1,Q9Y234,0.674,0.462,3.8254e-08,DTO_05007624,Enzyme,C4225379,LIPOYLTRANSFERASE 1 DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2018.0,ALL
51602,NOP58,Q9Y2X3,0.931,0.077,0.003652,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
51603,EEF1AKNMT,Q8N6R0,0.729,0.269,1.6253e-09,,,C1854274,"DEAFNESS, NONSYNDROMIC, MODIFIER 1 (disorder)",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.3,,,,,ALL
51604,PIGT,Q969N2,0.633,0.615,7.2959e-10,,,C3809356,MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3,,,disease,Disease or Syndrome,0.71,1.0,,2013.0,2017.0,ALL
51605,TRMT6,Q9UJA5,0.89,0.077,2.4031e-05,DTO_05007557,Nucleic acid binding,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
51606,ATP6V1H,Q9UI12,0.78,0.346,0.00014523,DTO_05007405,Transporter,C0029453,Osteopenia,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
51608,GET4,Q7L5D6,,,0.56164,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
51611,DPH5,Q9H2P9,1.0,0.038,8.1083e-07,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
51614,ERGIC3,Q9Y282,0.805,0.115,2.2416e-05,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.34,1.0,,2013.0,2020.0,ALL
51617,NSG2,Q9Y328,0.861,0.231,0.88363,,,C0582591,Processing speed,,,phenotype,Mental Process,0.1,1.0,,2011.0,2011.0,ALL
51621,KLF13,Q9Y2Y9,0.674,0.577,0.40432,DTO_05007557,Nucleic acid binding,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,1.0,,2011.0,2015.0,ALL
51622,CCZ1,P86790;P86791,,,3.5878e-06,,,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
51626,DYNC2LI1,Q8TCX1,0.601,0.5,3.154e-09,DTO_05007530,Cellular structure,C4310724,SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY,,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2015.0,ALL
51629,SLC25A39,Q9BZJ4,,,5.3953e-11,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51631,LUC7L2,Q9Y383,1.0,0.077,0.00028277,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
51633,OTUD6B,Q8N6M0,0.659,0.538,1.2841e-07,DTO_05007624,Enzyme,C4479520,"INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES",,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
51634,RBMX2,Q9Y388,0.89,0.115,0.93892,,,C0279671,Cervical Squamous Cell Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
51635,DHRS7,Q9Y394,0.76,0.192,9.8631e-12,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
51637,RTRAF,Q9Y224,0.644,0.692,0.20165,,,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.04,1.0,,2015.0,2018.0,ALL
51639,SF3B6,Q9Y3B4,0.544,0.808,0.58902,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2002.0,2019.0,ALL
51642,MRPL48,Q96GC5,1.0,0.038,0.004333,DTO_05007557,Nucleic acid binding,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
51643,TMBIM4,Q9HC24,0.743,0.5,3.8876e-06,,,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
51645,PPIL1,Q9Y3C6,0.76,0.231,0.12108,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
51646,YPEL5,P62699,0.931,0.154,0.46474,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
51647,CIAO2B,Q9Y3D0,1.0,0.154,0.003824,,,C0268138,"Xeroderma Pigmentosum, Complementation Group D",C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
51649,MRPS23,Q9Y3D9,0.839,0.115,0.12774,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2014.0,2017.0,ALL
51650,MRPS33,Q9Y291,0.861,0.038,0.0036885,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2019.0,2019.0,ALL
51651,PTRH2,Q9Y3E5,0.641,0.577,0.00063822,,,C4015728,"NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET",,,disease,Disease or Syndrome,0.71,1.0,,2014.0,2016.0,ALL
51652,CHMP3,Q9Y3E7,0.792,0.231,0.0040006,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
51654,CDK5RAP1,Q96SZ6,0.839,0.115,7.7821e-19,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0,,2008.0,2018.0,ALL
51655,RASD1,Q9Y272,0.666,0.654,0.038736,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
51657,STYXL1,Q9Y6J8,0.839,0.269,1.3247e-08,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
51659,GINS2,Q9Y248,0.638,0.577,1.5745e-08,DTO_05007624,Enzyme,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
51660,MPC1,Q9Y5U8,0.653,0.577,0.038495,DTO_05007405,Transporter,C3553607,MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2016.0,ALL
51661,FKBP7,Q9Y680,0.821,0.192,4.1828e-08,,,C0374997,Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.02,1.0,,2015.0,2018.0,ALL
51663,ZFR,Q96KR1,0.729,0.346,1.0,DTO_05007557,Nucleic acid binding,C0026106,Mild Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,,,,,ALL
51665,ASB1,Q9Y576,0.89,0.077,0.0029925,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2016.0,ALL
51666,ASB4,Q9Y574,0.931,0.077,1.118e-10,,,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.2,1.0,,2014.0,2016.0,ALL
51667,NUB1,Q9Y5A7,0.792,0.308,0.00039037,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51668,HSPB11,Q9Y547,0.839,0.269,0.0020199,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
51669,SARAF,Q96BY9,0.839,0.115,0.0019871,,,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
51673,TPPP3,Q9BW30,0.736,0.385,0.37331,DTO_05007530,Cellular structure,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,1988.0,1991.0,ALL
51676,ASB2,Q96Q27,0.769,0.308,6.774e-15,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0,,2017.0,2017.0,ALL
51678,MPP6,Q9NZW5,0.821,0.077,0.81619,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
51684,SUFU,Q9UMX1,0.493,0.769,0.99992,,,C0004779,Basal Cell Nevus Syndrome,C16;C04;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Neoplastic Process,1.0,0.938,,2006.0,2018.0,ALL
51686,OAZ3,Q9UMX2,,,2.2775e-05,DTO_05007584,Enzyme modulator,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
51690,LSM7,Q9UK45,,,0.46157,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
51692,CPSF3,Q9UKF6,0.821,0.192,3.0292e-07,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51693,TRAPPC2L,Q9UL33,0.805,0.269,3.6837e-11,,,C0034372,Quadriplegia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
51696,HECA,Q9UBI9,0.931,0.115,0.61493,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2019.0,ALL
51699,VPS29,Q9UBQ0,0.89,0.038,0.74696,DTO_05007405,Transporter,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
51700,CYB5R2,Q6BCY4,0.821,0.192,6.8195e-10,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
51701,NLK,Q9UBE8,0.59,0.692,0.99991,DTO_03300101,Kinase,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
51702,PADI3,Q9ULW8,0.78,0.192,2.3615e-10,,,C0432347,Uncombable hair syndrome,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.51,1.0,,2016.0,2016.0,ALL
51703,ACSL5,Q9ULC5,0.641,0.5,2.8888e-09,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2005.0,2017.0,ALL
51704,GPRC5B,Q9NZH0,0.805,0.385,0.024183,DTO_02300001,G-protein coupled receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.03,1.0,,2010.0,2014.0,ALL
51705,EMCN,Q9ULC0,0.716,0.423,8.6416e-05,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2011.0,2018.0,ALL
51706,CYB5R1,Q9UHQ9,0.861,0.077,4.3643e-09,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
51710,ZNF44,P15621,0.78,0.308,0.0025686,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
51714,SELENOT,P62341,0.861,0.077,0.11531,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2019.0,2019.0,ALL
51715,RAB23,Q9ULC3,0.541,0.654,0.0056143,,,C1275078,Acrocephalopolysyndactyly type 2,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.75,0.833,strong,2007.0,2018.0,ALL
51716,CES1P1,Q9UKY3,0.861,0.077,,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
51719,CAB39,Q9Y376,0.751,0.269,0.068013,DTO_05007616,Calcium-binding protein,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2017.0,2017.0,ALL
51720,UIMC1,Q96RL1,0.736,0.346,8.2815e-07,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
51725,FBXO40,Q9UH90,1.0,0.038,5.5318e-09,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2009.0,2009.0,ALL
51726,DNAJB11,Q9UBS4,0.751,0.346,0.22551,,,C4748044,POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE,,,disease,Disease or Syndrome,0.6,1.0,,2018.0,2018.0,ALL
51727,CMPK1,P30085,0.626,0.577,0.84789,DTO_03300101,Kinase,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,0.846,,1990.0,2019.0,ALL
51728,POLR3K,Q9Y2Y1,0.89,0.115,0.10849,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
51729,WBP11,Q9Y2W2,0.931,0.077,0.99994,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
51733,UPB1,Q9UBR1,0.722,0.346,7.3647e-12,DTO_05007624,Enzyme,C1291512,Beta-Ureidopropionase Deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,,2004.0,2016.0,ALL
51734,MSRB1,Q9NZV6,0.78,0.231,0.1304,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
51735,RAPGEF6,Q8TEU7,0.821,0.308,0.99644,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2006.0,2017.0,ALL
51738,GHRL,Q9UBU3,0.517,0.769,1.3921e-11,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.5,0.923,,2001.0,2019.0,ALL
51741,WWOX,Q9NZC7,0.453,0.808,1.2376e-15,DTO_05007624,Enzyme,C3280452,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12",,,disease,Disease or Syndrome,0.73,1.0,,2014.0,2019.0,ALL
51742,ARID4B,Q4LE39,0.631,0.615,1.0,DTO_05007542,Transcription factor,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
51744,CD244,Q9BZW8,0.653,0.5,0.057288,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.44,0.5,,2008.0,2011.0,ALL
51747,LUC7L3,O95232,0.691,0.5,0.99999,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
51750,RTEL1,Q9NZ71,0.459,0.808,8.8674e-10,DTO_05007624,Enzyme,C3554656,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5",,,disease,Disease or Syndrome,0.7,1.0,,2009.0,2018.0,ALL
51752,ERAP1,Q9NZ08,0.556,0.692,2.0562e-26,DTO_05007624,Enzyme,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,,2013.0,2020.0,ALL
51754,TMEM8B,A6NDV4,0.736,0.346,2.7974e-06,DTO_05007620,Cell adhesion,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.1,1.0,,2002.0,2018.0,ALL
51755,CDK12,Q9NYV4,0.638,0.462,1.0,DTO_03300101,Kinase,C0029925,Ovarian Carcinoma,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.33,1.0,,2015.0,2016.0,ALL
51760,SYT17,Q9BSW7,1.0,0.038,1.0974e-05,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
51761,ATP8A2,Q9NTI2,0.659,0.577,1.2026e-12,DTO_05007405,Transporter,C3808977,"CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4",,,disease,Disease or Syndrome,0.8,1.0,,1969.0,2018.0,ALL
51762,RAB8B,Q92930,1.0,0.077,0.00069486,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
51763,INPP5K,Q9BT40,0.587,0.654,4.2264e-05,DTO_05007624,Enzyme,C4479410,"MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY",,,disease,Disease or Syndrome,0.7,1.0,moderate,2017.0,2017.0,ALL
51764,GNG13,Q9P2W3,0.931,0.077,8.0284e-05,,,C0042345,Varicosity,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
51765,STK26,Q9P289,0.705,0.538,0.30798,DTO_03300101,Kinase,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
51773,RSF1,Q96T23,0.647,0.423,1.0,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.846,,2006.0,2020.0,ALL
51776,MAP3K20,Q9NYL2,0.564,0.769,8.4166e-09,DTO_03300101,Kinase,C4225167,SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY,,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2016.0,ALL
51778,MYOZ2,Q9NPC6,0.716,0.308,0.0015748,DTO_05007530,Cellular structure,C3151204,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16",,,disease,Disease or Syndrome,0.6,1.0,,2007.0,2007.0,ALL
51780,KDM3B,Q7LBC6,0.686,0.5,1.0,DTO_05007378,Epigenetic regulator,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.31,1.0,moderate,2019.0,2019.0,ALL
51802,ASIC5,Q9NY37,0.805,0.423,6.0266e-14,DTO_01300327,Ion channel,C0030779,Pelger-Huet Anomaly,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0,,1999.0,2003.0,ALL
51804,SIX4,Q9UIU6,0.792,0.192,0.69464,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
51806,CALML5,Q9NZT1,0.89,0.269,,DTO_05007616,Calcium-binding protein,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.05,1.0,,2013.0,2019.0,ALL
51807,TUBA8,Q9NY65,0.691,0.385,3.5702e-05,DTO_05007530,Cellular structure,C2750798,Polymicrogyria With Optic Nerve Hypoplasia,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2009.0,2017.0,ALL
51808,PHAX,Q9H814,0.839,0.308,3.0443e-06,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
51809,GALNT7,Q86SF2,0.736,0.308,2.5907e-06,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
51816,ADA2,Q9NZK5,0.545,0.846,8.1396e-08,DTO_05007624,Enzyme,C3887654,"POLYARTERITIS NODOSA, CHILDHOOD-ONSET",C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.76,1.0,strong,2014.0,2019.0,ALL
53335,BCL11A,Q9H165,0.541,0.769,0.96998,DTO_05007542,Transcription factor,C4310833,INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN,,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2018.0,ALL
53336,CPXCR1,Q8N123,1.0,0.115,,,,C1844830,"CLEFT PALATE, X-LINKED",C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
53339,BTBD1,Q9H0C5,1.0,0.038,0.00011935,DTO_05007624,Enzyme,C0520757,Delayed Emergence from Anesthesia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0,,2005.0,2005.0,ALL
53340,SPA17,Q15506,0.647,0.577,0.0066161,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.9,,2001.0,2019.0,ALL
53342,IL17D,Q8TAD2,0.464,0.808,0.19796,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2019.0,ALL
53343,NUDT9,Q9BW91,1.0,0.077,9.1759e-06,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
53344,CHIC1,Q5VXU3,1.0,0.115,0.85254,,,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
53345,TM6SF2,Q9BZW4,0.638,0.462,3.6097e-05,,,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.6,0.955,limited,2014.0,2020.0,ALL
53346,TM6SF1,Q9BZW5,0.89,0.154,1.0194e-07,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
53347,UBASH3A,P57075,0.638,0.538,1.0489e-10,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.4,1.0,,2016.0,2017.0,ALL
53349,ZFYVE1,Q9HBF4,1.0,0.077,0.19867,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
53353,LRP1B,Q9NZR2,0.626,0.615,2.5267e-06,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2019.0,ALL
53354,PANK1,Q8TE04,0.743,0.308,0.0026757,DTO_03300101,Kinase,C0202098,Insulin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
53358,SHC3,Q92529,0.587,0.731,0.046457,DTO_05007599,Signaling,C1337013,Differentiated Thyroid Gland Carcinoma,,,disease,Neoplastic Process,0.1,1.0,,2017.0,2019.0,ALL
53368,MDC1B,,0.931,0.115,,,,C0410174,Fukuyama Type Congenital Muscular Dystrophy,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
53369,HDL3,,0.663,0.423,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0,,2018.0,2018.0,ALL
53371,NUP54,Q7Z3B4,,,0.21559,DTO_05007405,Transporter,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2018.0,2018.0,ALL
53373,TPCN1,Q9ULQ1,0.711,0.269,0.003978,DTO_01300327,Ion channel,C0028960,Oligospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
53405,CLIC5,Q9NZA1,0.792,0.308,1.6209e-06,DTO_01300327,Ion channel,C4015050,"DEAFNESS, AUTOSOMAL RECESSIVE 103",,,disease,Disease or Syndrome,0.6,1.0,moderate,2015.0,2015.0,ALL
53407,STX18,Q9P2W9,0.78,0.269,2.4881e-07,DTO_05007405,Transporter,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
53615,MBD3,O95983,0.682,0.462,0.9765,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
53616,ADAM22,Q9P0K1,0.678,0.615,0.25101,DTO_05007624,Enzyme,C4693688,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61",,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2019.0,ALL
53630,BCO1,Q9HAY6,0.705,0.462,5.5008e-12,DTO_05007624,Enzyme,C2676023,"Hypercarotenemia And Vitamin A Deficiency, Autosomal Dominant",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.6,1.0,,2007.0,2007.0,ALL
53632,PRKAG3,Q9UGI9,0.792,0.308,4.618e-12,DTO_05007584,Enzyme modulator,C0007001,"Carbohydrate Metabolism, Inborn Errors",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.3,1.0,,2000.0,2007.0,ALL
53635,PTOV1,Q86YD1,0.641,0.692,0.75737,DTO_05007542,Transcription factor,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
53637,S1PR5,Q9H228,0.716,0.462,0.15713,DTO_02300001,G-protein coupled receptor,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.31,1.0,,2017.0,2017.0,ALL
53820,RIPPLY3,P57055,0.839,0.192,0.083551,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.02,0.5,,2011.0,2018.0,ALL
53826,FXYD6,Q9H0Q3,0.78,0.192,0.61886,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,0.4,,2007.0,2011.0,ALL
53827,FXYD5,Q96DB9,0.615,0.577,0.0020871,DTO_01300327,Ion channel,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
53828,FXYD4,P59646,0.89,0.077,0.00031646,DTO_01300327,Ion channel,C0153252,Systemic candidiasis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,2014.0,2018.0,ALL
53829,P2RY13,Q9BPV8,0.821,0.154,0.00030364,DTO_02300001,G-protein coupled receptor,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2015.0,2018.0,ALL
53831,GPR84,Q9NQS5,0.821,0.308,3.2998e-09,DTO_02300001,G-protein coupled receptor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
53832,IL20RA,Q9UHF4,0.716,0.346,0.027129,DTO_05007575,Receptor,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
53833,IL20RB,Q6UXL0,0.769,0.346,3.6539e-08,DTO_05007575,Receptor,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
53834,FGFRL1,Q8N441,0.588,0.615,0.011908,DTO_05007624,Enzyme,C1956097,Wolf-Hirschhorn Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.51,1.0,,2009.0,2017.0,ALL
53836,GPR87,Q9BY21,0.76,0.308,4.8062e-06,DTO_02300001,G-protein coupled receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
53838,C11orf24,Q96F05,,,0.0023262,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
53840,TRIM34,Q9BYJ4,0.89,0.077,1.3303e-06,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
53841,CDHR5,Q9HBB8,0.729,0.423,7.7447e-19,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2017.0,ALL
53842,CLDN22,Q8N7P3,1.0,0.038,0.038131,DTO_05007527,Cell-cell junction,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
53844,COPG2IT1,,1.0,0.077,,,,C0175693,Russell-Silver syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,0.0,,2003.0,2003.0,ALL
53904,MYO3A,Q8NEV4,0.78,0.269,1.8056e-45,DTO_03300101,Kinase,C1846784,"Deafness, Autosomal Recessive 30",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.81,1.0,strong,2011.0,2018.0,ALL
53905,DUOX1,Q9NRD9,0.57,0.692,6.2238e-33,DTO_05007624,Enzyme,C0018203,Chronic granulomatous disease,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.1,1.0,,1996.0,2019.0,ALL
53916,RAB4B,P61018,0.89,0.192,0.67089,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
53917,RAB24,Q969Q5,0.931,0.154,0.14963,,,C0004138,"Ataxias, Hereditary",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
53918,PELO,Q9BRX2,1.0,0.077,0.010494,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
53919,SLCO1C1,Q9NYB5,0.751,0.423,3.9889e-12,DTO_05007405,Transporter,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
53938,PPIL3,Q9H2H8,0.751,0.269,0.90243,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
53940,FTHL17,Q9BXU8,0.839,0.269,,DTO_05007612,Storage,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
53942,CNTN5,O94779,0.695,0.462,6.1963e-05,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
53944,CSNK1G1,Q9HCP0,1.0,0.038,0.99911,DTO_03300101,Kinase,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
53947,A4GALT,Q9NPC4,0.751,0.346,7.6668e-06,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2002.0,2002.0,ALL
53981,CPSF2,Q9P2I0,0.821,0.154,5.13e-08,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
54014,BRWD1,Q9NSI6,0.839,0.192,1.0,,,C0028960,Oligospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
54020,SLC37A1,P57057,0.821,0.154,0.00058122,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
54033,RBM11,P57052,0.931,0.115,2.2392e-05,DTO_05007557,Nucleic acid binding,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
54039,PCBP3,P57721,0.89,0.115,0.84326,DTO_05007624,Enzyme,C0021655,Insulin Resistance,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.1,1.0,,2011.0,2011.0,ALL
54045,IMMTP1,,0.805,0.423,,,,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
54058,C21orf58,P58505,,,1.2579e-12,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
54059,YBEY,P58557,,,1.3393e-07,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,0.0,,2005.0,2005.0,ALL
54064,LINC00160,,0.861,0.115,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
54065,SMIM11A,P58511,,,0.62261,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
54067,C21orf62-AS1,Q17RA5,1.0,0.038,0.16434,,,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
54082,TSPEAR-AS1,,0.821,0.269,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
54084,TSPEAR,Q8WU66,0.736,0.385,2.4371e-17,,,C3553932,"DEAFNESS, AUTOSOMAL RECESSIVE 98",,,disease,Disease or Syndrome,0.51,1.0,,2012.0,2018.0,ALL
54090,LINC00111,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
54093,SETD4,Q9NVD3,0.78,0.346,4.042e-13,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
54097,FAM3B,P58499,0.682,0.385,2.4285e-08,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
54099,FBXW11P1,,1.0,0.077,,,,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
54101,RIPK4,P57078,0.565,0.654,0.0039646,DTO_03300101,Kinase,C1849718,"POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE",C16;C11;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.79,1.0,,2012.0,2018.0,ALL
54102,CLIC6,Q96NY7,,,3.5342e-05,DTO_01300327,Ion channel,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
54103,GSAP,A4D1B5,0.751,0.346,2.5479e-23,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
54106,TLR9,Q9NR96,0.411,0.885,9.8117e-06,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.37,1.0,,2004.0,2018.0,ALL
54107,POLE3,Q9NRF9,0.705,0.423,0.030709,,,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.1,0.941,,1991.0,2020.0,ALL
54108,CHRAC1,Q9NRG0,0.89,0.077,0.06952,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
54109,CORD8,,0.89,0.077,,,,C3489532,Cone-Rod Dystrophy 2,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
54110,RP29,,1.0,0.077,,,,C0339526,Autosomal recessive retinitis pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0,,2001.0,2001.0,ALL
54112,GPR88,Q9GZN0,0.805,0.115,0.75488,DTO_02300001,G-protein coupled receptor,C4310787,"CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION",,,disease,Disease or Syndrome,0.4,,,,,ALL
54113,VUR,,0.722,0.385,,,,C4551858,Vesicoureteral Reflux 1,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2019.0,ALL
54115,PTOS2,,1.0,0.077,,,,C0266573,Congenital ptosis,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0,,2008.0,2008.0,ALL
54119,EIM,,0.839,0.269,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.02,0.5,,2005.0,2017.0,ALL
54145,H2BS1,P57053,0.711,0.615,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2016.0,ALL
54147,BACH1-IT3,,,,,,,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2009.0,2009.0,ALL
54148,MRPL39,Q9NYK5,0.861,0.115,4.3077e-06,DTO_05007624,Enzyme,C0024232,Lymphatic Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
54149,C21orf91,Q9NYK6,0.861,0.231,0.00087035,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
54165,DCUN1D1,Q96GG9,0.67,0.538,0.98526,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
54187,NANS,Q9NR45,0.545,0.692,,DTO_05007624,Enzyme,C1864872,"Spondyloepimetaphyseal dysplasia, Genevieve type",C23;C16;C17;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
54205,CYCS,P99999,0.599,0.769,0.63647,,,C2677608,Thrombocytopenia 4,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.71,1.0,,2008.0,2018.0,ALL
54206,ERRFI1,Q9UJM3,0.612,0.538,0.012152,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.31,1.0,,2011.0,2011.0,ALL
54207,KCNK10,P57789,0.751,0.231,0.0031431,DTO_01300327,Ion channel,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.21,1.0,,2005.0,2008.0,ALL
54209,TREM2,Q9NZC2,0.519,0.769,3.2892e-09,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.7,0.977,limited,2007.0,2020.0,ALL
54210,TREM1,Q9NP99,0.515,0.808,0.0062776,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2013.0,ALL
54212,SNTG1,Q9NSN8,0.792,0.192,0.1634,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
54221,SNTG2,Q9NY99,0.89,0.077,1.3092e-14,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
54329,GPR85,P60893,1.0,0.038,0.77281,DTO_02300001,G-protein coupled receptor,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2015.0,2015.0,ALL
54331,GNG2,P59768,0.821,0.346,0.50556,DTO_05007584,Enzyme modulator,C0037290,Skin Pigmentation,,,phenotype,Organ or Tissue Function,0.1,1.0,,2013.0,2013.0,ALL
54332,GDAP1,Q8TB36,0.612,0.538,3.2448e-08,,,C1842983,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,,1985.0,2017.0,ALL
54344,DPM3,Q9P2X0,0.839,0.308,0.23318,,,C2752007,"Congenital Disorder of Glycosylation, Type Io",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2000.0,2017.0,ALL
54345,SOX18,P35713,0.578,0.692,0.15103,DTO_05007542,Transcription factor,C1843004,HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.76,1.0,,2003.0,2018.0,ALL
54346,UNC93A,Q86WB7,0.89,0.115,1.1634e-15,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2002.0,2002.0,ALL
54360,CYTL1,Q9NRR1,0.7,0.423,1.0733e-05,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
54361,WNT4,P56705,0.552,0.731,0.12766,DTO_05007599,Signaling,C2675014,Mullerian Aplasia and Hyperandrogenism,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.71,1.0,,2004.0,2019.0,ALL
54363,HAO1,Q9UJM8,0.78,0.269,1.4578e-07,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
54386,TERF2IP,Q9NYB0,0.548,0.731,2.6683e-05,,,C2314896,Familial Atypical Mole Melanoma Syndrome,C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
54407,SLC38A2,Q96QD8,0.686,0.654,0.99709,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
54413,NLGN3,Q9NZ94,0.653,0.462,0.97641,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,0.96,strong,2003.0,2019.0,ALL
54414,SIAE,Q9HAT2,0.711,0.577,7.7865e-12,DTO_05007624,Enzyme,C3150797,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6",,,disease,Finding,0.4,1.0,,2010.0,2010.0,ALL
54429,TAS2R5,Q9NYW4,0.931,0.038,0.0011523,DTO_02300001,G-protein coupled receptor,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
54431,DNAJC10,Q8IXB1,0.769,0.385,1.1869e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
54432,YIPF1,Q9Y548,,,0.0031753,,,C0006625,Cachexia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2017.0,2017.0,ALL
54433,GAR1,Q9NY12,0.839,0.192,0.10049,DTO_05007557,Nucleic acid binding,C0265965,Dyskeratosis Congenita,C16;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.32,1.0,,2006.0,2012.0,ALL
54434,SSH1,Q8WYL5,0.769,0.192,0.00033003,,,C0265970,"Porokeratosis, Disseminated Superficial Actinic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.33,1.0,limited,2004.0,2008.0,ALL
54436,SH3TC1,Q8TE82,1.0,0.077,6.0939e-35,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,1.0,,2011.0,2011.0,ALL
54437,SEMA5B,Q9P283,0.792,0.308,2.6361e-10,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
54438,GFOD1,Q9NXC2,0.931,0.192,0.053666,DTO_05007624,Enzyme,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
54440,SASH3,O75995,1.0,0.077,0.38496,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
54441,STAG3L1,P0CL83,0.931,0.077,,DTO_05007557,Nucleic acid binding,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
54442,KCTD5,Q9NXV2,,,0.054252,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54443,ANLN,Q9NQW6,0.644,0.5,0.14261,,,C4014993,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8,,,disease,Disease or Syndrome,0.6,1.0,moderate,2014.0,2018.0,ALL
54453,RIN2,Q8WYP3,0.623,0.692,0.00081408,DTO_05007584,Enzyme modulator,C2751321,"Macrocephaly, Alopecia, Cutis Laxa, and Scoliosis",C23;C16;C17;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2009.0,2020.0,ALL
54454,ATAD2B,Q9ULI0,0.76,0.192,1.0,DTO_05007378,Epigenetic regulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54455,FBXO42,Q6P3S6,0.861,0.154,0.99503,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
54456,MOV10L1,Q9BXT6,0.751,0.231,1.0518e-17,DTO_05007624,Enzyme,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
54457,TAF7L,Q5H9L4,0.89,0.077,0.98636,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
54458,PRR13,Q9NZ81,0.769,0.308,0.013585,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.32,0.5,,2011.0,2019.0,ALL
54460,MRPS21,P82921,,,0.061313,DTO_05007557,Nucleic acid binding,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
54461,FBXW5,Q969U6,0.839,0.115,2.2808e-16,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
54463,RETREG1,Q9H6L5,0.623,0.538,6.3577e-06,,,C2751092,"Neuropathy, Hereditary Sensory And Autonomic, Type IIB",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,,2009.0,2014.0,ALL
54464,XRN1,Q8IZH2,0.716,0.346,1.0,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54465,ETAA1,Q9NY74,0.861,0.154,0.0077974,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
54466,SPIN2A,Q99865,0.805,0.192,0.0011466,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2005.0,2005.0,ALL
54467,ANKIB1,Q9P2G1,0.861,0.077,0.99996,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54469,ZFAND6,Q6FIF0,0.805,0.192,0.46236,DTO_05007557,Nucleic acid binding,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
54471,MIEF1,Q9NQG6,0.716,0.385,0.011698,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
54472,TOLLIP,Q9H0E2,0.65,0.462,0.081141,,,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.16,1.0,,2013.0,2019.0,ALL
54474,KRT20,P35900,0.388,0.846,9.0776e-11,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.4,0.87,,1993.0,2020.0,ALL
54475,NLE1,Q9NVX2,0.839,0.231,0.0002959,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
54476,RNF216,Q9NWF9,0.67,0.615,2.2561e-06,,,C1859305,Cerebellar Ataxia and Hypogonadotropic Hypogonadism,C23;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.75,1.0,,2013.0,2019.0,ALL
54477,PLEKHA5,Q9HAU0,0.861,0.192,1.0,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.3,1.0,,2018.0,2018.0,ALL
54478,PIMREG,Q9BSJ6,0.729,0.385,0.0011659,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,2014.0,2019.0,ALL
54480,CHPF2,Q9P2E5,0.931,0.077,2.1868e-17,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54487,DGCR8,Q8WYQ5,0.579,0.731,0.99973,,,C0012236,DiGeorge Syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.34,1.0,,2003.0,2018.0,ALL
54490,UGT2B28,Q9BY64,0.769,0.5,5.2426e-18,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,0.667,,2016.0,2019.0,ALL
54491,OTULINL,Q9NUU6,0.861,0.192,3.4462e-09,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
54492,NEURL1B,A8MQ27,,,0.70887,DTO_05007624,Enzyme,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
54495,TMX3,Q96JJ7,0.89,0.077,0.0044014,,,C0003119,Anophthalmos,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0,,2010.0,2010.0,ALL
54496,PRMT7,Q9NVM4,0.674,0.538,5.5036e-15,DTO_05007378,Epigenetic regulator,C4310689,"SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES",,,disease,Disease or Syndrome,0.71,1.0,strong,2015.0,2018.0,ALL
54497,HEATR5B,Q9P2D3,,,3.066e-22,,,C0018803,Heart Function Tests,,,phenotype,Diagnostic Procedure,0.1,1.0,,2010.0,2010.0,ALL
54498,SMOX,Q9NWM0,0.603,0.769,0.39964,,,C0740391,Middle Cerebral Artery Occlusion,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Acquired Abnormality,0.31,1.0,,2019.0,2019.0,ALL
54499,TMCO1,Q9UM00,0.588,0.654,9.41e-10,,,C1859252,Cerebrofaciothoracic Dysplasia,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.63,1.0,strong,2010.0,2019.0,ALL
54501,CLQTL1,,0.89,0.115,,,,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
54502,RBM47,A0AV96,0.729,0.308,0.98493,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
54503,ZDHHC13,Q8IUH4,0.729,0.346,1.1955e-19,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.31,1.0,,2010.0,2014.0,ALL
54504,CPVL,Q9H3G5,0.653,0.615,3.3502e-11,DTO_05007624,Enzyme,C0007117,Basal cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
54505,DHX29,Q7Z478,0.931,0.077,3.773e-09,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
54507,ADAMTSL4,Q6UY14,0.656,0.577,2.6008e-28,DTO_05007624,Enzyme,C3541474,"ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.8,1.0,strong,2010.0,2015.0,ALL
54508,EPB41L4A-DT,,0.736,0.308,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2016.0,2020.0,ALL
54509,RHOF,Q9HBH0,0.638,0.5,0.00017569,DTO_05007584,Enzyme modulator,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
54510,PCDH18,Q9HCL0,0.839,0.154,0.12675,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
54511,HMGCLL1,Q8TB92,1.0,0.077,2.9827e-07,DTO_05007624,Enzyme,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
54512,EXOSC4,Q9NPD3,0.839,0.192,0.068017,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
54514,DDX4,Q9NQI0,0.653,0.346,0.99826,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2002.0,2017.0,ALL
54516,MTRF1L,Q9UGC7,,,2.9554e-10,DTO_05007557,Nucleic acid binding,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2016.0,ALL
54517,PUS7,Q96PZ0,0.769,0.308,1.3457e-09,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.43,1.0,strong,2018.0,2019.0,ALL
54518,APBB1IP,Q7Z5R6,0.769,0.346,0.85443,DTO_05007575,Receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
54520,CCDC93,Q567U6,0.931,0.154,6.7876e-08,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
54522,ANKRD16,Q6P6B7,0.89,0.192,7.4267e-10,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
54531,MIER2,Q8N344,0.931,0.077,0.89593,DTO_05007557,Nucleic acid binding,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
54532,USP53,Q70EK8,1.0,0.038,1.6605e-13,DTO_05007624,Enzyme,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
54535,CCHCR1,Q8TD31,0.505,0.808,1.0122e-16,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,1.0,,2011.0,2011.0,ALL
54536,EXOC6,Q8TAG9,1.0,0.077,2.435e-07,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
54537,SHLD2,Q86V20,0.861,0.231,1.2384e-05,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
54538,ROBO4,Q8WZ75,0.641,0.615,2.942e-15,DTO_05007575,Receptor,C0149630,Bicuspid aortic valve,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.41,1.0,,2019.0,2019.0,ALL
54539,NDUFB11,Q9NX14,0.566,0.692,0.80382,DTO_05007624,Enzyme,C0796070,"MICROPHTHALMIA, SYNDROMIC 7",C16;C11;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.72,1.0,,2015.0,2017.0,ALL
54540,FAM193B,Q96PV7,0.861,0.038,0.9933,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
54541,DDIT4,Q9NX09,0.576,0.769,0.00068309,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.38,1.0,,2006.0,2018.0,ALL
54543,TOMM7,Q9P0U1,1.0,0.077,0.0097668,,,C0337428,Fibrinogen assay,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2016.0,ALL
54544,CRCT1,Q9UGL9,0.821,0.192,0.0019397,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
54545,MTMR12,Q9C0I1,0.861,0.115,0.99638,DTO_05007624,Enzyme,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
54546,RNF186,Q9NXI6,1.0,0.038,0.082589,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.03,1.0,,2013.0,2017.0,ALL
54549,SDK2,Q58EX2,0.839,0.154,0.0041393,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
54550,NECAB2,Q7Z6G3,1.0,0.115,2.2364e-13,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
54551,MAGEL2,Q9UJ55,0.56,0.654,0.97506,DTO_05007620,Cell adhesion,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,strong,1999.0,2019.0,ALL
54552,GNL3L,Q9NVN8,0.89,0.154,0.99558,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
54553,MIR4453HG,,0.931,0.077,,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
54554,WDR5B,Q86VZ2,,,1.7993e-05,,,C0201925,Calcium measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
54555,DDX49,Q9Y6V7,0.861,0.115,5.2505e-14,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
54556,ING3,Q9NXR8,0.695,0.269,0.99933,,,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2002.0,2019.0,ALL
54557,SGTB,Q96EQ0,1.0,0.077,0.040724,,,C0039263,Takayasu Arteritis,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
54558,SPATA6,Q9NWH7,0.931,0.038,3.4185e-21,,,C0015944,"Fetal Membranes, Premature Rupture",C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,1.0,,2019.0,2019.0,ALL
54566,EPB41L4B,Q9H329,0.769,0.346,0.99972,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2019.0,ALL
54567,DLL4,Q9NR61,0.494,0.769,0.99982,,,C4225271,ADAMS-OLIVER SYNDROME 6,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2018.0,ALL
54568,UGT2B29P,,,,,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2016.0,2016.0,ALL
54570,UGT2B26P,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
54573,UGT1A12P,,,,,,,C0344395,Bilirubin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
54574,UGT1A11P,,,,,,,C0344395,Bilirubin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2013.0,ALL
54575,UGT1A10,Q9HAW8,0.588,0.615,4.5886e-19,,,C0010324,"Crigler Najjar syndrome, type 1",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.2,1.0,,1994.0,2015.0,ALL
54576,UGT1A8,Q9HAW9,0.588,0.654,1.3092e-09,,,C0010324,"Crigler Najjar syndrome, type 1",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.2,1.0,,1994.0,2015.0,ALL
54577,UGT1A7,Q9HAW7,0.55,0.692,8.6636e-14,,,C0010324,"Crigler Najjar syndrome, type 1",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.2,1.0,,1994.0,2015.0,ALL
54578,UGT1A6,P19224,0.56,0.654,3.0491e-07,,,C0011616,Contact Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
54579,UGT1A5,P35504,0.656,0.462,9.3665e-09,,,C0010324,"Crigler Najjar syndrome, type 1",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.18,1.0,,1994.0,2015.0,ALL
54580,UGT1A2P,,,,,,,C0344395,Bilirubin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2012.0,ALL
54581,SCAND2P,Q9GZW5,1.0,0.231,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
54583,EGLN1,Q9GZT9,0.54,0.731,0.97403,,,C1853286,"Erythrocytosis, Familial, 3",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2007.0,ALL
54584,GNB1L,Q9BYB4,0.743,0.346,4.7419e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,1.0,,2008.0,2012.0,ALL
54585,LZTFL1,Q9NQ48,0.638,0.692,0.059115,,,C3714980,BARDET-BIEDL SYNDROME 17,,,disease,Disease or Syndrome,0.9,1.0,,2012.0,2016.0,ALL
54586,EQTN,Q9NQ60,1.0,0.077,5.4219e-12,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
54587,MXRA8,Q9BRK3,0.931,0.115,1.6738e-07,,,C4021085,Abnormality of brain morphology,,,phenotype,Anatomical Abnormality,0.1,,,,,ALL
54596,L1TD1,Q5T7N2,0.729,0.154,5.3285e-07,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.11,1.0,,2019.0,2019.0,ALL
54600,UGT1A9,O60656,0.59,0.577,5.3634e-08,,,C0860207,Drug-Induced Liver Disease,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,phenotype,Disease or Syndrome,0.31,1.0,,2011.0,2015.0,ALL
54602,NDFIP2,Q9NV92,,,0.52743,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
54606,DDX56,Q9NY93,0.695,0.308,8.2145e-08,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
54617,INO80,Q9ULG1,0.751,0.385,1.0,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54619,CCNJ,Q5T5M9,0.78,0.231,0.99796,DTO_05007584,Enzyme modulator,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
54620,FBXL19,Q6PCT2,0.821,0.192,0.99997,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.41,1.0,,2010.0,2015.0,ALL
54622,ARL15,Q9NXU5,0.769,0.346,0.00093584,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.14,1.0,,2009.0,2019.0,ALL
54623,PAF1,Q8N7H5,0.678,0.577,0.00016932,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2007.0,2018.0,ALL
54625,PARP14,Q460N5,0.736,0.423,0.0067415,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.03,1.0,,2013.0,2019.0,ALL
54626,HES2,Q9Y543,0.839,0.115,0.0026323,DTO_05007542,Transcription factor,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
54629,MINDY2,Q8NBR6,0.931,0.038,1.7641e-05,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
54657,UGT1A4,P22310,0.595,0.654,5.9807e-07,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
54658,UGT1A1,P22309,0.464,0.769,3.2577e-06,,,C0010324,"Crigler Najjar syndrome, type 1",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,1.0,0.984,,1992.0,2019.0,ALL
54659,UGT1A3,P35503,0.623,0.538,1.3092e-09,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
54661,PCDHB17P,,0.89,0.115,2.3485e-05,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
54663,WDR74,Q6RFH5,1.0,0.038,3.4256e-09,DTO_05007616,Calcium-binding protein,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
54664,TMEM106B,Q9NUM4,0.59,0.462,0.32576,,,C4693779,"LEUKODYSTROPHY, HYPOMYELINATING, 16",,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2018.0,ALL
54665,RSBN1,Q5VWQ0,0.89,0.115,0.099107,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
54674,LRRN3,Q9H3W5,0.821,0.115,0.032413,DTO_05007575,Receptor,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
54675,CRLS1,Q9UJA2,0.659,0.538,0.0031076,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
54676,GTPBP2,Q9BX10,0.736,0.423,0.31663,DTO_05007624,Enzyme,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,,strong,,,ALL
54677,CROT,Q9UKG9,0.805,0.346,4.4315e-25,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
54680,ZNHIT6,Q9NWK9,0.931,0.192,7.5337e-12,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
54681,P4HTM,Q9NXG6,0.666,0.5,3.9204e-09,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,strong,2014.0,2019.0,ALL
54682,MANSC1,Q9H8J5,,,0.0077616,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54700,RRN3,Q9NYV6,0.711,0.346,1.618e-05,DTO_05007542,Transcription factor,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
54704,PDP1,Q9P0J1,0.691,0.462,0.45106,DTO_05007624,Enzyme,C1837429,Pyruvate dehydrogenase phosphatase deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.7,1.0,,2005.0,2019.0,ALL
54707,GPN2,Q9H9Y4,,,0.01424,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54708,MARCHF5,Q9NX47,0.729,0.346,0.89339,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2013.0,2019.0,ALL
54714,CNGB3,Q9NQW8,0.633,0.192,7.7723e-19,DTO_01300327,Ion channel,C1849792,Achromatopsia 3,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.93,1.0,,2000.0,2018.0,ALL
54715,RBFOX1,Q9NWB1,0.584,0.692,0.95263,DTO_05007557,Nucleic acid binding,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.909,,2007.0,2019.0,ALL
54716,SLC6A20,Q9NP91,0.805,0.269,2.6621e-17,DTO_05007405,Transporter,C0268654,Iminoglycinuria,C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.6,1.0,,2008.0,2011.0,ALL
54718,BTN2A3P,Q96KV6,1.0,0.115,,DTO_05007584,Enzyme modulator,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
54719,RNANC,,0.931,0.077,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2014.0,2014.0,ALL
54726,OTUD4,Q01804,0.663,0.538,0.99997,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
54729,NKX1-1,Q15270,1.0,0.077,0.71465,DTO_05007542,Transcription factor,C0007760,Cerebellar Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
54732,TMED9,Q9BVK6,0.666,0.538,0.0059542,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,0.923,,2001.0,2019.0,ALL
54733,SLC35F2,Q8IXU6,0.76,0.231,0.00026278,DTO_05007405,Transporter,C0201899,Aspartate aminotransferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
54734,RAB39A,Q14964,0.861,0.115,0.00089193,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
54737,MPHOSPH8,Q99549,0.861,0.115,0.0014733,DTO_05007378,Epigenetic regulator,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2010.0,2020.0,ALL
54738,FEV,Q99581,0.593,0.692,0.0081114,DTO_05007542,Transcription factor,C0038644,Sudden infant death syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.32,1.0,,2007.0,2009.0,ALL
54739,XAF1,Q6GPH4,0.587,0.769,6.8151e-12,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2005.0,2010.0,ALL
54741,LEPROT,O15243,0.792,0.385,0.43754,DTO_05007575,Receptor,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
54742,LY6K,Q17RY6,0.691,0.346,0.014203,,,C0013295,Duodenal Ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
54749,EPDR1,Q9UM22,0.769,0.308,0.017864,,,C0017605,Angle Closure Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.31,1.0,,2016.0,2019.0,ALL
54751,FBLIM1,Q8WUP2,0.572,0.654,5.3941e-05,DTO_05007584,Enzyme modulator,C1864997,Majeed syndrome,C16;C01;C05;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Infections;    Musculoskeletal Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
54753,ZNF853,P0CG23,,,0.0017819,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
54754,NUTM2F,A1L443,,,4.2727e-09,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
54756,IL17RD,Q8NFM7,0.617,0.654,1.053e-06,,,C3808975,HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2013.0,ALL
54757,FAM20A,Q96MK3,0.7,0.346,2.1513e-07,,,C2931783,Amelogenesis imperfecta nephrocalcinosis,C16;C18;C13;C12;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.78,1.0,,2011.0,2019.0,ALL
54758,KLHDC4,Q8TBB5,1.0,0.115,4.5566e-31,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
54760,PCSK4,Q6UW60,0.931,0.077,1.3398e-12,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
54762,GRAMD1C,Q8IYS0,,,5.6287e-21,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
54763,ROPN1,Q9HAT0,0.89,0.115,9.9631e-05,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
54764,ZRANB1,Q9UGI0,0.839,0.115,0.99885,DTO_05007624,Enzyme,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
54765,TRIM44,Q96DX7,0.612,0.423,0.053808,,,C0003076,Aniridia,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.61,1.0,,2015.0,2015.0,ALL
54766,BTG4,Q9NY30,0.821,0.192,0.16682,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2003.0,2009.0,ALL
54768,HYDIN,Q4G0P3,0.641,0.538,2.2706e-24,,,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.63,1.0,,1973.0,2013.0,ALL
54769,DIRAS2,Q96HU8,1.0,0.038,0.47802,DTO_05007584,Enzyme modulator,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0,,2011.0,2018.0,ALL
54776,PPP1R12C,Q9BZL4,0.626,0.654,0.086713,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2005.0,2018.0,ALL
54777,CFAP46,Q8IYW2,0.931,0.154,1.0615e-33,,,C0030319,Panic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,0.0,,2019.0,2019.0,ALL
54778,RNF111,Q6ZNA4,0.7,0.5,0.99987,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
54788,DNAJB12,Q9NXW2,,,0.44012,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
54790,TET2,Q6N021,0.458,0.808,4.3334e-54,,,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.8,0.973,limited,2009.0,2020.0,ALL
54793,KCTD9,Q7L273,0.821,0.154,0.061749,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54795,TRPM4,Q8TD43,0.633,0.577,5.6531e-33,DTO_01300327,Ion channel,C1970298,"Progressive Familial Heart Block, Type Ib",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,,2005.0,2018.0,ALL
54796,BNC2,Q6ZN30,0.612,0.615,0.92762,DTO_05007557,Nucleic acid binding,C0238506,Congenital posterior urethral valves,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.6,1.0,strong,2019.0,2019.0,ALL
54797,MED18,Q9BUE0,0.736,0.423,0.00015906,,,C0013720,Ehlers-Danlos Syndrome,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,2016.0,2016.0,ALL
54798,DCHS2,Q6V1P9,0.839,0.385,7.4152e-47,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.12,1.0,,2012.0,2016.0,ALL
54799,MBTD1,Q05BQ5,0.78,0.192,1.0,DTO_05007378,Epigenetic regulator,C0153633,Malignant neoplasm of brain,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.02,1.0,,2014.0,2019.0,ALL
54800,KLHL24,Q6TFL4,0.821,0.115,0.0016745,,,C4310631,"EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2018.0,ALL
54801,HAUS6,Q7Z4H7,0.792,0.154,6.4188e-17,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
54802,TRIT1,Q9H3H1,0.621,0.692,4.0895e-11,DTO_05007624,Enzyme,C4693466,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35,,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2017.0,ALL
54805,CNNM2,Q9H8M5,0.641,0.346,0.99521,,,C3151295,"HYPOMAGNESEMIA 6, RENAL",,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2016.0,ALL
54806,AHI1,Q8N157,0.513,0.846,1.0773e-25,,,C1837713,JOUBERT SYNDROME 3,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,1992.0,2017.0,ALL
54808,DYM,Q7RTS9,0.563,0.769,3.5939e-13,,,C1846431,SMITH-MCCORT DYSPLASIA,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.82,1.0,strong,2003.0,2017.0,ALL
54809,SAMD9,Q5K651,0.606,0.808,1.0521e-33,,,C4284088,MIRAGE SYNDROME,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.79,1.0,,2006.0,2020.0,ALL
54810,GIPC2,Q8TF65,0.736,0.423,3.1514e-09,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54811,ZNF562,Q6V9R5,1.0,0.077,0.056912,,,C0020445,"Hypercholesterolemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
54812,AFTPH,Q6ULP2,1.0,0.038,0.99997,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
54813,KLHL28,Q9NXS3,,,0.023745,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54814,QPCTL,Q9NXS2,0.805,0.346,1.5671e-08,DTO_05007624,Enzyme,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2010.0,2013.0,ALL
54815,GATAD2A,Q86YP4,0.792,0.231,0.99957,DTO_05007557,Nucleic acid binding,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2012.0,2017.0,ALL
54819,ZCCHC10,Q8TBK6,0.821,0.115,0.059669,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54820,NDE1,Q9NXR1,0.608,0.462,0.0066921,,,C1857977,MICROHYDRANENCEPHALY,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.62,1.0,strong,2011.0,2019.0,ALL
54821,ERCC6L,Q2NKX8,0.743,0.385,0.99932,,,C0015923,Fetal Alcohol Syndrome,C16;C13;C25,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
54822,TRPM7,Q96QT4,0.531,0.731,5.2086e-16,DTO_01300327,Ion channel,C0543859,"Amyotrophic Lateral Sclerosis, Guam Form",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.5,,,,,ALL
54823,SWT1,Q5T5J6,0.839,0.115,0.99759,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
54825,CDHR2,Q9BYE9,0.805,0.192,3.4271e-20,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2002.0,2019.0,ALL
54826,GIN1,Q9NXP7,0.89,0.269,2.4151e-05,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
54827,NXPE4,Q6UWF7,0.89,0.077,6.8642e-16,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
54828,BCAS3,Q9H6U6,0.716,0.538,0.00013819,,,C1561643,Chronic Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.12,1.0,,2010.0,2018.0,ALL
54829,ASPN,Q9BXN1,0.636,0.5,1.0389e-07,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.4,0.931,,2005.0,2019.0,ALL
54830,NUP62CL,Q9H1M0,1.0,0.077,0.0013073,,,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
54831,BEST2,Q8NFU1,0.839,0.115,1.5229e-13,DTO_01300327,Ion channel,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
54832,VPS13C,Q709C8,0.653,0.346,7.6491e-49,,,C4225186,"PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2018.0,ALL
54834,GDAP2,Q9NXN4,0.839,0.154,1.4591e-09,,,C0011168,Deglutition Disorders,C06;C09,   Digestive System Diseases;    Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.1,,,,,ALL
54838,WBP1L,Q9NX94,0.769,0.462,0.64011,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
54839,LRRC49,Q8IUZ0,0.931,0.077,9.3518e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
54840,APTX,Q7Z2E3,0.59,0.5,3.9924e-10,DTO_05007557,Nucleic acid binding,C1859598,"ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA",C23;C10;C15;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Hemic and Lymphatic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,1.0,,2000.0,2017.0,ALL
54841,BIVM,Q86UB2,1.0,0.038,0.00018694,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2005.0,2005.0,ALL
54842,MFSD6,Q6ZSS7,0.89,0.077,3.2855e-06,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
54843,SYTL2,Q9HCH5,0.621,0.308,4.2572e-21,,,C0002994,Angioedema,C17;C20;C14,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Cardiovascular Diseases,phenotype,Pathologic Function,0.1,,,,,ALL
54845,ESRP1,Q6NXG1,0.628,0.5,0.99934,DTO_05007557,Nucleic acid binding,C4693935,"DEAFNESS, AUTOSOMAL RECESSIVE 109",,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
54847,SIDT1,Q9NXL6,0.821,0.192,6.5084e-15,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
54848,ARHGEF38,Q9NXL2,0.861,0.154,1.1352e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
54849,DEF8,Q6ZN54,0.839,0.115,0.0025904,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
54851,ANKRD49,Q8WVL7,0.861,0.077,0.00053732,DTO_05007584,Enzyme modulator,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2009.0,2018.0,ALL
54852,PAQR5,Q9NXK6,0.931,0.077,0.037162,DTO_05007575,Receptor,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
54854,FAM83E,Q2M2I3,,,9.4341e-11,,,C0201850,Alkaline phosphatase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
54855,TENT5C,Q5VWP2,0.805,0.269,0.94762,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
54856,GON4L,Q3T8J9,0.861,0.269,0.9515,DTO_05007542,Transcription factor,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
54857,GDPD2,Q9HCC8,0.931,0.077,0.31473,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
54858,PGPEP1,Q9NXJ5,0.581,0.769,0.0084969,DTO_05007624,Enzyme,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.11,1.0,,2010.0,2019.0,ALL
54859,ELP6,Q0PNE2,0.931,0.154,0.00049822,,,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2014.0,2014.0,ALL
54860,MS4A12,Q9NXJ0,0.89,0.192,3.4953e-09,DTO_05007575,Receptor,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2009.0,2019.0,ALL
54861,SNRK,Q9NRH2,0.821,0.154,0.99961,DTO_03300101,Kinase,C1335167,Ovarian Mucinous Adenocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
54862,CC2D1A,Q6P1N0,0.628,0.462,0.0084599,,,C1838023,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.6,1.0,strong,2006.0,2006.0,ALL
54863,TOR4A,Q9NXH8,0.89,0.077,0.56079,DTO_05007613,Chaperone,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
54865,GPATCH4,Q5T3I0,,,5.6931e-05,DTO_05007584,Enzyme modulator,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
54867,TMEM214,Q6NUQ4,,,6.4957e-10,,,C0428568,Fasting blood glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
54869,EPS8L1,Q8TE68,1.0,0.038,2.0053e-15,DTO_05007575,Receptor,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
54870,QRICH1,Q2TAL8,0.716,0.423,0.99576,DTO_05007584,Enzyme modulator,C4693824,VERVERI-BRADY SYNDROME,,,disease,Disease or Syndrome,0.4,1.0,strong,2015.0,2015.0,ALL
54872,PIGG,Q5H8A4,0.792,0.231,5.4258e-15,,,C4310794,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53",,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2019.0,ALL
54873,PALMD,Q9NP74,0.931,0.115,0.00033855,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
54874,FNBP1L,Q5T0N5,0.861,0.115,0.75392,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2014.0,ALL
54875,CNTLN,Q9NXG0,0.805,0.269,3.9521e-49,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
54877,ZCCHC2,Q9C0B9,0.805,0.308,0.99376,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2019.0,2019.0,ALL
54878,DPP8,Q6V1X1,0.722,0.385,0.99791,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
54879,ST7L,Q8TDW4,0.769,0.192,2.2024e-09,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
54880,BCOR,Q6W2J9,0.471,0.808,1.0,,,C1846265,"Microphthalmia, syndromic 2",C16;C11;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2004.0,2020.0,ALL
54881,TEX10,Q9NXF1,0.805,0.231,1.0,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54882,ANKHD1,Q8IWZ3,0.729,0.615,1.0,,,C0236773,Depressed bipolar I disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
54883,CWC25,Q9NXE8,,,4.1031e-05,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
54884,RETSAT,Q6NUM9,0.839,0.385,6.8328e-14,,,C0796154,"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1",C23;C16;C05;C10;C19;F03;F01;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
54885,TBC1D8B,Q0IIM8,0.805,0.231,5.953e-09,DTO_05007624,Enzyme,C0403397,Steroid-resistant nephrotic syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.31,1.0,strong,2019.0,2019.0,ALL
54886,PLPPR1,Q8TBJ4,0.78,0.077,0.56614,DTO_05007624,Enzyme,C0022333,Jacksonian Seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
54887,UHRF1BP1,Q6BDS2,0.769,0.269,4.4659e-13,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.43,0.857,,2009.0,2019.0,ALL
54888,NSUN2,Q08J23,0.559,0.846,0.00025826,DTO_05007624,Enzyme,C1970199,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,,2011.0,2012.0,ALL
54890,ALKBH5,Q6P6C2,0.686,0.346,0.94974,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.06,1.0,,2018.0,2020.0,ALL
54891,INO80D,Q53TQ3,0.931,0.115,0.99962,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
54892,NCAPG2,Q86XI2,0.603,0.731,0.97764,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
54893,MTMR10,Q9NXD2,0.931,0.154,1.8913e-07,DTO_05007624,Enzyme,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2010.0,2010.0,ALL
54894,RNF43,Q68DV7,0.584,0.577,0.73452,,,C0206698,Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.5,1.0,,2012.0,2012.0,ALL
54896,SLC66A1,Q6ZP29,0.792,0.192,6.3479e-05,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
54897,CASZ1,Q86V15,0.553,0.731,1.0,DTO_05007542,Transcription factor,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.44,1.0,,2017.0,2018.0,ALL
54898,ELOVL2,Q9NXB9,0.722,0.423,8.3719e-10,DTO_05007624,Enzyme,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
54899,PXK,Q7Z7A4,0.821,0.231,0.010847,DTO_03300101,Kinase,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.67,0.875,,2008.0,2015.0,ALL
54900,LAX1,Q8IWV1,1.0,0.115,0.00029571,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
54901,CDKAL1,Q5VV42,0.617,0.615,0.016021,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,0.984,,2007.0,2019.0,ALL
54902,TTC19,Q6DKK2,0.663,0.385,1.3788e-08,,,C1852372,MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder),C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.53,1.0,,2011.0,2018.0,ALL
54903,MKS1,Q9NXB0,0.505,0.769,3.3768e-16,DTO_05007621,Extracellular structure,C3714506,Meckel syndrome type 1,C23;C16;C13;C11;C12;C08;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.8,0.929,,1969.0,2019.0,ALL
54904,NSD3,Q9BZ95,0.656,0.462,1.0,DTO_05007378,Epigenetic regulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
54905,CYP2W1,Q8TAV3,0.736,0.231,2.2124e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2006.0,2017.0,ALL
54906,TASOR2,Q5VWN6,0.861,0.077,0.30957,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54908,SPDL1,Q96EA4,,,8.5955e-17,,,C0410916,Neonatal Death,C23;C13,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Finding,0.1,,,,,ALL
54910,SEMA4C,Q9C0C4,0.769,0.192,1.0,DTO_05007599,Signaling,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
54913,RPP25,Q9BUL9,0.861,0.231,0.20939,DTO_05007624,Enzyme,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
54914,FOCAD,Q5VW36,0.769,0.192,7.2122e-37,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
54915,YTHDF1,Q9BYJ9,0.76,0.423,0.9942,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2019.0,2019.0,ALL
54916,TMEM260,Q9NX78,0.769,0.423,4.7299e-19,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2012.0,ALL
54918,CMTM6,Q9NX76,0.78,0.192,0.43302,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2018.0,ALL
54919,DNAAF5,Q86Y56,0.67,0.5,8.1011e-11,,,C3543825,"CILIARY DYSKINESIA, PRIMARY, 18",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2018.0,ALL
54920,DUS2,Q9NX74,0.839,0.115,3.7906e-11,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
54922,RASIP1,Q5U651,0.78,0.346,0.99803,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
54923,LIME1,Q9H400,1.0,0.077,0.00017155,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
54926,UBE2R2,Q712K3,,,0.97816,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
54927,CHCHD3,Q9NX63,0.89,0.077,0.027527,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
54928,IMPAD1,Q9NX62,0.7,0.385,0.015288,DTO_05007624,Enzyme,C3279757,"CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE",,,disease,Disease or Syndrome,0.71,1.0,,2011.0,2012.0,ALL
54929,TMEM161A,Q9NX61,1.0,0.077,1.1047e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
54931,TRMT10C,Q7L0Y3,0.839,0.154,9.7105e-05,,,C4310773,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30,,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
54932,EXD3,Q8N9H8,1.0,0.077,2.9843e-16,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2016.0,ALL
54933,RHBDL2,Q9NX52,0.861,0.115,8.9365e-08,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
54934,KANSL2,Q9H9L4,1.0,0.038,0.87965,,,C0272178,Drug-induced neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
54935,DUSP23,Q9BVJ7,0.821,0.154,0.000666,,,C0489786,Height,,,phenotype,Organism Attribute,0.1,1.0,,2011.0,2011.0,ALL
54936,ADPRS,Q9NX46,0.743,0.308,0.00057514,,,C4748527,"NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
54937,SOHLH2,Q9NX45,0.78,0.154,0.0012421,,,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.31,1.0,moderate,2014.0,2014.0,ALL
54938,SARS2,Q9NP81,0.57,0.692,9.77e-10,DTO_05007624,Enzyme,C3151209,"Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome",C23;C18;C13;C11;C05;C12;C08;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.72,1.0,,2011.0,2016.0,ALL
54939,COMMD4,Q9H0A8,1.0,0.077,0.00032013,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
54940,OCIAD1,Q9NX40,0.76,0.308,9.9492e-07,DTO_05007608,Immune response,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
54941,RNF125,Q96EQ8,0.647,0.654,4.6358e-05,,,C4015710,TENORIO SYNDROME,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2014.0,ALL
54942,ABITRAM,Q9NX38,0.931,0.231,4.3558e-06,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
54947,LPCAT2,Q7L5N7,0.792,0.346,1.1195e-10,DTO_05007624,Enzyme,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
54949,SDHAF2,Q9NX18,0.604,0.692,2.8312e-06,,,C1866552,PARAGANGLIOMAS 2 (disorder),C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",disease,Disease or Syndrome,0.71,1.0,strong,2009.0,2012.0,ALL
54951,COMMD8,Q9NX08,0.931,0.115,7.3184e-10,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2020.0,ALL
54953,ODR4,Q5SWX8,0.839,0.231,2.7079e-07,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
54954,FAM120C,Q9NX05,0.861,0.192,0.99998,,,C0036220,Kaposi Sarcoma,C04;C01,   Neoplasms;    Infections,disease,Neoplastic Process,0.05,1.0,,2017.0,2020.0,ALL
54955,C1orf109,Q9NX04,0.89,0.077,1.4731e-06,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
54957,TXNL4B,Q9NX01,0.931,0.077,0.0043549,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
54958,TMEM160,Q9NX00,1.0,0.077,0.099858,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
54959,ODAM,A1E959,0.736,0.269,1.5176e-15,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
54960,GEMIN8,Q9NWZ8,1.0,0.038,0.94464,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
54961,SSH3,Q8TE77,0.821,0.231,3.4726e-14,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
54962,TIPIN,Q9BVW5,0.792,0.269,0.00016045,DTO_05007542,Transcription factor,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
54963,UCKL1,Q9NWZ5,0.839,0.154,4.3613e-15,DTO_03300101,Kinase,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
54964,C1orf56,Q9BUN1,0.931,0.077,9.6918e-06,,,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
54965,PIGX,Q8TBF5,0.78,0.308,2.3843e-05,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
54967,CT55,Q8WUE5,0.736,0.308,0.48549,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2007.0,2012.0,ALL
54968,TMEM70,Q9BUB7,0.636,0.654,0.029285,,,C3279699,"Encephalocardiomyopathy, Mitochondrial, Neonatal, Due To Atp Synthase Deficiency",C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2008.0,2016.0,ALL
54970,TTC12,Q9H892,0.78,0.192,1.7871e-17,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2007.0,2010.0,ALL
54971,BANP,Q8N9N5,0.743,0.269,0.99388,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2007.0,2019.0,ALL
54972,TMEM132A,Q24JP5,0.792,0.308,2.041e-09,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
54973,INTS11,Q5TA45,0.805,0.192,5.991e-14,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
54974,THG1L,Q9NWX6,0.805,0.192,5.2821e-05,,,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.32,1.0,,2011.0,2017.0,ALL
54976,C20orf27,Q9GZN8,,,0.0086621,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2016.0,ALL
54977,SLC25A38,Q96DW6,0.716,0.462,9.4313e-06,DTO_05007405,Transporter,C4225425,"ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY",,,disease,Disease or Syndrome,0.6,1.0,,2009.0,2015.0,ALL
54978,SLC35F6,Q8N357,0.861,0.231,0.00011541,DTO_05007405,Transporter,C0030297,Pancreatic Neoplasm,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
54979,PLAAT2,Q9NWW9,1.0,0.077,6.7817e-05,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
54980,C2orf42,Q9NWW7,0.931,0.192,0.005143,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
54981,NMRK1,Q9NWW6,0.931,0.038,3.5697e-08,DTO_03300101,Kinase,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
54982,CLN6,Q9NWW5,0.67,0.231,0.00010025,,,C1866282,"CEROID LIPOFUSCINOSIS, NEURONAL, 6",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.92,1.0,,1998.0,2019.0,ALL
54984,PINX1,Q96BK5,0.587,0.692,4.5977e-09,DTO_05007584,Enzyme modulator,C0001144,Acne Vulgaris,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
54985,HCFC1R1,Q9NWW0,0.743,0.308,0.00059302,,,C0023485,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,2016.0,2017.0,ALL
54986,ULK4,Q96C45,0.722,0.385,4.4336e-38,DTO_03300101,Kinase,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.4,1.0,,2011.0,2017.0,ALL
54993,ZSCAN2,Q7Z7L9,1.0,0.038,3.5648e-05,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
54994,GID8,Q9NWU2,0.89,0.077,0.93963,DTO_05007405,Transporter,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2012.0,2019.0,ALL
54995,OXSM,Q9NWU1,0.861,0.115,2.4742e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
54996,MTARC2,Q969Z3,0.792,0.192,0.00021936,,,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
54997,TESC,Q96BS2,0.57,0.692,0.10778,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.962,,1994.0,2019.0,ALL
55000,TUG1,,0.522,0.769,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.875,,2015.0,2019.0,ALL
55001,TTC22,Q5TAA0,0.78,0.077,1.7098e-06,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.11,1.0,,2019.0,2019.0,ALL
55002,TMCO3,Q6UWJ1,0.931,0.077,4.936e-16,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55003,PAK1IP1,Q9NWT1,,,0.36265,,,C0334070,Maturation defect,,,phenotype,Acquired Abnormality,0.01,1.0,,2017.0,2017.0,ALL
55004,LAMTOR1,Q6IAA8,0.597,0.615,0.72085,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.938,,1990.0,2018.0,ALL
55005,RMND1,Q9NWS8,0.674,0.462,1.0863e-09,,,C3554067,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11,,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2016.0,ALL
55006,TRMT61B,Q9BVS5,1.0,,4.107e-08,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55007,FAM118A,Q9NWS6,0.821,0.154,6.3156e-05,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55008,HERC6,Q8IVU3,0.89,0.308,1.5098e-14,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
55009,FAM174C,Q9BVV8,,,2.8876e-07,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55010,PARPBP,Q9NWS1,0.716,0.462,1.1929e-16,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55011,PIH1D1,Q9NWS0,0.931,0.077,0.0001069,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
55012,PPP2R3C,Q969Q6,0.7,0.538,6.818e-09,DTO_05007624,Enzyme,C0003466,"Anus, Imperforate",C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.1,,,,,ALL
55013,MCUB,Q9NWR8,0.861,0.192,2.2776e-08,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
55014,STX17,P56962,0.792,0.308,9.4629e-05,DTO_05007405,Transporter,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.4,1.0,,2010.0,2010.0,ALL
55016,MARCHF1,Q8TCQ1,0.54,0.808,0.0086782,,,C0018810,heart rate,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
55018,ANKRD40CL,Q53H64,0.769,0.231,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
55020,TTC38,Q5R3I4,1.0,0.115,3.2628e-13,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
55022,PID1,Q7Z2X4,0.7,0.231,0.003148,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
55023,PHIP,Q8WWQ0,0.595,0.769,1.0,DTO_05007378,Epigenetic regulator,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.61,1.0,strong,2016.0,2018.0,ALL
55024,BANK1,Q8NDB2,0.653,0.538,4.7905e-12,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,0.955,,2008.0,2019.0,ALL
55027,HEATR3,Q7Z4Q2,0.7,0.231,3.5205e-07,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
55028,C17orf80,Q9BSJ5,0.931,0.077,1.2297e-07,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
55030,FBXO34,Q9NWN3,,,0.1166,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55031,USP47,Q96K76,0.78,0.154,1.0,DTO_05007624,Enzyme,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55032,SLC35A5,Q9BS91,,,1.8916e-06,DTO_05007405,Transporter,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55033,FKBP14,Q9NWM8,0.65,0.654,1.5229e-06,,,C3281160,"EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2",,,disease,Disease or Syndrome,0.72,1.0,,2012.0,2018.0,ALL
55034,MOCOS,Q96EN8,0.617,0.654,1.6193e-19,,,C1863688,"Xanthinuria, Type II",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.72,1.0,,2001.0,2018.0,ALL
55035,NOL8,Q76FK4,0.89,0.115,1.7627e-13,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
55036,CCDC40,Q4G0X9,0.656,0.538,3.8155e-17,,,C3151137,"CILIARY DYSKINESIA, PRIMARY, 15",C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.6,1.0,,2011.0,2013.0,ALL
55037,PTCD3,Q96EY7,0.769,0.192,2.487e-22,,,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,limited,2009.0,2019.0,ALL
55038,CDCA4,Q9BXL8,0.839,0.077,0.083527,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
55039,TRMT12,Q53H54,0.931,0.077,0.32607,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
55040,EPN3,Q9H201,0.769,0.154,7.4151e-17,,,C1135196,"Heart Failure, Diastolic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
55048,VPS37C,A5D8V6,0.861,0.115,0.038236,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
55051,NRDE2,Q9H7Z3,1.0,0.038,2.7953e-15,,,C0023980,Longevity,,,phenotype,Temporal Concept,0.1,1.0,,2010.0,2015.0,ALL
55054,ATG16L1,Q676U5,0.543,0.769,0.96452,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.7,0.953,,2001.0,2020.0,ALL
55055,ZWILCH,Q9H900,1.0,0.115,1.198e-13,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
55056,GABPB1-IT1,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
55057,CRYBG2,Q8N1P7,,,9.7435e-12,,,C0200637,Monocyte count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
55061,SUSD4,Q5VX71,0.931,0.077,0.00014466,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
55062,WIPI1,Q5MNZ9,0.751,0.269,0.0016999,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
55063,ZCWPW1,Q9H0M4,0.89,0.115,1.1227e-13,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.15,1.0,,2013.0,2019.0,ALL
55064,SPATA6L,Q8N4H0,0.861,0.308,1.0446e-16,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55065,SLC52A1,Q9NWF4,0.526,0.769,3.5163e-06,DTO_05007405,Transporter,C0035528,Riboflavin Deficiency,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.61,1.0,limited,2007.0,2017.0,ALL
55066,PDPR,Q8NCN5,,,9.3527e-09,DTO_05007624,Enzyme,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
55068,ENOX1,Q8TC92,0.76,0.538,2.3323e-06,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
55069,TMEM248,Q9NWD8,1.0,0.038,0.7422,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
55070,DET1,Q7L5Y6,,,0.67903,DTO_05007624,Enzyme,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2014.0,2019.0,ALL
55072,RNF31,Q96EP0,0.736,0.346,1.0,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
55073,LRRC37A4P,,0.931,0.192,,,,C0027831,Neurofibromatosis 1,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
55074,OXR1,Q8N573,0.78,0.462,0.84148,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.31,1.0,,2019.0,2019.0,ALL
55075,UACA,Q9BZF9,0.78,0.269,3.2462e-29,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.2,1.0,,2010.0,2010.0,ALL
55076,TMEM45A,Q9NWC5,0.736,0.308,0.0047645,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
55079,FEZF2,Q8TBJ5,0.722,0.577,0.9886,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.02,0.5,,2018.0,2019.0,ALL
55080,TAPBPL,Q9BX59,0.861,0.154,2.3058e-10,DTO_05007575,Receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55081,IFT57,Q9NWB7,0.716,0.308,3.3347e-10,DTO_05007584,Enzyme modulator,C4693651,OROFACIODIGITAL SYNDROME XVIII,,,disease,Disease or Syndrome,0.4,,limited,,,ALL
55082,ARGLU1,Q9NWB6,0.931,0.077,0.86183,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
55083,KIF26B,Q2KJY2,0.67,0.5,0.99999,DTO_05007530,Cellular structure,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
55084,SOBP,A7XYQ1,0.839,0.192,0.99972,,,C3150924,"MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS",,,disease,Disease or Syndrome,0.61,1.0,limited,2007.0,2010.0,ALL
55088,CCDC186,Q7Z3E2,,,0.0013961,DTO_05007608,Immune response,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55089,SLC38A4,Q969I6,0.839,0.154,0.56028,DTO_05007405,Transporter,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55090,MED9,Q9NWA0,0.839,0.231,0.4077,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55092,TMEM51,Q9NW97,0.931,0.038,0.30495,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
55094,GPATCH1,Q9BRR8,0.792,0.154,1.5481e-11,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2012.0,2012.0,ALL
55100,WDR70,Q9NW82,1.0,0.077,1.5777e-09,,,C0005411,Biliary Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.1,1.0,,2010.0,2010.0,ALL
55101,DMAC2,Q9NW81,,,1.9807e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
55102,ATG2B,Q96BY7,0.722,0.385,1.0208e-08,,,C0023466,"Leukemia, Monocytic, Chronic",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
55103,RALGPS2,Q86X27,0.805,0.154,0.26225,DTO_05007584,Enzyme modulator,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
55105,GPATCH2,Q9NW75,0.839,0.346,1.0165e-11,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55106,SLFN12,Q8IYM2,0.792,0.269,4.6915e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
55107,ANO1,Q5XXA6,0.516,0.769,0.87426,DTO_01300327,Ion channel,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55109,AGGF1,Q8N302,0.65,0.462,2.7334e-05,,,C0022739,Klippel-Trenaunay-Weber Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.58,1.0,,2004.0,2016.0,ALL
55110,MAGOHB,Q96A72,0.89,0.154,0.32706,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55112,WDR60,Q8WVS4,0.592,0.654,4.3207e-12,DTO_05007530,Cellular structure,C0265275,Jeune thoracic dystrophy,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.62,1.0,strong,2013.0,2018.0,ALL
55113,XKR8,Q9H6D3,,,4.0749e-08,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
55114,ARHGAP17,Q68EM7,0.792,0.192,0.019749,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
55117,SLC6A15,Q9H2J7,0.78,0.269,0.00060384,DTO_05007405,Transporter,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2011.0,2018.0,ALL
55118,CRTAC1,Q9NQ79,0.78,0.269,7.4918e-07,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
55119,PRPF38B,Q5VTL8,0.743,0.269,0.70194,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.07,1.0,,2008.0,2019.0,ALL
55120,FANCL,Q9NW38,0.551,0.731,5.9404e-23,DTO_05007624,Enzyme,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,,2003.0,2020.0,ALL
55122,AKIRIN2,Q53H80,0.716,0.346,0.92355,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.21,1.0,,2008.0,2013.0,ALL
55124,PIWIL2,Q8TC59,0.612,0.577,2.7078e-08,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
55125,CEP192,Q8TEP8,1.0,0.038,1.2397e-22,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55127,HEATR1,Q9H583,0.805,0.231,1.0,DTO_05007557,Nucleic acid binding,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
55128,TRIM68,Q6AZZ1,0.821,0.308,8.0709e-19,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0,,2001.0,2012.0,ALL
55129,ANO10,Q9NW15,0.663,0.5,1.0162e-14,,,C3150998,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10",,,disease,Disease or Syndrome,0.73,1.0,,2010.0,2019.0,ALL
55130,ARMC4,Q5T2S8,0.641,0.615,1.9031e-25,,,C3809548,"CILIARY DYSKINESIA, PRIMARY, 23",,,disease,Disease or Syndrome,0.9,1.0,,2013.0,2014.0,ALL
55131,RBM28,Q9NW13,0.682,0.423,6.2318e-12,,,C2677535,"Alopecia, Neurologic Defects, and Endocrinopathy Syndrome",C23;C17;C10;C19;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.73,1.0,limited,2008.0,2016.0,ALL
55132,LARP1B,Q659C4,0.931,0.077,1.5265e-11,DTO_05007557,Nucleic acid binding,C0005283,beta Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
55133,SRBD1,Q8N5C6,0.839,0.154,1.6921e-20,DTO_05007557,Nucleic acid binding,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.11,1.0,,2010.0,2013.0,ALL
55135,WRAP53,Q9BUR4,0.603,0.692,5.3544e-05,,,C3151442,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2011.0,ALL
55137,FIGN,Q5HY92,1.0,0.038,0.98917,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55139,ANKZF1,Q9H8Y5,,,5.8245e-26,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
55140,ELP3,Q9H9T3,0.751,0.231,3.0115e-14,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
55143,CDCA8,Q53HL2,0.659,0.5,0.0071651,,,C1563716,Thyroid Dysgenesis,C16;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Endocrine System Diseases",disease,Congenital Abnormality,0.31,1.0,moderate,2017.0,2018.0,ALL
55144,LRRC8D,Q7L1W4,1.0,0.077,0.97752,,,C0012242,Digestive System Disorders,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
55145,THAP1,Q9NVV9,0.644,0.462,0.80123,,,C1414216,"Dystonia 6, torsion (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.98,1.0,,2009.0,2019.0,ALL
55146,ZDHHC4,Q9NPG8,1.0,0.077,5.2991e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55147,RBM23,Q86U06,0.861,0.231,4.8221e-11,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
55148,UBR7,Q8N806,0.861,0.231,0.49449,,,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
55149,MTPAP,Q9NVV4,0.581,0.769,0.99904,DTO_05007624,Enzyme,C3150925,"SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2017.0,ALL
55151,TMEM38B,Q9NVV0,0.78,0.231,0.019501,DTO_01300327,Ion channel,C3554428,"OSTEOGENESIS IMPERFECTA, TYPE XIV",,,disease,Disease or Syndrome,0.51,1.0,strong,2012.0,2017.0,ALL
55152,DALRD3,Q5D0E6,1.0,,1.6886e-10,DTO_05007624,Enzyme,C4748790,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18",,,disease,Disease or Syndrome,0.1,,,,,ALL
55153,SDAD1,Q9NVU7,0.821,0.192,1.8319e-20,,,C0023980,Longevity,,,phenotype,Temporal Concept,0.1,1.0,,2010.0,2010.0,ALL
55154,MSTO1,Q9BUK6,0.582,0.692,1.6182e-09,,,C4540096,"MYOPATHY, MITOCHONDRIAL, AND ATAXIA",,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2018.0,ALL
55157,DARS2,Q6PI48,0.638,0.577,9.7876e-13,DTO_05007624,Enzyme,C1970180,Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.78,1.0,,2007.0,2019.0,ALL
55159,RFWD3,Q6PCD5,0.569,0.731,3.5331e-10,DTO_05007624,Enzyme,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.41,1.0,,2013.0,2017.0,ALL
55160,ARHGEF10L,Q9HCE6,0.792,0.192,0.00047308,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55161,TMEM33,P57088,1.0,0.077,0.0052903,,,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
55163,PNPO,Q9NVS9,0.659,0.5,1.1024e-08,DTO_05007624,Enzyme,C1864723,Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency,C23;C18;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.71,1.0,,2005.0,2019.0,ALL
55164,SHQ1,Q6PI26,0.743,0.308,4.7806e-11,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2014.0,ALL
55165,CEP55,Q53EZ4,0.534,0.731,1.964e-12,,,C1856053,Hydranencephaly with Renal Aplasia-Dysplasia,C16;C13;C12;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.62,1.0,,2017.0,2019.0,ALL
55166,CENPQ,Q7L2Z9,,,1.045e-07,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
55167,MSL2,Q9HCI7,0.821,0.269,0.62406,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55168,MRPS18A,Q9NVS2,0.931,0.077,8.6298e-06,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
55170,PRMT6,Q96LA8,0.67,0.462,0.0033368,DTO_05007378,Epigenetic regulator,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2016.0,2016.0,ALL
55172,DNAAF2,Q9NVR5,0.678,0.538,6.4811e-09,,,C2675867,"CILIARY DYSKINESIA, PRIMARY, 10",C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,,2008.0,2019.0,ALL
55174,INTS10,Q9NVR2,0.931,0.154,0.99999,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55175,KLHL11,Q9NVR0,,,0.20133,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
55176,SEC61A2,Q9H9S3,,,0.0073737,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55177,RMDN3,Q96TC7,0.534,0.769,5.1687e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,1999.0,2019.0,ALL
55179,FAIM,Q9NVQ4,1.0,0.115,0.00011755,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
55180,LINS1,Q8NG48,0.691,0.231,2.3746e-07,,,C3280538,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27",,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2018.0,ALL
55181,SMG8,Q8ND04,0.78,0.346,0.0072559,,,C2698399,Myeloperoxidase Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
55182,RNF220,Q5VTB9,1.0,0.038,0.99958,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
55183,RIF1,Q5UIP0,0.7,0.462,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55184,DZANK1,Q9NVP4,1.0,0.077,5.3034e-21,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
55186,SLC25A36,Q96CQ1,0.89,0.192,0.033543,DTO_05007405,Transporter,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
55187,VPS13D,Q5THJ4,0.769,0.346,1.0749e-06,,,C1846492,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2018.0,2018.0,ALL
55188,RIC8B,Q9NVN3,0.821,0.115,0.99892,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
55190,NUDT11,Q96G61,0.647,0.615,0.10316,DTO_05007624,Enzyme,C0085859,Polyglandular Type I Autoimmune Syndrome,C20;C19,   Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,1997.0,2018.0,ALL
55191,NADSYN1,Q6IA69,0.78,0.231,1.2527e-16,,,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.3,1.0,strong,2020.0,2020.0,ALL
55192,DNAJC17,Q9NVM6,0.839,0.231,0.0020308,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
55193,PBRM1,Q86U86,0.566,0.615,1.0,DTO_05007378,Epigenetic regulator,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.7,1.0,,2011.0,2020.0,ALL
55196,RESF1,Q9HCM1,0.931,0.115,0.009294,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55197,RPRD1A,Q96P16,0.89,0.077,0.2218,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
55198,APPL2,Q8NEU8,0.7,0.423,1.1641e-18,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
55199,FAM86C1,Q9NVL1,0.931,0.077,5.5551e-12,,,C0869220,"Adverse effects, not elsewhere classified",,,disease,Injury or Poisoning,0.1,1.0,,2019.0,2019.0,ALL
55200,PLEKHG6,Q3KR16,0.76,0.192,3.7173e-19,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
55201,MAP1S,Q66K74,0.686,0.5,0.4197,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
55203,LGI2,Q8N0V4,0.839,0.077,1.4941e-06,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2010.0,2016.0,ALL
55204,GOLPH3L,Q9H4A5,0.736,0.231,1.2615e-05,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55205,ZNF532,Q9HCE3,0.931,0.077,0.98896,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55206,SBNO1,A3KN83,0.686,0.5,1.0,DTO_05007624,Enzyme,C0409959,"Osteoarthritis, Knee",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.4,1.0,,2018.0,2019.0,ALL
55207,ARL8B,Q9NVJ2,0.861,0.231,0.12959,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,0.0,,2019.0,2019.0,ALL
55208,DCUN1D2,Q6PH85,,,2.9667e-08,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55209,SETD5,Q9C0A6,0.56,0.731,0.99997,,,C3810406,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 23",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2018.0,ALL
55210,ATAD3A,Q9NVI7,0.628,0.692,4.0861e-09,DTO_05007624,Enzyme,C4310677,HAREL-YOON SYNDROME,,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2018.0,ALL
55211,DPPA4,Q7L190,0.805,0.115,0.00029363,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
55212,BBS7,Q8IWZ6,0.682,0.462,7.0515e-09,,,C1859565,BARDET-BIEDL SYNDROME 7,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2003.0,2015.0,ALL
55213,RCBTB1,Q8NDN9,0.572,0.692,1.5605e-06,DTO_05007584,Enzyme modulator,C4310680,RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES,,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2016.0,ALL
55214,P3H2,Q8IVL5,0.743,0.308,7.7878e-21,DTO_05007621,Extracellular structure,C3280346,"MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2011.0,ALL
55215,FANCI,Q9NVI1,0.543,0.731,8.9116e-37,,,C1836861,"FANCONI ANEMIA, COMPLEMENTATION GROUP I",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.71,1.0,,2001.0,2018.0,ALL
55217,TMLHE,Q9NVH6,0.821,0.231,7.9575e-05,,,C3550875,"AUTISM, SUSCEPTIBILITY TO, X-LINKED 6",,,disease,Disease or Syndrome,0.6,1.0,limited,2011.0,2015.0,ALL
55218,EXD2,Q9NVH0,0.89,0.154,3.6578e-12,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
55219,MACO1,Q8N5G2,1.0,0.038,0.99757,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
55222,LRRC20,Q8TCA0,,,0.04387,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55223,TRIM62,Q9BVG3,0.716,0.192,3.1787e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2014.0,2016.0,ALL
55225,RAVER2,Q9HCJ3,0.821,0.154,1.5171e-08,DTO_05007557,Nucleic acid binding,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
55226,NAT10,Q9H0A0,0.536,0.769,4.1206e-22,,,C0020630,Hypophosphatasia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,1988.0,2018.0,ALL
55227,LRRC1,Q9BTT6,0.861,0.154,0.93181,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2013.0,2017.0,ALL
55229,PANK4,Q9NVE7,0.861,0.115,0.98325,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55230,USP40,Q9NVE5,0.931,0.038,1.1506e-25,DTO_05007624,Enzyme,C0344395,Bilirubin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2011.0,ALL
55233,MOB1A,Q9H8S9,0.736,0.269,0.95091,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2005.0,2017.0,ALL
55234,SMU1,Q2TAY7,1.0,0.077,0.99994,,,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
55236,UBA6,A0AVT1,0.821,0.154,3.7296e-09,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2017.0,2017.0,ALL
55237,VRTN,Q9H8Y1,1.0,0.077,0.98901,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55238,SLC38A7,Q9NVC3,0.76,0.346,2.8965e-05,DTO_05007405,Transporter,C3548805,response to aromatase inhibitor,,,phenotype,Cell Function,0.1,1.0,,2019.0,2019.0,ALL
55239,OGFOD1,Q8N543,0.839,0.231,3.3103e-17,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
55240,STEAP3,Q658P3,0.666,0.385,5.3195e-09,,,C3808920,"ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2",,,disease,Disease or Syndrome,0.6,1.0,moderate,2011.0,2011.0,ALL
55243,KIRREL1,Q96J84,0.76,0.346,0.99855,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
55244,SLC47A1,Q96FL8,0.729,0.462,1.9605e-14,DTO_05007405,Transporter,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
55245,UQCC1,Q9NVA1,0.821,0.154,3.1978e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55246,CCDC25,Q86WR0,0.89,0.154,0.0091245,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55247,NEIL3,Q8TAT5,0.729,0.462,1.522e-09,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
55248,PACC1,Q9H813,0.565,0.731,5.4081e-10,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55249,YY1AP1,Q9H869,0.711,0.462,1.9461e-18,DTO_05007542,Transcription factor,C1865267,"Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly",C16;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.74,1.0,strong,2017.0,2019.0,ALL
55250,ELP2,Q6IA86,0.716,0.538,4.1811e-20,,,C4310641,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58",,,disease,Disease or Syndrome,0.7,1.0,limited,2015.0,2015.0,ALL
55251,PCMTD2,Q9NV79,,,0.0079948,DTO_05007624,Enzyme,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
55252,ASXL2,Q76L83,0.617,0.692,1.0,,,C4310672,SHASHI-PENA SYNDROME,,,disease,Disease or Syndrome,0.4,1.0,strong,2016.0,2016.0,ALL
55253,TYW1,Q9NV66,0.89,,1.9626e-10,DTO_05007624,Enzyme,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
55254,TMEM39A,Q9NV64,0.839,0.231,0.95467,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55255,WDR41,Q9HAD4,0.89,0.115,6.4998e-14,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
55256,ADI1,Q9BV57,0.674,0.654,3.1509e-05,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,2007.0,2019.0,ALL
55257,MRGBP,Q9NV56,0.839,0.154,0.93142,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2010.0,2011.0,ALL
55258,THNSL2,Q86YJ6,0.861,0.154,1.4828e-06,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.02,1.0,,2009.0,2013.0,ALL
55259,CASC1,Q6TDU7,0.76,0.269,3.8887e-14,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.34,1.0,,2003.0,2014.0,ALL
55262,MAP11,Q8WVR3,0.736,0.423,0.18133,,,C3711387,Autosomal Recessive Primary Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,,2019.0,2019.0,ALL
55266,TMEM19,Q96HH6,0.931,0.115,0.0052014,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2017.0,2017.0,ALL
55267,PRR34,Q9NV39,0.931,0.115,0.038713,,,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
55268,ECHDC2,Q86YB7,1.0,0.077,1.55e-10,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
55269,PSPC1,Q8WXF1,0.821,0.231,0.99013,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
55270,NUDT15,Q9NV35,0.67,0.538,0.0016748,,,C4225160,NUDT15 deficiency,,,disease,Disease or Syndrome,0.3,,,,,ALL
55272,IMP3,Q9NV31,0.566,0.462,1.5469e-07,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2009.0,2019.0,ALL
55273,TMEM100,Q9NV29,0.78,0.192,0.53437,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2015.0,2020.0,ALL
55274,PHF10,Q8WUB8,0.861,0.192,0.0002878,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2010.0,2019.0,ALL
55275,VPS53,Q5VIR6,0.659,0.654,1.3999e-07,,,C4014488,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2E",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,1989.0,2018.0,ALL
55276,PGM2,Q96G03,,,5.0352e-12,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
55277,FGGY,Q96C11,0.89,0.115,3.1851e-18,DTO_03300101,Kinase,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
55278,QRSL1,Q9H0R6,0.563,0.731,4.8771e-08,DTO_05007624,Enzyme,C3532239,Mitochondrial cardiomyopathy,,,disease,Disease or Syndrome,0.4,1.0,strong,2016.0,2018.0,ALL
55279,ZNF654,Q8IZM8,0.582,0.5,0.99753,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2001.0,2019.0,ALL
55280,CWF19L1,Q69YN2,0.691,0.346,1.4404e-15,,,C4015301,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2018.0,ALL
55281,TMEM140,Q9NV12,0.931,0.115,0.053997,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55282,LRRC36,Q1X8D7,,,7.7277e-12,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55283,MCOLN3,Q8TDD5,0.931,0.192,7.3204e-11,DTO_01300327,Ion channel,C0238286,Mucolipidosis Type IV,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.03,0.667,,2009.0,2017.0,ALL
55284,UBE2W,Q96B02,,,0.092355,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
55286,C4orf19,Q8IY42,0.861,0.115,0.09431,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
55287,TMEM40,Q8WWA1,0.839,0.269,2.4842e-08,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
55288,RHOT1,Q8IXI2,0.722,0.308,0.79851,DTO_05007584,Enzyme modulator,C0085084,Motor Neuron Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
55289,ACOXL,Q9NUZ1,0.674,0.577,5.2479e-15,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.41,1.0,,2008.0,2017.0,ALL
55290,BRF2,Q9HAW0,0.743,0.192,3.7481e-12,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2008.0,2015.0,ALL
55291,PPP6R3,Q5H9R7,0.716,0.385,0.99487,DTO_05007584,Enzyme modulator,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2014.0,2018.0,ALL
55293,UEVLD,Q8IX04,,,3.7228e-07,DTO_05007624,Enzyme,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2009.0,2009.0,ALL
55294,FBXW7,Q969H0,0.465,0.808,0.99949,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,1.0,,2001.0,2019.0,ALL
55295,KLHL26,Q53HC5,1.0,0.038,2.193e-06,,,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
55296,TBC1D19,Q8N5T2,,,0.00063144,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
55297,CCDC91,Q7Z6B0,0.729,0.423,3.8084e-06,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
55298,RNF121,Q9H920,0.89,0.154,0.31902,DTO_05007624,Enzyme,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
55300,PI4K2B,Q8TCG2,0.821,0.115,2.1895e-07,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2009.0,2009.0,ALL
55301,OLAH,Q9NV23,,,4.5721e-10,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
55303,GIMAP4,Q9NUV9,0.89,0.154,0.0017434,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
55304,SPTLC3,Q9NUV7,0.821,0.192,3.2277e-07,DTO_05007624,Enzyme,C0031117,Peripheral Neuropathy,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
55308,DDX19A,Q9NUU7,0.792,0.308,0.83991,,,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0,,1997.0,2001.0,ALL
55311,ZNF444,Q8N0Y2,1.0,0.038,0.8667,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
55312,RFK,Q969G6,1.0,0.077,0.063854,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
55313,CPPED1,Q9BRF8,,,2.3183e-07,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
55315,SLC29A3,Q9BZD2,0.578,0.769,1.2925e-07,DTO_05007405,Transporter,C1864445,Histiocytosis with joint contractures and sensorineural deafness,C23;C05;C10;C09;C15,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,,1998.0,2019.0,ALL
55316,RSAD1,Q9HA92,1.0,0.077,2.1726e-06,,,C0730314,Chronic central serous chorioretinopathy,C23;C11,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
55319,TMA16,Q96EY4,1.0,0.077,9.6522e-05,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
55321,TMEM74B,Q9NUR3,1.0,0.077,0.00030413,,,C0202231,Thyroxine measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55323,LARP6,Q9BRS8,0.631,0.5,0.66874,DTO_05007557,Nucleic acid binding,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.975,,1992.0,2019.0,ALL
55324,ABCF3,Q9NUQ8,,,1.5114e-05,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
55325,UFSP2,Q9NUQ7,0.736,0.192,3.0583e-06,,,C1840572,"HIP DYSPLASIA, BEUKES TYPE",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,,2015.0,2018.0,ALL
55326,AGPAT5,Q9NUQ2,,,7.0782e-06,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
55327,LIN7C,Q9NUP9,0.861,0.269,0.051327,DTO_05007527,Cell-cell junction,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
55328,RNLS,Q5VYX0,0.678,0.423,3.796e-06,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
55329,MNS1,Q8NEH6,0.89,0.077,2.0964e-21,DTO_05007530,Cellular structure,C0018935,Hematocrit procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55330,BLOC1S4,Q9NUP1,0.89,0.308,0.10151,,,C0079504,Hermanski-Pudlak Syndrome,C16;C18;C11;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.21,1.0,,2000.0,2000.0,ALL
55331,ACER3,Q9NUN7,0.743,0.423,0.87464,,,C4540358,"LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET",,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2018.0,ALL
55332,DRAM1,Q8N682,0.678,0.385,0.22771,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
55333,SYNJ2BP,P57105,0.805,0.154,0.51218,DTO_05007575,Receptor,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2014.0,2014.0,ALL
55334,SLC39A9,Q9NUM3,0.769,0.115,0.72946,DTO_05007405,Transporter,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
55335,NIPSNAP3B,Q9BS92,0.89,0.115,4.9158e-10,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
55336,FBXL8,Q96CD0,,,3.9237e-09,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
55337,SHFL,Q9NUL5,1.0,0.077,0.13736,,,C0036220,Kaposi Sarcoma,C04;C01,   Neoplasms;    Infections,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
55338,LINC01949,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55340,GIMAP5,Q96F15,0.78,0.346,0.096506,,,C0024312,Lymphopenia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.26,1.0,,2002.0,2018.0,ALL
55341,LSG1,Q9H089,1.0,0.038,4.5543e-12,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2014.0,2014.0,ALL
55342,STRBP,Q96SI9,0.839,0.269,0.99958,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55343,SLC35C1,Q96A29,0.705,0.577,0.023545,DTO_05007405,Transporter,C0398739,"Congenital disorder of glycosylation, type 2C",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2001.0,2016.0,ALL
55345,ZGRF1,Q86YA3,1.0,0.115,2.1633e-42,DTO_05007624,Enzyme,C0750927,"Apraxia, Developmental Verbal",C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,,,,,ALL
55346,TCP11L1,Q9NUJ3,1.0,0.115,0.0043702,DTO_05007575,Receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
55347,ABHD10,Q9NUJ1,,,1.2865e-05,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
55349,CHDH,Q8NE62,0.529,0.769,1.685e-06,DTO_05007624,Enzyme,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,0.909,,2009.0,2020.0,ALL
55350,VNN3,Q9NY84,0.821,0.269,0.0043252,DTO_05007624,Enzyme,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.32,1.0,,2009.0,2020.0,ALL
55351,STK32B,Q9NY57,0.78,0.423,4.9116e-08,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55352,COPRS,Q9NQ92,0.931,0.154,0.25305,,,C0751690,Malignant Peripheral Nerve Sheath Tumor,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
55353,LAPTM4B,Q86VI4,0.579,0.692,4.2764e-13,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.923,,2010.0,2019.0,ALL
55355,HJURP,Q8NCD3,0.691,0.269,2.0485e-07,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2017.0,2019.0,ALL
55356,SLC22A15,Q8IZD6,0.931,0.115,2.516e-09,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
55357,TBC1D2,Q9BYX2,0.839,0.346,2.9932e-10,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
55359,STYK1,Q6J9G0,0.67,0.346,9.1009e-11,DTO_03300101,Kinase,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55361,PI4K2A,Q9BTU6,0.821,0.269,8.744e-07,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2016.0,2020.0,ALL
55362,TMEM63B,Q5T3F8,1.0,0.115,0.99999,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55363,HEMGN,Q9BXL5,0.729,0.5,1.0292e-09,,,C0202230,Thyroid stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
55364,IMPACT,Q9P2X3,0.593,0.808,4.8274e-08,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2001.0,2001.0,ALL
55365,TMEM176A,Q96HP8,0.716,0.231,0.0093723,DTO_05007575,Receptor,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55366,LGR4,Q9BXB1,0.617,0.808,0.48705,DTO_02300001,G-protein coupled receptor,C3714987,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17,,,phenotype,Finding,0.4,,,,,ALL
55367,PIDD1,Q9HB75,0.76,0.231,6.435e-17,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
55370,PPP4R1L,Q9P1A2,0.931,0.077,,DTO_05007624,Enzyme,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55374,TMCO6,Q96DC7,,,1.2724e-09,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
55379,LRRC59,Q96AG4,0.705,0.5,0.43432,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
55384,MEG3,,0.471,0.846,,,,C1842466,"Uniparental disomy, paternal, chromosome 14",C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.31,1.0,,2008.0,2015.0,ALL
55388,MCM10,Q7L590,0.691,0.462,4.3797e-15,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
55390,PRO2268,,0.931,0.038,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
55422,ZNF331,Q9NQX6,0.612,0.577,0.97927,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
55423,SIRPG,Q9P1W8,0.821,0.231,3.476e-15,DTO_05007599,Signaling,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.12,1.0,,2009.0,2019.0,ALL
55425,GPALPP1,Q8IXQ4,,,1.7222e-05,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
55432,YOD1,Q5VVQ6,0.751,0.269,0.1348,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55435,AP1AR,Q63HQ0,0.89,0.077,0.14205,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
55437,STRADB,Q9C0K7,0.89,0.115,0.0010128,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55450,CAMK2N1,Q7Z7J9,0.716,0.308,0.16681,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2014.0,2018.0,ALL
55451,LINC00216,,1.0,0.077,,,,C0153676,Secondary malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
55454,CSGALNACT2,Q8N6G5,0.861,0.192,0.23766,DTO_05007624,Enzyme,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.11,1.0,,2009.0,2014.0,ALL
55466,DNAJA4,Q8WW22,0.89,0.077,0.0020027,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
55486,PARL,Q9H300,0.729,0.308,0.00019181,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2015.0,2015.0,ALL
55500,ETNK1,Q9HBU6,0.716,0.385,0.92558,DTO_03300101,Kinase,C1292772,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
55501,CHST12,Q9NRB3,0.839,0.192,4.6561e-05,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
55502,HES6,Q96HZ4,0.686,0.308,0.083905,DTO_05007542,Transcription factor,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2009.0,ALL
55503,TRPV6,Q9H1D0,0.603,0.615,6.1719e-07,DTO_01300327,Ion channel,C1300287,Transient neonatal hyperparathyroidism,C23;C19,"   Pathological Conditions, Signs and Symptoms;    Endocrine System Diseases",phenotype,Disease or Syndrome,0.61,1.0,,2018.0,2019.0,ALL
55504,TNFRSF19,Q9NS68,0.7,0.423,0.032926,,,C0027439,Nasopharyngeal Neoplasms,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,group,Neoplastic Process,0.4,1.0,,2010.0,2016.0,ALL
55505,NOP10,Q9NPE3,0.631,0.654,0.76943,DTO_05007557,Nucleic acid binding,C1857144,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1",,,disease,Disease or Syndrome,0.6,1.0,,2007.0,2007.0,ALL
55506,MACROH2A2,Q9P0M6,0.78,0.192,0.97635,DTO_05007557,Nucleic acid binding,C0003463,Anus Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
55507,GPRC5D,Q9NZD1,0.67,0.538,0.0012463,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2005.0,2010.0,ALL
55508,SLC35E3,Q7Z769,,,5.8322e-07,DTO_05007405,Transporter,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
55509,BATF3,Q9NR55,0.659,0.385,0.03171,DTO_05007542,Transcription factor,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.31,1.0,,2015.0,2015.0,ALL
55510,DDX43,Q9NXZ2,0.722,0.462,2.4641e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2003.0,2019.0,ALL
55511,SAGE1,Q9NXZ1,0.588,0.654,8.5732e-18,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2000.0,2018.0,ALL
55512,SMPD3,Q9NY59,0.659,0.615,0.59429,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2008.0,2008.0,ALL
55515,ASIC4,Q96FT7,0.769,0.115,0.0028675,DTO_01300327,Ion channel,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
55520,ELAC1,Q9H777,,,0.88118,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55521,TRIM36,Q9NQ86,0.78,0.231,3.415e-05,,,C0002902,Anencephaly,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.61,1.0,,2017.0,2017.0,ALL
55526,DHTKD1,Q96HY7,0.711,0.385,2.7884e-30,,,C3554366,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q",,,disease,Disease or Syndrome,0.9,1.0,,2012.0,2018.0,ALL
55527,FEM1A,Q9BSK4,0.805,0.308,8.3375e-10,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2005.0,2008.0,ALL
55529,PIP4P2,Q8N4L2,1.0,0.038,0.00042164,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2006.0,2006.0,ALL
55531,ELMOD1,Q8N336,0.931,0.192,0.79258,DTO_05007599,Signaling,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
55532,SLC30A10,Q6XR72,0.578,0.654,0.97952,DTO_05007405,Transporter,C2750442,Hypermanganesemia with Dystonia Polycythemia and Cirrhosis,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.74,1.0,,2012.0,2018.0,ALL
55534,MAML3,Q96JK9,0.653,0.577,0.99984,DTO_05007542,Transcription factor,C0018798,Congenital Heart Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.4,1.0,,2013.0,2013.0,ALL
55536,CDCA7L,Q96GN5,0.686,0.615,0.00017861,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.11,1.0,,2011.0,2016.0,ALL
55539,KCNQ1DN,Q9H478,0.931,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2000.0,2019.0,ALL
55540,IL17RB,Q9NRM6,0.601,0.808,4.4601e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2007.0,2019.0,ALL
55544,RBM38,Q9H0Z9,0.67,0.5,0.71583,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2019.0,ALL
55545,MSX2P1,,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
55552,ZNF823,P16415,0.931,0.115,0.3764,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
55553,SOX6,P35712,0.578,0.615,0.99984,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2012.0,2012.0,ALL
55554,KLK15,Q9H2R5,0.705,0.385,0.015191,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2002.0,2003.0,ALL
55556,ENOSF1,Q7L5Y1,0.617,0.654,9.0272e-19,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55558,PLXNA3,P51805,0.67,0.769,0.054893,,,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
55559,HAUS7,Q99871,0.931,0.115,0.98913,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
55561,CDC42BPG,Q6DT37,0.89,0.192,4.5623e-26,DTO_03300101,Kinase,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55565,ZNF821,O75541,,,0.0027859,DTO_05007542,Transcription factor,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
55567,DNAH3,Q8TD57,0.89,0.231,1.5364e-64,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55568,GALNT10,Q86SR1,0.839,0.231,1.987e-05,DTO_05007624,Enzyme,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
55572,FOXRED1,Q96CU9,0.633,0.462,1.9872e-16,DTO_05007624,Enzyme,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.6,1.0,strong,1998.0,2016.0,ALL
55573,CDV3,Q9UKY7,1.0,0.077,0.76817,,,C0337439,Iron measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
55576,STAB2,Q8WWQ8,0.743,0.423,9.2343e-62,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2013.0,2017.0,ALL
55577,NAGK,Q9UJ70,0.931,0.154,4.5517e-09,DTO_03300101,Kinase,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
55578,SUPT20H,Q8NEM7,0.751,0.346,2.7313e-14,DTO_05007542,Transcription factor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2019.0,2019.0,ALL
55582,KIF27,Q86VH2,1.0,0.038,1.7585e-24,DTO_05007530,Cellular structure,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0,,2012.0,2012.0,ALL
55584,CHRNA9,Q9UGM1,0.78,0.192,7.0378e-06,DTO_01300327,Ion channel,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
55585,UBE2Q1,Q7Z7E8,0.76,0.308,0.99919,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2015.0,2018.0,ALL
55586,MIOX,Q9UGB7,0.76,0.346,1.0702e-17,DTO_05007624,Enzyme,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.04,1.0,,2000.0,2019.0,ALL
55588,MED29,Q9NX70,0.931,0.115,0.0010191,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
55589,BMP2K,Q9NSY1,0.792,0.346,0.21901,DTO_03300101,Kinase,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55591,VEZT,Q9HBM0,0.839,0.308,0.11018,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.15,1.0,,2012.0,2018.0,ALL
55593,OTUD5,Q96G74,0.861,0.115,0.99717,DTO_05007624,Enzyme,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
55596,ZCCHC8,Q6NZY4,0.78,0.269,0.96584,DTO_05007557,Nucleic acid binding,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
55599,RNPC3,Q96LT9,0.608,0.731,0.00019596,,,C4748435,"ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V",,,disease,Disease or Syndrome,0.5,1.0,,2014.0,2018.0,ALL
55600,ITLN1,Q8WWA0,0.656,0.577,3.4119e-06,,,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2005.0,2017.0,ALL
55601,DDX60,Q8IY21,0.839,0.192,5.2091e-16,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
55602,CDKN2AIP,Q9NXV6,,,0.96386,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2011.0,2018.0,ALL
55603,TENT5A,Q96IP4,0.695,0.577,0.92482,,,C4693736,"OSTEOGENESIS IMPERFECTA, TYPE XVIII",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
55604,CARMIL1,Q5VZK9,0.722,0.5,0.033641,DTO_05007542,Transcription factor,C0003125,Anorexia Nervosa,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
55605,KIF21A,Q7Z4S6,0.653,0.423,2.865e-08,DTO_05007530,Cellular structure,C1851102,"Fibrosis Of Extraocular Muscles, Congenital, 1",C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.97,0.923,strong,2001.0,2016.0,ALL
55607,PPP1R9A,Q9ULJ8,0.769,0.269,1.0812e-05,,,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
55608,ANKRD10,Q9NXR5,,,0.1645,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55609,ZNF280C,Q8ND82,1.0,0.077,0.99899,,,C0035344,Retinopathy of Prematurity,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
55610,VPS50,Q96JG6,0.89,0.192,0.8139,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
55611,OTUB1,Q96FW1,0.67,0.423,0.97107,DTO_05007624,Enzyme,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
55612,FERMT1,Q9BQL6,0.599,0.577,2.9163e-11,,,C0406557,Poikiloderma of Kindler,C23;C16;C17;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,1.0,0.957,,2003.0,2019.0,ALL
55613,MTMR8,Q96EF0,1.0,0.077,7.0105e-19,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55614,KIF16B,Q96L93,0.792,0.423,2.1e-19,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55615,PRR5,P85299,0.89,0.115,0.066916,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
55616,ASAP3,Q8TDY4,0.722,0.192,8.33e-12,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2017.0,2019.0,ALL
55617,TASP1,Q9H6P5,0.805,0.346,0.60781,DTO_05007624,Enzyme,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.12,1.0,,2018.0,2019.0,ALL
55619,DOCK10,Q96BY6,0.861,0.192,2.5524e-06,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
55620,STAP2,Q9UGK3,0.711,0.462,1.6296e-16,DTO_05007575,Receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.08,1.0,,2017.0,2019.0,ALL
55621,TRMT1,Q9NXH9,0.821,0.269,1.8899e-12,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.52,1.0,strong,2011.0,2017.0,ALL
55622,TTC27,Q6P3X3,1.0,0.077,4.9343e-14,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
55623,THUMPD1,Q9NXG2,0.78,0.269,3.9721e-12,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55624,POMGNT1,Q8WZA1,0.537,0.538,1.9454e-20,,,C3150412,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3",,,disease,Disease or Syndrome,0.9,1.0,strong,2001.0,2017.0,ALL
55625,ZDHHC7,Q9NXF8,0.861,0.192,0.00097756,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55626,AMBRA1,Q9C0C7,0.729,0.308,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2012.0,2019.0,ALL
55627,SMPD4,Q9NXE4,0.861,0.308,1.7125e-19,,,C0003886,Arthrogryposis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
55628,ZNF407,Q9C0G0,0.792,0.269,1.0,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
55629,PNRC2,Q9NPJ4,0.89,0.115,0.33763,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
55630,SLC39A4,Q6P5W5,0.628,0.692,0.00031401,DTO_05007405,Transporter,C0221036,Acrodermatitis enteropathica,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,0.957,,2002.0,2019.0,ALL
55632,G2E3,Q7L622,,,0.97083,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55633,TBC1D22B,Q9NU19,,,0.025486,DTO_05007624,Enzyme,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
55634,KRBOX4,Q5JUW0,1.0,0.038,0.64798,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,1994.0,1994.0,ALL
55635,DEPDC1,Q5TB30,0.67,0.577,7.635e-10,DTO_05007557,Nucleic acid binding,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2014.0,2019.0,ALL
55636,CHD7,Q9P2D1,0.441,0.846,1.0,,,C0265354,CHARGE Syndrome,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,1.0,0.981,definitive,2004.0,2020.0,ALL
55638,SYBU,Q9NX95,0.546,0.769,9.7732e-05,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,1999.0,2019.0,ALL
55640,FLVCR2,Q9UPI3,0.736,0.346,3.4299e-06,DTO_05007405,Transporter,C1856972,Encephaloclastic Proliferative Vasculopathy,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,,2010.0,2016.0,ALL
55643,BTBD2,Q9BX70,0.931,0.038,0.87534,DTO_05007624,Enzyme,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
55644,OSGEP,Q9NPF4,0.626,0.615,7.0838e-08,DTO_05007624,Enzyme,C4540266,GALLOWAY-MOWAT SYNDROME 3,,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
55646,LYAR,Q9NX58,0.805,0.077,3.758e-07,,,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
55647,RAB20,Q9NX57,0.839,0.154,0.0038974,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
55650,PIGV,Q9NUD9,0.636,0.615,1.5131e-08,,,C1855923,Hyperphosphatasia with Mental Retardation,C23;C16;C18;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.74,1.0,strong,2010.0,2017.0,ALL
55651,NHP2,Q9NX24,0.623,0.654,0.05011,DTO_05007557,Nucleic acid binding,C3151441,"DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2",,,disease,Disease or Syndrome,0.7,1.0,limited,2001.0,2014.0,ALL
55652,SLC48A1,Q6P1K1,0.89,0.077,0.7342,DTO_05007405,Transporter,C0302486,Erythrophagocytosis,,,disease,Disease or Syndrome,0.02,1.0,,2013.0,2018.0,ALL
55653,BCAS4,Q8TDM0,0.89,0.269,5.6789e-05,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2002.0,2017.0,ALL
55654,TMEM127,O75204,0.638,0.615,0.012865,,,C0031511,Pheochromocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.8,1.0,strong,2010.0,2020.0,ALL
55655,NLRP2,Q9NX02,0.515,0.731,1.4201e-38,,,C0004135,Ataxia Telangiectasia,C16;C18;C20;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2002.0,2011.0,ALL
55656,INTS8,Q75QN2,0.792,0.385,0.9439,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
55657,ZNF692,Q9BU19,0.805,0.192,1.2582e-11,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
55658,RNF126,Q9BV68,0.821,0.231,0.95379,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
55660,PRPF40A,O75400,0.716,0.692,0.0391,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
55661,DDX27,Q96GQ7,0.821,0.231,0.58326,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55662,HIF1AN,Q9NWT6,0.656,0.462,0.073885,,,C0202177,Phospholipid measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
55663,ZNF446,Q9NWS9,,,5.6695e-08,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
55664,CDC37L1,Q7L3B6,0.89,0.154,0.96614,DTO_05007584,Enzyme modulator,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
55665,URGCP,Q8TCY9,0.674,0.385,0.57799,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.05,1.0,,2012.0,2018.0,ALL
55666,NPLOC4,Q8TAT6,0.743,0.385,0.99998,,,C0339682,Regular astigmatism - corneal,C11,   Eye Diseases,disease,Disease or Syndrome,0.11,1.0,,2018.0,2018.0,ALL
55668,GPATCH2L,Q9NWQ4,1.0,0.115,0.0028216,DTO_05007557,Nucleic acid binding,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55669,MFN1,Q8IWA4,0.644,0.577,2.5118e-10,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55670,PEX26,Q7Z412,0.584,0.615,0.93189,,,C3553951,PEROXISOME BIOGENESIS DISORDER 7B,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2003.0,2017.0,ALL
55671,PPP4R3A,Q6IN85,0.931,0.077,0.99992,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55672,NBPF1,Q3BBV0,0.751,0.269,2.3773e-25,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.08,1.0,,2005.0,2017.0,ALL
55676,SLC30A6,Q6NXT4,0.711,0.346,6.906e-09,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.34,1.0,,2006.0,2014.0,ALL
55677,IWS1,Q96ST2,1.0,0.077,0.99727,,,C0883409,Cardiac troponin I measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55679,LIMS2,Q7Z4I7,0.751,0.308,5.0526e-05,DTO_05007530,Cellular structure,C4225192,"MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE",,,disease,Disease or Syndrome,0.7,1.0,limited,2015.0,2015.0,ALL
55680,RUFY2,Q8WXA3,1.0,0.077,0.00067843,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
55681,SCYL2,Q6P3W7,1.0,0.038,0.077114,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55683,KANSL3,Q9P2N6,1.0,0.038,0.99998,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
55684,RABL6,Q3YEC7,0.792,0.231,0.99817,,,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
55686,MREG,Q8N565,0.839,0.308,1.7187e-07,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2009.0,2015.0,ALL
55687,TRMU,O75648,0.716,0.385,1.5307e-16,,,C3278664,"LIVER FAILURE, INFANTILE, TRANSIENT",,,disease,Disease or Syndrome,0.7,1.0,strong,2009.0,2016.0,ALL
55689,YEATS2,Q9ULM3,0.89,0.192,0.99639,DTO_05007557,Nucleic acid binding,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2012.0,ALL
55690,PACS1,Q6VY07,0.603,0.615,0.99999,,,C3554343,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 17",C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.73,1.0,strong,2012.0,2019.0,ALL
55691,FRMD4A,Q9P2Q2,0.65,0.538,1.0,,,C4225193,"CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2019.0,ALL
55692,LUC7L,Q9NQ29,0.861,0.115,0.46952,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
55693,KDM4D,Q6B0I6,0.792,0.154,0.43196,DTO_05007378,Epigenetic regulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2018.0,ALL
55695,NSUN5,Q96P11,0.663,0.423,8.2394e-13,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,1993.0,2013.0,ALL
55697,VAC14,Q08AM6,0.588,0.731,0.18554,DTO_05007575,Receptor,C4310743,"STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET",,,disease,Disease or Syndrome,0.7,1.0,,2008.0,2016.0,ALL
55698,RADIL,Q96JH8,0.861,0.192,6.2671e-23,,,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55699,IARS2,Q9NSE4,0.59,0.654,0.081336,DTO_05007624,Enzyme,C4014942,"CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA",,,disease,Disease or Syndrome,0.73,1.0,,2014.0,2018.0,ALL
55701,ARHGEF40,Q8TER5,0.89,0.154,6.6277e-09,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55702,YJU2,Q9BW85,0.931,0.077,8.2518e-07,DTO_05007557,Nucleic acid binding,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
55703,POLR3B,Q9NW08,0.628,0.654,1.6812e-23,DTO_05007624,Enzyme,C2676243,"Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism",C23;C16;C10;C19;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Endocrine System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.73,1.0,strong,2011.0,2018.0,ALL
55704,CCDC88A,Q3V6T2,0.61,0.615,1.0,DTO_05007584,Enzyme modulator,C1850056,"Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome",C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.54,0.75,,2003.0,2020.0,ALL
55705,IPO9,Q96P70,0.78,0.192,0.9999,DTO_05007584,Enzyme modulator,C0424678,Lean body mass,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
55706,NDC1,Q9BTX1,0.769,0.231,0.99932,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
55707,NECAP2,Q9NVZ3,0.89,0.115,1.9626e-09,,,C0011633,Dermatomyositis,C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
55709,KBTBD4,Q9NVX7,0.89,0.038,2.9136e-06,,,C0042487,Venous Thrombosis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.1,1.0,,2012.0,2012.0,ALL
55711,FAR2,Q96K12,0.805,0.308,0.55963,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.21,1.0,,2018.0,2018.0,ALL
55713,ZNF334,Q9HCZ1,1.0,0.115,1.6122e-09,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
55714,TENM3,Q9P273,0.599,0.692,0.99955,,,C3554592,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9",,,disease,Disease or Syndrome,0.6,1.0,strong,2012.0,2012.0,ALL
55715,DOK4,Q8TEW6,0.805,0.154,0.091531,,,C0007124,Noninfiltrating Intraductal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
55717,WDR11,Q9BZH6,0.524,0.808,1.3704e-08,,,C0162809,Kallmann Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.74,1.0,,2010.0,2018.0,ALL
55718,POLR3E,Q9NVU0,0.805,0.308,0.013199,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55719,SLF2,Q8IX21,0.931,0.115,2.8868e-06,,,C0233794,Memory impairment,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
55720,TSR1,Q2NL82,1.0,0.077,5.1573e-21,,,C1852540,"Coronary Artery Dissection, Spontaneous",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
55721,IQCC,Q4KMZ1,0.861,0.154,4.0474e-09,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
55722,CEP72,Q9P209,0.729,0.346,1.5766e-19,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
55723,ASF1B,Q9NVP2,0.769,0.269,6.3325e-05,DTO_05007557,Nucleic acid binding,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
55726,INTS13,Q9NVM9,0.751,0.308,0.86229,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55727,BTBD7,Q9P203,0.751,0.154,0.0001076,,,C0337443,Sodium measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
55728,N4BP2,Q86UW6,0.931,0.154,3.7496e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55729,ATF7IP,Q6VMQ6,0.543,0.769,0.99993,,,C0039590,Testicular Neoplasms,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,group,Neoplastic Process,0.4,1.0,,2010.0,2013.0,ALL
55731,FAM222B,Q8WU58,,,0.29182,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55732,C1orf112,Q9NSG2,1.0,0.038,3.3523e-10,,,C0001144,Acne Vulgaris,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
55733,HHAT,Q5VTY9,0.608,0.577,3.246e-08,DTO_05007624,Enzyme,C1838654,Nivelon Nivelon Mabille syndrome,C16;C13;C05;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.5,1.0,,2012.0,2014.0,ALL
55734,ZFP64,Q9NTW7,0.839,0.192,0.00016534,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55735,DNAJC11,Q9NVH1,0.89,0.077,0.99893,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
55737,VPS35,Q96QK1,0.656,0.5,0.96921,DTO_05007405,Transporter,C3280133,PARKINSON DISEASE 17,,,disease,Disease or Syndrome,0.9,1.0,,2011.0,2015.0,ALL
55738,ARFGAP1,Q8N6T3,0.839,0.154,0.0015429,,,C0008073,Developmental Disabilities,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
55739,NAXD,Q8IW45,0.839,0.231,0.0069972,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
55740,ENAH,Q8N8S7,0.647,0.577,0.99994,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
55741,EDEM2,Q9BV94,0.89,0.115,6.8274e-07,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
55742,PARVA,Q9NVD7,0.769,0.154,0.40854,DTO_05007530,Cellular structure,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
55743,CHFR,Q96EP1,0.633,0.5,0.00078671,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.55,0.8,,2008.0,2015.0,ALL
55744,COA1,Q9GZY4,0.931,0.115,0.0088335,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55745,AP5M1,Q9H0R1,0.695,0.385,1.3325e-09,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
55746,NUP133,Q8WUM0,0.678,0.577,9.2587e-05,,,C4748549,"NEPHROTIC SYNDROME, TYPE 18",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
55748,CNDP2,Q96KP4,0.659,0.5,1.0067e-07,DTO_05007624,Enzyme,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.34,0.75,,2008.0,2013.0,ALL
55749,CCAR1,Q8IX12,0.663,0.385,0.99999,DTO_05007616,Calcium-binding protein,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
55750,AGK,Q53H12,0.65,0.654,5.9973e-09,,,C1859317,Cataract and cardiomyopathy,C11;C14,   Eye Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.78,1.0,,1986.0,2017.0,ALL
55751,TMEM184C,Q9NVA4,0.861,0.077,0.068601,DTO_05007405,Transporter,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
55752,SEPTIN11,Q9NVA2,0.7,0.346,0.95924,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
55753,OGDHL,Q9ULD0,0.76,0.308,9.6942e-10,,,C4021085,Abnormality of brain morphology,,,phenotype,Anatomical Abnormality,0.1,,,,,ALL
55754,TMEM30A,Q9NV96,0.769,0.231,0.0031923,,,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
55755,CDK5RAP2,Q96SN8,0.682,0.577,4.6171e-23,,,C3711387,Autosomal Recessive Primary Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.69,0.889,,2007.0,2017.0,ALL
55756,INTS9,Q9NV88,,,4.3201e-07,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
55757,UGGT2,Q9NYU1,0.931,0.154,1.3209e-41,DTO_05007624,Enzyme,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55758,RCOR3,Q9P2K3,0.89,0.115,0.988,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
55759,WDR12,Q9GZL7,0.769,0.192,0.00032559,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.41,1.0,,2009.0,2015.0,ALL
55760,DHX32,Q7L7V1,0.76,0.269,1.6487e-09,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
55761,TTC17,Q96AE7,1.0,0.077,0.99996,,,C0337428,Fibrinogen assay,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2017.0,ALL
55763,EXOC1,Q9NV70,0.792,0.154,0.00069012,DTO_05007405,Transporter,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.12,1.0,,2013.0,2017.0,ALL
55764,IFT122,Q9HBG6,0.56,0.846,2.3816e-24,,,C0432235,CRANIOECTODERMAL DYSPLASIA 1,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.73,1.0,,2009.0,2018.0,ALL
55765,INAVA,Q3KP66,0.743,0.346,0.00022109,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.42,1.0,,2011.0,2018.0,ALL
55766,H2AJ,Q9BTM1,0.861,0.115,0.24627,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
55768,NGLY1,Q96IV0,0.601,0.654,1.5117e-13,DTO_05007624,Enzyme,C3808991,NGLY1 deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.77,1.0,definitive,2012.0,2020.0,ALL
55770,EXOC2,Q96KP1,0.751,0.423,2.8675e-09,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
55771,PRR11,Q96HE9,0.7,0.308,8.4224e-07,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.08,1.0,,2013.0,2019.0,ALL
55773,TBC1D23,Q9NUY8,0.729,0.308,1.782e-05,,,C4540164,"PONTOCEREBELLAR HYPOPLASIA, TYPE 11",,,disease,Congenital Abnormality,0.6,1.0,strong,2017.0,2018.0,ALL
55775,TDP1,Q9NUW8,0.612,0.538,1.2652e-17,DTO_05007624,Enzyme,C1846574,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,0.923,limited,2002.0,2020.0,ALL
55777,MBD5,Q9P267,0.581,0.808,1.0,,,C1969562,"Mental Retardation, Autosomal Dominant 1",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.61,1.0,strong,2007.0,2017.0,ALL
55778,ZNF839,A8K0R7,,,3.8218e-05,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
55779,CFAP44,Q96MT7,0.792,0.077,6.1049e-15,,,C4539824,SPERMATOGENIC FAILURE 20,,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
55780,ERMARD,Q5T6L9,0.647,0.538,5.7789e-16,,,C1868720,Periventricular Nodular Heterotopia,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,limited,2013.0,2017.0,ALL
55781,RIOK2,Q9BVS4,0.821,0.154,0.00013402,DTO_03300101,Kinase,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,,,,,ALL
55783,CMTR2,Q8IYT2,0.722,0.462,5.3475e-10,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
55784,MCTP2,Q6DN12,0.623,0.577,6.03e-52,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2009.0,ALL
55785,FGD6,Q6ZV73,0.792,0.192,2.4019e-08,DTO_05007584,Enzyme modulator,C2237660,exudative macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.4,1.0,,2015.0,2016.0,ALL
55786,ZNF415,Q09FC8,0.711,0.346,0.21655,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
55787,TXLNG,Q9NUQ3,0.931,0.154,0.99845,DTO_05007608,Immune response,C0201544,Prostate specific antigen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
55788,LMBRD1,Q9NUN5,0.716,0.385,9.0253e-11,,,C1848578,"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE (disorder)",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.63,1.0,,2009.0,2016.0,ALL
55789,DEPDC1B,Q8WUY9,0.729,0.385,4.4233e-10,DTO_05007557,Nucleic acid binding,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2019.0,ALL
55790,CSGALNACT1,Q8TDX6,0.716,0.423,9.2684e-14,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
55791,LRIF1,Q5T3J3,0.931,0.038,0.00043397,,,C0016057,Fibrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
55793,MINDY1,Q8N5J2,1.0,0.077,4.5522e-16,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
55794,DDX28,Q9NUL7,,,1.3284e-08,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
55795,PCID2,Q5JVF3,0.931,0.077,5.2663e-13,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2016.0,ALL
55796,MBNL3,Q9NUK0,0.89,0.231,0.68597,DTO_05007557,Nucleic acid binding,C0005699,Blast Phase,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
55798,METTL2B,Q6P1Q9,1.0,0.038,1.6691e-09,DTO_05007624,Enzyme,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
55799,CACNA2D3,Q8IZS8,0.711,0.577,0.57778,DTO_01300327,Ion channel,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2017.0,2017.0,ALL
55800,SCN3B,Q9NY72,0.686,0.269,0.05103,DTO_01300327,Ion channel,C2751088,Brugada Syndrome 7,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.9,1.0,limited,2009.0,2016.0,ALL
55801,IL26,Q9NPH9,0.631,0.538,0.00053514,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.12,1.0,,2009.0,2019.0,ALL
55802,DCP1A,Q9NPI6,0.821,0.192,0.68989,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
55803,ADAP2,Q9NPF8,0.839,0.308,4.2394e-10,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2008.0,2017.0,ALL
55805,LRP2BP,Q9P2M1,0.821,0.269,2.3523e-06,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
55806,HR,O43593,0.722,0.192,7.438e-10,DTO_05007542,Transcription factor,C1859592,ATRICHIA WITH PAPULAR LESIONS,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.9,1.0,,1998.0,2008.0,ALL
55808,ST6GALNAC1,Q9NSC7,0.682,0.346,1.3809e-11,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
55809,TRERF1,Q96PN7,0.729,0.346,1.0,,,C1458155,Mammary Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,group,Neoplastic Process,0.32,1.0,,2006.0,2009.0,ALL
55810,FOXJ2,Q9P0K8,0.821,0.154,0.99846,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
55811,ADCY10,Q96PN6,0.663,0.654,7.3834e-41,,,C0342639,Familial idiopathic hypercalciuria,C23,"   Pathological Conditions, Signs and Symptoms",disease,Congenital Abnormality,0.5,1.0,moderate,2002.0,2002.0,ALL
55812,SPATA7,Q9P0W8,0.656,0.385,5.1769e-13,,,C1858677,LEBER CONGENITAL AMAUROSIS 3 (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2015.0,2015.0,ALL
55813,UTP6,Q9NYH9,0.89,0.308,3.113e-08,DTO_05007557,Nucleic acid binding,C0027831,Neurofibromatosis 1,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.02,1.0,,2007.0,2019.0,ALL
55814,BDP1,A6H8Y1,0.89,0.154,1.3294e-21,DTO_05007557,Nucleic acid binding,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.3,1.0,limited,2013.0,2013.0,ALL
55815,TSNAXIP1,Q2TAA8,,,5.2807e-29,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
55816,DOK5,Q9P104,0.769,0.308,0.00022609,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
55818,KDM3A,Q9Y4C1,0.599,0.654,0.99999,DTO_05007378,Epigenetic regulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,0.833,,2015.0,2019.0,ALL
55819,RNF130,Q86XS8,0.839,0.192,0.00030327,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
55821,ALLC,Q8N6M5,0.695,0.385,4.2324e-16,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2014.0,2014.0,ALL
55823,VPS11,Q9H270,0.633,0.654,1.8905e-05,DTO_05007405,Transporter,C4225247,"LEUKODYSTROPHY, HYPOMYELINATING, 12",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2016.0,ALL
55824,PAG1,Q9NWQ8,0.505,0.808,0.017764,,,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.33,1.0,,2000.0,2018.0,ALL
55825,PECR,Q9BY49,0.89,0.192,4.0029e-08,DTO_05007624,Enzyme,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
55827,DCAF6,Q58WW2,0.729,0.385,0.086476,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.37,1.0,,2001.0,2017.0,ALL
55829,SELENOS,Q9BQE4,0.628,0.615,1.4301e-09,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
55830,GLT8D1,Q68CQ7,0.711,0.462,1.1343e-08,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.43,1.0,,2019.0,2020.0,ALL
55831,EMC3,Q9P0I2,0.805,0.308,0.28563,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
55832,CAND1,Q86VP6,0.729,0.346,1.0,DTO_05007542,Transcription factor,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
55833,UBAP2,Q5T6F2,0.729,0.385,3.4324e-07,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
55835,CENPJ,Q9HC77,0.546,0.846,2.0603e-27,DTO_05007624,Enzyme,C0265202,Seckel syndrome,C23;C16;C05;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.71,1.0,,2010.0,2010.0,ALL
55837,EAPP,Q56P03,1.0,0.115,2.2259e-10,,,C0079541,Holoprosencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2005.0,2005.0,ALL
55839,CENPN,Q96H22,1.0,0.077,0.0044226,,,C0201874,Amino acids measurement,,,group,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
55840,EAF2,Q96CJ1,0.695,0.538,2.2166e-07,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.39,1.0,,2006.0,2019.0,ALL
55841,WWC3,Q9ULE0,0.805,0.154,0.99996,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2017.0,2018.0,ALL
55843,ARHGAP15,Q53QZ3,0.682,0.462,1.372e-08,DTO_05007584,Enzyme modulator,C4317009,Diverticular Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.41,1.0,,2017.0,2019.0,ALL
55844,PPP2R2D,Q66LE6,0.89,0.115,0.91708,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55845,BRK1,Q8WUW1,0.743,0.308,0.68706,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.04,0.5,,2004.0,2009.0,ALL
55847,CISD1,Q9NZ45,0.716,0.577,0.021714,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.06,1.0,,2012.0,2019.0,ALL
55848,PLGRKT,Q9HBL7,1.0,0.077,4.604e-08,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
55850,USE1,Q9NZ43,0.592,0.769,2.0712e-05,,,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.04,0.75,,1989.0,2019.0,ALL
55851,PSENEN,Q9NZ42,0.695,0.423,0.87614,,,C3714534,dowling-degos disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.52,1.0,strong,2010.0,2018.0,ALL
55852,TEX2,Q8IWB9,,,0.00014978,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
55854,ZC3H15,Q8WU90,0.861,0.077,0.90263,DTO_05007542,Transcription factor,C0023465,Acute monocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
55856,ACOT13,Q9NPJ3,0.729,0.423,3.1271e-06,,,C0476254,Dyslexia,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.02,1.0,,2006.0,2012.0,ALL
55857,KIZ,Q2M2Z5,0.722,0.308,,,,C4014312,RETINITIS PIGMENTOSA 69,,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2014.0,ALL
55858,TMEM165,Q9HC07,0.711,0.385,0.28339,DTO_05007405,Transporter,C3553571,Carbohydrate deficient glycoprotein syndrome type 2k,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2016.0,ALL
55859,BEX1,Q9HBH7,0.729,0.115,0.54273,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2006.0,2018.0,ALL
55860,ACTR10,Q9NZ32,1.0,0.038,0.0015053,DTO_05007530,Cellular structure,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2001.0,2003.0,ALL
55861,DBNDD2,Q9BQY9,1.0,0.077,0.0083064,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
55862,ECHDC1,Q9NTX5,0.736,0.269,5.5968e-09,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
55863,TMEM126B,Q8IUX1,0.716,0.385,0.00018551,,,C4748830,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2016.0,ALL
55867,SLC22A11,Q9NSA0,0.839,0.154,1.2995e-07,DTO_05007405,Transporter,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
55869,HDAC8,Q9BY41,0.511,0.885,0.97707,DTO_05007378,Epigenetic regulator,C0270972,Cornelia De Lange Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.6,0.963,definitive,2009.0,2019.0,ALL
55870,ASH1L,Q9NR48,0.623,0.577,1.0,,,C4540478,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 52",,,disease,Mental or Behavioral Dysfunction,0.6,1.0,strong,2012.0,2017.0,ALL
55871,CBWD1,Q9BRT8,1.0,0.115,1.369e-06,,,C1968949,Cakut,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,1.0,limited,2020.0,2020.0,ALL
55872,PBK,Q96KB5,0.541,0.769,1.2188e-06,DTO_03300101,Kinase,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2010.0,2019.0,ALL
55876,GSDMB,Q8TAX9,0.67,0.5,3.3446e-07,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,1.0,,2007.0,2019.0,ALL
55879,GABRQ,Q9UN88,0.722,0.5,0.0042977,DTO_01300327,Ion channel,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.33,1.0,limited,2008.0,2018.0,ALL
55884,WSB2,Q9NYS7,0.839,0.077,0.92938,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
55885,LMO3,Q8TAP4,0.716,0.423,0.70695,,,C0040517,Gilles de la Tourette syndrome,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
55888,ZKSCAN7,Q9P0L1,0.792,0.192,1.3415e-05,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
55890,GPRC5C,Q9NQ84,0.674,0.538,0.00047422,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0,,2005.0,2010.0,ALL
55892,MYNN,Q9NPC7,0.722,0.423,0.57129,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.11,1.0,,2014.0,2019.0,ALL
55893,ZNF395,Q9H8N7,0.666,0.577,0.30888,DTO_05007542,Transcription factor,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.07,1.0,,2004.0,2019.0,ALL
55894,DEFB103B,P81534,0.572,0.731,,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.06,1.0,,2014.0,2018.0,ALL
55897,MESP1,Q9BRJ9,0.805,0.192,8.6067e-05,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2016.0,2017.0,ALL
55898,UNC45A,Q9H3U1,0.821,0.154,3.2704e-11,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2015.0,2019.0,ALL
55900,ZNF302,Q9NR11,1.0,0.115,0.00019368,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
55901,THSD1,Q9NS62,0.792,0.346,5.5521e-08,,,C0455988,"Hydrops Fetalis, Non-Immune",C23;C16;C13;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.41,0.5,,2015.0,2018.0,ALL
55902,ACSS2,Q9NR19,0.506,0.808,1.1443e-13,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2009.0,2020.0,ALL
55904,KMT2E,Q8IZD2,0.682,0.423,1.0,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.41,1.0,strong,2019.0,2019.0,ALL
55905,RNF114,Q9Y508,0.839,0.077,0.052109,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.47,1.0,,2008.0,2018.0,ALL
55906,ZC4H2,Q9NQZ6,0.561,0.731,0.90752,,,C0796200,Wieacker-Wolff syndrome,C23;C16;C11;C05;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.71,1.0,,2013.0,2017.0,ALL
55907,CMAS,Q8NFW8,0.644,0.769,0.56141,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2011.0,2019.0,ALL
55908,ANGPTL8,Q6UXH0,0.65,0.577,6.8776e-12,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2019.0,ALL
55909,BIN3,Q9NQY0,0.931,0.115,5.8224e-13,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2017.0,2018.0,ALL
55911,APOBR,Q0VD83,0.792,0.231,9.3975e-08,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
55914,ERBIN,Q96RT1,0.7,0.231,0.99402,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
55915,LANCL2,Q9NS86,0.805,0.231,0.3128,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.03,1.0,,2014.0,2018.0,ALL
55917,CTTNBP2NL,Q9P2B4,1.0,0.077,0.0027461,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
55920,RCC2,Q9P258,0.686,0.385,0.95567,,,C0007117,Basal cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2016.0,2019.0,ALL
55922,NKRF,O15226,0.78,0.385,0.99661,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2011.0,2015.0,ALL
55924,INKA2,Q9NTI7,0.931,0.077,0.0079857,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
55929,DMAP1,Q9NPF5,0.821,0.192,0.041133,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
55930,MYO5C,Q9NQX4,0.805,0.231,7.8146e-37,DTO_05007530,Cellular structure,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
55937,APOM,O95445,0.59,0.769,0.00095567,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.13,1.0,,2007.0,2014.0,ALL
55954,ZMAT5,Q9UDW3,,,1.5247e-05,DTO_05007624,Enzyme,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
55957,LIN37,Q96GY3,,,0.0065239,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
55958,KLHL9,Q9P2J3,0.839,0.154,0.82017,,,C0206157,"Myopathies, Nemaline",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
55959,SULF2,Q8IWU5,0.603,0.615,0.010585,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,2005.0,2016.0,ALL
55964,SEPTIN3,Q9UH03,0.839,0.231,0.089413,DTO_05007584,Enzyme modulator,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
55966,AJAP1,Q9UKB5,0.722,0.192,0.99469,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.917,,2006.0,2019.0,ALL
55967,NDUFA12,Q9UI09,0.659,0.462,7.427e-05,,,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.51,1.0,limited,2011.0,2016.0,ALL
55968,NSFL1C,Q9UNZ2,0.76,0.308,0.049492,DTO_05007405,Transporter,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2008.0,2015.0,ALL
55969,RAB5IF,Q9BUV8,1.0,0.077,0.66964,,,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
55970,GNG12,Q9UBI6,0.78,0.154,0.58936,DTO_05007584,Enzyme modulator,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
55971,BAIAP2L1,Q9UHR4,0.805,0.308,0.00010429,DTO_05007575,Receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
55972,SLC25A40,Q8TBP6,0.931,0.231,3.9328e-07,DTO_05007405,Transporter,C0020557,Hypertriglyceridemia,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.02,1.0,,2013.0,2019.0,ALL
55973,BCAP29,Q9UHQ4,0.861,0.077,0.25556,DTO_05007405,Transporter,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
55974,SLC50A1,Q9BRV3,0.686,0.538,0.0019259,DTO_05007405,Transporter,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
55975,KLHL7,Q8IXQ5,0.581,0.731,4.559e-05,,,C2751986,RETINITIS PIGMENTOSA 42,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2009.0,2011.0,ALL
55997,CFC1,P0CG37,0.588,0.577,0.10509,DTO_05007616,Calcium-binding protein,C1415817,"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",,,disease,Disease or Syndrome,0.9,1.0,,2000.0,2015.0,ALL
55998,NXF5,Q9H1B4,0.805,0.346,3.7443e-14,DTO_05007557,Nucleic acid binding,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.32,1.0,limited,2001.0,2013.0,ALL
55999,NXF4,,,,,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,1.0,limited,2015.0,2015.0,ALL
56000,NXF3,Q9H4D5,0.805,0.346,0.0085216,DTO_05007557,Nucleic acid binding,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2013.0,2018.0,ALL
56001,NXF2,Q9GZY0,0.769,0.462,0.44568,DTO_05007557,Nucleic acid binding,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
56005,MYDGF,Q969H8,0.451,0.846,3.4923e-06,,,C0022548,Keloid,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Acquired Abnormality,0.3,1.0,,2010.0,2010.0,ALL
56006,SMG9,Q9H0W8,0.729,0.346,3.4628e-13,,,C4310793,HEART AND BRAIN MALFORMATION SYNDROME,,,disease,Disease or Syndrome,0.6,1.0,moderate,2016.0,2019.0,ALL
56033,BARX1,Q9HBU1,0.751,0.308,0.58571,DTO_05007542,Transcription factor,C0279628,Adenocarcinoma Of Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.43,1.0,,2013.0,2018.0,ALL
56034,PDGFC,Q9NRA1,0.621,0.692,0.99374,DTO_05007599,Signaling,C0025500,Mesothelioma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
56052,ALG1,Q9BT22,0.61,0.808,3.622e-19,DTO_05007624,Enzyme,C2931005,Congenital disorder of glycosylation type 1K,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.74,1.0,,2004.0,2017.0,ALL
56062,KLHL4,Q9C0H6,0.931,0.115,0.66283,,,C1844830,"CLEFT PALATE, X-LINKED",C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
56099,PCDHGB7,Q9Y5F8,0.839,0.154,1.5509e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
56100,PCDHGB6,Q9Y5F9,0.78,0.115,2.0925e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
56105,PCDHGA11,Q9Y5H2,0.931,0.038,1.267e-08,,,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
56106,PCDHGA10,Q9Y5H3,,,1.1725e-06,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
56107,PCDHGA9,Q9Y5G4,0.931,0.077,1.0018e-07,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
56108,PCDHGA7,Q9Y5G6,0.931,0.077,1.2273e-12,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
56111,PCDHGA4,Q9Y5G9,1.0,0.038,2.1897e-11,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
56112,PCDHGA3,Q9Y5H0,0.89,0.192,4.6058e-08,,,C0024301,"Lymphoma, Follicular",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
56113,PCDHGA2,Q9Y5H1,1.0,0.077,5.4715e-16,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2014.0,2014.0,ALL
56114,PCDHGA1,Q9Y5H4,1.0,0.077,1.5784e-07,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2014.0,2014.0,ALL
56115,PCDHG@,,0.861,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
56116,PCDHB@,,0.805,0.154,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2012.0,2013.0,ALL
56117,PCDHA@,,0.736,0.346,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
56121,PCDHB15,Q9Y5E8,1.0,0.077,9.7376e-12,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
56123,PCDHB13,Q9Y5F0,1.0,0.077,4.4828e-12,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
56127,PCDHB9,Q9Y5E1,0.861,0.115,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
56128,PCDHB8,Q9UN66,1.0,0.038,1.3226e-06,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
56131,PCDHB4,Q9Y5E5,0.931,0.077,7.0275e-12,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
56132,PCDHB3,Q9Y5E6,0.839,0.154,1.5891e-07,,,C0007113,Rectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
56134,PCDHAC2,Q9Y5I4,1.0,0.115,0.93114,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
56135,PCDHAC1,Q9H158,,,7.5673e-11,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56136,PCDHA13,Q9Y5I0,0.931,0.077,2.4469e-14,,,C0152101,Hypoplastic Left Heart Syndrome,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
56137,PCDHA12,Q9UN75,,,2.4185e-13,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56138,PCDHA11,Q9Y5I1,,,5.4635e-17,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56139,PCDHA10,Q9Y5I2,,,4.0942e-14,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56140,PCDHA8,Q9Y5H6,0.931,0.077,1.2881e-18,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56141,PCDHA7,Q9UN72,1.0,0.077,4.98e-09,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56142,PCDHA6,Q9UN73,0.931,0.115,3.6156e-11,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56143,PCDHA5,Q9Y5H7,0.931,0.115,5.8373e-08,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56144,PCDHA4,Q9UN74,0.839,0.115,1.9754e-23,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56145,PCDHA3,Q9Y5H8,0.861,0.192,8.3984e-16,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
56146,PCDHA2,Q9Y5H9,0.931,0.115,1.0354e-23,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56147,PCDHA1,Q9Y5I3,0.805,0.192,6.0001e-08,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
56154,TEX15,Q9BXT5,0.769,0.115,4.9939e-25,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
56155,TEX14,Q8IWB6,0.78,0.231,9.139e-36,DTO_03300101,Kinase,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
56159,TEX11,Q8IYF3,0.686,0.5,1.0,,,C1839841,"SPERMATOGENIC FAILURE, X-LINKED, 2",,,disease,Disease or Syndrome,0.5,1.0,,2015.0,2017.0,ALL
56160,NSMCE3,Q96MG7,0.751,0.346,0.056212,DTO_05007620,Cell adhesion,C4310653,"LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
56163,RNF17,Q9BXT8,0.805,0.423,1.0,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2015.0,ALL
56164,STK31,Q9BXU1,0.751,0.231,0.006616,DTO_03300101,Kinase,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
56165,TDRD1,Q9BXT4,0.792,0.115,1.0,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.06,1.0,,2013.0,2019.0,ALL
56169,GSDMC,Q9BYG8,0.861,0.115,8.0925e-14,,,C0029410,Osteoarthritis of hip,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
56171,DNAH7,Q8WXX0,0.769,0.346,1.3505e-71,DTO_05007624,Enzyme,C0006267,Bronchiectasis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
56172,ANKH,Q9HCJ1,0.606,0.692,0.27856,DTO_05007405,Transporter,C1852502,"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT",C05;C07,   Musculoskeletal Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.99,1.0,strong,1999.0,2018.0,ALL
56180,MOSPD1,Q9UJG1,0.89,0.231,0.92491,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
56181,MTFR1L,Q9H019,,,0.31279,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
56203,LMOD3,Q0VAK6,0.7,0.423,1.5519e-07,DTO_05007530,Cellular structure,C4015360,NEMALINE MYOPATHY 10,,,disease,Disease or Syndrome,0.9,1.0,definitive,2014.0,2018.0,ALL
56241,SUSD2,Q9UGT4,0.711,0.385,1.8144e-21,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2013.0,2013.0,ALL
56242,ZNF253,O75346,0.736,0.346,0.0032064,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2017.0,2019.0,ALL
56243,KIAA1217,Q5T5P2,0.769,0.308,0.00023185,,,C0027902,Neuropsychological Tests,,,phenotype,Diagnostic Procedure,0.1,1.0,,2010.0,2010.0,ALL
56244,BTNL2,Q9UIR0,0.546,0.808,8.5607e-11,DTO_05007584,Enzyme modulator,C0036202,Sarcoidosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,1.0,,2005.0,2019.0,ALL
56245,C21orf62,Q9NYP8,0.931,0.115,0.0026248,,,C0344395,Bilirubin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
56246,MRAP,Q8TCY5,0.674,0.5,0.002081,,,C4049714,Familial Glucocorticoid Deficiency Type 2,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.61,1.0,strong,2005.0,2010.0,ALL
56252,YLPM1,P49750,0.861,0.115,0.99965,DTO_05007557,Nucleic acid binding,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
56253,CRTAM,O95727,0.89,0.231,8.0626e-09,,,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
56254,RNF20,Q5VTR2,0.722,0.346,1.7545e-10,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2008.0,2019.0,ALL
56257,MEPCE,Q7L2J0,1.0,,0.99804,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2019.0,2019.0,ALL
56259,CTNNBL1,Q8WYA6,0.621,0.731,0.0097107,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.11,1.0,,2008.0,2019.0,ALL
56261,GPCPD1,Q9NPB8,0.931,0.154,0.2018,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.31,1.0,,2012.0,2014.0,ALL
56262,LRRC8A,Q8IWT6,0.644,0.692,0.94398,,,C0001768,Agammaglobulinemia,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.62,0.5,limited,2003.0,2017.0,ALL
56265,CPXM1,Q96SM3,0.931,0.077,3.7553e-12,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
56267,KYAT3,Q6YP21,0.76,0.269,7.1258e-16,DTO_05007624,Enzyme,C0024517,"Major depression, single episode",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
56269,IRGC,Q6NXR0,1.0,0.038,0.047269,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,0.0,,2010.0,2010.0,ALL
56270,WDR45B,Q5MNZ6,0.76,0.269,0.15624,,,C4693816,NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES,,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
56271,BEX4,Q9NWD9,0.76,0.231,0.67195,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
56286,DAD1P1,,1.0,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
56287,GKN1,Q9NS71,0.628,0.615,1.1309e-06,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2004.0,2019.0,ALL
56288,PARD3,Q8TEW0,0.608,0.615,0.95577,,,C3891448,"NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO",,,disease,Finding,0.4,1.0,,2017.0,2017.0,ALL
56300,IL36G,Q9NZH8,0.743,0.346,0.00011765,,,C3815172,Interleukin 1 Beta Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
56301,SLC7A10,Q9NS82,0.743,0.423,0.00013879,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2008.0,2011.0,ALL
56302,TRPV5,Q9NQA5,0.663,0.538,2.6365e-14,DTO_01300327,Ion channel,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
56311,ANKRD7,Q92527,0.89,0.346,4.2975e-06,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
56339,METTL3,Q86U44,0.585,0.538,1.799e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2020.0,ALL
56341,PRMT8,Q9NR22,0.743,0.231,0.98023,DTO_05007378,Epigenetic regulator,C0523953,Cardiac troponin T measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
56342,PPAN,Q9NQ55,0.729,0.577,1.7244e-12,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
56413,LTB4R2,Q9NPC1,0.631,0.615,1.3821e-05,DTO_02300001,G-protein coupled receptor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.06,1.0,,2010.0,2017.0,ALL
56474,CTPS2,Q9NRF8,0.839,0.077,0.81923,DTO_05007624,Enzyme,C0038661,Suicide,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
56475,RPRM,Q9NS64,0.743,0.115,0.14925,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
56476,ABCB10P1,,0.839,0.231,,,,C0011757,Developmental Coordination Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.06,1.0,,2017.0,2019.0,ALL
56477,CCL28,Q9NRJ3,0.587,0.769,0.051599,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.21,1.0,,2009.0,2018.0,ALL
56478,EIF4ENIF1,Q9NRA8,0.76,0.192,0.99999,,,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.32,1.0,moderate,2013.0,2019.0,ALL
56479,KCNQ5,Q9NR82,0.686,0.5,0.98011,DTO_01300327,Ion channel,C4539851,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 46",,,disease,Mental or Behavioral Dysfunction,0.6,1.0,strong,2017.0,2019.0,ALL
56521,DNAJC12,Q9UKB3,0.705,0.423,2.0723e-06,,,C4479270,"HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT",,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
56547,MMP26,Q9NRE1,0.65,0.615,5.3574e-11,DTO_05007624,Enzyme,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.32,1.0,,2005.0,2006.0,ALL
56548,CHST7,Q9NS84,0.821,0.154,0.068651,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
56603,CYP26B1,Q9NR63,0.666,0.5,0.97987,DTO_05007624,Enzyme,C3280729,RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES,,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2016.0,ALL
56604,TUBB7P,,1.0,0.115,,,,C1834673,Facioscapulohumeral muscular dystrophy 1a,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
56605,ERO1B,Q86YB8,0.89,0.192,2.7587e-09,DTO_05007624,Enzyme,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.11,1.0,,2017.0,2017.0,ALL
56606,SLC2A9,Q9NRM0,0.619,0.731,6.9451e-10,DTO_05007405,Transporter,C2677549,"Hypouricemia, Renal, 2",C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.72,1.0,,2008.0,2019.0,ALL
56616,DIABLO,Q9NR28,0.555,0.692,2.5722e-06,,,C3279948,"DEAFNESS, AUTOSOMAL DOMINANT 64",,,disease,Disease or Syndrome,0.7,1.0,moderate,2011.0,2016.0,ALL
56623,INPP5E,Q9NRR6,0.561,0.615,0.0031048,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.78,1.0,,2003.0,2017.0,ALL
56624,ASAH2,Q9NR71,0.716,0.538,0.0042718,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
56647,BCCIP,Q9P287,0.705,0.385,0.0078502,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
56648,EIF5A2,Q9GZV4,0.603,0.462,0.00021146,DTO_05007557,Nucleic acid binding,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2008.0,2019.0,ALL
56649,TMPRSS4,Q9NRS4,0.628,0.385,1.2055e-08,DTO_05007624,Enzyme,C4755252,Autosomal recessive cerebral atrophy,,,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
56650,CLDND1,Q9NY35,0.861,0.192,0.16354,,,C3548479,response to bronchodilator,,,phenotype,Organism Function,0.1,1.0,,2015.0,2015.0,ALL
56651,LINC00470,Q9BZP3,0.78,0.077,,,,C0429087,Electrocardiogram: P-R interval,,,phenotype,Finding,0.1,1.0,,2013.0,2013.0,ALL
56652,TWNK,Q96RR1,0.516,0.692,0.0032311,DTO_05007624,Enzyme,C1849096,Infantile onset spinocerebellar ataxia,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.77,1.0,,1997.0,2019.0,ALL
56654,NPDC1,Q9NQX5,0.711,0.423,0.02958,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
56655,POLE4,Q9NR33,0.653,0.538,0.00069897,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2004.0,2019.0,ALL
56658,TRIM39,Q9HCM9,0.792,0.462,0.99474,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
56659,KCNK13,Q9HB14,0.821,0.231,0.05263,DTO_01300327,Ion channel,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
56660,KCNK12,Q9HB15,1.0,0.077,0.91853,DTO_01300327,Ion channel,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
56664,VTRNA1-1,,0.931,0.077,,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0,,2018.0,2019.0,ALL
56666,PANX2,Q96RD6,0.736,0.5,4.4188e-06,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,0.5,,2007.0,2016.0,ALL
56667,MUC13,Q9H3R2,0.633,0.5,0.0024356,,,C0022116,Ischemia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.2,1.0,,2012.0,2012.0,ALL
56670,SUCNR1,Q9BXA5,0.647,0.577,0.00076877,DTO_02300001,G-protein coupled receptor,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2018.0,ALL
56672,AKIP1,Q9NQ31,0.705,0.308,1.1363e-05,,,C1135196,"Heart Failure, Diastolic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
56674,TMEM9B,Q9NQ34,,,0.53075,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
56675,NRIP3,Q9NQ35,,,2.219e-08,DTO_05007624,Enzyme,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
56681,SAR1A,Q9NR31,0.743,0.538,0.37178,,,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.07,1.0,,2012.0,2020.0,ALL
56683,CFAP298,P57076,0.678,0.5,1.1187e-06,,,C3809684,"CILIARY DYSKINESIA, PRIMARY, 26",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2013.0,ALL
56704,JPH1,Q9HDC5,0.705,0.269,0.76731,,,C1842983,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
56729,RETN,Q9HD89,0.454,0.808,0.036545,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.5,0.95,,2001.0,2020.0,ALL
56731,SLC2A4RG,Q9NR83,0.615,0.692,0.21856,DTO_05007542,Transcription factor,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2013.0,2017.0,ALL
56751,BARHL1,Q9BZE3,0.805,0.308,0.14582,DTO_05007542,Transcription factor,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
56776,FMN2,Q9NZ56,0.61,0.538,0.99772,,,C4015444,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47",,,disease,Disease or Syndrome,0.4,,,,,ALL
56829,ZC3HAV1,Q7Z2W4,0.729,0.462,2.3159e-05,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
56832,IFNK,Q9P0W0,0.751,0.385,9.0615e-10,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
56833,SLAMF8,Q9P0V8,0.839,0.154,5.341e-06,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
56834,GPR137,Q96N19,0.686,0.231,0.66798,DTO_02300001,G-protein coupled receptor,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
56848,SPHK2,Q9NRA0,0.546,0.731,1.28e-07,DTO_03300101,Kinase,C0740391,Middle Cerebral Artery Occlusion,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Acquired Abnormality,0.31,1.0,,2012.0,2012.0,ALL
56849,TCEAL7,Q9BRU2,0.792,0.231,0.4847,DTO_05007542,Transcription factor,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
56851,EMC7,Q9NPA0,,,0.86665,,,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
56852,RAD18,Q9NS91,0.691,0.346,1.5787e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
56853,CELF4,Q9BZC1,0.743,0.385,0.99817,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
56882,CDC42SE1,Q9NRR8,0.89,0.231,0.0035427,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
56884,FSTL5,Q8N475,0.716,0.192,1.4042e-06,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2019.0,2019.0,ALL
56886,UGGT1,Q9NYU2,0.682,0.385,5.1934e-10,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
56888,KCMF1,Q9P0J7,0.839,0.115,0.97719,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2010.0,2014.0,ALL
56889,TM9SF3,Q9HD45,0.861,0.154,0.99999,DTO_05007405,Transporter,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2014.0,2015.0,ALL
56890,MDM1,Q8TC05,1.0,0.038,4.7231e-12,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.21,0.0,,2008.0,2008.0,ALL
56891,LGALS14,Q8TCE9,0.695,0.423,0.0002747,DTO_05007599,Signaling,C4552766,Miscarriage,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,1.0,,2008.0,2019.0,ALL
56892,TCIM,Q9NR00,0.636,0.5,0.0086883,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2015.0,2017.0,ALL
56893,UBQLN4,Q9NRR5,0.805,0.308,0.98252,,,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
56894,AGPAT3,Q9NRZ7,0.931,0.038,0.99933,,,C0270715,"Degenerative Diseases, Central Nervous System",C10,   Nervous System Diseases,group,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
56895,AGPAT4,Q9NRZ5,0.89,0.115,0.1021,,,C1096202,Lipoprotein (a) measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2015.0,2017.0,ALL
56896,DPYSL5,Q9BPU6,0.644,0.5,0.99991,DTO_05007624,Enzyme,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
56897,WRNIP1,Q96S55,0.931,0.115,0.024592,DTO_05007624,Enzyme,C0043119,Werner Syndrome,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
56898,BDH2,Q9BUT1,0.7,0.462,8.5318e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2005.0,2020.0,ALL
56899,ANKS1B,Q7Z6G8,0.686,0.423,0.99998,DTO_05007575,Receptor,C0019202,Hepatolenticular Degeneration,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
56901,NDUFA4L2,Q9NRX3,0.736,0.346,0.086367,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
56902,PNO1,Q9NRX1,0.564,0.615,0.22652,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2019.0,ALL
56904,SH3GLB2,Q9NR46,0.805,0.154,0.0014857,,,C0858004,Influenza A virus infection,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2017.0,ALL
56906,THAP10,Q9P2Z0,0.89,0.077,0.045791,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
56907,SPIRE1,Q08AE8,1.0,0.038,0.042486,DTO_05007530,Cellular structure,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
56910,STARD7,Q9NQZ5,0.769,0.231,0.47179,,,C1842852,"EPILEPSY, MYOCLONIC, BENIGN ADULT FAMILIAL, TYPE 2",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2019.0,2019.0,ALL
56911,MAP3K7CL,P57077,0.751,0.192,8.3352e-08,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0,,2018.0,2018.0,ALL
56912,IFT46,Q9NQC8,1.0,0.038,0.16822,,,C0004903,Beckwith-Wiedemann Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
56913,C1GALT1,Q9NS00,0.67,0.538,0.76313,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2019.0,2019.0,ALL
56914,OTOR,Q9NRC9,0.805,0.154,0.0048775,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
56915,EXOSC5,Q9NQT4,0.76,0.231,0.0040091,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
56916,SMARCAD1,Q9H4L7,0.656,0.423,1.0,DTO_05007624,Enzyme,C0406707,Basan syndrome,C23;C16;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.73,1.0,moderate,2014.0,2018.0,ALL
56918,C2orf83,Q53S99,0.89,0.115,6.7173e-06,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
56919,DHX33,Q9H6R0,0.751,0.192,9.1366e-06,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2016.0,2019.0,ALL
56920,SEMA3G,Q9NS98,0.931,0.115,6.2569e-18,DTO_05007599,Signaling,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
56922,MCCC1,Q96RQ3,0.7,0.308,4.0152e-12,DTO_05007624,Enzyme,C0268600,3-methylcrotonyl CoA carboxylase 1 deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.73,1.0,definitive,2001.0,2016.0,ALL
56923,NMUR2,Q9GZQ4,0.751,0.423,0.00051924,DTO_02300001,G-protein coupled receptor,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
56924,PAK6,Q9NQU5,0.729,0.385,4.3077e-05,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.36,1.0,,2008.0,2015.0,ALL
56925,LXN,Q9BS40,0.633,0.615,1.8254e-06,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.34,1.0,,2006.0,2018.0,ALL
56926,NCLN,Q969V3,0.931,0.115,0.7551,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
56928,SPPL2B,Q8TCT7,0.861,0.192,,DTO_05007624,Enzyme,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
56929,FEM1C,Q96JP0,0.931,0.154,0.62927,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
56931,DUS3L,Q96G46,,,2.1445e-11,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
56934,CA10,Q9NS85,0.705,0.5,0.56746,,,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
56935,SMCO4,Q9NRQ5,,,0.00019629,,,C0428568,Fasting blood glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
56937,PMEPA1,Q969W9,0.633,0.462,0.93577,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
56938,ARNTL2,Q8WYA1,0.644,0.654,6.0435e-10,DTO_05007542,Transcription factor,C0085762,Alcohol abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2012.0,ALL
56940,DUSP22,Q9NRW4,0.659,0.615,0.0093421,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
56941,HMCES,Q96FZ2,0.931,0.192,1.9468e-07,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,1984.0,1984.0,ALL
56942,CMC2,Q9NRP2,0.792,0.192,0.1991,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2008.0,2008.0,ALL
56943,ENY2,Q9NPA8,0.821,0.154,0.87471,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
56944,OLFML3,Q9NRN5,0.89,0.154,5.6198e-08,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
56945,MRPS22,P82650,0.638,0.5,1.4768e-05,,,C2673642,Combined Oxidative Phosphorylation Deficiency 5,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2007.0,2017.0,ALL
56946,EMSY,Q7Z589,0.628,0.423,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.38,1.0,,2004.0,2017.0,ALL
56947,MFF,Q9GZY8,0.705,0.462,0.065397,,,C4310726,ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2,,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2016.0,ALL
56949,XAB2,Q9HCS7,0.743,0.308,0.97281,DTO_05007557,Nucleic acid binding,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2007.0,2014.0,ALL
56950,SMYD2,Q9NRG4,0.628,0.538,2.4631e-06,DTO_05007378,Epigenetic regulator,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
56952,PRTFDC1,Q9NRG1,0.805,0.385,2.3671e-13,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
56953,NT5M,Q9NPB1,1.0,0.077,1.0052e-08,,,C0795864,Smith-Magenis syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
56954,NIT2,Q9NQR4,0.89,0.154,1.1471e-17,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
56955,MEPE,Q9NQ76,0.628,0.654,0.0086273,,,C3887650,Adult Rickets,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.33,1.0,,2000.0,2014.0,ALL
56956,LHX9,Q9NQ69,0.805,0.231,0.98062,DTO_05007557,Nucleic acid binding,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2001.0,2001.0,ALL
56957,OTUD7B,Q6GQQ9,0.76,0.192,0.011339,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2014.0,ALL
56963,RGMA,Q96B86,0.656,0.692,0.16472,,,C0014556,"Epilepsy, Temporal Lobe",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.22,1.0,,2015.0,2019.0,ALL
56964,WDR93,Q6P2C0,1.0,0.038,4.0651e-17,,,C1298684,Autistic spectrum disorder with isolated skills,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,,,,,ALL
56965,PARP6,Q2NL67,0.821,0.154,0.99996,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
56970,ATXN7L3,Q14CW9,0.89,0.077,0.99892,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
56971,CEACAM19,Q7Z692,0.78,0.308,6.6095e-10,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2011.0,2018.0,ALL
56975,FAM20C,Q8IXL6,0.578,0.731,0.31465,,,C1850106,RAINE SYNDROME,C16;C11;C05;C10;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2000.0,2019.0,ALL
56977,STOX2,Q9P2F5,,,0.48409,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
56978,PRDM8,Q9NQV8,0.678,0.462,0.77626,,,C4225258,"EPILEPSY, PROGRESSIVE MYOCLONIC, 10",,,disease,Disease or Syndrome,0.7,1.0,limited,2012.0,2012.0,ALL
56979,PRDM9,Q9NQV7,0.686,0.5,4.8301e-27,,,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2015.0,ALL
56980,PRDM10,Q9NQV6,0.76,0.385,0.15304,DTO_05007542,Transcription factor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
56981,PRDM11,Q9NQV5,0.839,0.231,0.97355,,,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
56983,POGLUT1,Q8NBL1,0.691,0.385,1.5575e-08,,,C3714534,dowling-degos disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.62,1.0,strong,2014.0,2017.0,ALL
56984,PSMG2,Q969U7,0.839,0.115,2.3824e-07,,,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
56985,ADPRM,Q3LIE5,,,0.00039545,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
56986,DTWD1,Q8N5C7,1.0,0.038,2.8135e-10,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
56987,BBX,Q8WY36,0.839,0.231,0.51752,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
56990,CDC42SE2,Q9NRR3,0.76,0.231,0.76835,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2006.0,2011.0,ALL
56992,KIF15,Q9NS87,0.617,0.654,9.5235e-25,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2017.0,2019.0,ALL
56994,CHPT1,Q8WUD6,0.474,0.846,0.00024252,DTO_05007624,Enzyme,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.31,0.5,,2005.0,2018.0,ALL
56995,TULP4,Q9NRJ4,0.89,0.231,1.0,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
56996,SLC12A9,Q9BXP2,0.454,0.769,1.1806e-15,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.967,,1995.0,2019.0,ALL
56997,COQ8A,Q8NI60,0.674,0.385,9.2856e-11,DTO_03300101,Kinase,C2677589,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 9",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,2008.0,2019.0,ALL
56998,CTNNBIP1,Q9NSA3,0.663,0.423,0.024772,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
56999,ADAMTS9,Q9P2N4,0.633,0.692,1.0004e-06,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.37,1.0,,2008.0,2019.0,ALL
57001,SDHAF3,Q9NRP4,0.821,0.192,0.0026353,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2008.0,2015.0,ALL
57002,YAE1,Q9NRH1,,,0.001499,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
57003,CCDC47,Q96A33,0.678,0.462,6.1333e-08,,,C0343073,Wooly hair,C17,   Skin and Connective Tissue Diseases,phenotype,Finding,0.4,1.0,strong,2018.0,2018.0,ALL
57007,ACKR3,P25106,0.428,0.885,0.39134,DTO_02300001,G-protein coupled receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,0.963,,2004.0,2019.0,ALL
57008,RLFP1,,0.769,0.423,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
57010,CABP4,P57796,0.711,0.154,1.6786e-10,,,C4041558,"Cone-rod synaptic disorder, congenital nonprogressive",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2006.0,ALL
57016,AKR1B10,O60218,0.546,0.769,7.5723e-09,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,2007.0,2019.0,ALL
57017,COQ9,O75208,0.7,0.423,5.5253e-06,,,C3553374,"COENZYME Q10 DEFICIENCY, PRIMARY, 5",,,disease,Disease or Syndrome,0.7,1.0,,2001.0,2017.0,ALL
57018,CCNL1,Q9UK58,0.769,0.385,0.99575,DTO_05007584,Enzyme modulator,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0,,2011.0,2016.0,ALL
57019,CIAPIN1,Q6FI81,0.691,0.385,0.0019035,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2008.0,2019.0,ALL
57020,VPS35L,Q7Z3J2,0.931,0.077,2.2319e-09,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
57026,PDXP,Q96GD0,0.533,0.731,0.25559,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.969,,1988.0,2019.0,ALL
57030,SLC17A7,Q9P2U7,0.636,0.308,0.99988,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.25,,2004.0,2019.0,ALL
57035,RSRP1,Q9BUV0,0.89,0.231,4.3086e-14,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
57038,RARS2,Q5T160,0.663,0.462,7.7352e-14,,,C1969084,Pontocerebellar Hypoplasia Type 6,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.79,0.933,strong,2010.0,2020.0,ALL
57042,IBD7,,1.0,0.038,,,,C0009806,Constipation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2019.0,2019.0,ALL
57044,IDDM18,,1.0,0.115,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
57045,TWSG1,Q9GZX9,0.621,0.692,0.0061123,,,C0079541,Holoprosencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.32,1.0,,2004.0,2011.0,ALL
57047,PLSCR2,Q9NRY7,1.0,0.077,1.1863e-06,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
57048,PLSCR3,Q9NRY6,1.0,0.077,,DTO_05007405,Transporter,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.2,1.0,,2004.0,2004.0,ALL
57050,UTP3,Q9NQZ2,0.839,0.115,1.9374e-05,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
57053,CHRNA10,Q9GZZ6,1.0,0.077,4.7867e-10,DTO_01300327,Ion channel,C0028043,Nicotine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2010.0,2010.0,ALL
57054,DAZ3,Q9NR90,0.821,0.154,,DTO_05007557,Nucleic acid binding,C1507149,Partial chromosome Y deletion,C23;C16;C13;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2004.0,2010.0,ALL
57055,DAZ2,Q13117,0.821,0.115,0.288,DTO_05007557,Nucleic acid binding,C1507149,Partial chromosome Y deletion,C23;C16;C13;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2002.0,2010.0,ALL
57057,TBX20,Q9UMR3,0.663,0.346,0.97302,DTO_05007542,Transcription factor,C1969657,Atrial Septal Defect 4,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.7,1.0,,2007.0,2010.0,ALL
57060,PCBP4,P57723,0.523,0.808,0.0023713,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1997.0,2019.0,ALL
57061,HYMAI,,0.67,0.538,,,,C1832386,"Diabetes Mellitus, Transient Neonatal, 1",C16;C18;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.52,1.0,,2000.0,2011.0,ALL
57062,DDX24,Q9GZR7,,,0.68465,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
57082,KNL1,Q8NG31,0.644,0.615,0.78348,,,C1858516,"MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2012.0,2016.0,ALL
57084,SLC17A6,Q9P2U8,0.678,0.5,0.16199,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,1.0,,2008.0,2019.0,ALL
57085,AGTRAP,Q6RW13,0.89,0.115,0.18842,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.21,1.0,,2008.0,2019.0,ALL
57088,PLSCR4,Q9NRQ2,0.722,0.462,1.8979e-06,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2007.0,2007.0,ALL
57091,CASS4,Q9NQ75,0.722,0.231,0.36682,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.42,1.0,,2013.0,2019.0,ALL
57092,PCNP,Q8WW12,0.839,0.192,0.78553,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
57094,CPA6,Q8N4T0,0.716,0.346,4.3984e-17,DTO_05007624,Enzyme,C3280730,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 5",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2012.0,ALL
57095,PITHD1,Q9GZP4,,,0.0080936,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
57096,RPGRIP1,Q96KN7,0.553,0.654,1.2632e-23,DTO_05007584,Enzyme modulator,C1854260,LEBER CONGENITAL AMAUROSIS 6 (disorder),C11,   Eye Diseases,disease,Disease or Syndrome; Congenital Abnormality,0.9,1.0,,2001.0,2018.0,ALL
57097,PARP11,Q9NR21,0.931,0.115,6.1763e-09,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
57099,AVEN,Q9NQS1,0.76,0.231,2.7422e-09,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
57101,ANO2,Q9NQ90,0.751,0.346,1.7082e-22,DTO_01300327,Ion channel,C0030319,Panic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2009.0,2012.0,ALL
57102,C12orf4,Q9NQ89,0.691,0.308,1.0655e-05,,,C4748732,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66",,,disease,Disease or Syndrome,0.4,1.0,,2015.0,2017.0,ALL
57103,TIGAR,Q9NQ88,0.599,0.692,0.7348,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2013.0,2013.0,ALL
57104,PNPLA2,Q96AD5,0.511,0.846,0.0041069,DTO_05007624,Enzyme,C1853136,Neutral Lipid Storage Disease with Myopathy,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,2007.0,2019.0,ALL
57105,CYSLTR2,Q9NS75,0.633,0.538,9.9817e-05,DTO_02300001,G-protein coupled receptor,C0220633,Uveal melanoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.53,1.0,,2016.0,2019.0,ALL
57107,PDSS2,Q86YH6,0.626,0.577,4.3743e-08,,,C3553358,"COENZYME Q10 DEFICIENCY, PRIMARY, 3",,,disease,Disease or Syndrome,0.7,1.0,,2006.0,2016.0,ALL
57108,KMT5AP1,,0.716,0.423,,,,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0,,2009.0,2012.0,ALL
57109,REXO4,Q9GZR2,0.89,0.115,8.7916e-07,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
57110,PLAAT1,Q9HDD0,0.711,0.462,0.00025029,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0,,2009.0,2019.0,ALL
57111,RAB25,P57735,0.628,0.385,1.1227e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2006.0,2018.0,ALL
57113,TRPC7,Q9HCX4,0.839,0.115,0.00019479,DTO_01300327,Ion channel,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2001.0,2001.0,ALL
57115,PGLYRP4,Q96LB8,0.78,0.231,2.9387e-15,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
57116,ZNF695,Q8IW36,0.805,0.154,0.00030547,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
57117,INTS12,Q96CB8,0.89,0.077,0.7537,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.11,1.0,,2012.0,2019.0,ALL
57118,CAMK1D,Q8IU85,0.743,0.423,0.9962,DTO_03300101,Kinase,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.18,1.0,,2008.0,2019.0,ALL
57119,EPPIN,O95925,,,7.4025e-05,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
57120,GOPC,Q9HD26,0.561,0.654,0.00084252,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
57121,LPAR5,Q9H1C0,0.751,0.385,0.051408,DTO_02300001,G-protein coupled receptor,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
57122,NUP107,P57740,0.595,0.5,2.5555e-09,DTO_05007405,Transporter,C4225228,"NEPHROTIC SYNDROME, TYPE 11",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2018.0,ALL
57124,CD248,Q9HCU0,0.615,0.577,0.059017,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2005.0,2005.0,ALL
57125,PLXDC1,Q8IUK5,0.716,0.385,1.3423e-07,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
57126,CD177,Q8N6Q3,0.595,0.654,,,,C0032463,Polycythemia Vera,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,0.917,,2000.0,2008.0,ALL
57127,RHBG,Q9H310,,,1.0751e-13,DTO_05007405,Transporter,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
57128,LYRM4,Q9HD34,0.736,0.385,0.19951,,,C3810055,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19,,,disease,Disease or Syndrome,0.7,1.0,moderate,2013.0,2013.0,ALL
57129,MRPL47,Q9HD33,1.0,0.115,0.00042814,DTO_05007557,Nucleic acid binding,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
57130,ATP13A1,Q9HD20,0.931,0.077,0.98939,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
57132,CHMP1B,Q7LBR1,0.736,0.462,0.73182,DTO_05007405,Transporter,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,0.5,,2005.0,2007.0,ALL
57134,MAN1C1,Q9NR34,0.805,0.308,0.20933,DTO_05007613,Chaperone,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
57135,DAZ4,Q86SG3,0.861,0.154,,DTO_05007557,Nucleic acid binding,C1507149,Partial chromosome Y deletion,C23;C16;C13;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2004.0,2010.0,ALL
57136,APMAP,Q9HDC9,0.805,0.231,9.3261e-11,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
57139,RGL3,Q3MIN7,,,9.9866e-32,DTO_05007584,Enzyme modulator,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
57140,RNPEPL1,Q9HAU8,1.0,0.077,4.124e-05,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
57142,RTN4,Q9NQC3,0.621,0.692,0.45318,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.917,,2002.0,2018.0,ALL
57143,ADCK1,Q86TW2,0.89,0.192,9.4776e-15,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2017.0,2019.0,ALL
57144,PAK5,Q9P286,0.631,0.462,0.99977,DTO_03300101,Kinase,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
57146,TMEM159,Q96B96,0.89,0.077,0.0034061,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
57147,SCYL3,Q8IZE3,0.931,0.077,0.28151,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
57148,RALGAPB,Q86X10,0.659,0.577,1.0,,,C0011848,Diabetes Insipidus,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
57149,LYRM1,O43325,,,3.7249e-09,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
57150,SMIM8,Q96KF7,1.0,0.038,0.0055617,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
57152,SLURP1,P55000,0.56,0.654,0.25934,,,C0025221,Meleda Disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome; Congenital Abnormality,1.0,0.973,strong,2001.0,2019.0,ALL
57153,SLC44A2,Q8IWA5,0.743,0.462,0.00011917,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
57154,SMURF1,Q9HCE7,0.595,0.615,0.6118,DTO_05007624,Enzyme,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2018.0,2018.0,ALL
57156,TMEM63C,Q9P1W3,1.0,0.077,0.24344,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
57157,PHTF2,Q8N3S3,1.0,0.077,0.00017719,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57158,JPH2,Q9BR39,0.736,0.154,4.5187e-05,,,C3151264,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17",,,disease,Disease or Syndrome,0.7,1.0,moderate,2004.0,2019.0,ALL
57159,TRIM54,Q9BYV2,0.861,0.231,5.5065e-18,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
57161,PELI2,Q9HAT8,0.839,0.231,0.82955,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57162,PELI1,Q96FA3,0.603,0.731,0.39038,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
57165,GJC2,Q5T442,0.593,0.692,0.010438,DTO_05007527,Cell-cell junction,C1837355,"Leukodystrophy, Hypomyelinating, 2",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.93,1.0,,2004.0,2019.0,ALL
57167,SALL4,Q9UJQ4,0.489,0.769,0.99997,DTO_05007542,Transcription factor,C1623209,Okihiro Syndrome,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1984.0,2019.0,ALL
57169,ZNFX1,Q9P2E3,0.78,0.192,0.99983,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
57171,DOLPP1,Q86YN1,0.931,0.077,0.17497,DTO_05007624,Enzyme,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
57172,CAMK1G,Q96NX5,0.839,0.154,0.00039801,DTO_03300101,Kinase,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2013.0,2013.0,ALL
57175,CORO1B,Q9BR76,0.89,0.115,4.5885e-05,DTO_05007530,Cellular structure,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
57176,VARS2,Q5ST30,0.666,0.577,5.8321e-17,,,C4014660,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2014.0,ALL
57178,ZMIZ1,Q9ULJ6,0.588,0.615,0.99937,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.42,1.0,,2010.0,2014.0,ALL
57180,ACTR3B,Q9P1U1,0.89,0.154,0.99911,DTO_05007530,Cellular structure,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2001.0,2003.0,ALL
57181,SLC39A10,Q9ULF5,0.78,0.231,0.9927,DTO_05007405,Transporter,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0,,2007.0,2007.0,ALL
57182,ANKRD50,Q9ULJ7,0.931,0.192,0.9792,,,C0024143,Lupus Nephritis,C13;C17;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
57184,FAM219B,Q5XKK7,,,0.00015708,,,C0233849,Personality Traits,F01,   Behavior and Behavior Mechanisms,group,Finding,0.1,1.0,,2012.0,2012.0,ALL
57185,NIPAL3,Q6P499,1.0,0.077,6.9573e-05,DTO_05007405,Transporter,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
57186,RALGAPA2,Q2PPJ7,0.861,0.115,3.0325e-17,DTO_05007584,Enzyme modulator,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
57187,THOC2,Q8NI27,0.65,0.538,1.0,DTO_05007542,Transcription factor,C0796218,"MENTAL RETARDATION, X-LINKED 12",,,disease,Disease or Syndrome,0.7,1.0,,2009.0,2015.0,ALL
57188,ADAMTSL3,P82987,0.729,0.346,1.3662e-19,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2009.0,2019.0,ALL
57189,DENND11,A4D1U4,0.821,0.192,0.00028067,,,C2350521,Taste Perception (mental process),,,phenotype,Mental Process,0.1,1.0,,2011.0,2011.0,ALL
57190,SELENON,Q9NZV5,0.575,0.692,9.7863e-10,,,C0410180,Eichsfeld type congenital muscular dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,1999.0,2019.0,ALL
57191,VN1R1,Q9GZP7,1.0,0.038,,DTO_02300001,G-protein coupled receptor,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
57192,MCOLN1,Q9GZU1,0.601,0.654,0.00058027,DTO_01300327,Ion channel,C0238286,Mucolipidosis Type IV,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.97,,2000.0,2020.0,ALL
57194,ATP10A,O60312,0.792,0.346,0.0018269,DTO_05007405,Transporter,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2001.0,2011.0,ALL
57198,ATP8B2,P98198,1.0,0.077,0.0056318,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
57205,ATP10D,Q9P241,0.861,0.154,7.561e-20,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
57209,ZNF248,Q8NDW4,0.821,0.231,0.32621,DTO_05007542,Transcription factor,C0008497,Choriocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
57210,SLC45A4,Q5BKX6,,,0.00010424,DTO_05007405,Transporter,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2016.0,2019.0,ALL
57211,ADGRG6,Q86SQ4,0.666,0.385,6.6088e-05,DTO_02300001,G-protein coupled receptor,C4225303,LETHAL CONGENITAL CONTRACTURE SYNDROME 9,,,disease,Disease or Syndrome,0.71,1.0,,2015.0,2019.0,ALL
57212,TP73-AS1,,0.599,0.577,,,,C0028945,oligodendroglioma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
57213,SPRYD7,Q5W111,0.931,0.115,0.00020923,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
57214,CEMIP,Q8WUJ3,0.617,0.615,4.4023e-17,,,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.31,1.0,disputed,2003.0,2016.0,ALL
57215,THAP11,Q96EK4,0.769,0.346,0.82624,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
57216,VANGL2,Q9ULK5,0.588,0.615,0.84283,,,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.6,1.0,,1990.0,2015.0,ALL
57217,TTC7A,Q9ULT0,0.641,0.577,1.5359e-31,,,C0220744,Multiple gastrointestinal atresias (disorder),C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.76,1.0,,2013.0,2019.0,ALL
57221,ARFGEF3,Q5TH69,0.769,0.192,1.0,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,2009.0,2019.0,ALL
57222,ERGIC1,Q969X5,0.7,0.423,0.64747,,,C1859721,"ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE (disorder)",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.6,1.0,,2018.0,2018.0,ALL
57223,PPP4R3B,Q5MIZ7,0.861,0.192,0.70636,,,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.2,1.0,,2009.0,2009.0,ALL
57224,NHSL1,Q5SYE7,1.0,0.115,0.46052,,,C0796085,Nance-Horan syndrome,C16;C11;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
57226,LYRM2,Q9NU23,0.931,0.077,0.00025796,,,C0424678,Lean body mass,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
57228,SMAGP,Q0VAQ4,0.821,0.154,0.25441,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57231,SNX14,Q9Y5W7,0.659,0.423,6.0711e-17,DTO_05007584,Enzyme modulator,C4225355,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20",,,disease,Disease or Syndrome,0.61,1.0,,2014.0,2017.0,ALL
57232,ZNF630,Q2M218,0.89,0.269,0.000119,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
57282,SLC4A10,Q6U841,0.678,0.269,0.13404,DTO_05007405,Transporter,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.32,1.0,,2008.0,2010.0,ALL
57291,DANCR,P0C864,0.601,0.615,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.917,,2017.0,2019.0,ALL
57292,KIR2DL5A,Q8N109,0.711,0.423,,DTO_05007575,Receptor,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.03,1.0,,2008.0,2017.0,ALL
57306,CUP2Q35,,0.839,0.077,,,,C0039075,Syndactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0,,1998.0,1998.0,ALL
57309,SPG14,,0.89,0.192,,,,C1854568,"SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE (disorder)",C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.3,,,,,ALL
57324,TSE2,,0.931,0.077,,,,C0238462,Medullary carcinoma of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,0.5,,2002.0,2003.0,ALL
57325,KAT14,Q9H8E8,0.89,0.077,1.326e-09,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,,,,,ALL
57326,PBXIP1,Q96AQ6,0.711,0.385,9.7925e-11,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
57332,CBX8,Q9HC52,0.686,0.269,0.9927,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.13,1.0,,2005.0,2018.0,ALL
57333,RCN3,Q96D15,0.839,0.077,3.8085e-11,DTO_05007616,Calcium-binding protein,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
57337,SENP7,Q9BQF6,0.821,0.192,0.073339,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
57338,JPH3,Q8WXH2,0.608,0.538,0.99855,,,C1847987,HUNTINGTON DISEASE-LIKE 2,C23;C16;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.8,1.0,limited,2001.0,2020.0,ALL
57343,ZNF304,Q9HCX3,0.89,0.115,0.032902,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
57348,TTYH1,Q9H313,0.861,0.115,0.99539,DTO_01300327,Ion channel,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
57369,GJD2,Q9UKL4,0.705,0.5,0.19681,DTO_05007527,Cell-cell junction,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.34,1.0,,2013.0,2019.0,ALL
57379,AICDA,Q9GZX7,0.463,0.885,9.2098e-06,DTO_05007624,Enzyme,C1720956,"Hyper-IgM Immunodeficiency Syndrome, Type 2",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.73,1.0,strong,2000.0,2017.0,ALL
57380,MRS2,Q9HD23,0.792,0.269,1.9516e-08,,,C0011303,Demyelinating Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
57381,RHOJ,Q9H4E5,0.686,0.308,0.0064012,DTO_05007584,Enzyme modulator,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
57393,CLTRN,Q9HBJ8,0.839,0.269,0.00011309,,,C0041956,Ureteral obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Disease or Syndrome,0.3,1.0,,2003.0,2003.0,ALL
57402,S100A14,Q9HCY8,0.663,0.385,0.0018638,DTO_05007616,Calcium-binding protein,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2009.0,2019.0,ALL
57403,RAB22A,Q9UL26,0.663,0.346,0.10273,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.07,1.0,,2010.0,2019.0,ALL
57404,CYP20A1,Q6UW02,0.821,0.154,8.8921e-17,,,C0035242,Respiratory Tract Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
57405,SPC25,Q9HBM1,0.729,0.346,0.025506,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
57406,ABHD6,Q9BV23,0.751,0.385,2.2313e-05,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2009.0,2017.0,ALL
57407,NMRAL1,Q9HBL8,1.0,0.077,9.2538e-06,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
57408,LRTM1,Q9HBL6,1.0,0.115,3.3678e-16,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57409,MIF4GD,A9UHW6,1.0,0.077,6.7828e-09,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
57410,SCYL1,Q96KG9,0.582,0.769,2.5187e-08,DTO_03300101,Kinase,C4225236,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21",,,disease,Disease or Syndrome,0.61,1.0,,2015.0,2019.0,ALL
57412,AS3MT,Q9HBK9,0.638,0.538,7.9768e-11,DTO_05007624,Enzyme,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2013.0,2015.0,ALL
57413,TMIGD3,P0DMS9,0.839,0.077,,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
57414,RHBDD2,Q6NTF9,0.839,0.115,0.63858,DTO_05007575,Receptor,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
57418,WDR18,Q9BV38,0.931,0.154,0.99271,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
57419,SLC24A3,Q9HC58,0.7,0.423,0.87946,DTO_05007405,Transporter,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
57446,NDRG3,Q9UGV2,0.722,0.308,0.36564,DTO_05007624,Enzyme,C0919677,Protein C measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
57447,NDRG2,Q9UN36,0.518,0.692,2.2044e-05,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2004.0,2014.0,ALL
57448,BIRC6,Q9NR09,0.604,0.577,1.0,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.34,1.0,,2008.0,2015.0,ALL
57449,PLEKHG5,O94827,0.674,0.385,3.3605e-06,,,C1970211,"Spinal Muscular Atrophy, Distal, Autosomal Recessive, 4",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2007.0,2013.0,ALL
57451,TENM2,Q9NT68,0.678,0.5,1.0,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
57452,GALNT16,Q8N428,0.821,0.115,0.00013872,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2019.0,ALL
57453,DSCAML1,Q8TD84,0.839,0.346,1.0,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
57455,REXO1,Q8N1G1,0.695,0.346,0.9864,DTO_05007624,Enzyme,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
57458,TMCC3,Q9ULS5,1.0,0.115,2.7391e-05,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
57459,GATAD2B,Q8WXI9,0.593,0.654,0.99998,DTO_05007557,Nucleic acid binding,C3554448,"MENTAL RETARDATION, AUTOSOMAL DOMINANT 18",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2017.0,ALL
57460,PPM1H,Q9ULR3,0.805,0.154,0.79216,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57462,MYORG,Q6NSJ0,0.805,0.269,1.0871e-11,DTO_05007624,Enzyme,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,strong,2019.0,2019.0,ALL
57463,AMIGO1,Q86WK6,0.931,0.077,0.98411,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
57464,STRIP2,Q9ULQ0,0.931,0.038,1.6433e-15,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
57465,TBC1D24,Q9ULP9,0.53,0.808,1.2788e-08,DTO_05007584,Enzyme modulator,C3809173,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16",,,disease,Disease or Syndrome,0.8,1.0,strong,2010.0,2019.0,ALL
57466,SCAF4,O95104,0.89,0.308,1.0,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57468,SLC12A5,Q9H2X9,0.57,0.654,1.0,DTO_05007405,Transporter,C4225257,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2016.0,ALL
57470,LRRC47,Q8N1G4,0.89,0.192,0.87056,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
57471,ERMN,Q8TAM6,0.861,0.115,1.1805e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2009.0,2009.0,ALL
57472,CNOT6,Q9ULM6,0.839,0.154,0.019515,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
57473,ZNF512B,Q96KM6,0.931,0.077,0.99992,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57474,ZNF490,Q9ULM2,,,0.00031512,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
57475,PLEKHH1,Q9ULM0,1.0,0.077,4.6782e-09,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
57476,GRAMD1B,Q3KR37,0.736,0.385,0.99929,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2014.0,2018.0,ALL
57477,SHROOM4,Q9ULL8,0.7,0.5,0.99965,,,C1845530,Stocco dos Santos syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,moderate,2006.0,2010.0,ALL
57479,PRR12,Q9ULL5,0.716,0.385,1.0,,,C4025846,Abnormality of vision,,,disease,Finding,0.4,1.0,strong,2018.0,2018.0,ALL
57480,PLEKHG1,Q9ULL1,0.89,0.115,0.012728,,,C0028043,Nicotine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
57481,KIAA1210,Q9ULL0,,,0.0091034,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
57482,CRACD,Q6ZU35,0.792,0.192,5.3193e-05,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2007.0,2007.0,ALL
57484,RNF150,Q9ULK6,0.839,0.154,0.00073035,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.12,1.0,,2012.0,2015.0,ALL
57486,NLN,Q9BYT8,0.597,0.731,3.9148e-12,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
57488,ESYT2,A0FGR8,0.89,0.154,7.7928e-06,,,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
57489,ODF2L,Q9ULJ1,1.0,0.115,5.6731e-19,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
57491,AHRR,A9YTQ3,0.666,0.577,0.00018111,DTO_05007542,Transcription factor,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.13,1.0,,1990.0,2017.0,ALL
57492,ARID1B,Q8NFD5,0.503,0.846,1.0,,,C0265338,Coffin-Siris syndrome,C23;C16;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,1.0,1.0,definitive,2012.0,2020.0,ALL
57493,HEG1,Q9ULI3,0.821,0.385,1.8858e-07,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
57494,RIMKLB,Q9ULI2,,,0.59273,DTO_05007557,Nucleic acid binding,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
57495,NWD2,Q9ULI1,1.0,0.038,0.98388,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
57496,MRTFB,Q9ULH7,0.76,0.308,0.99999,,,C0524528,Pervasive Development Disorder,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2018.0,ALL
57497,LRFN2,Q9ULH4,0.769,0.308,0.013743,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,,,,,ALL
57498,KIDINS220,Q9ULH0,0.534,0.769,0.073562,,,C4284592,"SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY",,,disease,Disease or Syndrome,0.63,1.0,,2016.0,2019.0,ALL
57501,KIAA1257,Q9ULG3,0.931,0.038,1.1741e-09,,,C1142127,Pneumococcal bacteraemia,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
57502,NLGN4X,Q8N0W4,0.686,0.423,0.99267,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,0.926,,2003.0,2019.0,ALL
57504,MTA3,Q9BTC8,0.67,0.462,0.03435,DTO_05007557,Nucleic acid binding,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2007.0,2019.0,ALL
57505,AARS2,Q5JTZ9,0.644,0.5,4.9777e-17,DTO_05007557,Nucleic acid binding,C3279793,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8,,,disease,Disease or Syndrome,0.71,1.0,strong,2011.0,2018.0,ALL
57506,MAVS,Q7Z434,0.585,0.692,6.7045e-07,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,0.957,,2005.0,2019.0,ALL
57507,ZNF608,Q9ULD9,0.821,0.346,0.99999,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57508,INTS2,Q9H0H0,0.59,0.654,0.99698,,,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.11,1.0,,1995.0,2011.0,ALL
57509,MTUS1,Q9ULD2,0.626,0.577,3.579e-11,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2006.0,2006.0,ALL
57510,XPO5,Q9HAV4,0.623,0.654,0.99971,DTO_05007575,Receptor,C0023176,Lead Poisoning,C25,   Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2016.0,2016.0,ALL
57511,COG6,Q9Y2V7,0.644,0.577,6.3567e-16,,,C3553230,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl",,,disease,Disease or Syndrome,0.71,1.0,,2002.0,2019.0,ALL
57512,GPR158,Q5T848,0.678,0.423,0.00055056,DTO_02300001,G-protein coupled receptor,C4317009,Diverticular Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.4,1.0,,2018.0,2019.0,ALL
57514,ARHGAP31,Q2M1Z3,0.581,0.615,0.99999,,,C4551482,Adams-Oliver syndrome 1,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.65,1.0,,1979.0,2018.0,ALL
57515,SERINC1,Q9NRX5,0.931,0.115,0.0074634,DTO_05007575,Receptor,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,0.0,,2017.0,2017.0,ALL
57519,STARD9,Q9P2P6,0.839,0.115,1.0336e-38,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2019.0,2019.0,ALL
57520,HECW2,Q9P2P5,0.705,0.423,0.9997,DTO_05007624,Enzyme,C4310643,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2017.0,ALL
57521,RPTOR,Q8N122,0.628,0.692,1.0,,,C0028043,Nicotine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
57522,SRGAP1,Q7Z6B7,0.686,0.5,0.99845,DTO_05007584,Enzyme modulator,C4225426,"THYROID CANCER, NONMEDULLARY, 2",,,disease,Neoplastic Process,0.6,1.0,,2013.0,2013.0,ALL
57523,NYNRIN,Q9P2P1,,,1.4848e-09,DTO_05007557,Nucleic acid binding,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
57524,CASKIN1,Q8WXD9,1.0,0.038,1.0,DTO_05007575,Receptor,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
57526,PCDH19,Q8TAB3,0.599,0.462,0.99975,,,C1848137,"EPILEPSY, FEMALE-RESTRICTED, WITH MENTAL RETARDATION (disorder)",C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.72,1.0,strong,1990.0,2017.0,ALL
57528,KCTD16,Q68DU8,1.0,0.038,0.99329,DTO_05007584,Enzyme modulator,C0014038,Encephalitis,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
57530,CGN,Q9P2M7,0.931,0.115,1.8942e-31,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
57531,HACE1,Q8IYU2,0.601,0.692,6.0798e-06,DTO_05007624,Enzyme,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.61,1.0,,2012.0,2012.0,ALL
57532,NUFIP2,Q7Z417,0.641,0.577,0.99891,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2013.0,2018.0,ALL
57533,TBC1D14,Q9P2M4,,,0.039267,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57534,MIB1,Q86YT6,0.438,0.769,3.3574e-88,DTO_05007624,Enzyme,C3554496,LEFT VENTRICULAR NONCOMPACTION 7,,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2013.0,ALL
57535,KIAA1324,Q6UXG2,0.751,0.192,7.0266e-13,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
57536,KIAA1328,Q86T90,,,3.2984e-08,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
57537,SORCS2,Q96PQ0,0.743,0.346,0.0031696,DTO_05007405,Transporter,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2016.0,ALL
57538,ALPK3,Q96L96,0.792,0.462,8.4158e-25,DTO_03300101,Kinase,C4748014,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27",,,disease,Disease or Syndrome,0.41,1.0,strong,2016.0,2019.0,ALL
57539,WDR35,Q9P2L0,0.525,0.692,1.0462e-22,,,C3279792,SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY,,,disease,Disease or Syndrome; Congenital Abnormality,0.92,1.0,,2007.0,2018.0,ALL
57540,DISP3,Q9P2K9,1.0,0.077,3.626e-08,,,C0030283,Pancreatic Cyst,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
57541,ZNF398,Q8TD17,0.695,0.308,0.14568,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,0.8,,1999.0,2006.0,ALL
57542,KLHL42,Q9P2K6,0.861,0.231,0.012525,,,C1821417,RESTING HEART RATE,,,phenotype,Finding,0.1,1.0,,2016.0,2016.0,ALL
57544,TXNDC16,Q9P2K2,0.861,0.154,9.949e-06,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2012.0,2012.0,ALL
57545,CC2D2A,Q9P2K1,0.532,0.692,1.6721e-27,,,C1857662,COACH syndrome,C23;C16;C06;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2008.0,2017.0,ALL
57546,PDP2,Q9P2J9,0.931,0.154,8.1837e-05,DTO_05007624,Enzyme,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
57547,ZNF624,Q9P2J8,1.0,0.077,0.032471,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
57549,IGSF9,Q9P2J2,0.839,0.154,3.4386e-12,DTO_05007575,Receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
57551,TAOK1,Q7L7X3,0.792,0.269,0.99787,DTO_03300101,Kinase,C0018781,Noise-induced hearing loss,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Injury or Poisoning,0.3,1.0,,2013.0,2013.0,ALL
57552,NCEH1,Q6PIU2,0.861,0.115,0.012968,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
57553,MICAL3,Q7RTP6,0.792,0.269,0.99499,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57554,LRRC7,Q96NW7,0.722,0.462,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
57555,NLGN2,Q8NFZ4,0.722,0.269,0.99974,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.54,1.0,,2011.0,2019.0,ALL
57556,SEMA6A,Q9H2E6,0.486,0.808,0.99976,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2020.0,ALL
57558,USP35,Q9P2H5,0.931,0.115,5.4853e-07,DTO_05007624,Enzyme,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
57559,STAMBPL1,Q96FJ0,0.729,0.462,1.1971e-14,DTO_05007624,Enzyme,C0009782,Connective Tissue Diseases,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.1,,,,,ALL
57560,IFT80,Q9P2H3,0.575,0.692,1.4059e-19,,,C1970005,Asphyxiating Thoracic Dystrophy 2,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2007.0,2011.0,ALL
57561,ARRDC3,Q96B67,0.711,0.308,0.98715,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2010.0,2018.0,ALL
57562,CEP126,Q9P2H0,0.839,0.192,5.2173e-18,,,C1865384,"Amyotrophy, monomelic",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,,2012.0,2012.0,ALL
57563,KLHL8,Q9P2G9,,,3.1232e-06,,,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
57565,KLHL14,Q9P2G3,0.89,0.077,0.0535,,,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
57568,SIPA1L2,Q9P2F8,0.821,0.192,0.99215,DTO_05007584,Enzyme modulator,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.14,1.0,,2014.0,2018.0,ALL
57569,ARHGAP20,Q9P2F6,0.861,0.231,0.029187,DTO_05007584,Enzyme modulator,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
57570,TRMT5,Q32P41,0.769,0.231,0.049774,DTO_05007624,Enzyme,C4225290,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26,,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2017.0,ALL
57571,CARNS1,A5YM72,,,2.0274e-06,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
57572,DOCK6,Q96HP0,0.61,0.577,1.2563e-26,DTO_05007584,Enzyme modulator,C4551482,Adams-Oliver syndrome 1,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2019.0,ALL
57573,ZNF471,Q9BX82,0.792,0.192,6.0899e-06,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
57574,MARCHF4,Q9P2E8,1.0,0.038,0.13283,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
57575,PCDH10,Q9P2E7,0.582,0.769,0.89066,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2017.0,ALL
57576,KIF17,Q9P2E2,0.792,0.346,3.7556e-18,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2010.0,2020.0,ALL
57578,UNC79,Q9P2D8,1.0,0.038,1.0,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
57580,PREX1,Q8TCU6,0.644,0.615,1.0,DTO_05007584,Enzyme modulator,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,,,,,ALL
57582,KCNT1,Q5JUK3,0.61,0.308,2.7613e-05,DTO_01300327,Ion channel,C3554195,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14",,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2017.0,ALL
57583,TMEM181,Q9P2C4,1.0,0.038,0.0074859,,,C0017612,"Glaucoma, Open-Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
57584,ARHGAP21,Q5T5U3,0.722,0.308,1.0,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57585,CRAMP1,Q96RY5,0.805,0.308,0.050239,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
57586,SYT13,Q7L8C5,0.805,0.192,0.68807,DTO_05007405,Transporter,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
57587,CFAP97,Q9P2B7,0.638,0.769,0.00010469,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,2017.0,2018.0,ALL
57589,RIC1,Q4ADV7,0.89,0.231,0.0011554,,,C0035242,Respiratory Tract Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
57590,WDFY1,Q8IWB7,,,6.3352e-05,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
57591,MRTFA,Q969V6,0.572,0.615,0.99768,,,C1856453,Mild thrombocytopenia,,,phenotype,Finding,0.3,1.0,limited,2015.0,2015.0,ALL
57592,ZNF687,Q8N1G0,0.821,0.154,0.97101,,,C4085250,PAGET DISEASE OF BONE 6,,,disease,Disease or Syndrome,0.4,1.0,,2016.0,2016.0,ALL
57594,HOMEZ,Q8IX15,1.0,0.038,0.015814,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57595,PDZD4,Q76G19,0.89,0.154,0.84853,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
57596,BEGAIN,Q9BUH8,0.821,0.115,0.97002,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
57597,BAHCC1,Q9P281,,,,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
57599,WDR48,Q8TAF3,0.628,0.615,0.99985,,,C0037772,Spastic Paraplegia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.4,1.0,moderate,2014.0,2014.0,ALL
57600,FNIP2,Q9P278,0.76,0.231,1.0,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
57602,USP36,Q9P275,0.89,0.192,1.877e-05,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
57604,TRMT9B,Q9P272,0.792,0.192,1.6974e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,0.8,,2004.0,2018.0,ALL
57605,PITPNM2,Q9BZ72,0.861,0.231,1.0,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2017.0,2019.0,ALL
57606,SLAIN2,Q9P270,0.861,0.077,0.79312,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2015.0,ALL
57608,JCAD,Q9P266,0.751,0.269,0.0029966,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.47,1.0,,2011.0,2019.0,ALL
57609,DIP2B,Q9P265,0.76,0.308,0.99924,,,C1969893,"Mental Retardation, Fra12a Type",C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.5,1.0,limited,2007.0,2007.0,ALL
57610,RANBP10,Q6VN20,0.931,0.077,0.96855,DTO_05007405,Transporter,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
57611,ISLR2,Q6UXK2,0.821,0.115,0.11102,DTO_05007575,Receptor,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.06,0.833,,2017.0,2019.0,ALL
57612,ERV3-2,,1.0,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
57613,FAM234B,A2RU67,,,0.025269,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57614,RELCH,Q9P260,0.89,0.192,0.99993,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
57615,ZNF492,Q9P255,1.0,0.115,0.18998,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
57616,TSHZ3,Q63HK5,0.711,0.423,0.99053,DTO_05007542,Transcription factor,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2016.0,2019.0,ALL
57617,VPS18,Q9P253,0.861,0.115,0.4761,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
57619,SHROOM3,Q8TF72,0.736,0.462,0.31709,,,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.33,1.0,moderate,2015.0,2019.0,ALL
57620,STIM2,Q9P246,0.65,0.654,0.9906,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
57621,ZBTB2,Q8N680,0.792,0.154,0.9982,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
57623,ZFAT,Q9P243,0.769,0.423,1.275e-08,DTO_05007542,Transcription factor,C0920350,Autoimmune thyroiditis,C20;C19,   Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,,,,,ALL
57624,NYAP2,Q9P242,,,0.00030753,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
57626,KLHL1,Q9NR64,0.569,0.654,7.1907e-07,,,C0022350,"Jaundice, Chronic Idiopathic",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,1998.0,2017.0,ALL
57628,DPP10,Q8N608,0.695,0.577,0.99999,DTO_05007624,Enzyme,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
57630,SH3RF1,Q7Z6J0,0.78,0.231,0.010761,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
57633,LRRN1,Q6UXK5,0.805,0.231,0.96996,DTO_05007575,Receptor,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
57634,EP400,Q96L91,0.751,0.385,1.0,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
57636,ARHGAP23,Q9P227,0.931,0.115,0.99988,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
57639,CCDC146,Q8IYE0,1.0,,1.3126e-26,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57642,COL20A1,Q9P218,,,1.3806e-40,DTO_05007575,Receptor,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
57643,ZSWIM5,Q9P217,0.76,0.154,0.03976,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
57644,MYH7B,A7E2Y1,0.792,0.308,4.3419e-46,,,C1960469,Left ventricular noncompaction,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
57646,USP28,Q96RU2,0.691,0.269,4.5284e-13,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
57647,DHX37,Q8IY37,0.792,0.385,0.99252,DTO_05007624,Enzyme,C1843367,Poor school performance,,,phenotype,Finding,0.1,,,,,ALL
57648,KIAA1522,Q9P206,0.805,0.192,0.026865,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
57649,PHF12,Q96QT6,0.931,0.115,1.0,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57650,CIP2A,Q8TCG1,0.524,0.808,1.3591e-13,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2009.0,2018.0,ALL
57654,UVSSA,Q2YD98,0.805,0.269,5.4127e-25,,,C1833561,UV-Sensitive Syndrome,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.66,1.0,limited,2012.0,2019.0,ALL
57655,GRAMD1A,Q96CP6,1.0,0.077,0.0013146,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
57657,HCN3,Q9P1Z3,0.792,0.308,2.5694e-05,DTO_01300327,Ion channel,C0011406,Dental Pulp Exposure,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.2,1.0,,2007.0,2007.0,ALL
57658,CALCOCO1,Q9P1Z2,0.931,0.115,1.202e-06,,,C0030319,Panic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2009.0,2009.0,ALL
57659,ZBTB4,Q9P1Z0,0.78,0.269,0.99991,DTO_05007542,Transcription factor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
57661,PHRF1,Q9P1Y6,0.743,0.346,0.056521,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.47,0.875,,2008.0,2012.0,ALL
57662,CAMSAP3,Q9P1Y5,1.0,0.077,1.0,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
57664,PLEKHA4,Q9H4M7,0.931,0.115,1.7952e-12,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
57665,RDH14,Q9HBH5,0.89,0.115,1.7034e-05,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
57666,FBRSL1,Q9HCM7,0.805,0.154,0.0058888,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
57669,EPB41L5,Q9HCM4,0.78,0.346,0.020795,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
57670,KIAA1549,Q9HCM3,0.615,0.346,0.98607,,,C0334583,Pilocytic Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
57673,BEND3,Q5T5X7,0.931,0.154,0.93555,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
57674,RNF213,Q63HN8,0.628,0.538,4.9078e-55,,,C1846689,MOYAMOYA DISEASE 2,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.6,1.0,,2011.0,2016.0,ALL
57678,GPAM,Q9HCL2,0.792,0.192,1.2373e-09,,,C0002152,Alloxan Diabetes,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.3,1.0,,1998.0,1998.0,ALL
57679,ALS2,Q96Q42,0.647,0.423,8.7204e-12,,,C2931441,"Hereditary spastic paralysis, infantile onset ascending",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2001.0,2018.0,ALL
57680,CHD8,Q9HCK8,0.656,0.577,1.0,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.8,0.974,definitive,2012.0,2020.0,ALL
57683,ZDBF2,Q9HCK1,0.89,0.154,0.010294,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
57685,CACHD1,Q5VU97,0.89,0.115,5.8276e-09,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
57687,VAT1L,Q9HCJ6,0.931,0.077,9.9386e-07,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
57688,ZSWIM6,Q9HCJ5,0.626,0.577,1.0,,,C1863616,ACROMELIC FRONTONASAL DYSOSTOSIS,C16;C11;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.74,1.0,,2014.0,2017.0,ALL
57689,LRRC4C,Q9HCJ2,0.792,0.192,0.97233,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
57690,TNRC6C,Q9HCJ0,0.821,0.231,1.0,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
57692,MAGEE1,Q9HCI5,0.736,0.423,0.97046,DTO_05007620,Cell adhesion,C0005395,Bile Duct Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
57693,ZNF317,Q96PQ6,1.0,0.077,5.7842e-05,,,C0020445,"Hypercholesterolemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
57695,USP37,Q86T82,0.792,0.192,0.99999,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
57697,FANCM,Q8IYD8,0.543,0.731,2.3536e-15,DTO_05007624,Enzyme,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,0.941,,2005.0,2019.0,ALL
57698,SHTN1,A0MZ66,0.839,0.192,0.0386,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2010.0,2018.0,ALL
57699,CPNE5,Q9HCH3,0.839,0.308,0.00037837,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
57700,FAM160B1,Q5W0V3,0.861,0.192,0.99898,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,limited,2019.0,2019.0,ALL
57703,CWC22,Q9HCG8,0.861,0.115,0.0008992,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2019.0,ALL
57704,GBA2,Q9HCG7,0.636,0.654,1.9892e-20,,,C2828721,"SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.71,1.0,,2013.0,2018.0,ALL
57705,WDFY4,Q6ZS81,0.792,0.192,0.34009,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2019.0,2019.0,ALL
57706,DENND1A,Q8TEH3,0.736,0.538,0.99976,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,0.913,,2011.0,2019.0,ALL
57707,MEAK7,Q6P9B6,0.931,0.154,9.7663e-18,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
57708,MIER1,Q8N108,0.792,0.346,0.28881,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,0.0,,2012.0,2012.0,ALL
57709,SLC7A14,Q8TBB6,0.695,0.308,0.022116,DTO_05007405,Transporter,C3810380,RETINITIS PIGMENTOSA 68,,,disease,Disease or Syndrome,0.7,1.0,limited,2014.0,2014.0,ALL
57710,KIAA1614,Q5VZ46,1.0,0.038,1.1531e-15,DTO_05007527,Cell-cell junction,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57713,SFMBT2,Q5VUG0,0.716,0.346,0.99939,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57715,SEMA4G,Q9NTN9,0.839,0.115,1.3518e-08,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
57716,PRX,Q9BXM0,0.65,0.577,2.1337e-14,,,C0011195,Dejerine-Sottas Disease (disorder),C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.78,1.0,,2000.0,2019.0,ALL
57717,PCDHB16,Q9NRJ7,,,5.5748e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57718,PPP4R4,Q6NUP7,1.0,0.038,2.2494e-09,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
57719,ANO8,Q9HCE9,0.89,0.192,0.95634,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
57720,GPR107,Q5VW38,0.89,0.077,0.28858,DTO_02300001,G-protein coupled receptor,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
57721,METTL14,Q9HCE5,0.716,0.346,0.0013331,DTO_05007542,Transcription factor,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
57722,IGDCC4,Q8TDY8,1.0,0.077,2.3605e-06,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
57724,EPG5,Q9HCE0,0.623,0.769,1.3508e-13,,,C1855772,Absent corpus callosum cataract immunodeficiency,C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,strong,1988.0,2020.0,ALL
57727,NCOA5,Q9HCD5,0.631,0.692,0.99926,DTO_05007575,Receptor,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,1997.0,2020.0,ALL
57728,WDR19,Q8NEZ3,0.554,0.769,4.632e-11,,,C0432235,CRANIOECTODERMAL DYSPLASIA 1,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.63,1.0,,2011.0,2018.0,ALL
57730,ANKRD36B,Q8N2N9,0.584,0.5,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2001.0,2019.0,ALL
57731,SPTBN4,Q9H254,0.686,0.462,1.0,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
57732,ZFYVE28,Q9HCC9,1.0,0.077,0.07234,,,C0685938,Malignant neoplasm of gastrointestinal tract,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
57733,GBA3,Q9H227,0.705,0.538,,DTO_05007624,Enzyme,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
57758,SCUBE2,Q9NQ36,0.743,0.231,3.5629e-21,DTO_05007621,Extracellular structure,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57760,SPG16,,0.722,0.423,,,,C1846046,"SPASTIC PARAPLEGIA 16, X-LINKED (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
57761,TRIB3,Q96RU7,0.573,0.692,1.1597e-13,DTO_03300101,Kinase,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.33,1.0,,2008.0,2017.0,ALL
57762,NS2,,0.78,0.269,,,,C0375023,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.09,1.0,,2004.0,2019.0,ALL
57763,ANKRA2,Q9H9E1,0.89,0.269,3.5443e-06,DTO_05007542,Transcription factor,C0242583,Bare Lymphocyte Syndrome,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
57786,RBAK,Q9NYW8,0.821,0.231,1.1355e-08,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
57787,MARK4,Q96L34,0.641,0.615,0.99777,DTO_03300101,Kinase,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
57794,SUGP1,Q8IWZ8,0.623,0.615,0.99568,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.17,1.0,,2012.0,2019.0,ALL
57798,GATAD1,Q8WUU5,0.736,0.385,0.42971,,,C3553409,"CARDIOMYOPATHY, DILATED, 2B",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2011.0,ALL
57799,RAB40C,Q96S21,0.839,0.308,0.01538,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
57801,HES4,Q9HCC6,0.743,0.231,1.3746e-05,DTO_05007542,Transcription factor,C0014474,Ependymoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
57804,POLD4,Q9HCU8,0.647,0.577,0.1451,DTO_05007624,Enzyme,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.04,1.0,,2012.0,2019.0,ALL
57805,CCAR2,Q8N163,0.631,0.577,0.94099,DTO_05007616,Calcium-binding protein,C0043020,Wallerian Degeneration,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2014.0,2014.0,ALL
57817,HAMP,P81172,0.433,0.846,0.0081797,,,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,0.966,,2002.0,2020.0,ALL
57818,G6PC2,Q9NQR9,0.751,0.231,2.9565e-16,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2006.0,2018.0,ALL
57819,LSM2,Q9Y333,0.65,0.577,2.4045e-05,DTO_05007557,Nucleic acid binding,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,1997.0,2020.0,ALL
57820,CCNB1IP1,Q9NPC3,1.0,0.077,0.00010395,,,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
57821,CCDC181,Q5TID7,0.861,0.115,1.9512e-10,,,C0042487,Venous Thrombosis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.1,1.0,,2012.0,2012.0,ALL
57822,GRHL3,Q8TE85,0.572,0.692,0.99292,DTO_05007542,Transcription factor,C0175697,Van der Woude syndrome,C23;C16;C04;C05;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.79,0.889,strong,2014.0,2017.0,ALL
57823,SLAMF7,Q9NQ25,0.678,0.423,0.03635,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.1,1.0,,2008.0,2020.0,ALL
57824,HMHB1,O97980,1.0,0.115,0.0094526,,,C0027859,Acoustic Neuroma,C04;C10;C09,   Neoplasms;    Nervous System Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
57826,RAP2C,Q9Y3L5,0.89,0.038,0.29631,DTO_05007584,Enzyme modulator,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,0.5,,2017.0,2018.0,ALL
57827,C6orf47,O95873,0.722,0.423,0.066412,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
57829,ZP4,Q12836,0.89,0.154,1.7419e-18,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
57834,CYP4F11,Q9HBI6,0.931,0.077,1.4678e-21,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,0.5,,2012.0,2012.0,ALL
57835,SLC4A5,Q9BY07,1.0,0.115,1.1368e-13,DTO_05007405,Transporter,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
57862,ZNF410,Q86VK4,0.585,0.769,0.35337,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
57863,CADM3,Q8N126,0.861,0.154,0.93386,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2009.0,2019.0,ALL
57864,SLC46A2,Q9BY10,0.89,0.077,1.3414e-11,DTO_05007405,Transporter,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0,,2006.0,2008.0,ALL
57876,MUC3B,Q9H195,0.666,0.462,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,0.778,,1994.0,2007.0,ALL
58155,PTBP2,Q9UKA9,0.628,0.615,0.99883,,,C0041327,"Tuberculosis, Pulmonary",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.09,1.0,,2007.0,2019.0,ALL
58156,OPA4,,0.861,0.154,,,,C1854430,OPTIC ATROPHY 4 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
58157,NGB,Q9NPG2,0.631,0.462,0.0045474,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2007.0,2019.0,ALL
58158,NEUROD4,Q9HD90,0.792,0.231,0.097046,DTO_05007624,Enzyme,C0026975,Myelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2018.0,2018.0,ALL
58160,NFE4,Q86UQ8,1.0,0.115,,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
58163,RBPJP4,,0.805,0.423,,,,C0003125,Anorexia Nervosa,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2018.0,2018.0,ALL
58189,WFDC1,Q9HC57,0.743,0.346,3.4678e-11,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2006.0,2009.0,ALL
58190,CTDSP1,Q9GZU7,0.711,0.577,0.99254,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,0.8,,2001.0,2017.0,ALL
58191,CXCL16,Q9H2A7,0.502,0.769,3.4546e-05,DTO_05007599,Signaling,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
58472,SQOR,Q9Y6N5,0.821,0.308,4.1314e-10,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0,,2015.0,2018.0,ALL
58473,PLEKHB1,Q9UF11,0.792,0.154,0.00022133,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
58475,MS4A7,Q9GZW8,,,3.4763e-06,DTO_05007575,Receptor,C1608408,Malignant transformation,,,phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
58476,TP53INP2,Q8IXH6,0.722,0.385,0.8117,,,C0919677,Protein C measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
58477,SRPRB,Q9Y5M8,0.839,0.115,0.0058306,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2011.0,2011.0,ALL
58478,ENOPH1,Q9UHY7,0.76,0.308,0.0061227,DTO_05007624,Enzyme,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,1996.0,2005.0,ALL
58480,RHOU,Q7L0Q8,0.743,0.308,0.077808,DTO_05007584,Enzyme modulator,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
58484,NLRC4,Q9NPP4,0.556,0.769,9.8714e-12,,,C4015276,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4,,,disease,Disease or Syndrome,0.8,1.0,,2014.0,2017.0,ALL
58485,TRAPPC1,Q9Y5R8,0.931,0.115,0.086507,DTO_05007405,Transporter,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
58487,CREBZF,Q9NS37,0.65,0.538,0.1003,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.03,1.0,,2018.0,2020.0,ALL
58488,PCTP,Q9UKL6,0.861,0.077,8.7596e-12,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
58489,ABHD17C,Q6PCB6,1.0,0.077,0.95762,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
58490,RPRD1B,Q9NQG5,0.751,0.115,0.041768,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2012.0,2019.0,ALL
58491,ZNF71,Q9NQZ8,0.931,0.115,1.835e-08,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
58492,ZNF77,Q15935,0.861,0.192,0.004558,DTO_05007542,Transcription factor,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
58493,INIP,Q9NRY2,0.931,0.115,0.032654,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2014.0,2014.0,ALL
58494,JAM2,P57087,0.736,0.462,0.006155,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
58495,OVOL2,Q9BRP0,0.633,0.462,0.70889,,,C1852555,"CORNEAL ENDOTHELIAL DYSTROPHY 1, AUTOSOMAL DOMINANT",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.67,0.875,strong,2003.0,2020.0,ALL
58496,LY6G5B,Q8NDX9,0.931,0.192,8.1818e-06,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
58497,PRUNE1,Q86TP1,0.678,0.308,0.0091474,,,C4479566,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES",,,disease,Disease or Syndrome,0.71,1.0,moderate,2015.0,2019.0,ALL
58498,MYL7,Q01449,0.76,0.231,1.8314e-06,DTO_05007616,Calcium-binding protein,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,,1998.0,2001.0,ALL
58499,ZNF462,Q96JM2,0.711,0.462,1.0,DTO_05007542,Transcription factor,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
58500,ZNF250,P15622,0.89,0.038,0.2783,,,C0023269,leiomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
58503,OPRPN,Q99935,0.716,0.385,0.38851,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.07,1.0,,2007.0,2015.0,ALL
58504,ARHGAP22,Q7Z5H3,0.805,0.308,3.4043e-09,,,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.13,1.0,,2011.0,2018.0,ALL
58505,OSTC,Q9NRP0,1.0,0.077,0.018353,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
58506,SCAF1,Q9H7N4,0.666,0.5,0.99819,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.11,1.0,,2019.0,2019.0,ALL
58508,KMT2C,Q8NEZ4,0.558,0.692,1.0,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.41,1.0,,2012.0,2017.0,ALL
58510,PRODH2,Q9UF12,0.89,0.269,2.452e-13,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2002.0,2017.0,ALL
58511,DNASE2B,Q8WZ79,1.0,0.038,3.6644e-16,DTO_05007624,Enzyme,C0029531,Other cataract,C11,   Eye Diseases,disease,Disease or Syndrome,0.2,1.0,,2003.0,2003.0,ALL
58512,DLGAP3,O95886,0.736,0.269,0.99998,DTO_05007575,Receptor,C0028768,Obsessive-Compulsive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.08,1.0,,2009.0,2019.0,ALL
58513,EPS15L1,Q9UBC2,0.743,0.385,0.99964,DTO_05007584,Enzyme modulator,C0265554,Ectrodactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.3,1.0,,2018.0,2018.0,ALL
58515,SELENOK,Q9Y6D0,0.78,0.308,0.00011124,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
58516,SINHCAF,Q9NP50,0.76,0.231,0.96459,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2019.0,ALL
58517,RBM25,P49756,0.805,0.154,1.0,,,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
58524,DMRT3,Q9NQL9,0.653,0.5,6.1531e-06,,,C4510744,"46,XY partial gonadal dysgenesis",,,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
58526,MID1IP1,Q9NPA3,0.805,0.346,0.57733,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
58527,ABRACL,Q9P1F3,0.931,0.077,0.24171,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
58528,RRAGD,Q9NQL2,,,0.81991,DTO_05007584,Enzyme modulator,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2019.0,ALL
58529,MYOZ1,Q9NP98,0.861,0.115,1.7902e-05,DTO_05007530,Cellular structure,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.33,1.0,,2014.0,2018.0,ALL
58530,LY6G6D,O95868,0.805,0.385,0.032554,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
58531,PRM3,Q9NNZ6,0.663,0.5,0.35959,DTO_05007557,Nucleic acid binding,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.07,1.0,,2002.0,2019.0,ALL
58533,SNX6,Q9UNH7,0.89,0.154,0.49898,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
58538,MPP4,Q96JB8,0.792,0.308,3.418e-18,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
58985,IL22RA1,Q8N6P7,0.682,0.538,0.0056855,DTO_05007575,Receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2015.0,2019.0,ALL
58986,PGAP6,Q9HCN3,1.0,0.038,4.3704e-10,DTO_05007620,Cell adhesion,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
59067,IL21,Q9HBE4,0.441,0.769,0.6254,,,C4014258,"IMMUNODEFICIENCY, COMMON VARIABLE, 11",,,disease,Disease or Syndrome,0.7,1.0,moderate,2009.0,2014.0,ALL
59082,CARD18,P57730,0.861,0.154,0.001415,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
59084,ENPP5,Q9UJA9,1.0,0.077,3.1565e-10,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
59269,HIVEP3,Q5T1R4,0.722,0.462,0.90584,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
59271,EVA1C,P58658,0.931,0.077,0.001458,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
59272,ACE2,Q9BYF1,0.477,0.769,0.99769,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.6,0.982,,2003.0,2019.0,ALL
59274,TLNRD1,Q9H1K6,0.861,0.154,0.9137,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2012.0,2019.0,ALL
59277,NTN4,Q9HB63,0.695,0.538,0.91585,DTO_05007584,Enzyme modulator,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
59283,CACNG8,Q8WXS5,1.0,0.038,0.9638,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2013.0,2016.0,ALL
59284,CACNG7,P62955,,,0.88714,DTO_01300327,Ion channel,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
59285,CACNG6,Q9BXT2,0.839,0.192,3.097e-05,DTO_01300327,Ion channel,C0004059,aspirin intolerance,,,phenotype,Sign or Symptom,0.01,1.0,,2010.0,2010.0,ALL
59286,UBL5,Q9BZL1,0.686,0.5,0.016321,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.03,1.0,,2003.0,2008.0,ALL
59307,SIGIRR,Q6IA17,0.67,0.615,5.9288e-06,DTO_05007575,Receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0,,2010.0,2020.0,ALL
59330,GER,,0.678,0.538,,,,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,0.923,,2005.0,2020.0,ALL
59331,RFH1,,0.861,0.154,,,,C0024131,Lupus Vulgaris,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
59332,VSPA,,1.0,0.192,,,,C0041408,Turner Syndrome,C16;C13;C12;C19;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
59335,PRDM12,Q9H4Q4,0.839,0.231,0.93018,,,C4225308,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2017.0,ALL
59336,PRDM13,Q9H4Q3,0.78,0.231,0.56307,,,C0730294,North Carolina macular dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
59338,PLEKHA1,Q9HB21,0.769,0.269,0.0002347,DTO_05007378,Epigenetic regulator,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.42,1.0,,2014.0,2019.0,ALL
59339,PLEKHA2,Q9HB19,0.861,0.154,0.83804,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
59340,HRH4,Q9H3N8,0.659,0.462,5.2213e-08,DTO_02300001,G-protein coupled receptor,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
59341,TRPV4,Q9HBA0,0.457,0.808,2.237e-16,DTO_01300327,Ion channel,C0265281,Metatropic dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.8,1.0,,2009.0,2020.0,ALL
59342,SCPEP1,Q9HB40,0.674,0.615,1.2284e-13,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,0.8,,2001.0,2017.0,ALL
59343,SENP2,Q9HC62,0.663,0.577,0.98262,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2018.0,2018.0,ALL
59344,ALOXE3,Q9BYJ1,0.644,0.538,5.1284e-20,DTO_05007624,Enzyme,C0079154,Congenital Nonbullous Ichthyosiform Erythroderma,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.65,1.0,,2003.0,2016.0,ALL
59345,GNB4,Q9HAV0,0.751,0.346,0.0023672,DTO_05007624,Enzyme,C3554654,"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2017.0,ALL
59348,ZNF350,Q9GZX5,0.78,0.269,0.000639,DTO_05007542,Transcription factor,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2004.0,2018.0,ALL
59349,KLHL12,Q53G59,0.89,0.115,0.030342,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.02,0.5,,2018.0,2019.0,ALL
59350,RXFP1,Q9HBX9,0.659,0.538,1.3875e-12,DTO_02300001,G-protein coupled receptor,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,1.0,,2009.0,2011.0,ALL
59351,PBOV1,Q9GZY1,0.743,0.308,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2007.0,2018.0,ALL
59352,LGR6,Q9HBX8,0.502,0.923,2.9439e-06,DTO_02300001,G-protein coupled receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.52,1.0,,2008.0,2018.0,ALL
60312,AFAP1,Q8N556,0.653,0.538,2.3828e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
60314,C12orf10,Q9HB07,0.821,0.077,4.3496e-10,,,C0042900,Vitiligo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.03,1.0,,2010.0,2019.0,ALL
60343,FAM3A,P98173,0.805,0.269,0.66899,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
60358,ERVK-5,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
60370,AVPI1,Q5T686,1.0,0.077,3.8026e-05,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
60385,TSKS,Q9UJT2,0.89,0.077,0.99652,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
60386,SLC25A19,Q9HC21,0.653,0.577,0.64923,DTO_05007405,Transporter,C1846648,"MICROCEPHALY, AMISH TYPE (disorder)",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,0.8,,2002.0,2019.0,ALL
60401,EDA2R,Q9HAV5,0.736,0.423,0.00054689,,,C0162359,Christ-Siemens-Touraine syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
60412,EXOC4,Q96A65,0.743,0.5,3.4137e-13,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
60436,TGIF2,Q9GZN2,0.695,0.462,0.13641,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2008.0,2016.0,ALL
60439,TTTY2,,0.89,0.077,,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.02,1.0,,2015.0,2017.0,ALL
60467,BPESC1,Q9GZL8,1.0,0.192,,,,C0220663,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS (disorder)",C16;C13;C11;C17;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
60468,BACH2,Q9BYV9,0.539,0.731,0.99803,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.44,1.0,,2010.0,2018.0,ALL
60481,ELOVL5,Q9NYP7,0.638,0.462,0.93341,DTO_05007624,Enzyme,C4518337,Spinocerebellar ataxia type 38,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,,2014.0,2019.0,ALL
60482,SLC5A7,Q9GZV3,0.597,0.654,0.015272,DTO_05007405,Transporter,C1834703,"Neuropathy, Distal Hereditary Motor, Type VIIA",C23;C16;C08;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.61,1.0,,2012.0,2018.0,ALL
60484,HAPLN2,Q9GZV7,0.931,0.077,7.1205e-07,DTO_05007621,Extracellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2009.0,2019.0,ALL
60485,SAV1,Q9H4B6,0.659,0.5,0.00090373,,,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.22,1.0,,2018.0,2018.0,ALL
60487,TRMT11,Q7Z4G4,0.729,0.269,3.9134e-12,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
60488,MRPS35,P82673,1.0,0.077,3.0487e-09,DTO_05007557,Nucleic acid binding,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2018.0,ALL
60489,APOBEC3G,Q9HC16,0.653,0.346,5.672e-21,DTO_05007624,Enzyme,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2005.0,2019.0,ALL
60490,PPCDC,Q96CD2,0.861,0.192,0.00047853,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
60491,NIF3L1,Q9GZT8,0.674,0.462,9.7207e-09,,,C1851920,Dopa-Responsive Dystonia,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,0.944,,1994.0,2010.0,ALL
60493,FASTKD5,Q7L8L6,1.0,0.038,3.5791e-08,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
60494,CCDC81,Q6ZN84,1.0,0.115,5.0855e-23,,,C0341106,Eosinophilic esophagitis,C06;C20;C15,   Digestive System Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
60495,HPSE2,Q8WWQ2,0.588,0.692,0.00015083,DTO_05007624,Enzyme,C0403555,Ochoa syndrome,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.89,1.0,,2009.0,2019.0,ALL
60496,AASDHPPT,Q9NRN7,0.89,0.192,0.033866,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
60498,IGAN1,,0.524,0.808,,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2002.0,2019.0,ALL
60500,BRCA3,,0.705,0.269,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.9,,1997.0,2017.0,ALL
60502,CPAT1,,0.674,0.654,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.05,1.0,,2001.0,2017.0,ALL
60506,NYX,Q9GZU5,0.678,0.192,0.12961,DTO_05007575,Receptor,C3495587,"Night Blindness, Congenital Stationary, Type 1A",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.92,1.0,,1998.0,2019.0,ALL
60509,AGBL5,Q8NDL9,0.711,0.269,2.3696e-08,DTO_05007624,Enzyme,C4310759,RETINITIS PIGMENTOSA 75,,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2016.0,ALL
60526,LDAH,Q9H6V9,0.839,0.231,0.00035525,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.45,1.0,,2010.0,2018.0,ALL
60528,ELAC2,Q9BQ52,0.67,0.346,1.7245e-20,,,C3809526,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17,,,disease,Disease or Syndrome,0.7,1.0,moderate,2012.0,2016.0,ALL
60529,ALX4,Q9H161,0.56,0.692,0.35736,,,C1868598,PARIETAL FORAMINA,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.89,1.0,,2000.0,2019.0,ALL
60558,GUF1,Q8N442,0.805,0.154,5.3495e-18,DTO_05007624,Enzyme,C4310737,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40",,,disease,Disease or Syndrome,0.6,1.0,moderate,2016.0,2016.0,ALL
60559,SPCS3,P61009,1.0,0.038,0.81991,DTO_05007624,Enzyme,C0270736,Essential Tremor,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
60560,NAA35,Q5VZE5,0.931,0.154,1.0,DTO_05007624,Enzyme,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
60561,RINT1,Q6NUQ1,0.743,0.231,5.293e-13,,,C0346153,"Breast Cancer, Familial",C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,disputed,2001.0,2016.0,ALL
60592,SCOC,Q9UIL1,1.0,0.077,0.011142,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
60598,KCNK15,Q9H427,0.931,0.077,0.033356,DTO_01300327,Ion channel,C0021125,Impulsive Behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.05,1.0,,2016.0,2018.0,ALL
60626,RIC8A,Q9NPQ8,0.792,0.192,0.00063968,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2019.0,ALL
60672,MIIP,Q5JXC2,0.7,0.308,1.3121e-20,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
60673,ATG101,Q9BSB4,1.0,0.077,0.60623,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
60674,GAS5,,0.497,0.808,,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
60675,PROK2,Q9HC23,0.555,0.769,0.013828,DTO_05007599,Signaling,C0162809,Kallmann Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.6,1.0,,2007.0,2019.0,ALL
60676,PAPPA2,Q9BXP8,0.751,0.423,7.7879e-08,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
60677,CELF6,Q96J87,0.839,0.231,0.0044515,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
60678,EEFSEC,P57772,0.751,0.385,2.6975e-08,DTO_05007624,Enzyme,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.4,1.0,,2017.0,2019.0,ALL
60680,CELF5,Q8N6W0,,,0.99844,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
60681,FKBP10,Q96AY3,0.606,0.538,2.3826e-06,,,C1850168,Bruck syndrome 1,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2010.0,2013.0,ALL
60682,SMAP1,Q8IYB5,0.89,0.154,0.99357,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
60684,TRAPPC11,Q7Z392,0.65,0.5,4.5628e-10,,,C4517996,Autosomal recessive limb girdle muscular dystrophy type 2S,,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2018.0,ALL
60685,ZFAND3,Q9H8U3,0.792,0.192,0.92174,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.42,1.0,,2011.0,2019.0,ALL
60686,C14orf93,Q9H972,0.839,0.077,0.01085,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
63027,SLC22A23,A1A5C7,0.769,0.269,0.82731,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
63035,BCORL1,Q5H9F3,0.682,0.5,0.99999,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
63036,CELA2A,P08217,0.839,0.192,1.9736e-16,DTO_05007624,Enzyme,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,,2019.0,2019.0,ALL
63826,SRR,Q9GZT4,0.617,0.692,0.0057964,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,0.75,,2005.0,2019.0,ALL
63827,BCAN,Q96GW7,0.7,0.269,1.7582e-06,DTO_05007621,Extracellular structure,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.28,1.0,,1998.0,2017.0,ALL
63869,PSORS6,,0.931,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.05,1.0,,2003.0,2015.0,ALL
63870,PSORS5,,0.931,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.04,1.0,,2004.0,2011.0,ALL
63875,MRPL17,Q9NRX2,0.861,0.192,0.028198,DTO_05007557,Nucleic acid binding,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
63876,PKNOX2,Q96KN3,0.743,0.5,0.99174,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2011.0,2015.0,ALL
63891,RNF123,Q5XPI4,0.736,0.269,8.4689e-05,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.31,0.5,,2012.0,2013.0,ALL
63892,THADA,Q6YHU6,0.686,0.5,4.6208e-41,DTO_05007575,Receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.49,1.0,,2008.0,2019.0,ALL
63893,UBE2O,Q9C0C9,0.78,0.269,1.0,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
63894,VIPAS39,Q9H9C1,0.705,0.5,7.2613e-10,,,C1859722,"Arthrogryposis, renal dysfunction, and cholestasis 1",C16;C06;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2010.0,2018.0,ALL
63895,PIEZO2,Q9H5I5,0.529,0.769,8.0992e-07,DTO_01300327,Ion channel,C1862472,Oculomelic amyoplasia,C23;C16;C11;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.75,1.0,strong,2013.0,2019.0,ALL
63897,HEATR6,Q6AI08,0.678,0.462,5.1848e-21,DTO_05007608,Immune response,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2001.0,2019.0,ALL
63898,SH2D4A,Q9H788,0.89,0.115,3.1396e-22,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
63899,NSUN3,Q9H649,1.0,0.038,9.0405e-09,DTO_05007624,Enzyme,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
63901,FAM111A,Q96PZ2,0.663,0.462,0.002225,,,C1865639,Gracile bone dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2013.0,2019.0,ALL
63904,DUSP21,Q9H596,0.931,0.077,0.0003235,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
63906,GPATCH3,Q96I76,0.861,0.077,6.3952e-14,,,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
63908,NAPB,Q9H115,0.89,0.231,0.11216,DTO_05007405,Transporter,C2825856,Factor VII measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
63910,SLC17A9,Q9BYT1,0.78,0.346,6.0979e-17,DTO_05007405,Transporter,C4015128,"POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE",,,disease,Disease or Syndrome,0.7,1.0,moderate,2014.0,2015.0,ALL
63915,BLOC1S5,Q8TDH9,0.89,0.231,2.8546e-09,,,C0079504,Hermanski-Pudlak Syndrome,C16;C18;C11;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.21,1.0,,2015.0,2015.0,ALL
63916,ELMO2,Q96JJ3,0.729,0.538,1.0384e-05,DTO_05007599,Signaling,C1847197,"Vascular Malformation, Primary Intraosseous",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.63,1.0,,2016.0,2019.0,ALL
63917,GALNT11,Q8NCW6,0.839,0.269,1.6685e-05,DTO_05007624,Enzyme,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
63922,CHTF18,Q8WVB6,0.89,0.154,3.0747e-28,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2016.0,ALL
63923,TNN,Q9UQP3,0.805,0.154,1.5729e-28,DTO_05007599,Signaling,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
63924,CIDEC,Q96AQ7,0.666,0.462,0.0089662,,,C3808940,"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5",,,disease,Disease or Syndrome,0.6,1.0,limited,2009.0,2009.0,ALL
63925,ZNF335,Q9H4Z2,0.711,0.462,6.8885e-07,DTO_05007542,Transcription factor,C3554499,"MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2017.0,ALL
63926,ANKEF1,Q9NU02,0.89,0.231,8.5371e-10,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
63928,CHP2,O43745,0.805,0.231,9.6292e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2007.0,2015.0,ALL
63929,XPNPEP3,Q9NQH7,0.769,0.269,1.8555e-08,DTO_05007624,Enzyme,C3150419,NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1,,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2010.0,ALL
63930,LINC01749,,,,,,,C4317009,Diverticular Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
63931,MRPS14,O60783,0.805,0.231,0.00016481,DTO_05007557,Nucleic acid binding,C0001125,"Acidosis, Lactic",C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.11,1.0,,2019.0,2019.0,ALL
63932,CXorf56,Q9H5V9,0.705,0.385,0.95204,,,C2931498,"Mental Retardation, X-Linked 1",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
63933,MCUR1,Q96AQ8,1.0,0.077,1.1206e-06,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
63934,ZNF667,Q5HYK9,0.839,0.154,2.3796e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
63935,PCIF1,Q9H4Z3,0.89,0.077,0.99999,,,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0,,2017.0,2020.0,ALL
63939,FAM217B,Q9NTX9,0.931,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
63940,GPSM3,Q9Y4H4,0.751,0.423,0.28641,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2007.0,2016.0,ALL
63941,NECAB3,Q96P71,0.861,0.192,2.751e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
63943,FKBPL,Q9UIM3,0.736,0.346,7.9526e-11,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2010.0,2019.0,ALL
63944,SCZD10,,0.89,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2012.0,2012.0,ALL
63948,DMRTB1,Q96MA1,1.0,0.038,0.82857,,,C0205851,Germ cell tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
63950,DMRTA2,Q96SC8,,,0.91608,,,C0266449,Congenital anomaly of brain,C16;C13;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Nervous System Diseases",group,Congenital Abnormality,0.01,1.0,,2016.0,2016.0,ALL
63951,DMRTA1,Q5VZB9,0.729,0.5,6.3708e-06,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
63967,CLSPN,Q9HAW4,0.743,0.423,0.0025864,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,0.75,,2008.0,2010.0,ALL
63970,TP53AIP1,Q9HCN2,0.716,0.269,1.3043e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2004.0,2019.0,ALL
63971,KIF13A,Q9H1H9,0.792,0.192,0.99999,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
63973,NEUROG2,Q9H2A3,0.716,0.5,0.81093,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,0.5,,2010.0,2018.0,ALL
63974,NEUROD6,Q96NK8,0.861,0.115,0.88454,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
63976,PRDM16,Q9HAZ2,0.522,0.808,0.99999,,,C3809288,LEFT VENTRICULAR NONCOMPACTION 8,,,disease,Disease or Syndrome,0.7,1.0,limited,2013.0,2013.0,ALL
63977,PRDM15,P57071,,,8.2172e-06,DTO_05007542,Transcription factor,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
63978,PRDM14,Q9GZV8,0.644,0.5,0.019397,,,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.4,1.0,,2013.0,2017.0,ALL
63979,FIGNL1,Q6PIW4,0.805,0.385,0.00012046,DTO_05007530,Cellular structure,C0022665,Kidney Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
63982,ANO3,Q9BYT9,0.716,0.385,1.2489e-17,,,C3554374,DYSTONIA 24,,,disease,Disease or Syndrome,0.71,1.0,,2012.0,2016.0,ALL
64002,PCGEM1,,0.722,0.269,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2000.0,2018.0,ALL
64005,MYO1G,B0I1T2,0.861,0.231,4.3609e-10,DTO_05007530,Cellular structure,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
64006,ERVK-6,,0.521,0.808,,,,C0011311,Dengue Fever,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,1992.0,2020.0,ALL
64061,TSPYL2,Q9H2G4,0.615,0.769,0.87393,DTO_05007584,Enzyme modulator,C0014170,Endometrial Neoplasms,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,group,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
64062,RBM26,Q5T8P6,1.0,0.038,1.0,DTO_05007557,Nucleic acid binding,C0003165,Anthracosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
64063,PRSS22,Q9GZN4,0.821,0.192,0.0029749,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
64065,PERP,Q96FX8,0.663,0.577,0.079462,,,C2609071,Olmsted syndrome,,,disease,Disease or Syndrome,0.3,1.0,,2019.0,2019.0,ALL
64066,MMP27,Q9H306,,,6.3444e-22,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
64067,NPAS3,Q8IXF0,0.729,0.269,0.99974,DTO_05007542,Transcription factor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2003.0,2015.0,ALL
64069,ATOD1,,0.769,0.115,,,,C0036508,Seborrheic dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0,,2001.0,2017.0,ALL
64072,CDH23,Q9H251,0.539,0.769,3.1819e-06,,,C1832394,"Deafness, Autosomal Recessive 12",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.95,1.0,,1989.0,2018.0,ALL
64073,C19orf33,Q9GZP8,0.861,0.115,0.70447,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
64077,LHPP,Q9H008,0.716,0.423,1.6345e-07,DTO_05007624,Enzyme,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2009.0,2019.0,ALL
64078,SLC28A3,Q9HAS3,0.674,0.615,2.6549e-23,DTO_05007405,Transporter,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2005.0,2005.0,ALL
64080,RBKS,Q9H477,0.89,0.077,5.1575e-09,DTO_03300101,Kinase,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
64081,PBLD,P30039,0.821,0.115,2.3448e-11,,,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
64083,GOLPH3,Q9H4A6,0.53,0.808,0.23586,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64084,CLSTN2,Q9H4D0,0.716,0.423,3.5246e-06,DTO_05007616,Calcium-binding protein,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
64087,MCCC2,Q9HCC0,0.674,0.423,4.5134e-11,DTO_05007624,Enzyme,C1859499,3-methylcrotonyl CoA carboxylase 2 deficiency,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2001.0,2016.0,ALL
64089,SNX16,P57768,,,1.416e-11,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
64090,GAL3ST2,Q9H3Q3,0.805,0.192,2.9341e-11,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
64091,POPDC2,Q9HBU9,0.805,0.192,4.0063e-05,,,C0877015,Pelvic Organ Prolapse,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.02,1.0,,2018.0,2018.0,ALL
64092,SAMSN1,Q9NSI8,0.716,0.385,5.0417e-11,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.02,1.0,,2014.0,2015.0,ALL
64093,SMOC1,Q9H4F8,0.565,0.846,0.0094673,DTO_05007616,Calcium-binding protein,C0599973,Waardenburg Anophthalmia Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.99,1.0,,2011.0,2019.0,ALL
64094,SMOC2,Q9H3U7,0.67,0.462,0.0025279,DTO_05007616,Calcium-binding protein,C0399379,"Dentin dysplasia, type 1",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.51,1.0,moderate,2011.0,2013.0,ALL
64096,GFRA4,Q9GZZ7,0.821,0.308,0.0013789,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.03,1.0,,2011.0,2018.0,ALL
64097,EPB41L4A,Q9HCS5,0.89,0.231,3.5133e-21,,,C0037772,Spastic Paraplegia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
64098,PARVG,Q9HBI0,0.805,0.115,1.4217e-05,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2003.0,2005.0,ALL
64100,ELSPBP1,Q96BH3,0.89,0.154,1.5208e-11,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2012.0,2012.0,ALL
64101,LRRC4,Q9HBW1,0.617,0.577,0.99787,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
64102,TNMD,Q9H2S6,0.588,0.692,0.0035119,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.07,1.0,,2007.0,2019.0,ALL
64105,CENPK,Q9BS16,0.743,0.423,3.0771e-11,,,C3658266,"Prostatic Cancer, Castration-Resistant",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
64106,NPFFR1,Q9GZQ6,,,9.5481e-15,DTO_02300001,G-protein coupled receptor,C0020429,Hyperalgesia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
64108,RTP4,Q96DX8,0.89,0.154,0.59616,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
64109,CRLF2,Q9HC73,0.615,0.538,3.3104e-07,DTO_05007599,Signaling,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.6,1.0,,2009.0,2019.0,ALL
64110,MAGEF1,Q9HAY2,0.839,0.077,0.0030065,DTO_05007620,Cell adhesion,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2001.0,2018.0,ALL
64111,NPVF,Q9HCQ7,0.805,0.346,0.00010444,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0,,2001.0,2018.0,ALL
64112,MOAP1,Q96BY2,0.7,0.577,1.1736e-09,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2010.0,2019.0,ALL
64114,TMBIM1,Q969X1,0.711,0.154,1.3647e-08,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
64115,VSIR,Q9H7M9,0.573,0.654,0.76097,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
64116,SLC39A8,Q9C0K1,0.584,0.769,0.66924,DTO_05007405,Transporter,C4225234,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn",,,disease,Disease or Syndrome,0.71,1.0,strong,2015.0,2019.0,ALL
64118,DUS1L,Q6P1R4,1.0,0.077,5.726e-10,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
64121,RRAGC,Q9HB90,0.792,0.154,0.97538,DTO_05007584,Enzyme modulator,C0024301,"Lymphoma, Follicular",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.32,1.0,,2016.0,2016.0,ALL
64122,FN3K,Q9H479,0.769,0.346,2.0577e-08,DTO_03300101,Kinase,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64123,ADGRL4,Q9HBW9,0.76,0.192,2.78e-11,DTO_02300001,G-protein coupled receptor,C3160814,Cannabis use,,,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
64127,NOD2,Q9HC29,0.423,0.923,1.9834e-30,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,1.0,0.937,moderate,1998.0,2019.0,ALL
64129,TINAGL1,Q9GZM7,0.659,0.538,0.00032933,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
64130,LIN7B,Q9HAP6,0.89,0.115,0.85352,DTO_05007527,Cell-cell junction,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
64131,XYLT1,Q86Y38,0.581,0.731,0.92418,,,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.63,1.0,moderate,2005.0,2017.0,ALL
64132,XYLT2,Q9H1B5,0.566,0.808,0.92576,,,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.52,1.0,,2006.0,2007.0,ALL
64135,IFIH1,Q9BYX4,0.471,0.808,6.9819e-44,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.7,1.0,,2006.0,2019.0,ALL
64137,ABCG4,Q9H172,0.751,0.346,3.8043e-07,DTO_05007405,Transporter,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
64145,RBSN,Q9H1K0,1.0,,0.022662,,,C3809031,"NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
64146,PDF,Q9HBH1,0.792,0.308,5.8706e-06,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
64147,KIF9,Q9HAQ2,0.805,0.192,5.4841e-22,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64150,DIO3OS,,0.839,0.115,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
64151,NCAPG,Q9BPX3,0.743,0.269,4.0848e-07,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,0.8,,2017.0,2019.0,ALL
64167,ERAP2,Q6P179,0.615,0.577,1.0028e-28,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.42,1.0,,2010.0,2017.0,ALL
64168,NECAB1,Q8N987,,,0.025009,,,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,1990.0,1990.0,ALL
64170,CARD9,Q9H257,0.566,0.654,8.1491e-13,,,C1859353,"Candidiasis, Familial, 2",C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2009.0,2013.0,ALL
64174,DPEP2,Q9H4A9,0.805,0.269,3.2234e-10,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
64175,P3H1,Q32P28,0.736,0.231,2.2869e-20,DTO_05007621,Extracellular structure,C1970458,"Osteogenesis imperfecta, type VIII",C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.83,1.0,strong,2007.0,2018.0,ALL
64180,DPEP3,Q9H4B8,0.931,0.038,5.2742e-10,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
64184,EDDM3B,P56851,1.0,0.115,,DTO_05007599,Signaling,C0266667,Cyclocephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2017.0,2017.0,ALL
64207,IRF2BPL,Q9H1B7,0.631,0.462,0.83623,,,C4748127,"NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES",,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2019.0,ALL
64208,POPDC3,Q9HBV1,0.769,0.269,0.010916,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2010.0,2012.0,ALL
64210,MMS19,Q96T76,0.751,0.385,0.0082883,DTO_05007542,Transcription factor,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2012.0,2016.0,ALL
64211,LHX5,Q9H2C1,1.0,0.038,0.94591,DTO_05007557,Nucleic acid binding,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2003.0,2003.0,ALL
64215,DNAJC1,Q96KC8,0.821,0.154,1.3254e-08,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
64216,TFB2M,Q9H5Q4,0.861,0.231,8.7667e-06,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,,limited,,,ALL
64218,SEMA4A,Q9H3S1,0.569,0.692,1.8394e-05,DTO_05007599,Signaling,C1846529,CONE-ROD DYSTROPHY 10,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2006.0,ALL
64219,PJA1,Q8NG27,0.821,0.269,0.92754,,,C0220767,Craniofrontonasal dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.3,1.0,limited,2001.0,2001.0,ALL
64220,STRA6,Q9BX79,0.597,0.731,1.5068e-10,,,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.8,1.0,,2007.0,2017.0,ALL
64221,ROBO3,Q96MS0,0.52,0.808,1.9977e-15,DTO_05007575,Receptor,C4551964,"GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1",C23;C18;C11;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,2004.0,2015.0,ALL
64222,TOR3A,Q9H497,0.861,0.231,2.3045e-12,DTO_05007613,Chaperone,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
64223,MLST8,Q9BVC4,0.751,0.385,0.0082177,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
64224,HERPUD2,Q9BSE4,0.839,0.115,0.94702,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
64225,ATL2,Q8NHH9,0.861,0.231,0.011822,DTO_05007584,Enzyme modulator,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
64231,MS4A6A,Q9H2W1,0.821,0.231,8.3775e-13,DTO_05007575,Receptor,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
64232,MS4A5,Q9H3V2,0.931,0.115,0.00037917,DTO_05007575,Receptor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
64236,PDLIM2,Q96JY6,0.65,0.385,0.00022117,DTO_05007530,Cellular structure,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
64240,ABCG5,Q9H222,0.592,0.577,3.081e-21,DTO_05007405,Transporter,C0342907,Sitosterolemia,C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Congenital Abnormality,0.8,0.976,,2000.0,2020.0,ALL
64241,ABCG8,Q9H221,0.573,0.538,2.3838e-20,DTO_05007405,Transporter,C0342907,Sitosterolemia,C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Congenital Abnormality,1.0,1.0,,2000.0,2019.0,ALL
64282,TENT4B,Q8NDF8,0.792,0.269,0.99943,DTO_05007624,Enzyme,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
64283,ARHGEF28,Q8N1W1,0.615,0.423,8.1044e-21,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.37,1.0,moderate,2013.0,2020.0,ALL
64284,RAB17,Q9H0T7,0.839,0.154,0.074599,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
64285,RHBDF1,Q96CC6,0.67,0.308,5.4089e-15,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
64288,ZSCAN31,Q96LW9,0.76,0.346,3.647e-08,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2014.0,2015.0,ALL
64318,NOC3L,Q8WTT2,0.821,0.154,2.8342e-14,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64319,FBRS,Q9HAH7,0.653,0.654,0.99987,,,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
64320,RNF25,Q96BH1,1.0,0.077,0.017639,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
64321,SOX17,Q9H6I2,0.555,0.615,0.88495,DTO_05007542,Transcription factor,C3150927,VESICOURETERAL REFLUX 3,,,disease,Disease or Syndrome,0.6,1.0,,2010.0,2010.0,ALL
64324,NSD1,Q96L73,0.505,0.769,1.0,DTO_05007378,Epigenetic regulator,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.7,1.0,strong,2002.0,2019.0,ALL
64326,COP1,Q8NHY2,0.666,0.538,0.99994,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2009.0,2009.0,ALL
64327,LMBR1,Q8WVP7,0.619,0.308,1.2575e-08,DTO_05007575,Receptor,C0265559,Acheiropodia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.82,1.0,strong,2001.0,2016.0,ALL
64328,XPO4,Q9C0E2,0.751,0.192,1.0,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64332,NFKBIZ,Q9BYH8,0.674,0.577,0.99981,,,C0009405,Hereditary Nonpolyposis Colorectal Neoplasms,C16;C06;C04;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Nutritional and Metabolic Diseases",group,Neoplastic Process,0.3,1.0,limited,2015.0,2015.0,ALL
64333,ARHGAP9,Q9BRR9,0.743,0.346,3.9385e-11,DTO_05007584,Enzyme modulator,C0010073,Coronary Artery Vasospasm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.31,1.0,,2010.0,2010.0,ALL
64342,HS1BP3,Q53T59,0.861,0.077,1.1873e-06,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
64343,AZI2,Q9H6S1,0.76,0.577,0.0069113,,,C0343386,Clostridium difficile infection,C01,   Infections,disease,Disease or Syndrome,0.1,0.917,,2008.0,2018.0,ALL
64344,HIF3A,Q9Y2N7,0.682,0.538,0.0015428,DTO_05007542,Transcription factor,C0020542,Pulmonary Hypertension,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.2,1.0,,2005.0,2005.0,ALL
64359,NXN,Q6DKJ4,0.584,0.577,0.99725,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2014.0,2019.0,ALL
64374,SIL1,Q9H173,0.584,0.731,0.012265,,,C0024814,Marinesco-Sjogren syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,2001.0,2019.0,ALL
64375,IKZF4,Q9H2S9,0.861,0.192,0.89759,DTO_05007542,Transcription factor,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.4,1.0,,2010.0,2010.0,ALL
64376,IKZF5,Q9H5V7,0.792,0.269,0.7796,DTO_05007542,Transcription factor,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.31,1.0,strong,2019.0,2019.0,ALL
64377,CHST8,Q9H2A9,0.769,0.346,0.00010793,DTO_05007624,Enzyme,C4015729,PEELING SKIN SYNDROME 3,,,disease,Disease or Syndrome,0.6,1.0,limited,2012.0,2012.0,ALL
64386,MMP25,Q9NPA2,0.678,0.5,8.7309e-14,DTO_05007624,Enzyme,C0002452,Amelogenesis Imperfecta,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.03,1.0,,2003.0,2013.0,ALL
64388,GREM2,Q9H772,0.722,0.5,0.031824,,,C4310638,"TOOTH AGENESIS, SELECTIVE, 9",,,disease,Congenital Abnormality,0.6,1.0,,2015.0,2015.0,ALL
64393,ZMAT3,Q9HA38,0.751,0.269,0.00019034,,,C0027746,Nerve Degeneration,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell or Molecular Dysfunction,0.3,1.0,,2007.0,2007.0,ALL
64395,GMCL1,Q96IK5,0.736,0.385,3.5709e-07,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
64396,GMCL2,Q8NEA9,0.751,0.308,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
64397,ZNF106,Q9H2Y7,0.89,0.154,0.00010529,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.21,1.0,,2017.0,2017.0,ALL
64398,MPP5,Q8N3R9,0.861,0.154,0.2351,DTO_05007624,Enzyme,C0339527,Leber Congenital Amaurosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.21,1.0,,2012.0,2012.0,ALL
64399,HHIP,Q96QV1,0.55,0.654,0.95436,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.42,1.0,,1999.0,2019.0,ALL
64400,AKTIP,Q9H8T0,0.743,0.346,0.40379,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
64403,CDH24,Q86UP0,0.89,0.192,2.0554e-08,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
64405,CDH22,Q9UJ99,0.821,0.192,0.4999,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
64407,RGS18,Q9NS28,0.861,0.154,0.0014903,DTO_05007584,Enzyme modulator,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
64409,GALNT17,Q6IS24,0.931,0.115,0.11671,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
64410,KLHL25,Q9H0H3,0.89,0.077,1.5932e-15,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64411,ARAP3,Q8WWN8,0.751,0.346,1.647e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2014.0,2017.0,ALL
64412,GZF1,Q9H116,0.76,0.231,0.0017798,,,C4540020,"JOINT LAXITY, SHORT STATURE, AND MYOPIA",,,disease,Disease or Syndrome,0.6,1.0,limited,2017.0,2017.0,ALL
64417,TMEM267,Q0VDI3,,,1.1396e-07,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
64418,TMEM168,Q9H0V1,1.0,0.038,0.0042658,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
64419,MTMR14,Q8NCE2,0.674,0.615,1.3607e-07,,,C1834558,"Myopathy, Centronuclear, Autosomal Dominant",C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.6,1.0,,2006.0,2006.0,ALL
64420,SUSD1,Q6UWL2,1.0,0.077,2.169e-13,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64421,DCLRE1C,Q96SD1,0.544,0.808,2.4874e-07,,,C1865370,Severe combined immunodeficiency with sensitivity to ionizing radiation,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.91,1.0,strong,2001.0,2015.0,ALL
64422,ATG3,Q9NT62,0.686,0.423,0.00071299,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.05,1.0,,2016.0,2020.0,ALL
64423,INF2,Q27J81,0.644,0.423,0.97346,,,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2010.0,2019.0,ALL
64425,POLR1E,Q9GZS1,,,3.7381e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
64426,SUDS3,Q9H7L9,1.0,0.038,0.0045448,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
64428,CIAO3,Q9H6Q4,0.7,0.462,1.8864e-09,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64429,ZDHHC6,Q9H6R6,0.931,0.077,1.6026e-05,,,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
64431,ACTR6,Q9GZN1,0.931,0.038,5.4629e-09,DTO_05007530,Cellular structure,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
64433,LINC00244,,1.0,0.077,,,,C0345354,Radial polydactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0,,1999.0,1999.0,ALL
64434,NOM1,Q5C9Z4,0.89,0.192,4.1868e-10,DTO_05007624,Enzyme,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
64446,DNAI2,Q9GZS0,0.666,0.5,9.5317e-13,DTO_05007530,Cellular structure,C2676235,"CILIARY DYSKINESIA, PRIMARY, 9",C16;C08;C09;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,,2008.0,2015.0,ALL
64478,CSMD1,Q96PZ7,0.61,0.5,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.7,1.0,,2011.0,2020.0,ALL
64499,TPSB2,P20231;Q15661,0.78,0.385,5.3313e-09,DTO_05007624,Enzyme,C0022548,Keloid,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Acquired Abnormality,0.3,1.0,,2010.0,2010.0,ALL
64506,CPEB1,Q9BZB8,0.638,0.538,0.99899,DTO_05007557,Nucleic acid binding,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
64518,TEKT3,Q9BXF9,1.0,0.077,1.9845e-17,DTO_05007530,Cellular structure,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
64577,ALDH8A1,Q9H2A2,0.931,0.038,2.4846e-12,DTO_05007624,Enzyme,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
64579,NDST4,Q9H3R1,0.821,0.154,6.3382e-08,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
64581,CLEC7A,Q9BXN2,0.553,0.769,5.5087e-12,,,C0004030,Aspergillosis,C01,   Infections,disease,Disease or Syndrome,0.31,1.0,,2010.0,2010.0,ALL
64582,GPR135,Q8IZ08,0.839,0.192,6.4853e-05,DTO_02300001,G-protein coupled receptor,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
64585,BOS2,,1.0,0.038,,,,C4273131,Branchiootic syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
64595,TTTY15,,0.839,0.192,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
64598,MOSPD3,O75425,1.0,,0.00024549,DTO_05007405,Transporter,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2017.0,2017.0,ALL
64599,GIGYF1,O75420,0.751,0.269,3.4196e-06,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
64601,VPS16,Q9H269,0.89,0.077,2.2652e-15,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
64641,EBF2,Q9HAK2,0.716,0.538,0.99976,,,C0003466,"Anus, Imperforate",C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.31,1.0,,2018.0,2018.0,ALL
64644,GINGF2,,0.805,0.269,,,,C0399440,Hereditary gingival fibromatosis,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.32,1.0,,2001.0,2005.0,ALL
64645,MFSD14A,Q96MC6,1.0,0.115,0.97172,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
64648,SPANXD,Q9BXN6,0.89,0.077,0.077485,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
64651,CSRNP1,Q96S65,0.805,0.269,0.34269,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
64663,SPANXC,Q9NY87,0.805,0.231,0.072819,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2004.0,2012.0,ALL
64682,ANAPC1,Q9H1A4,0.743,0.385,0.94532,DTO_05007624,Enzyme,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2012.0,2012.0,ALL
64689,GORASP1,Q9BQQ3,0.428,0.846,0.019543,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.15,1.0,,2002.0,2017.0,ALL
64693,CTAGE1,Q96RT6,0.861,0.231,,DTO_05007599,Signaling,C0079773,"Lymphoma, T-Cell, Cutaneous",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,2001.0,2014.0,ALL
64695,SLEB3,,1.0,0.077,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
64699,TMPRSS3,P57727,0.65,0.538,6.0739e-11,DTO_05007624,Enzyme,C1832827,"DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2001.0,2017.0,ALL
64708,COPS7B,Q9H9Q2,0.931,0.115,0.60071,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
64710,NUCKS1,Q9H1E3,0.691,0.5,0.96937,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
64711,HS3ST6,Q96QI5,0.931,0.077,0.43595,,,C0004681,Bagassosis,C08;C24,   Respiratory Tract Diseases;    Occupational Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
64714,PDIA2,Q13087,0.638,0.692,8.4515e-33,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.03,1.0,,2017.0,2020.0,ALL
64717,TRG-CCC2-2,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,0.833,,2012.0,2019.0,ALL
64718,UNKL,Q9H9P5,,,0.81729,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64743,WDR13,Q9H1Z4,0.839,0.154,0.93514,,,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
64744,SMAP2,Q8WU79,0.931,0.231,0.017751,,,C0004059,aspirin intolerance,,,phenotype,Sign or Symptom,0.01,1.0,,2010.0,2010.0,ALL
64745,METTL17,Q9H7H0,,,4.0832e-11,,,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
64746,ACBD3,Q9H3P7,0.805,0.385,0.010653,,,C0014378,Enterovirus Infections,C01,   Infections,group,Disease or Syndrome,0.07,1.0,,2014.0,2020.0,ALL
64747,MFSD1,Q9H3U5,0.89,0.077,3.3314e-17,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.11,1.0,,2013.0,2019.0,ALL
64748,PLPPR2,Q96GM1,1.0,0.077,0.99025,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
64750,SMURF2,Q9HAU4,0.623,0.615,0.87235,DTO_05007624,Enzyme,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.23,1.0,,2013.0,2019.0,ALL
64753,CCDC136,Q96JN2,0.861,0.192,9.1226e-14,DTO_05007613,Chaperone,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2014.0,2014.0,ALL
64754,SMYD3,Q9H7B4,0.633,0.462,1.4438e-07,DTO_05007378,Epigenetic regulator,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
64755,C16orf58,Q96GQ5,0.89,0.269,1.1367e-17,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
64756,ATPAF1,Q5TC12,0.792,0.269,0.013464,DTO_05007613,Chaperone,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
64757,MTARC1,Q5VT66,0.821,0.192,4.5163e-08,,,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
64759,TNS3,Q68CZ2,0.653,0.615,1.0,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.11,1.0,,2005.0,2019.0,ALL
64761,PARP12,Q9H0J9,0.821,0.269,9.2524e-08,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
64762,GAREM1,Q9H706,0.931,0.115,0.19888,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64763,ZNF574,Q6ZN55,1.0,0.038,0.080197,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
64764,CREB3L2,Q70SY1,0.691,0.115,0.0015297,,,C3714524,Fibromyxosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
64766,S100PBP,Q96BU1,0.861,0.231,0.94509,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2005.0,2008.0,ALL
64768,IPPK,Q9H8X2,0.89,0.231,0.8741,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2014.0,ALL
64769,MEAF6,Q9HAF1,0.821,0.154,0.12785,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64770,CCDC14,Q49A88,1.0,0.077,7.7963e-15,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
64771,ILRUN,Q9H6K1,0.705,0.385,0.85127,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
64772,ENGASE,Q8NFI3,0.861,0.231,4.4142e-25,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,1987.0,1989.0,ALL
64777,RMND5B,Q96G75,0.861,0.269,1.9471e-13,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
64778,FNDC3B,Q53EP0,0.674,0.385,1.0,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.35,1.0,,2013.0,2019.0,ALL
64779,MTHFSD,Q2M296,0.931,0.154,6.5987e-12,DTO_05007624,Enzyme,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
64780,MICAL1,Q8TDZ2,0.736,0.308,3.3837e-22,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2016.0,2018.0,ALL
64781,CERK,Q8TCT0,0.76,0.385,2.5948e-05,DTO_03300101,Kinase,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
64782,AEN,Q8WTP8,1.0,0.077,2.0092e-10,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
64783,RBM15,Q96T37,0.736,0.154,0.99474,,,C4706584,Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13),,,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
64784,CRTC3,Q6UUV7,0.705,0.269,0.86585,DTO_05007542,Transcription factor,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.11,1.0,,2012.0,2017.0,ALL
64785,GINS3,Q9BRX5,0.769,0.154,1.505e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2010.0,2018.0,ALL
64787,EPS8L2,Q9H6S3,0.89,0.231,1.494e-06,DTO_05007575,Receptor,C4539954,"DEAFNESS, AUTOSOMAL RECESSIVE 106",,,disease,Disease or Syndrome,0.4,1.0,,2017.0,2017.0,ALL
64788,LMF1,Q96S06,0.769,0.231,5.1419e-16,,,C1855498,Lipase deficiency combined,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2007.0,2018.0,ALL
64789,EXO5,Q9H790,0.839,0.115,2.2661e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
64794,DDX31,Q9H8H2,0.78,0.115,1.9816e-12,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
64795,RMND5A,Q9H871,0.89,0.231,0.89983,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
64798,DEPTOR,Q8TB45,0.626,0.654,3.7245e-12,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
64799,IQCH,Q86VS3,0.931,0.077,1.0865e-21,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
64800,EFCAB6,Q5THR3,0.89,0.154,1.1933e-45,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
64801,ARV1,Q9H2C2,0.691,0.423,3.5867e-06,,,C4310762,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2016.0,ALL
64802,NMNAT1,Q9HAN9,0.656,0.269,0.035353,DTO_05007624,Enzyme,C1837873,LEBER CONGENITAL AMAUROSIS 9 (disorder),C11,   Eye Diseases,disease,Disease or Syndrome,0.94,1.0,,2003.0,2018.0,ALL
64805,P2RY12,Q9H244,0.533,0.731,0.0016859,DTO_02300001,G-protein coupled receptor,C1853278,Bleeding Disorder Due To P2RY12 Defect,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,,2001.0,2015.0,ALL
64806,IL25,Q9H293,0.529,0.846,0.00092347,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2002.0,2020.0,ALL
64816,CYP3A43,Q9HB55,0.821,0.154,1.7165e-11,DTO_05007624,Enzyme,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.37,1.0,,2004.0,2016.0,ALL
64834,ELOVL1,Q9BW60,0.76,0.385,0.67897,DTO_05007624,Enzyme,C0000889,Acanthosis Nigricans,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
64837,KLC2,Q9H0B6,0.736,0.346,0.97506,,,C1836010,"Spastic Paraplegia, Optic Atrophy, and Neuropathy",C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2015.0,2015.0,ALL
64838,FNDC4,Q9H6D8,0.821,0.192,0.88104,,,C0023794,Lipoidosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2005.0,2007.0,ALL
64839,FBXL17,Q9UF56,0.931,0.077,0.99901,,,C0015396,Eye Color,,,phenotype,Organism Attribute,0.1,1.0,,2012.0,2012.0,ALL
64840,PORCN,Q9H237,0.545,0.692,0.99953,DTO_05007624,Enzyme,C0016395,Focal Dermal Hypoplasia,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,0.968,,1962.0,2019.0,ALL
64841,GNPNAT1,Q96EK6,0.89,0.115,0.012367,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
64843,ISL2,Q96A47,1.0,0.038,0.11148,DTO_05007542,Transcription factor,C4317009,Diverticular Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
64844,MARCHF7,Q9H992,0.705,0.462,0.66162,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64847,SPATA20,Q8TB22,0.931,0.077,1.9878e-09,,,C0028960,Oligospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
64848,YTHDC2,Q9H6S0,0.805,0.192,1.0,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
64849,SLC13A3,Q8WWT9,0.821,0.308,9.4522e-07,DTO_05007405,Transporter,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
64850,ETNPPL,Q8TBG4,0.78,0.192,7.5088e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2008.0,2012.0,ALL
64851,AD6,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,0.0,,2004.0,2004.0,ALL
64852,TUT1,Q9H6E5,0.805,0.192,4.5457e-11,DTO_05007624,Enzyme,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
64853,AIDA,Q96BJ3,0.751,0.346,0.00015469,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
64854,USP46,P62068,0.769,0.192,0.79135,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
64855,NIBAN2,Q96TA1,0.716,0.269,0.016975,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
64856,VWA1,Q6PCB0,,,0.0052878,DTO_05007575,Receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
64857,PLEKHG2,Q9H7P9,0.705,0.423,1.3557e-09,,,C4225213,LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA,,,disease,Disease or Syndrome,0.7,1.0,moderate,2016.0,2016.0,ALL
64858,DCLRE1B,Q9H816,0.716,0.577,0.53912,,,C1846142,HOYERAAL-HREIDARSSON SYNDROME,C23;C16;C13;C17;C05;C10;F03;C15;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Hemic and Lymphatic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.31,1.0,strong,2010.0,2010.0,ALL
64859,NABP1,Q96AH0,0.711,0.423,3.2763e-05,DTO_05007557,Nucleic acid binding,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2013.0,2013.0,ALL
64863,METTL4,Q8N3J2,1.0,0.038,7.825e-08,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
64864,RFX7,Q2KHR2,0.78,0.385,1.0,DTO_05007624,Enzyme,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
64866,CDCP1,Q9H5V8,0.604,0.654,0.0001002,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
64881,PCDH20,Q8N6Y1,0.78,0.192,0.86222,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
64895,PAPOLG,Q9BWT3,0.821,0.231,0.9979,DTO_05007557,Nucleic acid binding,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
64897,C12orf43,Q96C57,0.861,0.115,0.00010484,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
64900,LPIN3,Q9BQK8,1.0,0.077,2.251e-13,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
64901,RANBP17,Q9H2T7,1.0,0.115,7.1728e-45,DTO_05007405,Transporter,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
64902,AGXT2,Q9BYV1,0.729,0.385,3.7108e-28,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2014.0,2014.0,ALL
64919,BCL11B,Q9C0K0,0.568,0.731,0.98881,DTO_05007542,Transcription factor,C4310656,IMMUNODEFICIENCY 49,,,disease,Disease or Syndrome,0.7,1.0,limited,2016.0,2018.0,ALL
64921,CASD1,Q96PB1,0.805,0.269,0.044844,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2000.0,2018.0,ALL
64924,SLC30A5,Q8TAD4,0.931,0.077,0.068068,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
64926,RASAL3,Q86YV0,0.839,0.077,1.114e-10,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2015.0,2015.0,ALL
64927,TTC23,Q5W5X9,1.0,0.077,7.3763e-24,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
64928,MRPL14,Q6P1L8,1.0,0.115,9.2387e-05,DTO_05007557,Nucleic acid binding,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
64943,NT5DC2,Q9H857,0.821,0.115,1.211e-05,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
64946,CENPH,Q9H3R5,0.705,0.308,1.5465e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2005.0,2017.0,ALL
64963,MRPS11,P82912,0.89,0.077,4.6918e-08,DTO_05007557,Nucleic acid binding,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
64968,MRPS6,P82932,0.89,0.077,0.0006614,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
64969,MRPS5,P82675,0.839,0.077,0.00036306,DTO_05007557,Nucleic acid binding,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
64975,MRPL41,Q8IXM3,0.666,0.308,0.55531,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,0.778,,2004.0,2018.0,ALL
64976,MRPL40,Q9NQ50,0.89,0.269,0.052924,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,1999.0,2000.0,ALL
64978,MRPL38,Q96DV4,0.89,0.077,4.508e-09,DTO_05007584,Enzyme modulator,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
64979,MRPL36,Q9P0J6,0.76,0.308,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,2006.0,2018.0,ALL
64981,MRPL34,Q9BQ48,1.0,0.077,6.9136e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2010.0,2010.0,ALL
65003,MRPL11,Q9Y3B7,,,1.5371e-06,DTO_05007557,Nucleic acid binding,C0018671,Head and Neck Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
65005,MRPL9,Q9BYD2,0.861,0.077,0.00015633,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
65009,NDRG4,Q9ULP0,0.67,0.462,0.011627,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2018.0,ALL
65010,SLC26A6,Q9BXS9,0.695,0.5,9.897e-13,DTO_01300327,Ion channel,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
65012,SLC26A10,Q8NG04,1.0,0.077,2.0972e-15,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
65018,PINK1,Q9BXM7,0.516,0.769,1.8749e-10,DTO_03300101,Kinase,C1853833,"Parkinson Disease 6, Autosomal Recessive Early-Onset",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.93,1.0,,2004.0,2017.0,ALL
65055,REEP1,Q9H902,0.653,0.423,0.98632,DTO_05007405,Transporter,C1853247,"SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.92,1.0,,2006.0,2018.0,ALL
65057,ACD,Q96AP0,0.603,0.731,1.1148e-12,,,C4225284,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
65059,RAPH1,Q70E73,0.593,0.654,0.99985,DTO_05007575,Receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,2004.0,2018.0,ALL
65061,CDK15,Q96Q40,0.663,0.5,2.2449e-17,DTO_03300101,Kinase,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,,,,,ALL
65062,TMEM237,Q96Q45,0.612,0.538,1.8704e-12,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.51,1.0,,2011.0,2012.0,ALL
65065,NBEAL1,Q6ZS30,0.638,0.692,5.1093e-33,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
65078,RTN4R,Q9BZR6,0.595,0.692,0.95882,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.67,0.857,,2004.0,2017.0,ALL
65080,MRPL44,Q9H9J2,0.805,0.308,2.0628e-09,DTO_05007624,Enzyme,C3809339,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16,,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2013.0,ALL
65082,VPS33A,Q96AX1,0.695,0.538,0.18206,DTO_05007405,Transporter,C4310627,MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME,,,disease,Disease or Syndrome,0.7,1.0,,2017.0,2017.0,ALL
65083,NOL6,Q9H6R4,1.0,,1.0,DTO_05007557,Nucleic acid binding,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
65084,TMEM135,Q86UB9,0.751,0.346,0.7786,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
65094,JMJD4,Q9H9V9,1.0,0.077,1.4886e-09,DTO_05007575,Receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
65095,KRI1,Q8N9T8,,,6.0373e-15,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
65108,MARCKSL1,P49006,0.508,0.731,0.014253,,,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.2,1.0,,2000.0,2000.0,ALL
65109,UPF3B,Q9BZI7,0.619,0.615,0.98497,,,C1970822,"Mental Retardation, X-Linked, Syndromic 14",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2007.0,2012.0,ALL
65110,UPF3A,Q9H1J1,1.0,0.115,9.1728e-07,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
65117,RSRC2,Q7L4I2,0.769,0.308,0.99905,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
65123,INTS3,Q68E01,0.821,0.231,0.99972,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,1996.0,2017.0,ALL
65125,WNK1,Q9H4A3,0.416,0.846,1.0,DTO_03300101,Kinase,C1840391,"Pseudohypoaldosteronism, Type IIc",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.6,1.0,,2001.0,2005.0,ALL
65211,FRTS1,,0.599,0.654,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2019.0,ALL
65217,PCDH15,Q96QU1,0.601,0.577,8.0283e-25,,,C1836027,"Deafness, Autosomal Recessive 23",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.92,1.0,,2003.0,2017.0,ALL
65220,NADK,O95544,1.0,0.115,1.1284e-10,DTO_03300101,Kinase,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
65243,ZFP69B,Q9UJL9,0.89,0.115,5.0197e-13,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
65244,SPATS2,Q86XZ4,,,0.97239,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
65245,PSORS7,,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
65250,CPLANE1,Q9H799,0.575,0.692,5.8778e-36,,,C3553264,JOUBERT SYNDROME 17,,,disease,Disease or Syndrome,0.8,1.0,,2012.0,2018.0,ALL
65251,ZNF649,Q9BS31,1.0,0.038,0.073744,DTO_05007542,Transcription factor,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
65258,MPPE1,Q53F39,0.736,0.346,1.2197e-09,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
65260,COA7,Q96BR5,0.792,0.231,0.059686,,,C0013362,Dysarthria,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.1,,,,,ALL
65263,PYCR3,Q53H96,,,2.338e-05,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
65264,UBE2Z,Q9H832,0.601,0.654,0.93838,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.12,1.0,,2011.0,2017.0,ALL
65265,C8orf33,Q9H7E9,0.931,0.154,2.0873e-09,,,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
65266,WNK4,Q96J92,0.644,0.538,6.8806e-25,DTO_03300101,Kinase,C1840390,"Pseudohypoaldosteronism, Type IIb",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2001.0,2013.0,ALL
65267,WNK3,Q9BYP7,0.751,0.346,0.99999,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
65268,WNK2,Q9Y3S1,0.678,0.462,1.0,DTO_03300101,Kinase,C0007787,Transient Ischemic Attack,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.2,1.0,,2017.0,2017.0,ALL
65975,STK33,Q9BYT3,0.666,0.346,2.1656e-06,DTO_03300101,Kinase,C0345958,Large cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
65979,PHACTR4,Q8IZ21,,,2.8359e-06,DTO_05007584,Enzyme modulator,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
65980,BRD9,Q9H8M2,0.729,0.308,0.015373,DTO_05007378,Epigenetic regulator,C0036920,Sezary Syndrome,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
65981,CAPRIN2,Q6IMN6,0.861,0.077,0.10241,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
65982,ZSCAN18,Q8TBC5,0.821,0.231,0.047469,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
65983,GRAMD2B,Q96HH9,0.89,0.154,2.5212e-12,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
65985,AACS,Q86V21,0.751,0.308,9.1275e-17,DTO_05007624,Enzyme,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2002.0,2002.0,ALL
65986,ZBTB10,Q96DT7,0.821,0.231,0.99067,DTO_05007624,Enzyme,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
65989,DLK2,Q6UY11,0.821,0.154,0.77915,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
65990,ANTKMT,Q9BQD7,1.0,0.115,0.00087746,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
65991,FUNDC2,Q9BWH2,0.76,0.385,0.059823,,,C0034065,Pulmonary Embolism,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Pathologic Function,0.1,1.0,,2016.0,2016.0,ALL
65992,DDRGK1,Q96HY6,0.736,0.269,3.0689e-07,,,C1865185,"Spondyloepimetaphyseal Dysplasia, Shohat Type",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.41,1.0,,2017.0,2017.0,ALL
65993,MRPS34,P82930,0.722,0.346,0.0026375,,,C4540029,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32,,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
65996,CENPBD1P1,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
65997,RASL11B,Q9BPW5,0.839,0.192,0.0074739,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
65998,C11orf95,C9JLR9,0.78,0.115,,,,C0014474,Ependymoma,C04,   Neoplasms,disease,Neoplastic Process,0.5,1.0,,2014.0,2020.0,ALL
66000,TMEM108,Q6UXF1,0.931,0.077,0.99555,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
66001,MLVI4,,0.89,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,1989.0,2004.0,ALL
66002,CYP4F12,Q9HCS2,0.89,0.154,1.474e-17,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.21,1.0,,2005.0,2017.0,ALL
66004,LYNX1,P0DP58,0.751,0.269,0.026317,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2019.0,ALL
66005,CHID1,Q9BWS9,0.861,0.192,1.3831e-05,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
66008,TRAK2,O60296,0.839,0.269,1.9123e-14,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
66035,SLC2A11,Q9BYW1,0.805,0.385,6.2349e-13,DTO_05007405,Transporter,C1859726,ARTERIAL TORTUOSITY SYNDROME,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.08,0.875,,2006.0,2020.0,ALL
66036,MTMR9,Q96QG7,0.89,0.115,0.0012631,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.13,1.0,,2007.0,2014.0,ALL
66037,BOLL,Q8N9W6,0.792,0.346,0.058307,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
78986,DUSP26,Q9BV47,0.682,0.346,0.00023011,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2010.0,2015.0,ALL
78987,CRELD1,Q96HD1,0.67,0.269,1.3432e-11,DTO_05007616,Calcium-binding protein,C1853508,"ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2",,,disease,Finding,0.6,1.0,moderate,2003.0,2005.0,ALL
78989,COLEC11,Q9BWP8,0.641,0.654,0.017539,DTO_05007697,Surfactant,C0796279,Carnevale syndrome,C16;C11;C05;C12;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1989.0,2017.0,ALL
78990,OTUB2,Q96DC9,0.861,0.192,4.5366e-11,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
78992,YIPF2,Q9BWQ6,0.931,0.077,4.3157e-08,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
78994,PRR14,Q9BWN1,0.839,0.115,0.16859,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
78995,HROB,Q8N3J3,,,4.4469e-11,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2009.0,2009.0,ALL
78996,CYREN,Q9BWK5,0.821,0.269,0.25971,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
78997,GDAP1L1,Q96MZ0,0.931,0.154,0.4453,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
78998,RHPN1-AS1,Q9BWJ2,0.78,0.231,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2019.0,2020.0,ALL
78999,LRFN4,Q6PJG9,0.839,0.154,0.91295,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
79000,AUNIP,Q9H7T9,0.931,0.077,3.4534e-09,,,C0004153,Atherosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
79001,VKORC1,Q9BQB6,0.603,0.731,0.16163,DTO_05007624,Enzyme,C0750384,Coumarin Resistance,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.8,0.933,strong,2004.0,2018.0,ALL
79003,MIS12,Q9H081,1.0,0.077,0.14672,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
79004,CUEDC2,Q9H467,0.722,0.308,0.060805,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
79005,SCNM1,Q9BWG6,,,2.9187e-06,,,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,1999.0,1999.0,ALL
79006,METRN,Q9UJH8,0.78,0.346,0.094738,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,2018.0,2019.0,ALL
79007,DBNDD1,Q9H9R9,1.0,0.038,6.35e-05,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
79008,SLX1B,Q9BQ83,1.0,0.154,0.04422,,,C0151638,Fanconi like syndrome,C04;C17;C20;C15,   Neoplasms;    Skin and Connective Tissue Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.2,1.0,,2013.0,2013.0,ALL
79009,DDX50,Q9BQ39,1.0,0.038,9.7491e-07,,,C0011311,Dengue Fever,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
79012,CAMKV,Q8NCB2,0.931,0.077,0.99696,DTO_03300101,Kinase,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
79015,LINC01260,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
79016,DDA1,Q9BW61,0.736,0.308,0.93718,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
79017,GGCT,O75223,0.552,0.808,0.000143,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.929,,2003.0,2020.0,ALL
79018,GID4,Q8IVV7,1.0,0.038,0.92062,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
79019,CENPM,Q9NSP4,0.736,0.269,0.01501,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2019.0,ALL
79023,NUP37,Q8NFH4,0.736,0.423,1.0763e-05,DTO_05007405,Transporter,C0027726,Nephrotic Syndrome,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.3,1.0,limited,2018.0,2018.0,ALL
79026,AHNAK,Q09666,0.623,0.615,0.89827,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
79027,ZNF655,Q8N720,,,0.15423,,,C0201983,Dehydroepiandrosterone sulfate measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79029,SPATA5L1,Q9BVQ7,1.0,0.077,3.5478e-11,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
79031,PDCL3,Q9H2J4,1.0,0.077,8.2348e-06,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
79035,NABP2,Q9BQ15,0.751,0.5,0.97257,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2013.0,2017.0,ALL
79036,KXD1,Q9BQD3,1.0,0.192,0.034926,,,C0079504,Hermanski-Pudlak Syndrome,C16;C18;C11;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.2,,,,,ALL
79037,PVRIG,Q6DKI7,0.861,0.077,0.0040685,,,C0441683,Hormone measurement,,,group,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
79039,DDX54,Q8TDD1,0.821,0.192,4.7418e-09,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
79041,TMEM38A,Q9H6F2,1.0,0.038,0.00058271,DTO_01300327,Ion channel,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
79042,TSEN34,Q9BSV6,0.722,0.346,0.3613,DTO_05007624,Enzyme,C2676465,Pontocerebellar Hypoplasia Type 2C,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2008.0,2011.0,ALL
79047,KCTD15,Q96SI1,0.792,0.192,0.035511,DTO_05007584,Enzyme modulator,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.39,0.8,,2009.0,2018.0,ALL
79048,SECISBP2,Q96T21,0.792,0.269,2.1874e-18,,,C1864761,"Thyroid Hormone Metabolism, Abnormal",C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.73,1.0,,2005.0,2018.0,ALL
79052,PTCPRN,,1.0,0.038,,,,C0012546,Diphtheria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
79053,ALG8,Q9BVK2,0.659,0.577,1.1804e-08,DTO_05007624,Enzyme,C2931002,Congenital disorder of glycosylation type 1H,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.74,1.0,strong,2004.0,2020.0,ALL
79054,TRPM8,Q7Z2W7,0.553,0.808,4.5964e-29,DTO_01300327,Ion channel,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.5,0.917,,2011.0,2019.0,ALL
79056,PRRG4,Q9BZD6,0.805,0.423,0.11277,DTO_05007624,Enzyme,C0206115,WAGR Syndrome,C16;C04;C13;C11;C12;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.03,1.0,,2014.0,2017.0,ALL
79058,ASPSCR1,Q9BZE9,0.653,0.538,4.4156e-12,,,C0206657,Alveolar Soft Part Sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.7,1.0,,2001.0,2020.0,ALL
79065,ATG9A,Q7Z3C6,0.691,0.308,0.97081,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2017.0,ALL
79066,METTL16,Q86W50,0.931,0.077,0.61175,DTO_05007624,Enzyme,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
79068,FTO,Q9C0B1,0.486,0.885,8.364e-08,,,C2752001,"Growth Retardation, Developmental Delay, Coarse Facies, And Early Death",C23;C16;C05;C19;F03,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Mental Disorders",disease,Congenital Abnormality,0.7,1.0,,2009.0,2016.0,ALL
79070,POGLUT2,Q6UW63,0.931,0.038,4.9115e-09,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2005.0,2005.0,ALL
79071,ELOVL6,Q9H5J4,0.623,0.731,0.96581,DTO_05007624,Enzyme,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
79072,FASTKD3,Q14CZ7,1.0,0.077,5.8599e-10,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
79073,TMEM109,Q9BVC6,0.861,0.192,7.507e-05,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
79074,C2orf49,Q9BVC5,0.931,0.115,0.017223,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
79075,DSCC1,Q9BVC3,0.805,0.192,0.0084752,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2008.0,2018.0,ALL
79077,DCTPP1,Q9H773,0.861,0.115,0.46087,,,C0337443,Sodium measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79080,CCDC86,Q9H6F5,0.931,0.154,1.6652e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
79081,LBHD1,Q9BQE6,1.0,,2.0614e-05,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
79083,MLPH,Q9BV36,0.743,0.423,4.383e-10,DTO_05007530,Cellular structure,C1836573,"GRISCELLI SYNDROME, TYPE 3",C23;C16;C18;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,1.0,moderate,2003.0,2003.0,ALL
79084,WDR77,Q9BQA1,0.695,0.423,0.0002454,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
79085,SLC25A23,Q9BV35,0.931,0.077,0.0020617,DTO_05007405,Transporter,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
79087,ALG12,Q9BV10,0.705,0.5,1.1758e-07,DTO_05007624,Enzyme,C2931001,Congenital disorder of glycosylation type 1G,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,,2002.0,2016.0,ALL
79090,TRAPPC6A,O75865,0.931,,5.145e-08,,,C0432072,Dysmorphic features,,,disease,Congenital Abnormality,0.31,1.0,limited,2018.0,2018.0,ALL
79092,CARD14,Q9BXL6,0.546,0.846,1.2051e-19,,,C1864497,PSORIASIS 2,,,disease,Disease or Syndrome,0.81,1.0,strong,2012.0,2018.0,ALL
79094,CHAC1,Q9BUX1,0.7,0.462,0.00020552,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
79095,C9orf16,Q9BUW7,0.861,0.154,0.018442,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
79096,C11orf49,Q9H6J7,0.931,0.077,2.2431e-11,,,C0001144,Acne Vulgaris,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
79097,TRIM48,Q8IWZ4,0.861,0.038,1.0995e-27,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
79098,C1orf116,Q9BW04,0.931,0.077,0.0017075,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
79100,LINC00626,,,,,,,C0201976,"Creatinine measurement, serum (procedure)",,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
79101,TAF1D,Q9H5J8,0.821,0.115,8.4009e-06,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
79102,RNF26,Q9BY78,0.839,0.115,0.65284,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
79104,MEG8,,0.76,0.192,,,,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
79109,MAPKAP1,Q9BPZ7,0.61,0.731,0.99991,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.11,1.0,,2011.0,2018.0,ALL
79132,DHX58,Q96C10,0.705,0.308,3.2013e-13,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
79133,NDUFAF5,Q5TEU4,0.674,0.462,3.1138e-10,,,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.6,1.0,strong,2008.0,2019.0,ALL
79135,APOO,Q9BUR5,0.839,0.192,0.60201,,,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0,,2014.0,2017.0,ALL
79136,LY6G6E,,0.931,0.115,0.004387,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
79137,RETREG2,Q8NC44,0.839,0.115,0.24917,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
79139,DERL1,Q9BUN8,0.576,0.654,0.00021136,DTO_05007575,Receptor,C0014518,Toxic Epidermal Necrolysis,C17;C20;C25;C07,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Chemically-Induced Disorders;    Stomatognathic Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
79140,CCDC28B,Q9BUN5,0.659,0.538,3.2253e-09,DTO_05007575,Receptor,C2936862,Bardet-Biedl syndrome 1 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,limited,2013.0,2013.0,ALL
79142,PHF23,Q9BUL5,0.839,0.077,0.99774,DTO_05007378,Epigenetic regulator,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
79143,MBOAT7,Q96N66,0.612,0.5,0.113,DTO_05007624,Enzyme,C4310673,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57",,,disease,Disease or Syndrome,0.6,1.0,strong,2012.0,2012.0,ALL
79144,PPDPF,Q9H3Y8,0.861,0.115,0.00010213,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
79145,CHCHD7,Q9BUK0,1.0,0.038,0.034885,,,C0026277,Mixed Salivary Gland Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
79147,FKRP,Q9H9S5,0.513,0.731,9.8362e-06,,,C1847759,"MUSCULAR DYSTROPHY, CONGENITAL, 1C",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.96,1.0,,2000.0,2016.0,ALL
79148,MMP28,Q9H239,0.653,0.462,6.0903e-05,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0,,2011.0,2019.0,ALL
79149,ZSCAN5A,Q9BUG6,1.0,0.077,0.0081938,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
79152,FA2H,Q7L5A8,0.573,0.654,0.14678,DTO_05007624,Enzyme,C3496228,"Leukodystrophy, Dysmyelinating, And Spastic Paraparesis With Or Without Dystonia",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.95,1.0,,2008.0,2020.0,ALL
79153,GDPD3,Q7L5L3,1.0,0.077,1.6968e-15,,,C0023794,Lipoidosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2005.0,2007.0,ALL
79154,DHRS11,Q6UWP2,0.653,0.423,2.2434e-06,DTO_05007624,Enzyme,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
79155,TNIP2,Q8NFZ5,0.78,0.308,0.0015926,,,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
79156,PLEKHF1,Q96S99,0.743,0.385,0.012523,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
79158,GNPTAB,Q3T906,0.592,0.731,7.6824e-19,,,C2673377,MUCOLIPIDOSIS II ALPHA/BETA (disorder),C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.93,1.0,strong,2004.0,2019.0,ALL
79161,TMEM243,Q9BU79,,,1.0471e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
79166,LILRP2,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
79168,LILRA6,Q6PI73,0.805,0.269,3.9025e-05,DTO_05007575,Receptor,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79170,PRR15L,Q9BU68,,,0.51009,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
79172,CENPO,Q9BU64,0.805,0.269,1.8941e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2017.0,ALL
79174,CRELD2,Q6UXH1,0.839,0.269,2.7906e-08,,,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
79180,EFHD2,Q96C19,0.729,0.577,0.0090981,DTO_05007616,Calcium-binding protein,C0556346,Binge Drinking,C25;F03;F01,   Chemically-Induced Disorders;    Mental Disorders;    Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.3,1.0,,2018.0,2018.0,ALL
79183,TTPAL,Q9BTX7,0.931,0.077,0.116,DTO_05007405,Transporter,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
79184,BRCC3,P46736,0.686,0.5,0.0063932,DTO_05007624,Enzyme,C0026654,Moyamoya Disease,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.34,1.0,limited,2011.0,2017.0,ALL
79187,FSD1,Q9BTV5,0.486,0.808,0.25199,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2006.0,2019.0,ALL
79188,TMEM43,Q9BTV4,0.653,0.462,1.1608e-12,,,C1858379,"ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5 (disorder)",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,,2008.0,2017.0,ALL
79190,IRX6,P78412,0.931,0.115,2.4989e-12,DTO_05007542,Transcription factor,C0848558,Hypospadias,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
79191,IRX3,P78415,0.705,0.462,0.89165,DTO_05007542,Transcription factor,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
79192,IRX1,P78414,0.695,0.538,0.0004765,DTO_05007542,Transcription factor,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
79228,THOC6,Q86W42,0.705,0.577,0.00047835,,,C3150939,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.73,1.0,strong,2013.0,2020.0,ALL
79258,MMEL1,Q495T6,0.606,0.692,1.2441e-22,DTO_05007624,Enzyme,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.5,1.0,,2010.0,2010.0,ALL
79273,OR7E94P,,1.0,0.038,,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
79297,OR5H5P,,1.0,0.115,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
79300,OR51P1P,,,,,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
79308,OR4P1P,,,,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
79363,CPLANE2,Q9BU20,0.769,0.192,8.8551e-06,,,C0220708,VATER Association,C16;C06;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,,,,,ALL
79364,ZXDC,Q2QGD7,1.0,0.038,1.1449e-09,DTO_05007542,Transcription factor,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
79365,BHLHE41,Q9C0J9,0.623,0.577,0.99212,DTO_05007542,Transcription factor,C0751509,Short Sleeper Syndrome,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.32,1.0,,2009.0,2017.0,ALL
79366,HMGN5,P82970,0.65,0.423,0.30957,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.36,1.0,,2010.0,2019.0,ALL
79368,FCRL2,Q96LA5,0.861,0.192,1.4548e-11,DTO_05007620,Cell adhesion,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
79369,B3GNT4,Q9C0J1,,,7.6758e-07,DTO_05007624,Enzyme,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79370,BCL2L14,Q9BZR8,0.78,0.192,3.3304e-05,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79400,NOX5,Q96PH1,0.631,0.538,3.049e-28,,,C0279628,Adenocarcinoma Of Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2006.0,2016.0,ALL
79412,KREMEN2,Q8NCW0,0.861,0.231,3.7207e-05,DTO_05007575,Receptor,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
79414,LRFN3,Q9BTN0,0.931,0.038,0.97322,,,C0206655,Alveolar rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
79415,CYBC1,Q9BQA9,0.736,0.462,0.0006032,,,C0018203,Chronic granulomatous disease,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.31,1.0,,2018.0,2018.0,ALL
79441,HAUS3,Q68CZ6,1.0,0.077,1.2992e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79442,LRRC2,Q9BYS8,1.0,0.115,5.5017e-07,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
79443,FYCO1,Q9BQS8,0.769,0.269,5.4118e-27,,,C1864908,"Cataract, autosomal recessive congenital 2",C11,   Eye Diseases,disease,Disease or Syndrome,0.7,1.0,,2001.0,2011.0,ALL
79444,BIRC7,Q96CA5,0.621,0.5,1.1004e-07,DTO_05007584,Enzyme modulator,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.37,1.0,,2007.0,2018.0,ALL
79446,WDR25,Q64LD2,,,2.1449e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79447,PAGR1,Q9BTK6,0.597,0.808,0.74265,,,C0031350,Pharyngitis,C01;C08;C07;C09,   Infections;    Respiratory Tract Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,0.944,,2003.0,2020.0,ALL
79465,ULBP3,Q9BZM4,0.792,0.231,4.7366e-11,,,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
79469,DLEU2L,,1.0,0.115,0.37476,,,C4721414,Mantle cell lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
79513,OR10R1P,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
79529,OR52J2P,,,,,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
79567,RIPOR1,Q6ZS17,,,0.949,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
79568,MAIP1,Q8WWC4,1.0,0.038,3.0232e-06,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
79570,NKAIN1,Q4KMZ8,1.0,0.077,0.24678,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
79571,GCC1,Q96CN9,0.769,0.192,1.4478e-06,,,C0006868,Cannabis Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2006.0,2006.0,ALL
79572,ATP13A3,Q9H7F0,0.89,0.077,0.99998,,,C0340543,Familial primary pulmonary hypertension,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,strong,2019.0,2019.0,ALL
79573,TTC13,Q8NBP0,,,1.739e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79574,EPS8L3,Q8TE67,0.78,0.231,9.2378e-14,DTO_05007575,Receptor,C2931059,Marie Unna congenital hypotrichosis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.32,1.0,,2012.0,2019.0,ALL
79575,ABHD8,Q96I13,0.861,0.192,0.97027,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2010.0,2010.0,ALL
79576,NKAP,Q8N5F7,0.76,0.269,0.99735,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.3,1.0,strong,2019.0,2019.0,ALL
79577,CDC73,Q6P1J9,0.543,0.615,0.99995,,,C0687150,Parathyroid Gland Adenocarcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.8,0.947,strong,2002.0,2019.0,ALL
79581,SLC52A2,Q9HAB3,0.483,0.808,0.0024777,DTO_05007405,Transporter,C3553538,BROWN-VIALETTO-VAN LAERE SYNDROME 2,,,disease,Disease or Syndrome,0.7,1.0,definitive,2010.0,2017.0,ALL
79582,SPAG16,Q8N0X2,0.76,0.385,1.4037e-34,DTO_05007530,Cellular structure,C0009928,Contrast Sensitivity,,,phenotype,Mental Process,0.1,1.0,,2014.0,2014.0,ALL
79583,TMEM231,Q9H6L2,0.554,0.692,3.1399e-07,,,C3554235,JOUBERT SYNDROME 20,,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2016.0,ALL
79585,CORO7,P57737,0.628,0.692,1.8292e-25,DTO_05007530,Cellular structure,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,0.938,,2017.0,2020.0,ALL
79586,CHPF,Q8IZ52,0.769,0.423,0.15067,DTO_05007624,Enzyme,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
79587,CARS2,Q9HA77,0.7,0.423,9.5929e-08,DTO_05007624,Enzyme,C4225251,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2018.0,ALL
79589,RNF128,Q8TEB7,0.769,0.385,0.22826,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
79590,MRPL24,Q96A35,0.861,0.192,1.9123e-06,DTO_05007557,Nucleic acid binding,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
79591,ARMH3,Q5T2E6,0.931,0.077,6.2765e-06,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
79594,MUL1,Q969V5,0.473,0.808,1.9108e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.938,,2005.0,2019.0,ALL
79595,SAP130,Q9H0E3,0.805,0.154,1.0,,,C0152101,Hypoplastic Left Heart Syndrome,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.5,1.0,,2017.0,2017.0,ALL
79596,OBI1,Q5W0B1,0.839,0.231,6.8612e-08,,,C0272325,"Factor 8 deficiency, acquired",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
79598,CEP97,Q8IW35,1.0,,2.0368e-11,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,,,,,ALL
79600,TCTN1,Q2MV58,0.597,0.615,1.0708e-15,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.61,1.0,,2011.0,2017.0,ALL
79602,ADIPOR2,Q86V24,0.564,0.731,0.36218,DTO_05007575,Receptor,C0021361,Female infertility,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
79603,CERS4,Q9HA82,0.751,0.269,1.3519e-22,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
79605,PGBD5,Q8N414,0.931,0.038,0.0021166,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
79608,RIC3,Q7Z5B4,0.839,0.231,2.1447e-06,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
79611,ACSS3,Q9H6R3,0.89,0.115,5.0483e-13,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
79612,NAA16,Q6N069,0.78,0.231,1.8144e-18,DTO_05007624,Enzyme,C0201544,Prostate specific antigen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
79613,TANGO6,Q9C0B7,0.89,0.077,6.3244e-14,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
79618,HMBOX1,Q6NT76,0.722,0.346,0.99805,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2017.0,2019.0,ALL
79621,RNASEH2B,Q5TBB1,0.595,0.615,3.2569e-09,,,C3489724,Aicardi-Goutieres Syndrome 2,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2018.0,ALL
79622,SNRNP25,Q9BV90,0.89,0.038,0.0013382,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2014.0,2016.0,ALL
79623,GALNT14,Q96FL9,0.631,0.538,7.0648e-17,DTO_05007624,Enzyme,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2012.0,ALL
79624,ARMT1,Q9H993,,,5.119e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
79625,NDNF,Q8TB73,0.78,0.192,0.38029,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
79626,TNFAIP8L2,Q6P589,0.575,0.615,0.038364,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2016.0,2020.0,ALL
79627,OGFRL1,Q5TC84,1.0,0.077,0.003634,DTO_05007575,Receptor,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
79628,SH3TC2,Q8TF17,0.666,0.385,8.3409e-16,,,C1866636,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,2003.0,2019.0,ALL
79630,C1orf54,Q8WWF1,1.0,0.077,0.0002318,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2017.0,ALL
79631,EFL1,Q7Z2Z2,0.638,0.577,5.1247e-08,DTO_05007624,Enzyme,C4693704,SHWACHMAN-DIAMOND SYNDROME 2,,,disease,Disease or Syndrome,0.6,1.0,moderate,2017.0,2018.0,ALL
79632,FAM184A,Q8NB25,0.821,0.115,1.0625e-21,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
79633,FAT4,Q6V0I7,0.539,0.808,1.0,,,C3809875,VAN MALDERGEM SYNDROME 2,,,disease,Disease or Syndrome,0.6,1.0,strong,2013.0,2014.0,ALL
79641,ROGDI,Q9GZN7,0.663,0.462,2.5516e-09,,,C0406740,Kohlschutter Tonz syndrome,C16;C10;F03;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases",disease,Disease or Syndrome,0.74,1.0,strong,1995.0,2017.0,ALL
79642,ARSJ,Q5FYB0,,,1.1319e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79643,CHMP6,Q96FZ7,1.0,0.115,0.98358,DTO_05007405,Transporter,C0338451,Frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
79644,SRD5A3,Q9H8P0,0.604,0.692,0.00024941,,,C4317224,Congenital disorder of glycosylation type 1q,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2008.0,2016.0,ALL
79646,PANK3,Q9H999,0.931,0.115,4.5167e-05,DTO_03300101,Kinase,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
79648,MCPH1,Q8NEM0,0.54,0.846,7.76e-30,DTO_05007557,Nucleic acid binding,C1855081,"MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.76,1.0,strong,2002.0,2014.0,ALL
79649,MAP7D3,Q8IWC1,,,4.6062e-10,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,1.0,limited,1989.0,1989.0,ALL
79650,USB1,Q9BQ65,0.636,0.577,0.000687,,,C1858723,Poikiloderma with Neutropenia,C16;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.8,1.0,,2010.0,2018.0,ALL
79651,RHBDF2,Q6PJF5,0.595,0.538,0.0011919,DTO_05007624,Enzyme,C1835664,TYLOSIS WITH ESOPHAGEAL CANCER,C16;C06;C04;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms;    Skin and Connective Tissue Diseases",disease,Neoplastic Process,0.74,1.0,strong,2012.0,2019.0,ALL
79652,TMEM204,Q9BSN7,0.931,0.115,0.91273,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
79654,HECTD3,Q5T447,0.821,0.231,0.088789,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
79656,BEND5,Q7L4P6,0.931,0.115,0.054336,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
79658,ARHGAP10,A1A4S6,0.76,0.269,1.3092e-17,DTO_05007584,Enzyme modulator,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
79659,DYNC2H1,Q8NCM8,0.555,0.731,1.1366e-44,DTO_05007624,Enzyme,C0036069,Saldino-Noonan Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.91,1.0,,2009.0,2018.0,ALL
79660,PPP1R3B,Q86XI6,0.686,0.462,0.065025,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
79661,NEIL1,Q96FI4,0.623,0.769,4.9641e-07,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.5,1.0,,2006.0,2011.0,ALL
79663,HSPBAP1,Q96EW2,0.821,0.269,4.4074e-11,,,C1333985,Hereditary clear cell renal cell carcinoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.3,1.0,,2003.0,2003.0,ALL
79664,ICE2,Q659A1,0.89,0.077,1.3236e-13,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
79665,DHX40,Q8IX18,0.608,0.769,0.7556,DTO_05007624,Enzyme,C0013575,Ectodermal Dysplasia,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.3,,limited,,,ALL
79667,KLF3-AS1,,0.89,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79668,PARP8,Q8N3A8,0.931,0.115,0.059603,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
79669,C3orf52,Q5BVD1,,,8.6244e-05,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79670,TUT7,Q5VYS8,0.861,0.346,1.0,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
79671,NLRX1,Q86UT6,0.641,0.654,7.7345e-31,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2016.0,2018.0,ALL
79672,FN3KRP,Q9HA64,1.0,0.077,4.557e-09,DTO_03300101,Kinase,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
79673,ZNF329,Q86UD4,1.0,0.077,0.00036998,DTO_05007542,Transcription factor,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
79674,VEPH1,Q14D04,0.805,0.231,2.296e-22,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
79675,FASTKD1,Q53R41,0.931,0.038,4.5631e-29,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
79677,SMC6,Q96SB8,0.931,0.077,2.659e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
79679,VTCN1,Q7Z7D3,0.529,0.692,1.3669e-12,DTO_05007584,Enzyme modulator,C3495559,Juvenile arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.15,0.8,,2009.0,2015.0,ALL
79680,RTL10,Q7L3V2,0.67,0.577,,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
79682,CENPU,Q71F23,0.695,0.346,5.7948e-08,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
79683,ZDHHC14,Q8IZN3,0.861,0.115,0.7151,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79684,MSANTD2,Q6P1R3,1.0,0.038,0.90277,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
79685,SAP30L,Q9HAJ7,0.805,0.269,0.0014279,DTO_05007557,Nucleic acid binding,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
79689,STEAP4,Q687X5,0.686,0.462,1.1959e-07,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,2005.0,2019.0,ALL
79690,GAL3ST4,Q96RP7,0.89,0.154,2.2251e-12,,,C1821417,RESTING HEART RATE,,,phenotype,Finding,0.1,1.0,,2016.0,2016.0,ALL
79692,ZNF322,Q6U7Q0,0.805,0.115,0.02988,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
79693,YRDC,Q86U90,1.0,0.231,0.0021751,,,C0376618,Endotoxemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",phenotype,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
79694,MANEA,Q5SRI9,0.729,0.385,0.00052273,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2013.0,2013.0,ALL
79695,GALNT12,Q8IXK2,0.78,0.269,9.3863e-07,DTO_05007624,Enzyme,C1837315,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 1",,,disease,Finding,0.7,1.0,limited,2004.0,2016.0,ALL
79696,ZC2HC1C,Q53FD0,0.931,0.038,1.8005e-09,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
79697,RIOX1,Q9H6W3,0.67,0.5,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,1998.0,2019.0,ALL
79698,ZMAT4,Q9H898,0.78,0.192,0.075538,,,C0034951,Refractive Errors,C11,   Eye Diseases,group,Disease or Syndrome,0.11,1.0,,2013.0,2014.0,ALL
79699,ZYG11B,Q9C0D3,1.0,0.077,0.99836,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
79701,OGFOD3,Q6PK18,,,1.6332e-09,,,C0242339,Dyslipidemias,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
79703,C11orf80,Q8N6T0,0.931,0.115,2.0062e-09,,,C0678213,Complete hydatidiform mole,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
79705,LRRK1,Q38SD2,0.78,0.115,4.5228e-10,DTO_03300101,Kinase,C3554665,OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA,,,disease,Disease or Syndrome,0.43,1.0,,2016.0,2020.0,ALL
79707,NOL9,Q5SY16,0.931,0.077,0.008884,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2005.0,2019.0,ALL
79709,COLGALT1,Q8NBJ5,0.76,0.346,5.9074e-08,DTO_05007624,Enzyme,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
79710,MORC4,Q8TE76,0.751,0.269,0.99783,,,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.11,1.0,,2012.0,2020.0,ALL
79711,IPO4,Q8TEX9,0.861,0.154,1.0269e-18,DTO_05007405,Transporter,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
79712,GTDC1,Q4AE62,0.89,0.115,1.0127e-12,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
79713,IGFLR1,Q9H665,,,2.5896e-06,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
79714,CCDC51,Q96ER9,0.821,0.269,3.1061e-08,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
79716,NPEPL1,Q8NDH3,0.931,0.077,9.8457e-07,DTO_05007624,Enzyme,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79717,PPCS,Q9HAB8,0.792,0.308,0.0080389,DTO_05007624,Enzyme,C4748647,"CARDIOMYOPATHY, DILATED, 2C",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
79718,TBL1XR1,Q9BZK7,0.534,0.808,0.99995,,,C1865644,"Plantar Lipomatosis, Unusual Facies, and Developmental Delay",C23;C18;C17;F03,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Mental Disorders",disease,Disease or Syndrome,0.75,1.0,strong,1998.0,2018.0,ALL
79719,AAGAB,Q6PD74,0.695,0.538,3.8664e-07,,,C1835662,Keratosis palmoplantaris papulosa,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2012.0,2017.0,ALL
79720,VPS37B,Q9H9H4,,,0.058263,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
79722,ANKRD55,Q3KP44,0.65,0.462,6.7577e-08,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.44,1.0,,2010.0,2019.0,ALL
79723,SUV39H2,Q9H5I1,0.65,0.5,0.92921,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
79725,THAP9,Q9H5L6,0.931,0.231,9.9922e-13,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
79726,WDR59,Q6PJI9,0.861,0.115,3.061e-14,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79727,LIN28A,Q9H9Z2,0.523,0.731,0.019369,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,0.976,,2009.0,2020.0,ALL
79728,PALB2,Q86YC2,0.485,0.769,3.0379e-19,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.8,0.97,,2006.0,2020.0,ALL
79729,SH3D21,A4FU49,0.931,0.115,8.7925e-12,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79730,NSUN7,Q8NE18,1.0,0.038,4.7893e-06,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.31,1.0,,2007.0,2015.0,ALL
79731,NARS2,Q96I59,0.65,0.577,7.1092e-08,DTO_05007624,Enzyme,C4015643,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24,,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2015.0,ALL
79733,E2F8,A0AVK6,0.674,0.423,0.81778,DTO_05007557,Nucleic acid binding,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2010.0,2019.0,ALL
79734,KCTD17,Q8N5Z5,0.743,0.308,0.017683,,,C4225341,"DYSTONIA 26, MYOCLONIC",,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2015.0,ALL
79736,TEFM,Q96QE5,1.0,0.077,0.51424,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
79738,BBS10,Q8TAM1,0.644,0.538,1.7467e-12,,,C1859568,BARDET-BIEDL SYNDROME 10,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,2006.0,2017.0,ALL
79739,TTLL7,Q6ZT98,,,0.0035761,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
79740,ZBBX,A8MT70,0.931,0.077,2.9306e-21,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
79741,CCDC7,Q96M83,0.931,0.077,3.2918e-12,,,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
79742,DIPK2B,Q9H7Y0,0.861,0.269,3.2801e-05,,,C1136249,"Mental Retardation, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,,2011.0,2011.0,ALL
79744,ZNF419,Q96HQ0,0.861,0.192,0.0053294,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
79745,CLIP4,Q8N3C7,0.839,0.154,5.9018e-08,DTO_05007530,Cellular structure,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
79746,ECHDC3,Q96DC8,0.931,0.115,4.7572e-06,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,2015.0,2019.0,ALL
79747,ADGB,Q8N7X0,0.861,0.231,3.7201e-22,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
79748,LMAN1L,Q9HAT1,,,2.6071e-13,DTO_05007405,Transporter,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
79750,ZNF385D,Q9H6B1,0.76,0.269,0.65437,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
79751,SLC25A22,Q9H936,0.595,0.577,0.0066081,DTO_05007405,Transporter,C0270855,Early myoclonic encephalopathy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2005.0,2016.0,ALL
79752,ZFAND1,Q8TCF1,1.0,0.192,4.9277e-08,DTO_05007557,Nucleic acid binding,C1833662,INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA,C16;C18;C05;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
79753,SNIP1,Q8TAD8,0.682,0.462,0.42167,,,C3281055,"PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM",,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2012.0,ALL
79755,ZNF750,Q32MQ0,0.743,0.385,0.86616,,,C1853258,Seborrhea-Like Dermatitis with Psoriasiform Elements,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.6,1.0,,2006.0,2011.0,ALL
79758,DHRS12,A0PJE2,,,1.0374e-08,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79759,ZNF668,Q96K58,0.76,0.154,0.00029449,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
79760,GEMIN7,Q9H840,0.861,0.115,0.64543,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2019.0,ALL
79762,C1orf115,Q9H7X2,,,0.040906,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
79763,ISOC2,Q96AB3,0.931,0.038,1.297e-05,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
79767,ELMO3,Q96BJ8,0.743,0.192,6.6894e-16,DTO_05007599,Signaling,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
79770,TXNDC15,Q96J42,0.736,0.615,0.0096478,,,C3714506,Meckel syndrome type 1,C23;C16;C13;C11;C12;C08;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.32,1.0,,2016.0,2019.0,ALL
79772,MCTP1,Q6DN14,1.0,0.038,9.3096e-05,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2009.0,2009.0,ALL
79774,GRTP1,Q5TC63,0.89,0.038,4.0399e-13,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
79776,ZFHX4,Q86UP3,0.743,0.269,1.0,,,C0266573,Congenital ptosis,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.41,1.0,,2002.0,2008.0,ALL
79777,ACBD4,Q8NC06,1.0,0.077,1.0857e-06,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
79778,MICALL2,Q8IY33,0.839,0.269,3.442e-26,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
79780,CCDC82,Q8N4S0,1.0,0.038,2.383e-07,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
79782,LRRC31,Q6UY01,0.839,0.269,2.0007e-06,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2014.0,2014.0,ALL
79783,SUGCT,Q9HAC7,0.686,0.385,2.8168e-09,,,C0342873,Glutaric Aciduria III,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2008.0,2016.0,ALL
79784,MYH14,Q7Z406,0.663,0.577,0.042236,,,C1833503,"Deafness, Autosomal Dominant 4",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.71,1.0,,2004.0,2019.0,ALL
79785,RERGL,Q9H628,0.792,0.269,2.4541e-10,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
79789,CLMN,Q96JQ2,0.839,0.154,1.5344e-08,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
79791,FBXO31,Q5XUX0,0.653,0.423,0.44439,,,C4014864,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45",,,disease,Disease or Syndrome,0.4,,,,,ALL
79792,GSDMD,P57764,0.641,0.692,1.0789e-13,,,C0149745,Oral Ulcer,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
79794,C12orf49,Q9H741,0.89,0.231,0.0061628,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
79796,ALG9,Q9H6U8,0.644,0.654,0.00064044,DTO_05007624,Enzyme,C2931006,Congenital disorder of glycosylation type 1L,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,,2004.0,2020.0,ALL
79797,ZNF408,Q9H9D4,0.678,0.269,1.1792e-06,,,C4225315,RETINITIS PIGMENTOSA 72,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2015.0,ALL
79798,ARMC5,Q96C12,0.67,0.5,0.1075,,,C4014803,ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2,,,disease,Disease or Syndrome,0.68,1.0,strong,2013.0,2018.0,ALL
79799,UGT2A3,Q6UWM9,,,1.2614e-15,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
79800,CARF,Q8N187,0.769,0.269,8.0424e-07,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
79801,SHCBP1,Q8NEM2,0.606,0.654,9.3806e-08,,,C0039101,synovial sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2016.0,2017.0,ALL
79802,HHIPL2,Q6UWX4,1.0,0.038,6.7268e-23,,,C0282193,Iron Overload,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
79803,HPS6,Q86YV9,0.769,0.308,0.00027656,,,C0079504,Hermanski-Pudlak Syndrome,C16;C18;C11;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.61,1.0,strong,2017.0,2019.0,ALL
79804,HAND2-AS1,,0.663,0.462,,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,,,,,ALL
79805,VASH2,Q86V25,0.678,0.423,0.24217,,,C0015396,Eye Color,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2013.0,ALL
79807,GSTCD,Q8NEC7,0.839,0.231,1.4216e-07,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
79809,TTC21B,Q7Z4L5,0.619,0.654,2.704e-26,,,C0265275,Jeune thoracic dystrophy,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2014.0,ALL
79810,PTCD2,Q8WV60,1.0,0.077,7.1321e-11,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
79811,SLTM,Q9NWH9,0.78,0.231,0.99785,,,C0265275,Jeune thoracic dystrophy,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
79812,MMRN2,Q9H8L6,0.861,0.115,4.8869e-11,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
79813,EHMT1,Q9H9B1,0.46,0.808,1.0,DTO_05007378,Epigenetic regulator,C0795833,KLEEFSTRA SYNDROME 1,C23;C16;C05;C10;F03;F01;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms;    Cardiovascular Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,2006.0,2019.0,ALL
79814,AGMAT,Q9BSE5,0.839,0.231,1.2369e-07,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
79815,NIPAL2,Q9H841,1.0,0.077,4.3665e-12,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
79816,TLE6,Q9H808,0.931,0.038,3.0216e-06,DTO_05007542,Transcription factor,C4225197,PREIMPLANTATION EMBRYONIC LETHALITY 1,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2015.0,ALL
79817,MOB3B,Q86TA1,0.931,0.154,0.016386,DTO_05007584,Enzyme modulator,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2010.0,2015.0,ALL
79819,WDR78,Q5VTH9,,,4.2723e-17,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79820,CATSPERB,Q9H7T0,,,6.8843e-18,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79822,ARHGAP28,Q9P2N2,0.89,0.077,2.629e-09,DTO_05007584,Enzyme modulator,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
79823,CAMKMT,Q7Z624,0.51,0.808,1.3806e-15,,,C1848030,Hypotonia-Cystinuria Syndrome,C23;C16;C18;C13;C05;C12;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.52,1.0,,2008.0,2018.0,ALL
79825,EFCC1,Q9HA90,,,1.0453e-07,DTO_05007557,Nucleic acid binding,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79827,CLMP,Q9H6B4,0.705,0.462,1.5718e-07,,,C0021847,Intestinal Pseudo-Obstruction,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.74,1.0,,2012.0,2016.0,ALL
79828,METTL8,Q9H825,0.743,0.654,5.5478e-11,DTO_05007624,Enzyme,C0342286,Woodhouse Sakati syndrome,C23;C18;C17;C10;C19;F03;F01;C14,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
79829,NAA40,Q86UY6,0.792,0.115,9.7852e-09,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
79830,ZMYM1,Q5SVZ6,0.931,0.077,1.317e-08,DTO_05007584,Enzyme modulator,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
79831,KDM8,Q8N371,0.743,0.231,2.5238e-05,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2016.0,2017.0,ALL
79833,GEMIN6,Q8WXD5,0.89,0.077,0.00010596,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
79834,PEAK1,Q9H792,0.705,0.385,0.00086831,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
79836,LONRF3,Q496Y0,1.0,0.077,0.41779,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
79837,PIP4K2C,Q8TBX8,0.78,0.346,0.0018314,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.36,1.0,,2005.0,2014.0,ALL
79838,TMC5,Q6UXY8,0.839,0.154,6.9877e-08,DTO_01300327,Ion channel,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
79839,CCDC102B,Q68D86,0.821,0.154,3.2182e-16,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
79840,NHEJ1,Q9H9Q4,0.705,0.385,0.0041944,,,C1969799,"Severe Combined Immunodeficiency with Microcephaly, Growth Retardation, and Sensitivity to Ionizing Radiation",C23;C16;C18;C05;C20;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2006.0,2012.0,ALL
79841,AGBL2,Q5U5Z8,0.644,0.654,3.9622e-16,DTO_05007624,Enzyme,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
79842,ZBTB3,Q9H5J0,1.0,0.077,0.019277,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
79843,FAM124B,Q9H5Z6,0.931,0.154,1.0746e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
79844,ZDHHC11,Q9H8X9,0.89,0.115,1.1047e-15,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
79845,RNF122,Q9H9V4,1.0,0.038,0.14077,,,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
79846,CFAP69,A5D8W1,0.931,0.038,7.3323e-08,,,C0403823,Asthenozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
79847,MFSD13A,Q14CX5,0.821,0.231,0.049526,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
79848,CSPP1,Q1MSJ5,0.544,0.769,3.26e-29,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.55,1.0,,2014.0,2019.0,ALL
79849,PDZD3,Q86UT5,0.931,0.038,1.3463e-12,,,C0348898,Irritable bowel syndrome with diarrhea,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
79850,TLCD3A,Q8TBR7,0.89,0.077,0.25619,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2004.0,2017.0,ALL
79852,EPHX3,Q9H6B9,0.839,0.115,1.6489e-15,DTO_05007624,Enzyme,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
79853,TM4SF20,Q53R12,0.931,0.038,0.0001862,,,C3809483,SPECIFIC LANGUAGE IMPAIRMENT 5,,,disease,Disease or Syndrome,0.5,1.0,limited,2013.0,2013.0,ALL
79854,LINC00115,,0.861,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
79856,SNX22,Q96L94,1.0,0.115,0.0047609,,,C1850169,"OSTEOGENESIS IMPERFECTA, TYPE IX (disorder)",C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
79858,NEK11,Q8NG66,0.839,0.154,1.0374e-21,DTO_03300101,Kinase,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
79863,RBFA,Q8N0V3,1.0,0.038,9.5095e-05,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2014.0,2014.0,ALL
79864,JHY,Q6NUN7,,,2.9259e-12,,,C0424574,Duration of sleep,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
79865,TREML2,Q5T2D2,0.861,0.192,1.1362e-09,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79866,BORA,Q6PGQ7,0.931,0.115,0.00032563,,,C0001815,Primary Myelofibrosis,C15,   Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
79867,TCTN2,Q96GX1,0.578,0.654,1.8379e-14,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.6,1.0,limited,2011.0,2015.0,ALL
79868,ALG13,Q9NP73,0.631,0.577,0.99998,,,C3550904,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2012.0,2016.0,ALL
79869,CPSF7,Q8N684,0.821,0.115,0.99873,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
79870,BAALC,Q8WXS3,0.631,0.385,0.0044356,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.4,1.0,,2003.0,2018.0,ALL
79871,RPAP2,Q8IXW5,1.0,0.077,2.5763e-07,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
79872,CBLL1,Q75N03,0.805,0.231,0.99918,DTO_05007624,Enzyme,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
79873,NUDT18,Q6ZVK8,0.861,0.115,1.8736e-06,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79874,RABEP2,Q9H5N1,0.682,0.654,0.0011388,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2013.0,ALL
79875,THSD4,Q6ZMP0,0.78,0.269,4.8082e-07,DTO_05007624,Enzyme,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
79876,UBA5,Q9GZZ9,0.582,0.731,0.00025218,DTO_05007624,Enzyme,C4310700,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2016.0,ALL
79879,CCDC134,Q9H6E4,0.769,0.308,6.0044e-07,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
79882,ZC3H14,Q6PJT7,0.691,0.308,0.88291,,,C4310703,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56",,,disease,Disease or Syndrome,0.6,1.0,limited,2011.0,2011.0,ALL
79883,PODNL1,Q6PEZ8,,,4.4042e-13,,,C0854723,Retinal Dystrophies,C11,   Eye Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
79884,MAP9,Q49MG5,0.729,0.462,2.5444e-15,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
79885,HDAC11,Q96DB2,0.636,0.654,0.0069318,DTO_05007378,Epigenetic regulator,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.03,1.0,,2018.0,2018.0,ALL
79886,CAAP1,Q9H8G2,0.861,0.077,0.78449,,,C0869220,"Adverse effects, not elsewhere classified",,,disease,Injury or Poisoning,0.1,1.0,,2019.0,2019.0,ALL
79887,PLBD1,Q6P4A8,1.0,0.077,1.1759e-16,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
79888,LPCAT1,Q8NF37,0.659,0.577,0.13713,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2013.0,2019.0,ALL
79890,RIN3,Q8TB24,0.792,0.269,4.2837e-10,DTO_05007584,Enzyme modulator,C0029401,Osteitis Deformans,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.33,1.0,,2011.0,2019.0,ALL
79891,ZNF671,Q8TAW3,0.769,0.231,4.2147e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2015.0,2019.0,ALL
79892,MCMBP,Q9BTE3,,,0.99565,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
79893,GGNBP2,Q9H3C7,0.7,0.423,1.0,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
79895,ATP8B4,Q8TF62,0.931,0.115,3.6708e-34,DTO_05007405,Transporter,C0037290,Skin Pigmentation,,,phenotype,Organ or Tissue Function,0.1,1.0,,2007.0,2017.0,ALL
79897,RPP21,Q9H633,0.839,0.269,4.8992e-05,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
79898,ZNF613,Q6PF04,1.0,0.077,0.00081785,DTO_05007542,Transcription factor,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2015.0,2015.0,ALL
79899,PRR5L,Q6MZQ0,0.736,0.346,0.065457,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
79901,CYBRD1,Q53TN4,0.729,0.269,0.011568,DTO_05007624,Enzyme,C0282193,Iron Overload,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.32,1.0,strong,2004.0,2017.0,ALL
79902,NUP85,Q9BW27,0.792,0.154,1.0,DTO_05007530,Cellular structure,C4748545,"NEPHROTIC SYNDROME, TYPE 17",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
79903,NAA60,Q9H7X0,,,0.51694,DTO_05007624,Enzyme,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79905,TMC7,Q7Z402,,,4.5498e-10,DTO_01300327,Ion channel,C0019360,Herpes zoster disease,C01,   Infections,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
79906,MORN1,Q5T089,0.931,0.115,1.6137e-11,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
79908,BTNL8,Q6UX41,0.861,0.154,1.4502e-05,DTO_05007584,Enzyme modulator,C0029410,Osteoarthritis of hip,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
79912,PYROXD1,Q8WU10,0.769,0.269,6.2976e-09,DTO_05007624,Enzyme,C4310645,"MYOPATHY, MYOFIBRILLAR, 8",,,disease,Disease or Syndrome,0.7,1.0,definitive,2016.0,2019.0,ALL
79913,ACTR5,Q9H9F9,0.931,0.077,1.1352e-09,DTO_05007530,Cellular structure,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
79915,ATAD5,Q96QE3,0.711,0.385,1.0,,,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.32,1.0,,2015.0,2016.0,ALL
79918,SETD6,Q8TBK2,0.821,0.269,1.8383e-18,,,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
79919,MAB21L4,Q08AI8,1.0,0.038,2.5445e-08,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
79921,TCEAL4,Q96EI5,0.839,0.077,0.74827,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2006.0,2006.0,ALL
79922,MRM1,Q6IN84,,,6.6719e-06,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
79923,NANOG,Q9H9S0,0.531,0.654,0.72022,DTO_05007542,Transcription factor,C0205851,Germ cell tumor,C04,   Neoplasms,disease,Neoplastic Process,0.33,1.0,,2005.0,2011.0,ALL
79924,ADM2,Q7Z4H4,0.711,0.462,0.020009,DTO_05007599,Signaling,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
79925,SPEF2,Q9C093,0.792,0.269,3.1152e-25,,,C4551720,Primary Ciliary Dyskinesia,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.32,1.0,,2018.0,2020.0,ALL
79929,MAP6D1,Q9H9H5,,,0.11028,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
79930,DOK3,Q7L591,0.805,0.308,0.00090501,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.31,1.0,,2010.0,2010.0,ALL
79931,TNIP3,Q96KP6,0.76,0.308,0.01544,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
79932,KIAA0319L,Q8IZA0,0.711,0.423,0.0012186,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.41,1.0,,2013.0,2013.0,ALL
79933,SYNPO2L,Q9H987,0.89,0.115,2.7515e-10,DTO_05007530,Cellular structure,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.41,1.0,,2012.0,2018.0,ALL
79934,COQ8B,Q96D53,0.722,0.423,2.8159e-13,DTO_03300101,Kinase,C3809965,"NEPHROTIC SYNDROME, TYPE 9",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2016.0,ALL
79935,CNTD2,Q9H8S5,0.821,0.115,0.00048667,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
79937,CNTNAP3,Q9BZ76,0.861,0.192,1.7092e-11,,,C0005689,Bladder Exstrophy,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,0.0,,2005.0,2005.0,ALL
79939,SLC35E1,Q96K37,,,0.1273,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
79940,LINC00472,Q9H8W2,0.729,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2015.0,2019.0,ALL
79944,L2HGDH,Q9H9P8,0.653,0.462,4.2231e-05,DTO_05007624,Enzyme,C1855995,L-2-HYDROXYGLUTARIC ACIDURIA,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,2004.0,2018.0,ALL
79947,DHDDS,Q86SQ9,0.468,0.885,0.24533,DTO_05007624,Enzyme,C3151227,RETINITIS PIGMENTOSA 59,,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2017.0,ALL
79948,PLPPR3,Q6T4P5,,,0.0095649,DTO_05007624,Enzyme,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79949,PLEKHS1,Q5SXH7,,,2.1435e-22,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
79953,SYNDIG1,Q9H7V2,1.0,0.038,0.30249,,,C0086132,Depressive Symptoms,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.3,1.0,,2011.0,2011.0,ALL
79954,NOL10,Q9BSC4,0.89,0.077,0.050667,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
79955,PDZD7,Q9H5P4,0.659,0.385,7.6433e-10,,,C1848634,"USHER SYNDROME, TYPE IIA",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.6,,limited,,,ALL
79956,ERMP1,Q7Z2K6,0.861,0.154,1.6343e-12,DTO_05007624,Enzyme,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
79957,PAQR6,Q6TCH4,1.0,0.077,6.5548e-05,DTO_05007575,Receptor,C1833683,"NEPHROLITHIASIS, CALCIUM OXALATE",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
79959,CEP76,Q8TAP6,,,4.5108e-09,,,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
79960,JADE1,Q6IE81,0.743,0.308,0.99885,DTO_05007542,Transcription factor,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
79961,DENND2D,Q9H6A0,0.736,0.154,0.00081369,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
79966,SCD5,Q86SK9,0.682,0.654,0.0010398,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
79968,WDR76,Q9H967,0.839,0.192,2.7667e-09,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2017.0,2019.0,ALL
79969,ATAT1,Q5SQI0,0.7,0.5,1.3216e-07,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
79970,ZNF767P,Q75MW2,1.0,0.077,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
79971,WLS,Q5T9L3,0.513,0.731,0.020463,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
79973,ZNF442,Q9H7R0,1.0,0.077,0.03048,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
79974,CPED1,A4D0V7,0.769,0.5,1.8689e-24,,,C0022336,Creutzfeldt-Jakob disease,C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
79977,GRHL2,Q6ISB3,0.59,0.731,0.99683,DTO_05007542,Transcription factor,C4014987,"Nail and tooth abnormalities, marginal palmoplantar keratoderma, oral hyperpigmentation syndrome",C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
79980,DSN1,Q9H410,0.89,0.077,8.8514e-08,,,C2825856,Factor VII measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79981,FRMD1,Q8N878,,,3.6693e-14,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
79983,POF1B,Q8WVV4,0.751,0.308,4.507e-11,,,C1845105,Premature Ovarian Failure 2b,C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,1.0,moderate,2004.0,2016.0,ALL
79987,SVEP1,Q4LDE5,0.78,0.308,0.99995,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0,,2013.0,2016.0,ALL
79989,TTC26,A0AVF1,1.0,0.038,2.4322e-08,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
79990,PLEKHH3,Q7Z736,0.931,0.077,4.8445e-07,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
79991,STN1,Q9H668,0.604,0.769,2.295e-10,,,C4479220,CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2,,,disease,Disease or Syndrome,0.6,1.0,moderate,2016.0,2016.0,ALL
79993,ELOVL7,A1L3X0,0.821,0.231,0.010183,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
80000,GREB1L,Q9C091,0.686,0.423,1.0,,,C4540497,RENAL HYPODYSPLASIA/APLASIA 3,,,disease,Congenital Abnormality,0.6,1.0,strong,2017.0,2017.0,ALL
80003,PCNX2,A6NKB5,0.805,0.192,1.7151e-23,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
80004,ESRP2,Q9H6T0,0.76,0.346,2.3333e-07,DTO_05007557,Nucleic acid binding,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.3,1.0,moderate,2018.0,2018.0,ALL
80005,DOCK5,Q9H7D0,0.792,0.231,2.8994e-09,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
80007,C10orf88,Q9H8K7,0.861,0.115,0.012888,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
80008,TMEM156,Q8N614,,,3.3366e-10,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
80010,RMI1,Q9H9A7,0.743,0.308,3.6565e-06,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
80012,PHC3,Q8NDX5,0.839,0.115,1.0,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
80013,MINDY3,Q9H8M7,0.743,0.462,0.011165,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
80014,WWC2,Q6AWC2,0.839,0.077,1.5899e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
80017,DGLUCY,Q7Z3D6,0.839,0.154,1.6561e-22,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2019.0,ALL
80018,NAA25,Q14CX7,0.603,0.692,1.0,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,0.667,,1993.0,2017.0,ALL
80019,UBTD1,Q9HAC8,0.931,0.077,0.74558,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
80023,NRSN2,Q9GZP1,0.78,0.192,0.0042391,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,0.667,,2009.0,2017.0,ALL
80024,SLC8B1,Q6J4K2,0.861,0.077,2.0302e-16,DTO_05007405,Transporter,C2937358,Cerebral Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",phenotype,Pathologic Function,0.2,1.0,,2013.0,2013.0,ALL
80025,PANK2,Q9BZ23,0.559,0.808,7.4034e-07,DTO_03300101,Kinase,C0018523,Hallervorden-Spatz Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.989,,2001.0,2019.0,ALL
80028,FBXL18,Q96ME1,0.861,0.115,0.00015442,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
80031,SEMA6D,Q8NFY4,0.7,0.385,0.93948,DTO_05007599,Signaling,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
80034,CSRNP3,Q8WYN3,0.805,0.192,0.50018,,,C0000786,Spontaneous abortion,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.3,1.0,,2008.0,2008.0,ALL
80036,TRPM3,Q9HCF6,0.663,0.769,5.6853e-07,DTO_01300327,Ion channel,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,moderate,2017.0,2019.0,ALL
80045,GPR157,Q5UAW9,,,0.00097453,DTO_02300001,G-protein coupled receptor,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
80054,CEBPA-DT,,0.821,0.115,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
80055,PGAP1,Q75T13,0.65,0.423,3.1628e-08,DTO_05007405,Transporter,C4014343,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42",,,disease,Disease or Syndrome,0.6,1.0,moderate,2007.0,2015.0,ALL
80059,LRRTM4,Q86VH4,0.861,0.192,0.085808,DTO_05007575,Receptor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
80063,ATF7IP2,Q5U623,1.0,0.038,0.15781,,,C1536085,Geographic Atrophy,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
80067,DCAF17,Q5H9S7,0.653,0.577,3.74e-07,,,C0342286,Woodhouse Sakati syndrome,C23;C18;C17;C10;C19;F03;F01;C14,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,1.0,,2008.0,2020.0,ALL
80069,LINC00574,Q9H8X3,0.89,0.115,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
80070,ADAMTS20,P59510,0.76,0.385,4.4534e-38,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
80078,LCAL1,,0.89,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
80086,TUBA4B,Q9H853,0.736,0.269,,DTO_05007530,Cellular structure,C3828530,Platelet Component Distribution Width Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
80095,ZNF606,Q8WXB4,0.792,0.192,0.41765,DTO_05007542,Transcription factor,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
80110,ZNF614,Q8N883,0.931,0.115,1.5117e-07,DTO_05007542,Transcription factor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
80114,BICC1,Q9H694,0.636,0.577,0.83685,DTO_05007405,Transporter,C3275898,"RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO",,,disease,Finding,0.6,1.0,limited,2012.0,2012.0,ALL
80115,BAIAP2L2,Q6UXY1,0.89,0.077,1.2298e-09,DTO_05007575,Receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
80117,ARL14,Q8N4G2,0.931,0.038,1.2351e-06,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
80119,PIF1,Q9H611,0.722,0.462,1.8307e-16,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,0.5,,2012.0,2018.0,ALL
80122,MAP3K19,Q56UN5,0.78,0.269,1.7574e-22,DTO_03300101,Kinase,C0022578,Keratoconus,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
80124,VCPIP1,Q96JH7,0.839,0.154,1.0,DTO_05007624,Enzyme,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
80125,CCDC33,Q8N5R6,0.839,0.269,4.9566e-20,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
80127,BBOF1,Q8ND07,0.89,0.192,1.0672e-16,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
80128,TRIM46,Q7Z4K8,0.76,0.308,0.99925,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2016.0,2017.0,ALL
80129,CCDC170,Q8IYT3,0.751,0.308,8.6099e-24,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.18,1.0,,2010.0,2017.0,ALL
80131,LRRC8E,Q6NSJ5,0.861,0.115,1.7415e-06,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,2016.0,2016.0,ALL
80135,RPF1,Q9H9Y2,1.0,0.038,2.3931e-08,DTO_05007557,Nucleic acid binding,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
80139,ZNF703,Q9H7S9,0.722,0.269,0.35636,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2011.0,2016.0,ALL
80142,PTGES2,Q9H7Z7,0.711,0.423,2.361e-09,DTO_05007624,Enzyme,C0040136,Thyroid Neoplasm,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
80143,SIKE1,Q9BRV8,1.0,0.038,0.19572,,,C1861453,Pseudohyperkalemia Cardiff,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
80144,FRAS1,Q86XX4,0.56,0.577,3.0802e-45,,,C0265233,Cryptophthalmos syndrome,C16;C13;C11;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,1.0,0.867,strong,2006.0,2017.0,ALL
80145,THOC7,Q6I9Y2,1.0,0.038,0.0060818,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
80146,UXS1,Q8NBZ7,0.839,0.154,0.0029371,DTO_05007624,Enzyme,C0376634,Craniofacial Abnormalities,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Congenital Abnormality,0.3,1.0,,2006.0,2006.0,ALL
80148,SLC66A2,Q8N2U9,1.0,0.077,0.010336,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
80149,ZC3H12A,Q5D1E8,0.578,0.654,0.14015,DTO_05007557,Nucleic acid binding,C0003838,Arterial Occlusive Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
80150,ASRGL1,Q7L266,0.494,0.808,2.7632e-05,DTO_05007624,Enzyme,C0162820,"Dermatitis, Allergic Contact",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
80152,CENPT,Q96BT3,0.821,0.231,5.8498e-06,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
80153,EDC3,Q96F86,0.682,0.308,0.026011,,,C4225319,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50",,,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2015.0,2015.0,ALL
80155,NAA15,Q9BXJ9,0.7,0.423,0.99578,DTO_05007624,Enzyme,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.63,1.0,strong,2015.0,2018.0,ALL
80157,CWH43,Q9H720,0.931,0.115,7.2561e-22,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
80162,PGGHG,Q32M88,,,2.3064e-14,,,C0201850,Alkaline phosphatase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
80168,MOGAT2,Q3SYC2,0.839,0.192,0.010537,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
80169,CTC1,Q2NKJ3,0.601,0.538,1.6015e-11,,,C2677299,CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS (disorder),C23;C16;C04;C18;C11;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.76,1.0,strong,2012.0,2018.0,ALL
80173,IFT74,Q96LB3,0.716,0.423,5.7205e-13,,,C4310707,BARDET-BIEDL SYNDROME 20,,,disease,Disease or Syndrome,0.5,1.0,,2016.0,2016.0,ALL
80174,DBF4B,Q8NFT6,0.931,0.077,2.677e-11,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
80176,SPSB1,Q96BD6,0.722,0.577,0.51982,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
80177,MYCT1,Q8N699,0.792,0.308,0.0003656,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
80178,TEDC2,Q7L2K0,1.0,0.077,7.1044e-12,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
80179,MYO19,Q96H55,0.931,0.077,1.5479e-34,DTO_05007530,Cellular structure,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
80183,RUBCNL,Q9H714,0.736,0.269,4.3599e-18,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.03,1.0,,2009.0,2018.0,ALL
80184,CEP290,O15078,0.517,0.769,1.0549e-60,,,C1857780,JOUBERT SYNDROME 5,C23;C13;C11;C12;C10,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,,2006.0,2019.0,ALL
80185,TTI2,Q6NXR4,0.736,0.346,3.6074e-07,,,C3809853,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2013.0,ALL
80194,TMEM134,Q9H6X4,0.931,0.154,2.0372e-10,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2016.0,2016.0,ALL
80195,TMEM254,Q8TBM7,1.0,0.038,0.0013335,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
80196,RNF34,Q969K3,0.61,0.577,0.61057,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
80198,MUS81,Q96NY9,0.686,0.462,8.8469e-13,,,C0024796,Marfan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,2007.0,2007.0,ALL
80199,FUZ,Q9BT04,0.597,0.731,1.2613e-05,,,C0344490,Sacral agenesis,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.6,1.0,,2011.0,2011.0,ALL
80201,HKDC1,Q2TB90,0.743,0.269,1.6205e-14,DTO_03300101,Kinase,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
80204,FBXO11,Q86XK2,0.604,0.692,1.0,DTO_05007624,Enzyme,C4748135,INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES,,,disease,Disease or Syndrome,0.6,1.0,,2006.0,2018.0,ALL
80205,CHD9,Q3L8U1,0.805,0.231,1.0,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
80206,FHOD3,Q2V2M9,0.722,0.346,0.066509,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.44,0.75,strong,2013.0,2020.0,ALL
80207,OPA3,Q9H6K4,0.653,0.385,0.5657,,,C0574084,3-Methylglutaconic aciduria type 3,C23;C16;C18;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.9,1.0,,2001.0,2016.0,ALL
80208,SPG11,Q96JI7,0.576,0.538,1.6013e-39,,,C1858479,"Spastic paraplegia 11, autosomal recessive",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.96,1.0,,2004.0,2019.0,ALL
80209,PROSER1,Q86XN7,0.931,0.038,0.71143,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
80210,ARMC9,Q7Z3E5,0.612,0.731,6.2032e-17,,,C4539937,JOUBERT SYNDROME 30,,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
80212,CCDC92,Q53HC0,0.839,0.154,0.29985,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.33,1.0,,2017.0,2018.0,ALL
80213,TM2D3,Q9BRN9,0.89,0.115,7.9392e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
80215,RUNX1-IT1,,0.805,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
80216,ALPK1,Q96QP1,0.644,0.615,1.0188e-19,DTO_03300101,Kinase,C0011849,Diabetes Mellitus,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.32,1.0,,2013.0,2019.0,ALL
80217,CFAP43,Q8NDM7,0.931,0.038,1.3459e-22,,,C4539818,SPERMATOGENIC FAILURE 19,,,disease,Disease or Syndrome,0.8,1.0,limited,2017.0,2018.0,ALL
80218,NAA50,Q9GZZ1,0.716,0.346,0.73486,DTO_05007624,Enzyme,C0027889,Hereditary Sensory and Autonomic Neuropathies,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Disease or Syndrome,0.03,1.0,,2013.0,2018.0,ALL
80219,COQ10B,Q9H8M1,1.0,0.038,0.29421,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
80221,ACSF2,Q96CM8,0.931,0.038,1.4241e-05,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
80222,TARS2,Q9BW92,0.729,0.423,1.2185e-12,DTO_05007624,Enzyme,C4014668,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21,,,disease,Disease or Syndrome,0.7,1.0,moderate,2014.0,2016.0,ALL
80223,RAB11FIP1,Q6WKZ4,0.89,0.077,7.3324e-11,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.06,1.0,,2015.0,2019.0,ALL
80224,NUBPL,Q8TB37,0.67,0.423,1.0705e-05,,,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.61,1.0,,2010.0,2016.0,ALL
80228,ORAI2,Q96SN7,0.839,0.038,0.20459,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
80230,RUFY1,Q96T51,0.861,0.192,2.1203e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
80231,CXorf21,Q9HAI6,0.89,0.269,0.84298,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.12,1.0,,2015.0,2019.0,ALL
80232,WDR26,Q9H7D7,0.606,0.769,1.0,,,C4539927,SKRABAN-DEARDORFF SYNDROME,,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
80233,FAAP100,Q0VG06,0.931,0.115,2.6956e-05,,,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0,,2018.0,2019.0,ALL
80235,PIGZ,Q86VD9,1.0,0.038,1.2688e-05,DTO_05007624,Enzyme,C0023290,"Leishmaniasis, Visceral",C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
80237,ELL3,Q9HB65,0.89,0.154,1.6997e-12,DTO_05007527,Cell-cell junction,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
80243,PREX2,Q70Z35,0.743,0.385,3.3283e-16,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
80254,CEP63,Q96MT8,0.666,0.5,6.2444e-25,DTO_05007530,Cellular structure,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.6,1.0,strong,2011.0,2015.0,ALL
80255,SLC35F5,Q8WV83,1.0,0.115,3.5033e-08,DTO_05007405,Transporter,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
80256,FAM214B,Q7L5A3,1.0,0.038,0.80243,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2014.0,2018.0,ALL
80258,EFHC2,Q5JST6,0.792,0.538,0.9991,,,C0041408,Turner Syndrome,C16;C13;C12;C19;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.05,1.0,,2007.0,2018.0,ALL
80262,C16orf70,Q9BSU1,0.931,0.038,0.98056,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
80263,TRIM45,Q9H8W5,0.78,0.077,2.061e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2020.0,ALL
80264,ZNF430,Q9H8G1,0.931,0.115,0.0086151,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
80267,EDEM3,Q9BZQ6,0.931,0.154,0.0024686,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
80270,HSD3B7,Q9H2F3,0.7,0.385,2.694e-08,DTO_05007624,Enzyme,C1843116,"Bile acid synthesis defect, congenital, 1",C16;C06;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2000.0,2016.0,ALL
80271,ITPKC,Q96DU7,0.78,0.346,0.15241,DTO_03300101,Kinase,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.5,1.0,,2008.0,2018.0,ALL
80273,GRPEL1,Q9HAV7,0.931,0.192,0.13916,DTO_05007613,Chaperone,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.3,1.0,,2004.0,2004.0,ALL
80274,SCUBE1,Q8IWY4,0.743,0.5,0.96076,DTO_05007621,Extracellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
80279,CDK5RAP3,Q96JB5,0.7,0.462,7.6348e-15,,,C0014548,"Epilepsy, Generalized",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
80298,MTERF2,Q49AM1,1.0,0.077,2.464e-06,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
80303,EFHD1,Q9BUP0,0.89,0.115,0.0051487,DTO_05007616,Calcium-binding protein,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
80304,WDCP,Q9H6R7,0.89,0.115,0.0010242,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
80305,TRABD,Q9H4I3,0.839,0.308,0.022862,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
80306,MED28,Q9H204,0.78,0.192,0.00011083,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2005.0,2018.0,ALL
80307,FER1L4,A9Z1Z3,0.711,0.346,,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
80308,FLAD1,Q8NFF5,0.638,0.692,0.0093637,,,C4310822,LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,moderate,2006.0,2016.0,ALL
80309,SPHKAP,Q2M3C7,0.695,0.462,0.93594,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2015.0,2019.0,ALL
80310,PDGFD,Q9GZP0,0.579,0.538,0.0017145,DTO_05007599,Signaling,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2017.0,2019.0,ALL
80311,KLHL15,Q96M94,0.805,0.192,0.99422,,,C4310818,"MENTAL RETARDATION, X-LINKED 103",,,disease,Disease or Syndrome,0.5,1.0,limited,2016.0,2016.0,ALL
80312,TET1,Q8NFU7,0.523,0.808,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2013.0,2018.0,ALL
80314,EPC1,Q9H2F5,0.743,0.423,1.0,DTO_05007557,Nucleic acid binding,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2019.0,ALL
80315,CPEB4,Q17RY0,0.621,0.462,0.98555,DTO_05007557,Nucleic acid binding,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
80316,PPP1R2C,O14990,0.478,0.846,,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,1991.0,2020.0,ALL
80317,ZKSCAN3,Q9BRR0,0.736,0.462,1.9697e-11,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2008.0,2018.0,ALL
80318,GKAP1,Q5VSY0,1.0,0.077,0.061133,DTO_05007530,Cellular structure,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
80319,CXXC4,Q9H2H0,0.751,0.192,0.88863,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2009.0,2018.0,ALL
80320,SP6,Q3SY56,0.769,0.308,0.14961,DTO_05007557,Nucleic acid binding,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
80321,CEP70,Q8NHQ1,0.743,0.462,4.5554e-15,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
80323,CCDC68,Q9H2F9,0.821,0.346,8.7053e-13,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
80324,PUS1,Q9Y606,0.695,0.462,0.0016656,DTO_05007624,Enzyme,C1838103,MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.64,1.0,limited,2007.0,2014.0,ALL
80325,ABTB1,Q969K4,1.0,0.077,2.1295e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
80326,WNT10A,Q9GZT5,0.547,0.731,4.1667e-09,DTO_05007599,Signaling,C1857069,SCHOPF-SCHULZ-PASSARGE SYNDROME (disorder),C16;C04;C11;C17;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.77,1.0,strong,2009.0,2018.0,ALL
80328,ULBP2,Q9BZM5,0.678,0.5,1.8392e-09,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
80329,ULBP1,Q9BZM6,0.674,0.346,6.885e-07,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2005.0,2014.0,ALL
80331,DNAJC5,Q9H3Z4,0.653,0.5,0.81216,,,C1834207,"Ceroid Lipofuscinosis, Neuronal, Parry Type",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2011.0,2013.0,ALL
80332,ADAM33,Q9BZ11,0.636,0.423,2.1487e-15,DTO_05007624,Enzyme,C0085129,Bronchial Hyperreactivity,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.4,1.0,,2002.0,2011.0,ALL
80333,KCNIP4,Q6PIL6,0.716,0.385,0.82064,DTO_01300327,Ion channel,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
80335,WDR82,Q6UXN9,0.861,0.115,0.88696,DTO_05007624,Enzyme,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
80336,PABPC1L,Q4VXU2,0.931,0.077,0.00043212,,,C0424574,Duration of sleep,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
80339,PNPLA3,Q9NST1,0.556,0.692,5.7409e-08,DTO_05007624,Enzyme,C0023891,"Liver Cirrhosis, Alcoholic",C23;C06;C25,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.5,0.917,,2010.0,2019.0,ALL
80341,BPIFB2,Q8N4F0,0.861,0.385,4.7491e-12,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
80342,TRAF3IP3,Q9Y228,0.839,0.192,2.1912e-12,DTO_05007613,Chaperone,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
80344,DCAF11,Q8TEB1,0.89,0.038,0.0063315,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
80345,ZSCAN16,Q9H4T2,1.0,0.077,2.1302e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
80346,REEP4,Q9H6H4,1.0,0.038,0.027532,DTO_05007405,Transporter,C0005747,Blepharospasm,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
80347,COASY,Q13057,0.551,0.654,8.0903e-10,DTO_05007624,Enzyme,C3810230,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2018.0,ALL
80349,WDR61,Q9GZS3,,,0.0048017,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
80350,LPAL2,Q16609,0.626,0.731,,DTO_05007624,Enzyme,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.16,1.0,,1991.0,2017.0,ALL
80351,TNKS2,Q9H2K2,0.695,0.385,3.6661e-05,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
80352,RNF39,Q9H2S5,0.76,0.538,2.0207e-05,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
80380,PDCD1LG2,Q9BQ51,0.496,0.769,1.203e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
80381,CD276,Q5ZPR3,0.505,0.731,2.4699e-09,DTO_05007584,Enzyme modulator,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.35,1.0,,2011.0,2019.0,ALL
80700,UBXN6,Q9BZV1,0.931,0.154,5.4834e-06,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
80704,SLC19A3,Q9BZV2,0.61,0.692,0.1039,DTO_05007405,Transporter,C1843807,"Basal ganglia disease, biotin-responsive",C10,   Nervous System Diseases,disease,Disease or Syndrome,1.0,1.0,,2005.0,2019.0,ALL
80705,TSGA10,Q9BZW7,0.674,0.385,0.10999,DTO_05007584,Enzyme modulator,C4022698,Acephalic spermatozoa,,,disease,Disease or Syndrome,0.11,1.0,,2018.0,2018.0,ALL
80709,AKNA,Q7Z591,0.805,0.269,0.00012945,,,C0201836,Alanine aminotransferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
80712,ESX1,Q8N693,0.769,0.154,0.52687,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2011.0,2019.0,ALL
80714,PBX4,Q9BYU1,0.839,0.231,5.2605e-05,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
80723,SLC35G2,Q8TBE7,0.89,0.115,0.039734,DTO_05007405,Transporter,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
80724,ACAD10,Q6JQN1,0.76,0.308,1.0177e-30,DTO_05007624,Enzyme,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.11,1.0,,2016.0,2019.0,ALL
80725,SRCIN1,Q9C0H9,0.636,0.462,0.99987,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2016.0,2016.0,ALL
80726,IQCN,Q9H0B3,1.0,0.038,1.548e-08,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
80727,TTYH3,Q9C0H2,0.931,0.038,0.99916,DTO_01300327,Ion channel,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
80728,ARHGAP39,Q9C0H5,,,0.0081913,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
80731,THSD7B,Q9C0I4,0.89,0.154,2.6474e-19,DTO_05007621,Extracellular structure,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2011.0,2011.0,ALL
80736,SLC44A4,Q53GD3,0.678,0.615,1.0036e-14,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
80737,VWA7,Q9Y334,0.839,0.308,2.3119e-11,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
80739,MPIG6B,O95866,0.695,0.5,1.0837e-06,,,C4479504,"THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS",,,disease,Disease or Syndrome,0.5,1.0,,2012.0,2017.0,ALL
80740,LY6G6C,O95867,0.821,0.385,0.00049312,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
80741,LY6G5C,Q5SRR4,0.931,0.192,0.40546,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2009.0,ALL
80742,PRR3,P79522,0.931,0.154,0.0013939,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
80745,THUMPD2,Q9BTF0,1.0,0.077,1.5442e-09,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
80746,TSEN2,Q8NCE0,0.705,0.423,1.0092e-11,DTO_05007624,Enzyme,C2676466,Pontocerebellar Hypoplasia Type 2B,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2008.0,2011.0,ALL
80758,PRR7,Q8TB68,,,0.86893,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
80760,ITIH5,Q86UX2,0.663,0.462,7.0952e-21,DTO_05007584,Enzyme modulator,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
80762,NDFIP1,Q9BT67,0.716,0.462,0.97747,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0,,2012.0,2012.0,ALL
80763,SPX,Q9BT56,0.695,0.462,0.00011029,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.09,0.889,,2016.0,2020.0,ALL
80764,THAP7,Q9BT49,1.0,0.038,0.013291,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
80772,CPTP,Q5TA50,1.0,0.038,0.02254,DTO_05007405,Transporter,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
80774,LIMD2,Q9BT23,0.705,0.308,0.16402,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2009.0,2010.0,ALL
80775,TMEM177,Q53S58,,,0.0089914,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
80776,B9D2,Q9BPU9,0.606,0.577,5.2557e-05,DTO_05007621,Extracellular structure,C3280036,"MECKEL SYNDROME, TYPE 10",,,disease,Disease or Syndrome,0.5,1.0,,2011.0,2015.0,ALL
80777,CYB5B,O43169,0.861,0.192,0.093498,DTO_05007624,Enzyme,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
80778,ZNF34,Q8IZ26,0.931,0.115,0.00068775,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
80781,COL18A1,P39060,0.449,0.808,1.7414e-10,,,C1849409,Knobloch syndrome,C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2000.0,2018.0,ALL
80789,INTS5,Q6P9B9,,,0.5135,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
80790,CMIP,Q8IY22,0.682,0.577,0.99999,DTO_05007542,Transcription factor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.43,1.0,,2011.0,2019.0,ALL
80816,ASXL3,Q9C0F0,0.59,0.577,1.0,,,C3809650,BAINBRIDGE-ROPERS SYNDROME,,,disease,Disease or Syndrome,0.76,1.0,,2013.0,2019.0,ALL
80818,ZNF436,Q9C0F3,0.67,0.5,5.1273e-05,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
80820,EEPD1,Q7L9B9,0.89,0.115,0.054875,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
80821,DDHD1,Q8NEL9,0.716,0.423,0.902,DTO_05007624,Enzyme,C1836295,"SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE (disorder)",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.62,1.0,,2012.0,2018.0,ALL
80823,BHLHB9,Q6PI77,1.0,0.077,0.02025,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2004.0,2011.0,ALL
80824,DUSP16,Q9BY84,0.743,0.385,0.088867,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
80829,ZFP91,Q96JP5,0.78,0.154,0.9997,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.22,1.0,,2003.0,2014.0,ALL
80830,APOL6,Q9BWW8,0.839,0.269,0.096029,DTO_05007405,Transporter,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
80831,APOL5,Q9BWW9,1.0,,6.0075e-07,DTO_05007405,Transporter,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
80832,APOL4,Q9BPW4,0.839,0.231,0.0010662,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,,,,,ALL
80833,APOL3,O95236,0.805,0.231,0.00043634,DTO_05007405,Transporter,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
80834,TAS1R2,Q8TE23,0.861,0.192,7.6139e-17,DTO_02300001,G-protein coupled receptor,C0858600,Taste sweet,,,phenotype,Sign or Symptom,0.09,0.889,,2008.0,2019.0,ALL
80835,TAS1R1,Q7RTX1,0.89,0.077,7.3432e-14,DTO_02300001,G-protein coupled receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
80853,KDM7A,Q6ZMT4,0.769,0.308,0.99986,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
80854,SETD7,Q8WTS6,0.628,0.615,0.0042257,DTO_05007378,Epigenetic regulator,C0005398,"Cholestasis, Extrahepatic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.2,1.0,,2014.0,2014.0,ALL
80856,LNPK,Q9C0E8,0.716,0.346,0.00062151,,,C0344482,Hypoplasia of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.4,1.0,moderate,2018.0,2018.0,ALL
80862,ZNRD1ASP,,0.691,0.538,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.11,1.0,,2012.0,2016.0,ALL
80863,PRRT1,Q99946,0.821,0.269,0.29845,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
80864,EGFL8,Q99944,0.792,0.269,1.1262e-07,DTO_05007616,Calcium-binding protein,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
80868,HCG4B,,1.0,0.038,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
80895,ILKAP,Q9H0C8,0.821,0.115,0.98116,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
80896,NPL,Q9BXD5,0.663,0.577,1.5688e-07,DTO_05007624,Enzyme,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
80975,TMPRSS5,Q9H3S3,0.89,0.038,2.2562e-09,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
81025,GJA9,P57773,,,4.6528e-12,DTO_05007527,Cell-cell junction,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
81027,TUBB1,Q9H4B7,0.78,0.385,1.0217e-07,DTO_05007530,Cellular structure,C2751259,"Macrothrombocytopenia, Autosomal Dominant, Tubb1-Related",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.7,1.0,,2009.0,2014.0,ALL
81029,WNT5B,Q9H1J7,0.67,0.462,0.58535,DTO_05007599,Signaling,C0023267,Fibroid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2005.0,2005.0,ALL
81030,ZBP1,Q9H171,0.666,0.654,1.8259e-14,,,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.04,1.0,,2017.0,2019.0,ALL
81031,SLC2A10,O95528,0.55,0.615,1.5672e-08,DTO_05007405,Transporter,C1859726,ARTERIAL TORTUOSITY SYNDROME,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.8,0.913,strong,2003.0,2020.0,ALL
81033,KCNH6,Q9H252,0.736,0.269,7.1244e-31,DTO_01300327,Ion channel,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
81034,SLC25A32,Q9H2D1,0.821,0.115,6.7625e-09,DTO_05007405,Transporter,C4225187,"EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2017.0,ALL
81035,COLEC12,Q5KU26,0.76,0.423,0.90761,DTO_05007621,Extracellular structure,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
81037,CLPTM1L,Q96KA5,0.551,0.654,4.3885e-05,DTO_05007624,Enzyme,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.5,0.978,,2008.0,2019.0,ALL
81207,OR5BE1P,,,,,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
81246,OR52Q1P,,,,,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
81261,OR52H2P,,,,,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
81270,OR52B5P,,,,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
81282,OR51G2,Q8NGK0,,,0.0036881,DTO_02300001,G-protein coupled receptor,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
81285,OR51E2,Q9H255,0.751,0.192,0.00015308,DTO_02300001,G-protein coupled receptor,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.2,1.0,,2014.0,2014.0,ALL
81309,OR4C15,Q8NGM1,,,6.5425e-09,DTO_02300001,G-protein coupled receptor,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
81345,OR10Q2P,,,,,,,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
81363,OR7E108P,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
81488,POLR2M,P0CAP1;P0CAP2;Q6EEV4,0.89,0.269,0.031082,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
81491,GPR63,Q9BZJ6,0.839,0.154,0.19747,DTO_02300001,G-protein coupled receptor,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
81492,RSPH6A,Q9H0K4,0.821,0.308,2.3355e-10,DTO_05007530,Cellular structure,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
81493,SYNC,Q9H7C4,,,1.8569e-05,,,C0027868,Neuromuscular Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
81494,CFHR5,Q9BXR6,0.659,0.385,2.1117e-32,,,C3553720,CFHR5 DEFICIENCY,,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2017.0,ALL
81501,DCSTAMP,Q9H295,0.722,0.346,1.8609e-06,,,C0029401,Osteitis Deformans,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.45,0.833,,2010.0,2019.0,ALL
81502,HM13,Q8TCT9,0.628,0.538,0.68958,DTO_05007624,Enzyme,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
81532,MOB2,Q70IA6,0.78,0.269,0.051345,DTO_05007584,Enzyme modulator,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
81533,ITFG1,Q8TB96,0.736,0.423,0.071163,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
81537,SGPP1,Q9BX95,0.792,0.192,0.0001389,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2017.0,ALL
81539,SLC38A1,Q9H2H9,0.615,0.769,0.93067,DTO_05007405,Transporter,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
81542,TMX1,Q9H3N1,0.76,0.269,0.00074607,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
81543,LRRC3,Q9BY71,1.0,0.077,0.0027024,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
81544,GDPD5,Q8WTR4,0.76,0.308,0.00025041,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
81545,FBXO38,Q6PIJ6,0.792,0.115,0.99879,,,C3888271,"NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2013.0,2013.0,ALL
81550,TDRD3,Q9H7E2,0.861,0.192,4.1011e-06,,,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2012.0,2019.0,ALL
81551,STMN4,Q9H169,0.861,0.115,0.090756,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2009.0,2009.0,ALL
81552,VOPP1,Q96AW1,0.711,0.423,0.32523,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2008.0,2008.0,ALL
81553,CYRIA,Q9H0Q0,0.89,0.192,0.20603,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
81554,RCC1L,Q96I51,0.89,0.154,0.00086789,,,C0339528,X-linked retinitis pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.02,1.0,,2005.0,2006.0,ALL
81555,YIPF5,Q969M3,0.89,0.077,0.98529,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
81556,INTS14,Q96SY0,,,9.833e-06,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2017.0,2017.0,ALL
81557,MAGED4B,Q96JG8,0.612,0.423,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1994.0,2007.0,ALL
81558,FAM117A,Q9C073,,,5.9668e-05,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
81559,TRIM11,Q96F44,0.686,0.385,0.91729,,,C0038868,Progressive supranuclear palsy,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.11,1.0,,2018.0,2018.0,ALL
81562,LMAN2L,Q9H0V9,0.641,0.385,1.9629e-11,DTO_05007405,Transporter,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.61,1.0,,2013.0,2019.0,ALL
81563,C1orf21,Q9H246,0.89,0.154,0.89204,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
81565,NDEL1,Q9GZM8,0.666,0.462,0.98351,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.75,,2007.0,2019.0,ALL
81567,TXNDC5,Q8NBS9,0.615,0.577,4.872e-13,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.35,1.0,,2011.0,2018.0,ALL
81569,ACTL8,Q9H568,0.769,0.192,0.31835,DTO_05007530,Cellular structure,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
81570,CLPB,Q9H078,0.631,0.654,0.00049945,,,C4225393,3-methylglutaconic aciduria type 7,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2015.0,2017.0,ALL
81572,PDRG1,Q9NUG6,0.76,0.231,0.00025916,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
81575,APOLD1,Q96LR9,0.89,0.192,0.00011689,DTO_05007405,Transporter,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2016.0,2016.0,ALL
81576,CCDC130,P13994,,,0.0031562,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
81577,GFOD2,Q3B7J2,1.0,0.038,0.046624,DTO_05007624,Enzyme,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
81578,COL21A1,Q96P44,0.861,0.154,5.2336e-24,DTO_05007575,Receptor,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
81579,PLA2G12A,Q9BZM1,0.805,0.192,0.00037886,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
81602,CDADC1,Q9BWV3,,,3.1468e-10,DTO_05007624,Enzyme,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
81603,TRIM8,Q9BZR9,0.588,0.731,0.99438,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,strong,2013.0,2013.0,ALL
81605,URM1,Q9BTM9,0.89,0.154,0.031327,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
81606,LBH,Q53QV2,0.686,0.5,0.01436,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
81607,NECTIN4,Q96NY8,0.599,0.538,0.8353,,,C3150807,ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1,,,disease,Disease or Syndrome,0.73,1.0,strong,2010.0,2018.0,ALL
81608,FIP1L1,Q6UN15,0.575,0.577,0.7889,,,C0206141,Idiopathic Hypereosinophilic Syndrome,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.4,0.981,,2003.0,2019.0,ALL
81609,SNX27,Q96L92,0.722,0.346,0.99977,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2020.0,ALL
81610,FAM83D,Q9H4H8,0.769,0.192,3.128e-08,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2016.0,2019.0,ALL
81611,ANP32E,Q9BTT0,0.839,0.115,0.84376,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
81614,NIPA2,Q8N8Q9,0.805,0.192,0.92086,DTO_05007405,Transporter,C0014553,Absence Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,2012.0,2019.0,ALL
81615,TMEM163,Q8TC26,0.805,0.269,0.039734,,,C0033687,Proteinuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.2,1.0,,2011.0,2011.0,ALL
81616,ACSBG2,Q5FVE4,0.931,0.192,1.0757e-10,DTO_05007624,Enzyme,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
81617,CAB39L,Q9H9S4,0.769,0.192,6.3887e-05,DTO_05007616,Calcium-binding protein,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
81618,ITM2C,Q9NQX7,1.0,0.115,0.70418,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
81619,TSPAN14,Q8NG11,0.78,0.231,0.97908,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
81620,CDT1,Q9H211,0.597,0.731,2.5825e-10,,,C1868684,"EAR, PATELLA, SHORT STATURE SYNDROME",C23;C16;C05;C07;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.62,1.0,,2011.0,2018.0,ALL
81621,KAZALD1,Q96I82,0.769,0.115,9.6662e-07,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
81622,UNC93B1,Q9H1C4,0.666,0.538,0.1428,,,C0276226,Herpes encephalitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.64,1.0,,2006.0,2010.0,ALL
81623,DEFB126,Q9BYW3,0.78,0.231,0.40842,,,C0729353,Subfertility,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.03,1.0,,2011.0,2016.0,ALL
81624,DIAPH3,Q9NSV4,0.656,0.462,1.9877e-15,,,C1836743,"AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.71,1.0,moderate,2010.0,2018.0,ALL
81628,TSC22D4,Q9Y3Q8,0.839,0.154,0.96057,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
81629,TSSK3,Q96PN8,1.0,,0.057013,DTO_03300101,Kinase,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
81631,MAP1LC3B,Q9GZQ8,0.506,0.846,0.0019065,DTO_05007530,Cellular structure,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
81669,CCNL2,Q96S94,0.792,0.308,0.16094,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
81671,VMP1,Q96GC9,0.674,0.462,0.96271,DTO_05007599,Signaling,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.11,0.667,,2013.0,2019.0,ALL
81689,ISCA1,Q9BUE6,0.792,0.231,0.17085,,,C4539919,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5,,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2018.0,ALL
81693,AMN,Q9BXJ7,0.678,0.577,0.00026529,,,C4551825,Megaloblastic Anemia 1,C23;C06;C18;C13;C12;C15,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.77,1.0,,2003.0,2018.0,ALL
81694,OR2W2P,,,,,,,C4049938,Physical Activity Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
81696,OR5V1,Q9UGF6,0.769,0.385,0.013153,DTO_02300001,G-protein coupled receptor,C0001175,Acquired Immunodeficiency Syndrome,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
81697,OR2B2,Q9GZK3,1.0,0.038,0.0099618,DTO_02300001,G-protein coupled receptor,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
81704,DOCK8,Q8NF50,0.578,0.731,1.487e-11,DTO_05007584,Enzyme modulator,C1968689,"Hyper-Immunoglobulin E Syndrome, Autosomal Recessive",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2009.0,2019.0,ALL
81706,PPP1R14C,Q8TAE6,0.861,0.115,0.002032,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2012.0,2012.0,ALL
81786,TRIM7,Q9C029,0.931,0.115,0.02684,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
81788,NUAK2,Q9H093,0.7,0.231,4.9899e-05,DTO_03300101,Kinase,C0346163,Endometrioid carcinoma ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,,,,,ALL
81790,RNF170,Q96K19,0.861,0.231,0.51091,,,C1837015,"ATAXIA, SENSORY, AUTOSOMAL DOMINANT",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2011.0,2011.0,ALL
81792,ADAMTS12,P58397,0.7,0.462,2.4806e-17,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
81793,TLR10,Q9BXR5,0.592,0.654,3.4787e-09,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.17,0.875,,2004.0,2019.0,ALL
81794,ADAMTS10,Q9H324,0.641,0.5,0.84288,DTO_05007624,Enzyme,C0265313,Weill-Marchesani syndrome,C16;C11;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.77,1.0,strong,2004.0,2019.0,ALL
81796,SLCO5A1,Q9H2Y9,0.78,0.346,1.5378e-06,DTO_05007405,Transporter,C1838162,Mesomelia-synostoses syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.31,1.0,limited,2010.0,2017.0,ALL
81797,OR12D3,Q9UGF7,0.743,0.385,0.0078534,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
81831,NETO2,Q8NC67,0.78,0.192,0.062704,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
81832,NETO1,Q8TDF5,0.839,0.115,0.052622,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
81839,VANGL1,Q8TAA9,0.57,0.538,0.020285,,,C0344490,Sacral agenesis,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.7,1.0,limited,2007.0,2007.0,ALL
81844,TRIM56,Q9BRZ2,0.729,0.5,0.00013625,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
81846,SBF2,Q86WG5,0.619,0.577,6.3771e-10,DTO_05007624,Enzyme,C1858278,"Charcot-Marie-Tooth disease, Type 4B2",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,,2003.0,2019.0,ALL
81847,RNF146,Q9NTX7,0.705,0.577,0.81992,,,C0008928,Cleidocranial Dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.21,1.0,,2017.0,2017.0,ALL
81848,SPRY4,Q9C004,0.553,0.769,0.0004821,DTO_05007599,Signaling,C3808971,HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.7,1.0,limited,2013.0,2013.0,ALL
81849,ST6GALNAC5,Q9BVH7,0.729,0.346,0.16967,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
81851,KRTAP1-1,Q07627,0.89,0.115,5.9686e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2017.0,2018.0,ALL
81853,TMEM14B,Q9NUH8,0.931,0.077,9.7154e-09,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
81854,ZNF205-AS1,,0.931,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2016.0,2016.0,ALL
81856,ZNF611,Q8N823,1.0,0.077,0.067163,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
81857,MED25,Q71SY5,0.582,0.654,8.4174e-07,DTO_05007542,Transcription factor,C1854150,"Charcot-Marie-Tooth disease, Type 2B2",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,limited,2009.0,2018.0,ALL
81858,SHARPIN,Q9H0F6,0.638,0.615,2.312e-05,DTO_05007624,Enzyme,C0011603,Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.35,1.0,,2010.0,2019.0,ALL
81864,EVR3,,1.0,0.077,,,,C1854002,EXUDATIVE VITREORETINOPATHY 3,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,,2001.0,2001.0,ALL
81865,BFIC2,,0.89,0.077,,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2012.0,2012.0,ALL
81876,RAB1B,Q9H0U4,0.705,0.423,0.88438,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
81887,LAS1L,Q9Y4W2,0.682,0.654,0.99955,,,C1839736,WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME,C23;C16;C18;C17;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,limited,2016.0,2016.0,ALL
81888,HYI,Q5T013,1.0,0.077,2.2375e-14,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
81889,FAHD1,Q6P587,1.0,0.077,1.9528e-12,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
81890,QTRT1,Q9BXR0,0.659,0.538,2.5932e-07,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
81892,SLIRP,Q9GZT3,1.0,0.115,9.7265e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
81894,SLC25A28,Q96A46,0.931,0.115,0.92954,DTO_05007405,Transporter,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
81928,CABLES2,Q9BTV7,0.805,0.077,0.00020975,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
81929,SEH1L,Q96EE3,1.0,0.038,0.14936,DTO_05007405,Transporter,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
81930,KIF18A,Q8NI77,0.729,0.308,0.0014835,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2014.0,2019.0,ALL
81931,ZNF93,P35789,0.78,0.115,0.00039048,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
83259,PCDH11Y,Q9BZA8,0.839,0.154,0.00016811,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.31,1.0,,2002.0,2006.0,ALL
83394,PITPNM3,Q9BZ71,0.705,0.385,0.99992,DTO_05007624,Enzyme,C1832976,Cone-Rod Dystrophy 5,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.72,1.0,limited,2003.0,2007.0,ALL
83401,ELOVL3,Q9HB03,0.805,0.269,0.01884,DTO_05007624,Enzyme,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.02,1.0,,2015.0,2018.0,ALL
83416,FCRL5,Q96RD9,0.722,0.462,4.6105e-17,DTO_05007620,Cell adhesion,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
83417,FCRL4,Q96PJ5,0.67,0.5,7.9109e-10,DTO_05007620,Cell adhesion,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
83439,TCF7L1,Q9HCS4,0.666,0.462,0.36022,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
83442,SH3BGRL3,Q9H299,0.751,0.308,0.149,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
83444,INO80B,Q9C086,0.792,0.192,0.75864,,,C0020175,Hunger,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.02,1.0,,2017.0,2019.0,ALL
83447,SLC25A31,Q9H0C2,0.931,0.038,7.3162e-10,DTO_05007405,Transporter,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
83449,PMFBP1,Q8TBY8,0.821,0.115,9.339e-34,,,C4748234,SPERMATOGENIC FAILURE 31,,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
83450,DRC3,Q9H069,1.0,0.038,2.5027e-09,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
83451,ABHD11,Q8NFV4,0.839,0.154,0.0029581,,,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
83452,RAB33B,Q9H082,0.821,0.192,0.67523,,,C3714896,SMITH-MCCORT DYSPLASIA 2,,,disease,Disease or Syndrome,0.6,1.0,strong,2012.0,2017.0,ALL
83460,EMC6,Q9BV81,0.769,0.154,0.52298,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
83461,CDCA3,Q99618,0.736,0.231,0.6885,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2015.0,2018.0,ALL
83463,MXD3,Q9BW11,0.743,0.231,0.0030954,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
83464,APH1B,Q8WW43,0.821,0.231,2.8377e-11,DTO_05007584,Enzyme modulator,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.14,0.8,,2008.0,2019.0,ALL
83468,GLT8D2,Q9H1C3,0.931,0.115,1.7287e-14,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
83473,KATNAL2,Q8IYT4,0.89,0.038,1.1784e-06,DTO_05007530,Cellular structure,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2017.0,2017.0,ALL
83475,DOHH,Q9BU89,0.743,0.154,0.015986,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
83478,ARHGAP24,Q8N264,0.456,0.808,3.9495e-10,,,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.31,1.0,limited,2011.0,2011.0,ALL
83479,DDX59,Q5T1V6,0.65,0.423,5.8502e-07,,,C1868118,Orofaciodigital syndrome 5,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.7,1.0,,2013.0,2019.0,ALL
83480,PUS3,Q9BZE2,0.78,0.346,1.4003e-08,DTO_05007624,Enzyme,C4310745,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
83481,EPPK1,P58107,0.931,0.154,1.0343e-37,DTO_05007530,Cellular structure,C0263454,Chloracne,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
83482,SCRT1,Q9BWW7,0.861,0.154,0.22224,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
83483,PLVAP,Q9BX97,0.695,0.538,2.3021e-06,,,C4748579,"DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE",,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2018.0,ALL
83538,TTC25,Q96NG3,0.674,0.538,,,,C4310721,"CILIARY DYSKINESIA, PRIMARY, 35",,,disease,Disease or Syndrome,0.8,1.0,,2016.0,2016.0,ALL
83539,CHST9,Q7L1S5,0.729,0.308,6.9512e-09,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
83540,NUF2,Q9BZD4,0.678,0.346,3.8169e-05,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2014.0,2019.0,ALL
83541,FAM110A,Q9BQ89,0.931,0.077,0.36091,,,C1260903,Dysfibrinogenemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
83543,AIF1L,Q9BQI0,0.821,0.192,0.0063739,DTO_05007616,Calcium-binding protein,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
83544,DNAL1,Q4LDG9,0.682,0.5,0.0088801,,,C3151460,"CILIARY DYSKINESIA, PRIMARY, 16",,,disease,Disease or Syndrome,0.7,1.0,,2011.0,2011.0,ALL
83546,RTBDN,Q9BSG5,0.839,0.038,3.0152e-10,,,C0014474,Ependymoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
83547,RILP,Q96NA2,0.89,0.154,4.3414e-11,DTO_05007557,Nucleic acid binding,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
83548,COG3,Q96JB2,0.931,0.192,0.99993,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
83549,UCK1,Q9HA47,0.839,0.115,1.0175e-05,DTO_03300101,Kinase,C0027743,Nerve compression syndrome,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0,,1999.0,1999.0,ALL
83550,GPR101,Q96P66,0.631,0.538,0.70375,DTO_02300001,G-protein coupled receptor,C4012409,"PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING",,,disease,Neoplastic Process,0.4,1.0,,2014.0,2014.0,ALL
83552,MFRP,Q9BY79,0.621,0.538,1.3093e-15,DTO_05007624,Enzyme,C1836006,NANOPHTHALMOS 2 (disorder),C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2005.0,2006.0,ALL
83590,TMUB1,Q9BVT8,0.861,0.269,0.036741,,,C1318485,Liver regeneration disorder,C06,   Digestive System Diseases,phenotype,Disease or Syndrome,0.03,1.0,,2018.0,2019.0,ALL
83592,AKR1E2,Q96JD6,0.805,0.269,2.0973e-11,DTO_05007624,Enzyme,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
83593,RASSF5,Q8WWW0,0.641,0.577,0.043347,DTO_05007584,Enzyme modulator,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2008.0,2012.0,ALL
83595,SOX7,Q9BT81,0.599,0.577,3.4831e-07,DTO_05007542,Transcription factor,C0019284,Diaphragmatic Hernia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Disease or Syndrome,0.21,1.0,,2012.0,2012.0,ALL
83596,BCL2L12,Q9HB09,0.606,0.654,3.8273e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
83597,RTP3,Q9BQQ7,0.861,0.115,0.20085,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
83598,LRRC2-AS1,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
83604,TMEM47,Q9BQJ4,0.821,0.154,0.79685,,,C0010964,Dandy-Walker Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
83605,CCM2,Q9BSQ5,0.636,0.385,0.0092809,,,C1864041,CEREBRAL CAVERNOUS MALFORMATIONS 2,C23;C16;C05;C10;F03;C07;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Stomatognathic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,1.0,1.0,strong,1988.0,2019.0,ALL
83606,GUCD1,Q96NT3,0.931,0.115,0.24228,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
83608,C18orf21,Q32NC0,1.0,0.077,5.6865e-07,,,C0040479,Torsades de Pointes,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
83636,C19orf12,Q9NSK7,0.641,0.615,0.34416,,,C3280371,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4,,,disease,Disease or Syndrome,0.73,1.0,,2010.0,2020.0,ALL
83637,ZMIZ2,Q8NF64,1.0,0.038,0.99981,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
83638,C11orf68,Q9H3H3,1.0,0.038,0.24562,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
83639,TEX101,Q9BY14,0.78,0.154,0.00079525,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
83640,RAMAC,Q9BTL3,0.839,0.115,0.008396,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
83641,FAM107B,Q9H098,0.722,0.538,7.4318e-08,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
83642,SELENOO,Q9BVL4,0.931,0.077,5.1473e-18,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
83643,CCDC3,Q9BQI4,0.861,0.077,0.0048709,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
83647,LINC00529,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
83648,FAM167A,Q96KS9,0.678,0.692,1.0164e-11,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
83655,LINC00208,,1.0,0.077,,,,C0279628,Adenocarcinoma Of Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
83656,FAM167A-AS1,Q96KT0,0.931,0.231,0.037394,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
83657,DYNLRB2,Q8TF09,0.861,0.077,6.1715e-05,DTO_05007530,Cellular structure,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
83658,DYNLRB1,Q9NP97,0.792,0.154,0.16147,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
83659,TEKT1,Q969V4,0.839,0.308,8.9486e-07,,,C2076600,Influenza due to Influenza A virus subtype H1N1,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
83660,TLN2,Q9Y4G6,0.76,0.231,0.99231,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.11,1.0,,2010.0,2018.0,ALL
83661,MS4A8,Q9BY19,0.861,0.115,2.4834e-05,DTO_05007575,Receptor,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
83666,PARP9,Q8IXQ6,0.554,0.808,4.998e-09,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0,,2013.0,2017.0,ALL
83667,SESN2,P58004,0.508,0.808,4.1912e-07,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2017.0,2019.0,ALL
83690,CRISPLD1,Q9H336,0.89,0.038,1.8207e-09,DTO_05007608,Immune response,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
83692,CD99L2,Q8TCZ2,1.0,0.077,0.00017021,,,C0014070,Encephalomyelitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
83693,HSDL1,Q3SXM5,0.821,0.192,0.0034111,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
83694,RPS6KL1,Q9Y6S9,1.0,0.038,1.2741e-07,DTO_03300101,Kinase,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
83695,RHNO1,Q9BSD3,0.89,0.077,0.0027455,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2010.0,2014.0,ALL
83696,TRAPPC9,Q96Q05,0.603,0.577,2.2898e-14,,,C2750791,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.6,1.0,strong,2009.0,2009.0,ALL
83697,SLC4A9,Q96Q91,0.839,0.192,3.2089e-22,DTO_05007405,Transporter,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.05,1.0,,2000.0,2015.0,ALL
83698,CALN1,Q9BXU9,0.76,0.385,0.031937,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.13,1.0,,2015.0,2019.0,ALL
83699,SH3BGRL2,Q9UJC5,0.839,0.115,1.5983e-07,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
83700,JAM3,Q9BX67,0.619,0.654,0.0006158,,,C3151000,"HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION, AND CATARACTS",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2013.0,ALL
83706,FERMT3,Q86UX7,0.638,0.538,0.00026014,,,C2748536,"Leukocyte Adhesion Deficiency, Type III",C16;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases",disease,Disease or Syndrome,0.93,1.0,definitive,2006.0,2020.0,ALL
83714,NRIP2,Q9BQI9,0.931,0.077,1.6264e-10,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
83715,ESPN,B1AK53,0.7,0.385,2.8667e-09,DTO_05007530,Cellular structure,C1837007,"DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT",,,disease,Disease or Syndrome,0.6,1.0,,1998.0,2017.0,ALL
83716,CRISPLD2,Q9H0B8,0.585,0.769,7.8157e-09,DTO_05007608,Immune response,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.31,1.0,,2010.0,2020.0,ALL
83719,YPEL3,P61236,0.805,0.231,0.041612,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
83723,TLCD3B,Q71RH2,0.705,0.346,0.66468,,,C4085590,Cone-Rod Dystrophies,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
83729,INHBE,P58166,0.821,0.308,1.1184e-08,DTO_05007599,Signaling,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
83732,RIOK1,Q9BRS2,0.751,0.231,2.2477e-14,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
83733,SLC25A18,Q9H1K4,0.821,0.154,1.8732e-07,DTO_05007405,Transporter,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,0.5,,1984.0,1986.0,ALL
83734,ATG10,Q9H0Y0,0.653,0.577,2.1789e-08,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.42,1.0,,2013.0,2018.0,ALL
83737,ITCH,Q96J02,0.556,0.769,0.99997,DTO_05007624,Enzyme,C3150649,"AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM",,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2016.0,ALL
83741,TFAP2D,Q7Z6R9,0.89,0.115,0.99199,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
83742,MARVELD1,Q9BSK0,0.751,0.192,0.35958,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2012.0,2019.0,ALL
83743,GRWD1,Q9BQ67,0.931,0.077,0.00039721,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
83744,ZNF484,Q5JVG2,0.805,0.115,1.156e-08,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
83746,L3MBTL2,Q969R5,0.729,0.308,1.0289e-08,DTO_05007557,Nucleic acid binding,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
83752,LONP2,Q86WA8,0.861,0.115,4.2411e-28,,,C0020458,Hyperhidrosis disorder,C17,   Skin and Connective Tissue Diseases,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
83756,TAS1R3,Q7RTX0,0.792,0.346,6.7868e-25,DTO_02300001,G-protein coupled receptor,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
83758,RBP5,P82980,0.89,0.192,4.9181e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
83786,FRMD8,Q9BZ67,1.0,0.038,0.11432,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
83787,ARMC10,Q8N2F6,0.931,0.115,0.00012123,,,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
83795,KCNK16,Q96T55,0.89,0.154,0.00010207,DTO_01300327,Ion channel,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.45,1.0,,2011.0,2019.0,ALL
83844,USP26,Q9BXU7,0.736,0.154,,DTO_05007624,Enzyme,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.1,0.846,,2005.0,2019.0,ALL
83850,ESYT3,A0FGR9,0.89,0.038,2.3108e-25,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
83851,SYT16,Q17RD7,,,2.0162e-06,,,C0019158,Hepatitis,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
83852,SETDB2,Q96T68,0.716,0.423,2.3171e-05,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
83853,ROPN1L,Q96C74,0.617,0.692,2.7455e-06,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
83854,ANGPTL6,Q8NI99,0.656,0.462,2.3705e-08,DTO_05007599,Signaling,C1862932,"ANEURYSM, INTRACRANIAL BERRY, 1 (disorder)",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
83855,KLF16,Q9BXK1,0.792,0.154,0.19517,DTO_05007557,Nucleic acid binding,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
83856,FSD1L,Q9BXM9,0.488,0.808,0.23386,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2011.0,2019.0,ALL
83857,TMTC1,Q8IUR5,0.743,0.269,1.329e-09,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.12,1.0,,2000.0,2019.0,ALL
83858,ATAD3B,Q5T9A4,0.792,0.231,1.0032e-22,DTO_05007624,Enzyme,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
83860,TAF3,Q5VWG9,0.931,0.038,0.99997,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
83861,RSPH3,Q86UC2,0.682,0.5,9.8725e-08,DTO_05007530,Cellular structure,C4225311,"CILIARY DYSKINESIA, PRIMARY, 32",,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2015.0,ALL
83868,TTTY13,Q9BZ97,1.0,0.038,,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
83871,RAB34,P0DI83;Q9BZG1,0.792,0.385,5.4311e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
83872,HMCN1,Q96RW7,0.736,0.577,3.6259e-38,,,C1864205,"Macular Degeneration, Age-Related, 1",C11,   Eye Diseases,disease,Disease or Syndrome,0.6,1.0,,2003.0,2003.0,ALL
83873,GPR61,Q9BZJ8,1.0,0.077,0.77771,DTO_02300001,G-protein coupled receptor,C0455829,Waist Circumference,,,phenotype,Clinical Attribute,0.1,1.0,,2015.0,2015.0,ALL
83874,TBC1D10A,Q9BXI6,0.931,0.077,0.0042922,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
83875,BCO2,Q9BYV7,0.78,0.231,3.7829e-18,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2014.0,2018.0,ALL
83876,MRO,Q9BYG7,0.729,0.346,1.7975e-06,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
83877,TM2D2,Q9BX73,1.0,0.115,0.0064454,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
83878,USHBP1,Q8N6Y0,0.705,0.269,2.9968e-17,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2010.0,2013.0,ALL
83879,CDCA7,Q9BWT1,0.626,0.654,0.010816,,,C4310799,IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3,,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2015.0,ALL
83881,MIXL1,Q9H2W2,0.666,0.654,0.017075,,,C0598766,Leukemogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.02,1.0,,2007.0,2014.0,ALL
83882,TSPAN10,Q9H1Z9,0.821,0.269,9.7125e-06,,,C0339682,Regular astigmatism - corneal,C11,   Eye Diseases,disease,Disease or Syndrome,0.11,1.0,,2018.0,2018.0,ALL
83884,SLC25A2,Q9BXI2,1.0,0.154,0.0022001,DTO_05007405,Transporter,C0268540,HHH syndrome,C23;C16;C18;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,0.5,,2003.0,2006.0,ALL
83886,PRSS27,Q9BQR3,0.805,0.154,8.0112e-05,DTO_05007624,Enzyme,C0027022,Myeloproliferative disease,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
83888,FGFBP2,Q9BYJ0,0.805,0.385,0.0038934,,,C0149678,Epstein-Barr Virus Infections,C01,   Infections,group,Disease or Syndrome,0.02,1.0,,2001.0,2016.0,ALL
83889,WDR87,Q6ZQQ6,0.931,0.038,6.1602e-20,,,C0086543,Cataract,C11,   Eye Diseases,disease,Acquired Abnormality,0.01,1.0,,2017.0,2017.0,ALL
83890,SPATA9,Q9BWV2,0.931,0.115,3.4805e-05,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
83891,SNX25,Q9H3E2,0.931,0.038,8.178e-05,DTO_05007584,Enzyme modulator,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
83892,KCTD10,Q9H3F6,0.805,0.231,0.86253,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.12,1.0,,2011.0,2019.0,ALL
83893,SPATA16,Q9BXB7,0.861,0.154,1.4475e-10,,,C0403825,Globozoospermia,C12,   Male Urogenital Diseases,phenotype,Finding,0.6,1.0,,2007.0,2007.0,ALL
83894,TTC29,Q8NA56,,,1.3375e-08,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
83903,HASPIN,Q8TF76,0.931,0.115,4.9913e-07,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
83931,STK40,Q8N2I9,0.839,0.231,0.99624,DTO_03300101,Kinase,C1319315,Adenocarcinoma of large intestine,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
83932,SPRTN,Q9H040,0.691,0.5,0.97354,,,C4015461,RUIJS-AALFS SYNDROME,,,disease,Disease or Syndrome,0.73,1.0,,2014.0,2017.0,ALL
83933,HDAC10,Q969S8,0.695,0.346,2.9729e-31,DTO_05007378,Epigenetic regulator,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
83937,RASSF4,Q9H2L5,0.736,0.346,1.7281e-13,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
83938,LRMDA,Q9H2I8,0.659,0.577,0.0002589,,,C3808786,"ALBINISM, OCULOCUTANEOUS, TYPE VII",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2016.0,ALL
83939,EIF2A,Q9BY44,0.78,0.346,6.0385e-09,DTO_05007624,Enzyme,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2019.0,2019.0,ALL
83940,TATDN1,Q6P1N9,0.839,0.192,6.4923e-16,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2019.0,ALL
83941,TM2D1,Q9BX74,1.0,0.077,0.00010999,,,C0029443,Osteomyelitis,C01;C05,   Infections;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2000.0,2000.0,ALL
83942,TSSK1B,Q9BXA7,0.792,0.154,0.00013409,DTO_03300101,Kinase,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.2,1.0,,2004.0,2004.0,ALL
83943,IMMP2L,Q96T52,0.628,0.577,0.011165,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2007.0,2014.0,ALL
83953,FCAMR,Q8WWV6,1.0,0.038,4.483e-10,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
83955,NACA4P,Q9BZK3,1.0,0.038,,DTO_05007542,Transcription factor,C1456145,Dental caries of smooth surface,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
83956,RACGAP1P,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
83959,SLC4A11,Q8NBS3,0.674,0.385,4.6435e-15,DTO_05007405,Transporter,C1857569,CORNEAL ENDOTHELIAL DYSTROPHY 2,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,1.0,1.0,,2006.0,2020.0,ALL
83983,TSSK6,Q9BXA6,,,0.741,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
83985,SPNS1,Q9H2V7,0.716,0.385,0.020414,DTO_05007405,Transporter,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
83986,FAM234A,Q9H0X4,1.0,0.077,1.459e-12,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2017.0,2018.0,ALL
83987,CCDC8,Q9H0W5,0.599,0.692,0.25395,,,C1848862,Miller-McKusick-Malvaux-Syndrome (3M Syndrome),C23;C16;C05;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.55,1.0,limited,2011.0,2017.0,ALL
83988,NCALD,P61601,0.751,0.385,0.8931,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
83989,FAM172A,Q8WUF8,0.792,0.192,0.00024392,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
83990,BRIP1,Q9BX63,0.507,0.731,6.206e-17,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.8,0.951,,2001.0,2020.0,ALL
83992,CTTNBP2,Q8WZ74,0.722,0.5,1.7221e-11,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
83998,REG4,Q9BYZ8,0.615,0.385,0.00075276,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.39,1.0,,2007.0,2018.0,ALL
83999,KREMEN1,Q96MU8,0.729,0.462,0.011362,DTO_05007575,Receptor,C4479322,"ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE",,,disease,Disease or Syndrome,0.6,1.0,limited,2016.0,2016.0,ALL
84000,TMPRSS13,Q9BYE2,0.545,0.846,1.4759e-08,DTO_05007624,Enzyme,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.1,0.957,,1994.0,2019.0,ALL
84002,B3GNT5,Q9BYG0,1.0,0.038,0.72579,DTO_05007624,Enzyme,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
84033,OBSCN,Q5VST9,0.736,0.538,1.8605e-164,DTO_03300101,Kinase,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.32,1.0,limited,2001.0,2019.0,ALL
84034,EMILIN2,Q9BXX0,0.861,0.115,1.6186e-14,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2014.0,2018.0,ALL
84056,KATNAL1,Q9BW62,0.839,0.269,0.53169,DTO_05007530,Cellular structure,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.02,1.0,,2014.0,2018.0,ALL
84057,MND1,Q9BWT6,1.0,0.038,3.2813e-09,,,C4021107,Non-obstructive azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
84058,WDR54,Q9H977,0.931,0.077,1.5733e-11,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
84059,ADGRV1,Q8WXG9,0.572,0.731,3.1737e-39,DTO_02300001,G-protein coupled receptor,C2931213,"Usher syndrome, type 2C",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.94,1.0,definitive,1998.0,2018.0,ALL
84060,RBM48,Q5RL73,1.0,0.077,1.5329e-07,,,C0687120,Nephronophthisis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
84061,MAGT1,Q9H0U3,0.548,0.769,0.96138,DTO_05007405,Transporter,C3275445,"X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.73,1.0,,2011.0,2020.0,ALL
84062,DTNBP1,Q96EV8,0.588,0.615,6.8375e-06,,,C3279756,HERMANSKY-PUDLAK SYNDROME 7,,,disease,Disease or Syndrome,0.8,1.0,,1991.0,2017.0,ALL
84063,KIRREL2,Q6UWL6,0.89,0.077,5.805e-10,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
84064,HDHD2,Q9H0R4,,,3.8702e-06,DTO_05007624,Enzyme,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
84066,TEX35,Q5T0J7,1.0,0.077,9.433e-08,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2018.0,ALL
84067,FAM160A2,Q8N612,,,0.99023,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
84068,SLC10A7,Q0GE19,0.711,0.269,1.9761e-05,DTO_05007405,Transporter,C0029422,Osteochondrodysplasias,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Disease or Syndrome,0.31,1.0,strong,2018.0,2018.0,ALL
84069,PLEKHN1,Q494U1,1.0,0.038,1.1549e-14,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84070,FAM186B,Q8IYM0,1.0,0.077,5.5062e-24,,,C0687120,Nephronophthisis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
84071,ARMC2,Q8NEN0,0.805,0.115,2.4785e-09,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.31,1.0,,2019.0,2019.0,ALL
84072,HORMAD1,Q86X24,0.751,0.346,0.94885,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
84073,MYCBPAP,Q8TBZ2,0.769,0.231,9.491e-09,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0,,2005.0,2019.0,ALL
84074,QRICH2,Q9H0J4,0.861,0.308,1.0765e-28,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
84075,FSCB,Q5H9T9,1.0,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84076,TKTL2,Q9H0I9,0.861,0.115,1.1378e-07,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
84077,C3orf20,Q8ND61,1.0,0.115,2.381e-21,,,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
84078,KBTBD7,Q8WVZ9,0.89,0.154,3.5716e-06,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
84079,ANKRD27,Q96NW4,0.861,0.269,3.8647e-31,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84080,ENKD1,Q9H0I2,,,2.5321e-08,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
84081,NSRP1,Q9H0G5,1.0,0.077,0.012099,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84083,ZRANB3,Q5FWF4,0.78,0.577,4.2341e-21,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.12,0.5,,2019.0,2019.0,ALL
84084,RAB6C,Q9H0N0,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
84085,FBXO30,Q8TB52,1.0,0.077,0.35835,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
84100,ARL6,Q9H0F7,0.636,0.462,0.01013,,,C1859564,Bardet-Biedl syndrome 3,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.72,1.0,,2004.0,2013.0,ALL
84101,USP44,Q9H0E7,0.705,0.385,9.8051e-15,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
84102,SLC41A2,Q96JW4,0.931,0.077,0.96597,DTO_05007405,Transporter,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
84103,C4orf17,Q53FE4,1.0,,1.2018e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84105,PCBD2,Q9H0N5,0.821,0.231,0.026044,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
84106,PRAM1,Q96QH2,0.7,0.462,0.0003004,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,1994.0,2008.0,ALL
84107,ZIC4,Q8N9L1,0.705,0.423,0.00049286,DTO_05007542,Transcription factor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
84108,PCGF6,Q9BYE7,,,5.1527e-05,DTO_05007624,Enzyme,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
84109,QRFPR,Q96P65,0.821,0.231,7.8556e-11,DTO_02300001,G-protein coupled receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
84124,ZNF394,Q53GI3,,,2.2429e-06,,,C0201983,Dehydroepiandrosterone sulfate measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
84126,ATRIP,Q8WXE1,0.666,0.692,1.9918e-05,,,C0265202,Seckel syndrome,C23;C16;C05;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.51,1.0,limited,2012.0,2012.0,ALL
84129,ACAD11,Q709F0,,,5.1833e-15,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84131,CEP78,Q5JTW2,0.686,0.346,6.1656e-12,,,C4310657,CONE-ROD DYSTROPHY AND HEARING LOSS,,,disease,Disease or Syndrome,0.71,1.0,strong,2016.0,2017.0,ALL
84132,USP42,Q9H9J4,0.839,0.077,1.0,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2006.0,2019.0,ALL
84133,ZNRF3,Q9ULT6,0.691,0.385,0.98884,,,C0206686,Adrenocortical carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2014.0,2016.0,ALL
84134,TOMM40L,Q969M1,1.0,0.077,0.66713,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
84135,UTP15,Q8TED0,,,0.99993,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
84138,SLC7A6OS,Q96CW6,1.0,0.038,0.16755,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2019.0,ALL
84140,FAM161A,Q3B820,0.691,0.308,5.1034e-13,,,C1419614,RETINITIS PIGMENTOSA 28,,,disease,Disease or Syndrome,0.81,1.0,,2010.0,2015.0,ALL
84141,EVA1A,Q9H8M9,0.736,0.346,0.065594,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,0.833,,2012.0,2018.0,ALL
84142,ABRAXAS1,Q6UWZ7,0.76,0.269,5.0739e-07,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,0.714,,2009.0,2019.0,ALL
84146,ZNF644,Q9H582,0.821,0.192,0.99914,DTO_05007542,Transcription factor,C3279997,"MYOPIA 21, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.6,1.0,,2011.0,2014.0,ALL
84148,KAT8,Q9H7Z6,0.592,0.654,0.22493,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
84152,PPP1R1B,Q9UD71,0.617,0.5,0.24098,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.6,1.0,,2006.0,2019.0,ALL
84153,RNASEH2C,Q8TDP1,0.59,0.731,0.0054985,,,C1835916,AICARDI-GOUTIERES SYNDROME 3,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2018.0,ALL
84154,RPF2,Q9H7B2,,,0.046405,DTO_05007624,Enzyme,C0456909,Blindness,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
84159,ARID5B,Q14865,0.638,0.5,1.0,DTO_05007542,Transcription factor,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.48,1.0,,2009.0,2019.0,ALL
84162,KIAA1109,Q2LD37,0.603,0.654,3.2559e-21,,,C4693347,ALKURAYA-KUCINSKAS SYNDROME,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2019.0,ALL
84163,GTF2IRD2,Q86UP8,0.931,0.154,3.1521e-08,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2017.0,ALL
84164,ASCC2,Q9H1I8,0.633,0.615,0.031027,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2017.0,2018.0,ALL
84166,NLRC5,Q86WI3,0.653,0.5,9.4211e-08,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84168,ANTXR1,Q9H6X2,0.584,0.731,0.98631,DTO_05007575,Receptor,C0406723,"Growth retardation, Alopecia, Pseudoanodontia and Optic atrophy",C23;C16;C11;C17;C10;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.77,0.857,,1990.0,2019.0,ALL
84171,LOXL4,Q96JB6,0.65,0.423,9.1912e-20,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.33,1.0,,2007.0,2018.0,ALL
84172,POLR1B,Q9H9Y6,0.931,0.192,0.99946,DTO_05007624,Enzyme,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
84173,ELMOD3,Q96FG2,0.821,0.269,5.0378e-16,DTO_05007599,Signaling,C2829267,"DEAFNESS, AUTOSOMAL RECESSIVE 88",,,disease,Disease or Syndrome,0.7,1.0,limited,2013.0,2013.0,ALL
84174,SLA2,Q9H6Q3,0.722,0.423,0.076311,DTO_05007584,Enzyme modulator,C0406208,Suntan,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
84179,SLC49A3,Q6UXD7,,,3.0952e-18,DTO_05007405,Transporter,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
84181,CHD6,Q8TD26,0.78,0.346,1.0,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
84182,MINDY4,Q4G0A6,0.538,0.731,3.2175e-19,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2001.0,2018.0,ALL
84186,ZCCHC7,Q8N3Z6,0.839,0.231,3.8612e-09,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
84187,TMEM164,Q5U3C3,0.792,0.154,0.94373,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
84188,FAR1,Q8WVX9,0.751,0.423,0.98504,,,C4015344,PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
84189,SLITRK6,Q9H5Y7,0.76,0.269,5.6989e-14,,,C3806275,DEAFNESS AND MYOPIA,,,disease,Disease or Syndrome,0.71,1.0,strong,2009.0,2018.0,ALL
84190,METTL25,Q8N6Q8,0.931,0.038,9.188e-13,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
84191,CIAO2A,Q9H5X1,0.931,0.077,1.9655e-05,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84193,SETD3,Q86TU7,0.76,0.423,0.02084,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2013.0,2019.0,ALL
84196,USP48,Q86UV5,0.743,0.308,1.0,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2019.0,2019.0,ALL
84197,POMK,Q9H5K3,0.59,0.5,1.9487e-08,DTO_03300101,Kinase,C4015184,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2018.0,ALL
84203,TXNDC2,Q86VQ3,1.0,0.038,0.6341,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
84206,MEX3B,Q6ZN04,0.931,0.077,0.55508,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
84215,ZNF541,Q9H0D2,1.0,0.077,1.0,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84216,TMEM117,Q9H0C3,0.821,0.077,2.9608e-06,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
84221,SPATC1L,Q9H0A9,0.792,0.154,1.7055e-08,,,C0011053,Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Finding,0.3,1.0,,2019.0,2019.0,ALL
84223,IQCG,Q9H095,0.861,0.154,3.022e-21,,,C1260899,"Anemia, Diamond-Blackfan",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
84224,NBPF3,Q9H094,0.931,0.115,8.0766e-19,,,C0201850,Alkaline phosphatase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
84225,ZMYND15,Q9H091,0.861,0.038,5.2919e-12,,,C4014454,SPERMATOGENIC FAILURE 14,,,disease,Disease or Syndrome,0.4,,,,,ALL
84226,C2orf16,Q68DN1,0.89,0.115,1.3435e-14,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2013.0,ALL
84230,LRRC8C,Q8TDW0,,,0.00078506,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84231,TRAF7,Q6Q0C0,0.623,0.423,0.021819,,,C4748484,"CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY",,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2018.0,ALL
84232,MAF1,Q9H063,0.78,0.231,0.94812,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2015.0,2019.0,ALL
84233,TMEM126A,Q9H061,0.805,0.269,0.002157,,,C2751812,OPTIC ATROPHY 7 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2009.0,2019.0,ALL
84236,RHBDD1,Q8TEB9,0.751,0.231,1.0582e-12,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84239,ATP13A4,Q4VNC1,0.861,0.077,3.3306e-26,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
84240,ZCCHC9,Q8N567,0.839,0.115,0.0011065,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
84243,ZDHHC18,Q9NUE0,0.861,0.154,0.0024011,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2019.0,2019.0,ALL
84245,MRI1,Q9BV20,0.839,0.231,0.00040621,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2009.0,2018.0,ALL
84247,RTL6,Q6ICC9,0.861,0.115,0.018186,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
84248,FYTTD1,Q96QD9,1.0,0.038,0.39504,,,C0019340,Herpes NOS,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
84249,PSD2,Q9BQI7,0.89,0.192,0.00022099,,,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
84250,SLF1,Q9BQI6,1.0,0.038,5.8495e-10,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
84251,SGIP1,Q9BQI5,0.89,0.154,0.99997,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.5,,2010.0,2016.0,ALL
84253,GARNL3,Q5VVW2,,,6.8913e-06,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
84254,CAMKK1,Q8N5S9,0.861,0.154,0.00033981,DTO_03300101,Kinase,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
84255,SLC37A3,Q8NCC5,1.0,0.077,1.124e-13,DTO_05007405,Transporter,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,moderate,2017.0,2017.0,ALL
84256,FLYWCH1,Q4VC44,0.839,0.115,8.6719e-19,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
84258,SYT3,Q9BQG1,1.0,0.077,0.80772,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84259,DCUN1D5,Q9BTE7,1.0,0.115,0.99432,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
84260,TCHP,Q9BT92,0.57,0.692,1.8026e-16,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
84262,PSMG3,Q9BT73,0.931,0.154,0.2003,,,C0011119,Decompression Sickness,C26,   Wounds and Injuries,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
84263,HSDL2,Q6YN16,0.711,0.346,5.1377e-05,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
84264,HAGHL,Q6PII5,,,1.984e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84265,POLR3GL,Q9BT43,0.839,0.231,2.3404e-05,DTO_05007624,Enzyme,C4082304,Oligodontia,,,disease,Congenital Abnormality,0.12,1.0,,2020.0,2020.0,ALL
84266,ALKBH7,Q9BT30,0.89,0.154,1.7207e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
84267,C9orf64,Q5T6V5,,,1.0255e-06,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
84268,RPAIN,Q86UA6,0.619,0.692,5.5657e-11,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84269,CHCHD5,Q9BSY4,0.839,0.192,0.049956,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
84271,POLDIP3,Q9BY77,0.76,0.385,0.11779,DTO_05007557,Nucleic acid binding,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,1.0,,2012.0,2013.0,ALL
84272,YIPF4,Q9BSR8,,,0.06083,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84273,NOA1,Q8NC60,0.821,0.192,9.6433e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84274,COQ5,Q5HYK3,0.89,0.192,2.8412e-05,DTO_05007624,Enzyme,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
84275,SLC25A33,Q9BSK2,0.89,0.115,0.0059223,DTO_05007405,Transporter,C0175683,Citrullinemia,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
84276,NICN1,Q9BSH3,0.931,0.154,0.038834,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
84277,DNAJC30,Q96LL9,1.0,0.115,0.023092,,,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
84279,PRADC1,Q9BSG0,1.0,0.077,1.4051e-05,,,C0034186,Pyelonephritis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,1987.0,1989.0,ALL
84280,BTBD10,Q9BSF8,0.89,0.154,0.0029452,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
84281,C2orf88,Q9BSF0,0.821,0.192,0.0027643,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
84282,RNF135,Q8IUD6,0.686,0.5,2.1992e-09,,,C3280095,"MACROCEPHALY, MACROSOMIA, AND FACIAL DYSMORPHISM SYNDROME",,,disease,Disease or Syndrome,0.5,1.0,limited,2007.0,2015.0,ALL
84283,TMEM79,Q9BSE2,0.821,0.192,4.3888e-06,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.24,1.0,,2013.0,2018.0,ALL
84284,NTPCR,Q9BSD7,0.805,0.115,0.0025124,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,1.0,,1999.0,2004.0,ALL
84285,EIF1AD,Q8N9N8,0.931,0.077,0.0034032,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
84286,TMEM175,Q9BSA9,0.861,0.154,3.0549e-09,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.16,1.0,,2011.0,2020.0,ALL
84287,ZDHHC16,Q969W1,0.89,0.154,0.00016495,,,C0020102,HTLV-II Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
84288,EFCAB2,Q5VUJ9,0.792,0.115,5.9198e-07,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
84289,ING5,Q8WYH8,0.617,0.462,0.61851,DTO_05007557,Nucleic acid binding,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2010.0,2019.0,ALL
84290,CAPNS2,Q96L46,0.89,0.154,0.0019337,,,C0009952,Febrile Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
84292,WDR83,Q9BRX9,0.89,0.192,6.4459e-12,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84293,PRXL2A,Q9BRX8,0.861,0.154,1.9627e-10,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
84294,UTP23,Q9BRU9,0.711,0.385,0.086364,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.12,1.0,,2012.0,2019.0,ALL
84295,PHF6,Q8IWS0,0.581,0.692,0.99784,DTO_05007557,Nucleic acid binding,C0265339,Borjeson-Forssman-Lehmann syndrome,C23;C16;C18;C10;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,2002.0,2020.0,ALL
84296,GINS4,Q9BRT9,0.769,0.308,0.00013735,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
84299,MIEN1,Q9BRT3,0.751,0.269,0.55257,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
84300,UQCC2,Q9BRT2,0.705,0.462,0.01866,,,C4014408,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7",,,disease,Disease or Syndrome,0.4,1.0,,2013.0,2013.0,ALL
84301,DDI2,Q5TDH0,1.0,0.077,0.99819,DTO_05007624,Enzyme,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
84303,CHCHD6,Q9BRQ6,0.839,0.269,5.5744e-09,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
84305,PYM1,Q9BRP8,1.0,0.077,0.021852,,,C0206608,Flavivirus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
84309,NUDT16L1,Q9BRJ7,,,0.00012536,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2017.0,2017.0,ALL
84310,C7orf50,Q9BRJ6,1.0,0.077,3.4242e-06,,,C0023980,Longevity,,,phenotype,Temporal Concept,0.1,1.0,,2010.0,2010.0,ALL
84312,BRMS1L,Q5PSV4,0.67,0.346,0.057843,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2004.0,2019.0,ALL
84314,TMEM107,Q6UX40,0.592,0.692,3.0521e-08,,,C4539729,OROFACIODIGITAL SYNDROME XVI,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2016.0,ALL
84315,MON1A,Q86VX9,,,2.2952e-09,,,C0012715,Iron Metabolism Disorders,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
84316,NAA38,Q9BRA0,,,9.7053e-07,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
84317,CCDC115,Q96NT0,0.743,0.308,1.2061e-07,,,C4225191,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo",,,disease,Congenital Abnormality,0.7,1.0,,2016.0,2016.0,ALL
84318,CCDC77,Q9BR77,1.0,0.077,8.0291e-20,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
84319,CMSS1,Q9BQ75,0.839,0.269,0.0011173,DTO_05007624,Enzyme,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2012.0,2017.0,ALL
84320,ACBD6,Q9BR61,0.89,0.269,2.2569e-06,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.5,1.0,limited,2011.0,2011.0,ALL
84324,SARNP,P82979,0.678,0.5,0.99574,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
84327,ZBED3,Q96IU2,0.805,0.231,0.082483,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2019.0,2019.0,ALL
84328,LZIC,Q8WZA0,0.861,0.077,0.0011711,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.2,1.0,,2009.0,2009.0,ALL
84329,HVCN1,Q96D96,0.751,0.346,0.62735,DTO_01300327,Ion channel,C0740392,"Infarction, Middle Cerebral Artery",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,2019.0,2019.0,ALL
84332,DYDC2,Q96IM9,,,0.0034876,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
84333,PCGF5,Q86SE9,0.931,0.077,0.98007,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84334,COA8,Q96IL0,0.682,0.538,0.00020615,,,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.72,1.0,,2014.0,2019.0,ALL
84335,AKT1S1,Q96B36,0.615,0.385,0.111,,,C0035126,Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Injury or Poisoning,0.3,1.0,,2006.0,2006.0,ALL
84337,ELOF1,P60002,0.736,0.346,0.090121,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0,,2002.0,2008.0,ALL
84340,GFM2,Q969S9,0.736,0.269,1.4922e-18,DTO_05007624,Enzyme,C0003886,Arthrogryposis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.31,1.0,limited,2015.0,2015.0,ALL
84342,COG8,Q96MW5,0.653,0.5,2.9725e-09,,,C1970021,"Congenital Disorder Of Glycosylation, Type IIH",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.72,1.0,,2002.0,2016.0,ALL
84343,HPS3,Q969F9,0.769,0.308,2.9433e-21,,,C3888001,HERMANSKY-PUDLAK SYNDROME 3,,,disease,Disease or Syndrome,0.82,1.0,,1988.0,2017.0,ALL
84364,ARFGAP2,Q8N6H7,0.89,0.115,0.0048866,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
84365,NIFK,Q9BYG3,1.0,0.077,0.00027756,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
84366,PRAC1,Q96KF2,0.89,0.077,0.01593,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.04,1.0,,2001.0,2017.0,ALL
84376,HOOK3,Q86VS8,0.78,0.308,1.0,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84417,ECRG4,Q9H1Z8,0.7,0.346,0.00040522,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84418,CYSTM1,Q9H1C7,0.931,0.192,0.42254,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
84419,C15orf48,Q9C002,0.839,0.154,5.5498e-05,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2002.0,2008.0,ALL
84432,PROK1,P58294,0.636,0.462,6.1702e-06,DTO_05007599,Signaling,C3495676,Anorectal Malformations,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",group,Anatomical Abnormality,0.3,1.0,,2013.0,2013.0,ALL
84433,CARD11,Q9BXL7,0.582,0.615,0.99995,,,C4551967,B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY,,,disease,Disease or Syndrome,0.71,1.0,strong,2012.0,2017.0,ALL
84435,ADGRA1,Q86SQ6,1.0,0.077,0.013687,DTO_02300001,G-protein coupled receptor,C0201512,Thyroglobulin antibody measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84439,HHIPL1,Q96JK4,0.805,0.077,2.3678e-06,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.41,1.0,,2011.0,2019.0,ALL
84440,RAB11FIP4,Q86YS3,0.821,0.154,0.99199,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
84441,MAML2,Q8IZL2,0.592,0.577,0.99987,DTO_05007542,Transcription factor,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
84444,DOT1L,Q8TEK3,0.599,0.692,1.0,DTO_05007378,Epigenetic regulator,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
84445,LZTS2,Q9BRK4,0.743,0.346,0.046089,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84446,BRSK1,Q8TDC3,0.722,0.462,0.99982,DTO_03300101,Kinase,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
84447,SYVN1,Q86TM6,0.599,0.731,0.9997,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.08,1.0,,2003.0,2019.0,ALL
84448,ABLIM2,Q6H8Q1,0.89,0.231,0.0045858,DTO_05007530,Cellular structure,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84449,ZNF333,Q96JL9,,,7.7896e-18,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84450,ZNF512,Q96ME7,0.839,0.192,0.9765,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2013.0,ALL
84451,MAP3K21,Q5TCX8,0.751,0.154,1.0441e-06,DTO_03300101,Kinase,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2013.0,2019.0,ALL
84455,EFCAB7,A8K855,1.0,0.115,2.6115e-17,,,C0013903,Ellis-Van Creveld Syndrome,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
84456,L3MBTL3,Q96JM7,0.7,0.423,0.99744,DTO_05007378,Epigenetic regulator,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2017.0,2018.0,ALL
84457,PHYHIPL,Q96FC7,0.89,0.038,0.82096,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
84458,LCOR,Q96JN0,0.769,0.308,0.95022,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84460,ZMAT1,Q5H9K5,0.839,0.154,0.0010485,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
84461,NEURL4,Q96JN8,0.89,,0.99999,DTO_05007624,Enzyme,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
84464,SLX4,Q8IY92,0.565,0.731,1.5676e-22,,,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2009.0,2017.0,ALL
84465,MEGF11,A6BM72,,,2.3668e-30,DTO_05007621,Extracellular structure,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
84466,MEGF10,Q96KG7,0.682,0.462,0.3904,DTO_05007621,Extracellular structure,C3280679,"MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET",,,disease,Disease or Syndrome,0.74,1.0,definitive,2007.0,2017.0,ALL
84467,FBN3,Q75N90,0.805,0.269,5.439e-42,DTO_05007616,Calcium-binding protein,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2015.0,ALL
84498,FAM120B,Q96EK7,0.89,0.154,7.4692e-11,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
84501,SPIRE2,Q8WWL2,,,2.4375e-09,DTO_05007530,Cellular structure,C0406208,Suntan,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
84502,JPH4,Q96JJ6,0.89,0.231,0.99948,,,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
84504,NKX6-2,Q9C056,0.695,0.5,0.028854,DTO_05007542,Transcription factor,C4479653,"SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY",,,disease,Disease or Syndrome,0.7,1.0,,2004.0,2018.0,ALL
84513,PLPP5,Q8NEB5,0.78,0.231,1.8573e-12,DTO_05007624,Enzyme,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2006.0,2014.0,ALL
84515,MCM8,Q9UJA3,0.678,0.385,1.0536e-16,DTO_05007624,Enzyme,C4225402,PREMATURE OVARIAN FAILURE 10,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2015.0,ALL
84516,DCTN5,Q9BTE1,0.839,0.269,0.0070514,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
84517,ACTRT3,Q9BYD9,0.792,0.077,3.7565e-08,DTO_05007530,Cellular structure,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
84518,CNFN,Q9BYD5,0.89,0.077,0.026008,,,C0278996,Malignant Head and Neck Neoplasm,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
84519,ACRBP,Q8NEB7,0.705,0.308,2.6954e-10,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
84520,GON7,Q9BXV9,1.0,0.231,0.007687,,,C0795949,Galloway Mowat syndrome,C23;C16;C13;C05;C12;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
84522,JAGN1,Q8N5M9,0.839,0.115,0.0074462,,,C4014954,"NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,strong,2000.0,2014.0,ALL
84525,HOPX,Q9BPY8,0.61,0.577,5.3973e-06,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
84527,ZNF559,Q9BR84,0.931,0.077,1.4172e-05,DTO_05007542,Transcription factor,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
84528,RHOXF2,Q9BQY4,0.861,0.154,0.00021767,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
84529,C15orf41,Q9Y2V0,0.805,0.115,3.2889e-07,,,C3810185,"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib",,,disease,Disease or Syndrome,0.6,1.0,strong,1997.0,2019.0,ALL
84530,SRRM4,A7MD48,0.736,0.231,0.46456,,,C0042594,Vestibular Diseases,C09,   Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
84532,ACSS1,Q9NUB1,0.743,0.346,3.0776e-07,DTO_05007624,Enzyme,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
84539,MCHR2,Q969V1,0.656,0.538,5.1594e-06,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2010.0,ALL
84541,KBTBD8,Q8NFY9,0.931,0.192,9.4672e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84542,KIAA1841,Q6NSI8,,,7.5851e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
84545,MRPL43,Q8N983,0.931,0.077,1.8937e-07,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
84546,SNORD35B,,0.653,0.538,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2009.0,2019.0,ALL
84547,PGBD1,Q96JS3,0.821,0.269,4.7252e-10,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.43,0.8,,2011.0,2014.0,ALL
84548,TMEM185A,Q8NFB2,0.839,0.192,0.016569,,,C4274329,FRAXF syndrome,,,disease,Disease or Syndrome,0.3,1.0,,1994.0,1994.0,ALL
84549,MAK16,Q9BXY0,0.566,0.615,0.96452,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2019.0,ALL
84552,PARD6G,Q9BYG4,,,0.095027,DTO_05007527,Cell-cell junction,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
84557,MAP1LC3A,Q9H492,0.61,0.654,0.027922,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
84559,GOLGA2P2Y,,1.0,0.038,,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
84560,MT4,P47944,0.931,0.115,0.00013052,,,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
84561,SLC12A8,A0AV02,0.861,0.077,5.3107e-19,DTO_05007405,Transporter,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0,,2002.0,2005.0,ALL
84565,LCS1,,0.78,0.269,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.05,1.0,,2011.0,2018.0,ALL
84570,COL25A1,Q9BXS0,0.599,0.538,1.6393e-18,,,C4015552,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5",,,disease,Disease or Syndrome,0.7,1.0,moderate,2015.0,2015.0,ALL
84572,GNPTG,Q9UJJ9,0.705,0.423,4.6332e-09,DTO_05007624,Enzyme,C1854896,Mucolipidosis III Gamma,C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.77,1.0,strong,2000.0,2018.0,ALL
84617,TUBB6,Q9BUF5,0.686,0.462,0.00016645,DTO_05007530,Cellular structure,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
84618,NT5C1A,Q9BXI3,0.615,0.654,8.335e-05,,,C4048329,Immunosuppression,,,disease,Disease or Syndrome,0.1,0.955,,2006.0,2019.0,ALL
84619,ZGPAT,Q8N5A5,0.653,0.654,0.00038328,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.11,1.0,,1997.0,2013.0,ALL
84620,ST6GAL2,Q96JF0,0.931,0.077,0.005662,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
84623,KIRREL3,Q8IZU9,0.821,0.269,0.96992,,,C2675487,"Mental Retardation, Autosomal Dominant 4",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.4,1.0,,2008.0,2008.0,ALL
84624,FNDC1,Q4ZHG4,0.76,0.308,4.7841e-12,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
84626,KRBA1,A5PL33,1.0,0.038,8.2344e-16,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
84627,ZNF469,Q96JG9,0.584,0.769,0.71866,,,C0268344,Ehlers-Danlos syndrome 6B,C16;C11;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2008.0,2019.0,ALL
84628,NTNG2,Q96CW9,0.7,0.423,0.99866,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.51,0.5,,2008.0,2010.0,ALL
84629,TNRC18,O15417,,,0.99093,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84630,TTBK1,Q5TCY1,0.792,0.231,0.99967,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
84631,SLITRK2,Q9H156,0.931,0.154,0.0064131,,,C0015923,Fetal Alcohol Syndrome,C16;C13;C25,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Chemically-Induced Disorders",disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
84632,AFAP1L2,Q8N4X5,0.682,0.231,0.0021581,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
84634,KISS1R,Q969F8,0.515,0.769,0.43649,DTO_02300001,G-protein coupled receptor,C3553841,HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.9,1.0,,2003.0,2014.0,ALL
84636,GPR174,Q9BXC1,0.792,0.231,0.39757,DTO_02300001,G-protein coupled receptor,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,2013.0,2018.0,ALL
84639,IL1F10,Q8WWZ1,0.636,0.462,2.023e-06,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
84640,USP38,Q8NB14,0.839,0.231,3.8483e-07,DTO_05007624,Enzyme,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
84641,MFSD14B,Q5SR56,1.0,0.077,0.00043286,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
84643,KIF2B,Q8N4N8,0.839,0.115,1.6069e-10,DTO_05007530,Cellular structure,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
84647,PLA2G12B,Q9BX93,1.0,0.115,0.00095391,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
84648,LCE3D,Q9BYE3,0.89,0.038,0.020613,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.31,1.0,,2010.0,2014.0,ALL
84649,DGAT2,Q96PD7,0.686,0.423,8.3643e-12,DTO_05007624,Enzyme,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
84650,EBPL,Q9BY08,0.615,0.577,7.8199e-05,DTO_05007624,Enzyme,C1096202,Lipoprotein (a) measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
84651,SPINK7,P58062,0.722,0.308,0.078398,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2017.0,ALL
84654,SPZ1,Q9BXG8,0.507,0.769,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2006.0,2006.0,ALL
84656,GLYR1,Q49A26,0.861,0.192,0.99973,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84657,LINC00852,,0.931,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
84658,ADGRE3,Q9BY15,0.839,0.038,5.3919e-28,DTO_02300001,G-protein coupled receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
84659,RNASE7,Q9H1E1,0.705,0.423,0.11606,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.03,1.0,,2011.0,2018.0,ALL
84660,CCDC62,Q6P9F0,0.805,0.308,4.3887e-16,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
84661,DPY30,Q9C005,0.7,0.462,0.17695,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
84662,GLIS2,Q9BZE0,0.608,0.462,0.85834,DTO_05007542,Transcription factor,C1969092,NEPHRONOPHTHISIS 7,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.8,1.0,moderate,2007.0,2013.0,ALL
84665,MYPN,Q86TC9,0.612,0.615,2.611e-06,,,C3714995,"CARDIOMYOPATHY, DILATED, 1KK",,,disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2013.0,ALL
84666,RETNLB,Q9BQ08,0.769,0.231,0.04265,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2012.0,2015.0,ALL
84667,HES7,Q9BYE0,0.647,0.538,0.827,DTO_05007542,Transcription factor,C3150942,"SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.6,1.0,strong,2008.0,2010.0,ALL
84668,FAM126A,Q9BYI3,0.682,0.423,0.12103,,,C1864663,HYPOMYELINATION AND CONGENITAL CATARACT,C16;C18;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.74,1.0,,2006.0,2016.0,ALL
84669,USP32,Q8NFA0,0.861,0.192,1.0,,,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
84674,CARD6,Q9BX69,0.861,0.115,3.3903e-13,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
84675,TRIM55,Q9BYV6,0.821,0.154,6.9041e-14,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
84676,TRIM63,Q969Q1,0.617,0.538,4.3041e-13,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.64,0.857,limited,2001.0,2019.0,ALL
84677,DSCR8,Q96T75,0.931,0.077,5.4635e-05,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84678,KDM2B,Q8NHM5,0.592,0.692,1.0,DTO_05007378,Epigenetic regulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
84679,SLC9A7,Q96T83,0.695,0.577,0.99352,DTO_05007405,Transporter,C2931498,"Mental Retardation, X-Linked 1",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2019.0,2019.0,ALL
84680,ACCS,Q96QU6,0.522,0.731,8.9836e-07,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2017.0,2018.0,ALL
84681,HINT2,Q9BX68,0.792,0.308,5.3536e-06,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,2006.0,2019.0,ALL
84684,INSM2,Q96T92,0.821,0.192,0.88177,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,1999.0,2018.0,ALL
84687,PPP1R9B,Q96SB3,0.678,0.423,0.99975,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2004.0,2009.0,ALL
84688,C9orf24,Q8NCR6,1.0,0.038,2.1359e-06,,,C1384583,Congenital absence of germinal epithelium of testes,C12,   Male Urogenital Diseases,disease,Congenital Abnormality,0.01,1.0,,2017.0,2017.0,ALL
84689,MS4A14,Q96JA4,1.0,0.038,7.7109e-07,DTO_05007575,Receptor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
84690,SPATA22,Q8NHS9,0.839,0.231,0.00042457,,,C0154778,"Myopia, Degenerative",C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
84691,FAM71F1,Q96KD3,1.0,0.077,1.0457e-07,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.03,1.0,,2008.0,2018.0,ALL
84692,CCDC54,Q8NEL0,0.659,0.5,1.1084e-10,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.9,,2001.0,2019.0,ALL
84693,MCEE,Q96PE7,0.792,0.385,0.026913,DTO_05007624,Enzyme,C1855100,Methylmalonyl-CoA Epimerase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2017.0,ALL
84694,GJA10,Q969M2,1.0,0.077,5.3123e-10,DTO_05007527,Cell-cell junction,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
84695,LOXL3,P58215,0.666,0.462,2.6584e-13,,,C2020284,"Stickler syndrome, type 1",C23;C11;C17;C05;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.33,1.0,,2015.0,2019.0,ALL
84696,ABHD1,Q96SE0,1.0,0.077,3.3799e-25,DTO_05007624,Enzyme,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
84698,CAPS2,Q9BXY5,0.839,0.077,6.0736e-24,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.04,1.0,,2013.0,2017.0,ALL
84699,CREB3L3,Q68CJ9,0.792,0.192,8.0596e-14,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84700,MYO18B,Q8IUG5,0.628,0.615,1.0329e-31,,,C4225285,"KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM",,,disease,Disease or Syndrome,0.7,1.0,limited,2003.0,2017.0,ALL
84701,COX4I2,Q96KJ9,0.716,0.5,0.00013995,,,C2675184,"Exocrine Pancreatic Insufficiency, Dyserythropoietic Anemia, and Calvarial Hyperostosis",C16;C06;C05;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Musculoskeletal Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.6,1.0,,2009.0,2012.0,ALL
84705,GTPBP3,Q969Y2,0.805,0.154,4.1886e-09,,,C4015447,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2016.0,ALL
84706,GPT2,Q8TD30,0.65,0.577,0.00034046,DTO_05007624,Enzyme,C4225388,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49",,,disease,Mental or Behavioral Dysfunction,0.7,1.0,,2015.0,2016.0,ALL
84707,BEX2,Q9BXY8,0.705,0.231,0.10078,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.06,1.0,,2010.0,2019.0,ALL
84708,LNX1,Q8TBB1,0.769,0.154,2.0033e-06,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
84709,MGARP,Q8TDB4,1.0,0.115,3.8778e-05,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
84717,HDGFL2,Q7Z4V5,0.722,0.269,0.77498,DTO_05007599,Signaling,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84720,PIGO,Q8TEQ8,0.636,0.615,6.1434e-11,,,C1855923,Hyperphosphatasia with Mental Retardation,C23;C16;C18;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.64,1.0,,2012.0,2019.0,ALL
84722,PSRC1,Q6PGN9,0.76,0.269,8.556e-09,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
84725,PLEKHA8,Q96JA3,0.861,0.115,2.1757e-09,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84727,SPSB2,Q99619,0.76,0.192,0.02137,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
84733,CBX2,Q14781,0.674,0.269,0.99503,DTO_05007378,Epigenetic regulator,C2751317,"46, XY Sex Reversal 5",C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.6,1.0,limited,2009.0,2009.0,ALL
84734,FAM167B,Q9BTA0,1.0,0.077,0.00077413,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
84735,CNDP1,Q96KN2,0.656,0.538,1.1834e-09,DTO_05007624,Enzyme,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,0.929,,2005.0,2019.0,ALL
84740,AFAP1-AS1,,0.573,0.538,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,,2017.0,2017.0,ALL
84747,UNC119B,A6NIH7,,,0.78353,DTO_05007575,Receptor,C0337438,Glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
84749,USP30,Q70CQ3,0.821,0.154,8.2501e-05,DTO_05007624,Enzyme,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
84750,FUT10,Q6P4F1,0.76,0.308,5.4119e-09,DTO_05007624,Enzyme,C0002622,Amnesia,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
84752,B3GNT9,Q6UX72,1.0,0.115,1.7363e-05,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
84759,PCGF1,Q9BSM1,0.821,0.038,0.99713,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
84765,ZNF577,Q9BSK1,0.861,0.192,4.2594e-05,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
84766,CRACR2A,Q9BSW2,0.792,0.231,7.4288e-12,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
84769,MPV17L2,Q567V2,1.0,0.077,6.4336e-07,DTO_05007575,Receptor,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
84777,DLGAP1-AS2,,0.931,0.154,,,,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
84779,NAA11,Q9BSU3,0.931,0.115,0.010415,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
84787,KMT5C,Q86Y97,0.792,0.269,0.54685,DTO_05007378,Epigenetic regulator,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2011.0,2011.0,ALL
84790,TUBA1C,Q9BQE3,0.663,0.577,0.0074331,DTO_05007530,Cellular structure,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
84791,LINC00467,,0.736,0.269,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2019.0,2019.0,ALL
84793,FOXD2-AS1,,0.644,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2019.0,ALL
84795,PYROXD2,Q8N2H3,0.792,0.308,1.0027e-15,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
84798,C19orf48,Q6RUI8,0.695,0.462,,,,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,2004.0,2010.0,ALL
84803,GPAT3,Q53EU6,0.792,0.308,4.8042e-12,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
84804,MFSD9,Q8NBP5,0.931,0.154,9.3451e-10,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84808,PERM1,Q5SV97,1.0,0.077,1.1667e-15,,,C0026848,Myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
84811,BUD13,Q9BRD0,0.751,0.538,2.0613e-06,,,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.14,1.0,,2011.0,2017.0,ALL
84812,PLCD4,Q9BRC7,0.861,0.154,1.2913e-13,DTO_05007624,Enzyme,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84814,PLPP7,Q8NBV4,1.0,0.038,0.0079976,DTO_05007624,Enzyme,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
84816,RTN4IP1,Q8WWV3,0.792,0.154,3.1428e-06,,,C4225227,"OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2018.0,ALL
84817,TXNDC17,Q9BRA2,0.805,0.192,0.038897,DTO_05007405,Transporter,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
84818,IL17RC,Q8NAC3,0.633,0.615,2.3004e-14,,,C4225324,"CANDIDIASIS, FAMILIAL, 9",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
84820,POLR2J4,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
84823,LMNB2,Q03252,0.636,0.615,0.99996,,,C4225289,"EPILEPSY, PROGRESSIVE MYOCLONIC, 9",,,disease,Disease or Syndrome,0.7,1.0,limited,2006.0,2015.0,ALL
84824,FCRLA,Q7L513,0.805,0.346,2.4445e-09,DTO_05007620,Cell adhesion,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84826,SFT2D3,Q587I9,1.0,0.077,0.1013,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
84830,ADTRP,Q96IZ2,0.805,0.154,4.0967e-07,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.37,1.0,,2011.0,2017.0,ALL
84833,ATP5MD,Q96IX5,0.821,0.231,0.048038,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
84836,ABHD14B,Q96IU4,0.931,0.077,0.00014378,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
84837,ARHGAP5-AS1,Q96IT6,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
84838,ZNF496,Q96IT1,0.931,0.077,0.99624,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
84839,RAX2,Q96IS3,0.78,0.192,0.0082874,,,C1835865,Cone-Rod Dystrophy 11,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2004.0,2004.0,ALL
84842,HPDL,Q96IR7,1.0,0.077,2.2634e-05,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
84844,PHF5A,Q7RTV0,0.686,0.308,0.86605,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
84847,LINC00525,,1.0,0.077,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
84848,MIR503HG,,0.743,0.308,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
84851,TRIM52,Q96A61,0.769,0.231,1.1417e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
84852,ATP1A1-AS1,Q5TC04,1.0,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84856,LINC00839,,1.0,0.077,,,,C2362324,Pediatric Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
84858,ZNF503,Q96F45,0.821,0.192,0.94589,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
84861,KLHL22,Q53GT1,0.931,0.077,0.42419,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
84864,RIOX2,Q8IUF8,0.612,0.538,2.2584e-08,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.33,1.0,,1998.0,2010.0,ALL
84866,TMEM25,Q86YD3,0.805,0.154,2.6304e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
84867,PTPN5,P54829,0.666,0.538,0.0014228,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2012.0,2018.0,ALL
84868,HAVCR2,Q8TDQ0,0.45,0.808,0.03866,,,C0522624,Subcutaneous panniculitis-like T-cell lymphoma,C04;C17;C20;C15,   Neoplasms;    Skin and Connective Tissue Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.53,1.0,,2017.0,2019.0,ALL
84869,CBR4,Q8N4T8,0.89,0.115,6.0745e-06,DTO_05007624,Enzyme,C0005411,Biliary Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.1,1.0,,2010.0,2010.0,ALL
84870,RSPO3,Q9BXY4,0.653,0.423,0.089252,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2007.0,2018.0,ALL
84871,AGBL4,Q5VU57,0.76,0.231,2.4767e-06,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
84872,ZC3H10,Q96K80,1.0,0.038,0.31615,,,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
84873,ADGRG7,Q96K78,0.821,0.346,8.0386e-18,DTO_02300001,G-protein coupled receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
84875,PARP10,Q53GL7,0.792,0.346,1.8208e-08,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
84876,ORAI1,Q96D31,0.52,0.808,1.9068e-05,DTO_01300327,Ion channel,C2748568,Immune dysfunction with T-cell inactivation due to calcium entry defect 1,C16;C18;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2005.0,2009.0,ALL
84878,ZBTB45,Q96K62,,,2.8819e-05,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
84879,MFSD2A,Q8NA29,0.626,0.538,0.011025,DTO_05007405,Transporter,C4225310,"MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,strong,2002.0,2015.0,ALL
84883,AIFM2,Q9BRQ8,0.839,0.192,1.1064e-05,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
84885,ZDHHC12,Q96GR4,1.0,0.038,0.00052913,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
84886,C1orf198,Q9H425,,,0.00062943,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
84888,SPPL2A,Q8TCT8,0.792,0.192,0.028995,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.11,1.0,,2013.0,2019.0,ALL
84889,SLC7A3,Q8WY07,0.821,0.154,0.99614,DTO_05007405,Transporter,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
84890,ADO,Q96SZ5,0.67,0.538,0.48027,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
84891,ZSCAN10,Q96SZ4,0.89,0.077,8.0366e-05,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2012.0,2013.0,ALL
84892,POMGNT2,Q8NAT1,0.628,0.5,5.5559e-06,DTO_05007624,Enzyme,C0265221,Walker-Warburg congenital muscular dystrophy,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.62,1.0,strong,2012.0,2015.0,ALL
84893,FBH1,Q8NFZ0,0.821,0.154,8.2171e-05,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
84894,LINGO1,Q96FE5,0.682,0.385,0.99413,DTO_05007575,Receptor,C4748192,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64",,,disease,Disease or Syndrome,0.6,1.0,moderate,2018.0,2018.0,ALL
84895,MIGA2,Q7L4E1,1.0,0.077,2.959e-05,,,C0023794,Lipoidosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
84896,ATAD1,Q8NBU5,0.545,0.692,0.0013367,,,C4693933,HYPEREKPLEXIA 4,,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2018.0,ALL
84897,TBRG1,Q3YBR2,0.89,0.077,0.00017381,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2007.0,2016.0,ALL
84898,PLXDC2,Q6UX71,0.736,0.269,0.13416,,,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.12,0.5,,2011.0,2015.0,ALL
84899,TMTC4,Q5T4D3,0.89,0.115,2.8555e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
84900,RNFT2,Q96EX2,1.0,0.077,1.2018e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
84901,NFATC2IP,Q8NCF5,,,1.742e-05,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
84902,CEP89,Q96ST8,0.931,0.192,8.3504e-26,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
84904,ARHGEF39,Q8N4T4,0.821,0.192,1.1334e-10,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2012.0,2019.0,ALL
84905,ZNF341,Q9BYN7,0.792,0.385,2.4063e-06,DTO_05007542,Transcription factor,C3887645,Job Syndrome,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
84908,FAM136A,Q96C01,0.89,0.154,0.00058595,,,C0025281,Meniere Disease,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.3,1.0,moderate,2015.0,2015.0,ALL
84909,AOPEP,Q8N6M6,0.729,0.423,4.9823e-15,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.42,1.0,,2012.0,2018.0,ALL
84910,TMEM87B,Q96K49,0.861,0.115,3.741e-13,,,C0007196,Restrictive cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
84911,ZNF382,Q96SR6,0.76,0.192,0.029397,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2010.0,2019.0,ALL
84912,SLC35B4,Q969S0,0.839,0.192,2.6127e-05,DTO_05007405,Transporter,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
84913,ATOH8,Q96SQ7,0.711,0.346,0.91391,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
84915,FAM222A,Q5U5X8,1.0,0.038,0.85124,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
84916,UTP4,Q969X6,0.821,0.231,7.7093e-07,,,C1858051,NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.57,1.0,limited,2000.0,2013.0,ALL
84918,LRP11,Q86VZ4,,,0.0039782,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
84919,PPP1R15B,Q5SWA1,0.722,0.462,0.15053,,,C4225195,"MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2016.0,ALL
84920,ALG10,Q5BKT4,0.821,0.269,1.3151e-06,,,C3150943,Long Qt Syndrome 2,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,,,,,ALL
84923,FAM104A,Q969W3,,,0.24589,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
84924,ZNF566,Q969W8,,,0.41475,DTO_05007542,Transcription factor,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
84925,SLC49A4,Q96SL1,0.78,0.231,2.2526e-09,DTO_05007405,Transporter,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.43,1.0,,2002.0,2017.0,ALL
84926,SPRYD3,Q8NCJ5,,,0.14961,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84928,TMEM209,Q96SK2,0.89,0.077,6.0536e-13,,,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
84929,FIBCD1,Q8N539,0.931,0.077,1.9395e-14,DTO_05007599,Signaling,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
84930,MASTL,Q96GX5,0.674,0.385,5.4383e-13,DTO_03300101,Kinase,C0040034,Thrombocytopenia,C15,   Hemic and Lymphatic Diseases,phenotype,Disease or Syndrome,0.33,1.0,,2003.0,2018.0,ALL
84931,LINC01101,,1.0,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
84932,RAB2B,Q8WUD1,0.931,0.115,0.0028028,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
84934,RITA1,Q96K30,0.659,0.5,0.003797,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2008.0,2019.0,ALL
84935,MEDAG,Q5VYS4,0.89,0.192,1.6145e-05,,,C2076600,Influenza due to Influenza A virus subtype H1N1,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
84936,ZFYVE19,Q96K21,0.931,0.038,3.2046e-14,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
84937,ZNRF1,Q8ND25,0.89,0.192,0.90588,,,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
84938,ATG4C,Q96DT6,0.821,0.231,4.674e-17,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
84939,PWWP3A,Q2TAK8,0.636,0.385,0.0021523,,,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,0.962,,2000.0,2020.0,ALL
84940,CORO6,Q6QEF8,0.89,0.154,7.1605e-07,DTO_05007530,Cellular structure,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
84941,HSH2D,Q96JZ2,0.722,0.462,,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
84942,WDR73,Q6P4I2,0.61,0.5,2.8229e-09,,,C0795949,Galloway Mowat syndrome,C23;C16;C13;C05;C12;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.6,1.0,,2014.0,2019.0,ALL
84944,MAEL,Q96JY0,0.76,0.308,0.0014038,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2011.0,2016.0,ALL
84947,SERAC1,Q96JX3,0.686,0.385,3.9339e-06,,,C3553597,"3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME",,,disease,Disease or Syndrome,0.72,1.0,,2006.0,2019.0,ALL
84948,TIGD5,Q53EQ6,,,0.0011744,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
84951,TNS4,Q8IZW8,0.682,0.346,3.525e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2011.0,2019.0,ALL
84952,CGNL1,Q0VF96,0.931,0.038,4.686e-42,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
84954,MPND,Q8N594,,,5.2689e-05,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84955,NUDCD1,Q96RS6,0.705,0.308,2.6721e-11,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2001.0,2019.0,ALL
84957,RELT,Q969Z4,0.821,0.077,1.0729e-06,,,C0002452,Amelogenesis Imperfecta,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.32,1.0,,2019.0,2019.0,ALL
84958,SYTL1,Q8IYJ3,0.839,0.308,1.1537e-11,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2002.0,2012.0,ALL
84959,UBASH3B,Q8TF42,0.561,0.769,4.7054e-05,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
84961,FBXL20,Q96IG2,0.839,0.192,0.99691,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
84962,AJUBA,Q96IF1,0.716,0.308,0.79717,DTO_05007542,Transcription factor,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2014.0,2017.0,ALL
84964,ALKBH6,Q3KRA9,0.931,0.038,0.10641,,,C0206655,Alveolar rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
84966,IGSF21,Q96ID5,0.792,0.308,0.20912,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
84969,TOX2,Q96NM4,0.736,0.154,0.031987,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
84970,C1orf94,Q6P1W5,1.0,0.154,0.0093207,,,C0154830,Proliferative diabetic retinopathy,C23;C11;C19;C14,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
84971,ATG4D,Q86TL0,0.792,0.231,0.00026752,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
84973,SNHG7,,0.619,0.5,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
84976,DISP1,Q96F81,0.644,0.692,8.8581e-08,,,C0079541,Holoprosencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.43,1.0,strong,2007.0,2016.0,ALL
84978,FRMD5,Q7Z6J6,0.805,0.192,0.99724,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
84981,MIR22HG,Q0VDD5,0.659,0.423,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
84983,FAM222A-AS1,,1.0,0.038,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
84984,CEP19,Q96LK0,0.729,0.346,0.015687,,,C3810324,MORBID OBESITY AND SPERMATOGENIC FAILURE,,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2013.0,ALL
84985,FAM83A,Q86UY5,0.76,0.192,3.0324e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2005.0,2019.0,ALL
84986,ARHGAP19,Q14CB8,,,1.4213e-12,DTO_05007584,Enzyme modulator,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
84987,COX14,Q96I36,0.705,0.577,0.3573,,,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.7,1.0,,2012.0,2016.0,ALL
84988,PPP1R16A,Q96I34,,,0.004389,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
84991,RBM17,Q96I25,0.76,0.308,0.99981,DTO_05007557,Nucleic acid binding,C0752120,Spinocerebellar Ataxia Type 1,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,,2008.0,2008.0,ALL
84992,PIGY,Q3MUY2,0.628,0.577,0.09724,,,C4225201,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2015.0,ALL
84993,UBL7,Q96S82,0.839,0.231,0.0011746,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2017.0,2017.0,ALL
85003,BFSP2-AS1,,1.0,,,,,C3808115,"CATARACT 12, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.1,,,,,ALL
85004,RERG,Q96A58,0.821,0.308,1.2001e-05,DTO_05007584,Enzyme modulator,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
85007,PHYKPL,Q8IUZ5,0.89,0.192,4.7744e-14,,,C3554344,Phosphohydroxylysinuria,,,disease,Disease or Syndrome,0.62,1.0,limited,2012.0,2016.0,ALL
85013,TMEM128,Q5BJH2,,,0.00019994,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
85015,USP45,Q70EL2,0.792,0.154,1.363e-17,DTO_05007624,Enzyme,C0339527,Leber Congenital Amaurosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.31,1.0,,2019.0,2019.0,ALL
85016,CFAP300,Q9BRQ4,0.682,0.5,2.0691e-06,,,C4748052,"CILIARY DYSKINESIA, PRIMARY, 38",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
85019,TMEM241,Q24JQ0,0.861,0.192,8.471e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
85021,REPS1,Q96D71,0.769,0.269,0.98506,DTO_05007584,Enzyme modulator,C4693583,NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7,,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
85025,TMEM60,Q9H2L4,0.821,0.115,0.75498,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
85028,SNHG12,Q9BXW3,0.628,0.538,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0,,2017.0,2020.0,ALL
85235,H2AC12,Q96KK5,0.931,0.115,0.00049143,DTO_05007557,Nucleic acid binding,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
85236,H2BC12,O60814,0.743,0.308,4.2884e-06,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2008.0,2008.0,ALL
85300,ATCAY,Q86WG3,0.805,0.192,0.62076,,,C1832585,"CEREBELLAR ATAXIA, CAYMAN TYPE",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.81,1.0,,2003.0,2006.0,ALL
85301,COL27A1,Q8IZC6,0.78,0.269,0.5864,,,C3554594,STEEL SYNDROME,,,disease,Disease or Syndrome,0.63,1.0,,2015.0,2017.0,ALL
85302,FBF1,Q8TES7,1.0,0.038,1.7393e-20,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
85313,PPIL4,Q8WUA2,0.861,0.154,1.6878e-09,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2019.0,ALL
85315,PAQR8,Q8TEZ7,0.931,0.077,0.15149,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
85317,BAGE4,Q86Y28,0.861,0.154,,,,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,2005.0,2009.0,ALL
85318,BAGE3,Q86Y29,0.821,0.269,,,,C0024143,Lupus Nephritis,C13;C17;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2002.0,2005.0,ALL
85319,BAGE2,Q86Y30,0.931,0.115,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
85320,ABCC11,Q96J66,0.565,0.769,3.9884e-46,DTO_05007405,Transporter,C0235874,Disease Exacerbation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2012.0,2012.0,ALL
85329,LGALS12,Q96DT0,0.805,0.154,6.5191e-13,DTO_05007599,Signaling,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2015.0,2016.0,ALL
85340,KRT90P,,0.751,0.423,,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0,,2015.0,2018.0,ALL
85348,KRT88P,,0.705,0.385,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,1983.0,2019.0,ALL
85349,KRT87P,A6NCN2,,,,,,C1841621,FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1,,,phenotype,Finding,0.3,1.0,strong,2015.0,2015.0,ALL
85352,SHISAL1,Q3SXP7,1.0,0.038,0.039764,,,C0015944,"Fetal Membranes, Premature Rupture",C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,1.0,,2019.0,2019.0,ALL
85358,SHANK3,Q9BYB0,0.55,0.731,1.0,,,C1853490,22q13.3 Deletion Syndrome,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,1.0,1.0,definitive,2001.0,2020.0,ALL
85359,DGCR6L,Q9BY27,0.931,0.192,5.0636e-05,,,C0012236,DiGeorge Syndrome,C16;C05;C19;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
85360,SYDE1,Q6ZW31,1.0,0.115,0.7662,,,C1335302,Pancreatic Ductal Adenocarcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,,,,,ALL
85363,TRIM5,Q9C035,0.7,0.385,5.9675e-05,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.33,1.0,,2004.0,2009.0,ALL
85364,ZCCHC3,Q9NUD5,1.0,,0.011938,,,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
85365,ALG2,Q9H553,0.67,0.423,8.0497e-05,,,C1842836,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,,2003.0,2016.0,ALL
85366,MYLK2,Q9H1R3,0.705,0.269,0.23336,DTO_03300101,Kinase,C3495498,"Cardiomyopathy, Familial Hypertrophic, 1 (disorder)",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,,2001.0,2019.0,ALL
85369,STRIP1,Q5VSL9,0.931,0.154,1.2538e-05,,,C1876203,Frontonasal dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,,,,,ALL
85377,MICALL1,Q8N3F8,1.0,0.077,1.1968e-07,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
85378,TUBGCP6,Q96RT7,0.695,0.308,2.5559e-31,DTO_05007530,Cellular structure,C3502492,"Microcephaly with Chorioretinopathy, Autosomal Recessive",C16;C11;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.5,1.0,,2012.0,2012.0,ALL
85388,SNORD14B,,0.656,0.538,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2009.0,2019.0,ALL
85389,SNORD14C,,0.653,0.538,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2009.0,2019.0,ALL
85390,SNORD14D,,0.653,0.538,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2009.0,2019.0,ALL
85391,SNORD14E,,0.653,0.538,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2009.0,2019.0,ALL
85397,RGS8,P57771,0.821,0.192,0.30184,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
85403,EAF1,Q96JC9,0.821,0.115,0.06149,,,C3495676,Anorectal Malformations,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",group,Anatomical Abnormality,0.3,1.0,,2013.0,2013.0,ALL
85406,DNAJC14,Q6Y2X3,0.805,0.423,0.99999,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,0.75,,2005.0,2017.0,ALL
85407,NKD1,Q969G9,0.621,0.385,0.99344,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
85409,NKD2,Q969F2,0.729,0.192,1.5159e-12,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
85413,SLC22A16,Q86VW1,0.626,0.5,6.3118e-27,DTO_05007405,Transporter,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2005.0,2005.0,ALL
85414,SLC45A3,Q96JT2,0.78,0.192,0.0052658,DTO_05007405,Transporter,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
85415,RHPN2,Q8IUC4,0.711,0.192,1.0678e-07,DTO_05007584,Enzyme modulator,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.44,1.0,,2008.0,2019.0,ALL
85416,ZIC5,Q96T25,0.711,0.231,0.76534,DTO_05007542,Transcription factor,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.32,1.0,,2004.0,2012.0,ALL
85417,CCNB3,Q8WWL7,0.705,0.154,0.8585,DTO_05007584,Enzyme modulator,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2012.0,2018.0,ALL
85437,ZCRB1,Q8TBF4,0.931,0.154,0.0035488,,,C0026552,Morphine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2007.0,2007.0,ALL
85438,CABS1,Q96KC9,1.0,0.077,0.0076333,,,C0002792,anaphylaxis,C20,   Immune System Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
85439,STON2,Q8WXE9,0.821,0.192,0.00016537,DTO_05007621,Extracellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2013.0,ALL
85440,DOCK7,Q96N67,0.682,0.423,6.358e-06,DTO_05007584,Enzyme modulator,C4014492,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
85441,HELZ2,Q9BYK8,0.861,0.115,1.3364e-08,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
85443,DCLK3,Q9C098,0.647,0.615,0.13686,DTO_03300101,Kinase,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2013.0,2013.0,ALL
85444,LRRCC1,Q9C099,0.722,0.577,7.2293e-21,,,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.1,,,,,ALL
85445,CNTNAP4,Q9C0A0,0.839,0.192,7.7552e-07,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
85446,ZFHX2,Q9C0A1,0.89,0.077,0.99711,,,C4538468,MARSILI SYNDROME,,,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
85449,KIAA1755,Q5JYT7,0.931,0.077,2.8893e-17,,,C0018810,heart rate,,,phenotype,Clinical Attribute,0.1,1.0,,2013.0,2013.0,ALL
85450,ITPRIP,Q8IWB1,0.89,0.346,4.7954e-11,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
85451,UNK,Q9C0B0,,,0.99994,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
85452,CFAP74,Q9C0B2,1.0,0.077,8.7836e-11,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2015.0,2019.0,ALL
85453,TSPYL5,Q86VY4,0.711,0.346,0.84935,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2006.0,2017.0,ALL
85455,DISP2,A7MBM2,,,0.19897,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
85456,TNKS1BP1,Q9C0C2,0.931,0.077,0.082629,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2017.0,ALL
85458,DIXDC1,Q155Q3,0.647,0.385,7.3213e-11,DTO_05007599,Signaling,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2018.0,2018.0,ALL
85460,ZNF518B,Q9C0D4,0.861,0.192,0.0022867,,,C0018099,Gout,C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.11,1.0,,2010.0,2015.0,ALL
85461,TANC1,Q9C0D5,0.736,0.115,2.1625e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
85462,FHDC1,Q9C0D6,0.839,0.231,6.336e-05,,,C0004997,Benign Ovarian Neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
85463,ZC3H12C,Q9C0D7,0.931,0.038,0.99838,DTO_05007557,Nucleic acid binding,C0030246,Pustulosis of Palms and Soles,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
85464,SSH2,Q76I76,0.821,0.269,0.99684,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
85465,SELENOI,Q9C0D9,0.769,0.385,0.64206,DTO_05007624,Enzyme,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.4,,,,,ALL
85474,LBX2,Q6XYB7,0.839,0.231,0.0058839,DTO_05007542,Transcription factor,C0018817,Atrial Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0,,2018.0,2018.0,ALL
85476,GFM1,Q96RP9,0.623,0.692,9.278e-13,,,C1836797,Combined Oxidative Phosphorylation Deficiency 1,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2004.0,2016.0,ALL
85477,SCIN,Q9Y6U3,0.67,0.346,1.718e-36,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
85478,CCDC65,Q8IXS2,0.674,0.5,5.7685e-11,,,C3809701,"CILIARY DYSKINESIA, PRIMARY, 27",,,disease,Disease or Syndrome,0.6,,,,,ALL
85479,DNAJC5B,Q9UF47,0.931,0.115,2.2936e-06,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
85480,TSLP,Q969D9,0.486,0.808,0.0040357,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.6,1.0,,2002.0,2020.0,ALL
85481,PSKH2,Q96QS6,0.89,0.077,7.2081e-09,DTO_03300101,Kinase,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
85495,RPPH1,,0.78,0.346,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,0.333,,1994.0,2019.0,ALL
85502,SCAR3,,0.931,0.115,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
85507,DFNA18,,,,,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
85509,MBD3L1,Q8WWY6,1.0,0.115,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
85569,GALP,Q9UBC7,0.76,0.231,2.9414e-05,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.21,1.0,,2004.0,2018.0,ALL
85865,GTPBP10,A4D1E9,0.931,0.077,0.0041528,,,C2242817,Homocysteine measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
86123,YWHAZP5,,0.931,0.077,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2015.0,2015.0,ALL
86614,HSFY1,Q96LI6,0.821,0.077,,,,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",C16;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
86781,RPS2P7,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
87178,PNPT1,Q8TCS8,0.653,0.462,0.00040072,DTO_05007624,Enzyme,C3554129,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13,,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2019.0,ALL
87769,GGACT,Q9BVM4,0.931,0.154,0.00075371,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
88455,ANKRD13A,Q8IZ07,,,0.00020646,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
89122,TRIM4,Q9C037,0.89,0.115,8.502e-12,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
89765,RSPH1,Q8WYR4,0.666,0.5,2.054e-06,,,C3809634,"CILIARY DYSKINESIA, PRIMARY, 24",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2014.0,ALL
89766,UMODL1,Q5DID0,0.931,0.038,4.2869e-36,,,C0018810,heart rate,,,phenotype,Clinical Attribute,0.1,1.0,,2012.0,2012.0,ALL
89777,SERPINB12,Q96P63,1.0,0.115,2.772e-25,DTO_05007584,Enzyme modulator,C0341106,Eosinophilic esophagitis,C06;C20;C15,   Digestive System Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
89780,WNT3A,P56704,0.532,0.769,0.96491,DTO_05007599,Signaling,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,limited,2014.0,2014.0,ALL
89781,HPS4,Q9NQG7,0.743,0.385,0.00013778,,,C0079504,Hermanski-Pudlak Syndrome,C16;C18;C11;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.67,1.0,strong,2002.0,2019.0,ALL
89782,LMLN,Q96KR4,0.528,0.846,1.8746e-14,DTO_05007624,Enzyme,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.1,0.957,,1994.0,2019.0,ALL
89790,SIGLEC10,Q96LC7,0.931,0.038,6.8352e-06,DTO_05007575,Receptor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2019.0,ALL
89792,GAL3ST3,Q96A11,,,1.9296e-08,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
89795,NAV3,Q8IVL0,0.653,0.615,1.0,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
89796,NAV1,Q8NEY1,0.821,0.154,1.0,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
89797,NAV2,Q8IVL1,0.722,0.385,0.99995,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
89801,PPP1R3F,Q6ZSY5,0.931,0.077,4.1516e-05,DTO_05007584,Enzyme modulator,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
89822,KCNK17,Q96T54,0.78,0.269,4.1781e-06,DTO_01300327,Ion channel,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0,,2010.0,2014.0,ALL
89832,CHRFAM7A,P36544;Q494W8,0.659,0.385,0.00023228,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,1998.0,2018.0,ALL
89839,ARHGAP11B,Q3KRB8,0.931,0.038,2.6229e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2016.0,2019.0,ALL
89845,ABCC10,Q5T3U5,0.682,0.385,1.2887e-26,DTO_05007405,Transporter,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
89846,FGD3,Q5JSP0,0.839,0.231,1.3311e-06,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2014.0,2019.0,ALL
89849,ATG16L2,Q8NAA4,0.769,0.462,4.6874e-16,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.14,1.0,,2014.0,2019.0,ALL
89853,MVB12B,Q9H7P6,0.861,0.038,0.55867,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
89857,KLHL6,Q8WZ60,0.805,0.154,4.0253e-06,,,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
89858,SIGLEC12,Q96PQ1,0.839,0.385,1.2163e-13,DTO_05007575,Receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
89866,SEC16B,Q96JE7,0.805,0.346,2.0871e-25,,,C0005910,Body Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.4,1.0,,2009.0,2012.0,ALL
89869,PLCZ1,Q86YW0,0.89,0.231,1.5016e-12,DTO_05007624,Enzyme,C4310666,SPERMATOGENIC FAILURE 17,,,disease,Disease or Syndrome,0.5,1.0,,2016.0,2016.0,ALL
89870,TRIM15,Q9C019,0.743,0.308,7.758e-09,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2009.0,ALL
89872,AQP10,Q96PS8,0.839,0.115,0.0013339,DTO_01300327,Ion channel,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
89874,SLC25A21,Q9BQT8,0.636,0.654,1.4479e-11,DTO_05007405,Transporter,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.12,1.0,,2008.0,2017.0,ALL
89876,MAATS1,Q7Z4T9,,,1.5718e-13,,,C3714514,Infection,C01,   Infections,group,Pathologic Function,0.01,1.0,,2003.0,2003.0,ALL
89882,TPD52L3,Q96J77,,,0.19798,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
89884,LHX4,Q969G2,0.621,0.462,0.017521,DTO_05007557,Nucleic acid binding,C2678408,"PITUITARY HORMONE DEFICIENCY, COMBINED, 4",C16;C05;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,1.0,,2001.0,2015.0,ALL
89885,FATE1,Q969F0,0.78,0.346,0.0071681,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
89886,SLAMF9,Q96A28,0.861,0.192,1.2303e-05,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
89887,ZNF628,Q5EBL2,1.0,0.077,0.91268,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
89891,WDR34,Q96EX3,0.597,0.692,1.7342e-07,DTO_05007530,Cellular structure,C0265275,Jeune thoracic dystrophy,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.62,1.0,strong,2013.0,2013.0,ALL
89894,TMEM116,Q8NCL8,,,5.1196e-13,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
89910,UBE3B,Q7Z3V4,0.59,0.692,4.1871e-08,,,C1855663,Kaufman oculocerebrofacial syndrome,C23;C16;C11;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.75,1.0,moderate,2012.0,2018.0,ALL
89927,BMERB1,Q96MC5,1.0,0.115,0.13691,,,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
89932,PAPLN,O95428,0.805,0.115,7.4895e-38,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
89941,RHOT2,Q8IXI1,1.0,0.038,8.9033e-27,DTO_05007584,Enzyme modulator,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1991.0,1991.0,ALL
89944,GLB1L2,Q8IW92,1.0,0.038,4.5015e-19,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
89953,KLC4,Q9NSK0,0.743,0.308,0.0011939,,,C0037772,Spastic Paraplegia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,limited,2015.0,2015.0,ALL
89958,SAPCD2,Q86UD0,0.861,0.192,0.0039417,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2011.0,2014.0,ALL
89970,RSPRY1,Q96DX4,0.705,0.385,0.99981,,,C4225232,"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE",,,disease,Disease or Syndrome,0.61,1.0,,2015.0,2018.0,ALL
89978,DPH6,Q7L8W6,1.0,0.038,1.1419e-05,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
90007,MIDN,Q504T8,0.89,0.038,0.17862,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
90011,KIR3DX1,Q9H7L2,,,,DTO_05007575,Receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
90019,SYT8,Q8NBV8,0.931,0.077,9.8941e-25,DTO_05007405,Transporter,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
90025,UBE3D,Q7Z6J8,0.839,0.115,5.9771e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
90050,FAM181A,Q8N9Y4,1.0,0.077,0.00076374,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
90070,LACRT,Q9GZZ8,0.89,0.154,0.0001187,,,C0005741,Blepharitis,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
90102,PHLDB2,Q86SQ0,0.769,0.385,1.6748e-08,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
90113,VWA5B2,Q8N398,,,5.2466e-07,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
90121,TSR2,Q969E8,0.743,0.5,0.80082,,,C4225422,DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS,,,disease,Disease or Syndrome,0.7,1.0,moderate,2014.0,2014.0,ALL
90134,KCNH7,Q9NS40,0.729,0.346,0.28183,DTO_01300327,Ion channel,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.11,1.0,,2008.0,2019.0,ALL
90139,TSPAN18,Q96SJ8,0.792,0.231,0.082002,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.45,1.0,,2011.0,2016.0,ALL
90141,EFCAB11,Q9BUY7,0.931,0.115,0.00023166,DTO_05007616,Calcium-binding protein,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
90161,HS6ST2,Q96MM7,0.729,0.423,0.0010077,DTO_05007624,Enzyme,C0271183,Severe myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.11,1.0,,2019.0,2019.0,ALL
90167,FRMD7,Q6ZUT3,0.682,0.462,0.72983,,,C1839580,"Nystagmus 1, congenital, X- linked",C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2013.0,ALL
90187,EMILIN3,Q9NT22,,,9.24e-06,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
90196,SYS1,Q8N2H4,0.89,0.115,0.070915,DTO_05007405,Transporter,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
90226,UCN2,Q96RP3,0.633,0.577,0.037947,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.36,1.0,,2005.0,2020.0,ALL
90231,KIAA2013,Q8IYS2,,,0.0097782,,,C0427418,"Folic acid measurement, RBC",,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
90249,UNC5A,Q6ZN44,0.729,0.423,0.99983,DTO_05007575,Receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
90268,OTULIN,Q96BN8,0.751,0.346,0.2201,,,C4310614,OTULIN-related autoinflammatory syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.72,1.0,strong,2016.0,2019.0,ALL
90273,CEACAM21,Q3KPI0,0.89,0.192,1.2439e-12,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2012.0,2012.0,ALL
90293,KLHL13,Q9P2N7,1.0,0.115,0.035016,,,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
90313,TP53I13,Q8NBR0,,,0.00011241,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
90316,TGIF2LX,Q8IUE1,0.821,0.192,,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
90324,CCDC97,Q96F63,1.0,0.038,1.6817e-09,,,C0018965,Hematuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
90326,THAP3,Q8WTV1,0.931,0.115,0.0072819,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
90332,EXOC3L2,Q2M3D2,0.722,0.5,0.76039,DTO_05007405,Transporter,C0010964,Dandy-Walker Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.4,1.0,,2016.0,2019.0,ALL
90338,ZNF160,Q9HCG1,0.805,0.346,0.028175,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
90342,FER1L5,A0AVI2,,,,DTO_05007405,Transporter,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
90353,CTU1,Q7Z7A3,0.769,0.192,0.067155,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2016.0,2018.0,ALL
90355,MACIR,Q96GV9,0.691,0.462,0.42746,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2014.0,2019.0,ALL
90362,FAM110B,Q8TC76,0.861,0.115,0.36414,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
90378,SAMD1,Q6SPF0,0.89,0.077,0.23605,DTO_05007557,Nucleic acid binding,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
90379,DCAF15,Q66K64,0.839,0.192,0.9942,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
90381,TICRR,Q7Z2Z1,0.769,0.423,7.2142e-14,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
90390,MED30,Q96HR3,0.769,0.308,0.40259,,,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
90407,TMEM41A,Q96HV5,0.89,0.115,0.00029269,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
90410,IFT20,Q8IY31,0.839,0.231,0.10302,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
90411,MCFD2,Q8NI22,0.716,0.269,0.10011,DTO_05007405,Transporter,C3150889,"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2",,,disease,Disease or Syndrome,0.7,1.0,strong,2003.0,2010.0,ALL
90417,KNSTRN,Q9Y448,0.729,0.5,2.1336e-06,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2014.0,2014.0,ALL
90423,ATP6V1E2,Q96A05,0.89,0.038,0.0029486,DTO_05007405,Transporter,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
90427,BMF,Q96LC9,0.663,0.423,0.006758,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.42,1.0,,2012.0,2017.0,ALL
90441,ZNF622,Q969S3,,,0.11086,DTO_05007557,Nucleic acid binding,C0275518,Acute infectious disease,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
90459,ERI1,Q8IV48,0.89,0.192,1.1866e-05,DTO_05007624,Enzyme,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
90480,GADD45GIP1,Q8TAE8,0.716,0.423,0.00010261,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
90488,TMEM263,Q8WUH6,1.0,0.038,0.0088522,,,C0152136,Low Tension Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
90506,LRRC46,Q96FV0,0.931,0.115,0.0011032,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
90507,SCRN2,Q96FV2,0.931,0.231,5.7373e-12,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
90522,YIF1B,Q5BJH7,,,3.4314e-05,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
90523,MLIP,Q5VWP3,0.682,0.577,3.1564e-16,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
90525,SHF,Q7M4L6,0.821,0.231,0.16039,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
90527,DUOXA1,Q1HG43,0.729,0.385,7.5867e-05,,,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
90529,STPG1,Q5TH74,1.0,0.077,1.2043e-09,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
90550,MCU,Q8NE86,0.67,0.577,0.83258,DTO_01300327,Ion channel,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
90586,AOC4P,,0.839,0.077,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2015.0,2019.0,ALL
90624,LYRM7,Q5U5X0,0.716,0.346,0.022082,,,C4014440,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2018.0,ALL
90625,ERVH48-1,M5A8F1,0.839,0.231,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2007.0,2008.0,ALL
90627,STARD13,Q9Y3M8,0.641,0.538,2.3524e-08,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
90632,LINC00473,A8K010,0.695,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2016.0,2019.0,ALL
90634,N4BP2L1,Q5TBK1,0.931,0.077,0.8446,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
90637,ZFAND2A,Q8N6M9,1.0,0.038,0.0029921,DTO_05007557,Nucleic acid binding,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
90639,COX19,Q49B96,0.931,0.077,0.0043158,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
90665,TBL1Y,Q9BQ87,0.705,0.385,4.03e-13,,,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.11,1.0,,2000.0,2000.0,ALL
90668,CARMIL3,Q8ND23,0.821,0.192,1.2106e-07,DTO_05007542,Transcription factor,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
90678,LRSAM1,Q6UWE0,0.638,0.5,3.1008e-13,,,C3280797,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P",,,disease,Disease or Syndrome,0.91,1.0,strong,2010.0,2019.0,ALL
90693,CCDC126,Q96EE4,1.0,0.077,0.11918,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
90701,SEC11C,Q9BY50,1.0,0.115,0.72415,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
90737,PAGE5,Q96GU1,0.931,0.077,0.020689,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2012.0,2017.0,ALL
90768,TENM3-AS1,,0.78,0.192,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2008.0,2008.0,ALL
90780,PYGO2,Q9BRQ0,0.686,0.346,0.96676,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.11,1.0,,2016.0,2016.0,ALL
90799,CEP95,Q96GE4,,,1.4612e-19,,,C0883409,Cardiac troponin I measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
90806,ANGEL2,Q5VTE6,,,5.565e-06,DTO_05007624,Enzyme,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
90826,PRMT9,Q6P2P2,0.821,0.154,2.5269e-12,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
90827,ZNF479,Q96JC4,0.89,0.115,9.0123e-05,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
90835,CCDC189,A1A4V9,1.0,0.038,2.7592e-08,,,C0403823,Asthenozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
90850,ZNF598,Q86UK7,,,0.54824,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
90853,SPOCD1,Q6ZMY3,0.792,0.192,2.491e-12,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
90861,JPT2,Q9H910,0.821,0.154,0.23277,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
90864,SPSB3,Q6PJ21,0.89,0.115,0.036104,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
90865,IL33,O95760,0.409,0.885,8.2925e-10,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,0.985,,2009.0,2020.0,ALL
90933,TRIM41,Q8WV44,0.861,0.115,0.97384,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
90952,ESAM,Q96AP7,0.722,0.385,0.20185,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
90956,ADCK2,Q7Z695,,,3.6479e-07,DTO_03300101,Kinase,C0162670,Mitochondrial Myopathies,C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.2,1.0,,2019.0,2019.0,ALL
90957,DHX57,Q6P158,,,9.0569e-16,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
90990,KIFC2,Q96AC6,,,1.3832e-11,DTO_05007530,Cellular structure,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
90993,CREB3L1,Q96BA8,0.601,0.615,0.98488,,,C4015610,"OSTEOGENESIS IMPERFECTA, TYPE XVI",,,disease,Disease or Syndrome,0.4,1.0,strong,2019.0,2019.0,ALL
91010,FMNL3,Q8IVF7,0.839,0.192,0.46549,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
91012,CERS5,Q8N5B7,0.839,0.231,6.4962e-09,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
91039,DPP9,Q86TI2,0.659,0.577,0.98708,DTO_05007624,Enzyme,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.5,1.0,,2013.0,2013.0,ALL
91050,CCDC149,Q6ZUS6,0.931,0.115,1.9023e-05,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
91056,AP5B1,Q2VPB7,0.769,0.5,4.2746e-11,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
91057,CCDC34,Q96HJ3,0.722,0.308,5.013e-06,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
91074,ANKRD30A,Q9BXX3,0.678,0.346,2.685e-45,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.38,1.0,,2001.0,2019.0,ALL
91107,TRIM47,Q96LD4,0.821,0.308,0.00033657,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
91120,ZNF682,O95780,1.0,0.077,0.018503,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
91133,L3MBTL4,Q8NA19,0.821,0.231,3.1e-11,DTO_05007378,Epigenetic regulator,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.11,1.0,,2016.0,2016.0,ALL
91137,SLC25A46,Q96AG3,0.695,0.308,1.3077e-05,DTO_05007405,Transporter,C4225302,"NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB",,,disease,Disease or Syndrome,0.9,1.0,,2015.0,2017.0,ALL
91147,TMEM67,Q5HYA8,0.512,0.769,2.0654e-24,,,C1846357,Meckel syndrome type 3,C23;C16;C13;C12;C08;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.95,1.0,,1977.0,2019.0,ALL
91149,RAPGEF4-AS1,,,,,,,C0337438,Glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
91156,IGFN1,Q86VF2,0.821,0.154,3.2796e-51,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
91179,SCARF2,Q96GP6,0.691,0.423,0.9998,DTO_05007575,Receptor,C1833136,Marden Walker like syndrome,C16;C11;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.62,1.0,,2010.0,2014.0,ALL
91181,NUP210L,Q5VU65,,,0.0003199,DTO_05007405,Transporter,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
91252,SLC39A13,Q96H72,0.666,0.538,0.0025092,DTO_05007405,Transporter,C2676510,"Spondylocheirodysplasia, Ehlers-Danlos Syndrome-Like",C16;C17;C05;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.71,1.0,,2008.0,2017.0,ALL
91272,BOD1,Q96IK1,0.931,0.077,0.24853,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
91283,MSANTD3,Q96H12,0.89,0.077,0.016091,,,C0206685,Acinar Cell Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
91289,LMF2,Q9BU23,0.89,0.154,2.3979e-50,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
91300,R3HDM4,Q96D70,,,0.00046251,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
91304,TMEM259,Q4ZIN3,1.0,0.038,0.99408,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
91316,GUSBP11,Q6P575,0.821,0.115,,,,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
91319,DERL3,Q96Q80,0.691,0.462,0.000219,DTO_05007575,Receptor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,1996.0,2014.0,ALL
91351,DDX60L,Q5H9U9,0.861,0.115,1.0665e-38,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
91355,LRP5L,A4QPB2,0.931,0.115,5.3205e-11,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
91368,CDKN2AIPNL,Q96HQ2,1.0,0.077,0.34205,DTO_05007557,Nucleic acid binding,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
91373,UAP1L1,Q3KQV9,1.0,0.077,3.4123e-06,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
91392,ZNF502,Q8TBZ5,,,4.1603e-08,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
91404,SESTD1,Q86VW0,0.821,0.231,0.99802,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
91419,ATP23,Q9Y6H3,0.792,0.038,1.6095e-05,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
91433,RCCD1,A6NED2,0.729,0.231,3.2679e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
91442,FAAP24,Q9BTP7,0.89,0.154,9.2129e-08,,,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.04,1.0,,2008.0,2016.0,ALL
91445,RNF185,Q96GF1,0.861,0.269,0.17727,DTO_05007624,Enzyme,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
91452,ACBD5,Q5T8D3,0.931,0.192,0.006148,DTO_05007584,Enzyme modulator,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.3,,,,,ALL
91461,PKDCC,Q504Y2,0.821,0.154,2.1316e-05,DTO_03300101,Kinase,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0,,2009.0,2014.0,ALL
91464,ISX,Q2M1V0,0.805,0.115,3.5552e-05,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,2013.0,2017.0,ALL
91522,COL23A1,Q86Y22,0.792,0.154,6.6455e-13,,,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
91523,PCED1B,Q96HM7,0.931,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
91526,ANKRD44,Q8N8A2,0.78,0.269,0.33657,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
91543,RSAD2,Q8WXG1,0.641,0.577,9.4432e-15,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.33,1.0,,2012.0,2016.0,ALL
91544,UBXN11,Q5T124,0.659,0.538,1.3973e-13,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
91574,C12orf65,Q9H3J6,0.678,0.346,0.20896,DTO_05007557,Nucleic acid binding,C3150801,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7,,,disease,Disease or Syndrome,0.7,1.0,strong,2010.0,2016.0,ALL
91582,RPS19BP1,Q86WX3,1.0,0.077,2.6748e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
91584,PLXNA4,Q9HCM2,0.792,0.231,0.99999,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.13,1.0,,2014.0,2018.0,ALL
91603,ZNF830,Q96NB3,,,0.059572,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
91607,SLFN11,Q7Z7L1,0.67,0.385,8.2249e-19,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2020.0,ALL
91608,RASL10B,Q96S79,0.89,0.154,0.0041933,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
91612,CHURC1,Q8WUH1,0.931,0.038,2.0933e-06,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
91614,DEPDC7,Q96QD5,0.805,0.231,8.3246e-11,DTO_05007557,Nucleic acid binding,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
91624,NEXN,Q0ZGT2,0.695,0.269,3.9115e-11,,,C3151267,"CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20",,,disease,Disease or Syndrome,0.9,1.0,limited,2009.0,2017.0,ALL
91646,TDRD12,Q587J7,1.0,0.038,2.9169e-13,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
91647,ATPAF2,Q8N5M1,0.729,0.423,2.2116e-09,,,C3276276,"MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1",,,disease,Disease or Syndrome,0.6,1.0,,2004.0,2016.0,ALL
91653,BOC,Q9BWV1,0.666,0.423,1.7426e-07,,,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.41,1.0,,2018.0,2019.0,ALL
91661,ZNF765,Q7L2R6,0.821,0.115,8.6566e-06,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
91662,NLRP12,P59046,0.569,0.846,3.6493e-28,,,C2673198,Familial Cold Autoinflammatory Syndrome 2,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.71,1.0,strong,2008.0,2018.0,ALL
91663,MYADM,Q96S97,0.839,0.269,0.0062904,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
91683,SYT12,Q8IV01,0.931,0.115,1.7402e-05,DTO_05007405,Transporter,C0153381,Malignant neoplasm of mouth,C04;C07,   Neoplasms;    Stomatognathic Diseases,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
91689,SMDT1,Q9H4I9,0.931,0.115,0.18284,,,C0751651,Mitochondrial Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.1,,,,,ALL
91694,LONRF1,Q17RB8,0.931,0.038,0.61157,DTO_05007624,Enzyme,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
91695,RRP7BP,Q9NSQ0,1.0,0.077,,DTO_05007557,Nucleic acid binding,C2076600,Influenza due to Influenza A virus subtype H1N1,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
91703,ACY3,Q96HD9,0.839,0.154,5.4152e-06,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2007.0,2018.0,ALL
91734,IDI2,Q9BXS1,0.931,0.154,2.3124e-09,DTO_05007624,Enzyme,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2016.0,2016.0,ALL
91746,YTHDC1,Q96MU7,0.839,0.269,1.0,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
91748,MIDEAS,Q6PJG2,,,1.0,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
91749,MFSD4B,Q5TF39,0.805,0.269,8.298e-06,DTO_05007405,Transporter,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
91750,LIN52,Q52LA3,1.0,0.077,0.91836,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2010.0,2010.0,ALL
91752,ZNF804A,Q7Z570,0.647,0.654,0.0055255,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2008.0,2020.0,ALL
91754,NEK9,Q8TD19,0.623,0.5,8.2095e-18,DTO_03300101,Kinase,C0265987,Nevus comedonicus,C16;C04;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Skin and Connective Tissue Diseases",disease,Neoplastic Process,0.71,1.0,,2016.0,2016.0,ALL
91768,CABLES1,Q8TDN4,0.7,0.385,0.0054966,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
91801,ALKBH8,Q96BT7,0.716,0.423,0.00020414,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,,2019.0,2019.0,ALL
91807,MYLK3,Q32MK0,0.7,0.385,5.8848e-07,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
91828,EXOC3L4,Q17RC7,0.931,0.154,5.2374e-09,DTO_05007405,Transporter,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2015.0,ALL
91833,WDR20,Q8TBZ3,0.595,0.769,0.91532,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
91851,CHRDL1,Q9BU40,0.659,0.538,0.2164,,,C0344530,Congenital keratoglobus,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.75,1.0,,2012.0,2016.0,ALL
91862,MARVELD3,Q96A59,0.821,0.154,2.5885e-07,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
91869,RFT1,Q96AA3,0.7,0.5,3.7445e-13,,,C2677590,"Congenital Disorder Of Glycosylation, Type In",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,,2008.0,2016.0,ALL
91875,TTC5,Q8N0Z6,1.0,0.038,4.6155e-06,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
91937,TIMD4,Q96H15,0.644,0.654,2.6444e-10,,,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
91942,NDUFAF2,Q8N183,0.641,0.577,2.078e-06,,,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.6,1.0,,2005.0,2016.0,ALL
91947,ARRDC4,Q8NCT1,0.931,0.115,1.7064e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
91948,LINC00923,,,,0.20785,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
91949,COG7,P83436,0.686,0.5,2.5926e-07,,,C2931010,Congenital disorder of glycosylation type 2E,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,,2004.0,2016.0,ALL
91966,EOLA1,Q8TE69,1.0,0.115,0.59015,,,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.02,1.0,,2004.0,2005.0,ALL
91975,ZNF300,Q96RE9,0.76,0.115,1.1172e-05,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.11,1.0,,2010.0,2017.0,ALL
91977,MYOZ3,Q8TDC0,0.931,0.231,2.7932e-05,DTO_05007530,Cellular structure,C0024301,"Lymphoma, Follicular",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
92002,CCNQ,Q8N1B3,0.663,0.462,0.90384,DTO_05007584,Enzyme modulator,C2678045,"TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS",C16;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.76,1.0,,1996.0,2018.0,ALL
92014,SLC25A51,Q9H1U9,0.931,0.115,0.0032782,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
92017,SNX29,Q8TEQ0,0.805,0.115,2.6167e-10,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
92070,CTBP1-DT,,0.931,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.12,1.0,,2012.0,2019.0,ALL
92086,GGTLC1,Q9BX51,0.559,0.731,3.3367e-05,DTO_05007624,Enzyme,C0687132,heavy drinking,,,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2014.0,2014.0,ALL
92105,INTS4,Q96HW7,0.705,0.538,1.1349e-11,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
92106,OXNAD1,Q96HP4,1.0,0.077,4.4226e-08,,,C0007114,Malignant neoplasm of skin,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
92126,DSEL,Q8IZU8,0.839,0.346,7.2945e-06,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
92129,RIPPLY1,Q0D2K3,0.89,0.077,0.0094433,,,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.11,1.0,,2015.0,2018.0,ALL
92140,MTDH,Q86UE4,0.491,0.769,0.32924,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.976,,2006.0,2020.0,ALL
92154,MTSS2,Q765P7,0.839,0.231,0.97998,DTO_05007530,Cellular structure,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,,,,,ALL
92162,TMEM88,Q6PEY1,0.751,0.231,0.27743,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2015.0,2015.0,ALL
92170,MTG1,Q9BT17,0.621,0.769,0.013299,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2017.0,2019.0,ALL
92196,DAPL1,A0PJW8,1.0,0.038,4.2949e-05,DTO_05007584,Enzyme modulator,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
92211,CDHR1,Q96JP9,0.67,0.308,2.8422e-21,,,C3150912,CONE-ROD DYSTROPHY 15,,,disease,Disease or Syndrome,0.7,1.0,,2010.0,2015.0,ALL
92241,RCSD1,Q6JBY9,0.821,0.192,0.036157,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
92249,LINC01278,,0.931,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
92255,LMBRD2,Q68DH5,,,0.00016404,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2019.0,ALL
92259,MRPS36,P82909,,,0.10812,,,C2697766,Interleukin 18 Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
92270,ATP6AP1L,Q52LC2,0.839,0.115,0.029928,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
92285,ZNF585B,Q52M93,1.0,0.038,3.6865e-07,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
92291,CAPN13,Q6MZZ7,0.931,0.115,2.1544e-22,DTO_05007624,Enzyme,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
92292,GLYATL1,Q969I3,0.839,0.115,0.0033704,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
92293,TMEM132C,Q8N3T6,0.805,0.231,0.63879,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
92304,SCGB3A1,Q96QR1,0.633,0.654,0.030493,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
92305,TMEM129,A0AVI4,0.89,0.115,2.3074e-11,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
92312,MEX3A,A1L020,0.931,0.115,0.97977,DTO_05007624,Enzyme,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
92335,STRADA,Q7RTN6,0.711,0.462,4.4847e-06,DTO_03300101,Kinase,C1970203,"Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy",C23;C16;C13;C05;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,strong,2010.0,2018.0,ALL
92342,METTL18,O95568,1.0,0.077,2.8027e-05,,,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
92344,GORAB,Q5T7V8,0.647,0.538,6.6537e-06,,,C0432255,Geroderma osteodysplastica,C16;C17;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.77,1.0,,2008.0,2019.0,ALL
92345,NAF1,Q96HR8,0.7,0.5,0.97793,,,C0265965,Dyskeratosis Congenita,C16;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.32,1.0,strong,2010.0,2019.0,ALL
92346,C1orf105,O95561,0.931,0.192,1.1007e-05,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
92359,CRB3,Q9BUF7,0.716,0.308,0.35784,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2015.0,2019.0,ALL
92369,SPSB4,Q96A44,0.89,0.115,0.00041849,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
92370,PXYLP1,Q8TE99,1.0,0.038,0.0030898,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
92399,MRRF,Q96E11,0.931,0.192,4.4057e-07,DTO_05007557,Nucleic acid binding,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.02,1.0,,1994.0,2008.0,ALL
92421,CHMP4C,Q96CF2,0.769,0.192,2.9916e-07,DTO_05007405,Transporter,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.41,1.0,,2013.0,2019.0,ALL
92482,BBIP1,A8MTZ0,0.695,0.423,0.004174,,,C3806174,BARDET-BIEDL SYNDROME 18,,,disease,Disease or Syndrome,0.8,1.0,,2013.0,2014.0,ALL
92483,LDHAL6B,Q9BYZ2,0.861,0.077,0.073409,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
92507,RPS4XP2,,,,,,,C0162534,Prion Diseases,C01;C10,   Infections;    Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
92521,SPECC1,Q5M775,0.659,0.577,0.00086772,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
92552,ATXN3L,Q9H3M9,0.931,0.077,,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
92565,FANK1,Q8TC84,0.931,0.038,1.6807e-09,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
92579,G6PC3,Q9BUM1,0.606,0.731,4.7177e-06,,,C2675526,"Neutropenia, Severe Congenital, Autosomal Recessive 4",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.71,1.0,strong,2009.0,2017.0,ALL
92591,ASB16,Q96NS5,1.0,0.038,1.0959e-16,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
92595,ZNF764,Q96H86,0.931,0.038,8.2354e-05,DTO_05007542,Transcription factor,C2940786,Thyroid Hormone Resistance Syndrome,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
92597,MOB1B,Q7L9L4,0.931,0.038,0.035037,DTO_05007584,Enzyme modulator,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
92609,TIMM50,Q3ZCQ8,0.678,0.5,0.0017835,,,C4540171,"3-METHYLGLUTACONIC ACIDURIA, TYPE IX",,,disease,Disease or Syndrome,0.7,1.0,,2017.0,2019.0,ALL
92610,TIFA,Q96CG3,0.89,0.077,0.12501,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
92659,MAFG-DT,,0.78,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
92667,MGME1,Q9BQP7,0.695,0.423,0.001847,,,C3554462,MITOCHONDRIAL DNA DEPLETION SYNDROME 11,,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2017.0,ALL
92675,DTD1,Q8TEA8,0.769,0.462,0.0018054,DTO_05007624,Enzyme,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
92689,FAM114A1,Q8IWE2,0.931,0.038,1.4659e-20,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
92703,TMEM183A,Q8IXX5,1.0,0.038,0.70022,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
92714,ARRDC1,Q8N5I2,0.839,0.231,1.3606e-06,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
92715,DPH7,Q9BTV6,0.931,0.077,1.8603e-08,,,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
92736,OTOP2,Q7RTS6,0.861,0.269,3.5925e-14,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
92737,DNER,Q8NFT8,0.493,0.769,0.1859,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.13,1.0,,2014.0,2019.0,ALL
92745,SLC38A5,Q8WUX1,0.751,0.346,0.97676,DTO_05007405,Transporter,C0376618,Endotoxemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",phenotype,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
92747,BPIFB1,Q8TDL5,0.751,0.346,2.3224e-08,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
92749,DRC1,Q96MC2,0.641,0.654,8.3157e-20,,,C3809087,"CILIARY DYSKINESIA, PRIMARY, 21",,,disease,Disease or Syndrome,0.8,,,,,ALL
92797,HELB,Q8NG08,0.861,0.192,9.5899e-26,DTO_05007624,Enzyme,C0200641,Blood basophil count (lab test),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
92799,SHKBP1,Q8TBC3,0.821,0.192,7.8108e-08,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
92815,H2AW,Q7L7L0,1.0,0.077,0.53421,DTO_05007557,Nucleic acid binding,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
92822,ZNF276,Q8N554,0.861,0.192,7.8951e-06,DTO_05007542,Transcription factor,C0015625,Fanconi Anemia,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.11,1.0,,1997.0,2018.0,ALL
92840,REEP6,Q96HR9,0.67,0.385,1.6861e-05,DTO_05007405,Transporter,C4310626,RETINITIS PIGMENTOSA 77,,,disease,Disease or Syndrome,0.9,1.0,strong,2014.0,2018.0,ALL
92856,IMP4,Q96G21,1.0,0.077,8.8614e-07,DTO_05007557,Nucleic acid binding,C0004610,Bacteremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
92906,HNRNPLL,Q8WVV9,0.861,0.077,0.91907,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
92912,UBE2Q2,Q8WVN8,0.729,0.5,8.744e-08,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
92922,CCDC102A,Q96A19,,,6.8219e-05,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
92935,MARS2,Q96GW9,0.682,0.538,5.4482e-05,DTO_05007624,Enzyme,C1969645,"Ataxia, Spastic, 3, Autosomal Recessive",C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2006.0,2016.0,ALL
92949,ADAMTSL1,Q8N6G6,0.682,0.654,3.1241e-12,DTO_05007624,Enzyme,C0020302,Hydrophthalmos,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.11,1.0,,2017.0,2017.0,ALL
92979,MARCHF9,Q86YJ5,0.743,0.385,0.73089,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
93010,B3GNT7,Q8NFL0,0.861,0.077,0.70639,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
93034,NT5C1B,Q96P26,0.931,0.038,4.541e-10,,,C0003125,Anorexia Nervosa,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2013.0,2013.0,ALL
93035,PKHD1L1,Q86WI1,0.805,0.308,1.3739e-109,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
93058,COQ10A,Q96MF6,1.0,0.077,0.00036102,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
93081,TEX30,Q5JUR7,,,0.00060198,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
93082,NEURL3,Q96EH8,0.861,0.192,,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
93099,DMKN,Q6E0U4,0.729,0.308,8.3445e-13,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2010.0,2010.0,ALL
93100,NAPRT,Q6XQN6,0.7,0.346,1.1537e-18,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2013.0,2019.0,ALL
93107,KCNG4,Q8TDN1,0.861,0.192,4.2136e-16,DTO_01300327,Ion channel,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
93109,TMEM44,Q2T9K0,,,7.1934e-16,,,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2009.0,2009.0,ALL
93129,ORAI3,Q9BRQ5,0.76,0.269,0.034454,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.06,1.0,,2011.0,2019.0,ALL
93134,ZNF561,Q8N587,1.0,0.077,3.0091e-05,,,C0020445,"Hypercholesterolemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
93145,OLFM2,O95897,0.78,0.231,0.080225,DTO_05007530,Cellular structure,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
93164,HTR7P1,,1.0,0.038,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,1999.0,1999.0,ALL
93166,PRDM6,Q9NQX0,0.638,0.692,0.60835,,,C4310753,PATENT DUCTUS ARTERIOSUS 3,,,disease,Congenital Abnormality,0.6,1.0,,2016.0,2016.0,ALL
93183,PIGM,Q9H3S5,0.695,0.346,5.3861e-05,DTO_05007624,Enzyme,C1853205,Glycosylphosphatidylinositol deficiency,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.61,1.0,,2006.0,2014.0,ALL
93185,IGSF8,Q969P0,0.76,0.192,4.6329e-11,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2009.0,2017.0,ALL
93210,PGAP3,Q96FM1,0.628,0.731,0.00194,,,C3810354,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4,,,disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2019.0,ALL
93233,CCDC114,Q96M63,0.674,0.5,6.6333e-09,,,C3540844,"CILIARY DYSKINESIA, PRIMARY, 20",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2013.0,ALL
93273,LEMD1,Q68G75,0.805,0.154,3.3433e-06,DTO_05007599,Signaling,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
93323,HAUS8,Q9BT25,1.0,0.115,1.5207e-06,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
93343,MVB12A,Q96EY5,,,8.024e-06,,,C4016733,"HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS",,,phenotype,Finding,0.1,,,,,ALL
93349,SP140L,Q9H930,1.0,0.077,6.7873e-09,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
93377,OPALIN,Q96PE5,1.0,0.115,0.0014919,,,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2019.0,2019.0,ALL
93426,SYCE1,Q8N0S2,0.751,0.308,7.0153e-08,,,C4310779,SPERMATOGENIC FAILURE 15,,,disease,Disease or Syndrome,0.4,,,,,ALL
93432,MGAM2,Q2M2H8,,,0.41039,DTO_05007624,Enzyme,C1513302,Mild Adverse Event,,,phenotype,Finding,0.1,1.0,,2017.0,2017.0,ALL
93436,ARMC6,Q6NXE6,,,1.8352e-10,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
93487,MAPK1IP1L,Q8NDC0,0.89,0.077,0.64991,,,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
93492,TPTE2,Q6XPS3,0.78,0.154,1.8753e-12,DTO_05007624,Enzyme,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
93517,SDR42E1,Q8WUS8,0.931,0.192,1.5615e-09,DTO_05007624,Enzyme,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
93550,ZFAND4,Q86XD8,0.89,0.077,1.1579e-11,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
93556,EGFEM1P,Q0D2K5,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
93587,TRMT10A,Q8TBZ6,0.743,0.385,3.8911e-10,,,C4014997,"MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2016.0,ALL
93589,CACNA2D4,Q7Z3S7,0.716,0.269,1.4894e-34,DTO_01300327,Ion channel,C1864849,RETINAL CONE DYSTROPHY 4,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.6,1.0,,2016.0,2016.0,ALL
93594,TBC1D31,Q96DN5,0.89,0.154,8.6043e-20,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
93611,FBXO44,Q9H4M3,0.89,0.154,2.1091e-06,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
93621,MRFAP1,Q9Y605,0.861,0.231,0.31404,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
93624,TADA2B,Q86TJ2,,,0.72366,,,C0200633,Neutrophil count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
93627,TBCK,Q8TEA7,0.65,0.654,2.0935e-15,DTO_03300101,Kinase,C4225161,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3",,,disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2017.0,ALL
93643,TJAP1,Q5JTD0,,,1.7649e-05,,,C0429087,Electrocardiogram: P-R interval,,,phenotype,Finding,0.1,1.0,,2013.0,2013.0,ALL
93649,MYOCD,Q8IZQ8,0.619,0.615,0.33364,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
93650,ACP4,Q9BZG2,0.805,0.269,8.621e-15,DTO_05007624,Enzyme,C4310630,"AMELOGENESIS IMPERFECTA, TYPE IJ",,,disease,Congenital Abnormality,0.7,1.0,strong,2016.0,2017.0,ALL
93653,ST7-AS1,,0.931,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
93654,ST7-AS2,,0.931,0.038,,,,C0557874,Global developmental delay,,,disease,Mental or Behavioral Dysfunction,0.1,,,,,ALL
93655,ST7-OT3,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
93659,CGB5,P0DN86,0.579,0.654,0.025362,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.32,1.0,,2005.0,2013.0,ALL
93663,ARHGAP18,Q8N392,0.736,0.346,8.4436e-12,DTO_05007584,Enzyme modulator,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2009.0,2017.0,ALL
93664,CADPS2,Q86UW7,0.716,0.231,0.36785,DTO_05007616,Calcium-binding protein,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,1.0,,2003.0,2012.0,ALL
93668,HPYR1,,1.0,0.038,,,,C0850666,Infection caused by Helicobacter pylori,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
93953,GCNA,Q96QF7,0.89,0.231,0.98788,DTO_05007542,Transcription factor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
93974,ATP5IF1,Q9UII2,0.769,0.346,0.00010367,DTO_05007624,Enzyme,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.2,1.0,,2002.0,2005.0,ALL
93978,CLEC6A,Q6EIG7,0.666,0.423,1.1269e-06,DTO_05007575,Receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2009.0,2016.0,ALL
93979,CPA5,Q8WXQ8,,,0.00018213,DTO_05007624,Enzyme,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
93983,DYT13,,0.821,0.231,,,,C1843264,"DYSTONIA 13, TORSION",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2001.0,2001.0,ALL
93985,FGS3,,1.0,0.154,,,,C0220769,FG syndrome,C23;C16;C06;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
93986,FOXP2,O15409,0.545,0.808,0.99994,,,C0750927,"Apraxia, Developmental Verbal",C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.8,1.0,,2001.0,2019.0,ALL
93999,OTSC2,,0.931,0.038,,,,C0029899,Otosclerosis,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.06,1.0,,2001.0,2010.0,ALL
94005,PIGS,Q96S52,0.705,0.346,1.8127e-05,,,C4748357,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18,,,disease,Disease or Syndrome,0.6,1.0,,2018.0,2018.0,ALL
94008,SCA18,,,,,,,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
94009,SERHL,Q9NQF3,0.931,0.154,,DTO_05007624,Enzyme,C0008533,Hemophilia B,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
94015,TTYH2,Q9BSA4,0.76,0.154,9.9328e-05,DTO_01300327,Ion channel,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2016.0,2016.0,ALL
94017,TRS-TGA2-1,,,,,,,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
94025,MUC16,Q8WXI7,0.479,0.808,8.2703e-112,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.4,1.0,,1987.0,2020.0,ALL
94026,POM121L2,Q96KW2,0.861,0.192,0.32747,DTO_05007557,Nucleic acid binding,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
94027,CGB7,P0DN87,,,0.0052599,DTO_05007599,Signaling,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
94031,HTRA3,P83110,0.674,0.5,6.5843e-08,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2008.0,2019.0,ALL
94032,CAMK2N2,Q96S95,1.0,0.077,0.22046,,,C0155877,Allergic asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
94033,FTMT,Q8N4E7,0.686,0.423,0.0056072,DTO_05007612,Storage,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2015.0,2017.0,ALL
94039,ZNF101,Q8IZC7,1.0,0.077,0.77153,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
94081,SFXN1,Q9H9B4,0.597,0.731,0.00097212,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
94086,HSPB9,Q9BQS6,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
94097,SFXN5,Q8TD22,1.0,0.038,0.0001472,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
94101,ORMDL1,Q9P0S3,1.0,0.077,0.12321,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
94103,ORMDL3,Q8N138,0.666,0.423,0.78329,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,0.986,,2007.0,2019.0,ALL
94104,PAXBP1,Q9Y5B6,1.0,,0.99999,DTO_05007557,Nucleic acid binding,C0424605,Developmental delay (disorder),F03,   Mental Disorders,phenotype,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
94115,CGB8,P0DN86,0.585,0.654,0.015956,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1990.0,2018.0,ALL
94120,SYTL3,Q4VX76,0.89,0.269,2.2377e-20,,,C1096202,Lipoprotein (a) measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2015.0,2015.0,ALL
94121,SYTL4,Q96C24,0.861,0.115,0.014122,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
94122,SYTL5,Q8TDW5,0.931,0.038,0.00026919,,,C0003125,Anorexia Nervosa,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2013.0,2013.0,ALL
94134,ARHGAP12,Q8IWW6,0.931,0.038,5.513e-07,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
94137,RP1L1,Q8IWN7,0.78,0.154,1.8205e-10,,,C3150833,OCCULT MACULAR DYSTROPHY,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.8,1.0,strong,2010.0,2019.0,ALL
94158,CDRT15P1,,1.0,0.038,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
94160,ABCC12,Q96J65,0.931,0.077,4.5659e-49,DTO_05007405,Transporter,C0005956,Bone Marrow Diseases,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
94161,SNORD46,,,,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
94233,OPN4,Q9UHM6,0.579,0.769,9.0073e-13,DTO_02300001,G-protein coupled receptor,C0085159,Seasonal Affective Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,0.75,,2009.0,2019.0,ALL
94234,FOXQ1,Q9C009,0.61,0.615,0.61849,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2011.0,2019.0,ALL
94235,GNG8,Q9UK08,0.931,0.115,0.164,DTO_05007584,Enzyme modulator,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
94239,H2AZ2,Q71UI9,,,0.4713,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
94240,EPSTI1,Q96J88,0.805,0.154,3.3095e-25,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,2002.0,2018.0,ALL
94241,TP53INP1,Q96A56,0.595,0.654,0.00046552,,,C0524620,Metabolic Syndrome X,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.2,1.0,,2007.0,2015.0,ALL
94274,PPP1R14A,Q96A00,0.716,0.423,0.12672,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2007.0,2017.0,ALL
94313,AUTS5,,1.0,0.038,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0,,2009.0,2014.0,ALL
95681,CEP41,Q9BYV8,0.636,0.5,3.5915e-06,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.52,1.0,limited,2012.0,2019.0,ALL
96459,FNIP1,Q8TF40,0.743,0.346,0.99957,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
96597,TBC1D27P,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
96610,BMS1P20,,0.682,0.577,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.05,1.0,,2001.0,2009.0,ALL
96626,LIMS3,P0CW19;P0CW20,0.839,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
96764,TGS1,Q96RS0,0.839,0.154,1.1034e-12,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
103910,MYL12B,O14950;P19105,0.691,0.462,0.11325,DTO_05007616,Calcium-binding protein,C0949658,"Cardiomyopathy, Hypertrophic, Familial",C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.03,1.0,,2005.0,2019.0,ALL
112398,EGLN2,Q96KS0,0.604,0.731,0.72166,,,C1708353,Hereditary Paraganglioma-Pheochromocytoma Syndrome,C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",disease,Disease or Syndrome,0.3,1.0,limited,2015.0,2015.0,ALL
112399,EGLN3,Q9H6Z9,0.575,0.654,0.0094753,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
112401,BIRC8,Q96P09,0.861,0.192,,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
112464,CAVIN3,Q969G5,0.674,0.423,7.9971e-05,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,1996.0,2014.0,ALL
112476,PRRT2,Q7Z6L0,0.448,0.808,0.57919,,,C1865926,"Infantile convulsions and paroxysmal choreoathetosis, familial (disorder)",C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.8,0.957,definitive,2000.0,2017.0,ALL
112479,ERI2,A8K979,1.0,0.077,5.0234e-10,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
112483,SAT2,Q96F10,0.686,0.462,2.7832e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.05,1.0,,2004.0,2015.0,ALL
112574,SNX18,Q96RF0,0.839,0.077,0.95637,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2007.0,2007.0,ALL
112597,CYTOR,,0.568,0.577,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.952,,2013.0,2020.0,ALL
112609,MRAP2,Q96G30,0.792,0.269,2.5633e-07,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.42,1.0,limited,2013.0,2019.0,ALL
112616,CMTM7,Q96FZ5,0.751,0.308,0.038169,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
112714,TUBA3E,Q6PEY2,0.861,0.115,2.0308e-08,DTO_05007530,Cellular structure,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
112724,RDH13,Q8NBN7,0.821,0.115,6.0402e-14,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
112744,IL17F,Q96PD4,0.48,0.808,0.039165,,,C3151405,"CANDIDIASIS, FAMILIAL, 6",,,disease,Disease or Syndrome,0.7,1.0,moderate,2011.0,2011.0,ALL
112752,IFT43,Q96FT9,0.617,0.577,1.8153e-11,,,C0432235,CRANIOECTODERMAL DYSPLASIA 1,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.61,1.0,,2011.0,2018.0,ALL
112755,STX1B,P61266,0.65,0.308,0.98766,DTO_05007405,Transporter,C4015395,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2014.0,ALL
112802,KRT71,Q3SY84,0.743,0.308,9.011e-07,,,C4014616,HYPOTRICHOSIS 13,,,disease,Disease or Syndrome,0.8,1.0,,2012.0,2012.0,ALL
112812,FDX2,Q6P4F2,0.78,0.346,0.001652,,,C0162670,Mitochondrial Myopathies,C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.71,1.0,strong,2014.0,2018.0,ALL
112817,HOGA1,Q86XE5,0.792,0.192,1.5812e-14,DTO_05007624,Enzyme,C3150878,Primary hyperoxaluria type III,C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.78,1.0,,2010.0,2019.0,ALL
112849,L3HYPDH,Q96EM0,1.0,0.077,9.2642e-07,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
112858,TP53RK,Q96S44,0.659,0.615,0.00077469,DTO_03300101,Kinase,C4540270,GALLOWAY-MOWAT SYNDROME 4,,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2017.0,ALL
112869,SGF29,Q96ES7,0.792,0.269,0.002139,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
112885,PHF21B,Q96EK2,0.792,0.154,0.98689,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2017.0,ALL
112939,NACC1,Q96RE7,0.61,0.577,0.99763,,,C4479333,"NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION",,,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
112942,CFAP36,Q96G28,,,2.1256e-05,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
112950,MED8,Q96G25,0.805,0.154,2.844e-06,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
113026,PLCD3,Q8N3E9,0.805,0.462,1.3373e-07,DTO_05007624,Enzyme,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
113091,PTH2,Q96A98,0.931,0.154,0.0026248,,,C0022595,Keratosis Follicularis,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
113115,MTFR2,Q6P444,0.861,0.077,2.6584e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
113130,CDCA5,Q96FF9,0.563,0.808,0.0011583,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2017.0,2019.0,ALL
113146,AHNAK2,Q8IVF2,0.78,0.462,0.00064799,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
113157,RPLP0P2,,0.89,0.154,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
113174,SAAL1,Q96ER3,0.89,0.115,4.3242e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
113178,SCAMP4,Q969E2,0.931,0.077,0.0045692,DTO_05007624,Enzyme,C0038379,Strabismus,C11;C10,   Eye Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
113179,ADAT3,Q96EY9,0.736,0.385,0.0056059,,,C3809039,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2018.0,ALL
113189,CHST14,Q8NCH0,0.638,0.654,0.44727,DTO_05007624,Enzyme,C1866294,"EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 1",C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.73,1.0,,2009.0,2016.0,ALL
113201,CASC4,Q6P4E1,1.0,0.077,7.1603e-05,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
113220,KIF12,Q96FN5,0.861,0.154,4.1596e-12,DTO_05007530,Cellular structure,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
113235,SLC46A1,Q96NT5,0.606,0.731,0.021858,DTO_05007405,Transporter,C0342705,"Folate Malabsorption, Hereditary",C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.8,1.0,,2001.0,2020.0,ALL
113246,C12orf57,Q99622,0.641,0.5,5.2408e-05,,,C1857512,Temtamy syndrome,C23;C16;C11;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2011.0,2018.0,ALL
113251,LARP4,Q71RC2,0.78,0.192,0.86884,DTO_05007557,Nucleic acid binding,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
113263,GLCCI1,Q86VQ1,0.716,0.385,0.05903,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2019.0,ALL
113277,TMEM106A,Q96A25,0.839,0.192,1.8357e-07,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
113278,SLC52A3,Q9NQ40,0.61,0.654,0.019348,DTO_05007405,Transporter,C0796274,Brown-Vialetto-Van Laere Syndrome 1,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.8,0.957,definitive,2010.0,2019.0,ALL
113444,SMIM12,Q96EX1,0.78,0.192,0.56679,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
113451,AZIN2,Q96A70,0.499,0.808,8.8707e-07,DTO_05007624,Enzyme,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1993.0,2019.0,ALL
113452,TMEM54,Q969K7,0.716,0.5,0.0030921,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,1995.0,2019.0,ALL
113457,TUBA3D,P0DPH7;P0DPH8,0.839,0.269,7.2364e-10,,,C0234632,Reduced visual acuity,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",phenotype,Finding,0.1,,,,,ALL
113510,HELQ,Q8TDG4,0.729,0.308,6.4877e-12,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
113540,CMTM1,Q8IZ96,0.769,0.269,0.0022376,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
113612,CYP2U1,Q7Z449,0.722,0.462,0.0014201,,,C3539507,"SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2014.0,ALL
113622,ADPRHL1,Q8NDY3,1.0,0.077,3.491e-11,DTO_05007624,Enzyme,C0220633,Uveal melanoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
113675,SDSL,Q96GA7,,,1.3641e-11,DTO_05007624,Enzyme,C0040822,Tremor,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
113730,KLHDC7B,Q96G42,0.861,0.154,1.192e-09,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
113746,ODF3,Q96PU9,0.839,0.154,0.14655,DTO_05007530,Cellular structure,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
113791,PIK3IP1,Q96FE7,0.769,0.385,0.015067,DTO_05007624,Enzyme,C1135196,"Heart Failure, Diastolic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
113802,HENMT1,Q5T8I9,0.821,0.308,6.8224e-10,,,C0022735,Klinefelter Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
113828,FAM83F,Q8NEG4,0.792,0.231,1.762e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
113829,SLC35A4,Q96G79,0.821,0.231,8.8682e-05,DTO_05007405,Transporter,C0004565,"Melanoma, B16",C04,   Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.01,1.0,,2001.0,2001.0,ALL
113835,ZNF257,Q9Y2Q1,0.931,0.154,0.018857,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2019.0,2019.0,ALL
113878,DTX2,Q86UW9,0.792,0.077,0.028903,DTO_05007624,Enzyme,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
114034,TOE1,Q96GM8,0.682,0.462,6.0443e-16,DTO_05007557,Nucleic acid binding,C3554226,Congenital pontocerebellar hypoplasia type 7,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2017.0,2017.0,ALL
114036,LINC00310,P59036,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
114038,LINC00313,P59037,0.736,0.154,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
114041,B3GALT5-AS1,P59052,0.78,0.115,0.22348,,,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
114042,LINC00334,,,,,,,C1285654,Memory performance,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
114044,MCM3AP-AS1,,0.76,0.154,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
114049,BUD23,O43709,0.839,0.269,7.6593e-05,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
114086,DBA2,,0.599,0.731,,,,C1853666,"Anemia, Diamond-Blackfan, 2",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,1.0,,1986.0,2018.0,ALL
114088,TRIM9,Q9C026,0.705,0.5,0.99973,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
114112,TXNRD3,Q86VQ6,0.653,0.615,8.3449e-08,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.07,1.0,,1994.0,2020.0,ALL
114131,UCN3,Q969E3,0.593,0.731,0.043878,,,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.31,1.0,,2006.0,2017.0,ALL
114134,SLC2A13,Q96QE2,0.78,0.269,0.83307,DTO_05007405,Transporter,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
114293,ANBC,,0.861,0.077,,,,C0152244,"Bone Cysts, Aneurysmal",C04;C05,   Neoplasms;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.06,1.0,,2007.0,2019.0,ALL
114294,LACTB,P83111,0.839,0.192,1.975e-06,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
114327,EFHC1,Q5JVL4,0.659,0.231,1.8959e-17,,,C0270853,Juvenile Myoclonic Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,1.0,0.979,disputed,1993.0,2019.0,ALL
114335,CGB1,A6NKQ9,0.861,0.115,0.036312,DTO_05007599,Signaling,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2019.0,ALL
114336,CGB2,Q6NT52,0.861,0.115,0.030408,DTO_05007599,Signaling,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2019.0,ALL
114475,AD7,,0.861,0.192,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
114548,NLRP3,Q96P20,0.361,0.962,0.00081103,,,C0409818,"Chronic Infantile Neurological, Cutaneous, and Articular Syndrome",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,1.0,1.0,,2002.0,2019.0,ALL
114568,NMTC3,,0.89,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
114569,MAL2,Q969L2,0.711,0.231,0.13691,DTO_05007405,Transporter,C1262886,Osteoprotegerin test,,,phenotype,Laboratory Procedure,0.1,1.0,,2014.0,2014.0,ALL
114571,SLC22A9,Q8IVM8,0.89,0.269,4.2676e-19,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
114609,TIRAP,P58753,0.604,0.769,0.00076118,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.38,0.889,,2007.0,2019.0,ALL
114614,MIR155HG,,0.617,0.615,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.06,1.0,,2003.0,2015.0,ALL
114625,ERMAP,Q96PL5,,,4.9067e-10,DTO_05007584,Enzyme modulator,C1862204,RADIN BLOOD GROUP ANTIGEN,,,phenotype,Body Substance,0.1,,,,,ALL
114659,LRRC37B,Q96QE4,1.0,0.115,0.0064058,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2010.0,ALL
114757,CYGB,Q8WWM9,0.579,0.577,0.10249,,,C0005398,"Cholestasis, Extrahepatic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
114769,CARD16,Q5EG05,0.695,0.615,0.38275,,,C0266574,Ablepharon,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.03,1.0,,2017.0,2018.0,ALL
114770,PGLYRP2,Q96PD5,0.805,0.231,2.6765e-11,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
114771,PGLYRP3,Q96LB9,0.792,0.192,9.6075e-08,,,C0009319,Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
114780,PKD1L2,Q7Z442,0.861,0.154,2.0902e-05,DTO_01300327,Ion channel,C0201874,Amino acids measurement,,,group,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
114781,BTBD9,Q96Q07,0.691,0.423,7.0655e-09,,,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.7,0.967,,2007.0,2020.0,ALL
114783,LMTK3,Q96Q04,0.736,0.269,0.99997,DTO_03300101,Kinase,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.08,1.0,,2011.0,2019.0,ALL
114784,CSMD2,Q7Z408,0.695,0.269,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2011.0,2017.0,ALL
114785,MBD6,Q96DN6,0.931,0.192,0.99937,,,C0019202,Hepatolenticular Degeneration,C16;C06;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
114786,XKR4,Q5GH76,0.821,0.154,0.99912,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
114787,GPRIN1,Q7Z2K8,1.0,0.038,0.97001,,,C0031106,Aggressive Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
114788,CSMD3,Q7Z407,0.695,0.5,0.057105,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2008.0,ALL
114789,SLC25A25,Q6KCM7,0.89,0.154,0.023986,DTO_05007405,Transporter,C0014457,Eosinophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
114790,STK11IP,Q8N1F8,0.861,0.192,8.598e-20,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2005.0,2013.0,ALL
114791,TUBGCP5,Q96RT8,0.769,0.346,1.2275e-12,DTO_05007530,Cellular structure,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2006.0,2006.0,ALL
114792,KLHL32,Q96NJ5,0.931,0.115,0.0093469,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2014.0,2014.0,ALL
114793,FMNL2,Q96PY5,0.729,0.231,0.9932,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
114794,ELFN2,Q5R3F8,0.861,0.038,0.96483,DTO_05007575,Receptor,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
114795,TMEM132B,Q14DG7,0.861,0.154,0.99876,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
114796,PSMG3-AS1,Q96PY0,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
114798,SLITRK1,Q96PX8,0.736,0.308,0.95737,,,C0040517,Gilles de la Tourette syndrome,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.7,0.952,,2005.0,2015.0,ALL
114799,ESCO1,Q5FWF5,0.682,0.462,0.99995,,,C1281901,Fatty acid measurement,,,group,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
114800,CCDC85A,Q96PX6,0.931,0.077,1.5427e-05,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
114801,TMEM200A,Q86VY9,0.89,0.038,0.85062,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
114803,MYSM1,Q5VVJ2,0.7,0.462,0.043365,DTO_05007624,Enzyme,C4748257,BONE MARROW FAILURE SYNDROME 4,,,disease,Disease or Syndrome,0.6,1.0,moderate,2013.0,2017.0,ALL
114804,RNF157,Q96PX1,1.0,0.077,6.3025e-09,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
114805,GALNT13,Q8IUC8,0.89,0.154,0.99066,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
114814,GNRHR2,Q96P88,0.821,0.192,,DTO_02300001,G-protein coupled receptor,C0175703,Thrombocytopenia-Absent Radius Syndrome,C16;C05;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
114815,SORCS1,Q8WY21,0.751,0.346,0.55937,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
114818,KLHL29,Q96CT2,0.89,0.115,0.98532,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
114819,CROCCP3,Q8IVE0,,,,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
114821,ZBED9,Q6R2W3,0.821,0.269,3.9877e-09,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
114822,RHPN1,Q8TCX5,0.821,0.192,1.025e-12,DTO_05007584,Enzyme modulator,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
114823,LENG8,Q96PV6,1.0,0.077,0.99938,,,C0263313,Pemphigus Foliaceus,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
114825,PWWP2A,Q96N64,1.0,0.077,0.98292,,,C4021085,Abnormality of brain morphology,,,phenotype,Anatomical Abnormality,0.1,,,,,ALL
114826,SMYD4,Q8IYR2,0.792,0.077,8.7782e-15,,,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
114827,FHAD1,B1AJZ9,0.839,0.154,0.00013667,,,C0010051,Coronary Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
114836,SLAMF6,Q96DU3,0.751,0.346,0.018712,DTO_05007624,Enzyme,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2013.0,2013.0,ALL
114876,OSBPL1A,Q9BXW6,0.769,0.346,2.576e-07,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
114879,OSBPL5,Q9H0X9,0.792,0.346,4.6494e-06,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
114880,OSBPL6,Q9BZF3,1.0,0.077,0.99999,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.11,1.0,,2016.0,2016.0,ALL
114881,OSBPL7,Q9BZF2,0.931,0.154,0.0028675,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
114882,OSBPL8,Q9BZF1,0.821,0.269,0.010518,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
114883,OSBPL9,Q96SU4,0.931,0.192,0.97558,,,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
114884,OSBPL10,Q9BXB5,0.78,0.269,3.3256e-07,,,C1704436,Peripheral Arterial Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.11,1.0,,2010.0,2010.0,ALL
114885,OSBPL11,Q9BXB4,0.861,0.192,0.83432,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
114897,C1QTNF1,Q9BXJ1,0.7,0.346,0.00042421,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0,,2014.0,2017.0,ALL
114899,C1QTNF3,Q9BXJ4,0.695,0.577,1.8089e-07,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2010.0,2010.0,ALL
114900,C1QTNF4,Q9BXJ3,0.861,0.154,0.17229,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
114902,C1QTNF5,Q9BXJ0,0.663,0.346,0.83565,,,C1854065,LATE-ONSET RETINAL DEGENERATION (disorder),C11,   Eye Diseases,disease,Disease or Syndrome,1.0,1.0,,2003.0,2019.0,ALL
114904,C1QTNF6,Q9BXI9,0.682,0.577,9.0082e-06,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.41,1.0,,2008.0,2015.0,ALL
114905,C1QTNF7,Q9BXJ2,0.861,0.192,8.9772e-05,,,C0149654,Conduct Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
114907,FBXO32,Q969P5,0.636,0.615,0.99692,,,C0026846,Muscular Atrophy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.54,1.0,,2001.0,2010.0,ALL
114915,EPB41L4A-AS1,,1.0,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2006.0,2019.0,ALL
114926,SMIM19,Q96E16,,,0.34399,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
114928,GPRASP2,Q96D09,0.839,0.154,0.98751,,,C4746975,"DEAFNESS, X-LINKED 7",,,disease,Disease or Syndrome,0.5,1.0,,2017.0,2017.0,ALL
114960,TSGA13,Q96PP4,0.78,0.154,7.3935e-10,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
114971,PTPMT1,Q8WUK0,0.805,0.154,0.012681,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
114987,WDR31,Q8NA23,,,1.5482e-09,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
114990,VASN,Q6EMK4,0.722,0.269,0.67248,DTO_05007575,Receptor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2015.0,2018.0,ALL
114991,ZNF618,Q5T7W0,0.839,0.308,0.99842,DTO_05007542,Transcription factor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
115004,CGAS,Q8N884,0.705,0.538,8.6912e-09,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2014.0,2019.0,ALL
115019,SLC26A9,Q7LBE3,0.743,0.423,0.012733,DTO_05007405,Transporter,C0021843,Intestinal Obstruction,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
115024,NT5C3B,Q969T7,1.0,0.077,3.662e-10,DTO_05007624,Enzyme,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
115106,HAUS1,Q96CS2,1.0,0.077,3.5522e-08,,,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
115110,TNFRSF14-AS1,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
115111,SLC26A7,Q8TE54,0.751,0.423,1.9125e-09,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
115123,MARCHF3,Q86UD3,0.743,0.423,0.17324,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
115201,ATG4A,Q8WYN0,0.76,0.192,0.98953,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
115207,KCTD12,Q96CX2,0.78,0.231,0.061693,DTO_05007584,Enzyme modulator,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2015.0,2015.0,ALL
115209,OMA1,Q96E52,0.716,0.462,1.2241e-11,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
115265,DDIT4L,Q96D03,1.0,0.038,1.5197e-06,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
115273,RAB42,Q8N4Z0,1.0,0.038,0.0029709,DTO_05007584,Enzyme modulator,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
115286,SLC25A26,Q70HW3,0.716,0.308,2.5832e-07,DTO_05007405,Transporter,C4225206,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28,,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2015.0,ALL
115290,FBXO17,Q96EF6,0.839,0.115,5.6825e-13,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
115294,PCMTD1,Q96MG8,0.89,0.077,0.26735,DTO_05007624,Enzyme,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
115330,GPR146,Q96CH1,1.0,0.038,0.1493,DTO_02300001,G-protein coupled receptor,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
115350,FCRL1,Q96LA6,0.751,0.308,3.9509e-06,DTO_05007620,Cell adhesion,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2011.0,2015.0,ALL
115352,FCRL3,Q96P31,0.612,0.769,5.9739e-21,DTO_05007620,Cell adhesion,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.48,1.0,,2006.0,2016.0,ALL
115353,LRRC42,Q9Y546,0.89,0.077,1.3431e-08,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
115361,GBP4,Q96PP9,1.0,0.077,9.1784e-16,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
115362,GBP5,Q96PP8,0.78,0.385,8.112e-10,DTO_05007584,Enzyme modulator,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
115399,LRRC56,Q8IYG6,0.67,0.5,7.6752e-10,,,C4748841,"CILIARY DYSKINESIA, PRIMARY, 39",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
115416,MALSU1,Q96EH3,,,1.6777e-11,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
115426,UHRF2,Q96PU4,0.7,0.308,0.99928,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2011.0,2011.0,ALL
115509,ZNF689,Q96CS4,0.821,0.154,0.41789,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,0.667,,2011.0,2019.0,ALL
115548,FCHO2,Q0JRZ9,,,0.99973,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
115557,ARHGEF25,Q86VW2,0.792,0.231,2.9481e-10,DTO_05007599,Signaling,C0035412,Rhabdomyosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
115560,ZNF501,Q96CX3,0.792,0.308,0.28125,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
115572,TENT5B,Q96A09,0.931,0.077,0.18261,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
115584,SLC5A11,Q8WWX8,0.792,0.423,1.6748e-13,DTO_05007405,Transporter,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2008.0,2014.0,ALL
115650,TNFRSF13C,Q96RJ3,0.54,0.731,0.26993,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.6,1.0,,2005.0,2015.0,ALL
115653,KIR3DL3,Q8N743,0.861,0.346,0.00012102,DTO_05007575,Receptor,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
115677,NOSTRIN,Q8IVI9,0.805,0.346,3.2029e-16,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0,,2001.0,2001.0,ALL
115701,ALPK2,Q86TB3,0.751,0.346,1.0376e-21,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
115703,ARHGAP33,O14559,1.0,0.038,0.028562,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
115704,EVI5L,Q96CN4,,,0.99985,DTO_05007624,Enzyme,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2014.0,2014.0,ALL
115708,TRMT61A,Q96FX7,0.931,0.038,0.024387,DTO_05007624,Enzyme,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
115727,RASGRP4,Q8TDF6,0.78,0.231,0.037579,DTO_05007584,Enzyme modulator,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
115752,DIS3L,Q8TF46,0.89,0.038,1.4172e-18,DTO_05007624,Enzyme,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
115761,ARL11,Q969Q4,0.67,0.423,0.0052678,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.32,0.667,,2005.0,2006.0,ALL
115795,FANCD2OS,Q96PS1,1.0,0.115,0.022748,,,C3160738,"FANCONI ANEMIA, COMPLEMENTATION GROUP D2",C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
115811,IQCD,Q96DY2,1.0,0.077,1.7712e-09,,,C2751898,"Ventricular Fibrillation, Paroxysmal Familial, 1",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,2019.0,2019.0,ALL
115817,DHRS1,Q96LJ7,,,3.9562e-15,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
115825,WDFY2,Q96P53,0.821,0.154,1.5198e-08,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
115861,NXNL1,Q96CM4,1.0,0.077,0.011891,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.04,1.0,,2004.0,2015.0,ALL
115908,CTHRC1,Q96CG8,0.556,0.692,2.6661e-05,DTO_05007624,Enzyme,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.41,1.0,,2011.0,2011.0,ALL
115948,CCDC151,A5D8V7,0.659,0.577,3.4684e-15,,,C4015016,"CILIARY DYSKINESIA, PRIMARY, 30",,,disease,Disease or Syndrome,0.8,1.0,,2014.0,2019.0,ALL
115992,RNF166,Q96A37,,,0.48668,,,C0406208,Suntan,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
116028,RMI2,Q96E14,0.666,0.5,0.018953,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
116039,OSR2,Q8N2R0,0.792,0.385,0.13046,DTO_05007542,Transcription factor,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
116064,LRRC58,Q96CX6,0.931,0.077,0.003659,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
116068,LYSMD3,Q7Z3D4,0.931,0.077,0.30382,,,C0028043,Nicotine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
116071,BATF2,Q8N1L9,0.638,0.385,0.58536,DTO_05007542,Transcription factor,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2012.0,2014.0,ALL
116085,SLC22A12,Q96S37,0.647,0.538,1.6891e-13,DTO_05007405,Transporter,C0473219,Renal hypouricemia,C23;C16;C18;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,0.971,,2002.0,2019.0,ALL
116092,DNTTIP1,Q9H147,0.861,0.077,0.7272,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
116093,DIRC1,Q969H9,0.861,0.154,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
116113,FOXP4,Q8IVH2,0.7,0.346,0.98242,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.44,1.0,,2010.0,2019.0,ALL
116115,ZNF526,Q8TF50,0.89,0.192,0.52316,,,C0020796,Profound Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
116135,LRRC3B,Q96PB8,0.695,0.308,0.44415,DTO_05007575,Receptor,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2012.0,2018.0,ALL
116143,WDR92,Q96MX6,0.931,0.077,0.008485,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
116150,NUS1,Q96E22,0.619,0.615,0.98117,,,C4310727,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2018.0,ALL
116151,FAM210B,Q96KR6,0.89,0.115,0.087064,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
116154,PHACTR3,Q96KR7,0.861,0.231,0.99687,DTO_05007584,Enzyme modulator,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2019.0,ALL
116159,CYYR1,Q96J86,,,0.00044425,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
116173,CMTM5,Q96DZ9,0.743,0.231,0.065782,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2007.0,2017.0,ALL
116179,TGM7,Q96PF1,0.839,0.154,7.8438e-20,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
116211,TM4SF19,Q96DZ7,1.0,0.077,2.9569e-06,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
116224,FAM122A,Q96E09,1.0,0.077,0.4938,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
116225,ZMYND19,Q96E35,1.0,0.077,0.95174,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
116228,COX20,Q5RI15,0.705,0.538,0.020118,,,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.71,1.0,,2013.0,2018.0,ALL
116236,ABHD15,Q6UXT9,0.931,0.115,3.5459e-08,DTO_05007624,Enzyme,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
116255,MOGAT1,Q96PD6,0.861,0.115,1.566e-10,DTO_05007624,Enzyme,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
116285,ACSM1,Q08AH1,0.769,0.269,2.2841e-15,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2015.0,ALL
116328,C8orf34,Q49A92,0.931,0.154,1.4855e-12,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
116337,PANX3,Q96QZ0,0.751,0.308,3.9672e-05,DTO_01300327,Ion channel,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0,,2015.0,2017.0,ALL
116349,EXOC3-AS1,Q8N2X6,1.0,0.038,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
116362,RBP7,Q96R05,0.792,0.346,0.54133,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2005.0,2019.0,ALL
116369,SLC26A8,Q96RN1,0.722,0.308,4.2638e-12,DTO_05007405,Transporter,C4721889,SPERMATOGENIC FAILURE 3,,,disease,Disease or Syndrome,0.4,1.0,,2013.0,2013.0,ALL
116372,LYPD1,Q8N2G4,0.805,0.346,0.00055354,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
116379,IL22RA2,Q969J5,0.682,0.5,1.2114e-16,DTO_05007575,Receptor,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,2010.0,2019.0,ALL
116437,LINC01257,,,,,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
116441,TM4SF18,Q96CE8,0.89,0.231,2.1148e-06,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
116442,RAB39B,Q96DA2,0.619,0.615,0.82529,,,C0796195,Waisman syndrome,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.75,1.0,definitive,1986.0,2018.0,ALL
116443,GRIN3A,Q8TCU5,0.743,0.423,0.45327,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2004.0,2015.0,ALL
116444,GRIN3B,O60391,0.792,0.231,2.0223e-07,DTO_01300327,Ion channel,C0200633,Neutrophil count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
116447,TOP1MT,Q969P6,0.805,0.154,2.4353e-34,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
116448,OLIG1,Q8TAK6,0.722,0.423,0.66074,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2004.0,2017.0,ALL
116449,CLNK,Q7Z7G1,0.792,0.269,1.7251e-29,DTO_05007599,Signaling,C0042900,Vitiligo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
116461,TSEN15,Q8WW01,0.769,0.115,0.27906,,,C4310757,"PONTOCEREBELLAR HYPOPLASIA, TYPE 2F",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2016.0,ALL
116496,NIBAN1,Q9BZQ8,0.716,0.346,7.1694e-20,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
116511,MAS1L,P35410,1.0,0.077,,DTO_02300001,G-protein coupled receptor,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
116512,MRGPRD,Q8TDS7,0.861,0.192,,DTO_02300001,G-protein coupled receptor,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.21,1.0,,2019.0,2019.0,ALL
116519,APOA5,Q6Q788,0.587,0.615,5.5765e-10,,,C0020481,Hyperlipoproteinemia Type V,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2005.0,2018.0,ALL
116535,MRGPRF,Q96AM1,0.659,0.769,0.024083,DTO_02300001,G-protein coupled receptor,C0036220,Kaposi Sarcoma,C04;C01,   Neoplasms;    Infections,disease,Neoplastic Process,0.1,1.0,,2000.0,2020.0,ALL
116710,FRA18C,,1.0,0.038,,,,C0004903,Beckwith-Wiedemann Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
116832,RPL39L,Q96EH5,0.861,0.192,,DTO_05007557,Nucleic acid binding,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
116833,ANIB1,,0.608,0.5,,,,C1862932,"ANEURYSM, INTRACRANIAL BERRY, 1 (disorder)",C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
116835,HSPA12B,Q96MM6,0.751,0.269,0.00045299,,,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.02,1.0,,2011.0,2017.0,ALL
116840,CNTROB,Q8N137,0.821,0.269,1.8222e-16,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
116841,SNAP47,Q5SQN1,0.805,0.385,2.0687e-05,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
116842,LEAP2,Q969E1,0.839,0.308,0.0012684,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
116843,SLC18B1,Q6NT16,0.89,0.077,1.0193e-17,DTO_05007405,Transporter,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
116844,LRG1,P02750,0.564,0.731,0.095143,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2014.0,2019.0,ALL
116931,MED12L,Q86YW9,0.839,0.269,1.0,DTO_05007542,Transcription factor,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.32,1.0,moderate,2019.0,2019.0,ALL
116933,CLRN1-AS1,,0.821,0.269,,,,C1568248,"Usher Syndrome, Type III",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.11,1.0,,2001.0,2015.0,ALL
116935,RPL3P2,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
116937,SNORD83A,,1.0,,,,,C2363741,HIV-1 infection,,,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
116966,WDR17,Q8IZU2,0.861,0.231,9.6547e-25,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
116969,ART5,Q96L15,1.0,0.038,0.00045797,,,C0008354,Cholera,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
116984,ARAP2,Q8WZ64,0.839,0.269,8.7668e-14,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
116985,ARAP1,Q96P48,0.769,0.308,0.12294,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.17,1.0,,2010.0,2019.0,ALL
116986,AGAP2,Q99490,0.729,0.385,0.99816,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
116987,AGAP1,Q9UPQ3,0.839,0.154,0.99984,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2005.0,2019.0,ALL
116988,AGAP3,Q96P47,0.839,0.115,0.91091,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
117084,CANDF1,,,,,,,C0026838,Muscle Spasticity,C23;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2017.0,2017.0,ALL
117143,TADA1,Q96BN2,0.705,0.654,0.090708,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
117144,CATSPER1,Q8NEC5,0.861,0.192,1.008e-11,DTO_01300327,Ion channel,C2751811,Spermatogenic Failure 7,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.4,,,,,ALL
117145,THEM4,Q5T1C6,0.674,0.462,3.8919e-07,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2013.0,2013.0,ALL
117154,DACH2,Q96NX9,0.861,0.154,0.16242,DTO_05007542,Transcription factor,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.31,0.5,moderate,2000.0,2004.0,ALL
117155,CATSPER2,Q96P56,0.805,0.154,5.8613e-17,DTO_01300327,Ion channel,C1970187,"Deafness, Sensorineural, And Male Infertility",C23;C12;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Male Urogenital Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.5,1.0,,2007.0,2007.0,ALL
117156,SCGB3A2,Q96PL1,0.686,0.462,0.0061075,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.5,1.0,,2001.0,2017.0,ALL
117157,SH2D1B,O14796,1.0,0.038,0.013037,,,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2014.0,2014.0,ALL
117159,DCD,P81605,0.619,0.654,0.00015781,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.31,1.0,,2008.0,2010.0,ALL
117177,RAB3IP,Q96QF0,0.861,0.115,1.6698e-08,DTO_05007584,Enzyme modulator,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
117178,SSX2IP,Q9Y2D8,0.89,0.192,2.307e-09,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
117189,GRDX,,0.839,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2010.0,2018.0,ALL
117193,THMA,,0.931,0.077,,,,C0023003,Langer-Giedion Syndrome,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0,,1999.0,2011.0,ALL
117194,MRGPRX2,Q96LB1,0.743,0.423,,DTO_02300001,G-protein coupled receptor,C0002792,anaphylaxis,C20,   Immune System Diseases,phenotype,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
117195,MRGPRX3,Q96LB0,0.529,0.923,,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
117196,MRGPRX4,Q96LA9,0.531,0.923,,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
117246,FTSJ3,Q8IY81,0.839,0.192,0.037201,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
117247,SLC16A10,Q8TF71,0.711,0.5,0.30853,DTO_05007405,Transporter,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
117248,GALNT15,Q8N3T1,1.0,0.077,3.6481e-18,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
117283,IP6K3,Q96PC2,0.839,0.231,3.0854e-07,DTO_03300101,Kinase,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
117286,CIB3,Q96Q77,0.839,0.154,2.3448e-09,,,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
117289,TAGAP,Q8N103,0.7,0.462,0.84621,DTO_05007584,Enzyme modulator,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.37,1.0,,2010.0,2018.0,ALL
117531,TMC1,Q8TDI8,0.769,0.346,9.1808e-19,DTO_01300327,Ion channel,C1847626,"Deafness, Autosomal Dominant 36",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.91,1.0,strong,1980.0,2014.0,ALL
117532,TMC2,Q8TDI7,0.931,0.154,2.083e-27,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
117579,RLN3,Q8WXF3,0.751,0.423,0.013378,,,C0020507,Hyperplasia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0,,2005.0,2005.0,ALL
117581,TWIST2,Q8WVJ9,0.518,0.731,0.56004,DTO_05007542,Transcription factor,C1744559,Congenital ectodermal dysplasia of face,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.77,1.0,,1963.0,2016.0,ALL
117583,PARD3B,Q8TEW8,0.78,0.269,7.2829e-13,,,C1535926,Neurodevelopmental Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2017.0,2017.0,ALL
117584,RFFL,Q8WZ73,,,0.40723,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
117854,TRIM6,Q9C030,0.839,0.115,1.1425e-12,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
118421,LINC00161,,0.805,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
118424,UBE2J2,Q8N2K1,0.931,0.077,0.90974,DTO_05007624,Enzyme,C0744869,Metastatic hepatocellular carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
118425,PCAT4,,0.839,0.192,,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.03,1.0,,2001.0,2007.0,ALL
118426,BORCS5,Q969J3,0.805,0.192,0.0012418,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,,,,,ALL
118427,OLFM3,Q96PB7,0.931,0.115,0.0010163,DTO_05007530,Cellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
118429,ANTXR2,P58335,0.568,0.808,0.086921,DTO_05007575,Receptor,C2745948,"Hyalinosis, Systemic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,1.0,,2003.0,2019.0,ALL
118430,MUCL1,Q96DR8,0.805,0.154,3.0923e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2004.0,2016.0,ALL
118460,EXOSC6,Q5RKV6,0.674,0.462,0.52473,DTO_05007624,Enzyme,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2006.0,2019.0,ALL
118461,C10orf71,Q711Q0,1.0,0.077,1.9625e-09,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
118471,PRAP1,Q96NZ9,0.621,0.615,0.032463,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0,,1995.0,2017.0,ALL
118487,CHCHD1,Q96BP2,1.0,0.077,6.7411e-06,,,C0279671,Cervical Squamous Cell Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
118490,MSS51,Q4VC12,0.89,0.154,3.2758e-11,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
118491,CFAP70,Q5T0N1,1.0,0.038,5.8673e-08,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
118611,C10orf90,Q96M02,0.805,0.192,8.315e-15,,,C0015944,"Fetal Membranes, Premature Rupture",C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,1.0,,2019.0,2019.0,ALL
118672,PSTK,Q8IV42,,,7.3998e-06,DTO_03300101,Kinase,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
118738,ZNF488,Q96MN9,1.0,0.115,3.0911e-06,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
118788,PIK3AP1,Q6ZUJ8,0.78,0.346,1.0,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
118812,MORN4,Q8NDC4,0.89,0.115,0.54999,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,2014.0,2014.0,ALL
118813,ZFYVE27,Q5T4F4,0.805,0.308,1.0613e-09,,,C1853251,"Spastic Paraplegia 33, Autosomal Dominant",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2006.0,2018.0,ALL
118856,MMP21,Q8N119,0.621,0.385,1.3213e-09,DTO_05007624,Enzyme,C4225217,"HETEROTAXY, VISCERAL, 7, AUTOSOMAL",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2015.0,ALL
118881,COMTD1,Q86VU5,1.0,0.038,3.3099e-05,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2013.0,2013.0,ALL
118932,ANKRD22,Q5VYY1,0.821,0.115,1.1192e-09,,,C4049938,Physical Activity Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
118980,SFXN2,Q96NB2,,,0.0010626,DTO_05007405,Transporter,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
118987,PDZD8,Q8NEN9,0.89,0.038,0.99984,,,C2363741,HIV-1 infection,,,disease,Disease or Syndrome,0.02,0.5,,2010.0,2015.0,ALL
119016,AGAP4,Q96P64,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
119032,BORCS7,Q96B45,0.89,0.115,2.2921e-07,,,C0037773,"Spastic Paraplegia, Hereditary",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.2,,,,,ALL
119180,LYZL2,Q7Z4W2,1.0,0.038,1.1221e-07,,,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.11,1.0,,2013.0,2014.0,ALL
119391,GSTO2,Q9H4Y5,0.631,0.692,2.6125e-09,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2012.0,2015.0,ALL
119392,SFR1,Q86XK3,0.931,0.077,4.7059e-10,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
119395,CALHM3,Q86XJ0,1.0,0.038,0.003306,DTO_01300327,Ion channel,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
119504,ANAPC16,Q96DE5,1.0,0.115,0.022882,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
119548,PNLIPRP3,Q17RR3,0.931,0.154,2.1705e-11,DTO_05007624,Enzyme,C2076600,Influenza due to Influenza A virus subtype H1N1,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
119559,SFXN4,Q6P4A7,0.89,0.192,1.2428e-07,,,C3810001,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18,,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2013.0,ALL
119587,CPXM2,Q8N436,0.821,0.192,5.487e-13,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
119682,OR51L1,Q8NGJ5,,,0.00090531,DTO_02300001,G-protein coupled receptor,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
119696,OR51N1P,,1.0,0.038,,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
119710,IFTAP,Q86VG3,0.931,0.154,7.605e-06,,,C0018621,Hay fever,C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
119749,OR4C46,A6NHA9,1.0,0.038,3.5175e-08,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
120071,LARGE2,Q8N3Y3,0.78,0.346,1.6044e-12,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
120103,SLC36A4,Q6YBV0,0.931,0.077,1.8141e-17,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
120114,FAT3,Q8TDW7,0.861,0.192,0.99995,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
120224,TMEM45B,Q96B21,0.729,0.308,1.266e-11,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2017.0,2018.0,ALL
120227,CYP2R1,Q6VVX0,0.563,0.731,3.793e-10,,,C1838657,"Vitamin D Hydroxylation-Deficient Rickets, Type 1B",C16;C18;C13;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.73,1.0,,2004.0,2017.0,ALL
120237,DBX1,A6NMT0,0.89,0.077,0.060952,,,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2002.0,2002.0,ALL
120376,COLCA2,A8K830,0.769,0.154,0.75066,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.14,1.0,,2008.0,2019.0,ALL
120400,NXPE1,Q8N323,0.839,0.115,1.3061e-12,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
120406,NXPE2,Q96DL1,0.931,0.077,1.1215e-08,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
120425,JAML,Q86YT9,0.861,0.192,0.000747,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
120526,DNAJC24,Q6P3W2,0.861,0.154,5.0103e-07,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
120528,CYCSP25,,0.78,0.231,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,0.5,,2002.0,2018.0,ALL
120534,ARL14EP,Q8N8R7,0.861,0.192,0.37864,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2019.0,ALL
120863,DEPDC4,Q8N2C3,0.931,0.038,1.0075e-09,DTO_05007557,Nucleic acid binding,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
120892,LRRK2,Q5S007,0.51,0.808,2.5757e-30,DTO_03300101,Kinase,C1846862,PARKINSON DISEASE 8 (disorder),,,disease,Disease or Syndrome,0.93,1.0,,2004.0,2019.0,ALL
120935,CCDC38,Q502W7,,,1.8346e-13,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2012.0,2012.0,ALL
120939,TMEM52B,Q4KMG9,0.861,0.154,0.0010679,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
121006,FAM186A,A6NE01,1.0,0.077,8.3001e-27,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
121053,C12orf45,Q8N5I9,,,0.010456,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
121214,SDR9C7,Q8NEX9,0.695,0.538,0.012329,DTO_05007624,Enzyme,C4539772,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13",,,disease,Congenital Abnormality,0.6,1.0,strong,2016.0,2017.0,ALL
121227,LRIG3,Q6UXM1,0.743,0.231,1.1655e-09,DTO_05007575,Receptor,C0029410,Osteoarthritis of hip,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
121256,TMEM132D,Q14C87,0.617,0.692,0.99907,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2012.0,2015.0,ALL
121260,SLC15A4,Q8N697,0.805,0.269,1.9296e-06,DTO_05007405,Transporter,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.44,1.0,,2009.0,2017.0,ALL
121268,RHEBL1,Q8TAI7,0.89,0.115,2.1883e-06,DTO_05007584,Enzyme modulator,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
121273,C12orf54,Q6X4T0,1.0,0.077,1.1347e-07,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
121274,ZNF641,Q96N77,,,0.0045726,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
121275,OR10AD1,Q8NGE0,,,0.0085157,DTO_02300001,G-protein coupled receptor,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
121278,TPH2,Q8IWU9,0.546,0.654,2.5364e-07,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.8,0.8,,2004.0,2019.0,ALL
121328,GGTA2P,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,1990.0,1990.0,ALL
121340,SP7,Q8TDD2,0.711,0.462,0.58269,DTO_05007557,Nucleic acid binding,C3151433,"OSTEOGENESIS IMPERFECTA, TYPE XII",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
121355,GTSF1,Q8WW33,0.821,0.269,0.022144,,,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.01,1.0,,2015.0,2015.0,ALL
121391,KRT74,Q7RTS7,0.736,0.192,2.1183e-14,,,C1860238,"WOOLLY HAIR, AUTOSOMAL DOMINANT",,,disease,Finding,0.6,1.0,,2010.0,2010.0,ALL
121441,NEDD1,Q8NHV4,0.931,0.077,0.42159,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
121457,IKBIP,Q70UQ0,0.931,0.077,7.6128e-08,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
121504,H4-16,P62805,0.54,0.692,0.022279,DTO_05007557,Nucleic acid binding,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2005.0,2019.0,ALL
121512,FGD4,Q96M96,0.678,0.462,0.0098247,DTO_05007584,Enzyme modulator,C1836336,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.96,1.0,,2005.0,2019.0,ALL
121536,AEBP2,Q6ZN18,0.821,0.192,0.99921,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.2,1.0,,2011.0,2011.0,ALL
121551,BTBD11,A6QL63,0.839,0.192,0.99993,DTO_05007599,Signaling,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
121599,SPIC,Q8N5J4,0.861,0.154,0.30668,DTO_05007542,Transcription factor,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
121601,ANO4,Q32M45,0.78,0.192,0.00032204,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
121642,ALKBH2,Q6NS38,0.76,0.154,0.0032745,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2015.0,2019.0,ALL
121643,FOXN4,Q96NZ1,0.931,0.077,0.86055,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
121665,SPPL3,Q8TCT6,0.638,0.615,0.99656,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2009.0,2019.0,ALL
121775,CHDM,,0.861,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2019.0,2019.0,ALL
121793,TEX29,Q8N6K0,,,7.7723e-06,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
121838,NRAD1,,0.792,0.192,,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
122011,CSNK1A1L,Q8N752,1.0,0.077,0.013174,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
122042,RXFP2,Q8WXD0,0.729,0.308,9.8971e-16,DTO_02300001,G-protein coupled receptor,C0010417,Cryptorchidism,C16;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.6,0.85,,2002.0,2019.0,ALL
122046,TEX26,Q8N6G2,1.0,0.038,3.1421e-09,,,C0149630,Bicuspid aortic valve,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.01,1.0,,2016.0,2016.0,ALL
122060,SLAIN1,Q8ND83,1.0,0.077,0.90094,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
122199,LGMNP1,,0.839,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
122258,SPACA7,Q96KW9,1.0,0.077,1.329e-06,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
122335,PPIAP24,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
122402,TDRD9,Q8NDG6,0.711,0.385,7.2697e-15,DTO_05007624,Enzyme,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.11,1.0,,2011.0,2011.0,ALL
122416,ANKRD9,Q96BM1,0.805,0.192,0.29363,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
122481,AK7,Q96M32,0.839,0.231,3.0553e-13,DTO_05007624,Enzyme,C4693784,SPERMATOGENIC FAILURE 27,,,disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
122525,C14orf28,Q4W4Y0,0.89,0.115,2.2179e-10,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
122553,TRAPPC6B,Q86SZ2,0.751,0.308,0.00015283,,,C4693390,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY",,,disease,Disease or Syndrome,0.4,1.0,,1990.0,2018.0,ALL
122618,PLD4,Q96BZ4,0.78,0.5,7.7337e-13,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.41,1.0,,2012.0,2018.0,ALL
122622,ADSS1,Q8N142,0.722,0.385,2.8155e-07,DTO_05007624,Enzyme,C4310754,"MYOPATHY, DISTAL, 5",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2017.0,ALL
122664,TPPP2,P59282,0.601,0.731,0.023554,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.938,,1990.0,2018.0,ALL
122769,LRR1,Q96L50,0.89,0.038,1.107e-08,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
122773,KLHDC1,Q8N7A1,1.0,0.038,4.4754e-08,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
122786,FRMD6,Q96NE9,0.839,0.269,0.027916,,,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
122809,SOCS4,Q8WXH5,0.769,0.423,1.4208e-05,DTO_05007584,Enzyme modulator,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
122830,NAA30,Q147X3,0.861,0.038,0.98682,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
122876,GPHB5,Q86YW7,1.0,0.038,,DTO_05007599,Signaling,C0015300,Exophthalmos,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
122945,NOXRED1,Q6NXP6,,,0.024779,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
122953,JDP2,Q8WYK2,0.711,0.346,0.35921,DTO_05007542,Transcription factor,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2010.0,2019.0,ALL
122961,ISCA2,Q86U28,0.743,0.231,2.4343e-08,,,C4225348,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4,,,disease,Disease or Syndrome,0.72,1.0,,2015.0,2019.0,ALL
122970,ACOT4,Q8N9L9,1.0,0.077,1.0412e-08,,,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
123016,TTC8,Q8TAM2,0.631,0.5,1.1846e-06,,,C1859566,BARDET-BIEDL SYNDROME 8,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.8,1.0,,2003.0,2011.0,ALL
123036,TC2N,Q8N9U0,0.805,0.154,1.1879e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
123041,SLC24A4,Q8NFF2,0.751,0.346,2.2032e-11,DTO_05007405,Transporter,C4014578,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5",,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2016.0,ALL
123096,SLC25A29,Q8N8R3,0.821,0.231,0.0010861,DTO_05007405,Transporter,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
123099,DEGS2,Q6QHC5,0.861,0.154,0.0002409,,,C0085298,Sudden Cardiac Death,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.1,1.0,,2011.0,2011.0,ALL
123103,KLHL33,A6NCF5,1.0,0.077,1.0165e-05,,,C0039263,Takayasu Arteritis,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
123169,LEO1,Q8WVC0,0.931,0.077,0.87094,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
123228,SENP8,Q96LD8,0.805,0.154,0.00054686,,,C0011311,Dengue Fever,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,1994.0,2019.0,ALL
123263,MTFMT,Q96DP5,0.595,0.808,1.4994e-07,DTO_05007624,Enzyme,C3554182,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15,,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2016.0,ALL
123264,SLC51B,Q86UW2,0.78,0.077,0.24475,DTO_05007405,Transporter,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.33,1.0,,2006.0,2018.0,ALL
123283,TARS3,A2RTX5,0.805,0.269,3.7422e-15,DTO_05007624,Enzyme,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
123355,LRRC28,Q86X40,0.89,0.115,2.0078e-11,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
123591,TMEM266,Q2M3C6,1.0,0.038,1.9439e-07,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
123606,NIPA1,Q7RTP0,0.682,0.462,0.0058703,DTO_05007405,Transporter,C1838192,"SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.73,1.0,,2003.0,2018.0,ALL
123624,AGBL1,Q96MI9,0.78,0.231,1.4377e-30,DTO_05007624,Enzyme,C3809798,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8",,,disease,Disease or Syndrome,0.7,1.0,moderate,2013.0,2013.0,ALL
123688,HYKK,A2RU49,0.769,0.346,7.3257e-06,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
123720,WHAMM,Q8TF30,0.931,0.077,4.8122e-13,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
123722,FSD2,A1L4K1,1.0,0.038,1.5277e-21,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
123745,PLA2G4E,Q3MJ16,1.0,0.038,6.3171e-13,DTO_05007624,Enzyme,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
123803,NTAN1,Q96AB6,0.931,0.154,2.7337e-06,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
123811,FOPNL,Q96NB1,0.76,0.462,1.8256e-06,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.12,1.0,,2001.0,2015.0,ALL
123872,DNAAF1,Q8NEP3,0.633,0.654,8.4672e-12,,,C2750790,"CILIARY DYSKINESIA, PRIMARY, 13",C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,,2008.0,2014.0,ALL
123876,ACSM2A,Q08AH3,0.89,0.077,3.2754e-23,DTO_05007624,Enzyme,C0007789,Cerebral Palsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
123879,DCUN1D3,Q8IWE4,,,0.8666,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.3,,,,,ALL
123904,NRN1L,Q496H8,,,9.5233e-05,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
123920,CMTM3,Q96MX0,0.736,0.231,0.00014974,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
124044,SPATA2L,Q8IUW3,,,0.040562,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
124045,SPATA33,Q96N06,0.861,0.115,0.0001257,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2013.0,ALL
124056,NOXO1,Q8NFA2,0.78,0.269,8.3428e-11,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
124093,CCDC78,A2IDD5,0.76,0.115,2.969e-31,,,C0175709,Centronuclear myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.5,1.0,limited,2012.0,2015.0,ALL
124152,IQCK,Q8N0W5,0.792,0.154,2.0032e-06,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.31,1.0,,2014.0,2019.0,ALL
124220,ZG16B,Q96DA0,0.736,0.308,0.00029994,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
124221,PRSS30P,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
124222,PAQR4,Q8N4S7,0.821,0.192,1.1796e-06,DTO_05007575,Receptor,C0027643,"Neoplasm Recurrence, Local",C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
124245,ZC3H18,Q86VM9,0.89,0.115,1.0,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
124274,GPR139,Q6DWJ6,0.89,0.192,0.036904,DTO_02300001,G-protein coupled receptor,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
124359,CDYL2,Q8N8U2,0.931,0.077,0.019293,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.11,1.0,,2016.0,2016.0,ALL
124401,ANKS3,Q6ZW76,0.821,0.192,1.8852e-07,,,C0037221,Situs Inversus,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.3,1.0,,2016.0,2016.0,ALL
124404,SEPTIN12,Q8IYM1,0.792,0.038,3.35e-19,DTO_05007584,Enzyme modulator,C3553793,SPERMATOGENIC FAILURE 10,,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2015.0,ALL
124446,TMEM219,Q86XT9,0.76,0.269,8.1671e-05,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2019.0,2019.0,ALL
124454,EARS2,Q5JPH6,0.666,0.538,1.1238e-08,DTO_05007624,Enzyme,C3554079,COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12,,,disease,Disease or Syndrome,0.75,1.0,,2012.0,2017.0,ALL
124460,SNX20,Q7Z614,0.89,0.077,1.2791e-05,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.11,1.0,,2007.0,2017.0,ALL
124491,TMEM170A,Q8WVE7,0.89,0.038,5.716e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
124512,METTL23,Q86XA0,0.682,0.231,1.3147e-07,,,C4014745,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
124535,HSF5,Q4G112,1.0,0.038,0.98254,DTO_05007542,Transcription factor,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2015.0,2019.0,ALL
124540,MSI2,Q96DH6,0.592,0.577,0.99478,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2016.0,2017.0,ALL
124565,SLC38A10,Q9HBR0,1.0,0.077,2.426e-10,DTO_05007405,Transporter,C0023980,Longevity,,,phenotype,Temporal Concept,0.1,1.0,,2010.0,2010.0,ALL
124583,CANT1,Q8WVQ1,0.619,0.731,2.5437e-06,,,C4012146,DESBUQUOIS DYSPLASIA 1,C23;C16;C05;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.61,1.0,,2009.0,2019.0,ALL
124590,USH1G,Q495M9,0.659,0.346,3.7481e-05,,,C1847089,"USHER SYNDROME, TYPE IG",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.92,1.0,,1992.0,2017.0,ALL
124599,CD300LB,A8K4G0,0.89,0.077,7.086e-08,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
124626,ZPBP2,Q6X784,0.729,0.308,1.2212e-08,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
124641,OVCA2,Q8WZ82,0.78,0.077,1.2811e-06,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
124739,USP43,Q70EL4,0.931,0.077,0.16359,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
124751,KRBA2,Q6ZNG9,1.0,0.077,1.8795e-07,,,C0598766,Leukemogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,0.0,,2017.0,2017.0,ALL
124783,SPATA32,Q96LK8,1.0,0.077,1.3702e-09,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
124801,LSM12,Q3MHD2,,,0.97211,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
124808,CCDC43,Q96MW1,0.931,0.077,0.00028825,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
124817,CNTD1,Q8N815,1.0,0.077,0.0045358,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
124842,TMEM132E,Q6IEE7,0.805,0.231,4.4887e-05,,,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.32,1.0,,2015.0,2020.0,ALL
124857,WFIKKN2,Q8TEU8,,,0.0036109,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
124872,B4GALNT2,Q8NHY0,0.751,0.385,1.7413e-17,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
124912,SPACA3,Q8IXA5,0.861,0.192,0.00011484,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
124925,SEZ6,Q53EL9,0.805,0.385,1.7486e-06,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
124930,ANKRD13B,Q86YJ7,1.0,0.038,0.36217,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2010.0,ALL
124935,SLC43A2,Q8N370,0.821,0.231,0.0055443,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
124936,CYB5D2,Q8WUJ1,0.76,0.269,4.4253e-06,DTO_05007599,Signaling,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
124944,C17orf49,Q8IXM2,0.89,0.077,0.069318,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
124961,ZFP3,Q96NJ6,,,0.0014304,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
124975,GGT6,Q6P531,0.931,0.115,2.9754e-08,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
124976,SPNS2,Q8IVW8,0.729,0.423,1.2449e-05,DTO_05007405,Transporter,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0,,2009.0,2017.0,ALL
124989,EFCAB13,Q8IY85,0.89,0.115,6.4531e-32,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
124997,WDR81,Q562E7,0.67,0.462,6.7458e-08,,,C2750234,"Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 2",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.7,1.0,,2011.0,2017.0,ALL
125050,RN7SK,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
125058,TBC1D16,Q8TBP0,0.839,0.154,2.5682e-07,DTO_05007624,Enzyme,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
125061,AFMID,Q63HM1,0.931,0.077,4.4977e-09,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
125111,GJD3,Q8N144,0.89,0.154,3.3471e-05,DTO_05007527,Cell-cell junction,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2013.0,2013.0,ALL
125113,KRT222,Q8N1A0,0.931,0.115,1.4228e-05,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
125115,KRT40,Q6A162,0.861,0.077,7.0984e-10,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
125144,SNHG29,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
125150,ZSWIM7,Q19AV6,,,0.00089609,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2015.0,2015.0,ALL
125170,MIEF2,Q96C03,1.0,0.038,0.016043,,,C0162670,Mitochondrial Myopathies,C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
125206,SLC5A10,A0PJK1,0.89,0.115,8.0689e-14,DTO_05007405,Transporter,C1513302,Mild Adverse Event,,,phenotype,Finding,0.1,1.0,,2017.0,2017.0,ALL
125228,FAM210A,Q96ND0,1.0,0.077,1.0564e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
125336,LOXHD1,Q8IVV2,0.792,0.231,5.5941e-26,,,C2746083,"DEAFNESS, AUTOSOMAL RECESSIVE 77 (disorder)",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.61,1.0,,2011.0,2019.0,ALL
125476,INO80C,Q6PI98,0.805,0.192,0.0004148,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
125488,TTC39C,Q8N584,0.931,0.154,0.00043602,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
125893,ZNF816,Q0VGE8,0.839,0.115,0.00014159,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.33,1.0,,2010.0,2014.0,ALL
125919,ZNF543,Q08ER8,0.931,0.154,3.5236e-17,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
125931,CEACAM20,Q6UY09,0.931,0.115,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2019.0,ALL
125950,RAVER1,Q8IY67,0.805,0.231,0.91101,DTO_05007557,Nucleic acid binding,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
125958,OR7D4,Q8NG98,0.931,0.077,0.015502,DTO_02300001,G-protein coupled receptor,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
125972,CALR3,Q96L12,0.839,0.154,6.9788e-10,DTO_05007616,Calcium-binding protein,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,limited,2007.0,2007.0,ALL
125981,ACER1,Q8TDN7,1.0,0.077,0.0021705,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.02,1.0,,2016.0,2017.0,ALL
125988,MICOS13,Q5XKP0,0.736,0.346,0.00083352,,,C0574084,3-Methylglutaconic aciduria type 3,C23;C16;C18;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
125997,MBD3L2,Q8NHZ7,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
126006,PCP2,Q8IVA1,0.839,0.192,3.0021e-05,,,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
126014,OSCAR,Q8IYS5,0.743,0.462,0.00033644,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0,,2011.0,2017.0,ALL
126017,ZNF813,Q6ZN06,1.0,0.077,0.63585,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
126069,ZNF491,Q8N8L2,,,,DTO_05007542,Transcription factor,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
126074,SWSAP1,Q6NVH7,1.0,0.115,0.0042206,,,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
126129,CPT1C,Q8TCG5,0.691,0.5,2.1926e-09,DTO_05007624,Enzyme,C4225387,"SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2018.0,ALL
126133,ALDH16A1,Q8IZ83,0.861,0.231,2.3658e-20,DTO_05007624,Enzyme,C0740394,Hyperuricemia,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.31,1.0,,2013.0,2013.0,ALL
126147,NTN5,Q8WTR8,,,3.7923e-15,DTO_05007584,Enzyme modulator,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,1.0,,2016.0,2016.0,ALL
126204,NLRP13,Q86W25,,,9.0301e-16,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
126205,NLRP8,Q86W28,0.931,0.115,6.0834e-25,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
126206,NLRP5,P59047,0.78,0.231,1.1427e-13,,,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2002.0,2011.0,ALL
126208,ZNF787,Q6DD87,1.0,0.038,0.8911,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
126248,WDR88,Q6ZMY6,1.0,0.077,1.5429e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
126259,TMIGD2,Q96BF3,0.805,0.154,1.0895e-05,DTO_05007608,Immune response,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
126282,TNFAIP8L1,Q8WVP5,0.682,0.346,0.5379,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
126295,ZNF57,Q68EA5,0.89,0.077,0.004632,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
126299,ZNF428,Q96B54,,,0.5013,,,C2825895,Granulocyte Colony Stimulating Factor Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
126306,JSRP1,Q96MG2,0.89,0.192,6.1014e-10,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
126308,MOB3A,Q96BX8,0.931,0.192,2.9101e-05,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
126321,MFSD12,Q6NUT3,0.839,0.115,6.7265e-18,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
126326,GIPC3,Q8TF64,0.78,0.231,0.0093379,DTO_05007624,Enzyme,C1866094,"DEAFNESS, AUTOSOMAL RECESSIVE 15",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,1997.0,2011.0,ALL
126328,NDUFA11,Q86Y39,0.705,0.308,0.017814,,,C1838979,MITOCHONDRIAL COMPLEX I DEFICIENCY,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.5,1.0,,2008.0,2016.0,ALL
126353,MISP,Q8IVT2,0.931,0.115,4.3142e-12,,,C0032580,Adenomatous Polyposis Coli,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
126364,LRRC25,Q8N386,1.0,0.077,0.945,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
126374,WTIP,A6NIX2,0.821,0.192,6.6719e-05,DTO_05007542,Transcription factor,C0848558,Hypospadias,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.02,1.0,,2012.0,2014.0,ALL
126382,NR2C2AP,Q86WQ0,1.0,0.077,0.24422,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
126393,HSPB6,O14558,0.705,0.385,0.088703,,,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.32,1.0,,2008.0,2011.0,ALL
126410,CYP4F22,Q6NT55,0.705,0.462,5.2921e-06,DTO_05007624,Enzyme,C0079154,Congenital Nonbullous Ichthyosiform Erythroderma,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.65,1.0,limited,2011.0,2020.0,ALL
126433,FBXO27,Q8NI29,,,2.2725e-11,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
126520,PLK5,Q496M5,0.78,0.192,9.1971e-05,DTO_03300101,Kinase,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
126526,C19orf47,Q8N9M1,1.0,0.038,0.17091,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
126549,ANKLE1,Q8NAG6,0.805,0.192,5.2059e-18,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.13,1.0,,2010.0,2018.0,ALL
126567,C2CD4C,Q8TF44,,,0.46612,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
126626,GABPB2,Q8TAK5,,,5.413e-06,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
126637,TCHHL1,Q5QJ38,0.78,0.231,0.58371,,,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,1992.0,1993.0,ALL
126638,RPTN,Q6XPR3,0.792,0.308,2.5475e-05,,,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,1992.0,1993.0,ALL
126668,TDRD10,Q5VZ19,0.89,0.115,1.1461e-05,DTO_05007624,Enzyme,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
126695,KDF1,Q8NAX2,0.729,0.269,0.15422,,,C4310616,"ECTODERMAL DYSPLASIA 12, HYPOHIDROTIC/HAIR/TOOTH/NAIL TYPE",,,disease,Disease or Syndrome,0.5,1.0,,2017.0,2017.0,ALL
126789,PUSL1,Q8N0Z8,1.0,0.077,2.6543e-20,DTO_05007624,Enzyme,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
126792,B3GALT6,Q96L58,0.631,0.615,0.022667,,,C3809210,"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2",,,disease,Disease or Syndrome,0.7,1.0,,2013.0,2017.0,ALL
126820,WDR63,Q8IWG1,0.89,0.154,2.9016e-13,DTO_05007530,Cellular structure,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
126859,AXDND1,Q5T1B0,0.931,0.077,4.3137e-26,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
126917,IFFO2,Q5TF58,1.0,0.115,0.72617,,,C0202159,Parathyroid hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
126961,H3C14,Q71DI3,0.861,0.154,,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
126969,SLC44A3,Q8N4M1,1.0,0.038,3.5957e-27,DTO_05007405,Transporter,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
127002,ATXN7L2,Q5T6C5,,,0.87066,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
127003,C1orf194,Q5T5A4,0.792,0.115,3.9833e-06,,,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
127018,LYPLAL1,Q5VWZ2,0.821,0.192,2.6427e-05,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.04,1.0,,2011.0,2019.0,ALL
127064,OR2T12,Q8NG77,1.0,0.038,,DTO_02300001,G-protein coupled receptor,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
127086,XRCC6P3,,1.0,0.038,,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
127124,ATP6V1G3,Q96LB4,1.0,0.115,0.10745,DTO_05007405,Transporter,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
127254,ERICH3,Q5RHP9,0.931,0.038,1.0824e-42,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2016.0,2019.0,ALL
127255,LRRIQ3,A6PVS8,,,1.374e-13,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
127262,TPRG1L,Q5T0D9,0.839,0.231,8.4721e-07,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
127294,MYOM3,Q5VTT5,0.89,0.038,1.4264e-47,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
127343,DMBX1,Q8NFW5,0.78,0.115,0.92957,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
127385,OR10J5,Q8NHC4,0.931,0.038,0.027185,DTO_02300001,G-protein coupled receptor,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
127428,TCEANC2,Q96MN5,1.0,0.038,2.7615e-07,DTO_05007557,Nucleic acid binding,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2015.0,2015.0,ALL
127435,PODN,Q7Z5L7,0.861,0.192,9.5675e-10,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
127495,LRRC39,Q96DD0,,,0.00023447,,,C0878544,Cardiomyopathies,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
127534,GJB4,Q9NTQ9,0.691,0.462,0.00055114,DTO_05007527,Cell-cell junction,C0265961,Erythrokeratodermia variabilis,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.67,0.875,strong,2002.0,2019.0,ALL
127540,HMGB4,Q8WW32,0.861,0.154,0.004348,DTO_05007557,Nucleic acid binding,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
127544,RNF19B,Q6ZMZ0,1.0,0.077,0.92372,DTO_05007624,Enzyme,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
127550,A3GALT2,U3KPV4,,,1.2823e-10,DTO_05007624,Enzyme,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
127579,DCST2,Q5T1A1,,,1.8188e-12,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
127602,DNAH14,Q0VDD8,0.89,0.154,2.6938e-16,DTO_05007624,Enzyme,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
127623,OR2B11,Q5JQS5,,,0.00022477,DTO_02300001,G-protein coupled receptor,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
127700,OSCP1,Q8WVF1,0.61,0.692,7.0317e-10,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2018.0,ALL
127707,KLHDC7A,Q5VTJ3,0.821,0.231,4.9895e-19,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
127731,VWA5B1,Q5TIE3,,,9.1392e-33,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
127795,C1orf87,Q8N0U7,0.931,0.154,6.1824e-25,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
127829,ARL8A,Q96BM9,1.0,0.077,0.94173,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
127833,SYT2,Q8N9I0,0.647,0.538,0.98133,DTO_05007405,Transporter,C4015038,"MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2018.0,ALL
127841,LINC00628,,0.78,0.115,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
127845,GOLT1A,Q6ZVE7,0.839,0.115,0.23676,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
127933,UHMK1,Q8TAS1,0.674,0.462,0.83404,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,0.5,,2007.0,2011.0,ALL
127943,FCRLB,Q6BAA4,1.0,0.115,2.51e-10,DTO_05007620,Cell adhesion,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
128025,WDR64,B1ANS9,1.0,0.038,4.9565e-32,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
128077,LIX1L,Q8IVB5,1.0,0.077,0.00034864,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
128102,HSD3BP4,,1.0,0.077,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
128153,SPATA17,Q96L03,0.931,0.038,1.4658e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
128178,EDARADD,Q8WWZ3,0.638,0.462,0.0003182,,,C3541517,"ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.8,0.857,strong,2005.0,2019.0,ALL
128209,KLF17,Q5JT82,0.695,0.346,4.6604e-09,DTO_05007557,Nucleic acid binding,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.08,1.0,,2009.0,2018.0,ALL
128218,TMEM125,Q96AQ2,0.861,0.115,1.0028e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
128229,TSACC,Q96A04,0.659,0.577,0.017937,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,1.0,,2007.0,2014.0,ALL
128239,IQGAP3,Q86VI3,0.729,0.308,2.3959e-33,DTO_05007584,Enzyme modulator,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2017.0,2019.0,ALL
128240,NAXE,Q8NCW5,0.743,0.346,2.4443e-06,,,C4310675,"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2019.0,ALL
128272,ARHGEF19,Q8IW93,0.861,0.077,3.9492e-20,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
128338,DRAM2,Q6UX65,0.729,0.462,0.0001357,,,C4049066,Retinal dystrophy with early macular involvement,C11,   Eye Diseases,disease,Disease or Syndrome,0.61,1.0,,2015.0,2015.0,ALL
128344,PIFO,Q8TCI5,0.736,0.346,8.9379e-08,,,C0392514,Hereditary hemochromatosis,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2017.0,ALL
128360,OR10T2,Q8NGX3,1.0,0.192,0.12008,DTO_02300001,G-protein coupled receptor,C0162671,MELAS Syndrome,C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
128366,OR6P1,Q8NGX9,0.931,0.077,5.8864e-05,DTO_02300001,G-protein coupled receptor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
128368,OR10Z1,Q8NGY1,,,0.11093,DTO_02300001,G-protein coupled receptor,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
128372,OR6N1,Q8NGY5,,,0.0001156,DTO_02300001,G-protein coupled receptor,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
128408,BHLHE23,Q8NDY6,0.722,0.385,0.19596,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2005.0,2010.0,ALL
128414,NKAIN4,Q8IVV8,,,0.0073144,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
128434,VSTM2L,Q96N03,0.931,0.077,0.24663,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
128439,SNHG11,,0.89,0.077,,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
128486,FITM2,Q8N6M3,0.821,0.385,2.7203e-06,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,0.5,,2017.0,2019.0,ALL
128497,SPATA25,Q9BR10,0.931,0.038,0.0014577,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
128553,TSHZ2,Q9NRE2,0.792,0.231,0.9814,DTO_05007542,Transcription factor,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2019.0,ALL
128602,C20orf85,Q9H1P6,0.78,0.115,1.8292e-05,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.05,1.0,,2007.0,2019.0,ALL
128611,ZNF831,Q5JPB2,0.792,0.192,7.8727e-10,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
128637,TBC1D20,Q96BZ9,0.621,0.5,0.93074,,,C3810265,WARBURG MICRO SYNDROME 4,,,disease,Disease or Syndrome,0.61,1.0,,2004.0,2015.0,ALL
128646,SIRPD,Q9H106,,,3.9148e-08,DTO_05007599,Signaling,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
128674,PROKR2,Q8NFJ6,0.538,0.731,2.4388e-06,DTO_02300001,G-protein coupled receptor,C0162809,Kallmann Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.7,0.933,strong,2006.0,2019.0,ALL
128710,SLX4IP,Q5VYV7,0.839,0.115,1.7889e-12,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
128821,CST9L,Q9H4G1,1.0,0.154,5.992e-12,,,C2930618,Intersex Conditions,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.01,1.0,,2002.0,2002.0,ALL
128822,CST9,Q5W186,0.839,0.346,0.0010911,,,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
128826,MIR1-1HG,Q9H1L0,0.931,0.077,0.0034664,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
128853,DUSP15,Q9H1R2,0.931,0.115,3.7139e-06,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
128859,BPIFB6,Q8NFQ5,1.0,0.077,2.8058e-13,,,C0007113,Rectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
128861,BPIFA3,Q9BQP9,0.89,0.077,5.9419e-13,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2008.0,2011.0,ALL
128866,CHMP4B,Q9H444,0.76,0.231,0.95771,DTO_05007405,Transporter,C1854311,"Cataract, posterior polar, 3",C11,   Eye Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2007.0,2007.0,ALL
128869,PIGU,Q9H490,0.67,0.462,1.9003e-05,,,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,strong,2019.0,2019.0,ALL
128876,FAM83C,Q9BQN1,,,8.2423e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
128977,C22orf39,Q6P5X5,1.0,0.038,1.9976e-05,,,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
128989,TANGO2,Q6ICL3,0.666,0.615,0.00014769,,,C4225171,"METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2019.0,ALL
129025,ZNF280A,P59817,0.931,0.077,4.017e-08,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
129049,SGSM1,Q2NKQ1,0.89,0.192,1.5957e-05,DTO_05007624,Enzyme,C0004106,Astigmatism,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
129080,EMID1,Q96A84,0.931,0.077,6.0551e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
129099,CPSF1P1,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
129285,PPP1R21,Q6ZMI0,0.769,0.231,1.3024e-10,,,C0019214,Hepatosplenomegaly,C23;C06;C15,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases;    Hemic and Lymphatic Diseases",phenotype,Sign or Symptom,0.3,1.0,strong,2019.0,2019.0,ALL
129293,TRABD2A,Q86V40,,,2.2361e-09,DTO_05007624,Enzyme,C0523953,Cardiac troponin T measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
129303,TMEM150A,Q86TG1,1.0,0.038,0.023588,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
129401,NUP35,Q8NFH5,0.89,0.192,0.022182,,,C0021847,Intestinal Pseudo-Obstruction,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
129446,XIRP2,A4UGR9,0.821,0.308,2.0803e-52,DTO_05007530,Cellular structure,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
129521,NMS,Q5H8A3,0.711,0.423,1.3331e-11,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2012.0,2019.0,ALL
129530,LYG1,Q8N1E2,,,3.133e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
129531,MITD1,Q8WV92,1.0,,1.1445e-05,,,C4225379,LIPOYLTRANSFERASE 1 DEFICIENCY,,,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
129563,DIS3L2,Q8IYB7,0.647,0.5,0.944,,,C0796113,"Nephroblastomatosis, fetal ascites, macrosomia and Wilms tumor",C23;C16;C04;C13;C12;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,1999.0,2019.0,ALL
129607,CMPK2,Q5EBM0,0.663,0.615,1.1285e-06,DTO_03300101,Kinase,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,0.923,,1990.0,2019.0,ALL
129642,MBOAT2,Q6ZWT7,1.0,0.154,0.51629,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
129684,CNTNAP5,Q8WYK1,0.821,0.154,0.99167,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
129685,TAF8,Q7Z7C8,0.751,0.423,7.3155e-13,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
129787,TMEM18,Q96B42,0.729,0.308,0.0022182,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,0.966,,2009.0,2019.0,ALL
129804,FBLN7,Q53RD9,0.78,0.077,8.4159e-06,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2014.0,2014.0,ALL
129807,NEU4,Q8WWR8,0.805,0.077,4.0412e-07,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
129831,RBM45,Q8IUH3,0.383,0.846,2.1132e-10,,,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,1995.0,2019.0,ALL
129852,C2orf73,Q8N5S3,,,3.6668e-07,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
129868,TRIM43,Q96BQ3,1.0,0.077,0.010008,,,C0019372,Herpesviridae Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
129880,BBS5,Q8N3I7,0.659,0.577,4.8446e-06,,,C3892039,BARDET-BIEDL SYNDROME 5,,,disease,Disease or Syndrome,0.72,1.0,,2004.0,2016.0,ALL
130013,ACMSD,Q8TDX5,0.78,0.423,1.392e-08,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,2002.0,2009.0,ALL
130026,ICA1L,Q8NDH6,,,0.00077913,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
130074,FAM168B,A1KXE4,0.792,0.462,0.015675,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,1988.0,1991.0,ALL
130106,CIB4,A0PJX0,,,1.115e-07,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
130120,REG3G,Q6UW15,0.716,0.385,1.2831e-07,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
130132,RFTN2,Q52LD8,,,7.921e-06,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2016.0,ALL
130162,CLHC1,Q8NHS4,,,5.5753e-21,DTO_05007405,Transporter,C0231712,Waddling gait,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.1,,,,,ALL
130271,PLEKHH2,Q8IVE3,0.89,0.115,4.8228e-34,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
130340,AP1S3,Q96PC3,0.711,0.385,0.016298,DTO_05007405,Transporter,C4015235,"PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO",,,disease,Finding,0.6,1.0,,2014.0,2016.0,ALL
130355,C2orf76,Q3KRA6,1.0,0.038,0.0054177,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
130367,SGPP2,Q8IWX5,0.805,0.154,0.0028191,DTO_05007624,Enzyme,C0233849,Personality Traits,F01,   Behavior and Behavior Mechanisms,group,Finding,0.1,1.0,,2012.0,2012.0,ALL
130399,ACVR1C,Q8NER5,0.7,0.423,0.00085157,DTO_03300101,Kinase,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
130497,OSR1,Q8TAX0,0.603,0.615,0.86296,DTO_05007542,Transcription factor,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,0.846,,1998.0,2020.0,ALL
130507,UBR3,Q6ZT12,0.89,0.115,1.0,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
130535,KCTD18,Q6PI47,1.0,0.077,5.8625e-08,DTO_05007584,Enzyme modulator,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
130540,FLACC1,Q96Q35,0.729,0.269,1.3086e-22,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.41,1.0,,2015.0,2018.0,ALL
130557,ZNF513,Q8N8E2,0.691,0.346,0.81634,DTO_05007542,Transcription factor,C3150879,RETINITIS PIGMENTOSA 58,,,disease,Disease or Syndrome,0.6,1.0,limited,2010.0,2010.0,ALL
130560,SPATA3,Q8NHX4,1.0,0.038,0.0010708,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
130574,LYPD6,Q86Y78,0.89,0.154,4.0193e-06,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
130589,GALM,Q96C23,0.792,0.192,4.8791e-11,DTO_05007624,Enzyme,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,0.871,,1998.0,2015.0,ALL
130617,ZFAND2B,Q8WV99,0.931,0.115,2.4827e-05,DTO_05007557,Nucleic acid binding,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
130733,TMEM178A,Q8NBL3,0.931,0.154,0.66946,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
130749,CPO,Q8IVL8,0.736,0.538,7.271e-21,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
130802,DNMT3AP1,,1.0,0.115,,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
130814,SLC66A3,Q8N755,0.89,0.115,4.4278e-10,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
130827,TMEM182,Q6ZP80,0.839,0.154,0.05562,,,C0029516,Other and unspecified reactive psychosis,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
130872,AHSA2P,Q719I0,0.805,0.346,0.00018,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
130916,MTERF4,Q7Z6M4,0.839,0.077,3.4049e-05,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
130940,CCDC148,Q8NFR7,1.0,0.077,1.5603e-30,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
130951,M1AP,Q8TC57,,,3.1588e-19,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
131034,CPNE4,Q96A23,0.861,0.192,0.085866,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
131076,CCDC58,Q4VC31,,,0.0040567,,,C0201925,Calcium measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
131096,KCNH8,Q96L42,0.603,0.654,2.286e-10,DTO_01300327,Ion channel,C1306557,Chronic venous insufficiency,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
131118,DNAJC19,Q96DA6,0.663,0.577,0.00061275,,,C1857776,"3-@METHYLGLUTACONIC ACIDURIA, TYPE V",C23;C16;C18;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.73,1.0,,2006.0,2017.0,ALL
131149,OTOL1,A6NHN0,1.0,0.115,1.4999e-15,,,C0155502,Benign Paroxysmal Positional Vertigo,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
131177,FAM3D,Q96BQ1,0.821,0.269,0.00024114,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
131368,ZPLD1,Q8TCW7,0.89,0.231,4.448e-08,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
131375,LYZL4,Q96KX0,0.931,0.154,0.53187,,,C0684328,Reasoning,,,phenotype,Mental Process,0.1,1.0,,2011.0,2011.0,ALL
131377,KLHL40,Q2TBA0,0.722,0.385,3.5382e-06,,,C3809209,NEMALINE MYOPATHY 8,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.9,1.0,definitive,2013.0,2017.0,ALL
131405,TRIM71,Q2Q1W2,0.861,0.192,0.99969,DTO_05007624,Enzyme,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
131408,FAM131A,Q6UXB0,0.861,0.115,0.0066732,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
131450,CD200R1,Q8TD46,0.623,0.769,4.3137e-09,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
131474,CHCHD4,Q8N4Q1,1.0,0.115,0.18737,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
131540,ZDHHC19,Q8WVZ1,,,0.0071821,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2018.0,ALL
131544,CRYBG3,Q68DQ2,0.861,0.077,9.2709e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
131566,DCBLD2,Q96PD2,0.729,0.615,0.095418,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2008.0,2008.0,ALL
131578,LRRC15,Q8TF66,0.931,0.115,2.7349e-09,DTO_05007575,Receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
131583,FAM43A,Q8N2R8,0.931,0.115,0.40754,DTO_05007599,Signaling,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
131601,TPRA1,Q86W33,,,0.014654,DTO_02300001,G-protein coupled receptor,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
131669,UROC1,Q96N76,0.78,0.385,2.0787e-15,,,C0268514,Urocanase deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,,2009.0,2009.0,ALL
131870,NUDT16,Q96DE0,0.931,0.154,0.0046241,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
131873,COL6A6,A6NMZ7,0.861,0.269,8.4528e-46,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
131890,GRK7,Q8WTQ7,0.792,0.192,1.9791e-08,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
131920,TMEM207,Q6UWW9,0.792,0.231,4.2258e-11,,,C0345988,Neoplasm of skin with adnexal differentiation,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.2,,,,,ALL
131965,METTL6,Q8TCB7,0.861,0.077,2.1044e-05,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
132001,TAMM41,Q96BW9,0.89,0.077,1.0996e-06,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
132014,IL17RE,Q8NFR9,0.751,0.385,8.5681e-08,,,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
132112,RTP1,P59025,1.0,0.077,8.5587e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
132158,GLYCTK,Q8IVS8,0.751,0.308,9.6521e-11,DTO_03300101,Kinase,C0342765,D-Glyceric aciduria,,,disease,Disease or Syndrome,0.63,1.0,,2010.0,2019.0,ALL
132200,C3orf49,Q96BT1,1.0,0.038,4.0628e-08,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
132203,SNTN,A6NMZ2,1.0,0.115,0.00010257,DTO_05007616,Calcium-binding protein,C4268744,Atypical femoral fracture,,,phenotype,Pathologic Function,0.1,1.0,,2019.0,2019.0,ALL
132204,SYNPR,Q8TBG9,0.839,0.192,0.0041913,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2010.0,2010.0,ALL
132243,H1-8,Q8IZA3,,,0.06964,DTO_05007557,Nucleic acid binding,C0424678,Lean body mass,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
132299,OCIAD2,Q56VL3,0.821,0.346,3.5288e-05,DTO_05007608,Immune response,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2007.0,2018.0,ALL
132320,SCLT1,Q96NL6,0.663,0.577,4.3816e-16,,,C0029294,Orofaciodigital Syndromes,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.32,1.0,limited,2014.0,2017.0,ALL
132321,C4orf33,Q8N1A6,0.931,0.038,3.5241e-05,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
132332,TMEM155,Q4W5P6,1.0,0.077,0.036443,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
132430,PABPC4L,P0CB38,1.0,,0.00053305,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
132612,ADAD1,Q96M93,0.821,0.269,0.038952,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.11,0.5,,2009.0,2011.0,ALL
132625,ZFP42,Q96MM3,0.678,0.346,,DTO_05007542,Transcription factor,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
132660,LIN54,Q6MZP7,1.0,0.077,0.99994,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
132671,SPATA18,Q8TC71,0.805,0.115,1.0088e-13,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
132724,TMPRSS11B,Q86T26,0.89,0.077,4.2885e-19,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
132789,GNPDA2,Q8TDQ7,0.792,0.346,0.0084836,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,0.846,,2009.0,2019.0,ALL
132864,CPEB2,Q7Z5Q1,0.805,0.192,0.00013675,DTO_05007557,Nucleic acid binding,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
132884,EVC2,Q86UK5,0.585,0.692,1.0207e-34,,,C0013903,Ellis-Van Creveld Syndrome,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,1.0,1.0,definitive,2002.0,2018.0,ALL
132946,ARL9,Q6T311,1.0,0.077,0.44485,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
132949,AASDH,Q4L235,0.931,0.077,1.6629e-13,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
132954,PDCL2,Q8N4E4,0.931,0.077,0.0014645,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
133022,TRAM1L1,Q8N609,1.0,,0.0066436,,,C3699402,Alcohol abuse or dependence,,,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
133060,OTOP1,Q7RTM1,1.0,,4.8437e-24,DTO_01300327,Ion channel,C0000846,Agenesis,,,disease,Congenital Abnormality,0.01,1.0,,2003.0,2003.0,ALL
133121,ENPP6,Q6UWR7,0.931,0.154,6.7521e-09,DTO_05007624,Enzyme,C0021603,Sleep Initiation and Maintenance Disorders,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
133308,SLC9B2,Q86UD5,0.89,0.269,7.5781e-06,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2018.0,ALL
133383,SETD9,Q8NE22,0.931,0.077,8.3912e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
133396,IL31RA,Q8NI17,0.601,0.692,4.204e-16,DTO_05007599,Signaling,C3151404,"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2",,,disease,Disease or Syndrome,0.5,1.0,limited,2010.0,2010.0,ALL
133418,EMB,Q6PCB8,0.633,0.615,1.0084e-11,DTO_05007575,Receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
133482,SLCO6A1,Q86UG4,0.412,0.885,2.8807e-11,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.18,1.0,,2009.0,2018.0,ALL
133491,C5orf47,Q569G3,,,1.0442e-07,,,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
133522,PPARGC1B,Q86YN6,0.569,0.731,0.50321,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.39,1.0,,2003.0,2019.0,ALL
133584,EGFLAM,Q63HQ2,0.743,0.462,3.7564e-19,DTO_05007584,Enzyme modulator,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
133619,PRRC1,Q96M27,0.931,0.115,2.091e-12,,,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
133686,NADK2,Q4G0N4,0.691,0.346,0.065215,DTO_03300101,Kinase,C1857252,"2,4-Dienoyl-CoA Reductase Deficiency",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.6,1.0,moderate,2012.0,2018.0,ALL
133690,CAPSL,Q8WWF8,0.931,0.154,2.8442e-07,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,0.667,,2008.0,2009.0,ALL
133746,JMY,Q8N9B5,0.861,0.115,0.96031,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
134111,UBE2QL1,A1L167,0.861,0.192,0.6783,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
134145,ATPSCKMT,Q6P4H8,0.931,0.115,1.7847e-09,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0,,2013.0,2018.0,ALL
134187,POU5F2,Q8N7G0,1.0,0.038,0.00040316,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
134218,DNAJC21,Q5F1R6,0.606,0.731,2.1006e-07,,,C4310744,BONE MARROW FAILURE SYNDROME 3,,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2018.0,ALL
134265,AFAP1L1,Q8TED9,0.792,0.154,4.9556e-14,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
134266,GRPEL2,Q8TAA5,,,0.00035876,DTO_05007613,Chaperone,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
134285,TMEM171,Q8WVE6,0.931,0.154,7.7679e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
134359,POC5,Q8NA72,0.78,0.308,1.2092e-07,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2018.0,2019.0,ALL
134391,GPR151,Q8TDV0,0.53,0.923,3.2266e-08,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
134430,WDR36,Q8NI36,0.751,0.192,0.0005724,,,C1835933,"Glaucoma 1, Open Angle, G",C11,   Eye Diseases,disease,Disease or Syndrome,0.7,1.0,limited,2005.0,2008.0,ALL
134466,ZNF300P1,,0.89,0.192,,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
134510,UBLCP1,Q8WVY7,0.861,0.077,0.094508,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
134526,ACOT12,Q8WYK0,0.805,0.192,2.7282e-14,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.21,1.0,,1989.0,1997.0,ALL
134549,SHROOM1,Q2M3G4,1.0,0.038,0.045738,,,C0027794,Neural Tube Defects,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Congenital Abnormality,0.01,1.0,,2018.0,2018.0,ALL
134637,ADAT2,Q7Z6V5,0.89,0.115,1.007e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2017.0,ALL
134701,RIPPLY2,Q5TAB7,0.65,0.462,0.0093945,,,C0265343,Jarcho-Levin syndrome,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.51,1.0,,2007.0,2019.0,ALL
134728,IRAK1BP1,Q5VVH5,0.78,0.346,1.449e-06,,,C0086981,Sicca Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
134829,CLVS2,Q5SYC1,1.0,0.038,0.013557,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
134864,TAAR1,Q96RJ0,0.682,0.423,0.00039183,DTO_02300001,G-protein coupled receptor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.57,1.0,,2007.0,2020.0,ALL
134957,STXBP5,Q5T5C0,0.839,0.231,0.99956,DTO_05007405,Transporter,C1264039,"von Willebrand Disease, Type 1",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.04,1.0,,2012.0,2018.0,ALL
135112,NCOA7,Q8NI08,0.729,0.5,3.2987e-05,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
135114,HINT3,Q9NQE9,1.0,0.077,3.4813e-06,DTO_05007557,Nucleic acid binding,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
135138,PACRG,Q96M98,0.722,0.308,2.4288e-07,,,C1868675,"PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
135152,B3GAT2,Q9NPZ5,0.931,0.115,3.3253e-05,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
135154,SDHAF4,Q5VUM1,1.0,0.077,0.098879,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
135228,CD109,Q6YHK3,0.595,0.654,2.2707e-44,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,1.0,,2008.0,2011.0,ALL
135250,RAET1E,Q8TD07,0.89,0.269,2.3144e-07,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
135293,PM20D2,Q8IYS1,,,6.8342e-05,DTO_05007624,Enzyme,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
135295,SRSF12,Q8WXF0,,,0.033102,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
135398,C6orf141,Q5SZD1,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
135458,HUS1B,Q8NHY5,1.0,0.077,,,,C0022548,Keloid,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Acquired Abnormality,0.01,1.0,,2015.0,2015.0,ALL
135644,TRIM40,Q6P9F5,0.89,0.192,6.1659e-11,,,C0162823,"Dermatitis, Irritant",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
135656,MUCL3,Q3MIW9,0.691,0.731,1.2265e-05,,,C0878555,Diffuse panbronchiolitis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.51,1.0,,2002.0,2012.0,ALL
135892,TRIM50,Q86XT4,0.839,0.269,1.5479e-10,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
135932,TMEM139,Q8IV31,1.0,0.077,0.0075458,,,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0,,2015.0,2015.0,ALL
135935,NOBOX,O60393,0.805,0.154,2.0629e-05,,,C1969060,Premature Ovarian Failure 5,C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2007.0,2016.0,ALL
136051,ZNF786,Q8N393,,,2.3543e-12,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
136227,COL26A1,Q96A83,0.839,0.423,2.9274e-06,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
136242,PRSS37,A4D1T9,,,2.4898e-06,DTO_05007624,Enzyme,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
136259,KLF14,Q8TD94,0.691,0.385,0.01598,DTO_05007557,Nucleic acid binding,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,1.0,,2011.0,2018.0,ALL
136319,MTPN,P58546,0.729,0.346,0.81778,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
136332,LRGUK,Q96M69,1.0,0.077,1.4489e-15,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2013.0,ALL
136371,ASB10,Q8WXI3,0.805,0.077,2.6403e-12,,,C1863926,"GLAUCOMA 1, OPEN ANGLE, F (disorder)",C11,   Eye Diseases,disease,Disease or Syndrome,0.7,1.0,limited,2012.0,2012.0,ALL
136541,PRSS58,Q8IYP2,0.931,0.038,3.0681e-09,DTO_05007624,Enzyme,C0009375,Colonic Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
136647,MPLKIP,Q8TAP9,0.604,0.654,0.00016384,,,C1955934,Trichothiodystrophy Syndromes,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.55,1.0,,2005.0,2016.0,ALL
136895,C7orf31,Q8N865,1.0,0.038,8.0549e-11,,,C1514422,"Glioblastoma, IDH-Wildtype",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
136991,ASZ1,Q8WWH4,0.729,0.346,6.6692e-09,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
137075,CLDN23,Q96B33,0.805,0.231,2.2989e-05,DTO_05007527,Cell-cell junction,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.02,1.0,,2011.0,2019.0,ALL
137196,CCDC26,Q8TAB7,0.647,0.615,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.5,1.0,,2009.0,2020.0,ALL
137209,ZNF572,Q7Z3I7,1.0,0.077,0.012997,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
137392,FAM92A,A1XBS5,0.729,0.308,5.788e-08,,,C0220697,"POLYDACTYLY, POSTAXIAL",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.51,1.0,,2019.0,2019.0,ALL
137492,VPS37A,Q8NEZ2,0.656,0.577,0.00067936,,,C3539494,"SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2012.0,ALL
137529,CKS1BP7,,0.61,0.577,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.909,,2003.0,2019.0,ALL
137682,NDUFAF6,Q330K2,0.659,0.615,9.0736e-08,,,C0023264,Leigh Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.44,1.0,strong,2008.0,2019.0,ALL
137735,ABRA,Q8N0Z2,1.0,0.038,6.1508e-06,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
137814,NKX2-6,A6NCS4,0.695,0.385,0.018885,DTO_05007542,Transcription factor,C1857586,CONOTRUNCAL HEART MALFORMATIONS (disorder),C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2005.0,2015.0,ALL
137835,TMEM71,Q6P5X7,0.821,0.077,7.986e-11,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
137868,SGCZ,Q96LD1,0.751,0.385,6.4001e-09,DTO_05007530,Cellular structure,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
137872,ADHFE1,Q8IWW8,0.76,0.346,8.5168e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
137886,UBXN2B,Q14CS0,0.751,0.269,0.10316,DTO_05007405,Transporter,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
137902,PXDNL,A1KZ92,0.805,0.269,2.2028e-35,DTO_05007624,Enzyme,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
137964,GPAT4,Q86UL3,0.931,0.115,0.088075,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,0.0,,2013.0,2013.0,ALL
137970,UNC5D,Q6UXZ4,0.716,0.462,0.92929,DTO_05007575,Receptor,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
137994,LETM2,Q2VYF4,0.931,0.115,1.1029e-18,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2019.0,ALL
138009,DCAF4L2,Q8NA75,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
138046,RALYL,Q86SE5,0.769,0.231,0.45873,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
138050,HGSNAT,Q68CP4,0.628,0.577,6.3392e-08,,,C0026706,Mucopolysaccharidosis III,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,1.0,,2006.0,2016.0,ALL
138065,RNF183,Q96D59,0.89,0.077,0.001513,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2017.0,ALL
138151,NACC2,Q96BF6,,,0.31484,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2017.0,2017.0,ALL
138162,C9orf116,Q5BN46,,,2.2657e-05,,,C1318485,Liver regeneration disorder,C06,   Digestive System Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
138307,LCN8,Q6JVE9,,,0.00087637,DTO_05007624,Enzyme,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
138311,DIPK1B,Q5VUD6,,,0.012466,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
138428,PTRH1,Q86Y79,0.663,0.462,0.00016798,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
138429,PIP5KL1,Q5T9C9,0.821,0.115,2.9295e-05,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2010.0,2010.0,ALL
138474,TAF1L,Q8IZX4,0.839,0.154,0.96182,DTO_05007378,Epigenetic regulator,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
138639,PTPDC1,A2A3K4,1.0,0.038,2.9858e-05,,,C4511452,Sporadic Parkinson disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
138649,ANKRD19P,Q9H560,0.931,0.038,,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
138799,OR13C5,Q8NGS8,,,,DTO_02300001,G-protein coupled receptor,C2239219,von Willebrand's factor (lab test),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
138883,OR1N1,Q8NGS0,1.0,0.077,,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
138948,DBH-AS1,,0.78,0.192,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
139065,SLITRK4,Q8IW52,1.0,0.077,0.79447,,,C2076600,Influenza due to Influenza A virus subtype H1N1,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
139081,MAGEC3,Q8TD91,0.736,0.5,7.6566e-16,DTO_05007620,Cell adhesion,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
139105,BEND2,Q8NDZ0,0.839,0.115,0.088486,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
139135,PASD1,Q8IV76,0.78,0.269,0.82307,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
139189,DGKK,Q5KSL6,0.78,0.385,,DTO_05007624,Enzyme,C0848558,Hypospadias,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Congenital Abnormality,0.47,1.0,,2011.0,2019.0,ALL
139212,PIH1D3,Q9NQM4,0.674,0.538,0.85529,,,C4478372,"CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED",,,disease,Disease or Syndrome,0.6,1.0,strong,2017.0,2017.0,ALL
139221,PWWP3B,Q5H9M0,0.89,0.038,0.48293,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2015.0,2015.0,ALL
139285,AMER1,Q5JTC6,0.57,0.654,0.8538,,,C0432268,Osteopathia striata cranial sclerosis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.99,1.0,strong,2009.0,2019.0,ALL
139324,HDX,Q7Z353,0.839,0.154,0.075851,,,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
139341,FUNDC1,Q8IVP5,0.686,0.385,0.042053,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0,,2018.0,2019.0,ALL
139411,PTCHD1,Q96NR3,0.678,0.385,0.98224,DTO_05007575,Receptor,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.47,1.0,,2010.0,2019.0,ALL
139420,PPP4R3C,Q6ZMV5,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
139538,VENTXP1,P0C5K6,0.931,0.192,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
139562,OTUD6A,Q7L8S5,1.0,0.115,0.28466,DTO_05007624,Enzyme,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
139596,UPRT,Q96BW1,0.7,0.462,0.5784,,,C0011853,"Diabetes Mellitus, Experimental",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.2,1.0,,1992.0,1992.0,ALL
139599,MAGEE2,Q8TD90,0.821,0.269,1.9687e-12,DTO_05007620,Cell adhesion,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
139604,MAGEB16,A2A368,1.0,0.115,0.37021,DTO_05007620,Cell adhesion,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
139628,FOXR2,Q6PJQ5,0.674,0.462,0.076682,,,C0206727,Nerve Sheath Tumors,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
139716,GAB3,Q8WWW8,0.839,0.231,0.9536,DTO_05007575,Receptor,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
139728,PNCK,Q6P2M8,0.89,0.269,1.0166e-05,DTO_03300101,Kinase,C1845862,"Creatine deficiency, X-linked",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
139741,ACTRT1,Q8TDG2,0.711,0.308,0.0037403,DTO_05007530,Cellular structure,C0346104,Follicular atrophoderma and basal cell epitheliomata,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
139760,GPR119,Q8TDV5,0.695,0.346,0.0086183,DTO_02300001,G-protein coupled receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2008.0,2020.0,ALL
139818,DOCK11,Q5JSL3,0.606,0.731,0.012097,DTO_05007584,Enzyme modulator,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.03,1.0,,2017.0,2017.0,ALL
140032,RPS4Y2,Q8TD47,0.931,0.077,0.00074913,DTO_05007557,Nucleic acid binding,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",C16;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
140290,TCP10L,Q8TDR4,0.89,0.115,0.0032979,DTO_05007624,Enzyme,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
140451,SCA9,,1.0,0.038,,,,C0948089,Acute Coronary Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
140453,MUC17,Q685J3,0.638,0.577,7.8985e-63,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.8,,1994.0,2018.0,ALL
140454,PSORS8,,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
140456,ASB11,Q8WXH4,1.0,,1.961e-06,,,C3840565,Autoimmune thyroid disease (AITD),,,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
140459,ASB6,Q9NWX5,0.931,0.077,0.00080472,DTO_05007575,Receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
140461,ASB8,Q9H765,,,3.767e-05,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
140465,MYL6B,P14649,0.931,0.154,6.0924e-06,DTO_05007616,Calcium-binding protein,C0022548,Keloid,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Acquired Abnormality,0.3,1.0,,2010.0,2010.0,ALL
140467,ZNF358,Q9NW07,,,0.78754,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
140468,COX11P1,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
140469,MYO3B,Q8WXR4,0.861,0.192,2.0329e-36,DTO_03300101,Kinase,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
140545,RNF32,Q9H0A6,1.0,0.077,1.1058e-15,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
140564,APOBEC3D,Q96AK3,,,1.3595e-18,DTO_05007624,Enzyme,C0021051,Immunologic Deficiency Syndromes,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
140576,S100A16,Q96FQ6,0.686,0.462,0.0010573,DTO_05007616,Calcium-binding protein,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2009.0,2018.0,ALL
140578,CHODL,Q9H9P2,0.769,0.231,2.1485e-08,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
140596,DEFB104A,Q8WTQ1,0.638,0.692,0.093748,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.03,1.0,,2010.0,2018.0,ALL
140606,SELENOM,Q8WWX9,0.839,0.269,1.6327e-06,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
140609,NEK7,Q8TDX7,0.722,0.346,0.88018,DTO_03300101,Kinase,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
140623,FAUP1,,1.0,0.077,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
140625,ACTRT2,Q8TDY3,1.0,0.077,0.0004766,DTO_05007530,Cellular structure,C0022548,Keloid,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Acquired Abnormality,0.3,1.0,,2010.0,2010.0,ALL
140628,GATA5,Q9BWX5,0.578,0.615,0.28478,,,C4693563,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5",,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2015.0,ALL
140660,RPL21P4,,1.0,0.192,,,,C0677776,Hereditary Breast and Ovarian Cancer Syndrome,C16;C04;C13;C17;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Endocrine System Diseases",disease,Neoplastic Process,0.1,,,,,ALL
140679,SLC32A1,Q9H598,0.743,0.577,0.96675,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.333,,2008.0,2011.0,ALL
140680,C20orf96,Q9NUD7,,,1.178e-14,,,C1285654,Memory performance,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
140683,BPIFA2,Q96DR5,0.608,0.808,8.0124e-07,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
140685,ZBTB46,Q86UZ6,0.716,0.5,0.80852,DTO_05007624,Enzyme,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2011.0,2019.0,ALL
140687,GCNT7,Q6ZNI0,0.89,0.115,0.087274,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,1997.0,1997.0,ALL
140688,NOL4L,Q96MY1,0.931,0.154,0.99496,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
140689,CBLN4,Q9NTU7,0.89,0.154,0.16726,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
140690,CTCFL,Q8NI51,0.599,0.692,0.00039547,DTO_05007542,Transcription factor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2002.0,2019.0,ALL
140691,TRIM69,Q86WT6,0.612,0.731,2.5727e-09,,,C0344315,Depressed mood,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
140699,MROH8,Q9H579,,,3.3158e-16,,,C0406208,Suntan,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
140707,BRI3BP,Q8WY22,0.743,0.154,0.064384,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0,,2003.0,2014.0,ALL
140710,SOGA1,O94964,1.0,0.077,1.0,,,C0406208,Suntan,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
140730,RIMS4,Q9H426,,,0.23281,DTO_05007584,Enzyme modulator,C0239337,Deformity of limb,,,group,Anatomical Abnormality,0.01,1.0,,2013.0,2013.0,ALL
140732,SUN5,Q8TC36,0.805,0.154,7.7476e-14,DTO_05007530,Cellular structure,C4310674,SPERMATOGENIC FAILURE 16,,,disease,Disease or Syndrome,0.75,1.0,,2016.0,2018.0,ALL
140733,MACROD2,A1Z1Q3,0.686,0.423,0.43472,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.43,1.0,,2010.0,2019.0,ALL
140735,DYNLL2,Q96FJ2,0.743,0.269,0.74311,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2003.0,2019.0,ALL
140738,TMEM37,Q8WXS4,0.792,0.154,0.0023933,DTO_01300327,Ion channel,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
140739,UBE2F,Q969M7,0.736,0.231,0.92267,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.11,1.0,,2019.0,2019.0,ALL
140750,RPL36P4,,,,,,,C0919677,Protein C measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
140758,RPS10P2,,0.931,0.038,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
140760,RPL24P2,,1.0,0.038,,,,C0553580,Ewings sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
140766,ADAMTS14,Q8WXS8,0.792,0.423,4.7565e-14,DTO_05007624,Enzyme,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
140767,NRSN1,Q8IZ57,0.604,0.731,0.00030819,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,limited,2012.0,2018.0,ALL
140775,SMCR8,Q8TEV9,0.931,0.115,0.001598,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
140801,RPL10L,Q96L21,,,0.0051677,DTO_05007557,Nucleic acid binding,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
140803,TRPM6,Q9BX84,0.656,0.538,2.719e-10,DTO_03300101,Kinase,C1865974,"Hypomagnesemia 1, Intestinal",C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.8,1.0,,2002.0,2019.0,ALL
140805,HT,,0.505,0.731,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,0.96,,2000.0,2020.0,ALL
140807,KRT72,Q14CN4,0.861,0.154,1.3674e-11,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
140809,SRXN1,Q9BYN0,0.751,0.385,0.069723,,,C0740391,Middle Cerebral Artery Occlusion,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Acquired Abnormality,0.02,1.0,,2017.0,2018.0,ALL
140821,RSS,,0.578,0.692,,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,0.964,,2017.0,2020.0,ALL
140823,ROMO1,P60602,0.666,0.615,0.234,,,C0029866,Other ureteric obstruction,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Anatomical Abnormality,0.2,1.0,,2017.0,2017.0,ALL
140828,LINC00261,,0.705,0.308,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
140831,ZSWIM3,Q96MP5,1.0,0.077,5.5178e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
140834,LINC01620,,0.805,0.269,0.45157,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
140836,BANF2,Q9H503,1.0,0.077,0.014314,,,C0041327,"Tuberculosis, Pulmonary",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
140838,NANP,Q8TBE9,0.839,0.231,6.429e-05,,,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
140850,DEFB127,Q9H1M4,1.0,0.038,0.40494,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
140851,MT1P3,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
140862,ISM1,B1AKI9,0.78,0.154,0.0062863,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
140865,LINC00686,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
140873,C20orf173,Q96LM9,,,1.0938e-06,,,C0919677,Protein C measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
140875,LINC00028,,0.89,0.038,,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
140876,RIPOR3,Q96MK2,0.792,0.077,7.0058e-20,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
140880,CST11,Q9H112,,,7.8838e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
140883,ZNF280B,Q86YH2,0.861,0.115,0.036302,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
140885,SIRPA,P78324,0.592,0.769,0.67197,DTO_05007599,Signaling,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
140890,SREK1,Q8WXA9,1.0,0.077,0.9148,DTO_05007557,Nucleic acid binding,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
140892,TCPT,,,,,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2019.0,2019.0,ALL
140894,CNBD2,Q96M20,,,3.8389e-17,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
140895,HSPE1P1,,1.0,0.038,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
140901,STK35,Q8TDR2,0.805,0.154,0.48076,DTO_03300101,Kinase,C0015944,"Fetal Membranes, Premature Rupture",C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,1.0,,2019.0,2019.0,ALL
140902,R3HDML,Q9H3Y0,0.931,0.115,1.884e-06,DTO_05007608,Immune response,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
140907,SPG19,,0.931,0.077,,,,C1846685,"SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
140947,DCANP1,Q8TF63,0.839,0.154,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.667,,2010.0,2013.0,ALL
142678,MIB2,Q96AX9,0.78,0.269,2.8024e-07,DTO_05007624,Enzyme,C1960469,Left ventricular noncompaction,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
142679,DUSP19,Q8WTR2,0.931,0.115,0.010044,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
142680,SLC34A3,Q8N130,0.695,0.308,5.8863e-14,DTO_05007405,Transporter,C1853271,"HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY",C23;C16;C18;C13;C05;C12,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.8,1.0,,2006.0,2019.0,ALL
142684,RAB40A,Q8WXH6,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
142685,ASB15,Q8WXK1,0.792,0.231,1.84e-15,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
142686,ASB14,A6NK59,0.931,0.038,1.1236e-22,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
142689,ASB12,Q8WXK4,1.0,0.192,0.00069764,,,C0585984,Laryngotracheomalacia,C16;C17;C05;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Anatomical Abnormality,0.01,1.0,,2013.0,2013.0,ALL
142891,SAMD8,Q96LT4,1.0,0.038,0.0017634,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
142913,CFL1P1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
142940,TRUB1,Q8WWH5,0.931,0.115,2.3333e-06,DTO_05007624,Enzyme,C0265965,Dyskeratosis Congenita,C16;C17;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
143098,MPP7,Q5T2T1,0.769,0.462,2.1745e-11,DTO_05007624,Enzyme,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
143162,FRMPD2,Q68DX3,0.839,0.269,1.5123e-32,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
143187,VTI1A,Q96AJ9,0.674,0.154,0.00054173,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.42,1.0,,2011.0,2019.0,ALL
143241,DYDC1,Q8WWB3,,,0.00026003,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
143244,EIF5AL1,Q6IS14,0.792,0.308,0.34147,DTO_05007557,Nucleic acid binding,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
143279,HECTD2,Q5U5R9,0.805,0.231,0.99806,,,C0162534,Prion Diseases,C01;C10,   Infections;    Nervous System Diseases,group,Disease or Syndrome,0.04,0.75,,2009.0,2011.0,ALL
143282,FGFBP3,Q8TAT2,0.821,0.154,0.0010279,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
143379,C10orf82,Q8WW14,0.821,0.192,0.011358,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
143384,CACUL1,Q86Y37,0.638,0.577,0.96315,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2012.0,2019.0,ALL
143425,SYT9,Q86SS6,0.821,0.269,0.30911,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
143458,LDLRAD3,Q86YD5,0.805,0.308,0.016213,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
143471,PSMA8,Q8TAA3,1.0,0.077,5.4953e-05,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
143501,C11orf40,Q8WZ69,0.931,0.115,1.0628e-06,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
143502,OR52I2,Q8NH67,,,0.44271,DTO_02300001,G-protein coupled receptor,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
143503,OR51E1,Q8TCB6,0.78,0.192,0.0030352,DTO_02300001,G-protein coupled receptor,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
143570,XRRA1,Q6P2D8,1.0,0.077,8.3651e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2003.0,2017.0,ALL
143630,UBQLNL,Q8IYU4,,,2.1123e-12,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
143662,MUC15,Q8N387,0.729,0.308,5.0143e-05,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
143684,FAM76B,Q5HYJ3,1.0,0.077,0.34062,,,C0041327,"Tuberculosis, Pulmonary",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
143686,SESN3,P58005,0.705,0.423,0.68496,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
143689,PIWIL4,Q7Z3Z4,0.579,0.692,1.8323e-06,,,C0028960,Oligospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.31,1.0,,2010.0,2010.0,ALL
143872,ARHGAP42,A6NI28,0.792,0.385,1.0,DTO_05007584,Enzyme modulator,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.13,1.0,,2011.0,2019.0,ALL
143884,CWF19L2,Q2TBE0,1.0,0.038,3.9267e-12,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
143888,POGLUT3,Q7Z4H8,0.89,0.154,1.1421e-10,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
143903,LAYN,Q6UX15,0.722,0.385,1.3423e-13,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2008.0,2019.0,ALL
143941,TTC36,A6NLP5,0.805,0.308,0.00022268,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2015.0,2017.0,ALL
144097,SPINDOC,Q9BUA3,,,0.99142,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
144100,PLEKHA7,Q6IQ23,0.729,0.423,6.22e-09,,,C0017605,Angle Closure Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.4,1.0,,2012.0,2019.0,ALL
144108,SPTY2D1,Q68D10,1.0,0.077,0.94476,DTO_05007557,Nucleic acid binding,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
144125,OR2AG1,Q9H205,0.582,0.808,3.1156e-11,DTO_02300001,G-protein coupled receptor,C0027498,Nausea and vomiting,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.08,1.0,,2003.0,2019.0,ALL
144132,DNHD1,Q96M86,0.792,0.154,1.2016e-72,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
144165,PRICKLE1,Q96MT3,0.647,0.615,0.99999,DTO_05007530,Cellular structure,C2676254,Prickle1-Related Progressive Myoclonus Epilepsy with Ataxia,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2008.0,2011.0,ALL
144193,AMDHD1,Q96NU7,1.0,0.077,3.1269e-08,DTO_05007624,Enzyme,C0523979,Vitamin D3 measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
144195,SLC2A14,Q8TDB8,0.821,0.308,0.041173,DTO_05007405,Transporter,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
144203,OVOS2,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
144233,BCDIN3D,Q7Z5W3,0.931,0.077,3.8663e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
144245,ALG10B,Q5I7T1,0.839,0.115,2.0263e-08,,,C3150943,Long Qt Syndrome 2,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
144347,RFLNA,Q6ZTI6,0.821,0.231,0.23296,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
144348,ZNF664,Q8N3J9,0.821,0.231,0.0013267,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2019.0,ALL
144360,LINC00477,Q96M19,0.861,0.154,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
144402,CPNE8,Q86YQ8,0.89,0.115,0.0080248,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
144404,TMEM120B,A0PK00,1.0,0.115,0.0071229,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
144406,WDR66,Q8TBY9,0.792,0.115,2.9422e-13,,,C0021359,Infertility,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Pathologic Function,0.1,,,,,ALL
144423,GLT1D1,Q96MS3,0.861,0.231,6.1378e-08,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.12,1.0,,2018.0,2018.0,ALL
144453,BEST3,Q8N1M1,0.792,0.308,2.0104e-19,DTO_01300327,Ion channel,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
144455,E2F7,Q96AV8,0.678,0.346,0.99317,DTO_05007557,Nucleic acid binding,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2019.0,ALL
144481,SOCS2-AS1,,0.89,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
144501,KRT80,Q6KB66,0.839,0.154,3.4641e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
144535,CFAP54,Q96N23,0.931,0.192,3.7412e-41,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2010.0,2010.0,ALL
144568,A2ML1,A8K2U0,0.59,0.692,1.6109e-34,DTO_05007584,Enzyme modulator,C0028326,Noonan Syndrome,C16;C17;C05;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,disputed,2015.0,2016.0,ALL
144577,C12orf66,Q96MD2,0.931,0.115,0.44192,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
144608,C12orf60,Q5U649,1.0,0.192,0.048314,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2013.0,ALL
144699,FBXL14,Q8N1E6,0.861,0.154,0.82537,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
144715,RAD9B,Q6WBX8,1.0,0.038,3.0239e-13,DTO_05007584,Enzyme modulator,C0036631,Seminoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
144717,PHETA1,Q8N4B1,0.805,0.385,0.010042,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2005.0,2005.0,ALL
144766,LINC00355,,0.821,0.154,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
144811,LACC1,Q8IV20,0.7,0.423,1.1655e-05,,,C1384600,Systemic onset juvenile chronic arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.35,1.0,,2015.0,2019.0,ALL
144920,LINC00343,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
145165,ST13P4,Q8IZP2,0.839,0.154,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2002.0,2003.0,ALL
145173,B3GLCT,Q6Y288,0.554,0.731,7.1449e-17,DTO_05007624,Enzyme,C0796012,Krause-Kivlin syndrome,C23;C16;C05;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.7,0.933,strong,2006.0,2019.0,ALL
145200,LINC00239,,1.0,0.038,0.36123,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
145216,LINC00637,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
145226,RDH12,Q96NR8,0.65,0.308,2.2626e-09,DTO_05007624,Enzyme,C2675186,LEBER CONGENITAL AMAUROSIS 13,C11,   Eye Diseases,disease,Disease or Syndrome,0.71,1.0,,2004.0,2019.0,ALL
145258,GSC,P56915,0.631,0.615,0.013852,,,C1865361,"SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL ABNORMALITIES",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.63,1.0,strong,1997.0,2013.0,ALL
145264,SERPINA12,Q8IW75,0.736,0.308,7.7169e-07,DTO_05007584,Enzyme modulator,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.27,1.0,,2005.0,2020.0,ALL
145270,PRIMA1,Q86XR5,0.595,0.615,0.62894,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,0.667,,2015.0,2016.0,ALL
145282,MIPOL1,Q8TD10,0.89,0.192,2.0845e-11,,,C0152427,Polydactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.31,1.0,,2002.0,2017.0,ALL
145376,PPP1R36,Q96LQ0,,,1.7114e-10,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
145389,SLC38A6,Q8IZM9,0.821,0.231,2.382e-20,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,1998.0,2003.0,ALL
145407,ARMH4,Q86TY3,0.931,0.154,1.7348e-07,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2019.0,ALL
145447,ABHD12B,Q7Z5M8,0.931,0.115,3.7965e-15,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
145482,PTGR2,Q8N8N7,0.792,0.346,2.7131e-07,DTO_05007624,Enzyme,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2016.0,ALL
145501,ISM2,Q6H9L7,1.0,0.077,2.3337e-11,,,C0200633,Neutrophil count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
145508,CEP128,Q6ZU80,0.78,0.423,4.7157e-23,,,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2011.0,2019.0,ALL
145553,MDP1,Q86V88,0.839,0.231,1.9265e-05,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
145567,TTC7B,Q86TV6,0.861,0.154,0.99998,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
145581,LRFN5,Q96NI6,0.839,0.077,0.55863,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.12,1.0,,2015.0,2019.0,ALL
145624,PWAR1,,0.49,0.769,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.34,0.75,,1996.0,2001.0,ALL
145741,C2CD4A,Q8NCU7,0.931,0.077,0.017468,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.34,1.0,,2010.0,2018.0,ALL
145748,LYSMD4,Q5XG99,1.0,0.038,0.00056203,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
145781,GCOM1,P0CAP1;P0CAP2;Q6EEV4,0.805,0.308,2.3874e-19,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
145814,PGPEP1L,A6NFU8,,,8.7056e-09,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
145820,LINC00924,,0.931,0.077,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
145837,DRAIC,,0.736,0.423,,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.11,1.0,,2010.0,2019.0,ALL
145858,C15orf32,Q32M92,1.0,0.077,0.0011665,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
145864,HAPLN3,Q96S86,0.861,0.154,1.0068e-06,DTO_05007621,Extracellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2011.0,2011.0,ALL
145873,MESP2,Q0VG99,0.653,0.462,3.1138e-06,,,C1837549,"SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 2",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.6,1.0,,2004.0,2008.0,ALL
145942,TMCO5A,Q8N6Q1,,,4.4861e-06,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2015.0,2015.0,ALL
145957,NRG4,Q8WWG1,0.623,0.654,0.027981,DTO_05007599,Signaling,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
145978,LINC00052,Q96N35,0.716,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2017.0,2019.0,ALL
146057,TTBK2,Q6IQ55,0.682,0.423,0.99875,DTO_03300101,Kinase,C1858351,SPINOCEREBELLAR ATAXIA 11,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.66,1.0,,2007.0,2019.0,ALL
146059,CDAN1,Q8IWY9,0.61,0.731,1.1134e-12,,,C0271933,"Congenital dyserythropoietic anemia, type I",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.78,1.0,,2002.0,2018.0,ALL
146167,SLC38A8,A6NNN8,0.743,0.269,3.3217e-24,DTO_05007405,Transporter,C3807873,FOVEAL HYPOPLASIA 2,,,disease,Disease or Syndrome,0.7,1.0,strong,2013.0,2014.0,ALL
146177,VWA3A,A6NCI4,0.931,0.115,1.6824e-25,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
146183,OTOA,Q7RTW8,0.76,0.423,3.0274e-10,DTO_05007621,Extracellular structure,C1846896,"Deafness, Autosomal Recessive 22",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2012.0,2019.0,ALL
146198,ZFP90,Q8TF47,0.78,0.231,0.031662,DTO_05007542,Transcription factor,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.11,0.8,,2009.0,2017.0,ALL
146206,CARMIL2,Q6F5E8,0.695,0.462,2.9337e-11,DTO_05007542,Transcription factor,C4748304,IMMUNODEFICIENCY 58,,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2018.0,ALL
146212,KCTD19,Q17RG1,1.0,0.038,5.0661e-15,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
146223,CMTM4,Q8IZR5,0.805,0.154,0.23064,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2009.0,2019.0,ALL
146225,CMTM2,Q8TAZ6,0.78,0.231,2.9425e-05,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
146227,BEAN1,Q3B7T3,0.705,0.385,6.7615e-06,,,C1861736,SPINOCEREBELLAR ATAXIA 31 (disorder),C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.63,1.0,,2007.0,2019.0,ALL
146279,TEKT5,Q96M29,0.821,0.192,3.081e-20,DTO_05007530,Cellular structure,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
146325,PRR35,P0CG20,,,0.02116,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
146330,FBXL16,Q8N461,1.0,0.038,0.96981,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
146336,SSTR5-AS1,,0.89,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
146395,GSG1L,Q6UXU4,,,0.7676,DTO_05007530,Cellular structure,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
146429,SLC22A31,A6NKX4,,,7.91e-11,DTO_05007405,Transporter,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
146433,IL34,Q6ZMJ4,0.56,0.769,0.55444,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
146456,TMED6,Q8WW62,0.769,0.192,8.6323e-05,DTO_05007405,Transporter,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
146513,LINC02135,,,,,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
146540,ZNF785,A8K8V0,0.931,0.077,2.7478e-06,DTO_05007542,Transcription factor,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
146542,ZNF688,P0C7X2,0.931,0.154,7.0023e-06,DTO_05007542,Transcription factor,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
146547,PRSS36,Q5K4E3,1.0,0.038,4.51e-19,DTO_05007624,Enzyme,C0236773,Depressed bipolar I disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
146664,MGAT5B,Q3V5L5,0.78,0.231,0.014591,DTO_05007624,Enzyme,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
146691,TOM1L2,Q6ZVM7,0.89,0.077,0.0015723,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
146705,TEPSIN,Q96N21,0.931,0.154,9.8236e-09,,,C0338451,Frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
146712,B3GNTL1,Q67FW5,0.76,0.346,4.0733e-28,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,1988.0,1988.0,ALL
146713,RBFOX3,A6NFN3,0.751,0.192,0.99785,DTO_05007557,Nucleic acid binding,C0376532,"Epilepsy, Rolandic",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2013.0,2018.0,ALL
146722,CD300LF,Q8TDQ1,0.716,0.385,1.0563e-08,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
146754,DNAH2,Q9P225,0.931,0.115,1.2998e-44,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
146760,RTN4RL1,Q86UN2,0.821,0.385,0.96024,DTO_05007575,Receptor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
146771,TCAM1P,,0.931,0.154,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
146802,SLC47A2,Q86VL8,1.0,0.115,9.2836e-15,DTO_05007405,Transporter,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
146845,CFAP52,Q8N1V2,0.89,0.154,8.1211e-18,,,C0037221,Situs Inversus,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.3,1.0,,2015.0,2015.0,ALL
146849,CCDC42,Q96M95,1.0,0.077,3.6229e-06,,,C0019337,Heroin Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2016.0,2016.0,ALL
146852,ODF4,Q2M2E3,0.821,0.154,0.010768,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2018.0,2018.0,ALL
146857,SLFN13,Q68D06,,,1.9958e-16,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
146862,UNC45B,Q8IWX7,0.805,0.192,2.9085e-15,,,C4225389,CATARACT 43,,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
146880,ARHGAP27P1,,0.805,0.154,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
146894,CD300LG,Q6UXG3,1.0,0.077,0.00073606,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
146909,KIF18B,Q86Y91,0.839,0.192,0.002309,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
146923,RUNDC1,Q96C34,,,0.0023691,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
146956,EME1,Q96AY2,0.931,0.077,2.4963e-14,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
147007,TMEM199,Q8N511,0.792,0.231,1.9938e-05,,,C4225190,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp",,,disease,Disease or Syndrome; Congenital Abnormality,0.7,1.0,,2016.0,2016.0,ALL
147011,PROCA1,Q8NCQ7,,,4.4649e-08,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
147015,DHRS13,Q6UX07,,,0.025578,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
147040,KCTD11,Q693B1,0.736,0.385,0.0054961,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2004.0,2019.0,ALL
147081,LINC02210,,0.861,0.154,,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
147093,LINC00974,,0.931,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
147111,NOTUM,Q6P988,0.821,0.192,0.0021564,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
147138,TMC8,Q8IU68,0.705,0.231,1.1401e-14,DTO_01300327,Ion channel,C0014522,Epidermodysplasia Verruciformis,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.6,1.0,,2002.0,2018.0,ALL
147166,TRIM16L,Q309B1,1.0,0.077,3.3944e-06,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
147179,WIPF2,Q8TF74,0.76,0.385,0.18669,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
147183,KRT25,Q7Z3Z0,0.736,0.269,4.6459e-09,,,C4225214,"WOOLLY HAIR, AUTOSOMAL RECESSIVE 3",,,disease,Disease or Syndrome,0.6,1.0,strong,2015.0,2018.0,ALL
147184,TMEM99,Q8N816,0.89,0.077,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
147199,SCGB1C1,P0DMR2;Q8TD33,0.931,0.154,2.1497e-05,DTO_05007599,Signaling,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
147323,STARD6,P59095,,,0.00026527,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
147339,C18orf25,Q96B23,0.931,0.231,0.89046,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
147372,CCBE1,Q6UXH8,0.585,0.769,1.5315e-07,DTO_05007616,Calcium-binding protein,C4012050,HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1,C16;C05;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2003.0,2014.0,ALL
147381,CBLN2,Q8IUK8,0.751,0.308,0.12162,,,C0020542,Pulmonary Hypertension,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.3,1.0,,2013.0,2013.0,ALL
147407,SLC25A52,Q3SY17,0.931,0.077,0.0005017,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
147409,DSG4,Q86SJ6,0.686,0.423,5.9129e-13,DTO_05007620,Cell adhesion,C1842839,HYPOTRICHOSIS 6,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.8,1.0,strong,1996.0,2004.0,ALL
147429,AQP4-AS1,,0.751,0.577,,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
147463,ANKRD29,Q8N6D5,1.0,0.077,6.3522e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
147468,WBP2P1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
147495,APCDD1,Q8J025,0.644,0.538,0.0073159,,,C4551976,HYPOTRICHOSIS 1,,,disease,Disease or Syndrome,0.6,1.0,strong,2010.0,2012.0,ALL
147525,LINC00526,Q96FQ7,0.861,0.115,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
147645,VSIG10L,Q86VR7,0.931,0.077,1.086e-08,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
147650,SPACA6,W5XKT8,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
147657,ZNF480,Q8WV37,0.931,0.115,0.03557,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
147660,ZNF578,Q96N58,,,0.0013064,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
147685,C19orf18,Q8NEA5,0.89,0.077,4.3311e-07,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
147686,ZNF418,Q8TF45,0.839,0.115,1.0016e-09,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
147687,ZNF417,Q8TAU3,1.0,0.038,0.0067514,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
147694,ZNF548,Q8NEK5,,,0.33982,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
147699,PPM1N,Q8N819,0.931,0.115,5.3345e-06,DTO_05007624,Enzyme,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
147700,KLC3,Q6P597,1.0,0.077,3.8573e-18,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
147710,IGSF23,A1L1A6,0.861,0.154,0.0096591,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2019.0,ALL
147711,ZNF285B,,1.0,0.077,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
147719,LYPD4,Q6UWN0,0.601,0.692,9.0339e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,1997.0,2019.0,ALL
147727,ILF3-DT,,0.805,0.077,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
147741,ZNF560,Q96MR9,0.931,0.077,9.6685e-06,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
147746,HIPK4,Q8NE63,,,2.1439e-05,DTO_03300101,Kinase,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
147798,TMC4,Q7Z404,0.805,0.192,1.7195e-13,DTO_01300327,Ion channel,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
147837,ZNF563,Q8TA94,1.0,0.077,0.7644,,,C0020445,"Hypercholesterolemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
147841,SPC24,Q8NBT2,0.711,0.192,0.00014316,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2019.0,ALL
147872,CCDC155,Q8N6L0,,,2.3366e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
147906,DACT3,Q96B18,0.805,0.231,0.50555,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
147912,SIX5,Q8N196,0.666,0.5,0.006924,DTO_05007542,Transcription factor,C1970479,Branchiootorenal Syndrome 2,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.7,1.0,,1999.0,2007.0,ALL
147923,ZNF420,Q8TAQ5,,,1.8575e-11,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
147929,ZNF565,Q8N9K5,0.931,0.077,1.0169e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
147945,NLRP4,Q96MN2,0.805,0.192,3.1842e-09,,,C0201512,Thyroglobulin antibody measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
147947,ZNF542P,Q5EBM4,1.0,0.077,,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
147948,ZNF582,Q96NG8,0.743,0.192,0.00052539,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2019.0,ALL
147949,ZNF583,Q96ND8,1.0,0.077,0.007156,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
147965,FAM98C,Q17RN3,0.931,0.115,1.0622e-07,,,C0152427,Polydactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,,,,,ALL
147968,CAPN12,Q6ZSI9,0.89,0.077,1.226e-33,DTO_05007624,Enzyme,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
147991,DPY19L3,Q6ZPD9,1.0,0.038,2.8534e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
148003,LGALS16,A8MUM7,0.839,0.192,0.00010017,DTO_05007599,Signaling,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,1996.0,2014.0,ALL
148014,TTC9B,Q8N6N2,0.89,0.115,0.21638,DTO_05007624,Enzyme,C0221074,"Depression, Postpartum",C13;F03,   Female Urogenital Diseases and Pregnancy Complications;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2014.0,2020.0,ALL
148022,TICAM1,Q8IUC6,0.593,0.846,,,,C0276226,Herpes encephalitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.63,0.333,,2011.0,2015.0,ALL
148066,ZNRF4,Q8WWF5,1.0,0.038,0.48866,,,C0023860,Listeriosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
148103,ZNF599,Q96NL3,1.0,,2.1284e-07,DTO_05007542,Transcription factor,C4311048,"CHROMOSOME 19q13.11 DELETION SYNDROME, DISTAL",,,disease,Disease or Syndrome,0.3,1.0,limited,2012.0,2012.0,ALL
148113,CILP2,Q8IUL8,0.76,0.346,8.0314e-08,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
148137,PROSER3,Q2NL68,1.0,0.077,5.0594e-10,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
148170,CDC42EP5,Q6NZY7,1.0,0.115,0.32109,,,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
148189,LINC00662,,0.751,0.231,,,,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
148198,ZNF98,A6NK75,0.931,0.077,0.0034454,,,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
148229,ATP8B3,O60423,0.931,0.115,1.4666e-26,DTO_05007405,Transporter,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
148252,DIRAS1,O95057,0.722,0.231,0.388,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2013.0,2018.0,ALL
148254,ZNF555,Q8NEP9,1.0,0.038,9.7445e-08,DTO_05007542,Transcription factor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
148266,ZNF569,Q5MCW4,0.666,0.538,6.5987e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
148281,SYT6,Q5T7P8,0.89,0.192,0.0081153,DTO_05007405,Transporter,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
148327,CREB3L4,Q8TEY5,0.722,0.385,5.1401e-06,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.32,1.0,,2002.0,2016.0,ALL
148345,C1orf127,Q8N9H9,0.729,0.308,1.4917e-11,,,C0008780,Ciliary Motility Disorders,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",group,Disease or Syndrome,0.2,,,,,ALL
148398,SAMD11,Q96NU1,0.89,0.154,4.7681e-14,DTO_05007557,Nucleic acid binding,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
148418,SAMD13,Q5VXD3,,,0.0062299,DTO_05007557,Nucleic acid binding,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
148423,C1orf52,Q8N6N3,0.691,0.5,0.047382,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.04,1.0,,2009.0,2017.0,ALL
148479,PHF13,Q86YI8,0.821,0.192,0.98042,DTO_05007378,Epigenetic regulator,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
148534,TLCD4,Q96MV1,0.931,0.038,0.26127,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
148581,UBE2U,Q5VVX9,1.0,0.231,1.3492e-07,,,C0085437,"Meningitis, Bacterial",C01;C10,   Infections;    Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
148641,SLC35F3,Q8IY50,0.805,0.231,0.0996,DTO_05007405,Transporter,C4317009,Diverticular Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
148645,LINC00337,Q8N6G1,1.0,0.077,,,,C1821417,RESTING HEART RATE,,,phenotype,Finding,0.1,1.0,,2017.0,2017.0,ALL
148713,PTPRVP,,0.705,0.577,,,,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
148738,HJV,Q6ZVN8,0.621,0.654,0.0042363,,,C1865614,"HEMOCHROMATOSIS, TYPE 2A",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.9,1.0,,2004.0,2016.0,ALL
148753,FAM163A,Q96GL9,0.839,0.154,0.1155,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2009.0,2019.0,ALL
148756,OVAAL,,0.931,0.077,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
148789,B3GALNT2,Q8NCR0,0.578,0.577,2.8116e-07,DTO_05007624,Enzyme,C3554638,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2017.0,ALL
148808,MFSD4A,Q8N468,0.89,0.077,0.0023547,DTO_05007405,Transporter,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
148811,PM20D1,Q6GTS8,0.821,0.308,1.8989e-18,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2012.0,ALL
148823,GCSAML,Q5JQS6,,,0.12474,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2016.0,ALL
148867,SLC30A7,Q8NEW0,0.792,0.385,4.4049e-07,DTO_05007405,Transporter,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
148870,CCDC27,Q2M243,,,2.8657e-28,,,C0518015,Hemoglobin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
148932,MOB3C,Q70IA8,1.0,0.077,1.7788e-05,DTO_05007584,Enzyme modulator,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
148979,GLIS1,Q8NBF1,0.751,0.308,0.038902,,,C0026267,Mitral Valve Prolapse Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.11,1.0,,2015.0,2019.0,ALL
149018,LELP1,Q5T871,0.89,0.154,0.42789,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.02,1.0,,2016.0,2017.0,ALL
149041,RC3H1,Q5TC82,0.821,0.154,0.99309,,,C0024291,"Lymphohistiocytosis, Hemophagocytic",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.31,1.0,,2019.0,2019.0,ALL
149076,ZNF362,Q5T0B9,,,0.94115,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
149086,LDC1P,,0.89,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
149095,DCST1,Q5T197,,,1.2681e-19,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2019.0,ALL
149111,CNIH3,Q8TBE1,0.821,0.154,0.84533,DTO_05007599,Signaling,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2012.0,ALL
149175,MANEAL,Q5VSG8,,,0.004939,,,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
149233,IL23R,Q5VWK5,0.466,0.769,0.00055961,DTO_05007599,Signaling,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.7,0.982,,2006.0,2020.0,ALL
149297,FAM78B,Q5VT40,1.0,0.077,0.31111,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
149371,EXOC8,Q8IYI6,,,0.99902,,,C0518015,Hemoglobin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
149420,PDIK1L,Q8N165,0.534,0.769,0.26436,DTO_03300101,Kinase,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2013.0,ALL
149428,BNIPL,Q7Z465,0.931,0.077,3.0268e-10,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
149461,CLDN19,Q8N6F1,0.659,0.423,0.0049681,DTO_05007527,Cell-cell junction,C1855466,"Hypomagnesemia 5, Renal, with Ocular Involvement",C16;C18;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.6,1.0,,2006.0,2006.0,ALL
149465,CFAP57,Q96MR6,0.89,0.231,1.0541e-12,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2014.0,ALL
149466,C1orf210,Q8IVY1,1.0,0.077,0.00017017,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
149483,CCDC17,Q96LX7,,,3.9155e-22,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
149563,SRARP,Q8NEQ6,0.839,0.115,0.10907,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.33,1.0,,2012.0,2017.0,ALL
149603,RNF187,Q5TA31,0.769,0.192,0.096678,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
149620,CHIAP2,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
149628,PYHIN1,Q6K0P9,0.839,0.231,7.7771e-10,DTO_05007542,Transcription factor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.43,1.0,,2011.0,2015.0,ALL
149647,FAM71A,Q8IYT1,1.0,0.077,,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
149685,ADIG,Q0VDE8,1.0,0.077,,,,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
149708,WFDC5,Q8TCV5,,,0.033893,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
149773,APCDD1L-DT,,1.0,0.077,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
149775,GNAS-AS1,,0.729,0.346,,,,C0033805,Pseudohypoaldosteronism,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
149830,PRNT,Q86SH4,1.0,0.115,,,,C0022336,Creutzfeldt-Jakob disease,C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
149837,LINC00654,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
149840,SHLD1,Q8IYI0,1.0,0.077,0.16633,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
149950,NOL4L-DT,,,,0.021323,,,C0200637,Monocyte count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
149951,COMMD7,Q86VX2,0.861,0.308,9.7494e-08,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
149954,BPIFB4,P59827,0.89,0.077,4.6976e-21,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
149992,ANKRD30BP2,,1.0,0.038,,,,C0022104,Irritable Bowel Syndrome,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
149998,LIPI,Q6XZB0,0.931,0.115,1.0155e-19,DTO_05007624,Enzyme,C0020480,Hyperlipoproteinemia Type IV,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.5,1.0,limited,2003.0,2016.0,ALL
150000,ABCC13,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
150084,IGSF5,Q9NSI5,1.0,0.077,3.6345e-17,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
150094,SIK1,A0A0B4J2F2;P57059,0.544,0.731,0.93716,DTO_03300101,Kinase,C4225360,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2015.0,ALL
150142,ZNF295-AS1,Q8N0V1,1.0,0.038,,,,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,1.0,,2013.0,2013.0,ALL
150159,SLC9B1,Q4ZJI4,0.821,0.308,5.1677e-07,DTO_05007405,Transporter,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
150165,XKR3,Q5GH77,1.0,0.038,0.078713,,,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
150209,AIFM3,Q96NN9,0.861,0.192,1.9474e-14,DTO_05007624,Enzyme,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
150223,YDJC,A8MPS7,0.805,0.231,0.062374,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
150244,ZDHHC8P1,,0.861,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
150274,HSCB,Q8IWL3,,,0.0035209,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
150280,HORMAD2,Q8N7B1,0.716,0.385,7.1353e-05,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.12,1.0,,2011.0,2014.0,ALL
150353,DNAJB7,Q7Z6W7,0.716,0.269,8.592e-09,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0,,2008.0,2019.0,ALL
150356,CHADL,Q6NUI6,0.89,0.038,2.8914e-08,DTO_05007575,Receptor,C0029410,Osteoarthritis of hip,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.41,1.0,,2017.0,2018.0,ALL
150365,MEI1,Q5TIA1,0.861,0.115,4.711e-12,,,C0678213,Complete hydatidiform mole,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
150368,PHETA2,Q6ICB4,0.931,0.231,3.3928e-06,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2017.0,ALL
150372,NFAM1,Q8NET5,1.0,0.038,6.2864e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
150379,PNPLA5,Q7Z6Z6,0.931,0.077,1.1936e-06,DTO_05007624,Enzyme,C0020445,"Hypercholesterolemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
150465,TTL,Q8NG68,0.805,0.154,0.35695,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,1998.0,2015.0,ALL
150468,CKAP2L,Q8IYA6,0.666,0.577,0.00015885,,,C0795940,Filippi syndrome,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.72,1.0,,2002.0,2016.0,ALL
150483,TEKT4,Q8WW24,0.839,0.192,5.2301e-15,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2014.0,2014.0,ALL
150538,SATB2-AS1,,0.839,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
150568,LINC01102,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
150572,SMYD1,Q8NB12,0.78,0.192,2.1406e-07,DTO_05007542,Transcription factor,C0424574,Duration of sleep,,,phenotype,Finding,0.1,1.0,,2016.0,2016.0,ALL
150577,LINC01104,,0.805,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2019.0,ALL
150596,LINC01931,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
150622,SILC1,,0.861,0.115,,,,C0272178,Drug-induced neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
150684,COMMD1,Q8N668,0.633,0.692,0.2201,,,C0019189,"Hepatitis, Chronic",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2011.0,2015.0,ALL
150696,PROM2,Q8N271,0.805,0.308,9.4559e-15,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
150726,FBXO41,Q8TF61,0.89,0.077,0.99944,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
150737,TTC30B,Q8N4P2,1.0,0.077,4.5661e-08,,,C2699746,"Syndactyly, type 2",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
150759,LINC00342,,0.78,0.154,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
150763,GPAT2,Q6NUI2,0.861,0.231,4.8416e-14,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
150771,ITPRIPL1,Q6GPH6,1.0,0.038,1.8771e-10,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
150864,FAM117B,Q6P1L5,1.0,0.038,0.0090079,,,C0036202,Sarcoidosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
150946,GAREM2,Q75VX8,0.89,0.077,0.43898,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
150962,PUS10,Q3MIT2,0.736,0.346,7.8796e-14,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
150992,LINC00309,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
151011,SEPTIN10,Q9P0V9,0.89,0.231,4.7356e-10,DTO_05007584,Enzyme modulator,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
151050,KANSL1L,A0AUZ9,,,0.65684,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
151056,PLB1,Q6P1J6,0.488,0.846,1.7315e-72,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.33,1.0,,2004.0,2014.0,ALL
151112,ZSWIM2,Q8NEG5,0.931,0.154,3.8377e-15,DTO_05007624,Enzyme,C0014060,"Encephalitis, St. Louis",C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.01,0.0,,2009.0,2009.0,ALL
151121,LINC01854,,0.931,0.077,,,,C0038580,Substance Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
151126,ZNF385B,Q569K4,0.729,0.538,0.0010962,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
151171,LINC01107,,,,,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2016.0,ALL
151176,ERFE,Q4G0M1,0.647,0.538,0.0025225,DTO_05007621,Extracellular structure,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
151188,ARL6IP6,Q8N6S5,0.686,0.615,0.018099,,,C0345419,Cutis marmorata telangiectatica congenita,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Congenital Abnormality,0.31,1.0,,2015.0,2015.0,ALL
151194,METTL21A,Q8WXB1,0.861,0.077,0.00050104,DTO_05007378,Epigenetic regulator,C1842675,AMYOTROPHIC LATERAL SCLEROSIS 6 (disorder),,,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
151195,CCNYL1,Q8N7R7,,,0.58564,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
151230,KLHL23,Q8NBE8,0.89,0.038,0.0041626,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
151242,PPP1R1C,Q8WVI7,0.839,0.077,2.3484e-05,DTO_05007584,Enzyme modulator,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
151246,SGO2,Q562F6,0.931,0.269,3.6085e-07,,,C0685838,Gonadal dysgenesis XX type deafness,C23;C16;C13;C12;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.31,1.0,moderate,2017.0,2017.0,ALL
151254,C2CD6,Q53TS8,0.931,0.115,2.9765e-16,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
151295,SLC23A3,Q6PIS1,1.0,0.038,7.3605e-07,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2013.0,2013.0,ALL
151306,GPBAR1,Q8TDU6,0.548,0.731,1.3633e-09,DTO_02300001,G-protein coupled receptor,C0009806,Constipation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.3,1.0,,2013.0,2013.0,ALL
151354,LRATD1,Q96KN4,0.769,0.462,0.88828,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
151393,RMDN2,Q96LZ7,0.531,0.769,4.4061e-24,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
151449,GDF7,Q7Z4P5,0.792,0.423,0.63062,DTO_05007599,Signaling,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.12,1.0,,2015.0,2016.0,ALL
151477,LINC00471,Q8N535,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2013.0,ALL
151507,MSL3P1,P0C860,0.89,0.115,,DTO_05007557,Nucleic acid binding,C0022336,Creutzfeldt-Jakob disease,C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
151516,ASPRV1,Q53RT3,0.705,0.462,0.0087846,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2019.0,2019.0,ALL
151531,UPP2,O95045,0.792,0.231,0.0012599,DTO_05007624,Enzyme,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2012.0,2017.0,ALL
151534,LBX2-AS1,,0.805,0.346,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
151556,GPR155,Q7Z3F1,0.821,0.154,6.0431e-16,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2007.0,2007.0,ALL
151613,TTC14,Q96N46,,,1.176e-09,,,C0008780,Ciliary Motility Disorders,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",group,Disease or Syndrome,0.1,1.0,,2011.0,2013.0,ALL
151636,DTX3L,Q8TDB6,0.78,0.231,5.2697e-06,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
151647,TAFA4,Q96LR4,0.743,0.192,0.00065997,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
151648,SGO1,Q5FBB7,0.674,0.346,2.5902e-12,,,C4015474,Chronic atrial and intestinal dysrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.72,1.0,limited,2014.0,2014.0,ALL
151651,EFHB,Q8N7U6,1.0,0.115,5.7973e-24,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
151658,LINC00635,,,,,,,C0424574,Duration of sleep,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
151742,PPM1L,Q5SGD2,0.821,0.231,0.47287,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
151790,WDR49,Q8IV35,0.931,0.115,1.0465e-19,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
151827,LRRC34,Q8IZ02,0.821,0.269,5.5187e-07,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
151871,DPPA2,Q7Z7J5,0.839,0.192,4.7882e-09,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,1998.0,2010.0,ALL
151887,CCDC80,Q76M96,0.659,0.462,6.0008e-06,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.31,1.0,,2012.0,2012.0,ALL
151888,BTLA,Q7Z6A9,0.593,0.577,0.020987,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
151903,CCDC12,Q8WUD4,,,0.040132,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
151963,MB21D2,Q8IYB1,0.861,0.038,0.042673,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
151987,PPP4R2,Q9NY27,1.0,0.115,0.99835,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
152002,XXYLT1,Q8NBI6,0.78,0.231,0.0013246,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
152006,RNF38,Q9H0F5,0.821,0.154,0.99995,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
152007,GLIPR2,Q9H4G4,0.861,0.231,4.8573e-05,DTO_05007608,Immune response,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2013.0,2013.0,ALL
152015,ROPN1B,Q9BZX4,0.931,0.038,2.0225e-05,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
152024,LINC00691,,1.0,0.077,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
152065,C3orf22,Q8N5N4,,,0.1001,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
152078,SLC66A1L,A1A4F0,,,0.002394,,,C0424574,Duration of sleep,,,phenotype,Finding,0.1,1.0,,2013.0,2013.0,ALL
152100,CMC1,Q7Z7K0,0.711,0.308,0.1073,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
152110,NEK10,Q6ZWH5,0.705,0.269,7.6572e-10,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
152118,LINC02877,P0CE67,,,0.056297,,,C2699541,Cytokine Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
152137,CCDC50,Q8IVM0,0.751,0.423,3.9152e-07,,,C1843895,"Deafness, Autosomal Dominant 44",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.51,1.0,strong,2007.0,2016.0,ALL
152138,PYDC2,Q56P42,0.805,0.192,,,,C0877015,Pelvic Organ Prolapse,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.02,1.0,,2018.0,2018.0,ALL
152189,CMTM8,Q8IZV2,0.805,0.154,0.059614,DTO_05007405,Transporter,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
152206,CCDC13,Q8IYE1,,,9.0281e-09,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
152217,NCBP2AS2,Q69YL0,0.861,0.115,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
152225,LINC02085,,0.89,0.115,,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2019.0,ALL
152273,FGD5,Q6ZNL6,0.78,0.346,1.0,DTO_05007584,Enzyme modulator,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2014.0,2018.0,ALL
152302,CIDECP1,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
152330,CNTN4,Q8IWV2,0.653,0.577,3.3013e-06,DTO_05007575,Receptor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2008.0,2013.0,ALL
152404,IGSF11,Q5DX21,0.839,0.154,0.00099965,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
152485,ZNF827,Q17R98,0.769,0.192,0.99965,DTO_05007542,Transcription factor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2012.0,ALL
152518,NFXL1,Q6ZNB6,0.805,0.154,1.2429e-05,DTO_05007542,Transcription factor,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
152519,NIPAL1,Q6NVV3,0.76,0.346,2.4544e-10,DTO_05007405,Transporter,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
152559,PAQR3,Q6TCH7,0.653,0.423,3.7364e-05,DTO_05007575,Receptor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.895,,2008.0,2019.0,ALL
152573,SHISA3,A0PJX4,0.751,0.346,3.6402e-05,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
152578,LINC01618,,0.931,0.038,,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
152579,SCFD2,Q8WU76,0.839,0.231,6.0175e-13,DTO_05007405,Transporter,C0021603,Sleep Initiation and Maintenance Disorders,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
152586,MGAT4D,A6NG13,,,4.0771e-06,,,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2007.0,2007.0,ALL
152687,ZNF595,Q8IYB9,1.0,0.115,0.3055,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
152742,LINC01085,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
152789,JAKMIP1,Q96N16,0.839,0.269,0.99986,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2007.0,2007.0,ALL
152816,ODAPH,Q17RF5,0.839,0.077,0.049615,,,C3553830,"AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4",,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2012.0,ALL
152831,KLB,Q86Z14,0.647,0.5,0.036433,DTO_05007624,Enzyme,C0400966,Non-alcoholic Fatty Liver Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2018.0,2020.0,ALL
152877,FAM53A,Q6NSI3,0.839,0.192,0.0035705,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
152926,PPM1K,Q8N3J5,0.656,0.5,0.00014736,DTO_05007624,Enzyme,C0024776,Maple Syrup Urine Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.52,1.0,,2009.0,2013.0,ALL
152940,C4orf45,Q96LM5,,,4.3689e-07,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2017.0,ALL
152992,TRMT44,Q8IYL2,,,2.0315e-22,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
153020,RASGEF1B,Q0VAM2,0.821,0.154,0.92073,DTO_05007584,Enzyme modulator,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
153090,DAB2IP,Q5VWQ8,0.588,0.538,0.99995,DTO_05007584,Enzyme modulator,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.46,1.0,,2010.0,2019.0,ALL
153129,SLC38A9,Q8NBW4,1.0,0.077,0.28628,DTO_05007405,Transporter,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
153201,SLC36A2,Q495M3,0.861,0.154,6.1509e-10,DTO_05007405,Transporter,C0543541,HYPERGLYCINURIA (disorder),C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2008.0,2008.0,ALL
153218,SPINK13,Q1W4C9,0.821,0.192,0.00047605,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
153222,CREBRF,Q8IUR6,0.636,0.5,0.99997,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
153241,CEP120,Q8N960,0.564,0.731,4.0887e-15,,,C4225378,SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY,,,disease,Disease or Syndrome,0.6,1.0,,2015.0,2018.0,ALL
153328,SLC25A48,Q6ZT89,1.0,0.077,0.00015155,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
153339,TMEM167A,Q8TBQ9,1.0,0.038,0.00042515,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0,,2019.0,2019.0,ALL
153396,TMEM161B,Q8NDZ6,0.861,0.115,1.2449e-05,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,0.5,,2018.0,2019.0,ALL
153443,SRFBP1,Q8NEF9,0.861,0.038,7.1253e-12,,,C0345050,Congenital aneurysm of ascending aorta,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.1,,,,,ALL
153469,JAKMIP2-AS1,,1.0,0.115,,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
153478,PLEKHG4B,Q96PX9,1.0,0.077,1.0827e-32,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
153562,MARVELD2,Q8N4S9,0.705,0.462,1.2584e-12,DTO_05007527,Cell-cell junction,C1857811,"DEAFNESS, AUTOSOMAL RECESSIVE 49",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.81,1.0,,2006.0,2015.0,ALL
153571,C5orf38,Q86SI9,1.0,0.077,0.0017218,,,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
153572,IRX2,Q9BZI1,0.769,0.192,0.021836,DTO_05007542,Transcription factor,C0334488,Clear cell sarcoma of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2016.0,ALL
153579,BTNL9,Q6UXG8,0.89,0.192,7.8754e-14,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
153642,ARSK,Q6UWY0,,,3.9395e-10,,,C0085078,Lysosomal Storage Diseases,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
153733,CCDC112,Q8NEF3,1.0,0.038,0.84869,,,C0007124,Noninfiltrating Intraductal Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
153768,PRELID2,Q8N945,,,6.6487e-09,,,C0202252,VITAMIN B12 MEASUREMENT,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
153769,SH3RF2,Q8TEC5,1.0,0.038,1.2714e-13,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
153770,PLAC8L1,A1L4L8,1.0,0.038,0.0083287,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
153830,RNF145,Q96MT1,1.0,0.038,0.98031,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
153918,ZC2HC1B,Q5TFG8,,,2.5401e-09,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
153932,SRP72P2,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
154043,CNKSR3,Q6P9H4,0.751,0.615,0.028166,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
154064,RAET1L,Q5VY80,0.931,0.077,2.4837e-10,,,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2010.0,2010.0,ALL
154089,LINC01312,,0.931,0.077,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
154091,SLC2A12,Q8TD20,0.729,0.5,5.551e-05,DTO_05007405,Transporter,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
154092,LINC01010,,0.821,0.231,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
154141,MBOAT1,Q6ZNC8,0.931,0.115,2.1535e-12,DTO_05007624,Enzyme,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
154197,PNLDC1,Q8NA58,,,2.1216e-14,DTO_05007557,Nucleic acid binding,C0001723,"Affective Disorders, Psychotic",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
154214,RNF217,Q8TC41,0.839,0.115,2.0177e-05,DTO_05007624,Enzyme,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
154215,NKAIN2,Q5VXU1,0.716,0.462,0.023684,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
154288,KHDC3L,Q587J8,0.76,0.115,0.12327,,,C0678213,Complete hydatidiform mole,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.52,1.0,,2011.0,2014.0,ALL
154386,LINC01600,Q96MT4,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
154467,CCDC167,Q9P0B6,0.931,0.115,4.6515e-07,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
154661,RUNDC3B,Q96NL0,0.931,0.115,0.00093163,,,C0429087,Electrocardiogram: P-R interval,,,phenotype,Finding,0.1,1.0,,2013.0,2013.0,ALL
154664,ABCA13,Q86UQ4,0.722,0.308,8.7753e-114,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2009.0,2017.0,ALL
154754,PRSS3P2,Q8NHM4,0.805,0.385,,DTO_05007624,Enzyme,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
154791,FMC1,Q96HJ9,0.861,0.077,0.012631,,,C0030569,Secondary Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
154796,AMOT,Q4VCS5,0.641,0.538,0.99666,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
154807,VKORC1L1,Q8N0U8,0.861,0.154,0.84443,DTO_05007624,Enzyme,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
154810,AMOTL1,Q8IY63,0.736,0.423,0.0018316,,,C3495676,Anorectal Malformations,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",group,Anatomical Abnormality,0.3,1.0,,2013.0,2013.0,ALL
154822,LINC00689,,0.931,0.115,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
154860,FEZF1-AS1,,0.644,0.615,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0,,2017.0,2019.0,ALL
154865,IQUB,Q8NA54,0.861,0.115,1.7274e-14,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
154881,KCTD7,Q96MP8,0.65,0.423,0.00063083,DTO_05007584,Enzyme modulator,C2673257,"EPILEPSY, PROGRESSIVE MYOCLONIC 3",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.71,1.0,,1990.0,2018.0,ALL
155006,TMEM213,A2RRL7,1.0,0.115,0.086669,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
155038,GIMAP8,Q8ND71,,,7.1512e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
155061,ZNF746,Q6NUN9,0.792,0.269,0.65205,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2014.0,2019.0,ALL
155184,SLC2A7,Q6PXP3,0.931,0.077,5.5393e-21,DTO_05007405,Transporter,C0021828,Intestinal Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
155185,AMZ1,Q400G9,0.821,0.154,3.7114e-23,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2016.0,2019.0,ALL
155370,SBDSP1,,0.89,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2017.0,ALL
155382,VPS37D,Q86XT2,,,0.91622,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
155435,RBM33,Q96EV2,0.89,0.231,1.0,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
155465,AGR3,Q8TD06,0.691,0.308,2.2088e-19,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,2012.0,2020.0,ALL
157285,PRAG1,Q86YV5,0.931,0.154,1.6825e-35,DTO_03300101,Kinase,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
157310,PEBP4,Q96S96,0.711,0.577,4.575e-05,DTO_05007584,Enzyme modulator,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
157313,CDCA2,Q69YH5,0.751,0.192,1.5175e-11,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
157317,CYCSP55,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
157376,FER1L6-AS2,Q96M78,0.89,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
157378,TMEM65,Q6PI78,0.931,0.192,0.11083,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
157381,LINC00964,,0.839,0.269,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
157489,SDAD1P1,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
157506,RDH10,Q8IZV5,0.805,0.269,0.98594,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
157567,ANKRD46,Q86W74,1.0,0.077,0.51507,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
157570,ESCO2,Q56NI9,0.581,0.615,3.1642e-07,,,C0392475,Roberts-SC phocomelia syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,1.0,,1979.0,2019.0,ALL
157574,FBXO16,Q8IX29,0.861,0.038,4.6108e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
157627,LINC00599,,0.76,0.192,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
157638,LRATD2,Q96KN1,0.751,0.269,0.00036638,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
157657,C8orf37,Q96NL8,0.628,0.538,2.3711e-05,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.95,1.0,strong,2012.0,2016.0,ALL
157680,VPS13B,Q7Z7G8,0.579,0.769,2.5029e-45,,,C0265223,Cohen syndrome,C23;C16;C18;C11;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Eye Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Congenital Abnormality,0.8,1.0,,1994.0,2020.0,ALL
157695,TDRP,Q86YL5,1.0,0.038,1.5111e-09,,,C0344395,Bilirubin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
157697,ERICH1,Q86X53,0.931,0.192,1.1389e-14,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
157724,SLC7A13,Q8TCU3,0.769,0.192,1.483e-13,DTO_05007405,Transporter,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
157739,TDH,Q8IZJ6,0.931,0.077,,DTO_05007624,Enzyme,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.02,1.0,,2000.0,2006.0,ALL
157753,TMEM74,Q96NL1,0.792,0.192,0.00034376,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
157807,CLVS1,Q8IUQ0,0.792,0.308,0.85398,DTO_05007405,Transporter,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
157848,NKX6-3,A6NJ46,0.931,0.115,0.016469,DTO_05007542,Transcription factor,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
157855,KCNU1,A8MYU2,1.0,0.077,2.7854e-16,DTO_01300327,Ion channel,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
157869,SBSPON,Q8IVN8,0.931,0.077,6.7083e-06,,,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
157922,CAMSAP1,Q5T5Y3,0.821,0.231,0.99985,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
158035,LINC00032,P0C843,0.839,0.077,,DTO_05007624,Enzyme,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
158038,LINGO2,Q7L985,0.674,0.615,0.85665,DTO_05007575,Receptor,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
158056,MAMDC4,Q6UXC1,0.931,0.115,1.3953e-51,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
158067,AK8,Q96MA6,0.931,0.077,2.0053e-11,DTO_03300101,Kinase,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.2,1.0,,2012.0,2012.0,ALL
158135,TTLL11,Q8NHH1,0.931,0.077,6.2403e-09,DTO_05007624,Enzyme,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
158158,RASEF,Q8IZ41,0.821,0.154,2.2309e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2005.0,2014.0,ALL
158172,SERPINH1P1,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2019.0,2019.0,ALL
158219,TTC39B,Q5VTQ0,0.89,0.154,2.179e-15,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
158228,FAM201A,Q5SY85,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
158257,LINC02603,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
158293,FAM120AOS,Q5T036,0.861,0.154,0.022322,,,C0010495,Cutis Laxa,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
158297,SAXO1,Q8IYX7,0.89,0.115,2.3001e-21,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
158314,LINC00475,,0.931,0.115,,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
158326,FREM1,Q5H8C1,0.633,0.423,1.5685e-52,,,C1855425,Marles Greenberg Persaud syndrome,C16;C11;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.75,0.875,,2001.0,2017.0,ALL
158358,KIAA2026,Q5HYC2,1.0,0.077,0.65923,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
158376,SPAAR,A0A1B0GVQ0,0.711,0.385,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
158399,ZNF483,Q8TF39,,,0.96736,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
158401,SHOC1,Q5VXU9,0.78,0.385,3.7079e-22,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
158405,KIAA1958,Q8N8K9,0.931,0.115,0.011171,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
158452,ASS1P3,,0.931,0.115,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
158471,PRUNE2,Q8WUY3,0.716,0.346,4.9601e-28,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
158506,CBLL2,Q8N7E2,0.476,0.808,,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.938,,2005.0,2019.0,ALL
158511,CSAG1,Q6PB30,1.0,0.038,0.003607,,,C0008479,Chondrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
158521,FMR1NB,Q8N0W7,0.861,0.154,0.081815,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2016.0,2018.0,ALL
158584,FAAH2,Q6GMR7,0.821,0.115,1.8917e-21,DTO_05007624,Enzyme,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
158747,MOSPD2,Q8NHP6,0.89,0.077,0.99105,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
158763,ARHGAP36,Q6ZRI8,0.89,0.038,0.87324,DTO_05007530,Cellular structure,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2014.0,2016.0,ALL
158800,RHOXF1,Q8NHV9,0.931,0.077,0.77494,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
158809,MAGEB6,Q8N7X4,0.76,0.115,,DTO_05007620,Cell adhesion,C0007113,Rectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2007.0,2019.0,ALL
158833,AWAT1,Q58HT5,0.861,0.269,0.00026614,DTO_05007624,Enzyme,C0011175,Dehydration,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
158835,AWAT2,Q6E213,0.89,0.269,0.18858,DTO_05007624,Enzyme,C0023240,Legionellosis,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
158866,ZDHHC15,Q96MV8,0.792,0.269,0.83968,,,C1845142,"MENTAL RETARDATION, X-LINKED 91 (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,limited,2005.0,2005.0,ALL
158880,USP51,Q70EK9,0.861,0.115,0.12613,DTO_05007624,Enzyme,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
158983,H2BW1,Q7Z2G1,0.931,0.038,0.0024619,DTO_05007557,Nucleic acid binding,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.04,1.0,,2009.0,2018.0,ALL
159119,HSFY2,Q96LI6,0.805,0.115,,DTO_05007542,Transcription factor,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
159195,USP54,Q70EL1,0.861,0.154,3.3877e-11,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
159296,NKX2-3,Q8TAU0,0.716,0.231,0.95047,DTO_05007542,Transcription factor,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.4,1.0,,2008.0,2014.0,ALL
159371,SLC35G1,Q2M3R5,0.615,0.654,0.16174,DTO_05007405,Transporter,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0,,1985.0,2017.0,ALL
159963,SLC5A12,Q1EHB4,0.861,0.192,8.5695e-07,DTO_05007405,Transporter,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
159989,DEUP1,Q05D60,0.716,0.231,8.1904e-13,DTO_05007530,Cellular structure,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
160065,PATE1,Q8WXA2,0.89,0.077,7.3818e-09,,,C0403823,Asthenozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,2015.0,2016.0,ALL
160140,C11orf65,Q8NCR3,0.67,0.462,2.0163e-14,,,C0004135,Ataxia Telangiectasia,C16;C18;C20;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,1953.0,2018.0,ALL
160335,TMTC2,Q8N394,0.76,0.269,0.022549,,,C0011053,Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Finding,0.5,1.0,,2016.0,2016.0,ALL
160364,CLEC12A,Q5QGZ9,0.686,0.346,2.6022e-07,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.32,0.667,,2007.0,2016.0,ALL
160365,CLECL1,Q8IZS7,1.0,0.077,0.25929,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
160418,TMTC3,Q6ZXV5,0.636,0.538,4.6335e-05,,,C4310646,LISSENCEPHALY 8,,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2016.0,ALL
160419,C12orf50,Q8NA57,,,4.7252e-07,DTO_05007557,Nucleic acid binding,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
160428,ALDH1L2,Q3SY69,0.821,0.115,1.7337e-17,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2015.0,2015.0,ALL
160492,LMNTD1,Q8N9Z9,0.931,0.115,1.093e-10,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.3,1.0,,2004.0,2004.0,ALL
160518,DENND5B,Q6ZUT9,0.792,0.115,1.0,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
160622,GRASP,Q7Z6J2,0.805,0.231,0.90123,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,0.667,,2011.0,2019.0,ALL
160728,SLC5A8,Q8N695,0.615,0.577,4.9955e-16,DTO_05007405,Transporter,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.38,1.0,,2003.0,2017.0,ALL
160760,PPTC7,Q8NI37,0.839,0.077,0.93813,DTO_05007624,Enzyme,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
160762,CCDC63,Q8NA47,0.861,0.192,5.2679e-19,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
160777,CCDC60,Q8IWA6,0.931,0.154,7.7084e-10,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2009.0,2009.0,ALL
160851,DGKH,Q86XP1,0.678,0.346,0.026429,DTO_03300101,Kinase,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,1.0,,2008.0,2019.0,ALL
160857,CCDC122,Q5T0U0,0.931,0.077,3.7759e-06,,,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.12,1.0,,2009.0,2016.0,ALL
160897,GPR180,Q86V85,0.751,0.231,4.0903e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
161003,STOML3,Q8TAV4,0.743,0.423,2.5754e-14,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2005.0,2019.0,ALL
161142,FAM71D,Q8N9W8,1.0,0.038,,,,C0403823,Asthenozoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
161145,TMEM229B,Q8NBD8,0.931,0.115,0.13003,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
161159,ACTN1-AS1,,,,,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
161176,SYNE3,Q6ZMZ3,0.931,0.115,1.7571e-25,,,C0202022,Follicle stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
161198,CLEC14A,Q86T13,0.769,0.308,1.4324e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,0.833,,2012.0,2019.0,ALL
161247,FITM1,A5D6W6,0.89,0.192,0.00025936,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2014.0,2019.0,ALL
161253,REM2,Q8IYK8,,,1.0585e-05,,,C0027686,Pathologic Neovascularization,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0,,2008.0,2008.0,ALL
161291,TMEM30B,Q3MIR4,0.821,0.154,2.7589e-05,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2006.0,2006.0,ALL
161357,MDGA2,Q7Z553,0.76,0.308,0.66457,,,C1842981,NEUROTICISM,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2008.0,2011.0,ALL
161394,SAMD15,Q9P1V8,,,1.2383e-10,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
161424,NOP9,Q86U38,0.839,0.077,1.6985e-11,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.5,1.0,,2008.0,2008.0,ALL
161436,EML5,Q05BV3,0.821,0.231,5.7122e-07,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2009.0,2011.0,ALL
161497,STRC,Q7RTU9,0.7,0.192,1.7748e-15,DTO_05007621,Extracellular structure,C1863561,"Deafness, Autosomal Recessive 16",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.83,1.0,strong,2001.0,2018.0,ALL
161502,CFAP161,Q6P656,1.0,0.077,0.016334,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
161514,TBC1D21,Q8IYX1,1.0,0.038,3.1602e-07,DTO_05007624,Enzyme,C0206368,Exfoliation Syndrome,C11,   Eye Diseases,disease,Disease or Syndrome,0.11,1.0,,2014.0,2014.0,ALL
161582,DNAAF4,Q8WXU2,0.623,0.731,9.7181e-10,,,C3809641,"CILIARY DYSKINESIA, PRIMARY, 25",,,disease,Disease or Syndrome,0.8,1.0,,2013.0,2013.0,ALL
161725,OTUD7A,Q8TE49,0.792,0.308,0.95249,DTO_05007624,Enzyme,C2677613,Chromosome 15q13.3 Microdeletion Syndrome,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Congenital Abnormality,0.2,1.0,,2018.0,2018.0,ALL
161742,SPRED1,Q7Z699,0.644,0.577,0.97246,DTO_05007575,Receptor,C1969623,"NEUROFIBROMATOSIS, TYPE 1-LIKE SYNDROME",C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.8,0.963,definitive,2005.0,2019.0,ALL
161779,PGBD4,Q96DM1,1.0,0.038,0.33709,,,C0038663,Suicide attempt,F01,   Behavior and Behavior Mechanisms,phenotype,Injury or Poisoning,0.1,1.0,,2019.0,2019.0,ALL
161829,EXD1,Q8NHP7,1.0,0.077,6.4033e-14,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
161835,FSIP1,Q8NA03,0.663,0.615,7.6972e-14,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,0.923,,2002.0,2019.0,ALL
161882,ZFPM1,Q8IX07,0.736,0.385,0.2429,DTO_05007542,Transcription factor,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.11,1.0,,2015.0,2017.0,ALL
161931,ADAD2,Q8NCV1,1.0,0.077,2.3904e-12,DTO_05007624,Enzyme,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
162083,C16orf82,Q7Z2V1,0.743,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,1998.0,2019.0,ALL
162239,ZFP1,Q6P2D0,0.931,0.077,0.013918,,,C0010414,Infection by Cryptococcus neoformans,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
162282,ANKFN1,Q8N957,0.89,0.154,2.0906e-10,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
162333,MARCHF10,Q8NA82,0.716,0.5,3.2957e-24,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
162394,SLFN5,Q08AF3,0.7,0.269,1.7046e-12,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
162417,NAGS,Q8N159,0.716,0.423,4.0325e-08,,,C0268543,"Hyperammonemia, type III",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.76,1.0,definitive,1971.0,2018.0,ALL
162427,RETREG3,Q86VR2,0.792,0.077,0.13001,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2015.0,2015.0,ALL
162461,TMEM92,Q6UXU6,0.89,0.038,0.0063256,,,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
162466,PHOSPHO1,Q8TCT1,0.839,0.269,0.51421,DTO_05007624,Enzyme,C0005944,Metabolic Bone Disorder,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,group,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
162494,RHBDL3,P58872,1.0,0.077,1.0358e-07,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
162514,TRPV3,Q8NET8,0.61,0.577,4.6013e-20,DTO_01300327,Ion channel,C2609071,Olmsted syndrome,,,disease,Disease or Syndrome,0.8,1.0,,2012.0,2019.0,ALL
162515,SLC16A11,Q8NCK7,0.861,0.115,4.9198e-06,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.2,0.933,,2014.0,2019.0,ALL
162517,FBXO39,Q8N4B4,0.792,0.115,6.7347e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
162540,SPPL2C,Q8IUH8,0.76,0.192,0.00018192,DTO_05007624,Enzyme,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
162632,USP32P1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
162681,C18orf54,Q8IYD9,0.931,0.038,1.8657e-06,,,C0024121,Lung Neoplasms,C04;C08,   Neoplasms;    Respiratory Tract Diseases,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
162699,ELOA3,Q3SY89;Q8NG57,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2016.0,ALL
162963,ZNF610,Q8N9Z0,1.0,0.038,0.00010546,,,C0850666,Infection caused by Helicobacter pylori,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
162966,ZNF600,Q6ZNG1,,,,,,C0202177,Phospholipid measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
162979,ZNF296,Q8WUU4,0.769,0.115,0.95906,DTO_05007542,Transcription factor,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
162993,ZNF846,Q147U1,1.0,0.077,1.2532e-06,DTO_05007542,Transcription factor,C0020445,"Hypercholesterolemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
163049,ZNF791,Q3KP31,1.0,0.077,0.13394,DTO_05007557,Nucleic acid binding,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
163059,ZNF433,Q8N7K0,0.89,0.154,0.012227,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2010.0,2010.0,ALL
163087,ZNF383,Q8NA42,0.931,0.077,3.6577e-11,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
163131,ZNF780B,Q9Y6R6,1.0,0.038,0.0032592,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
163175,LGI4,Q8N135,0.678,0.308,0.0071501,,,C4479539,"ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT",,,disease,Disease or Syndrome,0.7,1.0,,2006.0,2017.0,ALL
163183,SYNE4,Q8N205,0.861,0.115,4.188e-12,,,C3147083,"DEAFNESS, AUTOSOMAL RECESSIVE 76",,,disease,Disease or Syndrome,0.6,1.0,strong,2018.0,2018.0,ALL
163223,ZNF676,Q8N7Q3,1.0,0.038,0.18308,,,C0040128,Thyroid Diseases,C19,   Endocrine System Diseases,group,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
163255,ZNF540,Q8NDQ6,1.0,0.077,0.39014,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
163351,GBP6,Q6ZN66,0.861,0.115,5.233e-16,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2019.0,2019.0,ALL
163404,PLPPR5,Q32ZL2,0.89,0.115,0.0593,DTO_05007624,Enzyme,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
163486,DENND1B,Q6P3S1,0.716,0.308,0.20408,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.4,1.0,,2011.0,2015.0,ALL
163589,TDRD5,Q8NAT2,0.931,0.154,0.97247,DTO_05007624,Enzyme,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
163590,TOR1AIP2,Q8NFQ8;Q9H496,,,3.2484e-09,,,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.02,1.0,,2009.0,2009.0,ALL
163688,CALML6,Q8TD86,0.931,0.077,2.6089e-08,DTO_05007616,Calcium-binding protein,C0006111,Brain Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
163702,IFNLR1,Q8IU57,0.647,0.615,0.062532,DTO_05007575,Receptor,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.33,1.0,,2010.0,2019.0,ALL
163720,CYP4Z2P,Q8N1L4,0.89,0.077,,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,1.0,,2004.0,2020.0,ALL
163732,CITED4,Q96RK1,0.711,0.269,0.34638,DTO_05007542,Transcription factor,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2004.0,2016.0,ALL
163747,LEXM,Q3ZCV2,0.821,0.269,2.1352e-13,,,C0268238,Triglyceride storage disease with ichthyosis,C16;C18;C17;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
163782,KANK4,Q5T7N3,0.839,0.269,2.0713e-09,,,C0016781,Fuchs Endothelial Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
163786,SASS6,Q6UVJ0,0.691,0.423,1.7379e-07,,,C4225338,"MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE",,,disease,Disease or Syndrome,0.7,1.0,moderate,2014.0,2014.0,ALL
163882,CNST,Q6PJW8,,,1.238e-06,,,C0040128,Thyroid Diseases,C19,   Endocrine System Diseases,group,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
163933,FAM43B,Q6ZT52,1.0,0.077,0.10664,DTO_05007599,Signaling,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
164045,HFM1,A2PYH4,0.659,0.615,4.7342e-32,,,C3810376,PREMATURE OVARIAN FAILURE 9,,,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2016.0,ALL
164091,PAQR7,Q86WK9,0.711,0.308,0.00028797,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
164118,TTC24,A2A3L6,,,2.3067e-08,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
164153,UBL4B,Q8N7F7,1.0,0.115,0.030024,,,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
164312,LRRN4,Q8WUT4,0.931,0.115,1.2137e-09,DTO_05007575,Receptor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
164380,CST13P,,1.0,0.077,,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
164395,TTLL9,Q3SXZ7,0.861,0.154,3.1982e-18,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
164592,CCDC116,Q8IYX3,0.861,0.115,3.9339e-06,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
164656,TMPRSS6,Q8IU80,0.584,0.654,4.1369e-10,DTO_05007624,Enzyme,C0085576,Iron-Refractory Iron Deficiency Anemia,C18;C15,   Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.8,1.0,,2008.0,2019.0,ALL
164668,APOBEC3H,Q6NTF7,0.805,0.154,0.00202,DTO_05007624,Enzyme,C2363741,HIV-1 infection,,,disease,Disease or Syndrome,0.06,1.0,,2011.0,2018.0,ALL
164684,WBP2NL,Q6ICG8,0.805,0.115,8.182e-08,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
164714,TTLL8,A6PVC2,1.0,0.077,7.2171e-15,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
164781,DAW1,Q8N136,0.861,0.231,1.0715e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
164832,LONRF2,Q1L5Z9,1.0,0.077,0.0011706,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
165082,ADGRF3,Q8IZF5,0.931,0.038,1.1879e-22,DTO_02300001,G-protein coupled receptor,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
165140,OXER1,Q8TDS5,0.529,0.923,7.3192e-08,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
165186,TOGARAM2,Q6ZUX3,1.0,0.077,1.31e-16,DTO_05007530,Cellular structure,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2013.0,2013.0,ALL
165215,FAM171B,Q6P995,0.89,0.077,0.48535,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
165257,C1QL2,Q7Z5L3,1.0,0.077,0.035707,,,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2020.0,2020.0,ALL
165324,UBXN2A,P68543,0.861,0.077,1.3932e-06,DTO_05007405,Transporter,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
165530,CLEC4F,Q8N1N0,1.0,0.077,3.0707e-14,DTO_05007575,Receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
165545,DQX1,Q8TE96,1.0,0.077,5.0034e-20,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
165631,PARP15,Q460N3,0.89,0.077,6.7366e-09,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2013.0,2016.0,ALL
165679,SPTSSB,Q8NFR3,1.0,0.038,0.00086955,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
165721,DNAJB8,Q8NHS0,0.861,0.192,0.095207,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
165904,XIRP1,Q702N8,0.78,0.269,2.2682e-30,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
165918,RNF168,Q8IYW5,0.653,0.731,2.0514e-13,,,C2677792,Riddle Syndrome,C23;C16;C05;C20;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Immune System Diseases;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.97,1.0,,2007.0,2017.0,ALL
166012,CHST13,Q8NET6,0.861,0.115,0.0001213,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
166336,PRICKLE2,Q7Z3G6,0.711,0.423,0.99544,DTO_05007530,Cellular structure,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
166378,SPATA5,Q8NB90,0.67,0.654,9.0776e-20,,,C4225276,"EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME",,,disease,Disease or Syndrome,0.71,1.0,,2015.0,2017.0,ALL
166379,BBS12,Q6ZW61,0.674,0.462,2.3352e-07,,,C1859570,BARDET-BIEDL SYNDROME 12,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2007.0,2014.0,ALL
166614,DCLK2,Q8N568,0.931,0.077,0.95706,DTO_03300101,Kinase,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
166647,ADGRA3,Q8IWK6,0.839,0.115,0.29336,DTO_02300001,G-protein coupled receptor,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
166655,TRIM60,Q495X7,1.0,0.038,,,,C0201512,Thyroglobulin antibody measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
166752,FREM3,P0C091,0.805,0.269,1.5219e-19,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.51,1.0,,2012.0,2015.0,ALL
166785,MMAA,Q8IVH4,0.743,0.346,9.3982e-13,,,C1855109,Methylmalonic aciduria cblA type,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2002.0,2017.0,ALL
166793,ZBTB49,Q6ZSB9,,,1.3752e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
166824,RASSF6,Q6ZTQ3,0.626,0.654,2.7376e-26,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2009.0,2019.0,ALL
166863,RBM46,Q8TBY0,,,0.47301,,,C0018965,Hematuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
166929,SGMS2,Q8NHU3,0.653,0.538,0.056938,,,C1852022,"Doughnut Lesions of Skull, Familial",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.4,1.0,,2019.0,2019.0,ALL
166968,MIER3,Q7Z3K6,0.861,0.115,0.99856,DTO_05007557,Nucleic acid binding,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2012.0,2017.0,ALL
166979,CDC20B,Q86Y33,1.0,0.038,5.1167e-12,DTO_05007584,Enzyme modulator,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2017.0,ALL
167127,UGT3A2,Q3SY77,1.0,0.077,7.1897e-10,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
167153,TENT2,Q6PIY7,0.931,0.115,8.6949e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
167359,NIM1K,Q8IY84,1.0,0.077,2.9002e-12,DTO_03300101,Kinase,C0345958,Large cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
167410,LIX1,Q8N485,0.861,0.115,0.0019611,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2006.0,2010.0,ALL
167465,ZNF366,Q8N895,0.729,0.423,0.070315,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.55,1.0,,2010.0,2019.0,ALL
167681,PRSS35,Q8N3Z0,0.861,0.269,3.28e-10,DTO_05007624,Enzyme,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
167691,LCA5,Q86VQ0,0.674,0.269,4.0606e-05,,,C1858301,LEBER CONGENITAL AMAUROSIS 5,C11,   Eye Diseases,disease,Disease or Syndrome,0.91,1.0,,2007.0,2017.0,ALL
167826,OLIG3,Q7RTU3,0.861,0.192,0.83391,DTO_05007624,Enzyme,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.05,1.0,,2007.0,2018.0,ALL
168002,DACT2,Q5SW24,0.644,0.385,0.0094032,,,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2013.0,2014.0,ALL
168330,PRSS3P1,,1.0,0.077,,,,C0376670,"Pancreatitis, Alcoholic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
168374,ZNF92,Q03936,0.839,0.154,6.2887e-05,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2014.0,ALL
168391,GALNTL5,Q7Z4T8,0.931,0.115,3.5947e-16,DTO_05007624,Enzyme,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
168400,DDX53,Q86TM3,0.568,0.846,0.66167,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
168417,ZNF679,Q8IYX0,1.0,0.115,0.17547,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
168451,THAP5,Q7Z6K1,0.931,0.077,8.6157e-06,,,C0018799,Heart Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
168455,CCDC71L,Q8N9Z2,,,0.57806,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
168507,PKD1L1,Q8TDX9,0.729,0.231,1.0852e-40,DTO_01300327,Ion channel,C4310668,"HETEROTAXY, VISCERAL, 8, AUTOSOMAL",,,disease,Disease or Syndrome,0.7,1.0,,2016.0,2016.0,ALL
168537,GIMAP7,Q8NHV1,0.89,0.231,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
168620,BHLHA15,Q7RTS1,0.691,0.462,0.0065801,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,0.8,,2016.0,2019.0,ALL
168667,BMPER,Q8N8U9,0.641,0.577,6.5881e-07,DTO_05007584,Enzyme modulator,C1842691,Diaphanospondylodysostosis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.73,1.0,strong,2010.0,2019.0,ALL
168850,ZNF800,Q2TB10,0.931,0.077,0.99985,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
169026,SLC30A8,Q8IWU4,0.623,0.731,7.4306e-12,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.5,0.963,,2007.0,2019.0,ALL
169044,COL22A1,Q8NFW1,0.792,0.385,4.4899e-45,DTO_05007621,Extracellular structure,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
169166,SNX31,Q8N9S9,0.931,0.077,3.6683e-13,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
169200,TMEM64,Q6YI46,0.931,0.077,0.49005,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
169270,ZNF596,Q8TC21,0.89,0.115,1.8321e-13,DTO_05007542,Transcription factor,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
169355,IDO2,Q6ZQW0,0.695,0.577,3.1422e-09,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2009.0,2019.0,ALL
169436,STKLD1,Q8NE28,0.931,0.115,1.5666e-23,DTO_03300101,Kinase,C1621958,Glioblastoma Multiforme,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
169522,KCNV2,Q8TDN2,0.736,0.115,1.1944e-26,DTO_01300327,Ion channel,C1835897,Retinal Cone Dystrophy 3B,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.74,1.0,limited,2006.0,2013.0,ALL
169611,OLFML2A,Q68BL7,0.931,0.154,1.2885e-09,DTO_05007530,Cellular structure,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
169693,TMEM252,Q8N6L7,,,0.19897,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
169714,QSOX2,Q6ZRP7,0.89,0.077,9.8463e-08,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
169792,GLIS3,Q8NEA6,0.59,0.654,5.5977e-08,,,C1857775,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",C16;C18;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.9,1.0,,2003.0,2009.0,ALL
169834,ZNF883,P0CG24,1.0,0.115,,,,C0278689,Recurrent ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
169841,ZNF169,Q14929,0.931,0.154,9.5983e-12,DTO_05007542,Transcription factor,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.31,1.0,,2018.0,2018.0,ALL
169966,TENT5D,Q8NEK8,1.0,0.154,0.83028,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
169981,SPIN3,Q5JUX0,0.931,0.077,0.77837,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
170082,TCEANC,Q8N8B7,,,0.051926,DTO_05007557,Nucleic acid binding,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
170261,ZCCHC12,Q6PEW1,0.78,0.308,0.04647,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
170302,ARX,Q96QS3,0.516,0.654,0.90814,,,C0393706,Early infantile epileptic encephalopathy with suppression bursts,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.78,0.944,definitive,2007.0,2018.0,ALL
170384,FUT11,Q495W5,0.769,0.231,1.7598e-06,DTO_05007624,Enzyme,C0374997,Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site,,,disease,Disease or Syndrome,0.04,1.0,,2017.0,2019.0,ALL
170392,OIT3,Q8WWZ8,0.821,0.154,3.392e-11,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2003.0,2017.0,ALL
170394,PWWP2B,Q6NUJ5,0.931,0.115,0.8409,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
170425,LINC00858,,0.792,0.115,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
170463,SSBP4,Q9BWG4,1.0,0.077,0.37022,,,C0200637,Monocyte count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
170474,HFM,,0.722,0.385,,,,C3495417,Hemifacial microsomia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,1.0,,2001.0,2019.0,ALL
170482,CLEC4C,Q8WTT0,0.678,0.5,5.7708e-07,DTO_05007575,Receptor,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0,,2013.0,2017.0,ALL
170506,DHX36,Q9H2U1,0.931,0.077,0.47221,DTO_05007624,Enzyme,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2019.0,ALL
170508,DFNB33,,,,,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
170532,OTSC3,,0.931,0.038,,,,C0029899,Otosclerosis,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
170534,PARK10,,0.89,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,0.917,,2005.0,2020.0,ALL
170555,TPM3P2,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
170572,HTR3C,Q8WXA8,0.769,0.192,2.5562e-10,DTO_01300327,Ion channel,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2009.0,2009.0,ALL
170575,GIMAP1,Q8WWP7,1.0,0.077,0.40351,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
170589,GPHA2,Q96T91,0.89,0.154,1.4418e-08,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
170591,S100Z,Q8WXG8,1.0,0.038,0.01321,DTO_05007616,Calcium-binding protein,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
170595,IBD8,,,,,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
170622,COMMD6,Q7Z4G1,0.89,0.077,0.17236,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
170626,XAGE3,Q8WTP9,0.89,0.077,0.094852,,,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2014.0,2018.0,ALL
170679,PSORS1C1,Q9UIG5,0.656,0.731,0.00026534,,,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.42,1.0,,2011.0,2013.0,ALL
170680,PSORS1C2,Q9UIG4,0.769,0.308,0.0024913,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.4,1.0,,2013.0,2013.0,ALL
170682,SLEH1,,0.931,0.115,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2002.0,2002.0,ALL
170685,NUDT10,Q8NFP7,0.705,0.423,0.1065,DTO_05007624,Enzyme,C0271737,Addison's disease due to autoimmunity,C20;C19,   Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.07,0.857,,2000.0,2019.0,ALL
170689,ADAMTS15,Q8TE58,0.769,0.231,1.6672e-06,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2009.0,2009.0,ALL
170690,ADAMTS16,Q8TE57,0.711,0.346,0.00044629,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.22,1.0,,2009.0,2019.0,ALL
170691,ADAMTS17,Q8TE56,0.678,0.385,2.802e-15,DTO_05007624,Enzyme,C2750787,Weill-Marchesani-Like Syndrome,C16;C11;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.75,0.857,strong,2009.0,2019.0,ALL
170692,ADAMTS18,Q8TE60,0.636,0.654,1.0716e-29,DTO_05007624,Enzyme,C3809567,"MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS",,,disease,Disease or Syndrome,0.71,1.0,strong,2013.0,2013.0,ALL
170712,COX7B2,Q8TF08,0.931,0.154,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
170825,GSX2,Q9BZM3,0.861,0.154,0.25702,,,C1862939,AMYOTROPHIC LATERAL SCLEROSIS 1,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2002.0,2002.0,ALL
170850,KCNG3,Q8TAE7,0.89,0.115,0.27167,DTO_01300327,Ion channel,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
170949,DEFT1P,,0.931,0.077,,,,C2363741,HIV-1 infection,,,disease,Disease or Syndrome,0.02,1.0,,2004.0,2009.0,ALL
170954,PPP1R18,Q6NYC8,0.78,0.346,0.00050298,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
170961,ANKRD24,Q8TF21,,,3.2559e-16,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
171013,SLI1,,1.0,0.077,,,,C0454651,Specific language impairment,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0,,2004.0,2010.0,ALL
171014,SLI2,,1.0,0.077,,,,C0454651,Specific language impairment,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2007.0,2010.0,ALL
171017,ZNF384,Q8TF68,0.705,0.269,0.99842,,,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.07,1.0,,2002.0,2018.0,ALL
171019,ADAMTS19,Q8TE59,0.792,0.269,5.9648e-08,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
171022,ABHD11-AS1,,0.722,0.192,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0,,2018.0,2019.0,ALL
171023,ASXL1,Q8IXJ9,0.482,0.808,1.2511e-14,,,C0796232,Bohring syndrome,C23;C16;C05;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.8,0.933,,2011.0,2019.0,ALL
171024,SYNPO2,Q9UMS6,0.743,0.269,8.5623e-08,DTO_05007530,Cellular structure,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.32,1.0,,2015.0,2017.0,ALL
171089,DYX5,,0.861,0.154,,,,C0476254,Dyslexia,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.01,1.0,,2009.0,2009.0,ALL
171157,SHFM5,,0.839,0.115,,,,C1839258,SPLIT-HAND/FOOT MALFORMATION 2,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.02,1.0,,2006.0,2006.0,ALL
171177,RHOV,Q96L33,0.67,0.5,0.76153,DTO_05007584,Enzyme modulator,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,1983.0,2019.0,ALL
171221,DNAJB1P1,,0.65,0.654,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2009.0,2018.0,ALL
171389,NLRP6,P59044,0.628,0.769,0.00027432,,,C0003507,Aortic Valve Stenosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.08,1.0,,2017.0,2019.0,ALL
171392,ZNF675,Q8TD23,1.0,0.038,0.12265,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
171420,HSPE1P28,,1.0,0.077,,,,C0263314,Pemphigus and fogo selvagem,C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,1992.0,1992.0,ALL
171422,CRPP1,,,,,,,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2019.0,ALL
171423,PDIA3P1,,0.839,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
171425,CLYBL,Q8N0X4,0.743,0.5,1.6434e-09,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
171427,CYP2F2P,,,,,,,C0018935,Hematocrit procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
171482,FAM9A,Q8IZU1,1.0,0.038,3.0977e-12,,,C0023267,Fibroid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
171484,FAM9C,Q8IZT9,1.0,0.077,4.8778e-07,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
171511,ADIPQTL2,,,,,,,C1847530,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2",,,phenotype,Finding,0.3,1.0,,2001.0,2001.0,ALL
171512,ADIPQTL3,,0.931,0.077,,,,C1847529,"ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3",,,phenotype,Finding,0.3,1.0,,2001.0,2001.0,ALL
171515,HBFQTL4,,1.0,0.038,,,,C0002874,Aplastic Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
171523,CYP2T1P,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2016.0,2016.0,ALL
171558,PTCRA,Q6ISU1,0.656,0.692,0.14449,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
171568,POLR3H,Q9Y535,0.769,0.346,0.0059858,DTO_05007624,Enzyme,C0685837,"Pure Gonadal Dysgenesis, 46, XX",C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.3,1.0,,2019.0,2019.0,ALL
171586,ABHD3,Q8WU67,,,1.6717e-09,DTO_05007624,Enzyme,C0202177,Phospholipid measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
191585,PLAC4,Q8WY50,0.861,0.192,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.06,1.0,,2007.0,2017.0,ALL
192111,PGAM5,Q96HS1,0.711,0.5,6.4116e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2020.0,ALL
192115,MGR1,,0.821,0.231,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.05,0.8,,2001.0,2017.0,ALL
192134,B3GNT6,Q6ZMB0,0.769,0.269,1.093e-09,DTO_05007624,Enzyme,C0036346,"Schizophrenia, Childhood",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
192142,RLS1,,0.705,0.423,,,,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,0.87,,2006.0,2019.0,ALL
192286,HIGD2A,Q9BW72,0.931,0.077,0.19087,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
192644,DFNA21,,1.0,0.115,,,,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
192668,CYS1,Q717R9,0.792,0.308,0.10934,,,C0085548,Autosomal Recessive Polycystic Kidney Disease,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.21,1.0,,1982.0,2009.0,ALL
192669,AGO3,Q9H9G7,0.839,0.154,0.99997,,,C0004763,Barrett Esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
192670,AGO4,Q9HCK5,0.931,0.077,0.9999,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
192677,SLEN1,,1.0,0.077,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,0.0,,2002.0,2002.0,ALL
192679,SLEN2,,1.0,0.077,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,0.0,,2002.0,2002.0,ALL
192683,SCAMP5,Q8TAC9,0.839,0.192,0.65099,DTO_05007624,Enzyme,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2018.0,ALL
195827,PRXL2C,Q7RTV5,0.89,0.115,1.0063e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
195828,ZNF367,Q7RTV3,0.821,0.154,0.90568,DTO_05007557,Nucleic acid binding,C3658266,"Prostatic Cancer, Castration-Resistant",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
195977,ANTXRL,A6NF34,,,3.1476e-08,DTO_05007575,Receptor,C1277709,Transferrin saturation measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
196047,EMX2OS,,0.861,0.231,,,,C1863416,Autosomal dominant compelling helio ophthalmic outburst syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
196051,PLPP4,Q5VZY2,0.805,0.231,0.0001828,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
196074,METTL15,A6NJ78,,,2.7801e-10,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
196264,MPZL3,Q6UWV2,0.821,0.154,2.2417e-14,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
196294,IMMP1L,Q96LU5,0.686,0.5,2.4628e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2005.0,2019.0,ALL
196383,RILPL2,Q969X0,0.89,0.115,0.00389,DTO_05007557,Nucleic acid binding,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
196385,DNAH10,Q8IVF4,0.89,0.154,1.3846e-57,DTO_05007624,Enzyme,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
196394,AMN1,Q8IY45,,,0.32526,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
196403,DTX3,Q8N9I9,0.839,0.115,0.88755,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
196410,METTL7B,Q6UX53,0.792,0.231,0.066221,DTO_05007624,Enzyme,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
196441,ZFC3H1,O60293,0.839,0.115,1.0,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
196446,MYRFL,Q96LU7,,,3.0843e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
196463,PLBD2,Q8NHP8,1.0,0.038,1.7226e-11,DTO_05007624,Enzyme,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
196475,RMST,,0.769,0.385,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,1.0,,2013.0,2013.0,ALL
196477,CCER1,Q8TC90,1.0,0.038,4.1961e-05,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
196500,PIANP,Q8IYJ0,0.931,0.038,0.37791,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,1.0,,2019.0,2019.0,ALL
196513,DCP1B,Q8IZD4,0.792,0.269,1.6028e-10,DTO_05007542,Transcription factor,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
196527,ANO6,Q4KMQ2,0.736,0.423,7.3158e-32,DTO_01300327,Ion channel,C0796149,Scott Syndrome,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.66,0.889,strong,2010.0,2019.0,ALL
196528,ARID2,Q68CP9,0.543,0.808,1.0,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.6,0.923,,2011.0,2018.0,ALL
196541,METTL21C,Q5VZV1,0.89,0.154,1.0629e-06,,,C0678909,Brain Waves,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
196740,VSTM4,Q8IW00,0.931,0.115,0.033816,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
196743,PAOX,Q6QHF9,0.729,0.462,4.8573e-09,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
196792,FAM24B,Q8N5W8,,,0.088274,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
196872,LINC00638,,0.931,0.154,,,,C0221775,Lumbar disc disease,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
196883,ADCY4,Q8NFM4,0.839,0.154,1.0791e-18,,,C0151526,Premature Birth,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,1.0,,2018.0,2018.0,ALL
196951,FAM227B,Q96M60,0.792,0.154,4.3472e-23,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
196993,CT62,P0C5K7,0.931,0.077,0.016698,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
196996,GRAMD2A,Q8IUY3,,,3.4911e-13,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
197021,LCTL,Q6UWM7,0.931,0.038,9.6021e-20,DTO_05007624,Enzyme,C0409959,"Osteoarthritis, Knee",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
197131,UBR1,Q8IWV7,0.612,0.731,0.0054862,,,C0175692,Johanson-Blizzard syndrome,C23;C16;C06;C17;C10;C19;F03;C09;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,1.0,1.0,strong,2002.0,2018.0,ALL
197135,PATL2,C9JE40,1.0,,1.21e-11,DTO_05007557,Nucleic acid binding,C4540284,OOCYTE MATURATION DEFECT 4,,,disease,Disease or Syndrome,0.4,1.0,,2017.0,2017.0,ALL
197187,SNAI3-AS1,,1.0,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
197196,LINC00311,Q8N616,0.89,0.154,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
197257,LDHD,Q86WU2,0.861,0.308,1.3494e-13,DTO_05007624,Enzyme,C1855552,Lactic Aciduria due to D-Lactic Acid,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,1.0,,2019.0,2019.0,ALL
197258,FCSK,Q8N0W3,0.769,0.192,1.0421e-29,DTO_03300101,Kinase,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.4,1.0,moderate,2018.0,2018.0,ALL
197259,MLKL,Q8NB16,0.57,0.731,2.0931e-14,DTO_03300101,Kinase,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
197320,ZNF778,Q96MU6,0.931,0.038,7.1255e-06,DTO_05007542,Transcription factor,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2010.0,2010.0,ALL
197322,ACSF3,Q4G176,0.743,0.308,2.3246e-26,DTO_05007624,Enzyme,C3280314,Combined Malonic and Methylmalonic Aciduria,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,,2011.0,2019.0,ALL
197335,WDR90,Q96KV7,1.0,0.038,1.2637e-64,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
197342,EME2,A4GXA9,0.931,0.115,3.756e-23,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
197358,NLRC3,Q7RTR2,0.769,0.269,2.2317e-25,DTO_05007624,Enzyme,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
197370,NSMCE1,Q8WV22,0.89,0.154,2.1753e-05,,,C1704436,Peripheral Arterial Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
199221,DZIP1L,Q8IYY4,0.769,0.308,2.3897e-25,DTO_05007557,Nucleic acid binding,C0085548,Autosomal Recessive Polycystic Kidney Disease,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.81,0.0,strong,2017.0,2017.0,ALL
199223,TTC21A,Q8NDW8,0.89,0.077,2.8878e-24,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
199675,MCEMP1,Q8IX19,0.89,0.154,0.00014188,,,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
199692,ZNF627,Q7L945,0.861,0.231,0.33124,,,C1842763,SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION,C16;C05;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
199699,DAND5,Q8N907,0.78,0.154,0.0020422,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2017.0,ALL
199704,ZNF585A,Q6P3V2,,,2.7835e-05,DTO_05007542,Transcription factor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
199713,NLRP7,Q8WX94,0.7,0.269,1.8058e-16,,,C0678213,Complete hydatidiform mole,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.56,0.875,,2009.0,2014.0,ALL
199720,GGN,Q86UU5,0.861,0.231,0.0018569,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
199731,CADM4,Q8NFZ8,0.716,0.5,0.99762,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2006.0,2018.0,ALL
199786,NIBAN3,Q86XR2,,,2.2418e-16,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
199800,ADM5,C9JUS6,1.0,0.115,0.39555,DTO_05007599,Signaling,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
199834,LCE4A,Q5TA78,0.89,0.192,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
199857,ALG14,Q96F25,0.722,0.308,0.00093727,,,C4015596,"MYASTHENIC SYNDROME, CONGENITAL, 15",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2017.0,ALL
199899,LINC00466,,0.861,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
199920,FYB2,Q5VWT5,0.931,0.038,1.3041e-41,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
199953,TMEM201,Q5SNT2,0.729,0.346,0.99004,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.04,1.0,,2005.0,2020.0,ALL
199974,CYP4Z1,Q86W10,0.821,0.154,1.8745e-17,DTO_05007624,Enzyme,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2004.0,2020.0,ALL
199990,FAAP20,Q6NZ36,0.89,0.115,0.52558,,,C0429087,Electrocardiogram: P-R interval,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
200008,CDCP2,Q5VXM1,1.0,0.038,9.4718e-11,DTO_05007624,Enzyme,C0201836,Alanine aminotransferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
200010,SLC5A9,Q2M3M2,,,9.2114e-27,DTO_05007405,Transporter,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
200035,NUDT17,P0C025,0.805,0.269,1.1109e-07,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
200081,TXLNA,P40222,0.716,0.385,0.99731,DTO_05007608,Immune response,C1527336,Sjogren's Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.03,1.0,,2009.0,2019.0,ALL
200150,PLD5,Q8N7P1,0.89,0.077,0.030678,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
200159,C1orf100,Q5SVJ3,,,1.2575e-07,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2012.0,2012.0,ALL
200162,SPAG17,Q6Q759,0.769,0.308,1.1892e-24,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
200172,SLFNL1,Q499Z3,,,3.8491e-05,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
200185,KRTCAP2,Q8N6L1,,,0.00035184,,,C0424621,Body Fat Distribution,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
200186,CRTC2,Q53ET0,0.633,0.538,0.99891,DTO_05007542,Transcription factor,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.24,1.0,,2005.0,2019.0,ALL
200197,TMEM51-AS1,,1.0,0.115,,,,C0280324,Laryngeal Squamous Cell Carcinoma,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
200205,IBA57,Q5T440,0.666,0.423,0.0083921,,,C3809165,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3,,,disease,Disease or Syndrome,0.71,1.0,,2013.0,2018.0,ALL
200298,LINC00528,Q8N1L1,0.931,0.154,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
200315,APOBEC3A,P31941,0.612,0.692,0.0010454,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.4,1.0,,2011.0,2019.0,ALL
200316,APOBEC3F,Q8IUX4,0.792,0.154,1.346e-07,DTO_05007624,Enzyme,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.07,0.857,,2006.0,2014.0,ALL
200350,FOXD4L1,Q9NU39,1.0,0.115,0.0076622,DTO_05007542,Transcription factor,C0280324,Laryngeal Squamous Cell Carcinoma,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
200373,CFAP221,Q4G0U5,0.805,0.231,8.7186e-17,,,C0022521,Kartagener Syndrome,C16;C08;C09;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.32,1.0,,2008.0,2020.0,ALL
200403,VWA3B,Q502W6,0.729,0.154,9.7397e-28,,,C4310781,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22",,,disease,Disease or Syndrome,0.4,1.0,,2016.0,2016.0,ALL
200420,ALMS1P1,,1.0,0.077,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2019.0,ALL
200424,TET3,O43151,0.633,0.615,1.0,,,C0026650,Movement Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.3,,,,,ALL
200504,GKN2,Q86XP6,0.769,0.269,0.00023223,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,1992.0,2019.0,ALL
200539,ANKRD23,Q86SG2,0.861,0.154,3.5366e-19,,,C1135196,"Heart Failure, Diastolic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
200558,APLF,Q8IW19,0.78,0.269,1.3266e-18,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
200575,CRYGEP,,0.666,0.538,,,,C0018802,Congestive heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
200576,PIKFYVE,Q9Y2I7,0.722,0.577,1.1074e-06,DTO_03300101,Kinase,C1562113,Fleck corneal dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.75,1.0,strong,2005.0,2015.0,ALL
200634,KRTCAP3,Q53RY4,0.839,0.115,2.078e-05,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
200728,TMEM17,Q86X19,0.743,0.231,0.0094291,,,C0238198,Gastrointestinal Stromal Tumors,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
200734,SPRED2,Q7Z698,0.711,0.577,2.8684e-07,DTO_05007575,Receptor,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,1.0,,2010.0,2019.0,ALL
200765,TIGD1,Q96MW7,0.89,0.077,0.0036808,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
200810,ALG1L,Q6GMV1,0.89,0.077,1.0994e-08,DTO_05007624,Enzyme,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2015.0,2015.0,ALL
200844,C3orf67,Q6ZVT6,0.89,0.192,9.4026e-11,DTO_05007624,Enzyme,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
200845,KCTD6,Q8NC69,0.89,0.038,0.016939,DTO_05007584,Enzyme modulator,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
200879,LIPH,Q8WWY8,0.691,0.346,6.5309e-11,DTO_05007624,Enzyme,C1836672,"Total Hypotrichosis, Mari type",C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2016.0,ALL
200894,ARL13B,Q3SXY8,0.631,0.538,2.6559e-09,,,C2676771,JOUBERT SYNDROME 8 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2017.0,ALL
200895,DHFR2,Q86XF0,0.89,0.154,0.22496,DTO_05007624,Enzyme,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
200909,HTR3D,Q70Z44,0.839,0.077,5.0168e-08,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
200916,RPL22L1,Q6P5R6,0.792,0.231,0.0010477,DTO_05007557,Nucleic acid binding,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
200931,SLC51A,Q86UW1,0.792,0.231,0.069643,DTO_05007405,Transporter,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2006.0,2014.0,ALL
200933,FBXO45,P0C2W1,0.821,0.192,0.97063,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
200942,KLHDC8B,Q8IXV7,0.691,0.346,0.001791,,,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.41,1.0,,2018.0,2018.0,ALL
200958,MUC20,Q8N307,0.729,0.5,0.0047211,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2016.0,2018.0,ALL
200959,GABRR3,A8MPY1,0.89,0.077,,DTO_01300327,Ion channel,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,0.5,,2018.0,2019.0,ALL
201134,CEP112,Q8N8E3,0.931,0.077,7.0861e-39,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
201140,DHRS7C,A6NNS2,0.931,0.038,3.2734e-08,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
201161,CENPV,Q7Z7K6,0.711,0.577,0.33194,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2014.0,ALL
201163,FLCN,Q8NFG4,0.537,0.885,0.78892,,,C0346010,Multiple fibrofolliculomas,C16;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms",disease,Disease or Syndrome,1.0,0.968,definitive,2002.0,2020.0,ALL
201164,PLD6,Q8N2A8,1.0,0.038,0.0023012,DTO_05007624,Enzyme,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
201176,ARHGAP27,Q6ZUM4,0.861,0.192,0.0012114,DTO_05007584,Enzyme modulator,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
201191,SAMD14,Q8IZD0,0.805,0.192,0.00073677,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
201229,LYRM9,A8MSI8,1.0,0.077,0.014671,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
201232,SLC16A13,Q7RTY0,1.0,0.077,3.5696e-11,DTO_05007405,Transporter,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2014.0,2014.0,ALL
201254,CENPX,A8MT69,0.736,0.423,0.11069,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
201266,SLC39A11,Q8N1S5,0.711,0.308,2.3522e-18,DTO_05007405,Transporter,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2012.0,ALL
201283,AMZ2P1,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
201292,TRIM65,Q6PJ69,0.743,0.346,2.7066e-21,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
201294,UNC13D,Q70J99,0.659,0.5,1.091e-18,,,C1837174,"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3",C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.86,1.0,strong,2003.0,2019.0,ALL
201299,RDM1,Q8NG50,0.743,0.231,1.5827e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2020.0,ALL
201305,SPNS3,Q6ZMD2,1.0,0.077,1.7173e-12,DTO_05007405,Transporter,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
201456,FBXO15,Q8NCQ5,0.861,0.154,0.71072,,,C0025303,Meningococcal Infections,C01,   Infections,group,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
201475,RAB12,Q6IQ22,0.839,0.154,0.042786,,,C0151744,Myocardial Ischemia,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
201501,ZBTB7C,A1YPR0,0.691,0.577,0.16087,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
201514,ZNF584,Q8IVC4,,,0.00010489,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
201516,ZSCAN4,Q8NAM6,,,4.3321e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
201562,HACD2,Q6Y1H2,,,0.070281,,,C0424574,Duration of sleep,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
201595,STT3B,Q8TCJ2,0.76,0.385,0.99896,DTO_05007624,Enzyme,C2931007,Congenital disorder of glycosylation type 1X,C16;C18;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,limited,2013.0,2013.0,ALL
201625,DNAH12,Q6ZR08,,,9.0946e-10,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
201626,PDE12,Q6L8Q7,0.861,0.038,0.044374,DTO_05007624,Enzyme,C0035235,Respiratory Syncytial Virus Infections,C01,   Infections,group,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
201627,DENND6A,Q8IWF6,1.0,0.038,0.0017721,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
201633,TIGIT,Q495A1,0.623,0.538,0.017915,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2019.0,ALL
201725,C4orf46,Q504U0,0.861,0.115,0.039595,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
201799,TMEM154,Q6P9G4,1.0,0.077,3.8695e-07,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.03,1.0,,2014.0,2016.0,ALL
201853,LINC00504,,0.839,0.154,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
201895,SMIM14,Q96QK8,,,0.79188,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
201931,TMEM192,Q8IY95,,,2.9274e-06,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
201965,RWDD4,Q6NW29,0.839,0.115,0.017447,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
201973,PRIMPOL,Q96LW4,0.839,0.269,1.3322e-18,,,C3809464,"MYOPIA 22, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2014.0,ALL
202018,TAPT1,Q6NXT6,0.674,0.538,0.032078,,,C4225162,"OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2015.0,ALL
202020,TAPT1-AS1,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
202052,DNAJC18,Q9H819,1.0,,4.8219e-08,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
202151,RANBP3L,Q86VV4,1.0,0.038,7.8033e-16,DTO_05007584,Enzyme modulator,C1704272,Benign Prostatic Hyperplasia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
202243,CCDC125,Q86Z20,0.89,0.154,8.5885e-10,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
202299,LINC01554,Q52M75,0.931,0.077,0.076951,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
202309,GAPT,Q8N292,1.0,0.077,0.30619,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
202333,CMYA5,Q8N3K9,0.711,0.423,1.3454e-54,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.37,1.0,,2011.0,2019.0,ALL
202374,STK32A,Q8WU08,1.0,0.038,1.9819e-07,DTO_03300101,Kinase,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
202500,TCTE1,Q5JU00,0.931,0.115,7.7278e-11,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.2,,,,,ALL
202559,KHDRBS2,Q5VWX1,0.861,0.154,0.038537,DTO_05007557,Nucleic acid binding,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
202658,TRIM39-RPP21,,0.821,0.269,0.74425,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
202781,PAXIP1-AS1,,0.861,0.115,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
202865,C7orf33,Q8WU49,1.0,0.038,1.6048e-05,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
203062,TSNARE1,Q96NA8,0.861,0.077,9.6275e-07,DTO_05007405,Transporter,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.44,1.0,,2013.0,2019.0,ALL
203068,TUBB,P07437,0.603,0.692,0.97889,DTO_05007530,Cellular structure,C4014283,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2018.0,ALL
203069,R3HCC1,Q9Y3T6,,,0.00014338,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
203074,PRSS55,Q6UWB4,0.513,0.769,3.1731e-11,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1999.0,2019.0,ALL
203076,C8orf74,Q6P047,,,7.0341e-12,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
203100,HTRA4,P83105,0.839,0.154,2.2705e-12,DTO_05007624,Enzyme,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.03,1.0,,2015.0,2019.0,ALL
203102,ADAM32,Q8TC27,,,2.1571e-15,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
203190,LGI3,Q8N145,0.805,0.115,1.78e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
203228,C9orf72,Q96LT7,0.496,0.769,1.0647e-06,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.8,0.985,limited,2009.0,2020.0,ALL
203238,CCDC171,Q6TFL3,1.0,0.077,3.035e-47,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
203245,NAIF1,Q69YI7,0.78,0.115,0.28561,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2011.0,2014.0,ALL
203286,ANKS6,Q68DC2,0.682,0.346,6.9447e-06,,,C3809320,NEPHRONOPHTHISIS 16,,,disease,Disease or Syndrome,0.7,1.0,strong,1990.0,2013.0,ALL
203328,SUSD3,Q96L08,0.931,0.077,0.00060938,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
203413,CT83,Q5H943,0.722,0.269,0.083699,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2012.0,2019.0,ALL
203427,SLC25A43,Q8WUT9,0.821,0.115,0.089593,DTO_05007405,Transporter,C0029401,Osteitis Deformans,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
203430,RTL3,Q8N8U3,0.89,0.269,4.4007e-11,,,C0005699,Blast Phase,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.01,1.0,,1979.0,1979.0,ALL
203447,NRK,Q7Z2Y5,0.666,0.538,0.99274,DTO_03300101,Kinase,C0152093,Hypermobility syndrome,C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,limited,2011.0,2011.0,ALL
203477,HMGA1P1,,,,,,,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
203547,VMA21,Q3ZAQ7,0.821,0.231,0.57236,,,C1839615,X-linked myopathy with excessive autophagy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.77,1.0,strong,2000.0,2015.0,ALL
203562,TMEM31,Q5JXX7,0.89,0.115,0.0012864,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
203611,CDY2B,Q9Y6F7,0.839,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
203859,ANO5,Q75V66,0.619,0.538,2.8542e-22,,,C1969785,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L (disorder)",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.92,1.0,,2010.0,2017.0,ALL
204010,RPSAP52,,0.931,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
204219,CERS3,Q8IU89,0.705,0.308,0.0056921,,,C3554349,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9",,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2013.0,ALL
204474,PDILT,Q8N807,0.839,0.231,1.2202e-05,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
204801,NLRP11,P59045,0.931,0.077,2.1548e-09,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
204851,HIPK1,Q86Z02,0.716,0.269,1.0,DTO_03300101,Kinase,C0238198,Gastrointestinal Stromal Tumors,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
204962,SLC44A5,Q8NCS7,1.0,0.038,7.6779e-05,DTO_05007405,Transporter,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
205147,AMER3,Q8N944,1.0,0.115,0.61869,,,C0032580,Adenomatous Polyposis Coli,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.02,1.0,,2014.0,2019.0,ALL
205251,MTLN,Q8NCU8,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
205428,DIPK2A,Q8NDZ4,0.78,0.385,0.00051408,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2008.0,2011.0,ALL
205564,SENP5,Q96HI0,0.931,0.077,0.99978,DTO_05007624,Enzyme,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
205717,USF3,Q68DE3,0.821,0.115,1.0,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
205860,TRIML2,Q8N7C3,0.839,0.192,1.154e-05,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
206338,LVRN,Q6Q4G3,0.89,0.192,5.3008e-17,DTO_05007624,Enzyme,C0004106,Astigmatism,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
206358,SLC36A1,Q7Z2H8,0.743,0.462,1.397e-06,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2000.0,2018.0,ALL
207107,SFTA1P,,0.839,0.115,,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
219285,SAMD9L,Q8IVG5,0.7,0.5,5.5651e-15,,,C1327919,Myelocerebellar Disorder,C23;C10;C15,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.72,1.0,,2016.0,2019.0,ALL
219287,AMER2,Q8N7J2,0.89,0.192,0.083487,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
219333,USP12,O75317,0.821,0.231,0.97053,DTO_05007624,Enzyme,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.02,1.0,,2018.0,2018.0,ALL
219402,MTIF3,Q9H2K0,0.89,0.115,3.9011e-07,DTO_05007557,Nucleic acid binding,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2010.0,2013.0,ALL
219445,OR7E5P,,,,,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
219477,OR8J1,Q8NGP2,1.0,0.077,1.0089e-06,DTO_02300001,G-protein coupled receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
219527,LRRC55,Q6ZSA7,1.0,0.038,0.037827,DTO_01300327,Ion channel,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
219537,SMTNL1,A8MU46,1.0,0.115,2.6675e-12,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2011.0,2013.0,ALL
219539,YPEL4,Q96NS1,1.0,0.077,0.1956,,,C0009777,Conn Adenoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
219541,MED19,A0JLT2,0.628,0.615,0.78193,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2011.0,2019.0,ALL
219578,ZNF804B,A4D1E1,1.0,0.038,5.3504e-18,,,C1281901,Fatty acid measurement,,,group,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
219595,FOLH1B,Q9HBA9,0.682,0.538,,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.07,1.0,,1997.0,2018.0,ALL
219621,CABCOCO1,Q8IVU9,1.0,0.038,0.00036502,,,C0019209,Hepatomegaly,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",phenotype,Finding,0.3,1.0,,2017.0,2017.0,ALL
219623,TMEM26,Q6ZUK4,0.861,0.231,2.0721e-08,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
219654,ZCCHC24,Q8N2G6,,,0.942,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
219670,ENKUR,Q8TC29,0.805,0.269,7.0721e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
219681,ARMC3,Q5W041,0.839,0.192,3.5404e-13,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
219699,UNC5B,Q8IZJ1,0.682,0.462,2.6935e-07,DTO_05007575,Receptor,C0038525,Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.32,1.0,,2018.0,2019.0,ALL
219731,PROSER2-AS1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
219736,STOX1,Q6ZVD7,0.729,0.462,1.4404e-16,,,C0032914,Pre-Eclampsia,C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.61,1.0,,2008.0,2011.0,ALL
219743,TYSND1,Q2T9J0,1.0,0.231,0.00068197,DTO_05007624,Enzyme,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
219749,ZNF25,P17030,1.0,0.077,4.0774e-05,DTO_05007542,Transcription factor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
219770,GJD4,Q96KN9,1.0,0.077,0.014965,DTO_05007527,Cell-cell junction,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
219771,CCNY,Q8ND76,0.711,0.269,0.80672,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.43,1.0,,2008.0,2011.0,ALL
219790,RTKN2,Q8IZC4,0.722,0.385,5.4633e-15,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.41,1.0,,2014.0,2015.0,ALL
219793,TBATA,Q96M53,0.729,0.308,4.7461e-10,,,C3888239,"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1",,,disease,Finding,0.1,,,,,ALL
219844,HYLS1,Q96M11,0.572,0.692,2.3152e-09,,,C1856016,HYDROLETHALUS SYNDROME 1,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2005.0,2016.0,ALL
219854,TMEM218,A2RU14,0.769,0.192,0.0016754,,,C0022681,Medullary sponge kidney,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome; Congenital Abnormality,0.2,1.0,,2015.0,2015.0,ALL
219855,SLC37A2,Q8TED4,0.839,0.192,1.2292e-14,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
219899,TBCEL,Q5QJ74,0.839,0.192,0.97472,DTO_05007530,Cellular structure,C0221357,Brachydactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.02,1.0,,1996.0,2004.0,ALL
219902,TLCD5,Q6ZRR5,1.0,0.038,0.0050232,,,C0206368,Exfoliation Syndrome,C11,   Eye Diseases,disease,Disease or Syndrome,0.31,1.0,,2017.0,2018.0,ALL
219927,MRPL21,Q7Z2W9,1.0,0.077,2.4125e-14,DTO_05007557,Nucleic acid binding,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
219931,TPCN2,Q8NHX9,0.76,0.346,3.1241e-10,DTO_01300327,Ion channel,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2016.0,2018.0,ALL
219938,SPATA19,Q7Z5L4,0.839,0.077,3.5133e-08,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
219956,OR9Q1,Q8NGQ5,0.931,0.077,0.00083932,DTO_02300001,G-protein coupled receptor,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
219965,OR5B17,Q8NGF7,,,0.44075,DTO_02300001,G-protein coupled receptor,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
219972,MPEG1,Q2M385,0.575,0.731,3.5925e-16,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2001.0,2001.0,ALL
219981,OR5A2,Q8NGI9,,,,DTO_02300001,G-protein coupled receptor,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
220001,VWCE,Q96DN2,0.751,0.231,3.0509e-12,,,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
220042,DDIAS,Q8IXT1,0.792,0.154,2.338e-09,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.04,1.0,,2014.0,2018.0,ALL
220047,CCDC83,Q8IWF9,0.861,0.231,1.1628e-09,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
220064,LTO1,Q8WV07,0.729,0.231,0.0018149,,,C0424621,Body Fat Distribution,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
220074,LRTOMT,Q8WZ04;Q96E66,0.792,0.192,6.9976e-05,DTO_05007624,Enzyme,C1969621,"DEAFNESS, AUTOSOMAL RECESSIVE 63",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.9,1.0,definitive,2008.0,2017.0,ALL
220081,ERICH6B,Q5W0A0,1.0,0.038,1.0046e-14,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
220082,CBY2,Q8NA61,0.931,0.077,3.6118e-05,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
220107,DLEU7,Q6UYE1,0.705,0.346,0.18452,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
220134,SKA1,Q96BD8,0.65,0.462,1.7022e-05,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2013.0,2019.0,ALL
220136,CFAP53,Q96M91,0.78,0.115,9.6973e-19,,,C3553676,"HETEROTAXY, VISCERAL, 6, AUTOSOMAL",,,disease,Disease or Syndrome,0.7,1.0,strong,2012.0,2017.0,ALL
220164,DOK6,Q6PKX4,0.805,0.231,0.15534,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
220202,ATOH7,Q8N100,0.674,0.192,0.050896,DTO_05007624,Enzyme,C1969783,"Persistent Hyperplastic Primary Vitreous, Autosomal Recessive",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.6,1.0,,2002.0,2012.0,ALL
220213,OTUD1,Q5VV17,0.805,0.231,0.65091,DTO_05007624,Enzyme,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
220296,HEPACAM,Q14CZ8,0.621,0.5,0.86791,,,C1858854,MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS,C23;C16;C04;C18;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.7,0.933,,2011.0,2019.0,ALL
220323,OAF,Q86UD1,0.931,0.077,0.0034624,,,C2697774,Interleukin 25 Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
220388,CCDC89,Q8N998,1.0,0.077,7.8532e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
220429,CTAGE10P,,,,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
220441,RNF152,Q8N8N0,0.89,0.115,0.12894,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
220729,LOC220729,,1.0,0.038,,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
220832,FABP5P3,A8MUU1,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
220929,ZNF438,Q7Z4V0,0.861,0.115,2.6656e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
220930,ZEB1-AS1,,0.636,0.423,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.917,,2016.0,2019.0,ALL
220963,SLC16A9,Q7RTY1,0.861,0.192,0.007078,DTO_05007405,Transporter,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2019.0,ALL
220965,FAM13C,Q8NE31,0.89,0.077,5.8127e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
220972,MARCHF8,Q5T0T0,0.59,0.692,5.8689e-07,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.31,1.0,,2007.0,2017.0,ALL
220980,TMEM72-AS1,,,,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
220988,HNRNPA3,P51991,0.751,0.308,0.99543,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2005.0,2005.0,ALL
220992,ZNF485,Q8NCK3,,,5.4641e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
221002,RASGEF1A,Q8N9B8,0.931,0.192,0.97444,DTO_05007584,Enzyme modulator,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.11,1.0,,2009.0,2014.0,ALL
221035,REEP3,Q6NUK4,0.792,0.308,0.015097,DTO_05007405,Transporter,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
221037,JMJD1C,Q15652,0.517,0.769,1.0,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2007.0,2018.0,ALL
221044,UCMA,Q8WVF2,0.78,0.192,9.061e-06,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
221061,FAM171A1,Q5VUB5,0.821,0.231,0.98528,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
221074,SLC39A12,Q504Y0,0.89,0.154,8.3413e-07,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
221078,NSUN6,Q8TEA1,0.805,0.154,4.9452e-19,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
221079,ARL5B,Q96KC2,0.89,0.154,0.0017521,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
221092,HNRNPUL2,Q1KMD3,1.0,0.077,0.99979,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
221120,ALKBH3,Q96Q83,0.67,0.462,2.7442e-12,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
221143,EEF1AKMT1,Q8WVE0,,,2.4358e-06,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
221150,SKA3,Q8IX90,0.743,0.231,1.5109e-07,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2019.0,ALL
221154,MICU2,Q8IYU8,0.931,0.077,9.7216e-21,DTO_05007616,Calcium-binding protein,C0429087,Electrocardiogram: P-R interval,,,phenotype,Finding,0.1,1.0,,2018.0,2019.0,ALL
221178,SPATA13,Q96N96,0.792,0.154,0.0026387,DTO_05007584,Enzyme modulator,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
221191,PRSS54,Q6PEW0,0.89,0.115,0.10056,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
221241,LINC00305,Q7Z4B0,0.89,0.077,,,,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
221262,CCDC162P,,0.89,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
221264,AK9,Q5TCS8,0.751,0.346,3.687e-26,DTO_03300101,Kinase,C0751883,"Congenital Myasthenic Syndromes, Postsynaptic",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
221294,NT5DC1,Q5TFE4,0.792,0.269,5.1357e-07,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
221302,ZUP1,Q96AP4,0.751,0.462,2.1193e-09,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
221303,FAM162B,Q5T6X4,,,4.2377e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
221322,TBC1D32,Q96NH3,0.743,0.462,8.002e-27,,,C0796102,Orofaciodigital syndrome 9,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.3,1.0,moderate,2014.0,2014.0,ALL
221336,BEND6,Q5SZJ8,,,0.00076917,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
221357,GSTA5,Q7RTV2,,,1.7989e-11,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
221391,OPN5,Q6U736,0.711,0.385,0.8602,DTO_02300001,G-protein coupled receptor,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
221393,ADGRF4,Q8IZF3,0.89,0.154,2.7656e-14,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
221395,ADGRF5,Q8IZF2,0.78,0.308,0.023976,DTO_02300001,G-protein coupled receptor,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
221400,TDRD6,O60522,0.89,0.115,5.4437e-45,DTO_05007624,Enzyme,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
221416,C6orf223,Q8N319,0.89,0.038,0.00050936,,,C0271084,Exudative age-related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
221421,RSPH9,Q9H1X1,0.659,0.615,2.3881e-09,DTO_05007557,Nucleic acid binding,C2675228,"CILIARY DYSKINESIA, PRIMARY, 12",C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.6,,,,,ALL
221442,ADCY10P1,,1.0,0.038,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
221443,OARD1,Q9Y530,0.931,0.077,0.0005506,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
221458,KIF6,Q6ZMV9,0.729,0.385,3.0905e-27,DTO_05007530,Cellular structure,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.39,1.0,,2008.0,2015.0,ALL
221468,TMEM217,Q8N7C4,0.931,0.269,7.1339e-05,,,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
221472,FGD2,Q7Z6J4,0.839,0.231,5.7084e-09,DTO_05007584,Enzyme modulator,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
221476,PI16,Q6UXB8,0.861,0.192,7.1384e-09,DTO_05007608,Immune response,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
221481,ARMC12,Q5T9G4,0.89,0.077,1.1597e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
221491,SMIM29,Q86T20,,,0.62416,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2011.0,2019.0,ALL
221496,LEMD2,Q8NC56,0.769,0.308,0.75293,,,C0220721,"CATARACT 46, JUVENILE-ONSET",,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2016.0,ALL
221527,ZBTB12,Q9Y330,0.89,0.115,0.94882,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
221547,RANP1,,0.931,0.077,,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,1995.0,1995.0,ALL
221584,ZSCAN12P1,,0.931,0.077,,,,C0036202,Sarcoidosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
221613,H2AC1,Q96QV6,0.931,0.115,0.0014225,DTO_05007557,Nucleic acid binding,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
221656,KDM1B,Q8NB78,0.736,0.385,0.0014005,DTO_05007378,Epigenetic regulator,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
221662,RBM24,Q9BX46,0.76,0.346,0.086409,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2018.0,2019.0,ALL
221687,RNF182,Q8N6D2,0.839,0.115,0.0046762,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.5,1.0,,2008.0,2008.0,ALL
221692,PHACTR1,Q9C0D0,0.663,0.423,0.63537,DTO_05007584,Enzyme modulator,C4749023,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70",,,disease,Disease or Syndrome,0.6,1.0,strong,2012.0,2018.0,ALL
221711,SYCP2L,Q5T4T6,0.839,0.154,3.0127e-23,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
221718,LINC00518,Q8N0U6,0.769,0.192,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0,,2014.0,2019.0,ALL
221749,PXDC1,Q5TGL8,1.0,0.077,0.0043291,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
221756,SERPINB9P1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
221785,ZSCAN25,Q6NSZ9,0.931,0.154,0.0001926,,,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
221786,FAM200A,Q8TCP9,,,6.4144e-08,,,C0441683,Hormone measurement,,,group,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
221830,TWISTNB,Q3B726,1.0,0.115,0.61708,DTO_05007624,Enzyme,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
221833,SP8,Q8IXZ3,0.931,0.038,0.9658,DTO_05007557,Nucleic acid binding,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
221883,HOXA11-AS,,0.61,0.423,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2017.0,2019.0,ALL
221895,JAZF1,Q86VZ6,0.582,0.654,0.89582,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.63,0.8,,2009.0,2017.0,ALL
221914,GPC2,Q8N158,0.792,0.154,0.031538,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2001.0,2001.0,ALL
221927,BRAT1,Q6PJG6,0.695,0.231,7.4316e-13,,,C3281029,"RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL",,,disease,Disease or Syndrome,0.78,0.917,,2012.0,2018.0,ALL
221935,SDK1,Q7Z5N4,0.76,0.346,4.1564e-06,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
221937,FOXK1,P85037,0.631,0.462,0.80522,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
221955,DAGLB,Q8NCG7,0.931,0.154,2.6256e-12,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
221960,CCZ1B,P86790;P86791,1.0,0.077,8.9699e-13,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
221981,THSD7A,Q9UPZ6,0.644,0.654,1.0,DTO_05007621,Extracellular structure,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2019.0,2019.0,ALL
222008,VSTM2A,Q8TAG5,0.839,0.077,0.27277,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
222068,TMED4,Q7Z7H5,,,0.24339,DTO_05007405,Transporter,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
222166,MTURN,Q8N3F0,0.89,0.077,0.43876,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
222171,PRR15,Q8IV56,1.0,0.077,0.53532,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
222183,SRRM3,A6NNA2,0.931,0.077,0.20868,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
222194,RSBN1L,Q6PCB5,1.0,0.038,0.79546,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
222223,KIAA1324L,A8MWY0,0.861,0.077,2.036e-05,,,C0036508,Seborrheic dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
222229,LRWD1,Q9UFC0,0.792,0.269,1.5745e-20,DTO_05007575,Receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
222234,FAM185A,Q8N0U4,,,0.040688,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2016.0,ALL
222235,FBXL13,Q8NEE6,1.0,0.077,2.0856e-12,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2013.0,2013.0,ALL
222236,NAPEPLD,Q6IQ20,0.861,0.154,2.9414e-05,,,C0157946,"Osteoarthrosis, localized, not specified whether primary or secondary",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.2,1.0,,2010.0,2010.0,ALL
222255,ATXN7L1,Q9ULK2,0.89,0.154,0.99884,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
222256,CDHR3,Q6ZTQ4,0.805,0.192,2.3071e-24,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.45,1.0,,2014.0,2019.0,ALL
222389,BEND7,Q8N7W2,1.0,0.077,0.0060711,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
222484,LNX2,Q8N448,0.861,0.154,7.3132e-06,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
222487,ADGRG3,Q86Y34,0.931,0.154,8.9433e-14,DTO_02300001,G-protein coupled receptor,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
222537,HS3ST5,Q8IZT8,0.931,0.077,0.16621,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
222545,GPRC6A,Q5T6X5,0.526,0.923,5.5919e-17,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
222546,RFX6,Q8HWS3,0.686,0.385,0.00040925,DTO_05007542,Transcription factor,C2748662,Mitchell-Riley Syndrome,C16;C06;C18;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nutritional and Metabolic Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.75,0.909,,2010.0,2019.0,ALL
222553,SLC35F1,Q5T1Q4,0.805,0.154,0.95133,DTO_05007405,Transporter,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2017.0,2018.0,ALL
222584,FAM83B,Q5T0W9,0.722,0.346,6.3264e-08,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
222611,ADGRF2,Q8IZF7,1.0,0.077,2.5133e-24,DTO_02300001,G-protein coupled receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
222643,UNC5CL,Q8IV45,0.89,0.115,2.0365e-13,DTO_05007575,Receptor,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
222658,KCTD20,Q7Z5Y7,0.861,0.192,0.00094347,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
222659,PXT1,Q8NFP0,1.0,0.077,2.5199e-06,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
222662,LHFPL5,Q8TAF8,0.861,0.192,0.00040199,,,C1853223,"Deafness, Autosomal Recessive 67",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2006.0,2018.0,ALL
222663,SCUBE3,Q8IX30,0.839,0.115,0.99939,DTO_05007621,Extracellular structure,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
222696,ZSCAN23,Q3MJ62,1.0,0.038,4.1094e-10,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
222698,NKAPL,Q5M9Q1,0.89,0.231,9.2219e-05,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.43,1.0,,2011.0,2015.0,ALL
222865,TMEM130,Q8N3G9,1.0,0.115,1.4003e-08,DTO_05007599,Signaling,C0022680,Polycystic Kidney Diseases,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",group,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
222894,FERD3L,Q96RJ6,0.839,0.192,0.31875,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
222950,NYAP1,Q6ZVC0,,,0.99917,,,C0018935,Hematocrit procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
222962,SLC29A4,Q7RTT9,0.805,0.269,1.1358e-05,DTO_05007405,Transporter,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
223075,ITPRID1,Q6ZRS4,0.89,0.115,6.5498e-36,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
223082,ZNRF2,Q8NHG8,0.839,0.115,0.072297,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
223117,SEMA3D,O95025,0.678,0.423,4.0219e-08,DTO_05007599,Signaling,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.43,1.0,,2012.0,2017.0,ALL
225689,MAPK15,Q8TD08,0.729,0.385,1.8682e-21,DTO_03300101,Kinase,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
245711,SPDYA,Q5MJ70,0.695,0.462,0.551,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
245802,MS4A6E,Q96DS6,1.0,0.077,0.029203,DTO_05007575,Receptor,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.04,0.75,,2013.0,2017.0,ALL
245806,VGLL2,Q8N8G2,0.821,0.077,0.70547,DTO_05007542,Transcription factor,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
245812,CNPY4,Q8N129,1.0,0.077,1.0277e-13,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
245909,DEFB106A,Q8N104,0.931,0.038,0.0085821,,,C0030354,Papilloma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,1995.0,1995.0,ALL
245910,DEFB107A,Q8IZN7,1.0,0.038,0.32633,,,C0747085,Recurrent otitis media,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
245911,DEFB108B,Q8NET1,1.0,0.038,0.001604,,,C4721806,"Carcinoma, Basal Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
245930,DEFB116,Q30KQ4,,,0.0019336,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
245932,DEFB119,Q8N690,,,0.096676,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
245934,DEFB121,Q5J5C9,1.0,0.077,0.096502,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
245972,ATP6V0D2,Q8N8Y2,0.751,0.385,2.4683e-11,DTO_05007405,Transporter,C0010093,Corpus Luteum Cyst,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
245973,ATP6V1C2,Q8NEY4,0.89,0.038,2.8499e-08,DTO_05007405,Transporter,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
246100,CTAG1A,P78358,0.508,0.731,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.98,,2000.0,2020.0,ALL
246119,TTTY10,Q9BZA0,1.0,0.077,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
246126,TXLNGY,Q9BZA5,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
246175,CNOT6L,Q96LI5,1.0,0.115,0.99821,DTO_05007624,Enzyme,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
246176,GAS2L2,Q8NHY3,0.678,0.5,1.5879e-06,,,C4551720,Primary Ciliary Dyskinesia,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.51,1.0,moderate,2019.0,2019.0,ALL
246181,AKR7L,Q8NHP1,,,0.0002237,DTO_05007624,Enzyme,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
246184,CDC26,Q8NHZ8,1.0,0.077,0.66035,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
246210,IKBKGP1,,1.0,0.077,,,,C0021171,Bloch Sulzberger syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.02,1.0,,2003.0,2009.0,ALL
246213,SLC17A8,Q8NDX2,0.729,0.462,0.0013196,DTO_05007405,Transporter,C1854158,"DEAFNESS, AUTOSOMAL DOMINANT 25 (disorder)",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.91,1.0,strong,2008.0,2018.0,ALL
246243,RNASEH1,O60930,0.711,0.462,0.011173,,,C4225312,"PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2",,,disease,Disease or Syndrome,0.7,1.0,strong,2015.0,2015.0,ALL
246260,BDA1B,,1.0,0.077,,,,C0221357,Brachydactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0,,2015.0,2015.0,ALL
246269,AFG1L,Q8WV93,1.0,0.038,6.4428e-09,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2010.0,2010.0,ALL
246289,DFNA47,,1.0,,,,,C0859886,Inherited hearing loss,,,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
246312,C21orf91-OT1,,,,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
246319,VAMAS6,,0.729,0.269,,,,C0042900,Vitiligo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.04,1.0,,2005.0,2020.0,ALL
246329,STAC3,Q96MF2,0.633,0.654,0.00017244,,,C1850625,Native American myopathy,C23;C16;C05;C10;C07,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.76,1.0,strong,2013.0,2017.0,ALL
246330,PELI3,Q8N2H9,0.861,0.192,0.0094922,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
246704,LINC00315,P59091,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
246744,STH,Q8IWL8,0.705,0.385,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2012.0,2015.0,ALL
246750,MYAS1,,1.0,0.115,,,,C0026896,Myasthenia Gravis,C04;C20;C10,   Neoplasms;    Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
246777,SPESP1,Q6UW49,0.711,0.538,0.39465,,,C0004610,Bacteremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.03,0.667,,2004.0,2016.0,ALL
246778,IL27,Q8NEV9,0.457,0.808,0.78232,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.37,1.0,,2011.0,2019.0,ALL
252839,TMEM9,Q9P0T7,0.805,0.115,0.0036291,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
252842,AAT1,,0.931,0.038,,,,C0345050,Congenital aneurysm of ascending aorta,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.02,1.0,,2001.0,2005.0,ALL
252884,ZNF396,Q96N95,0.89,0.077,8.7621e-06,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
252969,NEIL2,Q969S2,0.7,0.538,2.8655e-11,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
252983,STXBP4,Q6ZWJ1,0.76,0.231,2.5154e-14,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.45,1.0,,2009.0,2019.0,ALL
252995,FNDC5,Q8NAU1,0.631,0.538,0.5458,,,C0018800,Cardiomegaly,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Finding,0.3,1.0,,2019.0,2019.0,ALL
253012,HEPACAM2,A8MVW5,0.89,0.308,1.566e-10,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
253017,TECRL,Q5HYJ1,0.805,0.192,3.1983e-12,DTO_05007624,Enzyme,C3151463,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3",,,disease,Disease or Syndrome,0.6,1.0,moderate,2016.0,2016.0,ALL
253018,HCG27,,0.805,0.346,0.023063,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
253039,CUTALP,,0.89,,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
253128,LINC00612,Q8N6U2,0.89,0.115,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
253143,PRR14L,Q5THK1,0.931,0.077,0.99705,,,C0023480,"Leukemia, Myelomonocytic, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
253175,CDY1B,Q9Y6F8,0.931,0.077,,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.02,0.5,,2014.0,2016.0,ALL
253190,SERHL2,Q9H4I8,1.0,0.077,2.8325e-15,DTO_05007624,Enzyme,C2076600,Influenza due to Influenza A virus subtype H1N1,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
253260,RICTOR,Q6R327,0.592,0.615,1.0,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.33,1.0,,2015.0,2017.0,ALL
253264,ZNF503-AS1,,1.0,0.038,,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
253430,IPMK,Q8NFU5,0.751,0.423,0.96258,DTO_03300101,Kinase,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2012.0,2015.0,ALL
253461,ZBTB38,Q8NAP3,0.663,0.615,0.99949,DTO_05007542,Transcription factor,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
253512,SLC25A30,Q5SVS4,1.0,0.077,6.1722e-09,DTO_05007405,Transporter,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
253558,LCLAT1,Q6UWP7,0.821,0.154,0.00025546,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
253559,CADM2,Q8N3J6,0.67,0.538,0.89097,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.14,1.0,,2012.0,2019.0,ALL
253573,LINC02052,,0.89,0.115,,,,C0017612,"Glaucoma, Open-Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
253639,ZNF620,Q6ZNG0,1.0,0.115,0.00041957,DTO_05007542,Transcription factor,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
253650,ANKRD18A,Q8IVF6,0.89,0.077,8.7789e-11,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2012.0,2012.0,ALL
253714,MMS22L,Q6ZRQ5,0.861,0.154,8.3003e-05,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
253724,TTC41P,Q6P2S7,0.89,0.154,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2008.0,2008.0,ALL
253738,EBF3,Q9H4W6,0.595,0.731,0.99993,,,C4310618,"HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME",,,disease,Disease or Syndrome,0.7,1.0,,2017.0,2017.0,ALL
253769,WDR27,A2RRH5,0.931,0.192,3.8042e-17,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
253782,CERS6,Q6ZMG9,0.65,0.615,0.038583,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
253827,MSRB3,Q8IXL7,0.729,0.308,0.003766,,,C2239351,"DEAFNESS, AUTOSOMAL RECESSIVE 74",,,disease,Disease or Syndrome,0.91,1.0,strong,2011.0,2014.0,ALL
253832,ZDHHC20,Q5W0Z9,,,0.00051998,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2010.0,2016.0,ALL
253868,MIR1-1HG-AS1,Q96NR2,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
253935,ANGPTL5,Q86XS5,0.839,0.308,4.1332e-10,DTO_05007599,Signaling,C3495559,Juvenile arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
253943,YTHDF3,Q7Z739,0.78,0.308,0.99704,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
253959,RALGAPA1,Q6GYQ0,0.861,0.231,0.99999,DTO_05007584,Enzyme modulator,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.3,1.0,,2020.0,2020.0,ALL
253962,CACNA1G-AS1,,0.736,0.346,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
253970,SFTA3,P0C7M3,0.821,0.308,0.38679,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
253980,KCTD13,Q8WZ19,0.821,0.154,0.00091544,,,C0337443,Sodium measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
253982,ASPHD1,Q5U4P2,,,0.0022416,,,C0337443,Sodium measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
253986,RPL10AP2,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
254042,METAP1D,Q6UB28,0.89,0.077,2.5794e-06,DTO_05007624,Enzyme,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
254050,LRRC43,Q8N309,0.931,0.038,4.7157e-15,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
254065,BRWD3,Q6RI45,0.716,0.538,1.0,,,C1970841,"MENTAL RETARDATION, X-LINKED 93 (disorder)",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,strong,2007.0,2019.0,ALL
254099,LINC01342,,0.89,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
254100,ZNRD2-AS1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2010.0,ALL
254102,EHBP1L1,Q8N3D4,0.89,0.115,7.1163e-13,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2014.0,2014.0,ALL
254122,SNX32,Q86XE0,0.861,0.077,1.8347e-18,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
254128,NIFK-AS1,,0.89,0.115,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
254170,FBXO33,Q7Z6M2,0.931,0.115,0.99417,,,C0024408,Machado-Joseph Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
254173,TTLL10,Q6ZVT0,1.0,0.077,1.2286e-11,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
254187,TSGA10IP,Q3SY00,,,,,,C0424621,Body Fat Distribution,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
254225,RNF169,Q8NCN4,0.931,0.077,0.039503,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
254240,BPIFC,Q8NFQ6,0.89,0.115,1.589e-07,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
254251,LCORL,Q8N3X6,0.89,0.192,0.92374,DTO_05007624,Enzyme,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.4,1.0,,2013.0,2019.0,ALL
254263,CNIH2,Q6PI25,0.931,0.115,0.95171,DTO_05007599,Signaling,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2016.0,2017.0,ALL
254268,AKNAD1,Q5T1N1,0.89,0.269,3.6153e-23,,,C0011053,Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Finding,0.1,,,,,ALL
254295,PHYHD1,Q5SRE7,0.89,0.077,4.0371e-13,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
254359,ZDHHC24,Q6UX98,0.722,0.462,0.0004208,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
254394,MCM9,Q9NXL9,0.716,0.346,6.6222e-14,DTO_05007624,Enzyme,C4015409,OVARIAN DYSGENESIS 4,,,disease,Disease or Syndrome,0.7,1.0,strong,1989.0,2014.0,ALL
254427,PROSER2,Q86WR7,0.931,0.077,1.1594e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
254428,SLC41A1,Q8IVJ1,0.769,0.385,0.65493,DTO_05007405,Transporter,C0687120,Nephronophthisis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.31,1.0,limited,2013.0,2013.0,ALL
254528,MEIOB,Q8N635,0.769,0.192,2.9857e-14,,,C4540179,SPERMATOGENIC FAILURE 22,,,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
254531,LPCAT4,Q643R3,0.931,0.077,0.48207,DTO_05007624,Enzyme,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
254559,MIR9-3HG,,0.89,0.077,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
254773,LYG2,Q86SG7,,,2.1715e-09,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
254778,VXN,Q8TAG6,,,0.12991,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
254827,NAALADL2,Q58DX5,0.729,0.577,8.7292e-08,DTO_05007624,Enzyme,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.11,1.0,,2014.0,2015.0,ALL
254863,TMEM256,Q8N2U0,0.861,0.154,0.00061452,DTO_05007624,Enzyme,C0035229,Respiratory Insufficiency,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.1,,,,,ALL
254879,OR2T6,Q8NHC8,0.931,0.077,4.1385e-05,DTO_02300001,G-protein coupled receptor,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
254887,ZDHHC23,Q8IYP9,0.78,0.192,3.8421e-12,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
254956,MORN5,Q5VZ52,1.0,0.077,8.1711e-05,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
254958,REXO1L1P,Q8IX06,0.792,0.077,,DTO_05007624,Enzyme,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,0.786,,1990.0,2014.0,ALL
255022,CALHM1,Q8IU99,0.769,0.269,1.7556e-05,DTO_01300327,Ion channel,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
255027,MPV17L,Q2QL34,1.0,0.077,7.3866e-07,DTO_05007575,Receptor,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
255031,LINC00957,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
255061,TAC4,Q86UU9,0.711,0.462,3.6126e-05,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.05,1.0,,2010.0,2019.0,ALL
255082,CASC2,,0.612,0.462,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2004.0,2019.0,ALL
255101,CFAP65,Q6ZU64,0.931,0.115,4.7186e-27,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
255104,TMCO4,Q5TGY1,0.931,0.115,1.6674e-20,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2017.0,2017.0,ALL
255119,CFAP299,Q6V702,0.931,0.077,2.0896e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
255130,IGFBP7-AS1,,0.839,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
255167,LINC01018,,0.931,0.231,,,,C1970199,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5",C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.1,,,,,ALL
255180,GOLGA2P11,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
255189,PLA2G4F,Q68DD2,1.0,0.038,1.1507e-27,DTO_05007624,Enzyme,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
255220,TXNDC8,Q6A555,1.0,0.038,0.0079737,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
255231,MCOLN2,Q8IZK6,0.805,0.192,1.2502e-14,DTO_01300327,Ion channel,C0085078,Lysosomal Storage Diseases,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",group,Disease or Syndrome,0.02,0.0,,2009.0,2016.0,ALL
255239,ANKK1,Q8NFD2,0.604,0.462,7.4008e-12,DTO_03300101,Kinase,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.8,,2004.0,2017.0,ALL
255252,LRRC57,Q8N9N7,0.89,0.077,0.0013041,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
255308,EIF2S3B,Q2VIR3,,,0.00017977,DTO_05007624,Enzyme,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
255313,CT47A11,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
255324,EPGN,Q6UW88,0.76,0.385,0.00023928,DTO_05007599,Signaling,C0002312,alpha-Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,1984.0,1984.0,ALL
255374,MBLAC1,A4D2B0,,,0.21273,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
255426,RASGEF1C,Q8N431,,,9.6077e-06,DTO_05007584,Enzyme modulator,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
255480,TBX5-AS1,,1.0,0.077,,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
255488,RNF144B,Q7Z419,0.89,0.077,6.3516e-10,DTO_05007624,Enzyme,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
255520,ELMOD2,Q8IZ81,0.89,0.038,0.41822,DTO_05007599,Signaling,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.3,1.0,limited,2006.0,2006.0,ALL
255626,H2BC1,Q96A08,0.89,0.154,0.10308,DTO_05007557,Nucleic acid binding,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
255631,COL24A1,Q17RW2,0.931,0.038,4.9779e-44,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
255738,PCSK9,Q8NBP7,0.482,0.808,2.7059e-17,DTO_05007624,Enzyme,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.7,0.966,strong,2003.0,2020.0,ALL
255743,NPNT,Q6UXI9,0.659,0.654,2.7295e-10,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.11,1.0,,2011.0,2019.0,ALL
255758,TCTEX1D2,Q8WW35,0.751,0.346,0.00032126,DTO_05007530,Cellular structure,C0221357,Brachydactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.4,1.0,,2015.0,2015.0,ALL
255762,PDZD9,Q8IXQ8,,,0.0028043,,,C4280669,Velopharyngeal dysfunction,,,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
255798,SMCO1,Q147U7,,,0.00015503,,,C1318485,Liver regeneration disorder,C06,   Digestive System Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
255877,BCL6B,Q8N143,0.792,0.192,0.046898,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
255926,ADAM5,Q6NVV9,1.0,0.038,,DTO_05007624,Enzyme,C0263859,"Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
255928,SYT14,Q8NB59,0.716,0.346,0.94463,,,C3280226,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11",,,disease,Disease or Syndrome,0.6,1.0,limited,2011.0,2011.0,ALL
255967,PAN3,Q58A45,0.89,0.115,0.99999,DTO_03300101,Kinase,C0200637,Monocyte count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
256006,ANKRD31,Q8N7Z5,1.0,0.077,1.8697e-21,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
256021,LINC01619,G3V211,0.931,0.192,0.00083157,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
256076,COL6A5,A8TX70,0.78,0.346,5.609e-45,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2013.0,ALL
256126,SYCE2,Q6PIF2,1.0,0.115,0.28077,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2018.0,ALL
256130,TMEM196,Q5HYL7,0.839,0.269,4.2115e-06,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
256158,HMCN2,Q8NDA2,1.0,0.038,1.8027e-12,DTO_05007575,Receptor,C0149630,Bicuspid aortic valve,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.01,0.0,,2017.0,2017.0,ALL
256227,STEAP1B,Q6NZ63,1.0,0.077,1.2368e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
256236,NAPSB,,0.89,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,1997.0,1997.0,ALL
256297,PTF1A,Q7RTS3,0.601,0.692,0.16565,,,C1836780,PANCREATIC AND CEREBELLAR AGENESIS,C23;C16;C18;C13;C19,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases",disease,Disease or Syndrome,0.72,1.0,,1999.0,2019.0,ALL
256302,NATD1,Q8N6N6,,,0.64837,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
256356,GK5,Q6ZS86,0.743,0.192,0.0063366,DTO_03300101,Kinase,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
256364,EML3,Q32P44,,,3.748e-06,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
256369,CCDC197,Q8NCU1,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
256380,SCML4,Q8N228,0.89,0.077,7.5932e-06,DTO_05007557,Nucleic acid binding,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
256394,SERPINA11,Q86U17,0.89,0.077,8.5963e-10,DTO_05007584,Enzyme modulator,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
256435,ST6GALNAC3,Q8NDV1,0.839,0.192,0.00026424,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
256471,MFSD8,Q8NHS3,0.682,0.231,2.5375e-12,,,C1838571,"Ceroid Lipofuscinosis, Neuronal, 7",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.97,1.0,,2007.0,2019.0,ALL
256472,TMEM151A,Q8N4L1,0.931,0.115,0.0029247,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
256536,TCERG1L,Q5VWI1,0.78,0.269,6.8376e-09,DTO_05007542,Transcription factor,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.51,1.0,,2011.0,2012.0,ALL
256646,NUTM1,Q86Y26,0.612,0.346,0.0023642,,,C1707291,NUT midline carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.4,0.98,,2009.0,2019.0,ALL
256691,MAMDC2,Q7Z304,1.0,0.077,3.1044e-10,,,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
256710,GLIPR1L1,Q6UWM5,1.0,0.038,1.0546e-06,DTO_05007608,Immune response,C1301194,Salivary duct carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
256714,MAP7D2,Q96T17,1.0,0.077,0.041409,DTO_05007530,Cellular structure,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
256764,WDR72,Q3MJ13,0.716,0.385,2.733e-27,,,C2750771,"Amelogenesis Imperfecta, Hypomaturation Type, Iia3",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.8,1.0,strong,2009.0,2018.0,ALL
256815,C10orf67,Q8IYJ2,0.89,0.154,1.7976e-08,,,C0036202,Sarcoidosis,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
256880,H2AZ1-DT,,1.0,0.115,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
256892,OR51F1,A6NGY5,1.0,0.038,0.030324,DTO_02300001,G-protein coupled receptor,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
256933,NPB,Q8NG41,0.792,0.385,0.0989,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
256949,KANK3,Q6NY19,1.0,0.077,2.734e-08,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
256957,HEATR9,A2RTY3,1.0,0.077,4.8498e-16,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
256979,SUN3,Q8TAQ9,1.0,0.077,3.0029e-12,DTO_05007530,Cellular structure,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
256987,SERINC5,Q86VE9,0.805,0.115,6.6351e-06,DTO_05007575,Receptor,C0272178,Drug-induced neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
257000,TINCR,,0.7,0.462,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.07,1.0,,2017.0,2019.0,ALL
257019,FRMD3,A2A2Y4,0.76,0.269,0.27023,,,C0263454,Chloracne,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
257044,CATSPERE,Q5SY80,1.0,0.077,4.9865e-12,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
257068,PLCXD2,Q0VAA5,0.931,0.154,4.6567e-08,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
257101,ZNF683,Q8IZ20,0.89,0.115,1.1234e-07,,,C0263454,Chloracne,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
257106,ARHGAP30,Q7Z6I6,0.792,0.231,0.9999,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
257144,GCSAM,Q8N6F7,0.705,0.346,0.06403,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
257160,RNF214,Q8ND24,,,0.9096,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
257169,C9orf43,Q8TAL5,1.0,,4.3555e-11,,,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
257194,NEGR1,Q7Z3B1,0.695,0.577,0.99173,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.4,0.917,,2009.0,2019.0,ALL
257202,GPX6,P59796,0.769,0.385,2.582e-06,DTO_05007624,Enzyme,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
257203,DSCR9,P59020,0.931,0.115,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
257218,SHPRH,Q149N8,0.821,0.077,1.7017e-06,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
257240,KLHL34,Q8N239,0.89,0.038,3.0037e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2015.0,2015.0,ALL
257313,UTS2B,Q765I0,0.839,0.346,0.00022271,,,C0003803,Arnold Chiari Malformation,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
257397,TAB3,Q8N5C8,0.674,0.615,0.61714,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
257415,FAM133B,Q5BKY9,0.839,0.231,0.00071452,DTO_05007624,Enzyme,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
257629,ANKS4B,Q8N8V4,0.743,0.385,1.4867e-05,,,C0877015,Pelvic Organ Prolapse,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
257641,NPCA1,,0.861,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
258010,SVIP,Q8NHG7,0.89,0.192,0.00030038,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
259173,ALS2CL,Q60I27,0.861,0.192,4.297e-28,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
259197,NCR3,O14931,0.638,0.769,0.00036824,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.33,1.0,,2007.0,2017.0,ALL
259215,LY6G6F,Q5SQ64,0.861,0.308,9.5579e-07,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2009.0,ALL
259217,HSPA12A,O43301,0.67,0.346,0.98436,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2004.0,2004.0,ALL
259230,SGMS1,Q86VZ5,0.674,0.577,0.94507,,,C0034063,Pulmonary Edema,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.2,1.0,,2002.0,2002.0,ALL
259232,NALCN,Q8IZF0,0.587,0.615,8.5243e-14,DTO_01300327,Ion channel,C4225398,"CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY",,,disease,Disease or Syndrome,0.74,1.0,strong,2013.0,2019.0,ALL
259234,DSCR10,P59022,1.0,0.077,,,,C1860787,DOWN SYNDROME CRITICAL REGION,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
259236,TMIE,Q8NEW7,0.89,0.115,7.749e-05,,,C1832992,"DEAFNESS, AUTOSOMAL RECESSIVE 6",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2002.0,2002.0,ALL
259249,MRGPRX1,Q96LB2,0.531,0.923,,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
259266,ASPM,Q8IZT6,0.526,0.769,3.3502e-49,,,C3711387,Autosomal Recessive Primary Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2000.0,2018.0,ALL
259282,BOD1L1,Q8NFC6,0.839,0.154,0.99985,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
259283,MDS2,Q8NDY4,0.861,0.115,0.37737,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
259289,TAS2R43,P59537,0.931,0.115,,DTO_02300001,G-protein coupled receptor,C0033845,Pseudotumor Cerebri,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
259290,TAS2R31,P59538,1.0,0.115,,DTO_02300001,G-protein coupled receptor,C0432230,Langer Mesomelic Dysplasia Syndrome,C23;C16;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
259292,TAS2R46,P59540,0.931,0.077,,DTO_02300001,G-protein coupled receptor,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2017.0,2017.0,ALL
259295,TAS2R20,P59543,1.0,0.077,,DTO_02300001,G-protein coupled receptor,C0010278,Craniosynostosis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
259296,TAS2R50,P59544,0.861,0.154,,DTO_02300001,G-protein coupled receptor,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,2011.0,2012.0,ALL
259307,IL4I1,Q96RQ9,0.686,0.5,0.0039601,,,C0025303,Meningococcal Infections,C01,   Infections,group,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
260293,CYP4X1,Q8N118,1.0,0.038,4.7167e-12,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
260328,ALRH,,0.839,0.154,,,,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.05,1.0,,2018.0,2019.0,ALL
260332,ECEL1P3,,,,,,,C3548805,response to aromatase inhibitor,,,phenotype,Cell Function,0.1,1.0,,2019.0,2019.0,ALL
260402,IS1,,0.593,0.615,,,,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.07,1.0,,2007.0,2019.0,ALL
260415,SCASI,,0.89,0.192,,,,C0023211,Left Bundle-Branch Block,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
260425,MAGI3,Q5TCQ9,0.751,0.346,0.02978,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.11,1.0,,2016.0,2017.0,ALL
260429,PRSS33,Q8NF86,,,2.455e-07,DTO_05007624,Enzyme,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
260431,COPD,,0.456,0.885,,,,C0001883,Airway Obstruction,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,0.923,,1986.0,2020.0,ALL
260434,PYDC1,Q8WXC3,0.805,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
260436,FDCSP,Q8NFU4,0.805,0.385,0.081818,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2010.0,2017.0,ALL
261726,TIPRL,O75663,0.716,0.423,0.95372,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
261729,STEAP2,Q8NFT2,0.805,0.154,2.2453e-07,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.07,1.0,,2002.0,2020.0,ALL
261734,NPHP4,O75161,0.674,0.423,1.743e-29,,,C1847013,NEPHRONOPHTHISIS 4,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.9,1.0,,2002.0,2016.0,ALL
266553,OFCC1,Q8IZS5,0.78,0.154,1.8876e-06,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2011.0,ALL
266626,CLCP1,,0.89,0.077,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2002.0,2007.0,ALL
266629,SEC14L3,Q9UDX4,0.722,0.5,3.6612e-23,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
266655,BRD3OS,A0A1B0GUI7,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
266656,TAS2R12P,,0.861,0.154,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
266675,BEST4,Q8NFU0,1.0,0.077,4.6984e-06,DTO_01300327,Ion channel,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
266678,MRX81,,1.0,0.077,,,,C1136249,"Mental Retardation, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
266691,DYX6,,0.931,0.115,,,,C0476254,Dyslexia,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.01,1.0,,2009.0,2009.0,ALL
266700,BMP6P1,,0.839,0.154,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
266719,RRDX,,0.805,0.154,,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2013.0,2013.0,ALL
266722,HS6ST3,Q8IZP7,0.792,0.423,0.99001,DTO_05007624,Enzyme,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.11,0.0,,2011.0,2011.0,ALL
266723,PSMC6P1,,,,,,,C0206625,Malignant Mixed Tumor,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
266727,MDGA1,Q8NFP4,0.821,0.154,0.97574,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,1.0,,2008.0,2020.0,ALL
266740,MAGEA2B,P43356,0.7,0.385,,DTO_05007620,Cell adhesion,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,1994.0,2018.0,ALL
266743,NPAS4,Q8IUM7,0.695,0.5,0.97335,DTO_05007542,Transcription factor,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2012.0,2019.0,ALL
266747,RGL4,Q8IZJ4,1.0,0.115,7.1404e-13,DTO_05007584,Enzyme modulator,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
266790,HCA1,,0.633,0.654,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,1997.0,2020.0,ALL
266812,NAP1L5,Q96NT1,0.89,0.154,0.6928,DTO_05007584,Enzyme modulator,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
266977,ADGRF1,Q5T601,0.736,0.308,2.0011e-22,DTO_02300001,G-protein coupled receptor,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
267004,PGBD3,Q8N328,0.861,0.269,0.041167,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
267010,RNU12,,0.792,0.346,,,,C0009952,Febrile Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
267012,DAOA,P59103,0.678,0.346,0.00014043,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.5,0.965,,2002.0,2018.0,ALL
267013,HLA-DPA3,,0.805,0.308,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
267015,HLA-S,,0.931,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
280636,SELENOH,Q8IZQ5,0.821,0.192,0.0013219,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2019.0,ALL
282566,LINC00515,,0.839,0.231,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
282616,IFNL2,Q8IZJ0,0.666,0.615,4.9903e-08,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,0.9,,2005.0,2019.0,ALL
282617,IFNL3,Q8IZI9,0.506,0.808,2.4233e-08,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.4,0.976,,2009.0,2020.0,ALL
282618,IFNL1,Q8IU54,0.599,0.654,0.00028469,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,0.944,,2005.0,2019.0,ALL
282679,AQP11,Q8NBQ7,0.861,0.192,0.00053022,DTO_01300327,Ion channel,C0022658,Kidney Diseases,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,group,Disease or Syndrome,0.02,1.0,,2016.0,2019.0,ALL
282706,DAOA-AS1,,0.729,0.154,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,1.0,,2004.0,2014.0,ALL
282763,OR51B5,Q9H339,0.931,0.115,9.5367e-08,DTO_02300001,G-protein coupled receptor,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
282775,OR5J2,Q8NH18,,,0.0023661,DTO_02300001,G-protein coupled receptor,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
282808,RAB40AL,P0C0E4,0.792,0.346,0.31342,,,C1845285,Martin-Probst Deafness-Mental Retardation Syndrome,C23;C16;C10;F03;C09;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Otorhinolaryngologic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.6,1.0,limited,2012.0,2015.0,ALL
282809,POC1B,Q8TC44,0.705,0.385,3.0483e-08,,,C4014856,CONE-ROD DYSTROPHY 20,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2018.0,ALL
282849,SLEN3,,1.0,0.077,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
282890,ZNF311,Q5JNZ3,1.0,0.077,1.2064e-08,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
282966,C10orf53,Q8N6V4,0.821,0.154,0.58427,,,C0017606,Primary angle-closure glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
282973,JAKMIP3,Q5VZ66,0.89,0.192,0.067007,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
282974,STK32C,Q86UX6,0.76,0.346,0.20408,DTO_03300101,Kinase,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
282991,BLOC1S2,Q6QNY1,0.76,0.346,0.011948,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
282996,RBM20,Q5T481,0.716,0.269,0.98954,,,C2750995,"Cardiomyopathy, Dilated, 1DD",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.7,1.0,strong,1990.0,2019.0,ALL
282997,PDCD4-AS1,,,,,,,C0201899,Aspartate aminotransferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
283008,NUTM2E,B1AL46,1.0,0.115,1.4976e-05,,,C0334488,Clear cell sarcoma of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
283014,EIF2S2P3,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
283033,LINC00841,,0.89,0.038,,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
283050,ZMIZ1-AS1,,0.78,0.115,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
283078,MKX,Q8IYA7,1.0,0.115,0.88427,DTO_05007542,Transcription factor,C2699541,Cytokine Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
283092,OR4C13,Q8NGP0,0.821,0.115,2.5329e-10,DTO_02300001,G-protein coupled receptor,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
283104,SBF2-AS1,,0.67,0.385,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
283106,CSNK2A3,Q8NEV1,0.821,0.077,2.1007e-10,DTO_03300101,Kinase,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2010.0,2010.0,ALL
283110,OR52Z1,P0C646,,,,DTO_02300001,G-protein coupled receptor,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
283116,TRIM49B,A6NDI0,1.0,0.077,6.3896e-09,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
283120,H19,,0.494,0.923,,,,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.63,1.0,,2005.0,2013.0,ALL
283129,MAJIN,Q3KP22,,,0.00050954,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
283130,SLC25A45,Q8N413,0.821,0.154,4.2329e-07,DTO_05007405,Transporter,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
283131,NEAT1,,0.502,0.769,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.36,1.0,,2014.0,2020.0,ALL
283140,LINC02762,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
283149,BCL9L,Q86UU0,0.743,0.423,0.99939,,,C0266642,Situs ambiguus,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.3,1.0,moderate,2012.0,2012.0,ALL
283150,FOXR1,Q6PIV2,0.821,0.077,1.551e-06,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
283174,MIR4697HG,,0.89,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
283177,LOC283177,,1.0,0.115,,,,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
283208,P4HA3,Q7Z4N8,0.839,0.192,7.8011e-10,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
283212,KLHL35,Q6PF15,0.861,0.192,2.3745e-15,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
283219,KCTD21,Q4G0X4,0.861,0.077,0.0030552,DTO_05007584,Enzyme modulator,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2011.0,2019.0,ALL
283229,CRACR2B,Q8N4Y2,0.931,0.077,3.6358e-11,,,C0008677,"Bronchitis, Chronic",C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.11,1.0,,2014.0,2014.0,ALL
283234,CCDC88B,A6NC98,0.743,0.192,1.399e-09,DTO_05007584,Enzyme modulator,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.41,1.0,,2015.0,2015.0,ALL
283237,TTC9C,Q8N5M4,0.931,0.115,0.00017609,DTO_05007624,Enzyme,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
283238,SLC22A24,Q8N4F4,0.89,0.077,1.7875e-14,DTO_05007405,Transporter,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0,,2013.0,2015.0,ALL
283248,RCOR2,Q8IZ40,,,0.2071,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
283257,TRIM51FP,,,,,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
283267,LINC00294,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
283284,IGSF22,Q8N9C0,1.0,0.077,3.9627e-41,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
283297,OR10A4,Q9H209,0.54,0.808,1.6786e-05,DTO_02300001,G-protein coupled receptor,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,0.818,,2003.0,2014.0,ALL
283298,OLFML1,Q6UWY5,1.0,0.038,1.5857e-08,DTO_05007530,Cellular structure,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2018.0,2018.0,ALL
283310,OTOGL,Q3ZCN5,0.805,0.269,4.7009e-52,DTO_05007584,Enzyme modulator,C3554159,"DEAFNESS, AUTOSOMAL RECESSIVE 84B",,,disease,Disease or Syndrome,0.6,1.0,,2012.0,2012.0,ALL
283316,CD163L1,Q9NR16,0.861,0.154,5.791e-26,DTO_05007624,Enzyme,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
283337,ZNF740,Q8NDX6,0.89,0.038,0.18968,DTO_05007542,Transcription factor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
283349,RASSF3,Q86WH2,0.76,0.308,1.7804e-05,DTO_05007584,Enzyme modulator,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
283358,B4GALNT3,Q6L9W6,0.78,0.192,6.7902e-15,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2019.0,ALL
283373,ANKRD52,Q8NB46,0.89,0.115,1.0,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
283375,SLC39A5,Q6ZMH5,0.792,0.154,7.3793e-11,DTO_05007405,Transporter,C4014762,"MYOPIA 24, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
283377,SPRYD4,Q8WW59,1.0,0.077,0.0079114,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
283383,ADGRD1,Q6QNK2,0.861,0.077,2.5037e-14,DTO_02300001,G-protein coupled receptor,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2009.0,2019.0,ALL
283385,MORN3,Q6PF18,,,1.5357e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
283392,TRHDE-AS1,,0.89,0.077,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
283398,SUCLG2P2,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
283404,LINC00592,,,,,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
283417,DPY19L2,Q6NUT2,0.89,0.077,1.0936e-13,,,C3151407,SPERMATOGENIC FAILURE 9,,,disease,Disease or Syndrome,0.42,1.0,,2019.0,2019.0,ALL
283420,CLEC9A,Q6UXN8,0.76,0.269,1.8488e-05,,,C0012546,Diphtheria,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,2012.0,2018.0,ALL
283422,LINC01559,Q495D7,0.931,0.115,0.03436,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
283432,LINC00485,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
283440,ITFG2-AS1,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
283446,MYO1H,Q8N1T3,0.751,0.385,2.0646e-25,DTO_05007530,Cellular structure,C1275808,Congenital central hypoventilation,C23;C08;C10,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
283450,HECTD4,Q9Y4D8,0.7,0.462,1.0,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
283455,KSR2,Q6VAB6,0.743,0.231,1.0,DTO_03300101,Kinase,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.41,1.0,,2013.0,2019.0,ALL
283459,GATC,O43716,0.821,0.115,0.00065888,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
283460,HNF1A-AS1,,0.621,0.538,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
283463,MUC19,Q7Z5P9,0.736,0.615,6.2216e-32,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.4,1.0,,2011.0,2012.0,ALL
283464,GXYLT1,Q4G148,,,0.12503,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
283480,FGF14-IT1,,,,,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
283481,FGF14-AS2,,0.89,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
283487,LINC00346,Q8IVM7,0.76,0.346,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2019.0,2020.0,ALL
283489,CHAMP1,Q96JM3,0.691,0.5,0.99197,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.42,1.0,strong,2015.0,2016.0,ALL
283514,SIAH3,Q8IW03,,,0.0009634,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
283518,KCNRG,Q8N5I3,0.805,0.269,4.1306e-05,DTO_05007584,Enzyme modulator,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,2003.0,2010.0,ALL
283537,SLC46A3,Q7Z3Q1,0.931,0.115,6.9222e-09,DTO_05007405,Transporter,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
283547,LINC00639,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
283551,LINC01588,,,,7.519e-05,,,C4280669,Velopharyngeal dysfunction,,,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
283556,UBE2L1,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,1995.0,1995.0,ALL
283571,PROX2,Q3B8N5,0.931,0.077,5.5007e-12,DTO_05007542,Transcription factor,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
283575,LINC02288,,,,,,,C0424563,Quality of sleep,,,phenotype,Finding,0.1,1.0,,2013.0,2013.0,ALL
283592,FAM181A-AS1,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
283596,SNHG10,,0.89,0.154,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
283598,C14orf177,Q52M58,,,0.030533,,,C0524851,Neurodegenerative Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
283600,SLC25A47,Q6Q0C1,0.839,0.077,8.2217e-15,DTO_05007405,Transporter,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2004.0,2017.0,ALL
283601,LINC00523,Q86TU6,1.0,0.077,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
283624,LINC00641,,0.769,0.385,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,0.5,,2018.0,2019.0,ALL
283629,TSSK4,Q6SA08,,,5.4619e-09,DTO_03300101,Kinase,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
283635,FAM177A1,Q8N128,0.769,0.231,0.0011791,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
283638,CEP170B,Q9Y4F5,1.0,0.038,0.99671,DTO_05007613,Chaperone,C0018939,Hematological Disease,C15,   Hemic and Lymphatic Diseases,group,Disease or Syndrome,0.01,0.0,,2008.0,2008.0,ALL
283651,HMGN2P46,Q86SG4,0.89,0.077,,DTO_05007557,Nucleic acid binding,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2004.0,2014.0,ALL
283652,SLC24A5,Q71RS6,0.76,0.308,5.1503e-10,DTO_05007405,Transporter,C3805375,"ALBINISM, OCULOCUTANEOUS, TYPE VI",,,disease,Disease or Syndrome,0.43,1.0,,2013.0,2019.0,ALL
283659,PRTG,Q2VWP7,0.861,0.154,1.1959e-07,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
283673,EWSAT1,,0.792,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,0.667,,2017.0,2018.0,ALL
283677,REC114,Q7Z4M0,1.0,0.077,3.2736e-05,,,C0678213,Complete hydatidiform mole,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
283682,LINC01579,,0.861,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
283685,GOLGA6L2,Q8N9W4,0.89,0.231,1.0579e-06,DTO_05007530,Cellular structure,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
283692,CPEB1-AS1,,0.931,0.038,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
283693,ACTG1P17,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
283710,LOC283710,,1.0,0.115,,,,C0341106,Eosinophilic esophagitis,C06;C20;C15,   Digestive System Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
283726,SAXO2,Q658L1,,,8.3284e-11,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
283731,LOC283731,,0.861,0.038,0.00046915,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
283742,FAM98B,Q52LJ0,1.0,0.077,0.010312,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
283748,PLA2G4D,Q86XP0,0.861,0.231,2.6287e-14,DTO_05007624,Enzyme,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2005.0,2005.0,ALL
283768,GOLGA8G,Q08AF8,1.0,0.115,0.19562,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
283777,FAM169B,Q8N8A8,1.0,0.115,0.012612,,,C3495559,Juvenile arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
283807,FBXL22,Q6P050,0.931,,0.0014582,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
283849,EXOC3L1,Q86VI1,1.0,0.077,1.7404e-19,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
283854,CASC22,,0.89,0.115,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
283860,LINC00304,Q8N9R0,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
283867,LINC00922,,0.821,0.154,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
283869,NPW,Q8N729,0.89,0.192,0.00088233,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
283871,PGP,A6NDG6,0.606,0.808,0.16263,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,1993.0,1995.0,ALL
283875,LINC00514,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
283899,INO80E,Q8NBZ0,,,0.0086846,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2017.0,2017.0,ALL
283902,HCCAT5,,0.716,0.462,,,,C0085580,Essential Hypertension,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0,,2017.0,2019.0,ALL
283914,LINC01566,,1.0,0.038,,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
283927,NUDT7,P0C024,0.89,0.154,8.4378e-07,DTO_05007624,Enzyme,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
283932,FBXL19-AS1,Q494R0,0.743,0.192,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
283953,TMEM114,B3SHH9,0.861,0.231,0.033213,,,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
283982,LINC00469,Q8N7U9,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
283985,FADS6,Q8N9I5,1.0,0.192,1.1478e-09,,,C0271097,Usher Syndrome,C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
283987,HID1,Q8IV36,0.931,0.115,0.026841,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2001.0,2001.0,ALL
283989,TSEN54,Q7Z6J9,0.659,0.5,1.7512e-07,,,C1848526,Pontocerebellar Hypoplasia Type 2A,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2008.0,2018.0,ALL
283999,TMEM235,A6NFC5,1.0,0.115,0.00045831,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
284001,CCDC57,Q2TAC2,1.0,0.077,6.5038e-16,,,C0042133,Uterine Fibroids,C04,   Neoplasms,group,Neoplastic Process,0.11,0.5,,2012.0,2019.0,ALL
284004,HEXD,Q8WVB3,0.78,0.308,4.3406e-11,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
284013,VMO1,Q7Z5L0,0.821,0.115,2.1183e-06,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
284018,C17orf58,Q2M2W7,1.0,0.077,0.19122,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
284021,MILR1,Q7Z6M3,0.861,0.154,0.024528,DTO_05007620,Cell adhesion,C0002792,anaphylaxis,C20,   Immune System Diseases,phenotype,Disease or Syndrome,0.03,1.0,,2010.0,2020.0,ALL
284029,LINC00324,,0.805,0.115,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
284034,LINC00670,,0.821,0.077,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
284058,KANSL1,Q7Z3B3,0.592,0.731,0.99972,,,C1864871,Chromosome 17q21.31 Deletion Syndrome,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.75,0.9,,2009.0,2018.0,ALL
284076,TTLL6,Q8N841,0.89,0.115,9.7742e-20,DTO_05007624,Enzyme,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2018.0,2019.0,ALL
284080,PICART1,,0.821,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
284085,KRT18P55,,0.861,0.077,,,,C1842675,AMYOTROPHIC LATERAL SCLEROSIS 6 (disorder),,,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
284086,NEK8,Q86SG6,0.631,0.5,6.4566e-09,DTO_03300101,Kinase,C3151188,NEPHRONOPHTHISIS 9,,,disease,Disease or Syndrome,0.72,1.0,,2008.0,2016.0,ALL
284098,PIGW,Q7Z7B1,0.633,0.654,1.172e-05,DTO_05007624,Enzyme,C4014958,GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11,,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2018.0,ALL
284106,CISD3,P0C7P0,0.711,0.577,0.019823,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,2008.0,2013.0,ALL
284110,GSDMA,Q96QA5,0.792,0.308,1.619e-16,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.17,0.917,,2010.0,2016.0,ALL
284111,SLC13A5,Q86YT5,0.608,0.577,0.00050598,DTO_05007405,Transporter,C4014621,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2017.0,ALL
284114,TMEM102,Q8N9M5,0.931,0.154,8.5749e-06,,,C0025517,Metabolic Diseases,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
284116,KRT42P,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
284119,CAVIN1,Q6NZI2,0.559,0.654,0.0049657,DTO_05007542,Transcription factor,C2750069,"Lipodystrophy, Congenital Generalized, Type 4",C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.83,1.0,,2008.0,2015.0,ALL
284123,FAM27E5,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
284129,SLC26A11,Q86WA9,0.89,0.269,3.0064e-19,DTO_05007405,Transporter,C0086647,Mucopolysaccharidosis Type IIIA,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2014.0,ALL
284131,ENDOV,Q8N8Q3,0.805,0.385,1.0129e-09,,,C0043346,Xeroderma Pigmentosum,C16;C04;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.03,1.0,,1986.0,1993.0,ALL
284184,NDUFAF8,A1L188,1.0,0.115,0.14285,,,C0338451,Frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
284203,RNASEH1P1,,,,,,,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2017.0,2017.0,ALL
284207,METRNL,Q641Q3,0.76,0.269,0.74538,,,C0271650,Impaired glucose tolerance,C18,   Nutritional and Metabolic Diseases,phenotype,Disease or Syndrome,0.31,1.0,,2018.0,2018.0,ALL
284217,LAMA1,P25391,0.582,0.808,3.2248e-32,,,C4014821,"Cerebellar ataxia, intellectual disability, oculomotor apraxia, cerebellar cysts syndrome",C23;C16;C11;C10;F03;F01;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.61,1.0,strong,2011.0,2014.0,ALL
284232,ANKRD20A9P,,,,,,,C0023980,Longevity,,,phenotype,Temporal Concept,0.1,1.0,,2016.0,2016.0,ALL
284252,KCTD1,Q719H9,0.682,0.615,0.85538,DTO_05007584,Enzyme modulator,C1867020,SCALP-EAR-NIPPLE SYNDROME,C23;C16;C13;C12;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.73,0.667,,2013.0,2019.0,ALL
284254,DYNAP,Q8N1N2,,,0.0025806,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2010.0,2015.0,ALL
284260,LINC00907,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
284266,SIGLEC15,Q6ZMC9,0.89,0.192,8.2148e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
284273,ZADH2,Q8N4Q0,1.0,0.077,0.002543,DTO_05007624,Enzyme,C2239222,Vascular Endothelial Growth Factor Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
284274,SMIM21,Q3B7S5,1.0,0.077,2.1196e-05,,,C0240912,Vertical Talus,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0,,2013.0,2013.0,ALL
284276,LINC00908,,0.89,0.115,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.3,1.0,,2015.0,2015.0,ALL
284293,HMSD,A8MTL9,0.839,0.192,0.012863,DTO_05007584,Enzyme modulator,C4310710,PEELING SKIN SYNDROME 5,,,disease,Disease or Syndrome,0.1,,,,,ALL
284294,LINC01924,,1.0,0.038,,,,C0035227,Respiratory Function Tests,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
284297,SSC5D,A1L4H1,,,8.1581e-23,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
284306,ZNF547,Q8IVP9,0.931,0.077,0.0080575,,,C0038015,Spondyloepiphyseal Dysplasia,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,0.0,,2000.0,2000.0,ALL
284307,ZIK1,Q3SY52,1.0,0.077,2.7592e-05,,,C0334037,Intestinal metaplasia,,,phenotype,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
284312,ZSCAN1,Q8NBB4,0.78,0.308,4.3802e-07,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
284340,CXCL17,Q6UXB2,0.647,0.615,0.0048138,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2006.0,2020.0,ALL
284346,ZNF575,Q86XF7,1.0,0.192,0.11491,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
284348,LYPD5,Q6UWN5,0.608,0.615,0.00047161,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2006.0,2019.0,ALL
284352,PPP1R37,O75864,0.89,0.115,0.99448,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2011.0,2018.0,ALL
284353,NKPD1,Q17RQ9,0.89,0.115,7.0389e-07,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2011.0,2019.0,ALL
284358,MAMSTR,Q6ZN01,0.792,0.115,0.0054856,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
284359,IZUMO1,Q8IYV9,0.89,0.115,3.0387e-08,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2016.0,2016.0,ALL
284361,EMC10,Q5UCC4,0.76,0.231,9.4077e-11,,,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
284366,KLK9,Q9UKQ9,0.805,0.192,1.2997e-07,DTO_05007624,Enzyme,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2001.0,2017.0,ALL
284370,ZNF615,Q8N8J6,0.861,0.038,8.376e-12,DTO_05007542,Transcription factor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
284371,ZNF841,Q6ZN19,1.0,0.077,0.023931,DTO_05007542,Transcription factor,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
284382,ACTL9,Q8TC94,0.861,0.192,0.0040543,DTO_05007530,Cellular structure,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.33,1.0,,2012.0,2015.0,ALL
284385,ZNF561-AS1,K7EIQ3,1.0,0.077,0.0016695,,,C0020445,"Hypercholesterolemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
284390,ZNF763,Q0D2J5,0.691,0.5,0.018273,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
284403,WDR62,O43379,0.597,0.615,2.3562e-23,,,C1858535,"MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 2 (disorder)",,,disease,Disease or Syndrome,0.62,1.0,,2010.0,2018.0,ALL
284406,ZFP82,Q8N141,0.751,0.423,0.57889,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
284415,VSTM1,Q6UX27,0.821,0.192,6.372e-08,DTO_05007575,Receptor,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
284417,TMEM150B,A6NC51,0.89,0.115,3.5074e-08,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
284424,MIR7-3HG,Q8N6C7,0.736,0.192,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
284427,SLC25A41,Q8N5S1,0.931,0.077,6.8621e-12,DTO_05007405,Transporter,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
284434,NWD1,Q149M9,0.805,0.192,1.49e-26,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
284439,SLC25A42,Q86VD7,0.76,0.269,0.48948,DTO_05007405,Transporter,C0162670,Mitochondrial Myopathies,C18;C05;C10,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,group,Disease or Syndrome,0.41,1.0,strong,2016.0,2018.0,ALL
284440,LINC00663,,0.861,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
284443,ZNF493,Q6ZR52,1.0,0.038,5.829e-06,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
284454,LOC284454,,0.839,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
284459,ZNF875,P10072,0.839,0.115,1.6877e-19,DTO_05007542,Transcription factor,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
284467,TAFA3,Q7Z5A8,1.0,0.038,3.6668e-05,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.2,,,,,ALL
284486,THEM5,Q8N1Q8,0.89,0.115,3.7917e-11,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
284498,C1orf167,Q5SNV9,1.0,0.038,9.1452e-34,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
284521,OR2L13,Q8N349,1.0,0.038,0.00098315,DTO_02300001,G-protein coupled receptor,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
284525,SLC9C2,Q5TAH2,0.792,0.462,0.00019485,DTO_05007405,Transporter,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
284541,CYP4A22,Q5TCH4,0.931,0.192,1.4246e-29,DTO_05007624,Enzyme,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0,,2006.0,2008.0,ALL
284546,C1orf185,Q5T7R7,0.89,0.115,5.0044e-07,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
284551,LINC01226,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
284565,NBPF15,Q8N660,1.0,,6.0603e-07,,,C4285789,Systemic viral infection,,,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
284573,LINC00303,Q3SY05,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
284611,FAM102B,Q5T8I3,1.0,0.077,0.00039858,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
284612,SYPL2,Q5VXT5,0.821,0.192,1.8911e-05,DTO_05007405,Transporter,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2016.0,2019.0,ALL
284613,CYB561D1,Q8N8Q1,1.0,0.038,7.1834e-05,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
284615,ANKRD34A,Q69YU3,0.861,0.077,0.98103,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
284618,RUSC1-AS1,Q66K80,0.861,0.154,,,,C4225262,"POROKERATOSIS 9, MULTIPLE TYPES",,,disease,Disease or Syndrome,0.1,,,,,ALL
284654,RSPO1,Q2MKA7,0.593,0.731,1.4418e-06,,,C3149931,"PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL",,,disease,Neoplastic Process,0.5,1.0,strong,2006.0,2011.0,ALL
284656,EPHA10,Q5JZY3,0.78,0.192,1.2428e-26,DTO_03300101,Kinase,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
284677,SNHG28,P0DPA3,1.0,0.077,1.2953e-08,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
284688,LINC01142,,0.931,0.077,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
284695,ZNF326,Q5BKZ1,0.76,0.192,0.90182,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
284697,BTBD8,Q5XKL5,0.547,0.692,6.077e-07,,,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2005.0,2019.0,ALL
284739,C20orf204,A0A1B0GTL2,0.861,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
284751,LINC01270,,1.0,0.038,,,,C0202230,Thyroid stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
284757,MIR646HG,,0.861,0.077,,,,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
284759,SIRPB2,Q5JXA9,,,0.00036633,DTO_05007599,Signaling,C2698399,Myeloperoxidase Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
284800,FAM182A,Q5T1J6,0.805,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2015.0,2015.0,ALL
284801,MIR663AHG,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
284805,C20orf203,Q8NBC4,1.0,0.077,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
284825,LINC01697,,1.0,0.077,,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2019.0,ALL
284835,LINC00323,,0.89,0.038,,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
284836,LINC00319,,0.711,0.385,,,,C4280669,Velopharyngeal dysfunction,,,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
284837,AATBC,,0.89,0.115,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
284889,MIF-AS1,,0.663,0.577,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.03,1.0,,1999.0,2018.0,ALL
284900,TTC28-AS1,,0.89,0.192,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
284904,SEC14L4,Q9UDX3,,,1.3104e-11,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
284948,SH2D6,Q7Z4S9,1.0,0.038,3.7712e-05,DTO_05007599,Signaling,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
284996,RNF149,Q8NC42,0.839,0.154,0.00057831,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
285016,ALKAL2,Q6UX46,0.839,0.154,0.031797,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
285025,CCDC141,Q6ZP82,0.666,0.538,1.5924e-33,,,C0162809,Kallmann Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.32,1.0,,2016.0,2017.0,ALL
285045,LINC00486,,1.0,0.115,,,,C2607914,Allergic rhinitis (disorder),C08;C20;C09,   Respiratory Tract Diseases;    Immune System Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
285051,STPG4,Q8N801,0.659,0.577,9.5142e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
285084,LINC01305,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
285148,IAH1,Q2TAA2,,,0.0034427,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
285150,FLJ33534,,1.0,0.077,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
285154,CYP1B1-AS1,,0.769,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
285172,FAM126B,Q8IXS8,0.89,0.154,0.17863,,,C0043094,Weight Gain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Finding,0.3,1.0,,2008.0,2008.0,ALL
285175,UNC80,Q8N2C7,0.626,0.462,0.052307,,,C4225203,"HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2018.0,ALL
285180,RUFY4,Q6ZNE9,,,5.0653e-14,,,C0200641,Blood basophil count (lab test),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
285193,DUSP28,Q4G0W2,0.861,0.115,0.17995,,,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
285194,TUSC7,,0.705,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2015.0,2019.0,ALL
285195,SLC9A9,Q8IVB4,0.656,0.577,5.3311e-12,DTO_05007405,Transporter,C3150677,"AUTISM, SUSCEPTIBILITY TO, 16",,,disease,Finding,0.4,1.0,limited,2003.0,2003.0,ALL
285203,EOGT,Q5NDL2,0.641,0.5,5.038e-09,DTO_05007624,Enzyme,C3809092,ADAMS-OLIVER SYNDROME 4,,,disease,Disease or Syndrome,0.6,1.0,,2013.0,2018.0,ALL
285205,LINC00636,,,,,,,C0424574,Duration of sleep,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
285220,EPHA6,Q9UF33,0.751,0.308,0.67037,DTO_03300101,Kinase,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
285224,DNAJB8-AS1,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
285231,FBXW12,Q6X9E4,0.89,0.154,7.0808e-10,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
285237,C3orf38,Q5JPI3,1.0,0.038,0.00061331,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
285242,HTR3E,A5X5Y0,0.839,0.077,4.2286e-10,DTO_01300327,Ion channel,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2009.0,2010.0,ALL
285266,ENTPD3-AS1,,,,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
285282,RABL3,Q5HYI8,0.751,0.231,0.00080229,,,C2931038,"Pancreatic carcinoma, familial",C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2019.0,2019.0,ALL
285286,LINC00877,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
285313,IGSF10,Q6WRI0,0.792,0.346,5.8027e-49,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
285314,PABPC1P10,,0.861,0.115,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,0.0,,1993.0,1993.0,ALL
285326,LINC00692,,1.0,0.115,0.32549,,,C1456868,Diabetic foot ulcer,C17;C19;C14,   Skin and Connective Tissue Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
285331,CCDC66,A2RUB6,0.743,0.154,5.6053e-36,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.21,1.0,,2011.0,2011.0,ALL
285335,SLC9C1,Q4G0N8,0.78,0.308,3.0455e-15,DTO_05007405,Transporter,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0,,1997.0,2006.0,ALL
285343,TCAIM,Q8N3R3,1.0,0.038,2.2334e-05,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
285349,ZNF660,Q6AZW8,0.931,0.077,4.3113e-07,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
285352,KIF9-AS1,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
285362,SUMF1,Q8NBK3,0.641,0.538,2.2828e-08,,,C0268263,Multiple Sulfatase Deficiency Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,strong,2003.0,2019.0,ALL
285370,LINC00606,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
285375,LINC00620,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
285381,DPH3,Q96FX2,0.821,0.077,0.066294,,,C0007114,Malignant neoplasm of skin,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
285382,C3orf70,A6NLC5,1.0,0.077,4.8695e-05,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
285386,TPRG1,Q6ZUI0,0.931,0.038,1.9365e-10,,,C0023798,Lipoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
285401,LINC00698,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
285419,LINC01091,,0.821,0.231,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
285423,IQCM,A0A1B0GVH7,0.861,0.154,,,,C0007113,Rectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2015.0,2015.0,ALL
285440,CYP4V2,Q6ZWL3,0.67,0.577,2.1975e-10,DTO_05007624,Enzyme,C1859486,BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,1.0,0.976,,2004.0,2019.0,ALL
285441,F11-AS1,,0.805,0.308,,,,C0015523,Hereditary Factor XI Deficiency,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,1.0,,1989.0,2019.0,ALL
285456,RPL34-AS1,,0.839,0.115,,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
285463,CTBP1-AS,,0.76,0.346,,,,C0026650,Movement Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.1,1.0,,1995.0,2017.0,ALL
285489,DOK7,Q18PE1,0.615,0.615,0.00010263,,,C1850792,Congenital myasthenic syndrome ib,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.91,1.0,strong,1990.0,2018.0,ALL
285498,RNF212,Q495C1,1.0,0.038,0.0015645,,,C2677576,RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1,,,phenotype,Finding,0.1,,,,,ALL
285513,GPRIN3,Q6ZVF9,,,4.0589e-13,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
285521,COX18,Q8N8Q8,1.0,0.077,6.0435e-15,DTO_05007405,Transporter,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0,,2009.0,2009.0,ALL
285525,YIPF7,Q8N8F6,1.0,0.192,8.1847e-06,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
285527,FRYL,O94915,0.751,0.192,0.99727,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
285533,RNF175,Q8N4F7,,,6.8141e-13,DTO_05007624,Enzyme,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2014.0,2014.0,ALL
285548,LINC01096,,0.931,0.077,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
285555,STPG2,Q8N412,0.931,0.038,9.3325e-17,DTO_05007530,Cellular structure,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
285556,C4orf54,D6RIA3,0.931,,9.3027e-09,,,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
285577,LINC01019,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
285588,EFCAB9,A8MZ26,1.0,,0.00010712,,,C0221106,Alkalemia,,,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
285590,SH3PXD2B,A1X283,0.631,0.577,0.0041589,,,C1855305,Ter Haar syndrome,C16;C05;F03;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Mental Disorders;    Cardiovascular Diseases",disease,Disease or Syndrome,0.78,1.0,,1982.0,2019.0,ALL
285600,KIAA0825,Q8IV33,0.861,0.192,5.2834e-09,,,C3887487,Postaxial polydactyly type A,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.4,1.0,,2019.0,2019.0,ALL
285601,GPR150,Q8NGU9,0.931,0.115,1.3878e-05,DTO_02300001,G-protein coupled receptor,C1140680,Malignant neoplasm of ovary,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2007.0,2007.0,ALL
285605,DTWD2,Q8NBA8,,,2.8104e-09,,,C1277709,Transferrin saturation measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
285627,LINC01845,,1.0,0.077,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
285634,INTS6P1,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
285643,KIF4B,Q2VIQ3,1.0,0.077,4.6327e-25,DTO_05007530,Cellular structure,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
285659,OR2V2,Q96R30,,,0.081893,DTO_02300001,G-protein coupled receptor,C0202230,Thyroid stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
285668,C5orf64,Q2M2E5,,,0.0071986,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
285671,RNF180,Q86T96,0.805,0.269,2.7621e-06,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.05,1.0,,2012.0,2016.0,ALL
285672,SREK1IP1,Q8N9Q2,1.0,0.077,0.3871,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
285692,LINC02112,,1.0,0.077,,,,C0917799,Hypersomnia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
285704,RGMB,Q6NW40,0.711,0.462,0.071955,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2007.0,2007.0,ALL
285708,LINC00491,,0.89,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
285735,LINC00326,,,,,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2013.0,2014.0,ALL
285740,PHACTR2-AS1,,0.89,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
285753,CEP57L1,Q8IYX8,,,2.8112e-08,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
285755,PPIL6,Q8IXY8,0.861,0.154,1.7495e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2014.0,ALL
285758,MROCKI,,0.821,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
285761,DCBLD1,Q8N8Z6,0.729,0.231,6.325e-08,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
285768,LINC01622,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
285780,LY86-AS1,,0.861,0.192,,,,C0005411,Biliary Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.1,1.0,,2010.0,2010.0,ALL
285782,CAGE1,Q8TC20,0.89,0.115,8.7071e-14,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2003.0,2006.0,ALL
285796,PACRG-AS1,,,,,,,C1096202,Lipoprotein (a) measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2015.0,2015.0,ALL
285830,HLA-F-AS1,,0.861,0.269,,,,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
285834,HCG22,E2RYF7,0.736,0.423,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2009.0,ALL
285848,PNPLA1,Q8N8W4,0.7,0.423,0.00018528,DTO_05007624,Enzyme,C3554355,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10",,,disease,Disease or Syndrome,0.9,1.0,,2012.0,2017.0,ALL
285852,TREML4,Q6UXN2,0.792,0.192,7.7513e-10,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
285857,LINC02537,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
285888,CNPY1,Q3B7I2,,,2.1539e-05,,,C3272931,Fibroblast Growth Factor 23 Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
285908,LINC00174,,0.931,0.077,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2019.0,2020.0,ALL
285943,HOXA-AS2,,0.663,0.385,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2016.0,2017.0,ALL
285958,SNHG15,,0.633,0.615,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
285962,WEE2-AS1,,0.931,0.115,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
285965,EPHA1-AS1,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2011.0,2019.0,ALL
285971,ZNF775,Q96BV0,1.0,0.077,0.00070042,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
285972,LINC00996,,0.89,0.115,,,,C0678909,Brain Waves,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
285973,ATG9B,Q674R7,0.792,0.269,1.2544e-17,,,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
285987,DLX6-AS1,,0.628,0.423,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
285989,ZNF789,Q5FWF6,,,2.9215e-07,,,C0201983,Dehydroepiandrosterone sulfate measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
286002,SLC26A4-AS1,,0.861,0.269,,,,C0011053,Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Finding,0.1,,,,,ALL
286016,TPI1P2,,0.839,0.115,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
286042,FAM86B3P,,0.931,0.115,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
286046,XKR6,Q5GH73,0.729,0.538,0.99934,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.12,1.0,,2008.0,2018.0,ALL
286053,NSMCE2,Q96MF7,0.682,0.615,0.037899,,,C4310647,SECKEL SYNDROME 10,,,disease,Disease or Syndrome,0.4,1.0,,2014.0,2014.0,ALL
286077,FAM83H,Q6ZRV2,0.686,0.269,0.89239,,,C0399376,"Amelogenesis Imperfecta, Type III",C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.75,1.0,strong,2008.0,2017.0,ALL
286102,TMED10P1,,0.663,0.615,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.05,1.0,,2008.0,2019.0,ALL
286114,LINC02153,,1.0,0.038,,,,C0015944,"Fetal Membranes, Premature Rupture",C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,1.0,,2019.0,2019.0,ALL
286128,ZFP41,Q8N8Y5,,,0.00035717,DTO_05007542,Transcription factor,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
286133,SCARA5,Q6ZMJ2,0.695,0.385,1.0417e-05,DTO_05007624,Enzyme,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
286144,TRIQK,Q629K1,1.0,0.077,0.0099534,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
286151,FBXO43,Q4G163,1.0,0.038,1.1268e-05,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
286183,NKAIN3,Q8N8D7,0.861,0.192,0.05385,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
286184,LINC01289,,,,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
286186,LINC01299,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
286187,PPP1R42,Q7Z4L9,0.76,0.385,1.7442e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
286204,CRB2,Q5IJ48,0.678,0.269,1.4884e-14,,,C1857423,Cystic Kidney Disease with Ventriculomegaly,C13;C12;C10,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2015.0,2019.0,ALL
286205,SCAI,Q8N9R8,0.716,0.346,0.99936,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
286257,PAXX,Q9BUH6,1.0,0.038,0.0054207,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
286262,TPRN,Q4KMQ1,0.839,0.115,0.0072201,,,C2750082,"Deafness, Autosomal Recessive 79",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.81,1.0,strong,2010.0,2019.0,ALL
286310,LCN1P1,Q5VSP4,,,,DTO_05007624,Enzyme,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
286319,TUSC1,Q2TAM9,0.716,0.231,0.042737,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2013.0,2017.0,ALL
286333,FAM225A,,,,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
286343,LURAP1L,Q8IV03,0.736,0.269,0.025029,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
286380,FOXD4L3,Q6VB84,1.0,0.077,0.49542,DTO_05007542,Transcription factor,C0598766,Leukemogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
286410,ATP11C,Q8NB49,0.751,0.269,0.9997,DTO_05007405,Transporter,C4746970,"HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED",,,disease,Disease or Syndrome,0.4,1.0,,2016.0,2016.0,ALL
286436,H2BW2,P0C1H6,1.0,0.115,0.014026,DTO_05007557,Nucleic acid binding,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
286451,YIPF6,Q96EC8,0.89,0.077,0.89735,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
286467,FIRRE,,0.839,0.192,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
286494,BRAFP1,,0.931,0.038,,,,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
286499,FAM133A,Q8N9E0,0.839,0.154,0.39581,DTO_05007624,Enzyme,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
286527,TMSB15B,P0CG34;P0CG35,0.743,0.269,0.38882,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2007.0,2007.0,ALL
286530,P2RY8,Q86VZ1,0.7,0.385,0.0034012,DTO_02300001,G-protein coupled receptor,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.34,1.0,,2009.0,2017.0,ALL
286676,ILDR1,Q86SU0,0.729,0.346,2.6072e-12,,,C1864818,"DEAFNESS, AUTOSOMAL RECESSIVE 42 (disorder)",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2011.0,2015.0,ALL
286749,STON1-GTF2A1L,Q9Y6Q2,0.682,0.385,1.5167e-22,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2013.0,ALL
286751,OTSC4,,1.0,0.038,,,,C0029899,Otosclerosis,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
286753,TRARG1,Q8IXB3,0.805,0.269,0.00052419,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
286826,LIN9,Q5TKA1,0.743,0.346,0.99771,DTO_05007557,Nucleic acid binding,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
286827,TRIM59,Q8IWR1,0.599,0.577,0.0014575,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
286887,KRT6C,P48668,0.751,0.269,3.8079e-22,,,C3810394,"PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE",,,disease,Disease or Syndrome,0.7,1.0,strong,2010.0,2013.0,ALL
287015,TRIM42,Q8IWZ5,1.0,0.038,3.0721e-19,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2014.0,ALL
317648,NOP14-AS1,,,,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
317649,EIF4E3,Q8N5X7,0.78,0.231,0.018058,DTO_05007557,Nucleic acid binding,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
317662,FAM149B1,Q96BN6,0.663,0.423,2.4901e-13,,,C0029294,Orofaciodigital Syndromes,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.31,1.0,moderate,2019.0,2019.0,ALL
317664,DFNA49,,0.861,0.154,,,,C0007959,Charcot-Marie-Tooth Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
317668,MCDR3,,1.0,0.077,,,,C0730294,North Carolina macular dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.02,0.5,,2017.0,2017.0,ALL
317669,IBD9,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
317671,RFESD,Q8TAC1,0.861,0.038,6.7235e-06,DTO_05007624,Enzyme,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
317682,OTSC5,,1.0,0.038,,,,C0029899,Otosclerosis,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
317685,NYS4,,1.0,0.115,,,,C0585539,X-Linked Infantile Nystagmus,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2011.0,2011.0,ALL
317701,VN1R2,Q8NFZ6,,,,DTO_02300001,G-protein coupled receptor,C0275524,Coinfection,C01,   Infections,phenotype,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
317703,VN1R4,Q7Z5H5,,,,DTO_02300001,G-protein coupled receptor,C0275524,Coinfection,C01,   Infections,phenotype,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
317705,VN1R5,Q7Z5H4,,,,DTO_02300001,G-protein coupled receptor,C0275524,Coinfection,C01,   Infections,phenotype,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
317714,DYT15,,0.89,0.154,,,,C1834570,Myoclonic dystonia,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.32,0.5,,2007.0,2017.0,ALL
317716,BPIFA4P,Q86YQ2,0.711,0.654,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,2002.0,2018.0,ALL
317719,KLHL10,Q6JEL2,0.861,0.038,0.97852,,,C3554453,SPERMATOGENIC FAILURE 11,,,disease,Disease or Syndrome,0.6,1.0,,2006.0,2006.0,ALL
317754,POTED,Q86YR6,0.751,0.269,0.00041359,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2006.0,2019.0,ALL
317761,C14orf39,Q8N1H7,0.861,0.038,2.7282e-06,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
317762,CCDC85C,A6NKD9,0.89,0.077,0.7501,,,C0020255,Hydrocephalus,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.23,1.0,,2004.0,2020.0,ALL
317772,H2AC21,Q8IUE6,1.0,0.077,0.61467,DTO_05007557,Nucleic acid binding,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
317773,MGR6,,0.89,0.154,,,,C0338484,Familial Hemiplegic Migraine,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2008.0,2018.0,ALL
317781,DDX51,Q8N8A6,0.821,0.154,8.6133e-12,,,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
317782,CELIAC2,,0.653,0.577,,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.06,1.0,,1981.0,2009.0,ALL
319089,TTC6,Q86TZ1,0.931,0.154,1.0591e-25,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
319100,TAAR6,Q96RI8,0.78,0.231,0.016668,DTO_02300001,G-protein coupled receptor,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2010.0,ALL
319101,KRT73,Q86Y46,0.861,0.192,7.1972e-12,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
319129,RPSAP5,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
326340,ZAR1,Q86SH2,0.674,0.269,4.3531e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2011.0,2019.0,ALL
326342,ADGRE4P,Q86SQ3,0.78,0.231,,DTO_02300001,G-protein coupled receptor,C4721579,Secondary malignant neoplasm of colon and/or rectum,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2015.0,2019.0,ALL
326343,MT1DP,A1L3X4,0.743,0.269,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,2016.0,2016.0,ALL
326624,RAB37,Q96AX2,0.76,0.231,8.1116e-08,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
326625,MMAB,Q96EY8,0.695,0.538,0.0041291,DTO_05007624,Enzyme,C1855102,Methylmalonic aciduria cblB type,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.73,1.0,strong,2002.0,2018.0,ALL
326628,RPA2P1,,1.0,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
327657,SERPINA9,Q86WD7,0.769,0.231,1.2106e-13,DTO_05007584,Enzyme modulator,C0079744,Diffuse Large B-Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,2003.0,2009.0,ALL
327659,PUDPP2,,0.89,0.154,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
333926,PPM1J,Q5JR12,,,2.2494e-09,DTO_05007624,Enzyme,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
333929,SNAI3,Q3KNW1,0.76,0.115,0.013249,,,C0520459,Necrotizing Enterocolitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
333932,H3C15,Q71DI3,0.821,0.231,,,,C0024131,Lupus Vulgaris,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
337867,UBAC2,Q8NBM4,0.638,0.654,0.0062623,,,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.34,1.0,,2009.0,2017.0,ALL
337874,H2BC19P,Q6DRA6,1.0,0.115,,DTO_05007557,Nucleic acid binding,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
337876,CHSY3,Q70JA7,0.805,0.269,0.0028439,DTO_05007624,Enzyme,C1876187,"TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.02,1.0,,2009.0,2016.0,ALL
337879,KRTAP8-1,Q8IUC2,1.0,0.038,0.1027,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
337892,MGR3,,0.861,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,1997.0,2004.0,ALL
337975,KRTAP20-1,Q3LI63,1.0,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
337977,KRTAP21-1,Q3LI58,1.0,0.077,0.35324,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
337991,DFNB38,,1.0,0.115,,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
338005,LINC00221,,0.931,0.115,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.31,1.0,,2017.0,2019.0,ALL
338030,GLM4,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
338069,ST7-OT4,,,,0.020808,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
338090,SPG24,,0.931,0.077,,,,C1843569,"SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE (disorder)",C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
338094,FAM151A,Q8WW52,,,6.5453e-17,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
338321,NLRP9,Q7RTR0,0.89,0.154,8.8603e-25,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
338322,NLRP10,Q86W26,0.861,0.192,1.0095e-08,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
338323,NLRP14,Q86W24,0.861,0.192,5.7416e-36,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
338324,S100A7A,Q86SG5,0.7,0.231,0.002523,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
338328,GPIHBP1,Q8IV16,0.686,0.269,0.13866,,,C4014767,"HYPERLIPOPROTEINEMIA, TYPE ID",,,disease,Disease or Syndrome,0.7,1.0,strong,2009.0,2018.0,ALL
338332,CELIAC5,,0.861,0.115,,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
338339,CLEC4D,Q8WXI8,0.587,0.538,2.4548e-06,,,C0024115,Lung diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
338340,MMS,,0.792,0.192,,,,C0026654,Moyamoya Disease,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2012.0,2018.0,ALL
338376,IFNE,Q86WN2,0.769,0.269,0.014672,,,C0036916,Sexually Transmitted Diseases,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,group,Disease or Syndrome,0.03,1.0,,2013.0,2018.0,ALL
338382,RAB7B,Q96AH8,0.615,0.731,,,,C0001787,"Osteoporosis, Age-Related",C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
338386,HSR,,0.716,0.423,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,1993.0,2018.0,ALL
338398,TAS2R60,P59551,1.0,0.038,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
338399,TAS2R62P,,0.729,0.192,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,0.923,,1997.0,2019.0,ALL
338412,TAS2R64P,,0.678,0.385,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,1997.0,2016.0,ALL
338413,TAS2R63P,,0.931,0.077,,,,C0014173,Endometrial Hyperplasia,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
338414,TAS2R18P,,1.0,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1988.0,1988.0,ALL
338428,SNORD109A,,1.0,0.115,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
338429,SNORD109B,,1.0,0.115,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
338433,SNORD115-1,,0.682,0.423,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,,2006.0,2006.0,ALL
338435,SCA25,,0.931,0.077,,,,C1837518,Spinocerebellar ataxia 25,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,,2005.0,2005.0,ALL
338436,BLACE,A4D250,0.931,0.115,,,,C0280100,Solid Neoplasm,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
338440,ANO9,A1A5B4,0.861,0.154,8.4487e-16,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,2012.0,2016.0,ALL
338442,HCAR2,Q8TDS4,0.631,0.692,0.00018933,,,C0016382,Flushing,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.36,1.0,,2005.0,2019.0,ALL
338557,FFAR4,Q5NUL3,0.621,0.577,1.3634e-05,,,C2675659,BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10,,,phenotype,Finding,0.4,,,,,ALL
338567,KCNK18,Q7Z418,0.78,0.192,0.0013568,,,C3150908,"MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13",,,disease,Finding,0.6,1.0,,2010.0,2012.0,ALL
338588,LINC00705,,1.0,0.038,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
338596,ST8SIA6,P61647,1.0,0.115,7.1568e-10,,,C0730345,Microalbuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
338599,DUPD1,Q68J44,1.0,0.038,2.4781e-07,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
338645,LUZP2,Q86TE4,0.821,0.346,2.3478e-10,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.11,1.0,,2012.0,2018.0,ALL
338653,KCNQ1-AS1,,0.861,0.115,,,,C0003811,Cardiac Arrhythmia,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Disease or Syndrome,0.1,,,,,ALL
338657,CCDC84,Q86UT8,,,5.4698e-14,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
338661,TMEM225,Q6GV28,,,0.0016225,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
338667,VSIG10L2,P0DP72,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
338675,OR5AP2,Q8NGF4,,,0.0041572,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
338699,ANKRD42,Q8N9B4,0.931,0.115,2.1439e-10,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
338707,B4GALNT4,Q76KP1,1.0,0.115,2.2451e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
338761,C1QL4,Q86Z23,,,0.4244,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
338773,TMEM119,Q4V9L6,0.78,0.346,0.62503,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2017.0,2018.0,ALL
338799,LINC01089,,0.89,0.115,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
338811,TAFA2,Q8N3H0,0.78,0.192,0.34104,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2018.0,2018.0,ALL
338821,SLCO1B7,G3V0H7,0.839,0.115,3.8127e-26,,,C0344395,Bilirubin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2018.0,ALL
338864,LINC00347,,,,,,,C0202177,Phospholipid measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
338872,C1QTNF9,P0C862,0.695,0.385,1.1372e-05,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,1.0,,2017.0,2019.0,ALL
338917,VSX2,P58304,0.695,0.462,0.00016481,,,C1864720,"MICROPHTHALMIA, ISOLATED 2",C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2004.0,2011.0,ALL
339005,WHAMMP3,Q1A5X7,1.0,0.115,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
339044,PKD1P1,,0.89,0.192,,,,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
339105,PRSS53,Q2L4Q9,1.0,0.038,9.3515e-17,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
339122,RAB43,Q86YS6,0.89,0.077,0.56224,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
339123,JMJD8,Q96S16,0.861,0.192,6.0633e-14,,,C0013362,Dysarthria,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.1,,,,,ALL
339145,FAM92B,Q6ZTR7,0.839,0.038,4.7704e-10,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.33,0.5,,2007.0,2012.0,ALL
339168,TMEM95,Q3KNT9,,,2.2408e-08,,,C0848676,"Subfertility, Male",C12,   Male Urogenital Diseases,phenotype,Sign or Symptom,0.01,1.0,,2014.0,2014.0,ALL
339184,CCDC144NL,Q6NUI1,0.89,0.115,9.0476e-14,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
339201,ASB16-AS1,Q495Z4,0.931,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
339210,C17orf67,Q0P5P2,0.792,0.308,6.5469e-06,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
339221,ENPP7,Q6UWV6,0.821,0.192,1.1797e-14,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
339230,CCDC137,Q6PK04,1.0,0.038,5.9139e-07,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
339231,ARL16,Q0P5N6,1.0,0.038,1.6932e-06,,,C0036346,"Schizophrenia, Childhood",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
339263,LINC02693,A8MQB3,1.0,0.038,0.11492,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
339287,MSL1,Q68DK7,1.0,0.038,0.9989,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
339290,LINC00667,,0.89,0.115,,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
339324,ZNF260,Q3ZCT1,1.0,0.115,6.0163e-05,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
339327,ZNF546,Q86UE3,0.931,0.192,5.0239e-12,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
339344,MYPOP,Q86VE0,0.89,0.077,0.66892,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
339345,NANOS2,P60321,0.678,0.462,0.051664,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.31,1.0,,2012.0,2018.0,ALL
339366,ADAMTSL5,Q6ZMM2,0.861,0.154,3.7025e-11,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.04,1.0,,2017.0,2019.0,ALL
339390,CLEC4G,Q6UXB4,0.821,0.154,9.3088e-06,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
339398,LINGO4,Q6UY18,1.0,0.038,8.2397e-05,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
339400,FLG-AS1,,0.7,0.538,,,,C0003862,Arthralgia,C23;C05,"   Pathological Conditions, Signs and Symptoms;    Musculoskeletal Diseases",phenotype,Sign or Symptom,0.1,1.0,,2006.0,2006.0,ALL
339403,RXFP4,Q8TDU9,,,6.008e-06,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
339416,ANKRD45,Q5TZF3,,,0.00058172,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
339451,KLHL17,Q6TDP4,0.931,0.115,1.3052e-16,,,C1845118,"SHORT STATURE, IDIOPATHIC, X-LINKED",C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Congenital Abnormality,0.01,1.0,,2011.0,2011.0,ALL
339453,TMEM240,Q5SV17,0.76,0.231,0.22904,,,C1843891,SPINOCEREBELLAR ATAXIA 21,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.74,1.0,,2008.0,2019.0,ALL
339456,TMEM52,Q8NDY8,,,0.014909,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
339476,ERVMER61-1,,0.89,0.115,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
339479,BRINP3,Q76B58,0.695,0.308,0.14554,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
339487,ZBTB8OS,Q8IWT0,0.821,0.269,0.70542,,,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
339488,TFAP2E,Q6VUC0,0.78,0.231,2.4455e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2014.0,2017.0,ALL
339500,ZNF678,Q5SXM1,,,0.015898,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2008.0,2008.0,ALL
339524,LINC01140,,1.0,0.038,,,,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
339529,LINC02774,,1.0,0.115,,,,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
339535,LINC01139,,0.691,0.538,,,,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.09,0.889,,2016.0,2019.0,ALL
339541,ARMH1,Q6PIY5,0.553,0.692,1.6479e-05,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.8,,2012.0,2020.0,ALL
339559,ZFP69,Q49AA0,0.931,0.077,1.5454e-08,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
339622,LINC01692,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
339665,SLC35E4,Q6ICL7,,,0.015961,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
339669,TEX33,O43247,,,1.2009e-07,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
339745,SPOPL,Q6IQ16,0.89,0.038,0.011897,,,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
339751,MAP3K20-AS1,,0.792,0.154,,,,C0432028,Split foot,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,,,,,ALL
339761,CYP27C1,Q4G0S4,,,9.2035e-07,,,C0919677,Protein C measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2017.0,ALL
339766,MROH2A,A6NES4,0.931,0.077,3.9287e-21,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
339788,LINC00298,,0.861,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
339789,LINC00299,Q6ZSB3,0.743,0.346,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2019.0,ALL
339804,C2orf74,A8MZ97,0.792,0.154,0.13499,,,C1415817,"HETEROTAXY, VISCERAL, 2, AUTOSOMAL",,,disease,Disease or Syndrome,0.2,,,,,ALL
339807,LINC02579,,,,,,,C1527304,Allergic Reaction,C20,   Immune System Diseases,phenotype,Pathologic Function,0.1,1.0,,2017.0,2017.0,ALL
339829,CCDC39,Q9UFE4,0.641,0.615,7.9127e-12,,,C3151136,"CILIARY DYSKINESIA, PRIMARY, 14",C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.9,1.0,,2011.0,2014.0,ALL
339834,CCDC36,Q8IYA8,,,0.024502,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
339855,KY,Q8NBH2,0.736,0.231,1.542e-10,,,C4310711,"MYOPATHY, MYOFIBRILLAR, 7",,,disease,Disease or Syndrome,0.4,1.0,,2016.0,2016.0,ALL
339881,EIF4BP8,,,,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
339883,C3orf35,Q8IVJ8,0.821,0.115,0.048577,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2003.0,2010.0,ALL
339894,LINC00880,,0.839,0.154,,,,C0429087,Electrocardiogram: P-R interval,,,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
339896,GADL1,Q6ZQY3,0.497,0.808,1.3724e-21,,,C0853193,Bipolar I disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2014.0,2019.0,ALL
339902,LOC339902,,1.0,0.038,,,,C4511452,Sporadic Parkinson disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
339926,EHHADH-AS1,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
339929,LPP-AS2,,0.931,0.115,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
339965,CCDC158,Q5M9N0,,,1.5547e-25,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
339967,TMPRSS11A,Q6ZMR5,0.78,0.115,1.8331e-15,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.05,0.8,,2006.0,2013.0,ALL
339970,GCOM2,Q9BZD3,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
339976,TRIML1,Q8N9V2,1.0,0.077,3.704e-11,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
339983,NAT8L,Q8N9F0,0.722,0.346,0.86458,,,C3279716,N-ACETYLASPARTATE DEFICIENCY,,,disease,Disease or Syndrome,0.3,1.0,limited,2009.0,2009.0,ALL
340024,SLC6A19,Q695T7,0.695,0.577,1.7664e-24,,,C0018609,Hartnup Disease,C16;C18;C13;C12;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases",disease,Disease or Syndrome,1.0,1.0,,2004.0,2019.0,ALL
340037,PRR7-AS1,,,,,,,C2239219,von Willebrand's factor (lab test),,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
340061,STING1,Q86WV6,0.522,0.769,0.0012067,,,C4014722,"STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET",,,disease,Disease or Syndrome,0.74,1.0,strong,2014.0,2019.0,ALL
340075,ARSI,Q5FYB1,0.656,0.615,5.958e-15,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2020.0,ALL
340146,SLC35D3,Q5M8T2,0.861,0.269,0.036075,,,C0012546,Diphtheria,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
340152,ZC3H12D,A2A288,0.682,0.5,0.15589,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
340156,MYLK4,Q86YV6,0.89,0.154,3.0554e-13,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
340204,CLPSL1,A2RUU4,,,2.1662e-05,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
340205,TREML1,Q86YW5,0.743,0.346,1.5671e-12,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
340206,TREML3P,,0.931,0.115,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
340260,UNCX,A6NJT0,,,0.63399,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
340267,COL28A1,Q2UY09,0.89,0.154,3.6797e-32,,,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
340273,ABCB5,Q2M3G0,0.623,0.538,1.5072e-37,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.51,1.0,,2012.0,2018.0,ALL
340348,TSPAN33,Q86UF1,0.606,0.731,7.0071e-05,,,C0007785,Cerebral Infarction,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2009.0,2019.0,ALL
340351,AGBL3,Q8NEM8,0.861,0.115,4.1796e-16,,,C2699541,Cytokine Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
340371,NRBP2,Q9NSY0,0.861,0.115,0.015594,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
340419,RSPO2,Q6UXX9,0.558,0.577,0.024608,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.3,,,,,ALL
340441,POTEA,Q6S8J7,1.0,0.077,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
340451,CPP,,0.631,0.731,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2018.0,2020.0,ALL
340460,KRT18P24,,,,,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
340485,ACER2,Q5QJU3,0.931,0.038,0.040225,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2010.0,2018.0,ALL
340526,RTL5,Q5HYW3,,,0.00018633,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1994.0,1994.0,ALL
340527,NHSL2,Q5HYW2,,,0.11655,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
340533,NEXMIF,Q5QGS0,0.659,0.385,0.99968,,,C3806730,"MENTAL RETARDATION, X-LINKED 98",,,disease,Disease or Syndrome,0.7,1.0,,2004.0,2016.0,ALL
340542,BEX5,Q5H9J7,1.0,0.038,0.0025394,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
340547,VSIG1,Q86XK7,0.769,0.269,0.0023894,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2012.0,2017.0,ALL
340571,SIAH1P1,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
340595,RTL4,Q6ZR62,0.89,0.269,3.4473e-06,,,C0005699,Blast Phase,C23;C04;C15,"   Pathological Conditions, Signs and Symptoms;    Neoplasms;    Hemic and Lymphatic Diseases",disease,Neoplastic Process,0.01,1.0,,1979.0,1979.0,ALL
340602,EZHIP,Q86X51,0.805,0.115,,,,C0014474,Ependymoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
340654,LIPM,Q5VYY2,,,3.025e-10,,,C4522123,Nerve Growth Factor Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
340665,CYP26C1,Q6V0L0,0.743,0.308,0.0016358,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2009.0,2009.0,ALL
340706,VWA2,Q5GFL6,0.78,0.308,1.2242e-17,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2018.0,2019.0,ALL
340719,NANOS1,Q8WY41,0.7,0.423,0.54106,,,C3809427,SPERMATOGENIC FAILURE 12,,,disease,Disease or Syndrome,0.4,,,,,ALL
340784,HMX3,A6NHT5,0.89,0.115,0.91992,,,C0266589,Congenital ear anomaly NOS (disorder),C16;C13;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Otorhinolaryngologic Diseases",group,Congenital Abnormality,0.01,1.0,,2009.0,2009.0,ALL
340895,MALRD1,Q5VYJ5,0.821,0.346,9.3765e-21,,,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
340990,OTOG,Q6ZRI0,0.805,0.231,6.6065e-37,,,C3554163,"DEAFNESS, AUTOSOMAL RECESSIVE 18B",,,disease,Disease or Syndrome,0.91,1.0,strong,1997.0,2015.0,ALL
341019,DCDC1,M0R2J8,0.931,0.115,4.7858e-08,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2009.0,2018.0,ALL
341032,C11orf53,Q8IXP5,0.792,0.077,0.0019229,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.11,1.0,,2008.0,2019.0,ALL
341208,HEPHL1,Q6MZM0,0.792,0.231,1.1459e-34,,,C1849811,Pili torti developmental delay neurological abnormalities,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",phenotype,Disease or Syndrome,0.3,1.0,,2019.0,2019.0,ALL
341346,SMCO2,A6NFE2,1.0,0.077,2.9097e-08,,,C0520679,"Sleep Apnea, Obstructive",C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
341359,SYT10,Q6XYQ8,0.931,0.077,6.2437e-05,,,C0270824,Visual seizure,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.2,1.0,,1997.0,1997.0,ALL
341405,ANKRD33,Q7Z3H0,1.0,0.077,1.4957e-17,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
341567,H1-7,Q75WM6,,,,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
341568,OR8S1,Q8NH09,0.931,0.115,1.4449e-06,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
341640,FREM2,Q5SZK8,0.566,0.577,3.5958e-11,,,C0265233,Cryptophthalmos syndrome,C16;C13;C11;C05;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Musculoskeletal Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.9,0.929,strong,2005.0,2018.0,ALL
341676,NEK5,Q6P3R8,0.931,0.077,1.0081e-23,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
341880,SLC35F4,A4IF30,0.931,0.038,0.0085933,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
342035,GLDN,Q6ZMI3,0.769,0.346,2.5809e-13,,,C4310670,LETHAL CONGENITAL CONTRACTURE SYNDROME 11,,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
342096,GOLGA6A,Q9NYA3,0.592,0.654,1.61e-05,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2017.0,2020.0,ALL
342125,TMC3,Q7Z5M5,0.931,0.077,3.8941e-22,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
342132,ZNF774,Q6NX45,0.931,0.115,2.2808e-15,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
342184,FMN1,Q68DA7,0.686,0.423,3.5863e-18,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.11,1.0,,2008.0,2019.0,ALL
342346,C16orf96,A6NNT2,0.931,0.038,5.5816e-21,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
342371,ATXN1L,P0C7T5,0.792,0.115,0.97897,,,C0087012,"Ataxia, Spinocerebellar",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,,2005.0,2007.0,ALL
342372,PKD1L3,Q7Z443,0.931,0.154,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
342510,CD300E,Q496F6,0.931,0.077,0.023692,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
342527,SMTNL2,Q2TAL5,1.0,0.115,0.00023793,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2017.0,2017.0,ALL
342538,NACA2,Q9H009,1.0,0.077,0.032413,,,C0009081,Congenital clubfoot,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0,,2012.0,2012.0,ALL
342618,SLFN14,P0C7P3,0.931,,3.5128e-09,,,C4310797,"BLEEDING DISORDER, PLATELET-TYPE, 20",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2016.0,ALL
342667,STAC2,Q6ZMT1,0.839,0.115,8.4083e-07,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
342897,NCCRP1,Q6ZVX7,0.931,0.077,7.6409e-09,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
342898,SYCN,Q0VAF6,1.0,0.077,4.4492e-05,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
342900,LEUTX,A8MZ59,1.0,0.038,0.001599,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
342908,ZNF404,Q494X3,0.861,0.077,2.6828e-08,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2017.0,2018.0,ALL
342918,C19orf81,C9J6K1,1.0,0.077,1.233e-05,,,C4277682,Chemical and Drug Induced Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
342926,ZNF677,Q86XU0,0.821,0.115,1.6591e-08,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
342931,RFPL4A,A6NLU0,0.931,0.077,0.042929,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
342933,ZSCAN5B,A6NJL1,,,1.0007e-12,,,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
342945,ZSCAN22,P10073,1.0,0.077,8.2509e-08,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.3,1.0,,2009.0,2009.0,ALL
342977,NANOS3,P60323,0.631,0.538,0.039203,,,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.34,0.75,moderate,2007.0,2016.0,ALL
343035,RD3,Q7Z3Z2,0.7,0.308,2.5702e-05,,,C1857743,LEBER CONGENITAL AMAUROSIS 12 (disorder),C11,   Eye Diseases,disease,Disease or Syndrome,0.81,1.0,,1993.0,2013.0,ALL
343045,CYCSP51,,0.751,0.423,,,,C0025229,Melioidosis,C01,   Infections,disease,Disease or Syndrome,0.04,1.0,,2015.0,2019.0,ALL
343099,CCDC18,Q5T9S5,0.89,0.077,1.9627e-37,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
343169,OR6F1,Q8NGZ6,1.0,0.038,0.00069042,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
343263,MYBPHL,A2RUH7,,,0.0036874,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
343381,NBPF2P,,,,,,,C0202251,Vitamin B6 measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
343413,FCRL6,Q6DN72,0.792,0.269,2.7809e-23,,,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
343450,KCNT2,Q6UVM3,0.711,0.308,0.041658,,,C4540411,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57",,,disease,Disease or Syndrome,0.5,1.0,strong,2017.0,2018.0,ALL
343472,BARHL2,Q9NY43,0.931,0.154,0.61149,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
343505,NBPF7,P0C2Y1,0.89,0.077,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
343637,RSPO4,Q2I0M5,0.821,0.231,8.5962e-08,,,C3277900,"NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4",,,disease,Disease or Syndrome,0.7,1.0,,2006.0,2008.0,ALL
343641,TGM6,O95932,0.644,0.423,1.1154e-24,,,C3888031,SPINOCEREBELLAR ATAXIA 35,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.75,1.0,,2010.0,2019.0,ALL
343702,XKR7,Q5GH72,,,0.90831,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
343930,MSGN1,A6NI15,0.821,0.115,0.072006,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
343990,KIAA1211L,Q6NV74,,,0.99694,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
344018,FIGLA,Q6QHK4,0.78,0.231,0.0022269,,,C2676742,Premature Ovarian Failure 6,C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.5,1.0,moderate,2008.0,2008.0,ALL
344148,NCKAP5,O14513,1.0,0.077,8.4671e-06,,,C0086132,Depressive Symptoms,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.31,1.0,,2012.0,2012.0,ALL
344167,FOXI3,A8MTJ6,0.805,0.308,,,,C1842937,"AURAL ATRESIA, CONGENITAL",C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.31,1.0,limited,2015.0,2015.0,ALL
344191,EVX2,Q03828,0.861,0.154,0.39955,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
344387,CDKL4,Q5MAI5,1.0,0.077,5.0101e-14,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
344558,SH3RF3,Q8TEJ3,0.821,0.192,0.028368,,,C0236733,Amphetamine-Related Disorders,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
344595,DUBR,,0.861,0.154,,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
344657,LRRIQ4,A6NIV6,1.0,0.154,1.7762e-07,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
344658,SAMD7,Q7Z3H4,0.931,0.077,1.1415e-06,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
344758,GPR149,Q86SP6,0.931,0.154,4.3654e-09,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
344787,ZNF860,A6NHJ4,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
344805,TMPRSS7,Q7RTY8,0.839,0.154,3.9482e-18,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
344807,CD200R1L,Q6Q8B3,1.0,0.077,0.0030387,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
344838,PAQR9,Q6ZVX9,1.0,0.077,0.1367,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
344875,COL6A4P1,,0.711,0.385,,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.06,1.0,,2009.0,2016.0,ALL
344887,NMRAL2P,,0.78,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
344901,OSTN,P61366,0.821,0.269,0.00053727,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
344905,ATP13A5,Q4VNC0,1.0,0.038,2.4077e-49,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
344967,LOC344967,,1.0,0.115,,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
345079,SOWAHB,A6NEL2,,,0.00071474,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
345193,LRIT3,Q3SXY7,0.716,0.115,2.0418e-11,,,C3554399,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F",,,disease,Disease or Syndrome,0.8,1.0,,2013.0,2017.0,ALL
345222,MSANTD1,Q6ZTZ1,0.931,0.115,0.80456,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
345274,SLC10A6,Q3KNW5,0.839,0.115,4.5131e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
345275,HSD17B13,Q7Z5P4,0.623,0.538,2.7371e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
345456,PFN3,P60673,0.89,0.154,0.50096,,,C0022650,Kidney Calculi,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
345557,PLCXD3,Q63HM9,0.861,0.154,0.0089141,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2014.0,2014.0,ALL
345611,IRGM,A1A4Y4,0.617,0.538,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.7,0.939,,2007.0,2020.0,ALL
345643,MCIDAS,D6RGH6,0.566,0.769,0.013264,,,C4551906,"Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus",C16;C08;C09;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2014.0,2014.0,ALL
345651,ACTBL2,Q562R1,0.539,0.769,5.8166e-16,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,1996.0,2019.0,ALL
345757,FAM174A,Q8TBP5,,,8.5833e-05,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
345778,MTX3,Q5HYI7,,,0.00016475,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
345895,RSPH4A,Q5TD94,0.666,0.538,7.5712e-11,,,C2675229,"CILIARY DYSKINESIA, PRIMARY, 11",C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.7,1.0,,2009.0,2014.0,ALL
345930,ECT2L,Q008S8,0.769,0.192,7.8004e-48,,,C1961099,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.3,,,,,ALL
346007,EYS,Q5T1H1,0.631,0.538,3.7216e-41,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,0.974,strong,2005.0,2019.0,ALL
346157,ZNF391,Q9UJN7,1.0,0.115,6.4452e-08,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
346171,ZFP57,Q9NU63,0.65,0.577,0.00054557,,,C1832386,"Diabetes Mellitus, Transient Neonatal, 1",C16;C18;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.72,1.0,,2008.0,2016.0,ALL
346288,SEPTIN14,Q6ZU15,0.805,0.077,6.8701e-06,,,C0334588,Giant Cell Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.5,1.0,,2013.0,2013.0,ALL
346389,MACC1,Q6ZN28,0.561,0.538,6.0053e-19,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.962,,2011.0,2020.0,ALL
346517,OR6V1,Q8N148,,,0.0002477,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
346562,GNAT3,A8MTJ3,0.821,0.231,1.6347e-05,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
346606,MOGAT3,Q86VF5,0.931,0.115,1.8376e-12,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2007.0,2009.0,ALL
346653,FAM71F2,Q6NXP2,0.931,0.115,0.021409,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
346673,STRA8,Q7Z7C7,0.821,0.269,0.00060861,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
346689,KLRG2,A4D1S0,0.931,0.077,5.1131e-12,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
347088,ADGRD2,Q7Z7M1,0.89,0.115,1.7455e-15,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
347148,QRFP,P83859,0.821,0.192,,,,C0020459,Hyperinsulinism,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,1.0,,2019.0,2019.0,ALL
347240,KIF24,Q5T7B8,0.89,0.154,1.3904e-17,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
347252,IGFBPL1,Q8WX77,0.821,0.154,4.0352e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
347273,CAVIN4,Q5BKX8,0.89,0.038,5.0529e-05,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.31,1.0,,2011.0,2019.0,ALL
347344,ZNF81,P51508,0.705,0.385,0.55402,,,C1136249,"Mental Retardation, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,limited,2006.0,2006.0,ALL
347365,ITIH6,Q6UXX5,,,1.5096e-24,,,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
347376,H3P44,,0.636,0.462,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0,,1992.0,2002.0,ALL
347487,CXorf66,Q5JRM2,0.839,0.115,0.029379,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
347516,DGAT2L6,Q6ZPD8,0.931,0.038,5.5267e-11,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
347527,ARSH,Q5FYA8,0.695,0.577,7.3193e-08,,,C0026705,Mucopolysaccharidosis II,C16;C18;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,1992.0,2007.0,ALL
347541,MAGEB5,Q9BZ81,0.931,0.115,,,,C0039234,"Tachycardia, Ectopic Atrial",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
347598,RBMY2DP,,0.76,0.385,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2006.0,2011.0,ALL
347688,TUBB8,Q3ZCM7,1.0,,0.017934,,,C4225210,OOCYTE MATURATION DEFECT 2,,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2016.0,ALL
347689,SOX2-OT,,0.597,0.615,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2016.0,2016.0,ALL
347713,DFNA42,,0.931,0.115,,,,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
347716,USP32P3,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
347730,LRRTM1,Q86UE6,0.931,0.038,0.5945,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.54,1.0,,2007.0,2014.0,ALL
347731,LRRTM3,Q86VH5,0.805,0.154,0.97519,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
347732,CATSPER3,Q86XQ3,,,7.5245e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
347733,TUBB2B,Q9BVA1,0.61,0.385,0.9884,,,C3552236,"CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7",,,disease,Disease or Syndrome,0.9,1.0,,2009.0,2016.0,ALL
347734,SLC35B2,Q8TB61,0.666,0.423,0.071488,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.07,1.0,,1992.0,2015.0,ALL
347735,SERINC2,Q96SA4,0.792,0.192,3.9153e-13,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2013.0,2013.0,ALL
347736,NME9,Q86XW9,0.89,0.154,7.8887e-09,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
347745,PWAR4,,0.573,0.769,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
347746,PWARSN,,1.0,0.115,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
347853,TBX10,O75333,,,2.0686e-08,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
347862,GATD1,Q8NB37,1.0,0.077,0.46045,,,C0016781,Fuchs Endothelial Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
347902,AMIGO2,Q86SJ2,0.729,0.615,0.59743,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2004.0,2019.0,ALL
347918,EP400P1,Q6ZTU2,,,4.4654e-06,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
348013,TMEM255B,Q8WV15,,,7.7218e-12,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
348021,LINC00442,,,,,,,C1278049,Serum gamma-glutamyl transferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
348093,RBPMS2,Q6ZRY4,0.931,0.154,0.87683,,,C0002793,Anaplasia,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
348094,ANKDD1A,Q495B1,0.931,0.038,7.7415e-17,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
348110,ARPIN,Q7Z6K5,0.861,0.115,1.5397e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
348120,LINC01193,,0.565,0.692,,,,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,0.864,,2004.0,2020.0,ALL
348158,ACSM2B,Q68CK6,,,6.2689e-26,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2014.0,2014.0,ALL
348180,CTU2,Q2VPK5,0.695,0.423,3.9682e-22,,,C4748348,"MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME",,,disease,Disease or Syndrome,0.4,1.0,strong,2016.0,2019.0,ALL
348235,SKA2,Q8WVK7,0.736,0.423,1.996e-07,,,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.04,0.75,,2015.0,2016.0,ALL
348249,CCL15-CCL14,,0.861,0.231,,,,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
348254,CCDC144CP,Q8IYA2,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
348303,SELENOV,P59797,1.0,,9.6824e-11,,,C0238421,Selenium deficiency,,,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
348327,ZNF530,Q6P9A1,1.0,0.038,0.007439,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
348378,SHISAL2A,Q6UWV7,,,5.1161e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
348645,C22orf34,Q6ZV56,0.931,0.038,0.00013821,,,C0008350,Cholelithiasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
348654,GEN1,Q17RS7,0.682,0.5,3.7299e-15,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2010.0,2012.0,ALL
348751,FTCDNL1,E5RQL4,0.89,0.192,0.40524,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.12,1.0,,2011.0,2015.0,ALL
348793,WDR53,Q7Z5U6,1.0,0.077,0.0024918,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
348807,CFAP100,Q494V2,0.861,0.077,4.6757e-18,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
348808,NPHP3-AS1,,1.0,0.077,,,,C0687120,Nephronophthisis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
348910,RAF1P1,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
348932,SLC6A18,Q96N87,0.751,0.308,6.795e-22,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.32,0.333,,2004.0,2008.0,ALL
348938,NIPAL4,Q0D2K0,0.682,0.423,0.0013718,,,C2677065,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6",,,disease,Disease or Syndrome,0.7,1.0,,2004.0,2016.0,ALL
348980,HCN1,O60741,0.564,0.654,0.99989,,,C4014531,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24",,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2018.0,ALL
348995,NUP43,Q8NFH3,0.7,0.423,2.4136e-05,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
349075,ZNF713,Q8N859,0.931,0.038,4.3462e-06,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,limited,2014.0,2014.0,ALL
349114,LINC00265,,0.861,0.115,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
349149,GJC3,Q8NFK1,1.0,0.115,0.00052869,,,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.05,0.8,,2010.0,2017.0,ALL
349152,DPY19L2P2,Q6ZN68,1.0,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
349334,FOXD4L4,Q8WXT5,0.839,0.077,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
349386,NANOGP9,,1.0,0.077,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
349408,TLR8-AS1,,1.0,,,,,C3887876,OSTEOARTHRITIS SUSCEPTIBILITY 1,,,disease,Finding,0.1,,,,,ALL
349565,NMNAT3,Q96T66,0.821,0.346,6.2389e-08,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
349633,PLET1,Q6UQ28,,,6.8789e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
349667,RTN4RL2,Q86UN3,1.0,0.077,0.87694,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
350383,GPR142,Q7Z601,0.89,0.077,1.8753e-10,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,2016.0,2018.0,ALL
352909,DNAAF3,Q8N9W5,0.599,0.731,5.5391e-08,,,C1847554,"CILIARY DYSKINESIA, PRIMARY, 2 (disorder)",C16;C08;C09;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.9,1.0,,2012.0,2012.0,ALL
352954,CASTOR3,Q8NAP1,0.805,0.231,0.0096067,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
352961,HCG26,,1.0,0.115,,,,C0022408,Arthropathy,C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
352962,HLA-V,,0.861,0.192,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
352963,HLA-P,,0.931,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
352990,HCP5B,,0.931,0.115,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
352999,C6orf58,Q6P5S2,0.931,0.192,7.0978e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
353088,ZNF429,Q86V71,,,4.0549e-05,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
353091,RAET1G,Q6H3X3,,,6.8212e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
353094,RAET1M,,1.0,0.038,,,,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
353128,AD8,,1.0,0.038,,,,C1270972,Mild cognitive disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
353131,LCE1A,Q5T7P2,0.861,0.115,0.0043743,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,0.0,,2010.0,2010.0,ALL
353133,LCE1C,Q5T751,1.0,0.077,0.027961,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.03,1.0,,2006.0,2018.0,ALL
353135,LCE1E,Q5T753,1.0,0.115,0.16972,,,C1275122,Familial multiple trichoepitheliomata,C16;C04;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Skin and Connective Tissue Diseases",disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
353142,LCE3A,Q5TA76,0.931,0.077,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0,,2015.0,2017.0,ALL
353143,LCE3B,Q5TA77,0.751,0.231,0.0034323,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.4,0.862,,2009.0,2017.0,ALL
353144,LCE3C,Q5T5A8,0.743,0.269,0.47523,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.4,0.867,,2009.0,2017.0,ALL
353147,POROK4,,0.931,0.077,,,,C0162838,"Porokeratosis, Palmoplantar",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
353164,TAS2R42,Q7RTR8,1.0,0.077,,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
353174,ZACN,Q401N2,0.659,0.538,4.2739e-22,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1999.0,2019.0,ALL
353189,SLCO4C1,Q6ZQN7,0.805,0.231,1.0568e-08,,,C0035078,Kidney Failure,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.2,1.0,,2004.0,2004.0,ALL
353219,KAAG1,Q9UBP8,0.89,0.115,0.28715,,,C4015542,NEPHRONOPHTHISIS 19,,,disease,Disease or Syndrome,0.1,,,,,ALL
353238,PADI6,Q6TGC4,0.76,0.269,,,,C4310659,PREIMPLANTATION EMBRYONIC LETHALITY 2,,,disease,Disease or Syndrome,0.6,1.0,,2016.0,2016.0,ALL
353299,RGSL1,A5PLK6,0.821,0.115,2.0941e-11,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2008.0,2011.0,ALL
353322,ANKRD37,Q7Z713,1.0,0.115,0.00053673,,,C2931852,Clear-cell metastatic renal cell carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
353345,GPR141,Q7Z602,0.89,0.115,8.531e-08,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2013.0,2019.0,ALL
353355,ZNF233,A6NK53,1.0,0.077,0.00018665,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
353376,TICAM2,Q86XR7;Q9Y3B3,0.438,0.769,0.0025936,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.925,,1996.0,2019.0,ALL
353497,POLN,Q7Z5Q5,1.0,0.038,9.488e-41,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
353500,BMP8A,Q7Z5Y6,0.839,0.154,1.9786e-06,,,C1704436,Peripheral Arterial Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.41,1.0,,2016.0,2016.0,ALL
353514,LILRA5,A6NI73,0.839,0.115,7.2545e-09,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
359787,DPPA3,Q6W0C5,0.792,0.192,0.21667,,,C0205851,Germ cell tumor,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2005.0,2016.0,ALL
359794,TUSC2P1,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
359796,KDM5DP1,,1.0,0.038,,,,C0036323,Schistosomiasis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
359804,DAP3P1,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
359806,PCNAP1,,0.821,0.154,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2018.0,2018.0,ALL
359809,PEG13,,0.931,0.154,,,,C0008073,Developmental Disabilities,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,0.0,,2014.0,2014.0,ALL
359825,PSORS9,,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.05,0.8,,2006.0,2014.0,ALL
359845,RFLNB,Q8N5W9,0.931,0.077,0.26962,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
359948,IRF2BP2,Q7Z5L9,0.641,0.5,0.84558,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.53,1.0,,2015.0,2019.0,ALL
360023,ZBTB41,Q5SVQ8,,,0.22393,,,C0523688,Hemopexin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
360155,CYCSP52,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
360163,CYCTP,,1.0,0.038,,,,C1864851,"Pigmented Nodular Adrenocortical Disease, Primary, 2",C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2006.0,2006.0,ALL
360184,CYCSP38,,0.78,0.231,,,,C0343641,Human papilloma virus infection,C01,   Infections,disease,Disease or Syndrome,0.06,1.0,,2003.0,2017.0,ALL
360200,TMPRSS9,Q7Z410,0.861,0.192,1.6181e-17,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2017.0,ALL
360203,GLT6D1,Q7Z4J2,0.861,0.038,0.11957,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.12,0.5,,2010.0,2014.0,ALL
360205,PRAC2,D3DTV9,0.839,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
360219,GCRG224,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2003.0,2003.0,ALL
360226,PRSS41,Q7RTY9,1.0,0.115,,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
373071,AIS1,,0.861,0.115,,,,C0042900,Vitiligo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0,,2002.0,2003.0,ALL
373073,CLAM,,0.89,0.077,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2013.0,2013.0,ALL
373156,GSTK1,Q9Y2Q3,0.412,0.885,1.9374e-06,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.909,,1999.0,2019.0,ALL
373509,USP50,Q70EL3,,,2.6279e-18,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
373861,H1-9P,P60008,1.0,0.192,,,,C2936332,Alpha-Sarcoglycanopathies,C16;C05;C08;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
373863,DND1,Q8IYX4,0.736,0.231,0.43615,,,C0205851,Germ cell tumor,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2007.0,2008.0,ALL
374286,CDRT1,O95170,0.931,0.115,4.9801e-14,,,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2013.0,2013.0,ALL
374291,NDUFS7,O75251,0.579,0.769,0.9142,,,C4748752,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3",,,disease,Disease or Syndrome,0.6,1.0,,1999.0,2004.0,ALL
374308,PTCHD3,Q3KNS1,0.839,0.269,3.3312e-10,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
374354,NHLRC2,Q8NBF2,0.729,0.346,8.3194e-06,,,C4748939,"FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS",,,disease,Disease or Syndrome,0.43,1.0,,2018.0,2018.0,ALL
374378,GALNT18,Q6P9A2,0.931,0.192,0.00030345,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
374383,NCR3LG1,Q68D85,0.705,0.308,8.8569e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2020.0,ALL
374393,FAM111B,Q6SJ93,0.691,0.423,0.098549,,,C3810325,"POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS",,,disease,Disease or Syndrome,0.71,1.0,,2013.0,2019.0,ALL
374407,DNAJB13,P59910,0.682,0.5,0.0028524,,,C4310722,"CILIARY DYSKINESIA, PRIMARY, 34",,,disease,Disease or Syndrome,0.7,1.0,strong,2016.0,2016.0,ALL
374454,KRT77,Q7Z794,,,1.4217e-12,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
374462,PTPRQ,Q9UMZ3,0.751,0.462,4.2188e-21,,,C3150654,"DEAFNESS, AUTOSOMAL RECESSIVE 84A",,,disease,Disease or Syndrome,0.71,1.0,strong,2010.0,2010.0,ALL
374470,C12orf42,Q96LP6,0.805,0.154,2.7519e-10,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
374491,TPTE2P6,,0.931,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2006.0,2006.0,ALL
374569,ASPG,Q86U10,0.559,0.654,6.1787e-13,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2000.0,2017.0,ALL
374618,TEX9,Q8N6V9,0.839,0.154,6.4247e-22,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
374654,KIF7,Q2M1P5,0.528,0.731,2.2711e-22,,,C0796147,Acrocallosal Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.98,1.0,,2009.0,2019.0,ALL
374655,ZNF710,Q8N1W2,,,0.99003,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
374659,HDDC3,Q8N4P3,0.931,0.077,0.019263,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
374739,TEPP,Q6URK8,0.931,0.115,0.0002319,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
374768,SPEM1,Q8N4L4,0.931,0.038,1.3289e-05,,,C4021107,Non-obstructive azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
374786,EFCAB5,A4FU69,0.931,0.077,4.1975e-23,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
374819,LRRC37A3,O60309,1.0,0.115,3.0883e-10,,,C0023895,Liver diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
374864,CCDC178,Q5BJE1,1.0,0.077,1.4511e-23,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
374868,ATP9B,O43861,0.839,0.192,1.1822e-14,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
374875,HSD11B1L,Q7Z5J1,0.821,0.231,0.00027093,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
374877,TEX45,Q8NA69,1.0,0.038,1.0898e-17,,,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
374879,ZNF699,Q32M78,0.805,0.192,5.7677e-06,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2006.0,2015.0,ALL
374882,TMEM205,Q6UW68,0.89,0.077,0.030328,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
374887,YJEFN3,A6XGL0,0.89,0.154,1.2695e-05,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
374897,SBSN,Q6UWP8,0.743,0.5,6.2352e-06,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2012.0,2019.0,ALL
374899,ZNF829,Q3KNS6,1.0,0.077,5.8965e-11,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
374900,ZNF568,Q3ZCX4,,,2.2849e-09,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
374907,B3GNT8,Q7Z7M8,0.931,0.077,4.8063e-09,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
374918,IGFL1,Q6UW32,1.0,0.038,1.9891e-08,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
374920,ZSWIM9,Q86XI8,0.931,0.115,0.96181,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
374946,DRAXIN,Q8NBI3,1.0,0.038,1.8935e-10,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
374955,SPATA21,Q7Z572,0.839,0.269,1.1342e-17,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
374969,SVBP,Q8N300,1.0,0.077,0.0011348,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
374977,MROH7,Q68CQ1,0.89,0.154,4.8111e-24,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
374986,MIGA1,Q8NAN2,1.0,0.038,1.8254e-07,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
374987,NEXN-AS1,Q8NBZ9,0.839,0.115,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2019.0,2020.0,ALL
375033,PEAR1,Q5VY43,0.722,0.346,3.4806e-20,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
375056,MIA3,Q5JRA6,0.716,0.423,0.03675,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.44,1.0,,2011.0,2019.0,ALL
375057,STUM,Q69YW2,1.0,0.154,0.0043627,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
375061,FAM89A,Q96GI7,1.0,0.077,0.25672,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
375190,FAM228B,P0C875,1.0,0.038,1.8573e-07,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
375248,ANKRD36,A6QL64,0.931,0.115,8.3217e-86,,,C0149516,Chronic sinusitis,C01;C08;C09,   Infections;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
375287,RBM43,Q6ZSC3,0.931,0.077,0.13251,,,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
375295,LINC01116,,0.691,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,0.8,,2018.0,2019.0,ALL
375298,CERKL,Q49MI3,0.678,0.308,9.8447e-25,,,C1842127,Retinitis Pigmentosa 26,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2004.0,2017.0,ALL
375318,AQP12A,Q8IXF9,0.89,0.077,0.017909,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
375323,LHFPL4,Q7Z7J7,0.89,0.077,0.65247,,,C0337428,Fibrinogen assay,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
375337,TOPAZ1,Q8N9V7,,,0.97746,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
375341,C3orf62,Q6ZUJ4,,,0.00012633,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
375346,STIMATE,Q86TL2,1.0,0.038,0.18873,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
375387,NRROS,Q86YC3,0.861,0.231,0.32564,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
375444,C5orf34,Q96MH7,0.89,0.154,8.9961e-15,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
375449,MAST4,O15021,0.805,0.346,0.00011694,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
375484,SIMC1,Q8NDZ2,1.0,0.077,3.9164e-06,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
375519,GJB7,Q6PEY0,0.89,0.154,9.8644e-07,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
375567,VWC2,Q2TAL6,,,0.97088,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2019.0,ALL
375593,TRIM73,Q86UV7,1.0,0.115,0.00010272,,,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
375611,SLC26A5,P58743,0.666,0.615,6.9851e-08,,,C3151230,"DEAFNESS, AUTOSOMAL RECESSIVE 61",,,disease,Disease or Syndrome,0.6,1.0,strong,2016.0,2016.0,ALL
375612,LHFPL3,Q86UP9,0.751,0.269,0.93153,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
375616,KCP,Q6ZWJ8,0.839,0.154,,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
375704,ENHO,Q6UWT2,0.599,0.769,0.10526,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.07,0.857,,2008.0,2019.0,ALL
375748,ERCC6L2,Q5T890,0.729,0.346,5.0596e-07,,,C3810350,Bone marrow failure syndrome 2,,,disease,Disease or Syndrome,0.7,1.0,,2014.0,2016.0,ALL
375757,SWI5,Q1ZZU3,1.0,0.077,0.0013862,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2015.0,2018.0,ALL
375775,PNPLA7,Q6ZV29,1.0,0.077,5.3653e-37,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
375790,AGRN,O00468,0.626,0.538,5.4727e-07,,,C3808739,"MYASTHENIC SYNDROME, CONGENITAL, 8",,,disease,Disease or Syndrome,0.8,1.0,,2009.0,2014.0,ALL
375940,DMBT1L1,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
376132,LRRC10,Q5BKY1,0.861,0.115,0.43469,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
376267,RAB15,P59190,0.821,0.115,0.0059597,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
376497,SLC27A1,Q6PCB7,0.711,0.423,2.5752e-16,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.22,1.0,,2000.0,2019.0,ALL
376693,RPS10P7,,1.0,0.077,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
376844,SDC4P,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
377047,PRSS45P,Q7RTY3,,,0.00020122,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
377630,USP17L2,Q6R6M4,0.686,0.385,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,1.0,,2010.0,2019.0,ALL
377677,CA13,Q8N1Q1,0.722,0.538,1.7599e-06,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
377841,ENTPD8,Q5MY95,0.861,0.192,1.0421e-11,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
378108,TRIM74,Q86UV6,1.0,0.115,0.0091423,,,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
378484,MRX82,,1.0,0.077,,,,C1136249,"Mental Retardation, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
378708,CENPS,Q8N2Z9,0.805,0.192,5.75e-06,,,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2010.0,2010.0,ALL
378805,LINC-PINT,,0.663,0.577,,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.11,1.0,,2014.0,2018.0,ALL
378807,CATSPER4,Q7RTX7,1.0,0.077,5.7136e-11,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2009.0,2009.0,ALL
378825,PICSAR,,0.821,0.308,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2006.0,2015.0,ALL
378884,NHLRC1,Q6VVB1,0.656,0.423,0.094266,,,C0751783,Lafora Disease,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,1.0,0.98,,2003.0,2019.0,ALL
378938,MALAT1,,0.435,0.846,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2009.0,2020.0,ALL
378949,RBMY1D,P0C7P1;P0DJD3,0.743,0.423,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2006.0,2011.0,ALL
379003,DFNB40,,1.0,0.115,,,,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
379025,PSMA3-AS1,,0.931,0.154,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
386593,CHKB-CPT1B,,0.769,0.385,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.12,1.0,,2008.0,2016.0,ALL
386597,RNF144A-AS1,,1.0,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
386607,ZFP91-CNTF,,,,,,,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
386617,KCTD8,Q6ZWB6,,,0.00037542,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
386627,SAP30L-AS1,,0.89,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
386653,IL31,Q6EBC2,0.575,0.731,0.011445,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.4,1.0,,2005.0,2020.0,ALL
386677,KRTAP10-1,P60331,,,0.00016762,,,C0027765,nervous system disorder,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
386681,KRTAP10-8,P60410,0.931,0.115,3.2911e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
386724,AMIGO3,Q86WK7,0.89,0.154,0.00020785,,,C0037926,Compression of spinal cord,C10;C26,   Nervous System Diseases;    Wounds and Injuries,disease,Disease or Syndrome,0.2,1.0,,2013.0,2013.0,ALL
386757,SLC6A10P,,,,,,,C0521158,Recurrent tumor,,,phenotype,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
386758,ZNF582-AS1,,0.931,0.077,,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
387032,ZKSCAN4,Q969J2,0.839,0.269,0.00014184,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,1.0,,2011.0,2019.0,ALL
387036,GUSBP2,,1.0,0.038,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
387044,RPL13P,,1.0,0.038,,,,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
387055,LINC00533,,1.0,0.077,,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
387065,HMGA1P7,,0.89,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
387066,SNHG5,,0.67,0.462,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
387082,SUMO4,Q6EEV6,0.653,0.577,,,,C1838260,"DIABETES MELLITUS, INSULIN-DEPENDENT, 5",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,,,,,ALL
387103,CENPW,Q5EE01,0.839,0.231,0.40523,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
387111,LINC00222,,1.0,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
387119,CEP85L,Q5SZL2,0.656,0.423,4.5367e-09,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2013.0,2013.0,ALL
387122,WASF5P,,1.0,0.038,,,,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
387129,NPSR1,Q6W5P4,0.608,0.615,2.0518e-09,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.4,0.947,,2004.0,2019.0,ALL
387263,C6orf120,Q7Z4R8,0.89,0.192,,,,C0001175,Acquired Immunodeficiency Syndrome,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
387264,KRTAP5-1,Q6L8H4,1.0,0.077,0.089364,,,C0079153,"Hyperkeratosis, Epidermolytic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Congenital Abnormality,0.01,1.0,,2002.0,2002.0,ALL
387267,KRTAP5-4,Q6L8H1,,,0.018983,,,C0206062,"Lung Diseases, Interstitial",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
387323,H2AC9P,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2008.0,2019.0,ALL
387325,H1-12P,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
387332,TBPL2,Q6SJ96,0.7,0.423,1.4914e-10,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
387338,NSUN4,Q96CB9,0.839,0.154,1.2267e-06,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
387357,THEMIS,Q8N1K5,0.682,0.654,1.9597e-06,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.41,1.0,,2010.0,2016.0,ALL
387486,LINC00320,,0.931,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
387496,RASL11A,Q6T310,0.89,0.115,1.592e-06,,,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.31,1.0,,2018.0,2019.0,ALL
387509,GPR153,Q6NV75,0.89,0.115,6.8764e-07,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
387521,TMEM189,A5PLL7;Q13404,0.659,0.577,0.0083949,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2017.0,2019.0,ALL
387522,TMEM189-UBE2V1,A5PLL7;Q13404,0.659,0.577,0.0083949,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2017.0,2019.0,ALL
387569,ACF,,0.729,0.462,,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2001.0,2004.0,ALL
387570,DUH1,,0.89,0.115,,,,C2930995,Dyschromatosis universalis hereditaria,C23;C16;C17,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.06,1.0,,2008.0,2018.0,ALL
387572,PAND1,,1.0,0.038,,,,C0206526,"Tuberculosis, Multidrug-Resistant",C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,2016.0,2018.0,ALL
387573,CHDS3,,1.0,0.038,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2006.0,2006.0,ALL
387578,AITD1,,0.861,0.115,,,,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,0.5,,1999.0,2003.0,ALL
387583,SPG25,,1.0,0.154,,,,C2936860,"Spastic paraplegia 25, autosomal recessive",C23;C16;C05;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
387590,TPTEP1,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2011.0,2019.0,ALL
387597,ILDR2,Q71H61,0.931,0.115,0.95385,,,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
387601,SLC22A25,Q6T423,1.0,0.077,1.2149e-16,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
387644,FAM238C,,1.0,0.077,,,,C0035335,Retinoblastoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
387694,SH2D4B,Q5SQS7,0.821,0.269,6.3396e-06,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
387695,C10orf99,Q6UWK7,0.931,0.038,0.21211,,,C0011603,Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
387700,SLC16A12,Q6ZSM3,0.716,0.385,0.49267,,,C4310806,CATARACT 47,,,disease,Disease or Syndrome,0.5,1.0,,2008.0,2010.0,ALL
387712,ENO4,A6NNW6,,,8.0499e-07,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
387715,ARMS2,P0C7Q2,0.67,0.308,0.00051801,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.7,0.951,limited,2005.0,2019.0,ALL
387718,TEX36,Q5VZQ5,1.0,0.038,0.00021489,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
387723,C10orf143,A0A1B0GUT2,0.78,0.269,,,,C0347071,Malignant neoplasm of other and unspecified sites,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
387733,IFITM5,A6NNB3,0.736,0.231,2.1754e-06,,,C2931093,"Osteogenesis imperfecta, type 5",C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.8,0.941,,2012.0,2019.0,ALL
387742,FAM99A,,,,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
387758,FIBIN,Q8TAL6,1.0,0.038,0.41581,,,C1135196,"Heart Failure, Diastolic",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
387763,C11orf96,Q7Z7L8,0.89,0.154,0.0096256,,,C0007282,Carotid Stenosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
387775,SLC22A10,Q63ZE4,0.769,0.308,1.8871e-19,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2019.0,2019.0,ALL
387787,LIPT2,A6NK58,0.821,0.154,0.62575,,,C4540052,"ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES",,,disease,Disease or Syndrome,0.6,1.0,,2017.0,2019.0,ALL
387836,CLEC2A,Q6UVW9,1.0,0.038,2.191e-06,,,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
387837,CLEC12B,Q2HXU8,1.0,0.038,9.9015e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
387841,RPL13AP20,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
387882,C12orf75,Q8TAD7,0.729,0.423,0.63977,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
387890,TMEM233,B4DJY2,1.0,,0.090614,,,C0869220,"Adverse effects, not elsewhere classified",,,disease,Injury or Poisoning,0.1,1.0,,2019.0,2019.0,ALL
387893,KMT5A,Q9NQR1,0.633,0.538,0.98528,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
387895,LINC00944,,1.0,0.038,,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
387911,C1QTNF9B,B2RNN3,1.0,0.038,3.2529e-08,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
387914,SHISA2,Q6UWI4,0.931,0.077,0.073123,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
387923,SERP2,Q8N6R1,0.89,0.038,0.6681,,,C0027149,Myxoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,1998.0,2012.0,ALL
387978,LINC01551,Q86U37,1.0,0.077,0.19871,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
388007,SERPINA13P,Q6UXR4,0.619,0.692,,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.1,1.0,,2007.0,2016.0,ALL
388011,LINC01550,,0.931,0.077,0.0026919,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
388015,RTL1,A6NKG5,0.554,0.808,0.0056135,,,C1842466,"Uniparental disomy, paternal, chromosome 14",C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.31,1.0,,2008.0,2012.0,ALL
388021,TMEM179,Q6ZVK1,1.0,0.115,0.67923,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
388112,NANOGP8,Q6NSW7,0.769,0.192,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2006.0,2018.0,ALL
388115,CCDC9B,Q6ZUT6,1.0,0.077,1.405e-13,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
388121,TNFAIP8L3,Q5GJ75,0.736,0.231,1.8707e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2017.0,ALL
388125,C2CD4B,A6NLJ0,0.931,0.077,8.8732e-05,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.33,1.0,,2010.0,2018.0,ALL
388165,UBE2Q2P1,,0.89,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
388228,SBK1,Q52WX2,0.805,0.231,0.36812,,,C1335167,Ovarian Mucinous Adenocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
388325,SCIMP,Q6UWF3,1.0,0.077,0.0004268,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2013.0,2019.0,ALL
388327,C17orf100,A8MU93,1.0,,0.1311,,,C0201874,Amino acids measurement,,,group,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
388335,TMEM220,Q6QAJ8,0.931,0.077,1.3033e-06,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
388336,SHISA6,Q6ZSJ9,0.861,0.077,0.85318,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.11,1.0,,2015.0,2016.0,ALL
388364,TMIGD1,Q6UXZ0,0.861,0.115,2.1298e-07,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
388372,CCL4L1,P13236;Q8NHW4,0.534,0.885,0.33576,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,0.958,,1999.0,2019.0,ALL
388387,LINC00671,,0.861,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
388389,CCDC103,Q8IW40,0.666,0.538,0.00050909,,,C3542550,"CILIARY DYSKINESIA, PRIMARY, 17",,,disease,Disease or Syndrome,0.7,1.0,,2012.0,2018.0,ALL
388403,YPEL2,Q96QA6,0.931,0.077,0.95044,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
388407,LINC02875,Q86X59,1.0,0.077,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
388474,RPL7AP66,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
388503,C3P1,Q6ZMU1,0.931,0.115,,,,C0020445,"Hypercholesterolemia, Familial",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
388512,CLEC17A,Q6ZS10,1.0,0.115,9.0963e-08,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
388531,RGS9BP,Q6ZS82,0.931,,0.0023224,,,C1842073,Prolonged Electroretinal Response Suppression,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",phenotype,Finding,0.7,1.0,limited,2004.0,2004.0,ALL
388533,KRTDAP,P60985,1.0,0.038,0.08346,,,C0003486,Aortic Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
388550,CEACAM22P,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2019.0,ALL
388551,CEACAM16,Q2WEN9,0.805,0.192,1.5758e-05,,,C3281297,"DEAFNESS, AUTOSOMAL DOMINANT 4B",,,disease,Disease or Syndrome,0.7,1.0,strong,2011.0,2015.0,ALL
388552,BLOC1S3,Q6QNY0,0.729,0.385,0.004077,,,C3888026,HERMANSKY-PUDLAK SYNDROME 8,,,disease,Disease or Syndrome,0.81,1.0,,1981.0,2012.0,ALL
388553,BHMG1,C9JSJ3,0.931,0.154,0.0044198,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
388569,ZNF324B,Q6AW86,,,3.4989e-05,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
388581,C1QTNF12,Q5T7M4,0.769,0.308,6.2063e-08,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.04,1.0,,2012.0,2018.0,ALL
388585,HES5,Q5TA89,0.67,0.654,0.24882,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
388588,SMIM1,B2RUZ4,0.792,0.308,0.032962,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
388591,RNF207,Q6ZRF8,0.931,0.115,5.4736e-12,,,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0,,2015.0,2015.0,ALL
388595,TMEM82,A0PJX8,0.89,0.077,3.0094e-07,,,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
388610,TRNP1,Q6NT89,,,0.3788,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
388611,CD164L2,Q6UWJ8,1.0,0.038,1.1451e-05,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
388630,TRABD2B,A6NFA1,0.931,0.038,0.84273,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
388633,LDLRAD1,Q5T700,0.89,0.115,1.2294e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
388650,DIPK1A,Q5T7M9,0.743,0.423,0.58405,,,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0,,2008.0,2008.0,ALL
388662,SLC6A17,Q9H1V8,0.78,0.308,0.50353,,,C4225395,"MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48",,,disease,Disease or Syndrome,0.7,1.0,,2015.0,2015.0,ALL
388677,NOTCH2NLA,P0DPK4;Q7Z3S9,0.821,0.192,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
388685,LINC01138,,0.821,0.154,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
388697,HRNR,Q86YZ3,0.711,0.346,0.0004258,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.07,1.0,,2010.0,2019.0,ALL
388698,FLG2,Q5D862,0.78,0.192,0.017969,,,C4748093,PEELING SKIN SYNDROME 6,,,disease,Disease or Syndrome,0.4,1.0,,2017.0,2017.0,ALL
388743,CAPN8,A6NHC0,0.861,0.192,1.2513e-13,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
388753,COA6,Q5JTJ3,0.805,0.192,0.0056851,,,C1858424,"Cardioencephalomyopathy, Fatal Infantile, due to Cytochrome C Oxidase Deficiency",C16;C18;C05;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.6,1.0,strong,2014.0,2015.0,ALL
388796,SNHG17,,0.78,0.231,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2018.0,2019.0,ALL
388815,MIR99AHG,,0.78,0.192,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
388886,LRRC75B,Q2VPJ9,0.931,0.077,9.0241e-13,,,C1278049,Serum gamma-glutamyl transferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
388906,OGFRP1,,0.839,0.154,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
388931,MFSD2B,A6NFX1,,,6.3325e-11,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
388939,PCARE,A6NGG8,0.674,0.346,3.0058e-18,,,C3150691,RETINITIS PIGMENTOSA 54,,,disease,Disease or Syndrome,0.9,1.0,,2010.0,2015.0,ALL
388948,LINC01118,,0.89,0.154,1.9119e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
388951,TSPYL6,Q8N831,0.89,0.154,,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
388962,BOLA3,Q53S33,0.76,0.231,0.14911,,,C3280378,MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA,,,disease,Disease or Syndrome,0.71,1.0,,2001.0,2018.0,ALL
388969,C2orf68,Q2NKX9,0.839,0.115,5.7612e-06,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2013.0,2019.0,ALL
389015,SLC9A4,Q6AI14,0.89,0.154,8.286e-14,,,C0001122,Acidosis,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.3,1.0,,2010.0,2010.0,ALL
389023,DPP10-AS1,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
389053,HNRNPKP2,,1.0,0.077,,,,C0494165,Secondary malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
389058,SP5,Q6BEB4,1.0,0.077,0.51846,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.3,1.0,,2007.0,2007.0,ALL
389072,PLEKHM3,Q6ZWE6,0.861,0.231,0.00010037,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
389073,C2orf80,Q0P641,1.0,0.038,7.5e-11,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
389075,RESP18,Q5W5W9,0.931,0.154,8.716e-10,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.2,1.0,,2018.0,2018.0,ALL
389084,SNORC,Q6UX34,0.931,0.038,0.60161,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2019.0,ALL
389114,ZNF662,Q6ZS27,1.0,0.038,7.6715e-13,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
389118,CDHR4,A6H8M9,,,3.765e-13,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
389119,INKA1,Q96EL1,0.931,,0.00061425,,,C0280141,Acute Undifferentiated Leukemia,,,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
389120,ACTBP13,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
389125,MUSTN1,Q8IVN3,0.89,0.154,7.0616e-05,,,C0003615,Appendicitis,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
389136,VGLL3,A8MV65,0.716,0.346,0.069692,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
389161,ANKUB1,A6NFN9,1.0,0.077,1.1953e-08,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
389170,LEKR1,Q6ZMV7,0.89,0.231,0.13185,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
389177,TMEM212,A6NML5,1.0,0.038,1.833e-08,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
389197,C4orf50,Q6ZRC1,0.931,0.154,7.7361e-19,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
389203,SMIM20,Q8N5G0,0.821,0.192,0.57531,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.06,1.0,,2017.0,2019.0,ALL
389206,BEND4,Q6ZU67,0.839,0.154,0.98484,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
389207,GRXCR1,A8MXD5,0.861,0.115,3.9439e-11,,,C1414017,"DEAFNESS, AUTOSOMAL RECESSIVE 25",,,disease,Disease or Syndrome,0.7,1.0,strong,2010.0,2010.0,ALL
389208,TMPRSS11F,Q6ZWK6,0.931,0.115,1.2382e-09,,,C2076600,Influenza due to Influenza A virus subtype H1N1,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
389273,LINC02213,,0.839,0.115,0.012566,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
389289,ANXA2R,Q3ZCQ2,0.821,0.346,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
389333,PROB1,E7EW31,1.0,0.038,0.0054944,,,C0022578,Keratoconus,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
389362,PSMG4,Q5JS54,0.931,0.154,0.0018651,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
389376,SFTA2,Q6UW10,0.695,0.577,0.036441,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.11,1.0,,2009.0,2017.0,ALL
389383,CLPSL2,Q6UWE3,1.0,0.077,0.1858,,,C0729353,Subfertility,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
389400,GFRAL,Q6UXV0,0.89,0.154,6.5227e-10,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
389421,LIN28B,Q6ZN17,0.556,0.654,0.55513,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.9,1.0,,2012.0,2020.0,ALL
389432,SAMD5,Q5TGI4,0.839,0.154,0.012095,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
389434,IYD,Q6PHW0,0.7,0.5,0.0040758,,,C0342195,Thyroid Dyshormonogenesis 4,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.73,1.0,strong,2008.0,2014.0,ALL
389493,NUPR2,A6NF83,,,0.00050652,,,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0,,1992.0,1992.0,ALL
389549,FEZF1,A0PJY2,0.628,0.654,0.95043,,,C4014988,HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA,,,disease,Disease or Syndrome,0.6,1.0,,2014.0,2014.0,ALL
389558,FAM180A,Q6UWF9,0.89,0.115,0.0010025,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
389634,LINC00937,,1.0,,,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
389641,LOC389641,,0.89,0.231,,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
389643,NUGGC,Q68CJ6,1.0,0.038,3.387e-12,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
389658,ALKAL1,Q6UXT8,1.0,0.115,5.9081e-05,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
389668,XKR9,Q5GH70,,,4.0628e-09,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
389676,C8orf87,E5RJ46,1.0,0.038,0.069139,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
389677,RBM12B,Q8IXT5,,,0.0049816,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
389690,MROH5,Q6ZUA9,1.0,0.038,0.010417,,,C4511452,Sporadic Parkinson disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
389692,MAFA,Q8NHW3,0.751,0.269,0.0033727,,,C1578917,Islet cell adenomatosis,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.4,1.0,,2018.0,2018.0,ALL
389741,GLIDR,,0.931,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
389766,C9orf153,Q5TBE3,1.0,0.038,0.0076085,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
389792,IER5L,Q5T953,,,0.55377,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
389799,CFAP77,Q6ZQR2,0.931,0.154,1.693e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
389816,LRRC26,Q2I0M4,0.792,0.269,0.012698,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2006.0,2018.0,ALL
389827,MYMK,A6NI61,0.659,0.538,0.00017841,,,C1850746,"Myopathy, congenital nonprogressive with Moebius and Robin sequences",C16;C05;C10;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.72,1.0,strong,2017.0,2018.0,ALL
389840,MAP3K15,Q6ZN16,0.792,0.231,2.9348e-32,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,,,,,ALL
389856,USP27X,A6NNY8,0.705,0.462,0.92373,,,C4310816,"MENTAL RETARDATION, X-LINKED 105",,,disease,Disease or Syndrome,0.7,1.0,limited,2016.0,2016.0,ALL
389874,ZCCHC13,Q8WW36,0.861,0.077,0.0013939,,,C0220630,Adult Liver Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
389895,LOC389895,,,,,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0,,2016.0,2016.0,ALL
389898,UBE2NL,Q5JXB2,,,0.015382,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
389903,CSAG3,Q9Y5P2,0.7,0.346,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,1999.0,2006.0,ALL
389941,C1QL3,Q5VWW1,0.705,0.423,0.51567,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.04,1.0,,2016.0,2019.0,ALL
390003,GUCY2GP,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
390035,OR52K3P,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2019.0,2019.0,ALL
390038,OR51D1,Q8NGF3,,,0.0045855,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
390058,OR51B6,Q9H340,,,6.6815e-05,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2012.0,ALL
390059,OR51M1,Q9H341,,,0.0045344,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
390063,OR51I1,Q9H343,,,0.00085828,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
390064,OR51I2,Q9H344,1.0,0.077,0.036748,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
390082,OR52E5,Q8NH55,,,,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
390113,OR4X1,Q8NH49,,,6.3135e-06,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
390148,OR5W2,Q8NH69,,,0.00056247,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
390152,OR8H3,Q8N146,,,0.0114,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
390168,OR5M1,Q8NGP8,,,0.0019124,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,,limited,,,ALL
390191,OR5B12,Q96R08,,,0.020305,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
390195,OR5AN1,Q8NGI8,,,5.9253e-05,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
390205,LRRC10B,A6NIK2,,,0.044884,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
390211,KRT8P26,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
390213,DOC2GP,,,,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
390226,GUCY2EP,,0.78,0.154,,,,C0424574,Duration of sleep,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
390231,TRIM77,I1YAP6,1.0,0.038,1.0217e-05,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
390243,IZUMO1R,A6ND01,,,5.5093e-15,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
390259,BSX,Q3C1V8,1.0,0.077,0.0079075,,,C0795841,Jacobsen Distal 11q Deletion Syndrome,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
390275,OR8A1,Q8NGG7,,,0.005028,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2014.0,ALL
390321,OR6C1,Q96RD1,1.0,0.038,0.50471,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
390322,OR6C7P,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
390323,OR6C75,A6NL08,1.0,0.038,0.018817,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
390324,OR6C71P,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
390431,OR4K2,Q8NGD2,,,3.8826e-05,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
390502,SERPINA2,P20848,0.861,0.231,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
390535,GOLGA8EP,,1.0,0.115,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
390594,KBTBD13,C9JR72,0.729,0.385,2.2574e-10,,,C1836472,Nemaline myopathy 6,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.7,1.0,,2003.0,2010.0,ALL
390595,UBAP1L,F5GYI3,1.0,0.077,0.0060011,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
390598,SKOR1,P84550,0.792,0.269,6.8995e-09,,,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.09,1.0,,2007.0,2018.0,ALL
390612,RPL18P11,,0.931,0.077,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
390664,C1QTNF8,P60827,0.839,0.154,1.2959e-12,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
390667,PTX4,Q96A99,1.0,0.077,3.758e-13,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
390714,LOC390714,,0.617,0.615,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,0.974,,1989.0,2019.0,ALL
390732,CES1P2,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
390756,OR3A4P,P47883,0.931,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
390790,ARL5C,A6NH57,1.0,0.038,0.30967,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
390816,THA1P,,0.931,0.077,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
390858,OACYLP,,0.931,0.077,,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
390916,NUDT19,A8MXV4,1.0,0.077,2.9701e-15,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
390927,ZNF793,Q6ZN11,1.0,0.077,1.9629e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
390928,ACP7,Q6ZNF0,,,2.1396e-09,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
390992,HES3,Q5TGS1,0.839,0.154,0.27711,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
390998,RPL10P17,,1.0,0.115,,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
390999,PRAMEF12,O95522,,,5.2721e-05,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
391013,PLA2G2C,Q5R387,1.0,0.038,0.035718,,,C0206677,Adenomatous Polyps,C04,   Neoplasms,disease,Neoplastic Process,0.01,0.0,,1996.0,1996.0,ALL
391037,SKINT1L,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
391051,UOX,,0.711,0.385,,,,C0041364,Tumor Lysis Syndrome,C20;C15,   Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.34,1.0,,2003.0,2019.0,ALL
391104,VHLL,Q6RSH7,0.682,0.385,,,,C0021400,Influenza,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.07,0.857,,2012.0,2020.0,ALL
391110,OR10R3P,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
391112,OR6Y1,Q8NGX8,1.0,0.038,0.00095201,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
391119,OR10J7P,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
391120,OR10J9P,,,,,,,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
391123,VSIG8,P0DPA2,,,0.00020192,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
391189,OR11L1,Q8NGX0,1.0,0.038,0.050098,,,C0038436,Post-Traumatic Stress Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
391195,OR2T33,Q8NG76,0.931,0.038,0.11612,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
391253,SPINT4,Q6UDR6,,,0.084396,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
391257,SUMO1P1,G2XKQ0,1.0,0.115,,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
391356,PTRHD1,Q6GMV3,0.89,0.154,4.6245e-07,,,C0242422,Parkinsonian Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.32,1.0,moderate,2017.0,2018.0,ALL
391370,RPS12P4,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
391475,DYTN,A2CJ06,,,5.7188e-19,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
391533,FLT1P1,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
391589,KRT18P34,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
391627,USP17L9P,,0.722,0.308,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
391632,OR7E35P,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
391634,HSP90AB2P,Q58FF8,1.0,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
391723,HELT,A6NFD8,0.89,0.115,0.0010075,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
391850,RPL7AP33,,1.0,0.038,,,,C0700639,"Pyloric Stenosis, Hypertrophic",C06,   Digestive System Diseases,disease,Congenital Abnormality,0.1,1.0,,2012.0,2012.0,ALL
392197,USP17L7,P0C7H9,1.0,0.077,,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
392255,GDF6,Q6KF10,0.587,0.5,0.98833,,,C0022738,Klippel-Feil Syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.74,1.0,limited,2008.0,2015.0,ALL
392301,SLC25A5P8,,,,,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
392309,OR13J1,Q8NGT2,0.89,0.077,6.3322e-06,,,C0005283,beta Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,1994.0,1994.0,ALL
392387,AHCYP2,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
392399,LCN9,Q8WX39,1.0,0.038,0.0016951,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
392509,ARL13A,Q5H913,0.89,0.308,0.00059177,,,C0431399,Familial aplasia of the vermis,C16;C13;C11;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Male Urogenital Diseases",disease,Disease or Syndrome,0.02,1.0,,2013.0,2018.0,ALL
392617,ELFN1,P0C7U0,0.931,0.077,0.99882,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
392636,AGMO,Q6ZNB7,0.78,0.423,6.7791e-26,,,C0025958,Microcephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.31,1.0,,2016.0,2019.0,ALL
392843,IQCA1L,A6NCM1,1.0,,,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
392862,GRID2IP,A4D2P6,,,0.1245,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
394214,COL11A2P1,,0.805,0.462,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
394263,MUC21,Q5SSG8,0.743,0.346,0.080201,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
394269,BRCA1P1,,0.931,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2010.0,2017.0,ALL
399495,SLC2A3P4,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
399516,OTSC7,,1.0,0.038,,,,C0029899,Otosclerosis,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
399564,GLC1H,,0.931,0.038,,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.03,1.0,,2007.0,2015.0,ALL
399565,GLC3C,,1.0,0.115,,,,C1533041,Primary congenital glaucoma,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.05,0.6,,2009.0,2013.0,ALL
399664,MEX3D,Q86XN8,0.89,0.154,0.92303,,,C0027831,Neurofibromatosis 1,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
399665,FAM102A,Q5T9C2,0.861,0.038,0.10983,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
399668,SMIM10L2A,P0DMW4;P0DMW5,0.619,0.808,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2014.0,2017.0,ALL
399671,HEATR4,Q86WZ0,,,1.3711e-29,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
399687,MYO18A,Q92614,0.861,0.154,0.98723,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
399694,SHC4,Q6S5L8,0.805,0.154,7.1127e-11,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
399697,CTXN2,P0C2S0,,,0.035215,,,C0037290,Skin Pigmentation,,,phenotype,Organ or Tissue Function,0.1,1.0,,2007.0,2007.0,ALL
399706,LINC00200,,1.0,0.115,,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
399715,LINC02649,,0.792,0.308,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2019.0,ALL
399716,LINC02656,,0.931,0.154,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
399717,GATA3-AS1,,0.931,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
399726,MIR1915HG,Q5T4H9,,,0.084846,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
399806,LBX1-AS1,,0.792,0.231,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.11,1.0,,2013.0,2017.0,ALL
399818,EEF1AKMT2,Q5JPI9,1.0,0.038,2.254e-07,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
399823,FOXI2,Q6ZQN5,0.89,0.192,0.00029852,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
399881,HNRNPKP3,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
399886,LINC02687,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
399909,PCNX3,Q9H6A9,0.839,0.192,0.99999,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
399948,COLCA1,Q6ZS62,0.78,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.13,1.0,,2008.0,2019.0,ALL
399959,MIR100HG,,0.682,0.308,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
399972,GSEC,,0.751,0.269,,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
399979,SNX19,Q92543,0.861,0.115,8.8349e-12,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
400043,LINC02381,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
400046,LINC02389,,1.0,0.038,,,,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
400073,C12orf76,Q8N812,0.931,0.115,9.8749e-07,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
400121,LINC00547,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
400128,TUSC8,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
400224,PLEKHD1,A6NEE1,0.861,0.077,9.0931e-06,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
400242,DICER1-AS1,,0.805,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2019.0,ALL
400258,C14orf180,Q8N912,1.0,0.077,0.0043821,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
400359,LINC02694,Q8NAA6,0.78,0.308,0.01712,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.42,0.5,,2008.0,2019.0,ALL
400406,ADAMTS7P3,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
400410,ST20,Q9HBF5,0.751,0.231,0.37485,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
400451,FAM174B,Q3ZCQ3,,,0.0016376,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
400456,LINC01197,,0.931,0.231,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
400500,BCAR4,,0.653,0.346,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2006.0,2019.0,ALL
400506,KNOP1,Q1ED39,,,2.3895e-07,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
400511,LINC01567,,0.861,0.231,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
400533,LINC02167,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
400550,FENDRR,,0.653,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
400558,LINC02138,,,,,,,C0406208,Suntan,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
400566,C17orf97,Q6ZQX7,0.548,0.577,4.8417e-06,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.929,,1993.0,2020.0,ALL
400578,KRT16P2,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
400604,TOB1-AS1,,0.805,0.231,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
400618,SOX9-AS1,,0.839,0.269,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
400619,LINC00511,,0.638,0.423,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.14,1.0,,2017.0,2019.0,ALL
400620,LINC02092,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
400629,TEX19,Q8NA77,0.821,0.154,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
400643,LINC00668,,0.76,0.231,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0,,2019.0,2019.0,ALL
400654,LINC01538,,,,,,,C0035227,Respiratory Function Tests,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
400657,LINC00909,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
400660,LINC00683,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,0.0,,2019.0,2019.0,ALL
400668,PRSS57,Q6UWY2,0.729,0.231,2.8309e-05,,,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,0.867,,1995.0,2020.0,ALL
400680,LINC00664,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
400685,LINC01801,,,,,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2015.0,2015.0,ALL
400713,ZNF880,Q6PDB4,,,0.002911,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
400736,PRAMEF13,Q5VWM6,0.931,0.231,0.29184,,,C1527336,Sjogren's Syndrome,C11;C17;C05;C20;C07,   Eye Diseases;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
400745,SH2D5,Q6ZV89,0.839,0.154,6.4459e-08,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
400757,C1orf141,Q5JVX7,0.691,0.385,0.0032311,,,C0042170,Uveomeningoencephalitic Syndrome,C11;C20;C10,   Eye Diseases;    Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.12,1.0,,2014.0,2016.0,ALL
400765,MIR137HG,,0.839,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.46,0.5,,2011.0,2019.0,ALL
400794,LRRC52-AS1,,0.931,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
400798,C1orf220,Q5T0J3,1.0,0.077,0.23559,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2010.0,2010.0,ALL
400799,LINC01344,,1.0,0.077,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
400800,LINC02789,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
400818,NBPF9,P0DPF3,0.931,0.038,9.5156e-39,,,C0399526,Class III malocclusion,C07,   Stomatognathic Diseases,disease,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
400839,LINC01721,,1.0,0.077,,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
400892,BCRP2,,0.736,0.423,,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0,,1992.0,2010.0,ALL
400916,CHCHD10,Q8WYQ3,0.623,0.462,5.3661e-06,,,C3554398,"SPINAL MUSCULAR ATROPHY, JOKELA TYPE",,,disease,Disease or Syndrome,0.71,1.0,,2014.0,2018.0,ALL
400931,MIRLET7BHG,,0.861,0.154,0.10042,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
400932,LINC00898,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
400935,IL17REL,Q6ZVW7,0.861,0.192,0.0018916,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.42,1.0,,2010.0,2018.0,ALL
400945,LINC01376,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2007.0,2013.0,ALL
400950,C2orf91,Q6ZV80,0.931,0.115,0.00089143,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2017.0,2017.0,ALL
400952,LINC01121,,0.751,0.192,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
400954,EML6,Q6ZMW3,0.931,0.115,4.0925e-09,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
400955,LINC01122,,0.821,0.269,,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2013.0,ALL
400957,LINC01185,,0.743,0.346,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
400958,LINC02245,,0.821,0.231,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2018.0,ALL
400960,PCBP1-AS1,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
400961,PAIP2B,Q9ULR5,0.931,0.115,0.0014573,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
400966,RGPD1,P0DJD0,,,0.0070125,,,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2002.0,2002.0,ALL
400997,ACOXL-AS1,,0.861,0.154,,,,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
401014,TEX41,,0.743,0.269,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
401022,HAGLR,,0.619,0.385,,,,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.12,1.0,,2015.0,2019.0,ALL
401024,FSIP2,Q5CZC0,0.89,0.077,4.6257e-28,,,C0021359,Infertility,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,phenotype,Pathologic Function,0.1,,,,,ALL
401036,ASB18,Q6ZVZ8,0.931,0.038,6.1879e-08,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
401074,LINC00960,,1.0,0.038,,,,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
401081,C3orf85,A0A1B0GTC6,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
401093,MBNL1-AS1,,0.821,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2019.0,2020.0,ALL
401103,LINC01994,,,,,,,C2697999,Macrophage Colony Stimulating Factor Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
401106,LINC00884,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
401109,LINC00885,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
401115,C4orf48,Q5BLP8,1.0,0.038,0.51423,,,C1956097,Wolf-Hirschhorn Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
401124,DTHD1,Q6ZMT9,1.0,0.077,3.3986e-07,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
401134,LINC02232,,1.0,0.038,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
401138,AMTN,Q6UX39,0.792,0.192,8.1348e-11,,,C0002452,Amelogenesis Imperfecta,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.42,1.0,moderate,2016.0,2019.0,ALL
401145,CCSER1,Q9C0I3,0.805,0.308,0.000789,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
401149,LINC01061,,0.89,0.154,,,,C0206698,Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
401152,C4orf3,Q8WVX3,0.674,0.577,0.30797,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,1.0,,2017.0,2020.0,ALL
401164,LINC01060,,0.931,0.115,,,,C1285654,Memory performance,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
401172,LINC02145,,0.89,0.115,,,,C2239219,von Willebrand's factor (lab test),,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
401190,RGS7BP,Q6MZT1,0.89,0.308,0.95778,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
401207,C5orf63,A6NC05,0.89,0.077,0.0044611,,,C0013146,Drug abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
401236,STMND1,H3BQB6,,,9.8701e-05,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
401237,CASC15,,0.603,0.577,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.16,1.0,,2008.0,2018.0,ALL
401247,LINC00243,,0.729,0.423,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2009.0,ALL
401250,MCCD1,P59942,0.89,0.231,0.0019319,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
401251,SAPCD1,Q5SSQ6,0.931,0.154,1.8051e-07,,,C0039263,Takayasu Arteritis,C17;C14,   Skin and Connective Tissue Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
401253,LINC00336,Q6ZUF6,0.861,0.154,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
401260,LINC00951,,1.0,0.038,,,,C0003431,Antisocial Personality Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2016.0,2016.0,ALL
401262,CRIP3,Q6Q6R5,0.805,0.308,0.00064839,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
401264,TRAM2-AS1,,,,,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
401265,KLHL31,Q9H511,1.0,0.077,3.9256e-06,,,C0175709,Centronuclear myopathy,C05;C10,   Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.2,,,,,ALL
401289,LINC01624,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
401296,LNCRI,,,,,,,C1449861,"Micronuclei, Chromosome-Defective",C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Cell Component,0.3,1.0,,2018.0,2018.0,ALL
401321,LINC00997,,1.0,0.115,,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
401331,RASA4CP,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
401337,LINC01446,,0.861,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
401375,GTF2IRD2P1,,,,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
401387,LRRD1,A4D1F6,1.0,0.077,1.6779e-06,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
401393,AZGP1P2,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
401397,SMIM30,A4D0T7,1.0,0.038,0.38247,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
401472,GASAL1,,0.743,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
401474,SAMD12,Q8N8I0,0.7,0.269,0.0011661,,,C1832841,"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.5,1.0,,2018.0,2018.0,ALL
401491,VLDLR-AS1,,0.821,0.115,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
401492,LINC01235,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
401494,HACD4,Q5VWC8,0.931,0.038,2.0561e-05,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
401498,TMEM215,Q68D42,,,0.0041235,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
401505,TOMM5,Q8N4H5,0.861,0.154,0.49975,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
401541,CENPP,Q6IPU0,1.0,0.077,0.046312,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
401548,SNX30,Q5VWJ9,1.0,0.038,0.58843,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
401554,GPRACR,,,,,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
401563,C9orf139,Q6ZV77,1.0,0.077,0.0024581,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
401613,SERTM2,A0A1B0GWG4,0.931,0.077,,,,C0023267,Fibroid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
401630,FAM224A,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
401634,GOLGA2P3Y,,1.0,0.038,,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
401647,GOLGA7B,Q2TAP0,1.0,0.077,0.00599,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
401662,OR51A8P,,,,,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
401827,MSLNL,Q96KJ4,,,3.0489e-26,,,C0030193,Pain,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2019.0,2019.0,ALL
401944,LDLRAD2,Q5SZI1,0.931,0.077,0.00021385,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
401967,NBPF17P,,0.89,0.077,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
402117,VWC2L,B2RUY7,0.931,0.038,0.1298,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
402146,B3GAT3P1,,,,,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
402160,CFAP99,D6REC4,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2017.0,ALL
402359,KHSRPP1,,1.0,0.038,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
402381,SOHLH1,Q5JUK2,0.705,0.269,0.00226,,,C0085215,"Ovarian Failure, Premature",C13;C19,   Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.32,0.5,strong,2015.0,2019.0,ALL
402408,PKMP2,,1.0,0.077,,,,C4083212,"Alopecia, Male Pattern",C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
402569,KPNA7,A9QM74,0.805,0.308,3.3787e-15,,,C0026106,Mild Mental Retardation,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
402665,IGLON5,A6NGN9,0.839,0.308,0.40274,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
402682,UFSP1,Q6NVU6,1.0,0.077,0.027072,,,C1821417,RESTING HEART RATE,,,phenotype,Finding,0.1,1.0,,2010.0,2010.0,ALL
402778,IFITM10,A6NMD0,0.931,0.077,0.15714,,,C1285654,Memory performance,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
403283,OR6C66P,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
403323,LERFS,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
404024,TRIM26BP,,0.861,0.269,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
404026,MTCO3P1,,0.861,0.231,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
404037,HAPLN4,Q86UW8,0.805,0.154,0.01078,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
404093,CUEDC1,Q9NWM3,0.931,0.077,6.6336e-08,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
404201,WDFY3-AS2,,0.821,0.115,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
404203,SPINK6,Q6UWN8,0.76,0.385,3.5317e-07,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
404204,UGT1A13P,,,,,,,C0344395,Bilirubin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
404216,LINC01561,Q8N1V8,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
404266,HOXB-AS3,,0.751,0.308,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
404281,YY2,O15391,1.0,0.077,0.40781,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,,,,,ALL
404544,COX8BP,,,,,,,C0040580,Tracheal Diseases,C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
404550,C16orf74,Q96GX8,0.839,0.346,0.49655,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
404552,SCGB1D4,Q6XE38,0.861,0.231,0.057471,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
404635,NANOGP1,Q8N7R0,0.931,0.269,,,,C0018798,Congenital Heart Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0,,2016.0,2016.0,ALL
404663,LINC01194,,0.47,0.769,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.933,,1990.0,2019.0,ALL
404672,GTF2H5,Q6ZYL4,0.556,0.769,0.045238,,,C4017171,"TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE",,,disease,Disease or Syndrome,0.7,1.0,,2004.0,2004.0,ALL
404677,CIMT,,0.695,0.462,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.09,1.0,,2007.0,2019.0,ALL
404682,MYP5,,0.931,0.038,,,,C0014306,Enophthalmos,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
404684,PHOBS,,0.821,0.038,,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.02,1.0,,2017.0,2019.0,ALL
404714,SLEB4,,0.861,0.154,,,,C0024131,Lupus Vulgaris,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0,,2004.0,2005.0,ALL
404734,ANKHD1-EIF4EBP3,Q8IWZ3,0.805,0.346,1.0,,,C0236773,Depressed bipolar I disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
404744,NPSR1-AS1,,1.0,,,,,C0201512,Thyroglobulin antibody measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
404785,POTEG,Q6S5H5,0.89,0.077,4.8749e-11,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
405753,DUOXA2,Q1HG44,0.7,0.423,1.2666e-15,,,C0342196,Thyroid Dyshormonogenesis 5,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2008.0,2016.0,ALL
405754,ERVFRD-1,P60508,0.805,0.115,0.025857,,,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
406874,DYX8,,0.861,0.115,,,,C0476254,Dyslexia,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.06,1.0,,2004.0,2013.0,ALL
406881,MIRLET7A1,,0.805,0.192,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
406882,MIRLET7A2,,0.716,0.269,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2018.0,ALL
406883,MIRLET7A3,,0.751,0.269,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2017.0,ALL
406884,MIRLET7B,,0.493,0.769,,,,C0860207,Drug-Induced Liver Disease,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,phenotype,Disease or Syndrome,0.31,1.0,,2017.0,2018.0,ALL
406885,MIRLET7C,,0.514,0.808,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.32,0.667,,2011.0,2017.0,ALL
406886,MIRLET7D,,0.579,0.692,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
406887,MIRLET7E,,0.592,0.769,,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2011.0,2011.0,ALL
406888,MIRLET7F1,,0.839,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
406889,MIRLET7F2,,0.839,0.154,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
406890,MIRLET7G,,0.606,0.769,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
406891,MIRLET7I,,0.575,0.615,,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
406892,MIR100,,0.521,0.846,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
406893,MIR101-1,,0.78,0.231,,,,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
406894,MIR101-2,,0.821,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2014.0,2017.0,ALL
406895,MIR103A1,,0.89,0.077,,,,C0007786,Brain Ischemia,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
406896,MIR103A2,,0.89,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
406897,MIR105-1,,0.931,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2017.0,ALL
406899,MIR106A,,0.524,0.846,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
406900,MIR106B,,0.523,0.808,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2012.0,2019.0,ALL
406901,MIR107,,0.543,0.769,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2011.0,2013.0,ALL
406902,MIR10A,,0.513,0.846,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.35,1.0,,2010.0,2019.0,ALL
406903,MIR10B,,0.509,0.808,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2007.0,2019.0,ALL
406904,MIR1-1,,0.792,0.115,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2018.0,2018.0,ALL
406905,MIR1-2,,0.931,0.077,,,,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.2,1.0,,2018.0,2018.0,ALL
406906,MIR122,,0.468,0.808,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.4,0.939,,2011.0,2019.0,ALL
406907,MIR124-1,,0.663,0.5,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2008.0,2017.0,ALL
406908,MIR124-2,,0.716,0.269,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
406909,MIR124-3,,0.76,0.346,,,,C0006012,Borderline Personality Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2015.0,2015.0,ALL
406910,MIR125A,,0.48,0.769,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,0.944,,2009.0,2019.0,ALL
406911,MIR125B1,,0.656,0.538,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
406912,MIR125B2,,0.659,0.423,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.32,1.0,,2010.0,2018.0,ALL
406913,MIR126,,0.447,0.846,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.941,,2008.0,2020.0,ALL
406914,MIR127,,0.553,0.692,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.37,0.875,,2010.0,2020.0,ALL
406915,MIR128-1,,0.695,0.346,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,,2018.0,2018.0,ALL
406916,MIR128-2,,0.711,0.423,,,,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
406917,MIR129-1,,0.792,0.115,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2013.0,2014.0,ALL
406918,MIR129-2,,0.653,0.654,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.37,1.0,,2009.0,2018.0,ALL
406919,MIR130A,,0.522,0.808,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.35,1.0,,2009.0,2019.0,ALL
406920,MIR130B,,0.547,0.808,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
406921,MIR132,,0.485,0.846,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,1.0,,2010.0,2019.0,ALL
406922,MIR133A1,,0.821,0.308,,,,C0016059,Fibrosis,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.3,1.0,,2010.0,2010.0,ALL
406923,MIR133A2,,0.805,0.269,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
406924,MIR134,,0.542,0.769,,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
406925,MIR135A1,,0.861,0.077,,,,C0009404,Colorectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
406926,MIR135A2,,,,,,,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2019.0,2019.0,ALL
406927,MIR136,,0.584,0.731,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2014.0,2017.0,ALL
406928,MIR137,,0.513,0.846,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.4,0.954,,2011.0,2020.0,ALL
406929,MIR138-1,,0.861,0.192,,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
406930,MIR138-2,,0.931,0.154,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
406931,MIR139,,0.527,0.808,,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
406932,MIR140,,0.522,0.769,,,,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.32,1.0,,2017.0,2019.0,ALL
406933,MIR141,,0.497,0.808,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.944,,2010.0,2019.0,ALL
406934,MIR142,,0.48,0.846,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.31,1.0,,2014.0,2018.0,ALL
406935,MIR143,,0.462,0.885,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2006.0,2019.0,ALL
406936,MIR144,,0.5,0.769,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.36,1.0,,2011.0,2018.0,ALL
406937,MIR145,,0.431,0.846,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.4,0.923,,2010.0,2019.0,ALL
406938,MIR146A,,0.398,0.885,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.4,1.0,,2008.0,2019.0,ALL
406939,MIR147A,,0.716,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2016.0,ALL
406940,MIR148A,,0.506,0.846,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.31,1.0,,2013.0,2017.0,ALL
406941,MIR149,,0.524,0.769,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2012.0,2012.0,ALL
406942,MIR150,,0.455,0.808,,,,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2012.0,2019.0,ALL
406943,MIR152,,0.521,0.769,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.38,1.0,,2013.0,2020.0,ALL
406944,MIR153-1,,0.89,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
406946,MIR154,,0.593,0.577,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2014.0,2014.0,ALL
406947,MIR155,,0.384,0.885,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.4,1.0,,2007.0,2019.0,ALL
406948,MIR15A,,0.482,0.808,,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
406949,MIR15B,,0.532,0.769,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
406950,MIR16-1,,0.623,0.5,,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
406951,MIR16-2,,0.736,0.346,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
406952,MIR17,,0.459,0.846,,,,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.34,1.0,,2015.0,2019.0,ALL
406953,MIR18A,,0.52,0.846,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
406954,MIR181A2,,0.57,0.654,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2008.0,2017.0,ALL
406955,MIR181B1,,0.89,0.115,,,,C0280449,secondary acute myeloid leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2017.0,ALL
406957,MIR181C,,0.555,0.769,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.34,0.8,,2009.0,2019.0,ALL
406958,MIR182,,0.486,0.846,,,,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
406959,MIR183,,0.494,0.885,,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
406960,MIR184,,0.542,0.769,,,,C3280392,EDICT syndrome,,,disease,Disease or Syndrome,0.67,1.0,,2011.0,2017.0,ALL
406961,MIR185,,0.551,0.808,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
406962,MIR186,,0.551,0.808,,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
406963,MIR187,,0.593,0.731,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2018.0,ALL
406964,MIR188,,0.612,0.808,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
406965,MIR190A,,0.65,0.423,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
406966,MIR191,,0.548,0.731,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2018.0,ALL
406967,MIR192,,0.503,0.846,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.36,1.0,,2014.0,2019.0,ALL
406968,MIR193A,,0.541,0.731,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.39,1.0,,2012.0,2019.0,ALL
406969,MIR194-1,,0.821,0.154,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
406970,MIR194-2,,1.0,0.077,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
406971,MIR195,,0.496,0.769,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,,2014.0,2014.0,ALL
406972,MIR196A1,,0.599,0.577,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0,,2014.0,2019.0,ALL
406973,MIR196A2,,0.599,0.577,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.2,1.0,,2016.0,2016.0,ALL
406974,MIR197,,0.565,0.615,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.38,0.889,,2009.0,2019.0,ALL
406975,MIR198,,0.633,0.462,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2019.0,ALL
406976,MIR199A1,,0.578,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.962,,2010.0,2019.0,ALL
406977,MIR199A2,,0.578,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.962,,2010.0,2019.0,ALL
406978,MIR199B,,0.588,0.615,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2009.0,2019.0,ALL
406979,MIR19A,,0.512,0.808,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
406980,MIR19B1,,0.529,0.769,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2016.0,2018.0,ALL
406981,MIR19B2,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
406982,MIR20A,,0.498,0.769,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2012.0,2019.0,ALL
406983,MIR200A,,0.519,0.808,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.31,1.0,,2017.0,2019.0,ALL
406984,MIR200B,,0.5,0.769,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.952,,2010.0,2019.0,ALL
406985,MIR200C,,0.486,0.846,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2010.0,2020.0,ALL
406986,MIR203A,,0.471,0.808,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,0.979,,2009.0,2020.0,ALL
406987,MIR204,,0.487,0.808,,,,C4225233,RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT,,,disease,Disease or Syndrome,0.7,1.0,moderate,2015.0,2015.0,ALL
406988,MIR205,,0.482,0.846,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.97,,2009.0,2019.0,ALL
406989,MIR206,,0.477,0.846,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2007.0,2019.0,ALL
406990,MIR208A,,0.659,0.5,,,,C0876994,Cardiotoxicity,C23;C25;C14;C26,"   Pathological Conditions, Signs and Symptoms;    Chemically-Induced Disorders;    Cardiovascular Diseases;    Wounds and Injuries",disease,Injury or Poisoning,0.3,1.0,,2016.0,2016.0,ALL
406991,MIR21,,0.363,0.846,,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.4,1.0,,2011.0,2019.0,ALL
406992,MIR210,,0.46,0.846,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
406993,MIR211,,0.552,0.577,,,,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2011.0,2011.0,ALL
406994,MIR212,,0.535,0.808,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2013.0,2016.0,ALL
406995,MIR181A1,,0.792,0.231,,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
406996,MIR214,,0.48,0.808,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2010.0,2019.0,ALL
406997,MIR215,,0.559,0.654,,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,,2012.0,2019.0,ALL
406998,MIR216A,,0.582,0.654,,,,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.32,1.0,,2015.0,2018.0,ALL
406999,MIR217,,0.543,0.769,,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.32,1.0,,2015.0,2019.0,ALL
407000,MIR218-1,,0.722,0.231,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,,2015.0,2015.0,ALL
407001,MIR218-2,,0.716,0.385,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
407002,MIR219A1,,0.595,0.615,,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
407003,MIR219A2,,0.839,0.269,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2012.0,2012.0,ALL
407004,MIR22,,0.496,0.808,,,,C0079773,"Lymphoma, T-Cell, Cutaneous",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.31,1.0,,2015.0,2015.0,ALL
407006,MIR221,,0.449,0.846,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,0.981,,2008.0,2019.0,ALL
407007,MIR222,,0.486,0.808,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2008.0,2019.0,ALL
407008,MIR223,,0.433,0.808,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2017.0,2019.0,ALL
407009,MIR224,,0.534,0.654,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2009.0,2018.0,ALL
407010,MIR23A,,0.499,0.808,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
407011,MIR23B,,0.523,0.808,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
407012,MIR24-1,,0.584,0.731,,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
407013,MIR24-2,,0.711,0.192,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2011.0,2014.0,ALL
407014,MIR25,,0.517,0.769,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
407015,MIR26A1,,0.653,0.577,,,,C0003865,"Arthritis, Adjuvant-Induced",C05,   Musculoskeletal Diseases,disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
407016,MIR26A2,,0.821,0.115,,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
407017,MIR26B,,0.529,0.808,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.36,1.0,,2011.0,2018.0,ALL
407018,MIR27A,,0.466,0.846,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.37,1.0,,2012.0,2019.0,ALL
407019,MIR27B,,0.529,0.769,,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
407020,MIR28,,0.597,0.731,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
407021,MIR29A,,0.459,0.808,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
407022,MIR296,,0.564,0.654,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.31,1.0,,2015.0,2015.0,ALL
407023,MIR299,,0.626,0.462,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
407024,MIR29B1,,0.485,0.846,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2012.0,2019.0,ALL
407025,MIR29B2,,0.484,0.885,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2012.0,2012.0,ALL
407026,MIR29C,,0.496,0.808,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.36,1.0,,2013.0,2018.0,ALL
407027,MIR301A,,0.558,0.808,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,1.0,,2011.0,2018.0,ALL
407028,MIR302A,,0.601,0.5,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
407029,MIR30A,,0.478,0.808,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
407030,MIR30B,,0.555,0.808,,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,,2012.0,2017.0,ALL
407031,MIR30C1,,0.552,0.769,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.35,1.0,,2011.0,2018.0,ALL
407032,MIR30C2,,0.546,0.769,,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,,2012.0,2015.0,ALL
407033,MIR30D,,0.563,0.654,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
407034,MIR30E,,0.576,0.769,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.34,1.0,,2010.0,2015.0,ALL
407035,MIR31,,0.471,0.769,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2009.0,2019.0,ALL
407036,MIR32,,0.619,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2019.0,ALL
407037,MIR320A,,0.526,0.808,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
407039,MIR33A,,0.56,0.654,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,0.952,,2011.0,2019.0,ALL
407040,MIR34A,,0.421,0.846,,,,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.4,1.0,,2011.0,2018.0,ALL
407041,MIR34B,,0.509,0.808,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.37,1.0,,2008.0,2019.0,ALL
407042,MIR34C,,0.541,0.885,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.4,1.0,,2009.0,2018.0,ALL
407043,MIR7-1,,0.628,0.692,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2020.0,ALL
407044,MIR7-2,,0.623,0.692,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2020.0,ALL
407045,MIR7-3,,0.626,0.692,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2020.0,ALL
407046,MIR9-1,,0.705,0.577,,,,C0525041,Neurobehavioral Manifestations,C23;C10;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Behavior and Behavior Mechanisms",phenotype,Sign or Symptom,0.3,1.0,,2012.0,2012.0,ALL
407047,MIR9-2,,0.792,0.231,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2013.0,2016.0,ALL
407048,MIR92A1,,0.769,0.269,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.31,1.0,,2010.0,2018.0,ALL
407049,MIR92A2,,0.805,0.269,,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2010.0,2017.0,ALL
407050,MIR93,,0.507,0.808,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2012.0,2019.0,ALL
407051,MIR9-3,,0.716,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2010.0,2013.0,ALL
407052,MIR95,,0.663,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2011.0,2019.0,ALL
407053,MIR96,,0.536,0.769,,,,C3888123,"DEAFNESS, AUTOSOMAL DOMINANT 50",,,disease,Disease or Syndrome,0.6,1.0,moderate,2018.0,2018.0,ALL
407054,MIR98,,0.565,0.731,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.36,1.0,,2016.0,2019.0,ALL
407055,MIR99A,,0.536,0.808,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.38,1.0,,2009.0,2019.0,ALL
407056,MIR99B,,0.633,0.615,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.35,1.0,,2009.0,2019.0,ALL
407738,TAFA1,Q7Z5A9,0.931,0.038,0.33119,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
407973,SCA20,,1.0,0.077,,,,C1837541,SPINOCEREBELLAR ATAXIA 20,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
407975,MIR17HG,Q75NE6,0.483,0.808,,,,C0796068,Oculodigitoesophagoduodenal syndrome,C23;C16;C06;C05;C08;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Musculoskeletal Diseases;    Respiratory Tract Diseases;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.52,1.0,moderate,2009.0,2018.0,ALL
407977,TNFSF12-TNFSF13,O43508,0.579,0.615,0.76997,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.11,1.0,,2018.0,2018.0,ALL
408050,NOMO3,P69849,,,9.5825e-05,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
408186,OVOS,,1.0,0.077,,,,C0151779,Cutaneous Melanoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
408221,SCA26,,,,,,,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2005.0,2005.0,ALL
408259,HPC3,,0.805,0.115,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.07,0.857,,2001.0,2009.0,ALL
408260,HPC4,,0.931,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
414059,TBC1D3B,A6NDS4,0.931,0.077,0.21949,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
414060,TBC1D3C,Q6DHY5;Q6IPX1;Q8IZP1,0.931,0.077,0.00024562,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
414061,DNAJB3,Q8WWF6,0.931,0.115,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
414062,CCL3L3,P16619,0.743,0.269,0.31517,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2006.0,2006.0,ALL
414152,C10orf105,Q8TEF2,0.861,0.231,0.084246,,,C0000772,Multiple congenital anomalies,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.1,1.0,,2001.0,2001.0,ALL
414235,PRR26,Q8N8Z3,1.0,0.077,0.25576,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
414236,C10orf55,Q5SWW7,0.931,0.115,0.014376,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
414243,LINC00595,,0.89,0.115,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
414245,DNAJC9-AS1,A6NH13,1.0,0.192,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
414301,DDI1,Q8WTU0,0.861,0.115,2.1471e-09,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
414325,DEFB103A,P81534,0.573,0.731,,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.06,1.0,,2014.0,2018.0,ALL
414760,HCG14,,1.0,0.077,,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
414764,HCG23,,1.0,0.038,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
414765,HCG25,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
414771,DDR1-DT,,0.931,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2009.0,ALL
414777,HCG18,,0.722,0.538,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.12,1.0,,2007.0,2018.0,ALL
414778,HCG17,,0.769,0.346,,,,C0001175,Acquired Immunodeficiency Syndrome,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
414886,SPG27,,0.89,0.231,,,,C1836899,"SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
414899,BLID,Q8IZY5,0.736,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2015.0,ALL
414918,DENND6B,Q8NEG7,1.0,0.038,3.7856e-09,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
415056,CNTFR-AS1,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2019.0,2019.0,ALL
415116,PIM3,Q86V86,0.621,0.654,0.98192,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
425054,VCX3B,Q9H321,0.89,0.269,0.33685,,,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,0.0,,2008.0,2008.0,ALL
431704,RGS21,Q2M5E4,1.0,0.077,3.8018e-05,,,C0010278,Craniosynostosis,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,0.0,,2019.0,2019.0,ALL
431705,ASTL,Q6HA08,0.931,0.115,6.048e-07,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
431707,LHX8,Q68G74,0.805,0.231,0.51572,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
431708,MDD1,,0.682,0.308,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.07,1.0,,2008.0,2019.0,ALL
431709,MDD2,,0.89,0.154,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
431712,CMT2G,,1.0,0.077,,,,C0266574,Ablepharon,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.01,1.0,,2018.0,2018.0,ALL
432355,SLURP2,P0DP57,0.931,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
439916,LINC00615,Q96LM1,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
439921,MXRA7,P84157,0.89,0.154,0.00079422,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
439927,LINC01555,Q8NAE3,0.931,0.115,0.094516,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
439934,LINC00575,Q6W349,,,,,,C4304530,4q21 microdeletion syndrome,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",phenotype,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
439936,C5orf17,Q8NAS9,0.931,0.115,,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
439949,PRKCQ-AS1,,0.89,0.115,,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
439950,CELF2-AS2,,,,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
439990,LINC00857,,0.821,0.192,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
440026,TMEM41B,Q5BJD5,0.861,0.115,0.28842,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
440028,LINC02709,,1.0,0.038,,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
440040,LOC440040,,0.89,0.077,,,,C0178874,Tumor Progression,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
440044,SLC22A20P,A6NK97,,,,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2018.0,2018.0,ALL
440063,PPIAP43,,1.0,0.077,,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
440068,CARD17,Q5XLA6,0.89,0.077,6.6679e-05,,,C0021368,Inflammation,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Pathologic Function,0.01,1.0,,2004.0,2004.0,ALL
440073,IQSEC3,Q9UPP2,,,0.0038704,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.3,1.0,,2019.0,2019.0,ALL
440077,ZNF705A,Q6ZN79,1.0,0.077,0.00064453,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.2,1.0,,2014.0,2014.0,ALL
440087,SMCO3,A2RU48,,,0.014367,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2013.0,ALL
440093,H3-5,Q6NXT2,1.0,0.038,,,,C4023106,Obstructive azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
440097,DBX2,Q6ZNG2,0.89,0.231,6.0563e-06,,,C0026351,Moderate intellectual disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.01,1.0,,2015.0,2015.0,ALL
440117,LINC02372,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
440119,FZD10-AS1,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
440138,ALG11,Q2TAA5,0.722,0.346,6.1729e-09,,,C3150913,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.71,1.0,strong,2010.0,2019.0,ALL
440163,RNASE13,Q5GAN3,0.805,0.231,0.31626,,,C0029001,Onchocerciasis,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.02,1.0,,1991.0,1994.0,ALL
440193,CCDC88C,Q9P219,0.647,0.346,3.3027e-08,,,C1531647,Cerebral ventriculomegaly,C10,   Nervous System Diseases,phenotype,Finding,0.6,1.0,,2010.0,2012.0,ALL
440225,NF1P2,,1.0,0.115,,,,C0027831,Neurofibromatosis 1,C16;C04;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases",disease,Neoplastic Process,0.01,1.0,,1993.0,1993.0,ALL
440275,EIF2AK4,Q9P2K8,0.603,0.577,1.2356e-15,,,C0034091,Pulmonary Veno-Occlusive Disease (disorder),C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.7,1.0,strong,2014.0,2020.0,ALL
440278,CATSPER2P1,,0.931,0.038,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
440279,UNC13C,Q8NB66,0.931,0.115,2.1692e-15,,,C0027902,Neuropsychological Tests,,,phenotype,Diagnostic Procedure,0.1,1.0,,2009.0,2009.0,ALL
440288,UBL7-AS1,,1.0,,,,,C0026985,Myelodysplasia,,,disease,Congenital Abnormality,0.01,1.0,,2015.0,2015.0,ALL
440335,SMIM22,K7EJ46,0.931,0.077,6.5039e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
440348,NPIPB15,A6NHN6,1.0,0.038,5.3603e-06,,,C1335975,Skull Base Chordoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
440350,NPIPB7,O75200,1.0,0.038,0.016363,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
440359,YBX3P1,,0.805,0.115,,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
440387,CTRB2,Q6GPI1,0.861,0.115,0.00036704,,,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.21,1.0,,1991.0,2018.0,ALL
440400,RNASEK,Q6P5S7,0.861,0.154,0.50355,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
440416,CCDC144NL-AS1,,1.0,0.038,,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
440423,SUZ12P1,,0.89,0.115,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2016.0,2016.0,ALL
440435,GPR179,Q6PRD1,0.716,0.115,3.228e-27,,,C3281215,"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E",,,disease,Disease or Syndrome,0.8,1.0,,2012.0,2012.0,ALL
440503,PLIN5,Q00G26,0.695,0.346,1.0481e-11,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
440515,ZNF506,Q5JVG8,,,1.6558e-09,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
440533,PSG8,Q9UQ74,0.743,0.423,1.6761e-23,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2015.0,ALL
440556,PRDM16-DT,,0.805,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
440574,MICOS10,Q5TGZ0,0.931,0.038,0.78732,,,C0020550,Hyperthyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
440584,SLC2A1-AS1,,1.0,,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
440585,FAM183A,A6NL82,0.931,0.038,0.041627,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
440590,ZYG11A,Q6WRX3,0.861,0.115,1.2573e-11,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
440595,EEF1A1P11,,1.0,0.077,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
440603,BCL2L15,Q5TBC7,0.89,0.192,0.048246,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.11,1.0,,2009.0,2015.0,ALL
440689,H2BC18,Q5QNW6,,,0.004633,,,C4016211,"IgG RECEPTOR I, PHAGOCYTIC, FAMILIAL DEFICIENCY OF",,,phenotype,Finding,0.1,,,,,ALL
440695,ETV3L,Q6ZN32,,,6.196e-08,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
440699,LRRC52,Q8N7C0,,,7.3202e-06,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
440704,LINC01720,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
440714,LINC02869,,1.0,0.038,0.095863,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
440730,TRIM67,Q6ZTA4,0.821,0.231,0.96542,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
440738,MAP1LC3C,Q9BXW4,0.792,0.385,5.8124e-06,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2013.0,2018.0,ALL
440822,PIWIL3,Q7Z3Z3,0.839,0.115,5.3547e-32,,,C0028960,Oligospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.31,1.0,,2010.0,2010.0,ALL
440823,MIAT,,0.573,0.692,,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.5,1.0,,2006.0,2019.0,ALL
440829,SHISA8,B8ZZ34,0.861,0.231,0.37777,,,C0036220,Kaposi Sarcoma,C04;C01,   Neoplasms;    Infections,disease,Neoplastic Process,0.08,1.0,,1997.0,2012.0,ALL
440836,ODF3B,A8MYP8,0.931,0.115,0.0045516,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
440854,CAPN14,A8MX76,0.821,0.192,1.5664e-21,,,C0341106,Eosinophilic esophagitis,C06;C20;C15,   Digestive System Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.48,1.0,,2014.0,2019.0,ALL
440894,LINC01123,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
440900,LINC01191,,0.736,0.385,,,,C0346210,Vulval intraepithelial neoplasia,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.06,1.0,,1991.0,2019.0,ALL
440905,FAR2P1,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
440915,POTEKP,Q9BYX7,0.542,0.769,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,1996.0,2019.0,ALL
440926,H3P6,,1.0,0.038,,,,C0024198,Lyme Disease,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
440944,THUMPD3-AS1,,1.0,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
440957,SMIM4,Q8WVI0,0.89,0.154,0.19943,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
440970,LINC00971,,1.0,0.038,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
440993,MIR570HG,,1.0,0.038,,,,C0158266,Intervertebral Disc Degeneration,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
441024,MTHFD2L,Q9H903,,,6.8566e-06,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
441046,GUSBP5,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
441051,HSP90AA6P,,1.0,0.077,,,,C0546837,Malignant neoplasm of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
441061,MARCHF11,A6NNE9,0.769,0.385,0.003113,,,C0007113,Rectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
441094,NR2F1-AS1,,0.78,0.308,,,,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,1.0,,1999.0,2017.0,ALL
441108,IRF1-AS1,Q8N8D9,0.67,0.385,0.0041687,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2019.0,ALL
441151,TMEM151B,Q8IW70,0.792,0.346,0.13582,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
441168,CALHM6,Q5R3K3,0.89,0.192,0.009461,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
441194,PMS2CL,Q68D20,0.861,0.231,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
441204,LOC441204,,1.0,0.038,,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
441208,ZNRF2P1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
441212,RP9P,,0.931,0.077,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
441250,TYW1B,Q6NUM6,1.0,0.038,5.4289e-20,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2006.0,2006.0,ALL
441263,DTX2P1-UPK3BP1-PMS2P11,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2017.0,2017.0,ALL
441282,AKR1B15,C9JRZ8,,,3.6787e-22,,,C0023980,Longevity,,,phenotype,Temporal Concept,0.1,1.0,,2010.0,2010.0,ALL
441355,MIR2052HG,,0.861,0.115,0.16336,,,C0373680,Myoglobin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
441389,LINC01239,,1.0,0.038,,,,C0015944,"Fetal Membranes, Premature Rupture",C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,1.0,,2019.0,2019.0,ALL
441432,AQP7P3,A6NL99,0.861,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
441459,ANKRD18B,A2A2Z9,0.89,0.077,1.492e-10,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2015.0,2015.0,ALL
441461,STX17-AS1,,0.89,0.192,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
441478,NRARP,Q7Z6K4,0.722,0.308,0.20859,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.3,1.0,,2010.0,2010.0,ALL
441501,LINC00891,,,,,,,C0035235,Respiratory Syncytial Virus Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
441509,GLRA4,,1.0,0.038,9.3781e-09,,,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2016.0,2016.0,ALL
441531,PGAM4,Q8N0Y7,1.0,0.038,,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
441549,CDNF,Q49AH0,0.78,0.231,6.1335e-07,,,C0600427,Cocaine Dependence,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,0.0,,2009.0,2009.0,ALL
441631,TSPAN11,A1L157,0.931,0.038,6.945e-07,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
441897,PGBP,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
441925,BECN2,A8MW95,0.89,0.192,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
441931,VN1R17P,Q8TDU5,0.529,0.923,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
441933,OR13G1,Q8NGZ3,1.0,0.038,0.15033,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
441951,ZFAS1,,0.582,0.615,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2010.0,ALL
442038,SULT1C3,Q6IMI6,0.839,0.077,4.4266e-18,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2014.0,2014.0,ALL
442075,EMC3-AS1,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
442108,RPL22P13,,,,,,,C0524957,Corneal Topography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2013.0,ALL
442114,KRT19P3,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
442117,GALNTL6,Q49A17,,,4.3214e-09,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
442167,ASS1P1,,0.931,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
442184,OR2B3,O76000,1.0,0.038,0.0068596,,,C0162823,"Dermatitis, Irritant",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
442186,OR2J3,O76001,1.0,0.077,0.0098541,,,C3554456,"C3HEX, ABILITY TO SMELL",,,phenotype,Finding,0.1,,,,,ALL
442191,OR14J1,Q9UGF5,0.89,0.154,0.0016678,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
442204,MYL8P,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
442206,GPR166P,,0.531,0.923,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
442213,PTCHD4,Q6ZW05,,,0.00016171,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
442227,EEF1B2P5,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
442253,NEPNP,,1.0,0.115,,,,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
442425,FOXB2,Q5VYV0,0.839,0.154,6.7467e-05,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
442444,FAM47C,Q5HY64,0.931,0.077,,,,C0028960,Oligospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
442459,XRCC6P5,,0.579,0.769,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1997.0,2019.0,ALL
442524,DPY19L2P3,,1.0,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2006.0,2006.0,ALL
442582,STAG3L2,P0CL84,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
442721,LMOD2,Q6P5Q4,0.805,0.154,0.00055222,,,C0033975,Psychotic Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.3,1.0,,2009.0,2009.0,ALL
442862,PRY2,O14603,0.931,0.077,,,,C1839071,"Spermatogenic Failure, Nonobstructive, Y-Linked",C16;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Male Urogenital Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
442867,BPY2B,O14599,0.839,0.115,,,,C0028960,Oligospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,2002.0,2003.0,ALL
442868,BPY2C,O14599,0.839,0.115,,,,C0028960,Oligospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.02,1.0,,2002.0,2003.0,ALL
442890,MIR133B,,0.555,0.808,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
442891,MIR135B,,0.554,0.731,,,,C0035222,"Respiratory Distress Syndrome, Adult",C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
442892,MIR148B,,0.592,0.692,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.36,1.0,,2009.0,2019.0,ALL
442893,MIR151A,,0.682,0.538,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
442894,MIR302B,,0.65,0.462,,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.31,1.0,,2013.0,2017.0,ALL
442895,MIR302C,,0.711,0.269,,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
442896,MIR302D,,0.7,0.538,,,,C0007095,Carcinoid Tumor,C04,   Neoplasms,phenotype,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
442897,MIR323A,,0.641,0.577,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
442898,MIR324,,0.61,0.731,,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
442899,MIR325,,0.78,0.423,,,,C0018781,Noise-induced hearing loss,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Injury or Poisoning,0.3,1.0,,2013.0,2013.0,ALL
442900,MIR326,,0.56,0.731,,,,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.32,1.0,,2014.0,2019.0,ALL
442901,MIR328,,0.558,0.769,,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.34,1.0,,2015.0,2019.0,ALL
442902,MIR330,,0.584,0.692,,,,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
442903,MIR331,,0.612,0.615,,,,C0018781,Noise-induced hearing loss,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Injury or Poisoning,0.3,1.0,,2013.0,2013.0,ALL
442904,MIR335,,0.521,0.808,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
442905,MIR337,,0.61,0.692,,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
442906,MIR338,,0.535,0.808,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
442907,MIR339,,0.608,0.615,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
442908,MIR340,,0.561,0.692,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.32,1.0,,2014.0,2015.0,ALL
442909,MIR342,,0.547,0.769,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.39,1.0,,2010.0,2020.0,ALL
442910,MIR345,,0.619,0.462,,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
442911,MIR346,,0.631,0.615,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.35,1.0,,2009.0,2017.0,ALL
442912,MIR367,,0.59,0.654,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2012.0,2012.0,ALL
442913,MIR376C,,0.623,0.615,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2019.0,ALL
442914,MIR369,,0.666,0.5,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,limited,2017.0,2017.0,ALL
442915,MIR370,,0.546,0.808,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.39,1.0,,2009.0,2019.0,ALL
442916,MIR371A,,0.647,0.5,,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.2,1.0,,2011.0,2011.0,ALL
442917,MIR372,,0.593,0.615,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,0.909,,2010.0,2019.0,ALL
442918,MIR373,,0.556,0.692,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.9,,2008.0,2018.0,ALL
442919,MIR374A,,0.617,0.615,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.08,1.0,,2013.0,2019.0,ALL
442920,MIR196B,,0.561,0.731,,,,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,2011.0,2016.0,ALL
444882,IGFL4,Q6B9Z1,,,0.0011794,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
445329,SULT1A4,P0DMM9;P0DMN0,0.821,0.346,0.38477,,,C0751383,Juvenile Neuronal Ceroid Lipofuscinosis,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,1994.0,1995.0,ALL
445347,TARP,,0.638,0.5,,,,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,1987.0,2014.0,ALL
445372,TRIM6-TRIM34,,0.931,0.077,4.3078e-19,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
445582,POTEE,Q6S8J3,0.861,0.115,0.0011938,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
445815,PALM2AKAP2,Q8IXS6;Q9Y2D5,0.751,0.385,6.0664e-05,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
448831,FRG2,Q64ET8,0.931,0.154,0.36635,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.05,1.0,,2004.0,2011.0,ALL
448834,KPRP,Q5T749,0.821,0.192,3.0815e-12,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
448962,DFNA54,,0.931,0.115,,,,C0018784,Sensorineural Hearing Loss (disorder),C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
448990,TAS2R6P,,1.0,0.038,,,,C0016034,Breast Fibrocystic Disease,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,1988.0,1988.0,ALL
449483,DFNB45,,,,,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
449488,DFNB46,,1.0,0.115,,,,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
449489,DFNB47,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2008.0,2008.0,ALL
449520,GGNBP1,Q5YKI7,0.769,0.462,0.69112,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
449619,ERVK-7,,0.722,0.346,,,,C0006849,Oral candidiasis,C01;C07,   Infections;    Stomatognathic Diseases,disease,Disease or Syndrome,0.02,1.0,,1999.0,2004.0,ALL
450087,ADHD1,,,,,,,C0149931,Migraine Disorders,C10,   Nervous System Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
450088,ADHD2,,0.931,0.115,,,,C0040517,Gilles de la Tourette syndrome,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0,,1990.0,1990.0,ALL
450090,ADHD4,,1.0,0.038,,,,C0424101,Inattention,,,phenotype,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
450092,KTCN2,,1.0,0.038,,,,C0022568,Keratitis,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
450093,LNCR1,,0.711,0.423,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
450095,PLF,,0.544,0.731,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,1997.0,2019.0,ALL
450097,RLS2,,0.931,0.115,,,,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,0.0,,2007.0,2007.0,ALL
474159,DYX9,,0.931,0.115,,,,C0476254,Dyslexia,C23;C10;F03,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders",disease,Mental or Behavioral Dysfunction,0.01,1.0,,2009.0,2009.0,ALL
474168,WG,,0.595,0.808,,,,C0008728,Eosinophilic granulomatosis with polyangiitis,C20;C15;C14,   Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,1998.0,2019.0,ALL
474170,LRRC37A2,A6NM11,0.839,0.154,1.1396e-07,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
474338,SUMO1P3,,0.736,0.192,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
474344,GIMAP6,Q6P9H5,0.931,0.115,0.14212,,,C0149745,Oral Ulcer,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
474354,LRRC18,Q8N456,0.931,0.115,3.5136e-05,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2009.0,2012.0,ALL
474382,H2AB1,P0C5Y9,1.0,0.038,,,,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
474383,F8A2,P23610,0.931,0.154,,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.04,1.0,,2001.0,2019.0,ALL
474384,F8A3,P23610,0.931,0.154,,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.04,1.0,,2001.0,2019.0,ALL
493753,COA5,Q86WW8,0.821,0.192,0.018348,,,C4225154,"CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 3",,,disease,Disease or Syndrome,0.6,1.0,,2011.0,2011.0,ALL
493812,HCG11,,0.861,0.115,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
493818,MYMY3,,1.0,0.077,,,,C1837418,MOYAMOYA DISEASE 3,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.3,,,,,ALL
493821,ZNF603P,,1.0,0.038,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
493829,TRIM72,Q6ZMU5,0.705,0.385,4.632e-05,,,C0026850,Muscular Dystrophy,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.05,1.0,,2009.0,2013.0,ALL
493856,CISD2,Q8N5K1,0.59,0.692,0.41583,,,C1858028,WOLFRAM SYNDROME 2,C23;C18;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.9,1.0,,2007.0,2019.0,ALL
493861,EID3,Q8N140,0.931,0.077,0.40761,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2017.0,ALL
493869,GPX8,Q8TED1,1.0,0.077,0.053068,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
493900,TMEM9B-AS1,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
493901,RNASE12,Q5GAN4,0.931,0.154,0.0083516,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
494115,RBMXL1,Q96E39,0.805,0.308,0.029284,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
494141,SLC25A51P4,,,,0.035174,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
494143,CHAC2,Q8WUX2,0.861,0.077,2.2869e-06,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
494148,DFNB55,,,,,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
494188,FBXO47,Q5MNV8,0.931,0.192,0.035287,,,C0037019,Shy-Drager Syndrome,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
494323,MIR361,,0.578,0.654,,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
494324,MIR375,,0.476,0.769,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.4,0.923,,2010.0,2019.0,ALL
494325,MIR376A1,,0.7,0.346,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
494326,MIR377,,0.587,0.731,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.31,1.0,,2017.0,2018.0,ALL
494327,MIR378A,,0.532,0.808,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
494328,MIR379,,0.615,0.538,,,,C0027659,"Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2017.0,2017.0,ALL
494329,MIR380,,0.76,0.269,,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
494330,MIR381,,0.584,0.654,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
494331,MIR382,,0.603,0.692,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
494332,MIR383,,0.608,0.731,,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2011.0,2011.0,ALL
494333,MIR384,,0.612,0.731,,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.31,1.0,,2012.0,2017.0,ALL
494334,MIR422A,,0.653,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2011.0,2019.0,ALL
494335,MIR423,,0.566,0.769,,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.35,1.0,,2013.0,2019.0,ALL
494336,MIR424,,0.535,0.769,,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.3,1.0,,2013.0,2013.0,ALL
494337,MIR425,,0.581,0.654,,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
494470,RNF165,Q6ZSG1,0.89,0.269,0.97194,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
494513,PJVK,Q0ZLH3,0.769,0.115,3.7194e-08,,,C1857744,"DEAFNESS, AUTOSOMAL RECESSIVE 59",C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.9,1.0,strong,2006.0,2012.0,ALL
494514,TYMSOS,Q8TAI1,1.0,0.115,0.15771,,,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
494551,WEE2,P0C1S8,0.89,0.154,4.8102e-06,,,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
497188,GLC1I,,0.931,0.038,,,,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
497189,TIFAB,Q6ZNK6,0.839,0.154,1.4279e-05,,,C0010051,Coronary Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
497190,CLEC18B,Q6UXF7,0.839,0.038,1.2431e-06,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
497231,CLN9,,0.89,0.115,,,,C0027877,Neuronal Ceroid-Lipofuscinoses,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2004.0,2006.0,ALL
497258,BDNF-AS,,0.638,0.538,,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2009.0,2014.0,ALL
497657,ANIB3,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,1996.0,1996.0,ALL
503538,A1BG-AS1,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
503542,SPRN,Q5BIV9,0.839,0.154,0.29377,,,C0022336,Creutzfeldt-Jakob disease,C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,2008.0,2019.0,ALL
503569,RGMB-AS1,,0.769,0.231,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
503614,DEFB107B,Q8IZN7,1.0,0.038,,,,C0747085,Recurrent otitis media,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
503618,DEFB104B,Q8WTQ1,0.638,0.692,0.33176,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.03,1.0,,2010.0,2018.0,ALL
503637,DUXAP8,,0.7,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2017.0,2019.0,ALL
503638,DUXAP9,,0.628,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2016.0,2020.0,ALL
503639,DUXAP10,,0.691,0.308,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,2018.0,2019.0,ALL
503694,DEFB108A,A8MXU0,1.0,0.038,,,,C4721806,"Carcinoma, Basal Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
503834,DPRX,A6NFQ7,,,2.4069e-06,,,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
503835,DUXA,A6NLW8,0.931,0.115,3.0459e-08,,,C0013312,Dupuytren Contracture,C04;C17;C05,   Neoplasms;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2017.0,ALL
503837,DEFB108C,A8MXU0,1.0,0.038,,,,C4721806,"Carcinoma, Basal Cell",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
503841,DEFB106B,Q8N104,0.931,0.038,0.081151,,,C0030354,Papilloma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,1995.0,1995.0,ALL
541466,CT45A1,Q5HYN5,0.76,0.231,0.30048,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2009.0,2017.0,ALL
541468,LURAP1,Q96LR2,0.839,0.192,0.011822,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
541471,MIR4435-2HG,,0.604,0.692,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.36,1.0,,2015.0,2019.0,ALL
541472,IL6-AS1,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
541565,C8orf58,Q8NAV2,,,4.5689e-05,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
542767,PCOTH,Q58A44,0.861,0.115,,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
548313,SSX4B,O60224,0.821,0.154,0.15282,,,C0153594,Malignant neoplasm of testis,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2004.0,2006.0,ALL
548593,SLX1A,Q9BQ83,1.0,0.154,0.12268,,,C0151638,Fanconi like syndrome,C04;C17;C20;C15,   Neoplasms;    Skin and Connective Tissue Diseases;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.2,1.0,,2013.0,2013.0,ALL
548596,CKMT1A,P12532,0.792,0.154,4.2467e-07,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
548645,DNAJC25,Q9H1X3,,,1.2112e-05,,,C0085593,Chills,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
550112,UBA6-AS1,,0.861,0.154,,,,C0034012,Delayed Puberty,C19,   Endocrine System Diseases,phenotype,Pathologic Function,0.1,,,,,ALL
550631,CCDC157,Q569K6,1.0,0.038,7.1565e-22,,,C4021107,Non-obstructive azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
550643,NBDY,A0A0U1RRE5,0.861,0.269,,,,C1318315,Serum zinc measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
552860,SAMD12-AS1,,1.0,0.038,,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2009.0,2009.0,ALL
552889,ATXN7L3B,Q96GX2,0.931,0.077,0.14683,,,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2013.0,2013.0,ALL
552891,DNAJC25-GNG10,Q9H1X3,,,0.0013097,,,C0085593,Chills,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
552900,BOLA2,Q9H3K6,0.931,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
553103,MIR3936HG,,0.861,0.269,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2013.0,ALL
553115,PEF1,Q9UBV8,,,0.00015066,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
553117,RPL39P5,Q59GN2,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
553128,KIR2DL5B,Q8NHK3,0.682,0.423,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.03,1.0,,2010.0,2017.0,ALL
553158,PRR5-ARHGAP8,,0.821,0.154,2.1367e-28,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
553190,MYP7,,1.0,0.038,,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
553195,MYP10,,0.792,0.308,,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.03,1.0,,2005.0,2012.0,ALL
553989,LFS3,,,,,,,C0036572,Seizures,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2010.0,2010.0,ALL
554175,DNM1P33,,0.931,0.115,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
554188,FCMTE2,,0.743,0.231,,,,C1611743,Familial (FPAH),,,disease,Disease or Syndrome,0.03,1.0,,1999.0,2013.0,ALL
554202,MIR31HG,,0.65,0.462,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.31,1.0,,2016.0,2018.0,ALL
554203,JPX,,0.769,0.308,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
554210,MIR429,,0.544,0.731,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.38,1.0,,2010.0,2020.0,ALL
554212,MIR448,,0.61,0.615,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2015.0,2019.0,ALL
554213,MIR449A,,0.57,0.731,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2009.0,2019.0,ALL
554225,STRCP1,A6NGW2,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
554226,ANKRD30BL,A7E2S9,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
554250,GDF5-AS1,Q5U4N7,0.805,0.077,0.002636,,,C0265260,"Chondrodysplasia, Grebe type",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2003.0,2003.0,ALL
554251,FBXO48,Q5FWF7,0.931,0.192,0.0001068,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
554279,LINC00862,A6NCI5,1.0,0.038,,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
554300,KIR2DP1,,1.0,0.077,,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
554313,H4C15,P62805,0.541,0.692,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2005.0,2019.0,ALL
572558,PGM5-AS1,,0.839,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2020.0,ALL
574028,CLLU1,Q5K131,1.0,0.115,0.0016736,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2006.0,2019.0,ALL
574029,DUSP5P1,,0.89,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
574030,MIR362,,0.641,0.423,,,,C0007120,Bronchioloalveolar Adenocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
574031,MIR363,,0.578,0.692,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2013.0,2020.0,ALL
574032,MIR20B,,0.581,0.615,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.33,1.0,,2009.0,2019.0,ALL
574033,MIR18B,,0.682,0.538,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.33,1.0,,2009.0,2017.0,ALL
574034,MIR433,,0.604,0.538,,,,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
574038,MIR431,,0.621,0.577,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2018.0,ALL
574043,CDAGS,,,,,,,C0015230,Exanthema,C17,   Skin and Connective Tissue Diseases,phenotype,Sign or Symptom,0.01,1.0,,2005.0,2005.0,ALL
574045,HNP1,,0.638,0.654,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.03,1.0,,2019.0,2019.0,ALL
574077,GLC1K,,1.0,0.038,,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
574078,GLC1J,,1.0,0.038,,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
574408,MIR329-1,,0.89,0.077,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
574410,MIR323B,,0.722,0.462,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
574411,MIR451A,,0.505,0.769,,,,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
574412,MIR452,,0.633,0.5,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
574413,MIR409,,0.57,0.731,,,,C0007095,Carcinoid Tumor,C04,   Neoplasms,phenotype,Neoplastic Process,0.31,1.0,,2014.0,2015.0,ALL
574414,PRR9,Q5T870,1.0,0.038,3.2056e-06,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
574431,C1orf147,Q96MC9,,,0.017509,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
574433,MIR412,,0.805,0.192,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
574434,MIR410,,0.575,0.692,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.34,1.0,,2014.0,2018.0,ALL
574435,MIR376B,,0.736,0.346,,,,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
574436,MIR485,,0.593,0.731,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.33,1.0,,2017.0,2020.0,ALL
574441,MIR488,,0.633,0.692,,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
574442,MIR489,,0.647,0.423,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.36,1.0,,2010.0,2019.0,ALL
574443,MIR490,,0.588,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2019.0,ALL
574444,MIR491,,0.619,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
574445,MIR511,,0.647,0.538,,,,C0007095,Carcinoid Tumor,C04,   Neoplasms,phenotype,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
574447,MIR146B,,0.496,0.769,,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.32,1.0,,2010.0,2019.0,ALL
574448,MIR202,,0.579,0.769,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2019.0,ALL
574449,MIR492,,0.678,0.346,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0,,2015.0,2019.0,ALL
574450,MIR493,,0.626,0.538,,,,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
574451,MIR432,,0.644,0.577,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2015.0,2015.0,ALL
574452,MIR494,,0.531,0.692,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2014.0,2017.0,ALL
574453,MIR495,,0.573,0.654,,,,C0027659,"Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2017.0,2017.0,ALL
574454,MIR496,,0.691,0.462,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
574455,MIR193B,,0.536,0.808,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.31,1.0,,2014.0,2017.0,ALL
574456,MIR497,,0.539,0.808,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2013.0,2013.0,ALL
574457,MIR181D,,0.641,0.654,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.35,1.0,,2009.0,2019.0,ALL
574459,MIR512-2,,0.89,0.038,,,,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
574460,MIR498,,0.633,0.5,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2020.0,ALL
574461,MIR520E,,0.805,0.115,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
574464,MIR520F,,0.78,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
574466,MIR519C,,0.89,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.31,1.0,,2010.0,2019.0,ALL
574467,MIR520A,,0.805,0.115,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0,,2016.0,2018.0,ALL
574468,MIR526B,,0.821,0.192,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2015.0,2019.0,ALL
574469,MIR519B,,0.839,0.154,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2013.0,2019.0,ALL
574470,MIR525,,0.716,0.5,,,,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.03,1.0,,2012.0,2015.0,ALL
574471,MIR523,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
574473,MIR520B,,0.743,0.115,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
574474,MIR518B,,0.769,0.231,,,,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.04,1.0,,2012.0,2014.0,ALL
574476,MIR520C,,0.861,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2011.0,2019.0,ALL
574477,MIR518C,,0.821,0.192,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.02,1.0,,2014.0,2014.0,ALL
574478,MIR524,,0.722,0.231,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2012.0,2019.0,ALL
574479,MIR517A,,0.76,0.231,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
574480,MIR519D,,0.636,0.423,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.08,1.0,,2015.0,2018.0,ALL
574482,MIR520D,,0.839,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
574484,MIR520G,,0.743,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2015.0,2019.0,ALL
574487,MIR518E,,1.0,0.115,,,,C0038868,Progressive supranuclear palsy,C23;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
574489,MIR518D,,,,,,,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
574492,MIR517C,,0.839,0.077,,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
574493,MIR520H,,0.861,0.154,,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
574495,MIR522,,0.722,0.346,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
574497,MIR527,,0.839,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
574499,MIR516A2,,1.0,0.038,,,,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
574501,MIR499A,,0.519,0.846,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
574502,MIR500A,,0.682,0.192,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2017.0,2019.0,ALL
574503,MIR501,,0.663,0.462,,,,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
574504,MIR502,,0.641,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2010.0,2019.0,ALL
574506,MIR503,,0.551,0.808,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.38,1.0,,2009.0,2020.0,ALL
574507,MIR504,,0.67,0.462,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2020.0,ALL
574508,MIR505,,0.603,0.577,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
574511,MIR506,,0.585,0.615,,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
574512,MIR507,,0.805,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2016.0,ALL
574513,MIR508,,0.705,0.385,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.06,1.0,,2014.0,2019.0,ALL
574514,MIR509-1,,0.7,0.462,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2013.0,2017.0,ALL
574515,MIR510,,0.678,0.423,,,,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.03,1.0,,2019.0,2019.0,ALL
574537,UGT2A2,Q9Y4X1,0.931,0.115,4.7525e-14,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
594832,MYP11,,1.0,0.038,,,,C0271183,Severe myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,0.5,,2005.0,2011.0,ALL
594840,ZFAT-AS1,,0.931,0.077,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
594842,HAS2-AS1,,0.729,0.269,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.11,1.0,,2014.0,2017.0,ALL
594857,NPS,P0C0P6,0.619,0.615,0.00014091,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.4,1.0,,2009.0,2019.0,ALL
606293,KLKP1,Q107X0,0.839,0.154,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.32,1.0,,2006.0,2019.0,ALL
606500,SNORD68,,1.0,0.115,,,,C1337011,Well Differentiated Pancreatic Endocrine Tumor,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
606553,C8orf49,Q96NF6,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
606724,LOC606724,,1.0,0.038,,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
613126,CYP51A1-AS1,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
613212,CTXN3,Q4LDR2,0.931,0.077,0.13992,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2012.0,2015.0,ALL
613253,DEFA1A3,,0.751,0.423,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2003.0,2013.0,ALL
619207,SCART1,,0.931,0.038,,,,C0011603,Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
619279,ZNF704,Q6ZNC4,0.839,0.154,0.99532,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
619351,LINC00589,,0.805,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
619373,MBOAT4,Q96T53,0.729,0.423,1.3575e-07,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.07,1.0,,2009.0,2019.0,ALL
619379,SPG29,,0.931,0.077,,,,C1857855,"SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
619394,SPOAN,,1.0,0.154,,,,C1836010,"Spastic Paraplegia, Optic Atrophy, and Neuropathy",C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,2005.0,2019.0,ALL
619399,ETL2,,1.0,0.038,,,,C1858477,"Epilepsy, Partial, with Variable Foci",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
619406,HPE8,,0.89,0.154,,,,C0079541,Holoprosencephaly,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.03,1.0,,2005.0,2012.0,ALL
619407,MSSD,,1.0,0.077,,,,C0039075,Syndactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.01,1.0,,2014.0,2014.0,ALL
619434,LINC00051,,1.0,0.038,,,,C4511452,Sporadic Parkinson disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
619455,SPANXA2-OT1,Q8N9U9,,,,,,C4280669,Velopharyngeal dysfunction,,,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
619465,ERVK-8,,0.722,0.385,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2006.0,2006.0,ALL
619469,DELYQ11,,0.805,0.154,,,,C0268070,Hypocupremia,,,disease,Disease or Syndrome,0.02,1.0,,2007.0,2009.0,ALL
619488,SCZD12,,0.839,0.269,,,,C0001723,"Affective Disorders, Psychotic",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,1981.0,1981.0,ALL
619501,HCC,,0.644,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2009.0,2020.0,ALL
619503,FIQTL1,,0.821,0.192,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2018.0,2020.0,ALL
619505,SNORA21,,0.716,0.269,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
619509,WTRS,,0.89,0.192,,,,C0796117,Pitt-Rogers-Danks Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.3,1.0,,2014.0,2014.0,ALL
619511,MHB,,0.931,0.115,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
619538,OMS,,1.0,,,,,C0237123,Alcohol or Other Drugs use,,,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
619540,LOC619540,,,,,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
619552,MIR483,,0.537,0.769,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.32,1.0,,2012.0,2019.0,ALL
619553,MIR484,,0.638,0.577,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
619554,MIR486-1,,0.521,0.808,,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
619555,MIR487A,,0.716,0.423,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
619556,MIR455,,0.559,0.769,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
619562,SNORA3A,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
619564,SNORD72,,1.0,0.115,,,,C1337011,Well Differentiated Pancreatic Endocrine Tumor,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
619569,SNORA41,,0.839,0.231,,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
619570,SNORD95,,1.0,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
619571,SNORD96A,,1.0,0.115,,,,C1337011,Well Differentiated Pancreatic Endocrine Tumor,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
641311,RPL31P11,,1.0,0.077,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
641339,ZNF674,Q2M3X9,0.861,0.192,6.0351e-07,,,C1136249,"Mental Retardation, X-Linked",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.51,1.0,limited,2006.0,2013.0,ALL
641364,SLC7A11-AS1,,0.931,0.077,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
641365,LINC00616,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
641371,ACOT1,Q86TX2,0.78,0.192,6.4141e-05,,,C0002152,Alloxan Diabetes,C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Experimental Model of Disease,0.3,1.0,,2004.0,2004.0,ALL
641372,ACOT6,Q3I5F7,1.0,0.038,0.0035327,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2011.0,2011.0,ALL
641373,NRON,,0.805,0.269,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
641384,TMEM75,Q8N9X5,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
641455,POTEM,A6NI47,0.541,0.769,0.00031637,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,1996.0,2019.0,ALL
641517,DEFB109B,Q30KR1,0.89,0.115,,,,C0000880,Acanthamoeba Keratitis,C01;C11,   Infections;    Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
641518,LEF1-AS1,,0.705,0.269,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
641638,SNHG6,,0.633,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2016.0,2019.0,ALL
641654,HEPN1,Q6WQI6,0.931,0.154,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,2003.0,2015.0,ALL
641700,ECSCR,Q19T08,0.729,0.423,0.00042521,,,C0035455,Rhinitis,C01;C08;C09,   Infections;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.05,1.0,,2017.0,2019.0,ALL
641808,FAM185BP,,,,,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
641977,SEPTIN7P2,,1.0,0.115,,,,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
642475,MROH6,A6NGR9,0.931,0.077,4.1528e-18,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
642515,PRRT1B,A0A1B0GWB2,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
642559,POU5F1P3,,0.452,0.808,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2003.0,2020.0,ALL
642574,IQANK1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
642587,MIR205HG,,0.861,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
642597,AKAIN1,P0CW23,0.931,0.038,0.48916,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
642636,RAD21L1,Q9H4I0,0.931,0.038,4.5316e-06,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
642659,HNRNPA1P48,,,,,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2013.0,2013.0,ALL
642797,DNAH10OS,P0CZ25,1.0,0.077,0.00017857,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
642799,NPIPA2,E9PIF3;Q9UND3,0.89,0.231,,,,C0019270,Hernia,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Anatomical Abnormality,0.01,1.0,,2019.0,2019.0,ALL
642843,CPSF4L,A6NMK7,,,0.0016119,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
642852,LINC00205,,0.931,0.192,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
642934,CERNA2,,0.705,0.269,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.07,1.0,,2017.0,2019.0,ALL
642935,ADAMTS7P4,,,,,,,C0206062,"Lung Diseases, Interstitial",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
642946,FLVCR1-DT,Q8TAF5,0.743,0.269,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2018.0,2020.0,ALL
642968,FAM163B,P0C2L3,,,0.025948,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
642976,GRIK1-AS1,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
642987,TMEM232,C9JQI7,0.931,0.115,7.9307e-12,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.12,1.0,,2011.0,2018.0,ALL
643008,SMIM5,Q71RC9,1.0,0.115,0.13265,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
643036,SLED1,,1.0,0.077,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
643136,ZC3H11B,A0A1B0GTU1,0.89,0.038,,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0,,2018.0,2019.0,ALL
643159,ATF4P3,,1.0,0.038,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2020.0,2020.0,ALL
643160,CYMP,,,,,,,C2699541,Cytokine Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
643226,GRXCR2,A6NFK2,0.861,0.115,1.0145e-07,,,C3892049,"DEAFNESS, AUTOSOMAL RECESSIVE 101",,,disease,Disease or Syndrome,0.6,,,,,ALL
643236,TMEM72,A0PK05,0.89,0.154,0.78369,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
643246,MAP1LC3B2,A6NCE7,0.931,0.192,0.012693,,,C1961102,Precursor Cell Lymphoblastic Leukemia Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
643329,KRT18P57,,1.0,0.077,,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
643365,LINC00452,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
643387,LOC643387,,0.839,0.115,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2007.0,2007.0,ALL
643401,PURPL,,0.805,0.077,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
643414,LIPK,Q5VXJ0,0.89,0.038,1.7565e-06,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
643418,LIPN,Q5VXI9,0.736,0.423,3.1003e-05,,,C3553029,"ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8",,,disease,Disease or Syndrome,0.6,1.0,,2011.0,2011.0,ALL
643432,TSG1,,0.89,0.115,,,,C0029453,Osteopenia,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
643586,PKMP1,,1.0,0.038,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2014.0,ALL
643623,LINC02523,,0.931,0.154,,,,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.1,1.0,,2016.0,2018.0,ALL
643641,ZNF862,O60290,1.0,0.077,6.7801e-12,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
643669,CCER2,I3L3R5,0.931,0.077,0.0039706,,,C0026654,Moyamoya Disease,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
643677,CCDC168,Q8NDH2,1.0,0.077,1.2813e-06,,,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
643680,MS4A4E,Q96PG1,0.931,0.077,0.0010614,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.14,1.0,,2011.0,2017.0,ALL
643714,CASC16,,0.78,0.308,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.2,1.0,,2007.0,2020.0,ALL
643723,LYPLAL1-DT,,1.0,0.038,,,,C0001144,Acne Vulgaris,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
643733,CASP17P,,,,,,,C0428886,Mean blood pressure,,,phenotype,Finding,0.1,1.0,,2012.0,2012.0,ALL
643749,TRAF3IP2-AS1,,0.792,0.154,,,,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2019.0,ALL
643834,PGA3,P0DJD8,0.78,0.346,0.10495,,,C1168250,Laryngopharyngeal Reflux,C06;C08,   Digestive System Diseases;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2017.0,ALL
643837,LINC01128,,0.89,0.077,,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2016.0,ALL
643847,PGA4,P0DJD7,0.839,0.269,0.30546,,,C1168250,Laryngopharyngeal Reflux,C06;C08,   Digestive System Diseases;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2017.0,ALL
643853,TMPPE,Q6ZT21,0.821,0.192,0.0008517,,,C0085131,Gangliosidosis GM1,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,1994.0,2018.0,ALL
643865,KRT126P,,0.839,0.346,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
643911,CRNDE,,0.597,0.615,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.929,,2015.0,2019.0,ALL
643965,TMEM88B,A6NKF7,,,0.43487,,,C0002020,Alexithymia,F01,   Behavior and Behavior Mechanisms,phenotype,Mental or Behavioral Dysfunction,0.01,1.0,,2015.0,2015.0,ALL
644000,ARAFP2,,0.931,0.077,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,2009.0,2012.0,ALL
644032,PHKG1P2,,,,,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
644059,PYY3,Q5JQD4,0.89,0.192,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.02,1.0,,2005.0,2017.0,ALL
644076,GLYCAM1,Q8IVK1,0.861,0.077,,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2005.0,2005.0,ALL
644079,BCRP1,,0.716,0.269,,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
644096,SDHAF1,A6NFY7,0.656,0.462,0.087043,,,C1855008,Mitochondrial Complex II Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.7,1.0,,2009.0,2016.0,ALL
644128,RPL23AP53,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
644150,WIPF3,A6NGB9,0.821,0.077,0.002355,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
644165,BCRP3,,0.705,0.269,,,,C0040053,Thrombosis,C14,   Cardiovascular Diseases,phenotype,Pathologic Function,0.3,1.0,,2007.0,2007.0,ALL
644168,DRGX,A6NNA5,,,0.00023988,,,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
644172,MAPK8IP1P2,,1.0,0.077,,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
644186,SYCE3,A1L190,,,0.5999,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2016.0,ALL
644192,NR2F2-AS1,,0.729,0.269,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
644220,ACTBP11,,,,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
644246,KANSL1-AS1,,0.839,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
644248,SNCA-AS1,,1.0,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
644253,MAPK8IP1P1,,1.0,0.077,,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
644314,MT1IP,,0.653,0.654,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.07,1.0,,1998.0,2019.0,ALL
644315,RPS7P11,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
644397,LRRC37A17P,,,,,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
644449,HNRNPFP1,,,,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
644517,FAM86MP,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
644538,SMIM10,Q96HG1,1.0,0.038,0.31638,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
644596,SMIM10L2B,P0DMW4;P0DMW5,0.619,0.808,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2014.0,2017.0,ALL
644649,APOOP5,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
644794,LINC02604,,0.805,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,0.0,,2017.0,2017.0,ALL
644815,FAM83G,A6ND36,1.0,0.077,3.3167e-05,,,C4551675,"Keratoderma, Palmoplantar",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.3,1.0,limited,2018.0,2018.0,ALL
644838,LINC01829,,0.839,0.192,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
644844,PHGR1,C9JFL3,0.805,0.231,0.14245,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
644861,NBPF13P,,0.89,0.038,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
644873,LINC01184,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
644914,H3P16,,0.705,0.346,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2001.0,2017.0,ALL
644943,RASSF10,A6NK89,0.626,0.385,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2009.0,2019.0,ALL
644990,THRB-AS1,,,,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
644997,PIK3CD-AS1,Q5SR53,0.89,0.154,0.029774,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
645037,GAGE2B,Q13066,0.89,0.154,0.0022911,,,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,1995.0,1995.0,ALL
645073,GAGE12G,A1L429;O76087;P0CL80;P0CL81;P0CL82,0.821,0.192,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
645104,CLRN2,A0PK11,,,2.0187e-06,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
645158,CBX3P2,,1.0,0.077,,,,C0263383,Keratosis pilaris,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Acquired Abnormality,0.01,1.0,,2018.0,2018.0,ALL
645212,EIF3J-DT,,0.89,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
645249,MNX1-AS1,,0.615,0.346,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.36,1.0,,2017.0,2020.0,ALL
645280,SMPD4P1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
645323,LINC00461,,0.736,0.423,,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
645326,RPSAP11,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
645345,CHCHD2P9,Q5T1J5,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
645355,MIR3976HG,,,,,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
645369,TMEM200C,A6NKL6,,,0.10617,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
645434,LINC01625,,,,,,,C3548479,response to bronchodilator,,,phenotype,Organism Function,0.1,1.0,,2015.0,2015.0,ALL
645553,IGFL2-AS1,,1.0,0.115,,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
645591,LHFPL3-AS1,,1.0,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
645638,WFDC21P,,0.89,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
645652,MT1XP1,,0.931,0.077,,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
645682,POU5F1P4,,0.452,0.808,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2003.0,2020.0,ALL
645687,LINC00520,,0.839,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
645740,NOS2P1,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
645754,LGALS9DP,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
645771,PARP4P2,,0.861,0.077,,,,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
645811,CCDC154,A6NI56,0.861,0.077,7.2485e-17,,,C1850127,"Osteopetrosis, Autosomal Recessive 1",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.2,1.0,,2009.0,2009.0,ALL
645884,RPS7P5,,1.0,0.077,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
645949,LINC01822,,,,,,,C0005910,Body Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
645950,HNRNPA1P1,,0.931,0.154,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
645954,SVIL2P,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
645958,RPS18P9,,1.0,0.077,,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
645996,NAP1L6P,A6NFF2,0.89,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
646023,ADORA2A-AS1,P86434,1.0,0.038,,,,C0001144,Acne Vulgaris,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2018.0,ALL
646024,RAET1K,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
646113,LINC00643,Q86TS7,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
646241,LINC02223,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
646300,COL6A4P2,,0.89,0.115,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
646324,LINC00607,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
646383,ZBTB44-DT,,,,,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
646405,TPTE2P1,Q5T6R2,0.78,0.077,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2015.0,2019.0,ALL
646480,FABP9,Q0Z7S8,0.931,0.077,6.7502e-09,,,C0007097,Carcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
646486,FABP12,A6NFH5,0.931,0.115,0.0034043,,,C1275122,Familial multiple trichoepitheliomata,C16;C04;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Skin and Connective Tissue Diseases",disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
646506,LOC646506,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
646567,OSTCP2,,1.0,0.038,,,,C0031106,Aggressive Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
646576,HHIP-AS1,,1.0,0.077,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
646592,ZNF652P1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
646600,IGF2BP2-AS1,Q96M15,0.931,0.077,0.39559,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
646603,C4orf51,C9J302,,,6.0318e-06,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
646627,LYPD8,Q6UX82,0.839,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
646658,SYNDIG1L,A6NDD5,,,0.0087901,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
646702,HLA-DPA2,,0.78,0.538,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
646719,NIPBL-DT,,1.0,0.077,,,,C0270972,Cornelia De Lange Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
646730,LINC02618,,1.0,0.038,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
646736,LOC646736,,0.89,0.077,,,,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
646762,LOC646762,,0.931,0.038,,,,C0023465,Acute monocytic leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
646799,ZAR1L,A6NP61,1.0,0.077,0.099305,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
646851,FAM227A,F5H4B4,,,1.9662e-16,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
646892,SH2D7,A6NKC9,,,2.3722e-08,,,C3897558,Soluble Interleukin 6 Receptor Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
646960,PRSS56,P0CW18,0.743,0.115,0.00034082,,,C3150757,"MICROPHTHALMIA, ISOLATED 6",,,disease,Disease or Syndrome,0.9,1.0,,2011.0,2018.0,ALL
646962,HRCT1,Q6UXD1,,,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
646982,LINC00598,,0.743,0.192,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2016.0,2016.0,ALL
647060,SPATA31A1,Q5TZJ5,,,0.37761,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
647076,BRD7P2,,1.0,0.115,,,,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
647087,STMP1,E0CX11,1.0,0.038,0.55075,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
647107,LINC01192,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
647121,EMBP1,,0.839,0.269,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2009.0,2013.0,ALL
647169,GSTA12P,,,,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
647175,GSTA11P,,,,,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
647215,MROH3P,,0.89,0.192,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
647265,CYP2AB1P,,,,,,,C1629609,Age at menopause,,,phenotype,Finding,0.1,1.0,,2015.0,2015.0,ALL
647275,PNPP1,,1.0,0.077,,,,C0030486,Paraplegia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
647309,GMNC,A6NCL1,0.89,0.077,0.44666,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
647323,LINC02026,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
647859,OCLNP1,,1.0,0.038,,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
647946,MIR924HG,,0.931,0.077,,,,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
647979,NORAD,,0.631,0.462,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.34,1.0,,2016.0,2019.0,ALL
648791,PPP1R3G,B7ZBB8,0.89,0.115,4.4228e-05,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
649159,LINC00273,,0.585,0.846,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2006.0,2019.0,ALL
649179,PRAMENP,,1.0,0.115,,,,C0005689,Bladder Exstrophy,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
649446,DLGAP1-AS1,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
649458,MPTX1,A8MV57,,,,,,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
649946,RPL23AP64,,,,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
650655,ABCA17P,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
650669,GAS6-AS1,,0.861,0.154,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
651302,ZNF192P1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2013.0,ALL
651746,ANKRD33B,A6NCL7,,,0.43225,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
652070,SCFV,,0.647,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2002.0,2019.0,ALL
652966,SNORD10,,1.0,0.038,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
652968,CASTOR1,Q8WTX7,0.821,0.231,0.027533,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
652972,LRRC37A5P,Q49AS3,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
652975,RPL21P6,,,,,,,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
652991,SKOR2,Q2VWA4,1.0,0.038,0.75359,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
652995,UCA1,,0.512,0.808,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2006.0,2020.0,ALL
653067,XAGE1B,Q9HD64,0.743,0.231,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
653108,CXADRP1,,0.463,0.846,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.981,,2003.0,2020.0,ALL
653140,FAM228A,Q86W67,,,0.016302,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
653145,ANXA8,P13928;Q5VT79,0.705,0.269,,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0,,1992.0,1995.0,ALL
653188,GUSBP3,,0.861,0.077,,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2001.0,2016.0,ALL
653220,XAGE1A,Q9HD64,0.743,0.192,,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2013.0,2013.0,ALL
653247,PRB2,P02812,0.61,0.577,1.2951e-08,,,C0005129,Bernard-Soulier Syndrome,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,0.964,,1988.0,2019.0,ALL
653275,CFC1B,P0CG36,0.7,0.115,,,,C0013069,Double Outlet Right Ventricle,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.2,1.0,,1999.0,1999.0,ALL
653282,CT47A7,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
653308,ASAH2B,P0C7U1,0.931,0.077,0.00067646,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
653319,KIAA0895L,Q68EN5,,,0.0019404,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2016.0,ALL
653361,NCF1,P14598,0.521,0.808,2.8311e-05,,,C1856251,"Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I",C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.7,1.0,strong,2000.0,2013.0,ALL
653381,SORD2P,,0.931,0.038,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
653423,SPAG11A,Q08648;Q6PDA7,0.65,0.731,6.9645e-05,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2018.0,ALL
653427,FOXD4L5,Q5VV16,0.89,0.077,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
653440,WASH6P,Q9NQA3,0.78,0.308,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,2014.0,2017.0,ALL
653483,AFDN-DT,Q9Y6Z5,,,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
653486,SCGB1C2,P0DMR2;Q8TD33,0.931,0.154,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
653492,PSG10P,,0.805,0.192,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2004.0,2004.0,ALL
653499,LGALS7B,P47929,0.61,0.731,0.21829,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.9,,2003.0,2018.0,ALL
653509,SFTPA1,Q8IWL2,0.546,0.808,0.0003678,,,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.57,1.0,limited,2003.0,2019.0,ALL
653545,DUX4L5,P0CJ88,0.931,0.115,,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
653583,PHLDB3,Q6NSJ2,0.89,0.115,3.6204e-21,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
653590,GGTLC5P,,0.513,0.846,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1986.0,2019.0,ALL
653604,H3C13,Q71DI3,0.861,0.154,0.00070344,,,C0024131,Lupus Vulgaris,C01;C17,   Infections;    Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
653650,PDPK2P,Q6A1A2,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
653677,SEC1P,,0.792,0.385,,,,C0011991,Diarrhea,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.1,1.0,,2016.0,2016.0,ALL
653689,GSTT2B,P0CG30,0.792,0.385,0.72219,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
653702,RPL7P9,,1.0,0.077,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
653784,MZT2A,Q6P582,1.0,,8.001e-06,,,C4693660,KERATOCONUS 9,,,disease,Disease or Syndrome,0.1,,,,,ALL
653808,ZG16,O60844,0.839,0.077,0.62131,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
653820,FAM72B,Q86X60,0.705,0.385,0.0013854,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
653857,ACTR3C,Q9C0K3,1.0,0.038,7.2147e-06,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2001.0,2003.0,ALL
654170,RPS16P8,,1.0,0.077,,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
654231,OCM,P0CE72,0.751,0.423,1.0885e-08,,,C0220633,Uveal melanoma,C04;C11,   Neoplasms;    Eye Diseases,disease,Neoplastic Process,0.07,1.0,,2006.0,2018.0,ALL
654346,LGALS9C,Q6DKI2,,,6.2016e-09,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
654364,NME1-NME2,P22392,0.623,0.615,8.8471e-09,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
654433,PAX8-AS1,,0.792,0.231,,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2019.0,ALL
654434,SNHG20,,0.65,0.346,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0,,2017.0,2019.0,ALL
654463,FER1L6,Q2WGJ9,0.89,0.038,7.1267e-43,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
654483,BOLA2B,Q9H3K6,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
654502,IQCJ,Q1A5X6,0.839,0.115,0.0006522,,,C3548479,response to bronchodilator,,,phenotype,Organism Function,0.1,1.0,,2015.0,2015.0,ALL
654505,H3P38,,0.729,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2000.0,2015.0,ALL
654780,LOC654780,,0.931,0.115,,,,C0011633,Dermatomyositis,C17;C05;C10,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
654817,NCF1C,A8MVU1,1.0,0.038,,,,C0018203,Chronic granulomatous disease,C16;C20;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Hemic and Lymphatic Diseases",group,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
654841,MFF-DT,,0.78,0.269,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
664611,H3P37,,0.78,0.269,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2008.0,2015.0,ALL
664612,MIR539,,0.61,0.654,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2016.0,2019.0,ALL
664613,MIR544A,,0.695,0.423,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,0.8,,2016.0,2019.0,ALL
664614,MIR545,,0.674,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2014.0,2019.0,ALL
664615,MIR376A2,,0.89,0.077,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
664616,MIR487B,,0.67,0.423,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.31,1.0,,2013.0,2014.0,ALL
664617,MIR542,,0.592,0.538,,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
664709,HNRNPA1P10,,0.631,0.654,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.05,1.0,,2012.0,2018.0,ALL
664780,MYP12,,0.931,0.038,,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0,,2007.0,2009.0,ALL
677662,PARK12,,1.0,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
677766,SCARNA2,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
677768,SCARNA13,,0.89,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
677770,SCARNA22,,0.861,0.346,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2012.0,2017.0,ALL
677771,SCARNA4,,0.931,0.154,,,,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2016.0,2016.0,ALL
677772,SCARNA6,,1.0,0.077,,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
677775,SCARNA5,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
677779,LINC00488,,0.89,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
677792,SNORA1,,1.0,0.077,,,,C0010709,Cyst,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
677797,SNORA7B,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
677800,SNORA12,,0.931,0.115,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
677808,SNORA23,,0.931,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
677810,SNORA26,,1.0,0.077,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
677811,SNORA28,,1.0,0.038,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
677814,SNORA31,,1.0,0.077,,,,C0276226,Herpes encephalitis,C01;C10,   Infections;    Nervous System Diseases,disease,Disease or Syndrome,0.31,1.0,,2019.0,2019.0,ALL
677815,SNORA2C,,0.805,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
677820,SNORA38,,0.89,0.154,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
677823,SNORA80E,,0.78,0.154,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2012.0,2014.0,ALL
677825,SNORA44,,1.0,0.115,,,,C0271568,Laron Syndrome,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0,,1990.0,1990.0,ALL
677828,SNORA47,,0.931,0.115,,,,C0024232,Lymphatic Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
677830,SNORA50A,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
677831,SNORA51,,0.931,0.154,,,,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2008.0,2008.0,ALL
677833,SNORA54,,1.0,0.077,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
677834,SNORA55,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
677841,SNORA74B,,0.805,0.077,,,,C0153452,Malignant neoplasm of gallbladder,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
677842,SNORA50C,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
677844,SNORA78,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
678655,CD27-AS1,,1.0,,,,,C3554540,LYMPHOPROLIFERATIVE SYNDROME 2,,,disease,Disease or Syndrome,0.1,,,,,ALL
684959,SNORA25,,0.931,0.115,,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
692076,SNORD7,,1.0,0.077,,,,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
692088,SNORD50B,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.31,1.0,,2016.0,2016.0,ALL
692094,MSMP,Q1L6U9,0.805,0.154,0.048387,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
692107,SNORD66,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
692111,SNORD71,,0.931,0.115,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
692148,SCARNA10,,1.0,0.077,,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
692157,SNORA16B,,0.89,0.115,,,,C0022336,Creutzfeldt-Jakob disease,C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
692196,SNORD76,,0.821,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
692198,SNORD78,,0.821,0.115,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
692200,SNORD103C,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
692205,SNORD89,,0.89,0.115,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
692215,SNORD112,,1.0,0.038,,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
692219,DFNB65,,1.0,0.115,,,,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
692222,OPA5,,0.839,0.154,,,,C1853139,OPTIC ATROPHY 5 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
692226,SNORD96B,,1.0,0.077,,,,C0013902,"Elliptocytosis, Hereditary",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
692227,SNORD104,,1.0,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
692233,SNORD117,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
692236,SNORD116@,,0.705,0.692,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,0.973,,2002.0,2019.0,ALL
692312,PPAN-P2RY11,Q9NQ55,0.736,0.577,1.7244e-12,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.13,1.0,,2013.0,2019.0,ALL
693120,MIR33B,,0.601,0.615,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
693121,MIR411,,0.628,0.538,,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
693122,MIR421,,0.592,0.692,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
693123,MIR449B,,0.663,0.577,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,0.8,,2018.0,2019.0,ALL
693124,MIR532,,0.628,0.615,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.35,1.0,,2009.0,2019.0,ALL
693128,MIR548B,,0.931,0.077,,,,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
693129,MIR548C,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
693132,MIR549A,,1.0,0.115,,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
693135,MIR551A,,0.861,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2019.0,ALL
693136,MIR551B,,0.682,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2017.0,2019.0,ALL
693137,MIR552,,0.705,0.269,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.09,1.0,,2014.0,2019.0,ALL
693138,MIR553,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
693140,MIR555,,1.0,0.115,,,,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
693141,MIR556,,0.839,0.154,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
693142,MIR557,,0.805,0.269,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
693143,MIR558,,0.78,0.231,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2015.0,2016.0,ALL
693144,MIR559,,0.821,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
693146,MIR561,,0.861,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
693147,MIR562,,0.78,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
693148,MIR563,,0.821,0.115,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2015.0,2020.0,ALL
693149,MIR564,,0.695,0.269,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.32,1.0,,2009.0,2018.0,ALL
693152,MIR567,,0.792,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2012.0,2019.0,ALL
693153,MIR568,,0.821,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2014.0,ALL
693154,MIR569,,0.792,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
693155,MIR570,,0.682,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2013.0,2018.0,ALL
693156,MIR571,,0.89,0.115,,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
693157,MIR572,,0.716,0.423,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
693158,MIR573,,0.743,0.385,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
693159,MIR574,,0.599,0.577,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
693160,MIR575,,0.805,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2015.0,2019.0,ALL
693161,MIR576,,0.686,0.385,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2018.0,2020.0,ALL
693162,MIR577,,0.678,0.5,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.07,1.0,,2017.0,2019.0,ALL
693163,MIR578,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
693164,MIR579,,0.729,0.346,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2014.0,2019.0,ALL
693165,MIR580,,0.89,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
693166,MIR581,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
693167,MIR582,,0.636,0.5,,,,C0027055,Myocardial Reperfusion Injury,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",phenotype,Pathologic Function,0.3,1.0,,2012.0,2012.0,ALL
693169,MIR584,,0.65,0.385,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2011.0,2019.0,ALL
693170,MIR585,,0.78,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2011.0,2020.0,ALL
693171,MIR586,,0.89,0.038,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
693172,MIR587,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
693173,MIR588,,0.76,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
693174,MIR589,,0.656,0.538,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
693175,MIR590,,0.553,0.692,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2016.0,2019.0,ALL
693176,MIR591,,0.769,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2011.0,2019.0,ALL
693177,MIR592,,0.659,0.615,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2012.0,2017.0,ALL
693178,MIR593,,0.722,0.346,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
693180,MIR595,,0.722,0.346,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.31,1.0,,2009.0,2017.0,ALL
693181,MIR596,,0.769,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2010.0,2020.0,ALL
693182,MIR597,,0.751,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2019.0,ALL
693183,MIR598,,0.7,0.308,,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2011.0,2011.0,ALL
693184,MIR599,,0.729,0.308,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.06,1.0,,2017.0,2019.0,ALL
693185,MIR600,,0.705,0.346,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2017.0,2018.0,ALL
693186,MIR601,,0.716,0.231,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
693187,MIR602,,0.792,0.231,,,,C0019158,Hepatitis,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
693188,MIR603,,0.695,0.308,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2013.0,2019.0,ALL
693189,MIR604,,0.861,0.115,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
693190,MIR605,,0.644,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2013.0,2020.0,ALL
693192,MIR607,,0.931,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
693193,MIR608,,0.615,0.538,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2014.0,2018.0,ALL
693194,MIR609,,1.0,0.038,,,,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
693195,MIR610,,0.751,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
693196,MIR611,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
693197,MIR612,,0.695,0.385,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,1.0,,2013.0,2018.0,ALL
693198,MIR613,,0.608,0.615,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2016.0,2019.0,ALL
693199,MIR614,,0.89,0.115,,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
693200,MIR615,,0.647,0.615,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2012.0,2017.0,ALL
693201,MIR616,,0.682,0.385,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0,,2016.0,2018.0,ALL
693203,MIR618,,0.67,0.5,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0,,2017.0,2019.0,ALL
693204,MIR619,,0.931,0.115,,,,C0014457,Eosinophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
693205,MIR620,,0.805,0.154,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
693206,MIR621,,0.78,0.269,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
693207,MIR622,,0.638,0.5,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2011.0,2019.0,ALL
693208,MIR623,,0.78,0.154,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2016.0,2020.0,ALL
693209,MIR624,,0.821,0.115,,,,C0008479,Chondrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
693210,MIR625,,0.604,0.654,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
693211,MIR626,,0.839,0.192,,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0,,2019.0,2019.0,ALL
693212,MIR627,,0.705,0.192,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
693213,MIR628,,0.7,0.462,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
693214,MIR629,,0.653,0.538,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
693215,MIR630,,0.621,0.5,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.1,1.0,,2014.0,2020.0,ALL
693216,MIR631,,1.0,0.154,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
693217,MIR632,,0.805,0.269,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
693218,MIR633,,0.769,0.346,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
693219,MIR634,,0.743,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2014.0,2019.0,ALL
693220,MIR635,,0.861,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
693221,MIR636,,0.78,0.308,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2013.0,2020.0,ALL
693222,MIR637,,0.695,0.423,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2015.0,2019.0,ALL
693223,MIR638,,0.636,0.462,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.34,1.0,,2012.0,2019.0,ALL
693224,MIR639,,0.743,0.308,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
693225,MIR640,,0.805,0.308,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
693226,MIR641,,0.711,0.308,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
693227,MIR642A,,0.769,0.308,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2012.0,2017.0,ALL
693228,MIR643,,0.89,0.038,,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
693229,MIR644A,,0.861,0.154,,,,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
693230,MIR645,,0.729,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2014.0,2019.0,ALL
693231,MIR646,,0.711,0.308,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2014.0,2018.0,ALL
693232,MIR647,,0.792,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2017.0,2018.0,ALL
693233,MIR648,,0.839,0.192,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
693235,MIR92B,,0.59,0.654,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
723778,MIR650,,0.67,0.577,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.08,1.0,,2017.0,2019.0,ALL
723779,MIR651,,0.839,0.077,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
723788,MIG7,,0.76,0.192,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0,,2008.0,2018.0,ALL
723790,H2AC19,Q6FI13,0.89,0.115,,,,C0003864,Arthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
723961,INS-IGF2,F8WCM5,0.633,0.5,0.055811,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
724022,MIR652,,0.621,0.577,,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2011.0,2011.0,ALL
724023,MIR653,,0.769,0.269,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
724024,MIR654,,0.722,0.346,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2017.0,ALL
724025,MIR655,,0.678,0.385,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
724026,MIR656,,0.743,0.154,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
724027,MIR657,,0.861,0.269,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2013.0,2015.0,ALL
724028,MIR658,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
724029,MIR659,,0.805,0.192,,,,C0338451,Frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2008.0,2011.0,ALL
724030,MIR660,,0.666,0.615,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
724031,MIR661,,0.695,0.385,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.07,1.0,,2010.0,2019.0,ALL
724032,MIR662,,0.861,0.115,,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
724033,MIR663A,,0.576,0.769,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2019.0,ALL
724058,ANIB4,,1.0,0.077,,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
724066,ATXN8,Q156A1,0.743,0.269,,,,C1837454,SPINOCEREBELLAR ATAXIA 8,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.67,1.0,limited,1999.0,2019.0,ALL
724102,SNHG4,,0.78,0.154,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
724107,SPG32,,1.0,0.192,,,,C1970009,"SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE",C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.3,,,,,ALL
724110,SPG34,,1.0,0.077,,,,C2677897,"SPASTIC PARAPLEGIA 34, X-LINKED (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
727676,SNORD118,,0.686,0.462,,,,C3281200,"LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS",C16;C04;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.71,1.0,,2016.0,2019.0,ALL
727677,CASC8,,0.67,0.462,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.14,1.0,,2007.0,2019.0,ALL
727699,LINC00163,,0.861,0.154,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
727701,LINC00165,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
727758,ROCK1P1,,,,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
727764,MAFIP,Q8WZ33,0.821,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
727830,SPATA31A3,Q5VYP0,1.0,0.077,0.29526,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
727837,SSX2B,Q16385,0.599,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.969,,1996.0,2017.0,ALL
727857,BHLHA9,Q7RTU4,0.644,0.269,0.2959,,,C1836206,"Syndactyly, Mesoaxial Synostotic, with Phalangeal Reduction",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.71,1.0,,2012.0,2014.0,ALL
727897,MUC5B,Q9HC84,0.532,0.808,0.99999,,,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.7,0.952,limited,2011.0,2019.0,ALL
727910,TLCD2,A6NGC4,,,6.0895e-06,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
727915,AGBL1-AS1,,1.0,0.077,,,,C0006287,Bronchopulmonary Dysplasia,C16;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
727936,GXYLT2,A0PJZ3,,,5.3671e-14,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
727941,SLC25A24P1,,,,,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
727957,MROH1,Q8NDA8,,,0.20264,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
727993,PDYN-AS1,,1.0,0.077,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2008.0,2008.0,ALL
728012,MCHR2-AS1,,0.931,0.115,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
728036,CT47A10,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
728039,SSR4P1,,,,,,,C0518026,body fat percentage (physical finding),,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
728040,LINC02499,,,,,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
728042,CT47A9,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
728045,PPBPP1,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
728049,CT47A8,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
728062,CT47A6,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
728072,CT47A5,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
728075,CT47A4,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
728081,LINC00290,,,,,,,C3893645,response to ACE inhibitor,,,phenotype,Organism Function,0.1,1.0,,2017.0,2017.0,ALL
728082,CT47A3,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
728084,LINC02458,,0.931,0.038,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
728090,CT47A2,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
728096,CT47A1,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
728113,ANXA8L1,P13928;Q5VT79,0.729,0.269,0.00092573,,,C0023487,Acute Promyelocytic Leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0,,1992.0,1995.0,ALL
728116,ZBTB8B,Q8NAP8,1.0,0.077,0.0012501,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,,,,,ALL
728118,NUTM2A,Q5VT03;Q8IVF1,0.805,0.077,5.3583e-07,,,C0206630,Endometrial Stromal Sarcoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.36,1.0,,2012.0,2017.0,ALL
728130,NUTM2D,Q5VT03;Q8IVF1,0.89,0.077,0.37313,,,C0206630,Endometrial Stromal Sarcoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.05,1.0,,2012.0,2014.0,ALL
728137,TSPY3,P0CV98;P0CW01;Q01534,0.659,0.385,,,,C0206661,Gonadoblastoma,C16;C04;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Neoplastic Process,0.1,1.0,,1999.0,2019.0,ALL
728143,CHCHD4P4,,0.931,0.115,,,,C0022650,Kidney Calculi,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
728190,NUTM2A-AS1,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
728192,LINC00460,,0.647,0.462,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2019.0,ALL
728196,LOC728196,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
728215,FAM155A,B1AL88,0.78,0.308,0.97586,,,C0012813,Diverticulitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.42,1.0,,2017.0,2019.0,ALL
728226,GGTLC3,B5MD39,0.513,0.846,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1986.0,2019.0,ALL
728228,LINC01433,,0.805,0.115,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
728239,MAGED4,Q96JG8,0.61,0.423,0.32367,,,C0032927,Precancerous Conditions,C04,   Neoplasms,group,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
728264,CARMN,,0.751,0.385,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
728269,MAGEA9B,P43362,0.931,0.115,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
728276,CLEC19A,Q6UXS0,1.0,0.038,0.0037987,,,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2014.0,2014.0,ALL
728290,LINC02027,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
728294,D2HGDH,Q8N465,0.691,0.5,0.054343,,,C3152055,D-2-HYDROXYGLUTARIC ACIDURIA 1,,,disease,Disease or Syndrome,0.74,1.0,,2005.0,2019.0,ALL
728310,GOLGA6L7,A0A1B0GV03,,,,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
728343,NXF2B,Q9GZY0,1.0,0.038,0.71333,,,C4021107,Non-obstructive azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
728358,DEFA1B,P59665,0.674,0.692,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,1986.0,2016.0,ALL
728369,USP17L24,Q0WX57,0.751,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
728373,USP17L25,Q0WX57,0.751,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
728378,POTEF,A5A3E0,0.481,0.885,5.4522e-06,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1987.0,2018.0,ALL
728379,USP17L26,Q0WX57,0.751,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
728393,USP17L27,Q0WX57,0.751,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
728400,USP17L28,Q0WX57,0.751,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
728405,USP17L29,Q0WX57,0.751,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
728409,LINC01548,A6NM66,,,0.00035513,,,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
728410,DUX4L2,P0CJ85,1.0,0.115,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,2013.0,2018.0,ALL
728411,GUSBP1,Q15486,0.861,0.077,,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2001.0,2016.0,ALL
728419,USP17L30,Q0WX57,0.751,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2011.0,2019.0,ALL
728431,LINC01137,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
728432,ICE2P2,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
728434,LINC02871,Q9UGB4,0.931,0.115,0.004175,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2014.0,2014.0,ALL
728441,GGT2,P36268,0.513,0.846,0.00012986,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1986.0,2019.0,ALL
728448,PPIEL,,0.931,0.077,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2008.0,2018.0,ALL
728450,LINC00687,,0.931,0.115,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
728458,OPN1MW2,P04001;P0DN77;P0DN78,0.601,0.769,0.24464,,,C0024809,Marijuana Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.07,1.0,,2018.0,2020.0,ALL
728464,METTL24,Q5JXM2,0.931,0.077,1.0876e-05,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
728489,DNLZ,Q5SXM8,0.663,0.538,0.00024737,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,1991.0,2017.0,ALL
728492,SERF1B,O75920,0.89,0.115,0.30017,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,1998.0,2013.0,ALL
728519,NAIPP2,,0.931,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
728537,C2orf92,A0A1B0GVN3,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
728556,MEMO1P1,,0.792,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
728558,ENTPD1-AS1,,1.0,,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
728568,C12orf73,Q69YU5,,,0.024774,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
728586,CCDC192,P0DO97,1.0,0.038,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
728597,DCDC2C,A8MYV0,0.931,0.192,0.00071676,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
728606,PCAT18,,0.931,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
728609,SDHAP3,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
728621,CCDC30,Q5VVM6,,,1.4579e-17,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
728637,MEIKIN,A0A087WXM9,0.931,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
728638,KRT8P3,,0.644,0.538,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.08,1.0,,1995.0,2018.0,ALL
728642,CDK11A,Q9UQ88,0.78,0.192,1.385e-17,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,1999.0,2005.0,ALL
728655,HULC,,0.606,0.538,,,,C0345904,Malignant neoplasm of liver,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.33,1.0,,2016.0,2018.0,ALL
728661,SLC35E2B,P0CK96,,,0.0026282,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
728695,SPANXB1,Q9NS25,0.76,0.192,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2004.0,2008.0,ALL
728712,SPANXA2,Q9NS26,0.695,0.346,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2004.0,2015.0,ALL
728723,ZBED3-AS1,,0.931,0.115,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2018.0,ALL
728724,LINC00977,,0.931,0.038,,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.3,1.0,,2016.0,2016.0,ALL
728730,MAP4K3-DT,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
728734,NPIPB8,E9PQR5,,,0.0037575,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
728763,CROCC2,H7BZ55,,,1.3883e-13,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
728773,PABPC1P2,,1.0,0.115,,,,C0270952,"Muscular Dystrophy, Oculopharyngeal",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,0.917,,1998.0,2011.0,ALL
728780,ANKDD1B,A6NHY2,1.0,0.038,1.4401e-06,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2019.0,ALL
728798,FRMPD2B,Q6IN97,1.0,0.038,,,,C0039101,synovial sarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2004.0,2004.0,ALL
728806,NSFP1,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
728825,LOC728825,,,,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
728833,FAM72D,Q6L9T8,1.0,0.154,0.029905,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
728841,NBPF8,Q3BBV2,0.931,0.038,1.4181e-07,,,C0399526,Class III malocclusion,C07,   Stomatognathic Diseases,disease,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
728855,LINC00623,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
728882,FAM182B,Q5T319,,,0.087202,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
728888,NPIPB11,E5RHQ5,0.931,0.192,0.013863,,,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
728911,CT45A2,P0DMV1;P0DMV2;Q5DJT8,0.861,0.192,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
728929,ELOA3B,Q3SY89;Q8NG57,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2014.0,2016.0,ALL
728931,AMD1P3,,1.0,0.038,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
728978,UNC5B-AS1,,0.805,0.154,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
729013,ZBED5-AS1,,0.89,0.115,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
729032,RPL36P20,,1.0,0.154,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
729041,FAAHP1,,,,,,,C0344307,Absence of pain sensation,C23;F03,"   Pathological Conditions, Signs and Symptoms;    Mental Disorders",phenotype,Finding,0.3,1.0,limited,2019.0,2019.0,ALL
729059,TEX46,H3BTG2,0.861,0.115,0.0076505,,,C0003855,Arteriovenous fistula,C23;C16;C14,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",phenotype,Anatomical Abnormality,0.01,1.0,,2019.0,2019.0,ALL
729073,FAM92A1P1,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
729082,OIP5-AS1,,0.659,0.5,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.09,1.0,,2017.0,2019.0,ALL
729085,GASK1A,Q9UFP1,,,5.7508e-16,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2019.0,ALL
729156,GTF2IRD1P1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
729177,NBAT1,,0.65,0.423,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.14,1.0,,2008.0,2017.0,ALL
729178,STXBP5-AS1,,0.805,0.192,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
729224,KIAA2012-AS1,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
729230,CCR2,P41597,0.418,0.846,0.023412,,,C0034069,Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.33,0.75,,2003.0,2018.0,ALL
729238,SFTPA2,Q8IWL1,0.563,0.731,0.0092512,,,C1800706,Idiopathic Pulmonary Fibrosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.74,1.0,,2009.0,2017.0,ALL
729249,KLHL2P1,,0.89,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
729252,KRT16P1,,1.0,,,,,C0677944,Sentinel node (disorder),,,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
729262,NUTM2B,A6NNL0,0.839,0.115,0.020467,,,C0334488,Clear cell sarcoma of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.34,1.0,,2012.0,2017.0,ALL
729305,LINC02714,,1.0,0.038,,,,C0154778,"Myopia, Degenerative",C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
729330,OC90,Q02509,0.839,0.308,5.6811e-12,,,C0042594,Vestibular Diseases,C09,   Otorhinolaryngologic Diseases,group,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
729347,AKR1B1P3,,1.0,0.038,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
729359,PLIN4,Q96Q06,0.821,0.231,5.578e-16,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
729420,LMO7DN,F2Z398,,,9.3942e-09,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
729422,GAGE12C,A1L429;O76087;P0CL80;P0CL81;P0CL82,0.821,0.192,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
729428,GAGE12B,A1L429;O76087;P0CL80;P0CL81;P0CL82,0.821,0.192,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
729431,GAGE12E,A1L429;O76087;P0CL80;P0CL81;P0CL82,0.821,0.192,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
729438,CASTOR2,A6NHX0,1.0,0.077,0.42837,,,C0036220,Kaposi Sarcoma,C04;C01,   Neoplasms;    Infections,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
729447,GAGE2A,Q6NT46,0.89,0.154,0.10091,,,C0005695,Bladder Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,1995.0,1995.0,ALL
729453,PMS2P6,,0.861,0.115,,,,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
729533,FAM72A,Q5TYM5,0.705,0.462,0.032815,,,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.1,0.941,,1991.0,2020.0,ALL
729582,DIRC3,,0.78,0.308,3.4129e-07,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.4,1.0,,2013.0,2017.0,ALL
729668,GOLGA2P6,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
729723,DNAJC27-AS1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
729816,DHFRP2,,1.0,0.038,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
729830,FAM160A1,Q05DH4,,,1.1161e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
729838,GGTLC4P,,0.513,0.846,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1986.0,2019.0,ALL
729852,UMAD1,C9J7I0,0.931,0.154,0.22503,,,C0014518,Toxic Epidermal Necrolysis,C17;C20;C25;C07,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Chemically-Induced Disorders;    Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
729857,RGPD2,P0DJD1,0.695,0.346,0.0013791,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,1996.0,2019.0,ALL
729873,TBC1D3,Q6DHY5;Q6IPX1;Q8IZP1,0.861,0.115,0.53063,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2002.0,2017.0,ALL
729911,ANKRD34C-AS1,,1.0,,,,,C0034951,Refractive Errors,C11,   Eye Diseases,group,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
729920,CRPPA,A4D126,0.566,0.654,0.00025176,,,C4015095,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7",,,disease,Disease or Syndrome,0.7,1.0,strong,1989.0,2017.0,ALL
729950,LINC01915,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
729967,MORN2,Q502X0,1.0,0.038,0.15342,,,C0004623,Bacterial Infections,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
729970,LOC729970,,0.931,0.115,,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
729978,NPIPB2,A6NJ64,,,2.9717e-08,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
729991,BORCS8,Q96FH0,,,0.00025761,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
729993,SHISA9,B4DS77,0.89,0.231,0.87306,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
730005,SEC14L6,B5MCN3,1.0,0.038,2.4606e-08,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
730091,LINC00886,,0.931,0.115,,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
730100,LOC730100,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
730101,LOC730101,,0.805,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
730109,LINC01100,,0.861,0.192,0.072755,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2015.0,ALL
730138,PFN1P1,,1.0,0.038,,,,C0338656,Impaired cognition,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
730153,NPIPB10P,,0.931,0.192,,,,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
730198,MEIS1-AS3,,0.931,0.077,,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
730211,HSP90AA5P,Q58FG0,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
730249,ACOD1,A6NK06,0.861,0.154,4.5659e-06,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2014.0,2018.0,ALL
731220,RFX8,Q6ZV50,1.0,,5.3224e-09,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
731223,LINC01220,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
731275,LINC01347,,1.0,0.077,,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
732253,TDRG1,,0.722,0.231,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
732275,LINC00917,,1.0,0.115,,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
735301,SNHG9,,0.805,0.115,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
752014,CEMP1,Q6PRD7,0.78,0.269,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
767557,SYS1-DBNDD2,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
767558,LUZP6,Q538Z0,0.839,0.077,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
767561,SNORD113-1,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
767563,SNORD113-3,,1.0,0.192,,,,C2919945,Cavernous Hemangioma of Brain,C16;C04;C10;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.01,1.0,,2018.0,2018.0,ALL
767588,SNORD114-10,,0.89,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
767589,SNORD114-11,,0.89,0.115,,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
767600,SNORD114-22,,1.0,0.192,,,,C2919945,Cavernous Hemangioma of Brain,C16;C04;C10;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.01,1.0,,2018.0,2018.0,ALL
768096,HAR1A,,0.931,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
768097,HAR1B,,0.89,0.154,,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
768206,PRCD,Q00LT1,0.7,0.269,0.016018,,,C1864621,RETINITIS PIGMENTOSA 36,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.7,1.0,,2006.0,2016.0,ALL
768211,RELL1,Q8IUW5,0.89,0.115,0.95869,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
768212,MIR758,,0.656,0.462,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2017.0,2019.0,ALL
768213,MIR671,,0.636,0.577,,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2011.0,2011.0,ALL
768214,MIR668,,0.861,0.192,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
768215,MIR767,,0.821,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
768216,MIR454,,0.617,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2015.0,2019.0,ALL
768217,MIR769,,0.743,0.308,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
768218,MIR766,,0.633,0.577,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
768219,MIR802,,0.653,0.462,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.34,1.0,,2013.0,2018.0,ALL
768220,MIR765,,0.674,0.385,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0,,2014.0,2019.0,ALL
768222,MIR770,,0.705,0.462,,,,C0027659,"Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2017.0,2017.0,ALL
768239,PSAPL1,Q6NUJ1,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
777643,GLC1M,,1.0,0.038,,,,C1864653,"GLAUCOMA 1, OPEN ANGLE, M (disorder)",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
777645,GLC1N,,1.0,0.038,,,,C0339573,"Glaucoma, Primary Open Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
777778,OPA6,,0.931,0.115,,,,C1850281,OPTIC ATROPHY 6 (disorder),C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
780776,TVP23A,A6NH52,1.0,0.038,1.6882e-07,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
780851,SNORD3A,,0.89,0.115,,,,C0022336,Creutzfeldt-Jakob disease,C01;C10;F03,   Infections;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
780896,ACTD,,0.861,0.115,,,,C1328407,Hip Dysplasia,C05;C26,   Musculoskeletal Diseases;    Wounds and Injuries,disease,Anatomical Abnormality,0.03,1.0,,2009.0,2017.0,ALL
780897,HPP1,,0.686,0.346,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.09,1.0,,2001.0,2017.0,ALL
780898,APMR1,,1.0,0.077,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
780900,FGS5,,1.0,0.154,,,,C0220769,FG syndrome,C23;C16;C06;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
780901,NYS5,,1.0,0.115,,,,C0585539,X-Linked Infantile Nystagmus,C16;C11;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,2011.0,2011.0,ALL
780903,HHT3,,1.0,0.115,,,,C0345893,Juvenile polyposis syndrome,C16;C06;C04,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
780904,PSS,,0.608,0.654,,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.06,1.0,,2017.0,2020.0,ALL
780906,SLI3,,1.0,0.077,,,,C0454651,Specific language impairment,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
780910,PPR2,,1.0,0.038,,,,C0014550,Myoclonic Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
780912,AD10,,0.743,0.269,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2011.0,2018.0,ALL
780915,CHNG3,,0.821,0.115,,,,C2940785,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3",C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.02,1.0,,2005.0,2017.0,ALL
780916,GINGF3,,1.0,0.077,,,,C0399440,Hereditary gingival fibromatosis,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
780919,HRPT3,,1.0,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2001.0,2001.0,ALL
780922,SPD3,,0.89,0.115,,,,C2699746,"Syndactyly, type 2",C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.02,1.0,,2006.0,2007.0,ALL
790951,TRS-AGA3-1,,1.0,0.038,,,,C0027149,Myxoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
790952,ESRG,Q1W209,0.78,0.038,,,,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
790953,TSL,,0.743,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
790955,UQCC3,Q6UW78,0.839,0.038,0.032331,,,C4015253,"MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9",,,disease,Disease or Syndrome,0.6,1.0,moderate,2014.0,2017.0,ALL
791114,PWRN1,,0.67,0.5,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,,2007.0,2007.0,ALL
791115,PWRN2,,1.0,0.115,,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
791121,SHFL1,,1.0,0.038,,,,C2699510,Split-Hand/Foot Malformation,C23,"   Pathological Conditions, Signs and Symptoms",disease,Congenital Abnormality,0.03,1.0,,2012.0,2014.0,ALL
791122,KTWS,,0.705,0.269,,,,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.09,1.0,,1998.0,2018.0,ALL
791228,SPG36,,0.861,0.231,,,,C2936879,"SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
791229,MACOM,,1.0,0.077,,,,C0000768,Congenital Abnormality,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2007.0,2007.0,ALL
791230,TRV-AAC1-5,,1.0,0.077,,,,C0042749,Viremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0,,1997.0,1997.0,ALL
791254,EDS8,,0.839,0.269,,,,C0009782,Connective Tissue Diseases,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
100008586,GAGE12F,A1L429;O76087;P0CL80;P0CL81;P0CL82,0.821,0.192,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100008588,RNA18SN5,,0.76,0.269,,,,C0024530,Malaria,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,1997.0,2013.0,ALL
100008589,RNA28SN5,,0.705,0.346,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
100009613,LINC02584,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100009667,POU5F1P5,,0.931,0.077,,,,C0007103,Malignant neoplasm of endometrium,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100009675,MRT4,,,,,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0,,2011.0,2011.0,ALL
100033407,VN2R19P,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100033413,SNORD116-1,,0.682,0.423,,,,C0032897,Prader-Willi Syndrome,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.33,1.0,,2002.0,2005.0,ALL
100033431,SNORD116-20,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100033806,SNORD115-32,,1.0,0.192,,,,C2919945,Cavernous Hemangioma of Brain,C16;C04;C10;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Nervous System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Anatomical Abnormality,0.01,1.0,,2018.0,2018.0,ALL
100033819,MIR675,,0.595,0.654,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2010.0,2019.0,ALL
100034700,AA1,,1.0,0.115,,,,C0151650,Renal fibrosis,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100034703,AA2,,0.89,0.115,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100037417,DDTL,A6NHG4,0.931,0.115,0.33439,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2015.0,2015.0,ALL
100038246,TLX1NB,P0CAT3,0.674,0.423,,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2019.0,ALL
100038247,PTLS,,0.78,0.308,,,,C2931246,Potocki-Lupski syndrome,C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.06,1.0,,2012.0,2019.0,ALL
100048903,MCCD1P1,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
100048908,ZDHHC20P2,,0.89,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100048912,CDKN2B-AS1,,0.491,0.769,,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.45,1.0,,2010.0,2017.0,ALL
100049159,SPG37,,1.0,0.077,,,,C2936880,"SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
100049542,SHFM3,,0.78,0.115,,,,C0221373,Claw hand,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.05,1.0,,1996.0,2007.0,ALL
100049544,APMR2,,1.0,0.077,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
100049579,OCTN3,,0.805,0.308,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100049587,SIGLEC14,Q08ET2,0.736,0.269,0.0013412,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100049707,SPG38,,0.89,0.115,,,,C2676732,"SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
100049716,NINJ2-AS1,,,,,,,C0200637,Monocyte count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
100073347,MIMT1,,0.839,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100093630,SNHG8,,0.743,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,0.75,,2018.0,2019.0,ALL
100093698,GS1-600G8.3,,1.0,0.038,,,,C0009241,Cognition Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,0.0,,2004.0,2004.0,ALL
100101267,POM121C,A8CG34,1.0,,6.6064e-10,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
100101467,ZSCAN30,Q86W11,1.0,0.077,6.9946e-13,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100101490,MCTS2P,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
100113382,SNORD105B,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100113391,SNORD126,,0.89,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100113393,SNORD12B,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100113402,SNORD111B,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100113403,LIN28B-AS1,,0.861,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
100113404,LINC00583,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100113407,TMEM170B,Q5T4T1,0.931,0.077,0.78657,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100124415,EKD2,,0.89,0.077,,,,C4552000,Episodic Kinesigenic Dyskinesia 1,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.03,0.667,,2000.0,2002.0,ALL
100124696,TEC,,0.659,0.577,,,,C1275278,Extraskeletal Myxoid Chondrosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.05,1.0,,1999.0,2012.0,ALL
100124700,HOTAIR,,0.475,0.769,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2013.0,2019.0,ALL
100125288,ZGLP1,P0C6A0,0.512,0.808,0.3868,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.11,1.0,,2015.0,2019.0,ALL
100126270,FMR1-AS1,,0.839,0.231,,,,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.04,0.75,,1993.0,2019.0,ALL
100126296,MIR298,,0.729,0.346,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2018.0,2018.0,ALL
100126297,MIR300,,0.623,0.5,,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2011.0,2011.0,ALL
100126299,VTRNA2-1,,0.641,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2011.0,2020.0,ALL
100126302,MIR450B,,0.769,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
100126303,MIR890,,0.931,0.077,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100126304,MIR891B,,0.89,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100126306,MIR888,,0.76,0.192,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0,,2014.0,2019.0,ALL
100126307,MIR892B,,,,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100126308,MIR541,,0.76,0.269,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
100126309,MIR875,,0.743,0.231,,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
100126310,MIR876,,0.666,0.385,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2017.0,2019.0,ALL
100126311,MIR147B,,0.736,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2017.0,2020.0,ALL
100126313,MIR744,,0.617,0.615,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100126314,MIR877,,0.67,0.385,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
100126315,MIR665,,0.653,0.577,,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
100126316,MIR873,,0.601,0.538,,,,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.32,1.0,,2019.0,2019.0,ALL
100126317,MIR374B,,0.621,0.5,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
100126318,MIR301B,,0.674,0.423,,,,C0009171,Cocaine Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
100126319,MIR216B,,0.621,0.577,,,,C0030305,Pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2016.0,2016.0,ALL
100126320,MIR920,,0.839,0.231,,,,C0149896,Primary gout,C23;C16;C18;C05,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100126321,MIR922,,0.821,0.231,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
100126323,MIR924,,,,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100126324,MIR934,,0.769,0.192,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,0.0,,2019.0,2019.0,ALL
100126325,MIR935,,0.695,0.192,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2018.0,2019.0,ALL
100126326,MIR936,,0.821,0.231,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100126327,MIR938,,0.769,0.115,,,,C0007095,Carcinoid Tumor,C04,   Neoplasms,phenotype,Neoplastic Process,0.3,1.0,,2014.0,2014.0,ALL
100126328,MIR940,,0.604,0.577,,,,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0,,2017.0,2017.0,ALL
100126331,MIR942,,0.695,0.5,,,,C0239946,"Fibrosis, Liver",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.31,1.0,,2018.0,2018.0,ALL
100126332,MIR943,,0.839,0.192,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2014.0,2016.0,ALL
100126333,MIR708,,0.57,0.692,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
100126334,MIR885,,0.597,0.615,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.33,1.0,,2016.0,2018.0,ALL
100126335,MIR543,,0.593,0.692,,,,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.32,1.0,,2017.0,2019.0,ALL
100126336,MIR208B,,0.7,0.308,,,,C0155626,Acute myocardial infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.06,1.0,,2014.0,2018.0,ALL
100126337,MIR509-3,,0.861,0.115,,,,C0024232,Lymphatic Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100126338,MIR937,,0.78,0.269,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
100126340,MIR944,,0.678,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2013.0,2019.0,ALL
100126343,MIR874,,0.628,0.577,,,,C0027626,Neoplasm Invasiveness,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Pathologic Function,0.3,1.0,,2018.0,2018.0,ALL
100126345,MIR889,,0.695,0.462,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
100126346,MIR190B,,0.722,0.385,,,,C0018781,Noise-induced hearing loss,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Injury or Poisoning,0.3,1.0,,2013.0,2013.0,ALL
100126347,MIR887,,0.839,0.231,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100126348,MIR760,,0.674,0.385,,,,C0019207,"Hepatoma, Morris",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2011.0,2011.0,ALL
100126350,MIR933,,0.805,0.154,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2015.0,ALL
100126351,MIR939,,0.659,0.538,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100126354,MIR297,,0.751,0.192,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2012.0,2013.0,ALL
100126355,MIR365A,,0.705,0.423,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100126356,MIR365B,,0.769,0.308,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100126572,GJE1,A6NN92,1.0,0.077,0.10802,,,C4721453,Peripheral Nervous System Diseases,C10,   Nervous System Diseases,group,Disease or Syndrome,0.31,1.0,,2011.0,2011.0,ALL
100126593,MAFD4,,0.78,0.115,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,1995.0,2019.0,ALL
100126595,MGS,,0.839,0.269,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2011.0,2011.0,ALL
100126791,EGOT,,0.743,0.346,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
100126793,GHRLOS,,1.0,0.077,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
100126794,GAEC1,,0.769,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,2010.0,2019.0,ALL
100127888,SLCO4A1-AS1,,0.839,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.04,1.0,,2018.0,2019.0,ALL
100127902,BMI1P1,,0.861,0.038,,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100127976,VTI1BP3,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100127979,FUNDC2P4,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100128010,SUMO2P17,,1.0,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2019.0,ALL
100128017,TULP3P1,,1.0,0.038,,,,C0033845,Pseudotumor Cerebri,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100128025,WWTR1-AS1,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100128033,PIGPP3,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100128054,PLCE1-AS1,,1.0,0.077,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100128062,SLC2A3P1,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
100128071,FAM229A,H3BQW9,1.0,,0.080917,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
100128081,JAZF1-AS1,,1.0,0.115,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100128098,ST8SIA6-AS1,,0.931,0.077,,,,C0730345,Microalbuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
100128181,FMO10P,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
100128191,TMPO-AS1,,0.76,0.154,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
100128239,LINC02731,,,,,,,C4280669,Velopharyngeal dysfunction,,,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
100128252,ZNF667-AS1,,0.691,0.308,,,,C4048328,cervical cancer,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.32,1.0,,2017.0,2019.0,ALL
100128262,TNK2-AS1,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100128285,DNM1P35,,1.0,0.115,,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
100128292,DLG5-AS1,,,,,,,C1278049,Serum gamma-glutamyl transferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100128338,FAM83H-AS1,,0.705,0.346,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
100128505,ASTN2-AS1,,0.931,0.115,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2012.0,2012.0,ALL
100128537,MIR29B2CHG,,0.839,0.192,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100128554,LINC02347,,0.931,0.077,,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
100128560,MYHAS,,0.89,0.269,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
100128590,SLC8A1-AS1,,0.792,0.231,,,,C0001849,AIDS Dementia Complex,C01;C20;C10;F03,   Infections;    Immune System Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
100128640,ACVR2B-AS1,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100128675,HPN-AS1,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100128714,LINC02346,,,,,,,C0021655,Insulin Resistance,C18,   Nutritional and Metabolic Diseases,phenotype,Pathologic Function,0.1,1.0,,2011.0,2011.0,ALL
100128750,RBPMS-AS1,,,,,,,C0425782,Breast size,,,phenotype,Finding,0.1,1.0,,2016.0,2016.0,ALL
100128771,EIF4BP3,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100128782,LINC00476,Q8WZB0,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
100128787,LINC01349,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100128788,SRRM2-AS1,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100128836,HNRNPA1P36,,,,,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
100128881,VPS9D1-AS1,,0.722,0.423,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100128893,GATA6-AS1,,0.931,0.154,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
100128927,ZBTB42,B2RXF5,0.931,0.115,0.33802,,,C4015686,LETHAL CONGENITAL CONTRACTURE SYNDROME 6,,,disease,Disease or Syndrome,0.61,1.0,,2014.0,2014.0,ALL
100128977,MAPT-AS1,,0.711,0.269,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.12,1.0,,2009.0,2019.0,ALL
100128998,C20orf181,,0.479,0.885,,,,C0009178,Cocaine withdrawal,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2010.0,2010.0,ALL
100129004,RPL3P10,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100129007,FMO8P,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
100129029,PKP4-AS1,,,,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100129060,SEMA3F-AS1,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
100129061,RPL7P25,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100129075,KTN1-AS1,Q86SY8,0.861,0.077,,,,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
100129123,ACE3P,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100129148,LOC100129148,,1.0,0.115,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,0.0,,2017.0,2017.0,ALL
100129192,MICC,,0.89,0.154,,,,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100129193,MUPP,,0.792,0.308,,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100129195,ZSCAN16-AS1,,0.792,0.269,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
100129196,MATN1-AS1,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100129250,SMIM27,A0A1B0GUW7,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100129269,LINC01160,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100129271,C1orf68,Q5T750,0.861,0.231,1.3581e-07,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100129347,LINC00484,,1.0,0.038,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100129385,C9orf92,A6NGG3,0.89,0.115,4.1133e-08,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2010.0,ALL
100129387,GABPB1-AS1,,0.89,0.115,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
100129394,RPL12P42,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100129405,MSTO2P,,0.821,0.154,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
100129427,DDC-AS1,,1.0,,,,,C1291564,Deficiency of aromatic-L-amino-acid decarboxylase,,,disease,Disease or Syndrome,0.1,,,,,ALL
100129460,DPY19L1P1,,1.0,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100129480,MKRN2OS,H3BPM6,0.931,0.077,3.8261e-05,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100129518,SOD2-OT1,,0.722,0.5,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
100129528,MUC8,,0.89,0.154,,,,C0027430,Nasal Polyps,C23;C08;C09,"   Pathological Conditions, Signs and Symptoms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.04,1.0,,2002.0,2010.0,ALL
100129543,ZNF730,Q6ZMV8,1.0,0.038,6.3597e-05,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100129575,MR1P1,,0.931,0.038,,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100129583,FAM47E,Q6ZV65,1.0,0.038,0.0017029,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2009.0,2017.0,ALL
100129597,LINC00462,,0.861,0.192,,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100129654,TCF24,Q7RTU0,1.0,0.077,0.025682,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100129662,FGF13-AS1,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100129669,IZUMO3,Q5VZ72,,,3.0367e-11,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,0.0,,2018.0,2018.0,ALL
100129696,INHCAP,,0.89,0.231,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2011.0,2011.0,ALL
100129716,ARRDC3-AS1,,1.0,0.077,,,,C0373705,Progesterone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100129724,MAPRE3-AS1,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100129772,TMPOP1,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2009.0,ALL
100129781,MIR193BHG,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100129827,MRVI1-AS1,,0.89,0.115,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100129845,PCOLCE-AS1,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
100129882,RPL31P49,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100129921,RPL15P4,,1.0,0.077,,,,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100129940,HMGA2-AS1,,1.0,0.077,9.7977e-06,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2014.0,ALL
100129961,CCNT2-AS1,,0.931,0.115,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100129969,FAM205C,A6NFA0,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100129973,CERNA1,,,,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100129982,RPL12P19,,,,,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
100129983,UBE2CP3,,0.931,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
100129995,LINC01460,,0.931,0.115,0.21409,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
100130009,HMGA1P8,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
100130015,URAHP,,1.0,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100130029,HMGA1P6,,1.0,0.038,,,,C0011603,Dermatitis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100130060,GNPATP,,,,,,,C3548479,response to bronchodilator,,,phenotype,Organism Function,0.1,1.0,,2015.0,2015.0,ALL
100130097,KIF28P,B7ZC32,0.839,0.115,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.05,1.0,,2008.0,2015.0,ALL
100130099,MIPEPP2,,0.89,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100130105,TRIM51CP,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
100130148,MAPT-IT1,,0.931,0.115,,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
100130231,LINC00861,,0.89,0.154,,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100130239,UBA52P6,,1.0,0.038,,,,C0017612,"Glaucoma, Open-Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
100130275,TFAP2A-AS1,,0.89,0.115,,,,C0376524,Branchio-Oculo-Facial Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.1,,,,,ALL
100130298,LOC100130298,,,,,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100130311,C17orf107,Q6ZR85,0.821,0.115,0.06927,,,C0751882,"Myasthenic Syndromes, Congenital",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,1997.0,2018.0,ALL
100130319,TAF9BP2,,0.861,0.115,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
100130418,CECR7,,0.89,0.308,,,,C0265493,Cat eye syndrome,C23;C16;C11,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.02,1.0,,2006.0,2013.0,ALL
100130476,WAKMAR2,,0.931,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100130480,LINC01387,J3KSC0,0.931,0.115,0.082776,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100130535,VIM2P,,0.76,0.385,,,,C0004610,Bacteremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.03,1.0,,2011.0,2018.0,ALL
100130613,PRR32,B1ATL7,1.0,0.077,0.0045812,,,C0393847,Multifocal motor neuropathy,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
100130742,LRRC69,Q6ZNQ3,,,1.118e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100130776,AGAP2-AS1,,0.691,0.231,0.027534,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0,,2016.0,2019.0,ALL
100130855,USP3-AS1,,,,,,,C0202231,Thyroxine measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100130873,CARM1P1,,1.0,0.038,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
100130889,PSORS1C3,,0.769,0.269,,,,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100130890,TSTD3,H0UI37,1.0,0.077,,,,C0023893,"Liver Cirrhosis, Experimental",C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Experimental Model of Disease,0.3,1.0,,2014.0,2014.0,ALL
100130894,VAC14-AS1,,1.0,,,,,C4310743,"STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET",,,disease,Disease or Syndrome,0.1,,,,,ALL
100130934,ZNF663P,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100130954,LINC01502,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100130958,SYCE1L,A8MT33,0.57,0.654,2.4274e-14,,,C0022350,"Jaundice, Chronic Idiopathic",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,1998.0,2017.0,ALL
100130967,C6orf99,Q4VX62,0.931,0.115,0.12728,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
100130988,SPATA48,A4D263,0.76,0.231,3.77e-08,,,C0007117,Basal cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
100130995,ZNF969P,,,,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100130996,YPEL5P1,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100131017,ZNF316,A6NFI3,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100131047,DNAH8-AS1,,,,,,,C0008780,Ciliary Motility Disorders,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",group,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
100131089,SRP14-AS1,,1.0,0.038,,,,C0201983,Dehydroepiandrosterone sulfate measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100131096,TNRC6C-AS1,,0.705,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,1999.0,2020.0,ALL
100131130,HNRNPA1P13,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100131137,BSPH1,Q075Z2,0.839,0.115,0.016492,,,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.02,1.0,,1988.0,1989.0,ALL
100131138,LINC01405,,0.89,0.154,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
100131176,WDR86-AS1,,,,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100131187,TSTD1,Q8NFU3,0.78,0.154,0.38107,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2003.0,2016.0,ALL
100131208,SNAP25-AS1,,0.861,0.077,,,,C0014547,"Epilepsies, Partial",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
100131234,MIR181A1HG,,0.861,0.115,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
100131320,RAB6C-AS1,,0.839,0.154,,,,C0006118,Brain Neoplasms,C04;C10,   Neoplasms;    Nervous System Diseases,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100131327,UQCRC2P1,,1.0,0.077,,,,C0007570,Celiac Disease,C06;C18,   Digestive System Diseases;    Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,1.0,,2008.0,2014.0,ALL
100131434,LINC00893,,0.89,0.269,,,,C0026705,Mucopolysaccharidosis II,C16;C18;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,1997.0,2000.0,ALL
100131451,TLR12P,,,,,,,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2015.0,2015.0,ALL
100131551,LINC00887,,0.821,0.192,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100131564,CCDC18-AS1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100131609,HNRNPA1P2,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100131691,MZF1-AS1,,0.792,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
100131693,EIF4EP2,,1.0,0.077,,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
100131726,FAM83A-AS1,,0.821,0.115,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
100131796,DACOR1,,0.931,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
100131801,PET100,P0DJ07,0.65,0.577,0.00035883,,,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.62,1.0,,2013.0,2015.0,ALL
100131814,LINC00271,P0C7V0,0.769,0.192,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.667,,2006.0,2010.0,ALL
100131825,CADM3-AS1,,1.0,0.038,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
100131827,ZNF717,Q9BY31,1.0,0.077,0.018983,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100131897,INSYN2B,A6NMK8,0.89,0.077,0.98467,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100131953,ACTG1P22,,0.931,0.038,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
100131980,ZNF705G,A8MUZ8,,,1.6471e-08,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100132066,ALG1L3P,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
100132074,FOXO6,A8MYZ6,0.7,0.423,0.40546,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2018.0,2019.0,ALL
100132079,KARS1P3,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
100132111,C2CD4D-AS1,,,,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100132116,ACTA2-AS1,,0.769,0.231,,,,C2673186,"Aortic Aneurysm, Familial Thoracic 6",C23;C17;C14,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2007.0,2015.0,ALL
100132159,CALML3-AS1,,0.821,0.115,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100132163,PHKA2-AS1,,0.931,0.077,,,,C2748941,"Glycogen Storage Disease, Type IXA2",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
100132169,WASIR2,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100132273,NDUFA6-DT,,1.0,0.038,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2014.0,ALL
100132285,KIR2DS2,P43631,0.599,0.615,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100132354,LINC01512,,0.89,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100132399,GAGE12D,A1L429;O76087;P0CL80;P0CL81;P0CL82,0.821,0.192,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100132406,NBPF10,Q6P3W6,0.931,0.077,4.1008e-85,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100132417,FCGR1CP,,0.769,0.462,,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2010.0,2013.0,ALL
100132464,FAM99B,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100132501,LINC01415,,,,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100132529,TAT-AS1,,1.0,0.115,,,,C0268487,Tyrosine Transaminase Deficiency Disease,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,1992.0,2017.0,ALL
100132594,PGAM1P5,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
100132677,BSN-DT,,1.0,0.077,,,,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100132683,PDCL3P3,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100132735,FILNC1,,0.861,0.115,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100132774,KDM4A-AS1,,0.931,0.038,,,,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2019.0,ALL
100132891,MSC-AS1,,0.839,0.231,0.00069491,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100133204,C9orf147,,1.0,0.077,0.64518,,,C4551683,Adrenal Gland Pheochromocytoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100133205,LINC00240,,0.821,0.231,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
100133234,SBF1P1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100133308,RSU1P2,,,,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100133311,HOXA-AS3,,0.821,0.192,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
100133545,MRPL23-AS1,,,,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
100133941,CD24,P25063,0.472,0.769,,,,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.39,1.0,,2008.0,2017.0,ALL
100133957,UXT-AS1,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100133991,MAP3K14-AS1,,0.931,0.154,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100134229,KDM7A-DT,,0.861,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
100134444,KCNJ18,B7U540,0.722,0.346,,,,C2750473,"THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2",,,disease,Finding,0.7,1.0,limited,2010.0,2016.0,ALL
100134934,TEN1,Q86WV5,0.931,0.038,0.015092,,,C1406945,Thymus enlargement,,,disease,Disease or Syndrome,0.02,1.0,,1996.0,2000.0,ALL
100137047,JMJD7,P0C870,0.931,0.077,8.1582e-05,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100137049,PLA2G4B,P0C869,0.89,0.154,1.0582e-40,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2005.0,2005.0,ALL
100141515,C17orf99,Q6UX52,,,0.13177,,,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100144603,CHKB-DT,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
100144748,KLLN,B2CW77,0.578,0.654,0.0050546,,,C3554517,COWDEN SYNDROME 4,,,disease,Disease or Syndrome,0.5,,limited,,,ALL
100147773,TMCO1-AS1,,1.0,0.038,,,,C0017612,"Glaucoma, Open-Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100151683,RNU4ATAC,,0.556,0.808,,,,C1846059,Roifman syndrome,C16;C11;C05;C20;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Musculoskeletal Diseases;    Immune System Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.74,1.0,,2015.0,2018.0,ALL
100151684,RNU6ATAC,,1.0,0.038,,,,C0026847,Spinal Muscular Atrophy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
100169750,PRINS,,0.792,0.423,,,,C0001624,Adrenal Gland Neoplasms,C04;C19,   Neoplasms;    Endocrine System Diseases,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100169890,PEG3-AS1,,1.0,0.077,,,,C0686619,Secondary malignant neoplasm of lymph node,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100169989,DBIL5P2,,1.0,0.077,,,,C0013364,"Dysautonomia, Familial",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0,,2005.0,2005.0,ALL
100170222,SNAR-I,,0.805,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.31,1.0,,2018.0,2018.0,ALL
100187716,MIR1224,,0.666,0.385,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2011.0,2019.0,ALL
100187828,HBD,,0.78,0.269,,,,C0005283,beta Thalassemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.02,1.0,,2007.0,2019.0,ALL
100187907,TRAP,,0.579,0.731,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,0.857,,2001.0,2018.0,ALL
100188011,DIP,,0.678,0.462,,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.02,1.0,,1999.0,2015.0,ALL
100188278,FECD2,,0.821,0.154,,,,C1562113,Fleck corneal dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.03,1.0,,2006.0,2009.0,ALL
100188340,AOS,,0.792,0.462,,,,C0265268,Adams Oliver syndrome,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.02,1.0,,2014.0,2017.0,ALL
100188397,HLP,,0.691,0.346,,,,C0745103,Hyperlipoproteinemia Type IIa,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.03,1.0,,2000.0,2017.0,ALL
100188754,AD14,,0.821,0.192,,,,C0032285,Pneumonia,C01;C08,   Infections;    Respiratory Tract Diseases,disease,Disease or Syndrome,0.02,1.0,,2009.0,2009.0,ALL
100188771,AGA2,,1.0,0.115,,,,C0029434,Osteogenesis Imperfecta,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.02,1.0,,2008.0,2012.0,ALL
100188776,HEY,,0.805,0.231,,,,C4721610,"Carcinoma, Ovarian Epithelial",C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.06,1.0,,2002.0,2019.0,ALL
100188784,AFA1,,0.743,0.385,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,1994.0,2005.0,ALL
100188795,AD11,,0.722,0.462,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,1.0,,2002.0,2011.0,ALL
100188809,HPC7,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2000.0,2000.0,ALL
100188812,RLS3,,1.0,0.077,,,,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.03,0.667,,2007.0,2019.0,ALL
100188813,RLS4,,1.0,0.077,,,,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2010.0,2013.0,ALL
100188821,OS4,,,,,,,C1261473,Sarcoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,1997.0,1997.0,ALL
100188830,AD12,,0.711,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.923,,1982.0,2009.0,ALL
100188832,AUTS1,,0.89,0.115,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2001.0,2014.0,ALL
100188839,RLS5,,0.931,0.077,,,,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
100188844,MAFD6,,0.78,0.115,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,1995.0,2019.0,ALL
100188846,CELIAC6,,,,,,,C0917801,Sleeplessness,C10;F03,   Nervous System Diseases;    Mental Disorders,phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
100188847,MIR1225,,0.674,0.423,,,,C0085548,Autosomal Recessive Polycystic Kidney Disease,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
100188856,DEL22Q11.2,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2012.0,2012.0,ALL
100188863,ENDO1,,0.89,0.269,,,,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100188864,IH,,0.751,0.385,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2003.0,2019.0,ALL
100188881,MFT2,,0.601,0.692,,,,C0042029,Urinary tract infection,C13;C01;C12,   Female Urogenital Diseases and Pregnancy Complications;    Infections;    Male Urogenital Diseases,group,Disease or Syndrome,0.07,1.0,,2005.0,2020.0,ALL
100188949,LINC00426,,0.861,0.077,,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
100188953,LINC00092,,0.89,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100188954,DNMBP-AS1,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
100189220,TRG-GCC5-1,,1.0,0.038,,,,C0023267,Fibroid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100189363,TRV-CAC2-1,,1.0,0.038,,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100190785,IS4,,1.0,0.115,,,,C0023486,Prolymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
100190788,IBD20,,0.89,0.154,,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100190790,ADHD5,,0.931,0.038,,,,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2006.0,2018.0,ALL
100190791,ADHD6,,1.0,0.038,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
100190926,IBD19,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100190929,IBD15,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
100190931,IBD18,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
100190938,RAMP2-AS1,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100190939,TPT1-AS1,,0.821,0.115,,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
100190940,LINC02418,,0.89,0.115,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100190982,POROK5,,1.0,0.077,,,,C0265970,"Porokeratosis, Disseminated Superficial Actinic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
100190985,IS5,,1.0,0.077,,,,C0004610,Bacteremia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
100192312,IBD21,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
100192378,ZFHX4-AS1,,0.792,0.231,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100196911,POROK6,,1.0,0.077,,,,C0265970,"Porokeratosis, Disseminated Superficial Actinic",C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
100216001,MANCR,,0.769,0.231,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
100216344,DYT17,,1.0,0.038,,,,C2676281,"DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE (disorder)",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
100216546,LINC01004,,1.0,0.038,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
100217387,AGA3,,,,,,,C0015934,Fetal Growth Retardation,C23;C16;C13,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications",phenotype,Disease or Syndrome,0.01,0.0,,2019.0,2019.0,ALL
100233159,WAGRO,,1.0,0.077,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
100233209,PCED1B-AS1,,0.89,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100233226,MCI2,,0.89,0.077,,,,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
100240732,IBD22,,0.931,0.038,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
100240733,IBD23,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2006.0,2006.0,ALL
100240747,DEL18P,,1.0,0.077,,,,C4551854,HYPOPLASTIC LEFT HEART SYNDROME 1,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
100270639,IHPS5,,0.931,0.038,,,,C0700639,"Pyloric Stenosis, Hypertrophic",C06,   Digestive System Diseases,disease,Congenital Abnormality,0.01,1.0,,2017.0,2017.0,ALL
100270641,MYP16,,0.931,0.038,,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
100270679,LINC01432,,0.821,0.077,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100270680,CASC11,,0.641,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.14,1.0,,2014.0,2019.0,ALL
100270798,IBD24,,0.931,0.038,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
100270800,SHFLD3,,1.0,0.077,,,,C4551989,Tibial aplasia and ectrodactyly syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100270847,RPL6P9,,,,,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2016.0,2016.0,ALL
100270916,RPSAP35,,1.0,0.115,,,,C0014743,Erythema Nodosum,C17;C20;C25,   Skin and Connective Tissue Diseases;    Immune System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
100270937,RPL17P11,,,,,,,C0344395,Bilirubin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
100271007,RPL35P6,,,,,,,C0337438,Glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100271078,RPS19P6,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100271303,RPL30P11,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100271485,RPL31P58,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
100271525,RPL39P31,,,,,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
100271552,RPS12P27,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
100271700,NONOP2,,0.861,0.231,,,,C0003872,"Arthritis, Psoriatic",C17;C05,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2015.0,ALL
100271715,ARHGEF33,A8MVX0,1.0,0.038,7.7621e-06,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100271718,AD16,,0.861,0.192,,,,C0011263,Multi-infarct dementia,C23;C10;F03;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,1997.0,1997.0,ALL
100271722,LINC00899,,0.792,0.077,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
100271837,USH1H,,1.0,0.192,,,,C1568247,"Usher Syndrome, Type I",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
100271838,IBD26,,1.0,0.038,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100271846,ERVV-2,B6SEH9,1.0,0.077,,,,C0476089,Endometrial Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
100271849,MEF2B,Q02080,0.67,0.308,0.00092914,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
100271873,AIRN,,1.0,0.115,,,,C1292753,Primary Effusion Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100271922,BFIS4,,0.861,0.077,,,,C1843140,"SEIZURES, BENIGN FAMILIAL INFANTILE, 3",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
100271924,DFNA59,,1.0,0.115,,,,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
100272147,CMC4,P56277,0.931,0.192,0.1581,,,C0023492,"Leukemia, T-Cell",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,1994.0,1994.0,ALL
100272228,LINC00894,,,,,,,C0018935,Hematocrit procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100286844,BCDIN3D-AS1,,1.0,0.077,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
100286971,UBDP1,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
100287082,GACAT2,,0.821,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2014.0,2016.0,ALL
100287084,ZNF72P,,1.0,0.231,,,,C1840333,Barakat syndrome,C23;C13;C12;C10;C19;C09,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Nervous System Diseases;    Endocrine System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
100287087,H3P36,,0.792,0.308,,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.02,1.0,,2012.0,2013.0,ALL
100287098,TONSL-AS1,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100287171,WASHC1,A8K0Z3,0.78,0.308,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,2014.0,2017.0,ALL
100287225,LINC01630,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
100287226,ZNF729,A6NN14,1.0,0.038,0.39585,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
100287272,USP8P1,,0.805,0.269,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
100287284,MANSC4,A6NHS7,,,4.3796e-05,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100287314,LINC00941,,0.861,0.077,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100287362,PRSS46P,E5RG02,0.861,0.077,3.6604e-05,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.2,1.0,,2018.0,2018.0,ALL
100287366,OSTM1-AS1,,1.0,0.038,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
100287559,ADPGK-AS1,,0.78,0.231,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
100287569,LINC00173,Q6ZV60,0.89,0.115,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100287616,LOXL1-AS1,,0.678,0.5,,,,C0206368,Exfoliation Syndrome,C11,   Eye Diseases,disease,Disease or Syndrome,0.12,1.0,,2007.0,2018.0,ALL
100287632,SELENOKP3,,,,,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
100287722,AP4B1-AS1,,0.805,0.231,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2019.0,ALL
100287765,LINC00630,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100287814,LINC00582,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100287879,LINC00994,,0.839,0.154,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
100287898,TTC34,A8MYJ7,0.89,0.192,6.4816e-11,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100287932,TIMM23,O14925,0.78,0.462,0.0049452,,,C0026846,Muscular Atrophy,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Pathologic Function,0.2,1.0,,2011.0,2011.0,ALL
100288072,SDR42E2,A6NKP2,1.0,0.077,1.3652e-08,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
100288077,WTAPP1,,0.89,0.154,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100288152,SLC9A3-AS1,,0.861,0.192,,,,C0267663,"Congenital secretory diarrhea, sodium type (disorder)",C23;C16;C18,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Congenital Abnormality,0.1,,,,,ALL
100288170,UBE2V1P15,,1.0,0.038,,,,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100288181,LNCOC1,,0.861,0.154,,,,C0013295,Duodenal Ulcer,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
100288332,NPIPA5,E9PKD4,0.931,0.192,0.10805,,,C0033847,Pseudoxanthoma Elasticum,C16;C17;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
100288346,NCAM1-AS1,,1.0,0.038,,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
100288380,ULK4P2,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100288413,ERVMER34-1,Q9H9K5,1.0,0.038,,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
100288428,LMCD1-AS1,,0.78,0.346,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
100288687,DUX4,Q9UBX2,0.604,0.5,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.6,0.989,,2006.0,2019.0,ALL
100288690,FAM21FP,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100288695,LIMS4,P0CW19;P0CW20,0.839,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
100288711,DUX4L9,Q6RFH8,0.861,0.154,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0,,2009.0,2018.0,ALL
100288742,H2BC2P,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
100288797,TMEM239,Q8WW34,,,0.00081616,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
100288805,HYDIN2,,,,,,,C0376634,Craniofacial Abnormalities,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",group,Congenital Abnormality,0.3,1.0,,2008.0,2008.0,ALL
100288966,LOC100288966,Q86YR6,0.751,0.269,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2006.0,2019.0,ALL
100289019,SLC25A25-AS1,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100289061,ADAMTSL4-AS2,,0.89,0.154,,,,C0013581,Ectopia Lentis,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Congenital Abnormality,0.1,1.0,,2010.0,2017.0,ALL
100289087,TSPY10,P0CV98;P0CW01;Q01534,0.659,0.385,0.28371,,,C0206661,Gonadoblastoma,C16;C04;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Neoplastic Process,0.1,1.0,,1999.0,2019.0,ALL
100289141,H3P20,,0.89,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2008.0,2008.0,ALL
100289178,GNG12-AS1,,0.861,0.231,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100289187,TMEM225B,P0DP42,,,,,,C0441683,Hormone measurement,,,group,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
100289211,LINC00624,,1.0,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100289237,CEP164P1,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100289255,TMEM238L,,0.691,0.308,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.41,1.0,,2018.0,2019.0,ALL
100289274,DNAJC3-DT,,0.89,0.038,,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100289373,UBAC2-AS1,,0.931,0.115,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100289419,CTF2P,,,,,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2013.0,ALL
100289462,DEFB4B,O15263,0.51,0.769,0.067977,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.08,0.875,,2008.0,2017.0,ALL
100289475,LDHBP1,,1.0,0.077,,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100289545,H3C9P,,0.656,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,1995.0,2002.0,ALL
100289678,ZNF783,Q6ZMS7,0.931,0.077,2.1732e-06,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100289683,ERVH-3,,1.0,0.077,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.03,1.0,,2012.0,2018.0,ALL
100293090,MTND4P12,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100293516,ZNF587B,E7ETH6,0.89,0.154,3.8024e-13,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
100293534,C4B_2,P0C0L4;P0C0L5,0.67,0.731,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.07,0.571,,1984.0,1999.0,ALL
100294362,RNF213-AS1,,0.89,0.077,,,,C0026654,Moyamoya Disease,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100294715,BOP,,0.722,0.385,,,,C0017574,Gingivitis,C01;C07,   Infections;    Stomatognathic Diseases,disease,Disease or Syndrome,0.03,1.0,,1998.0,2019.0,ALL
100294716,MYP15,,0.931,0.038,,,,C0271183,Severe myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0,,2012.0,2019.0,ALL
100301525,DUH2,,0.89,0.115,,,,C1840392,"HYPERPIGMENTATION, FAMILIAL PROGRESSIVE",C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
100301527,SYNSTH,,1.0,0.038,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
100302059,IBD27,,0.89,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100302111,MIR1184-1,,0.861,0.192,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100302112,MIR1284,,0.705,0.308,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
100302113,MIR1200,,0.89,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
100302114,MIR513C,,0.861,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100302115,MIR1468,,0.751,0.154,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100302116,MIR1265,,0.821,0.154,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302117,MIR320B1,,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100302118,MIR1286,,0.821,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302121,MIR1276,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100302122,MIR1183,,0.821,0.231,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302123,MIR1275,,0.67,0.423,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
100302124,MIR1288,,0.751,0.115,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
100302126,MIR1471,,0.89,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100302127,MIR1470,,0.89,0.192,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100302129,MIR1915,,0.751,0.423,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
100302131,MIR302F,,1.0,0.115,,,,C0266642,Situs ambiguus,C16;C15;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases",disease,Congenital Abnormality,0.01,1.0,,2016.0,2016.0,ALL
100302132,MIR1182,,0.736,0.231,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2015.0,2019.0,ALL
100302133,MIR1287,,0.769,0.192,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
100302135,MIR320C1,,,,,,,C0015672,Fatigue,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2018.0,2018.0,ALL
100302136,MIR1252,,0.931,0.115,,,,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302137,MIR1914,,0.839,0.115,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
100302138,MIR1292,,0.931,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100302139,MIR1537,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
100302142,MIR1246,,0.592,0.808,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.34,1.0,,2012.0,2019.0,ALL
100302143,MIR1248,,0.861,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100302145,MIR1247,,0.604,0.5,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100302149,MIR1249,,0.743,0.269,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100302150,MIR1296,,0.736,0.231,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100302153,MIR1298,,0.769,0.346,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
100302155,MIR1256,,0.769,0.231,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2012.0,2019.0,ALL
100302156,MIR1229,,0.792,0.231,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
100302157,MIR1185-1,,1.0,0.038,,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100302158,MIR1231,,0.736,0.308,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2019.0,2020.0,ALL
100302160,MIR1233-1,,0.839,0.192,,,,C0039685,Tetralogy of Fallot,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.02,0.5,,2017.0,2018.0,ALL
100302161,MIR1205,,0.769,0.192,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2019.0,2019.0,ALL
100302164,MIR2113,,0.931,0.077,,,,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
100302166,MIR1322,,1.0,0.077,,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
100302167,MIR1299,,0.76,0.346,,,,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2020.0,ALL
100302168,MIR1257,,0.931,0.077,,,,C0205824,"Liposarcoma, Dedifferentiated",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
100302170,MIR1206,,0.839,0.154,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302171,MIR1321,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
100302172,MIR1258,,0.695,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2011.0,2018.0,ALL
100302174,MIR1307,,0.659,0.577,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100302175,MIR1207,,0.686,0.538,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2015.0,2019.0,ALL
100302177,MIR1269A,,0.751,0.192,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
100302178,MIR1295A,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100302179,MIR1270,,0.711,0.346,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
100302181,MIR1294,,0.716,0.308,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2018.0,2019.0,ALL
100302182,MIR1279,,0.931,0.115,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100302183,MIR1825,,0.821,0.231,,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2015.0,2018.0,ALL
100302185,MIR1204,,0.769,0.423,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2008.0,2019.0,ALL
100302187,MIR1297,,0.682,0.5,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2012.0,2019.0,ALL
100302188,MIR1243,,0.931,0.115,,,,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100302190,MIR1976,,0.89,0.154,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100302196,MIR1234,,0.861,0.192,,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100302197,MIR1306,,0.736,0.308,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100302201,MIR1228,,0.769,0.192,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100302202,MIR1266,,0.705,0.423,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2015.0,2019.0,ALL
100302203,MIR1271,,0.659,0.5,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.34,1.0,,2017.0,2019.0,ALL
100302208,MIR1253,,0.839,0.154,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
100302209,MIR1185-2,,1.0,0.115,,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100302210,MIR1909,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
100302211,MIR1203,,0.89,0.231,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302212,MIR1324,,0.931,0.115,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100302213,MIR1181,,0.792,0.269,,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2017.0,ALL
100302214,MIR1277,,0.931,0.115,,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100302217,MIR1827,,0.805,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2016.0,2020.0,ALL
100302218,MIR1285-1,,0.839,0.077,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100302219,MIR1245A,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
100302220,MIR1293,,0.861,0.269,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100302221,MIR1291,,0.722,0.308,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100302222,MIR1911,,1.0,0.077,,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302224,MIR2110,,0.89,0.077,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
100302225,MIR2053,,0.861,0.154,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302226,MIR1238,,0.78,0.115,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100302228,MIR1261,,0.931,0.115,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100302229,MIR1250,,1.0,0.038,,,,C0206624,Hepatoblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100302232,MIR1226,,0.792,0.269,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100302233,MIR1268A,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100302234,MIR664A,,0.644,0.538,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2017.0,2019.0,ALL
100302235,MIR1179,,0.7,0.231,,,,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2018.0,ALL
100302236,MIR1260A,,0.716,0.462,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100302237,MIR1281,,0.805,0.192,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302240,MIR1304,,0.711,0.423,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100302242,MIR1236,,0.686,0.423,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.06,1.0,,2014.0,2019.0,ALL
100302243,MIR1972-1,,0.839,0.115,,,,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302246,MIR1301,,0.711,0.269,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100302250,MIR1197,,0.861,0.115,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.3,1.0,,2017.0,2017.0,ALL
100302255,MIR1323,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2013.0,2019.0,ALL
100302256,MIR1180,,0.716,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2016.0,2018.0,ALL
100302258,MIR1469,,0.821,0.231,,,,C0007621,Neoplastic Cell Transformation,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.3,1.0,,2012.0,2012.0,ALL
100302259,MIR1202,,0.729,0.385,,,,C0041696,Unipolar Depression,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2014.0,2017.0,ALL
100302260,MIR2052,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302261,MIR1910,,0.931,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100302263,MIR1908,,0.67,0.577,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100302267,MIR2054,,1.0,0.038,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
100302270,MIR1305,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2019.0,2019.0,ALL
100302274,MIR1178,,0.861,0.154,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100302275,MIR548L,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100302276,MIR1290,,0.61,0.615,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100302279,MIR1262,,0.861,0.115,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100302280,MIR1237,,0.931,0.038,,,,C0008487,Chordoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100302281,MIR1208,,1.0,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302283,MIR1227,,1.0,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
100302284,MIR1303,,0.729,0.308,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100302285,MIR1244-1,,0.76,0.231,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2017.0,ALL
100302286,MIR1267,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100302289,MIR1251,,1.0,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302290,MIR1973,,1.0,0.077,,,,C0013080,Down Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
100302512,RLS6,,1.0,0.077,,,,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,0.5,,2009.0,2010.0,ALL
100302513,DFNB71,,,,,,,C1384666,hearing impairment,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",phenotype,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
100302522,PTCSC1,,,,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100302640,LINC00882,,0.861,0.192,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
100302650,BABAM2-AS1,,0.839,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100302666,CSPG4P13,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100302690,DLG2-AS1,,0.861,0.077,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2003.0,2003.0,ALL
100302691,LINC00184,,0.931,0.077,,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100302692,FTX,,0.743,0.346,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2017.0,2018.0,ALL
100302736,TMED7-TICAM2,Q86XR7;Q9Y3B3,0.438,0.769,0.0025936,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.925,,1996.0,2019.0,ALL
100302739,PCNA-AS1,,0.792,0.154,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2002.0,2014.0,ALL
100302740,FAS-AS1,,0.695,0.538,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
100302746,NCRUPAR,,0.839,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2014.0,2014.0,ALL
100303453,TSNAX-DISC1,,0.729,0.154,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.32,1.0,,2010.0,2012.0,ALL
100303491,ZEB2-AS1,,0.674,0.5,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.08,1.0,,2014.0,2019.0,ALL
100303716,PBC2,,0.931,0.192,,,,C0162309,Adrenoleukodystrophy,C16;C18;C10;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
100303728,SLC25A5-AS1,,0.89,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100303755,PET117,Q6UWS5,0.769,0.154,0.032067,,,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.31,1.0,,2017.0,2017.0,ALL
100306951,PITPNA-AS1,,1.0,0.077,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100307118,BCC1,,0.89,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
100307119,BCC2,,0.861,0.038,,,,C4721806,"Carcinoma, Basal Cell",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2000.0,2001.0,ALL
100307121,BCC4,,1.0,0.038,,,,C3811653,Experimental Organism Basal Cell Carcinoma,C04,   Neoplasms,phenotype,Neoplastic Process,0.01,1.0,,1999.0,1999.0,ALL
100309464,OTX2-AS1,,0.931,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100310785,ALL1,,0.636,0.269,,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,1993.0,2018.0,ALL
100310786,ALL2,,0.861,0.231,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100310846,ANKRD61,A6NGH8,,,0.0039262,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
100312787,VN1R31P,,,,,,,C0037274,Dermatologic disorders,C17,   Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100313770,MIR548K,,1.0,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100313777,MIR670,,1.0,0.077,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100313778,MIR759,,1.0,0.077,,,,C2363973,Chronic thromboembolic pulmonary hypertension,C08;C14,   Respiratory Tract Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
100313780,MIR2278,,1.0,0.077,,,,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100313781,MIR718,,0.751,0.192,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0,,2017.0,2020.0,ALL
100313822,MIR513B,,1.0,0.115,,,,C0238448,Testicular embryonal carcinoma,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100313824,MIR663B,,0.716,0.462,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2016.0,2018.0,ALL
100313837,MIR762,,0.769,0.423,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100313838,MIR764,,0.792,0.154,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2012.0,2012.0,ALL
100313842,MIR2276,,0.89,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100313843,MIR711,,0.751,0.269,,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,2013.0,2018.0,ALL
100313884,MIR548H4,,0.931,0.115,,,,C0151546,Oral Cavity Carcinoma,C06;C04;C07,   Digestive System Diseases;    Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100313886,MIR2116,,0.931,0.154,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100313892,MIR761,,0.682,0.308,,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2013.0,2013.0,ALL
100313914,MIR548J,,0.839,0.192,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100313923,MIR449C,,0.729,0.308,,,,C0015695,Fatty Liver,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
100316868,HOTTIP,,0.575,0.654,,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
100329167,AAA1,,0.695,0.615,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.02,1.0,,2019.0,2019.0,ALL
100329170,SCZD13,,0.931,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0,,1996.0,2008.0,ALL
100337589,FMO7P,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100359393,SCA30,,0.931,0.077,,,,C2936793,Spinocerebellar ataxia 30,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
100359402,SPG41,,1.0,,,,,C3888208,"SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT",,,disease,Disease or Syndrome,0.3,1.0,,2008.0,2008.0,ALL
100359403,PARK16,,0.861,0.077,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.4,0.963,,2009.0,2019.0,ALL
100359407,MYP14,,1.0,0.038,,,,C0027092,Myopia,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
100379174,MACROD2-AS1,,1.0,0.038,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2012.0,2015.0,ALL
100379198,ECT,,0.626,0.423,,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,0.8,,1979.0,2019.0,ALL
100379249,BOK-AS1,,0.931,0.077,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
100379251,NPPA-AS1,,0.861,0.077,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100379323,ERVW-2,,1.0,0.077,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
100379571,BACE1-AS,,0.76,0.385,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2005.0,2019.0,ALL
100380873,FECD3,,0.769,0.385,,,,C1562113,Fleck corneal dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.04,1.0,,2006.0,2017.0,ALL
100380875,FECD7,,1.0,0.077,,,,C0016781,Fuchs Endothelial Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
100381270,ZBED6,P86452,0.839,0.231,0.00039942,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100419006,NF1P1,,0.805,0.385,,,,C0013336,Dwarfism,C16;C05;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.01,1.0,,2002.0,2002.0,ALL
100419743,DBET,,0.931,0.154,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2012.0,2012.0,ALL
100419873,ZNF519P1,,,,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100419971,PRELID1P2,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
100419978,HMGB1P46,,,,,,,C0027796,Neuralgia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2015.0,2015.0,ALL
100420047,RAD51AP1P1,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2015.0,2015.0,ALL
100420159,RRM2P3,,1.0,0.154,,,,C0266526,Norrie disease,C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.01,1.0,,1995.0,1995.0,ALL
100420358,BUD13P1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100420410,H3P41,,0.705,0.308,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0,,1999.0,2001.0,ALL
100420591,OSBPL9P3,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
100421131,RCC2P6,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100421133,PGAM5P1,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
100421397,HNRNPA1P68,,1.0,0.077,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100421432,HNRNPA1P44,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
100421545,EIF4HP2,,,,,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
100421577,FAM21EP,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100421589,LRRC37A7P,,,,,,,C0202231,Thyroxine measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2015.0,2015.0,ALL
100421805,ENPP7P10,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100421816,ENPP7P4,,,,,,,C0523677,Glycine measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100421859,ENPP7P7,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
100422227,LOC100422227,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100422238,CYP4F23P,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
100422264,CYP51A1P3,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100422273,KCTD9P1,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
100422339,SDR42E1P5,,,,,,,C1527304,Allergic Reaction,C20,   Immune System Diseases,phenotype,Pathologic Function,0.1,1.0,,2013.0,2013.0,ALL
100422533,FCF1P1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100422536,FCF1P7,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100422737,LINC02532,,0.89,0.077,,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100422821,MIR1273C,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
100422823,MIR4300,,0.931,0.192,,,,C0039585,Androgen-Insensitivity Syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100422826,MIR4274,,0.89,0.038,,,,C0020258,"Hydrocephalus, Normal Pressure",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100422829,MIR4319,,0.743,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2019.0,2020.0,ALL
100422830,MIR3171,,0.931,0.115,,,,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
100422832,MIR3191,,0.931,0.077,,,,C0004134,Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2016.0,2016.0,ALL
100422833,MIR3188,,0.769,0.346,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100422837,MIR1193,,0.78,0.192,,,,C0027659,"Neoplasms, Experimental",C04,   Neoplasms,phenotype,Neoplastic Process; Experimental Model of Disease,0.3,1.0,,2017.0,2017.0,ALL
100422840,MIR4317,,0.861,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100422841,MIR3174,,0.89,0.077,,,,C0007113,Rectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422842,MIR3074,,0.89,0.231,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100422843,MIR4293,,0.839,0.231,,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2015.0,2017.0,ALL
100422846,MIR3164,,0.931,0.077,,,,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422847,MIR514B,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100422851,MIR4316,,0.839,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100422853,MIR3182,,0.839,0.115,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422855,MIR4301,,0.805,0.192,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100422861,MIR4306,,0.769,0.269,,,,C0027051,Myocardial Infarction,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100422867,MIR378C,,0.821,0.154,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100422868,MIR4270,,0.769,0.269,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422869,MIR3152,,1.0,0.115,,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100422871,MIR3117,,0.839,0.192,,,,C0023449,Acute lymphocytic leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100422874,MIR4279,,0.89,0.231,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100422876,MIR3148,,0.89,0.192,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
100422880,MIR3162,,0.805,0.308,,,,C0002965,"Angina, Unstable",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100422882,MIR3120,,0.89,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
100422889,MIR3194,,0.931,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100422893,MIR3154,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422894,MIR4260,,0.89,0.154,,,,C0079683,Herlitz Disease,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
100422896,MIR3140,,1.0,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
100422903,MIR4288,,0.821,0.192,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422908,MIR3129,,0.861,0.154,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100422909,MIR4295,,0.751,0.346,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
100422910,MIR2861,,0.76,0.269,,,,C3150680,BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15,,,phenotype,Finding,0.4,,,,,ALL
100422912,MIR3200,,0.805,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100422913,MIR320E,,0.821,0.269,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100422915,MIR3065,,0.861,0.231,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100422916,MIR3201,,0.931,0.077,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100422921,MIR3149,,0.839,0.192,,,,C0002965,"Angina, Unstable",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100422922,MIR1972-2,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100422926,MIR3137,,,,,,,C0206754,Neuroendocrine Tumors,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422928,MIR3127,,0.839,0.115,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0,,2014.0,2018.0,ALL
100422929,MIR4261,,0.89,0.077,,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422932,MIR4328,,1.0,0.038,,,,C0086543,Cataract,C11,   Eye Diseases,disease,Acquired Abnormality,0.01,1.0,,2019.0,2019.0,ALL
100422934,MIR3143,,1.0,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100422938,MIR3142,,1.0,0.077,,,,C0023473,"Myeloid Leukemia, Chronic",C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100422939,MIR3147,,0.89,0.077,,,,C0280856,Squamous cell carcinoma of vulva,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100422942,MIR3133,,1.0,0.115,,,,C0279702,Conventional (Clear Cell) Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422943,MIR3189,,0.792,0.077,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
100422945,MIR4326,,0.89,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,0.0,,2018.0,2018.0,ALL
100422948,MIR4284,,0.805,0.154,,,,C0003851,Arteriosclerosis Obliterans,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100422950,MIR3141,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100422951,MIR3144,,1.0,0.077,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100422952,MIR4271,,0.89,0.038,,,,C0010054,Coronary Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100422953,MIR3165,,0.931,0.077,,,,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100422955,MIR4273,,,,,,,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100422957,MIR3131,,1.0,0.077,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100422959,MIR4268,,0.89,0.115,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422964,MIR3150A,,0.931,0.154,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100422967,MIR3146,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100422969,MIR2909,,0.743,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2017.0,2017.0,ALL
100422971,MIR4312,,1.0,0.115,,,,C1832661,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,C16;C11;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100422974,MIR3178,,0.861,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2015.0,2018.0,ALL
100422979,MIR4324,,0.839,0.154,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.31,1.0,,2018.0,2019.0,ALL
100422981,MIR3173,,0.931,0.231,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100422982,MIR4286,,0.839,0.154,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
100422984,MIR4308,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100422986,MIR3125,,1.0,0.115,,,,C0398650,Immune thrombocytopenic purpura,C23;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Immune System Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100422991,MIR1260B,,0.711,0.423,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100422992,MIR3151,,0.805,0.192,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2014.0,2015.0,ALL
100422995,MIR3175,,0.861,0.077,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100422996,MIR4262,,0.722,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2017.0,2020.0,ALL
100422997,MIR4257,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100422998,MIR3199-2,,1.0,0.115,,,,C1306837,Papillary Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100423000,MIR3161,,1.0,0.038,,,,C0206368,Exfoliation Syndrome,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100423003,MIR3184,,0.839,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100423005,MIR4282,,0.861,0.115,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
100423011,MIR3138,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100423014,MIR3196,,0.78,0.385,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100423020,MIR4258,,0.931,0.077,,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
100423023,MIR3197,,0.89,0.231,,,,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
100423026,MIR4299,,0.821,0.231,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
100423028,MIR4254,,1.0,0.154,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100423029,MIR3163,,0.839,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2020.0,2020.0,ALL
100423030,MIR3126,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100423031,MIR4321,,1.0,0.154,,,,C1849930,Persistent Mullerian duct syndrome,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Anatomical Abnormality,0.1,,,,,ALL
100423032,MIR3121,,1.0,0.038,,,,C0242383,Age related macular degeneration,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
100423036,MIR2355,,0.931,0.077,,,,C0158266,Intervertebral Disc Degeneration,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100423038,MIR466,,0.722,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2017.0,2019.0,ALL
100423043,MIR4269,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100423062,IGLL5,B9A064,0.769,0.462,5.1865e-10,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.03,1.0,,2005.0,2009.0,ALL
100431177,BHLHB9P1,,1.0,0.115,,,,C0018213,Graves Disease,C11;C20;C19,   Eye Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100462812,FGFR3P1,,,,,,,C1527304,Allergic Reaction,C20,   Immune System Diseases,phenotype,Pathologic Function,0.1,1.0,,2013.0,2013.0,ALL
100463486,MTRNR2L8,P0CJ75,1.0,,,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100463488,MTRNR2L10,P0CJ77,1.0,0.038,,,,C0034494,Rabies (disorder),C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2009.0,2009.0,ALL
100463498,MTRNR2L12,P0DMP1,0.821,0.231,,,,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.04,1.0,,2014.0,2018.0,ALL
100463500,MTRNR2L13,S4R3P1,1.0,0.038,,,,C1168401,Squamous cell carcinoma of the head and neck,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
100498859,LINC00881,,1.0,0.038,,,,C0429087,Electrocardiogram: P-R interval,,,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
100499177,THAP9-AS1,,1.0,0.115,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100499183,BAALC-AS1,,0.76,0.115,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
100499227,USP2-AS1,,,,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
100499260,AMMEC,,1.0,0.385,,,,C1846242,"Alport Syndrome, Mental Retardation, Midface Hypoplasia, and Elliptocytosis",C23;C16;C13;C17;C05;C12;C10;F03;C15;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Male Urogenital Diseases;    Nervous System Diseases;    Mental Disorders;    Hemic and Lymphatic Diseases;    Behavior and Behavior Mechanisms",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100499405,LINC00987,,1.0,0.038,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100499467,LINC00673,,0.659,0.462,,,,C0346647,Malignant neoplasm of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.34,1.0,,2016.0,2019.0,ALL
100499483,CCDC180,Q9P1Z9,0.861,0.231,1.531e-40,,,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.02,1.0,,2009.0,2012.0,ALL
100500801,MIR3659,,,,,,,C0242339,Dyslipidemias,C18,   Nutritional and Metabolic Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100500807,MIR374C,,0.805,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100500808,MIR3917,,0.89,0.077,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100500809,MIR23C,,0.861,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
100500810,MIR3620,,1.0,0.038,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100500811,MIR3621,,0.931,0.115,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100500812,MIR3677,,0.89,0.115,,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100500813,MIR3646,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2016.0,ALL
100500819,MIR3609,,0.89,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100500824,MIR3650,,1.0,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100500827,MIR3614,,0.931,0.077,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100500828,MIR3619,,0.769,0.308,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2019.0,ALL
100500831,MIR3912,,0.931,0.115,,,,C0001857,AIDS related complex,C01;C20,   Infections;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100500832,MIR3658,,0.89,0.115,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100500835,MIR3907,,1.0,0.115,,,,C0085413,"Polycystic Kidney, Autosomal Dominant",C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100500837,MIR3606,,1.0,0.038,,,,C0036421,Systemic Scleroderma,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100500839,MIR3686,,0.931,0.115,,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100500841,MIR3678,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100500842,MIR3652,,1.0,0.038,,,,C0266929,Chronic Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100500843,MIR3922,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100500844,MIR3664,,0.805,0.154,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100500845,MIR642B,,0.805,0.308,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100500847,MIR3615,,0.821,0.115,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100500849,MIR3916,,1.0,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100500851,MIR3918,,1.0,0.038,,,,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100500855,MIR3713,,0.89,0.192,,,,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100500857,MIR3939,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100500858,MIR3622A,,0.839,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
100500861,MIR3665,,1.0,0.077,,,,C0812413,Malignant Pleural Mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100500862,MIR3648-1,,0.821,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100500866,MIR3941,,0.839,0.154,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100500871,MIR3622B,,0.805,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
100500873,MIR3934,,0.89,0.077,,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100500877,MIR3923,,0.89,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
100500878,MIR3679,,0.839,0.115,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100500880,MIR3662,,0.792,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100500881,MIR3688-1,,1.0,0.038,,,,C0149630,Bicuspid aortic valve,C14,   Cardiovascular Diseases,disease,Congenital Abnormality,0.02,1.0,,2017.0,2020.0,ALL
100500882,MIR3667,,0.861,0.154,,,,C0023890,Liver Cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100500888,MIR3940,,0.861,0.154,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2013.0,2017.0,ALL
100500893,MIR3663,,1.0,0.077,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100500896,MIR3666,,0.7,0.308,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
100500897,MIR3617,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100500900,MIR3691,,1.0,0.077,,,,C0018818,Ventricular Septal Defects,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",group,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
100500901,MIR3928,,0.861,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
100500904,MIR3942,,0.89,0.192,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100500907,MIR3150B,,0.89,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100500908,MIR3613,,0.78,0.192,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
100500909,MIR3908,,0.78,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100500917,MIR3680-1,,0.89,0.308,,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100500918,MIR3651,,0.89,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
100505385,IQCJ-SCHIP1,B3KU38,0.821,0.231,0.027313,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
100505474,LINC01539,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2019.0,ALL
100505475,SYNE1-AS1,,1.0,0.077,,,,C1853116,"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8 (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
100505477,LINC01602,,,,,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2010.0,2010.0,ALL
100505494,ANKRD10-IT1,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100505495,PCAT19,,0.839,0.154,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.12,1.0,,2013.0,2019.0,ALL
100505515,LINC01723,,1.0,0.077,,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100505518,EDNRB-AS1,,,,,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2018.0,ALL
100505530,LINC02520,,1.0,0.077,,,,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100505532,LINC01301,,1.0,0.038,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
100505545,LINC01095,,,,,,,C3548479,response to bronchodilator,,,phenotype,Organism Function,0.1,1.0,,2015.0,2015.0,ALL
100505566,LINC00578,,0.89,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100505573,INAFM2,P0DMQ5,0.89,0.115,,,,C0024299,Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100505576,LINC00672,,0.89,0.154,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100505591,LRRC3C,A6NJW4,0.931,0.115,0.029211,,,C0264408,Childhood asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
100505592,GAPLINC,,0.736,0.269,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2014.0,2018.0,ALL
100505621,C11orf72,Q8NBR9,,,,,,C0424621,Body Fat Distribution,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
100505625,LINC02102,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100505633,LINC01133,,0.638,0.5,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
100505635,DAAM2-AS1,,,,,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
100505636,MALINC1,,0.89,0.077,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100505641,FGD5-AS1,,0.89,0.077,,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100505648,RAD51-AS1,,0.839,0.192,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
100505666,DCST1-AS1,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
100505678,STARD4-AS1,,0.89,0.115,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100505679,UBE2Q2L,H0YL09,0.931,0.077,0.34005,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100505681,NAPA-AS1,,1.0,0.077,,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100505702,LINC01094,,1.0,0.115,,,,C0201973,Creatine kinase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100505704,ATP5MC1P6,,1.0,0.077,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
100505718,LINC01592,,0.821,0.154,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
100505741,SPATA1,Q5VX52,1.0,0.077,,,,C0524909,"Hepatitis B, Chronic",C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
100505746,ITGB2-AS1,,0.839,0.077,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
100505758,PRMT5-AS1,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100505761,RPARP-AS1,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100505771,MHENCR,,0.931,0.038,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100505776,LINC01541,,0.89,0.154,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100505783,OSER1-DT,,0.931,0.154,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100505806,SNHG18,,0.839,0.231,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100505812,CARD8-AS1,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100505817,LINC02582,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100505832,PROX1-AS1,,0.78,0.231,,,,C0004106,Astigmatism,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100505835,LINC01532,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100505839,SH3PXD2A-AS1,,0.89,0.115,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100505854,APTR,,0.931,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2014.0,ALL
100505869,CFAP58-DT,,,,,,,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100505875,LINC01088,,0.821,0.308,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
100505877,UBE2E2-AS1,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100505881,MAGI2-AS3,,0.7,0.346,,,,C4539896,"NEPHROTIC SYNDROME, TYPE 15",,,disease,Disease or Syndrome,0.1,,,,,ALL
100505887,LINC01672,,0.462,0.846,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2008.0,2019.0,ALL
100505894,TMEM161B-AS1,,0.931,0.077,,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
100505909,LOC100505909,,0.722,0.385,,,,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.03,1.0,,2010.0,2018.0,ALL
100505933,ADD3-AS1,,0.931,0.077,0.010446,,,C0005411,Biliary Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.11,1.0,,2010.0,2018.0,ALL
100505967,LINC00645,,0.89,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100505989,SMIM31,A0A1B0GVY4,0.89,0.154,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100505994,LUCAT1,,0.612,0.577,,,,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.12,1.0,,2019.0,2019.0,ALL
100505996,SOX1-OT,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100506007,RTCA-AS1,,1.0,0.077,,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100506012,PPP5D1,E7EU14,,,0.045235,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100506013,APELA,P0DMC3,0.792,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2012.0,2017.0,ALL
100506020,ARAP1-AS2,,0.931,0.115,,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100506023,LOC100506023,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100506025,CRPPA-AS1,,0.89,,,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100506035,LINC00989,,0.89,0.115,,,,C0021603,Sleep Initiation and Maintenance Disorders,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100506036,CNNM3-DT,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100506046,GAS5-AS1,,0.769,0.269,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100506047,LINC02580,,0.931,0.192,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100506068,DACT3-AS1,,0.931,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100506080,HMGA1P4,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100506084,ARL17B,Q8IVW1,0.78,0.269,0.33578,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2019.0,ALL
100506108,SIX3-AS1,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100506115,SMIM25,,1.0,0.192,,,,C0200637,Monocyte count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
100506119,LINC01503,,0.805,0.115,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100506126,LINC00867,,1.0,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100506127,GVQW3,Q3ZCU0,,,0.0049622,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
100506134,TTC21B-AS1,,0.769,0.346,,,,C0009714,"Hepatic Fibrosis, Congenital",C23;C16;C06,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2014.0,2017.0,ALL
100506172,LINC01568,,1.0,0.038,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2012.0,ALL
100506190,LINC00963,,0.7,0.269,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100506211,MIR210HG,,0.743,0.231,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100506229,LINC01093,,0.931,0.115,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
100506237,NKX2-1-AS1,,0.931,0.077,,,,C1314691,Age at menarche,F01,   Behavior and Behavior Mechanisms,phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
100506243,KRBOX1,C9JBD0,1.0,0.077,0.017643,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
100506272,LINC02492,,1.0,0.077,,,,C0005411,Biliary Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.1,1.0,,2010.0,2010.0,ALL
100506299,ID2-AS1,,1.0,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100506305,LINC00958,,0.691,0.462,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2019.0,2020.0,ALL
100506311,HOTAIRM1,,0.638,0.538,,,,C1832215,Athabaskan brainstem dysgenesis,C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
100506325,SP2-AS1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100506328,LINC01127,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100506334,LINC00649,,0.931,0.115,,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100506365,OTUD6B-AS1,,0.931,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100506368,FZD4-DT,,,,,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
100506377,LINC00973,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100506380,LINC01006,Q8NI28,0.78,0.269,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100506385,LINC01426,,0.839,0.308,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
100506392,SLC16A1-AS1,,,,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100506393,LINC02398,,0.931,0.115,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
100506394,GAS6-DT,,0.821,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
100506409,ELOVL2-AS1,,,,,,,C0202177,Phospholipid measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
100506421,PANTR1,,0.821,0.077,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2015.0,2019.0,ALL
100506428,CBR3-AS1,,0.705,0.231,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100506457,MIR3681HG,,0.736,0.269,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
100506462,SRD5A3-AS1,,0.931,0.077,,,,C0026827,Muscle hypotonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Finding,0.1,1.0,,2010.0,2017.0,ALL
100506465,LINC01234,,0.7,0.346,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
100506472,LOC100506472,,1.0,0.038,,,,C0003486,Aortic Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100506492,DSCAM-AS1,,0.722,0.346,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.06,1.0,,2016.0,2019.0,ALL
100506495,LIFR-AS1,,0.89,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100506526,C5orf64-AS1,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100506542,LINC01082,,0.861,0.154,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100506544,L3MBTL2-AS1,,0.931,0.115,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100506581,C16orf95,Q9H693,0.89,0.154,8.4064e-11,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100506622,LINC00540,,1.0,0.038,,,,C0162871,"Aortic Aneurysm, Abdominal",C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
100506649,PXN-AS1,,0.839,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100506658,OCLN,Q16625,0.507,0.846,8.5583e-07,,,C4552078,PSEUDO-TORCH SYNDROME 1,C16;C20;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Immune System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.7,1.0,,2010.0,2013.0,ALL
100506660,DDX11-AS1,,0.839,0.115,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
100506668,NRAV,,1.0,,,,,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
100506674,MRPS30-DT,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100506680,SACS-AS1,,0.89,0.115,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100506686,IQCH-AS1,,1.0,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
100506696,PCAT6,,0.666,0.269,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.08,1.0,,2016.0,2020.0,ALL
100506697,LINC00327,,1.0,0.077,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
100506713,ALOX12-AS1,,0.931,0.077,0.17573,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
100506714,NUP50-DT,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100506736,SLFN12L,Q6IEE8,,,7.6581e-11,,,C0037290,Skin Pigmentation,,,phenotype,Organ or Tissue Function,0.1,1.0,,2017.0,2017.0,ALL
100506742,CASP12,Q6UXS9,0.638,0.808,0.00012749,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.5,1.0,,2005.0,2013.0,ALL
100506753,AZIN1-AS1,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
100506755,MIR497HG,,0.839,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100506757,LINC00629,,0.89,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100506776,TRG-AS1,,0.861,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100506779,TSPOAP1-AS1,,0.792,0.346,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.11,1.0,,2017.0,2019.0,ALL
100506783,HOXD-AS2,,0.78,0.269,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100506791,LINC01511,,1.0,0.077,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100506795,LINC01354,,0.805,0.115,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100506797,THORLNC,,0.716,0.308,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2017.0,2019.0,ALL
100506810,LINC01132,,0.861,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100506811,H3P43,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100506815,FOXP1-IT1,,0.89,0.038,,,,C0007117,Basal cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2016.0,2016.0,ALL
100506826,MYLK-AS1,,0.931,,,,,C3151077,"AORTIC ANEURYSM, FAMILIAL THORACIC 7",,,disease,Disease or Syndrome,0.1,,,,,ALL
100506834,GAS1RR,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100506835,LINC00840,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
100506844,GIHCG,,0.736,0.231,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
100506860,LINC00513,,0.839,0.115,,,,C0007117,Basal cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
100506866,TTN-AS1,,0.599,0.577,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.4,1.0,,2018.0,2018.0,ALL
100506881,MKLN1-AS,,0.821,0.077,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100506915,CHRM3-AS2,,1.0,0.038,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100506922,MAP3K2-DT,,0.931,0.115,,,,C0264408,Childhood asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
100506930,LINC00665,,0.76,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
100506939,PRKG1-AS1,,1.0,0.038,,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100506963,ELOA-AS1,,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100506965,PWAR6,,0.89,0.115,,,,C0345967,Malignant mesothelioma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.3,1.0,,2015.0,2015.0,ALL
100507008,LINC00844,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2007.0,ALL
100507012,BMPR1B-DT,,1.0,0.038,,,,C0025322,Premature Menopause,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2005.0,2005.0,ALL
100507027,MRLN,P0DMT0,1.0,0.038,,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
100507034,PITRM1-AS1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507043,TUNAR,,0.839,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100507056,CCAT1,,0.585,0.5,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,1.0,,2012.0,2019.0,ALL
100507057,MELTF-AS1,,0.861,0.192,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100507064,TEX26-AS1,,1.0,0.077,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
100507073,LINC01798,,0.89,0.077,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2017.0,2017.0,ALL
100507086,DLG1-AS1,,0.839,0.115,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100507096,GIMD1,P0DJR0,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100507098,ADAMTS9-AS2,,0.656,0.462,,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100507118,PRC1-AS1,,0.931,0.154,,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
100507127,LINC00707,,0.769,0.231,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2019.0,2019.0,ALL
100507135,SPART-AS1,P0CW21,,,0.023665,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507140,LINC01792,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2012.0,2012.0,ALL
100507163,LINC00709,,,,,,,C0201925,Calcium measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
100507170,CT47A12,Q5JQC4,0.78,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
100507175,LINC02408,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507178,SLFNL1-AS1,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
100507195,LINC02384,,1.0,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2012.0,ALL
100507217,LINC01578,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507240,VWA8-AS1,,,,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507246,SNHG16,,0.608,0.577,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2015.0,2020.0,ALL
100507249,C8orf17,Q9NRJ1,0.861,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2003.0,2007.0,ALL
100507254,LINC01013,,0.89,0.115,,,,C0206180,Ki-1+ Anaplastic Large Cell Lymphoma,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100507257,MEG9,,1.0,0.077,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100507266,STX18-AS1,,0.89,0.154,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2017.0,ALL
100507274,LINC01210,,0.89,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100507300,ALKBH3-AS1,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507303,SNHG19,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100507308,TARID,,0.821,0.308,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
100507316,MINCR,,0.7,0.231,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2016.0,2019.0,ALL
100507321,ERVK13-1,Q9NX77,,,,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
100507347,VIM-AS1,,0.78,0.385,,,,C0009691,Congenital cataract,C23;C16;C13;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.1,1.0,,2016.0,2016.0,ALL
100507391,LINC01968,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100507392,SENCR,,0.931,0.038,,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
100507401,LRP4-AS1,,,,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
100507404,TMLHE-AS1,,0.931,0.115,,,,C0175754,Agenesis of corpus callosum,C23;C16;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Congenital Abnormality,0.1,,,,,ALL
100507406,LINC02539,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100507410,C1QTNF1-AS1,,1.0,0.077,0.53681,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
100507420,LINC01605,,0.792,0.269,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507421,TMEM178B,H3BS89,1.0,0.038,0.95458,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100507428,LINC00458,,0.931,0.077,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507431,LINC02551,,1.0,0.038,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
100507433,ZNF571-AS1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100507436,MICA,Q29983,0.473,0.846,0.0049697,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.4,0.972,,1997.0,2020.0,ALL
100507444,PPP1R2P1,Q96PQ5,1.0,0.038,,,,C0272139,Erythrocytosis due to low atmospheric pressure,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100507458,ZNF213-AS1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100507463,PSMB8-AS1,,0.839,0.385,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
100507466,DPH6-DT,,1.0,0.038,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507475,IDH1-AS1,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100507487,LINC02615,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100507495,SDCBP2-AS1,,,,,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
100507500,EGFR-AS1,,0.722,0.192,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.13,1.0,,2004.0,2019.0,ALL
100507501,LINC01569,,0.931,0.154,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100507506,ECI2-DT,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100507521,LINC02733,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
100507524,ARHGEF26-AS1,,,,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507527,THEG5,,0.931,0.077,,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
100507530,MCPH1-AS1,,1.0,0.115,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
100507533,SOX21-AS1,,0.751,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
100507540,LINC01504,,,,,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
100507567,RAB11B-AS1,,0.89,0.038,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100507582,BHLHE40-AS1,,1.0,0.038,,,,C0263361,Psoriasis vulgaris,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100507584,LINC01016,,0.839,0.154,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
100507588,TGFBR3L,H3BV60,0.89,0.077,0.084471,,,C0027819,Neuroblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100507589,NAGPA-AS1,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100507600,LCT-AS1,,0.861,0.077,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
100507602,TRIM52-AS1,,0.931,0.115,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100507612,LINC00402,,1.0,0.038,,,,C0278883,Metastatic melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100507632,LINC00968,,0.751,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2018.0,2019.0,ALL
100507651,LINC01606,,0.931,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100507679,MUC22,E2RYF6,0.729,0.5,0.014047,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
100507703,LOC100507703,,0.89,0.115,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,1999.0,1999.0,ALL
100508120,GMDS-DT,,0.861,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100509894,CPB2-AS1,,,,,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
100526664,LY75-CD302,O60449,0.711,0.423,7.4472e-46,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100526693,ARPC4-TTLL3,,0.89,0.115,1.3565e-13,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
100526694,MSANTD3-TMEFF1,Q8IYR6,,,0.23697,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100526737,RBM14-RBM4,Q96PK6,0.647,0.615,0.98438,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.06,1.0,,2007.0,2014.0,ALL
100526739,CENPS-CORT,Q8N2Z9,0.861,0.115,5.75e-06,,,C0008626,Congenital chromosomal disease,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",group,Congenital Abnormality,0.01,1.0,,2010.0,2010.0,ALL
100526740,ATP5MF-PTCD1,,1.0,0.115,2.9087e-14,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100526760,ABHD14A-ACY1,,1.0,0.077,1.7689e-10,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100526767,RNF103-CHMP3,Q9Y3E7,0.821,0.269,0.0040006,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
100526772,STIMATE-MUSTN1,,1.0,0.038,0.00066939,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
100526783,ARPIN-AP3S2,,1.0,0.077,1.1457e-11,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100526790,TST1,,0.78,0.231,,,,C0343401,MRSA - Methicillin resistant Staphylococcus aureus infection,C01,   Infections,disease,Disease or Syndrome,0.06,1.0,,2009.0,2019.0,ALL
100526794,NT5C1B-RDH14,Q96P26,,,7.3667e-10,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100526820,CAHM,,0.931,0.077,,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
100526823,TST2,,0.931,0.038,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.02,1.0,,2009.0,2018.0,ALL
100526825,INMT-MINDY4,,0.89,0.115,,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100526830,SLX1A-SULT1A3,,0.821,0.346,,,,C0751383,Juvenile Neuronal Ceroid Lipofuscinosis,C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,1994.0,1995.0,ALL
100526833,SEPT5-GP1BB,,0.89,0.192,,,,C0005129,Bernard-Soulier Syndrome,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.05,1.0,,2003.0,2019.0,ALL
100526835,FPGT-TNNI3K,Q59H18,0.89,0.154,3.2476e-48,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2010.0,2013.0,ALL
100526836,BLOC1S5-TXNDC5,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100526842,RPL17-C18orf32,,0.572,0.615,0.57502,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2016.0,2020.0,ALL
100527960,MROH7-TTC4,,0.931,0.115,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100527963,PMF1-BGLAP,Q6P1K2,0.861,0.192,1.073e-08,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
100527978,TLCD4-RWDD3,,0.931,0.038,0.0082291,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
100528007,BORCS7-ASMT,,0.805,0.154,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
100528016,TMX2-CTNND1,,0.538,0.769,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1991.0,2018.0,ALL
100528017,SAA2-SAA4,,,,,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2010.0,2010.0,ALL
100528020,FAM187A,A6NFU0,0.89,0.154,6.5367e-06,,,C0008780,Ciliary Motility Disorders,C16;C08;C09,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases",group,Disease or Syndrome,0.1,1.0,,2012.0,2018.0,ALL
100528021,ST20-MTHFS,,0.805,0.115,0.0076321,,,C0007758,Cerebellar Ataxia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Disease or Syndrome,0.1,,,,,ALL
100528023,PPR1,,0.729,0.423,,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,1993.0,1993.0,ALL
100528024,DEL11P13,,0.716,0.538,,,,C0025362,Mental Retardation,C23;C16;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",disease,Mental or Behavioral Dysfunction,0.1,1.0,,1989.0,2011.0,ALL
100528030,POC1B-GALNT4,Q8N4A0,0.89,0.115,0.10708,,,C0036346,"Schizophrenia, Childhood",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
100528032,KLRC4-KLRK1,P26718,0.469,0.769,,,,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.12,1.0,,2013.0,2019.0,ALL
100528062,ARMCX5-GPRASP2,Q96D09,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.02,1.0,,2004.0,2011.0,ALL
100528064,NEDD8-MDP1,,,,0.0025047,,,C0524587,Mean Corpuscular Volume (result),,,phenotype,Laboratory or Test Result,0.1,1.0,,2018.0,2018.0,ALL
100529063,BCL2L2-PABPN1,Q92843,0.653,0.5,0.27913,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
100529067,SERF2-C15ORF63,,,,,,,C0079731,B-Cell Lymphomas,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100529097,RPL36A-HNRNPH2,,0.861,0.154,0.36425,,,C0002986,Fabry Disease,C16;C18;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,1989.0,2018.0,ALL
100529141,LGTN,,0.861,0.115,,,,C0007114,Malignant neoplasm of skin,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2006.0,2006.0,ALL
100529144,CORO7-PAM16,,0.931,0.192,7.6179e-25,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2019.0,ALL
100529145,TEN1-CDK3,,1.0,,,,,C1406945,Thymus enlargement,,,disease,Disease or Syndrome,0.01,1.0,,1996.0,1996.0,ALL
100529148,MDNS,,,,,,,C0271680,Diabetic Polyneuropathies,C10;C19,   Nervous System Diseases;    Endocrine System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100529151,IBD11,,,,,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
100529209,RNASEK-C17orf49,,0.89,0.077,0.19065,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100529211,TMEM256-PLSCR3,,0.861,0.154,0.0059458,,,C0035229,Respiratory Insufficiency,C08,   Respiratory Tract Diseases,phenotype,Pathologic Function,0.1,,,,,ALL
100529215,ZNF559-ZNF177,Q13360,,,0.00044299,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
100529224,FWS,,1.0,0.038,,,,C3266262,Multiple Chronic Conditions,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100529229,FAME3,,0.89,0.077,,,,C0014544,Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2007.0,2010.0,ALL
100529239,RPS10-NUDT3,,0.931,0.154,0.95186,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100529240,ZNF816-ZNF321P,Q8N8H1,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2015.0,ALL
100529241,HSPE1-MOB4,,1.0,0.038,0.9709,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
100529251,CKLF-CMTM1,,1.0,0.038,0.034621,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
100529257,SYNJ2BP-COX16,,,,,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2014.0,2014.0,ALL
100529261,CHURC1-FNTB,P49356,,,5.3295e-05,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100529262,MIA-RAB4B,,0.821,0.385,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
100529264,RAB4B-EGLN2,,0.641,0.654,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100532724,NPHP3-ACAD11,,0.663,0.577,,,,C0022680,Polycystic Kidney Diseases,C16;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",group,Disease or Syndrome,0.11,1.0,,2010.0,2010.0,ALL
100532731,COMMD3-BMI1,P35226,0.488,0.769,0.0014998,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2002.0,2020.0,ALL
100532732,MSH5-SAPCD1,,0.76,0.423,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.11,1.0,,2015.0,2017.0,ALL
100532736,MICOS10-NBL1,P41271,0.691,0.462,0.028653,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100532737,ATP6V1G2-DDX39B,,0.769,0.423,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
100532746,PPT2-EGFL8,,0.792,0.462,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
100533107,RTEL1-TNFRSF6B,,0.682,0.385,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2019.0,ALL
100533179,UBE2F-SCLY,,1.0,0.115,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100533181,FXYD6-FXYD2,,0.89,0.231,0.85025,,,C1835171,"Hypomagnesemia 2, renal",C16;C18;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
100533183,ZNF664-RFLNA,Q6ZTI6,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100533184,ARHGAP19-SLIT1,,,,6.9829e-12,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100533195,FAM24B-CUZD1,,,,,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100533467,BIVM-ERCC5,,0.736,0.308,1.2783e-15,,,C0013362,Dysarthria,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Mental or Behavioral Dysfunction,0.1,,,,,ALL
100533483,DNAAF4-CCPG1,,1.0,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100533619,TMPOP2,,0.821,0.115,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.02,1.0,,2014.0,2019.0,ALL
100533642,FNBP1P1,,1.0,0.038,,,,C0003165,Anthracosis,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
100533665,PTCHD3P3,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
100533955,SENP3-EIF4A1,,,,,,,C0202022,Follicle stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
100533970,P2RX5-TAX1BP3,,0.588,0.769,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
100533990,APOC4-APOC2,,0.821,0.308,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100534593,STX16-NPEPL1,,,,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100534595,HNRNPUL2-BSCL2,,0.78,0.192,,,,C0221032,Familial generalized lipodystrophy,C16;C18;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
100534611,TM4SF19-TCTEX1D2,,,,,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
100534612,C1QTNF3-AMACR,,0.931,0.154,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100616100,ERVK-2,,0.674,0.423,,,,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.08,1.0,,1994.0,2019.0,ALL
100616101,ERVK-10,,0.729,0.346,,,,C0006849,Oral candidiasis,C01;C07,   Infections;    Stomatognathic Diseases,disease,Disease or Syndrome,0.02,1.0,,1999.0,2004.0,ALL
100616102,ERVK-9,,0.711,0.346,,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.03,1.0,,2010.0,2018.0,ALL
100616103,ERVK-21,,0.729,0.346,,,,C0006849,Oral candidiasis,C01;C07,   Infections;    Stomatognathic Diseases,disease,Disease or Syndrome,0.02,1.0,,1999.0,2004.0,ALL
100616105,ERVE-4,,0.931,0.115,,,,C0740457,Malignant neoplasm of kidney,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100616111,MIR4455,,0.89,0.154,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100616112,MIR4793,,1.0,0.115,,,,C0038525,Subarachnoid Hemorrhage,C23;C10;C14,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100616113,MIR4680,,0.89,0.192,,,,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.01,1.0,,2019.0,2019.0,ALL
100616114,MIR4668,,0.821,0.154,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100616115,MIR4469,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616116,MIR4648,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100616118,MIR4486,,1.0,0.038,,,,C0014457,Eosinophilia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100616119,MIR4697,,0.931,0.077,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2016.0,2018.0,ALL
100616120,MIR4695,,0.805,0.308,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616125,MIR4731,,0.931,0.115,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100616127,MIR4448,,0.839,0.077,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100616132,MIR4728,,0.769,0.269,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2018.0,ALL
100616134,MIR499B,,0.76,0.269,,,,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2015.0,2019.0,ALL
100616135,MIR4507,,0.839,0.077,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100616138,MIR4787,,1.0,0.038,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100616139,MIR4741,,0.89,0.192,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616140,MIR4506,,,,,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616141,MIR4428,,0.89,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616142,MIR4458,,0.76,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2017.0,ALL
100616146,MIR4534,,0.89,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
100616151,MIR4480,,0.861,0.192,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616152,MIR4804,,1.0,0.077,,,,C0151517,Complete atrioventricular block,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
100616157,MIR4772,,0.76,0.269,,,,C0281361,Adenocarcinoma of pancreas,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100616158,MIR4505,,0.931,0.192,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616159,MIR4779,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616161,MIR4795,,0.861,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
100616163,MIR4530,,0.931,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
100616170,MIR4739,,0.839,0.115,,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100616173,MIR203B,,1.0,0.038,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616175,MIR4633,,0.89,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616176,MIR4708,,0.931,0.077,,,,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100616178,MIR4641,,1.0,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616180,MIR4465,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616182,MIR4500,,0.769,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2019.0,ALL
100616183,MIR4513,,0.78,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616186,MIR4490,,1.0,0.115,,,,C0011881,Diabetic Nephropathy,C13;C12;C19,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100616200,ERVS71-2,,,,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
100616202,MIR4634,,1.0,0.038,,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100616206,MIR4652,,1.0,0.077,,,,C0259785,Malignant Meningioma,C04;C10,   Neoplasms;    Nervous System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616207,MIR4439,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616208,MIR4782,,0.931,0.115,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100616211,MIR4709,,0.89,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616213,MIR4437,,1.0,0.077,,,,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100616218,MIR3135B,,1.0,0.115,,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100616222,MIR4487,,0.839,0.154,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100616224,MIR4753,,0.931,0.077,,,,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616225,MIR4756,,0.861,0.231,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100616230,MIR4646,,0.931,0.077,,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
100616231,MIR4519,,0.931,0.077,,,,C0752347,Lewy Body Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100616234,MIR4454,,0.89,0.115,,,,C0020456,Hyperglycemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100616236,MIR4669,,0.89,0.154,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616237,MIR4640,,1.0,0.077,,,,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2013.0,2013.0,ALL
100616240,MIR4496,,0.89,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616241,MIR4717,,0.861,0.115,,,,C0003469,Anxiety Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.01,1.0,,2015.0,2015.0,ALL
100616247,MIR151B,,0.839,0.077,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100616249,MIR4768,,0.89,0.154,,,,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616251,MIR1587,,1.0,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
100616258,MIR4516,,0.695,0.385,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100616259,MIR378I,,0.821,0.115,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100616260,MIR4663,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616262,MIR4701,,0.931,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100616263,MIR4485,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616265,MIR4433A,,1.0,0.115,,,,C0079773,"Lymphoma, T-Cell, Cutaneous",C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616269,MIR4639,,0.89,0.077,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100616270,MIR4651,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616274,MIR4802,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616283,MIR4766,,0.931,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100616288,MIR4665,,0.861,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100616291,MIR4791,,1.0,0.115,,,,C1860224,ABLEPHARON-MACROSTOMIA SYNDROME,C16;C11;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Stomatognathic Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100616293,MIR4510,,0.931,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2017.0,2020.0,ALL
100616295,MIR4764,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
100616308,MIR4666A,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616312,MIR4478,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2015.0,2017.0,ALL
100616317,MIR4777,,1.0,0.077,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
100616318,MIR4664,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100616319,MIR4493,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616321,MIR378G,,1.0,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100616323,MIR4482,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
100616325,MIR4460,,1.0,0.077,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100616326,MIR4636,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100616327,MIR4484,,0.792,0.269,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100616330,MIR4491,,0.931,0.038,,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100616335,MIR219B,,,,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616338,MIR4794,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100616340,MIR4758,,0.821,0.038,,,,C0004114,Astrocytoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616342,MIR4638,,0.839,0.154,,,,C1328504,Hormone refractory prostate cancer,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
100616343,MIR4677,,0.931,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616346,MIR4649,,0.931,0.192,,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
100616349,MIR4451,,0.89,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616350,MIR4660,,1.0,0.077,,,,C1298681,Oxalosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100616354,MIR550A3,,0.861,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616357,MIR3591,,0.792,0.154,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100616360,MIR2467,,0.931,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100616361,MIR4775,,0.89,0.077,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
100616363,MIR4735,,0.805,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100616367,MIR4467,,0.805,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.3,1.0,,2015.0,2015.0,ALL
100616371,MIR4746,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616376,MIR4492,,0.76,0.385,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100616378,MIR4784,,0.861,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616379,MIR4511,,0.861,0.192,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616381,MIR4456,,1.0,0.077,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2020.0,2020.0,ALL
100616384,MIR548AC,,1.0,0.077,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.02,1.0,,2015.0,2019.0,ALL
100616385,MIR4732,,0.861,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2015.0,2019.0,ALL
100616386,MIR4654,,1.0,,,,,C0346360,Malignant melanoma of conjunctiva,,,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616387,MIR3064,,0.805,0.154,,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
100616388,MIR4723,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
100616389,MIR4463,,0.861,0.115,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2018.0,2018.0,ALL
100616390,MIR4427,,,,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616396,MIR4712,,1.0,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616401,MIR4520-1,,1.0,0.115,,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100616404,MIR4515,,1.0,0.115,,,,C0026691,Mucocutaneous Lymph Node Syndrome,C17;C15;C14,   Skin and Connective Tissue Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100616405,MIR4518,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616406,MIR4521,,0.861,0.115,,,,C0019069,Hemophilia A,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100616407,MIR4443,,0.729,0.385,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
100616408,MIR5047,,1.0,,,,,C0742132,cervical cancer metastasis,,,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616413,MIR4462,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616421,MIR4689,,0.931,0.077,,,,C0005411,Biliary Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.01,1.0,,2016.0,2016.0,ALL
100616424,MIR4707,,,,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100616430,MIR4644,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100616435,MIR4801,,1.0,0.077,,,,C0206139,"Lichen Planus, Oral",C17;C07,   Skin and Connective Tissue Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
100616436,MIR4449,,0.931,0.192,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616437,MIR1343,,0.839,0.077,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100616438,MIR4632,,0.931,0.115,,,,C0349530,Early gastric cancer,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616439,MIR4658,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616441,MIR4474,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616442,ERVK-12,,0.678,0.423,,,,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.08,1.0,,1994.0,2019.0,ALL
100616443,ERVK-15,,0.805,0.308,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
100616444,ERVK-20,,0.533,0.692,,,,C0001175,Acquired Immunodeficiency Syndrome,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,1985.0,2011.0,ALL
100616445,ERVK-22,,0.678,0.423,,,,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.08,1.0,,1994.0,2019.0,ALL
100616449,MIR4725,,0.931,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100616452,MIR2682,,0.805,0.154,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.31,1.0,,2014.0,2014.0,ALL
100616454,MIR4497,,1.0,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616464,MIR4778,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616465,MIR4656,,0.821,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616469,MIR4429,,0.751,0.192,,,,C0005411,Biliary Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.01,1.0,,2016.0,2016.0,ALL
100616470,MIR4488,,1.0,0.115,,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100616473,MIR4432,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
100616474,MIR4715,,0.861,0.115,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616476,MIR4446,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100616481,MIR4423,,0.861,0.115,,,,C0007194,Hypertrophic Cardiomyopathy,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100616483,MIR4751,,1.0,0.077,,,,C0521585,Gastrointestinal mucositis,C06;C07,   Digestive System Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100616487,MIR4517,,1.0,0.077,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100616491,MIR3978,,1.0,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
100616492,MIR378F,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100616494,MIR1269B,,0.861,0.154,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
100616495,MIR2392,,0.89,0.115,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100616496,ERVW-4,,0.686,0.615,,,,C0036337,Schizoaffective Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.3,1.0,,2001.0,2001.0,ALL
100616500,MIR4683,,0.931,0.077,,,,C1266136,"Gastrointestinal stromal tumor, benign",C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100616530,C8orf37-AS1,,0.821,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100616668,TPTE2P5,,,,,,,C0200641,Blood basophil count (lab test),,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100628307,DIO2-AS1,,,,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
100628315,DNM3OS,,0.751,0.231,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
100630918,PARTICL,,0.792,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2019.0,ALL
100631383,FAM47E-STBD1,Q6ZV65,1.0,0.038,7.6594e-12,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.11,1.0,,2009.0,2017.0,ALL
100642175,SPRY4-IT1,,0.619,0.462,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,0.917,,2014.0,2019.0,ALL
100652730,LINC00659,,0.861,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100652736,LINC01311,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
100652739,RAET1E-AS1,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100652759,PRICKLE2-AS1,,1.0,0.154,,,,C1843851,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis",C23;C16;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100652770,DSG2-AS1,,0.89,0.077,,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
100652772,NNT-AS1,,0.666,0.423,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100652824,KIAA2012,Q0VF49,,,3.209e-07,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
100652853,LINC01023,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100652883,ALOX15P1,,1.0,,,,,C0201874,Amino acids measurement,,,group,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
100652988,LINC00702,,0.821,0.192,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100653365,BED,,0.729,0.308,,,,C0013473,Eating Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.05,1.0,,2017.0,2020.0,ALL
100653366,PSC,,0.603,0.731,,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.07,1.0,,2017.0,2019.0,ALL
100653377,SPGF2,,0.792,0.115,,,,C0004509,Azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100653382,DEL13Q14,,0.805,0.192,,,,C0432408,Trisomy 12,C23;C16;C04;C20;C15,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases",phenotype,Disease or Syndrome,0.05,1.0,,2002.0,2017.0,ALL
100653384,IGAN2,,1.0,0.115,,,,C0017661,IGA Glomerulonephritis,C13;C12;C20,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
100653515,CEP295NL,Q96MC4,0.89,0.231,0.37682,,,C0013312,Dupuytren Contracture,C04;C17;C05,   Neoplasms;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100682260,HPPD,,0.839,0.192,,,,C0268490,"Tyrosinemia, Type I",C16;C18;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
100689074,POU6F2-AS2,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100689229,H3P12,,0.603,0.615,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,0.938,,1990.0,2018.0,ALL
100750225,PCAT1,,0.575,0.615,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.5,1.0,,2005.0,2019.0,ALL
100750246,HIF1A-AS1,,0.729,0.269,,,,C0003486,Aortic Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.04,1.0,,2014.0,2019.0,ALL
100750247,HIF1A-AS2,,0.711,0.269,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,1.0,,2016.0,2019.0,ALL
100750326,HTT-AS,,1.0,0.115,,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
100750329,TET18P,,1.0,0.038,,,,C0242621,Isochromosomes,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Acquired Abnormality,0.01,1.0,,1986.0,1986.0,ALL
100775105,ERVK-18,,0.56,0.654,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.33,0.667,,2008.0,2012.0,ALL
100775107,RBM5-AS1,,0.931,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100820631,MLSM7,,0.743,0.192,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2006.0,2011.0,ALL
100820829,MYZAP,P0CAP1;P0CAP2;Q6EEV4,0.769,0.308,4.4081e-17,,,C0087031,Juvenile-Onset Still Disease,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.3,1.0,,2009.0,2009.0,ALL
100846998,MIR5689,,0.861,0.154,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100847000,MIR5579,,1.0,0.115,,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
100847004,MIR5188,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100847006,MIR5571,,0.89,0.154,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100847013,MIR5692B,,1.0,0.038,,,,C1263846,Attention deficit hyperactivity disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
100847014,MIR5100,,0.769,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2015.0,2018.0,ALL
100847016,MIR5695,,0.931,0.077,,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
100847020,MIR5582,,0.931,0.038,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
100847024,MIR5698,,,,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100847028,MIR5587,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100847029,MIR5003,,0.89,0.154,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,0.0,,2019.0,2019.0,ALL
100847043,MIR5682,,1.0,0.077,,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100847050,MIR5191,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100847052,MIR664B,,0.931,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
100847053,MIR5702,,0.861,0.154,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100847054,MIR5588,,0.839,0.077,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100847057,MIR5189,,0.931,0.077,,,,C0018023,Nodular Goiter,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
100847059,MIR5094,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
100847062,MIR5195,,0.78,0.192,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
100847065,MIR5591,,1.0,,,,,C4728046,Diabetic wound,,,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100847069,MIR5590,,0.839,0.115,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100847070,MIR5196,,0.821,0.115,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
100847079,MIR5193,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100847090,MIR5187,,0.931,0.038,,,,C1299433,Left main coronary artery disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100852410,ZRANB2-AS2,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100859921,LINC00536,,0.89,0.115,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100859927,AAA4,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,1997.0,1997.0,ALL
100859930,HEIH,,0.722,0.269,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
100861402,CERS6-AS1,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
100861412,FSBP,O95073;Q9Y620,0.821,0.231,0.00070681,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2017.0,2017.0,ALL
100861439,CTRCT37,,1.0,0.038,,,,C0344523,"Cataract, congenital, cerulean type 1",C11,   Eye Diseases,disease,Congenital Abnormality,0.01,1.0,,2011.0,2011.0,ALL
100861440,DFNB96,,1.0,0.115,,,,C3711374,Nonsyndromic Deafness,C23;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
100861514,ELMO1-AS1,,1.0,0.077,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100861519,GDNF-AS1,,0.861,0.115,,,,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100861540,CYP3A7-CYP3A51P,P24462,0.821,0.154,,,,C0948089,Acute Coronary Syndrome,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100861542,LINC00554,,0.89,0.077,,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100861548,PINK1-AS,,0.821,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2012.0,2019.0,ALL
100861549,LINC00562,,,,,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
100861550,PLUT,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100861552,LINC00558,,0.931,0.077,,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100861555,LINC00565,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100861563,SCAANT1,,0.931,0.154,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100862683,ERVK-25,,0.729,0.346,,,,C0006849,Oral candidiasis,C01;C07,   Infections;    Stomatognathic Diseases,disease,Disease or Syndrome,0.02,1.0,,1999.0,2004.0,ALL
100862684,ERVK-24,,0.722,0.346,,,,C0006849,Oral candidiasis,C01;C07,   Infections;    Stomatognathic Diseases,disease,Disease or Syndrome,0.02,1.0,,1999.0,2004.0,ALL
100862688,ERVK-11,,0.663,0.423,,,,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.08,1.0,,1994.0,2019.0,ALL
100862697,ERVK3-2,,,,,,,C0852036,Pregnancy associated hypertension,C13;C14,   Female Urogenital Diseases and Pregnancy Complications;    Cardiovascular Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2008.0,2008.0,ALL
100862704,RB1-DT,,0.89,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100873065,PTCHD1-AS,,0.839,0.308,,,,C0001807,Aggressive behavior,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2014.0,2014.0,ALL
100873217,MTND1P31,,1.0,0.077,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
100873229,MTND2P23,,1.0,0.038,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
100873244,MTND4P22,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
100873354,MTND5P21,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
100873396,RNA5SP126,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100873408,RNA5SP141,,1.0,,,,,C0019348,Herpes Simplex Infections,C01;C17,   Infections;    Skin and Connective Tissue Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100873463,RNA5SP202,,1.0,0.038,,,,C0023267,Fibroid Tumor,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100873790,FHP1,,1.0,0.077,,,,C0001956,Alcohol Use Disorder,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2019.0,2019.0,ALL
100873882,ANKRD26P4,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100873904,MYB-AS1,,0.78,0.346,,,,C0010606,Adenoid Cystic Carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
100873924,HLX-AS1,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100873965,MED4-AS1,,0.931,0.115,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100873979,RBMS3-AS3,,0.89,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100873993,ITIH4-AS1,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874002,OXCT1-AS1,,0.89,0.115,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874009,BIRC6-AS1,,0.89,0.154,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100874011,XIRP2-AS1,,0.89,0.192,,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100874016,SYNPR-AS1,,1.0,0.077,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874018,EPN2-AS1,,,,,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
100874041,MACC1-AS1,,0.89,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
100874054,FALEC,,0.644,0.423,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100874056,NLGN4Y-AS1,,0.861,0.192,,,,C3266843,"47, XYY syndrome",C23;C16,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.02,1.0,,2015.0,2019.0,ALL
100874058,COX10-AS1,,0.805,0.192,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
100874074,DLEU7-AS1,,0.89,0.115,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100874075,ARAP1-AS1,,0.839,0.154,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874082,HTR2A-AS1,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874095,ADIPOQ-AS1,,1.0,0.077,,,,C2675519,Hypoadiponectinemia,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
100874100,STEAP2-AS1,,1.0,0.077,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874117,EGFLAM-AS1,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
100874145,LINC00364,,0.931,0.115,,,,C1863416,Autosomal dominant compelling helio ophthalmic outburst syndrome,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
100874146,LINC00365,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
100874151,LINC00381,,,,,,,C0023114,Handedness,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100874159,LINC00400,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,0.0,,2019.0,2019.0,ALL
100874167,LINC00423,,0.931,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874175,LINC00446,,0.805,0.077,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2016.0,2019.0,ALL
100874179,LINC00457,,0.931,0.154,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100874180,LINC00459,,1.0,0.038,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874187,LINC00559,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
100874189,NKX2-2-AS1,,0.89,0.038,,,,C0025149,Medulloblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
100874197,EFCAB6-AS1,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100874207,ST3GAL6-AS1,,0.931,0.192,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874216,ZNF385D-AS1,,1.0,0.038,,,,C2063866,"Depressive Disorder, Treatment-Resistant",F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
100874221,ZNF385D-AS2,,0.861,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874222,OBI1-AS1,,0.792,0.115,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2013.0,2013.0,ALL
100874231,SPATA13-AS1,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
100874236,COL18A1-AS2,,0.931,0.038,,,,C0345905,Intrahepatic Cholangiocarcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874241,STARD13-AS,,0.78,0.192,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100874251,KIRREL3-AS2,,1.0,0.038,,,,C1096063,Drug Resistant Epilepsy,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100874294,HLCS-IT1,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
100874323,HOXA10-AS,,0.821,0.231,,,,C1261502,Finding of Mean Corpuscular Hemoglobin,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
100874330,LINC01014,,0.931,0.115,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
100874333,OPCML-IT1,,0.861,0.154,,,,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874345,ZBTB40-IT1,,1.0,0.077,,,,C0029456,Osteoporosis,C18;C05,   Nutritional and Metabolic Diseases;    Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100874362,HOXB-AS1,,0.861,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874363,HOXC-AS1,,1.0,0.077,,,,C0577631,Carotid Atherosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
100874364,HOXC-AS2,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874365,HOXC-AS3,,0.839,0.231,,,,C0005940,Bone Diseases,C05,   Musculoskeletal Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100874366,HOXC13-AS,,0.769,0.231,,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
100874433,IQCJ-SCHIP1-AS1,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100874493,PIEZO1P2,,,,,,,C3548479,response to bronchodilator,,,phenotype,Organism Function,0.1,1.0,,2015.0,2015.0,ALL
100874502,ATP6V0E1P1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100874503,ATP6V0E1P2,,1.0,0.154,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
100874505,CYP2C59P,,,,,,,C2699541,Cytokine Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
100874523,HIF1AP1,,1.0,0.038,,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
100874532,IBGC2,,1.0,0.038,,,,C4324314,Primary familial brain calcification,C18,   Nutritional and Metabolic Diseases,disease,Congenital Abnormality,0.01,1.0,,2016.0,2016.0,ALL
100885773,DYT21,,0.931,0.077,,,,C3281236,DYSTONIA 21,,,disease,Disease or Syndrome,0.3,1.0,,2011.0,2011.0,ALL
100885775,BANCR,,0.7,0.423,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2018.0,2019.0,ALL
100885776,UGDH-AS1,,1.0,0.115,,,,C1704436,Peripheral Arterial Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
100885778,NALCN-AS1,,,,,,,C0004936,Mental disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2010.0,2010.0,ALL
100885779,LINC-ROR,,0.548,0.769,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2019.0,ALL
100885789,IFNG-AS1,,0.659,0.654,,,,C0021390,Inflammatory Bowel Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.12,1.0,,2012.0,2020.0,ALL
100885798,LINC00210,,0.792,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
100885803,KTCN8,,0.931,0.115,,,,C0022578,Keratoconus,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
100885864,RNA5SP244,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
100886964,PTCSC3,,0.722,0.385,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.34,1.0,,2012.0,2017.0,ALL
100887755,TRERNA1,,0.839,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
100913187,APOBEC3A_B,P31941,0.663,0.5,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2014.0,2019.0,ALL
100996266,COMETT,,0.678,0.538,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100996291,LINC01993,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100996295,DNAH17-AS1,,0.931,0.077,0.083797,,,C0349588,Short stature,,,phenotype,Finding,0.1,,,,,ALL
100996301,FOXD3-AS1,,0.743,0.192,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2018.0,2019.0,ALL
100996307,LIPE-AS1,,1.0,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100996315,CHIAP3,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100996324,LINC01882,,,,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
100996331,POTEB,A0A0A6YYL3;H3BUK9,1.0,0.115,0.35277,,,C0334102,Lymphangiomatosis,C04;C15;C14,   Neoplasms;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
100996338,LINC02169,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
100996348,CA3-AS1,,0.89,0.308,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
100996425,ARLNC1,,0.89,0.077,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100996465,LCA10,,0.839,0.308,0.00016221,,,C0339527,Leber Congenital Amaurosis,C11,   Eye Diseases,disease,Disease or Syndrome,0.04,1.0,,2017.0,2018.0,ALL
100996485,C5orf66,Q9H5L9,0.76,0.154,0.00052699,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100996490,LINC01206,,1.0,0.077,,,,C0202231,Thyroxine measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
100996492,CTXND1,A0A1B0GTU2,0.89,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100996511,LINC01355,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
100996521,CTXND2,A0A1B0GV90,1.0,0.038,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
100996567,ANTXRLP1,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
100996569,NAMA,,1.0,0.077,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
100996579,LINC01806,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
100996590,LINC01505,,0.821,0.192,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
100996597,LINC00690,,1.0,0.038,,,,C0023343,Leprosy,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
100996609,LINC01436,,0.821,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2019.0,2020.0,ALL
100996635,LINC02607,,1.0,0.038,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
100996693,SPEGNB,A0A087WV53,,,,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
100996717,NOTCH2NLC,P0DPK4;Q7Z3S9,0.78,0.192,,,,C1863843,Neuronal intranuclear inclusion disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.53,1.0,,2019.0,2019.0,ALL
100996724,LOC100996724,,0.931,0.192,,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2007.0,2007.0,ALL
100996758,NPY4R2,P0DQD5;P50391,0.805,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2001.0,2016.0,ALL
100996763,NOTCH2NLB,P0DPK3,0.821,0.192,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2018.0,2018.0,ALL
100996928,FMC1-LUC7L2,Q96HJ9,1.0,0.077,0.05528,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
100996939,PYURF,Q96I23,0.931,0.192,0.16154,,,C4225201,HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6,,,disease,Disease or Syndrome,0.1,,,,,ALL
100996949,PDA1,,0.89,0.077,,,,C0013274,Patent ductus arteriosus,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.02,1.0,,2002.0,2017.0,ALL
101054525,PGR-AS1,,0.514,0.808,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,0.923,,1995.0,2019.0,ALL
101055625,OVCH1-AS1,,1.0,0.077,0.46492,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
101059903,HMSN5,,1.0,0.077,,,,C0027888,Hereditary Motor and Sensory Neuropathies,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",group,Disease or Syndrome,0.01,0.0,,1997.0,1997.0,ALL
101060200,ZNF891,A8MT65,,,6.1344e-07,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
101060226,NBPF19,A0A087WUL8,1.0,0.038,,,,C1863843,Neuronal intranuclear inclusion disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
101060233,OPN1MW3,P04001;P0DN77;P0DN78,0.601,0.769,,,,C0024809,Marijuana Abuse,C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.07,1.0,,2018.0,2020.0,ALL
101060264,FOXP4-AS1,,0.736,0.154,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101060321,TBC1D3G,Q6DHY5;Q6IPX1;Q8IZP1,0.931,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
101060385,LINC01939,,0.89,0.115,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
101060389,TBC1D3D,A0A087WVF3,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
101060691,NUTM2B-AS1,,1.0,0.115,,,,C0270952,"Muscular Dystrophy, Oculopharyngeal",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,1.0,,2019.0,2019.0,ALL
101101692,HELLPAR,,0.76,0.269,,,,C0162739,HELLP Syndrome,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.3,1.0,,2012.0,2012.0,ALL
101101775,TMEM220-AS1,,0.792,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
101154687,LINC01081,,0.931,0.115,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101154753,PANDAR,,0.623,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2015.0,2019.0,ALL
101180900,MSE,,0.821,0.231,,,,C0014547,"Epilepsies, Partial",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
101180907,USH1K,,1.0,0.192,,,,C1568247,"Usher Syndrome, Type I",C23;C16;C11;C10;C09,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Nervous System Diseases;    Otorhinolaryngologic Diseases",disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
101180976,IFNL4,K9M1U5,0.67,0.577,,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.2,0.952,,2013.0,2020.0,ALL
101234261,LSINCT5,,0.67,0.346,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2012.0,2019.0,ALL
101241892,NPTN-IT1,,0.705,0.154,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.05,1.0,,2015.0,2018.0,ALL
101243555,PTENP1-AS,,0.821,0.192,,,,C0003486,Aortic Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
101290498,AD17,,0.839,0.308,,,,C0011265,Presenile dementia,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2016.0,2016.0,ALL
101290503,BANF1P5,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
101409257,EZR-AS1,,0.861,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
101410538,MMP24OS,A0A0U1RRL7,1.0,0.038,,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2015.0,ALL
101410542,UCHL1-AS1,,1.0,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
101448070,GLC1P,,1.0,0.038,,,,C0152136,Low Tension Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0,,2011.0,2014.0,ALL
101515984,LINC01080,,0.931,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
101669762,BLACAT1,,0.647,0.346,,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101669763,JADRR,,,,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
101669764,GPR1-AS,,1.0,0.077,,,,C0008497,Choriocarcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101669767,SCHLAP1,,0.751,0.192,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.38,1.0,,2013.0,2018.0,ALL
101730217,SPECC1L-ADORA2A,,0.89,0.231,,,,C0796179,Teebi syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
101735302,STAG3L5P,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101752399,STAG3L5P-PVRIG2P-PILRB,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101805488,CCAT2,,0.621,0.615,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.17,1.0,,2007.0,2019.0,ALL
101805491,LINC02583,,,,,,,C0019029,Hemoglobin concentration result,,,phenotype,Laboratory or Test Result,0.1,1.0,,2010.0,2010.0,ALL
101805492,CASC9,,0.644,0.462,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.14,1.0,,2013.0,2019.0,ALL
101867536,PRNCR1,,0.722,0.385,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.17,1.0,,2008.0,2019.0,ALL
101926885,OCA5,,0.931,0.154,,,,C3888401,"ALBINISM, OCULOCUTANEOUS, TYPE V",,,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
101926888,RALY-AS1,,,,,,,C0919677,Protein C measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2010.0,2010.0,ALL
101926895,CRTC3-AS1,,0.792,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
101926896,GLIS2-AS1,,0.931,0.077,,,,C0262587,Parathyroid Adenoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101926903,LSAMP-AS1,,1.0,0.115,,,,C0280324,Laryngeal Squamous Cell Carcinoma,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101926911,VPS33B-DT,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101926924,LINC01375,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
101926925,LINC01358,,0.931,0.077,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2016.0,2016.0,ALL
101926926,RDH10-AS1,,,,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
101926941,SPRY4-AS1,,0.89,0.192,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101926942,LINC02653,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
101926947,LINC01617,,0.931,0.077,,,,C0014859,Esophageal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
101926950,LINC01570,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
101926966,LINC01804,,0.931,0.115,0.10066,,,C0009324,Ulcerative Colitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
101926975,LINC01844,,1.0,0.077,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
101926978,LINC01111,,0.89,0.115,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101926996,RUNDC3A-AS1,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101927003,PKIA-AS1,,1.0,0.077,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
101927027,CHROMR,,0.861,0.154,,,,C0011615,"Dermatitis, Atopic",C16;C17;C20,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Immune System Diseases",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
101927034,ROR1-AS1,,0.751,0.192,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101927043,EPCAM-DT,,1.0,0.115,,,,C0235974,Pancreatic carcinoma,C06;C04;C19,   Digestive System Diseases;    Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101927056,LINC02614,,,,,,,C0523677,Glycine measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101927062,LINC02294,,1.0,0.038,,,,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
101927070,LINC02611,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101927074,LINC00682,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
101927075,FGF10-AS1,,0.839,0.077,,,,C0007117,Basal cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
101927087,LINC02516,,1.0,0.077,,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2020.0,2020.0,ALL
101927096,CLMAT3,,0.861,0.115,,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
101927112,LINC01581,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101927117,PLCG1-AS1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101927123,LINC02016,,,,,,,C2697761,Interleukin 13 Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
101927125,ELFN1-AS1,,0.821,0.154,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
101927134,LINC01470,,0.89,0.077,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
101927142,NPAS2-AS1,,1.0,0.038,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
101927149,LINC01471,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101927152,SAMMSON,,0.78,0.231,,,,C0424574,Duration of sleep,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
101927155,LMO7-AS1,,1.0,0.115,,,,C0011884,Diabetic Retinopathy,C11;C19;C14,   Eye Diseases;    Endocrine System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
101927156,LINC01934,,0.821,0.308,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
101927167,GATA2-AS1,,0.839,0.115,,,,C0600139,Prostate carcinoma,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
101927174,CHL1-AS2,,0.931,0.038,,,,C0036439,"Scoliosis, unspecified",C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
101927193,CHL1-AS1,,0.861,0.115,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
101927195,LINC00382,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2019.0,2019.0,ALL
101927211,ZNF451-AS1,,0.931,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
101927215,LINC01266,,1.0,0.077,,,,C4277682,Chemical and Drug Induced Liver Injury,C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
101927219,HNF4A-AS1,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2018.0,ALL
101927224,LINC01049,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101927256,CARD11-AS1,,1.0,,,,,C4551967,B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY,,,disease,Disease or Syndrome,0.1,,,,,ALL
101927273,LINC01416,,0.89,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2007.0,2007.0,ALL
101927275,NDUFV2-AS1,,1.0,,,,,C4748760,"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7",,,disease,Disease or Syndrome,0.1,,,,,ALL
101927279,EP300-AS1,,0.839,0.231,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
101927282,LINC02466,,1.0,0.038,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
101927285,LINC01793,,0.931,0.077,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
101927289,LINC01237,,0.931,0.115,,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
101927292,LINC02395,,1.0,0.038,,,,C0028768,Obsessive-Compulsive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2013.0,ALL
101927295,LINC01360,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2019.0,ALL
101927323,PPP4R1-AS1,,,,,,,C0200665,Platelet mean volume determination (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
101927324,LINC01475,,0.78,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
101927350,LINC01254,,0.89,0.115,,,,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
101927364,LINC01571,,,,,,,C0201657,C-reactive protein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
101927379,LINC02201,,0.931,0.038,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
101927381,LINC01163,,,,,,,C2697764,Interleukin 16 Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
101927394,LOC101927394,,0.931,0.115,,,,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101927411,LINC01782,,1.0,0.038,,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
101927417,FHAD1-AS1,,0.931,0.115,,,,C0010051,Coronary Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
101927460,LINC02240,,0.839,0.269,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101927477,LINC01507,,1.0,0.077,,,,C0279671,Cervical Squamous Cell Carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
101927487,LINC01609,,,,,,,C0337439,Iron measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
101927497,CDK6-AS1,,0.861,0.115,,,,C0279584,Childhood B Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
101927525,COL1A2-AS1,,1.0,0.038,,,,C0162810,"Cicatrix, Hypertrophic",C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.02,1.0,,2016.0,2018.0,ALL
101927542,LINC01712,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101927547,ANKRD44-IT1,,0.821,0.192,,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
101927549,LINC02627,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
101927554,LINC01250,,0.743,0.231,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
101927574,LINC01186,,0.805,0.231,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
101927579,DNM1P50,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
101927587,LINC01725,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2010.0,2011.0,ALL
101927592,LINC02405,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
101927597,NCK1-DT,,0.78,0.154,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
101927619,LINC01923,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101927621,LINC01534,,1.0,0.038,,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
101927624,LINC01150,,0.931,0.038,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
101927629,LINC02165,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
101927631,ADNP-AS1,,1.0,0.077,,,,C1837396,"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie",C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2016.0,ALL
101927640,LAMA4-AS1,,1.0,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
101927641,LINC01877,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
101927651,LINC01927,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101927655,ZASP,,0.821,0.192,,,,C0007193,"Cardiomyopathy, Dilated",C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.04,0.75,,2003.0,2016.0,ALL
101927667,LINC01535,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101927688,SEPTIN4-AS1,,1.0,0.115,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
101927697,LINC02227,,,,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
101927698,DSCAS,,0.931,0.115,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
101927700,LINC01524,,0.839,0.192,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101927703,FOXCUT,,0.821,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
101927718,DSG1-AS1,,0.931,0.077,,,,C1842839,HYPOTRICHOSIS 6,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
101927721,LNCPRESS1,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
101927728,LINC01476,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101927746,EMSLR,,0.695,0.5,,,,C0018790,Cardiac Arrest,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0,,2018.0,2019.0,ALL
101927750,ATP6V1B1-AS1,,,,,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
101927761,TH2LCRR,,0.751,0.385,,,,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
101927763,OLFM5P,,,,,,,C0200695,Fetal hemoglobin determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2008.0,2008.0,ALL
101927766,LINC01847,,0.89,0.154,,,,C0002895,"Anemia, Sickle Cell",C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101927768,HDAC2-AS2,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2013.0,2019.0,ALL
101927774,LINC00824,,0.695,0.346,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2019.0,ALL
101927777,SATB1-AS1,,0.931,0.077,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101927780,LINC01303,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101927813,HMMR-AS1,,0.792,0.154,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
101927821,LINC01425,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
101927835,LINC02143,,0.89,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2007.0,2007.0,ALL
101927843,LINC01687,,1.0,0.077,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
101927849,LINC02355,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101927866,LINC02010,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101927873,LINC01508,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101927880,LINC02669,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101927889,LINC01153,,,,,,,C2700366,Adiponectin Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2014.0,2014.0,ALL
101927891,PKN2-AS1,,0.769,0.385,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2010.0,2019.0,ALL
101927895,EMC1-AS1,,0.792,0.385,,,,C0003466,"Anus, Imperforate",C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.1,1.0,,2016.0,2017.0,ALL
101927904,LINC02660,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
101927921,LINC01478,,1.0,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101927947,LOC101927947,,1.0,0.038,,,,C4554344,IgE-mediated food allergy,C20,   Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
101927953,C5orf66-AS1,,0.792,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2018.0,2018.0,ALL
101927957,LINC01572,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2019.0,ALL
101927973,LINC01695,,,,,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
101927980,SLC14A2-AS1,,1.0,0.038,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
101927988,LINC01527,,0.931,0.154,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
101927990,TRDN-AS1,,0.931,0.077,,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
101928033,KCNIP1-OT1,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
101928062,PRANCR,,0.89,0.192,,,,C0017612,"Glaucoma, Open-Angle",C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
101928079,SLC44A3-AS1,,0.931,0.115,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2012.0,2012.0,ALL
101928098,ALG14-AS1,,1.0,,,,,C4015596,"MYASTHENIC SYNDROME, CONGENITAL, 15",,,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
101928099,PCAT7,,0.89,0.231,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101928100,LOC101928100,,1.0,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
101928103,SNHG31,,0.89,0.115,,,,C0020757,Ichthyoses,C16;C17,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
101928104,LINC01482,,1.0,0.192,,,,C0202178,Phosphorus measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
101928114,LINC01811,,0.89,0.192,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101928122,LINC01483,,0.89,0.077,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101928132,LINC02683,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
101928136,LINC01484,,,,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101928137,LINC02444,,,,,,,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
101928142,AADACL2-AS1,,0.89,0.192,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
101928153,ITGA9-AS1,,,,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101928154,LINC01485,,,,,,,C0200637,Monocyte count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
101928158,LAMA5-AS1,,1.0,0.154,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
101928167,LINC01917,,0.931,0.115,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,,,,,ALL
101928176,LINC01411,,1.0,0.115,,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
101928205,LINC02097,,,,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
101928223,LINC01612,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
101928227,LINC02345,,,,,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
101928231,CT69,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
101928241,LINC01787,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101928243,DARS-AS1,,0.805,0.231,,,,C0007115,Malignant neoplasm of thyroid,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101928248,LINC01229,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
101928270,LINC01708,,0.861,0.192,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
101928280,LINC02549,,1.0,0.038,,,,C0042345,Varicosity,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101928290,PLBD1-AS1,,0.931,0.038,,,,C2939175,Meconium ileus,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
101928292,LINC01488,,0.931,0.077,,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
101928324,DHDDS-AS1,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
101928337,PTCSC2,,0.751,0.231,,,,C0549473,Thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.11,1.0,,2009.0,2018.0,ALL
101928376,IL12A-AS1,,0.633,0.654,,,,C0004943,Behcet Syndrome,C16;C11;C17;C07;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases;    Skin and Connective Tissue Diseases;    Stomatognathic Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.41,1.0,,2013.0,2016.0,ALL
101928388,PLA2G4E-AS1,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
101928399,LINC01679,,0.931,0.077,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101928437,LOC101928437,,,,,,,C3714756,Intellectual Disability,C23;C10;F03;F01,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases;    Mental Disorders;    Behavior and Behavior Mechanisms",group,Mental or Behavioral Dysfunction,0.01,1.0,,2015.0,2015.0,ALL
101928442,LINC01491,,,,,,,C0037290,Skin Pigmentation,,,phenotype,Organ or Tissue Function,0.1,1.0,,2007.0,2007.0,ALL
101928448,C5orf67,F2Z3F1,0.89,0.115,0.022173,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
101928449,LINC02426,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
101928455,LINC01412,,0.931,0.115,,,,C0200641,Blood basophil count (lab test),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2018.0,ALL
101928464,ZNF433-AS1,,1.0,0.077,,,,C0026769,Multiple Sclerosis,C20;C10,   Immune System Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
101928478,LINC02269,,0.931,0.115,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101928483,NALT1,,0.89,0.154,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101928492,OR2A1-AS1,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101928509,LINC02268,,0.931,0.115,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
101928537,LINC01494,,0.931,0.115,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
101928555,LINC01537,,0.89,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101928583,SLC7A14-AS1,,1.0,,,,,C0015944,"Fetal Membranes, Premature Rupture",C13,   Female Urogenital Diseases and Pregnancy Complications,phenotype,Pathologic Function,0.1,1.0,,2019.0,2019.0,ALL
101928591,LINC02745,,0.89,0.115,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101928601,MEI4,A8MW99,1.0,0.077,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2011.0,2011.0,ALL
101928604,ZBTB46-AS1,,,,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101928607,TRPM2-AS,,0.736,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2015.0,2018.0,ALL
101928630,SMIM15-AS1,,1.0,0.038,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
101928638,LINC02692,,,,0.0011229,,,C0524957,Corneal Topography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2013.0,2013.0,ALL
101928646,ARNTL2-AS1,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
101928650,GORAB-AS1,,0.792,0.192,,,,C0029489,Other alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",phenotype,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
101928677,ETDA,Q3ZM63,1.0,0.038,,,,C0022578,Keratoconus,C11,   Eye Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
101928687,LNCAROD,,1.0,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101928694,LIPC-AS1,,0.839,0.154,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
101928710,SCAT1,,1.0,0.038,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
101928734,WWC2-AS1,,,,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101928736,MIR762HG,,1.0,0.077,,,,C0752347,Lewy Body Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101928765,LINC01807,,0.89,0.077,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2012.0,2019.0,ALL
101928776,LINC01258,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101928784,RORA-AS1,,0.931,0.115,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
101928791,LINC01147,,0.821,0.192,,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
101928812,LINC02696,,,,,,,C0040420,Tonometry,,,phenotype,Diagnostic Procedure,0.1,1.0,,2018.0,2018.0,ALL
101928891,LINC01637,,,,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
101928931,SEMA3B-AS1,,0.805,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
101928941,RHOXF1P1,,,,,,,C0042769,Virus Diseases,C01,   Infections,group,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
101928989,MIR4300HG,,0.839,0.077,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.11,1.0,,2017.0,2018.0,ALL
101928992,LINC02069,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
101928995,LINC01649,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
101929010,SIRPG-AS1,,1.0,0.115,,,,C0011854,"Diabetes Mellitus, Insulin-Dependent",C18;C20;C19,   Nutritional and Metabolic Diseases;    Immune System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
101929011,LINC02702,,1.0,0.038,,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2012.0,ALL
101929023,LINC01762,,1.0,0.038,,,,C0272178,Drug-induced neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101929025,LINC01516,,,,,,,C0150045,Urge Incontinence,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2015.0,2015.0,ALL
101929043,DLG2-AS2,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
101929052,LINC00836,,1.0,,,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
101929071,LINC01182,,1.0,0.077,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
101929077,LINC02334,,0.931,0.192,,,,C0201836,Alanine aminotransferase measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
101929080,LINC02292,,,,,,,C0428883,Diastolic blood pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
101929084,LINC02401,,,,,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
101929095,C1QTNF7-AS1,,1.0,0.038,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
101929110,CASC18,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101929111,LINC01149,,0.792,0.346,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101929144,LINC01858,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101929147,WARS2-AS1,,1.0,0.077,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
101929163,TSBP1-AS1,,0.638,0.692,,,,C0002171,Alopecia Areata,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
101929164,LINC01859,,1.0,0.115,,,,C1336708,Testicular Germ Cell Tumor,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101929199,LINC02261,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101929212,SMIM2-AS1,,,,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2019.0,ALL
101929218,LINC01517,,,,,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101929221,INSYN1-AS1,,,,,,,C4049919,Insulin Sensitivity Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2015.0,2015.0,ALL
101929222,DISC1FP1,,0.931,0.038,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2017.0,2019.0,ALL
101929224,DDX59-AS1,,1.0,0.038,,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2018.0,ALL
101929231,MMADHC-DT,,0.839,0.192,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
101929238,C3orf67-AS1,,0.89,0.154,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
101929241,LINC02325,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
101929244,CASC20,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2019.0,ALL
101929247,LINC01231,,,,,,,C1861172,Venous Thromboembolism,C14,   Cardiovascular Diseases,phenotype,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
101929265,LINC01428,,,,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
101929302,RFX3-AS1,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
101929316,PRICKLE2-DT,,,,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
101929328,KCNMA1-AS1,,0.705,0.654,,,,C0007384,Cataplexy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,,,,,ALL
101929335,ADAMTS9-AS1,,0.861,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101929344,LINC01198,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101929355,CFAP97D2,A0A1B0GU71,,,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
101929378,LINC01876,,0.861,0.115,,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
101929395,LINC01752,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101929397,LINC01518,,1.0,0.077,,,,C0279626,Squamous cell carcinoma of esophagus,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101929423,MEF2C-AS1,,0.861,0.154,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2013.0,2016.0,ALL
101929441,ERLNC1,,0.89,0.154,,,,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.04,1.0,,2014.0,2020.0,ALL
101929447,IATPR,,0.722,0.269,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.05,1.0,,2015.0,2019.0,ALL
101929448,LINC02428,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101929468,CXXC4-AS1,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2019.0,ALL
101929476,LINC01698,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
101929484,LINC01615,,0.89,0.154,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
101929495,LINC01339,,0.931,0.115,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
101929505,LINC02150,,1.0,0.038,,,,C4021107,Non-obstructive azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
101929516,PABPC4-AS1,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2019.0,ALL
101929517,ETS1-AS1,,0.821,0.192,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101929520,LINC00993,,0.729,0.269,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
101929529,GSTCD-AS1,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2010.0,2017.0,ALL
101929539,LINC01422,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
101929541,LINC02608,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101929544,LINC02217,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
101929549,GAU1,,,,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
101929559,LINC00211,,0.931,0.077,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101929567,LINC01814,,0.931,0.077,,,,C0013595,Eczema,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
101929582,LINC01241,,1.0,0.038,,,,C0026603,Motion Sickness,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
101929591,KIZ-AS1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2014.0,2014.0,ALL
101929596,LINC02613,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101929620,LINC01243,,1.0,0.038,,,,C0026603,Motion Sickness,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
101929624,LINC01519,,,,,,,C0202177,Phospholipid measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
101929637,NTM-AS1,Q6ZSK4,1.0,,,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
101929639,B4GALT1-AS1,,0.792,0.192,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
101929655,TMC3-AS1,,1.0,0.038,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
101929660,LINC02109,,0.821,0.115,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
101929663,LINC01427,,1.0,0.077,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
101929664,HORMAD2-AS1,,0.839,0.308,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
101929665,UBE2R2-AS1,,0.839,0.038,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101929680,SCN1A-AS1,,0.636,0.346,,,,C0004352,Autistic Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,,,,,ALL
101929685,LNCNEF,,0.716,0.231,,,,C0428568,Fasting blood glucose measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2015.0,2019.0,ALL
101929690,LINC01583,,1.0,0.038,0.049813,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101929707,LOC101929707,,1.0,0.077,,,,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
101929715,ODC1-DT,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101929717,LINC02044,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101929726,MYMX,A0A1B0GTQ4,0.7,0.5,,,,C0008055,Chikungunya Fever,C01,   Infections,disease,Disease or Syndrome,0.03,1.0,,2015.0,2019.0,ALL
101929745,LINC02119,,0.89,0.077,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
101929746,ZNF341-AS1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
101929753,MYO3B-AS1,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
101929754,ZBTB20-AS5,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101929760,PIK3IP1-AS1,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101929765,LINC01585,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101929768,OSMR-AS1,,1.0,0.077,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
101929769,LINC01063,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
101929951,MACORIS,,1.0,0.077,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
101930010,DST-AS1,,1.0,,,,,C3539003,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI",,,disease,Disease or Syndrome,0.1,,,,,ALL
101930023,LINC02391,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
101930114,HSD11B1-AS1,,1.0,,,,,C3553382,CORTISONE REDUCTASE DEFICIENCY 2,,,disease,Disease or Syndrome,0.1,,,,,ALL
101930370,LOC101930370,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
101954264,RNVU1-4,,0.931,0.077,,,,C0278701,Gastric Adenocarcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
101978719,LINC00970,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
101978785,PCAT14,,0.861,0.154,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.04,1.0,,2016.0,2017.0,ALL
102060282,RASSF1-AS1,,0.89,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102060414,C2-AS1,,0.821,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
102157401,PCBP2-OT1,,0.722,0.269,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.04,0.75,,2017.0,2019.0,ALL
102157402,AK6,Q9Y3D8,0.678,0.538,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
102191832,FBXW7-AS1,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
102216342,LINC01108,,1.0,0.038,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
102464817,MIR5787,,1.0,0.077,,,,C0349566,Squamous cell carcinoma of tongue,C04;C07,   Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102464826,MIR6073,,,,,,,C0013371,Shigella Infections,C06;C01,   Digestive System Diseases;    Infections,group,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
102464837,MIR6089,,0.931,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
102465134,MIR6126,,0.839,0.231,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
102465141,MIR6165,,0.89,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2012.0,2020.0,ALL
102465252,MIR6506,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465253,MIR6507,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465431,MIR6722,,0.931,0.077,,,,C0026654,Moyamoya Disease,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
102465437,MIR6731,,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
102465443,MIR6740,,1.0,0.077,,,,C0577631,Carotid Atherosclerosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
102465445,MIR6743,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
102465464,MIR6775,,0.89,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102465465,MIR6776,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
102465472,MIR6787,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465485,MIR6809,,0.89,0.115,,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465489,MIR6815,,0.839,0.077,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
102465491,MIR6819,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465496,MIR6826,,0.89,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
102465502,MIR6835,,0.89,0.115,,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
102465503,MIR6836,,1.0,0.038,,,,C0162810,"Cicatrix, Hypertrophic",C23,"   Pathological Conditions, Signs and Symptoms",disease,Acquired Abnormality,0.01,1.0,,2018.0,2018.0,ALL
102465504,MIR6838,,0.931,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465505,MIR6839,,0.931,0.115,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102465513,MIR6852,,0.736,0.154,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
102465515,MIR6856,,0.89,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465516,MIR6857,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102465519,MIR6861,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
102465524,MIR6869,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2018.0,ALL
102465526,MIR6872,,0.931,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465528,MIR6877,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465530,MIR6881,,1.0,0.077,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
102465531,MIR6882,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
102465532,MIR6883,,0.89,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
102465534,MIR6886,,0.861,0.077,,,,C0020443,Hypercholesterolemia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
102465537,MIR6891,,1.0,,,,,C1527304,Allergic Reaction,C20,   Immune System Diseases,phenotype,Pathologic Function,0.1,1.0,,2017.0,2017.0,ALL
102465667,MIR7110,,0.931,0.077,,,,C0036690,Septicemia,C23;C01,"   Pathological Conditions, Signs and Symptoms;    Infections",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
102465800,MIR7702,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,0.0,,2018.0,2018.0,ALL
102465802,MIR7704,,0.821,0.154,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
102465803,MIR7706,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102465833,MIR4433B,,0.839,0.077,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
102465841,MIR7855,,1.0,0.077,,,,C0151517,Complete atrioventricular block,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
102465858,MIR7977,,0.769,0.346,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
102465859,MIR7978,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465866,MIR8064,,1.0,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465872,MIR8073,,0.839,0.154,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102465874,MIR8075,,0.861,0.115,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465877,MIR8080,,1.0,0.077,,,,C1328504,Hormone refractory prostate cancer,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465976,MIR6807,,0.861,0.077,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102465993,MIR7847,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
102466104,MIR6090,,1.0,0.038,,,,C1956346,Coronary Artery Disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
102466223,MIR7114,,1.0,0.038,,,,C0038013,Ankylosing spondylitis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
102466225,MIR6077,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102466235,MIR7515,,0.89,0.077,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
102466247,MIR1273H,,0.839,0.077,,,,C0019193,"Hepatitis, Toxic",C06;C25,   Digestive System Diseases;    Chemically-Induced Disorders,disease,Injury or Poisoning,0.3,1.0,,2017.0,2017.0,ALL
102466251,MIR8061,,0.931,0.115,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
102466270,MIR6741,,0.805,0.308,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
102466271,MIR6893,,0.89,0.077,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102466515,MIR1199,,1.0,0.077,0.00067712,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
102466519,MIR6086,,,,,,,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
102466656,MIR6500,,0.931,0.077,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.3,1.0,,2018.0,2018.0,ALL
102466659,MIR6515,,0.89,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102466719,MIR6716,,0.861,0.192,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,0.0,,2017.0,2017.0,ALL
102466723,MIR6734,,0.89,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
102466728,MIR6754,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102466733,MIR6778,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102466734,MIR6783,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102466737,MIR6793,,1.0,0.038,,,,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
102466738,MIR6798,,0.861,0.038,,,,C0017636,Glioblastoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102466739,MIR6803,,0.839,0.192,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.3,1.0,,2017.0,2017.0,ALL
102466746,MIR6780B,,0.89,0.115,,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102466747,MIR6840,,0.931,0.192,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,0.0,,2020.0,2020.0,ALL
102466748,MIR6845,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
102466753,MIR6868,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102466755,MIR6875,,0.861,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
102466757,MIR6884,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102466854,MIR7705,,1.0,0.115,,,,C0279680,Transitional cell carcinoma of bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
102466864,MIR6516,,,,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102466911,MIR6785,,0.931,0.154,,,,C0002893,Refractory anemias,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
102466972,MIR6508,,1.0,0.077,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102467005,MIR8084,,0.839,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102467146,MAFTRR,,1.0,0.077,,,,C0202230,Thyroid stimulating hormone measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
102467213,LINC01950,,1.0,0.038,,,,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
102467224,LINC02147,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
102467225,LINC02215,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
102546226,LINC02060,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
102546227,LINC01340,,,,,,,C0429087,Electrocardiogram: P-R interval,,,phenotype,Finding,0.1,1.0,,2013.0,2013.0,ALL
102578074,PCAT5,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
102606463,LINC01152,,0.729,0.231,,,,C0042345,Varicosity,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2019.0,ALL
102659353,THRIL,,0.743,0.5,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
102723099,GHET1,,0.647,0.308,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.1,1.0,,2017.0,2019.0,ALL
102723100,OTSC10,,1.0,0.038,,,,C0029899,Otosclerosis,C09,   Otorhinolaryngologic Diseases,disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
102723165,LINC01169,,1.0,0.077,0.0093616,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
102723356,ZFPM2-AS1,,0.736,0.385,,,,C0013069,Double Outlet Right Ventricle,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.1,,,,,ALL
102723362,LINC01884,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2019.0,ALL
102723377,CDH23-AS1,,0.839,0.192,,,,C0035334,Retinitis Pigmentosa,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
102723407,LOC102723407,,0.514,0.769,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,1993.0,2017.0,ALL
102723426,LINC01496,,0.89,0.154,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2008.0,2008.0,ALL
102723465,ELF3-AS1,,0.89,0.115,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
102723475,KCNE1B,A0A087WTH5,1.0,0.077,,,,C0022387,Jervell-Lange Nielsen Syndrome,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Disease or Syndrome,0.2,1.0,,1996.0,2005.0,ALL
102723487,LINC01497,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
102723505,ROCR,,0.89,0.115,,,,C0042345,Varicosity,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2019.0,ALL
102723508,KANTR,,1.0,0.038,,,,C0009447,Common Variable Immunodeficiency,C20,   Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
102723526,LINC02218,,1.0,0.038,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
102723547,CSAG2,Q9Y5P2,0.691,0.346,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,1999.0,2006.0,ALL
102723557,LMNB1-DT,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
102723578,LINC01440,,1.0,0.038,,,,C0026603,Motion Sickness,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
102723605,LINC01445,,1.0,0.077,,,,C0302592,Cervix carcinoma,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
102723619,ATXN2-AS,,0.89,0.192,,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.04,1.0,,2010.0,2019.0,ALL
102723644,LINC01499,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
102723661,LINC02790,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
102723680,CT45A9,P0DMV1;P0DMV2;Q5DJT8,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
102723699,LINC02284,,0.931,0.154,,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
102723737,CT45A8,P0DMV1;P0DMV2;Q5DJT8,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
102723741,LINC02863,,0.821,0.154,,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
102723742,LINC01500,,0.76,0.192,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
102723775,LINC01315,,1.0,0.115,,,,C0596263,Carcinogenesis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
102723778,LINC02497,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2019.0,2019.0,ALL
102723818,LINC01248,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
102723828,LINC02506,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
102723839,LINC02224,,0.931,0.077,,,,C0011334,Dental caries,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
102723854,LINC01819,,,,,,,C0392885,High density lipoprotein measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
102723859,TBC1D3E,A0A087X179,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
102723886,LYPLAL1-AS1,,,,,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2017.0,2017.0,ALL
102723895,LINC02552,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
102723971,LOC102723971,,0.663,0.577,,,,C0266815,Cow milk allergy,C06;C20,   Digestive System Diseases;    Immune System Diseases,phenotype,Disease or Syndrome,0.1,0.909,,2001.0,2020.0,ALL
102723996,LOC102723996,,0.769,0.423,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.02,1.0,,2015.0,2017.0,ALL
102724023,GATD3B,A0A0B4J2D5;P0DPI2,0.636,0.577,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2009.0,2019.0,ALL
102724047,WWOX-AS1,,0.89,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
102724168,LINC02542,,0.861,0.115,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
102724197,LOC102724197,,0.559,0.731,,,,C0008370,Cholestasis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2001.0,2019.0,ALL
102724233,LINC02576,,0.931,0.154,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2018.0,ALL
102724250,LOC102724250,,0.89,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102724297,CCR5AS,,0.805,0.115,,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
102724334,LOC102724334,P57053,0.711,0.615,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2015.0,2016.0,ALL
102724341,NEURL1-AS1,,,,,,,C0032176,Platelet aggregation,,,phenotype,Cell Function,0.1,1.0,,2010.0,2010.0,ALL
102724344,LINC02188,,0.931,0.115,,,,C0022661,"Kidney Failure, Chronic",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
102724362,SPINT1-AS1,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102724373,LINC02831,,0.931,0.115,,,,C0017168,Gastroesophageal reflux disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
102724428,SIK1B,A0A0B4J2F2;P57059,0.653,0.385,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2014.0,2019.0,ALL
102724539,LINC01714,,1.0,0.038,,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
102724552,RERE-AS1,,0.89,0.077,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
102724555,ASB15-AS1,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
102724560,CBSL,P0DN79;P35520,0.54,0.808,,,,C0019880,Homocystinuria,C16;C18;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.3,0.988,,1992.0,2019.0,ALL
102724562,LOC102724562,,1.0,0.077,,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,1999.0,1999.0,ALL
102724571,LNCTAM34A,,0.931,0.077,,,,C0424678,Lean body mass,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
102724594,U2AF1L5,P0DN76;Q01081,0.769,0.308,,,,C3463824,MYELODYSPLASTIC SYNDROME,C15,   Hemic and Lymphatic Diseases,group,Neoplastic Process,0.04,1.0,,2012.0,2019.0,ALL
102724623,LINC01414,,1.0,0.038,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
102724652,CRYAA2,A0A140G945;P02489,0.821,0.192,,,,C0009691,Congenital cataract,C23;C16;C13;C11;C10,"   Pathological Conditions, Signs and Symptoms;    Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Eye Diseases;    Nervous System Diseases",disease,Congenital Abnormality,0.21,1.0,,1996.0,2018.0,ALL
102724659,C1orf167-AS1,,,,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2018.0,2018.0,ALL
102724661,LINC01645,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2017.0,2017.0,ALL
102724698,LINC01905,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2019.0,ALL
102724699,LINC02043,,,,,,,C2700366,Adiponectin Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2009.0,2009.0,ALL
102724714,LINC01857,,0.89,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
102724763,LINC02040,,1.0,0.038,,,,C0525045,Mood Disorders,F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
102724774,LINC01594,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
102724810,LINC02062,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
102724820,LANCL1-AS1,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
102724826,ZNF337-AS1,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2018.0,2018.0,ALL
102724834,LINC02822,,0.89,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
102724862,TBC1D3I,A0A087WXS9,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
102724913,LINC01899,,1.0,0.077,,,,C0008924,Cleft upper lip,C16;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2009.0,2009.0,ALL
102724927,LINC02861,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
102724971,LOC102724971,,0.527,0.769,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,1993.0,2017.0,ALL
102725035,LOC102725035,O75022,0.839,0.231,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
102725045,LINC02588,,1.0,0.115,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
102725509,LINC01232,,0.89,0.154,,,,C0151546,Oral Cavity Carcinoma,C06;C04;C07,   Digestive System Diseases;    Neoplasms;    Stomatognathic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
102725541,ELDR,,0.89,0.192,,,,C0002736,Amyotrophic Lateral Sclerosis,C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
102775567,DDH2,,0.821,0.115,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2012.0,2012.0,ALL
102800310,HAGLROS,,0.705,0.462,,,,C0919267,ovarian neoplasm,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.11,1.0,,2010.0,2019.0,ALL
102800311,TP53COR1,,0.628,0.5,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2013.0,2019.0,ALL
102800314,MIR7515HG,,1.0,0.077,,,,C4721579,Secondary malignant neoplasm of colon and/or rectum,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
102800316,LINC01222,,,,,,,C0206161,Reticulocyte count (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
102800317,TPTEP2-CSNK1E,P49674,0.678,0.5,,,,C3463992,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
102800446,LINC01230,,,,,,,C0856169,Endothelial dysfunction,,,phenotype,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
102800447,LINC01828,,0.89,0.115,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
103021164,CASC21,,0.861,0.154,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
103021165,CASC19,,0.769,0.423,,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
103021294,ABALON,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
103091864,SNHG22,,0.861,0.346,,,,C0085679,Hyperchloremia,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
103157000,PAUPAR,,0.89,0.115,,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
103164619,PCAT2,,0.751,0.462,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,0.5,,2017.0,2019.0,ALL
103344718,HOTS,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2011.0,2011.0,ALL
103344929,BGLT3,,0.89,0.077,,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
103344930,LINC01391,,1.0,0.077,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
103352539,LINC01410,,0.805,0.115,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
103352670,LINC01419,,0.805,0.115,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
103504730,MIR9500,,0.89,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
103504737,MIR8485,,1.0,0.077,,,,C0206139,"Lichen Planus, Oral",C17;C07,   Skin and Connective Tissue Diseases;    Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
103611090,CDR1-AS,,0.623,0.654,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2018.0,2019.0,ALL
103625681,LLPH-DT,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
103625684,RNU6-2,,0.839,0.192,,,,C0003486,Aortic Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
103689844,LINC01288,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
103689913,LINC00383,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
103689915,DLEU1-AS1,,0.861,0.154,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
103695363,FOXG1-AS1,,1.0,0.077,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
103695431,LINC01048,,1.0,0.077,,,,C0553723,Squamous cell carcinoma of skin,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,0.0,,2019.0,2019.0,ALL
103724389,LINC01170,,1.0,0.077,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
103724390,LINC01287,,0.861,0.154,,,,C1269955,Tumor Cell Invasion,,,phenotype,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
103752584,CCND2-AS1,,0.76,0.154,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
103752587,FOXC2-AS1,,0.751,0.231,,,,C0265345,Lymphedema distichiasis syndrome,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
103752588,PACERR,,0.839,0.154,,,,C0020538,Hypertensive disease,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
103753527,SCA37,,0.931,0.115,,,,C3889636,SPINOCEREBELLAR ATAXIA 37,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.31,1.0,,2013.0,2018.0,ALL
104266961,LINC01221,,1.0,0.038,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2019.0,ALL
104326052,NRIR,,1.0,0.038,,,,C0019101,Hemorrhagic Fever with Renal Syndrome,C01,   Infections,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
104326055,APOA1-AS,,0.76,0.269,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
104326057,GACAT1,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
104326193,DLX2-DT,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
104355217,ERICD,,0.691,0.654,,,,C1510586,Autism Spectrum Disorders,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.03,1.0,,2017.0,2020.0,ALL
104355218,LINC01177,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
104355219,LHX5-AS1,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
104355220,LINC01219,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
104355290,MIR217HG,,0.89,0.077,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
104457406,MIR222HG,,0.792,0.154,,,,C0003486,Aortic Aneurysm,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
104472713,PCAT29,,0.861,0.154,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.03,1.0,,2014.0,2017.0,ALL
104472715,SNHG14,,0.656,0.577,,,,C0162635,Angelman Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.17,1.0,,1999.0,2019.0,ALL
104472716,WARS2-IT1,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
104472848,IRAIN,,0.656,0.5,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.06,1.0,,2011.0,2019.0,ALL
104502417,MGAT3-AS1,,1.0,0.077,,,,C0022660,"Kidney Failure, Acute",C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
104548971,SALRNA1,,1.0,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
104564224,LUNAR1,,0.861,0.115,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
104564225,MHRT,,1.0,0.038,,,,C0152105,Hypertensive heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
104644205,ENPP7P13,,1.0,0.077,,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
104797537,GACAT3,,0.751,0.192,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.03,1.0,,2016.0,2018.0,ALL
104909134,LINC02210-CRHR1,P34998,0.57,0.692,,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.17,1.0,,2004.0,2019.0,ALL
104940698,DALIR,,0.89,0.077,,,,C0085207,Gestational Diabetes,C18;C13;C19,   Nutritional and Metabolic Diseases;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,phenotype,Disease or Syndrome,0.02,1.0,,2018.0,2020.0,ALL
105180392,HBB-3'HS1,,0.861,0.077,,,,C0019025,Hemoglobin F Disease,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,1994.0,1994.0,ALL
105221694,BISPR,,0.931,0.154,,,,C4016733,"HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS",,,phenotype,Finding,0.1,,,,,ALL
105259599,H19-ICR,,0.631,0.615,,,,C0004903,Beckwith-Wiedemann Syndrome,C16,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities",disease,Disease or Syndrome,0.4,1.0,,2007.0,2019.0,ALL
105274310,LOC105274310,,1.0,0.077,,,,C0175693,Russell-Silver syndrome,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.01,1.0,,2011.0,2011.0,ALL
105274375,TEMPS,,0.78,0.154,,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.02,1.0,,2005.0,2009.0,ALL
105369192,PPM1K-DT,,0.89,0.192,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
105369219,SIRPB3P,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
105369296,CYP4F9P,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105369343,MIR194-2HG,,0.931,0.038,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
105369347,RELA-DT,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
105369360,LINC02754,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105369427,LINC02748,,1.0,,,,,C0376705,Viral Load result,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
105369454,LINC02713,,,,,,,C3899405,Decreased Attention,,,phenotype,Sign or Symptom,0.1,1.0,,2018.0,2018.0,ALL
105369482,LINC02715,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
105369486,LINC02732,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105369563,LINC02725,,,,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
105369717,LINC02386,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
105369723,LINC02422,,0.931,0.038,,,,C0004106,Astigmatism,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
105369734,LINC02471,,0.861,0.154,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
105369738,LINC02451,,0.931,0.115,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
105369748,LOC105369748,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105369758,DDN-AS1,,0.89,0.077,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2019.0,2019.0,ALL
105369807,LINC02454,,0.931,0.077,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105369840,LINC02445,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
105369848,LNCOG,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105369876,LINC02820,,1.0,0.077,,,,C0008312,Primary biliary cirrhosis,C23;C06,"   Pathological Conditions, Signs and Symptoms;    Digestive System Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
105369893,LINC02392,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
105369920,LINC02410,,0.931,0.038,0.084786,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
105369929,LINC02409,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
105369942,LINC02456,,1.0,0.115,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105369984,LINC02356,,0.931,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2019.0,ALL
105370004,LINC02463,,0.931,0.077,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
105370060,LINC02824,,1.0,0.038,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
105370125,LINC02340,,,,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
105370158,LINC02343,,1.0,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105370177,LINC02341,,0.751,0.231,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
105370309,LINC02336,,0.861,0.192,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
105370333,PCCA-DT,,,,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2015.0,2015.0,ALL
105370423,LINC02281,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
105370425,LINC02326,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2019.0,ALL
105370431,G2E3-AS1,,0.89,0.115,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
105370479,LINC02303,,0.931,0.077,,,,C0025202,melanoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,1995.0,1995.0,ALL
105370496,LINC02310,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
105370498,LINC02319,,1.0,0.038,,,,C0029408,Degenerative polyarthritis,C05,   Musculoskeletal Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
105370503,LINC02331,,0.89,0.115,,,,C0410702,Adolescent idiopathic scoliosis,C05,   Musculoskeletal Diseases,disease,Anatomical Abnormality,0.1,1.0,,2018.0,2018.0,ALL
105370526,HIF1A-AS3,,,,,,,C0202236,Triglycerides measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
105370578,LINC01629,,1.0,0.077,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
105370607,LINC02309,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105370681,LINC02323,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
105370966,IDH2-DT,,,,,,,C0202239,Uric acid measurement (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
105371008,LINC02251,,1.0,,,,,C0424621,Body Fat Distribution,,,phenotype,Finding,0.1,1.0,,2011.0,2011.0,ALL
105371045,PERCC1,A0A1W2PR82,0.552,0.808,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2002.0,2019.0,ALL
105371260,LIX1L-AS1,,1.0,0.115,,,,C0175703,Thrombocytopenia-Absent Radius Syndrome,C16;C05;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2017.0,ALL
105371295,LINC02137,,,,,,,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2014.0,2014.0,ALL
105371333,LINC02136,,,,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
105371462,LINC02819,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
105371496,LINC01975,,,,,,,C1518922,peak expiratory flow (procedure),,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
105371590,LINC01675,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105371609,LINC01681,,0.931,0.115,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
105371708,LINC01992,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
105371743,SNHG30,,,,,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
105371786,LINC02594,,,,,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2009.0,2009.0,ALL
105371807,THRA1/BTR,,0.686,0.654,,,,C4722330,Generalized Thyroid Hormone Resistance,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.07,1.0,,1996.0,2019.0,ALL
105371809,LINC02086,,1.0,0.077,,,,C0035258,Restless Legs Syndrome,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
105371830,LINC01982,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
105371849,LOC105371849,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105371906,LACAT1,,1.0,0.038,,,,C0007137,Squamous cell carcinoma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105371919,LINC01977,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
105372030,LINC01894,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105372267,LINC01862,,0.931,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
105372360,LINC02841,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
105372419,GEMIN7-AS1,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2018.0,2019.0,ALL
105372444,LINC01872,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
105372481,ERVK3-1,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105372556,LINC00237,,0.931,0.385,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
105372589,BCL2L1-AS1,,,,,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
105372751,LINC01684,,1.0,0.038,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
105372779,MRAP-AS1,,1.0,0.038,,,,C4049714,Familial Glucocorticoid Deficiency Type 2,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,,,,,ALL
105372808,PCSEAT,,0.89,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
105372925,LINC01710,,,,,,,C0337439,Iron measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
105372972,LINC02559,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105372978,LINC01638,,0.722,0.346,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2018.0,2019.0,ALL
105372999,LINC02558,,,,,,,C1513302,Mild Adverse Event,,,phenotype,Finding,0.1,1.0,,2017.0,2017.0,ALL
105373010,LINC01643,,0.931,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
105373106,CNIH3-AS1,,,,,,,C0523465,Serum albumin measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2013.0,2013.0,ALL
105373113,LINC01703,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105373366,IDS2,,0.931,0.192,,,,C0026705,Mucopolysaccharidosis II,C16;C18;C17;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Skin and Connective Tissue Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0,,1995.0,2012.0,ALL
105373460,LINC01808,,,,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
105373538,LINC01885,,1.0,0.115,,,,C1277709,Transferrin saturation measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
105373557,SOCAR,,0.821,0.231,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
105373617,POTEF-AS1,,1.0,,,,,C1739135,Progression of prostate cancer,,,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
105373669,LINC01911,,,,,,,C0424574,Duration of sleep,,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
105373684,LINC01818,,1.0,0.077,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
105373708,LINC01958,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
105373853,MYOSLID,,0.805,0.115,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
105373869,LINC01614,,0.839,0.115,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105373885,ASIC4-AS1,,0.931,,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
105373934,LINC01891,,1.0,0.038,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2018.0,2018.0,ALL
105373962,LINC01937,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105373985,LOC105373985,,0.89,0.115,,,,C0149925,Small cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
105374057,LINC02024,,,,,,,C0202202,Protein measurement,,,group,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
105374165,LINC02006,,1.0,0.038,,,,C0518026,body fat percentage (physical finding),,,phenotype,Finding,0.1,1.0,,2019.0,2019.0,ALL
105374201,LINC01997,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105374205,MECOM-AS1,,0.931,0.077,,,,C0005823,Blood Pressure,,,phenotype,Organism Function,0.1,1.0,,2011.0,2011.0,ALL
105374219,LINC02068,,0.931,0.154,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105374244,LINC01995,,1.0,0.077,,,,C0002170,Alopecia,C23;C17,"   Pathological Conditions, Signs and Symptoms;    Skin and Connective Tissue Diseases",disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
105374251,LINC01839,,0.89,0.115,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
105374266,LINC01991,,0.89,0.115,,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
105374325,LOC105374325,,1.0,0.077,,,,C0017668,Focal glomerulosclerosis,C13;C12,   Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
105374394,LINC02484,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
105374400,LINC02505,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105374410,LINC02513,,,,,,,C0200635,Lymphocyte Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
105374484,LINC02360,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
105374540,LINC02357,,0.805,0.231,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2012.0,2015.0,ALL
105374561,LINC02472,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105374596,LINC01867,,1.0,0.115,,,,C0338451,Frontotemporal dementia,C18;C10;F03,   Nutritional and Metabolic Diseases;    Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
105374631,LINC02121,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
105374676,LINC02241,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
105374693,LINC02211,,1.0,0.038,,,,C0041296,Tuberculosis,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
105374716,LINC02160,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105374728,LINC02117,,,,,,,C1445957,Serum total cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
105374749,C5orf34-AS1,,,,,,,C0042834,Vital capacity,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
105374879,LOC105374879,,1.0,0.077,,,,C0149978,Adenocarcinoma of rectum,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105374885,LINC02521,,1.0,,,,,C2938924,Oestrogen receptor positive breast cancer,,,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
105374956,MIR548A1HG,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105374978,LINC02828,,,,,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
105375009,LINC02829,,0.89,0.231,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
105375014,LINC02570,,0.931,0.115,,,,C0042900,Vitiligo,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2010.0,2010.0,ALL
105375015,LINC02571,,0.743,0.5,,,,C0001175,Acquired Immunodeficiency Syndrome,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
105375037,ETV7-AS1,,0.931,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2019.0,ALL
105375077,RUNX2-AS1,,1.0,0.154,,,,C0026764,Multiple Myeloma,C04;C20;C15;C14,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases;    Cardiovascular Diseases,disease,Neoplastic Process,0.02,1.0,,2018.0,2019.0,ALL
105375355,UPK3B,Q9BT76,0.584,0.808,0.00023426,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2004.0,2019.0,ALL
105375380,LINC00972,,0.931,0.115,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
105375475,LINC02476,,1.0,0.115,,,,C0008925,Cleft Palate,C16;C05;C07,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Stomatognathic Diseases",disease,Congenital Abnormality,0.1,1.0,,2019.0,2019.0,ALL
105375606,MNX1-AS2,,1.0,0.115,,,,C1531773,Currarino triad,C16;C06;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,,,,,ALL
105375666,VPS13B-DT,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105375734,SMILR,,,,,,,C0042373,Vascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
105375819,TCONS_00068220,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
105375847,CERNA3,,0.531,0.808,,,,C0948008,Ischemic stroke,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2020.0,ALL
105376036,LINC01627,,0.931,0.115,,,,C0677886,Epithelial ovarian cancer,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105376072,TMEM252-DT,,0.931,0.038,,,,C0017654,Glomerular Filtration Rate,,,phenotype,Diagnostic Procedure,0.1,1.0,,2019.0,2019.0,ALL
105376162,HSD17B3-AS1,,1.0,0.154,,,,C0033804,Pseudohermaphroditism,C16;C13;C12;C19,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases;    Endocrine System Diseases",disease,Congenital Abnormality,0.1,,,,,ALL
105376261,TTLL11-IT1,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2011.0,2011.0,ALL
105376351,LINC02645,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
105376382,LINC02657,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105376468,LINC02652,,1.0,0.115,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
105376493,LINC02634,,1.0,0.038,,,,C0002438,Amebiasis,C01,   Infections,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
105376513,LINC02689,,,,,,,C0206062,"Lung Diseases, Interstitial",C08,   Respiratory Tract Diseases,group,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
105376550,LINC02752,,,,,,,C0001925,Albuminuria,C23;C13;C12,"   Pathological Conditions, Signs and Symptoms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",phenotype,Finding,0.1,1.0,,2018.0,2018.0,ALL
105376562,LINC02548,,,,,,,C0337439,Iron measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2011.0,2011.0,ALL
105376570,LINC02682,,1.0,0.038,,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
105376580,CSRP3-AS1,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2019.0,ALL
105376592,LINC02718,,,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105376599,ANO3-AS1,,1.0,0.077,,,,C0009952,Febrile Convulsions,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
105376603,LINC02742,,0.931,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105376605,LINC02755,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
105376609,MPPED2-AS1,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
105376640,LINC02741,,,,,,,C0202117,Low density lipoprotein cholesterol measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2012.0,2012.0,ALL
105376681,LINC02782,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105376736,EXOSC10-AS1,,,,,,,C0205682,Waist-Hip Ratio,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105376906,ERVK-19,,0.705,0.346,,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.03,1.0,,2010.0,2018.0,ALL
105376955,LINC02022,,0.931,0.038,,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
105377007,LINC01980,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105377031,LINC02033,,0.931,0.038,,,,C0005586,Bipolar Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2014.0,2014.0,ALL
105377068,LINC02009,,1.0,0.038,,,,C0149745,Oral Ulcer,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
105377098,LINC02030,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105377105,FLNB-AS1,,1.0,0.077,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105377108,FAM3D-AS1,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
105377180,LINC02008,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
105377338,LINC02267,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105377348,UBE2D3-AS1,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
105377349,LINC02503,,1.0,0.038,,,,C0003467,Anxiety,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
105377373,ANK2-AS1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105377390,LINC02263,,,,,,,C0429028,QT interval feature (observable entity),,,phenotype,Clinical Attribute,0.1,1.0,,2009.0,2009.0,ALL
105377391,LINC02264,,0.931,0.115,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2014.0,2014.0,ALL
105377441,LINC02511,,0.931,0.077,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
105377512,LINC02477,,1.0,,,,,C1836230,"HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO",,,disease,Finding,0.1,1.0,,2009.0,2009.0,ALL
105377540,SAP30-DT,,1.0,0.038,,,,C2711227,Steatohepatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
105377556,LINC02509,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105377656,LINC02283,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
105377682,LINC01932,,1.0,0.038,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
105377701,LINC01938,,1.0,0.038,,,,C1269683,Major Depressive Disorder,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2018.0,2018.0,ALL
105377703,LOC105377703,,,,,,,C0086132,Depressive Symptoms,F01,   Behavior and Behavior Mechanisms,phenotype,Sign or Symptom,0.01,1.0,,2017.0,2017.0,ALL
105377736,LINC01942,,,,,,,C0034885,Rectal Neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.1,1.0,,2015.0,2015.0,ALL
105377860,LINC02540,,,,,,,C3548510,response to antineoplastic agent,,,phenotype,Organism Function,0.1,1.0,,2013.0,2013.0,ALL
105377871,LOC105377871,,0.89,0.115,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
105377880,LINC01611,,0.931,0.154,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2014.0,ALL
105377946,LINC02527,,1.0,0.077,,,,C0268318,Cholestasis of pregnancy,C06;C13,   Digestive System Diseases;    Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
105378049,TAB2-AS1,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
105378065,LINC02840,,,,,,,C0008810,Circadian Rhythms,,,phenotype,Organism Function,0.1,1.0,,2016.0,2016.0,ALL
105378220,MARCOL,A0A1B0GUY1,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
105378325,LINC02621,,0.931,0.115,,,,C0020676,Hypothyroidism,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2019.0,ALL
105378425,LINC01374,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
105378427,XLOC_008559,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
105378478,LINC02661,,1.0,0.077,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
105378531,LINC02641,,0.931,0.077,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105378653,MIR3659HG,,1.0,0.115,,,,C0039590,Testicular Neoplasms,C04;C12;C19,   Neoplasms;    Male Urogenital Diseases;    Endocrine System Diseases,group,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
105378687,LOC105378687,,1.0,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
105378720,EPS15-AS1,,,,,,,C0005845,Blood urea nitrogen measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
105378738,LINC01755,,,,,,,C0035227,Respiratory Function Tests,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
105378763,LINC01748,,0.89,0.154,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
105378769,LINC01739,,,,,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2011.0,2011.0,ALL
105378799,LINC02797,,0.931,0.038,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
105378803,LRRC53,A6NM62,0.931,0.077,1.4846e-10,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
105378853,LINC02609,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2014.0,2017.0,ALL
105378889,LINC01661,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
105378912,LINC01357,,1.0,0.038,,,,C0272178,Drug-induced neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
105378949,LOC105378949,,1.0,0.077,,,,C0016781,Fuchs Endothelial Dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.01,1.0,,2010.0,2010.0,ALL
105378966,LINC02105,,,,,,,C0018498,Hair Color,,,phenotype,Organism Attribute,0.1,1.0,,2018.0,2018.0,ALL
105378991,ERCC8-AS1,,1.0,0.154,,,,C0751039,"Cockayne Syndrome, Type I",C16;C18;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.1,1.0,,2006.0,2017.0,ALL
105378992,LINC02057,,1.0,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105379054,VCAN-AS1,,0.861,0.192,,,,C0032460,Polycystic Ovary Syndrome,C04;C13;C19,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Endocrine System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
105379069,LINC02144,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
105379076,LINC02161,,1.0,0.077,,,,C0699791,Stomach Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105379098,LINC01846,,1.0,0.038,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
105379528,LOC105379528,,0.617,0.615,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.1,0.974,,1989.0,2019.0,ALL
105379778,LINC02794,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105416157,NKILA,,0.711,0.423,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
105447648,LINC02130,,1.0,0.077,,,,C0007766,Intracranial Aneurysm,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
105463123,XACT,,0.89,0.077,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
105463127,PFHB2,,1.0,0.077,,,,C1841658,"Progressive Familial Heart Block, Type II",C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2005.0,2005.0,ALL
105500239,XLOC_007697,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
105500240,XLOC_009911,,0.931,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
105616981,B3GALT1-AS1,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
105664404,WSPAR,,0.751,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2015.0,2018.0,ALL
105682749,CCEPR,,0.705,0.269,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.07,1.0,,2015.0,2019.0,ALL
105748977,LINC01693,,,,,,,C0427460,Red cell distribution width determination,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
105751187,LRP1-AS,,0.722,0.5,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2019.0,2019.0,ALL
105755953,LINC02676,,1.0,0.077,,,,C0039685,Tetralogy of Fallot,C16;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Cardiovascular Diseases",disease,Congenital Abnormality,0.1,1.0,,2013.0,2013.0,ALL
105804841,ZRS,,0.722,0.269,,,,C0152427,Polydactyly,C16;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases",disease,Congenital Abnormality,0.1,1.0,,2003.0,2018.0,ALL
105943586,LOC105943586,,0.931,0.115,,,,C0270911,"Charcot-Marie-Tooth Disease, Type Ia (disorder)",C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.03,1.0,,1995.0,1999.0,ALL
105943587,LOC105943587,,1.0,0.115,,,,C0393814,Hereditary liability to pressure palsies,C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.01,1.0,,1998.0,1998.0,ALL
105980073,LOC105980073,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
106007493,LOC106007493,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
106010958,HBB-HS-111,,1.0,0.077,,,,C0472767,Beta thalassemia intermedia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
106029243,CREST1,,1.0,0.077,,,,C0019196,Hepatitis C,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
106029244,CREST2,,0.89,0.192,,,,C0007282,Carotid Stenosis,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,disease,Disease or Syndrome,0.03,1.0,,2017.0,2017.0,ALL
106049960,SBE2,,0.931,0.154,,,,C0020635,Hypopituitarism,C10;C19,   Nervous System Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,0.0,,2015.0,2015.0,ALL
106099130,GSTT1-AS1,,0.931,0.115,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
106128905,LOC106128905,,0.931,0.077,,,,C2239176,Liver carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.02,1.0,,2017.0,2019.0,ALL
106144537,LINC01173,,0.805,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
106144538,KCNK15-AS1,,0.839,0.154,,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
106144539,FOXD1-AS1,,0.839,0.038,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
106144608,LINC00976,,0.931,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
106146148,PSLNR,,0.931,0.077,,,,C0033578,Prostatic Neoplasms,C04;C12,   Neoplasms;    Male Urogenital Diseases,group,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
106182249,LUADT1,,0.861,0.115,,,,C0152013,Adenocarcinoma of lung (disorder),C04,   Neoplasms,disease,Neoplastic Process,0.02,0.5,,2015.0,2019.0,ALL
106478911,CST12P,,0.641,0.615,,,,C0038454,Cerebrovascular accident,C10;C14,   Nervous System Diseases;    Cardiovascular Diseases,group,Disease or Syndrome,0.04,1.0,,2017.0,2018.0,ALL
106478954,EHMT2-AS1,,0.78,0.462,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2007.0,2011.0,ALL
106478956,MDC1-AS1,,0.743,0.308,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
106478967,SEC62-AS1,,1.0,0.077,,,,C0149782,Squamous cell carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
106478973,FMR1-IT1,,0.716,0.385,,,,C0016667,Fragile X Syndrome,C16;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases",disease,Disease or Syndrome,0.1,0.978,,1991.0,2015.0,ALL
106479034,LARP1BP2,,0.743,0.385,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2010.0,2010.0,ALL
106479059,OLA1P2,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
106479546,RNU6ATAC7P,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
106479573,RNU4-36P,,1.0,0.077,,,,C0024141,"Lupus Erythematosus, Systemic",C17;C20,   Skin and Connective Tissue Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
106479631,RNU6-148P,,0.931,0.077,,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
106479781,RNU6-484P,,1.0,0.077,,,,C0005411,Biliary Atresia,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Congenital Abnormality,0.1,1.0,,2010.0,2010.0,ALL
106479784,RNU6-491P,,0.931,0.077,,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
106479804,RNU6-537P,,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2019.0,2019.0,ALL
106479986,RNU6-950P,,,,,,,C0032181,Platelet Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2016.0,2016.0,ALL
106480141,RNU6-1318P,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2009.0,2009.0,ALL
106480219,RNU2-49P,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
106480298,NUTF2P3,,0.931,0.115,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
106480429,HLA-DQB1-AS1,,1.0,0.038,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
106480526,RN7SL697P,,1.0,0.077,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2009.0,2009.0,ALL
106480577,RNU6-392P,,0.743,0.385,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2010.0,2010.0,ALL
106480735,XIAP-AS1,,0.89,0.077,,,,C0007102,Malignant tumor of colon,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
106480738,OSTN-AS1,,0.931,0.077,,,,C3539878,Triple Negative Breast Neoplasms,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
106480868,RN7SKP114,,0.931,0.077,,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
106480948,RN7SL100P,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
106480950,RN7SL108P,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2012.0,2012.0,ALL
106480993,RN7SL263P,,0.496,0.808,,,,C0002871,Anemia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,0.893,,2011.0,2019.0,ALL
106481057,RN7SL494P,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
106481266,RNU6-277P,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
106481323,RNU6-456P,,0.931,0.077,,,,C2931456,"Prostate cancer, familial",C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.3,1.0,,2018.0,2018.0,ALL
106481464,RNU6-903P,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
106481524,RNU6-1093P,,,,,,,C0200638,Eosinophil count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
106481954,RNU1-55P,,0.931,0.077,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
106614088,MIR34AHG,,,,,,,C0424678,Lean body mass,,,phenotype,Clinical Attribute,0.1,1.0,,2017.0,2017.0,ALL
106633813,SIRT1-AS,,0.67,0.615,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2005.0,2019.0,ALL
106660610,MIR5689HG,,1.0,0.077,,,,C0678222,Breast Carcinoma,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,1.0,,2013.0,2013.0,ALL
106736613,MCS+9.7,,0.805,0.308,,,,C0019569,Hirschsprung Disease,C16;C06,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases",disease,Disease or Syndrome,0.03,1.0,,2011.0,2016.0,ALL
106783499,OPA8,,0.839,0.231,,,,C4085249,OPTIC ATROPHY 8,,,disease,Disease or Syndrome,0.3,,,,,ALL
106821730,BUB1B-PAK6,Q9NQU5,0.805,0.269,,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
106865367,MRD2,,1.0,0.038,,,,C0015300,Exophthalmos,C11,   Eye Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
107075107,SEPTIN14P21,,1.0,0.077,,,,C0684249,Carcinoma of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
107075116,MIR3142HG,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2020.0,2020.0,ALL
107075148,MTCO2P16,,0.931,0.077,,,,C1859807,"AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder)",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
107075155,MTCO3P16,,0.931,0.077,,,,C1859807,"AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder)",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
107075158,MTATP6P16,,0.931,0.077,,,,C1859807,"AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder)",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
107075210,MTND4LP16,,0.931,0.077,,,,C1859807,"AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder)",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
107075278,MTND3P16,,0.931,0.077,,,,C1859807,"AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder)",C18;C10,   Nutritional and Metabolic Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2001.0,2001.0,ALL
107075310,MTCO2P12,,0.368,0.962,,,,C0268237,Cytochrome-c Oxidase Deficiency,C16;C18,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.33,1.0,strong,1999.0,2011.0,ALL
107080638,TBC1D7-LOC100130357,Q9P0N9,1.0,0.077,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
107126360,AOX3P,,1.0,0.077,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
107161151,AOX3P-AOX2P,,1.0,0.077,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2015.0,2015.0,ALL
107181291,PYDC5,W6CW81,0.821,0.192,,,,C0877015,Pelvic Organ Prolapse,C23,"   Pathological Conditions, Signs and Symptoms",disease,Disease or Syndrome,0.02,1.0,,2017.0,2018.0,ALL
107197953,ORI6,,0.711,0.5,,,,C0238463,Papillary thyroid carcinoma,C04;C19,   Neoplasms;    Endocrine System Diseases,disease,Neoplastic Process,0.03,1.0,,2017.0,2018.0,ALL
107228383,LOC107228383,,0.839,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,1.0,,1998.0,2009.0,ALL
107305681,DHS6S1,,1.0,0.077,,,,C0730294,North Carolina macular dystrophy,C16;C11,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Eye Diseases",disease,Disease or Syndrome,0.5,1.0,,2016.0,2016.0,ALL
107436076,CYP2C23P,,,,,,,C2985280,Blood Protein Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2018.0,2018.0,ALL
107521942,RNU1-79P,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
107521946,RNU1-116P,,1.0,0.077,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2019.0,2019.0,ALL
107648861,DEL11P13,,0.861,0.231,,,,C0027708,Nephroblastoma,C16;C04;C13;C12,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases",disease,Neoplastic Process,0.02,1.0,,1984.0,1989.0,ALL
107648866,LOC107648866,,1.0,0.115,,,,C0023452,Childhood Acute Lymphoblastic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
107832851,LOC107832851,,1.0,0.077,,,,C0011860,"Diabetes Mellitus, Non-Insulin-Dependent",C18;C19,   Nutritional and Metabolic Diseases;    Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2012.0,2012.0,ALL
107966124,RER,,1.0,0.115,,,,C0029434,Osteogenesis Imperfecta,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0,,2010.0,2010.0,ALL
107983964,LINC02128,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
107984002,LINC02646,,1.0,0.077,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.1,1.0,,2008.0,2008.0,ALL
107984027,LINC02277,,1.0,0.038,,,,C4021107,Non-obstructive azoospermia,C12,   Male Urogenital Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
107984114,MIR583HG,,1.0,,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
107984117,LINC02058,,,,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2019.0,2019.0,ALL
107984137,LOC107984137,,1.0,0.038,,,,C0031099,Periodontitis,C07,   Stomatognathic Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
107984237,LINC02625,,1.0,0.038,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
107984280,LINC02666,,1.0,0.038,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
107984337,NRXN2-AS1,,0.931,0.115,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
107984355,LOC107984355,,1.0,0.115,,,,C0029434,Osteogenesis Imperfecta,C16;C17;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Skin and Connective Tissue Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome; Congenital Abnormality,0.01,1.0,,1988.0,1988.0,ALL
107984414,LINC02730,,1.0,0.038,,,,C0036341,Schizophrenia,F03,   Mental Disorders,disease,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
107984474,LRRK2-DT,,0.861,0.154,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
107984503,LINC02354,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
107984558,LOC107984558,,1.0,,,,,C0742468,Central nervous system lesion,,,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
107984565,LINC02335,,,,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
107984700,LINC02306,,0.931,0.038,,,,C0162701,Polysomnography,,,phenotype,Diagnostic Procedure,0.1,1.0,,2012.0,2012.0,ALL
107984773,LINC01852,,0.821,0.192,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
107984780,LINC02248,,1.0,0.077,,,,C0027404,Narcolepsy,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2009.0,2009.0,ALL
107984977,LINC02096,,,,,,,C0014772,Red Blood Cell Count measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
107985092,ARHGAP29-AS1,,,,,,,C0871470,Systolic Pressure,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
107985124,LINC02785,,,,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
107985210,ARHGEF2-AS1,,,,,,,C0005612,Birth Weight,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Organism Attribute,0.1,1.0,,2016.0,2016.0,ALL
107985257,LINC02602,,0.931,0.115,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
107985307,LINC01705,,0.839,0.077,,,,C0023467,"Leukemia, Myelocytic, Acute",C04,   Neoplasms,disease,Neoplastic Process,0.1,1.0,,2017.0,2017.0,ALL
107985457,LINC02770,,1.0,0.077,,,,C0520679,"Sleep Apnea, Obstructive",C08;C10,   Respiratory Tract Diseases;    Nervous System Diseases,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
107985578,NCF4-AS1,,1.0,0.038,,,,C0010346,Crohn Disease,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
107985770,LOC107985770,,0.805,0.154,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2017.0,2019.0,ALL
107985781,FSIP2-AS1,,1.0,,,,,C4748403,SPERMATOGENIC FAILURE 34,,,disease,Disease or Syndrome,0.1,,,,,ALL
107985816,LINC01956,,,,,,,C0005938,Bone Density,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2018.0,ALL
107985928,LINC01965,,1.0,0.077,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.1,1.0,,2016.0,2016.0,ALL
107986041,LINC01967,,0.931,0.115,,,,C0008313,"Cholangitis, Sclerosing",C06,   Digestive System Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
107986209,H3P14,,0.805,0.308,,,,C0013264,"Muscular Dystrophy, Duchenne",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.02,1.0,,1988.0,1991.0,ALL
107986264,LINC02438,,,,,,,C0596887,mathematical ability,,,phenotype,Mental Process,0.1,1.0,,2018.0,2018.0,ALL
107986313,LINC02465,,0.89,0.154,,,,C0028754,Obesity,C23;C18,"   Pathological Conditions, Signs and Symptoms;    Nutritional and Metabolic Diseases",disease,Disease or Syndrome,0.1,1.0,,2012.0,2012.0,ALL
107986322,LINC02272,,,,,,,C4317009,Diverticular Diseases,C06,   Digestive System Diseases,group,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
107986389,LINC02163,,0.931,0.077,,,,C0024623,Malignant neoplasm of stomach,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
107986402,LINC02196,,0.931,0.231,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2013.0,2013.0,ALL
107986480,LINC01863,,,,,,,C0023508,White Blood Cell Count procedure,,,phenotype,Laboratory Procedure,0.1,1.0,,2019.0,2019.0,ALL
107986809,ELN-AS1,,1.0,0.038,,,,C0003499,Supravalvular aortic stenosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.1,1.0,,1997.0,1997.0,ALL
107986810,WBSCR23,,1.0,0.115,,,,C0175702,Williams Syndrome,C16;C10;C14,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Cardiovascular Diseases",disease,Disease or Syndrome,0.01,1.0,,2002.0,2002.0,ALL
107986980,LINC02055,,0.839,0.269,,,,C0021704,Intelligence,F01,   Behavior and Behavior Mechanisms,phenotype,Mental Process,0.1,1.0,,2018.0,2019.0,ALL
107987106,CT70,,1.0,0.038,,,,C0037369,Smoking,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2017.0,2017.0,ALL
107987281,LOC107987281,,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
107987462,LOC107987462,O75022,0.839,0.231,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
107987479,LOC107987479,,0.597,0.769,,,,C0030567,Parkinson Disease,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.1,0.917,,1994.0,2017.0,ALL
107987484,LOC107987484,,1.0,0.115,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,2013.0,2018.0,ALL
107987485,LOC107987485,,1.0,0.115,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,2013.0,2018.0,ALL
107987486,LOC107987486,,1.0,0.115,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,2013.0,2018.0,ALL
107987487,LOC107987487,,1.0,0.115,,,,C0238288,"Muscular Dystrophy, Facioscapulohumeral",C16;C05;C10,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Musculoskeletal Diseases;    Nervous System Diseases",disease,Disease or Syndrome,0.04,1.0,,2013.0,2018.0,ALL
107988031,MSPC,,,,,,,C0015967,Fever,C23,"   Pathological Conditions, Signs and Symptoms",phenotype,Sign or Symptom,0.01,1.0,,2017.0,2017.0,ALL
108004545,LOC108004545,,0.76,0.308,,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.1,1.0,,1987.0,2019.0,ALL
108281177,LOC108281177,,0.89,0.154,,,,C0025289,Meningitis,C10,   Nervous System Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
108281178,SOX2-SRR2,,0.861,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2018.0,ALL
108353831,CNE-3,,1.0,0.115,,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,1996.0,1996.0,ALL
108353832,CNE-2,,0.729,0.346,,,,C2931822,Nasopharyngeal carcinoma,C04;C07;C09,   Neoplasms;    Stomatognathic Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.1,1.0,,2003.0,2019.0,ALL
108383238,CNE7,,1.0,0.115,,,,C0010418,Cryptosporidiosis,C06;C01;C22,   Digestive System Diseases;    Infections;    Animal Diseases,disease,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
108489980,ARF2P,,1.0,0.038,,,,C1842981,NEUROTICISM,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2017.0,2017.0,ALL
108570035,LINP1,,0.729,0.231,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.04,1.0,,2018.0,2019.0,ALL
108783646,DINOL,,0.821,0.346,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
108868751,GSC-DT,,0.931,0.038,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
109136578,MASCRNA,,0.931,0.038,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
109136579,TALAM1,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
109245082,PRAL,,0.839,0.231,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2016.0,2017.0,ALL
109280161,LOC109280161,,1.0,0.038,,,,C0010068,Coronary heart disease,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
109286563,LOC109286563,,1.0,0.077,,,,C0019163,Hepatitis B,C06;C01,   Digestive System Diseases;    Infections,disease,Disease or Syndrome,0.01,1.0,,2007.0,2007.0,ALL
109504726,ERV3-1-ZNF117,Q03924,,,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,1997.0,1997.0,ALL
109580095,HBB-LCR,,0.743,0.115,,,,C0002875,Cooley's anemia,C16;C15,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Hemic and Lymphatic Diseases",disease,Disease or Syndrome,0.3,,,,,ALL
109623460,SNORD138,,0.722,0.346,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.02,1.0,,2018.0,2018.0,ALL
109703458,HTD2,P86397,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2014.0,2019.0,ALL
109729127,KRT7-AS,,0.89,0.154,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2015.0,2015.0,ALL
109729133,LINC02236,,1.0,0.077,,,,C0015396,Eye Color,,,phenotype,Organism Attribute,0.1,1.0,,2013.0,2013.0,ALL
109729140,PSMD6-AS1,,1.0,0.038,,,,C0017638,Glioma,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
109729161,LNCSRLR,,0.931,0.115,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
109729169,LINC02154,,0.931,0.115,,,,C0007107,Malignant neoplasm of larynx,C04;C08;C09,   Neoplasms;    Respiratory Tract Diseases;    Otorhinolaryngologic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
109729182,DM1-AS,,0.839,0.115,,,,C1960398,HER2-positive carcinoma of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.03,1.0,,2018.0,2019.0,ALL
109731405,PDXDC2P,Q6P474,0.931,0.038,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
109864269,MIR302CHG,,1.0,0.269,,,,C2697764,Interleukin 16 Measurement,,,phenotype,Laboratory Procedure,0.1,1.0,,2017.0,2017.0,ALL
109864272,RNA28SN4,,0.805,0.231,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
110006328,ERVK-32,,0.522,0.692,,,,C0001175,Acquired Immunodeficiency Syndrome,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,1985.0,2018.0,ALL
110011217,LOC110011217,,0.89,0.077,,,,C0023440,Acute Erythroblastic Leukemia,C04;C15,   Neoplasms;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2005.0,2005.0,ALL
110013312,LOC110013312,,0.76,0.269,,,,C0029463,Osteosarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.06,1.0,,1996.0,2018.0,ALL
110175910,MIR4527HG,,1.0,0.038,,,,C0016529,Forced expiratory volume function,,,phenotype,Organ or Tissue Function,0.1,1.0,,2015.0,2015.0,ALL
110231149,PANCR,,0.89,0.154,,,,C0004238,Atrial Fibrillation,C23;C14,"   Pathological Conditions, Signs and Symptoms;    Cardiovascular Diseases",disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
110255168,RNA28S5,,0.805,0.231,,,,C0006413,Burkitt Lymphoma,C04;C01;C20;C15,   Neoplasms;    Infections;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2014.0,2014.0,ALL
110283621,LOC110283621,,0.743,0.385,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.03,1.0,,2012.0,2014.0,ALL
110351180,LOC110351180,,0.821,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2004.0,2012.0,ALL
110366354,LOC110366354,,0.769,0.269,,,,C0002395,Alzheimer's Disease,C10;F03,   Nervous System Diseases;    Mental Disorders,disease,Disease or Syndrome,0.01,1.0,,2020.0,2020.0,ALL
110386951,LOC110386951,,1.0,0.038,,,,C0014175,Endometriosis,C13,   Female Urogenital Diseases and Pregnancy Complications,disease,Disease or Syndrome,0.01,1.0,,1999.0,1999.0,ALL
110408762,LOC110408762,,,,,,,C0021364,Male infertility,C12,   Male Urogenital Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2014.0,2014.0,ALL
110599564,EEF1AKMT4,P0DPD7,,,,,,C1305855,Body mass index,,,phenotype,Clinical Attribute,0.1,1.0,,2018.0,2019.0,ALL
110599569,LOC110599569,,,,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
110599580,LOC110599580,,0.792,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2010.0,2010.0,ALL
110599583,EEF1AKMT4-ECE2,P0DPD6;P0DPD8,0.792,0.385,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.01,1.0,,2017.0,2017.0,ALL
110599590,C5-OT1,,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
110673971,LOC110673971,,0.89,0.269,,,,C0001622,Adrenal Gland Hyperfunction,C19,   Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
110673972,LOC110673972,,0.89,0.269,,,,C0001622,Adrenal Gland Hyperfunction,C19,   Endocrine System Diseases,phenotype,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
110806262,LOC110806262,,0.626,0.423,,,,C0011570,Mental Depression,F01,   Behavior and Behavior Mechanisms,disease,Mental or Behavioral Dysfunction,0.1,0.947,,1998.0,2019.0,ALL
110806263,LOC110806263,,0.464,0.731,,,,C0005684,Malignant neoplasm of urinary bladder,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.1,0.933,,2013.0,2020.0,ALL
110806265,MNS16A,,0.663,0.5,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.04,0.75,,2008.0,2019.0,ALL
110806272,BTG3-AS1,,0.792,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2017.0,2017.0,ALL
110806290,MYOCOS,A0A1B0GUC4,0.805,0.192,,,,C0017601,Glaucoma,C11,   Eye Diseases,disease,Disease or Syndrome,0.1,1.0,,2018.0,2018.0,ALL
110806307,STIN2-VNTR,,0.636,0.538,,,,C0014556,"Epilepsy, Temporal Lobe",C10,   Nervous System Diseases,disease,Disease or Syndrome,0.05,1.0,,2007.0,2012.0,ALL
110806308,GPC3-AS1,,0.861,0.115,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,0.0,,2019.0,2019.0,ALL
110841581,CAMTA1-DT,,1.0,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
111064646,TPM1-AS,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2013.0,2013.0,ALL
111188157,LYNX1-SLURP2,P0DP58,0.839,0.115,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.01,1.0,,2003.0,2003.0,ALL
111216279,RPS6KB2-AS1,,,,,,,C4528257,Corpuscular Hemoglobin Concentration Mean,,,phenotype,Laboratory or Test Result,0.1,1.0,,2012.0,2012.0,ALL
111216288,LOC111216288,,1.0,0.077,,,,C0001973,"Alcoholic Intoxication, Chronic",C25;F03,   Chemically-Induced Disorders;    Mental Disorders,disease,Mental or Behavioral Dysfunction,0.01,1.0,,2014.0,2014.0,ALL
111240474,CRYZL2P-SEC16B,,0.861,0.231,,,,C0005893,Body mass index procedure,,,phenotype,Diagnostic Procedure,0.1,1.0,,2009.0,2013.0,ALL
111365141,LOC111365141,,0.861,0.192,,,,C0004096,Asthma,C08;C20,   Respiratory Tract Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.01,1.0,,2016.0,2016.0,ALL
111365171,LOC111365171,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
111589215,LOC111589215,,0.76,0.231,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.06,1.0,,2000.0,2018.0,ALL
111674463,LOC111674463,,1.0,0.115,,,,C0010674,Cystic Fibrosis,C16;C06;C08,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Digestive System Diseases;    Respiratory Tract Diseases",disease,Disease or Syndrome,0.02,1.0,,1998.0,2000.0,ALL
111674464,LOC111674464,,0.89,0.231,,,,C0011847,Diabetes,C19,   Endocrine System Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
112267873,LINC02814,,0.931,0.192,,,,C0001948,Alcohol consumption,F01,   Behavior and Behavior Mechanisms,phenotype,Individual Behavior,0.1,1.0,,2013.0,2013.0,ALL
112268007,GRM3-AS1,,1.0,0.038,,,,C0008074,"Child Development Disorders, Pervasive",F03,   Mental Disorders,group,Mental or Behavioral Dysfunction,0.1,1.0,,2017.0,2017.0,ALL
112268223,CDC42-AS1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
112441427,GCASPC,,0.792,0.115,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
112441440,MRD4,,1.0,0.115,,,,C0023434,Chronic Lymphocytic Leukemia,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
112543478,MAPK6-DT,,0.89,0.077,,,,C0023903,Liver neoplasms,C06;C04,   Digestive System Diseases;    Neoplasms,group,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
112543491,LOC112543491,,0.839,0.115,,,,C0007847,Malignant tumor of cervix,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
112543493,SIRLNT,,0.931,0.077,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
112577459,LNCARSR,,0.722,0.269,,,,C0007134,Renal Cell Carcinoma,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.02,1.0,,2016.0,2019.0,ALL
112577518,MUC5B-AS1,,0.861,0.077,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
112694756,LOC112694756,,0.792,0.308,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.02,1.0,,2019.0,2019.0,ALL
112806053,TBILA,,1.0,0.077,,,,C0007131,Non-Small Cell Lung Carcinoma,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
112935892,LINC02605,,0.49,0.769,,,,C0004364,Autoimmune Diseases,C20,   Immune System Diseases,group,Disease or Syndrome,0.1,1.0,,2006.0,2018.0,ALL
113218500,MIR10393,,1.0,0.115,,,,C0019829,Hodgkin Disease,C04;C20;C15,   Neoplasms;    Immune System Diseases;    Hemic and Lymphatic Diseases,disease,Neoplastic Process,0.01,1.0,,2015.0,2015.0,ALL
113391337,ZEBTR,,0.931,0.115,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
113455421,DERPC,P0CG12,0.89,0.115,,,,C0022665,Kidney Neoplasm,C04;C13;C12,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2002.0,2002.0,ALL
113523636,SMIM40,Q5STR5,1.0,0.115,,,,C0003873,Rheumatoid Arthritis,C17;C05;C20,   Skin and Connective Tissue Diseases;    Musculoskeletal Diseases;    Immune System Diseases,disease,Disease or Syndrome,0.1,1.0,,2011.0,2011.0,ALL
113633881,HEAT2,,0.89,0.038,,,,C0018801,Heart failure,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
113664106,LOC113664106,,1.0,0.038,,,,C0007222,Cardiovascular Diseases,C14,   Cardiovascular Diseases,group,Disease or Syndrome,0.01,1.0,,2015.0,2015.0,ALL
114004396,LNCRNA-ATB,,0.678,0.423,,,,C0027627,Neoplasm Metastasis,C23;C04,"   Pathological Conditions, Signs and Symptoms;    Neoplasms",phenotype,Neoplastic Process,0.09,1.0,,2014.0,2019.0,ALL
114253699,TNDM1,,0.861,0.154,,,,C0342273,Transient neonatal diabetes mellitus,,,disease,Disease or Syndrome,0.04,1.0,,2010.0,2016.0,ALL
114349542,MXLPO,,0.769,0.154,,,,C0023827,liposarcoma,C04,   Neoplasms,disease,Neoplastic Process,0.03,1.0,,2017.0,2019.0,ALL
114483833,H2BE1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
114515514,RCC2-AS1,,0.89,0.077,,,,C0242379,Malignant neoplasm of lung,C04;C08,   Neoplasms;    Respiratory Tract Diseases,disease,Neoplastic Process,0.01,1.0,,2018.0,2018.0,ALL
115029024,DYT23,,,,,,,C0013421,Dystonia,C23;C10,"   Pathological Conditions, Signs and Symptoms;    Nervous System Diseases",phenotype,Sign or Symptom,0.01,1.0,,2014.0,2014.0,ALL
115072896,SLCO1B3-SLCO1B7,,0.839,0.077,,,,C0272178,Drug-induced neutropenia,C15,   Hemic and Lymphatic Diseases,disease,Disease or Syndrome,0.1,1.0,,2017.0,2017.0,ALL
115253418,COPDA1,,1.0,0.038,,,,C0024117,Chronic Obstructive Airway Disease,C08,   Respiratory Tract Diseases,disease,Disease or Syndrome,0.01,1.0,,2019.0,2019.0,ALL
115253422,DUS4L-BCAP29,,0.931,0.077,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.01,0.0,,2020.0,2020.0,ALL
115409980,NR4A1AS,,0.931,0.077,,,,C0009402,Colorectal Carcinoma,C06;C04,   Digestive System Diseases;    Neoplasms,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
115482683,H3P7,,0.686,0.538,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,0.5,,2018.0,2018.0,ALL
115482684,H3P9,,0.505,0.731,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,1995.0,2015.0,ALL
115482685,H3P13,,0.584,0.769,,,,C0033860,Psoriasis,C17,   Skin and Connective Tissue Diseases,disease,Disease or Syndrome,0.1,1.0,,2008.0,2019.0,ALL
115482690,H2BP5,,0.89,0.154,,,,C0003868,"Arthritis, Gouty",C16;C18;C05,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nutritional and Metabolic Diseases;    Musculoskeletal Diseases",disease,Disease or Syndrome,0.1,1.0,,2010.0,2013.0,ALL
115482693,H3P8,,0.544,0.808,,,,C0006826,Malignant Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2002.0,2019.0,ALL
115482694,H3P17,,0.674,0.615,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.05,1.0,,2002.0,2013.0,ALL
115482696,H3P23,,0.443,0.769,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.1,0.925,,1996.0,2019.0,ALL
115482697,H3P24,,0.686,0.577,,,,C0006142,Malignant neoplasm of breast,C04;C17,   Neoplasms;    Skin and Connective Tissue Diseases,disease,Neoplastic Process,0.02,1.0,,2012.0,2014.0,ALL
115482699,H3P28,,0.553,0.692,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.8,,2012.0,2020.0,ALL
115482700,H3P30,,0.736,0.346,,,,C0020179,Huntington Disease,C16;C10;F03,"   Congenital, Hereditary, and Neonatal Diseases and Abnormalities;    Nervous System Diseases;    Mental Disorders",disease,Disease or Syndrome,0.03,0.667,,2013.0,2018.0,ALL
115482704,H3P42,,0.641,0.577,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.04,1.0,,2003.0,2018.0,ALL
115482705,H3P45,,0.821,0.269,,,,C0001339,Acute pancreatitis,C06,   Digestive System Diseases,disease,Disease or Syndrome,0.01,1.0,,2018.0,2018.0,ALL
115482706,H3P47,,0.603,0.538,,,,C0020217,Hydatidiform Mole,C04;C13,   Neoplasms;    Female Urogenital Diseases and Pregnancy Complications,disease,Neoplastic Process,0.1,1.0,,2009.0,2019.0,ALL
115482708,H3P11,,0.711,0.385,,,,C3854222,Human immunodeficiency virus (HIV) II infection category B1,,,disease,Disease or Syndrome,0.1,0.941,,1991.0,2020.0,ALL
115482709,H3P19,,0.631,0.577,,,,C0019693,HIV Infections,C01;C20,   Infections;    Immune System Diseases,group,Disease or Syndrome,0.1,0.9,,1990.0,2019.0,ALL
115482710,H3P31,,0.821,0.231,,,,C0003850,Arteriosclerosis,C14,   Cardiovascular Diseases,disease,Disease or Syndrome,0.02,1.0,,2001.0,2010.0,ALL
115482712,H3P5,,0.656,0.538,,,,C0035309,Retinal Diseases,C11,   Eye Diseases,group,Disease or Syndrome,0.04,1.0,,2012.0,2019.0,ALL
115482713,H3P10,,0.35,0.846,,,,C0001418,Adenocarcinoma,C04,   Neoplasms,group,Neoplastic Process,0.1,0.897,,1995.0,2020.0,ALL
115482719,H3P22,,0.861,0.231,,,,C0398791,Nijmegen Breakage Syndrome,C18,   Nutritional and Metabolic Diseases,disease,Disease or Syndrome,0.02,0.5,,2014.0,2019.0,ALL
115482721,H3P29,,0.78,0.346,,,,C0001430,Adenoma,C04,   Neoplasms,group,Neoplastic Process,0.01,1.0,,2009.0,2009.0,ALL
115482722,H3P33,,0.736,0.346,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.05,1.0,,2006.0,2016.0,ALL
115482723,H3P40,,0.506,0.846,,,,C0027651,Neoplasms,C04,   Neoplasms,group,Neoplastic Process,0.1,1.0,,2009.0,2019.0,ALL
115561815,LNC-LBCS,,0.89,0.077,,,,C0376358,Malignant neoplasm of prostate,C04;C12,   Neoplasms;    Male Urogenital Diseases,disease,Neoplastic Process,0.01,1.0,,2019.0,2019.0,ALL
115804232,CEROX1,,,,,,,C0005890,Body Height,,,phenotype,Organism Attribute,0.1,1.0,,2019.0,2019.0,ALL
115891964,MIR223HG,,0.861,0.077,,,,C0023418,leukemia,C04,   Neoplasms,disease,Neoplastic Process,0.01,1.0,,2016.0,2016.0,ALL
